data_2l4s_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l4s _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 123.362 1.553 . . . . 2.49 111.175 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.65 178.77 5.36 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 112.515 -2.13 . . . . 1.24 110.509 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.0 t -106.32 110.95 33.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.762 -0.654 . . . . 2.16 110.52 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 110' ' ' THR . 33.6 t -77.66 108.45 10.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.751 -0.462 . . . . 1.65 109.751 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 1.038 ' HG2' ' HD3' ' A' ' 111' ' ' ARG . 0.3 OUTLIER -113.33 169.47 8.93 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.257 -0.577 . . . . 1.39 111.801 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -115.43 126.76 54.75 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.016 0.436 . . . . 4.11 111.719 -175.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.857 HG21 HE22 ' A' ' 14' ' ' GLN . 26.2 t -107.39 121.85 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.614 -0.721 . . . . 1.59 109.323 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -143.82 111.94 6.26 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.748 -0.464 . . . . 1.35 109.748 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.485 HG12 ' HB2' ' A' ' 65' ' ' PRO . 9.6 tp -139.18 148.79 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.568 -0.901 . . . . 1.33 108.568 -176.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 16.5 m-70 -79.36 115.8 19.22 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.981 -0.687 . . . . 0.7 109.411 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.848 ' HB2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -26.93 139.07 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 O-C-N 125.142 1.526 . . . . 4.39 112.715 178.402 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.1 tp -97.66 93.91 6.67 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 121.418 -0.802 . . . . 1.23 110.31 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -60.81 143.06 55.43 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.366 0.603 . . . . 4.63 112.183 -173.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.527 ' HB2' HD13 ' A' ' 28' ' ' ILE . 4.3 tp-100 -140.88 94.9 2.77 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.283 -0.871 . . . . 1.5 109.493 174.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.86 -82.49 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.042 -0.599 . . . . 1.33 112.506 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.513 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 18.2 mt-10 -118.4 -17.35 9.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.098 0.475 . . . . 2.33 110.561 -177.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.454 ' OD1' ' HB3' ' A' ' 23' ' ' GLN . 1.0 OUTLIER -112.85 -177.66 3.19 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.895 -0.593 . . . . 1.87 111.679 -169.162 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.848 HD13 ' HB2' ' A' ' 20' ' ' LYS . 2.1 pt? -126.98 138.25 53.23 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.764 -1.199 . . . . 2.8 107.764 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.3 mp -101.46 130.14 51.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.42 0.628 . . . . 1.45 110.4 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.449 HD11 HD11 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -96.08 125.47 40.64 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.088 -1.414 . . . . 1.87 108.652 172.051 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.424 ' O ' HG12 ' A' ' 60' ' ' VAL . . . -85.47 41.24 3.05 Favored Glycine 0 C--O 1.22 -0.745 0 C-N-CA 120.386 -0.911 . . . . 1.14 112.648 -175.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.619 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 42.5 p90 -157.07 154.67 29.86 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 122.752 0.421 . . . . 0.61 110.385 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.493 ' CB ' ' HB2' ' A' ' 59' ' ' ARG . 8.1 t -103.98 159.25 15.82 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.085 -1.45 . . . . 0.91 107.085 169.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -160.69 141.59 3.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 112.745 0.646 . . . . 1.24 112.745 -165.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.428 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -144.44 119.16 1.23 Allowed Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 110.089 -1.205 . . . . 0.78 110.089 157.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 1.049 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.92 118.14 1.27 Allowed Glycine 0 CA--C 1.492 -1.358 0 CA-C-O 118.555 -1.136 . . . . 1.66 111.621 171.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.722 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.69 143.77 8.58 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 117.483 -2.294 . . . . 0.95 113.796 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.3 pt -61.65 -19.31 20.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.104 -1.073 . . . . 1.15 108.104 149.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.828 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 0.4 OUTLIER -66.18 -35.15 79.71 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.749 -1.569 . . . . 0.72 109.97 174.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 . . . . . 0 C--N 1.339 0.143 0 CA-C-N 115.065 -0.971 . . . . 1.47 110.713 -178.013 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.449 ' C ' HD13 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.431 -1.696 0 N-CA-C 110.901 -0.88 . . . . 0.94 110.901 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 1.049 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -111.32 141.45 26.67 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 N-CA-C 107.297 -1.372 . . . . 1.27 107.297 176.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.655 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER -152.21 145.2 24.49 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 119.405 1.002 . . . . 1.91 110.99 -177.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.7 p -85.59 133.23 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-N 114.597 -1.183 . . . . 1.22 110.471 -171.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 37.7 m -100.09 -16.23 17.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.942 -1.026 . . . . 1.29 110.822 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.687 ' O ' HG22 ' A' ' 60' ' ' VAL . 72.2 mtt180 -149.04 -169.4 3.36 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.667 0.618 . . . . 2.63 112.667 175.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.687 HG22 ' O ' ' A' ' 59' ' ' ARG . 79.4 t -167.84 138.27 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 113.271 -1.786 . . . . 1.53 107.212 163.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.5 p -82.29 126.27 31.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.232 0.539 . . . . 2.38 110.88 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -57.19 112.24 1.31 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.429 -1.259 . . . . 1.85 110.841 171.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.0 -2.43 66.13 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.51 -0.852 . . . . 0.95 112.566 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.528 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -92.33 173.58 35.92 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 120.569 -0.824 . . . . 0.99 111.623 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.485 ' HB2' HG12 ' A' ' 18' ' ' ILE . 64.8 Cg_endo -70.7 -22.81 27.25 Favored 'Trans proline' 0 CA--C 1.504 -1.002 0 C-N-CA 122.732 2.288 . . . . 0.63 113.477 -165.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.537 ' HB1' ' HD1' ' A' ' 31' ' ' PHE . . . -66.84 -32.7 74.15 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.731 -1.122 . . . . 1.1 110.882 176.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -77.74 -30.08 51.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.236 0.541 . . . . 1.79 109.609 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.543 HD11 ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -68.98 -36.98 76.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.374 -0.83 . . . . 1.18 109.629 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.605 ' CB ' HG12 ' A' ' 16' ' ' VAL . . . -78.11 -25.34 47.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.746 -0.661 . . . . 1.07 110.838 176.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.89 43.62 1.9 Allowed Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.355 -0.926 . . . . 0.5 113.874 177.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.462 ' C ' HG21 ' A' ' 60' ' ' VAL . 14.1 tp -95.1 148.7 22.07 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.44 -0.948 . . . . 1.5 108.44 174.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.637 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 14.4 mt-30 -134.28 40.07 3.04 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 116.018 1.858 . . . . 1.53 116.018 -161.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.553 HG23 ' HA ' ' A' ' 59' ' ' ARG . 59.1 mt 69.85 -11.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 114.654 1.353 . . . . 1.43 114.654 162.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.37 43.72 0.33 Allowed Glycine 0 CA--C 1.508 -0.348 0 C-N-CA 120.163 -1.018 . . . . 0.37 111.846 -170.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.637 ' OD2' ' HB2' ' A' ' 72' ' ' GLN . 9.3 m-20 -119.61 141.27 49.45 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.047 -0.576 . . . . 0.89 111.831 -168.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.655 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -87.47 102.95 15.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.333 -0.849 . . . . 2.71 111.16 -175.352 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.531 HD11 ' CA ' ' A' ' 56' ' ' TYR . 5.1 mt -73.63 122.99 27.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 114.772 -1.104 . . . . 1.22 111.874 -177.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.808 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 2.2 mmt -93.32 -9.19 39.75 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.945 -1.025 . . . . 1.61 113.399 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.577 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -167.88 150.99 5.86 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.05 0.452 . . . . 0.88 112.196 -178.608 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.616 HG21 ' HB2' ' A' ' 93' ' ' ALA . 40.6 t -133.05 112.06 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 114.927 -1.033 . . . . 1.93 110.316 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.92 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 14.4 m120 57.4 27.85 14.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.727 -0.669 . . . . 1.8 112.613 174.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.84 -13.37 53.22 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 119.987 -1.101 . . . . 0.38 112.353 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.524 ' HB2' ' HE1' ' A' ' 85' ' ' MET . 74.1 m95 -80.68 170.16 16.68 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.875 -0.787 . . . . 0.91 108.875 176.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -115.47 112.88 22.92 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.098 0.475 . . . . 1.89 111.141 -172.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.649 ' HE2' HG11 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -106.28 100.88 10.39 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 122.43 1.11 . . . . 1.38 110.676 -177.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.9 p -137.22 -41.27 0.58 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.536 -1.665 . . . . 1.1 107.73 173.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.61 73.98 1.34 Allowed 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 112.777 -2.01 . . . . 2.15 108.31 174.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.722 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.2 t -135.57 140.76 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 108.89 -0.782 . . . . 1.68 108.89 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.655 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 70.1 p -55.77 148.75 15.89 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.08 0.467 . . . . 1.1 112.111 -177.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.828 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 21.8 t-160 -54.28 -42.94 70.59 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-O 121.616 0.722 . . . . 0.41 110.131 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.72 -30.38 66.9 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.188 -1.369 . . . . 1.67 110.445 -177.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.676 ' HG2' HG12 ' A' ' 88' ' ' VAL . 1.8 tp-100 -60.05 -47.62 85.12 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 122.039 0.923 . . . . 0.79 108.537 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.622 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -74.47 -40.95 61.54 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.433 -1.258 . . . . 1.06 110.444 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -66.22 -40.66 90.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.639 -0.71 . . . . 2.45 110.715 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.453 ' HD3' ' C ' ' A' ' 95' ' ' LYS . 1.2 tmtp? -64.33 -38.01 89.53 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 116.006 -0.543 . . . . 1.51 109.541 -177.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 9.9 mmm180 -64.83 -48.9 72.69 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.823 -0.626 . . . . 4.23 111.352 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.449 HD11 HD11 ' A' ' 29' ' ' LEU . 3.8 pp -79.25 -1.86 38.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.467 -0.333 . . . . 2.24 111.756 -176.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.56 ' HA ' HD22 ' A' ' 27' ' ' LEU . 3.3 m -115.84 23.55 12.18 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 122.114 0.959 . . . . 1.63 109.884 173.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.977 ' HE2' ' HA ' ' A' ' 99' ' ' LYS . 5.8 mmpt? -81.76 112.56 19.03 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.431 -0.804 . . . . 3.16 108.983 169.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.513 ' HD2' ' O ' ' A' ' 25' ' ' GLU . 35.6 ptt180 -71.26 19.06 0.06 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.652 -0.704 . . . . 4.79 111.023 -177.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.58 ' H ' ' C ' ' A' ' 99' ' ' LYS . 5.8 p -115.02 -22.96 9.29 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.32 -0.855 . . . . 2.83 109.948 -176.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -72.0 91.86 1.25 Allowed 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 122.13 0.967 . . . . 3.4 109.956 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.537 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 5.2 tp10 -52.5 -29.63 26.04 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.142 -1.845 . . . . 2.68 111.107 175.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 7.7 p -134.63 141.95 41.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.882 -0.784 . . . . 1.15 108.882 176.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.4 t -114.21 118.81 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 122.053 0.93 . . . . 1.13 112.168 -171.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.92 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.3 OUTLIER -101.08 126.16 47.75 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.584 -1.643 . . . . 2.28 111.942 -173.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.526 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 9.4 tt -134.75 129.11 34.14 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.316 -0.402 . . . . 1.68 109.999 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.808 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 24.5 tp -102.73 124.27 47.95 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 106.489 -1.671 . . . . 1.1 106.489 175.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.654 HG11 ' HG3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -127.47 145.22 35.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 119.147 -1.021 . . . . 1.39 111.648 -174.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.541 HG22 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -99.54 113.38 25.74 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.611 -0.836 . . . . 1.13 109.737 166.004 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 1.038 ' HD3' ' HG2' ' A' ' 14' ' ' GLN . 1.1 ptt180 -107.19 127.35 53.43 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.281 -1.327 . . . . 2.34 108.943 -174.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.57 ' N ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -99.53 -55.99 2.52 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.838 0.681 . . . . 1.97 112.838 -165.422 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.464 ' N ' ' HG2' ' A' ' 112' ' ' GLN . 1.4 t -159.93 19.13 0.16 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.181 -0.608 . . . . 2.0 111.037 -173.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 121.671 0.748 . . . . 2.0 109.271 178.317 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 N--CA 1.429 -1.52 0 CA-C-O 121.995 0.902 . . . . 2.49 110.651 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 111' ' ' ARG . . . -94.52 179.25 5.34 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.629 -1.623 . . . . 1.24 109.662 176.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 m -112.91 124.02 69.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.235 0.541 . . . . 2.16 110.523 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.584 HG22 HG23 ' A' ' 110' ' ' THR . 21.5 t -81.76 106.22 12.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.27 0.557 . . . . 1.65 110.025 -175.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.975 HE22 HG21 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -101.74 170.05 8.42 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.289 -0.869 . . . . 1.39 112.051 -177.235 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -115.02 139.83 49.54 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 116.112 -0.494 . . . . 4.11 111.359 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.975 HG21 HE22 ' A' ' 14' ' ' GLN . 12.4 t -128.86 126.46 64.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.868 -0.79 . . . . 1.59 108.868 173.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -142.09 121.52 13.21 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 122.11 -0.369 . . . . 1.35 110.188 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.525 HG12 ' HB2' ' A' ' 65' ' ' PRO . 10.9 tp -145.15 147.53 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 N-CA-C 108.973 -0.751 . . . . 1.33 108.973 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.72 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 13.5 m-70 -76.15 114.83 15.26 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.62 -0.511 . . . . 0.7 109.62 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.83 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -28.82 129.27 0.08 Allowed 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.437 1.086 . . . . 4.39 112.358 176.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.5 tp -99.88 89.94 4.25 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.469 0.652 . . . . 1.23 109.857 -173.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -77.58 143.49 38.28 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.185 -0.916 . . . . 4.63 112.213 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.53 94.17 3.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.844 -1.071 . . . . 1.5 108.142 175.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.31 -83.65 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.607 -0.806 . . . . 1.33 111.671 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -137.59 12.51 2.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.224 0.535 . . . . 2.33 110.724 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -115.93 135.73 53.71 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 108.584 -0.895 . . . . 1.87 108.584 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.502 HD21 ' HG3' ' A' ' 20' ' ' LYS . 9.6 mp -107.42 123.78 48.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.585 0.707 . . . . 2.8 110.959 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.419 ' O ' ' HE2' ' A' ' 20' ' ' LYS . 1.9 mp -98.15 129.47 48.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 114.933 -1.03 . . . . 1.45 110.06 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.469 HD23 ' OG1' ' A' ' 98' ' ' THR . 0.1 OUTLIER -89.81 -31.08 17.54 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.791 -0.641 . . . . 1.87 110.867 -176.603 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.847 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 86.55 9.92 74.44 Favored Glycine 0 C--O 1.224 -0.501 0 C-N-CA 120.591 -0.814 . . . . 1.14 112.559 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.614 ' HD2' ' HB1' ' A' ' 66' ' ' ALA . 47.0 p90 -150.28 149.53 30.27 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.72 0.295 . . . . 0.61 110.237 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.654 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -102.47 150.19 23.63 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.827 -0.805 . . . . 0.91 108.827 172.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.432 HG12 ' N ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -157.01 145.35 11.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 112.283 0.475 . . . . 1.24 112.283 -163.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.432 ' N ' HG12 ' A' ' 33' ' ' ILE . . . -142.1 119.0 1.37 Allowed Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 110.572 -1.011 . . . . 0.78 110.572 157.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.975 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -139.38 118.59 1.54 Allowed Glycine 0 CA--C 1.493 -1.328 0 CA-C-O 118.388 -1.229 . . . . 1.66 111.119 170.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -168.6 142.8 7.65 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 117.751 -2.166 . . . . 0.95 113.258 178.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.702 HG12 ' O ' ' A' ' 87' ' ' MET . 0.5 OUTLIER -65.71 -22.6 31.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 106.726 -1.583 . . . . 1.15 106.726 153.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.76 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 1.1 t70 -58.18 -36.72 73.48 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 112.839 -1.982 . . . . 0.72 109.222 169.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 . . . . . 0 CA--C 1.53 0.184 0 CA-C-N 115.165 -0.925 . . . . 1.47 110.488 -175.448 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.408 ' C ' HD12 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.44 -1.048 0 N-CA-C 109.984 -1.246 . . . . 0.94 109.984 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.975 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.7 mp -114.48 125.14 71.72 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.765 0 N-CA-C 108.225 -1.028 . . . . 1.27 108.225 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.939 ' HA ' HD13 ' A' ' 77' ' ' ILE . 0.8 OUTLIER -145.4 148.33 33.22 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 119.984 1.266 . . . . 1.91 112.261 -172.157 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.504 HG21 HD23 ' A' ' 71' ' ' LEU . 3.4 p -87.11 136.46 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-N 114.172 -1.376 . . . . 1.22 110.489 -173.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.3 m -106.33 -15.01 14.94 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.034 -0.984 . . . . 1.29 110.615 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.654 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 42.1 mtp180 -149.82 -167.16 2.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.024 0.75 . . . . 2.63 113.024 177.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 51.0 t -161.88 154.9 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 106.197 -1.779 . . . . 1.53 106.197 166.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.2 p -104.41 131.33 51.89 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.622 0.725 . . . . 2.38 111.552 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -63.42 107.57 1.14 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.464 -1.244 . . . . 1.85 111.281 175.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.74 -14.95 45.56 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 115.144 -0.935 . . . . 0.95 111.58 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.461 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -78.32 178.22 52.95 Favored Glycine 0 N--CA 1.438 -1.171 0 C-N-CA 120.514 -0.85 . . . . 0.99 111.451 177.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.847 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 97.4 Cg_endo -74.77 -27.15 10.73 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 122.379 2.053 . . . . 0.63 113.334 -168.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.614 ' HB1' ' HD2' ' A' ' 31' ' ' PHE . . . -66.11 -26.41 67.45 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.169 -0.923 . . . . 1.1 111.139 176.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -72.94 -31.45 64.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.805 0.812 . . . . 1.79 109.114 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.557 HD11 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -76.19 -39.8 35.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.908 -1.042 . . . . 1.18 110.631 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.627 ' CB ' HG12 ' A' ' 16' ' ' VAL . . . -77.85 -15.59 58.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.0 -0.545 . . . . 1.07 110.757 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.16 67.06 1.34 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.522 -0.847 . . . . 0.5 113.44 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.504 HD23 HG21 ' A' ' 57' ' ' VAL . 17.8 tp -110.1 151.99 26.55 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.763 -0.829 . . . . 1.5 108.763 175.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.495 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 9.7 mt-30 -123.06 28.98 6.94 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 115.701 1.741 . . . . 1.53 115.701 -164.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.588 HG23 ' HA ' ' A' ' 59' ' ' ARG . 75.5 mt 69.78 2.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-N 119.455 1.025 . . . . 1.43 113.308 167.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.89 48.36 0.19 Allowed Glycine 0 CA--C 1.51 -0.237 0 C-N-CA 119.528 -1.32 . . . . 0.37 112.77 -170.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.495 ' OD2' ' HB2' ' A' ' 72' ' ' GLN . 50.7 m-20 -120.83 145.92 47.1 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.376 -0.412 . . . . 0.89 110.852 -172.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.882 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 32.4 mmtt -97.23 105.48 17.63 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 121.35 0.595 . . . . 2.71 109.845 -174.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.981 HG13 HG21 ' A' ' 109' ' ' VAL . 2.7 mp -73.03 125.64 32.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.33 0.586 . . . . 1.22 112.139 -177.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.737 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 1.5 mmt -91.5 -18.37 24.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 113.504 -1.68 . . . . 1.61 111.769 177.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.744 ' HB2' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -171.88 157.62 4.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.972 0.415 . . . . 0.88 111.357 -175.212 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.812 HG23 ' HB3' ' A' ' 97' ' ' LEU . 6.5 p -145.45 120.84 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.859 -0.61 . . . . 1.93 110.576 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.793 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 19.6 m-80 54.88 29.81 12.72 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.503 -0.771 . . . . 1.8 112.264 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.35 -19.85 46.89 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.255 -0.974 . . . . 0.38 112.503 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.509 ' HB2' ' HE3' ' A' ' 85' ' ' MET . 39.9 m95 -86.21 120.68 27.84 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.678 -0.86 . . . . 0.91 108.678 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.744 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 6.6 p-10 -88.56 114.86 25.62 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 114.99 -1.005 . . . . 1.89 111.289 -172.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.668 ' HB3' HD11 ' A' ' 55' ' ' ILE . 12.0 mmt -107.32 103.24 12.55 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.847 -1.07 . . . . 1.38 110.965 -175.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.0 p -106.96 -20.77 13.22 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.801 -0.636 . . . . 1.1 110.075 172.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.702 ' O ' HG12 ' A' ' 37' ' ' ILE . 1.8 mtt -143.66 -42.96 0.28 Allowed 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.278 -0.874 . . . . 2.15 111.901 -172.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.811 ' O ' HD13 ' A' ' 55' ' ' ILE . 1.9 p -49.5 165.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 114.874 1.435 . . . . 1.68 114.874 -158.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 80.6 p -54.78 151.94 7.81 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.423 0.897 . . . . 1.1 113.423 -175.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.765 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 18.2 t-160 -59.38 -40.63 87.18 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.427 -0.806 . . . . 0.41 110.116 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.93 -32.17 73.24 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.292 -1.322 . . . . 1.67 109.779 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.76 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 4.1 tp-100 -61.6 -52.22 65.27 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.929 -0.767 . . . . 0.79 108.929 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.662 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -75.29 -34.78 61.34 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.15 -0.932 . . . . 1.06 110.69 -176.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.41 ' HA ' ' HG ' ' A' ' 97' ' ' LEU . 28.2 ttp180 -63.9 -36.58 84.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.118 0.485 . . . . 2.45 109.808 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.493 ' HD3' ' C ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -69.07 -36.04 77.18 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.809 -0.632 . . . . 1.51 109.823 178.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.76 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 20.8 mmt180 -75.87 -26.12 56.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.048 -0.524 . . . . 4.23 111.517 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.812 ' HB3' HG23 ' A' ' 80' ' ' VAL . 4.2 pp -88.47 -26.7 21.94 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 111.905 0.335 . . . . 2.24 111.905 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.574 ' HG1' HD11 ' A' ' 97' ' ' LEU . 67.1 m -148.72 109.77 4.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.642 0.734 . . . . 1.63 110.289 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.418 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 7.4 ptpp? -126.99 16.95 7.31 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.641 -1.163 . . . . 3.16 110.857 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.425 ' CA ' HD22 ' A' ' 27' ' ' LEU . 60.2 mtt180 66.69 6.03 4.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.965 -1.016 . . . . 4.79 111.829 175.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.464 ' C ' ' HG3' ' A' ' 102' ' ' GLU . 1.4 p -146.32 70.4 1.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.197 0.522 . . . . 2.83 111.002 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.629 ' HB2' ' HG3' ' A' ' 20' ' ' LYS . 14.9 mt-10 -142.26 151.86 42.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.716 -0.675 . . . . 3.4 110.733 -173.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -111.5 -29.15 7.88 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.765 -0.652 . . . . 2.68 110.62 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.72 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 6.3 p -150.6 146.23 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.99 -0.55 . . . . 1.15 109.58 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.648 HG23 ' HG2' ' A' ' 20' ' ' LYS . 31.5 t -126.63 119.91 54.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 CA-C-O 122.227 1.013 . . . . 1.13 112.361 -171.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.793 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 1.1 mpt_? -99.47 135.32 41.05 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.138 -1.846 . . . . 2.28 110.959 -175.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.573 HD13 HG12 ' A' ' 77' ' ' ILE . 19.9 tp -133.58 137.97 45.77 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.589 -0.278 . . . . 1.68 110.6 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.737 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 38.8 tp -116.05 120.52 39.34 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.259 -1.386 . . . . 1.1 107.259 172.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.981 HG21 HG13 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -130.18 152.2 37.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 121.22 0.533 . . . . 1.39 110.712 -174.352 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.584 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -96.58 116.06 28.46 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.502 -0.772 . . . . 1.13 109.377 168.763 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.411 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 7.8 ttt180 -100.58 135.56 41.83 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.187 -0.915 . . . . 2.34 110.547 -176.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.426 ' HG2' ' CD2' ' A' ' 114' ' ' LEU . 0.2 OUTLIER -117.26 -108.48 0.37 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.96 -0.564 . . . . 1.97 110.559 176.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.9 t -115.12 28.6 8.59 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.239 0.542 . . . . 2.0 111.074 -170.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 3.1 mm? . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 116.038 -0.528 . . . . 2.0 111.509 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.43 -1.443 0 CA-C-O 122.217 1.008 . . . . 2.49 111.589 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.42 177.09 5.29 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 113.581 -1.645 . . . . 1.24 109.337 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -123.66 127.92 74.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.231 0.538 . . . . 2.16 111.064 -177.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.596 HG21 HG22 ' A' ' 110' ' ' THR . 15.9 t -83.63 111.12 19.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.68 -0.489 . . . . 1.65 109.68 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 1.03 HE22 HG22 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -115.36 170.44 8.39 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.56 -0.746 . . . . 1.39 112.581 -174.224 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -123.9 113.86 19.06 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.65 -0.705 . . . . 4.11 110.544 -175.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 1.03 HG22 HE22 ' A' ' 14' ' ' GLN . 4.1 t -99.61 110.07 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 109.082 -0.71 . . . . 1.59 109.082 174.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -123.11 118.14 27.0 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.337 -0.616 . . . . 1.35 109.337 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.54 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 10.9 tp -138.12 145.73 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 108.673 -0.862 . . . . 1.33 108.673 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 11.0 m-70 -76.21 116.51 16.97 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.977 -0.689 . . . . 0.7 109.529 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -23.65 133.89 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 O-C-N 125.037 1.461 . . . . 4.39 112.31 176.345 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.3 tp -95.84 89.11 5.15 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.992 0.901 . . . . 1.23 110.379 -175.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -63.46 136.68 57.76 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.497 -1.229 . . . . 4.63 111.56 -173.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -132.99 94.47 3.37 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.983 -1.008 . . . . 1.5 108.437 175.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.01 -82.17 0.18 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.394 -0.908 . . . . 1.33 111.394 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -129.3 -5.93 4.83 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.148 0.499 . . . . 2.33 110.629 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 5.9 m-80 -94.0 169.95 9.9 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.711 -0.677 . . . . 1.87 109.889 -174.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 20' ' ' LYS . 2.0 pt? -128.39 126.74 41.25 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.698 -1.223 . . . . 2.8 107.698 171.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.42 138.15 23.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 109.441 -0.578 . . . . 1.45 109.441 -176.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.472 ' HG ' ' CE2' ' A' ' 31' ' ' PHE . 18.3 tp -91.5 -33.0 15.36 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.879 -1.055 . . . . 1.87 110.572 -171.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.676 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 89.87 -38.05 3.27 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.765 -0.731 . . . . 1.14 112.122 177.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.792 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 52.3 p90 -113.5 155.67 24.93 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 122.803 -0.233 . . . . 0.61 110.766 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.547 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 12.5 t -101.89 163.87 12.02 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.905 -1.146 . . . . 0.91 107.905 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.411 HD11 HD22 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -160.36 140.68 3.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 C-N-CA 120.981 -0.288 . . . . 1.24 111.352 -164.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -143.06 120.15 1.49 Allowed Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 110.547 -1.021 . . . . 0.78 110.547 158.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 1.05 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -138.35 119.09 1.72 Allowed Glycine 0 CA--C 1.492 -1.387 0 CA-C-O 118.784 -1.009 . . . . 1.66 110.771 171.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.944 ' HA3' ' HG2' ' A' ' 39' ' ' GLN . . . -156.13 118.52 0.85 Allowed Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 118.251 -1.928 . . . . 0.95 113.37 -170.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.591 HG12 ' C ' ' A' ' 88' ' ' VAL . 20.8 pt -64.4 -21.38 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 105.728 -1.953 . . . . 1.15 105.728 145.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.757 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 14.3 t70 -64.55 -36.42 84.17 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 112.672 -2.058 . . . . 0.72 110.782 171.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.944 ' HG2' ' HA3' ' A' ' 36' ' ' GLY . 25.4 mm-40 . . . . . 0 C--N 1.349 0.586 0 N-CA-C 112.486 0.55 . . . . 1.47 112.486 -171.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.509 ' C ' HD13 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.442 -0.931 0 N-CA-C 111.878 -0.489 . . . . 0.94 111.878 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 1.05 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.9 mp -118.76 147.13 22.46 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 N-CA-C 108.404 -0.961 . . . . 1.27 108.404 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.771 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -155.48 156.35 35.09 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 118.97 0.805 . . . . 1.91 111.215 178.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.598 HG21 HD22 ' A' ' 71' ' ' LEU . 8.1 p -92.38 132.84 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-N 115.481 -0.781 . . . . 1.22 110.92 -173.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.5 m -103.89 -17.14 15.14 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.497 -1.229 . . . . 1.29 111.467 -174.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.638 ' O ' HG21 ' A' ' 60' ' ' VAL . 46.2 mtt180 -143.63 -175.41 4.56 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.982 1.104 . . . . 2.63 113.982 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.638 HG21 ' O ' ' A' ' 59' ' ' ARG . 75.4 t -167.73 111.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 112.959 -1.928 . . . . 1.53 106.956 161.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.5 m -79.56 128.47 33.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.212 0.53 . . . . 2.38 110.655 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -50.43 116.59 1.97 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.679 -1.146 . . . . 1.85 111.47 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.29 -20.39 30.52 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.241 -0.89 . . . . 0.95 112.931 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.74 172.96 55.17 Favored Glycine 0 CA--C 1.502 -0.762 0 C-N-CA 120.345 -0.931 . . . . 0.99 111.771 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.676 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 73.2 Cg_endo -71.45 -19.2 28.92 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.43 2.087 . . . . 0.63 113.184 -169.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.792 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -67.2 -28.91 68.47 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.654 -1.157 . . . . 1.1 111.643 175.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -73.13 -34.85 66.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 122.013 0.911 . . . . 1.79 109.151 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.584 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -74.44 -38.06 45.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.526 -1.215 . . . . 1.18 110.221 -177.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.695 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -80.17 -20.26 45.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.361 -0.382 . . . . 1.07 110.699 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.13 65.24 1.12 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.37 -0.919 . . . . 0.5 114.017 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.598 HD22 HG21 ' A' ' 57' ' ' VAL . 18.1 tp -113.34 155.56 24.97 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.357 -0.609 . . . . 1.5 109.357 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.951 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 12.9 mt-30 -124.23 31.13 5.86 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 115.176 1.547 . . . . 1.53 115.176 -166.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.559 HG22 ' O ' ' A' ' 73' ' ' ILE . 42.6 mt 68.55 1.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 113.201 0.815 . . . . 1.43 113.201 166.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -172.53 51.02 0.17 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 119.757 -1.211 . . . . 0.37 112.355 -168.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.464 ' H ' ' CG1' ' A' ' 57' ' ' VAL . 32.1 m-20 -121.45 151.8 39.82 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.358 -0.608 . . . . 0.89 109.358 -175.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.771 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 64.0 mmtt -95.33 122.14 37.72 Favored 'General case' 0 C--O 1.208 -1.084 0 CA-C-O 121.302 0.572 . . . . 2.71 110.55 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.74 HG12 HD11 ' A' ' 107' ' ' LEU . 8.5 mt -88.11 125.36 41.53 Favored 'Isoleucine or valine' 0 C--O 1.258 1.525 0 CA-C-O 121.309 0.576 . . . . 1.22 112.006 -174.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.865 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -96.74 -16.4 20.89 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.202 -1.817 . . . . 1.61 111.649 -177.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.771 ' HB3' HD23 ' A' ' 108' ' ' LEU . 0.9 OUTLIER -168.99 150.51 4.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.729 0.299 . . . . 0.88 111.481 -175.33 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.898 ' HB ' ' HE2' ' A' ' 85' ' ' MET . 3.3 t -139.36 118.59 13.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.807 -0.633 . . . . 1.93 110.811 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.869 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 12.9 m120 52.87 31.05 10.06 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.01 -0.541 . . . . 1.8 111.856 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.11 -5.7 59.44 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.293 -0.956 . . . . 0.38 113.042 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.494 ' HE1' ' CZ ' ' A' ' 96' ' ' ARG . 54.7 m95 -87.03 175.21 8.22 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 110.091 -0.336 . . . . 0.91 110.091 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -115.88 113.2 23.01 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.751 -0.659 . . . . 1.89 109.938 -173.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.898 ' HE2' ' HB ' ' A' ' 80' ' ' VAL . 19.6 mmt -107.14 100.59 10.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.949 0.881 . . . . 1.38 110.152 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.4 p -132.98 -35.85 1.05 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.408 -1.269 . . . . 1.1 107.98 171.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.28 78.17 0.57 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 113.755 -1.566 . . . . 2.15 109.996 176.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.606 HG22 HE21 ' A' ' 92' ' ' GLN . 1.4 p -137.7 164.21 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 109.5 -0.555 . . . . 1.68 109.5 174.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.729 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 61.7 p -63.04 151.39 40.0 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.348 0.594 . . . . 1.1 112.312 -176.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.757 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 20.4 t-160 -61.86 -34.97 76.95 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-O 121.589 0.709 . . . . 0.41 109.882 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.65 -31.55 69.7 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 113.97 -1.468 . . . . 1.67 109.618 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.606 HE21 HG22 ' A' ' 88' ' ' VAL . 1.7 tp-100 -61.59 -52.21 65.34 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.681 -0.859 . . . . 0.79 108.681 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.636 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.08 -41.45 77.51 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.528 -1.214 . . . . 1.06 110.188 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.454 ' HA ' HD13 ' A' ' 97' ' ' LEU . 34.3 ttp180 -64.89 -41.32 95.71 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.157 -0.929 . . . . 2.45 111.201 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.623 ' HE3' ' HD3' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -68.33 -29.16 67.83 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 121.168 0.509 . . . . 1.51 109.848 -177.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 12.8 mmm180 -74.96 -48.77 22.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.023 -0.535 . . . . 4.23 112.276 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.636 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.5 pp -82.6 -4.81 58.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.021 0.439 . . . . 2.24 111.493 -178.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.2 m -138.12 78.7 1.7 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 122.137 0.97 . . . . 1.63 109.379 175.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.623 ' HD3' ' HE3' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -84.78 -79.18 0.23 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.006 -1.452 . . . . 3.16 110.347 -178.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 174.11 -26.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.158 -0.928 . . . . 4.79 111.059 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.7 m -160.89 40.05 0.16 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.955 0.407 . . . . 2.83 110.396 -171.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 46.1 mm-40 -58.86 156.61 11.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.838 -0.619 . . . . 3.4 110.714 175.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.548 ' HG3' HG11 ' A' ' 104' ' ' VAL . 6.0 pt-20 -84.74 -38.52 19.57 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.636 0.732 . . . . 2.68 109.474 172.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.548 HG11 ' HG3' ' A' ' 103' ' ' GLU . 3.1 p -156.8 156.04 4.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 114.745 -1.116 . . . . 1.15 108.332 -176.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.6 t -115.87 117.81 56.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 122.11 0.957 . . . . 1.13 111.643 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.869 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 1.4 mpt_? -100.55 123.73 45.15 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 113.422 -1.717 . . . . 2.28 111.626 -171.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.74 HD11 HG12 ' A' ' 77' ' ' ILE . 28.4 tp -132.12 125.77 32.1 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.88 -0.6 . . . . 1.68 110.756 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.865 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 31.8 tp -108.18 120.88 43.61 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 107.688 -1.227 . . . . 1.1 107.688 172.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.669 HG11 ' HG3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -132.95 150.33 32.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.398 0.618 . . . . 1.39 110.635 -172.212 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.596 HG22 HG21 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -95.76 116.58 29.09 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.295 -0.866 . . . . 1.13 109.37 168.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.771 ' HG3' HE22 ' A' ' 72' ' ' GLN . 27.4 ttt180 -110.58 139.75 45.54 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.474 -1.239 . . . . 2.34 110.755 -169.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.66 -90.87 0.57 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.531 0.567 . . . . 1.97 112.531 -176.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.8 m -151.33 41.75 0.73 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 112.539 0.57 . . . . 2.0 112.539 -164.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.951 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 0.3 OUTLIER . . . . . 0 C--N 1.32 -0.683 0 N-CA-C 109.516 -0.55 . . . . 2.0 109.516 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.433 -1.304 0 CA-C-O 122.167 0.984 . . . . 2.49 108.906 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.7 165.84 23.17 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.51 -1.677 . . . . 1.24 111.075 173.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.97 132.03 71.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 115.456 -0.793 . . . . 2.16 110.123 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.503 ' CG1' HD13 ' A' ' 108' ' ' LEU . 59.1 t -87.14 119.1 34.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.342 0.591 . . . . 1.65 111.497 -173.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 1.017 HE22 HG21 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -114.04 171.17 7.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.542 -0.753 . . . . 1.39 111.585 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.417 ' NE ' HD11 ' A' ' 108' ' ' LEU . 26.7 mmt180 -115.55 137.77 51.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.929 0.395 . . . . 4.11 111.959 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 1.017 HG21 HE22 ' A' ' 14' ' ' GLN . 23.0 t -123.55 123.4 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 109.234 -0.654 . . . . 1.59 109.234 171.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -144.78 123.87 12.85 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.831 -0.433 . . . . 1.35 109.831 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.527 HG12 ' HB2' ' A' ' 65' ' ' PRO . 10.2 tp -144.88 150.2 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 109.279 -0.638 . . . . 1.33 109.279 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 15.5 m-70 -81.0 109.93 16.06 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.231 -0.655 . . . . 0.7 109.231 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.401 ' N ' ' HD3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -27.49 135.22 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 O-C-N 125.228 1.58 . . . . 4.39 113.094 -177.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.1 tp -101.65 90.36 4.01 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.737 -0.468 . . . . 1.23 109.737 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 26.8 ptt180 -70.35 144.89 51.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.312 0.577 . . . . 4.63 111.191 -173.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.21 93.78 4.02 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.745 -0.835 . . . . 1.5 108.745 173.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.57 -88.85 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.625 -0.59 . . . . 1.33 111.625 -174.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.426 ' HB3' HH21 ' A' ' 100' ' ' ARG . 28.9 mm-40 -110.3 -5.45 15.25 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.261 -0.47 . . . . 2.33 111.524 -177.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -105.8 171.47 7.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.083 -0.508 . . . . 1.87 111.143 -173.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.803 HD13 ' HA ' ' A' ' 100' ' ' ARG . 7.8 mp -124.58 125.51 44.28 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.284 -1.006 . . . . 2.8 108.284 172.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.5 mm -97.18 116.22 38.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 109.291 -0.633 . . . . 1.45 109.291 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.446 ' CD2' ' H ' ' A' ' 29' ' ' LEU . 1.8 pt? -78.52 -32.6 48.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.684 -1.143 . . . . 1.87 110.707 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.63 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 82.51 17.08 69.4 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.487 -0.863 . . . . 1.14 113.027 173.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.631 ' HD2' ' HB3' ' A' ' 66' ' ' ALA . 48.1 p90 -154.24 161.49 41.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.733 0.267 . . . . 0.61 110.691 173.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.594 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 11.6 t -106.11 158.68 16.64 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.219 -1.03 . . . . 0.91 108.219 173.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -160.33 138.8 2.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 112.521 0.563 . . . . 1.24 112.521 -164.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.416 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -139.26 118.24 1.5 Allowed Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 119.679 -1.248 . . . . 0.78 110.283 156.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 1.065 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -140.26 117.42 1.29 Allowed Glycine 0 CA--C 1.492 -1.365 0 CA-C-O 118.925 -0.931 . . . . 1.66 111.657 170.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.657 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.01 143.51 8.35 Favored Glycine 0 C--N 1.3 -1.47 0 C-N-CA 118.364 -1.874 . . . . 0.95 112.563 174.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.41 HG12 ' C ' ' A' ' 88' ' ' VAL . 9.8 pt -62.14 -22.26 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 107.797 -1.186 . . . . 1.15 107.797 152.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.697 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 1.1 t70 -56.46 -47.7 78.61 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.473 -1.694 . . . . 0.72 110.345 171.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 . . . . . 0 C--O 1.231 0.123 0 CA-C-N 114.866 -1.061 . . . . 1.47 111.248 -174.041 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 86' ' ' THR . . . . . . . . 0 N--CA 1.446 -0.691 0 N-CA-C 111.295 -0.722 . . . . 0.94 111.295 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 1.065 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -110.68 137.4 43.26 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.166 0 N-CA-C 106.666 -1.605 . . . . 1.27 106.666 170.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.637 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -152.2 147.12 26.03 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 119.655 1.116 . . . . 1.91 111.215 -176.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.552 HG22 HD22 ' A' ' 71' ' ' LEU . 7.7 p -87.15 139.65 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 114.728 -1.124 . . . . 1.22 110.05 -172.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.9 m -110.88 -14.21 14.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.181 -0.918 . . . . 1.29 111.107 -174.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.594 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 37.6 mtt180 -146.86 -167.56 2.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.234 0.827 . . . . 2.63 113.234 175.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 63.9 t -161.58 148.66 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 112.413 -2.176 . . . . 1.53 106.44 162.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.4 p -91.82 137.33 32.45 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.06 0.457 . . . . 2.38 110.654 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -62.94 109.08 1.34 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.769 -1.105 . . . . 1.85 111.367 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.26 -10.89 67.49 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.484 -0.865 . . . . 0.95 111.903 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.472 ' O ' HD12 ' A' ' 68' ' ' ILE . . . -75.47 173.29 53.26 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 120.766 -0.731 . . . . 0.99 111.525 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.63 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 73.2 Cg_endo -72.25 -24.63 19.64 Favored 'Trans proline' 0 C--N 1.32 -0.935 0 C-N-CA 122.842 2.361 . . . . 0.63 113.252 -166.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.631 ' HB3' ' HD2' ' A' ' 31' ' ' PHE . . . -64.14 -31.38 72.55 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.717 -1.129 . . . . 1.1 111.283 176.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -74.49 -36.35 63.25 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.517 0.675 . . . . 1.79 109.189 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.568 ' N ' HD13 ' A' ' 68' ' ' ILE . 1.4 mp -64.79 -42.44 94.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.673 -1.149 . . . . 1.18 110.104 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.609 ' CB ' HG12 ' A' ' 16' ' ' VAL . . . -73.0 -24.4 60.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 1.07 110.543 175.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.66 58.3 1.06 Allowed Glycine 0 C--O 1.226 -0.354 0 C-N-CA 120.509 -0.853 . . . . 0.5 113.722 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.552 HD22 HG22 ' A' ' 57' ' ' VAL . 14.8 tp -102.77 154.25 19.36 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.876 -0.787 . . . . 1.5 108.876 175.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.546 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 6.5 mt-30 -129.33 34.19 4.42 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 115.604 1.705 . . . . 1.53 115.604 -166.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 73' ' ' ILE . 59.8 mt 69.2 0.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 N-CA-C 113.34 0.867 . . . . 1.43 113.34 165.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -174.18 55.68 0.14 Allowed Glycine 0 C--N 1.33 0.22 0 C-N-CA 119.984 -1.103 . . . . 0.37 112.914 -169.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.461 ' HB2' HG13 ' A' ' 57' ' ' VAL . 31.7 m-20 -122.72 142.3 50.85 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.644 -0.278 . . . . 0.89 111.524 -173.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.637 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 1.4 mptm? -83.31 102.8 12.22 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-O 120.983 0.421 . . . . 2.71 111.062 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.573 ' HB ' HG21 ' A' ' 55' ' ' ILE . 6.9 mt -76.56 125.85 36.69 Favored 'Isoleucine or valine' 0 C--O 1.254 1.337 0 C-N-CA 123.617 0.767 . . . . 1.22 111.594 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.793 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 9.1 mmt -90.52 -27.84 18.92 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.195 -1.366 . . . . 1.61 112.046 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.558 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 1.0 OUTLIER -159.52 150.6 19.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.858 0.361 . . . . 0.88 111.448 -171.523 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.66 HG11 ' SD ' ' A' ' 85' ' ' MET . 11.2 p -137.05 126.49 37.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.868 -0.605 . . . . 1.93 110.474 174.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.675 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 4.3 t-20 57.99 22.82 9.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.154 -0.93 . . . . 1.8 112.171 170.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.92 -5.52 46.69 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 119.683 -1.246 . . . . 0.38 113.316 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -92.75 156.85 16.76 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 109.471 -0.566 . . . . 0.91 109.471 175.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -111.94 99.17 7.89 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.075 -0.511 . . . . 1.89 110.682 -175.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.885 ' HB2' HD12 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -111.0 100.41 9.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.642 0.734 . . . . 1.38 112.091 -178.598 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.507 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 14.6 p -103.23 -35.62 8.38 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.867 -1.16 . . . . 1.1 107.867 165.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.07 76.6 1.55 Allowed 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.415 -1.72 . . . . 2.15 109.187 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.657 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -138.22 157.28 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 108.724 -0.843 . . . . 1.68 108.724 175.247 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.639 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 81.1 p -62.7 154.59 28.95 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 112.995 0.739 . . . . 1.1 112.995 -177.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.797 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 21.8 t-160 -58.69 -38.69 78.8 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-N 115.289 -0.868 . . . . 0.41 110.464 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.89 -30.95 67.45 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.169 -1.378 . . . . 1.67 109.732 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.533 ' HB3' HG12 ' A' ' 88' ' ' VAL . 1.6 tp-100 -63.82 -46.58 84.45 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.672 0.749 . . . . 0.79 109.265 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.613 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . -74.3 -36.17 63.72 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.025 -0.989 . . . . 1.06 110.756 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -67.23 -41.19 86.13 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.232 0.539 . . . . 2.45 110.514 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -68.1 -34.79 77.05 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.291 -0.868 . . . . 1.51 109.516 -177.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -75.46 -33.43 60.85 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.709 -0.678 . . . . 4.23 111.335 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.589 HD12 ' CZ ' ' A' ' 31' ' ' PHE . 3.1 tt -54.99 -61.04 2.57 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.385 -1.28 . . . . 2.24 111.861 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.507 HG21 HD21 ' A' ' 97' ' ' LEU . 12.6 p -110.36 -78.84 0.59 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.485 -0.486 . . . . 1.63 112.124 -176.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.491 ' HG2' ' HG ' ' A' ' 101' ' ' SER . 19.2 ttpt 70.05 -2.65 2.0 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.806 0.812 . . . . 3.16 112.185 176.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.803 ' HA ' HD13 ' A' ' 27' ' ' LEU . 78.4 mtp180 71.69 23.23 3.77 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.168 -0.924 . . . . 4.79 112.515 171.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.491 ' HG ' ' HG2' ' A' ' 99' ' ' LYS . 4.9 p -154.94 29.04 0.42 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.92 0.711 . . . . 2.83 112.92 -174.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -97.98 166.2 11.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.971 0.415 . . . . 3.4 111.731 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.505 ' HG3' HG11 ' A' ' 104' ' ' VAL . 18.7 pt-20 -114.05 -28.61 7.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.592 0.711 . . . . 2.68 110.159 177.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 3.9 p -152.92 143.05 14.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 107.756 -1.202 . . . . 1.15 107.756 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.6 t -115.2 117.5 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-O 122.238 1.018 . . . . 1.13 111.817 -170.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.675 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 1.3 mpt_? -99.82 129.02 45.88 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 113.036 -1.893 . . . . 2.28 111.118 -173.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.506 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 19.7 tp -133.31 129.61 37.77 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.87 -0.604 . . . . 1.68 109.931 177.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.793 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 22.6 tp -106.04 113.61 27.25 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 107.389 -1.337 . . . . 1.1 107.389 173.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.633 HG11 ' HG3' ' A' ' 14' ' ' GLN . 0.5 OUTLIER -121.9 143.96 32.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 C-N-CA 119.998 -0.681 . . . . 1.39 110.523 -173.092 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.493 HG23 HG22 ' A' ' 13' ' ' VAL . 1.3 m -96.77 120.31 36.87 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.313 -0.858 . . . . 1.13 110.623 173.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.767 ' HD2' ' HG2' ' A' ' 14' ' ' GLN . 7.7 ttt180 -90.74 153.41 20.28 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.57 -1.195 . . . . 2.34 109.794 -176.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.429 ' N ' ' CD ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -145.98 -60.82 0.32 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.134 0.791 . . . . 1.97 113.134 -168.299 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.9 t -157.77 10.87 0.19 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.89 0.376 . . . . 2.0 111.727 -174.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 3.1 mm? . . . . . 0 C--N 1.325 -0.49 0 O-C-N 122.13 -0.356 . . . . 2.0 111.44 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.2 p . . . . . 0 N--CA 1.429 -1.499 0 CA-C-O 122.057 0.932 . . . . 2.49 110.447 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -102.16 165.23 11.26 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.69 -1.595 . . . . 1.24 109.359 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.9 m -117.61 136.8 53.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 116.131 -0.486 . . . . 2.16 109.913 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.683 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 3.1 m -88.16 120.65 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 122.311 1.053 . . . . 1.65 110.878 -177.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.935 HE22 HG21 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -97.51 170.99 8.66 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 113.939 -1.482 . . . . 1.39 110.545 178.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -115.9 116.55 28.17 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.064 0.394 . . . . 4.11 112.064 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.935 HG21 HE22 ' A' ' 14' ' ' GLN . 3.9 t -104.58 118.19 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 109.352 -0.61 . . . . 1.59 109.352 173.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -132.3 115.75 16.02 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.335 -0.848 . . . . 1.35 109.117 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.616 ' HB ' ' HB1' ' A' ' 69' ' ' ALA . 9.3 tp -144.58 152.37 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 109.002 -0.74 . . . . 1.33 109.002 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 10.3 m-70 -79.99 114.32 18.82 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.621 -0.881 . . . . 0.7 108.621 174.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.992 ' HB2' HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -25.33 139.25 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.906 1.379 . . . . 4.39 113.335 177.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.588 HD21 ' HD3' ' A' ' 65' ' ' PRO . 32.3 tp -98.91 91.48 5.07 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 119.177 -1.009 . . . . 1.23 109.451 -177.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.563 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 28.7 ptt180 -76.24 135.91 39.68 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.617 0.722 . . . . 4.63 111.316 -173.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.535 ' HB2' HD11 ' A' ' 28' ' ' ILE . 4.8 tp-100 -119.36 94.88 4.57 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.04 -0.982 . . . . 1.5 108.422 176.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.53 -80.47 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.729 -0.748 . . . . 1.33 111.318 -173.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -134.9 10.95 3.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.003 0.43 . . . . 2.33 110.567 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.563 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 11.5 m-80 -110.35 173.89 6.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.963 -0.562 . . . . 1.87 110.625 -176.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.992 HD11 ' HB2' ' A' ' 20' ' ' LYS . 7.3 tp -127.11 123.75 37.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.378 0.608 . . . . 2.8 110.061 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.535 HD11 ' HB2' ' A' ' 23' ' ' GLN . 1.7 mp -98.81 132.51 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.227 -0.897 . . . . 1.45 108.955 175.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.647 HD12 HD22 ' A' ' 97' ' ' LEU . 0.6 OUTLIER -84.09 -42.74 15.78 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 114.657 -1.156 . . . . 1.87 109.964 -174.653 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.519 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 92.57 13.49 56.89 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 115.099 -0.955 . . . . 1.14 111.479 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 24.4 p90 -155.33 172.66 17.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.517 -0.179 . . . . 0.61 110.517 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.919 ' HB3' ' O ' ' A' ' 58' ' ' THR . 5.6 t -112.81 170.79 7.94 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.578 -0.897 . . . . 0.91 108.578 169.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.562 HG12 ' HE2' ' A' ' 90' ' ' HIS . 5.2 tt -148.36 136.4 14.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 120.448 -0.501 . . . . 1.24 112.138 -167.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -103.58 170.73 19.55 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.869 -0.892 . . . . 0.78 110.869 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.667 ' C ' HE22 ' A' ' 39' ' ' GLN . . . -103.97 166.13 15.5 Favored Glycine 0 N--CA 1.418 -2.52 0 N-CA-C 117.828 1.891 . . . . 1.66 117.828 -163.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.707 ' N ' HE22 ' A' ' 39' ' ' GLN . . . -86.37 -143.24 7.29 Favored Glycine 0 N--CA 1.417 -2.623 0 CA-C-N 110.073 -3.064 . . . . 0.95 113.392 -173.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.64 HD12 ' O ' ' A' ' 87' ' ' MET . 10.6 pt -83.52 -4.77 8.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.02 -0.59 . . . . 1.15 112.213 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.959 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 11.3 p-10 -70.91 -32.43 69.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.852 0.358 . . . . 0.72 110.511 -175.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.707 HE22 ' N ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER . . . . . 0 CA--C 1.519 -0.221 0 N-CA-C 108.752 -0.833 . . . . 1.47 108.752 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.6 0 N-CA-C 107.896 -2.082 . . . . 0.94 107.896 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.661 HG23 HD13 ' A' ' 77' ' ' ILE . 2.2 mp -93.74 119.43 41.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 119.89 1.845 . . . . 1.27 108.943 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.803 ' HA ' HD11 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -151.78 131.26 12.98 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.188 0.994 . . . . 1.91 110.122 -170.584 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.931 HG21 HD23 ' A' ' 71' ' ' LEU . 1.2 t -62.05 139.93 20.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 113.594 -1.639 . . . . 1.22 112.22 -173.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.919 ' O ' ' HB3' ' A' ' 32' ' ' SER . 6.4 m -129.28 64.17 1.48 Allowed 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.613 -1.176 . . . . 1.29 109.216 173.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.63 ' C ' ' HA ' ' A' ' 73' ' ' ILE . 15.4 mtt180 148.97 -171.22 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 125.391 1.476 . . . . 2.63 111.475 163.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 61.9 t -161.13 130.42 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 113.028 -1.897 . . . . 1.53 106.635 163.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.8 m -88.43 123.57 33.1 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.154 0.502 . . . . 2.38 109.991 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.475 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 77.3 mt-10 -52.1 118.54 3.56 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.935 -1.03 . . . . 1.85 111.876 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.79 -3.02 60.55 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.203 -0.908 . . . . 0.95 111.907 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.42 172.2 39.2 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.613 -0.803 . . . . 0.99 111.503 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.588 ' HD3' HD21 ' A' ' 21' ' ' LEU . 92.2 Cg_endo -74.1 -24.69 14.6 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 122.962 2.441 . . . . 0.63 113.408 -168.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.554 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -67.51 -23.91 65.51 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.05 -0.977 . . . . 1.1 110.928 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.475 ' OE1' ' HA ' ' A' ' 62' ' ' GLU . 28.2 tt0 -75.7 -36.77 59.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.771 0.796 . . . . 1.79 108.935 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.667 ' N ' HD13 ' A' ' 68' ' ' ILE . 1.5 mp -73.35 -42.14 57.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.145 -1.389 . . . . 1.18 110.351 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.683 ' CB ' HG11 ' A' ' 16' ' ' VAL . . . -71.23 -21.32 62.14 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.995 -0.548 . . . . 1.07 111.026 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.46 54.3 1.09 Allowed Glycine 0 C--O 1.225 -0.437 0 C-N-CA 120.037 -1.078 . . . . 0.5 114.174 174.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.931 HD23 HG21 ' A' ' 57' ' ' VAL . 6.5 tp -97.25 161.34 13.85 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.269 -0.641 . . . . 1.5 109.269 174.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.575 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 4.7 pt20 -131.47 29.57 4.54 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 115.071 1.508 . . . . 1.53 115.071 -168.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.63 ' HA ' ' C ' ' A' ' 59' ' ' ARG . 2.3 mp 75.3 -6.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-O 120.975 0.417 . . . . 1.43 111.349 173.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -164.82 66.32 0.22 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.851 -0.69 . . . . 0.37 111.628 -169.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.458 ' HB3' ' CG2' ' A' ' 109' ' ' VAL . 3.8 m-20 -118.8 135.88 54.29 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 115.613 -0.293 . . . . 0.89 110.966 -169.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.5 mmtt -95.49 102.95 14.8 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 121.054 0.454 . . . . 2.71 109.981 -174.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.803 HD11 ' HA ' ' A' ' 56' ' ' TYR . 2.9 mp -72.24 118.04 16.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 112.473 0.545 . . . . 1.22 112.473 -171.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.971 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 1.3 mmt -93.61 -10.48 34.49 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.088 -0.96 . . . . 1.61 112.869 177.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.615 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -172.23 154.01 3.2 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.329 0.492 . . . . 0.88 112.329 -178.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.494 ' N ' ' HG3' ' A' ' 79' ' ' GLN . 87.8 t -133.08 105.59 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.68 -0.691 . . . . 1.93 110.731 177.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.723 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 6.3 m120 55.13 33.22 19.98 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.969 0.729 . . . . 1.8 112.969 176.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.48 -12.26 50.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 119.77 -1.205 . . . . 0.38 112.202 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.441 ' NE1' ' HD2' ' A' ' 96' ' ' ARG . 90.2 m95 -75.92 162.69 27.9 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.875 -0.787 . . . . 0.91 108.875 171.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -116.54 115.14 25.2 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.406 -0.361 . . . . 1.89 110.466 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.4 mmt -106.89 101.4 10.84 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.567 0.699 . . . . 1.38 110.92 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.05 91.69 2.71 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.05 -0.977 . . . . 1.1 109.384 170.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.64 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER 48.88 65.14 1.45 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.711 -1.131 . . . . 2.15 110.332 -173.803 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.668 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 6.0 p -108.67 178.35 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 107.434 -1.321 . . . . 1.68 107.434 170.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.959 ' HB ' ' HB3' ' A' ' 38' ' ' ASP . 49.2 p -66.27 147.89 52.66 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 119.093 0.86 . . . . 1.1 111.601 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.574 ' CG ' ' HA2' ' A' ' 35' ' ' GLY . 20.7 t-160 -54.68 -38.46 67.01 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-O 122.121 0.962 . . . . 0.41 108.827 174.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.47 -33.04 74.81 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 113.109 -1.86 . . . . 1.67 109.865 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.746 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 3.7 tp-100 -59.45 -52.96 63.37 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 109.207 -0.664 . . . . 0.79 109.207 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.555 ' HB1' HG12 ' A' ' 55' ' ' ILE . . . -74.44 -35.73 63.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.233 -0.894 . . . . 1.06 110.375 -175.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -61.06 -44.2 97.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.936 -0.574 . . . . 2.45 110.356 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.628 ' HE3' ' O ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -71.2 -46.54 61.01 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.847 -0.615 . . . . 1.51 109.439 -176.51 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.746 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 29.4 mmt180 -65.6 -25.33 67.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.035 -0.53 . . . . 4.23 110.672 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.647 HD22 HD12 ' A' ' 29' ' ' LEU . 17.0 tp -68.45 -61.04 2.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.06 -0.518 . . . . 2.24 111.603 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.85 ' HA ' HD21 ' A' ' 27' ' ' LEU . 2.5 m -69.44 -32.64 71.72 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.256 -0.646 . . . . 1.63 109.256 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER 61.36 -105.72 0.21 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.713 -1.13 . . . . 3.16 110.87 168.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.453 ' H ' ' HB3' ' A' ' 99' ' ' LYS . 59.9 mtm180 -143.99 14.49 1.69 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.813 -1.18 . . . . 4.79 107.813 172.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.5 m 73.57 42.03 0.42 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.61 -1.177 . . . . 2.83 111.015 -173.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -57.07 154.17 10.29 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.032 -0.531 . . . . 3.4 109.793 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.589 ' HA ' ' HZ1' ' A' ' 20' ' ' LYS . 4.0 pt-20 -58.99 -25.18 63.39 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.87 1.063 . . . . 2.68 113.87 -164.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 7.2 p -146.38 151.91 14.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 120.758 -0.377 . . . . 1.15 110.298 -175.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 51.8 t -133.31 118.37 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.016 0 CA-C-O 122.344 1.069 . . . . 1.13 112.266 -169.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.723 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -100.98 130.53 46.99 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 113.023 -1.899 . . . . 2.28 110.309 -177.01 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.655 HD12 HG12 ' A' ' 77' ' ' ILE . 34.3 tp -131.84 131.79 43.14 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.574 -0.528 . . . . 1.68 109.574 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.971 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 15.3 tp -105.46 129.31 53.79 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 105.412 -2.07 . . . . 1.1 105.412 172.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.681 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -140.97 146.5 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 C-N-CA 119.916 -0.714 . . . . 1.39 110.267 -173.596 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.683 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -92.36 125.73 37.14 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.566 0.698 . . . . 1.13 111.077 172.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.559 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 34.6 ttt180 -111.45 146.81 36.56 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.224 -1.353 . . . . 2.34 110.958 -172.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.5 -105.66 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.637 -0.71 . . . . 1.97 111.232 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.7 t -136.15 36.34 2.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.2 0.524 . . . . 2.0 111.708 -171.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.558 ' HB2' ' HG3' ' A' ' 72' ' ' GLN . 2.9 mt . . . . . 0 C--N 1.319 -0.734 0 CA-C-O 121.41 0.624 . . . . 2.0 110.372 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.431 -1.407 0 CA-C-O 122.462 1.125 . . . . 2.49 108.79 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 111' ' ' ARG . . . -65.73 174.08 2.52 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.09 -1.868 . . . . 1.24 111.716 176.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.42 119.98 58.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.882 -1.053 . . . . 2.16 110.041 -175.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.529 HG23 HG23 ' A' ' 110' ' ' THR . 94.0 t -76.29 106.64 6.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 122.035 0.921 . . . . 1.65 111.532 -175.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.642 ' NE2' HG11 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -100.27 138.15 37.73 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.642 -1.617 . . . . 1.39 110.66 177.381 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.569 ' HG2' ' HA ' ' A' ' 108' ' ' LEU . 3.3 tmm_? -124.7 121.1 33.72 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 120.869 -1.144 . . . . 4.11 109.914 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.874 ' HB ' ' HB1' ' A' ' 69' ' ' ALA . 4.1 m -113.38 155.64 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 119.626 -0.83 . . . . 1.59 110.199 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -144.63 126.75 15.59 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.332 -0.849 . . . . 1.35 109.145 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.538 HG12 ' HB2' ' A' ' 65' ' ' PRO . 7.8 tp -146.07 143.35 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 C-N-CA 119.728 -0.789 . . . . 1.33 109.58 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.9 m-70 -72.6 112.11 8.37 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.735 -0.666 . . . . 0.7 109.455 -176.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.847 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -31.58 135.69 0.06 Allowed 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.329 1.018 . . . . 4.39 113.331 178.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.0 tp -100.71 98.61 9.13 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.197 0.523 . . . . 1.23 110.509 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -71.4 142.48 50.3 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.653 -0.703 . . . . 4.63 111.124 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.486 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -135.0 95.07 3.24 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.525 -0.762 . . . . 1.5 109.398 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.27 -81.85 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.362 -0.923 . . . . 1.33 112.14 -177.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -138.09 12.0 2.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.043 0.449 . . . . 2.33 111.357 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.486 ' OD1' ' HB3' ' A' ' 23' ' ' GLN . 1.5 p30 -127.05 171.06 11.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.063 -0.517 . . . . 1.87 110.715 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.46 HD22 ' HD3' ' A' ' 20' ' ' LYS . 10.3 mp -122.09 123.81 42.44 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.988 0.423 . . . . 2.8 110.619 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.436 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.7 mp -99.13 135.6 33.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.959 -0.564 . . . . 1.45 110.003 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.766 HD22 HD23 ' A' ' 97' ' ' LEU . 9.6 mt -86.8 -35.19 19.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.36 -0.837 . . . . 1.87 110.717 -174.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.863 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 89.87 10.48 64.76 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 115.321 -0.854 . . . . 1.14 110.967 -172.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.772 ' HD2' ' HB1' ' A' ' 66' ' ' ALA . 25.7 p90 -156.84 160.35 39.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 122.342 0.257 . . . . 0.61 110.793 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.521 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 22.1 t -104.1 160.7 14.63 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.77 -1.196 . . . . 0.91 107.77 170.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -161.19 138.99 2.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 120.253 -0.579 . . . . 1.24 112.561 -165.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -142.53 117.89 1.2 Allowed Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 110.431 -1.067 . . . . 0.78 110.431 156.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 1.06 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -140.15 117.28 1.28 Allowed Glycine 0 CA--C 1.49 -1.524 0 CA-C-O 118.927 -0.929 . . . . 1.66 111.518 171.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.697 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -165.41 144.46 9.29 Favored Glycine 0 C--N 1.3 -1.46 0 C-N-CA 118.17 -1.966 . . . . 0.95 112.77 175.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.51 HG22 ' HA ' ' A' ' 87' ' ' MET . 8.8 pt -61.23 -20.64 22.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 107.577 -1.268 . . . . 1.15 107.577 153.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.655 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 3.8 t70 -61.33 -37.87 84.84 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.239 -1.801 . . . . 0.72 110.747 174.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 . . . . . 0 CA--C 1.534 0.354 0 CA-C-N 115.369 -0.832 . . . . 1.47 112.658 -169.079 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.624 ' HA2' ' O ' ' A' ' 86' ' ' THR . . . . . . . . 0 N--CA 1.441 -1.016 0 N-CA-C 110.895 -0.882 . . . . 0.94 110.895 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 1.06 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -106.53 146.44 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 106.522 -1.658 . . . . 1.27 106.522 169.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.658 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -153.51 141.5 20.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 119.613 1.097 . . . . 1.91 111.072 178.706 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.513 HG22 HD21 ' A' ' 71' ' ' LEU . 2.5 p -81.5 132.39 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 CA-C-N 114.392 -1.276 . . . . 1.22 109.374 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.8 m -100.18 -18.52 16.86 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.075 -0.966 . . . . 1.29 110.294 -173.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.689 ' O ' HG22 ' A' ' 60' ' ' VAL . 50.5 mtt180 -146.34 -168.07 2.91 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.333 0.587 . . . . 2.63 112.022 174.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 59' ' ' ARG . 75.4 t -166.33 146.75 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 113.003 -1.908 . . . . 1.53 106.218 165.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.4 p -95.47 133.32 39.58 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.359 0.6 . . . . 2.38 111.519 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -64.83 115.03 4.9 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.456 -1.247 . . . . 1.85 110.138 171.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.88 -16.81 59.74 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 114.983 -1.008 . . . . 0.95 112.171 -177.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.444 ' O ' HD12 ' A' ' 68' ' ' ILE . . . -77.25 172.16 55.13 Favored Glycine 0 CA--C 1.502 -0.755 0 C-N-CA 120.588 -0.815 . . . . 0.99 111.551 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.863 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 60.0 Cg_endo -73.27 -28.1 12.85 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.273 1.982 . . . . 0.63 113.214 -166.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.772 ' HB1' ' HD2' ' A' ' 31' ' ' PHE . . . -58.75 -32.97 69.74 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.269 -0.878 . . . . 1.1 111.922 172.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -77.61 -28.94 51.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.558 0.694 . . . . 1.79 109.648 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.535 ' N ' HD13 ' A' ' 68' ' ' ILE . 1.4 mp -71.28 -41.15 74.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.199 -0.909 . . . . 1.18 108.888 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.874 ' HB1' ' HB ' ' A' ' 16' ' ' VAL . . . -69.54 -31.2 69.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.249 -0.887 . . . . 1.07 110.055 175.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.31 52.24 1.16 Allowed Glycine 0 CA--C 1.521 0.414 0 C-N-CA 121.043 -0.599 . . . . 0.5 113.66 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.513 HD21 HG22 ' A' ' 57' ' ' VAL . 19.8 tp -102.46 155.74 18.06 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.254 -0.647 . . . . 1.5 109.254 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.584 HE22 ' HG3' ' A' ' 111' ' ' ARG . 7.2 mt-30 -126.34 29.59 5.76 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 115.778 1.77 . . . . 1.53 115.778 -163.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.666 ' HA ' ' C ' ' A' ' 59' ' ' ARG . 53.9 mt 72.52 1.58 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-N 119.102 0.864 . . . . 1.43 113.026 166.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -172.24 51.41 0.17 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 119.668 -1.253 . . . . 0.37 113.118 -171.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.575 ' HB3' HG13 ' A' ' 109' ' ' VAL . 21.1 m-20 -122.08 142.55 50.25 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.595 -0.302 . . . . 0.89 111.736 -172.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.604 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 59.3 mttm -82.76 130.57 35.15 Favored 'General case' 0 C--O 1.207 -1.163 0 CA-C-O 121.138 0.494 . . . . 2.71 109.668 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.658 HD12 ' HA ' ' A' ' 56' ' ' TYR . 2.8 mp -99.8 125.22 53.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 C-N-CA 122.689 0.396 . . . . 1.22 110.562 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.775 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 7.5 mmt -90.81 -17.17 27.04 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 125.099 1.499 . . . . 1.61 112.941 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.499 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -163.99 151.48 12.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.041 0.448 . . . . 0.88 112.128 -175.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.415 ' N ' ' HG3' ' A' ' 79' ' ' GLN . 39.5 t -130.51 105.07 10.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.344 -0.844 . . . . 1.93 110.38 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.615 HD22 HG11 ' A' ' 105' ' ' VAL . 27.2 m-80 49.48 46.95 23.1 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.751 -0.659 . . . . 1.8 111.997 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.03 -15.17 61.93 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.337 -0.935 . . . . 0.38 112.978 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -85.58 170.16 12.85 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 109.782 -0.451 . . . . 0.91 109.782 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -115.92 112.47 21.94 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.114 0.483 . . . . 1.89 111.39 -172.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.484 ' HE2' ' HA ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -107.11 100.5 9.97 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.136 0.969 . . . . 1.38 110.922 -179.257 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.624 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 1.1 p -132.03 -58.38 0.96 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.939 -1.482 . . . . 1.1 107.408 170.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.51 ' HA ' HG22 ' A' ' 37' ' ' ILE . 1.3 mtt -125.36 79.33 1.8 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.642 -1.617 . . . . 2.15 108.563 172.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.723 HG12 ' HG2' ' A' ' 92' ' ' GLN . 1.2 t -139.25 137.28 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 115.351 -0.841 . . . . 1.68 108.879 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.655 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 79.3 p -56.78 152.6 12.16 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.333 0.587 . . . . 1.1 112.529 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.767 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 21.0 t-160 -57.11 -38.18 73.03 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 115.552 -0.749 . . . . 0.41 110.395 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.57 -32.05 69.29 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.491 -1.231 . . . . 1.67 109.877 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.723 ' HG2' HG12 ' A' ' 88' ' ' VAL . 1.0 OUTLIER -65.7 -45.05 84.25 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 109.088 -0.708 . . . . 0.79 109.088 -177.737 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.649 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -74.91 -37.41 62.08 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.173 -0.922 . . . . 1.06 110.565 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -65.05 -37.53 87.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.048 -0.524 . . . . 2.45 110.356 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.492 ' HE3' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -70.98 -40.79 71.71 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.631 -0.713 . . . . 1.51 110.175 -177.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 13.1 mmm180 -69.06 -27.71 65.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.2 0.524 . . . . 4.23 110.564 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.766 HD23 HD22 ' A' ' 29' ' ' LEU . 2.3 tt -78.59 -48.06 15.93 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.452 -0.795 . . . . 2.24 110.426 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.3 m -108.74 70.24 0.74 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.51 -0.768 . . . . 1.63 110.389 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.492 ' HB2' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -108.98 8.9 26.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.661 0.743 . . . . 3.16 110.839 -176.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 73.0 20.41 3.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.622 -1.172 . . . . 4.79 112.681 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.7 p -71.28 -46.02 61.82 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.457 -0.572 . . . . 2.83 109.457 174.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.45 ' HG2' HD21 ' A' ' 27' ' ' LEU . 35.6 mt-10 68.18 6.06 5.03 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.148 -0.933 . . . . 3.4 113.067 169.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.439 ' HG3' ' H ' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -70.58 -68.47 0.43 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.67 0.748 . . . . 2.68 109.767 174.636 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.693 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 4.8 p -159.58 156.14 3.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.816 -1.084 . . . . 1.15 108.52 -176.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.675 ' CG2' ' HG2' ' A' ' 20' ' ' LYS . 3.1 t -132.11 119.88 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-O 121.958 0.885 . . . . 1.13 112.968 -177.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.566 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 1.2 mpt_? -100.31 130.75 46.45 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.393 -1.731 . . . . 2.28 111.236 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.14 135.64 41.28 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.916 -0.314 . . . . 1.68 110.592 172.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.775 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 26.2 tp -98.45 130.34 45.06 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 107.008 -1.479 . . . . 1.1 107.008 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.575 HG13 ' HB3' ' A' ' 75' ' ' ASP . 2.2 t -128.32 142.53 43.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 121.611 0.719 . . . . 1.39 111.317 -170.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.529 HG23 HG23 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -98.74 114.29 26.75 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.511 -0.768 . . . . 1.13 109.973 164.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.584 ' HG3' HE22 ' A' ' 72' ' ' GLN . 20.1 ttt180 -98.68 146.52 25.78 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.102 -0.953 . . . . 2.34 110.31 -175.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.471 ' N ' ' CD ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -136.22 -69.44 0.48 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.036 0.754 . . . . 1.97 113.036 -171.346 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.9 t -158.38 26.91 0.24 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.059 0.457 . . . . 2.0 111.661 -173.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 4.0 mm? . . . . . 0 C--N 1.318 -0.781 0 N-CA-C 112.217 0.451 . . . . 2.0 112.217 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.435 -1.207 0 CA-C-O 122.632 1.206 . . . . 2.49 111.847 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.61 178.72 4.2 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.265 -1.789 . . . . 1.24 110.09 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.6 t -120.49 117.17 52.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 116.081 -0.509 . . . . 2.16 110.273 -174.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.606 HG23 HG22 ' A' ' 110' ' ' THR . 21.8 t -76.71 115.72 18.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.954 0.406 . . . . 1.65 109.942 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 1.034 HE22 HG22 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -105.48 172.37 6.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.708 -0.678 . . . . 1.39 110.637 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.632 ' NH1' ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -128.17 128.3 44.53 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.814 -0.175 . . . . 4.11 110.919 172.41 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 1.034 HG22 HE22 ' A' ' 14' ' ' GLN . 24.2 t -102.08 132.54 47.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 110.196 -0.298 . . . . 1.59 110.196 173.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.632 ' HB2' ' NH1' ' A' ' 15' ' ' ARG . 10.1 tt0 -144.71 115.47 7.75 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.357 -0.238 . . . . 1.35 110.357 171.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.532 HG12 ' HB2' ' A' ' 65' ' ' PRO . 9.0 tp -145.39 155.73 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 108.561 -0.903 . . . . 1.33 108.561 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -83.39 116.59 22.56 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 119.711 -0.796 . . . . 0.7 109.603 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -28.8 140.77 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.958 1.411 . . . . 4.39 112.441 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.418 HD22 ' HD3' ' A' ' 65' ' ' PRO . 39.6 tp -97.1 102.9 14.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.173 0.511 . . . . 1.23 110.24 -173.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 12.3 ptp180 -71.11 141.17 50.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.571 -0.74 . . . . 4.63 111.887 -175.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.487 ' HG3' HD13 ' A' ' 28' ' ' ILE . 6.7 mm-40 -132.66 92.28 3.04 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.398 -0.964 . . . . 1.5 108.398 170.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.27 -68.29 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.053 -0.594 . . . . 1.33 112.251 -173.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -147.08 12.42 1.08 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.45 0.643 . . . . 2.33 109.829 -176.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 34.0 m-80 -112.17 161.77 16.18 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.276 -0.875 . . . . 1.87 110.534 -174.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.603 ' HB2' HG23 ' A' ' 98' ' ' THR . 10.9 mp -121.93 113.07 19.09 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.758 -0.831 . . . . 2.8 108.758 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.487 HD13 ' HG3' ' A' ' 23' ' ' GLN . 1.2 mp -97.88 133.43 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 CA-C-O 121.311 0.577 . . . . 1.45 109.996 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.18 -41.29 42.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.647 -1.161 . . . . 1.87 109.832 -173.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.671 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 94.17 9.5 59.3 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.191 -0.913 . . . . 1.14 111.036 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 31.0 p90 -156.18 177.51 11.35 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 122.659 0.384 . . . . 0.61 110.299 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 t -114.45 161.23 18.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.619 -1.252 . . . . 0.91 107.619 169.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -161.45 136.09 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 112.6 0.593 . . . . 1.24 112.6 -167.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.473 ' HA2' ' CD2' ' A' ' 90' ' ' HIS . . . -143.82 118.72 1.22 Allowed Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 110.518 -1.033 . . . . 0.78 110.518 156.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 1.029 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -139.19 116.54 1.25 Allowed Glycine 0 CA--C 1.492 -1.36 0 CA-C-O 118.982 -0.899 . . . . 1.66 111.148 172.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.633 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.52 140.4 6.24 Favored Glycine 0 C--N 1.3 -1.465 0 C-N-CA 118.139 -1.982 . . . . 0.95 112.659 177.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.6 pt -58.26 -22.51 19.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 107.42 -1.326 . . . . 1.15 107.42 151.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.782 ' HB2' ' CB ' ' A' ' 89' ' ' THR . 13.0 t70 -57.97 -43.71 86.64 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 113.223 -1.808 . . . . 0.72 111.435 173.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 . . . . . 0 N--CA 1.466 0.349 0 CA-C-N 115.402 -0.817 . . . . 1.47 112.629 -168.058 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.453 ' C ' HD11 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.422 -2.247 0 N-CA-C 108.813 -1.715 . . . . 0.94 108.813 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 1.029 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -113.92 141.45 29.99 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 CA-C-N 118.935 1.368 . . . . 1.27 109.002 173.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.604 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -142.64 142.25 32.05 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 119.036 0.834 . . . . 1.91 110.791 -178.09 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.884 HG21 HD22 ' A' ' 71' ' ' LEU . 1.4 p -82.66 143.48 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-N 114.848 -1.069 . . . . 1.22 109.66 178.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.9 m -110.87 -17.6 13.29 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 124.191 0.932 . . . . 1.29 111.454 -173.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.465 ' CA ' ' HA ' ' A' ' 73' ' ' ILE . 78.7 mtt180 -152.56 -166.31 2.44 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.953 0.882 . . . . 2.63 112.097 175.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 8.7 p -173.35 139.58 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 112.982 -1.917 . . . . 1.53 107.529 164.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.6 m -109.05 136.89 47.82 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.474 0.654 . . . . 2.38 111.196 -173.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.37 125.93 26.2 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.555 -1.202 . . . . 1.85 110.777 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.54 -18.02 58.02 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 114.671 -1.15 . . . . 0.95 111.253 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.401 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -78.95 167.68 52.87 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.385 -0.912 . . . . 0.99 111.016 174.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.671 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 91.3 Cg_endo -75.95 -19.33 16.03 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 122.861 2.374 . . . . 0.63 113.912 -169.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.511 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -73.05 -26.71 61.39 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.962 -1.017 . . . . 1.1 111.695 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -72.88 -29.98 63.6 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.458 -0.941 . . . . 1.79 108.458 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.647 HD11 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -77.85 -35.4 20.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.689 -1.141 . . . . 1.18 110.095 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.774 ' CB ' HG11 ' A' ' 16' ' ' VAL . . . -81.66 -14.23 56.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.454 -0.794 . . . . 1.07 111.504 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.0 60.48 1.19 Allowed Glycine 0 CA--C 1.522 0.473 0 C-N-CA 119.291 -1.433 . . . . 0.5 114.314 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.884 HD22 HG21 ' A' ' 57' ' ' VAL . 35.2 tp -123.81 156.74 35.57 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.457 -0.572 . . . . 1.5 109.457 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.83 ' HG3' ' HB2' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -148.9 81.12 1.43 Allowed 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 115.532 1.678 . . . . 1.53 115.532 -177.144 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.554 HG13 HG11 ' A' ' 60' ' ' VAL . 4.2 mp 62.82 -22.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 117.001 2.223 . . . . 1.43 117.001 158.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -162.53 61.46 0.27 Allowed Glycine 0 CA--C 1.506 -0.51 0 O-C-N 120.732 -1.23 . . . . 0.37 112.194 -167.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 61.7 m-20 -121.88 152.05 40.02 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.356 -0.422 . . . . 0.89 110.668 -167.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.627 ' HD2' ' N ' ' A' ' 76' ' ' LYS . 3.7 mptt -103.8 101.61 11.43 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.79 0.805 . . . . 2.71 109.548 -173.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 1.046 HG13 HG23 ' A' ' 109' ' ' VAL . 3.3 mp -71.22 121.71 21.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 114.523 -1.217 . . . . 1.22 111.392 -176.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.869 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 1.4 mmt -89.05 -17.9 28.4 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 125.843 1.965 . . . . 1.61 111.215 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.496 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -172.12 153.25 3.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.808 0.337 . . . . 0.88 111.74 -175.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.525 HG11 ' CE ' ' A' ' 85' ' ' MET . 9.8 p -139.66 125.31 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 121.323 0.583 . . . . 1.93 109.87 175.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.921 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 13.0 m120 52.44 28.89 6.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.225 -0.898 . . . . 1.8 112.529 175.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.48 -16.64 44.44 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.093 -1.051 . . . . 0.38 113.309 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.559 ' HB2' ' HE2' ' A' ' 85' ' ' MET . 41.7 m95 -87.56 148.58 24.81 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 109.475 -0.565 . . . . 0.91 109.475 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -96.63 117.99 32.15 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.345 0.593 . . . . 1.89 111.305 -174.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.629 ' HE3' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -106.71 102.33 11.71 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.834 0.826 . . . . 1.38 111.355 -178.503 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 p -123.16 -38.38 2.59 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.805 -1.088 . . . . 1.1 108.433 167.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.38 76.95 1.23 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.21 -1.359 . . . . 2.15 109.255 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.633 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.5 OUTLIER -138.12 151.61 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 108.966 -0.753 . . . . 1.68 108.966 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.782 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 75.2 p -60.51 151.45 28.48 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 112.888 0.699 . . . . 1.1 112.888 -175.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.738 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 18.0 t-160 -57.71 -41.36 81.57 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 115.588 -0.733 . . . . 0.41 110.467 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.65 -30.1 67.71 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.188 -1.369 . . . . 1.67 109.964 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.549 ' HG2' HG13 ' A' ' 88' ' ' VAL . 2.4 tp-100 -62.55 -49.59 74.67 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.691 0.758 . . . . 0.79 109.467 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.527 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -73.92 -31.88 63.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.988 -1.005 . . . . 1.06 110.116 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -71.02 -41.8 70.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.411 -0.813 . . . . 2.45 111.004 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.547 ' HD3' ' HD2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -71.42 -30.8 66.5 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 119.773 -0.771 . . . . 1.51 109.873 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.547 ' HD2' ' HD3' ' A' ' 95' ' ' LYS . 2.4 mmm180 -67.41 -37.6 83.32 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.003 -0.679 . . . . 4.23 110.954 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.507 HD21 ' HG1' ' A' ' 98' ' ' THR . 4.6 tt -58.68 -55.34 36.34 Favored 'General case' 0 C--N 1.316 -0.859 0 O-C-N 124.232 0.958 . . . . 2.24 110.062 173.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.603 HG23 ' HB2' ' A' ' 27' ' ' LEU . 36.9 m -108.18 -94.96 0.39 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.789 -0.641 . . . . 1.63 112.55 -174.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 99' ' ' LYS . 0.3 OUTLIER 64.52 2.74 1.68 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.315 1.055 . . . . 3.16 110.963 -175.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.448 ' H ' ' C ' ' A' ' 98' ' ' THR . 41.6 mtm180 57.54 57.95 4.04 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.061 -1.427 . . . . 4.79 110.862 -177.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.2 t -155.11 -48.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.27 -0.572 . . . . 2.83 112.01 -175.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -53.83 135.44 41.86 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.044 0.449 . . . . 3.4 112.026 -174.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -89.0 -16.14 32.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.47 0.652 . . . . 2.68 110.54 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.7 p -152.47 148.54 14.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 108.39 -0.967 . . . . 1.15 108.39 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.0 t -114.42 117.61 56.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 122.229 1.014 . . . . 1.13 112.621 -173.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.921 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.2 OUTLIER -101.3 124.9 47.72 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 113.411 -1.722 . . . . 2.28 110.681 -176.367 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.975 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 25.3 tp -132.74 126.73 33.12 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.398 -0.364 . . . . 1.68 110.755 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.869 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 33.1 tp -109.96 115.94 30.71 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.105 -1.443 . . . . 1.1 107.105 172.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 1.046 HG23 HG13 ' A' ' 77' ' ' ILE . 0.5 OUTLIER -128.23 149.51 33.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 121.397 0.617 . . . . 1.39 110.591 -173.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.606 HG22 HG23 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -97.57 114.7 26.66 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.584 -0.734 . . . . 1.13 109.61 168.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -99.16 139.03 35.42 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.281 -0.872 . . . . 2.34 109.696 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.16 -73.08 0.65 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.854 0.359 . . . . 1.97 110.441 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.5 t 177.43 73.27 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.775 0.798 . . . . 2.0 110.723 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.83 ' HB2' ' HG3' ' A' ' 72' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.312 -1.064 0 CA-C-N 114.677 -1.147 . . . . 2.0 108.757 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.448 -0.55 0 CA-C-O 123.485 1.612 . . . . 2.49 111.081 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.29 148.29 23.28 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 111.99 -2.368 . . . . 1.24 108.0 168.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -95.42 130.38 44.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 121.185 0.517 . . . . 2.16 111.133 -173.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.599 HG21 HG21 ' A' ' 110' ' ' THR . 44.9 t -83.36 110.92 18.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.327 0.585 . . . . 1.65 110.556 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.658 ' HG3' HG11 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -119.45 163.04 17.85 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.426 -0.807 . . . . 1.39 109.757 175.145 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.466 ' HB3' ' CD1' ' A' ' 108' ' ' LEU . 2.3 ppt_? -127.08 124.45 39.27 Favored 'General case' 0 C--N 1.31 -1.113 0 O-C-N 121.491 -0.755 . . . . 4.11 111.649 -174.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.719 HG12 ' CB ' ' A' ' 69' ' ' ALA . 9.6 t -90.85 125.2 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-N 115.255 -0.884 . . . . 1.59 110.23 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -123.86 114.32 19.69 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.926 -0.398 . . . . 1.35 109.926 175.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.798 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 11.1 tp -144.57 137.12 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 109.108 -0.701 . . . . 1.33 109.108 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.962 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 15.0 m-70 -65.27 115.91 6.06 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.887 -0.597 . . . . 0.7 110.263 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.826 ' HD3' HD11 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -33.23 126.99 0.34 Allowed 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.364 1.04 . . . . 4.39 110.056 172.349 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.2 tp -103.58 79.59 1.7 Allowed 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 118.978 -1.089 . . . . 1.23 111.398 -163.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.939 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 15.1 ptt-85 -60.87 136.18 58.0 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.481 -0.781 . . . . 4.63 110.947 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.537 ' HB2' HG12 ' A' ' 28' ' ' ILE . 6.0 tp-100 -122.11 94.44 4.3 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.212 -0.904 . . . . 1.5 109.069 -174.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.24 -89.19 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.82 -0.705 . . . . 1.33 112.211 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -115.97 -6.54 11.99 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.477 0.656 . . . . 2.33 110.786 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.52 -178.08 3.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.384 -0.825 . . . . 1.87 109.078 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.939 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.4 pt? -130.69 144.46 51.45 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.107 -1.071 . . . . 2.8 108.107 167.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.537 HG12 ' HB2' ' A' ' 23' ' ' GLN . 11.6 mm -101.27 130.85 50.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-O 121.417 0.627 . . . . 1.45 111.374 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.745 HD11 HD21 ' A' ' 97' ' ' LEU . 13.1 tp -74.18 -58.22 3.44 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.474 -1.239 . . . . 1.87 109.917 175.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.928 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 100.96 -0.13 55.04 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.316 -0.945 . . . . 1.14 113.019 173.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.593 ' HD1' ' HB1' ' A' ' 66' ' ' ALA . 29.6 p90 -157.49 163.4 38.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.147 0.474 . . . . 0.61 110.865 175.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 35.6 t -102.74 160.74 14.32 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.038 -1.097 . . . . 0.91 108.038 173.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -161.77 141.77 2.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 C-N-CA 120.665 -0.414 . . . . 1.24 111.99 -166.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.4 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -144.97 118.75 1.15 Allowed Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.361 -0.923 . . . . 0.78 110.882 158.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 1.048 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -139.7 118.17 1.45 Allowed Glycine 0 CA--C 1.489 -1.539 0 CA-C-O 118.546 -1.141 . . . . 1.66 110.49 172.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.99 ' HA3' ' HG2' ' A' ' 39' ' ' GLN . . . -156.18 117.05 0.75 Allowed Glycine 0 N--CA 1.434 -1.469 0 C-N-CA 117.909 -2.091 . . . . 0.95 114.187 -171.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.597 HG23 ' O ' ' A' ' 87' ' ' MET . 5.1 pt -61.91 -26.61 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 104.798 -2.297 . . . . 1.15 104.798 146.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.965 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 7.1 t70 -55.31 -47.78 75.09 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 112.052 -2.34 . . . . 0.72 109.627 170.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.99 ' HG2' ' HA3' ' A' ' 36' ' ' GLY . 19.2 mm-40 . . . . . 0 C--N 1.345 0.407 0 CA-C-N 114.821 -1.081 . . . . 1.47 111.374 -172.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 86' ' ' THR . . . . . . . . 0 N--CA 1.444 -0.772 0 N-CA-C 109.989 -1.244 . . . . 0.94 109.989 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 1.048 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -108.33 146.07 14.61 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.855 0 CA-C-N 119.331 1.565 . . . . 1.27 108.413 172.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.784 ' HA ' HD13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -153.63 143.02 21.61 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.898 0.856 . . . . 1.91 111.44 178.433 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.473 HG22 HD22 ' A' ' 71' ' ' LEU . 8.4 p -83.11 127.96 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 CA-C-N 113.907 -1.497 . . . . 1.22 110.229 -177.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.2 m -94.88 -19.25 20.44 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.68 -1.145 . . . . 1.29 111.206 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.546 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 25.7 mtp180 -150.4 -165.15 2.19 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.92 0.711 . . . . 2.63 112.92 177.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 91.9 t -156.01 138.71 6.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 112.756 -2.02 . . . . 1.53 107.202 161.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.1 m -94.9 121.58 36.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.226 0.536 . . . . 2.38 110.217 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -52.74 127.6 23.75 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.531 -1.213 . . . . 1.85 111.869 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.14 -4.38 84.54 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.614 -0.803 . . . . 0.95 112.466 174.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.614 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -82.82 -153.2 12.53 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.256 -0.973 . . . . 0.99 110.95 173.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.928 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 40.4 Cg_endo -94.72 -33.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.081 1.854 . . . . 0.63 115.018 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.593 ' HB1' ' HD1' ' A' ' 31' ' ' PHE . . . -66.72 -25.54 66.57 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.073 0.463 . . . . 1.1 111.837 -174.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -72.78 -30.83 64.43 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.758 0.79 . . . . 1.79 108.923 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.614 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -78.03 -41.89 27.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.64 -1.164 . . . . 1.18 110.751 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.798 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . . . -72.55 -20.17 61.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.291 -0.413 . . . . 1.07 110.736 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.43 64.58 1.02 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.279 -0.963 . . . . 0.5 113.445 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.473 HD22 HG22 ' A' ' 57' ' ' VAL . 16.0 tp -109.45 149.28 29.79 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.151 -0.685 . . . . 1.5 109.151 175.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 1.044 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 30.3 mt-30 -115.05 23.74 12.28 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 115.031 1.493 . . . . 1.53 115.031 -164.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.624 HG23 ' O ' ' A' ' 73' ' ' ILE . 62.1 mt 69.51 2.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 CA-C-N 118.761 0.709 . . . . 1.43 112.477 168.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.71 46.77 0.21 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.268 -0.968 . . . . 0.37 112.4 -168.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.474 ' OD2' ' HB2' ' A' ' 72' ' ' GLN . 49.0 m-20 -120.89 152.9 37.88 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.614 -0.514 . . . . 0.89 109.614 -172.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.675 ' HD2' ' N ' ' A' ' 76' ' ' LYS . 8.9 mptt -102.29 122.75 44.83 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.822 -0.807 . . . . 2.71 108.822 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.784 HD13 ' HA ' ' A' ' 56' ' ' TYR . 4.2 mp -91.6 134.27 30.54 Favored 'Isoleucine or valine' 0 C--O 1.264 1.851 0 CA-C-O 121.168 0.508 . . . . 1.22 112.176 -172.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.582 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -92.43 -25.68 18.36 Favored 'General case' 0 C--N 1.346 0.452 0 O-C-N 126.381 2.3 . . . . 1.61 112.442 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.623 ' HA ' ' HG2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -170.77 156.02 4.98 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.281 0.475 . . . . 0.88 112.281 -172.347 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.487 HG12 ' CE ' ' A' ' 85' ' ' MET . 6.4 p -143.14 127.51 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.095 -0.502 . . . . 1.93 110.317 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.455 ' N ' HD21 ' A' ' 81' ' ' ASN . 0.9 OUTLIER 59.39 19.87 8.16 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.888 -0.597 . . . . 1.8 111.929 176.046 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.79 -6.21 58.59 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 119.96 -1.114 . . . . 0.38 112.262 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -83.13 124.18 30.24 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-O 121.332 0.587 . . . . 0.91 109.825 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -86.13 96.74 9.99 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.536 -1.211 . . . . 1.89 110.084 -177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.623 ' HG2' ' HA ' ' A' ' 79' ' ' GLN . 3.9 ptp -109.41 102.39 11.29 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.129 0.966 . . . . 1.38 111.534 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.416 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 4.6 p -101.91 -33.89 9.59 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.236 -1.347 . . . . 1.1 109.115 176.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.597 ' O ' HG23 ' A' ' 37' ' ' ILE . 1.7 mtt -129.03 -16.07 4.13 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 113.88 -1.509 . . . . 2.15 110.042 -176.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.686 ' O ' HD11 ' A' ' 55' ' ' ILE . 2.1 t -40.6 150.59 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 C-N-CA 125.726 1.61 . . . . 1.68 115.222 -167.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.965 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 47.7 p -60.25 150.44 30.24 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.778 -0.576 . . . . 1.1 111.637 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.728 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 21.9 t-160 -61.49 -33.69 74.21 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-N 115.975 -0.557 . . . . 0.41 109.886 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.94 -33.98 68.66 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.687 -1.142 . . . . 1.67 109.546 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.578 ' HG2' HG13 ' A' ' 88' ' ' VAL . 2.0 tp-100 -68.66 -46.56 68.81 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.402 -0.962 . . . . 0.79 108.402 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.546 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -66.68 -37.94 85.77 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.92 -1.036 . . . . 1.06 109.866 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 90' ' ' HIS . 27.6 ttp-105 -71.13 -43.64 67.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.626 -0.716 . . . . 2.45 110.814 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.513 ' HD3' ' C ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -69.39 -43.01 74.37 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 116.109 -0.496 . . . . 1.51 110.467 -177.664 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 28.2 mmt180 -72.08 -23.37 61.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.237 0.541 . . . . 4.23 110.555 -178.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.745 HD21 HD11 ' A' ' 29' ' ' LEU . 7.2 tp -78.57 -57.47 3.75 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.261 -0.881 . . . . 2.24 112.167 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.723 ' OG1' HD12 ' A' ' 29' ' ' LEU . 35.8 m -124.95 91.65 3.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.586 0.708 . . . . 1.63 110.872 -174.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.633 ' HG2' ' OE1' ' A' ' 102' ' ' GLU . 7.0 ptpp? -122.08 7.93 9.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.379 -0.828 . . . . 3.16 112.831 -176.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.874 ' HG2' HD21 ' A' ' 27' ' ' LEU . 26.3 mtm180 67.07 16.5 10.31 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.75 -0.659 . . . . 4.79 111.057 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.493 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 28.0 m -124.74 21.59 8.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.985 0.421 . . . . 2.83 111.441 -175.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.633 ' OE1' ' HG2' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -137.52 131.13 31.32 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.45 -0.341 . . . . 3.4 110.358 179.068 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -85.98 -22.29 27.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.374 0.607 . . . . 2.68 110.257 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.962 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 4.0 p -135.85 141.86 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.519 -0.764 . . . . 1.15 109.367 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.557 HG21 ' HB2' ' A' ' 20' ' ' LYS . 52.5 t -119.62 120.88 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-O 122.083 0.944 . . . . 1.13 111.904 -172.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.406 ' N ' ' CD ' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -99.26 129.39 45.49 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.271 -1.786 . . . . 2.28 109.789 -179.053 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.567 HD11 HG12 ' A' ' 77' ' ' ILE . 21.1 tp -133.29 134.12 43.47 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.927 -0.579 . . . . 1.68 109.643 -177.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.582 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 17.6 tp -110.23 124.51 51.74 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.682 -1.599 . . . . 1.1 106.682 173.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.723 HG22 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -129.88 149.31 33.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 121.757 0.789 . . . . 1.39 111.001 -171.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.599 HG21 HG21 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -98.04 114.71 26.95 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.355 -0.839 . . . . 1.13 109.205 165.187 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.642 ' HG3' HE22 ' A' ' 72' ' ' GLN . 22.3 ttt180 -105.33 131.5 52.69 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.15 -0.932 . . . . 2.34 110.498 -171.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.436 ' HG2' ' CD2' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -106.4 -89.67 0.43 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.39 -0.368 . . . . 1.97 111.845 -178.365 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.8 t -157.18 44.94 0.37 Allowed 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.168 -0.613 . . . . 2.0 112.071 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 1.044 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.592 0 N-CA-C 108.801 -0.814 . . . . 2.0 108.801 175.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.445 -0.688 0 CA-C-O 123.054 1.407 . . . . 2.49 109.788 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -109.98 178.85 4.28 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 112.626 -2.079 . . . . 1.24 110.583 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.8 t -110.18 149.07 13.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 108.894 -0.78 . . . . 2.16 108.894 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.633 HG21 HG21 ' A' ' 110' ' ' THR . 34.8 t -103.69 112.7 38.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 120.315 -0.554 . . . . 1.65 110.956 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 1.025 HE22 HG21 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -95.06 172.36 8.18 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.845 -0.616 . . . . 1.39 110.345 176.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.523 ' HD3' ' O ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -127.21 127.14 43.99 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 116.718 -0.219 . . . . 4.11 111.573 174.042 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 1.025 HG21 HE22 ' A' ' 14' ' ' GLN . 28.8 t -101.6 131.04 50.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.647 -0.501 . . . . 1.59 109.647 171.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 25.0 tt0 -145.68 112.96 6.19 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.699 -0.482 . . . . 1.35 109.699 173.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 8.8 tp -142.63 145.64 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 C-N-CA 120.012 -0.675 . . . . 1.33 109.281 -177.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.724 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 9.7 m-70 -75.66 112.73 12.32 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.207 -0.664 . . . . 0.7 109.207 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.711 ' CE ' ' HB3' ' A' ' 27' ' ' LEU . 25.6 mmmt -31.59 137.18 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.463 1.102 . . . . 4.39 112.578 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.3 tp -96.97 99.74 11.27 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.596 -0.52 . . . . 1.23 109.596 -173.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -92.83 144.74 24.98 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.671 0.748 . . . . 4.63 112.481 -172.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.475 ' CG ' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -124.12 92.89 3.76 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.22 -1.4 . . . . 1.5 107.22 170.166 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.85 -78.4 0.1 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.733 -0.746 . . . . 1.33 111.95 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -138.11 10.09 2.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.533 0.683 . . . . 2.33 110.503 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -107.94 118.74 37.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.238 -0.892 . . . . 1.87 109.119 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.998 HD23 ' HA ' ' A' ' 100' ' ' ARG . 8.8 mp -105.14 113.95 27.84 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.498 0.666 . . . . 2.8 110.437 -176.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.475 HD13 ' CG ' ' A' ' 23' ' ' GLN . 1.7 mp -94.97 141.46 15.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.831 -1.077 . . . . 1.45 109.56 -173.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.91 -38.78 13.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.064 -0.516 . . . . 1.87 110.811 -174.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.676 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 88.78 15.2 60.0 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.268 -0.968 . . . . 1.14 111.56 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.648 ' HD2' ' HB3' ' A' ' 66' ' ' ALA . 42.5 p90 -155.28 166.96 31.94 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 122.201 0.201 . . . . 0.61 110.651 176.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.566 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 17.2 t -109.93 159.0 17.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.493 -1.299 . . . . 0.91 107.493 170.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.406 HD13 HD23 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -161.26 138.08 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 C-N-CA 120.427 -0.509 . . . . 1.24 112.238 -164.376 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.41 ' HA2' ' CD2' ' A' ' 90' ' ' HIS . . . -141.57 117.8 1.25 Allowed Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.172 -1.013 . . . . 0.78 110.851 156.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 1.033 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -140.74 117.09 1.21 Allowed Glycine 0 CA--C 1.491 -1.417 0 CA-C-O 118.656 -1.08 . . . . 1.66 111.067 170.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.653 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -164.15 145.67 10.64 Favored Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 117.429 -2.319 . . . . 0.95 113.469 175.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.498 HG12 ' C ' ' A' ' 88' ' ' VAL . 34.1 pt -69.54 -11.53 14.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 107.282 -1.377 . . . . 1.15 107.282 152.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.823 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 0.1 OUTLIER -70.61 -39.14 73.94 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 113.815 -1.538 . . . . 0.72 109.852 172.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 . . . . . 0 N--CA 1.466 0.337 0 CA-C-N 115.188 -0.915 . . . . 1.47 111.409 -172.241 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.985 0 N-CA-C 109.247 -1.541 . . . . 0.94 109.247 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 1.033 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -110.83 138.03 40.7 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.113 0 CA-C-N 119.361 1.58 . . . . 1.27 107.364 168.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.809 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -152.67 151.72 30.9 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 119.865 1.211 . . . . 1.91 111.655 -177.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.53 HG22 HD21 ' A' ' 71' ' ' LEU . 3.4 p -91.19 131.93 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-N 114.621 -1.172 . . . . 1.22 109.862 -174.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.6 m -99.06 -16.16 18.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.157 -0.929 . . . . 1.29 110.796 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.647 ' O ' HG23 ' A' ' 60' ' ' VAL . 56.8 mtt180 -148.36 -167.04 2.7 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.553 0.692 . . . . 2.63 112.514 175.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 59' ' ' ARG . 75.7 t -163.68 117.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 112.46 -2.155 . . . . 1.53 106.972 159.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.4 m -65.8 117.7 8.59 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.137 0.494 . . . . 2.38 109.894 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -46.14 112.05 0.44 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.581 -1.191 . . . . 1.85 112.394 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.24 -14.89 56.79 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.692 -0.766 . . . . 0.95 112.607 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.468 ' O ' HD12 ' A' ' 68' ' ' ILE . . . -76.55 172.71 54.65 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.219 -0.991 . . . . 0.99 112.072 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.676 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 58.9 Cg_endo -68.91 -24.8 33.31 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 123.088 2.526 . . . . 0.63 113.158 -166.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.648 ' HB3' ' HD2' ' A' ' 31' ' ' PHE . . . -61.45 -36.32 80.05 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 114.783 -1.099 . . . . 1.1 111.392 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -77.75 -29.57 51.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.428 0.632 . . . . 1.79 109.461 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.542 ' N ' HD13 ' A' ' 68' ' ' ILE . 1.4 mp -69.42 -37.48 75.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.241 -0.891 . . . . 1.18 109.812 177.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.624 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -77.35 -23.01 50.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.025 -0.534 . . . . 1.07 110.601 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.27 52.46 0.93 Allowed Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.387 -0.911 . . . . 0.5 114.112 176.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.53 HD21 HG22 ' A' ' 57' ' ' VAL . 14.7 tp -106.52 148.0 28.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.597 -0.89 . . . . 1.5 108.597 174.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.695 HE22 ' HG3' ' A' ' 111' ' ' ARG . 4.6 mt-30 -130.11 38.34 3.8 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 115.375 1.62 . . . . 1.53 115.375 -164.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.618 ' HA ' ' C ' ' A' ' 59' ' ' ARG . 53.9 mt 72.22 -4.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 N-CA-C 114.186 1.18 . . . . 1.43 114.186 163.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.28 45.03 0.23 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 119.22 -1.467 . . . . 0.37 112.277 -171.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.52 ' OD2' ' HB2' ' A' ' 72' ' ' GLN . 20.9 m-20 -118.38 142.07 47.9 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 120.903 0.382 . . . . 0.89 111.558 -169.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.809 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 45.0 mmtm -86.41 103.37 14.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.629 -0.714 . . . . 2.71 110.566 -175.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.596 ' HB ' HG21 ' A' ' 55' ' ' ILE . 5.6 mt -74.4 128.82 36.76 Favored 'Isoleucine or valine' 0 C--O 1.259 1.587 0 C-N-CA 123.904 0.882 . . . . 1.22 112.001 -177.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.684 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 3.8 mmt -93.66 -25.95 17.26 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.569 -1.651 . . . . 1.61 112.234 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.522 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -160.28 156.88 27.13 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.61 -0.436 . . . . 0.88 112.116 -173.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.512 HG13 ' CE ' ' A' ' 85' ' ' MET . 10.4 p -148.44 128.44 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.278 -0.638 . . . . 1.93 109.278 175.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.472 ' OD1' ' HG3' ' A' ' 102' ' ' GLU . 0.9 OUTLIER 67.53 5.82 4.58 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.253 -0.431 . . . . 1.8 111.565 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.59 -7.54 53.7 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 119.882 -1.151 . . . . 0.38 111.403 -172.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -75.0 118.08 17.56 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.708 -0.849 . . . . 0.91 108.708 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.414 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 0.5 OUTLIER -89.69 94.94 10.04 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.661 -0.7 . . . . 1.89 109.594 -175.424 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.512 ' CE ' HG13 ' A' ' 80' ' ' VAL . 11.2 ptp -112.43 104.05 12.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.502 -0.772 . . . . 1.38 112.756 -172.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.1 p -96.86 -20.36 18.21 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 122.183 0.992 . . . . 1.1 108.773 170.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.87 81.65 0.65 Allowed 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.713 -1.585 . . . . 2.15 110.26 -175.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.653 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.9 OUTLIER -140.49 162.57 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 108.519 -0.919 . . . . 1.68 108.519 173.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.667 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 66.7 p -59.75 150.84 26.83 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 112.742 0.645 . . . . 1.1 112.742 -175.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.823 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 16.2 t-160 -59.89 -35.57 75.11 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 121.743 0.782 . . . . 0.41 109.855 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.4 -29.85 66.58 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 113.894 -1.503 . . . . 1.67 109.64 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.541 ' HB3' ' O ' ' A' ' 89' ' ' THR . 3.4 tp-100 -63.77 -48.81 75.43 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.691 0.758 . . . . 0.79 109.023 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.521 ' HB2' HG12 ' A' ' 55' ' ' ILE . . . -69.96 -39.29 76.1 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.905 -1.043 . . . . 1.06 109.52 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -66.39 -42.24 88.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.083 -0.962 . . . . 2.45 111.222 -175.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.552 ' HD3' ' HD2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -68.08 -31.08 70.45 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 119.91 -0.716 . . . . 1.51 109.809 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.552 ' HD2' ' HD3' ' A' ' 95' ' ' LYS . 13.8 mmm180 -67.29 -47.44 70.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 120.706 -0.398 . . . . 4.23 111.249 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 3.4 pp -83.39 0.96 43.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.35 -0.386 . . . . 2.24 111.684 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.1 m -128.4 28.24 5.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.413 0.625 . . . . 1.63 111.33 173.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.952 ' HE2' ' HA ' ' A' ' 99' ' ' LYS . 1.3 mmpt? -82.04 118.79 23.28 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.752 -0.833 . . . . 3.16 108.752 167.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.998 ' HA ' HD23 ' A' ' 27' ' ' LEU . 32.9 ptt180 -76.64 30.83 0.13 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.379 0.609 . . . . 4.79 110.719 -177.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 99' ' ' LYS . 40.9 t -123.51 -30.61 3.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.453 -0.794 . . . . 2.83 109.531 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.472 ' HG3' ' OD1' ' A' ' 81' ' ' ASN . 81.3 mm-40 -79.52 103.9 9.75 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.026 -0.534 . . . . 3.4 110.01 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -71.94 -14.56 61.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.962 -0.563 . . . . 2.68 111.404 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.724 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 5.5 p -138.04 134.79 45.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.36 0.6 . . . . 1.15 109.462 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.558 HG22 ' HG2' ' A' ' 20' ' ' LYS . 1.4 t -115.2 122.34 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-O 122.378 1.085 . . . . 1.13 111.817 -173.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -99.97 126.86 46.2 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 113.2 -1.818 . . . . 2.28 109.364 177.783 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.655 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 10.4 tt -133.9 127.0 31.58 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.534 -0.543 . . . . 1.68 109.534 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.684 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 39.5 tp -107.81 117.71 34.84 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.007 -1.479 . . . . 1.1 107.007 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.746 HG12 ' CG ' ' A' ' 14' ' ' GLN . 0.5 OUTLIER -123.96 148.79 27.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 C-N-CA 119.671 -0.811 . . . . 1.39 110.28 -176.298 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.633 HG21 HG21 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -95.85 117.48 30.65 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.195 -0.911 . . . . 1.13 109.39 169.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.695 ' HG3' HE22 ' A' ' 72' ' ' GLN . 28.0 ttp180 -91.56 114.74 27.36 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.814 -1.539 . . . . 2.34 109.255 -172.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.492 ' HG2' ' N ' ' A' ' 113' ' ' SER . 0.0 OUTLIER -109.76 -55.12 2.48 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.106 -1.037 . . . . 1.97 113.48 -171.11 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.492 ' N ' ' HG2' ' A' ' 112' ' ' GLN . 33.3 t -156.66 13.98 0.28 Allowed 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.759 -0.776 . . . . 2.0 111.965 -173.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 mm? . . . . . 0 C--N 1.321 -0.661 0 CA-C-O 121.657 0.741 . . . . 2.0 110.312 -177.258 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.44 -0.958 0 CA-C-O 122.562 1.172 . . . . 2.49 109.394 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.14 178.67 8.26 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 113.001 -1.909 . . . . 1.24 110.178 175.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.6 t -111.65 107.97 24.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.625 -0.716 . . . . 2.16 109.891 -174.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.55 HG23 HG23 ' A' ' 110' ' ' THR . 48.6 t -77.36 108.65 10.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.247 0.546 . . . . 1.65 109.585 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 1.065 HE22 HG22 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -108.58 167.54 9.98 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.372 -0.831 . . . . 1.39 111.612 -173.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -122.3 114.49 20.87 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.96 -0.564 . . . . 4.11 110.802 -172.327 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 1.065 HG22 HE22 ' A' ' 14' ' ' GLN . 4.9 t -99.24 132.6 44.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.211 -0.663 . . . . 1.59 109.211 176.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -144.63 117.1 8.55 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 110.137 -0.32 . . . . 1.35 110.137 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.552 ' HB ' ' HB1' ' A' ' 69' ' ' ALA . 10.9 tp -144.89 148.25 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 108.741 -0.837 . . . . 1.33 108.741 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.714 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 15.3 m-70 -76.22 116.08 16.57 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.008 -0.677 . . . . 0.7 109.693 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.666 ' HB2' HD13 ' A' ' 27' ' ' LEU . 3.1 pptp? -30.59 136.44 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 O-C-N 125.065 1.478 . . . . 4.39 112.108 177.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.452 ' HB3' ' HB ' ' A' ' 28' ' ' ILE . 47.1 tp -98.44 89.59 4.49 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 119.888 -0.725 . . . . 1.23 110.761 -171.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 24.7 ptt180 -68.71 139.22 55.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.072 0.463 . . . . 4.63 112.063 -172.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -129.47 93.95 3.66 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.651 -0.704 . . . . 1.5 109.238 174.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.28 -80.33 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.839 -0.696 . . . . 1.33 112.863 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -127.09 2.71 6.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.849 0.357 . . . . 2.33 111.699 -173.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -126.73 174.39 8.78 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.097 -0.501 . . . . 1.87 110.426 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.666 HD13 ' HB2' ' A' ' 20' ' ' LYS . 2.0 pt? -127.42 134.39 49.88 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.777 -1.194 . . . . 2.8 107.777 175.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 26.0 mm -98.92 136.28 30.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-O 121.13 0.491 . . . . 1.45 111.665 -171.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.402 HD11 HD23 ' A' ' 97' ' ' LEU . 0.6 OUTLIER -106.6 116.19 31.5 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.341 -1.299 . . . . 1.87 107.558 173.137 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' HG12 ' A' ' 60' ' ' VAL . . . -86.37 51.86 4.42 Favored Glycine 0 C--O 1.221 -0.691 0 C-N-CA 120.223 -0.989 . . . . 1.14 113.249 -172.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 29.2 p90 -158.47 170.74 21.53 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.591 -0.522 . . . . 0.61 109.591 176.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.864 ' HB3' ' O ' ' A' ' 58' ' ' THR . 1.0 OUTLIER -110.66 168.85 9.16 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 107.978 -1.119 . . . . 0.91 107.978 170.303 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -159.82 135.91 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 113.65 0.981 . . . . 1.24 113.65 -163.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.401 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -147.64 117.4 0.91 Allowed Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.592 -1.003 . . . . 0.78 110.592 155.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 1.044 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -142.58 117.78 1.18 Allowed Glycine 0 CA--C 1.488 -1.63 0 CA-C-O 118.427 -1.207 . . . . 1.66 111.141 171.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.68 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.59 137.99 4.92 Favored Glycine 0 C--N 1.298 -1.539 0 C-N-CA 117.222 -2.418 . . . . 0.95 113.086 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -60.53 -25.32 34.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 107.345 -1.354 . . . . 1.15 107.345 151.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.822 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 4.5 t70 -54.6 -40.2 68.62 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 113.524 -1.671 . . . . 0.72 110.179 169.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 . . . . . 0 C--O 1.234 0.285 0 CA-C-N 115.378 -0.828 . . . . 1.47 110.51 -173.448 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.48 ' C ' HD13 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.443 -0.855 0 N-CA-C 110.248 -1.141 . . . . 0.94 110.248 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 1.044 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.7 mp -112.1 142.57 24.07 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 N-CA-C 107.783 -1.191 . . . . 1.27 107.783 171.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.689 ' HA ' HD13 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -152.16 141.98 21.98 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 122.219 1.009 . . . . 1.91 111.577 -177.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 57' ' ' VAL . 1.8 p -79.92 135.98 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 113.928 -1.487 . . . . 1.22 109.565 -178.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.864 ' O ' ' HB3' ' A' ' 32' ' ' SER . 15.8 m -125.09 64.47 1.14 Allowed 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.322 -0.854 . . . . 1.29 109.372 175.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.529 ' HA ' HG22 ' A' ' 73' ' ' ILE . 64.2 mtt180 148.01 -168.5 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 125.939 1.696 . . . . 2.63 110.109 164.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.608 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 57.8 t -164.0 137.89 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 125.89 1.994 . . . . 1.53 106.29 164.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.3 m -75.03 121.57 22.19 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.915 -0.772 . . . . 2.38 108.915 173.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -50.39 108.94 0.26 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.174 -0.921 . . . . 1.85 111.927 177.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.58 -6.05 70.57 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.557 -0.747 . . . . 0.95 112.482 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.5 ' O ' HD12 ' A' ' 68' ' ' ILE . . . -80.12 174.47 55.03 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.726 -0.75 . . . . 0.99 112.17 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.438 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 46.7 Cg_endo -68.37 -28.4 32.99 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 122.837 2.358 . . . . 0.63 113.708 -164.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.439 ' HB3' ' HD2' ' A' ' 31' ' ' PHE . . . -65.57 -30.77 71.55 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.203 -0.908 . . . . 1.1 110.881 177.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -77.65 -31.2 52.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.326 0.584 . . . . 1.79 109.528 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.5 HD12 ' O ' ' A' ' 64' ' ' GLY . 1.3 mp -65.81 -39.77 85.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.314 -0.857 . . . . 1.18 109.84 175.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.698 ' CB ' HG12 ' A' ' 16' ' ' VAL . . . -75.27 -23.22 57.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.852 -0.613 . . . . 1.07 110.295 176.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.53 46.63 1.2 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.843 -1.17 . . . . 0.5 114.427 173.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.679 ' HG ' HG21 ' A' ' 16' ' ' VAL . 2.9 mt -91.93 156.51 17.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.62 0.71 . . . . 1.5 111.079 175.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.486 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 6.0 mt-30 -132.82 32.09 3.86 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 114.599 1.333 . . . . 1.53 114.599 -166.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.529 HG22 ' HA ' ' A' ' 59' ' ' ARG . 3.4 mp 75.05 -14.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 N-CA-C 114.059 1.133 . . . . 1.43 114.059 167.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.6 52.27 0.37 Allowed Glycine 0 N--CA 1.463 0.482 0 C-N-CA 119.761 -1.209 . . . . 0.37 112.405 -167.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -120.7 146.51 46.37 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.117 -0.541 . . . . 0.89 110.388 -169.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.588 ' HD2' ' N ' ' A' ' 76' ' ' LYS . 10.3 mptt -101.44 102.4 13.19 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.516 0.674 . . . . 2.71 110.483 -170.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.929 HG13 HG23 ' A' ' 109' ' ' VAL . 3.1 mp -64.49 122.79 16.05 Favored 'Isoleucine or valine' 0 C--O 1.256 1.424 0 CA-C-N 114.742 -1.117 . . . . 1.22 112.295 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.886 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 2.7 mmt -91.92 -16.91 25.95 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 125.909 2.006 . . . . 1.61 111.148 173.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.561 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -172.42 152.26 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.908 0.336 . . . . 0.88 111.908 -177.82 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.669 HG23 ' HB2' ' A' ' 97' ' ' LEU . 2.4 p -138.4 124.41 24.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.285 0.564 . . . . 1.93 110.133 173.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.471 ' OD1' HG22 ' A' ' 80' ' ' VAL . 20.0 m120 53.02 28.65 6.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.298 -0.864 . . . . 1.8 112.669 174.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.41 -13.75 47.46 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.285 -0.959 . . . . 0.38 113.132 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.485 ' HB2' ' HE2' ' A' ' 85' ' ' MET . 80.4 m95 -86.88 148.16 25.48 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.623 -0.51 . . . . 0.91 109.623 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.64 118.68 37.28 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.663 -0.698 . . . . 1.89 111.975 -173.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.485 ' HE2' ' HB2' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -107.13 103.48 12.89 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.901 0.858 . . . . 1.38 111.377 179.603 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 p -131.16 -48.3 1.0 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.221 -1.4 . . . . 1.1 107.221 168.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.86 84.67 2.1 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 112.622 -2.081 . . . . 2.15 107.509 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.743 ' O ' HD11 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -137.73 136.45 45.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.026 -0.988 . . . . 1.68 108.453 -177.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.765 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 72.9 p -58.1 149.9 22.46 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.161 0.505 . . . . 1.1 112.205 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.822 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 21.9 t-160 -58.11 -36.82 73.46 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.635 0.731 . . . . 0.41 109.792 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.72 -31.36 66.63 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.203 -1.362 . . . . 1.67 109.961 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.697 ' HG2' HG13 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -65.65 -50.47 64.84 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.583 -0.895 . . . . 0.79 108.583 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.72 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . -65.59 -37.2 85.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.678 -0.692 . . . . 1.06 110.274 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -68.53 -42.21 78.81 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.489 -0.778 . . . . 2.45 110.935 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.561 ' HD3' ' C ' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -72.8 -41.9 64.46 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 116.363 -0.38 . . . . 1.51 110.228 -176.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.688 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 29.8 mmt180 -68.04 -32.9 73.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.015 0.436 . . . . 4.23 110.315 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.669 ' HB2' HG23 ' A' ' 80' ' ' VAL . 10.8 tp -73.18 -55.24 6.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.394 -0.821 . . . . 2.24 110.203 173.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 m -94.23 77.59 3.99 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 122.949 1.357 . . . . 1.63 109.779 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.53 ' HB3' ' HE2' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -138.5 108.72 6.43 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 112.316 -2.22 . . . . 3.16 106.35 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -70.79 70.1 0.47 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.384 0.611 . . . . 4.79 112.091 -170.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.0 t -137.55 -31.49 0.8 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.784 -0.644 . . . . 2.83 110.805 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.488 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 19.3 mm-40 -68.21 141.32 56.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.476 -0.329 . . . . 3.4 110.9 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.477 ' HG3' HG11 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -94.84 -11.22 29.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.922 0.868 . . . . 2.68 108.872 169.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.714 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 3.7 p -153.2 145.55 14.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.237 -1.347 . . . . 1.15 108.211 -175.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.562 HG22 ' HB3' ' A' ' 20' ' ' LYS . 43.8 t -119.98 118.93 58.61 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.03 0 CA-C-O 122.439 1.114 . . . . 1.13 112.065 -169.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -99.62 129.31 45.76 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 112.72 -2.036 . . . . 2.28 111.006 -175.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.781 HD13 HG12 ' A' ' 77' ' ' ILE . 35.0 tp -132.8 130.77 40.31 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 116.489 -0.323 . . . . 1.68 110.745 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.886 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 35.5 tp -107.19 114.81 29.09 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 106.785 -1.561 . . . . 1.1 106.785 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.929 HG23 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -128.76 147.14 33.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 C-N-CA 120.313 -0.555 . . . . 1.39 110.562 -172.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.55 HG23 HG23 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -97.56 117.11 31.09 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.707 -0.797 . . . . 1.13 110.556 173.401 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.462 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -110.04 135.46 50.83 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.418 -1.265 . . . . 2.34 109.495 -175.456 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.49 ' OE1' HD21 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -114.25 -72.74 0.68 Allowed 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.687 0.625 . . . . 1.97 112.687 -169.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.4 t -140.87 18.15 2.31 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.647 0.737 . . . . 2.0 110.216 -172.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.49 HD21 ' OE1' ' A' ' 112' ' ' GLN . 4.1 mm? . . . . . 0 C--N 1.317 -0.811 0 CA-C-N 115.36 -0.836 . . . . 2.0 109.766 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 p . . . . . 0 N--CA 1.435 -1.19 0 CA-C-O 122.167 0.984 . . . . 2.49 111.445 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.556 ' CB ' ' HA ' ' A' ' 112' ' ' GLN . . . -86.5 178.4 7.11 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.614 -1.63 . . . . 1.24 111.045 177.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -129.46 138.46 54.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.268 -0.878 . . . . 2.16 108.986 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.659 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 0.9 OUTLIER -90.72 127.2 43.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 C-N-CA 119.413 -0.915 . . . . 1.65 110.897 -174.778 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.889 HE22 HG22 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -118.63 166.38 12.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.527 -1.215 . . . . 1.39 110.137 176.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.433 ' H ' ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -124.98 135.29 52.66 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.605 -0.685 . . . . 4.11 110.325 -175.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.889 HG22 HE22 ' A' ' 14' ' ' GLN . 4.1 t -105.95 109.04 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 CA-C-O 121.501 0.667 . . . . 1.59 109.436 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -109.31 119.53 39.76 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.37 -0.832 . . . . 1.35 109.586 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.678 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 11.3 tp -145.71 146.18 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.871 -0.789 . . . . 1.33 108.871 174.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 14.6 m-70 -80.15 112.0 17.05 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.529 -0.915 . . . . 0.7 108.529 177.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.677 ' HB2' HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -25.16 140.16 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 O-C-N 124.923 1.389 . . . . 4.39 112.814 -178.692 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.567 HD22 ' HA2' ' A' ' 64' ' ' GLY . 43.9 tp -96.16 97.5 9.59 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 119.102 -1.039 . . . . 1.23 110.009 -172.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.632 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 12.4 ptp180 -61.13 142.71 56.51 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.744 0.783 . . . . 4.63 112.067 -173.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.539 ' HB2' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -128.43 93.42 3.64 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.141 -1.059 . . . . 1.5 108.141 172.397 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.6 -78.16 0.26 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.418 -0.896 . . . . 1.33 111.352 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.446 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 54.5 mt-10 -139.2 11.44 2.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.156 0.503 . . . . 2.33 110.63 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.632 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 10.8 m-80 -108.48 -177.53 3.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.895 -0.593 . . . . 1.87 109.685 -177.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.677 HD11 ' HB2' ' A' ' 20' ' ' LYS . 1.0 OUTLIER -127.68 135.48 50.25 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 108.226 -1.027 . . . . 2.8 108.226 173.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.539 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.0 OUTLIER -102.49 138.0 28.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 120.99 0.424 . . . . 1.45 110.871 -179.173 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.8 tp -98.6 124.18 43.23 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.938 -1.483 . . . . 1.87 108.394 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.713 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -93.92 35.1 4.31 Favored Glycine 0 C--O 1.223 -0.582 0 C-N-CA 120.226 -0.988 . . . . 1.14 114.075 -170.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.608 ' CD1' HG22 ' A' ' 57' ' ' VAL . 39.8 p90 -157.77 169.84 23.71 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.544 -0.539 . . . . 0.61 109.544 177.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.685 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -104.43 159.75 15.47 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.845 -1.169 . . . . 0.91 107.845 171.512 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -152.91 135.24 6.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 113.354 0.872 . . . . 1.24 113.354 -167.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -145.06 118.06 1.07 Allowed Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 110.059 -1.216 . . . . 0.78 110.059 154.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 1.083 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -139.6 117.74 1.39 Allowed Glycine 0 CA--C 1.49 -1.487 0 CA-C-O 119.093 -0.837 . . . . 1.66 111.233 172.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.776 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.15 137.32 4.57 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 118.012 -2.042 . . . . 0.95 112.79 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.9 pt -58.75 -24.6 26.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.479 -1.304 . . . . 1.15 107.479 153.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.747 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 4.1 t70 -56.1 -43.71 78.36 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 113.156 -1.838 . . . . 0.72 110.182 171.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 . . . . . 0 C--O 1.233 0.225 0 CA-C-N 114.977 -1.01 . . . . 1.47 112.317 -171.469 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.507 ' C ' HD11 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.429 -1.778 0 N-CA-C 109.156 -1.577 . . . . 0.94 109.156 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 1.083 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -117.41 140.58 39.72 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.403 0 C-N-CA 119.656 -0.818 . . . . 1.27 108.889 176.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.632 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -142.36 142.43 32.45 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 119.553 1.069 . . . . 1.91 110.374 -176.111 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.608 HG22 ' CD1' ' A' ' 31' ' ' PHE . 11.9 p -82.63 136.23 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 114.664 -1.153 . . . . 1.22 110.301 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.685 ' O ' ' HB3' ' A' ' 32' ' ' SER . 23.7 m -127.23 66.05 1.3 Allowed 'General case' 0 N--CA 1.439 -1.006 0 O-C-N 124.346 1.029 . . . . 1.29 109.035 172.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 37.7 mtt180 150.01 -170.28 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.746 1.619 . . . . 2.63 110.434 162.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 90.8 t -160.97 111.46 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 113.595 -1.639 . . . . 1.53 106.625 161.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 m -70.76 158.52 36.16 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.504 0.669 . . . . 2.38 110.021 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -97.62 130.41 44.65 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.027 -0.988 . . . . 1.85 111.289 -169.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.9 -9.83 72.7 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.327 -0.94 . . . . 0.95 111.325 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.656 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -85.05 -158.95 30.35 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.607 -0.806 . . . . 0.99 111.436 174.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.713 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 40.5 Cg_endo -90.02 -30.21 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.664 2.243 . . . . 0.63 115.382 -171.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.17 -23.1 63.89 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 116.229 -0.441 . . . . 1.1 111.473 -174.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -72.03 -38.14 69.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.797 0.808 . . . . 1.79 108.959 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.656 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.3 mp -69.69 -45.29 78.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.526 -1.215 . . . . 1.18 110.585 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.68 ' CB ' HG11 ' A' ' 16' ' ' VAL . . . -67.26 -30.53 70.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 1.07 109.898 175.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.34 62.3 1.0 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.459 -0.877 . . . . 0.5 113.427 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.474 ' O ' HG22 ' A' ' 60' ' ' VAL . 21.6 tp -98.15 158.31 15.63 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.045 -0.724 . . . . 1.5 109.045 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.502 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 5.2 mt-30 -132.21 42.25 3.15 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 115.15 1.537 . . . . 1.53 115.15 -164.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' A' ' 58' ' ' THR . 3.4 mp 71.56 -20.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 N-CA-C 115.741 1.756 . . . . 1.43 115.741 161.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -164.06 57.77 0.27 Allowed Glycine 0 N--CA 1.463 0.484 0 C-N-CA 119.803 -1.189 . . . . 0.37 112.148 -164.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.574 ' HA ' HE22 ' A' ' 112' ' ' GLN . 9.5 m-20 -124.76 154.15 41.34 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.823 -0.688 . . . . 0.89 109.819 -168.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.632 ' HD3' ' HB3' ' A' ' 56' ' ' TYR . 72.2 mmtt -106.68 103.01 12.35 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.511 0.672 . . . . 2.71 109.878 -170.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 1.023 HG13 HG23 ' A' ' 109' ' ' VAL . 3.5 mp -73.65 125.14 32.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 114.696 -1.138 . . . . 1.22 113.344 -172.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.728 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 4.4 mmt -86.18 -21.8 27.32 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 113.053 -1.885 . . . . 1.61 112.174 176.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.505 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -168.91 149.95 4.51 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.455 0.539 . . . . 0.88 112.455 -174.586 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.645 HG21 ' SD ' ' A' ' 85' ' ' MET . 30.1 m -132.55 123.04 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.84 -0.618 . . . . 1.93 110.313 174.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.669 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 1.0 OUTLIER 56.87 25.13 10.07 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.071 0.767 . . . . 1.8 113.071 174.58 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.64 -7.13 57.62 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.358 -1.401 . . . . 0.38 112.669 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.45 ' CB ' ' HE2' ' A' ' 85' ' ' MET . 80.0 m95 -91.84 152.57 20.04 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.817 -0.809 . . . . 0.91 108.817 174.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -103.05 112.96 26.05 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.669 0.747 . . . . 1.89 111.742 -172.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.645 ' SD ' HG21 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -106.34 101.62 11.08 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.055 -0.975 . . . . 1.38 111.359 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.1 p -118.24 -41.33 2.87 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.745 1.259 . . . . 1.1 107.741 168.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -148.22 84.49 1.51 Allowed 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 112.556 -2.111 . . . . 2.15 107.825 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.776 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.5 t -140.04 135.05 37.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.219 -0.901 . . . . 1.68 109.56 -172.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.747 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 69.5 p -55.92 148.28 17.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.292 0.479 . . . . 1.1 112.292 -178.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.739 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 22.7 t-160 -56.14 -40.25 73.52 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 115.883 -0.599 . . . . 0.41 110.715 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.6 -32.29 70.94 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.115 -0.948 . . . . 1.67 109.365 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.812 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 2.5 tp-100 -63.0 -49.45 74.62 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 108.598 -0.89 . . . . 0.79 108.598 -178.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.723 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -73.06 -40.47 65.04 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.632 -0.713 . . . . 1.06 110.611 -177.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 94' ' ' ARG . 33.2 ttp180 -57.16 -44.32 83.37 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.304 0.573 . . . . 2.45 109.644 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.461 ' HD3' ' C ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -66.68 -35.51 80.33 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.368 -0.833 . . . . 1.51 109.638 -178.451 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.812 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 22.2 mmt180 -76.18 -26.36 56.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.006 -0.543 . . . . 4.23 111.602 -176.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 2.8 pp -101.49 -0.19 35.56 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.098 0.777 . . . . 2.24 113.098 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.667 ' HG1' HD13 ' A' ' 97' ' ' LEU . 4.2 m -126.67 65.47 1.26 Allowed 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 122.373 1.082 . . . . 1.63 110.871 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.536 ' C ' ' H ' ' A' ' 101' ' ' SER . 20.4 mtmt -112.25 114.32 27.04 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 113.937 -1.483 . . . . 3.16 108.538 171.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.446 ' HD2' ' O ' ' A' ' 25' ' ' GLU . 15.6 ptt180 -74.88 32.32 0.09 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.348 0.595 . . . . 4.79 110.764 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.536 ' H ' ' C ' ' A' ' 99' ' ' LYS . 13.2 p -119.73 -41.79 2.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.511 -0.768 . . . . 2.83 109.747 -177.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -52.1 142.84 15.32 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.466 -0.788 . . . . 3.4 110.477 175.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -93.66 -13.21 27.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.28 0.562 . . . . 2.68 110.43 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.621 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 5.7 p -151.06 146.74 16.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.77 -0.65 . . . . 1.15 109.547 -176.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.8 t -114.24 120.36 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-O 121.946 0.879 . . . . 1.13 111.708 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.669 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.2 OUTLIER -100.26 127.76 46.48 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.488 -1.687 . . . . 2.28 110.613 -177.114 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.765 HD13 HG12 ' A' ' 77' ' ' ILE . 31.1 tp -133.39 126.92 32.34 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.044 -0.526 . . . . 1.68 109.947 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.728 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 35.4 tp -111.53 116.01 30.14 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.47 -1.308 . . . . 1.1 107.47 175.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 1.023 HG23 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -120.93 153.74 24.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.019 0.438 . . . . 1.39 110.391 -173.507 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.659 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 0.7 OUTLIER -98.71 115.09 27.95 Favored 'General case' 0 N--CA 1.426 -1.673 0 C-N-CA 119.619 -0.832 . . . . 1.13 110.018 165.482 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.491 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 17.3 ttt180 -92.23 112.79 24.86 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.689 -1.142 . . . . 2.34 109.329 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.574 HE22 ' HA ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -86.1 -58.56 2.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.471 -0.786 . . . . 1.97 112.197 -171.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.2 t -149.17 8.59 0.73 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.164 0.507 . . . . 2.0 110.906 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.502 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 3.1 mm? . . . . . 0 N--CA 1.439 -0.975 0 N-CA-C 108.207 -1.034 . . . . 2.0 108.207 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.441 -0.91 0 CA-C-O 123.27 1.51 . . . . 2.49 109.639 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.22 177.01 9.25 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 112.215 -2.266 . . . . 1.24 110.05 172.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.9 m -120.72 132.41 70.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 116.039 -0.528 . . . . 2.16 110.371 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.509 HG21 HG23 ' A' ' 110' ' ' THR . 16.3 t -85.94 114.28 25.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.904 0.383 . . . . 1.65 110.626 -176.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.682 ' HG2' ' HB2' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -112.61 169.96 8.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.402 0.62 . . . . 1.39 112.232 -179.061 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -110.11 141.77 42.52 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.594 0.712 . . . . 4.11 112.409 -173.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.677 ' HB ' ' HB3' ' A' ' 107' ' ' LEU . 34.0 t -129.99 128.74 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 108.28 -1.008 . . . . 1.59 108.28 170.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -143.38 119.74 10.92 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.673 0.273 . . . . 1.35 110.418 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.529 HG12 ' HB2' ' A' ' 65' ' ' PRO . 10.7 tp -145.33 150.57 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.275 0 N-CA-C 108.818 -0.808 . . . . 1.33 108.818 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.747 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 15.8 m-70 -80.71 114.99 19.99 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.187 -0.605 . . . . 0.7 109.402 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.559 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 3.0 pptp? -27.62 136.2 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 O-C-N 125.051 1.469 . . . . 4.39 112.459 177.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.2 tp -109.14 98.1 7.61 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 120.656 -0.418 . . . . 1.23 110.684 -175.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 57.7 mtt180 -67.04 135.66 54.03 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.452 0.644 . . . . 4.63 111.537 177.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.76 92.41 3.76 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.107 -1.071 . . . . 1.5 108.107 172.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.1 -81.48 0.13 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.104 -0.57 . . . . 1.33 111.748 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -129.88 5.1 4.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.779 0.799 . . . . 2.33 110.819 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 7.4 m-80 -108.27 167.8 9.76 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.336 -0.847 . . . . 1.87 110.224 -177.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.421 HD12 ' HG2' ' A' ' 100' ' ' ARG . 6.6 mp -121.73 122.58 39.86 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.564 -0.902 . . . . 2.8 108.564 171.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.7 mm -98.0 127.71 50.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.599 -0.728 . . . . 1.45 110.234 -174.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.591 HD12 HD21 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -84.96 -38.27 19.5 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 114.581 -1.19 . . . . 1.87 109.063 -179.36 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.99 5.76 62.33 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.02 -0.991 . . . . 1.14 111.479 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 39.5 p90 -151.57 167.12 29.06 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.462 -0.57 . . . . 0.61 109.462 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.691 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -106.0 169.18 8.65 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 118.822 -1.151 . . . . 0.91 108.889 173.302 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 55' ' ' ILE . 6.8 tt -140.92 134.72 32.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 119.87 -0.732 . . . . 1.24 112.323 -164.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -103.14 173.17 22.11 Favored Glycine 0 C--N 1.329 0.191 0 N-CA-C 110.77 -0.932 . . . . 0.78 110.77 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.629 ' C ' HE22 ' A' ' 39' ' ' GLN . . . -110.46 168.57 13.06 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 118.243 2.057 . . . . 1.66 118.243 -162.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.673 ' N ' HE22 ' A' ' 39' ' ' GLN . . . -84.5 -142.42 5.55 Favored Glycine 0 N--CA 1.422 -2.254 0 CA-C-N 110.816 -2.692 . . . . 0.95 113.272 -176.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.717 HG23 ' O ' ' A' ' 87' ' ' MET . 8.7 pt -83.1 -5.2 8.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 113.258 0.836 . . . . 1.15 113.258 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.944 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 13.3 p-10 -70.02 -32.74 71.05 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 120.996 -0.282 . . . . 0.72 111.248 -173.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.673 HE22 ' N ' ' A' ' 36' ' ' GLY . 0.9 OUTLIER . . . . . 0 CA--C 1.517 -0.3 0 CA-C-O 121.616 0.722 . . . . 1.47 109.116 -172.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.582 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . . . . . . 0 N--CA 1.445 -0.749 0 N-CA-C 110.276 -1.13 . . . . 0.94 110.276 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.835 HG12 ' HB1' ' A' ' 93' ' ' ALA . 1.8 mp -108.89 146.07 14.96 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.175 0 N-CA-C 105.839 -1.911 . . . . 1.27 105.839 170.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.693 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 1.0 OUTLIER -153.54 140.27 19.0 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 119.295 0.952 . . . . 1.91 110.264 -169.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.599 ' O ' ' HA2' ' A' ' 74' ' ' GLY . 14.4 p -72.15 132.08 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 CA-C-N 115.44 -0.8 . . . . 1.22 110.718 -171.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.691 ' O ' ' HB3' ' A' ' 32' ' ' SER . 19.3 m -125.34 64.71 1.16 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.98 -1.009 . . . . 1.29 109.225 174.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.558 ' HA ' HG13 ' A' ' 73' ' ' ILE . 34.5 mtt180 149.38 -173.19 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.392 1.477 . . . . 2.63 111.407 165.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 4.8 p -174.34 120.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 113.167 -1.833 . . . . 1.53 108.269 162.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.9 m -94.27 133.92 37.29 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.132 0.492 . . . . 2.38 110.993 -175.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -61.4 124.51 20.83 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.643 -1.162 . . . . 1.85 110.382 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.07 -13.06 45.02 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.047 -0.979 . . . . 0.95 111.642 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.99 166.82 30.13 Favored Glycine 0 N--CA 1.438 -1.177 0 N-CA-C 111.026 -0.83 . . . . 0.99 111.026 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.564 ' HA ' HD13 ' A' ' 68' ' ' ILE . 77.7 Cg_endo -73.98 -23.03 16.57 Favored 'Trans proline' 0 C--N 1.325 -0.676 0 C-N-CA 122.798 2.332 . . . . 0.63 113.036 -170.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.497 ' HB2' HD23 ' A' ' 71' ' ' LEU . . . -63.13 -29.38 70.75 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.688 -1.142 . . . . 1.1 111.635 176.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -68.96 -37.29 78.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.417 0.627 . . . . 1.79 109.531 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.564 HD13 ' HA ' ' A' ' 65' ' ' PRO . 2.9 mp -67.76 -43.59 86.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 114.894 -1.048 . . . . 1.18 110.533 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.658 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -75.76 -19.58 58.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.288 0.566 . . . . 1.07 109.686 175.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.13 70.63 1.28 Allowed Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.365 -0.834 . . . . 0.5 113.258 176.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.57 ' CD2' HG12 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -79.23 170.09 17.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.808 0.813 . . . . 1.5 112.132 178.583 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 6.2 mm100 -108.26 -20.9 12.98 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 115.593 1.701 . . . . 1.53 115.593 -161.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.611 HD13 HG13 ' A' ' 60' ' ' VAL . 0.8 OUTLIER 82.41 -24.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 112.418 0.525 . . . . 1.43 112.418 -172.556 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.599 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -172.02 53.34 0.17 Allowed Glycine 0 C--N 1.341 0.826 0 C-N-CA 119.873 -1.156 . . . . 0.37 112.691 -164.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.671 ' HB3' HG22 ' A' ' 109' ' ' VAL . 0.7 OUTLIER -122.19 149.71 43.26 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 122.204 0.201 . . . . 0.89 110.548 -175.206 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.693 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 66.8 mttm -82.39 113.03 19.88 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.691 0.281 . . . . 2.71 111.16 -174.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 17.1 mt -85.66 122.3 38.26 Favored 'Isoleucine or valine' 0 C--O 1.264 1.827 0 CA-C-O 121.254 0.549 . . . . 1.22 111.571 -175.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.801 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 15.5 mmt -89.2 -20.01 24.73 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 125.831 1.957 . . . . 1.61 112.763 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.581 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -167.25 154.05 8.44 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.434 -0.506 . . . . 0.88 112.221 -174.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.77 HG22 ' HB2' ' A' ' 97' ' ' LEU . 12.0 p -139.61 125.49 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.381 -0.827 . . . . 1.93 110.029 174.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.78 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 13.6 m120 52.75 30.22 8.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.168 -0.924 . . . . 1.8 113.193 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.88 -10.64 62.32 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.085 -1.055 . . . . 0.38 112.849 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -80.7 149.74 29.62 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-N 117.06 0.43 . . . . 0.91 110.106 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -103.94 97.8 7.74 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.274 -0.875 . . . . 1.89 111.081 -175.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.555 ' SD ' HG11 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -113.3 101.88 9.82 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.842 -0.617 . . . . 1.38 111.19 176.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.4 p -99.02 -32.64 11.18 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.675 0.75 . . . . 1.1 110.258 173.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.717 ' O ' HG23 ' A' ' 37' ' ' ILE . 4.0 mtt -136.94 -15.48 1.53 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.756 -1.111 . . . . 2.15 110.284 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.641 HG13 ' HG2' ' A' ' 92' ' ' GLN . 1.3 p -56.51 169.45 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 120.888 0.375 . . . . 1.68 111.755 -162.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.944 ' HB ' ' HB3' ' A' ' 38' ' ' ASP . 72.4 p -56.56 145.02 29.46 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 122.223 -0.298 . . . . 1.1 111.756 -174.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.545 ' CG ' ' HA2' ' A' ' 35' ' ' GLY . 23.3 t-160 -55.84 -35.4 66.37 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 122.045 0.926 . . . . 0.41 108.614 175.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -69.02 -32.53 72.11 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 113.256 -1.793 . . . . 1.67 110.313 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.8 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 4.3 tp-100 -62.54 -47.86 82.06 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 108.008 -1.108 . . . . 0.79 108.008 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.835 ' HB1' HG12 ' A' ' 55' ' ' ILE . . . -76.72 -34.06 58.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.243 -0.889 . . . . 1.06 110.21 -173.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 94' ' ' ARG . 38.6 ttp180 -65.35 -43.53 90.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.386 -0.824 . . . . 2.45 110.395 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.546 ' HD3' ' C ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -69.35 -40.88 77.26 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.53 -0.759 . . . . 1.51 109.904 -176.403 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.8 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 21.9 mmt180 -70.36 -23.57 62.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.953 -0.567 . . . . 4.23 110.633 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.77 ' HB2' HG22 ' A' ' 80' ' ' VAL . 15.9 tp -83.26 -44.48 14.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.631 -0.713 . . . . 2.24 112.007 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.0 m -107.87 75.42 1.0 Allowed 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 122.807 1.289 . . . . 1.63 111.014 -169.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.516 ' HE2' ' HA ' ' A' ' 96' ' ' ARG . 6.6 mtmt -115.44 123.87 49.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.541 -2.118 . . . . 3.16 109.041 173.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.421 ' HG2' HD12 ' A' ' 27' ' ' LEU . 41.8 mtp180 -69.69 40.01 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 O-C-N 123.324 0.39 . . . . 4.79 111.229 177.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.435 ' H ' ' C ' ' A' ' 99' ' ' LYS . 18.4 m -136.41 -41.74 0.63 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.056 -0.35 . . . . 2.83 110.056 -172.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.559 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 46.9 mm-40 -56.36 140.69 44.53 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.383 -0.599 . . . . 3.4 109.383 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.76 -16.87 15.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.502 0.668 . . . . 2.68 109.862 176.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.747 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 3.0 p -143.26 150.29 17.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.128 -1.064 . . . . 1.15 108.128 -178.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.466 HG22 ' HB3' ' A' ' 20' ' ' LYS . 54.9 t -124.57 119.38 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.807 0 CA-C-O 122.22 1.009 . . . . 1.13 111.513 -170.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.78 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -100.68 133.62 44.86 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 113.342 -1.754 . . . . 2.28 110.73 -176.228 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.677 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 19.3 tp -132.4 132.58 42.98 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 110.007 -0.368 . . . . 1.68 110.007 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.801 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 23.8 tp -109.73 114.59 28.3 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.147 -1.797 . . . . 1.1 106.147 171.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.671 HG22 ' HB3' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -121.67 141.18 43.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.898 -0.721 . . . . 1.39 110.305 -173.641 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.509 HG23 HG21 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -96.28 115.81 28.02 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.831 -0.748 . . . . 1.13 110.313 173.68 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.682 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 1.6 ttt180 -90.28 104.27 16.86 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.289 -1.323 . . . . 2.34 109.655 -170.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.469 ' HG2' ' N ' ' A' ' 113' ' ' SER . 0.0 OUTLIER -91.59 -45.17 8.63 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.371 0.508 . . . . 1.97 112.371 -171.533 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.469 ' N ' ' HG2' ' A' ' 112' ' ' GLN . 22.8 t -163.1 14.92 0.07 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.408 0.623 . . . . 2.0 110.311 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.45 HD23 ' OD1' ' A' ' 75' ' ' ASP . 3.6 mm? . . . . . 0 C--N 1.322 -0.619 0 CA-C-O 121.382 0.611 . . . . 2.0 109.861 -176.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 49.2 p . . . . . 0 N--CA 1.434 -1.271 0 CA-C-O 122.309 1.052 . . . . 2.49 111.461 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.07 179.36 5.6 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.399 -1.728 . . . . 1.24 109.484 173.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.76 122.28 68.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.218 0.533 . . . . 2.16 110.711 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.571 HG23 HG22 ' A' ' 110' ' ' THR . 15.8 t -79.56 105.61 9.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.004 -0.543 . . . . 1.65 110.367 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.998 HE22 HG22 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -102.05 169.19 8.91 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.725 -0.67 . . . . 1.39 111.766 179.095 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.508 ' HD3' ' O ' ' A' ' 107' ' ' LEU . 1.8 mmt180 -123.96 116.09 22.31 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.334 -0.394 . . . . 4.11 110.932 -177.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.998 HG22 HE22 ' A' ' 14' ' ' GLN . 25.1 t -97.29 125.71 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.597 -0.52 . . . . 1.59 109.597 176.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -139.04 116.21 11.05 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.89 -0.781 . . . . 1.35 108.89 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.68 HG13 ' O ' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -144.57 139.8 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 107.841 -1.17 . . . . 1.33 107.841 -177.42 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.808 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 17.1 m-70 -72.06 115.09 10.88 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.139 -0.689 . . . . 0.7 109.139 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -31.96 141.01 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 O-C-N 124.958 1.411 . . . . 4.39 112.228 178.414 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.795 ' HB3' ' HB ' ' A' ' 28' ' ' ILE . 56.5 tp -98.18 102.58 14.37 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.595 -0.442 . . . . 1.23 110.764 -171.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -58.13 139.35 54.97 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.371 0.605 . . . . 4.63 112.069 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.461 ' HB3' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -142.99 92.46 2.4 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.555 -0.748 . . . . 1.5 109.13 172.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.35 -79.85 0.01 OUTLIER Glycine 0 CA--C 1.522 0.473 0 C-N-CA 121.455 -0.403 . . . . 1.33 112.541 -173.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -130.16 5.06 4.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.513 0.673 . . . . 2.33 110.508 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.461 ' HB2' ' HB3' ' A' ' 23' ' ' GLN . 12.0 m-80 -106.63 165.36 11.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.532 -0.758 . . . . 1.87 110.146 -177.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.892 HD23 ' HB ' ' A' ' 98' ' ' THR . 2.2 pt? -128.66 124.63 36.21 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.759 -1.2 . . . . 2.8 107.759 171.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.795 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 36.0 mm -98.43 115.95 40.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 116.028 -0.533 . . . . 1.45 110.731 -170.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.431 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.3 pt? -71.7 -26.54 62.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.632 -0.713 . . . . 1.87 110.353 175.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.07 -31.3 7.1 Favored Glycine 0 C--O 1.223 -0.585 0 C-N-CA 120.731 -0.747 . . . . 1.14 113.201 172.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.598 ' HZ ' HD12 ' A' ' 97' ' ' LEU . 44.9 p90 -112.24 163.07 14.79 Favored 'General case' 0 C--N 1.313 -0.999 0 O-C-N 122.264 -0.551 . . . . 0.61 110.815 -176.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.529 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 24.0 t -100.47 163.2 12.47 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.268 -1.382 . . . . 0.91 107.268 173.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -162.64 137.82 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 112.416 0.524 . . . . 1.24 112.416 -164.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.74 117.79 1.06 Allowed Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 110.616 -0.994 . . . . 0.78 110.616 157.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 1.018 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -142.65 118.56 1.27 Allowed Glycine 0 CA--C 1.49 -1.507 0 CA-C-O 118.607 -1.107 . . . . 1.66 111.564 173.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.68 144.86 9.42 Favored Glycine 0 C--N 1.294 -1.764 0 C-N-CA 117.133 -2.46 . . . . 0.95 113.319 177.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.45 HG12 ' C ' ' A' ' 88' ' ' VAL . 13.2 pt -62.58 -17.64 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.801 -1.185 . . . . 1.15 107.801 151.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.839 ' HB2' ' CB ' ' A' ' 89' ' ' THR . 21.9 t70 -62.89 -37.09 85.53 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 113.962 -1.472 . . . . 0.72 109.802 173.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 . . . . . 0 N--CA 1.456 -0.161 0 CA-C-N 114.662 -1.154 . . . . 1.47 110.704 -174.733 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.467 ' C ' HD11 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.433 -1.556 0 N-CA-C 111.026 -0.83 . . . . 0.94 111.026 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 1.018 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -114.25 144.25 22.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 N-CA-C 109.223 -0.658 . . . . 1.27 109.223 178.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.777 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -145.92 146.78 31.19 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 122.59 1.186 . . . . 1.91 113.334 178.218 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.87 HG22 HD13 ' A' ' 77' ' ' ILE . 54.5 t -72.21 137.42 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 112.509 -2.132 . . . . 1.22 110.38 175.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.7 m -113.73 -19.7 11.45 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 124.502 1.126 . . . . 1.29 111.478 -178.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.622 ' O ' HG22 ' A' ' 60' ' ' VAL . 72.8 mtt180 -149.48 -165.97 2.42 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.754 -0.591 . . . . 2.63 112.21 174.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.622 HG22 ' O ' ' A' ' 59' ' ' ARG . 79.7 t -168.4 138.61 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.705 1.602 . . . . 1.53 107.407 166.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.404 ' OG ' ' HA3' ' A' ' 64' ' ' GLY . 32.2 p -81.09 132.87 35.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.922 0.392 . . . . 2.38 111.123 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -58.71 111.17 1.17 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.864 -1.062 . . . . 1.85 110.52 170.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.26 -15.16 63.83 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.55 -0.834 . . . . 0.95 112.145 177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.423 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -72.21 175.51 42.51 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.515 -0.85 . . . . 0.99 111.35 177.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.68 ' O ' HG13 ' A' ' 18' ' ' ILE . 73.5 Cg_endo -72.8 -30.08 11.84 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.288 1.992 . . . . 0.63 112.69 -166.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.464 ' HB2' HG13 ' A' ' 60' ' ' VAL . . . -60.72 -28.25 68.52 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.011 -0.995 . . . . 1.1 111.415 178.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -76.0 -35.49 59.55 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.517 0.675 . . . . 1.79 109.287 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.5 HD11 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -65.27 -43.43 95.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.882 -1.053 . . . . 1.18 110.244 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.685 ' CB ' HG12 ' A' ' 16' ' ' VAL . . . -72.46 -22.87 61.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.908 -0.587 . . . . 1.07 110.52 177.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.89 66.38 0.86 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.019 -1.086 . . . . 0.5 113.389 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.518 HD12 HG21 ' A' ' 16' ' ' VAL . 9.0 tp -119.12 151.0 39.06 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.893 -0.41 . . . . 1.5 109.893 177.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.768 HE22 ' HG3' ' A' ' 111' ' ' ARG . 7.9 mt-30 -129.91 31.73 4.66 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 115.806 1.78 . . . . 1.53 115.806 -162.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 72' ' ' GLN . 2.7 mp 72.95 -8.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 CA-C-N 118.992 0.815 . . . . 1.43 112.988 170.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.13 54.58 0.32 Allowed Glycine 0 CA--C 1.507 -0.454 0 C-N-CA 119.155 -1.498 . . . . 0.37 112.69 -168.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.457 ' H ' ' HB ' ' A' ' 57' ' ' VAL . 16.8 m-20 -120.83 148.36 44.12 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.491 -0.354 . . . . 0.89 110.51 -168.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.777 ' HD3' ' HB3' ' A' ' 56' ' ' TYR . 14.0 mmtp -105.93 102.86 12.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.168 0.508 . . . . 2.71 110.0 -169.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 1.063 HG13 HG23 ' A' ' 109' ' ' VAL . 3.4 mp -72.99 126.99 34.63 Favored 'Isoleucine or valine' 0 C--O 1.257 1.471 0 N-CA-C 113.629 0.974 . . . . 1.22 113.629 -172.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.801 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 5.5 mmt -92.12 -28.55 17.03 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 126.265 2.228 . . . . 1.61 112.113 172.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.571 ' HB2' ' CB ' ' A' ' 108' ' ' LEU . 52.3 mt-30 -150.87 158.57 44.31 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.52 0.933 . . . . 0.88 113.52 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.579 ' HB ' ' CE ' ' A' ' 85' ' ' MET . 24.4 t -139.6 107.46 3.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 113.515 -1.675 . . . . 1.93 109.951 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 1.016 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 23.1 m-80 54.92 32.27 17.59 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.848 0.459 . . . . 1.8 112.007 176.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.46 -3.9 59.76 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.224 -0.989 . . . . 0.38 112.817 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.447 ' CE2' ' HD2' ' A' ' 96' ' ' ARG . 84.0 m95 -87.54 168.27 13.21 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.669 -0.493 . . . . 0.91 109.669 177.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -109.78 113.69 26.66 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.242 0.544 . . . . 1.89 111.155 -171.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.579 ' CE ' ' HB ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -106.95 101.97 11.36 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 122.217 1.008 . . . . 1.38 110.965 -179.702 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.8 p -142.1 -46.18 0.34 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.428 -1.714 . . . . 1.1 107.707 173.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.41 ' HA ' HG21 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -146.85 74.45 1.35 Allowed 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 113.704 -1.589 . . . . 2.15 110.127 176.105 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.754 ' HB ' HE21 ' A' ' 92' ' ' GLN . 22.9 m -133.3 154.93 40.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.285 -1.006 . . . . 1.68 108.285 171.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.839 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 72.0 p -62.57 154.4 29.02 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 120.792 0.33 . . . . 1.1 111.331 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.811 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 17.7 t-160 -52.59 -45.14 66.39 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 121.722 0.772 . . . . 0.41 110.143 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -71.35 -29.56 65.13 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 113.692 -1.594 . . . . 1.67 109.964 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.754 HE21 ' HB ' ' A' ' 88' ' ' VAL . 2.5 tt0 -60.19 -47.14 87.2 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.402 -0.592 . . . . 0.79 109.402 178.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.577 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -74.06 -41.0 62.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.322 0.582 . . . . 1.06 110.531 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -56.62 -44.17 80.94 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.817 -1.083 . . . . 2.45 110.896 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.413 ' HD3' ' C ' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -71.82 -34.35 69.25 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.396 -0.82 . . . . 1.51 109.92 -176.682 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.727 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 27.2 mmt180 -74.56 -26.15 59.76 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.172 -0.467 . . . . 4.23 110.712 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.598 HD12 ' HZ ' ' A' ' 31' ' ' PHE . 5.6 tt -68.94 -60.85 2.09 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.527 -0.76 . . . . 2.24 111.277 -176.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.892 ' HB ' HD23 ' A' ' 27' ' ' LEU . 5.8 p -97.43 -83.56 0.39 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.387 -0.369 . . . . 1.63 111.408 -176.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 99' ' ' LYS . 2.8 ttpt 66.97 -1.66 1.35 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.8 -0.636 . . . . 3.16 112.026 176.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.476 ' HA ' HD22 ' A' ' 27' ' ' LEU . 97.4 mtt180 60.34 47.79 8.61 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.026 -0.988 . . . . 4.79 111.188 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.1 t -137.02 -56.44 0.72 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.466 -0.334 . . . . 2.83 111.741 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.637 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 19.5 mm-40 -63.83 149.5 46.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.474 -0.33 . . . . 3.4 111.123 -174.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -93.5 -10.17 35.82 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.431 0.634 . . . . 2.68 109.843 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.808 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 3.8 p -147.58 142.18 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 108.634 -0.876 . . . . 1.15 108.634 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.5 t -116.64 120.24 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-O 122.02 0.914 . . . . 1.13 111.867 -169.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 1.016 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -99.66 128.33 45.77 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 113.444 -1.707 . . . . 2.28 111.322 -174.403 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.852 HD11 HG12 ' A' ' 77' ' ' ILE . 17.6 tp -134.49 133.87 40.85 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.127 -0.488 . . . . 1.68 110.492 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.801 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 29.9 tp -111.38 117.01 31.92 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 105.998 -1.853 . . . . 1.1 105.998 170.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 1.063 HG23 HG13 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -126.63 144.46 36.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.868 -0.733 . . . . 1.39 110.407 -174.578 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.571 HG22 HG23 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -95.68 115.29 27.22 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.614 -0.834 . . . . 1.13 109.297 169.608 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.768 ' HG3' HE22 ' A' ' 72' ' ' GLN . 8.5 ttt180 -102.97 138.9 39.24 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.258 -1.337 . . . . 2.34 110.482 -172.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.565 ' HG2' HD23 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -125.41 -96.35 0.44 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.326 0.491 . . . . 1.97 112.326 -178.433 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.0 t -124.97 35.39 4.79 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.273 0.559 . . . . 2.0 111.792 -168.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.565 HD23 ' HG2' ' A' ' 112' ' ' GLN . 0.3 OUTLIER . . . . . 0 C--N 1.319 -0.736 0 CA-C-O 121.32 0.581 . . . . 2.0 109.835 -178.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.447 -0.586 0 CA-C-O 123.605 1.669 . . . . 2.49 110.86 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 111' ' ' ARG . . . -110.9 178.19 4.43 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 112.196 -2.274 . . . . 1.24 110.541 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.8 t -111.64 118.19 56.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.989 -0.551 . . . . 2.16 110.487 -176.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.601 HG11 HD11 ' A' ' 108' ' ' LEU . 39.4 t -76.37 111.81 13.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.219 0.533 . . . . 1.65 109.637 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.976 HE22 HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -118.69 169.35 9.89 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.009 -0.541 . . . . 1.39 112.235 -171.465 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 15' ' ' ARG . 6.1 mmm-85 -124.06 118.11 26.21 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.998 0.428 . . . . 4.11 112.126 -175.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.976 HG23 HE22 ' A' ' 14' ' ' GLN . 7.7 t -108.26 119.59 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 108.25 -1.018 . . . . 1.59 108.25 171.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -132.75 114.41 14.1 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.93 -0.767 . . . . 1.35 108.93 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.7 HG13 ' O ' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -136.89 138.29 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 108.097 -1.075 . . . . 1.33 108.097 -173.619 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.832 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.3 m-70 -66.09 114.14 5.01 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.495 -0.32 . . . . 0.7 110.358 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.939 ' HB2' HD13 ' A' ' 27' ' ' LEU . 2.2 pptp? -28.02 135.4 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 O-C-N 125.097 1.498 . . . . 4.39 112.814 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.66 HD23 ' HD3' ' A' ' 65' ' ' PRO . 33.1 tp -96.68 90.24 5.24 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.937 0.875 . . . . 1.23 109.377 -175.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.418 ' CD ' ' H ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -62.3 133.23 54.84 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.854 -1.521 . . . . 4.63 111.311 -178.501 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -133.71 94.18 3.24 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.773 -0.825 . . . . 1.5 108.773 173.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.5 -80.26 0.12 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.828 -0.701 . . . . 1.33 111.778 -175.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -132.52 1.47 3.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.832 0.348 . . . . 2.33 110.511 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -107.61 172.04 7.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.24 0.543 . . . . 1.87 111.283 -171.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.939 HD13 ' HB2' ' A' ' 20' ' ' LYS . 2.7 tp -124.4 121.77 35.84 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.14 -0.936 . . . . 2.8 109.06 175.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.5 mp -99.25 129.65 49.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.686 -0.857 . . . . 1.45 108.686 176.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mt -84.7 -32.39 23.58 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.418 -0.81 . . . . 1.87 110.279 -174.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.457 ' O ' HG11 ' A' ' 60' ' ' VAL . . . 86.59 11.6 71.06 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.227 -0.987 . . . . 1.14 111.487 -175.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.617 ' HD2' ' HB1' ' A' ' 66' ' ' ALA . 33.3 p90 -155.0 167.73 29.37 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.305 -0.628 . . . . 0.61 109.305 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.539 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -107.67 164.09 12.53 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 107.873 -1.158 . . . . 0.91 107.873 172.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -148.78 136.47 14.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 119.573 -0.851 . . . . 1.24 112.664 -167.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.412 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -147.46 118.41 1.01 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.25 -0.976 . . . . 0.78 111.066 157.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.985 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -137.99 119.04 1.75 Allowed Glycine 0 CA--C 1.492 -1.354 0 CA-C-O 118.807 -0.996 . . . . 1.66 110.703 171.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 1.033 ' HA3' ' HG2' ' A' ' 39' ' ' GLN . . . -156.77 116.9 0.74 Allowed Glycine 0 N--CA 1.435 -1.423 0 C-N-CA 118.277 -1.916 . . . . 0.95 113.614 -169.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.537 HG12 ' C ' ' A' ' 88' ' ' VAL . 15.9 pt -67.86 -20.89 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 N-CA-C 105.738 -1.949 . . . . 1.15 105.738 147.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.758 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 2.8 t70 -63.17 -40.72 98.35 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 112.644 -2.071 . . . . 0.72 109.765 168.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 1.033 ' HG2' ' HA3' ' A' ' 36' ' ' GLY . 28.7 mm-40 . . . . . 0 C--N 1.345 0.373 0 CA-C-N 115.034 -0.984 . . . . 1.47 111.777 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.479 ' C ' HD13 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.44 -1.053 0 N-CA-C 109.732 -1.347 . . . . 0.94 109.732 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.985 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -117.1 141.16 36.7 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.151 0 C-N-CA 119.268 -0.973 . . . . 1.27 109.187 177.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.789 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -148.28 138.13 22.38 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.698 0.761 . . . . 1.91 110.509 -176.043 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.531 ' O ' ' HA2' ' A' ' 74' ' ' GLY . 14.6 p -79.49 137.17 22.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 114.485 -1.234 . . . . 1.22 110.468 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.617 ' O ' HG21 ' A' ' 58' ' ' THR . 12.1 t -127.18 68.91 1.28 Allowed 'General case' 0 C--O 1.21 -1.021 0 O-C-N 124.325 1.016 . . . . 1.29 108.998 174.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.632 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 18.0 mtt180 153.55 -172.9 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.897 -1.502 . . . . 2.63 110.939 159.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.457 HG11 ' O ' ' A' ' 30' ' ' GLY . 59.1 t -160.7 112.92 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 111.897 -2.41 . . . . 1.53 106.621 161.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 m -76.44 121.75 23.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.96 0.41 . . . . 2.38 109.933 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -48.14 116.72 1.63 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.01 -0.995 . . . . 1.85 112.066 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.41 -16.06 49.24 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.517 -0.849 . . . . 0.95 112.189 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.64 169.83 54.83 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.153 -1.022 . . . . 0.99 111.415 177.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.7 ' O ' HG13 ' A' ' 18' ' ' ILE . 90.5 Cg_endo -71.35 -24.59 22.68 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.603 2.202 . . . . 0.63 113.064 -170.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.617 ' HB1' ' HD2' ' A' ' 31' ' ' PHE . . . -63.15 -25.67 68.46 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.26 -0.882 . . . . 1.1 111.521 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -73.67 -37.42 65.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.656 -0.868 . . . . 1.79 108.656 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.535 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.2 mp -65.86 -47.99 83.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.245 -1.343 . . . . 1.18 111.095 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.732 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -71.93 -22.07 61.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.388 -0.369 . . . . 1.07 110.405 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.27 72.27 1.29 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.505 -0.855 . . . . 0.5 113.109 178.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.459 ' CD2' HG21 ' A' ' 57' ' ' VAL . 15.3 tp -105.04 158.16 16.75 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.699 -0.482 . . . . 1.5 109.699 176.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.659 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 35.2 mt-30 -114.04 20.83 15.37 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 114.756 1.391 . . . . 1.53 114.756 -168.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.632 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 75.8 mt 73.88 -5.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 113.059 0.762 . . . . 1.43 113.059 170.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.531 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -171.03 63.9 0.16 Allowed Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.667 -0.777 . . . . 0.37 111.621 -165.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.503 ' HB2' HG13 ' A' ' 57' ' ' VAL . 20.6 m-20 -122.66 148.26 45.49 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.245 -0.478 . . . . 0.89 110.055 -170.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -97.98 101.39 12.86 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.29 0.567 . . . . 2.71 109.775 -176.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.967 HG13 HG11 ' A' ' 109' ' ' VAL . 3.1 mp -73.86 121.89 25.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 115.29 -0.868 . . . . 1.22 112.005 -175.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.673 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 4.5 mmt -88.59 -21.74 23.88 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 125.687 1.867 . . . . 1.61 111.933 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.55 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -160.77 148.94 16.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.166 0.508 . . . . 0.88 112.194 -175.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.601 ' HB ' ' CE ' ' A' ' 85' ' ' MET . 21.9 t -129.49 110.52 20.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.172 -0.922 . . . . 1.93 110.594 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.769 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 5.9 m120 52.38 37.22 21.94 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.694 0.627 . . . . 1.8 112.694 174.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.9 -11.13 62.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.292 -0.956 . . . . 0.38 112.563 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.466 ' HB2' ' HE2' ' A' ' 85' ' ' MET . 80.1 m95 -89.57 161.87 15.95 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 109.282 -0.636 . . . . 0.91 109.282 177.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -108.81 111.79 23.71 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.197 -0.456 . . . . 1.89 110.653 -172.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.905 ' SD ' HG11 ' A' ' 88' ' ' VAL . 13.7 mmt -107.41 99.92 9.4 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 121.85 0.834 . . . . 1.38 109.91 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.64 -48.61 2.04 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.706 -1.134 . . . . 1.1 107.998 171.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.405 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 3.2 mtt -143.41 85.01 1.83 Allowed 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.517 -1.674 . . . . 2.15 108.022 173.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.905 HG11 ' SD ' ' A' ' 85' ' ' MET . 0.5 OUTLIER -140.32 151.2 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 115.781 -0.645 . . . . 1.68 109.904 -176.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.681 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 82.6 p -61.25 151.19 32.4 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.143 0.497 . . . . 1.1 112.278 -177.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.758 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 22.6 t-160 -61.53 -34.36 75.41 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 115.814 -0.63 . . . . 0.41 109.891 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -70.58 -33.24 70.85 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.171 -1.377 . . . . 1.67 109.235 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.726 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -63.56 -52.36 61.4 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.747 -0.834 . . . . 0.79 108.747 -179.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.703 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -66.72 -41.14 88.42 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.504 -0.771 . . . . 1.06 110.281 -178.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -60.25 -47.46 85.91 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.375 -0.829 . . . . 2.45 110.676 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.524 ' HD3' ' C ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -69.95 -39.45 76.04 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.67 -0.695 . . . . 1.51 110.203 -176.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.726 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 25.1 mmt180 -69.24 -23.01 63.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.991 -0.549 . . . . 4.23 112.152 -175.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.562 ' HB3' HG13 ' A' ' 80' ' ' VAL . 4.4 pp -98.93 -14.04 19.72 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.406 -0.517 . . . . 2.24 111.948 175.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.712 ' HA ' HD22 ' A' ' 27' ' ' LEU . 1.9 m -112.74 86.02 2.28 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 122.35 1.071 . . . . 1.63 109.945 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.51 ' HE3' ' HB2' ' A' ' 99' ' ' LYS . 4.6 mtmt -120.17 119.15 32.43 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 113.462 -1.699 . . . . 3.16 109.969 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -67.62 48.77 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.181 -0.918 . . . . 4.79 111.84 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.4 t -151.42 -54.11 0.14 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.311 0.486 . . . . 2.83 112.311 -172.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 43.9 mt-10 -71.67 158.51 36.02 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.323 0.49 . . . . 3.4 112.323 -171.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.74 ' HA ' ' HZ1' ' A' ' 20' ' ' LYS . 12.3 pt-20 -95.4 -18.34 20.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.81 -0.632 . . . . 2.68 111.399 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.832 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 4.9 p -142.41 148.25 20.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.726 0.298 . . . . 1.15 110.362 -172.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.496 HG23 ' HB3' ' A' ' 20' ' ' LYS . 44.1 t -119.73 119.78 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-O 121.813 0.816 . . . . 1.13 111.736 -173.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.769 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.9 OUTLIER -102.11 124.92 48.55 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 113.875 -1.511 . . . . 2.28 111.529 -174.039 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.52 131.06 39.33 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.19 0.519 . . . . 1.68 111.071 174.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.673 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 35.4 tp -103.2 113.99 27.91 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.011 -1.477 . . . . 1.1 107.011 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.967 HG11 HG13 ' A' ' 77' ' ' ILE . 23.1 m -118.12 152.06 20.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 C-N-CA 119.921 -0.712 . . . . 1.39 110.581 -176.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.529 HG21 HG21 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -95.73 115.18 27.06 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.825 -0.75 . . . . 1.13 109.287 167.129 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.58 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . 0.9 OUTLIER -105.16 143.08 33.84 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.925 -1.034 . . . . 2.34 110.475 -171.255 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.43 -89.27 0.49 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.067 -0.515 . . . . 1.97 110.633 -176.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.2 t -160.47 74.26 0.53 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.322 0.582 . . . . 2.0 110.998 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.659 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 6.8 mt . . . . . 0 C--N 1.312 -1.034 0 CA-C-N 115.284 -0.871 . . . . 2.0 110.081 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.448 -0.536 0 CA-C-O 123.559 1.647 . . . . 2.49 110.869 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.64 157.45 17.17 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 112.343 -2.208 . . . . 1.24 109.227 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.707 HG21 ' HG2' ' A' ' 111' ' ' ARG . 20.2 m -99.92 125.78 53.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 109.502 -0.555 . . . . 2.16 109.502 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.57 HG22 HG21 ' A' ' 110' ' ' THR . 56.1 t -77.19 97.67 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 122.0 0.905 . . . . 1.65 111.168 -176.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.712 ' NE2' HG21 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -95.91 139.84 31.54 Favored 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 114.095 -1.411 . . . . 1.39 109.515 175.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.3 ppt_? -125.6 129.05 48.87 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 120.32 -1.487 . . . . 4.11 111.326 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.755 HG11 ' CB ' ' A' ' 69' ' ' ALA . 22.7 t -92.57 133.93 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 114.909 -1.041 . . . . 1.59 110.259 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -135.32 112.51 10.44 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.008 -0.738 . . . . 1.35 109.008 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.632 HG13 ' O ' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -144.45 139.24 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 N-CA-C 107.742 -1.207 . . . . 1.33 107.742 -177.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 14.6 m-70 -73.75 114.88 12.53 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.054 -0.721 . . . . 0.7 109.054 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.76 ' HB2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -31.46 143.71 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 O-C-N 125.02 1.45 . . . . 4.39 112.424 -178.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.54 HD23 ' HD3' ' A' ' 65' ' ' PRO . 30.7 tp -94.98 97.59 10.08 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.847 -0.741 . . . . 1.23 110.037 -171.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.443 ' N ' ' HD3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -54.95 131.34 44.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.792 -1.094 . . . . 4.63 111.583 -178.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -139.8 102.13 4.35 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.755 -1.111 . . . . 1.5 108.549 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.9 -92.04 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.556 -0.831 . . . . 1.33 111.108 -175.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.454 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 35.7 mt-10 -126.6 -0.55 6.81 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.101 0.477 . . . . 2.33 110.607 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.44 ' HA ' ' CB ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -112.54 -175.94 2.79 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.969 -0.56 . . . . 1.87 110.457 -173.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.76 HD13 ' HB2' ' A' ' 20' ' ' LYS . 1.7 pt? -123.9 142.84 50.78 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.405 -0.961 . . . . 2.8 108.405 175.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 mp -106.78 130.89 57.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 121.062 0.458 . . . . 1.45 110.357 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.462 HD21 ' H ' ' A' ' 29' ' ' LEU . 1.3 pt? -96.28 117.33 30.58 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.032 -1.099 . . . . 1.87 108.032 172.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.627 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -81.5 43.54 2.93 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.738 -0.744 . . . . 1.14 113.521 -171.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 29.0 p90 -158.28 160.44 37.05 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 122.575 0.35 . . . . 0.61 110.33 178.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.537 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 18.6 t -103.89 159.9 15.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.183 -1.414 . . . . 0.91 107.183 170.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -160.3 140.15 3.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 120.695 -0.402 . . . . 1.24 111.778 -165.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -145.61 119.22 1.17 Allowed Glycine 0 N--CA 1.436 -1.314 0 N-CA-C 110.257 -1.137 . . . . 0.78 110.257 157.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 1.087 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -138.67 116.68 1.3 Allowed Glycine 0 CA--C 1.488 -1.643 0 N-CA-C 110.652 -0.979 . . . . 1.66 110.652 169.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.699 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.47 137.15 4.5 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 117.498 -2.287 . . . . 0.95 114.329 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.514 HG12 ' C ' ' A' ' 88' ' ' VAL . 23.3 pt -66.79 -11.4 13.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.773 -1.195 . . . . 1.15 107.773 149.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.815 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 0.0 OUTLIER -72.3 -40.69 67.32 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.091 -1.413 . . . . 0.72 108.789 170.351 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 . . . . . 0 C--O 1.234 0.287 0 CA-C-N 114.965 -1.016 . . . . 1.47 109.213 178.198 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.45 ' C ' HD11 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.446 -0.663 0 N-CA-C 109.828 -1.309 . . . . 0.94 109.828 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 1.087 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -115.32 141.25 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 106.755 -1.572 . . . . 1.27 106.755 168.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.646 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -153.85 146.97 24.61 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 119.42 1.009 . . . . 1.91 110.887 -178.615 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.638 HG22 HD21 ' A' ' 71' ' ' LEU . 1.4 p -81.88 140.84 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-N 114.732 -1.122 . . . . 1.22 109.71 -175.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.9 m -110.25 -14.47 14.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.295 -0.866 . . . . 1.29 110.841 -173.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.537 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 67.1 mtt180 -149.55 -166.59 2.59 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.728 0.775 . . . . 2.63 112.395 174.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.608 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 88.3 t -160.0 140.02 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 112.525 -2.125 . . . . 1.53 106.474 162.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.9 p -82.73 121.16 26.52 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 121.503 0.668 . . . . 2.38 110.308 175.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -60.46 101.08 0.12 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 113.965 -1.47 . . . . 1.85 111.08 174.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.88 -6.57 23.88 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.495 -0.86 . . . . 0.95 112.319 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.475 ' O ' HD12 ' A' ' 68' ' ' ILE . . . -91.82 -176.99 42.58 Favored Glycine 0 CA--C 1.5 -0.888 0 C-N-CA 120.914 -0.66 . . . . 0.99 111.7 177.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.632 ' O ' HG13 ' A' ' 18' ' ' ILE . 65.6 Cg_endo -71.89 -25.83 19.49 Favored 'Trans proline' 0 CA--C 1.509 -0.738 0 C-N-CA 122.94 2.427 . . . . 0.63 113.097 -168.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.597 ' HB3' ' HD2' ' A' ' 31' ' ' PHE . . . -67.93 -25.9 65.7 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.034 -0.985 . . . . 1.1 110.873 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -74.67 -32.47 62.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.934 0.874 . . . . 1.79 109.002 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.536 ' N ' HD13 ' A' ' 68' ' ' ILE . 1.4 mp -71.65 -44.47 69.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.477 -1.238 . . . . 1.18 110.549 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.755 ' CB ' HG11 ' A' ' 16' ' ' VAL . . . -75.3 -23.09 57.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.091 -0.504 . . . . 1.07 110.556 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.91 70.29 1.08 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.001 -1.095 . . . . 0.5 113.315 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.638 HD21 HG22 ' A' ' 57' ' ' VAL . 16.7 tp -112.17 155.24 24.28 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.25 -0.648 . . . . 1.5 109.25 174.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.403 HE21 ' HB2' ' A' ' 72' ' ' GLN . 0.5 OUTLIER -132.51 35.61 3.62 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 115.193 1.553 . . . . 1.53 115.193 -165.718 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.519 HG23 ' HA ' ' A' ' 59' ' ' ARG . 4.4 mp 68.89 -7.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 N-CA-C 113.793 1.034 . . . . 1.43 113.793 165.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.49 52.63 0.35 Allowed Glycine 0 CA--C 1.509 -0.311 0 C-N-CA 119.903 -1.141 . . . . 0.37 112.108 -170.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.61 ' HB3' HG13 ' A' ' 109' ' ' VAL . 40.7 m-20 -119.75 132.17 55.56 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.341 -0.43 . . . . 0.89 111.387 -168.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.646 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 10.8 mmmm -82.16 100.67 9.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.338 0.59 . . . . 2.71 110.466 -174.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 5.6 mt -73.64 123.38 28.62 Favored 'Isoleucine or valine' 0 C--O 1.261 1.674 0 CA-C-N 115.546 -0.752 . . . . 1.22 111.664 -176.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.803 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 10.6 mmt -94.73 -11.88 28.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 125.572 1.795 . . . . 1.61 113.075 177.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.509 ' HB3' ' CB ' ' A' ' 108' ' ' LEU . 2.6 tt0 -173.13 156.04 3.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.654 0.264 . . . . 0.88 111.513 -175.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.411 HG13 ' HE2' ' A' ' 85' ' ' MET . 12.8 p -145.36 122.93 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 121.415 0.626 . . . . 1.93 110.352 174.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.463 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 1.1 m-80 60.04 21.31 10.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.231 -0.895 . . . . 1.8 112.181 178.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.94 -10.33 55.54 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.019 -1.086 . . . . 0.38 112.432 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.449 ' CB ' ' HE3' ' A' ' 85' ' ' MET . 86.6 m95 -86.94 131.3 34.13 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 109.092 -0.707 . . . . 0.91 109.092 176.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -85.09 115.73 23.06 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.747 -1.115 . . . . 1.89 110.515 -174.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.536 ' HE2' ' HA ' ' A' ' 93' ' ' ALA . 23.2 mmt -106.66 101.12 10.59 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.097 -0.956 . . . . 1.38 111.134 -175.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 p -135.36 111.59 9.69 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.632 -1.167 . . . . 1.1 108.963 169.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 44.96 65.69 1.04 Allowed 'General case' 0 C--N 1.33 -0.28 0 O-C-N 124.052 0.845 . . . . 2.15 111.386 -176.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.699 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 3.8 p -129.71 166.48 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.146 -1.057 . . . . 1.68 108.146 172.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.654 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 71.7 p -58.35 149.63 24.15 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.987 0.736 . . . . 1.1 112.987 -175.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.815 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 19.0 t-160 -61.52 -35.71 78.5 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-O 121.499 0.666 . . . . 0.41 109.508 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.485 ' CG ' HH12 ' A' ' 94' ' ' ARG . 0.6 OUTLIER -67.27 -31.46 71.8 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 113.992 -1.458 . . . . 1.67 109.517 178.048 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.744 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 3.8 tp-100 -62.49 -51.65 66.59 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 108.965 -0.754 . . . . 0.79 108.965 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.645 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . -72.62 -36.61 68.11 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.5 -0.773 . . . . 1.06 110.195 -177.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.485 HH12 ' CG ' ' A' ' 91' ' ' ASP . 26.6 ttp-105 -67.01 -38.76 86.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.689 -0.687 . . . . 2.45 110.694 -177.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.514 ' HE3' ' O ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -70.79 -45.89 63.84 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.302 -0.629 . . . . 1.51 109.302 -178.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.744 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 25.2 mmt180 -67.71 -23.61 65.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.765 -0.652 . . . . 4.23 110.175 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.515 HD13 ' CZ ' ' A' ' 31' ' ' PHE . 4.1 tt -77.14 -53.55 7.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.674 -0.694 . . . . 2.24 110.985 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.5 m -90.97 90.23 7.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.92 0.867 . . . . 1.63 111.238 -169.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.603 ' HE2' ' O ' ' A' ' 96' ' ' ARG . 22.8 mtmt -133.85 110.11 9.53 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.023 -1.444 . . . . 3.16 109.241 176.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.454 ' HD2' ' O ' ' A' ' 25' ' ' GLU . 17.9 ptt180 -76.56 36.5 0.16 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.268 0.556 . . . . 4.79 110.833 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.464 ' H ' ' C ' ' A' ' 99' ' ' LYS . 4.0 p -124.4 -58.92 1.5 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.774 -0.648 . . . . 2.83 111.254 -176.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.22 147.84 42.93 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.084 0.468 . . . . 3.4 111.549 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -84.0 -18.74 36.15 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.66 0.615 . . . . 2.68 112.66 -172.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.66 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 6.9 p -144.01 145.36 21.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.775 0.321 . . . . 1.15 110.25 -171.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' A' ' 20' ' ' LYS . 48.9 t -114.84 118.46 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-O 122.502 1.144 . . . . 1.13 111.914 -175.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.463 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -98.75 129.81 45.2 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 113.065 -1.88 . . . . 2.28 109.766 -178.308 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.406 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 26.2 tp -133.98 125.72 28.76 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 116.218 -0.446 . . . . 1.68 110.097 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.803 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 14.6 tp -101.52 130.17 47.74 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.522 -1.288 . . . . 1.1 107.522 176.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.61 HG13 ' HB3' ' A' ' 75' ' ' ASP . 2.2 t -131.83 140.12 48.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.998 0.904 . . . . 1.39 111.018 -171.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.57 HG21 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -105.19 116.53 32.11 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.126 -0.943 . . . . 1.13 109.759 163.523 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.707 ' HG2' HG21 ' A' ' 12' ' ' VAL . 1.5 ptt180 -114.35 140.46 48.63 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.175 -0.92 . . . . 2.34 110.322 -170.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.451 HE22 ' HG2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -118.97 -41.52 2.76 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.034 0.921 . . . . 1.97 111.035 -170.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.441 ' H ' HD23 ' A' ' 114' ' ' LEU . 36.5 t -159.94 -128.84 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.029 -1.441 . . . . 2.0 107.521 -169.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.51 ' N ' HD13 ' A' ' 114' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.574 0 O-C-N 124.018 0.823 . . . . 2.0 111.826 171.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.442 -0.846 0 CA-C-O 122.307 1.051 . . . . 2.49 109.181 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.31 179.17 7.97 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.159 -1.837 . . . . 1.24 111.791 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.8 t -105.77 121.56 58.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.262 -0.881 . . . . 2.16 110.531 -176.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.511 HG21 HG21 ' A' ' 110' ' ' THR . 38.6 t -77.98 120.7 29.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.85 0.357 . . . . 1.65 110.968 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.937 HE22 HG21 ' A' ' 16' ' ' VAL . 3.7 pp0? -121.08 167.52 12.54 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.015 -0.539 . . . . 1.39 111.289 -178.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.584 ' HD3' ' O ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -124.12 113.6 18.57 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.676 0.391 . . . . 4.11 111.492 -175.778 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.937 HG21 HE22 ' A' ' 14' ' ' GLN . 2.2 t -98.16 130.76 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.753 -0.462 . . . . 1.59 109.753 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -142.51 117.81 10.19 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 110.119 -0.326 . . . . 1.35 110.119 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.511 ' HB ' ' HB1' ' A' ' 69' ' ' ALA . 11.2 tp -140.27 144.62 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 108.64 -0.874 . . . . 1.33 108.64 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.666 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.8 m-70 -77.03 111.09 12.23 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.248 -0.581 . . . . 0.7 109.772 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.508 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -23.77 136.64 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 O-C-N 125.433 1.708 . . . . 4.39 113.464 -179.425 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.1 tp -96.46 92.74 6.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.857 0.837 . . . . 1.23 109.96 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.43 ' N ' ' HD3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -65.3 135.93 55.94 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.186 -1.37 . . . . 4.63 111.275 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.405 HE21 ' HB2' ' A' ' 23' ' ' GLN . 2.1 tp-100 -138.39 93.97 2.8 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.115 -0.698 . . . . 1.5 109.115 173.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 60.59 -86.7 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.909 -0.663 . . . . 1.33 111.621 -174.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -131.89 12.07 4.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.261 0.553 . . . . 2.33 110.335 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -111.42 154.91 23.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.599 -0.728 . . . . 1.87 109.047 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.0 mp -120.8 122.13 39.66 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.431 -0.581 . . . . 2.8 109.431 174.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.8 mp -98.19 121.29 48.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 115.266 -0.879 . . . . 1.45 109.456 -177.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.637 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -89.72 -27.99 19.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.772 -1.103 . . . . 1.87 110.77 179.272 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.497 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 82.68 17.53 67.96 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.237 -0.982 . . . . 1.14 113.381 175.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.637 ' CE2' ' HB2' ' A' ' 29' ' ' LEU . 44.5 p90 -148.94 159.68 43.97 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.496 -0.557 . . . . 0.61 109.496 172.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.678 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -102.33 161.93 13.31 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 118.625 -1.23 . . . . 0.91 107.893 175.213 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -151.22 135.94 9.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 C-N-CA 119.672 -0.811 . . . . 1.24 112.658 -167.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.604 ' O ' ' HD1' ' A' ' 56' ' ' TYR . . . -147.41 117.2 0.89 Allowed Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.163 -1.175 . . . . 0.78 110.163 156.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 1.043 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.72 118.62 1.35 Allowed Glycine 0 CA--C 1.489 -1.589 0 CA-C-O 118.464 -1.186 . . . . 1.66 110.806 173.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.699 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.9 135.8 3.84 Favored Glycine 0 C--N 1.299 -1.525 0 C-N-CA 117.188 -2.434 . . . . 0.95 113.712 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.466 HG12 ' N ' ' A' ' 88' ' ' VAL . 0.6 OUTLIER -57.69 -26.58 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 107.541 -1.281 . . . . 1.15 107.541 150.062 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.808 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 0.5 OUTLIER -57.69 -39.98 78.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 113.446 -1.706 . . . . 0.72 110.435 171.075 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 . . . . . 0 N--CA 1.463 0.202 0 CA-C-N 115.266 -0.879 . . . . 1.47 110.721 -172.884 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.527 ' H ' ' HH ' ' A' ' 56' ' ' TYR . . . . . . . . 0 N--CA 1.437 -1.259 0 N-CA-C 111.064 -0.814 . . . . 0.94 111.064 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 1.043 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -110.15 145.93 16.05 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.738 0 N-CA-C 108.791 -0.818 . . . . 1.27 108.791 175.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.604 ' HD1' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -140.0 147.39 40.34 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 119.235 0.925 . . . . 1.91 110.281 -176.453 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.569 HG13 ' HB2' ' A' ' 75' ' ' ASP . 7.1 p -94.18 135.72 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 CA-C-N 115.14 -0.936 . . . . 1.22 109.796 175.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.678 ' O ' ' HB3' ' A' ' 32' ' ' SER . 21.4 m -128.32 68.49 1.36 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.765 -1.107 . . . . 1.29 109.198 176.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.555 ' HA ' HG23 ' A' ' 73' ' ' ILE . 34.0 mtm180 150.06 -179.95 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 125.512 1.525 . . . . 2.63 110.397 163.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.405 ' N ' HG12 ' A' ' 73' ' ' ILE . 40.1 t -163.55 134.77 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 O-C-N 125.542 1.776 . . . . 1.53 107.561 163.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.2 p -77.59 169.44 18.29 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.633 0.73 . . . . 2.38 111.031 175.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -103.43 128.43 50.58 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 114.783 -1.099 . . . . 1.85 110.198 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.68 -5.42 52.4 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.324 -0.853 . . . . 0.95 113.564 173.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.558 ' O ' HD12 ' A' ' 68' ' ' ILE . . . -76.24 -129.13 0.31 Allowed Glycine 0 CA--C 1.506 -0.525 0 C-N-CA 120.35 -0.929 . . . . 0.99 112.564 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.497 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 69.6 Cg_endo -102.76 -50.43 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 122.706 2.271 . . . . 0.63 115.572 177.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 29' ' ' LEU . . . -57.23 -32.43 66.52 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.534 0.938 . . . . 1.1 113.534 -172.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -74.46 -28.65 61.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.596 0.712 . . . . 1.79 109.418 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.583 ' N ' HD13 ' A' ' 68' ' ' ILE . 1.4 mp -74.32 -34.99 38.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.886 -1.052 . . . . 1.18 109.648 -178.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.673 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -77.82 -23.01 49.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.574 -0.739 . . . . 1.07 110.358 175.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.67 56.05 0.92 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.466 -0.873 . . . . 0.5 114.132 175.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.663 ' HG ' HG23 ' A' ' 16' ' ' VAL . 2.2 mt -100.56 158.52 15.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 117.302 0.551 . . . . 1.5 110.722 174.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 1.021 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 29.0 mt-30 -130.33 25.31 5.16 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 114.868 1.433 . . . . 1.53 114.868 -165.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.555 HG23 ' HA ' ' A' ' 59' ' ' ARG . 91.1 mt 72.95 -10.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 113.95 1.092 . . . . 1.43 113.95 168.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.62 60.58 0.24 Allowed Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.436 -0.888 . . . . 0.37 111.974 -166.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.569 ' HB2' HG13 ' A' ' 57' ' ' VAL . 36.6 m-20 -122.59 156.1 34.93 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.078 -0.561 . . . . 0.89 110.376 -170.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.484 ' HG3' ' HD2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -104.39 102.02 11.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.314 0.578 . . . . 2.71 109.546 -175.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 1.034 HG13 HG21 ' A' ' 109' ' ' VAL . 3.6 mp -74.71 125.37 34.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.491 -0.777 . . . . 1.22 112.311 -171.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.921 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 3.0 mmt -92.1 -18.41 23.6 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 125.607 1.817 . . . . 1.61 112.184 177.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.596 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -173.01 155.43 3.04 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.759 0.281 . . . . 0.88 111.759 -175.306 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.433 ' N ' ' HG3' ' A' ' 79' ' ' GLN . 11.7 p -142.35 126.9 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 121.291 0.567 . . . . 1.93 110.516 173.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.699 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 1.1 m-80 56.95 27.65 13.48 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.426 -0.806 . . . . 1.8 112.378 176.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.53 -11.1 63.14 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.122 -1.037 . . . . 0.38 112.605 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.468 ' HB2' ' HE3' ' A' ' 85' ' ' MET . 80.9 m95 -83.91 160.16 21.15 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 108.696 -0.853 . . . . 0.91 108.696 176.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -111.0 113.36 25.86 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.292 0.568 . . . . 1.89 111.858 -171.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.637 ' HG3' HG12 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -109.1 102.46 11.43 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.723 -0.671 . . . . 1.38 111.58 -178.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.44 -50.93 2.31 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.262 -1.014 . . . . 1.1 108.262 168.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -135.38 86.99 2.29 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.549 -1.66 . . . . 2.15 106.807 172.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.747 HG13 ' HG2' ' A' ' 92' ' ' GLN . 1.4 t -137.27 138.17 45.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.022 -0.99 . . . . 1.68 109.754 -172.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.803 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 70.4 p -57.87 147.56 28.24 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 122.159 -0.338 . . . . 1.1 111.609 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.808 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 19.8 t-160 -56.6 -40.63 75.64 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.312 0.577 . . . . 0.41 110.175 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.25 -30.45 68.58 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.455 -1.248 . . . . 1.67 110.042 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.759 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 2.3 tp-100 -63.48 -50.92 67.76 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.122 -1.066 . . . . 0.79 108.122 178.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.6 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -70.81 -32.72 69.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.532 -0.758 . . . . 1.06 110.856 -177.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -70.51 -40.04 73.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.067 -0.515 . . . . 2.45 110.666 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.432 ' HD3' ' C ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -70.27 -41.26 73.69 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.259 -0.645 . . . . 1.51 109.259 -178.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.759 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 21.9 mmt180 -71.33 -21.44 62.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.28 -0.873 . . . . 4.23 110.67 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.526 HD12 ' CZ ' ' A' ' 31' ' ' PHE . 2.4 tt -70.99 -58.22 3.79 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.938 -0.574 . . . . 2.24 110.443 175.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 m -100.71 90.04 4.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.599 0.714 . . . . 1.63 111.862 -171.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.696 ' HE2' ' O ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -110.42 118.19 35.6 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.766 -1.106 . . . . 3.16 109.34 170.476 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -68.54 31.62 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.989 0.515 . . . . 4.79 111.614 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 99' ' ' LYS . 14.2 m -139.07 -27.82 0.8 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.292 -0.413 . . . . 2.83 110.997 -173.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 66.3 mm-40 -67.13 143.1 56.82 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 110.165 -0.309 . . . . 3.4 110.165 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -94.27 -10.02 34.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.391 0.615 . . . . 2.68 109.985 176.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.666 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 6.2 p -152.32 148.42 14.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.482 -0.781 . . . . 1.15 109.482 -175.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.525 HG13 HD22 ' A' ' 81' ' ' ASN . 55.5 t -117.04 117.94 57.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 122.051 0.929 . . . . 1.13 111.53 -177.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.699 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.2 OUTLIER -99.29 133.02 44.19 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 113.426 -1.716 . . . . 2.28 110.305 -175.432 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.635 HD23 HD11 ' A' ' 71' ' ' LEU . 22.2 tp -134.63 134.69 41.49 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.541 -0.3 . . . . 1.68 110.901 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.921 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 40.0 tp -115.53 114.3 24.79 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 106.843 -1.54 . . . . 1.1 106.843 172.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 1.034 HG21 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -129.4 149.9 34.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 120.122 -0.631 . . . . 1.39 110.488 -171.545 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.511 HG21 HG21 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -97.65 115.62 28.28 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.637 0.732 . . . . 1.13 109.898 171.456 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.837 ' HB2' HE22 ' A' ' 72' ' ' GLN . 0.3 OUTLIER -99.61 136.71 39.13 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.006 -1.452 . . . . 2.34 109.596 -173.231 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.507 ' CD ' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -106.57 -56.99 2.11 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.104 -1.038 . . . . 1.97 112.762 -177.593 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.439 ' H ' ' HG2' ' A' ' 112' ' ' GLN . 23.2 t -174.95 27.83 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.609 -0.436 . . . . 2.0 112.125 -175.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 1.021 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.402 0 O-C-N 121.913 -0.492 . . . . 2.0 110.583 -175.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.442 -0.837 0 CA-C-O 121.731 0.777 . . . . 2.49 109.56 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.19 170.81 9.42 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.091 -1.413 . . . . 1.24 111.084 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.9 m -111.4 161.89 9.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.936 -1.029 . . . . 2.16 109.084 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.539 HG22 HG23 ' A' ' 110' ' ' THR . 94.6 t -106.55 119.99 56.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.267 0.556 . . . . 1.65 111.388 -176.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 1.0 HE22 HG11 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -111.47 155.49 23.14 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.507 0.67 . . . . 1.39 111.035 174.724 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.06 110.65 13.17 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.754 -0.657 . . . . 4.11 110.156 -172.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 1.006 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 12.7 m -106.29 149.58 9.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 119.434 -0.907 . . . . 1.59 110.325 176.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -145.23 121.37 10.8 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.005 -0.543 . . . . 1.35 109.953 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.526 ' HB ' ' HB1' ' A' ' 69' ' ' ALA . 10.9 tp -142.34 143.64 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 108.256 -1.016 . . . . 1.33 108.256 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.815 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.0 m-70 -74.96 117.67 17.06 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.307 -0.557 . . . . 0.7 109.528 -176.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.542 ' HD3' ' HG ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -29.47 127.16 0.11 Allowed 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.776 1.297 . . . . 4.39 111.256 177.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.416 ' HB3' ' HB ' ' A' ' 28' ' ' ILE . 45.6 tp -98.05 101.74 13.3 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.252 0.548 . . . . 1.23 110.478 -173.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -69.43 135.49 50.31 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.371 0.605 . . . . 4.63 111.366 -176.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -128.86 93.59 3.64 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.433 -0.951 . . . . 1.5 108.433 174.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.21 -87.94 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.772 -0.931 . . . . 1.33 110.772 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.52 14.34 4.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.324 0.583 . . . . 2.33 110.776 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -108.98 159.76 16.56 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.682 -0.69 . . . . 1.87 109.492 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.542 ' HG ' ' HD3' ' A' ' 20' ' ' LYS . 9.0 mp -112.77 119.18 37.14 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 109.062 -0.718 . . . . 2.8 109.062 174.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 40.5 mm -98.73 109.55 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 115.415 -0.811 . . . . 1.45 109.981 -176.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.653 HD12 HD11 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -83.93 -25.61 29.98 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.463 -1.244 . . . . 1.87 109.088 175.355 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.408 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 93.67 -27.11 13.14 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.119 -0.946 . . . . 1.14 112.673 174.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.621 ' HD2' ' HB1' ' A' ' 66' ' ' ALA . 32.8 p90 -110.43 151.32 27.65 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 122.291 -0.535 . . . . 0.61 111.384 -173.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.533 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 10.2 t -101.82 158.43 16.13 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 107.578 -1.267 . . . . 0.91 107.578 175.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -160.19 143.04 4.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 C-N-CA 120.158 -0.617 . . . . 1.24 112.529 -163.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.444 ' HA2' ' CD2' ' A' ' 90' ' ' HIS . . . -139.51 118.28 1.48 Allowed Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 110.007 -1.237 . . . . 0.78 110.007 154.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.996 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.39 119.06 1.43 Allowed Glycine 0 CA--C 1.491 -1.419 0 CA-C-O 118.518 -1.157 . . . . 1.66 111.42 172.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.658 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.29 146.49 10.78 Favored Glycine 0 C--N 1.303 -1.3 0 C-N-CA 117.304 -2.379 . . . . 0.95 113.1 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.451 HG12 ' N ' ' A' ' 88' ' ' VAL . 1.1 pt -68.43 -19.74 24.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 107.562 -1.273 . . . . 1.15 107.562 151.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.754 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 2.5 t70 -58.8 -36.6 74.75 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.026 -1.443 . . . . 0.72 109.541 168.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 . . . . . 0 C--N 1.338 0.067 0 CA-C-N 114.73 -1.123 . . . . 1.47 109.793 -176.843 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.4 ' C ' HD11 ' A' ' 55' ' ' ILE . . . . . . . . 0 C--O 1.241 0.567 0 N-CA-C 111.613 -0.595 . . . . 0.94 111.613 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.996 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -111.32 143.89 20.28 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 N-CA-C 106.846 -1.539 . . . . 1.27 106.846 172.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.732 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -154.96 148.35 25.11 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 120.155 1.343 . . . . 1.91 112.039 -178.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.527 HG22 HD23 ' A' ' 71' ' ' LEU . 1.5 p -87.49 136.68 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-N 114.529 -1.214 . . . . 1.22 110.421 -175.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.2 m -105.34 -11.97 16.25 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.116 -0.947 . . . . 1.29 110.697 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.689 ' O ' HG22 ' A' ' 60' ' ' VAL . 41.3 mtt180 -145.54 -170.11 3.38 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.083 0.771 . . . . 2.63 113.083 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 59' ' ' ARG . 53.2 t -170.33 146.37 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.37 1.868 . . . . 1.53 106.627 167.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.4 p -97.48 123.49 41.36 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.674 0.75 . . . . 2.38 112.088 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -66.0 112.34 3.79 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 113.658 -1.61 . . . . 1.85 110.359 169.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.76 -3.03 48.91 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.164 -0.925 . . . . 0.95 112.634 -177.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.616 ' O ' HD11 ' A' ' 68' ' ' ILE . . . -91.52 -139.66 8.63 Favored Glycine 0 CA--C 1.501 -0.835 0 C-N-CA 120.367 -0.921 . . . . 0.99 111.785 178.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.491 ' HB2' HG23 ' A' ' 18' ' ' ILE . 77.6 Cg_endo -102.07 -50.07 0.01 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 122.73 2.287 . . . . 0.63 114.959 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.621 ' HB1' ' HD2' ' A' ' 31' ' ' PHE . . . -50.45 -29.46 10.38 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.589 0.959 . . . . 1.1 113.589 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -71.46 -32.22 68.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.745 0.784 . . . . 1.79 109.463 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.616 HD11 ' O ' ' A' ' 64' ' ' GLY . 1.5 mp -79.08 -36.54 18.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.444 -1.253 . . . . 1.18 108.516 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 1.006 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . . . -66.17 -35.11 79.6 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.409 -1.268 . . . . 1.07 109.91 173.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.43 33.15 2.77 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.223 -0.989 . . . . 0.5 114.233 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.527 HD23 HG22 ' A' ' 57' ' ' VAL . 17.8 tp -90.66 154.79 19.31 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.466 -0.568 . . . . 1.5 109.466 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.432 HE22 ' HG3' ' A' ' 111' ' ' ARG . 4.6 mt-30 -129.34 31.89 4.76 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 115.449 1.648 . . . . 1.53 115.449 -165.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 73' ' ' ILE . 58.1 mt 71.33 2.1 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 CA-C-N 118.993 0.815 . . . . 1.43 113.188 167.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.17 46.19 0.25 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 119.58 -1.295 . . . . 0.37 112.439 -170.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.436 ' HB2' HG12 ' A' ' 57' ' ' VAL . 20.0 m-20 -119.83 142.31 48.74 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.331 -0.435 . . . . 0.89 110.864 -169.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.732 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 13.0 mptt -96.68 102.64 14.46 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.803 0.811 . . . . 2.71 111.0 -171.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.8 HG13 HG22 ' A' ' 109' ' ' VAL . 2.8 mp -63.05 123.42 15.78 Favored 'Isoleucine or valine' 0 C--O 1.255 1.342 0 CA-C-N 115.274 -0.876 . . . . 1.22 112.505 -178.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.886 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 2.0 mmt -91.74 -18.99 23.09 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 113.494 -1.685 . . . . 1.61 111.281 173.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.596 ' HB3' HD21 ' A' ' 108' ' ' LEU . 4.3 tt0 -172.03 151.53 2.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.071 -0.513 . . . . 0.88 111.876 -174.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.614 HG13 ' CE ' ' A' ' 85' ' ' MET . 9.8 p -145.53 127.21 8.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.729 -0.669 . . . . 1.93 109.735 173.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 58.44 20.0 7.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.75 -0.659 . . . . 1.8 111.874 178.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.69 -7.86 53.88 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 119.733 -1.222 . . . . 0.38 113.368 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.48 ' HB2' ' HE1' ' A' ' 85' ' ' MET . 68.0 m95 -85.21 159.85 20.02 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 117.451 0.626 . . . . 0.91 110.014 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -102.46 113.72 27.3 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.668 -0.696 . . . . 1.89 111.454 -172.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.614 ' CE ' HG13 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -104.57 100.58 10.25 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 122.667 1.222 . . . . 1.38 110.116 179.219 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.6 p -142.16 -49.9 0.38 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 112.854 -1.975 . . . . 1.1 105.83 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.41 ' HA ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -133.97 75.15 1.58 Allowed 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 112.178 -2.283 . . . . 2.15 108.828 173.4 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.783 ' O ' HD12 ' A' ' 55' ' ' ILE . 1.2 t -132.72 138.55 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 108.007 -1.108 . . . . 1.68 108.007 177.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.715 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 68.8 p -59.5 152.16 22.48 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.884 -0.51 . . . . 1.1 112.018 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.798 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 16.5 t-160 -57.25 -38.0 73.19 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-O 122.516 1.15 . . . . 0.41 109.925 -177.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -71.66 -31.78 67.18 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 112.79 -2.005 . . . . 1.67 109.889 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.717 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.5 OUTLIER -65.55 -39.15 91.38 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 108.158 -1.053 . . . . 0.79 108.158 179.842 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.574 ' HB1' HG12 ' A' ' 55' ' ' ILE . . . -74.75 -41.6 59.78 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.439 -1.255 . . . . 1.06 109.793 -176.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -68.22 -37.79 81.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.287 -0.869 . . . . 2.45 110.661 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.472 ' HD3' ' HD2' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -70.97 -30.09 66.26 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.012 0.434 . . . . 1.51 109.844 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.717 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 9.4 mmm180 -76.23 -24.35 54.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.223 -0.444 . . . . 4.23 111.881 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.653 HD11 HD12 ' A' ' 29' ' ' LEU . 3.3 pp -96.92 -8.26 31.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.236 0.458 . . . . 2.24 112.236 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.521 HG21 ' HB2' ' A' ' 27' ' ' LEU . 31.5 m -145.02 97.6 3.04 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.183 0.516 . . . . 1.63 111.225 174.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.478 ' HG3' ' HB2' ' A' ' 101' ' ' SER . 5.2 ptpp? -142.56 9.7 1.81 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.592 -0.731 . . . . 3.16 112.403 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 39.4 mtm-85 63.96 24.15 13.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.61 -0.723 . . . . 4.79 110.886 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.478 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 69.8 m -153.63 83.95 1.17 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.335 0.588 . . . . 2.83 110.46 -178.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.472 ' C ' ' H ' ' A' ' 104' ' ' VAL . 1.2 pm0 -163.0 -44.74 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.538 -0.755 . . . . 3.4 110.085 178.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 71.76 -41.97 0.52 Allowed 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.34 1.025 . . . . 2.68 111.045 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.815 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 2.7 p -133.33 133.4 57.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.351 -1.352 . . . . 1.15 107.351 176.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 53.3 t -109.85 119.37 58.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 122.151 0.976 . . . . 1.13 112.198 -171.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.93 123.05 41.74 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 113.397 -1.729 . . . . 2.28 109.803 -176.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.459 HD11 HG12 ' A' ' 77' ' ' ILE . 11.1 tp -131.42 116.76 17.93 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.656 -0.702 . . . . 1.68 111.171 -173.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.886 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 41.0 tp -104.31 117.87 35.24 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.611 -1.255 . . . . 1.1 107.611 177.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.8 HG22 HG13 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -131.35 152.4 37.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-O 121.38 0.61 . . . . 1.39 110.803 -173.092 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.539 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -97.53 117.21 31.28 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.721 -0.672 . . . . 1.13 110.321 171.429 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.596 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 30.7 ttt180 -97.76 136.48 38.03 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.597 -1.183 . . . . 2.34 110.375 -177.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.437 ' N ' ' CD ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -123.02 -70.61 0.76 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.753 0.649 . . . . 1.97 112.753 -174.181 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.09 27.79 0.52 Allowed 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.266 -0.574 . . . . 2.0 112.418 -170.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 114' ' ' LEU . 2.3 mm? . . . . . 0 C--N 1.323 -0.545 0 CA-C-O 121.485 0.66 . . . . 2.0 110.11 177.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.446 -0.668 0 CA-C-O 123.283 1.516 . . . . 2.49 111.078 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.3 179.05 5.31 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 112.087 -2.324 . . . . 1.24 109.758 173.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.17 108.41 25.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.328 -0.396 . . . . 2.16 110.386 -174.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.569 HG21 HG22 ' A' ' 110' ' ' THR . 26.1 t -76.83 98.52 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.291 0.567 . . . . 1.65 110.203 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.929 HE22 HG21 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -103.3 165.02 11.28 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.68 -0.691 . . . . 1.39 111.122 178.259 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.41 ' H ' ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -126.07 116.98 22.24 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.704 -0.623 . . . . 4.11 110.987 -178.791 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.929 HG21 HE22 ' A' ' 14' ' ' GLN . 4.9 t -88.85 127.41 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 115.303 -0.862 . . . . 1.59 109.597 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 31.9 tt0 -131.03 116.99 18.52 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.437 -0.579 . . . . 1.35 109.437 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.1 tp -145.1 146.43 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 108.562 -0.903 . . . . 1.33 108.562 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.72 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.3 m-70 -68.85 119.14 12.74 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.175 -0.676 . . . . 0.7 109.175 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.874 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -37.44 133.41 0.73 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.944 0.778 . . . . 4.39 110.105 171.782 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.5 tp -94.02 85.9 4.86 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.959 0.885 . . . . 1.23 109.747 -170.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -84.55 139.33 32.2 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.15 -1.386 . . . . 4.63 111.783 -174.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.508 ' HG3' HD13 ' A' ' 28' ' ' ILE . 2.9 mt-30 -139.47 94.14 2.75 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.125 -0.943 . . . . 1.5 109.145 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.68 -73.6 0.24 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.014 -0.612 . . . . 1.33 112.547 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -139.45 1.69 1.98 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.416 0.627 . . . . 2.33 110.388 -177.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -114.06 120.63 41.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.567 -0.742 . . . . 1.87 109.465 -173.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.528 HD22 ' HA ' ' A' ' 100' ' ' ARG . 7.6 mp -103.09 116.62 32.86 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.103 -0.703 . . . . 2.8 109.103 176.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.508 HD13 ' HG3' ' A' ' 23' ' ' GLN . 1.8 mp -96.01 126.5 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 115.493 -0.776 . . . . 1.45 110.2 -172.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 31' ' ' PHE . 0.4 OUTLIER -103.38 109.12 20.63 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.334 -1.303 . . . . 1.87 108.041 174.037 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.647 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -77.92 43.5 2.2 Favored Glycine 0 C--O 1.216 -0.987 0 C-N-CA 121.016 -0.611 . . . . 1.14 112.574 -175.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.595 ' HB2' ' CG2' ' A' ' 57' ' ' VAL . 40.0 p90 -159.7 147.15 16.84 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.417 -1.327 . . . . 0.61 107.417 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.617 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -102.4 163.82 12.02 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 118.466 -1.294 . . . . 0.91 107.605 176.184 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.526 HD13 HD22 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -154.26 139.83 10.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 119.242 -0.983 . . . . 1.24 113.0 -168.261 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -141.09 118.07 1.32 Allowed Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 109.83 -1.308 . . . . 0.78 109.83 154.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 1.041 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -142.39 117.69 1.18 Allowed Glycine 0 C--N 1.302 -1.323 0 CA-C-O 118.251 -1.305 . . . . 1.66 111.577 170.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.63 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.8 141.93 7.26 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 117.641 -2.219 . . . . 0.95 113.507 175.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.434 HG12 ' C ' ' A' ' 88' ' ' VAL . 13.7 pt -61.9 -20.37 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 N-CA-C 107.363 -1.347 . . . . 1.15 107.363 151.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.826 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 3.0 t70 -59.32 -43.95 92.65 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 113.588 -1.642 . . . . 0.72 109.759 171.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 . . . . . 0 CA--C 1.533 0.309 0 CA-C-N 115.008 -0.996 . . . . 1.47 109.967 -178.489 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 110.064 -1.214 . . . . 0.94 110.064 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 1.041 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -116.5 135.06 57.98 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.145 0 N-CA-C 107.423 -1.325 . . . . 1.27 107.423 174.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.68 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -152.49 150.53 29.71 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.052 0.842 . . . . 1.91 111.485 -177.245 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.595 ' CG2' ' HB2' ' A' ' 31' ' ' PHE . 10.0 p -93.5 133.58 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 114.574 -1.193 . . . . 1.22 111.191 -169.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.617 ' O ' ' HB3' ' A' ' 32' ' ' SER . 32.6 m -123.89 70.32 1.07 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.803 -1.09 . . . . 1.29 109.479 174.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.582 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 41.8 mtt180 151.73 177.25 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 125.47 1.508 . . . . 2.63 110.823 163.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 91.7 t -161.36 138.49 2.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 125.432 1.707 . . . . 1.53 107.249 163.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.7 p -86.16 122.93 30.86 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.191 0.519 . . . . 2.38 110.87 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -48.67 117.3 1.97 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.315 -1.311 . . . . 1.85 111.855 171.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.15 12.3 84.75 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.656 -0.783 . . . . 0.95 113.222 173.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.585 ' O ' HD12 ' A' ' 68' ' ' ILE . . . -87.29 -132.63 3.63 Favored Glycine 0 C--O 1.22 -0.755 0 C-N-CA 119.942 -1.123 . . . . 0.99 111.31 174.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.647 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 97.6 Cg_endo -101.15 -42.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.538 2.159 . . . . 0.63 115.463 177.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.563 ' HB2' ' HD1' ' A' ' 31' ' ' PHE . . . -64.48 -27.1 68.75 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.0 -0.546 . . . . 1.1 111.898 -173.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -70.81 -33.34 70.6 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.652 0.739 . . . . 1.79 109.151 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.585 HD12 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -71.48 -40.37 72.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.496 -1.229 . . . . 1.18 110.627 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.721 ' CB ' HG12 ' A' ' 16' ' ' VAL . . . -77.61 -15.59 59.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 1.07 110.626 177.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.0 47.68 2.83 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.124 -1.036 . . . . 0.5 114.123 173.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.496 HD22 HG21 ' A' ' 57' ' ' VAL . 19.7 tp -97.68 149.98 21.68 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.94 -0.763 . . . . 1.5 108.94 176.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.688 HE22 ' HG3' ' A' ' 111' ' ' ARG . 7.6 mt-30 -122.56 33.31 5.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 114.576 1.324 . . . . 1.53 114.576 -165.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.586 HG23 ' O ' ' A' ' 73' ' ' ILE . 56.2 mt 72.05 -1.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 113.185 0.809 . . . . 1.43 113.185 165.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -173.08 52.23 0.16 Allowed Glycine 0 CA--C 1.509 -0.298 0 C-N-CA 120.084 -1.055 . . . . 0.37 111.999 -164.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.425 ' H ' ' CG1' ' A' ' 57' ' ' VAL . 43.9 m-20 -120.48 149.67 42.02 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.157 -0.521 . . . . 0.89 110.603 -172.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.68 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -95.4 101.54 13.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.332 -0.394 . . . . 2.71 110.593 -173.71 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.655 HD11 ' HA ' ' A' ' 56' ' ' TYR . 4.3 mt -72.72 123.01 26.55 Favored 'Isoleucine or valine' 0 C--O 1.261 1.669 0 CA-C-O 121.434 0.635 . . . . 1.22 112.424 -175.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.623 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 4.2 mmt -89.92 -19.49 24.49 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 113.242 -1.799 . . . . 1.61 112.286 176.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.533 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -172.39 157.21 3.99 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.184 0.438 . . . . 0.88 112.184 -174.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.604 HG12 ' SD ' ' A' ' 85' ' ' MET . 12.3 p -141.59 122.74 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.247 0.546 . . . . 1.93 110.712 171.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.7 m120 50.1 36.5 12.29 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.371 -0.831 . . . . 1.8 112.192 176.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.67 -18.66 49.87 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.451 -0.88 . . . . 0.38 113.244 175.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.479 ' CB ' ' HE3' ' A' ' 85' ' ' MET . 52.9 m95 -81.84 149.39 28.34 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 109.684 -0.488 . . . . 0.91 109.684 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -95.91 116.33 28.76 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.635 -0.711 . . . . 1.89 111.0 -175.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.604 ' SD ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -105.8 99.36 8.96 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 122.626 1.203 . . . . 1.38 110.177 177.567 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.1 p -138.09 -44.42 0.51 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.112 -1.858 . . . . 1.1 106.765 173.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.428 ' HA ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -148.46 75.15 1.31 Allowed 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.514 -1.676 . . . . 2.15 109.674 177.284 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.63 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -140.96 154.25 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 108.779 -0.823 . . . . 1.68 108.779 173.723 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.7 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 74.7 p -60.01 151.95 25.09 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 113.168 0.803 . . . . 1.1 113.168 -173.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.826 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 21.5 t-160 -58.81 -40.37 83.92 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 115.74 -0.664 . . . . 0.41 110.092 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -66.17 -31.01 71.6 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.13 -1.395 . . . . 1.67 109.838 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.579 ' HB3' ' O ' ' A' ' 89' ' ' THR . 1.9 tp-100 -63.63 -51.81 63.57 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.677 0.751 . . . . 0.79 109.514 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.53 ' HB2' HG12 ' A' ' 55' ' ' ILE . . . -72.54 -33.38 66.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.935 -1.029 . . . . 1.06 109.801 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 90' ' ' HIS . 11.3 ttp180 -61.77 -48.46 80.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.2 -0.909 . . . . 2.45 110.642 -177.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.647 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -70.52 -28.45 64.95 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 119.768 -0.773 . . . . 1.51 110.647 -179.738 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.547 ' HD2' ' HD3' ' A' ' 95' ' ' LYS . 1.8 mmm180 -70.0 -41.66 74.07 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.196 -0.601 . . . . 4.23 112.155 -177.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.567 ' HB3' HG22 ' A' ' 80' ' ' VAL . 3.3 pp -80.58 -25.21 38.64 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.636 -0.426 . . . . 2.24 110.965 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.473 ' N ' HD12 ' A' ' 97' ' ' LEU . 21.5 m -153.68 95.27 1.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.442 0.639 . . . . 1.63 111.436 178.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.647 ' HB3' ' O ' ' A' ' 95' ' ' LYS . 7.0 ptpt -112.67 9.89 19.32 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.454 -0.794 . . . . 3.16 109.118 174.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.528 ' HA ' HD22 ' A' ' 27' ' ' LEU . 11.9 mtt180 70.01 19.05 7.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.09 -1.414 . . . . 4.79 111.904 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.6 t -137.29 9.96 2.98 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 120.623 -0.431 . . . . 2.83 111.827 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.469 ' HB2' ' HG3' ' A' ' 20' ' ' LYS . 6.1 mm-40 -85.39 148.48 25.99 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.998 0.428 . . . . 3.4 111.398 -177.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.515 ' HG3' HG12 ' A' ' 104' ' ' VAL . 7.3 pt-20 -95.83 -49.71 5.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.881 -0.6 . . . . 2.68 110.702 178.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.72 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 2.6 p -143.69 142.14 25.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.166 -1.05 . . . . 1.15 108.166 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.637 HG21 ' HG2' ' A' ' 20' ' ' LYS . 42.1 t -123.3 117.85 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 CA-C-O 122.22 1.01 . . . . 1.13 112.403 -164.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -101.16 127.32 47.78 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 112.865 -1.97 . . . . 2.28 109.954 -174.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.518 HD11 HG12 ' A' ' 77' ' ' ILE . 20.7 tp -130.87 124.4 31.12 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.915 -0.584 . . . . 1.68 109.587 -174.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.623 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 33.9 tp -100.31 119.84 39.02 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.247 -1.761 . . . . 1.1 106.247 176.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.701 HG11 ' HG3' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -126.6 150.66 32.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.239 0.542 . . . . 1.39 109.946 -171.763 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.569 HG22 HG21 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -98.07 115.13 27.6 Favored 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 119.436 -0.906 . . . . 1.13 109.421 168.266 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.688 ' HG3' HE22 ' A' ' 72' ' ' GLN . 7.9 ttm180 -105.39 149.23 26.3 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.384 -1.28 . . . . 2.34 110.704 -171.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.446 HE21 HD12 ' A' ' 114' ' ' LEU . 0.9 OUTLIER -138.29 -156.22 0.67 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.352 -0.981 . . . . 1.97 108.352 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.03 72.5 8.37 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.846 0.831 . . . . 2.0 112.223 -171.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 3.3 mt . . . . . 0 C--N 1.31 -1.114 0 CA-C-N 114.445 -1.252 . . . . 2.0 107.734 175.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.438 -1.07 0 CA-C-O 122.64 1.21 . . . . 2.49 110.115 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.497 ' HB1' HG21 ' A' ' 110' ' ' THR . . . -92.76 132.35 37.03 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 113.01 -1.905 . . . . 1.24 108.584 170.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 p -107.23 123.45 62.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.047 -0.524 . . . . 2.16 110.231 -173.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.755 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 1.0 OUTLIER -81.33 128.2 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 121.861 0.838 . . . . 1.65 111.124 -173.564 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.844 HE22 HG22 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -101.87 167.34 10.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.92 -1.036 . . . . 1.39 111.172 173.383 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.449 ' N ' HE21 ' A' ' 14' ' ' GLN . 0.0 OUTLIER -124.82 106.83 10.33 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.688 -0.687 . . . . 4.11 110.027 -174.109 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.844 HG22 HE22 ' A' ' 14' ' ' GLN . 1.5 t -104.78 133.19 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 109.857 -0.423 . . . . 1.59 109.857 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -137.81 126.66 23.99 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.778 -0.453 . . . . 1.35 109.778 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.517 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 9.8 tp -142.91 161.57 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 108.239 -1.023 . . . . 1.33 108.239 -178.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -95.2 113.09 24.73 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.822 -0.751 . . . . 0.7 109.838 -175.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.837 ' HB2' HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -26.8 130.01 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 125.125 1.515 . . . . 4.39 112.341 179.544 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 36.1 tp -100.61 95.76 6.9 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 119.936 -0.705 . . . . 1.23 109.208 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -74.67 140.02 43.92 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.499 -0.773 . . . . 4.63 111.54 -172.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.516 ' HB2' HD13 ' A' ' 28' ' ' ILE . 4.3 tp-100 -134.58 93.99 3.13 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.393 -0.966 . . . . 1.5 108.393 177.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.07 -83.28 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.686 -0.768 . . . . 1.33 111.545 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.775 ' HB3' HH11 ' A' ' 100' ' ' ARG . 30.5 mt-10 -132.38 8.24 4.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.926 0.393 . . . . 2.33 110.572 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -109.02 166.97 10.43 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.257 -0.428 . . . . 1.87 110.762 -173.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.991 HD22 ' HA ' ' A' ' 98' ' ' THR . 4.9 tp -119.91 122.86 42.2 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.78 -0.646 . . . . 2.8 109.388 173.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.516 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.7 mp -98.44 113.83 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 107.66 -1.237 . . . . 1.45 107.66 173.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.528 HD12 ' CE2' ' A' ' 31' ' ' PHE . 1.1 pt? -95.02 -15.31 23.58 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.053 -0.976 . . . . 1.87 110.833 -173.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.519 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 87.06 -9.65 71.66 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.45 -0.881 . . . . 1.14 113.718 172.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.781 ' HD1' ' HB2' ' A' ' 66' ' ' ALA . 48.5 p90 -133.43 165.72 24.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.296 0.548 . . . . 0.61 110.801 178.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.689 ' HB3' ' O ' ' A' ' 58' ' ' THR . 7.8 t -106.07 171.56 7.28 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.41 -0.589 . . . . 0.91 109.41 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.646 HG12 ' HE2' ' A' ' 90' ' ' HIS . 5.4 tt -150.17 131.83 5.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 C-N-CA 120.564 -0.454 . . . . 1.24 111.675 -167.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -102.97 171.66 20.94 Favored Glycine 0 C--O 1.237 0.341 0 N-CA-C 110.693 -0.963 . . . . 0.78 110.693 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.976 ' HA3' ' NE2' ' A' ' 39' ' ' GLN . . . -114.6 169.3 12.82 Favored Glycine 0 N--CA 1.42 -2.389 0 N-CA-C 118.855 2.302 . . . . 1.66 118.855 -160.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.448 ' H ' ' HB2' ' A' ' 90' ' ' HIS . . . -87.58 -162.14 37.53 Favored Glycine 0 N--CA 1.415 -2.726 0 CA-C-N 110.073 -3.063 . . . . 0.95 113.5 -165.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.56 HD11 ' O ' ' A' ' 87' ' ' MET . 27.5 pt -55.88 -9.6 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.434 0.635 . . . . 1.15 111.002 168.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 1.026 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 0.2 OUTLIER -59.92 -40.73 89.9 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.262 -0.881 . . . . 0.72 109.629 173.424 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.976 ' NE2' ' HA3' ' A' ' 35' ' ' GLY . 28.4 mt-30 . . . . . 0 CA--C 1.502 -0.899 0 CA-C-N 114.788 -1.096 . . . . 1.47 110.956 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.452 0 N-CA-C 111.63 -0.588 . . . . 0.94 111.63 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.532 HG23 ' CD1' ' A' ' 77' ' ' ILE . 2.2 mp -99.93 132.39 45.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 108.347 -0.983 . . . . 1.27 108.347 168.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.528 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -155.01 138.76 16.17 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 120.898 0.38 . . . . 1.91 110.339 -170.369 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 32' ' ' SER . 8.6 p -67.38 129.37 31.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.648 -0.706 . . . . 1.22 110.484 -176.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.689 ' O ' ' HB3' ' A' ' 32' ' ' SER . 18.5 m -125.64 59.59 1.28 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.463 -0.79 . . . . 1.29 109.896 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.584 ' HA ' HG22 ' A' ' 73' ' ' ILE . 13.9 mtt180 154.49 -179.88 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 126.084 1.754 . . . . 2.63 109.979 167.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 59' ' ' ARG . 88.0 t -166.7 125.71 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 O-C-N 125.638 1.836 . . . . 1.53 106.348 163.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.8 m -85.15 128.27 34.59 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.889 -0.725 . . . . 2.38 109.259 174.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -65.15 106.36 1.29 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.374 -0.83 . . . . 1.85 110.4 174.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 120.64 -21.56 8.48 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.27 -1.332 . . . . 0.95 110.396 -173.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 67' ' ' GLU . . . -72.76 152.82 48.05 Favored Glycine 0 CA--C 1.495 -1.214 0 N-CA-C 111.384 -0.686 . . . . 0.99 111.384 172.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.519 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 83.3 Cg_exo -47.13 -30.9 11.09 Favored 'Trans proline' 0 C--N 1.325 -0.659 0 C-N-CA 123.882 3.055 . . . . 0.63 114.17 -176.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.781 ' HB2' ' HD1' ' A' ' 31' ' ' PHE . . . -66.75 -26.73 67.12 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.016 -0.538 . . . . 1.1 111.454 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.493 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 5.5 tp10 -68.36 -31.61 71.12 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.247 0.546 . . . . 1.79 109.821 174.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.612 ' N ' HD13 ' A' ' 68' ' ' ILE . 2.7 mp -81.05 -36.78 15.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.807 -0.633 . . . . 1.18 109.938 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.717 ' HB1' HG11 ' A' ' 16' ' ' VAL . . . -79.56 -31.79 42.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.553 -0.748 . . . . 1.07 110.456 176.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.18 69.36 0.95 Allowed Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.442 -0.885 . . . . 0.5 113.562 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.439 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 21.9 tp -116.05 158.32 23.33 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.738 -0.468 . . . . 1.5 109.738 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.538 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 5.1 mt-30 -125.43 29.81 5.94 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 115.196 1.554 . . . . 1.53 115.196 -163.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' A' ' 59' ' ' ARG . 82.6 mt 75.97 -10.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 N-CA-C 114.621 1.341 . . . . 1.43 114.621 165.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -166.75 52.22 0.25 Allowed Glycine 0 N--CA 1.465 0.569 0 C-N-CA 118.983 -1.579 . . . . 0.37 113.432 -165.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.487 ' H ' ' CG1' ' A' ' 57' ' ' VAL . 17.6 m-20 -122.42 147.1 46.72 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.38 -0.41 . . . . 0.89 110.407 -172.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.528 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 1.3 mptm? -91.74 120.85 32.84 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-O 121.014 0.435 . . . . 2.71 110.673 -176.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.683 HG12 HD12 ' A' ' 107' ' ' LEU . 5.9 mt -80.3 120.46 31.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.172 0.511 . . . . 1.22 112.206 -170.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 1.012 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 11.0 mmt -88.38 -20.97 24.59 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.507 -1.224 . . . . 1.61 111.326 177.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.57 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -171.71 157.82 4.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.988 0.423 . . . . 0.88 111.2 -178.609 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.62 HG23 ' HG ' ' A' ' 97' ' ' LEU . 9.5 p -146.55 126.53 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.985 -0.552 . . . . 1.93 109.778 172.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.45 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 1.0 OUTLIER 62.64 9.72 3.69 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.015 -0.539 . . . . 1.8 112.213 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.89 -10.68 27.43 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.244 -0.979 . . . . 0.38 112.485 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.413 ' CD1' ' HB3' ' A' ' 96' ' ' ARG . 81.4 m95 -82.39 143.16 31.41 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 120.819 0.342 . . . . 0.91 110.587 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -92.06 110.88 22.25 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.235 -0.893 . . . . 1.89 111.84 -170.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.484 ' HE1' HG11 ' A' ' 80' ' ' VAL . 20.6 mmt -109.35 122.19 46.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.906 -0.588 . . . . 1.38 112.227 -175.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.5 p -137.38 -72.29 0.43 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.45 0.643 . . . . 1.1 109.281 167.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.56 ' O ' HD11 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -125.19 62.39 1.18 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.272 -0.876 . . . . 2.15 109.099 177.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.488 HG23 HE21 ' A' ' 92' ' ' GLN . 3.6 p -112.34 177.32 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 108.835 -0.802 . . . . 1.68 108.835 177.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 1.026 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 63.1 p -72.22 153.07 41.8 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 118.283 0.492 . . . . 1.1 111.432 -177.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.871 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 23.7 t-160 -56.78 -41.6 77.94 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 121.896 0.855 . . . . 0.41 108.928 177.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -67.25 -30.35 70.23 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.186 -1.824 . . . . 1.67 109.855 -175.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.808 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 2.4 tp-100 -59.65 -53.38 58.66 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.378 -0.601 . . . . 0.79 109.378 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 97' ' ' LEU . . . -74.38 -30.62 62.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.654 -0.703 . . . . 1.06 110.297 -176.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -63.35 -47.43 82.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.424 -0.807 . . . . 2.45 110.47 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.427 ' HD3' ' C ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -71.84 -41.73 67.78 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.743 -0.662 . . . . 1.51 109.823 -174.462 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.808 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 22.4 mmt180 -69.0 -24.3 64.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.927 -0.579 . . . . 4.23 110.271 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.62 ' HG ' HG23 ' A' ' 80' ' ' VAL . 3.8 tt -79.93 -52.47 7.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.777 -0.647 . . . . 2.24 110.86 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.991 ' HA ' HD22 ' A' ' 27' ' ' LEU . 5.3 m -94.83 92.05 6.75 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 122.685 1.231 . . . . 1.63 110.901 -169.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.48 ' HE3' ' HB2' ' A' ' 99' ' ' LYS . 3.6 mtmt -134.95 110.65 9.24 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 112.8 -2.0 . . . . 3.16 109.552 -177.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.775 HH11 ' HB3' ' A' ' 25' ' ' GLU . 37.6 ptt180 -67.4 5.31 0.79 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.73 -0.668 . . . . 4.79 112.105 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.447 ' H ' ' C ' ' A' ' 99' ' ' LYS . 3.0 p -107.73 -23.26 12.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.496 -0.32 . . . . 2.83 111.634 -174.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -68.16 151.61 46.73 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.193 -0.299 . . . . 3.4 110.193 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -97.71 -20.27 17.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.313 0.578 . . . . 2.68 110.315 175.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.29 145.27 18.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.783 -0.644 . . . . 1.15 109.51 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 74.5 t -113.53 118.35 57.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 122.089 0.947 . . . . 1.13 111.709 -176.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.45 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -99.29 134.55 41.99 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 113.619 -1.628 . . . . 2.28 110.298 -176.239 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.683 HD12 HG12 ' A' ' 77' ' ' ILE . 37.0 tp -132.86 132.33 41.98 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.199 -0.455 . . . . 1.68 110.596 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 1.012 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 40.1 tp -115.22 114.02 24.68 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.211 -1.774 . . . . 1.1 106.211 171.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.644 HG13 ' HG3' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -127.26 150.38 33.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 109.991 -0.374 . . . . 1.39 109.991 -171.331 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.755 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -95.88 121.26 37.43 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 120.32 -0.552 . . . . 1.13 110.936 171.258 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.432 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 2.4 ttt180 -110.46 139.53 45.58 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.876 -1.056 . . . . 2.34 110.987 -171.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.63 -107.04 0.35 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.899 -0.591 . . . . 1.97 111.468 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.406 ' O ' HD21 ' A' ' 114' ' ' LEU . 13.9 t -131.91 81.08 1.95 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.635 0.731 . . . . 2.0 110.579 -173.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 3.1 mt . . . . . 0 C--N 1.309 -1.159 0 CA-C-N 114.875 -1.057 . . . . 2.0 109.518 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.6 p . . . . . 0 N--CA 1.429 -1.515 0 CA-C-O 122.461 1.124 . . . . 2.49 110.413 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' A' ' 111' ' ' ARG . . . -88.76 177.83 6.62 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.97 -1.923 . . . . 1.24 110.618 176.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.67 129.59 40.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.658 -0.701 . . . . 2.16 110.169 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 45.1 t -77.04 112.93 15.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.969 0.414 . . . . 1.65 111.553 -175.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.642 ' HG3' HG13 ' A' ' 109' ' ' VAL . 0.1 OUTLIER -111.41 166.6 10.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.92 -0.582 . . . . 1.39 109.98 171.478 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -120.93 138.64 54.02 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 120.797 -1.189 . . . . 4.11 111.302 -176.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.645 HG12 ' CB ' ' A' ' 69' ' ' ALA . 19.7 t -108.29 108.57 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 CA-C-N 115.325 -0.852 . . . . 1.59 109.492 177.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -122.23 111.57 17.11 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.394 -0.821 . . . . 1.35 109.532 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.775 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 10.8 tp -134.89 147.93 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 108.817 -0.809 . . . . 1.33 108.817 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.635 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 14.2 m-70 -78.15 105.9 9.68 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.395 -0.965 . . . . 0.7 108.395 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.72 ' HB3' HG22 ' A' ' 105' ' ' VAL . 2.5 pptp? -27.34 139.89 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 O-C-N 125.376 1.672 . . . . 4.39 112.924 -175.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 43.8 tp -93.62 85.8 4.99 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 122.175 0.988 . . . . 1.23 109.703 -171.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.595 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -54.41 134.41 45.72 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 113.639 -1.619 . . . . 4.63 112.136 -175.291 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.506 ' HB2' HD12 ' A' ' 28' ' ' ILE . 6.3 tp-100 -123.78 94.5 4.25 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.501 -1.227 . . . . 1.5 108.471 176.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.77 -84.37 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.493 -0.86 . . . . 1.33 111.289 -173.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -129.57 6.73 5.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.199 0.523 . . . . 2.33 110.694 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 3.8 m-80 -110.71 -177.11 3.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.697 -0.683 . . . . 1.87 109.871 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.632 ' HB2' ' HB2' ' A' ' 20' ' ' LYS . 1.6 pt? -127.73 144.78 51.06 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.202 -1.036 . . . . 2.8 108.202 172.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.506 HD12 ' HB2' ' A' ' 23' ' ' GLN . 1.1 mp -113.24 139.96 35.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-O 121.142 0.496 . . . . 1.45 110.711 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.25 127.34 47.89 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.667 -1.152 . . . . 1.87 109.144 173.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.725 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -95.08 48.8 1.96 Allowed Glycine 0 C--O 1.22 -0.731 0 C-N-CA 120.165 -1.016 . . . . 1.14 113.154 -172.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 35.3 p90 -158.52 163.1 37.39 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.634 -0.876 . . . . 0.61 108.634 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.565 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.1 OUTLIER -105.14 161.06 14.58 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.865 -1.161 . . . . 0.91 107.865 170.569 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -156.72 137.32 4.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 119.107 -1.037 . . . . 1.24 113.757 -165.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.429 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -146.63 118.22 1.02 Allowed Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.43 -1.068 . . . . 0.78 110.43 156.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 1.053 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.45 117.48 1.22 Allowed Glycine 0 CA--C 1.492 -1.356 0 CA-C-O 118.641 -1.088 . . . . 1.66 111.401 172.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.29 143.25 8.12 Favored Glycine 0 C--N 1.299 -1.496 0 C-N-CA 117.929 -2.081 . . . . 0.95 112.954 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.634 HG12 ' O ' ' A' ' 87' ' ' MET . 5.2 pt -59.89 -26.1 34.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 106.813 -1.551 . . . . 1.15 106.813 151.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.997 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 6.0 t70 -53.08 -44.68 67.72 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 113.003 -1.908 . . . . 0.72 110.752 173.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 . . . . . 0 CA--C 1.535 0.393 0 CA-C-N 114.811 -1.086 . . . . 1.47 111.668 -172.497 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.202 0 N-CA-C 110.862 -0.895 . . . . 0.94 110.862 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 1.053 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -114.76 138.39 45.08 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 109.018 -0.734 . . . . 1.27 109.018 174.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.626 ' HA ' HD13 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -142.94 140.04 30.95 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 119.185 0.902 . . . . 1.91 110.405 -176.23 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.58 HG22 HD21 ' A' ' 71' ' ' LEU . 8.8 p -82.92 138.84 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 CA-C-N 114.623 -1.172 . . . . 1.22 110.056 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.669 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 23.5 m -127.98 68.55 1.33 Allowed 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.153 -0.931 . . . . 1.29 109.33 172.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 24.1 mtp180 148.54 -171.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.637 1.575 . . . . 2.63 111.001 162.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 58.4 t -162.14 143.5 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 125.543 1.777 . . . . 1.53 107.622 164.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.3 p -86.65 133.84 33.66 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.611 0.719 . . . . 2.38 110.88 175.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -71.45 105.62 3.64 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.195 -1.366 . . . . 1.85 111.055 178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.21 9.65 50.74 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 119.764 -1.208 . . . . 0.95 113.093 176.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.643 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -90.18 -140.05 8.08 Favored Glycine 0 C--O 1.217 -0.938 0 C-N-CA 120.279 -0.962 . . . . 0.99 111.082 175.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.725 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 66.0 Cg_endo -98.26 -32.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 122.475 2.116 . . . . 0.63 114.525 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.49 ' HB3' HG12 ' A' ' 60' ' ' VAL . . . -71.99 -22.83 61.37 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.906 -0.588 . . . . 1.1 111.727 -174.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -71.96 -30.92 65.78 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.626 -0.879 . . . . 1.79 108.626 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.643 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -81.57 -44.18 20.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.539 -1.21 . . . . 1.18 110.41 -176.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.775 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . . . -68.25 -26.4 65.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.936 -0.575 . . . . 1.07 110.31 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.08 70.03 1.01 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.368 -0.92 . . . . 0.5 113.278 177.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.58 HD21 HG22 ' A' ' 57' ' ' VAL . 13.9 tp -113.75 153.52 28.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.192 -0.669 . . . . 1.5 109.192 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.601 HE22 ' HG3' ' A' ' 111' ' ' ARG . 12.3 mt-30 -123.65 29.36 6.6 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 114.83 1.419 . . . . 1.53 114.83 -166.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.669 ' O ' ' HA ' ' A' ' 58' ' ' THR . 2.9 mp 72.06 -12.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 N-CA-C 113.418 0.895 . . . . 1.43 113.418 171.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -164.31 60.89 0.25 Allowed Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.225 -0.988 . . . . 0.37 111.407 -165.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.554 ' HB2' HG13 ' A' ' 57' ' ' VAL . 17.4 m-20 -123.09 153.26 40.16 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.015 -0.593 . . . . 0.89 109.593 -169.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -104.09 100.31 10.06 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.125 -0.63 . . . . 2.71 109.77 -177.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.978 HG13 HG22 ' A' ' 109' ' ' VAL . 4.8 mp -75.0 128.91 37.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.55 -0.75 . . . . 1.22 110.053 -175.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -114.02 4.6 15.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 112.863 0.69 . . . . 1.61 112.863 -179.067 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.531 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 2.2 tt0 -172.11 152.38 2.86 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 122.442 -0.161 . . . . 0.88 111.095 176.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.766 HG21 ' HB3' ' A' ' 97' ' ' LEU . 7.0 p -150.06 130.81 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 121.237 0.541 . . . . 1.93 111.317 175.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.494 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 14.3 m120 50.37 34.3 8.87 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.149 0.979 . . . . 1.8 112.787 176.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.32 3.62 64.95 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.482 -0.866 . . . . 0.38 113.24 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -99.74 161.61 13.51 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 109.524 -0.547 . . . . 0.91 109.524 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -110.69 97.78 7.11 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.45 -0.795 . . . . 1.89 110.082 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.752 ' HB2' HD12 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -107.45 98.15 7.8 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 122.151 0.977 . . . . 1.38 109.731 174.359 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.18 -10.57 13.85 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.982 -1.463 . . . . 1.1 107.841 175.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.634 ' O ' HG12 ' A' ' 37' ' ' ILE . 1.9 mtt -149.89 -42.29 0.13 Allowed 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 112.543 -2.117 . . . . 2.15 108.905 -171.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.711 HG11 ' HG2' ' A' ' 92' ' ' GLN . 0.9 OUTLIER -22.68 141.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 C-N-CA 126.249 1.82 . . . . 1.68 115.711 -177.825 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.997 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 49.7 p -58.17 154.1 13.72 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 112.475 0.546 . . . . 1.1 112.475 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.757 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 22.1 t-160 -56.27 -44.42 79.74 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 115.988 -0.551 . . . . 0.41 110.66 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.8 -31.76 68.61 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.13 -0.941 . . . . 1.67 110.139 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.779 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.7 OUTLIER -64.36 -49.69 70.65 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.78 -0.822 . . . . 0.79 108.78 -178.68 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.612 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -74.13 -32.88 63.35 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.709 -0.678 . . . . 1.06 110.528 -177.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.516 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 35.1 ttp180 -64.16 -44.58 91.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 2.45 109.991 177.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.464 ' HD3' ' C ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -67.02 -36.29 81.79 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.688 -0.687 . . . . 1.51 109.481 -178.609 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.779 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 22.7 mmt180 -70.96 -23.9 62.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.988 -0.551 . . . . 4.23 111.193 -176.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.766 ' HB3' HG21 ' A' ' 80' ' ' VAL . 3.4 pp -94.41 -15.09 24.6 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.964 -0.294 . . . . 2.24 110.901 177.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.2 m -111.53 89.47 3.06 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.866 0.841 . . . . 1.63 110.888 -175.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.434 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 12.1 mtmt -136.7 103.99 5.39 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.476 -1.238 . . . . 3.16 109.548 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.476 ' CB ' ' HA ' ' A' ' 26' ' ' ASN . 38.1 ptt180 -76.11 53.65 0.81 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.479 0.657 . . . . 4.79 111.072 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.0 t -140.41 -51.43 0.48 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.533 -0.758 . . . . 2.83 110.201 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 41.5 mt-10 -69.09 150.8 47.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.832 0.348 . . . . 3.4 111.303 -177.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.675 ' HA ' ' HZ1' ' A' ' 20' ' ' LYS . 10.3 pt-20 -84.83 -15.46 44.71 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.834 0.679 . . . . 2.68 112.834 -174.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.635 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 5.7 p -149.13 149.28 15.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.868 0.365 . . . . 1.15 110.274 -172.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.72 HG22 ' HB3' ' A' ' 20' ' ' LYS . 44.2 t -120.72 118.83 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 121.906 0.86 . . . . 1.13 111.523 -173.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER -99.75 125.18 45.6 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.593 -1.639 . . . . 2.28 110.385 -175.164 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.48 HD23 ' HB ' ' A' ' 16' ' ' VAL . 10.1 tt -133.73 128.09 34.18 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.547 -0.297 . . . . 1.68 110.229 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.531 ' HB3' ' HB3' ' A' ' 79' ' ' GLN . 9.8 tp -101.37 114.27 28.12 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 107.347 -1.353 . . . . 1.1 107.347 174.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.978 HG22 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -111.37 150.29 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 CA-C-O 121.522 0.677 . . . . 1.39 109.665 -175.382 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 1.3 m -97.35 113.48 25.13 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 118.512 -1.275 . . . . 1.13 108.748 167.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.601 ' HG3' HE22 ' A' ' 72' ' ' GLN . 1.0 OUTLIER -91.9 153.9 19.2 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.14 -1.391 . . . . 2.34 109.951 -173.257 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.467 ' N ' ' HG2' ' A' ' 111' ' ' ARG . 0.1 OUTLIER -125.1 -95.16 0.47 Allowed 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.692 -0.403 . . . . 1.97 111.675 -177.509 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.437 ' H ' ' CG ' ' A' ' 112' ' ' GLN . 9.0 t -149.78 38.33 0.75 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.645 0.736 . . . . 2.0 110.764 -170.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 6.3 mt . . . . . 0 C--N 1.314 -0.94 0 CA-C-N 115.21 -0.905 . . . . 2.0 109.225 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptm . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 120.277 0.084 . . . . 14.35 111.192 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 p -126.34 111.03 14.04 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.813 0.339 . . . . 11.48 111.385 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -157.3 122.85 4.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.919 -0.582 . . . . 9.53 109.743 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.568 HG13 ' HG3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -117.21 98.71 52.25 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-O 121.171 0.51 . . . . 6.82 110.252 -179.096 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.3 -41.66 20.42 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.711 2.274 . . . . 7.95 111.265 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.35 32.12 0.44 Allowed Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.512 -0.767 . . . . 6.42 111.311 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.548 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 3.5 pt20 -145.12 41.49 0.31 Allowed Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 114.16 1.17 . . . . 6.63 114.16 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.568 ' HG3' HG13 ' A' ' 4' ' ' ILE . 35.2 Cg_exo -56.79 122.62 12.13 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.753 1.636 . . . . 3.98 111.899 172.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.9 t 75.16 -44.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.33 0.652 . . . . 2.77 111.866 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 t -76.32 83.42 3.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 123.362 1.553 . . . . 2.49 111.175 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.65 178.77 5.36 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 112.515 -2.13 . . . . 1.24 110.509 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.0 t -106.32 110.95 33.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.762 -0.654 . . . . 2.16 110.52 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 110' ' ' THR . 33.6 t -77.66 108.45 10.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.751 -0.462 . . . . 1.65 109.751 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 1.038 ' HG2' ' HD3' ' A' ' 111' ' ' ARG . 0.3 OUTLIER -113.33 169.47 8.93 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.257 -0.577 . . . . 1.39 111.801 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -115.43 126.76 54.75 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.016 0.436 . . . . 4.11 111.719 -175.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.857 HG21 HE22 ' A' ' 14' ' ' GLN . 26.2 t -107.39 121.85 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.614 -0.721 . . . . 1.59 109.323 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -143.82 111.94 6.26 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.748 -0.464 . . . . 1.35 109.748 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.485 HG12 ' HB2' ' A' ' 65' ' ' PRO . 9.6 tp -139.18 148.79 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.568 -0.901 . . . . 1.33 108.568 -176.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 16.5 m-70 -79.36 115.8 19.22 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.981 -0.687 . . . . 0.7 109.411 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.848 ' HB2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -26.93 139.07 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 O-C-N 125.142 1.526 . . . . 4.39 112.715 178.402 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.1 tp -97.66 93.91 6.67 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 121.418 -0.802 . . . . 1.23 110.31 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -60.81 143.06 55.43 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.366 0.603 . . . . 4.63 112.183 -173.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.527 ' HB2' HD13 ' A' ' 28' ' ' ILE . 4.3 tp-100 -140.88 94.9 2.77 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.283 -0.871 . . . . 1.5 109.493 174.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.86 -82.49 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.042 -0.599 . . . . 1.33 112.506 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.513 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 18.2 mt-10 -118.4 -17.35 9.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.098 0.475 . . . . 2.33 110.561 -177.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.454 ' OD1' ' HB3' ' A' ' 23' ' ' GLN . 1.0 OUTLIER -112.85 -177.66 3.19 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.895 -0.593 . . . . 1.87 111.679 -169.162 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.848 HD13 ' HB2' ' A' ' 20' ' ' LYS . 2.1 pt? -126.98 138.25 53.23 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.764 -1.199 . . . . 2.8 107.764 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.3 mp -101.46 130.14 51.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.42 0.628 . . . . 1.45 110.4 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.449 HD11 HD11 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -96.08 125.47 40.64 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.088 -1.414 . . . . 1.87 108.652 172.051 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.424 ' O ' HG12 ' A' ' 60' ' ' VAL . . . -85.47 41.24 3.05 Favored Glycine 0 C--O 1.22 -0.745 0 C-N-CA 120.386 -0.911 . . . . 1.14 112.648 -175.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.619 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 42.5 p90 -157.07 154.67 29.86 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 122.752 0.421 . . . . 0.61 110.385 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.493 ' CB ' ' HB2' ' A' ' 59' ' ' ARG . 8.1 t -103.98 159.25 15.82 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.085 -1.45 . . . . 0.91 107.085 169.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -160.69 141.59 3.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 112.745 0.646 . . . . 1.24 112.745 -165.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.428 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -144.44 119.16 1.23 Allowed Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 110.089 -1.205 . . . . 0.78 110.089 157.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 1.049 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.92 118.14 1.27 Allowed Glycine 0 CA--C 1.492 -1.358 0 CA-C-O 118.555 -1.136 . . . . 1.66 111.621 171.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.722 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.69 143.77 8.58 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 117.483 -2.294 . . . . 0.95 113.796 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.3 pt -61.65 -19.31 20.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.104 -1.073 . . . . 1.15 108.104 149.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.828 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 0.4 OUTLIER -66.18 -35.15 79.71 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.749 -1.569 . . . . 0.72 109.97 174.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.502 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 29.2 mm-40 -71.37 -166.37 0.18 Allowed 'General case' 0 C--N 1.339 0.143 0 CA-C-N 115.065 -0.971 . . . . 1.47 110.713 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -85.44 104.91 5.68 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 116.03 -0.532 . . . . 2.57 110.736 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 39' ' ' GLN . 4.4 Cg_exo -83.97 6.91 5.5 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 123.653 2.902 . . . . 2.82 112.8 -177.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.8 t -95.54 32.21 1.85 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.059 -0.519 . . . . 3.26 111.37 -171.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -137.92 14.71 2.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.438 0.637 . . . . 3.88 109.614 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.959 ' HB3' ' HB2' ' A' ' 48' ' ' GLU . 9.3 p30 -178.72 59.24 0.12 Allowed Pre-proline 0 N--CA 1.435 -1.209 0 N-CA-C 107.967 -1.123 . . . . 5.7 107.967 -166.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.97 -4.54 10.34 Favored 'Trans proline' 0 CA--C 1.527 0.139 0 C-N-CA 122.817 2.345 . . . . 4.03 112.474 -169.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.406 ' C ' ' HG ' ' A' ' 47' ' ' SER . 77.4 m-85 -134.24 -53.82 0.85 Allowed 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.479 -1.304 . . . . 6.35 107.479 173.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.406 ' HG ' ' C ' ' A' ' 46' ' ' PHE . 7.0 m -160.2 156.42 26.57 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.677 -0.86 . . . . 3.85 108.677 173.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.959 ' HB2' ' HB3' ' A' ' 44' ' ' ASN . 37.5 tt0 -108.77 -26.5 10.27 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.726 0.774 . . . . 6.78 109.917 170.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.856 ' HB3' HG21 ' A' ' 51' ' ' THR . 20.8 t70 178.75 -144.49 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 104.771 -2.307 . . . . 5.47 104.771 -169.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.969 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 1.5 tmtp? -83.74 4.57 28.31 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 122.011 0.91 . . . . 3.54 108.613 170.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.856 HG21 ' HB3' ' A' ' 49' ' ' ASP . 1.7 t -84.33 -58.07 2.9 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.479 -0.782 . . . . 4.89 111.375 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.5 t70 44.81 -120.78 0.83 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.236 0.458 . . . . 2.6 112.236 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.553 ' HE3' ' OD1' ' A' ' 44' ' ' ASN . 20.6 mmtm -104.53 21.46 16.73 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 109.081 -0.711 . . . . 3.98 109.081 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.449 ' C ' HD13 ' A' ' 55' ' ' ILE . . . -85.5 -162.74 36.48 Favored Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 114.729 -1.123 . . . . 0.94 110.901 -174.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 1.049 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -111.32 141.45 26.67 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 N-CA-C 107.297 -1.372 . . . . 1.27 107.297 176.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.655 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER -152.21 145.2 24.49 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 119.405 1.002 . . . . 1.91 110.99 -177.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.7 p -85.59 133.23 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-N 114.597 -1.183 . . . . 1.22 110.471 -171.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 37.7 m -100.09 -16.23 17.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.942 -1.026 . . . . 1.29 110.822 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.687 ' O ' HG22 ' A' ' 60' ' ' VAL . 72.2 mtt180 -149.04 -169.4 3.36 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.667 0.618 . . . . 2.63 112.667 175.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.687 HG22 ' O ' ' A' ' 59' ' ' ARG . 79.4 t -167.84 138.27 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 113.271 -1.786 . . . . 1.53 107.212 163.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.5 p -82.29 126.27 31.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.232 0.539 . . . . 2.38 110.88 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -57.19 112.24 1.31 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.429 -1.259 . . . . 1.85 110.841 171.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.0 -2.43 66.13 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.51 -0.852 . . . . 0.95 112.566 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.528 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -92.33 173.58 35.92 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 120.569 -0.824 . . . . 0.99 111.623 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.485 ' HB2' HG12 ' A' ' 18' ' ' ILE . 64.8 Cg_endo -70.7 -22.81 27.25 Favored 'Trans proline' 0 CA--C 1.504 -1.002 0 C-N-CA 122.732 2.288 . . . . 0.63 113.477 -165.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.537 ' HB1' ' HD1' ' A' ' 31' ' ' PHE . . . -66.84 -32.7 74.15 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.731 -1.122 . . . . 1.1 110.882 176.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -77.74 -30.08 51.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.236 0.541 . . . . 1.79 109.609 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.543 HD11 ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -68.98 -36.98 76.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.374 -0.83 . . . . 1.18 109.629 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.605 ' CB ' HG12 ' A' ' 16' ' ' VAL . . . -78.11 -25.34 47.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.746 -0.661 . . . . 1.07 110.838 176.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.89 43.62 1.9 Allowed Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.355 -0.926 . . . . 0.5 113.874 177.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.462 ' C ' HG21 ' A' ' 60' ' ' VAL . 14.1 tp -95.1 148.7 22.07 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.44 -0.948 . . . . 1.5 108.44 174.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.637 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 14.4 mt-30 -134.28 40.07 3.04 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 116.018 1.858 . . . . 1.53 116.018 -161.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.553 HG23 ' HA ' ' A' ' 59' ' ' ARG . 59.1 mt 69.85 -11.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 114.654 1.353 . . . . 1.43 114.654 162.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.37 43.72 0.33 Allowed Glycine 0 CA--C 1.508 -0.348 0 C-N-CA 120.163 -1.018 . . . . 0.37 111.846 -170.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.637 ' OD2' ' HB2' ' A' ' 72' ' ' GLN . 9.3 m-20 -119.61 141.27 49.45 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.047 -0.576 . . . . 0.89 111.831 -168.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.969 ' HG3' ' HB3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -87.47 102.95 15.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.333 -0.849 . . . . 2.71 111.16 -175.352 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.531 HD11 ' CA ' ' A' ' 56' ' ' TYR . 5.1 mt -73.63 122.99 27.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 114.772 -1.104 . . . . 1.22 111.874 -177.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.808 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 2.2 mmt -93.32 -9.19 39.75 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.945 -1.025 . . . . 1.61 113.399 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.577 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -167.88 150.99 5.86 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.05 0.452 . . . . 0.88 112.196 -178.608 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.616 HG21 ' HB2' ' A' ' 93' ' ' ALA . 40.6 t -133.05 112.06 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 114.927 -1.033 . . . . 1.93 110.316 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.92 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 14.4 m120 57.4 27.85 14.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.727 -0.669 . . . . 1.8 112.613 174.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.84 -13.37 53.22 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 119.987 -1.101 . . . . 0.38 112.353 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.524 ' HB2' ' HE1' ' A' ' 85' ' ' MET . 74.1 m95 -80.68 170.16 16.68 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.875 -0.787 . . . . 0.91 108.875 176.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -115.47 112.88 22.92 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.098 0.475 . . . . 1.89 111.141 -172.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.649 ' HE2' HG11 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -106.28 100.88 10.39 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 122.43 1.11 . . . . 1.38 110.676 -177.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.9 p -137.22 -41.27 0.58 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.536 -1.665 . . . . 1.1 107.73 173.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.61 73.98 1.34 Allowed 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 112.777 -2.01 . . . . 2.15 108.31 174.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.722 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.2 t -135.57 140.76 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 108.89 -0.782 . . . . 1.68 108.89 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.655 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 70.1 p -55.77 148.75 15.89 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.08 0.467 . . . . 1.1 112.111 -177.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.828 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 21.8 t-160 -54.28 -42.94 70.59 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-O 121.616 0.722 . . . . 0.41 110.131 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.72 -30.38 66.9 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.188 -1.369 . . . . 1.67 110.445 -177.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.676 ' HG2' HG12 ' A' ' 88' ' ' VAL . 1.8 tp-100 -60.05 -47.62 85.12 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 122.039 0.923 . . . . 0.79 108.537 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.622 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -74.47 -40.95 61.54 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.433 -1.258 . . . . 1.06 110.444 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -66.22 -40.66 90.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.639 -0.71 . . . . 2.45 110.715 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.453 ' HD3' ' C ' ' A' ' 95' ' ' LYS . 1.2 tmtp? -64.33 -38.01 89.53 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 116.006 -0.543 . . . . 1.51 109.541 -177.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 9.9 mmm180 -64.83 -48.9 72.69 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.823 -0.626 . . . . 4.23 111.352 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.449 HD11 HD11 ' A' ' 29' ' ' LEU . 3.8 pp -79.25 -1.86 38.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.467 -0.333 . . . . 2.24 111.756 -176.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.56 ' HA ' HD22 ' A' ' 27' ' ' LEU . 3.3 m -115.84 23.55 12.18 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 122.114 0.959 . . . . 1.63 109.884 173.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.977 ' HE2' ' HA ' ' A' ' 99' ' ' LYS . 5.8 mmpt? -81.76 112.56 19.03 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.431 -0.804 . . . . 3.16 108.983 169.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.513 ' HD2' ' O ' ' A' ' 25' ' ' GLU . 35.6 ptt180 -71.26 19.06 0.06 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.652 -0.704 . . . . 4.79 111.023 -177.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.58 ' H ' ' C ' ' A' ' 99' ' ' LYS . 5.8 p -115.02 -22.96 9.29 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.32 -0.855 . . . . 2.83 109.948 -176.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -72.0 91.86 1.25 Allowed 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 122.13 0.967 . . . . 3.4 109.956 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.537 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 5.2 tp10 -52.5 -29.63 26.04 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.142 -1.845 . . . . 2.68 111.107 175.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 7.7 p -134.63 141.95 41.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.882 -0.784 . . . . 1.15 108.882 176.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.4 t -114.21 118.81 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 122.053 0.93 . . . . 1.13 112.168 -171.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.92 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.3 OUTLIER -101.08 126.16 47.75 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.584 -1.643 . . . . 2.28 111.942 -173.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.526 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 9.4 tt -134.75 129.11 34.14 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.316 -0.402 . . . . 1.68 109.999 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.808 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 24.5 tp -102.73 124.27 47.95 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 106.489 -1.671 . . . . 1.1 106.489 175.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.654 HG11 ' HG3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -127.47 145.22 35.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 119.147 -1.021 . . . . 1.39 111.648 -174.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.541 HG22 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -99.54 113.38 25.74 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.611 -0.836 . . . . 1.13 109.737 166.004 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 1.038 ' HD3' ' HG2' ' A' ' 14' ' ' GLN . 1.1 ptt180 -107.19 127.35 53.43 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.281 -1.327 . . . . 2.34 108.943 -174.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.57 ' N ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -99.53 -55.99 2.52 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.838 0.681 . . . . 1.97 112.838 -165.422 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.464 ' N ' ' HG2' ' A' ' 112' ' ' GLN . 1.4 t -159.93 19.13 0.16 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.181 -0.608 . . . . 2.0 111.037 -173.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -79.64 70.07 6.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.671 0.748 . . . . 2.0 109.271 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -82.08 125.25 30.62 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.922 -1.035 . . . . 3.83 111.171 -174.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -138.33 131.57 30.24 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.542 -0.754 . . . . 3.96 109.402 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 72.15 21.76 3.84 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.905 0.753 . . . . 3.76 111.179 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.0 p -62.82 128.5 24.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.045 -0.525 . . . . 5.11 110.298 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -93.52 133.18 37.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.94 -0.573 . . . . 8.35 110.753 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -77.57 145.28 36.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 6.63 111.13 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 50.9 m -144.97 108.8 4.71 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.617 -0.512 . . . . 8.94 109.617 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 43.1 tpp -79.83 109.66 14.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.09 -0.505 . . . . 12.46 111.471 -175.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.5 mt -95.58 116.11 28.38 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.022 -0.536 . . . . 13.06 109.683 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.585 -0.721 . . . . 14.64 110.741 -176.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.8 mmm . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.972 0.415 . . . . 14.35 110.7 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.9 p -129.59 -19.64 3.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.208 -0.451 . . . . 11.48 110.956 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -115.58 125.85 53.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.425 -0.352 . . . . 9.53 110.719 -174.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.556 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 19.0 pt -113.16 104.07 55.67 Favored Pre-proline 0 N--CA 1.451 -0.424 0 CA-C-O 121.126 0.489 . . . . 6.82 109.996 173.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 4' ' ' ILE . 7.2 Cg_exo -73.91 -44.2 0.5 Allowed 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.784 2.322 . . . . 7.95 113.204 -175.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.87 -4.26 69.67 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.727 -0.749 . . . . 6.42 112.803 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 57.25 86.95 0.15 Allowed Pre-proline 0 N--CA 1.466 0.371 0 CA-C-O 121.334 0.588 . . . . 6.63 111.68 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.556 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 3.3 Cg_endo -87.27 109.14 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.43 2.753 . . . . 3.98 111.48 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.433 ' HB ' ' O ' ' A' ' 8' ' ' PRO . 69.5 t 70.84 -59.26 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 123.542 0.526 . . . . 2.77 111.263 -175.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.1 p -75.59 82.48 2.61 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 121.995 0.902 . . . . 2.49 110.651 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 111' ' ' ARG . . . -94.52 179.25 5.34 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.629 -1.623 . . . . 1.24 109.662 176.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 m -112.91 124.02 69.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.235 0.541 . . . . 2.16 110.523 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.584 HG22 HG23 ' A' ' 110' ' ' THR . 21.5 t -81.76 106.22 12.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.27 0.557 . . . . 1.65 110.025 -175.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.975 HE22 HG21 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -101.74 170.05 8.42 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.289 -0.869 . . . . 1.39 112.051 -177.235 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -115.02 139.83 49.54 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 116.112 -0.494 . . . . 4.11 111.359 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.975 HG21 HE22 ' A' ' 14' ' ' GLN . 12.4 t -128.86 126.46 64.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.868 -0.79 . . . . 1.59 108.868 173.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -142.09 121.52 13.21 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 122.11 -0.369 . . . . 1.35 110.188 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.525 HG12 ' HB2' ' A' ' 65' ' ' PRO . 10.9 tp -145.15 147.53 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 N-CA-C 108.973 -0.751 . . . . 1.33 108.973 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.72 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 13.5 m-70 -76.15 114.83 15.26 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.62 -0.511 . . . . 0.7 109.62 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.83 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -28.82 129.27 0.08 Allowed 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.437 1.086 . . . . 4.39 112.358 176.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.5 tp -99.88 89.94 4.25 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.469 0.652 . . . . 1.23 109.857 -173.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -77.58 143.49 38.28 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.185 -0.916 . . . . 4.63 112.213 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.53 94.17 3.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.844 -1.071 . . . . 1.5 108.142 175.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.31 -83.65 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.607 -0.806 . . . . 1.33 111.671 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -137.59 12.51 2.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.224 0.535 . . . . 2.33 110.724 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -115.93 135.73 53.71 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 108.584 -0.895 . . . . 1.87 108.584 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.502 HD21 ' HG3' ' A' ' 20' ' ' LYS . 9.6 mp -107.42 123.78 48.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.585 0.707 . . . . 2.8 110.959 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.419 ' O ' ' HE2' ' A' ' 20' ' ' LYS . 1.9 mp -98.15 129.47 48.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 114.933 -1.03 . . . . 1.45 110.06 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.469 HD23 ' OG1' ' A' ' 98' ' ' THR . 0.1 OUTLIER -89.81 -31.08 17.54 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.791 -0.641 . . . . 1.87 110.867 -176.603 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.847 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 86.55 9.92 74.44 Favored Glycine 0 C--O 1.224 -0.501 0 C-N-CA 120.591 -0.814 . . . . 1.14 112.559 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.614 ' HD2' ' HB1' ' A' ' 66' ' ' ALA . 47.0 p90 -150.28 149.53 30.27 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.72 0.295 . . . . 0.61 110.237 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.654 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -102.47 150.19 23.63 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.827 -0.805 . . . . 0.91 108.827 172.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.432 HG12 ' N ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -157.01 145.35 11.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 112.283 0.475 . . . . 1.24 112.283 -163.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.432 ' N ' HG12 ' A' ' 33' ' ' ILE . . . -142.1 119.0 1.37 Allowed Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 110.572 -1.011 . . . . 0.78 110.572 157.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.975 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -139.38 118.59 1.54 Allowed Glycine 0 CA--C 1.493 -1.328 0 CA-C-O 118.388 -1.229 . . . . 1.66 111.119 170.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -168.6 142.8 7.65 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 117.751 -2.166 . . . . 0.95 113.258 178.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.702 HG12 ' O ' ' A' ' 87' ' ' MET . 0.5 OUTLIER -65.71 -22.6 31.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 106.726 -1.583 . . . . 1.15 106.726 153.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.76 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 1.1 t70 -58.18 -36.72 73.48 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 112.839 -1.982 . . . . 0.72 109.222 169.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -74.43 -67.93 0.58 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.165 -0.925 . . . . 1.47 110.488 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -161.05 113.36 1.29 Allowed Pre-proline 0 N--CA 1.461 0.112 0 CA-C-O 120.74 0.305 . . . . 2.57 110.802 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -95.46 10.6 1.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.847 3.031 . . . . 2.82 112.768 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.1 t -101.45 -10.6 20.04 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.399 0.518 . . . . 3.26 112.399 -164.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.439 HE21 ' HB3' ' A' ' 43' ' ' GLN . 1.7 pt20 -124.1 25.91 7.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.364 0.602 . . . . 3.88 109.956 -176.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.409 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 12.6 p30 -178.09 47.71 0.04 OUTLIER Pre-proline 0 N--CA 1.442 -0.837 0 CA-C-N 115.489 -0.778 . . . . 5.7 109.107 -166.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 44' ' ' ASN . 14.0 Cg_endo -53.88 -31.61 63.4 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.674 2.249 . . . . 4.03 111.05 -170.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -121.6 -53.34 2.0 Allowed 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 106.514 -1.661 . . . . 6.35 106.514 170.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.0 p -159.42 160.6 35.03 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 114.736 -1.12 . . . . 3.85 110.102 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -109.53 -30.21 8.03 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.939 -0.763 . . . . 6.78 108.939 171.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -175.2 -96.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.814 -1.085 . . . . 5.47 108.638 -176.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.504 ' HA ' ' CE ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -130.47 8.26 4.99 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.619 -0.882 . . . . 3.54 108.619 163.689 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.05 -48.22 6.6 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 108.431 -0.951 . . . . 4.89 108.431 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 44.89 -142.13 0.24 Allowed 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 114.835 -1.075 . . . . 2.6 112.082 170.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.428 ' C ' ' HD2' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -118.0 30.53 7.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.147 -0.933 . . . . 3.98 109.206 176.568 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.408 ' C ' HD12 ' A' ' 55' ' ' ILE . . . -78.58 -155.28 8.32 Favored Glycine 0 N--CA 1.44 -1.048 0 N-CA-C 109.984 -1.246 . . . . 0.94 109.984 -178.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.975 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.7 mp -114.48 125.14 71.72 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.765 0 N-CA-C 108.225 -1.028 . . . . 1.27 108.225 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.939 ' HA ' HD13 ' A' ' 77' ' ' ILE . 0.8 OUTLIER -145.4 148.33 33.22 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 119.984 1.266 . . . . 1.91 112.261 -172.157 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.504 HG21 HD23 ' A' ' 71' ' ' LEU . 3.4 p -87.11 136.46 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-N 114.172 -1.376 . . . . 1.22 110.489 -173.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.3 m -106.33 -15.01 14.94 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.034 -0.984 . . . . 1.29 110.615 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.654 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 42.1 mtp180 -149.82 -167.16 2.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.024 0.75 . . . . 2.63 113.024 177.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 51.0 t -161.88 154.9 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 106.197 -1.779 . . . . 1.53 106.197 166.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.2 p -104.41 131.33 51.89 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.622 0.725 . . . . 2.38 111.552 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -63.42 107.57 1.14 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.464 -1.244 . . . . 1.85 111.281 175.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.74 -14.95 45.56 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 115.144 -0.935 . . . . 0.95 111.58 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.461 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -78.32 178.22 52.95 Favored Glycine 0 N--CA 1.438 -1.171 0 C-N-CA 120.514 -0.85 . . . . 0.99 111.451 177.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.847 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 97.4 Cg_endo -74.77 -27.15 10.73 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 122.379 2.053 . . . . 0.63 113.334 -168.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.614 ' HB1' ' HD2' ' A' ' 31' ' ' PHE . . . -66.11 -26.41 67.45 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.169 -0.923 . . . . 1.1 111.139 176.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -72.94 -31.45 64.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.805 0.812 . . . . 1.79 109.114 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.557 HD11 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -76.19 -39.8 35.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.908 -1.042 . . . . 1.18 110.631 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.627 ' CB ' HG12 ' A' ' 16' ' ' VAL . . . -77.85 -15.59 58.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.0 -0.545 . . . . 1.07 110.757 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.16 67.06 1.34 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.522 -0.847 . . . . 0.5 113.44 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.504 HD23 HG21 ' A' ' 57' ' ' VAL . 17.8 tp -110.1 151.99 26.55 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.763 -0.829 . . . . 1.5 108.763 175.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.495 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 9.7 mt-30 -123.06 28.98 6.94 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 115.701 1.741 . . . . 1.53 115.701 -164.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.588 HG23 ' HA ' ' A' ' 59' ' ' ARG . 75.5 mt 69.78 2.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-N 119.455 1.025 . . . . 1.43 113.308 167.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.89 48.36 0.19 Allowed Glycine 0 CA--C 1.51 -0.237 0 C-N-CA 119.528 -1.32 . . . . 0.37 112.77 -170.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.495 ' OD2' ' HB2' ' A' ' 72' ' ' GLN . 50.7 m-20 -120.83 145.92 47.1 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.376 -0.412 . . . . 0.89 110.852 -172.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.882 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 32.4 mmtt -97.23 105.48 17.63 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 121.35 0.595 . . . . 2.71 109.845 -174.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.981 HG13 HG21 ' A' ' 109' ' ' VAL . 2.7 mp -73.03 125.64 32.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.33 0.586 . . . . 1.22 112.139 -177.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.737 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 1.5 mmt -91.5 -18.37 24.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 113.504 -1.68 . . . . 1.61 111.769 177.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.744 ' HB2' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -171.88 157.62 4.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.972 0.415 . . . . 0.88 111.357 -175.212 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.812 HG23 ' HB3' ' A' ' 97' ' ' LEU . 6.5 p -145.45 120.84 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.859 -0.61 . . . . 1.93 110.576 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.793 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 19.6 m-80 54.88 29.81 12.72 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.503 -0.771 . . . . 1.8 112.264 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.35 -19.85 46.89 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.255 -0.974 . . . . 0.38 112.503 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.509 ' HB2' ' HE3' ' A' ' 85' ' ' MET . 39.9 m95 -86.21 120.68 27.84 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.678 -0.86 . . . . 0.91 108.678 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.744 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 6.6 p-10 -88.56 114.86 25.62 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 114.99 -1.005 . . . . 1.89 111.289 -172.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.668 ' HB3' HD11 ' A' ' 55' ' ' ILE . 12.0 mmt -107.32 103.24 12.55 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.847 -1.07 . . . . 1.38 110.965 -175.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.0 p -106.96 -20.77 13.22 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.801 -0.636 . . . . 1.1 110.075 172.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.702 ' O ' HG12 ' A' ' 37' ' ' ILE . 1.8 mtt -143.66 -42.96 0.28 Allowed 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.278 -0.874 . . . . 2.15 111.901 -172.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.811 ' O ' HD13 ' A' ' 55' ' ' ILE . 1.9 p -49.5 165.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 114.874 1.435 . . . . 1.68 114.874 -158.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 80.6 p -54.78 151.94 7.81 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.423 0.897 . . . . 1.1 113.423 -175.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.765 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 18.2 t-160 -59.38 -40.63 87.18 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.427 -0.806 . . . . 0.41 110.116 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.93 -32.17 73.24 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.292 -1.322 . . . . 1.67 109.779 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.76 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 4.1 tp-100 -61.6 -52.22 65.27 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.929 -0.767 . . . . 0.79 108.929 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.662 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -75.29 -34.78 61.34 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.15 -0.932 . . . . 1.06 110.69 -176.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.41 ' HA ' ' HG ' ' A' ' 97' ' ' LEU . 28.2 ttp180 -63.9 -36.58 84.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.118 0.485 . . . . 2.45 109.808 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.493 ' HD3' ' C ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -69.07 -36.04 77.18 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.809 -0.632 . . . . 1.51 109.823 178.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.76 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 20.8 mmt180 -75.87 -26.12 56.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.048 -0.524 . . . . 4.23 111.517 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.812 ' HB3' HG23 ' A' ' 80' ' ' VAL . 4.2 pp -88.47 -26.7 21.94 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 111.905 0.335 . . . . 2.24 111.905 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.574 ' HG1' HD11 ' A' ' 97' ' ' LEU . 67.1 m -148.72 109.77 4.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.642 0.734 . . . . 1.63 110.289 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.418 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 7.4 ptpp? -126.99 16.95 7.31 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.641 -1.163 . . . . 3.16 110.857 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.425 ' CA ' HD22 ' A' ' 27' ' ' LEU . 60.2 mtt180 66.69 6.03 4.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.965 -1.016 . . . . 4.79 111.829 175.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.464 ' C ' ' HG3' ' A' ' 102' ' ' GLU . 1.4 p -146.32 70.4 1.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.197 0.522 . . . . 2.83 111.002 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.629 ' HB2' ' HG3' ' A' ' 20' ' ' LYS . 14.9 mt-10 -142.26 151.86 42.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.716 -0.675 . . . . 3.4 110.733 -173.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -111.5 -29.15 7.88 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.765 -0.652 . . . . 2.68 110.62 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.72 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 6.3 p -150.6 146.23 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.99 -0.55 . . . . 1.15 109.58 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.648 HG23 ' HG2' ' A' ' 20' ' ' LYS . 31.5 t -126.63 119.91 54.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 CA-C-O 122.227 1.013 . . . . 1.13 112.361 -171.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.793 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 1.1 mpt_? -99.47 135.32 41.05 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.138 -1.846 . . . . 2.28 110.959 -175.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.573 HD13 HG12 ' A' ' 77' ' ' ILE . 19.9 tp -133.58 137.97 45.77 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.589 -0.278 . . . . 1.68 110.6 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.737 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 38.8 tp -116.05 120.52 39.34 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.259 -1.386 . . . . 1.1 107.259 172.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.981 HG21 HG13 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -130.18 152.2 37.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 121.22 0.533 . . . . 1.39 110.712 -174.352 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.584 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -96.58 116.06 28.46 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.502 -0.772 . . . . 1.13 109.377 168.763 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.411 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 7.8 ttt180 -100.58 135.56 41.83 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.187 -0.915 . . . . 2.34 110.547 -176.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.426 ' HG2' ' CD2' ' A' ' 114' ' ' LEU . 0.2 OUTLIER -117.26 -108.48 0.37 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.96 -0.564 . . . . 1.97 110.559 176.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.9 t -115.12 28.6 8.59 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.239 0.542 . . . . 2.0 111.074 -170.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 3.1 mm? -92.62 29.64 1.71 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.038 -0.528 . . . . 2.0 111.509 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -54.51 105.15 0.14 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.34 0.59 . . . . 3.83 111.317 -175.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -109.54 -6.04 15.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.406 -0.815 . . . . 3.96 110.98 -172.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -164.27 21.85 0.07 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.418 -0.81 . . . . 3.76 110.481 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.1 t -105.98 130.24 57.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.925 -0.58 . . . . 5.11 110.844 -176.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -54.69 139.19 39.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.918 -1.037 . . . . 8.35 111.919 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -161.54 141.61 10.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.852 -0.613 . . . . 6.63 110.421 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.9 p -123.91 121.57 35.67 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.714 -0.476 . . . . 8.94 109.714 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 60.0 mtm -100.88 -39.06 7.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.043 -0.526 . . . . 12.46 111.392 -173.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 36.0 tp -82.24 99.38 9.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.148 0.499 . . . . 13.06 110.748 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 C--O 1.248 0.995 0 CA-C-N 115.565 -0.743 . . . . 14.64 109.173 177.332 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.1 mtp . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.682 0.277 . . . . 14.35 110.642 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m -69.31 139.01 54.28 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.092 -0.504 . . . . 11.48 111.795 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -128.11 159.25 35.68 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.778 -0.823 . . . . 9.53 108.778 173.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.529 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 17.8 pt -107.22 104.94 54.31 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 121.062 0.458 . . . . 6.82 111.396 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.25 109.59 2.7 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.016 2.477 . . . . 7.95 111.701 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.02 -15.42 60.97 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.863 -0.684 . . . . 6.42 112.467 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 67.65 98.58 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.236 0 C-N-CA 123.144 0.578 . . . . 6.63 111.362 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.529 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 1.1 Cg_endo -83.4 125.96 4.06 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.252 2.634 . . . . 3.98 111.366 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 8' ' ' PRO . 53.9 t 73.96 -54.19 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 O-C-N 123.604 0.565 . . . . 2.77 111.735 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.2 p -76.64 82.75 3.29 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.217 1.008 . . . . 2.49 111.589 -175.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.42 177.09 5.29 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 113.581 -1.645 . . . . 1.24 109.337 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -123.66 127.92 74.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.231 0.538 . . . . 2.16 111.064 -177.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.596 HG21 HG22 ' A' ' 110' ' ' THR . 15.9 t -83.63 111.12 19.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.68 -0.489 . . . . 1.65 109.68 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 1.03 HE22 HG22 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -115.36 170.44 8.39 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.56 -0.746 . . . . 1.39 112.581 -174.224 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -123.9 113.86 19.06 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.65 -0.705 . . . . 4.11 110.544 -175.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 1.03 HG22 HE22 ' A' ' 14' ' ' GLN . 4.1 t -99.61 110.07 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 109.082 -0.71 . . . . 1.59 109.082 174.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -123.11 118.14 27.0 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.337 -0.616 . . . . 1.35 109.337 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.54 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 10.9 tp -138.12 145.73 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 108.673 -0.862 . . . . 1.33 108.673 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 11.0 m-70 -76.21 116.51 16.97 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.977 -0.689 . . . . 0.7 109.529 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -23.65 133.89 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 O-C-N 125.037 1.461 . . . . 4.39 112.31 176.345 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.3 tp -95.84 89.11 5.15 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.992 0.901 . . . . 1.23 110.379 -175.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -63.46 136.68 57.76 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.497 -1.229 . . . . 4.63 111.56 -173.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -132.99 94.47 3.37 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.983 -1.008 . . . . 1.5 108.437 175.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.01 -82.17 0.18 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.394 -0.908 . . . . 1.33 111.394 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -129.3 -5.93 4.83 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.148 0.499 . . . . 2.33 110.629 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 5.9 m-80 -94.0 169.95 9.9 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.711 -0.677 . . . . 1.87 109.889 -174.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 20' ' ' LYS . 2.0 pt? -128.39 126.74 41.25 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.698 -1.223 . . . . 2.8 107.698 171.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.42 138.15 23.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 109.441 -0.578 . . . . 1.45 109.441 -176.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.472 ' HG ' ' CE2' ' A' ' 31' ' ' PHE . 18.3 tp -91.5 -33.0 15.36 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.879 -1.055 . . . . 1.87 110.572 -171.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.676 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 89.87 -38.05 3.27 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.765 -0.731 . . . . 1.14 112.122 177.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.792 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 52.3 p90 -113.5 155.67 24.93 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 122.803 -0.233 . . . . 0.61 110.766 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.547 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 12.5 t -101.89 163.87 12.02 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.905 -1.146 . . . . 0.91 107.905 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.411 HD11 HD22 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -160.36 140.68 3.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 C-N-CA 120.981 -0.288 . . . . 1.24 111.352 -164.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -143.06 120.15 1.49 Allowed Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 110.547 -1.021 . . . . 0.78 110.547 158.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 1.05 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -138.35 119.09 1.72 Allowed Glycine 0 CA--C 1.492 -1.387 0 CA-C-O 118.784 -1.009 . . . . 1.66 110.771 171.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.944 ' HA3' ' HG2' ' A' ' 39' ' ' GLN . . . -156.13 118.52 0.85 Allowed Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 118.251 -1.928 . . . . 0.95 113.37 -170.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.591 HG12 ' C ' ' A' ' 88' ' ' VAL . 20.8 pt -64.4 -21.38 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 105.728 -1.953 . . . . 1.15 105.728 145.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.757 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 14.3 t70 -64.55 -36.42 84.17 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 112.672 -2.058 . . . . 0.72 110.782 171.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.944 ' HG2' ' HA3' ' A' ' 36' ' ' GLY . 25.4 mm-40 -71.38 -100.17 0.01 OUTLIER 'General case' 0 C--N 1.349 0.586 0 N-CA-C 112.486 0.55 . . . . 1.47 112.486 -171.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.448 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 24.2 t70 -149.7 126.94 5.49 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.7 -0.227 . . . . 2.57 111.602 -173.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 9.9 Cg_endo -94.89 8.38 2.01 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.699 2.933 . . . . 2.82 113.14 176.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.2 t -103.87 10.93 36.2 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.052 0.453 . . . . 3.26 111.207 -171.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.423 HE21 ' HB2' ' A' ' 43' ' ' GLN . 2.1 mt-30 -134.12 21.81 3.78 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.163 0.982 . . . . 3.88 108.379 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.447 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 12.5 p30 -177.73 58.54 0.13 Allowed Pre-proline 0 N--CA 1.44 -0.95 0 CA-C-N 113.136 -1.847 . . . . 5.7 106.966 -175.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.447 ' HD3' ' N ' ' A' ' 44' ' ' ASN . 78.4 Cg_exo -53.42 -15.24 5.59 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.88 3.053 . . . . 4.03 114.293 -166.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -134.86 -47.44 0.73 Allowed 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.928 -1.138 . . . . 6.35 107.928 174.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 3.1 m -155.41 160.59 40.77 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 107.828 -1.175 . . . . 3.85 107.828 -177.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.492 ' HB3' HG21 ' A' ' 51' ' ' THR . 20.9 tt0 -107.18 -32.48 7.79 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.081 0.467 . . . . 6.78 110.79 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.537 ' OD2' ' HD2' ' A' ' 50' ' ' LYS . 23.1 t0 177.08 -130.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.288 -1.004 . . . . 5.47 108.288 -167.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.625 ' HG2' HG21 ' A' ' 110' ' ' THR . 3.7 mptt -75.63 -19.04 59.47 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.846 -0.798 . . . . 3.54 108.846 173.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.492 HG21 ' HB3' ' A' ' 48' ' ' GLU . 1.9 t -77.34 -48.27 17.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.952 -1.022 . . . . 4.89 110.716 -175.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.479 ' HB3' ' O ' ' A' ' 51' ' ' THR . 11.3 t70 73.03 -80.34 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.747 0.655 . . . . 2.6 110.035 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 87' ' ' MET . 0.0 OUTLIER -141.57 29.85 1.73 Allowed 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.134 -1.432 . . . . 3.98 107.134 175.321 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.509 ' C ' HD13 ' A' ' 55' ' ' ILE . . . -100.05 -145.44 17.81 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 114.033 -1.439 . . . . 0.94 111.878 -167.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 1.05 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.9 mp -118.76 147.13 22.46 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 N-CA-C 108.404 -0.961 . . . . 1.27 108.404 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.771 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -155.48 156.35 35.09 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 118.97 0.805 . . . . 1.91 111.215 178.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.598 HG21 HD22 ' A' ' 71' ' ' LEU . 8.1 p -92.38 132.84 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-N 115.481 -0.781 . . . . 1.22 110.92 -173.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.5 m -103.89 -17.14 15.14 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.497 -1.229 . . . . 1.29 111.467 -174.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.638 ' O ' HG21 ' A' ' 60' ' ' VAL . 46.2 mtt180 -143.63 -175.41 4.56 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.982 1.104 . . . . 2.63 113.982 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.638 HG21 ' O ' ' A' ' 59' ' ' ARG . 75.4 t -167.73 111.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 112.959 -1.928 . . . . 1.53 106.956 161.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.5 m -79.56 128.47 33.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.212 0.53 . . . . 2.38 110.655 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -50.43 116.59 1.97 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.679 -1.146 . . . . 1.85 111.47 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.29 -20.39 30.52 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.241 -0.89 . . . . 0.95 112.931 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.74 172.96 55.17 Favored Glycine 0 CA--C 1.502 -0.762 0 C-N-CA 120.345 -0.931 . . . . 0.99 111.771 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.676 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 73.2 Cg_endo -71.45 -19.2 28.92 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.43 2.087 . . . . 0.63 113.184 -169.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.792 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -67.2 -28.91 68.47 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.654 -1.157 . . . . 1.1 111.643 175.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -73.13 -34.85 66.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 122.013 0.911 . . . . 1.79 109.151 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.584 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -74.44 -38.06 45.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.526 -1.215 . . . . 1.18 110.221 -177.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.695 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -80.17 -20.26 45.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.361 -0.382 . . . . 1.07 110.699 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.13 65.24 1.12 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.37 -0.919 . . . . 0.5 114.017 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.598 HD22 HG21 ' A' ' 57' ' ' VAL . 18.1 tp -113.34 155.56 24.97 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.357 -0.609 . . . . 1.5 109.357 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.951 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 12.9 mt-30 -124.23 31.13 5.86 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 115.176 1.547 . . . . 1.53 115.176 -166.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.559 HG22 ' O ' ' A' ' 73' ' ' ILE . 42.6 mt 68.55 1.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 113.201 0.815 . . . . 1.43 113.201 166.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -172.53 51.02 0.17 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 119.757 -1.211 . . . . 0.37 112.355 -168.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.464 ' H ' ' CG1' ' A' ' 57' ' ' VAL . 32.1 m-20 -121.45 151.8 39.82 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.358 -0.608 . . . . 0.89 109.358 -175.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.771 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 64.0 mmtt -95.33 122.14 37.72 Favored 'General case' 0 C--O 1.208 -1.084 0 CA-C-O 121.302 0.572 . . . . 2.71 110.55 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.74 HG12 HD11 ' A' ' 107' ' ' LEU . 8.5 mt -88.11 125.36 41.53 Favored 'Isoleucine or valine' 0 C--O 1.258 1.525 0 CA-C-O 121.309 0.576 . . . . 1.22 112.006 -174.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.865 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -96.74 -16.4 20.89 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.202 -1.817 . . . . 1.61 111.649 -177.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.771 ' HB3' HD23 ' A' ' 108' ' ' LEU . 0.9 OUTLIER -168.99 150.51 4.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.729 0.299 . . . . 0.88 111.481 -175.33 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.898 ' HB ' ' HE2' ' A' ' 85' ' ' MET . 3.3 t -139.36 118.59 13.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.807 -0.633 . . . . 1.93 110.811 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.869 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 12.9 m120 52.87 31.05 10.06 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.01 -0.541 . . . . 1.8 111.856 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.11 -5.7 59.44 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.293 -0.956 . . . . 0.38 113.042 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.494 ' HE1' ' CZ ' ' A' ' 96' ' ' ARG . 54.7 m95 -87.03 175.21 8.22 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 110.091 -0.336 . . . . 0.91 110.091 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -115.88 113.2 23.01 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.751 -0.659 . . . . 1.89 109.938 -173.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.898 ' HE2' ' HB ' ' A' ' 80' ' ' VAL . 19.6 mmt -107.14 100.59 10.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.949 0.881 . . . . 1.38 110.152 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.4 p -132.98 -35.85 1.05 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.408 -1.269 . . . . 1.1 107.98 171.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -161.28 78.17 0.57 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 113.755 -1.566 . . . . 2.15 109.996 176.203 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.606 HG22 HE21 ' A' ' 92' ' ' GLN . 1.4 p -137.7 164.21 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 109.5 -0.555 . . . . 1.68 109.5 174.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.729 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 61.7 p -63.04 151.39 40.0 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.348 0.594 . . . . 1.1 112.312 -176.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.757 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 20.4 t-160 -61.86 -34.97 76.95 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-O 121.589 0.709 . . . . 0.41 109.882 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.65 -31.55 69.7 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 113.97 -1.468 . . . . 1.67 109.618 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.606 HE21 HG22 ' A' ' 88' ' ' VAL . 1.7 tp-100 -61.59 -52.21 65.34 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.681 -0.859 . . . . 0.79 108.681 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.636 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.08 -41.45 77.51 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.528 -1.214 . . . . 1.06 110.188 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.454 ' HA ' HD13 ' A' ' 97' ' ' LEU . 34.3 ttp180 -64.89 -41.32 95.71 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.157 -0.929 . . . . 2.45 111.201 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.623 ' HE3' ' HD3' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -68.33 -29.16 67.83 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 121.168 0.509 . . . . 1.51 109.848 -177.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 12.8 mmm180 -74.96 -48.77 22.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.023 -0.535 . . . . 4.23 112.276 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.636 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.5 pp -82.6 -4.81 58.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.021 0.439 . . . . 2.24 111.493 -178.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.2 m -138.12 78.7 1.7 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 122.137 0.97 . . . . 1.63 109.379 175.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.623 ' HD3' ' HE3' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -84.78 -79.18 0.23 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.006 -1.452 . . . . 3.16 110.347 -178.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 174.11 -26.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.158 -0.928 . . . . 4.79 111.059 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.7 m -160.89 40.05 0.16 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.955 0.407 . . . . 2.83 110.396 -171.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 46.1 mm-40 -58.86 156.61 11.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.838 -0.619 . . . . 3.4 110.714 175.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.548 ' HG3' HG11 ' A' ' 104' ' ' VAL . 6.0 pt-20 -84.74 -38.52 19.57 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.636 0.732 . . . . 2.68 109.474 172.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.548 HG11 ' HG3' ' A' ' 103' ' ' GLU . 3.1 p -156.8 156.04 4.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 114.745 -1.116 . . . . 1.15 108.332 -176.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.6 t -115.87 117.81 56.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 122.11 0.957 . . . . 1.13 111.643 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.869 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 1.4 mpt_? -100.55 123.73 45.15 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 113.422 -1.717 . . . . 2.28 111.626 -171.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.74 HD11 HG12 ' A' ' 77' ' ' ILE . 28.4 tp -132.12 125.77 32.1 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.88 -0.6 . . . . 1.68 110.756 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.865 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 31.8 tp -108.18 120.88 43.61 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 107.688 -1.227 . . . . 1.1 107.688 172.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.669 HG11 ' HG3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -132.95 150.33 32.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.398 0.618 . . . . 1.39 110.635 -172.212 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.625 HG21 ' HG2' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -95.76 116.58 29.09 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.295 -0.866 . . . . 1.13 109.37 168.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.771 ' HG3' HE22 ' A' ' 72' ' ' GLN . 27.4 ttt180 -110.58 139.75 45.54 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.474 -1.239 . . . . 2.34 110.755 -169.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.66 -90.87 0.57 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.531 0.567 . . . . 1.97 112.531 -176.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.8 m -151.33 41.75 0.73 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 112.539 0.57 . . . . 2.0 112.539 -164.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.951 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 0.3 OUTLIER -103.5 -0.79 29.38 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.516 -0.55 . . . . 2.0 109.516 177.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.433 ' HG3' ' OE1' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -52.76 136.13 34.14 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.542 -0.753 . . . . 3.83 111.658 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -81.48 23.9 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.952 -0.567 . . . . 3.96 111.776 -173.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 59.22 87.16 0.08 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.228 0.537 . . . . 3.76 110.899 -175.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.7 p -110.96 143.65 20.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.727 -0.67 . . . . 5.11 110.467 -176.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 62.03 71.07 0.55 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.662 -0.699 . . . . 8.35 110.681 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -122.47 -46.0 2.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.109 -0.496 . . . . 6.63 111.178 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.8 t -108.28 118.27 36.32 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.167 -0.469 . . . . 8.94 109.889 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 91.4 mmm -91.11 139.2 30.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.256 -0.429 . . . . 12.46 110.289 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 46.9 tp -68.92 135.61 51.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.202 -0.454 . . . . 13.06 110.801 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 41.6 t . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.659 -0.686 . . . . 14.64 109.297 177.761 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 120.898 0.38 . . . . 14.35 110.332 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.6 m -157.31 121.44 4.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.899 -0.591 . . . . 11.48 110.414 177.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -148.22 137.79 22.24 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.084 -0.709 . . . . 9.53 109.084 176.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.594 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 11.2 pt -113.27 95.35 35.05 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 121.37 0.605 . . . . 6.82 111.368 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.13 112.93 2.43 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 123.048 2.499 . . . . 7.95 112.125 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.06 -15.94 62.05 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.788 -0.72 . . . . 6.42 112.903 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 65.37 97.01 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.407 0 CA-C-O 121.352 0.596 . . . . 6.63 110.939 -177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.594 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 1.6 Cg_endo -82.87 -172.78 1.49 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.269 2.646 . . . . 3.98 112.392 -173.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 p -71.05 105.44 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.705 0.764 . . . . 2.77 109.724 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.23 79.7 6.76 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 122.167 0.984 . . . . 2.49 108.906 178.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.7 165.84 23.17 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.51 -1.677 . . . . 1.24 111.075 173.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.97 132.03 71.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 115.456 -0.793 . . . . 2.16 110.123 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.503 ' CG1' HD13 ' A' ' 108' ' ' LEU . 59.1 t -87.14 119.1 34.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.342 0.591 . . . . 1.65 111.497 -173.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 1.017 HE22 HG21 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -114.04 171.17 7.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.542 -0.753 . . . . 1.39 111.585 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.417 ' NE ' HD11 ' A' ' 108' ' ' LEU . 26.7 mmt180 -115.55 137.77 51.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.929 0.395 . . . . 4.11 111.959 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 1.017 HG21 HE22 ' A' ' 14' ' ' GLN . 23.0 t -123.55 123.4 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 109.234 -0.654 . . . . 1.59 109.234 171.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -144.78 123.87 12.85 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.831 -0.433 . . . . 1.35 109.831 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.527 HG12 ' HB2' ' A' ' 65' ' ' PRO . 10.2 tp -144.88 150.2 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 109.279 -0.638 . . . . 1.33 109.279 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 15.5 m-70 -81.0 109.93 16.06 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.231 -0.655 . . . . 0.7 109.231 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.401 ' N ' ' HD3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -27.49 135.22 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 O-C-N 125.228 1.58 . . . . 4.39 113.094 -177.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.1 tp -101.65 90.36 4.01 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.737 -0.468 . . . . 1.23 109.737 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 26.8 ptt180 -70.35 144.89 51.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.312 0.577 . . . . 4.63 111.191 -173.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.21 93.78 4.02 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.745 -0.835 . . . . 1.5 108.745 173.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.57 -88.85 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.625 -0.59 . . . . 1.33 111.625 -174.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.426 ' HB3' HH21 ' A' ' 100' ' ' ARG . 28.9 mm-40 -110.3 -5.45 15.25 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.261 -0.47 . . . . 2.33 111.524 -177.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -105.8 171.47 7.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.083 -0.508 . . . . 1.87 111.143 -173.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.803 HD13 ' HA ' ' A' ' 100' ' ' ARG . 7.8 mp -124.58 125.51 44.28 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.284 -1.006 . . . . 2.8 108.284 172.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.5 mm -97.18 116.22 38.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 109.291 -0.633 . . . . 1.45 109.291 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.446 ' CD2' ' H ' ' A' ' 29' ' ' LEU . 1.8 pt? -78.52 -32.6 48.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.684 -1.143 . . . . 1.87 110.707 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.63 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 82.51 17.08 69.4 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.487 -0.863 . . . . 1.14 113.027 173.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.631 ' HD2' ' HB3' ' A' ' 66' ' ' ALA . 48.1 p90 -154.24 161.49 41.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.733 0.267 . . . . 0.61 110.691 173.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.594 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 11.6 t -106.11 158.68 16.64 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.219 -1.03 . . . . 0.91 108.219 173.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -160.33 138.8 2.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 112.521 0.563 . . . . 1.24 112.521 -164.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.416 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -139.26 118.24 1.5 Allowed Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 119.679 -1.248 . . . . 0.78 110.283 156.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 1.065 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -140.26 117.42 1.29 Allowed Glycine 0 CA--C 1.492 -1.365 0 CA-C-O 118.925 -0.931 . . . . 1.66 111.657 170.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.657 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.01 143.51 8.35 Favored Glycine 0 C--N 1.3 -1.47 0 C-N-CA 118.364 -1.874 . . . . 0.95 112.563 174.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.41 HG12 ' C ' ' A' ' 88' ' ' VAL . 9.8 pt -62.14 -22.26 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 107.797 -1.186 . . . . 1.15 107.797 152.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.697 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 1.1 t70 -56.46 -47.7 78.61 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.473 -1.694 . . . . 0.72 110.345 171.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -60.57 -53.2 60.35 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 114.866 -1.061 . . . . 1.47 111.248 -174.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.518 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . 9.2 t0 -142.62 99.41 5.72 Favored Pre-proline 0 C--O 1.238 0.482 0 CA-C-N 116.127 -0.488 . . . . 2.57 110.451 -176.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -80.07 -16.98 10.87 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.434 2.756 . . . . 2.82 112.231 176.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.5 t -68.93 -50.93 45.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.57 -0.741 . . . . 3.26 109.863 -176.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -87.24 65.46 8.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.665 -0.698 . . . . 3.88 110.726 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.658 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 38.7 t30 -158.02 55.4 0.89 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.629 -0.714 . . . . 5.7 109.766 174.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.658 ' HD3' ' N ' ' A' ' 44' ' ' ASN . 85.2 Cg_endo -104.58 -0.53 0.24 Allowed 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 122.709 2.273 . . . . 4.03 111.798 175.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -169.87 22.37 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.53 0.681 . . . . 6.35 109.806 -173.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.74 ' HB3' ' HA ' ' A' ' 52' ' ' ASP . 2.8 m -122.98 115.57 22.11 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 108.509 -0.923 . . . . 3.85 108.509 -171.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.694 ' H ' HG22 ' A' ' 51' ' ' THR . 2.2 mt-10 -101.25 -42.38 6.35 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.785 -1.098 . . . . 6.78 112.191 -169.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.4 ' OD2' ' HB3' ' A' ' 48' ' ' GLU . 24.1 m-20 -139.85 -121.94 0.12 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 113.452 -1.704 . . . . 5.47 111.732 -158.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.512 ' HD2' ' SD ' ' A' ' 78' ' ' MET . 3.7 mppt? -66.54 -20.89 66.13 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.672 -1.149 . . . . 3.54 107.97 170.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.694 HG22 ' H ' ' A' ' 48' ' ' GLU . 2.5 t -72.05 -39.82 68.81 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 114.729 -1.123 . . . . 4.89 109.71 172.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.74 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 8.9 t70 -74.01 -166.05 0.36 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.716 0.769 . . . . 2.6 109.818 163.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.604 ' H ' ' CG ' ' A' ' 52' ' ' ASP . 3.2 ptpp? -95.53 -37.69 10.76 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.485 -0.78 . . . . 3.98 108.928 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 86' ' ' THR . . . 62.46 -139.88 45.89 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.487 -0.778 . . . . 0.94 111.295 178.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 1.065 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -110.68 137.4 43.26 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.166 0 N-CA-C 106.666 -1.605 . . . . 1.27 106.666 170.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.637 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -152.2 147.12 26.03 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 119.655 1.116 . . . . 1.91 111.215 -176.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.552 HG22 HD22 ' A' ' 71' ' ' LEU . 7.7 p -87.15 139.65 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 114.728 -1.124 . . . . 1.22 110.05 -172.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.9 m -110.88 -14.21 14.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.181 -0.918 . . . . 1.29 111.107 -174.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.594 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 37.6 mtt180 -146.86 -167.56 2.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.234 0.827 . . . . 2.63 113.234 175.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 63.9 t -161.58 148.66 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 112.413 -2.176 . . . . 1.53 106.44 162.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.4 p -91.82 137.33 32.45 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.06 0.457 . . . . 2.38 110.654 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -62.94 109.08 1.34 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.769 -1.105 . . . . 1.85 111.367 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.26 -10.89 67.49 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.484 -0.865 . . . . 0.95 111.903 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.472 ' O ' HD12 ' A' ' 68' ' ' ILE . . . -75.47 173.29 53.26 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 120.766 -0.731 . . . . 0.99 111.525 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.63 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 73.2 Cg_endo -72.25 -24.63 19.64 Favored 'Trans proline' 0 C--N 1.32 -0.935 0 C-N-CA 122.842 2.361 . . . . 0.63 113.252 -166.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.631 ' HB3' ' HD2' ' A' ' 31' ' ' PHE . . . -64.14 -31.38 72.55 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.717 -1.129 . . . . 1.1 111.283 176.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -74.49 -36.35 63.25 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.517 0.675 . . . . 1.79 109.189 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.568 ' N ' HD13 ' A' ' 68' ' ' ILE . 1.4 mp -64.79 -42.44 94.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.673 -1.149 . . . . 1.18 110.104 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.609 ' CB ' HG12 ' A' ' 16' ' ' VAL . . . -73.0 -24.4 60.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 1.07 110.543 175.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.66 58.3 1.06 Allowed Glycine 0 C--O 1.226 -0.354 0 C-N-CA 120.509 -0.853 . . . . 0.5 113.722 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.552 HD22 HG22 ' A' ' 57' ' ' VAL . 14.8 tp -102.77 154.25 19.36 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.876 -0.787 . . . . 1.5 108.876 175.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.546 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 6.5 mt-30 -129.33 34.19 4.42 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 115.604 1.705 . . . . 1.53 115.604 -166.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 73' ' ' ILE . 59.8 mt 69.2 0.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 N-CA-C 113.34 0.867 . . . . 1.43 113.34 165.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -174.18 55.68 0.14 Allowed Glycine 0 C--N 1.33 0.22 0 C-N-CA 119.984 -1.103 . . . . 0.37 112.914 -169.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.461 ' HB2' HG13 ' A' ' 57' ' ' VAL . 31.7 m-20 -122.72 142.3 50.85 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.644 -0.278 . . . . 0.89 111.524 -173.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.637 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 1.4 mptm? -83.31 102.8 12.22 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-O 120.983 0.421 . . . . 2.71 111.062 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.573 ' HB ' HG21 ' A' ' 55' ' ' ILE . 6.9 mt -76.56 125.85 36.69 Favored 'Isoleucine or valine' 0 C--O 1.254 1.337 0 C-N-CA 123.617 0.767 . . . . 1.22 111.594 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.793 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 9.1 mmt -90.52 -27.84 18.92 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.195 -1.366 . . . . 1.61 112.046 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.558 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 1.0 OUTLIER -159.52 150.6 19.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.858 0.361 . . . . 0.88 111.448 -171.523 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.66 HG11 ' SD ' ' A' ' 85' ' ' MET . 11.2 p -137.05 126.49 37.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.868 -0.605 . . . . 1.93 110.474 174.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.675 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 4.3 t-20 57.99 22.82 9.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.154 -0.93 . . . . 1.8 112.171 170.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.92 -5.52 46.69 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 119.683 -1.246 . . . . 0.38 113.316 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -92.75 156.85 16.76 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 109.471 -0.566 . . . . 0.91 109.471 175.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -111.94 99.17 7.89 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.075 -0.511 . . . . 1.89 110.682 -175.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.885 ' HB2' HD12 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -111.0 100.41 9.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.642 0.734 . . . . 1.38 112.091 -178.598 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.507 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 14.6 p -103.23 -35.62 8.38 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.867 -1.16 . . . . 1.1 107.867 165.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.07 76.6 1.55 Allowed 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.415 -1.72 . . . . 2.15 109.187 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.657 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -138.22 157.28 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 108.724 -0.843 . . . . 1.68 108.724 175.247 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.639 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 81.1 p -62.7 154.59 28.95 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 112.995 0.739 . . . . 1.1 112.995 -177.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.797 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 21.8 t-160 -58.69 -38.69 78.8 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-N 115.289 -0.868 . . . . 0.41 110.464 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.89 -30.95 67.45 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.169 -1.378 . . . . 1.67 109.732 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.533 ' HB3' HG12 ' A' ' 88' ' ' VAL . 1.6 tp-100 -63.82 -46.58 84.45 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.672 0.749 . . . . 0.79 109.265 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.613 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . -74.3 -36.17 63.72 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.025 -0.989 . . . . 1.06 110.756 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -67.23 -41.19 86.13 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.232 0.539 . . . . 2.45 110.514 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -68.1 -34.79 77.05 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.291 -0.868 . . . . 1.51 109.516 -177.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -75.46 -33.43 60.85 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.709 -0.678 . . . . 4.23 111.335 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.589 HD12 ' CZ ' ' A' ' 31' ' ' PHE . 3.1 tt -54.99 -61.04 2.57 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.385 -1.28 . . . . 2.24 111.861 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.507 HG21 HD21 ' A' ' 97' ' ' LEU . 12.6 p -110.36 -78.84 0.59 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.485 -0.486 . . . . 1.63 112.124 -176.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.491 ' HG2' ' HG ' ' A' ' 101' ' ' SER . 19.2 ttpt 70.05 -2.65 2.0 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.806 0.812 . . . . 3.16 112.185 176.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.803 ' HA ' HD13 ' A' ' 27' ' ' LEU . 78.4 mtp180 71.69 23.23 3.77 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.168 -0.924 . . . . 4.79 112.515 171.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.491 ' HG ' ' HG2' ' A' ' 99' ' ' LYS . 4.9 p -154.94 29.04 0.42 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.92 0.711 . . . . 2.83 112.92 -174.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -97.98 166.2 11.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.971 0.415 . . . . 3.4 111.731 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.505 ' HG3' HG11 ' A' ' 104' ' ' VAL . 18.7 pt-20 -114.05 -28.61 7.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.592 0.711 . . . . 2.68 110.159 177.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 3.9 p -152.92 143.05 14.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 107.756 -1.202 . . . . 1.15 107.756 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.6 t -115.2 117.5 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-O 122.238 1.018 . . . . 1.13 111.817 -170.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.675 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 1.3 mpt_? -99.82 129.02 45.88 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 113.036 -1.893 . . . . 2.28 111.118 -173.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.506 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 19.7 tp -133.31 129.61 37.77 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.87 -0.604 . . . . 1.68 109.931 177.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.793 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 22.6 tp -106.04 113.61 27.25 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 107.389 -1.337 . . . . 1.1 107.389 173.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.633 HG11 ' HG3' ' A' ' 14' ' ' GLN . 0.5 OUTLIER -121.9 143.96 32.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 C-N-CA 119.998 -0.681 . . . . 1.39 110.523 -173.092 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.493 HG23 HG22 ' A' ' 13' ' ' VAL . 1.3 m -96.77 120.31 36.87 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.313 -0.858 . . . . 1.13 110.623 173.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.767 ' HD2' ' HG2' ' A' ' 14' ' ' GLN . 7.7 ttt180 -90.74 153.41 20.28 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.57 -1.195 . . . . 2.34 109.794 -176.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.429 ' N ' ' CD ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -145.98 -60.82 0.32 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.134 0.791 . . . . 1.97 113.134 -168.299 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.6 ' HA ' HE22 ' A' ' 115' ' ' GLN . 20.9 t -157.77 10.87 0.19 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.89 0.376 . . . . 2.0 111.727 -174.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 3.1 mm? -101.01 17.92 21.06 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.13 -0.356 . . . . 2.0 111.44 -176.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.6 HE22 ' HA ' ' A' ' 113' ' ' SER . 2.3 mp0 -57.65 121.59 10.74 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.937 -0.574 . . . . 3.83 109.662 176.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -93.26 50.26 1.49 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.239 -0.437 . . . . 3.96 111.857 -167.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 59.68 100.86 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.136 -0.938 . . . . 3.76 111.461 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.1 p -127.19 143.61 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-O 121.164 0.507 . . . . 5.11 110.809 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -80.73 135.33 35.98 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.593 -0.73 . . . . 8.35 110.703 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -157.43 142.12 16.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.019 -0.537 . . . . 6.63 110.39 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.5 m -129.13 100.84 5.77 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.706 0.288 . . . . 8.94 110.625 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 70.2 mtm -77.22 -38.0 52.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.429 -0.351 . . . . 12.46 110.266 178.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 82.3 mt 67.91 108.75 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.347 -0.842 . . . . 13.06 111.559 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.1 m . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.425 -0.798 . . . . 14.64 109.658 -179.807 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.7 ttm . . . . . 0 N--CA 1.476 0.864 0 CA-C-O 120.867 0.365 . . . . 14.35 110.573 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 m -67.38 147.74 52.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.09 -0.504 . . . . 11.48 109.909 177.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -124.66 166.11 16.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.704 0.287 . . . . 9.53 110.644 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.734 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -96.33 113.36 62.29 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.148 -0.478 . . . . 6.82 109.783 175.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -58.69 -63.18 0.15 Allowed 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.11 2.54 . . . . 7.95 113.636 -174.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -119.53 24.01 8.23 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.408 -0.901 . . . . 6.42 112.324 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 60.53 93.15 0.06 OUTLIER Pre-proline 0 N--CA 1.467 0.379 0 CA-C-O 121.295 0.569 . . . . 6.63 111.058 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.734 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 4.1 Cg_endo -87.66 125.56 2.06 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.512 2.808 . . . . 3.98 112.075 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 8' ' ' PRO . 66.6 t 72.09 -57.38 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 123.639 0.587 . . . . 2.77 111.472 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.2 p -76.53 82.03 3.21 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 122.057 0.932 . . . . 2.49 110.447 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.504 ' HB3' ' HE2' ' A' ' 50' ' ' LYS . . . -102.16 165.23 11.26 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.69 -1.595 . . . . 1.24 109.359 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.9 m -117.61 136.8 53.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 116.131 -0.486 . . . . 2.16 109.913 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.683 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 3.1 m -88.16 120.65 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 122.311 1.053 . . . . 1.65 110.878 -177.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.935 HE22 HG21 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -97.51 170.99 8.66 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 113.939 -1.482 . . . . 1.39 110.545 178.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -115.9 116.55 28.17 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.064 0.394 . . . . 4.11 112.064 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.935 HG21 HE22 ' A' ' 14' ' ' GLN . 3.9 t -104.58 118.19 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 109.352 -0.61 . . . . 1.59 109.352 173.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -132.3 115.75 16.02 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.335 -0.848 . . . . 1.35 109.117 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.616 ' HB ' ' HB1' ' A' ' 69' ' ' ALA . 9.3 tp -144.58 152.37 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 109.002 -0.74 . . . . 1.33 109.002 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 10.3 m-70 -79.99 114.32 18.82 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.621 -0.881 . . . . 0.7 108.621 174.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.992 ' HB2' HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -25.33 139.25 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.906 1.379 . . . . 4.39 113.335 177.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.588 HD21 ' HD3' ' A' ' 65' ' ' PRO . 32.3 tp -98.91 91.48 5.07 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 119.177 -1.009 . . . . 1.23 109.451 -177.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.563 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 28.7 ptt180 -76.24 135.91 39.68 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.617 0.722 . . . . 4.63 111.316 -173.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.535 ' HB2' HD11 ' A' ' 28' ' ' ILE . 4.8 tp-100 -119.36 94.88 4.57 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.04 -0.982 . . . . 1.5 108.422 176.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.53 -80.47 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.729 -0.748 . . . . 1.33 111.318 -173.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -134.9 10.95 3.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.003 0.43 . . . . 2.33 110.567 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.563 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 11.5 m-80 -110.35 173.89 6.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.963 -0.562 . . . . 1.87 110.625 -176.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.992 HD11 ' HB2' ' A' ' 20' ' ' LYS . 7.3 tp -127.11 123.75 37.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.378 0.608 . . . . 2.8 110.061 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.535 HD11 ' HB2' ' A' ' 23' ' ' GLN . 1.7 mp -98.81 132.51 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.227 -0.897 . . . . 1.45 108.955 175.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.647 HD12 HD22 ' A' ' 97' ' ' LEU . 0.6 OUTLIER -84.09 -42.74 15.78 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 114.657 -1.156 . . . . 1.87 109.964 -174.653 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.519 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 92.57 13.49 56.89 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 115.099 -0.955 . . . . 1.14 111.479 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 24.4 p90 -155.33 172.66 17.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.517 -0.179 . . . . 0.61 110.517 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.919 ' HB3' ' O ' ' A' ' 58' ' ' THR . 5.6 t -112.81 170.79 7.94 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.578 -0.897 . . . . 0.91 108.578 169.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.562 HG12 ' HE2' ' A' ' 90' ' ' HIS . 5.2 tt -148.36 136.4 14.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 120.448 -0.501 . . . . 1.24 112.138 -167.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -103.58 170.73 19.55 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.869 -0.892 . . . . 0.78 110.869 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.667 ' C ' HE22 ' A' ' 39' ' ' GLN . . . -103.97 166.13 15.5 Favored Glycine 0 N--CA 1.418 -2.52 0 N-CA-C 117.828 1.891 . . . . 1.66 117.828 -163.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.707 ' N ' HE22 ' A' ' 39' ' ' GLN . . . -86.37 -143.24 7.29 Favored Glycine 0 N--CA 1.417 -2.623 0 CA-C-N 110.073 -3.064 . . . . 0.95 113.392 -173.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.64 HD12 ' O ' ' A' ' 87' ' ' MET . 10.6 pt -83.52 -4.77 8.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.02 -0.59 . . . . 1.15 112.213 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.959 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 11.3 p-10 -70.91 -32.43 69.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.852 0.358 . . . . 0.72 110.511 -175.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.707 HE22 ' N ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -75.32 -49.15 20.06 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.752 -0.833 . . . . 1.47 108.752 -175.471 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.609 ' OD2' ' HB2' ' A' ' 43' ' ' GLN . 1.6 t70 -138.36 107.47 7.91 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 114.394 -1.276 . . . . 2.57 110.29 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.603 ' HA ' HD22 ' A' ' 44' ' ' ASN . 23.1 Cg_endo -96.27 9.5 1.5 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.824 3.016 . . . . 2.82 112.737 177.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.1 t -109.09 5.55 24.15 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.301 -0.408 . . . . 3.26 111.824 -171.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.609 ' HB2' ' OD2' ' A' ' 40' ' ' ASP . 10.3 mt-30 -149.25 50.45 0.96 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.634 0.254 . . . . 3.88 110.355 -176.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.696 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 30.5 p30 -149.92 33.56 0.08 OUTLIER Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 112.91 0.708 . . . . 5.7 112.91 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.696 ' HD3' ' N ' ' A' ' 44' ' ' ASN . 87.6 Cg_endo -93.73 -1.5 3.19 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.767 1.644 . . . . 4.03 112.38 -173.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.2 t80 174.26 34.82 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 107.513 -1.291 . . . . 6.35 107.513 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.4 m -78.56 -175.99 4.6 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 114.285 -1.325 . . . . 3.85 112.59 -166.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -28.37 -68.75 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 O-C-N 124.978 1.424 . . . . 6.78 114.65 -172.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.455 ' OD2' ' HD2' ' A' ' 50' ' ' LYS . 32.1 t0 -178.78 -154.7 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.526 -0.916 . . . . 5.47 108.526 -170.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.689 ' HE3' HG22 ' A' ' 110' ' ' THR . 0.4 OUTLIER -68.03 0.01 4.0 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.839 0.352 . . . . 3.54 110.226 176.311 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.425 ' H ' ' C ' ' A' ' 49' ' ' ASP . 15.2 t -108.53 8.98 27.49 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.139 0.422 . . . . 4.89 112.139 -173.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.505 ' OD2' ' HG2' ' A' ' 53' ' ' LYS . 8.9 t70 -81.8 -125.82 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.747 0.308 . . . . 2.6 110.9 177.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.622 ' HB3' ' HA ' ' A' ' 37' ' ' ILE . 2.0 mmpp? -74.83 71.29 1.99 Allowed 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 107.574 -1.269 . . . . 3.98 107.574 169.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -136.04 163.92 25.04 Favored Glycine 0 N--CA 1.417 -2.6 0 N-CA-C 107.896 -2.082 . . . . 0.94 107.896 -172.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.661 HG23 HD13 ' A' ' 77' ' ' ILE . 2.2 mp -93.74 119.43 41.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 119.89 1.845 . . . . 1.27 108.943 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.803 ' HA ' HD11 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -151.78 131.26 12.98 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.188 0.994 . . . . 1.91 110.122 -170.584 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.931 HG21 HD23 ' A' ' 71' ' ' LEU . 1.2 t -62.05 139.93 20.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 113.594 -1.639 . . . . 1.22 112.22 -173.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.919 ' O ' ' HB3' ' A' ' 32' ' ' SER . 6.4 m -129.28 64.17 1.48 Allowed 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.613 -1.176 . . . . 1.29 109.216 173.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.63 ' C ' ' HA ' ' A' ' 73' ' ' ILE . 15.4 mtt180 148.97 -171.22 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 125.391 1.476 . . . . 2.63 111.475 163.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 61.9 t -161.13 130.42 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 113.028 -1.897 . . . . 1.53 106.635 163.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.8 m -88.43 123.57 33.1 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.154 0.502 . . . . 2.38 109.991 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.475 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 77.3 mt-10 -52.1 118.54 3.56 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.935 -1.03 . . . . 1.85 111.876 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.79 -3.02 60.55 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.203 -0.908 . . . . 0.95 111.907 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.42 172.2 39.2 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.613 -0.803 . . . . 0.99 111.503 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.588 ' HD3' HD21 ' A' ' 21' ' ' LEU . 92.2 Cg_endo -74.1 -24.69 14.6 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 122.962 2.441 . . . . 0.63 113.408 -168.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.554 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -67.51 -23.91 65.51 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.05 -0.977 . . . . 1.1 110.928 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.475 ' OE1' ' HA ' ' A' ' 62' ' ' GLU . 28.2 tt0 -75.7 -36.77 59.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.771 0.796 . . . . 1.79 108.935 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.667 ' N ' HD13 ' A' ' 68' ' ' ILE . 1.5 mp -73.35 -42.14 57.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.145 -1.389 . . . . 1.18 110.351 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.683 ' CB ' HG11 ' A' ' 16' ' ' VAL . . . -71.23 -21.32 62.14 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.995 -0.548 . . . . 1.07 111.026 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.46 54.3 1.09 Allowed Glycine 0 C--O 1.225 -0.437 0 C-N-CA 120.037 -1.078 . . . . 0.5 114.174 174.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.931 HD23 HG21 ' A' ' 57' ' ' VAL . 6.5 tp -97.25 161.34 13.85 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.269 -0.641 . . . . 1.5 109.269 174.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.575 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 4.7 pt20 -131.47 29.57 4.54 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 115.071 1.508 . . . . 1.53 115.071 -168.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.63 ' HA ' ' C ' ' A' ' 59' ' ' ARG . 2.3 mp 75.3 -6.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-O 120.975 0.417 . . . . 1.43 111.349 173.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -164.82 66.32 0.22 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.851 -0.69 . . . . 0.37 111.628 -169.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.458 ' HB3' ' CG2' ' A' ' 109' ' ' VAL . 3.8 m-20 -118.8 135.88 54.29 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 115.613 -0.293 . . . . 0.89 110.966 -169.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.5 mmtt -95.49 102.95 14.8 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 121.054 0.454 . . . . 2.71 109.981 -174.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.803 HD11 ' HA ' ' A' ' 56' ' ' TYR . 2.9 mp -72.24 118.04 16.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 112.473 0.545 . . . . 1.22 112.473 -171.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.971 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 1.3 mmt -93.61 -10.48 34.49 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.088 -0.96 . . . . 1.61 112.869 177.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.615 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -172.23 154.01 3.2 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.329 0.492 . . . . 0.88 112.329 -178.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.494 ' N ' ' HG3' ' A' ' 79' ' ' GLN . 87.8 t -133.08 105.59 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.68 -0.691 . . . . 1.93 110.731 177.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.723 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 6.3 m120 55.13 33.22 19.98 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.969 0.729 . . . . 1.8 112.969 176.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.48 -12.26 50.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 119.77 -1.205 . . . . 0.38 112.202 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.441 ' NE1' ' HD2' ' A' ' 96' ' ' ARG . 90.2 m95 -75.92 162.69 27.9 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.875 -0.787 . . . . 0.91 108.875 171.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -116.54 115.14 25.2 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.406 -0.361 . . . . 1.89 110.466 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.4 mmt -106.89 101.4 10.84 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.567 0.699 . . . . 1.38 110.92 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.05 91.69 2.71 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.05 -0.977 . . . . 1.1 109.384 170.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.64 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER 48.88 65.14 1.45 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.711 -1.131 . . . . 2.15 110.332 -173.803 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.668 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 6.0 p -108.67 178.35 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 107.434 -1.321 . . . . 1.68 107.434 170.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.959 ' HB ' ' HB3' ' A' ' 38' ' ' ASP . 49.2 p -66.27 147.89 52.66 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 119.093 0.86 . . . . 1.1 111.601 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.574 ' CG ' ' HA2' ' A' ' 35' ' ' GLY . 20.7 t-160 -54.68 -38.46 67.01 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-O 122.121 0.962 . . . . 0.41 108.827 174.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.47 -33.04 74.81 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 113.109 -1.86 . . . . 1.67 109.865 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.746 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 3.7 tp-100 -59.45 -52.96 63.37 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 109.207 -0.664 . . . . 0.79 109.207 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.555 ' HB1' HG12 ' A' ' 55' ' ' ILE . . . -74.44 -35.73 63.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.233 -0.894 . . . . 1.06 110.375 -175.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -61.06 -44.2 97.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.936 -0.574 . . . . 2.45 110.356 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.628 ' HE3' ' O ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -71.2 -46.54 61.01 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.847 -0.615 . . . . 1.51 109.439 -176.51 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.746 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 29.4 mmt180 -65.6 -25.33 67.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.035 -0.53 . . . . 4.23 110.672 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.647 HD22 HD12 ' A' ' 29' ' ' LEU . 17.0 tp -68.45 -61.04 2.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.06 -0.518 . . . . 2.24 111.603 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.85 ' HA ' HD21 ' A' ' 27' ' ' LEU . 2.5 m -69.44 -32.64 71.72 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.256 -0.646 . . . . 1.63 109.256 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER 61.36 -105.72 0.21 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.713 -1.13 . . . . 3.16 110.87 168.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.453 ' H ' ' HB3' ' A' ' 99' ' ' LYS . 59.9 mtm180 -143.99 14.49 1.69 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.813 -1.18 . . . . 4.79 107.813 172.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.5 m 73.57 42.03 0.42 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.61 -1.177 . . . . 2.83 111.015 -173.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -57.07 154.17 10.29 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.032 -0.531 . . . . 3.4 109.793 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.589 ' HA ' ' HZ1' ' A' ' 20' ' ' LYS . 4.0 pt-20 -58.99 -25.18 63.39 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.87 1.063 . . . . 2.68 113.87 -164.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 7.2 p -146.38 151.91 14.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 120.758 -0.377 . . . . 1.15 110.298 -175.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 51.8 t -133.31 118.37 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.016 0 CA-C-O 122.344 1.069 . . . . 1.13 112.266 -169.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.723 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -100.98 130.53 46.99 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 113.023 -1.899 . . . . 2.28 110.309 -177.01 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.655 HD12 HG12 ' A' ' 77' ' ' ILE . 34.3 tp -131.84 131.79 43.14 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.574 -0.528 . . . . 1.68 109.574 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.971 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 15.3 tp -105.46 129.31 53.79 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 105.412 -2.07 . . . . 1.1 105.412 172.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.681 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -140.97 146.5 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 C-N-CA 119.916 -0.714 . . . . 1.39 110.267 -173.596 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.689 HG22 ' HE3' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -92.36 125.73 37.14 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.566 0.698 . . . . 1.13 111.077 172.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.559 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 34.6 ttt180 -111.45 146.81 36.56 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.224 -1.353 . . . . 2.34 110.958 -172.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.5 -105.66 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.637 -0.71 . . . . 1.97 111.232 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.7 t -136.15 36.34 2.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.2 0.524 . . . . 2.0 111.708 -171.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.558 ' HB2' ' HG3' ' A' ' 72' ' ' GLN . 2.9 mt -110.57 -17.46 13.41 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.41 0.624 . . . . 2.0 110.372 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.568 HE21 ' NE2' ' A' ' 72' ' ' GLN . 64.2 mm-40 -47.26 124.91 7.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.563 -1.199 . . . . 3.83 112.526 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.775 ' H ' ' HD3' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -99.25 72.5 1.85 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.394 -0.821 . . . . 3.96 110.561 -178.267 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 51.59 81.51 0.07 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.005 -0.998 . . . . 3.76 111.603 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.7 p -90.35 140.27 16.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.893 0.377 . . . . 5.11 110.757 -177.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -70.32 123.89 22.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.574 -0.739 . . . . 8.35 110.723 177.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -118.53 -47.15 2.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.206 -0.452 . . . . 6.63 109.919 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.8 t -94.49 145.5 24.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.265 -0.88 . . . . 8.94 110.071 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -139.04 -175.06 4.02 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.973 -0.38 . . . . 12.46 109.973 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.524 ' HG ' ' H ' ' A' ' 124' ' ' SER . 21.9 tp -114.58 173.64 6.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.091 0.472 . . . . 13.06 111.075 -171.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.524 ' H ' ' HG ' ' A' ' 123' ' ' LEU . 21.4 m . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.725 -0.655 . . . . 14.64 109.427 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.8 mmm . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.393 0.139 . . . . 14.35 110.94 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.0 m 64.66 98.29 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.046 0.758 . . . . 11.48 113.046 173.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -101.85 105.16 15.96 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.78 -0.452 . . . . 9.53 109.78 172.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.605 HD11 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -106.07 108.18 61.17 Favored Pre-proline 0 C--O 1.216 -0.702 0 CA-C-O 120.879 0.371 . . . . 6.82 111.368 -178.601 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -80.68 -6.27 13.41 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.102 2.535 . . . . 7.95 111.127 173.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.59 -31.57 24.12 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.492 -0.777 . . . . 6.42 112.176 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.437 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 10.9 pt20 -150.02 50.01 0.71 Allowed Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 113.514 0.931 . . . . 6.63 113.514 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 7' ' ' GLN . 87.0 Cg_endo -81.46 -155.53 0.06 OUTLIER 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.565 2.177 . . . . 3.98 110.974 173.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.5 p -87.01 82.0 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 122.602 1.191 . . . . 2.77 108.989 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 m -77.54 79.84 4.03 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 113.841 -1.527 . . . . 2.49 108.79 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 111' ' ' ARG . . . -65.73 174.08 2.52 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.09 -1.868 . . . . 1.24 111.716 176.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.42 119.98 58.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.882 -1.053 . . . . 2.16 110.041 -175.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.529 HG23 HG23 ' A' ' 110' ' ' THR . 94.0 t -76.29 106.64 6.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 122.035 0.921 . . . . 1.65 111.532 -175.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.642 ' NE2' HG11 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -100.27 138.15 37.73 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.642 -1.617 . . . . 1.39 110.66 177.381 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.569 ' HG2' ' HA ' ' A' ' 108' ' ' LEU . 3.3 tmm_? -124.7 121.1 33.72 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 120.869 -1.144 . . . . 4.11 109.914 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.874 ' HB ' ' HB1' ' A' ' 69' ' ' ALA . 4.1 m -113.38 155.64 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 119.626 -0.83 . . . . 1.59 110.199 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -144.63 126.75 15.59 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.332 -0.849 . . . . 1.35 109.145 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.538 HG12 ' HB2' ' A' ' 65' ' ' PRO . 7.8 tp -146.07 143.35 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 C-N-CA 119.728 -0.789 . . . . 1.33 109.58 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.9 m-70 -72.6 112.11 8.37 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.735 -0.666 . . . . 0.7 109.455 -176.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.847 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -31.58 135.69 0.06 Allowed 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.329 1.018 . . . . 4.39 113.331 178.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.0 tp -100.71 98.61 9.13 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.197 0.523 . . . . 1.23 110.509 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -71.4 142.48 50.3 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.653 -0.703 . . . . 4.63 111.124 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.486 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -135.0 95.07 3.24 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.525 -0.762 . . . . 1.5 109.398 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.27 -81.85 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.362 -0.923 . . . . 1.33 112.14 -177.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -138.09 12.0 2.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.043 0.449 . . . . 2.33 111.357 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.486 ' OD1' ' HB3' ' A' ' 23' ' ' GLN . 1.5 p30 -127.05 171.06 11.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.063 -0.517 . . . . 1.87 110.715 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.46 HD22 ' HD3' ' A' ' 20' ' ' LYS . 10.3 mp -122.09 123.81 42.44 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.988 0.423 . . . . 2.8 110.619 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.436 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.7 mp -99.13 135.6 33.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.959 -0.564 . . . . 1.45 110.003 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.766 HD22 HD23 ' A' ' 97' ' ' LEU . 9.6 mt -86.8 -35.19 19.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.36 -0.837 . . . . 1.87 110.717 -174.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.863 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 89.87 10.48 64.76 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 115.321 -0.854 . . . . 1.14 110.967 -172.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.772 ' HD2' ' HB1' ' A' ' 66' ' ' ALA . 25.7 p90 -156.84 160.35 39.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 122.342 0.257 . . . . 0.61 110.793 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.521 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 22.1 t -104.1 160.7 14.63 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.77 -1.196 . . . . 0.91 107.77 170.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -161.19 138.99 2.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 120.253 -0.579 . . . . 1.24 112.561 -165.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -142.53 117.89 1.2 Allowed Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 110.431 -1.067 . . . . 0.78 110.431 156.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 1.06 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -140.15 117.28 1.28 Allowed Glycine 0 CA--C 1.49 -1.524 0 CA-C-O 118.927 -0.929 . . . . 1.66 111.518 171.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.697 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -165.41 144.46 9.29 Favored Glycine 0 C--N 1.3 -1.46 0 C-N-CA 118.17 -1.966 . . . . 0.95 112.77 175.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.51 HG22 ' HA ' ' A' ' 87' ' ' MET . 8.8 pt -61.23 -20.64 22.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 107.577 -1.268 . . . . 1.15 107.577 153.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.655 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 3.8 t70 -61.33 -37.87 84.84 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.239 -1.801 . . . . 0.72 110.747 174.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -67.24 -69.88 0.28 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.369 -0.832 . . . . 1.47 112.658 -169.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -145.2 115.98 5.07 Favored Pre-proline 0 N--CA 1.469 0.509 0 CA-C-O 120.944 0.402 . . . . 2.57 112.035 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -58.96 -32.43 97.49 Favored 'Trans proline' 0 N--CA 1.476 0.481 0 C-N-CA 123.892 3.061 . . . . 2.82 113.184 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.5 m -60.96 -17.92 54.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.376 -0.829 . . . . 3.26 111.703 -172.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.637 ' HB2' ' HG3' ' A' ' 53' ' ' LYS . 39.1 mm-40 -96.96 47.37 1.04 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 3.88 109.903 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.572 ' HB2' ' HZ1' ' A' ' 53' ' ' LYS . 4.5 t-20 -130.15 -52.17 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.681 0 CA-C-N 116.238 -0.437 . . . . 5.7 112.142 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.507 ' HD2' ' H ' ' A' ' 44' ' ' ASN . 4.4 Cg_endo -45.81 -12.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.365 1.395 0 C-N-CA 123.369 2.712 . . . . 4.03 115.026 173.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -136.59 25.71 3.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.125 0.488 . . . . 6.35 109.863 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.891 ' HB3' ' HA ' ' A' ' 52' ' ' ASP . 3.7 m -150.52 108.23 3.68 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 121.834 0.825 . . . . 3.85 108.822 -172.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.489 ' H ' ' HB ' ' A' ' 51' ' ' THR . 2.0 mp0 -85.53 -52.34 5.89 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.931 -1.031 . . . . 6.78 113.344 -171.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.406 ' OD2' ' HB3' ' A' ' 48' ' ' GLU . 22.2 m-20 -134.52 -109.09 0.22 Allowed 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.021 -1.445 . . . . 5.47 110.932 -159.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.54 ' HE2' HG22 ' A' ' 110' ' ' THR . 1.2 tmmt? -66.97 -26.75 66.97 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 106.184 -1.784 . . . . 3.54 106.184 161.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.489 ' HB ' ' H ' ' A' ' 48' ' ' GLU . 3.3 m -57.17 -40.7 77.84 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 112.863 -1.971 . . . . 4.89 109.764 172.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.891 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 12.8 t70 -56.2 174.99 0.11 Allowed 'General case' 0 N--CA 1.477 0.911 0 O-C-N 123.709 0.631 . . . . 2.6 110.732 170.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.637 ' HG3' ' HB2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -56.81 -53.44 57.85 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.361 -0.607 . . . . 3.98 109.361 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.624 ' HA2' ' O ' ' A' ' 86' ' ' THR . . . 64.53 -153.99 48.76 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.243 -0.89 . . . . 0.94 110.895 -175.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 1.06 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -106.53 146.44 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 106.522 -1.658 . . . . 1.27 106.522 169.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.658 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -153.51 141.5 20.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 119.613 1.097 . . . . 1.91 111.072 178.706 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.513 HG22 HD21 ' A' ' 71' ' ' LEU . 2.5 p -81.5 132.39 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 CA-C-N 114.392 -1.276 . . . . 1.22 109.374 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.8 m -100.18 -18.52 16.86 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.075 -0.966 . . . . 1.29 110.294 -173.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.689 ' O ' HG22 ' A' ' 60' ' ' VAL . 50.5 mtt180 -146.34 -168.07 2.91 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.333 0.587 . . . . 2.63 112.022 174.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 59' ' ' ARG . 75.4 t -166.33 146.75 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 113.003 -1.908 . . . . 1.53 106.218 165.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.4 p -95.47 133.32 39.58 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.359 0.6 . . . . 2.38 111.519 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -64.83 115.03 4.9 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.456 -1.247 . . . . 1.85 110.138 171.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.88 -16.81 59.74 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 114.983 -1.008 . . . . 0.95 112.171 -177.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.444 ' O ' HD12 ' A' ' 68' ' ' ILE . . . -77.25 172.16 55.13 Favored Glycine 0 CA--C 1.502 -0.755 0 C-N-CA 120.588 -0.815 . . . . 0.99 111.551 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.863 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 60.0 Cg_endo -73.27 -28.1 12.85 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.273 1.982 . . . . 0.63 113.214 -166.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.772 ' HB1' ' HD2' ' A' ' 31' ' ' PHE . . . -58.75 -32.97 69.74 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.269 -0.878 . . . . 1.1 111.922 172.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -77.61 -28.94 51.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.558 0.694 . . . . 1.79 109.648 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.535 ' N ' HD13 ' A' ' 68' ' ' ILE . 1.4 mp -71.28 -41.15 74.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.199 -0.909 . . . . 1.18 108.888 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.874 ' HB1' ' HB ' ' A' ' 16' ' ' VAL . . . -69.54 -31.2 69.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.249 -0.887 . . . . 1.07 110.055 175.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.31 52.24 1.16 Allowed Glycine 0 CA--C 1.521 0.414 0 C-N-CA 121.043 -0.599 . . . . 0.5 113.66 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.513 HD21 HG22 ' A' ' 57' ' ' VAL . 19.8 tp -102.46 155.74 18.06 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.254 -0.647 . . . . 1.5 109.254 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.584 HE22 ' HG3' ' A' ' 111' ' ' ARG . 7.2 mt-30 -126.34 29.59 5.76 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 115.778 1.77 . . . . 1.53 115.778 -163.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.666 ' HA ' ' C ' ' A' ' 59' ' ' ARG . 53.9 mt 72.52 1.58 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-N 119.102 0.864 . . . . 1.43 113.026 166.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -172.24 51.41 0.17 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 119.668 -1.253 . . . . 0.37 113.118 -171.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.575 ' HB3' HG13 ' A' ' 109' ' ' VAL . 21.1 m-20 -122.08 142.55 50.25 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.595 -0.302 . . . . 0.89 111.736 -172.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.604 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 59.3 mttm -82.76 130.57 35.15 Favored 'General case' 0 C--O 1.207 -1.163 0 CA-C-O 121.138 0.494 . . . . 2.71 109.668 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.658 HD12 ' HA ' ' A' ' 56' ' ' TYR . 2.8 mp -99.8 125.22 53.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 C-N-CA 122.689 0.396 . . . . 1.22 110.562 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.775 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 7.5 mmt -90.81 -17.17 27.04 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 125.099 1.499 . . . . 1.61 112.941 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.499 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -163.99 151.48 12.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.041 0.448 . . . . 0.88 112.128 -175.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.415 ' N ' ' HG3' ' A' ' 79' ' ' GLN . 39.5 t -130.51 105.07 10.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.344 -0.844 . . . . 1.93 110.38 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.615 HD22 HG11 ' A' ' 105' ' ' VAL . 27.2 m-80 49.48 46.95 23.1 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.751 -0.659 . . . . 1.8 111.997 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.03 -15.17 61.93 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.337 -0.935 . . . . 0.38 112.978 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -85.58 170.16 12.85 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 109.782 -0.451 . . . . 0.91 109.782 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -115.92 112.47 21.94 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.114 0.483 . . . . 1.89 111.39 -172.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.484 ' HE2' ' HA ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -107.11 100.5 9.97 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.136 0.969 . . . . 1.38 110.922 -179.257 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.624 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 1.1 p -132.03 -58.38 0.96 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.939 -1.482 . . . . 1.1 107.408 170.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.51 ' HA ' HG22 ' A' ' 37' ' ' ILE . 1.3 mtt -125.36 79.33 1.8 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.642 -1.617 . . . . 2.15 108.563 172.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.723 HG12 ' HG2' ' A' ' 92' ' ' GLN . 1.2 t -139.25 137.28 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 115.351 -0.841 . . . . 1.68 108.879 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.655 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 79.3 p -56.78 152.6 12.16 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.333 0.587 . . . . 1.1 112.529 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.767 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 21.0 t-160 -57.11 -38.18 73.03 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 115.552 -0.749 . . . . 0.41 110.395 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.57 -32.05 69.29 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.491 -1.231 . . . . 1.67 109.877 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.723 ' HG2' HG12 ' A' ' 88' ' ' VAL . 1.0 OUTLIER -65.7 -45.05 84.25 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 109.088 -0.708 . . . . 0.79 109.088 -177.737 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.649 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -74.91 -37.41 62.08 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.173 -0.922 . . . . 1.06 110.565 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -65.05 -37.53 87.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.048 -0.524 . . . . 2.45 110.356 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.492 ' HE3' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -70.98 -40.79 71.71 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.631 -0.713 . . . . 1.51 110.175 -177.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 13.1 mmm180 -69.06 -27.71 65.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.2 0.524 . . . . 4.23 110.564 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.766 HD23 HD22 ' A' ' 29' ' ' LEU . 2.3 tt -78.59 -48.06 15.93 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.452 -0.795 . . . . 2.24 110.426 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.3 m -108.74 70.24 0.74 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.51 -0.768 . . . . 1.63 110.389 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.492 ' HB2' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -108.98 8.9 26.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.661 0.743 . . . . 3.16 110.839 -176.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 73.0 20.41 3.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.622 -1.172 . . . . 4.79 112.681 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.7 p -71.28 -46.02 61.82 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.457 -0.572 . . . . 2.83 109.457 174.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.45 ' HG2' HD21 ' A' ' 27' ' ' LEU . 35.6 mt-10 68.18 6.06 5.03 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.148 -0.933 . . . . 3.4 113.067 169.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.439 ' HG3' ' H ' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -70.58 -68.47 0.43 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.67 0.748 . . . . 2.68 109.767 174.636 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.693 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 4.8 p -159.58 156.14 3.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.816 -1.084 . . . . 1.15 108.52 -176.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.675 ' CG2' ' HG2' ' A' ' 20' ' ' LYS . 3.1 t -132.11 119.88 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-O 121.958 0.885 . . . . 1.13 112.968 -177.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.566 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 1.2 mpt_? -100.31 130.75 46.45 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.393 -1.731 . . . . 2.28 111.236 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.14 135.64 41.28 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.916 -0.314 . . . . 1.68 110.592 172.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.775 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 26.2 tp -98.45 130.34 45.06 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 107.008 -1.479 . . . . 1.1 107.008 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.575 HG13 ' HB3' ' A' ' 75' ' ' ASP . 2.2 t -128.32 142.53 43.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 121.611 0.719 . . . . 1.39 111.317 -170.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.54 HG22 ' HE2' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -98.74 114.29 26.75 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.511 -0.768 . . . . 1.13 109.973 164.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.584 ' HG3' HE22 ' A' ' 72' ' ' GLN . 20.1 ttt180 -98.68 146.52 25.78 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.102 -0.953 . . . . 2.34 110.31 -175.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.471 ' N ' ' CD ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -136.22 -69.44 0.48 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.036 0.754 . . . . 1.97 113.036 -171.346 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.9 t -158.38 26.91 0.24 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.059 0.457 . . . . 2.0 111.661 -173.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 4.0 mm? -98.83 23.21 9.1 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.217 0.451 . . . . 2.0 112.217 -176.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.589 ' HB2' ' HB ' ' A' ' 118' ' ' VAL . 1.7 mp0 -72.6 158.42 35.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.873 0.368 . . . . 3.83 110.722 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -93.44 -61.09 1.63 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.915 0.864 . . . . 3.96 109.782 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -92.12 65.29 4.71 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.663 -1.153 . . . . 3.76 110.046 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 115' ' ' GLN . 13.1 p -111.67 -28.16 2.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.609 -0.723 . . . . 5.11 110.965 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.503 ' HG3' HG12 ' A' ' 118' ' ' VAL . 94.8 mt-30 -114.19 11.58 17.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.531 -0.759 . . . . 8.35 109.726 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -143.76 139.95 29.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.798 -1.092 . . . . 6.63 108.869 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.0 m -82.79 179.44 7.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.238 0.542 . . . . 8.94 112.405 -172.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 94.4 mmm -73.99 90.29 1.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.533 -0.758 . . . . 12.46 111.612 -175.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 27.8 tp -112.21 12.83 20.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.994 0.902 . . . . 13.06 108.771 172.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.7 m . . . . . 0 C--O 1.247 0.946 0 CA-C-N 114.78 -1.1 . . . . 14.64 109.032 178.996 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptt? . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 111.573 0.212 . . . . 14.35 111.573 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 t -165.04 154.16 12.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.901 0.381 . . . . 11.48 110.65 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -141.01 135.05 30.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.526 -0.761 . . . . 9.53 109.776 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.836 HG13 ' HB3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -110.53 98.19 35.63 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 121.107 0.48 . . . . 6.82 110.578 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.81 -16.0 20.96 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.887 2.392 . . . . 7.95 112.02 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.58 39.75 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.607 -0.724 . . . . 6.42 111.503 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.623 ' H ' ' HD3' ' A' ' 8' ' ' PRO . 17.8 pt20 -152.86 35.54 0.08 OUTLIER Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 114.084 1.142 . . . . 6.63 114.084 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.836 ' HB3' HG13 ' A' ' 4' ' ' ILE . 11.8 Cg_endo -80.27 114.3 3.05 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.046 1.83 . . . . 3.98 111.929 172.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 8' ' ' PRO . 24.3 t 78.85 -48.56 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 O-C-N 123.363 0.415 . . . . 2.77 111.419 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.3 p -70.51 82.55 0.58 Allowed 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 122.632 1.206 . . . . 2.49 111.847 -175.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.402 ' HB2' ' HZ2' ' A' ' 50' ' ' LYS . . . -112.61 178.72 4.2 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.265 -1.789 . . . . 1.24 110.09 174.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.6 t -120.49 117.17 52.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 116.081 -0.509 . . . . 2.16 110.273 -174.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.606 HG23 HG22 ' A' ' 110' ' ' THR . 21.8 t -76.71 115.72 18.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.954 0.406 . . . . 1.65 109.942 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 1.034 HE22 HG22 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -105.48 172.37 6.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.708 -0.678 . . . . 1.39 110.637 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.632 ' NH1' ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -128.17 128.3 44.53 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.814 -0.175 . . . . 4.11 110.919 172.41 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 1.034 HG22 HE22 ' A' ' 14' ' ' GLN . 24.2 t -102.08 132.54 47.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 110.196 -0.298 . . . . 1.59 110.196 173.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.632 ' HB2' ' NH1' ' A' ' 15' ' ' ARG . 10.1 tt0 -144.71 115.47 7.75 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.357 -0.238 . . . . 1.35 110.357 171.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.532 HG12 ' HB2' ' A' ' 65' ' ' PRO . 9.0 tp -145.39 155.73 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 108.561 -0.903 . . . . 1.33 108.561 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -83.39 116.59 22.56 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 119.711 -0.796 . . . . 0.7 109.603 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -28.8 140.77 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.958 1.411 . . . . 4.39 112.441 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.418 HD22 ' HD3' ' A' ' 65' ' ' PRO . 39.6 tp -97.1 102.9 14.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.173 0.511 . . . . 1.23 110.24 -173.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 12.3 ptp180 -71.11 141.17 50.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.571 -0.74 . . . . 4.63 111.887 -175.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.487 ' HG3' HD13 ' A' ' 28' ' ' ILE . 6.7 mm-40 -132.66 92.28 3.04 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.398 -0.964 . . . . 1.5 108.398 170.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.27 -68.29 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.053 -0.594 . . . . 1.33 112.251 -173.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -147.08 12.42 1.08 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.45 0.643 . . . . 2.33 109.829 -176.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 34.0 m-80 -112.17 161.77 16.18 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.276 -0.875 . . . . 1.87 110.534 -174.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.603 ' HB2' HG23 ' A' ' 98' ' ' THR . 10.9 mp -121.93 113.07 19.09 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.758 -0.831 . . . . 2.8 108.758 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.487 HD13 ' HG3' ' A' ' 23' ' ' GLN . 1.2 mp -97.88 133.43 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 CA-C-O 121.311 0.577 . . . . 1.45 109.996 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.18 -41.29 42.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.647 -1.161 . . . . 1.87 109.832 -173.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.671 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 94.17 9.5 59.3 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.191 -0.913 . . . . 1.14 111.036 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 31.0 p90 -156.18 177.51 11.35 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 122.659 0.384 . . . . 0.61 110.299 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 t -114.45 161.23 18.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.619 -1.252 . . . . 0.91 107.619 169.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -161.45 136.09 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 112.6 0.593 . . . . 1.24 112.6 -167.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.473 ' HA2' ' CD2' ' A' ' 90' ' ' HIS . . . -143.82 118.72 1.22 Allowed Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 110.518 -1.033 . . . . 0.78 110.518 156.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 1.029 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -139.19 116.54 1.25 Allowed Glycine 0 CA--C 1.492 -1.36 0 CA-C-O 118.982 -0.899 . . . . 1.66 111.148 172.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.633 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.52 140.4 6.24 Favored Glycine 0 C--N 1.3 -1.465 0 C-N-CA 118.139 -1.982 . . . . 0.95 112.659 177.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.6 pt -58.26 -22.51 19.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 107.42 -1.326 . . . . 1.15 107.42 151.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.782 ' HB2' ' CB ' ' A' ' 89' ' ' THR . 13.0 t70 -57.97 -43.71 86.64 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 113.223 -1.808 . . . . 0.72 111.435 173.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -63.4 -80.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.402 -0.817 . . . . 1.47 112.629 -168.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -170.18 111.12 0.45 Allowed Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.689 -0.232 . . . . 2.57 110.483 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.704 ' HA ' ' HE3' ' A' ' 53' ' ' LYS . 5.7 Cg_exo -83.79 -2.59 10.36 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 C-N-CA 123.341 2.694 . . . . 2.82 113.145 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 t -87.7 25.66 1.45 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.129 0.418 . . . . 3.26 112.129 -165.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -127.6 -7.81 5.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.092 0.472 . . . . 3.88 109.995 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.45 ' HB2' ' OE2' ' A' ' 48' ' ' GLU . 6.5 m-20 174.79 72.41 0.05 OUTLIER Pre-proline 0 N--CA 1.444 -0.729 0 N-CA-C 106.522 -1.658 . . . . 5.7 106.522 -169.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -86.59 30.44 0.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.948 2.432 . . . . 4.03 112.27 -169.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -144.81 -49.37 0.26 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.907 -1.042 . . . . 6.35 108.335 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.7 m -160.37 98.58 1.28 Allowed 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.577 -0.738 . . . . 3.85 110.493 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.86 ' H ' ' HA ' ' A' ' 52' ' ' ASP . 13.9 mm-40 -54.59 -57.6 10.8 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 122.312 1.053 . . . . 6.78 109.769 167.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.559 ' CG ' ' HE2' ' A' ' 76' ' ' LYS . 7.6 m-20 -130.04 -110.56 0.26 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.751 -1.568 . . . . 5.47 109.956 -172.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.479 ' HD2' ' HB3' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -91.09 -35.17 14.75 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.496 -1.229 . . . . 3.54 108.497 169.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.63 ' HG1' ' HE2' ' A' ' 78' ' ' MET . 0.3 OUTLIER -127.98 24.56 6.01 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 114.19 1.182 . . . . 4.89 114.19 -168.191 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.86 ' HA ' ' H ' ' A' ' 48' ' ' GLU . 34.9 t70 56.23 -130.99 1.76 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.533 -0.758 . . . . 2.6 112.764 164.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.704 ' HE3' ' HA ' ' A' ' 41' ' ' PRO . 29.8 mmtt -83.13 50.85 1.82 Allowed 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 122.18 0.991 . . . . 3.98 109.616 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.453 ' C ' HD11 ' A' ' 55' ' ' ILE . . . -86.55 -145.35 8.87 Favored Glycine 0 N--CA 1.422 -2.247 0 N-CA-C 108.813 -1.715 . . . . 0.94 108.813 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 1.029 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -113.92 141.45 29.99 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 CA-C-N 118.935 1.368 . . . . 1.27 109.002 173.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.604 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -142.64 142.25 32.05 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 119.036 0.834 . . . . 1.91 110.791 -178.09 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.884 HG21 HD22 ' A' ' 71' ' ' LEU . 1.4 p -82.66 143.48 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-N 114.848 -1.069 . . . . 1.22 109.66 178.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.9 m -110.87 -17.6 13.29 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 124.191 0.932 . . . . 1.29 111.454 -173.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.465 ' CA ' ' HA ' ' A' ' 73' ' ' ILE . 78.7 mtt180 -152.56 -166.31 2.44 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.953 0.882 . . . . 2.63 112.097 175.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 8.7 p -173.35 139.58 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 112.982 -1.917 . . . . 1.53 107.529 164.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.6 m -109.05 136.89 47.82 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.474 0.654 . . . . 2.38 111.196 -173.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.37 125.93 26.2 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.555 -1.202 . . . . 1.85 110.777 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.54 -18.02 58.02 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 114.671 -1.15 . . . . 0.95 111.253 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.401 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -78.95 167.68 52.87 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.385 -0.912 . . . . 0.99 111.016 174.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.671 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 91.3 Cg_endo -75.95 -19.33 16.03 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 122.861 2.374 . . . . 0.63 113.912 -169.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.511 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -73.05 -26.71 61.39 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.962 -1.017 . . . . 1.1 111.695 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -72.88 -29.98 63.6 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.458 -0.941 . . . . 1.79 108.458 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.647 HD11 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -77.85 -35.4 20.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.689 -1.141 . . . . 1.18 110.095 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.774 ' CB ' HG11 ' A' ' 16' ' ' VAL . . . -81.66 -14.23 56.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.454 -0.794 . . . . 1.07 111.504 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.0 60.48 1.19 Allowed Glycine 0 CA--C 1.522 0.473 0 C-N-CA 119.291 -1.433 . . . . 0.5 114.314 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.884 HD22 HG21 ' A' ' 57' ' ' VAL . 35.2 tp -123.81 156.74 35.57 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.457 -0.572 . . . . 1.5 109.457 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.83 ' HG3' ' HB2' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -148.9 81.12 1.43 Allowed 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 115.532 1.678 . . . . 1.53 115.532 -177.144 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.554 HG13 HG11 ' A' ' 60' ' ' VAL . 4.2 mp 62.82 -22.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 117.001 2.223 . . . . 1.43 117.001 158.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -162.53 61.46 0.27 Allowed Glycine 0 CA--C 1.506 -0.51 0 O-C-N 120.732 -1.23 . . . . 0.37 112.194 -167.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 61.7 m-20 -121.88 152.05 40.02 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.356 -0.422 . . . . 0.89 110.668 -167.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.627 ' HD2' ' N ' ' A' ' 76' ' ' LYS . 3.7 mptt -103.8 101.61 11.43 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.79 0.805 . . . . 2.71 109.548 -173.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 1.046 HG13 HG23 ' A' ' 109' ' ' VAL . 3.3 mp -71.22 121.71 21.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 114.523 -1.217 . . . . 1.22 111.392 -176.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.869 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 1.4 mmt -89.05 -17.9 28.4 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 125.843 1.965 . . . . 1.61 111.215 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.496 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -172.12 153.25 3.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.808 0.337 . . . . 0.88 111.74 -175.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.525 HG11 ' CE ' ' A' ' 85' ' ' MET . 9.8 p -139.66 125.31 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 121.323 0.583 . . . . 1.93 109.87 175.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.921 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 13.0 m120 52.44 28.89 6.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.225 -0.898 . . . . 1.8 112.529 175.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.48 -16.64 44.44 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.093 -1.051 . . . . 0.38 113.309 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.559 ' HB2' ' HE2' ' A' ' 85' ' ' MET . 41.7 m95 -87.56 148.58 24.81 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 109.475 -0.565 . . . . 0.91 109.475 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -96.63 117.99 32.15 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.345 0.593 . . . . 1.89 111.305 -174.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.629 ' HE3' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -106.71 102.33 11.71 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.834 0.826 . . . . 1.38 111.355 -178.503 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 p -123.16 -38.38 2.59 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.805 -1.088 . . . . 1.1 108.433 167.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.38 76.95 1.23 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.21 -1.359 . . . . 2.15 109.255 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.633 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.5 OUTLIER -138.12 151.61 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 108.966 -0.753 . . . . 1.68 108.966 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.782 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 75.2 p -60.51 151.45 28.48 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 112.888 0.699 . . . . 1.1 112.888 -175.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.738 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 18.0 t-160 -57.71 -41.36 81.57 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 115.588 -0.733 . . . . 0.41 110.467 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.65 -30.1 67.71 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.188 -1.369 . . . . 1.67 109.964 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.549 ' HG2' HG13 ' A' ' 88' ' ' VAL . 2.4 tp-100 -62.55 -49.59 74.67 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.691 0.758 . . . . 0.79 109.467 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.527 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -73.92 -31.88 63.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.988 -1.005 . . . . 1.06 110.116 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -71.02 -41.8 70.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.411 -0.813 . . . . 2.45 111.004 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.547 ' HD3' ' HD2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -71.42 -30.8 66.5 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 119.773 -0.771 . . . . 1.51 109.873 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.547 ' HD2' ' HD3' ' A' ' 95' ' ' LYS . 2.4 mmm180 -67.41 -37.6 83.32 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.003 -0.679 . . . . 4.23 110.954 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.507 HD21 ' HG1' ' A' ' 98' ' ' THR . 4.6 tt -58.68 -55.34 36.34 Favored 'General case' 0 C--N 1.316 -0.859 0 O-C-N 124.232 0.958 . . . . 2.24 110.062 173.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.603 HG23 ' HB2' ' A' ' 27' ' ' LEU . 36.9 m -108.18 -94.96 0.39 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.789 -0.641 . . . . 1.63 112.55 -174.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 99' ' ' LYS . 0.3 OUTLIER 64.52 2.74 1.68 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.315 1.055 . . . . 3.16 110.963 -175.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.448 ' H ' ' C ' ' A' ' 98' ' ' THR . 41.6 mtm180 57.54 57.95 4.04 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.061 -1.427 . . . . 4.79 110.862 -177.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.2 t -155.11 -48.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.27 -0.572 . . . . 2.83 112.01 -175.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -53.83 135.44 41.86 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.044 0.449 . . . . 3.4 112.026 -174.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -89.0 -16.14 32.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.47 0.652 . . . . 2.68 110.54 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.7 p -152.47 148.54 14.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 108.39 -0.967 . . . . 1.15 108.39 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.0 t -114.42 117.61 56.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 122.229 1.014 . . . . 1.13 112.621 -173.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.921 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.2 OUTLIER -101.3 124.9 47.72 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 113.411 -1.722 . . . . 2.28 110.681 -176.367 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.975 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 25.3 tp -132.74 126.73 33.12 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.398 -0.364 . . . . 1.68 110.755 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.869 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 33.1 tp -109.96 115.94 30.71 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.105 -1.443 . . . . 1.1 107.105 172.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 1.046 HG23 HG13 ' A' ' 77' ' ' ILE . 0.5 OUTLIER -128.23 149.51 33.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 121.397 0.617 . . . . 1.39 110.591 -173.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.606 HG22 HG23 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -97.57 114.7 26.66 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.584 -0.734 . . . . 1.13 109.61 168.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -99.16 139.03 35.42 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.281 -0.872 . . . . 2.34 109.696 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.16 -73.08 0.65 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.854 0.359 . . . . 1.97 110.441 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.5 t 177.43 73.27 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.775 0.798 . . . . 2.0 110.723 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.83 ' HB2' ' HG3' ' A' ' 72' ' ' GLN . 0.2 OUTLIER -135.9 -8.63 2.09 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.677 -1.147 . . . . 2.0 108.757 178.385 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.578 ' HB2' ' OE1' ' A' ' 72' ' ' GLN . 2.3 tp-100 -63.37 154.95 30.33 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.428 -1.26 . . . . 3.83 112.479 -175.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.532 ' N ' ' HD2' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -85.75 -178.12 6.54 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.077 -0.965 . . . . 3.96 108.762 178.251 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -80.53 56.56 2.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.527 0.679 . . . . 3.76 110.125 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 119' ' ' GLN . 3.6 p -81.83 -51.57 14.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.41 -0.814 . . . . 5.11 112.191 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.408 ' N ' HG13 ' A' ' 118' ' ' VAL . 32.4 tt0 -101.33 82.47 2.33 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.499 0.666 . . . . 8.35 110.978 -174.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -142.74 127.72 18.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.936 -1.029 . . . . 6.63 109.372 174.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.7 t -92.32 -41.69 10.23 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.438 -0.579 . . . . 8.94 109.438 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 47.1 ttp -69.62 -37.86 77.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.656 -0.702 . . . . 12.46 110.863 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 97.3 mt 68.0 -179.63 0.22 Allowed 'General case' 0 CA--C 1.531 0.22 0 O-C-N 123.823 0.702 . . . . 13.06 110.308 -173.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.556 -0.735 . . . . 14.64 110.377 -176.562 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtm . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 111.326 0.121 . . . . 14.35 111.326 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.2 m -71.59 146.33 48.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.632 0.253 . . . . 11.48 110.724 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.48 ' CE2' ' HG3' ' A' ' 5' ' ' PRO . 53.5 t80 -68.63 119.99 13.94 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.463 -0.569 . . . . 9.53 109.463 177.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.422 HD11 ' CD ' ' A' ' 8' ' ' PRO . 1.9 pt -120.09 89.31 42.61 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.798 -0.637 . . . . 6.82 111.481 -172.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.48 ' HG3' ' CE2' ' A' ' 3' ' ' TYR . 13.7 Cg_exo -70.06 -39.5 5.87 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.187 2.592 . . . . 7.95 112.516 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.87 -20.87 72.65 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.997 -0.621 . . . . 6.42 111.801 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 68.84 119.71 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.313 0 O-C-N 124.28 0.635 . . . . 6.63 112.193 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.422 ' CD ' HD11 ' A' ' 4' ' ' ILE . 1.0 OUTLIER -84.11 178.59 5.18 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.008 2.472 . . . . 3.98 111.969 177.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 t -95.18 -22.38 5.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 108.891 -0.781 . . . . 2.77 108.891 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.7 t -82.25 82.05 7.91 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 123.485 1.612 . . . . 2.49 111.081 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.29 148.29 23.28 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 111.99 -2.368 . . . . 1.24 108.0 168.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -95.42 130.38 44.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 121.185 0.517 . . . . 2.16 111.133 -173.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.599 HG21 HG21 ' A' ' 110' ' ' THR . 44.9 t -83.36 110.92 18.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.327 0.585 . . . . 1.65 110.556 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.658 ' HG3' HG11 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -119.45 163.04 17.85 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.426 -0.807 . . . . 1.39 109.757 175.145 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.466 ' HB3' ' CD1' ' A' ' 108' ' ' LEU . 2.3 ppt_? -127.08 124.45 39.27 Favored 'General case' 0 C--N 1.31 -1.113 0 O-C-N 121.491 -0.755 . . . . 4.11 111.649 -174.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.719 HG12 ' CB ' ' A' ' 69' ' ' ALA . 9.6 t -90.85 125.2 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-N 115.255 -0.884 . . . . 1.59 110.23 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -123.86 114.32 19.69 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.926 -0.398 . . . . 1.35 109.926 175.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.798 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 11.1 tp -144.57 137.12 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 109.108 -0.701 . . . . 1.33 109.108 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.962 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 15.0 m-70 -65.27 115.91 6.06 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.887 -0.597 . . . . 0.7 110.263 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.826 ' HD3' HD11 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -33.23 126.99 0.34 Allowed 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.364 1.04 . . . . 4.39 110.056 172.349 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.2 tp -103.58 79.59 1.7 Allowed 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 118.978 -1.089 . . . . 1.23 111.398 -163.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.939 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 15.1 ptt-85 -60.87 136.18 58.0 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.481 -0.781 . . . . 4.63 110.947 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.537 ' HB2' HG12 ' A' ' 28' ' ' ILE . 6.0 tp-100 -122.11 94.44 4.3 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.212 -0.904 . . . . 1.5 109.069 -174.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.24 -89.19 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.82 -0.705 . . . . 1.33 112.211 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -115.97 -6.54 11.99 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.477 0.656 . . . . 2.33 110.786 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.52 -178.08 3.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.384 -0.825 . . . . 1.87 109.078 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.939 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.4 pt? -130.69 144.46 51.45 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.107 -1.071 . . . . 2.8 108.107 167.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.537 HG12 ' HB2' ' A' ' 23' ' ' GLN . 11.6 mm -101.27 130.85 50.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-O 121.417 0.627 . . . . 1.45 111.374 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.745 HD11 HD21 ' A' ' 97' ' ' LEU . 13.1 tp -74.18 -58.22 3.44 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.474 -1.239 . . . . 1.87 109.917 175.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.928 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 100.96 -0.13 55.04 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.316 -0.945 . . . . 1.14 113.019 173.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.593 ' HD1' ' HB1' ' A' ' 66' ' ' ALA . 29.6 p90 -157.49 163.4 38.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.147 0.474 . . . . 0.61 110.865 175.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 35.6 t -102.74 160.74 14.32 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.038 -1.097 . . . . 0.91 108.038 173.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -161.77 141.77 2.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 C-N-CA 120.665 -0.414 . . . . 1.24 111.99 -166.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.4 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -144.97 118.75 1.15 Allowed Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.361 -0.923 . . . . 0.78 110.882 158.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 1.048 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -139.7 118.17 1.45 Allowed Glycine 0 CA--C 1.489 -1.539 0 CA-C-O 118.546 -1.141 . . . . 1.66 110.49 172.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.99 ' HA3' ' HG2' ' A' ' 39' ' ' GLN . . . -156.18 117.05 0.75 Allowed Glycine 0 N--CA 1.434 -1.469 0 C-N-CA 117.909 -2.091 . . . . 0.95 114.187 -171.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.793 HG21 HD21 ' A' ' 44' ' ' ASN . 5.1 pt -61.91 -26.61 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 104.798 -2.297 . . . . 1.15 104.798 146.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.965 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 7.1 t70 -55.31 -47.78 75.09 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 112.052 -2.34 . . . . 0.72 109.627 170.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.99 ' HG2' ' HA3' ' A' ' 36' ' ' GLY . 19.2 mm-40 -62.3 -43.61 98.42 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 114.821 -1.081 . . . . 1.47 111.374 -172.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.632 ' HB3' ' HD2' ' A' ' 53' ' ' LYS . 10.7 t70 -152.92 99.22 2.76 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.866 0.365 . . . . 2.57 110.523 176.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -86.87 16.95 1.85 Allowed 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.861 3.041 . . . . 2.82 112.456 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 t -102.2 -23.62 14.01 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.175 -0.466 . . . . 3.26 111.254 -171.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.49 71.32 1.33 Allowed 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 109.277 -0.638 . . . . 3.88 109.277 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.793 HD21 HG21 ' A' ' 37' ' ' ILE . 30.0 p-10 -158.68 34.61 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 113.119 0.785 . . . . 5.7 113.119 -174.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.707 ' HD3' ' N ' ' A' ' 44' ' ' ASN . 44.4 Cg_endo -99.21 -0.85 0.92 Allowed 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.275 1.983 . . . . 4.03 112.879 -174.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 18.4 t80 179.86 29.38 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.072 -1.084 . . . . 6.35 108.072 -172.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.466 ' HB3' ' CG ' ' A' ' 52' ' ' ASP . 30.5 m -81.09 -176.97 6.23 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.185 -1.37 . . . . 3.85 113.641 -165.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 26.8 mm-40 -39.28 -69.81 0.12 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.536 -1.666 . . . . 6.78 114.731 -168.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.478 ' CG ' ' HD3' ' A' ' 50' ' ' LYS . 17.2 t0 170.39 -156.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.681 -0.859 . . . . 5.47 108.681 -166.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.691 ' HB3' ' HE1' ' A' ' 78' ' ' MET . 0.0 OUTLIER -51.79 -28.3 15.03 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.726 0.41 . . . . 3.54 111.337 172.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 t -80.54 -6.43 58.2 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.075 -0.511 . . . . 4.89 111.414 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.54 ' OD2' ' HG2' ' A' ' 53' ' ' LYS . 17.9 t70 -83.71 -123.75 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.002 0.43 . . . . 2.6 110.365 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.642 ' HG3' ' HB3' ' A' ' 44' ' ' ASN . 15.1 mmtp -88.9 29.83 0.99 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.276 0.56 . . . . 3.98 109.841 177.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 86' ' ' THR . . . -72.43 -161.55 5.69 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 109.989 -1.244 . . . . 0.94 109.989 174.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 1.048 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -108.33 146.07 14.61 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.855 0 CA-C-N 119.331 1.565 . . . . 1.27 108.413 172.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.784 ' HA ' HD13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -153.63 143.02 21.61 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.898 0.856 . . . . 1.91 111.44 178.433 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.473 HG22 HD22 ' A' ' 71' ' ' LEU . 8.4 p -83.11 127.96 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 CA-C-N 113.907 -1.497 . . . . 1.22 110.229 -177.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.2 m -94.88 -19.25 20.44 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.68 -1.145 . . . . 1.29 111.206 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.546 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 25.7 mtp180 -150.4 -165.15 2.19 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.92 0.711 . . . . 2.63 112.92 177.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 91.9 t -156.01 138.71 6.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 112.756 -2.02 . . . . 1.53 107.202 161.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.1 m -94.9 121.58 36.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.226 0.536 . . . . 2.38 110.217 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -52.74 127.6 23.75 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.531 -1.213 . . . . 1.85 111.869 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.14 -4.38 84.54 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.614 -0.803 . . . . 0.95 112.466 174.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.614 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -82.82 -153.2 12.53 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.256 -0.973 . . . . 0.99 110.95 173.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.928 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 40.4 Cg_endo -94.72 -33.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.081 1.854 . . . . 0.63 115.018 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.593 ' HB1' ' HD1' ' A' ' 31' ' ' PHE . . . -66.72 -25.54 66.57 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.073 0.463 . . . . 1.1 111.837 -174.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -72.78 -30.83 64.43 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.758 0.79 . . . . 1.79 108.923 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.614 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -78.03 -41.89 27.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.64 -1.164 . . . . 1.18 110.751 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.798 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . . . -72.55 -20.17 61.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.291 -0.413 . . . . 1.07 110.736 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.43 64.58 1.02 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.279 -0.963 . . . . 0.5 113.445 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.473 HD22 HG22 ' A' ' 57' ' ' VAL . 16.0 tp -109.45 149.28 29.79 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.151 -0.685 . . . . 1.5 109.151 175.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 1.044 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 30.3 mt-30 -115.05 23.74 12.28 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 115.031 1.493 . . . . 1.53 115.031 -164.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.624 HG23 ' O ' ' A' ' 73' ' ' ILE . 62.1 mt 69.51 2.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 CA-C-N 118.761 0.709 . . . . 1.43 112.477 168.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.71 46.77 0.21 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.268 -0.968 . . . . 0.37 112.4 -168.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.474 ' OD2' ' HB2' ' A' ' 72' ' ' GLN . 49.0 m-20 -120.89 152.9 37.88 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.614 -0.514 . . . . 0.89 109.614 -172.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.675 ' HD2' ' N ' ' A' ' 76' ' ' LYS . 8.9 mptt -102.29 122.75 44.83 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.822 -0.807 . . . . 2.71 108.822 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.784 HD13 ' HA ' ' A' ' 56' ' ' TYR . 4.2 mp -91.6 134.27 30.54 Favored 'Isoleucine or valine' 0 C--O 1.264 1.851 0 CA-C-O 121.168 0.508 . . . . 1.22 112.176 -172.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.691 ' HE1' ' HB3' ' A' ' 50' ' ' LYS . 0.9 OUTLIER -92.43 -25.68 18.36 Favored 'General case' 0 C--N 1.346 0.452 0 O-C-N 126.381 2.3 . . . . 1.61 112.442 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.623 ' HA ' ' HG2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -170.77 156.02 4.98 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.281 0.475 . . . . 0.88 112.281 -172.347 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.487 HG12 ' CE ' ' A' ' 85' ' ' MET . 6.4 p -143.14 127.51 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.095 -0.502 . . . . 1.93 110.317 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.455 ' N ' HD21 ' A' ' 81' ' ' ASN . 0.9 OUTLIER 59.39 19.87 8.16 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.888 -0.597 . . . . 1.8 111.929 176.046 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.79 -6.21 58.59 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 119.96 -1.114 . . . . 0.38 112.262 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -83.13 124.18 30.24 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-O 121.332 0.587 . . . . 0.91 109.825 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -86.13 96.74 9.99 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.536 -1.211 . . . . 1.89 110.084 -177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.623 ' HG2' ' HA ' ' A' ' 79' ' ' GLN . 3.9 ptp -109.41 102.39 11.29 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.129 0.966 . . . . 1.38 111.534 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.416 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 4.6 p -101.91 -33.89 9.59 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.236 -1.347 . . . . 1.1 109.115 176.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.597 ' O ' HG23 ' A' ' 37' ' ' ILE . 1.7 mtt -129.03 -16.07 4.13 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 113.88 -1.509 . . . . 2.15 110.042 -176.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.686 ' O ' HD11 ' A' ' 55' ' ' ILE . 2.1 t -40.6 150.59 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 C-N-CA 125.726 1.61 . . . . 1.68 115.222 -167.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.965 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 47.7 p -60.25 150.44 30.24 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.778 -0.576 . . . . 1.1 111.637 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.728 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 21.9 t-160 -61.49 -33.69 74.21 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-N 115.975 -0.557 . . . . 0.41 109.886 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.94 -33.98 68.66 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.687 -1.142 . . . . 1.67 109.546 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.578 ' HG2' HG13 ' A' ' 88' ' ' VAL . 2.0 tp-100 -68.66 -46.56 68.81 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.402 -0.962 . . . . 0.79 108.402 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.546 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -66.68 -37.94 85.77 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.92 -1.036 . . . . 1.06 109.866 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 90' ' ' HIS . 27.6 ttp-105 -71.13 -43.64 67.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.626 -0.716 . . . . 2.45 110.814 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.513 ' HD3' ' C ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -69.39 -43.01 74.37 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 116.109 -0.496 . . . . 1.51 110.467 -177.664 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 28.2 mmt180 -72.08 -23.37 61.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.237 0.541 . . . . 4.23 110.555 -178.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.745 HD21 HD11 ' A' ' 29' ' ' LEU . 7.2 tp -78.57 -57.47 3.75 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.261 -0.881 . . . . 2.24 112.167 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.723 ' OG1' HD12 ' A' ' 29' ' ' LEU . 35.8 m -124.95 91.65 3.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.586 0.708 . . . . 1.63 110.872 -174.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.633 ' HG2' ' OE1' ' A' ' 102' ' ' GLU . 7.0 ptpp? -122.08 7.93 9.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.379 -0.828 . . . . 3.16 112.831 -176.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.874 ' HG2' HD21 ' A' ' 27' ' ' LEU . 26.3 mtm180 67.07 16.5 10.31 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.75 -0.659 . . . . 4.79 111.057 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.493 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 28.0 m -124.74 21.59 8.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.985 0.421 . . . . 2.83 111.441 -175.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.633 ' OE1' ' HG2' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -137.52 131.13 31.32 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.45 -0.341 . . . . 3.4 110.358 179.068 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -85.98 -22.29 27.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.374 0.607 . . . . 2.68 110.257 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.962 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 4.0 p -135.85 141.86 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.519 -0.764 . . . . 1.15 109.367 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.557 HG21 ' HB2' ' A' ' 20' ' ' LYS . 52.5 t -119.62 120.88 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-O 122.083 0.944 . . . . 1.13 111.904 -172.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.406 ' N ' ' CD ' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -99.26 129.39 45.49 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.271 -1.786 . . . . 2.28 109.789 -179.053 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.567 HD11 HG12 ' A' ' 77' ' ' ILE . 21.1 tp -133.29 134.12 43.47 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.927 -0.579 . . . . 1.68 109.643 -177.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.582 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 17.6 tp -110.23 124.51 51.74 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.682 -1.599 . . . . 1.1 106.682 173.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.723 HG22 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -129.88 149.31 33.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 121.757 0.789 . . . . 1.39 111.001 -171.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.599 HG21 HG21 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -98.04 114.71 26.95 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.355 -0.839 . . . . 1.13 109.205 165.187 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.642 ' HG3' HE22 ' A' ' 72' ' ' GLN . 22.3 ttt180 -105.33 131.5 52.69 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.15 -0.932 . . . . 2.34 110.498 -171.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.436 ' HG2' ' CD2' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -106.4 -89.67 0.43 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.39 -0.368 . . . . 1.97 111.845 -178.365 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.8 t -157.18 44.94 0.37 Allowed 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.168 -0.613 . . . . 2.0 112.071 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 1.044 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 0.2 OUTLIER -101.2 21.25 14.27 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.801 -0.814 . . . . 2.0 108.801 175.185 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.484 ' HG3' ' OE1' ' A' ' 72' ' ' GLN . 9.9 mt-30 -66.63 129.07 38.62 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 114.876 -1.056 . . . . 3.83 111.869 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -110.24 84.49 1.94 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.444 -0.798 . . . . 3.96 111.315 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 65.38 33.17 9.15 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.469 -0.787 . . . . 3.76 111.747 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.5 p -105.45 -15.9 8.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.402 0.62 . . . . 5.11 110.601 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -90.82 92.68 8.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.443 0.64 . . . . 8.35 110.64 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -100.21 84.35 2.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.253 -0.885 . . . . 6.63 110.616 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.6 m -89.0 -80.03 0.3 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.038 -0.528 . . . . 8.94 109.728 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.452 ' HG3' ' H ' ' A' ' 124' ' ' SER . 26.7 ptt? -158.76 -36.18 0.06 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.015 -0.365 . . . . 12.46 110.015 174.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.7 mt 63.8 30.3 14.57 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.688 -0.687 . . . . 13.06 111.461 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.452 ' H ' ' HG3' ' A' ' 122' ' ' MET . 50.8 m . . . . . 0 C--O 1.248 0.984 0 N-CA-C 109.366 -0.605 . . . . 14.64 109.366 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.445 ' HG3' ' H ' ' A' ' 2' ' ' SER . 20.4 ptm . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 120.827 0.346 . . . . 14.35 111.236 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.445 ' H ' ' HG3' ' A' ' 1' ' ' MET . 27.0 t -100.44 -37.03 9.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.023 0.439 . . . . 11.48 110.17 -177.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -101.73 108.46 19.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.236 -0.438 . . . . 9.53 110.365 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.6 pt -115.18 112.64 44.05 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.209 -0.451 . . . . 6.82 110.031 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.24 109.39 0.4 Allowed 'Trans proline' 0 N--CA 1.471 0.192 0 C-N-CA 123.439 2.759 . . . . 7.95 113.212 -176.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.43 -6.28 61.31 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-N 115.906 -0.588 . . . . 6.42 112.924 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 55.11 70.17 1.72 Allowed Pre-proline 0 CA--C 1.532 0.254 0 CA-C-O 121.309 0.576 . . . . 6.63 110.934 -176.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -90.62 20.78 0.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.744 2.963 . . . . 3.98 112.977 -170.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.0 t -124.43 -50.01 2.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.108 -0.951 . . . . 2.77 109.695 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 t -77.43 82.44 3.87 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 123.054 1.407 . . . . 2.49 109.788 174.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -109.98 178.85 4.28 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 112.626 -2.079 . . . . 1.24 110.583 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.8 t -110.18 149.07 13.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 108.894 -0.78 . . . . 2.16 108.894 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.633 HG21 HG21 ' A' ' 110' ' ' THR . 34.8 t -103.69 112.7 38.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 120.315 -0.554 . . . . 1.65 110.956 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 1.025 HE22 HG21 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -95.06 172.36 8.18 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.845 -0.616 . . . . 1.39 110.345 176.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.523 ' HD3' ' O ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -127.21 127.14 43.99 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 116.718 -0.219 . . . . 4.11 111.573 174.042 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 1.025 HG21 HE22 ' A' ' 14' ' ' GLN . 28.8 t -101.6 131.04 50.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.647 -0.501 . . . . 1.59 109.647 171.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 25.0 tt0 -145.68 112.96 6.19 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.699 -0.482 . . . . 1.35 109.699 173.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 8.8 tp -142.63 145.64 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 C-N-CA 120.012 -0.675 . . . . 1.33 109.281 -177.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.724 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 9.7 m-70 -75.66 112.73 12.32 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.207 -0.664 . . . . 0.7 109.207 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.711 ' CE ' ' HB3' ' A' ' 27' ' ' LEU . 25.6 mmmt -31.59 137.18 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.463 1.102 . . . . 4.39 112.578 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.3 tp -96.97 99.74 11.27 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.596 -0.52 . . . . 1.23 109.596 -173.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -92.83 144.74 24.98 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.671 0.748 . . . . 4.63 112.481 -172.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.475 ' CG ' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -124.12 92.89 3.76 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.22 -1.4 . . . . 1.5 107.22 170.166 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.85 -78.4 0.1 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.733 -0.746 . . . . 1.33 111.95 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -138.11 10.09 2.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.533 0.683 . . . . 2.33 110.503 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -107.94 118.74 37.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.238 -0.892 . . . . 1.87 109.119 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.998 HD23 ' HA ' ' A' ' 100' ' ' ARG . 8.8 mp -105.14 113.95 27.84 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.498 0.666 . . . . 2.8 110.437 -176.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.475 HD13 ' CG ' ' A' ' 23' ' ' GLN . 1.7 mp -94.97 141.46 15.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.831 -1.077 . . . . 1.45 109.56 -173.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.91 -38.78 13.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.064 -0.516 . . . . 1.87 110.811 -174.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.676 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 88.78 15.2 60.0 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.268 -0.968 . . . . 1.14 111.56 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.648 ' HD2' ' HB3' ' A' ' 66' ' ' ALA . 42.5 p90 -155.28 166.96 31.94 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 122.201 0.201 . . . . 0.61 110.651 176.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.566 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 17.2 t -109.93 159.0 17.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.493 -1.299 . . . . 0.91 107.493 170.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.406 HD13 HD23 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -161.26 138.08 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 C-N-CA 120.427 -0.509 . . . . 1.24 112.238 -164.376 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.41 ' HA2' ' CD2' ' A' ' 90' ' ' HIS . . . -141.57 117.8 1.25 Allowed Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.172 -1.013 . . . . 0.78 110.851 156.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 1.033 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -140.74 117.09 1.21 Allowed Glycine 0 CA--C 1.491 -1.417 0 CA-C-O 118.656 -1.08 . . . . 1.66 111.067 170.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.653 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -164.15 145.67 10.64 Favored Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 117.429 -2.319 . . . . 0.95 113.469 175.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.498 HG12 ' C ' ' A' ' 88' ' ' VAL . 34.1 pt -69.54 -11.53 14.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 107.282 -1.377 . . . . 1.15 107.282 152.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.823 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 0.1 OUTLIER -70.61 -39.14 73.94 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 113.815 -1.538 . . . . 0.72 109.852 172.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -60.25 -81.89 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.188 -0.915 . . . . 1.47 111.409 -172.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -157.7 93.29 2.16 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.764 0.792 . . . . 2.57 111.483 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.577 ' O ' ' HG3' ' A' ' 45' ' ' PRO . 4.1 Cg_exo -79.25 -9.99 15.04 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.178 2.585 . . . . 2.82 111.463 175.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.7 t -73.43 28.77 0.07 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.38 -0.827 . . . . 3.26 112.307 -171.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 44' ' ' ASN . 53.1 mm-40 -110.11 -49.39 3.08 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.926 -1.139 . . . . 3.88 107.926 176.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.46 ' C ' ' H ' ' A' ' 46' ' ' PHE . 53.5 t30 162.84 82.32 0.0 OUTLIER Pre-proline 0 N--CA 1.44 -0.933 0 N-CA-C 106.06 -1.83 . . . . 5.7 106.06 -171.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.577 ' HG3' ' O ' ' A' ' 41' ' ' PRO . 4.2 Cg_exo -77.36 26.16 0.47 Allowed 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.244 2.629 . . . . 4.03 112.381 -167.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.46 ' H ' ' C ' ' A' ' 44' ' ' ASN . 24.3 t80 -141.82 23.25 2.09 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.84 -1.073 . . . . 6.35 108.533 -173.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.519 ' HB2' ' CG ' ' A' ' 52' ' ' ASP . 19.6 m -71.66 -172.81 0.85 Allowed 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 114.852 -1.067 . . . . 3.85 112.243 -172.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -21.8 -69.81 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 112.924 -1.944 . . . . 6.78 116.115 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.574 ' OD2' ' HG3' ' A' ' 50' ' ' LYS . 22.8 t70 -173.01 -142.92 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.796 -0.446 . . . . 5.47 109.796 -167.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.574 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -60.79 -12.98 12.43 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 120.682 0.277 . . . . 3.54 111.346 174.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.5 t -78.07 -14.59 59.44 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 120.48 -0.488 . . . . 4.89 110.639 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.589 ' CG ' ' HE2' ' A' ' 53' ' ' LYS . 24.1 t0 -66.88 -162.17 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.627 -0.715 . . . . 2.6 110.79 172.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.589 ' HE2' ' CG ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -77.19 64.54 2.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.508 0.67 . . . . 3.98 112.037 178.38 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.44 -142.56 11.35 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 109.247 -1.541 . . . . 0.94 109.247 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 1.033 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -110.83 138.03 40.7 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.113 0 CA-C-N 119.361 1.58 . . . . 1.27 107.364 168.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.809 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -152.67 151.72 30.9 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 119.865 1.211 . . . . 1.91 111.655 -177.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.53 HG22 HD21 ' A' ' 71' ' ' LEU . 3.4 p -91.19 131.93 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-N 114.621 -1.172 . . . . 1.22 109.862 -174.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.6 m -99.06 -16.16 18.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.157 -0.929 . . . . 1.29 110.796 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.647 ' O ' HG23 ' A' ' 60' ' ' VAL . 56.8 mtt180 -148.36 -167.04 2.7 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.553 0.692 . . . . 2.63 112.514 175.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 59' ' ' ARG . 75.7 t -163.68 117.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 112.46 -2.155 . . . . 1.53 106.972 159.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.4 m -65.8 117.7 8.59 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.137 0.494 . . . . 2.38 109.894 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -46.14 112.05 0.44 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.581 -1.191 . . . . 1.85 112.394 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.24 -14.89 56.79 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.692 -0.766 . . . . 0.95 112.607 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.468 ' O ' HD12 ' A' ' 68' ' ' ILE . . . -76.55 172.71 54.65 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.219 -0.991 . . . . 0.99 112.072 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.676 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 58.9 Cg_endo -68.91 -24.8 33.31 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 123.088 2.526 . . . . 0.63 113.158 -166.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.648 ' HB3' ' HD2' ' A' ' 31' ' ' PHE . . . -61.45 -36.32 80.05 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 114.783 -1.099 . . . . 1.1 111.392 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -77.75 -29.57 51.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.428 0.632 . . . . 1.79 109.461 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.542 ' N ' HD13 ' A' ' 68' ' ' ILE . 1.4 mp -69.42 -37.48 75.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.241 -0.891 . . . . 1.18 109.812 177.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.624 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -77.35 -23.01 50.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.025 -0.534 . . . . 1.07 110.601 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.27 52.46 0.93 Allowed Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.387 -0.911 . . . . 0.5 114.112 176.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.53 HD21 HG22 ' A' ' 57' ' ' VAL . 14.7 tp -106.52 148.0 28.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.597 -0.89 . . . . 1.5 108.597 174.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.695 HE22 ' HG3' ' A' ' 111' ' ' ARG . 4.6 mt-30 -130.11 38.34 3.8 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 115.375 1.62 . . . . 1.53 115.375 -164.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.618 ' HA ' ' C ' ' A' ' 59' ' ' ARG . 53.9 mt 72.22 -4.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 N-CA-C 114.186 1.18 . . . . 1.43 114.186 163.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.28 45.03 0.23 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 119.22 -1.467 . . . . 0.37 112.277 -171.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.52 ' OD2' ' HB2' ' A' ' 72' ' ' GLN . 20.9 m-20 -118.38 142.07 47.9 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 120.903 0.382 . . . . 0.89 111.558 -169.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.809 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 45.0 mmtm -86.41 103.37 14.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.629 -0.714 . . . . 2.71 110.566 -175.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.596 ' HB ' HG21 ' A' ' 55' ' ' ILE . 5.6 mt -74.4 128.82 36.76 Favored 'Isoleucine or valine' 0 C--O 1.259 1.587 0 C-N-CA 123.904 0.882 . . . . 1.22 112.001 -177.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.684 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 3.8 mmt -93.66 -25.95 17.26 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.569 -1.651 . . . . 1.61 112.234 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.522 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -160.28 156.88 27.13 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.61 -0.436 . . . . 0.88 112.116 -173.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.512 HG13 ' CE ' ' A' ' 85' ' ' MET . 10.4 p -148.44 128.44 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.278 -0.638 . . . . 1.93 109.278 175.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.472 ' OD1' ' HG3' ' A' ' 102' ' ' GLU . 0.9 OUTLIER 67.53 5.82 4.58 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.253 -0.431 . . . . 1.8 111.565 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.59 -7.54 53.7 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 119.882 -1.151 . . . . 0.38 111.403 -172.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -75.0 118.08 17.56 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.708 -0.849 . . . . 0.91 108.708 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.414 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 0.5 OUTLIER -89.69 94.94 10.04 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.661 -0.7 . . . . 1.89 109.594 -175.424 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.512 ' CE ' HG13 ' A' ' 80' ' ' VAL . 11.2 ptp -112.43 104.05 12.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.502 -0.772 . . . . 1.38 112.756 -172.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.1 p -96.86 -20.36 18.21 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 122.183 0.992 . . . . 1.1 108.773 170.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.87 81.65 0.65 Allowed 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.713 -1.585 . . . . 2.15 110.26 -175.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.653 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.9 OUTLIER -140.49 162.57 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 108.519 -0.919 . . . . 1.68 108.519 173.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.667 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 66.7 p -59.75 150.84 26.83 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 112.742 0.645 . . . . 1.1 112.742 -175.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.823 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 16.2 t-160 -59.89 -35.57 75.11 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 121.743 0.782 . . . . 0.41 109.855 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.4 -29.85 66.58 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 113.894 -1.503 . . . . 1.67 109.64 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.541 ' HB3' ' O ' ' A' ' 89' ' ' THR . 3.4 tp-100 -63.77 -48.81 75.43 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.691 0.758 . . . . 0.79 109.023 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.521 ' HB2' HG12 ' A' ' 55' ' ' ILE . . . -69.96 -39.29 76.1 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.905 -1.043 . . . . 1.06 109.52 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -66.39 -42.24 88.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.083 -0.962 . . . . 2.45 111.222 -175.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.552 ' HD3' ' HD2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -68.08 -31.08 70.45 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 119.91 -0.716 . . . . 1.51 109.809 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.552 ' HD2' ' HD3' ' A' ' 95' ' ' LYS . 13.8 mmm180 -67.29 -47.44 70.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 120.706 -0.398 . . . . 4.23 111.249 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 3.4 pp -83.39 0.96 43.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.35 -0.386 . . . . 2.24 111.684 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.1 m -128.4 28.24 5.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.413 0.625 . . . . 1.63 111.33 173.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.952 ' HE2' ' HA ' ' A' ' 99' ' ' LYS . 1.3 mmpt? -82.04 118.79 23.28 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.752 -0.833 . . . . 3.16 108.752 167.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.998 ' HA ' HD23 ' A' ' 27' ' ' LEU . 32.9 ptt180 -76.64 30.83 0.13 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.379 0.609 . . . . 4.79 110.719 -177.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 99' ' ' LYS . 40.9 t -123.51 -30.61 3.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.453 -0.794 . . . . 2.83 109.531 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.472 ' HG3' ' OD1' ' A' ' 81' ' ' ASN . 81.3 mm-40 -79.52 103.9 9.75 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.026 -0.534 . . . . 3.4 110.01 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -71.94 -14.56 61.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.962 -0.563 . . . . 2.68 111.404 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.724 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 5.5 p -138.04 134.79 45.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.36 0.6 . . . . 1.15 109.462 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.558 HG22 ' HG2' ' A' ' 20' ' ' LYS . 1.4 t -115.2 122.34 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-O 122.378 1.085 . . . . 1.13 111.817 -173.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -99.97 126.86 46.2 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 113.2 -1.818 . . . . 2.28 109.364 177.783 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.655 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 10.4 tt -133.9 127.0 31.58 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.534 -0.543 . . . . 1.68 109.534 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.684 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 39.5 tp -107.81 117.71 34.84 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.007 -1.479 . . . . 1.1 107.007 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.746 HG12 ' CG ' ' A' ' 14' ' ' GLN . 0.5 OUTLIER -123.96 148.79 27.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 C-N-CA 119.671 -0.811 . . . . 1.39 110.28 -176.298 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.633 HG21 HG21 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -95.85 117.48 30.65 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.195 -0.911 . . . . 1.13 109.39 169.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.695 ' HG3' HE22 ' A' ' 72' ' ' GLN . 28.0 ttp180 -91.56 114.74 27.36 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.814 -1.539 . . . . 2.34 109.255 -172.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.492 ' HG2' ' N ' ' A' ' 113' ' ' SER . 0.0 OUTLIER -109.76 -55.12 2.48 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.106 -1.037 . . . . 1.97 113.48 -171.11 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.492 ' N ' ' HG2' ' A' ' 112' ' ' GLN . 33.3 t -156.66 13.98 0.28 Allowed 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.759 -0.776 . . . . 2.0 111.965 -173.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -104.63 21.41 16.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.657 0.741 . . . . 2.0 110.312 -177.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.527 ' HA ' ' OE1' ' A' ' 72' ' ' GLN . 34.5 mt-30 -68.96 101.18 1.33 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.785 -1.098 . . . . 3.83 110.972 -174.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -110.4 -28.83 8.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.593 -0.731 . . . . 3.96 111.183 -175.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -120.78 19.72 11.76 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.416 -0.811 . . . . 3.76 110.375 -176.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 115' ' ' GLN . 95.2 t -99.67 -71.2 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.223 -0.898 . . . . 5.11 110.852 -177.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -88.28 -60.38 1.98 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.345 -0.843 . . . . 8.35 110.789 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 60.05 85.59 0.1 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.794 -0.639 . . . . 6.63 111.027 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.5 t -91.3 98.4 11.69 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.063 -0.517 . . . . 8.94 109.678 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 14.8 tpt -88.31 112.38 22.77 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.636 -0.711 . . . . 12.46 109.829 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.42 107.55 3.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.146 -0.479 . . . . 13.06 110.659 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.3 p . . . . . 0 C--O 1.253 1.281 0 CA-C-O 118.173 -0.918 . . . . 14.64 109.653 178.292 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.3 mtp . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 109.845 -0.428 . . . . 14.35 109.845 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 t 73.72 168.93 0.31 Allowed 'General case' 0 CA--C 1.533 0.3 0 O-C-N 124.108 0.88 . . . . 11.48 109.514 -176.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.489 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 42.2 p90 -161.59 175.17 12.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.65 0.262 . . . . 9.53 111.146 -173.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.551 HD11 ' H ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -104.79 95.63 9.23 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.741 -0.663 . . . . 6.82 110.082 177.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 3' ' ' TYR . 24.5 Cg_exo -62.42 -49.16 6.3 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.77 2.314 . . . . 7.95 111.922 -176.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -145.88 32.95 1.54 Allowed Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.695 -0.684 . . . . 6.42 111.563 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.567 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 13.7 pt20 -148.71 45.35 0.39 Allowed Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 114.076 1.139 . . . . 6.63 114.076 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.567 ' HD3' ' N ' ' A' ' 7' ' ' GLN . 32.9 Cg_exo -64.64 -141.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.692 2.261 . . . . 3.98 112.218 165.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.7 m -92.0 2.9 7.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.68 -0.691 . . . . 2.77 109.354 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 m -72.88 79.83 1.16 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 122.562 1.172 . . . . 2.49 109.394 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.14 178.67 8.26 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 113.001 -1.909 . . . . 1.24 110.178 175.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.6 t -111.65 107.97 24.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.625 -0.716 . . . . 2.16 109.891 -174.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.55 HG23 HG23 ' A' ' 110' ' ' THR . 48.6 t -77.36 108.65 10.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.247 0.546 . . . . 1.65 109.585 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 1.065 HE22 HG22 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -108.58 167.54 9.98 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.372 -0.831 . . . . 1.39 111.612 -173.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -122.3 114.49 20.87 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.96 -0.564 . . . . 4.11 110.802 -172.327 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 1.065 HG22 HE22 ' A' ' 14' ' ' GLN . 4.9 t -99.24 132.6 44.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.211 -0.663 . . . . 1.59 109.211 176.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -144.63 117.1 8.55 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 110.137 -0.32 . . . . 1.35 110.137 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.552 ' HB ' ' HB1' ' A' ' 69' ' ' ALA . 10.9 tp -144.89 148.25 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 108.741 -0.837 . . . . 1.33 108.741 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.714 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 15.3 m-70 -76.22 116.08 16.57 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.008 -0.677 . . . . 0.7 109.693 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.666 ' HB2' HD13 ' A' ' 27' ' ' LEU . 3.1 pptp? -30.59 136.44 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 O-C-N 125.065 1.478 . . . . 4.39 112.108 177.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.452 ' HB3' ' HB ' ' A' ' 28' ' ' ILE . 47.1 tp -98.44 89.59 4.49 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 119.888 -0.725 . . . . 1.23 110.761 -171.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 24.7 ptt180 -68.71 139.22 55.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.072 0.463 . . . . 4.63 112.063 -172.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -129.47 93.95 3.66 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.651 -0.704 . . . . 1.5 109.238 174.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.28 -80.33 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.839 -0.696 . . . . 1.33 112.863 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -127.09 2.71 6.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.849 0.357 . . . . 2.33 111.699 -173.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -126.73 174.39 8.78 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.097 -0.501 . . . . 1.87 110.426 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.666 HD13 ' HB2' ' A' ' 20' ' ' LYS . 2.0 pt? -127.42 134.39 49.88 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.777 -1.194 . . . . 2.8 107.777 175.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 26.0 mm -98.92 136.28 30.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-O 121.13 0.491 . . . . 1.45 111.665 -171.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.402 HD11 HD23 ' A' ' 97' ' ' LEU . 0.6 OUTLIER -106.6 116.19 31.5 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.341 -1.299 . . . . 1.87 107.558 173.137 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' HG12 ' A' ' 60' ' ' VAL . . . -86.37 51.86 4.42 Favored Glycine 0 C--O 1.221 -0.691 0 C-N-CA 120.223 -0.989 . . . . 1.14 113.249 -172.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 29.2 p90 -158.47 170.74 21.53 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.591 -0.522 . . . . 0.61 109.591 176.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.864 ' HB3' ' O ' ' A' ' 58' ' ' THR . 1.0 OUTLIER -110.66 168.85 9.16 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 107.978 -1.119 . . . . 0.91 107.978 170.303 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -159.82 135.91 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 113.65 0.981 . . . . 1.24 113.65 -163.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.401 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -147.64 117.4 0.91 Allowed Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.592 -1.003 . . . . 0.78 110.592 155.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 1.044 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -142.58 117.78 1.18 Allowed Glycine 0 CA--C 1.488 -1.63 0 CA-C-O 118.427 -1.207 . . . . 1.66 111.141 171.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.68 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.59 137.99 4.92 Favored Glycine 0 C--N 1.298 -1.539 0 C-N-CA 117.222 -2.418 . . . . 0.95 113.086 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -60.53 -25.32 34.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 107.345 -1.354 . . . . 1.15 107.345 151.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.822 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 4.5 t70 -54.6 -40.2 68.62 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 113.524 -1.671 . . . . 0.72 110.179 169.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -62.91 -57.63 10.13 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.378 -0.828 . . . . 1.47 110.51 -173.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.458 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 0.3 OUTLIER -172.68 119.88 0.42 Allowed Pre-proline 0 N--CA 1.463 0.205 0 CA-C-O 121.147 0.498 . . . . 2.57 110.329 167.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 7.4 Cg_endo -92.89 10.36 2.31 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.391 2.727 . . . . 2.82 112.15 175.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.7 t -103.21 -34.57 8.77 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.1 -0.5 . . . . 3.26 111.664 -169.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.36 18.95 13.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.987 0.899 . . . . 3.88 108.584 -178.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.606 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 39.7 m-20 -161.24 54.97 0.58 Allowed Pre-proline 0 N--CA 1.443 -0.776 0 CA-C-N 113.813 -1.539 . . . . 5.7 109.275 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.606 ' HD3' ' N ' ' A' ' 44' ' ' ASN . 93.4 Cg_endo -102.46 0.92 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.716 2.278 . . . . 4.03 112.657 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -179.65 27.66 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.879 0.847 . . . . 6.35 108.987 -169.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.537 ' HG ' ' HA ' ' A' ' 44' ' ' ASN . 6.0 m -75.75 -173.08 2.1 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 113.754 1.02 . . . . 3.85 113.754 -169.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -19.68 -69.48 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 112.327 -2.215 . . . . 6.78 116.522 -175.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.68 ' HB3' HG21 ' A' ' 51' ' ' THR . 44.2 t0 -141.41 -157.62 0.78 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.05 -0.722 . . . . 5.47 109.05 -166.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.612 ' HD2' ' CG ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -60.55 -22.88 64.13 Favored 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 120.377 -0.529 . . . . 3.54 110.282 171.294 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.68 HG21 ' HB3' ' A' ' 49' ' ' ASP . 5.8 t -61.03 -52.94 62.84 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.338 -0.846 . . . . 4.89 110.598 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.412 ' OD2' ' NZ ' ' A' ' 53' ' ' LYS . 51.6 t0 24.19 -96.85 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 O-C-N 124.34 1.025 . . . . 2.6 113.288 166.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.595 ' C ' ' HD2' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -130.59 29.76 4.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.585 0.707 . . . . 3.98 109.568 172.643 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.48 ' C ' HD13 ' A' ' 55' ' ' ILE . . . -78.93 -156.73 10.15 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.248 -1.141 . . . . 0.94 110.248 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 1.044 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.7 mp -112.1 142.57 24.07 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 N-CA-C 107.783 -1.191 . . . . 1.27 107.783 171.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.689 ' HA ' HD13 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -152.16 141.98 21.98 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 122.219 1.009 . . . . 1.91 111.577 -177.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 57' ' ' VAL . 1.8 p -79.92 135.98 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 113.928 -1.487 . . . . 1.22 109.565 -178.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.864 ' O ' ' HB3' ' A' ' 32' ' ' SER . 15.8 m -125.09 64.47 1.14 Allowed 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.322 -0.854 . . . . 1.29 109.372 175.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.529 ' HA ' HG22 ' A' ' 73' ' ' ILE . 64.2 mtt180 148.01 -168.5 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 125.939 1.696 . . . . 2.63 110.109 164.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.608 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 57.8 t -164.0 137.89 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 125.89 1.994 . . . . 1.53 106.29 164.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.3 m -75.03 121.57 22.19 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.915 -0.772 . . . . 2.38 108.915 173.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -50.39 108.94 0.26 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.174 -0.921 . . . . 1.85 111.927 177.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.58 -6.05 70.57 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.557 -0.747 . . . . 0.95 112.482 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.5 ' O ' HD12 ' A' ' 68' ' ' ILE . . . -80.12 174.47 55.03 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.726 -0.75 . . . . 0.99 112.17 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.438 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 46.7 Cg_endo -68.37 -28.4 32.99 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 122.837 2.358 . . . . 0.63 113.708 -164.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.439 ' HB3' ' HD2' ' A' ' 31' ' ' PHE . . . -65.57 -30.77 71.55 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.203 -0.908 . . . . 1.1 110.881 177.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -77.65 -31.2 52.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.326 0.584 . . . . 1.79 109.528 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.5 HD12 ' O ' ' A' ' 64' ' ' GLY . 1.3 mp -65.81 -39.77 85.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.314 -0.857 . . . . 1.18 109.84 175.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.698 ' CB ' HG12 ' A' ' 16' ' ' VAL . . . -75.27 -23.22 57.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.852 -0.613 . . . . 1.07 110.295 176.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.53 46.63 1.2 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.843 -1.17 . . . . 0.5 114.427 173.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.679 ' HG ' HG21 ' A' ' 16' ' ' VAL . 2.9 mt -91.93 156.51 17.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.62 0.71 . . . . 1.5 111.079 175.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.486 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 6.0 mt-30 -132.82 32.09 3.86 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 114.599 1.333 . . . . 1.53 114.599 -166.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.529 HG22 ' HA ' ' A' ' 59' ' ' ARG . 3.4 mp 75.05 -14.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 N-CA-C 114.059 1.133 . . . . 1.43 114.059 167.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.6 52.27 0.37 Allowed Glycine 0 N--CA 1.463 0.482 0 C-N-CA 119.761 -1.209 . . . . 0.37 112.405 -167.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -120.7 146.51 46.37 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.117 -0.541 . . . . 0.89 110.388 -169.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.588 ' HD2' ' N ' ' A' ' 76' ' ' LYS . 10.3 mptt -101.44 102.4 13.19 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.516 0.674 . . . . 2.71 110.483 -170.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.929 HG13 HG23 ' A' ' 109' ' ' VAL . 3.1 mp -64.49 122.79 16.05 Favored 'Isoleucine or valine' 0 C--O 1.256 1.424 0 CA-C-N 114.742 -1.117 . . . . 1.22 112.295 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.886 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 2.7 mmt -91.92 -16.91 25.95 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 125.909 2.006 . . . . 1.61 111.148 173.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.561 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -172.42 152.26 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.908 0.336 . . . . 0.88 111.908 -177.82 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.669 HG23 ' HB2' ' A' ' 97' ' ' LEU . 2.4 p -138.4 124.41 24.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.285 0.564 . . . . 1.93 110.133 173.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.471 ' OD1' HG22 ' A' ' 80' ' ' VAL . 20.0 m120 53.02 28.65 6.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.298 -0.864 . . . . 1.8 112.669 174.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.41 -13.75 47.46 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.285 -0.959 . . . . 0.38 113.132 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.485 ' HB2' ' HE2' ' A' ' 85' ' ' MET . 80.4 m95 -86.88 148.16 25.48 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.623 -0.51 . . . . 0.91 109.623 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.64 118.68 37.28 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.663 -0.698 . . . . 1.89 111.975 -173.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.485 ' HE2' ' HB2' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -107.13 103.48 12.89 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.901 0.858 . . . . 1.38 111.377 179.603 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 p -131.16 -48.3 1.0 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.221 -1.4 . . . . 1.1 107.221 168.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.86 84.67 2.1 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 112.622 -2.081 . . . . 2.15 107.509 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.743 ' O ' HD11 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -137.73 136.45 45.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.026 -0.988 . . . . 1.68 108.453 -177.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.765 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 72.9 p -58.1 149.9 22.46 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.161 0.505 . . . . 1.1 112.205 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.822 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 21.9 t-160 -58.11 -36.82 73.46 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.635 0.731 . . . . 0.41 109.792 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.72 -31.36 66.63 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.203 -1.362 . . . . 1.67 109.961 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.697 ' HG2' HG13 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -65.65 -50.47 64.84 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.583 -0.895 . . . . 0.79 108.583 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.72 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . -65.59 -37.2 85.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.678 -0.692 . . . . 1.06 110.274 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -68.53 -42.21 78.81 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.489 -0.778 . . . . 2.45 110.935 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.561 ' HD3' ' C ' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -72.8 -41.9 64.46 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 116.363 -0.38 . . . . 1.51 110.228 -176.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.688 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 29.8 mmt180 -68.04 -32.9 73.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.015 0.436 . . . . 4.23 110.315 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.669 ' HB2' HG23 ' A' ' 80' ' ' VAL . 10.8 tp -73.18 -55.24 6.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.394 -0.821 . . . . 2.24 110.203 173.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 m -94.23 77.59 3.99 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 122.949 1.357 . . . . 1.63 109.779 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.53 ' HB3' ' HE2' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -138.5 108.72 6.43 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 112.316 -2.22 . . . . 3.16 106.35 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -70.79 70.1 0.47 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.384 0.611 . . . . 4.79 112.091 -170.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.0 t -137.55 -31.49 0.8 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.784 -0.644 . . . . 2.83 110.805 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.488 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 19.3 mm-40 -68.21 141.32 56.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.476 -0.329 . . . . 3.4 110.9 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.477 ' HG3' HG11 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -94.84 -11.22 29.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.922 0.868 . . . . 2.68 108.872 169.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.714 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 3.7 p -153.2 145.55 14.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.237 -1.347 . . . . 1.15 108.211 -175.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.562 HG22 ' HB3' ' A' ' 20' ' ' LYS . 43.8 t -119.98 118.93 58.61 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.03 0 CA-C-O 122.439 1.114 . . . . 1.13 112.065 -169.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -99.62 129.31 45.76 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 112.72 -2.036 . . . . 2.28 111.006 -175.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.781 HD13 HG12 ' A' ' 77' ' ' ILE . 35.0 tp -132.8 130.77 40.31 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 116.489 -0.323 . . . . 1.68 110.745 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.886 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 35.5 tp -107.19 114.81 29.09 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 106.785 -1.561 . . . . 1.1 106.785 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.929 HG23 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -128.76 147.14 33.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 C-N-CA 120.313 -0.555 . . . . 1.39 110.562 -172.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.55 HG23 HG23 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -97.56 117.11 31.09 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.707 -0.797 . . . . 1.13 110.556 173.401 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.462 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -110.04 135.46 50.83 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.418 -1.265 . . . . 2.34 109.495 -175.456 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.49 ' OE1' HD21 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -114.25 -72.74 0.68 Allowed 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.687 0.625 . . . . 1.97 112.687 -169.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.4 t -140.87 18.15 2.31 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.647 0.737 . . . . 2.0 110.216 -172.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.49 HD21 ' OE1' ' A' ' 112' ' ' GLN . 4.1 mm? -96.3 22.55 7.63 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.36 -0.836 . . . . 2.0 109.766 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.44 142.94 54.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.834 -1.076 . . . . 3.83 111.522 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -104.31 93.59 4.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.18 -0.464 . . . . 3.96 111.786 -175.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.563 ' HB3' HE21 ' A' ' 120' ' ' GLN . . . 40.2 80.2 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.297 0.998 . . . . 3.76 113.508 173.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.1 p -136.33 -7.76 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.022 0.439 . . . . 5.11 111.707 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -89.82 -16.65 29.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.826 0.346 . . . . 8.35 110.882 -175.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.563 HE21 ' HB3' ' A' ' 117' ' ' ALA . 25.5 pt20 -78.98 96.24 5.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.662 0.744 . . . . 6.63 110.63 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 40.8 t -83.85 -65.36 1.02 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.363 -0.835 . . . . 8.94 110.364 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 57.8 ttp -87.04 142.45 27.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.919 -0.582 . . . . 12.46 109.943 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 98.2 mt -84.65 135.26 34.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.772 0.32 . . . . 13.06 110.43 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.096 -0.954 . . . . 14.64 109.296 176.098 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.773 0.321 . . . . 14.35 110.392 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 p -88.7 107.24 18.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.295 0.569 . . . . 11.48 110.787 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.403 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 70.1 t80 -107.44 131.01 54.75 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.658 -0.701 . . . . 9.53 109.485 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.759 HG21 ' HG3' ' A' ' 7' ' ' GLN . 0.9 OUTLIER -113.17 94.13 29.11 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-O 121.227 0.537 . . . . 6.82 110.936 -178.242 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 3' ' ' TYR . 12.9 Cg_exo -67.69 -57.56 0.16 Allowed 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.702 2.268 . . . . 7.95 111.293 -177.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -135.4 36.03 2.09 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.659 -0.781 . . . . 6.42 112.187 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.759 ' HG3' HG21 ' A' ' 4' ' ' ILE . 19.6 pt20 -146.31 34.27 0.13 Allowed Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 115.27 1.581 . . . . 6.63 115.27 177.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.623 ' HD3' ' N ' ' A' ' 7' ' ' GLN . 5.3 Cg_exo -74.37 118.95 5.55 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.538 1.492 . . . . 3.98 111.13 167.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.56 ' HB ' ' O ' ' A' ' 8' ' ' PRO . 37.3 t 80.03 -51.64 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 122.803 0.441 . . . . 2.77 111.672 177.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 p -69.45 82.81 0.4 Allowed 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 122.167 0.984 . . . . 2.49 111.445 -176.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.556 ' CB ' ' HA ' ' A' ' 112' ' ' GLN . . . -86.5 178.4 7.11 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.614 -1.63 . . . . 1.24 111.045 177.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -129.46 138.46 54.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.268 -0.878 . . . . 2.16 108.986 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.659 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 0.9 OUTLIER -90.72 127.2 43.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 C-N-CA 119.413 -0.915 . . . . 1.65 110.897 -174.778 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.889 HE22 HG22 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -118.63 166.38 12.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.527 -1.215 . . . . 1.39 110.137 176.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.433 ' H ' ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -124.98 135.29 52.66 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.605 -0.685 . . . . 4.11 110.325 -175.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.889 HG22 HE22 ' A' ' 14' ' ' GLN . 4.1 t -105.95 109.04 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 CA-C-O 121.501 0.667 . . . . 1.59 109.436 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -109.31 119.53 39.76 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.37 -0.832 . . . . 1.35 109.586 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.678 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 11.3 tp -145.71 146.18 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.871 -0.789 . . . . 1.33 108.871 174.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 14.6 m-70 -80.15 112.0 17.05 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.529 -0.915 . . . . 0.7 108.529 177.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.677 ' HB2' HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -25.16 140.16 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 O-C-N 124.923 1.389 . . . . 4.39 112.814 -178.692 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.567 HD22 ' HA2' ' A' ' 64' ' ' GLY . 43.9 tp -96.16 97.5 9.59 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 119.102 -1.039 . . . . 1.23 110.009 -172.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.632 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 12.4 ptp180 -61.13 142.71 56.51 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.744 0.783 . . . . 4.63 112.067 -173.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.539 ' HB2' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -128.43 93.42 3.64 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.141 -1.059 . . . . 1.5 108.141 172.397 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.6 -78.16 0.26 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.418 -0.896 . . . . 1.33 111.352 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.446 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 54.5 mt-10 -139.2 11.44 2.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.156 0.503 . . . . 2.33 110.63 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.632 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 10.8 m-80 -108.48 -177.53 3.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.895 -0.593 . . . . 1.87 109.685 -177.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.677 HD11 ' HB2' ' A' ' 20' ' ' LYS . 1.0 OUTLIER -127.68 135.48 50.25 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 108.226 -1.027 . . . . 2.8 108.226 173.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.539 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.0 OUTLIER -102.49 138.0 28.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 120.99 0.424 . . . . 1.45 110.871 -179.173 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.8 tp -98.6 124.18 43.23 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.938 -1.483 . . . . 1.87 108.394 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.713 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -93.92 35.1 4.31 Favored Glycine 0 C--O 1.223 -0.582 0 C-N-CA 120.226 -0.988 . . . . 1.14 114.075 -170.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.608 ' CD1' HG22 ' A' ' 57' ' ' VAL . 39.8 p90 -157.77 169.84 23.71 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.544 -0.539 . . . . 0.61 109.544 177.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.685 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -104.43 159.75 15.47 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.845 -1.169 . . . . 0.91 107.845 171.512 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -152.91 135.24 6.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 113.354 0.872 . . . . 1.24 113.354 -167.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -145.06 118.06 1.07 Allowed Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 110.059 -1.216 . . . . 0.78 110.059 154.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 1.083 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -139.6 117.74 1.39 Allowed Glycine 0 CA--C 1.49 -1.487 0 CA-C-O 119.093 -0.837 . . . . 1.66 111.233 172.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.776 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.15 137.32 4.57 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 118.012 -2.042 . . . . 0.95 112.79 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.9 pt -58.75 -24.6 26.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.479 -1.304 . . . . 1.15 107.479 153.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.747 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 4.1 t70 -56.1 -43.71 78.36 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 113.156 -1.838 . . . . 0.72 110.182 171.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -63.75 -51.69 63.74 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 114.977 -1.01 . . . . 1.47 112.317 -171.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.591 ' OD2' ' HB2' ' A' ' 43' ' ' GLN . 0.4 OUTLIER -166.56 103.8 0.67 Allowed Pre-proline 0 C--O 1.214 -0.77 0 CA-C-O 121.323 0.582 . . . . 2.57 111.911 -174.453 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -88.7 12.94 2.63 Favored 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 123.222 2.615 . . . . 2.82 112.804 176.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' A' ' 43' ' ' GLN . 6.6 t -109.26 17.45 21.53 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.482 -0.326 . . . . 3.26 111.035 -172.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.591 ' HB2' ' OD2' ' A' ' 40' ' ' ASP . 8.1 mt-30 -150.9 50.53 0.86 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.642 0.734 . . . . 3.88 109.853 -178.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.545 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 4.4 p-10 -169.52 51.66 0.19 Allowed Pre-proline 0 N--CA 1.444 -0.749 0 CA-C-N 114.603 -1.181 . . . . 5.7 108.297 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 44' ' ' ASN . 50.2 Cg_exo -53.57 -28.04 43.92 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.805 2.337 . . . . 4.03 111.76 -171.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -132.81 -49.79 0.89 Allowed 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.999 -1.482 . . . . 6.35 106.999 170.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.482 ' HB2' ' OD1' ' A' ' 52' ' ' ASP . 2.5 p -159.76 171.37 19.63 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.559 -1.2 . . . . 3.85 108.857 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.575 ' HB3' HG22 ' A' ' 51' ' ' THR . 40.4 tt0 -111.1 -30.3 7.53 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 121.105 -0.238 . . . . 6.78 111.051 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.657 ' HB3' HG23 ' A' ' 51' ' ' THR . 9.7 t70 169.43 -114.99 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.379 -0.971 . . . . 5.47 108.379 -176.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.47 ' HD2' ' H ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -99.71 10.59 41.08 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.434 0.635 . . . . 3.54 109.672 161.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.781 ' HB ' ' HD2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -102.88 -54.81 2.55 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.281 -0.872 . . . . 4.89 109.116 -175.264 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.482 ' OD1' ' HB2' ' A' ' 47' ' ' SER . 18.4 m-20 52.74 30.77 9.36 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 124.07 0.856 . . . . 2.6 112.589 172.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.484 ' HD3' ' HA ' ' A' ' 53' ' ' LYS . 2.3 tppt? 68.52 40.14 1.99 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.132 0.968 . . . . 3.98 110.273 -178.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.507 ' C ' HD11 ' A' ' 55' ' ' ILE . . . -89.12 -135.34 5.47 Favored Glycine 0 N--CA 1.429 -1.778 0 N-CA-C 109.156 -1.577 . . . . 0.94 109.156 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 1.083 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -117.41 140.58 39.72 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.403 0 C-N-CA 119.656 -0.818 . . . . 1.27 108.889 176.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.632 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -142.36 142.43 32.45 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 119.553 1.069 . . . . 1.91 110.374 -176.111 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.608 HG22 ' CD1' ' A' ' 31' ' ' PHE . 11.9 p -82.63 136.23 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 114.664 -1.153 . . . . 1.22 110.301 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.685 ' O ' ' HB3' ' A' ' 32' ' ' SER . 23.7 m -127.23 66.05 1.3 Allowed 'General case' 0 N--CA 1.439 -1.006 0 O-C-N 124.346 1.029 . . . . 1.29 109.035 172.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 37.7 mtt180 150.01 -170.28 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.746 1.619 . . . . 2.63 110.434 162.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 90.8 t -160.97 111.46 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 113.595 -1.639 . . . . 1.53 106.625 161.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 m -70.76 158.52 36.16 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.504 0.669 . . . . 2.38 110.021 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -97.62 130.41 44.65 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.027 -0.988 . . . . 1.85 111.289 -169.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.9 -9.83 72.7 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.327 -0.94 . . . . 0.95 111.325 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.656 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -85.05 -158.95 30.35 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.607 -0.806 . . . . 0.99 111.436 174.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.713 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 40.5 Cg_endo -90.02 -30.21 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.664 2.243 . . . . 0.63 115.382 -171.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.17 -23.1 63.89 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 116.229 -0.441 . . . . 1.1 111.473 -174.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -72.03 -38.14 69.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.797 0.808 . . . . 1.79 108.959 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.656 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.3 mp -69.69 -45.29 78.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.526 -1.215 . . . . 1.18 110.585 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.68 ' CB ' HG11 ' A' ' 16' ' ' VAL . . . -67.26 -30.53 70.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 1.07 109.898 175.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.34 62.3 1.0 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.459 -0.877 . . . . 0.5 113.427 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.474 ' O ' HG22 ' A' ' 60' ' ' VAL . 21.6 tp -98.15 158.31 15.63 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.045 -0.724 . . . . 1.5 109.045 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.502 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 5.2 mt-30 -132.21 42.25 3.15 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 115.15 1.537 . . . . 1.53 115.15 -164.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' A' ' 58' ' ' THR . 3.4 mp 71.56 -20.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 N-CA-C 115.741 1.756 . . . . 1.43 115.741 161.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -164.06 57.77 0.27 Allowed Glycine 0 N--CA 1.463 0.484 0 C-N-CA 119.803 -1.189 . . . . 0.37 112.148 -164.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.574 ' HA ' HE22 ' A' ' 112' ' ' GLN . 9.5 m-20 -124.76 154.15 41.34 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.823 -0.688 . . . . 0.89 109.819 -168.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.781 ' HD2' ' HB ' ' A' ' 51' ' ' THR . 72.2 mmtt -106.68 103.01 12.35 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.511 0.672 . . . . 2.71 109.878 -170.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 1.023 HG13 HG23 ' A' ' 109' ' ' VAL . 3.5 mp -73.65 125.14 32.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 114.696 -1.138 . . . . 1.22 113.344 -172.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.728 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 4.4 mmt -86.18 -21.8 27.32 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 113.053 -1.885 . . . . 1.61 112.174 176.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.505 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -168.91 149.95 4.51 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.455 0.539 . . . . 0.88 112.455 -174.586 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.645 HG21 ' SD ' ' A' ' 85' ' ' MET . 30.1 m -132.55 123.04 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.84 -0.618 . . . . 1.93 110.313 174.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.669 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 1.0 OUTLIER 56.87 25.13 10.07 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.071 0.767 . . . . 1.8 113.071 174.58 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.64 -7.13 57.62 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.358 -1.401 . . . . 0.38 112.669 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.45 ' CB ' ' HE2' ' A' ' 85' ' ' MET . 80.0 m95 -91.84 152.57 20.04 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.817 -0.809 . . . . 0.91 108.817 174.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -103.05 112.96 26.05 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.669 0.747 . . . . 1.89 111.742 -172.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.645 ' SD ' HG21 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -106.34 101.62 11.08 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.055 -0.975 . . . . 1.38 111.359 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.1 p -118.24 -41.33 2.87 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.745 1.259 . . . . 1.1 107.741 168.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -148.22 84.49 1.51 Allowed 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 112.556 -2.111 . . . . 2.15 107.825 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.776 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.5 t -140.04 135.05 37.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.219 -0.901 . . . . 1.68 109.56 -172.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.747 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 69.5 p -55.92 148.28 17.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.292 0.479 . . . . 1.1 112.292 -178.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.739 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 22.7 t-160 -56.14 -40.25 73.52 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 115.883 -0.599 . . . . 0.41 110.715 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.6 -32.29 70.94 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.115 -0.948 . . . . 1.67 109.365 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.812 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 2.5 tp-100 -63.0 -49.45 74.62 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 108.598 -0.89 . . . . 0.79 108.598 -178.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.723 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -73.06 -40.47 65.04 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.632 -0.713 . . . . 1.06 110.611 -177.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 94' ' ' ARG . 33.2 ttp180 -57.16 -44.32 83.37 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.304 0.573 . . . . 2.45 109.644 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.461 ' HD3' ' C ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -66.68 -35.51 80.33 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.368 -0.833 . . . . 1.51 109.638 -178.451 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.812 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 22.2 mmt180 -76.18 -26.36 56.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.006 -0.543 . . . . 4.23 111.602 -176.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 2.8 pp -101.49 -0.19 35.56 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.098 0.777 . . . . 2.24 113.098 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.667 ' HG1' HD13 ' A' ' 97' ' ' LEU . 4.2 m -126.67 65.47 1.26 Allowed 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 122.373 1.082 . . . . 1.63 110.871 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.536 ' C ' ' H ' ' A' ' 101' ' ' SER . 20.4 mtmt -112.25 114.32 27.04 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 113.937 -1.483 . . . . 3.16 108.538 171.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.446 ' HD2' ' O ' ' A' ' 25' ' ' GLU . 15.6 ptt180 -74.88 32.32 0.09 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.348 0.595 . . . . 4.79 110.764 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.536 ' H ' ' C ' ' A' ' 99' ' ' LYS . 13.2 p -119.73 -41.79 2.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.511 -0.768 . . . . 2.83 109.747 -177.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -52.1 142.84 15.32 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.466 -0.788 . . . . 3.4 110.477 175.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -93.66 -13.21 27.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.28 0.562 . . . . 2.68 110.43 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.621 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 5.7 p -151.06 146.74 16.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.77 -0.65 . . . . 1.15 109.547 -176.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.8 t -114.24 120.36 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-O 121.946 0.879 . . . . 1.13 111.708 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.669 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.2 OUTLIER -100.26 127.76 46.48 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.488 -1.687 . . . . 2.28 110.613 -177.114 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.765 HD13 HG12 ' A' ' 77' ' ' ILE . 31.1 tp -133.39 126.92 32.34 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.044 -0.526 . . . . 1.68 109.947 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.728 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 35.4 tp -111.53 116.01 30.14 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.47 -1.308 . . . . 1.1 107.47 175.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 1.023 HG23 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -120.93 153.74 24.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.019 0.438 . . . . 1.39 110.391 -173.507 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.659 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 0.7 OUTLIER -98.71 115.09 27.95 Favored 'General case' 0 N--CA 1.426 -1.673 0 C-N-CA 119.619 -0.832 . . . . 1.13 110.018 165.482 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.491 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 17.3 ttt180 -92.23 112.79 24.86 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.689 -1.142 . . . . 2.34 109.329 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.574 HE22 ' HA ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -86.1 -58.56 2.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.471 -0.786 . . . . 1.97 112.197 -171.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.2 t -149.17 8.59 0.73 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.164 0.507 . . . . 2.0 110.906 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.502 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 3.1 mm? -81.66 106.19 13.41 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.207 -1.034 . . . . 2.0 108.207 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -128.63 149.5 50.62 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.643 -0.708 . . . . 3.83 110.191 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -138.82 145.33 39.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.568 0.223 . . . . 3.96 111.27 -174.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 53.91 56.21 7.41 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.554 -0.748 . . . . 3.76 110.987 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.04 -5.94 11.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.396 -0.82 . . . . 5.11 110.61 -175.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -123.85 99.5 6.3 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.356 -0.609 . . . . 8.35 109.356 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -139.35 115.31 10.22 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.006 -0.543 . . . . 6.63 110.534 -174.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.5 m -65.08 115.81 5.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.642 -0.708 . . . . 8.94 111.235 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 87.6 mtp -84.3 133.24 34.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.106 -0.497 . . . . 12.46 110.701 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.4 tp -124.73 14.89 8.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.631 0.729 . . . . 13.06 109.472 178.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.3 p . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.059 -0.972 . . . . 14.64 109.638 -176.493 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 110.289 -0.263 . . . . 14.35 110.289 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.6 t -93.94 174.26 7.25 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.09 -0.337 . . . . 11.48 110.09 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -115.41 134.73 54.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.376 -0.602 . . . . 9.53 109.376 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.939 HD11 ' HA ' ' A' ' 8' ' ' PRO . 7.4 pt -120.3 78.03 26.41 Favored Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-O 121.119 0.485 . . . . 6.82 111.169 -173.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.52 -38.42 3.4 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.25 1.967 . . . . 7.95 111.83 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.26 22.78 4.17 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.679 -0.692 . . . . 6.42 111.623 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.708 ' HG3' HG23 ' A' ' 4' ' ' ILE . 4.5 pt20 -145.3 38.98 0.24 Allowed Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 114.274 1.213 . . . . 6.63 114.274 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.939 ' HA ' HD11 ' A' ' 4' ' ' ILE . 50.6 Cg_exo -56.0 163.45 5.93 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.093 1.862 . . . . 3.98 112.213 171.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 9' ' ' VAL . 12.9 p -109.37 17.92 7.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.729 0.776 . . . . 2.77 109.437 -173.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 t -73.43 79.79 1.41 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 123.27 1.51 . . . . 2.49 109.639 173.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.22 177.01 9.25 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 112.215 -2.266 . . . . 1.24 110.05 172.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.9 m -120.72 132.41 70.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 116.039 -0.528 . . . . 2.16 110.371 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.509 HG21 HG23 ' A' ' 110' ' ' THR . 16.3 t -85.94 114.28 25.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.904 0.383 . . . . 1.65 110.626 -176.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.682 ' HG2' ' HB2' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -112.61 169.96 8.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.402 0.62 . . . . 1.39 112.232 -179.061 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -110.11 141.77 42.52 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.594 0.712 . . . . 4.11 112.409 -173.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.677 ' HB ' ' HB3' ' A' ' 107' ' ' LEU . 34.0 t -129.99 128.74 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 108.28 -1.008 . . . . 1.59 108.28 170.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -143.38 119.74 10.92 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.673 0.273 . . . . 1.35 110.418 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.529 HG12 ' HB2' ' A' ' 65' ' ' PRO . 10.7 tp -145.33 150.57 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.275 0 N-CA-C 108.818 -0.808 . . . . 1.33 108.818 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.747 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 15.8 m-70 -80.71 114.99 19.99 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.187 -0.605 . . . . 0.7 109.402 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.559 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 3.0 pptp? -27.62 136.2 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 O-C-N 125.051 1.469 . . . . 4.39 112.459 177.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.2 tp -109.14 98.1 7.61 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 120.656 -0.418 . . . . 1.23 110.684 -175.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 57.7 mtt180 -67.04 135.66 54.03 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.452 0.644 . . . . 4.63 111.537 177.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.76 92.41 3.76 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.107 -1.071 . . . . 1.5 108.107 172.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.1 -81.48 0.13 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.104 -0.57 . . . . 1.33 111.748 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -129.88 5.1 4.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.779 0.799 . . . . 2.33 110.819 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 7.4 m-80 -108.27 167.8 9.76 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.336 -0.847 . . . . 1.87 110.224 -177.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.421 HD12 ' HG2' ' A' ' 100' ' ' ARG . 6.6 mp -121.73 122.58 39.86 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.564 -0.902 . . . . 2.8 108.564 171.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.7 mm -98.0 127.71 50.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.599 -0.728 . . . . 1.45 110.234 -174.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.591 HD12 HD21 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -84.96 -38.27 19.5 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 114.581 -1.19 . . . . 1.87 109.063 -179.36 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.99 5.76 62.33 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.02 -0.991 . . . . 1.14 111.479 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 39.5 p90 -151.57 167.12 29.06 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.462 -0.57 . . . . 0.61 109.462 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.691 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -106.0 169.18 8.65 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 118.822 -1.151 . . . . 0.91 108.889 173.302 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 55' ' ' ILE . 6.8 tt -140.92 134.72 32.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 119.87 -0.732 . . . . 1.24 112.323 -164.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -103.14 173.17 22.11 Favored Glycine 0 C--N 1.329 0.191 0 N-CA-C 110.77 -0.932 . . . . 0.78 110.77 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.629 ' C ' HE22 ' A' ' 39' ' ' GLN . . . -110.46 168.57 13.06 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 118.243 2.057 . . . . 1.66 118.243 -162.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.673 ' N ' HE22 ' A' ' 39' ' ' GLN . . . -84.5 -142.42 5.55 Favored Glycine 0 N--CA 1.422 -2.254 0 CA-C-N 110.816 -2.692 . . . . 0.95 113.272 -176.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.717 HG23 ' O ' ' A' ' 87' ' ' MET . 8.7 pt -83.1 -5.2 8.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 113.258 0.836 . . . . 1.15 113.258 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.944 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 13.3 p-10 -70.02 -32.74 71.05 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 120.996 -0.282 . . . . 0.72 111.248 -173.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.673 HE22 ' N ' ' A' ' 36' ' ' GLY . 0.9 OUTLIER -59.36 -52.16 66.84 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.616 0.722 . . . . 1.47 109.116 -172.411 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.427 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 2.0 m-20 -143.0 118.07 6.42 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 114.516 -1.22 . . . . 2.57 110.29 171.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 17.7 Cg_exo -67.75 -1.93 7.66 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.096 2.531 . . . . 2.82 112.386 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.8 t -92.34 14.8 15.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.534 0.683 . . . . 3.26 109.342 176.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -123.93 34.76 4.98 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.943 -1.132 . . . . 3.88 107.943 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.593 ' H ' ' CD ' ' A' ' 45' ' ' PRO . 3.7 m-20 -115.56 -41.24 0.07 OUTLIER Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 113.731 -1.577 . . . . 5.7 109.763 -170.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.593 ' CD ' ' H ' ' A' ' 44' ' ' ASN . 22.7 Cg_exo -68.78 7.0 0.82 Allowed 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.23 1.953 . . . . 4.03 112.583 173.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 44' ' ' ASN . 98.0 m-85 -106.91 -6.56 17.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.023 -0.535 . . . . 6.35 110.256 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.416 ' HA ' ' HB2' ' A' ' 52' ' ' ASP . 3.8 m -85.5 97.3 9.97 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-O 122.525 1.155 . . . . 3.85 109.45 -171.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.779 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 3.4 tp10 -62.91 -39.97 96.17 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 113.163 -1.835 . . . . 6.78 110.307 -178.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 48' ' ' GLU . 14.7 t70 169.5 -128.87 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 106.263 -1.755 . . . . 5.47 106.263 -175.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.843 ' HZ1' ' HB3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -54.25 -33.88 59.51 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.9 0.857 . . . . 3.54 109.108 164.183 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.779 ' HB ' ' HB3' ' A' ' 48' ' ' GLU . 2.0 m -56.39 -22.9 34.42 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 113.859 -1.519 . . . . 4.89 112.612 -173.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.44 ' OD2' ' HD2' ' A' ' 53' ' ' LYS . 37.4 t70 -57.26 -106.64 0.0 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.677 0.751 . . . . 2.6 110.132 170.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.44 ' HD2' ' OD2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -172.63 -28.29 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.517 -0.765 . . . . 3.98 109.823 174.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.582 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 53.79 -121.2 17.25 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 110.276 -1.13 . . . . 0.94 110.276 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.835 HG12 ' HB1' ' A' ' 93' ' ' ALA . 1.8 mp -108.89 146.07 14.96 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.175 0 N-CA-C 105.839 -1.911 . . . . 1.27 105.839 170.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.693 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 1.0 OUTLIER -153.54 140.27 19.0 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 119.295 0.952 . . . . 1.91 110.264 -169.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.599 ' O ' ' HA2' ' A' ' 74' ' ' GLY . 14.4 p -72.15 132.08 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 CA-C-N 115.44 -0.8 . . . . 1.22 110.718 -171.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.691 ' O ' ' HB3' ' A' ' 32' ' ' SER . 19.3 m -125.34 64.71 1.16 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.98 -1.009 . . . . 1.29 109.225 174.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.558 ' HA ' HG13 ' A' ' 73' ' ' ILE . 34.5 mtt180 149.38 -173.19 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.392 1.477 . . . . 2.63 111.407 165.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 4.8 p -174.34 120.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 113.167 -1.833 . . . . 1.53 108.269 162.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.9 m -94.27 133.92 37.29 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.132 0.492 . . . . 2.38 110.993 -175.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -61.4 124.51 20.83 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.643 -1.162 . . . . 1.85 110.382 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.07 -13.06 45.02 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.047 -0.979 . . . . 0.95 111.642 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.99 166.82 30.13 Favored Glycine 0 N--CA 1.438 -1.177 0 N-CA-C 111.026 -0.83 . . . . 0.99 111.026 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.564 ' HA ' HD13 ' A' ' 68' ' ' ILE . 77.7 Cg_endo -73.98 -23.03 16.57 Favored 'Trans proline' 0 C--N 1.325 -0.676 0 C-N-CA 122.798 2.332 . . . . 0.63 113.036 -170.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.497 ' HB2' HD23 ' A' ' 71' ' ' LEU . . . -63.13 -29.38 70.75 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.688 -1.142 . . . . 1.1 111.635 176.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -68.96 -37.29 78.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.417 0.627 . . . . 1.79 109.531 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.564 HD13 ' HA ' ' A' ' 65' ' ' PRO . 2.9 mp -67.76 -43.59 86.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 114.894 -1.048 . . . . 1.18 110.533 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.658 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -75.76 -19.58 58.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.288 0.566 . . . . 1.07 109.686 175.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.13 70.63 1.28 Allowed Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.365 -0.834 . . . . 0.5 113.258 176.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.57 ' CD2' HG12 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -79.23 170.09 17.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.808 0.813 . . . . 1.5 112.132 178.583 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 6.2 mm100 -108.26 -20.9 12.98 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 115.593 1.701 . . . . 1.53 115.593 -161.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.611 HD13 HG13 ' A' ' 60' ' ' VAL . 0.8 OUTLIER 82.41 -24.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 112.418 0.525 . . . . 1.43 112.418 -172.556 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.599 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -172.02 53.34 0.17 Allowed Glycine 0 C--N 1.341 0.826 0 C-N-CA 119.873 -1.156 . . . . 0.37 112.691 -164.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.671 ' HB3' HG22 ' A' ' 109' ' ' VAL . 0.7 OUTLIER -122.19 149.71 43.26 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 122.204 0.201 . . . . 0.89 110.548 -175.206 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.693 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 66.8 mttm -82.39 113.03 19.88 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.691 0.281 . . . . 2.71 111.16 -174.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 17.1 mt -85.66 122.3 38.26 Favored 'Isoleucine or valine' 0 C--O 1.264 1.827 0 CA-C-O 121.254 0.549 . . . . 1.22 111.571 -175.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.801 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 15.5 mmt -89.2 -20.01 24.73 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 125.831 1.957 . . . . 1.61 112.763 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.581 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -167.25 154.05 8.44 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.434 -0.506 . . . . 0.88 112.221 -174.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.77 HG22 ' HB2' ' A' ' 97' ' ' LEU . 12.0 p -139.61 125.49 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.381 -0.827 . . . . 1.93 110.029 174.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.78 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 13.6 m120 52.75 30.22 8.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.168 -0.924 . . . . 1.8 113.193 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.88 -10.64 62.32 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.085 -1.055 . . . . 0.38 112.849 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -80.7 149.74 29.62 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-N 117.06 0.43 . . . . 0.91 110.106 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -103.94 97.8 7.74 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.274 -0.875 . . . . 1.89 111.081 -175.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.555 ' SD ' HG11 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -113.3 101.88 9.82 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.842 -0.617 . . . . 1.38 111.19 176.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.4 p -99.02 -32.64 11.18 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.675 0.75 . . . . 1.1 110.258 173.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.717 ' O ' HG23 ' A' ' 37' ' ' ILE . 4.0 mtt -136.94 -15.48 1.53 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.756 -1.111 . . . . 2.15 110.284 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.641 HG13 ' HG2' ' A' ' 92' ' ' GLN . 1.3 p -56.51 169.45 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 120.888 0.375 . . . . 1.68 111.755 -162.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.944 ' HB ' ' HB3' ' A' ' 38' ' ' ASP . 72.4 p -56.56 145.02 29.46 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 122.223 -0.298 . . . . 1.1 111.756 -174.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.545 ' CG ' ' HA2' ' A' ' 35' ' ' GLY . 23.3 t-160 -55.84 -35.4 66.37 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 122.045 0.926 . . . . 0.41 108.614 175.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -69.02 -32.53 72.11 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 113.256 -1.793 . . . . 1.67 110.313 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.8 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 4.3 tp-100 -62.54 -47.86 82.06 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 108.008 -1.108 . . . . 0.79 108.008 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.835 ' HB1' HG12 ' A' ' 55' ' ' ILE . . . -76.72 -34.06 58.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.243 -0.889 . . . . 1.06 110.21 -173.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 94' ' ' ARG . 38.6 ttp180 -65.35 -43.53 90.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.386 -0.824 . . . . 2.45 110.395 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.546 ' HD3' ' C ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -69.35 -40.88 77.26 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.53 -0.759 . . . . 1.51 109.904 -176.403 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.8 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 21.9 mmt180 -70.36 -23.57 62.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.953 -0.567 . . . . 4.23 110.633 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.77 ' HB2' HG22 ' A' ' 80' ' ' VAL . 15.9 tp -83.26 -44.48 14.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.631 -0.713 . . . . 2.24 112.007 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.0 m -107.87 75.42 1.0 Allowed 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 122.807 1.289 . . . . 1.63 111.014 -169.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.516 ' HE2' ' HA ' ' A' ' 96' ' ' ARG . 6.6 mtmt -115.44 123.87 49.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.541 -2.118 . . . . 3.16 109.041 173.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.421 ' HG2' HD12 ' A' ' 27' ' ' LEU . 41.8 mtp180 -69.69 40.01 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 O-C-N 123.324 0.39 . . . . 4.79 111.229 177.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.435 ' H ' ' C ' ' A' ' 99' ' ' LYS . 18.4 m -136.41 -41.74 0.63 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.056 -0.35 . . . . 2.83 110.056 -172.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.559 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 46.9 mm-40 -56.36 140.69 44.53 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.383 -0.599 . . . . 3.4 109.383 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.76 -16.87 15.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.502 0.668 . . . . 2.68 109.862 176.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.747 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 3.0 p -143.26 150.29 17.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.128 -1.064 . . . . 1.15 108.128 -178.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.466 HG22 ' HB3' ' A' ' 20' ' ' LYS . 54.9 t -124.57 119.38 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.807 0 CA-C-O 122.22 1.009 . . . . 1.13 111.513 -170.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.78 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -100.68 133.62 44.86 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 113.342 -1.754 . . . . 2.28 110.73 -176.228 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.677 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 19.3 tp -132.4 132.58 42.98 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 110.007 -0.368 . . . . 1.68 110.007 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.801 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 23.8 tp -109.73 114.59 28.3 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.147 -1.797 . . . . 1.1 106.147 171.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.671 HG22 ' HB3' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -121.67 141.18 43.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.898 -0.721 . . . . 1.39 110.305 -173.641 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.509 HG23 HG21 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -96.28 115.81 28.02 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.831 -0.748 . . . . 1.13 110.313 173.68 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.682 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 1.6 ttt180 -90.28 104.27 16.86 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.289 -1.323 . . . . 2.34 109.655 -170.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.469 ' HG2' ' N ' ' A' ' 113' ' ' SER . 0.0 OUTLIER -91.59 -45.17 8.63 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.371 0.508 . . . . 1.97 112.371 -171.533 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.469 ' N ' ' HG2' ' A' ' 112' ' ' GLN . 22.8 t -163.1 14.92 0.07 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.408 0.623 . . . . 2.0 110.311 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.45 HD23 ' OD1' ' A' ' 75' ' ' ASP . 3.6 mm? -92.66 83.32 4.85 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.382 0.611 . . . . 2.0 109.861 -176.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.46 144.42 31.68 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 113.645 0.98 . . . . 3.83 113.645 -176.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -161.24 145.77 13.51 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 113.49 -1.687 . . . . 3.96 107.227 175.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -43.73 108.96 0.12 Allowed 'General case' 0 C--N 1.322 -0.626 0 O-C-N 123.834 0.709 . . . . 3.76 111.054 174.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.76 -40.47 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.874 -0.603 . . . . 5.11 111.381 -175.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -126.41 63.75 1.26 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.458 0.647 . . . . 8.35 109.481 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -165.51 -28.68 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.311 -0.859 . . . . 6.63 109.915 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.5 m -93.1 170.5 9.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.718 -0.674 . . . . 8.94 109.797 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 15.2 tpt -84.66 129.91 34.78 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.942 -0.392 . . . . 12.46 109.942 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -135.39 166.74 22.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.291 -0.413 . . . . 13.06 110.165 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.7 m . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.461 -0.781 . . . . 14.64 111.073 -178.649 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.8 tpt . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 120.661 0.267 . . . . 14.35 110.426 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 t -137.55 122.02 18.37 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.713 -0.476 . . . . 11.48 109.713 178.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -109.01 126.84 53.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.437 -0.347 . . . . 9.53 110.584 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.1 pt -106.62 98.79 21.79 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 6.82 110.788 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -87.5 -11.34 5.03 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.462 2.108 . . . . 7.95 111.568 174.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.65 -42.15 4.56 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.674 -0.694 . . . . 6.42 112.405 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.431 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 3.0 pt20 -128.13 46.02 1.94 Allowed Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 114.286 1.217 . . . . 6.63 114.286 -177.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.556 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 9.4 Cg_endo -71.49 130.68 17.6 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.436 1.424 . . . . 3.98 110.564 172.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.556 ' HB ' ' O ' ' A' ' 8' ' ' PRO . 42.3 t 77.84 -47.63 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 O-C-N 123.426 0.454 . . . . 2.77 111.107 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 49.2 p -75.0 82.67 2.23 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 122.309 1.052 . . . . 2.49 111.461 -176.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.07 179.36 5.6 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.399 -1.728 . . . . 1.24 109.484 173.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.76 122.28 68.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.218 0.533 . . . . 2.16 110.711 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.571 HG23 HG22 ' A' ' 110' ' ' THR . 15.8 t -79.56 105.61 9.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.004 -0.543 . . . . 1.65 110.367 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.998 HE22 HG22 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -102.05 169.19 8.91 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.725 -0.67 . . . . 1.39 111.766 179.095 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.508 ' HD3' ' O ' ' A' ' 107' ' ' LEU . 1.8 mmt180 -123.96 116.09 22.31 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.334 -0.394 . . . . 4.11 110.932 -177.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.998 HG22 HE22 ' A' ' 14' ' ' GLN . 25.1 t -97.29 125.71 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.597 -0.52 . . . . 1.59 109.597 176.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -139.04 116.21 11.05 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.89 -0.781 . . . . 1.35 108.89 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.68 HG13 ' O ' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -144.57 139.8 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 107.841 -1.17 . . . . 1.33 107.841 -177.42 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.808 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 17.1 m-70 -72.06 115.09 10.88 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.139 -0.689 . . . . 0.7 109.139 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -31.96 141.01 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 O-C-N 124.958 1.411 . . . . 4.39 112.228 178.414 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.795 ' HB3' ' HB ' ' A' ' 28' ' ' ILE . 56.5 tp -98.18 102.58 14.37 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.595 -0.442 . . . . 1.23 110.764 -171.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -58.13 139.35 54.97 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.371 0.605 . . . . 4.63 112.069 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.461 ' HB3' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -142.99 92.46 2.4 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.555 -0.748 . . . . 1.5 109.13 172.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.35 -79.85 0.01 OUTLIER Glycine 0 CA--C 1.522 0.473 0 C-N-CA 121.455 -0.403 . . . . 1.33 112.541 -173.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -130.16 5.06 4.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.513 0.673 . . . . 2.33 110.508 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.461 ' HB2' ' HB3' ' A' ' 23' ' ' GLN . 12.0 m-80 -106.63 165.36 11.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.532 -0.758 . . . . 1.87 110.146 -177.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.892 HD23 ' HB ' ' A' ' 98' ' ' THR . 2.2 pt? -128.66 124.63 36.21 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.759 -1.2 . . . . 2.8 107.759 171.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.795 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 36.0 mm -98.43 115.95 40.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 116.028 -0.533 . . . . 1.45 110.731 -170.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.431 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.3 pt? -71.7 -26.54 62.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.632 -0.713 . . . . 1.87 110.353 175.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.07 -31.3 7.1 Favored Glycine 0 C--O 1.223 -0.585 0 C-N-CA 120.731 -0.747 . . . . 1.14 113.201 172.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.598 ' HZ ' HD12 ' A' ' 97' ' ' LEU . 44.9 p90 -112.24 163.07 14.79 Favored 'General case' 0 C--N 1.313 -0.999 0 O-C-N 122.264 -0.551 . . . . 0.61 110.815 -176.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.529 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 24.0 t -100.47 163.2 12.47 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.268 -1.382 . . . . 0.91 107.268 173.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -162.64 137.82 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 112.416 0.524 . . . . 1.24 112.416 -164.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.74 117.79 1.06 Allowed Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 110.616 -0.994 . . . . 0.78 110.616 157.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 1.018 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -142.65 118.56 1.27 Allowed Glycine 0 CA--C 1.49 -1.507 0 CA-C-O 118.607 -1.107 . . . . 1.66 111.564 173.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.68 144.86 9.42 Favored Glycine 0 C--N 1.294 -1.764 0 C-N-CA 117.133 -2.46 . . . . 0.95 113.319 177.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.599 ' HA ' ' HG3' ' A' ' 53' ' ' LYS . 13.2 pt -62.58 -17.64 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.801 -1.185 . . . . 1.15 107.801 151.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.839 ' HB2' ' CB ' ' A' ' 89' ' ' THR . 21.9 t70 -62.89 -37.09 85.53 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 113.962 -1.472 . . . . 0.72 109.802 173.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -74.0 -164.31 0.23 Allowed 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 114.662 -1.154 . . . . 1.47 110.704 -174.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.503 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 2.2 p-10 -98.79 122.39 53.09 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-O 121.429 0.633 . . . . 2.57 111.348 -175.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 10.3 Cg_exo -76.93 19.9 0.66 Allowed 'Trans proline' 0 N--CA 1.474 0.334 0 C-N-CA 123.853 3.035 . . . . 2.82 113.047 177.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 t -98.84 13.9 30.81 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.884 0.373 . . . . 3.26 111.553 -170.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -134.48 16.78 3.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.632 0.73 . . . . 3.88 109.429 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.409 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 13.9 p30 -177.8 56.33 0.1 Allowed Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-N 114.649 -1.16 . . . . 5.7 108.587 -168.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.07 -4.12 12.93 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.641 2.227 . . . . 4.03 113.009 -167.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -141.21 -42.28 0.38 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.047 -1.094 . . . . 6.35 108.047 176.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.6 m -157.26 158.88 36.93 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.826 -1.176 . . . . 3.85 107.826 174.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.523 ' HB3' HG23 ' A' ' 51' ' ' THR . 32.5 tt0 -107.25 -38.22 6.04 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.571 -0.9 . . . . 6.78 108.571 169.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.53 ' HB2' HG21 ' A' ' 51' ' ' THR . 21.2 m-20 -176.93 -147.93 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 105.758 -1.942 . . . . 5.47 105.758 -169.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.896 ' HG3' HG21 ' A' ' 110' ' ' THR . 0.1 OUTLIER -75.74 55.08 0.84 Allowed 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.625 -0.879 . . . . 3.54 108.625 163.12 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 1.119 ' HB ' ' HB3' ' A' ' 76' ' ' LYS . 7.3 t -151.17 -54.17 0.14 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 119.78 -0.768 . . . . 4.89 110.706 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.425 ' C ' ' HE3' ' A' ' 53' ' ' LYS . 19.9 t0 63.97 -99.05 0.07 Allowed 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 115.926 -0.579 . . . . 2.6 111.064 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.599 ' HG3' ' HA ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -111.52 33.09 4.92 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.402 -1.333 . . . . 3.98 107.402 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.467 ' C ' HD11 ' A' ' 55' ' ' ILE . . . -93.2 -154.21 30.94 Favored Glycine 0 N--CA 1.433 -1.556 0 CA-C-N 113.545 -1.662 . . . . 0.94 111.026 -169.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 1.018 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -114.25 144.25 22.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 N-CA-C 109.223 -0.658 . . . . 1.27 109.223 178.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.777 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -145.92 146.78 31.19 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 122.59 1.186 . . . . 1.91 113.334 178.218 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.87 HG22 HD13 ' A' ' 77' ' ' ILE . 54.5 t -72.21 137.42 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 112.509 -2.132 . . . . 1.22 110.38 175.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.7 m -113.73 -19.7 11.45 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 124.502 1.126 . . . . 1.29 111.478 -178.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.622 ' O ' HG22 ' A' ' 60' ' ' VAL . 72.8 mtt180 -149.48 -165.97 2.42 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.754 -0.591 . . . . 2.63 112.21 174.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.622 HG22 ' O ' ' A' ' 59' ' ' ARG . 79.7 t -168.4 138.61 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.705 1.602 . . . . 1.53 107.407 166.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.404 ' OG ' ' HA3' ' A' ' 64' ' ' GLY . 32.2 p -81.09 132.87 35.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.922 0.392 . . . . 2.38 111.123 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -58.71 111.17 1.17 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.864 -1.062 . . . . 1.85 110.52 170.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.26 -15.16 63.83 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.55 -0.834 . . . . 0.95 112.145 177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.423 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -72.21 175.51 42.51 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.515 -0.85 . . . . 0.99 111.35 177.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.68 ' O ' HG13 ' A' ' 18' ' ' ILE . 73.5 Cg_endo -72.8 -30.08 11.84 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.288 1.992 . . . . 0.63 112.69 -166.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.464 ' HB2' HG13 ' A' ' 60' ' ' VAL . . . -60.72 -28.25 68.52 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.011 -0.995 . . . . 1.1 111.415 178.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -76.0 -35.49 59.55 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.517 0.675 . . . . 1.79 109.287 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.5 HD11 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -65.27 -43.43 95.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.882 -1.053 . . . . 1.18 110.244 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.685 ' CB ' HG12 ' A' ' 16' ' ' VAL . . . -72.46 -22.87 61.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.908 -0.587 . . . . 1.07 110.52 177.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.89 66.38 0.86 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.019 -1.086 . . . . 0.5 113.389 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.518 HD12 HG21 ' A' ' 16' ' ' VAL . 9.0 tp -119.12 151.0 39.06 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.893 -0.41 . . . . 1.5 109.893 177.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.768 HE22 ' HG3' ' A' ' 111' ' ' ARG . 7.9 mt-30 -129.91 31.73 4.66 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 115.806 1.78 . . . . 1.53 115.806 -162.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 72' ' ' GLN . 2.7 mp 72.95 -8.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 CA-C-N 118.992 0.815 . . . . 1.43 112.988 170.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.13 54.58 0.32 Allowed Glycine 0 CA--C 1.507 -0.454 0 C-N-CA 119.155 -1.498 . . . . 0.37 112.69 -168.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.457 ' H ' ' HB ' ' A' ' 57' ' ' VAL . 16.8 m-20 -120.83 148.36 44.12 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.491 -0.354 . . . . 0.89 110.51 -168.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 1.119 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 14.0 mmtp -105.93 102.86 12.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.168 0.508 . . . . 2.71 110.0 -169.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 1.063 HG13 HG23 ' A' ' 109' ' ' VAL . 3.4 mp -72.99 126.99 34.63 Favored 'Isoleucine or valine' 0 C--O 1.257 1.471 0 N-CA-C 113.629 0.974 . . . . 1.22 113.629 -172.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.801 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 5.5 mmt -92.12 -28.55 17.03 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 126.265 2.228 . . . . 1.61 112.113 172.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.571 ' HB2' ' CB ' ' A' ' 108' ' ' LEU . 52.3 mt-30 -150.87 158.57 44.31 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.52 0.933 . . . . 0.88 113.52 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.579 ' HB ' ' CE ' ' A' ' 85' ' ' MET . 24.4 t -139.6 107.46 3.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 113.515 -1.675 . . . . 1.93 109.951 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 1.016 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 23.1 m-80 54.92 32.27 17.59 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.848 0.459 . . . . 1.8 112.007 176.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.46 -3.9 59.76 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.224 -0.989 . . . . 0.38 112.817 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.447 ' CE2' ' HD2' ' A' ' 96' ' ' ARG . 84.0 m95 -87.54 168.27 13.21 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.669 -0.493 . . . . 0.91 109.669 177.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -109.78 113.69 26.66 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.242 0.544 . . . . 1.89 111.155 -171.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.579 ' CE ' ' HB ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -106.95 101.97 11.36 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 122.217 1.008 . . . . 1.38 110.965 -179.702 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.8 p -142.1 -46.18 0.34 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.428 -1.714 . . . . 1.1 107.707 173.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.41 ' HA ' HG21 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -146.85 74.45 1.35 Allowed 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 113.704 -1.589 . . . . 2.15 110.127 176.105 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.754 ' HB ' HE21 ' A' ' 92' ' ' GLN . 22.9 m -133.3 154.93 40.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.285 -1.006 . . . . 1.68 108.285 171.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.839 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 72.0 p -62.57 154.4 29.02 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 120.792 0.33 . . . . 1.1 111.331 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.811 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 17.7 t-160 -52.59 -45.14 66.39 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 121.722 0.772 . . . . 0.41 110.143 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -71.35 -29.56 65.13 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 113.692 -1.594 . . . . 1.67 109.964 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.754 HE21 ' HB ' ' A' ' 88' ' ' VAL . 2.5 tt0 -60.19 -47.14 87.2 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.402 -0.592 . . . . 0.79 109.402 178.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.577 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -74.06 -41.0 62.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.322 0.582 . . . . 1.06 110.531 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -56.62 -44.17 80.94 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.817 -1.083 . . . . 2.45 110.896 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.413 ' HD3' ' C ' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -71.82 -34.35 69.25 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.396 -0.82 . . . . 1.51 109.92 -176.682 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.727 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 27.2 mmt180 -74.56 -26.15 59.76 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.172 -0.467 . . . . 4.23 110.712 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.598 HD12 ' HZ ' ' A' ' 31' ' ' PHE . 5.6 tt -68.94 -60.85 2.09 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.527 -0.76 . . . . 2.24 111.277 -176.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.892 ' HB ' HD23 ' A' ' 27' ' ' LEU . 5.8 p -97.43 -83.56 0.39 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.387 -0.369 . . . . 1.63 111.408 -176.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 99' ' ' LYS . 2.8 ttpt 66.97 -1.66 1.35 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.8 -0.636 . . . . 3.16 112.026 176.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.476 ' HA ' HD22 ' A' ' 27' ' ' LEU . 97.4 mtt180 60.34 47.79 8.61 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.026 -0.988 . . . . 4.79 111.188 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.1 t -137.02 -56.44 0.72 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.466 -0.334 . . . . 2.83 111.741 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.637 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 19.5 mm-40 -63.83 149.5 46.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.474 -0.33 . . . . 3.4 111.123 -174.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -93.5 -10.17 35.82 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.431 0.634 . . . . 2.68 109.843 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.808 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 3.8 p -147.58 142.18 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 108.634 -0.876 . . . . 1.15 108.634 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.5 t -116.64 120.24 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-O 122.02 0.914 . . . . 1.13 111.867 -169.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 1.016 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -99.66 128.33 45.77 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 113.444 -1.707 . . . . 2.28 111.322 -174.403 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.852 HD11 HG12 ' A' ' 77' ' ' ILE . 17.6 tp -134.49 133.87 40.85 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.127 -0.488 . . . . 1.68 110.492 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.801 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 29.9 tp -111.38 117.01 31.92 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 105.998 -1.853 . . . . 1.1 105.998 170.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 1.063 HG23 HG13 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -126.63 144.46 36.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.868 -0.733 . . . . 1.39 110.407 -174.578 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.896 HG21 ' HG3' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -95.68 115.29 27.22 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.614 -0.834 . . . . 1.13 109.297 169.608 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.768 ' HG3' HE22 ' A' ' 72' ' ' GLN . 8.5 ttt180 -102.97 138.9 39.24 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.258 -1.337 . . . . 2.34 110.482 -172.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.565 ' HG2' HD23 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -125.41 -96.35 0.44 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.326 0.491 . . . . 1.97 112.326 -178.433 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.0 t -124.97 35.39 4.79 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.273 0.559 . . . . 2.0 111.792 -168.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.565 HD23 ' HG2' ' A' ' 112' ' ' GLN . 0.3 OUTLIER -99.16 18.46 17.41 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.32 0.581 . . . . 2.0 109.835 -178.671 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -67.26 149.19 50.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.196 -0.911 . . . . 3.83 110.869 -176.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -126.7 67.06 1.25 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.021 0.438 . . . . 3.96 111.466 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 53.01 72.2 0.44 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.976 -1.011 . . . . 3.76 112.056 175.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.29 -20.22 7.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.468 0.652 . . . . 5.11 110.219 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -91.72 68.13 5.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.628 -0.715 . . . . 8.35 110.849 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -141.02 117.9 11.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.931 -0.577 . . . . 6.63 110.39 177.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.0 p -152.91 90.55 1.47 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.627 -0.715 . . . . 8.94 110.413 -177.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -91.54 -28.77 17.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.336 -0.393 . . . . 12.46 110.497 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 98.3 mt 64.09 174.97 0.18 Allowed 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.783 0.677 . . . . 13.06 110.948 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.304 -0.855 . . . . 14.64 109.72 179.366 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.8 mtp . . . . . 0 N--CA 1.482 1.129 0 CA-C-O 120.683 0.278 . . . . 14.35 111.079 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -59.62 -44.34 93.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.018 -0.537 . . . . 11.48 111.498 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -110.14 114.49 28.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.044 0.449 . . . . 9.53 110.521 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.523 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 8.5 pt -109.84 101.99 48.82 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.829 -0.623 . . . . 6.82 110.591 176.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -66.0 105.3 0.8 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.18 2.587 . . . . 7.95 112.284 -177.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.4 -24.75 30.1 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.99 -0.624 . . . . 6.42 112.424 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 70.36 113.44 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 123.49 0.716 . . . . 6.63 111.482 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.523 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 9.6 Cg_endo -89.17 172.78 4.16 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.064 2.509 . . . . 3.98 112.195 178.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.44 ' HA ' ' OD1' ' A' ' 49' ' ' ASP . 67.3 t 70.27 -68.12 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 123.439 0.696 . . . . 2.77 112.074 177.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 t -77.86 82.15 4.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 123.605 1.669 . . . . 2.49 110.86 -176.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.417 ' HB1' ' HZ1' ' A' ' 50' ' ' LYS . . . -110.9 178.19 4.43 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 112.196 -2.274 . . . . 1.24 110.541 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.8 t -111.64 118.19 56.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.989 -0.551 . . . . 2.16 110.487 -176.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.601 HG11 HD11 ' A' ' 108' ' ' LEU . 39.4 t -76.37 111.81 13.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.219 0.533 . . . . 1.65 109.637 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.976 HE22 HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -118.69 169.35 9.89 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.009 -0.541 . . . . 1.39 112.235 -171.465 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 15' ' ' ARG . 6.1 mmm-85 -124.06 118.11 26.21 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.998 0.428 . . . . 4.11 112.126 -175.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.976 HG23 HE22 ' A' ' 14' ' ' GLN . 7.7 t -108.26 119.59 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 108.25 -1.018 . . . . 1.59 108.25 171.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -132.75 114.41 14.1 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.93 -0.767 . . . . 1.35 108.93 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.7 HG13 ' O ' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -136.89 138.29 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 108.097 -1.075 . . . . 1.33 108.097 -173.619 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.832 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.3 m-70 -66.09 114.14 5.01 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.495 -0.32 . . . . 0.7 110.358 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.939 ' HB2' HD13 ' A' ' 27' ' ' LEU . 2.2 pptp? -28.02 135.4 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 O-C-N 125.097 1.498 . . . . 4.39 112.814 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.66 HD23 ' HD3' ' A' ' 65' ' ' PRO . 33.1 tp -96.68 90.24 5.24 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.937 0.875 . . . . 1.23 109.377 -175.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.418 ' CD ' ' H ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -62.3 133.23 54.84 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.854 -1.521 . . . . 4.63 111.311 -178.501 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -133.71 94.18 3.24 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.773 -0.825 . . . . 1.5 108.773 173.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.5 -80.26 0.12 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.828 -0.701 . . . . 1.33 111.778 -175.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -132.52 1.47 3.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.832 0.348 . . . . 2.33 110.511 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -107.61 172.04 7.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.24 0.543 . . . . 1.87 111.283 -171.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.939 HD13 ' HB2' ' A' ' 20' ' ' LYS . 2.7 tp -124.4 121.77 35.84 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.14 -0.936 . . . . 2.8 109.06 175.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.5 mp -99.25 129.65 49.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.686 -0.857 . . . . 1.45 108.686 176.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mt -84.7 -32.39 23.58 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.418 -0.81 . . . . 1.87 110.279 -174.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.457 ' O ' HG11 ' A' ' 60' ' ' VAL . . . 86.59 11.6 71.06 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.227 -0.987 . . . . 1.14 111.487 -175.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.617 ' HD2' ' HB1' ' A' ' 66' ' ' ALA . 33.3 p90 -155.0 167.73 29.37 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.305 -0.628 . . . . 0.61 109.305 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.539 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -107.67 164.09 12.53 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 107.873 -1.158 . . . . 0.91 107.873 172.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -148.78 136.47 14.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 119.573 -0.851 . . . . 1.24 112.664 -167.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.412 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -147.46 118.41 1.01 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.25 -0.976 . . . . 0.78 111.066 157.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.985 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -137.99 119.04 1.75 Allowed Glycine 0 CA--C 1.492 -1.354 0 CA-C-O 118.807 -0.996 . . . . 1.66 110.703 171.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 1.033 ' HA3' ' HG2' ' A' ' 39' ' ' GLN . . . -156.77 116.9 0.74 Allowed Glycine 0 N--CA 1.435 -1.423 0 C-N-CA 118.277 -1.916 . . . . 0.95 113.614 -169.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.537 HG12 ' C ' ' A' ' 88' ' ' VAL . 15.9 pt -67.86 -20.89 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 N-CA-C 105.738 -1.949 . . . . 1.15 105.738 147.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.758 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 2.8 t70 -63.17 -40.72 98.35 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 112.644 -2.071 . . . . 0.72 109.765 168.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 1.033 ' HG2' ' HA3' ' A' ' 36' ' ' GLY . 28.7 mm-40 -64.53 -70.4 0.23 Allowed 'General case' 0 C--N 1.345 0.373 0 CA-C-N 115.034 -0.984 . . . . 1.47 111.777 -175.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.504 ' O ' ' HG3' ' A' ' 53' ' ' LYS . 0.9 OUTLIER -138.71 95.98 9.66 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 120.609 -0.437 . . . . 2.57 111.136 -176.457 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.37 24.38 0.61 Allowed 'Trans proline' 0 C--N 1.332 -0.309 0 C-N-CA 122.838 2.358 . . . . 2.82 112.46 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.8 t -139.88 29.52 2.09 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.469 0.652 . . . . 3.26 110.078 -177.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.758 ' HB2' ' HE3' ' A' ' 53' ' ' LYS . 81.2 mm-40 -131.3 14.82 5.08 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.614 0.721 . . . . 3.88 109.294 -177.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.451 ' H ' ' HD2' ' A' ' 45' ' ' PRO . 8.5 m120 -86.59 -43.6 0.56 Allowed Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 114.773 -1.103 . . . . 5.7 109.408 -175.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.451 ' HD2' ' H ' ' A' ' 44' ' ' ASN . 1.6 Cg_endo -45.14 -29.31 4.02 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.016 2.477 . . . . 4.03 112.579 161.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -102.95 27.61 6.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.658 -0.701 . . . . 6.35 110.899 -178.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.0 t -70.02 140.78 52.92 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 122.52 1.152 . . . . 3.85 110.067 -176.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -107.78 -19.16 13.62 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-N 112.952 -1.931 . . . . 6.78 110.605 -163.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.531 ' CG ' ' HZ2' ' A' ' 50' ' ' LYS . 20.4 t0 168.1 -158.77 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.067 -1.086 . . . . 5.47 108.067 -162.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.531 ' HZ2' ' CG ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -66.49 1.71 1.58 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.525 0.203 . . . . 3.54 111.506 171.055 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.423 ' H ' ' C ' ' A' ' 49' ' ' ASP . 14.5 t -78.92 -54.62 5.86 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 120.202 -0.599 . . . . 4.89 110.296 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 t70 42.44 -120.24 0.54 Allowed 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.737 0.648 . . . . 2.6 110.765 170.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.758 ' HE3' ' HB2' ' A' ' 43' ' ' GLN . 20.3 mmtt -128.66 44.5 2.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.924 0.868 . . . . 3.98 110.276 171.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.479 ' C ' HD13 ' A' ' 55' ' ' ILE . . . -82.44 -144.77 5.18 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 109.732 -1.347 . . . . 0.94 109.732 172.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.985 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -117.1 141.16 36.7 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.151 0 C-N-CA 119.268 -0.973 . . . . 1.27 109.187 177.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.789 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -148.28 138.13 22.38 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.698 0.761 . . . . 1.91 110.509 -176.043 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.531 ' O ' ' HA2' ' A' ' 74' ' ' GLY . 14.6 p -79.49 137.17 22.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 114.485 -1.234 . . . . 1.22 110.468 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.617 ' O ' HG21 ' A' ' 58' ' ' THR . 12.1 t -127.18 68.91 1.28 Allowed 'General case' 0 C--O 1.21 -1.021 0 O-C-N 124.325 1.016 . . . . 1.29 108.998 174.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.632 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 18.0 mtt180 153.55 -172.9 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.897 -1.502 . . . . 2.63 110.939 159.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.457 HG11 ' O ' ' A' ' 30' ' ' GLY . 59.1 t -160.7 112.92 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 111.897 -2.41 . . . . 1.53 106.621 161.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 m -76.44 121.75 23.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.96 0.41 . . . . 2.38 109.933 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -48.14 116.72 1.63 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.01 -0.995 . . . . 1.85 112.066 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.41 -16.06 49.24 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.517 -0.849 . . . . 0.95 112.189 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.64 169.83 54.83 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.153 -1.022 . . . . 0.99 111.415 177.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.7 ' O ' HG13 ' A' ' 18' ' ' ILE . 90.5 Cg_endo -71.35 -24.59 22.68 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.603 2.202 . . . . 0.63 113.064 -170.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.617 ' HB1' ' HD2' ' A' ' 31' ' ' PHE . . . -63.15 -25.67 68.46 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.26 -0.882 . . . . 1.1 111.521 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -73.67 -37.42 65.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.656 -0.868 . . . . 1.79 108.656 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.535 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.2 mp -65.86 -47.99 83.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.245 -1.343 . . . . 1.18 111.095 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.732 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -71.93 -22.07 61.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.388 -0.369 . . . . 1.07 110.405 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.27 72.27 1.29 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.505 -0.855 . . . . 0.5 113.109 178.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.459 ' CD2' HG21 ' A' ' 57' ' ' VAL . 15.3 tp -105.04 158.16 16.75 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.699 -0.482 . . . . 1.5 109.699 176.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.659 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 35.2 mt-30 -114.04 20.83 15.37 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 114.756 1.391 . . . . 1.53 114.756 -168.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.632 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 75.8 mt 73.88 -5.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 113.059 0.762 . . . . 1.43 113.059 170.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.531 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -171.03 63.9 0.16 Allowed Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.667 -0.777 . . . . 0.37 111.621 -165.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.503 ' HB2' HG13 ' A' ' 57' ' ' VAL . 20.6 m-20 -122.66 148.26 45.49 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.245 -0.478 . . . . 0.89 110.055 -170.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -97.98 101.39 12.86 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.29 0.567 . . . . 2.71 109.775 -176.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.967 HG13 HG11 ' A' ' 109' ' ' VAL . 3.1 mp -73.86 121.89 25.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 115.29 -0.868 . . . . 1.22 112.005 -175.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.673 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 4.5 mmt -88.59 -21.74 23.88 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 125.687 1.867 . . . . 1.61 111.933 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.55 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -160.77 148.94 16.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.166 0.508 . . . . 0.88 112.194 -175.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.601 ' HB ' ' CE ' ' A' ' 85' ' ' MET . 21.9 t -129.49 110.52 20.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.172 -0.922 . . . . 1.93 110.594 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.769 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 5.9 m120 52.38 37.22 21.94 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.694 0.627 . . . . 1.8 112.694 174.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.9 -11.13 62.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.292 -0.956 . . . . 0.38 112.563 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.466 ' HB2' ' HE2' ' A' ' 85' ' ' MET . 80.1 m95 -89.57 161.87 15.95 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 109.282 -0.636 . . . . 0.91 109.282 177.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -108.81 111.79 23.71 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.197 -0.456 . . . . 1.89 110.653 -172.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.905 ' SD ' HG11 ' A' ' 88' ' ' VAL . 13.7 mmt -107.41 99.92 9.4 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 121.85 0.834 . . . . 1.38 109.91 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.64 -48.61 2.04 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.706 -1.134 . . . . 1.1 107.998 171.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.405 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 3.2 mtt -143.41 85.01 1.83 Allowed 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.517 -1.674 . . . . 2.15 108.022 173.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.905 HG11 ' SD ' ' A' ' 85' ' ' MET . 0.5 OUTLIER -140.32 151.2 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 115.781 -0.645 . . . . 1.68 109.904 -176.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.681 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 82.6 p -61.25 151.19 32.4 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.143 0.497 . . . . 1.1 112.278 -177.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.758 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 22.6 t-160 -61.53 -34.36 75.41 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 115.814 -0.63 . . . . 0.41 109.891 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -70.58 -33.24 70.85 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.171 -1.377 . . . . 1.67 109.235 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.726 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -63.56 -52.36 61.4 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.747 -0.834 . . . . 0.79 108.747 -179.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.703 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -66.72 -41.14 88.42 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.504 -0.771 . . . . 1.06 110.281 -178.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -60.25 -47.46 85.91 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.375 -0.829 . . . . 2.45 110.676 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.524 ' HD3' ' C ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -69.95 -39.45 76.04 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.67 -0.695 . . . . 1.51 110.203 -176.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.726 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 25.1 mmt180 -69.24 -23.01 63.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.991 -0.549 . . . . 4.23 112.152 -175.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.562 ' HB3' HG13 ' A' ' 80' ' ' VAL . 4.4 pp -98.93 -14.04 19.72 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.406 -0.517 . . . . 2.24 111.948 175.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.712 ' HA ' HD22 ' A' ' 27' ' ' LEU . 1.9 m -112.74 86.02 2.28 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 122.35 1.071 . . . . 1.63 109.945 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.51 ' HE3' ' HB2' ' A' ' 99' ' ' LYS . 4.6 mtmt -120.17 119.15 32.43 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 113.462 -1.699 . . . . 3.16 109.969 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -67.62 48.77 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.181 -0.918 . . . . 4.79 111.84 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.4 t -151.42 -54.11 0.14 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.311 0.486 . . . . 2.83 112.311 -172.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 43.9 mt-10 -71.67 158.51 36.02 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.323 0.49 . . . . 3.4 112.323 -171.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.74 ' HA ' ' HZ1' ' A' ' 20' ' ' LYS . 12.3 pt-20 -95.4 -18.34 20.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.81 -0.632 . . . . 2.68 111.399 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.832 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 4.9 p -142.41 148.25 20.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.726 0.298 . . . . 1.15 110.362 -172.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.496 HG23 ' HB3' ' A' ' 20' ' ' LYS . 44.1 t -119.73 119.78 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-O 121.813 0.816 . . . . 1.13 111.736 -173.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.769 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.9 OUTLIER -102.11 124.92 48.55 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 113.875 -1.511 . . . . 2.28 111.529 -174.039 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.52 131.06 39.33 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.19 0.519 . . . . 1.68 111.071 174.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.673 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 35.4 tp -103.2 113.99 27.91 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.011 -1.477 . . . . 1.1 107.011 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.967 HG11 HG13 ' A' ' 77' ' ' ILE . 23.1 m -118.12 152.06 20.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 C-N-CA 119.921 -0.712 . . . . 1.39 110.581 -176.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.529 HG21 HG21 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -95.73 115.18 27.06 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.825 -0.75 . . . . 1.13 109.287 167.129 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.58 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . 0.9 OUTLIER -105.16 143.08 33.84 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.925 -1.034 . . . . 2.34 110.475 -171.255 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.43 -89.27 0.49 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.067 -0.515 . . . . 1.97 110.633 -176.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.2 t -160.47 74.26 0.53 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.322 0.582 . . . . 2.0 110.998 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.659 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 6.8 mt -123.03 -10.18 8.18 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.284 -0.871 . . . . 2.0 110.081 -179.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.43 ' HG2' HG11 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -41.29 141.84 0.63 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.536 -1.211 . . . . 3.83 112.38 172.471 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -134.93 114.04 12.12 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.091 -0.504 . . . . 3.96 111.291 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 61.04 22.04 12.34 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.012 0.745 . . . . 3.76 113.012 170.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.43 HG11 ' HG2' ' A' ' 115' ' ' GLN . 12.2 p -86.2 -22.73 7.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.617 0.722 . . . . 5.11 110.886 -176.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -103.45 10.83 37.07 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.25 -0.886 . . . . 8.35 110.208 -175.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -113.02 84.78 2.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.876 -0.602 . . . . 6.63 110.622 -173.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.1 m -99.72 -5.96 27.9 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.351 0.596 . . . . 8.94 109.865 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 92.0 mmm -95.31 172.44 8.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.543 -0.753 . . . . 12.46 111.078 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.4 tp -110.38 138.36 46.87 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.504 -0.771 . . . . 13.06 110.146 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.4 t . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.764 -0.636 . . . . 14.64 109.595 175.65 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.9 ttp . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 109.873 -0.417 . . . . 14.35 109.873 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.8 m -93.88 117.92 30.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.927 0.394 . . . . 11.48 111.536 -174.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -80.83 -15.1 57.28 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.418 -0.586 . . . . 9.53 109.418 173.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.724 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 43.3 mm 72.55 118.84 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 114.788 -1.096 . . . . 6.82 110.804 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -52.7 -38.82 77.38 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.394 2.729 . . . . 7.95 113.38 -178.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.53 -1.36 56.59 Favored Glycine 0 C--O 1.23 -0.115 0 C-N-CA 120.669 -0.777 . . . . 6.42 111.631 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 66.78 137.22 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.806 0.842 . . . . 6.63 112.403 -176.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.724 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 43.0 Cg_exo -55.87 152.05 37.81 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 123.193 2.595 . . . . 3.98 113.199 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.8 t 76.16 -56.92 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.289 -0.869 . . . . 2.77 111.72 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.2 t -78.29 83.25 4.55 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 123.559 1.647 . . . . 2.49 110.869 -177.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.64 157.45 17.17 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 112.343 -2.208 . . . . 1.24 109.227 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.707 HG21 ' HG2' ' A' ' 111' ' ' ARG . 20.2 m -99.92 125.78 53.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 109.502 -0.555 . . . . 2.16 109.502 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.57 HG22 HG21 ' A' ' 110' ' ' THR . 56.1 t -77.19 97.67 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 122.0 0.905 . . . . 1.65 111.168 -176.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.712 ' NE2' HG21 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -95.91 139.84 31.54 Favored 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 114.095 -1.411 . . . . 1.39 109.515 175.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.3 ppt_? -125.6 129.05 48.87 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 120.32 -1.487 . . . . 4.11 111.326 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.755 HG11 ' CB ' ' A' ' 69' ' ' ALA . 22.7 t -92.57 133.93 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 114.909 -1.041 . . . . 1.59 110.259 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -135.32 112.51 10.44 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.008 -0.738 . . . . 1.35 109.008 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.632 HG13 ' O ' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -144.45 139.24 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 N-CA-C 107.742 -1.207 . . . . 1.33 107.742 -177.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 14.6 m-70 -73.75 114.88 12.53 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.054 -0.721 . . . . 0.7 109.054 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.76 ' HB2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -31.46 143.71 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 O-C-N 125.02 1.45 . . . . 4.39 112.424 -178.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.54 HD23 ' HD3' ' A' ' 65' ' ' PRO . 30.7 tp -94.98 97.59 10.08 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.847 -0.741 . . . . 1.23 110.037 -171.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.443 ' N ' ' HD3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -54.95 131.34 44.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.792 -1.094 . . . . 4.63 111.583 -178.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -139.8 102.13 4.35 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.755 -1.111 . . . . 1.5 108.549 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.9 -92.04 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.556 -0.831 . . . . 1.33 111.108 -175.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.454 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 35.7 mt-10 -126.6 -0.55 6.81 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.101 0.477 . . . . 2.33 110.607 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.44 ' HA ' ' CB ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -112.54 -175.94 2.79 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.969 -0.56 . . . . 1.87 110.457 -173.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.76 HD13 ' HB2' ' A' ' 20' ' ' LYS . 1.7 pt? -123.9 142.84 50.78 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.405 -0.961 . . . . 2.8 108.405 175.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 mp -106.78 130.89 57.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 121.062 0.458 . . . . 1.45 110.357 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.462 HD21 ' H ' ' A' ' 29' ' ' LEU . 1.3 pt? -96.28 117.33 30.58 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.032 -1.099 . . . . 1.87 108.032 172.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.627 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -81.5 43.54 2.93 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.738 -0.744 . . . . 1.14 113.521 -171.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 29.0 p90 -158.28 160.44 37.05 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 122.575 0.35 . . . . 0.61 110.33 178.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.537 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 18.6 t -103.89 159.9 15.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.183 -1.414 . . . . 0.91 107.183 170.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -160.3 140.15 3.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 120.695 -0.402 . . . . 1.24 111.778 -165.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -145.61 119.22 1.17 Allowed Glycine 0 N--CA 1.436 -1.314 0 N-CA-C 110.257 -1.137 . . . . 0.78 110.257 157.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 1.087 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -138.67 116.68 1.3 Allowed Glycine 0 CA--C 1.488 -1.643 0 N-CA-C 110.652 -0.979 . . . . 1.66 110.652 169.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.699 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.47 137.15 4.5 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 117.498 -2.287 . . . . 0.95 114.329 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.514 HG12 ' C ' ' A' ' 88' ' ' VAL . 23.3 pt -66.79 -11.4 13.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.773 -1.195 . . . . 1.15 107.773 149.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.815 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 0.0 OUTLIER -72.3 -40.69 67.32 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.091 -1.413 . . . . 0.72 108.789 170.351 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -63.2 -55.6 23.7 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.965 -1.016 . . . . 1.47 109.213 178.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -111.28 98.16 38.58 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.293 -0.867 . . . . 2.57 109.534 173.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -87.75 16.0 2.01 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.268 2.645 . . . . 2.82 112.086 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.6 t -97.84 -56.57 2.46 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.454 -0.794 . . . . 3.26 112.837 -167.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.79 52.06 0.63 Allowed 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 120.316 -0.554 . . . . 3.88 111.563 -167.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.714 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 6.3 p-10 -158.31 37.8 0.06 OUTLIER Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 112.576 0.584 . . . . 5.7 112.576 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.714 ' HD3' ' N ' ' A' ' 44' ' ' ASN . 41.4 Cg_endo -98.93 7.76 0.93 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.641 2.227 . . . . 4.03 111.611 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -167.11 23.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.746 -0.835 . . . . 6.35 108.746 -172.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.605 ' OG ' ' HA ' ' A' ' 44' ' ' ASN . 27.4 m -79.41 -172.1 3.06 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.187 -0.915 . . . . 3.85 111.959 -169.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -21.08 -72.41 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 115.32 1.6 . . . . 6.78 115.32 -174.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.563 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 27.9 t70 174.76 -140.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.648 -1.612 . . . . 5.47 106.648 -174.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.563 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -54.83 -28.21 47.91 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.985 0.898 . . . . 3.54 109.303 164.476 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.5 m -63.75 -18.74 64.35 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.348 -1.296 . . . . 4.89 111.896 -174.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.518 ' CG ' ' H ' ' A' ' 53' ' ' LYS . 22.6 t70 -71.2 -165.78 0.14 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.581 -0.896 . . . . 2.6 108.581 173.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.518 ' H ' ' CG ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -70.66 -49.66 44.96 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.821 -0.807 . . . . 3.98 108.821 178.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.45 ' C ' HD11 ' A' ' 55' ' ' ILE . . . 56.58 -131.69 51.35 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 109.828 -1.309 . . . . 0.94 109.828 -174.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 1.087 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -115.32 141.25 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 106.755 -1.572 . . . . 1.27 106.755 168.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.646 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -153.85 146.97 24.61 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 119.42 1.009 . . . . 1.91 110.887 -178.615 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.638 HG22 HD21 ' A' ' 71' ' ' LEU . 1.4 p -81.88 140.84 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-N 114.732 -1.122 . . . . 1.22 109.71 -175.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.9 m -110.25 -14.47 14.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.295 -0.866 . . . . 1.29 110.841 -173.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.537 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 67.1 mtt180 -149.55 -166.59 2.59 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.728 0.775 . . . . 2.63 112.395 174.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.608 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 88.3 t -160.0 140.02 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 112.525 -2.125 . . . . 1.53 106.474 162.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.9 p -82.73 121.16 26.52 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 121.503 0.668 . . . . 2.38 110.308 175.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -60.46 101.08 0.12 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 113.965 -1.47 . . . . 1.85 111.08 174.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.88 -6.57 23.88 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.495 -0.86 . . . . 0.95 112.319 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.475 ' O ' HD12 ' A' ' 68' ' ' ILE . . . -91.82 -176.99 42.58 Favored Glycine 0 CA--C 1.5 -0.888 0 C-N-CA 120.914 -0.66 . . . . 0.99 111.7 177.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.632 ' O ' HG13 ' A' ' 18' ' ' ILE . 65.6 Cg_endo -71.89 -25.83 19.49 Favored 'Trans proline' 0 CA--C 1.509 -0.738 0 C-N-CA 122.94 2.427 . . . . 0.63 113.097 -168.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.597 ' HB3' ' HD2' ' A' ' 31' ' ' PHE . . . -67.93 -25.9 65.7 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.034 -0.985 . . . . 1.1 110.873 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -74.67 -32.47 62.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.934 0.874 . . . . 1.79 109.002 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.536 ' N ' HD13 ' A' ' 68' ' ' ILE . 1.4 mp -71.65 -44.47 69.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.477 -1.238 . . . . 1.18 110.549 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.755 ' CB ' HG11 ' A' ' 16' ' ' VAL . . . -75.3 -23.09 57.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.091 -0.504 . . . . 1.07 110.556 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.91 70.29 1.08 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.001 -1.095 . . . . 0.5 113.315 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.638 HD21 HG22 ' A' ' 57' ' ' VAL . 16.7 tp -112.17 155.24 24.28 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.25 -0.648 . . . . 1.5 109.25 174.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.403 HE21 ' HB2' ' A' ' 72' ' ' GLN . 0.5 OUTLIER -132.51 35.61 3.62 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 115.193 1.553 . . . . 1.53 115.193 -165.718 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.519 HG23 ' HA ' ' A' ' 59' ' ' ARG . 4.4 mp 68.89 -7.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 N-CA-C 113.793 1.034 . . . . 1.43 113.793 165.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.49 52.63 0.35 Allowed Glycine 0 CA--C 1.509 -0.311 0 C-N-CA 119.903 -1.141 . . . . 0.37 112.108 -170.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.61 ' HB3' HG13 ' A' ' 109' ' ' VAL . 40.7 m-20 -119.75 132.17 55.56 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.341 -0.43 . . . . 0.89 111.387 -168.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.646 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 10.8 mmmm -82.16 100.67 9.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.338 0.59 . . . . 2.71 110.466 -174.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 5.6 mt -73.64 123.38 28.62 Favored 'Isoleucine or valine' 0 C--O 1.261 1.674 0 CA-C-N 115.546 -0.752 . . . . 1.22 111.664 -176.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.803 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 10.6 mmt -94.73 -11.88 28.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 125.572 1.795 . . . . 1.61 113.075 177.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.509 ' HB3' ' CB ' ' A' ' 108' ' ' LEU . 2.6 tt0 -173.13 156.04 3.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.654 0.264 . . . . 0.88 111.513 -175.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.411 HG13 ' HE2' ' A' ' 85' ' ' MET . 12.8 p -145.36 122.93 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 121.415 0.626 . . . . 1.93 110.352 174.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.463 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 1.1 m-80 60.04 21.31 10.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.231 -0.895 . . . . 1.8 112.181 178.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.94 -10.33 55.54 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.019 -1.086 . . . . 0.38 112.432 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.449 ' CB ' ' HE3' ' A' ' 85' ' ' MET . 86.6 m95 -86.94 131.3 34.13 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 109.092 -0.707 . . . . 0.91 109.092 176.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -85.09 115.73 23.06 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.747 -1.115 . . . . 1.89 110.515 -174.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.536 ' HE2' ' HA ' ' A' ' 93' ' ' ALA . 23.2 mmt -106.66 101.12 10.59 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.097 -0.956 . . . . 1.38 111.134 -175.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 p -135.36 111.59 9.69 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.632 -1.167 . . . . 1.1 108.963 169.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 44.96 65.69 1.04 Allowed 'General case' 0 C--N 1.33 -0.28 0 O-C-N 124.052 0.845 . . . . 2.15 111.386 -176.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.699 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 3.8 p -129.71 166.48 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.146 -1.057 . . . . 1.68 108.146 172.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.654 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 71.7 p -58.35 149.63 24.15 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.987 0.736 . . . . 1.1 112.987 -175.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.815 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 19.0 t-160 -61.52 -35.71 78.5 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-O 121.499 0.666 . . . . 0.41 109.508 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.485 ' CG ' HH12 ' A' ' 94' ' ' ARG . 0.6 OUTLIER -67.27 -31.46 71.8 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 113.992 -1.458 . . . . 1.67 109.517 178.048 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.744 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 3.8 tp-100 -62.49 -51.65 66.59 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 108.965 -0.754 . . . . 0.79 108.965 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.645 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . -72.62 -36.61 68.11 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.5 -0.773 . . . . 1.06 110.195 -177.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.485 HH12 ' CG ' ' A' ' 91' ' ' ASP . 26.6 ttp-105 -67.01 -38.76 86.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.689 -0.687 . . . . 2.45 110.694 -177.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.514 ' HE3' ' O ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -70.79 -45.89 63.84 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.302 -0.629 . . . . 1.51 109.302 -178.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.744 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 25.2 mmt180 -67.71 -23.61 65.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.765 -0.652 . . . . 4.23 110.175 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.515 HD13 ' CZ ' ' A' ' 31' ' ' PHE . 4.1 tt -77.14 -53.55 7.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.674 -0.694 . . . . 2.24 110.985 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.5 m -90.97 90.23 7.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.92 0.867 . . . . 1.63 111.238 -169.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.603 ' HE2' ' O ' ' A' ' 96' ' ' ARG . 22.8 mtmt -133.85 110.11 9.53 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.023 -1.444 . . . . 3.16 109.241 176.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.454 ' HD2' ' O ' ' A' ' 25' ' ' GLU . 17.9 ptt180 -76.56 36.5 0.16 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.268 0.556 . . . . 4.79 110.833 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.464 ' H ' ' C ' ' A' ' 99' ' ' LYS . 4.0 p -124.4 -58.92 1.5 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.774 -0.648 . . . . 2.83 111.254 -176.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.22 147.84 42.93 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.084 0.468 . . . . 3.4 111.549 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -84.0 -18.74 36.15 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.66 0.615 . . . . 2.68 112.66 -172.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.66 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 6.9 p -144.01 145.36 21.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.775 0.321 . . . . 1.15 110.25 -171.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' A' ' 20' ' ' LYS . 48.9 t -114.84 118.46 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-O 122.502 1.144 . . . . 1.13 111.914 -175.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.463 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -98.75 129.81 45.2 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 113.065 -1.88 . . . . 2.28 109.766 -178.308 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.406 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 26.2 tp -133.98 125.72 28.76 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 116.218 -0.446 . . . . 1.68 110.097 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.803 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 14.6 tp -101.52 130.17 47.74 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.522 -1.288 . . . . 1.1 107.522 176.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.61 HG13 ' HB3' ' A' ' 75' ' ' ASP . 2.2 t -131.83 140.12 48.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.998 0.904 . . . . 1.39 111.018 -171.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.57 HG21 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -105.19 116.53 32.11 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.126 -0.943 . . . . 1.13 109.759 163.523 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.707 ' HG2' HG21 ' A' ' 12' ' ' VAL . 1.5 ptt180 -114.35 140.46 48.63 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.175 -0.92 . . . . 2.34 110.322 -170.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.451 HE22 ' HG2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -118.97 -41.52 2.76 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.034 0.921 . . . . 1.97 111.035 -170.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.441 ' H ' HD23 ' A' ' 114' ' ' LEU . 36.5 t -159.94 -128.84 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.029 -1.441 . . . . 2.0 107.521 -169.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.51 ' N ' HD13 ' A' ' 114' ' ' LEU . 0.2 OUTLIER 64.74 -0.22 1.02 Allowed 'General case' 0 C--N 1.323 -0.574 0 O-C-N 124.018 0.823 . . . . 2.0 111.826 171.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -72.14 134.0 45.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.964 0.411 . . . . 3.83 111.337 -174.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -120.84 106.05 11.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.847 -0.615 . . . . 3.96 111.212 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 51.68 82.69 0.06 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.613 -0.721 . . . . 3.76 111.951 178.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.526 HG11 ' HG2' ' A' ' 119' ' ' GLN . 11.3 p -113.84 -33.13 2.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.134 0.492 . . . . 5.11 111.181 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.526 ' HG2' HG11 ' A' ' 118' ' ' VAL . 14.2 mm100 -107.01 16.7 23.94 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.031 -0.531 . . . . 8.35 110.249 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -100.98 152.03 21.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.066 -0.515 . . . . 6.63 111.242 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 41.7 t -73.61 136.59 43.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.805 -0.634 . . . . 8.94 110.26 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -72.39 -43.44 63.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.965 0.412 . . . . 12.46 110.07 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 52.3 tp -98.63 132.05 44.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.871 -0.604 . . . . 13.06 110.107 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.9 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.587 -0.721 . . . . 14.64 109.352 177.787 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.784 ' HG3' ' H ' ' A' ' 2' ' ' SER . 35.2 tpp . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.308 -0.627 . . . . 14.35 109.308 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.784 ' H ' ' HG3' ' A' ' 1' ' ' MET . 4.3 p -60.06 -41.27 92.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.976 0.417 . . . . 11.48 111.288 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -98.6 108.77 21.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.991 -0.55 . . . . 9.53 110.313 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.472 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 69.4 mt -121.23 127.79 26.0 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.46 -0.336 . . . . 6.82 110.105 174.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 4' ' ' ILE . 15.7 Cg_exo -70.54 37.81 0.29 Allowed 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 123.187 2.592 . . . . 7.95 112.054 176.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 4' ' ' ILE . . . -169.51 -45.3 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 121.045 -0.598 . . . . 6.42 112.75 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.402 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 7.6 pt20 -151.83 66.46 6.78 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 113.989 1.107 . . . . 6.63 113.989 -174.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 7' ' ' GLN . 20.7 Cg_exo -66.81 -148.46 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.697 2.265 . . . . 3.98 111.886 165.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.7 m -80.61 -11.69 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 121.42 0.629 . . . . 2.77 109.456 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.2 m -80.27 80.52 6.69 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.307 1.051 . . . . 2.49 109.181 173.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.31 179.17 7.97 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.159 -1.837 . . . . 1.24 111.791 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.8 t -105.77 121.56 58.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.262 -0.881 . . . . 2.16 110.531 -176.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.511 HG21 HG21 ' A' ' 110' ' ' THR . 38.6 t -77.98 120.7 29.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.85 0.357 . . . . 1.65 110.968 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.937 HE22 HG21 ' A' ' 16' ' ' VAL . 3.7 pp0? -121.08 167.52 12.54 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.015 -0.539 . . . . 1.39 111.289 -178.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.584 ' HD3' ' O ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -124.12 113.6 18.57 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.676 0.391 . . . . 4.11 111.492 -175.778 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.937 HG21 HE22 ' A' ' 14' ' ' GLN . 2.2 t -98.16 130.76 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.753 -0.462 . . . . 1.59 109.753 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -142.51 117.81 10.19 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 110.119 -0.326 . . . . 1.35 110.119 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.511 ' HB ' ' HB1' ' A' ' 69' ' ' ALA . 11.2 tp -140.27 144.62 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 108.64 -0.874 . . . . 1.33 108.64 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.666 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.8 m-70 -77.03 111.09 12.23 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.248 -0.581 . . . . 0.7 109.772 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.508 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -23.77 136.64 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 O-C-N 125.433 1.708 . . . . 4.39 113.464 -179.425 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.1 tp -96.46 92.74 6.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.857 0.837 . . . . 1.23 109.96 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.43 ' N ' ' HD3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -65.3 135.93 55.94 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.186 -1.37 . . . . 4.63 111.275 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.405 HE21 ' HB2' ' A' ' 23' ' ' GLN . 2.1 tp-100 -138.39 93.97 2.8 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.115 -0.698 . . . . 1.5 109.115 173.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 60.59 -86.7 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.909 -0.663 . . . . 1.33 111.621 -174.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -131.89 12.07 4.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.261 0.553 . . . . 2.33 110.335 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -111.42 154.91 23.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.599 -0.728 . . . . 1.87 109.047 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.0 mp -120.8 122.13 39.66 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.431 -0.581 . . . . 2.8 109.431 174.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.8 mp -98.19 121.29 48.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 115.266 -0.879 . . . . 1.45 109.456 -177.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.637 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -89.72 -27.99 19.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.772 -1.103 . . . . 1.87 110.77 179.272 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.497 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 82.68 17.53 67.96 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.237 -0.982 . . . . 1.14 113.381 175.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.637 ' CE2' ' HB2' ' A' ' 29' ' ' LEU . 44.5 p90 -148.94 159.68 43.97 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.496 -0.557 . . . . 0.61 109.496 172.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.678 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -102.33 161.93 13.31 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 118.625 -1.23 . . . . 0.91 107.893 175.213 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -151.22 135.94 9.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 C-N-CA 119.672 -0.811 . . . . 1.24 112.658 -167.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.604 ' O ' ' HD1' ' A' ' 56' ' ' TYR . . . -147.41 117.2 0.89 Allowed Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.163 -1.175 . . . . 0.78 110.163 156.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 1.043 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.72 118.62 1.35 Allowed Glycine 0 CA--C 1.489 -1.589 0 CA-C-O 118.464 -1.186 . . . . 1.66 110.806 173.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.699 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.9 135.8 3.84 Favored Glycine 0 C--N 1.299 -1.525 0 C-N-CA 117.188 -2.434 . . . . 0.95 113.712 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.555 HG22 ' HB2' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -57.69 -26.58 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 107.541 -1.281 . . . . 1.15 107.541 150.062 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.808 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 0.5 OUTLIER -57.69 -39.98 78.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 113.446 -1.706 . . . . 0.72 110.435 171.075 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -62.61 -61.38 2.47 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.266 -0.879 . . . . 1.47 110.721 -172.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -179.1 113.27 0.21 Allowed Pre-proline 0 N--CA 1.467 0.385 0 O-C-N 123.394 0.434 . . . . 2.57 110.129 172.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.721 ' HA ' ' HD2' ' A' ' 53' ' ' LYS . 72.6 Cg_endo -77.09 -16.32 15.84 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.701 2.267 . . . . 2.82 113.082 -178.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.3 t -94.13 10.53 33.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.915 0.388 . . . . 3.26 111.232 -170.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -88.38 -19.04 27.15 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.976 0.732 . . . . 3.88 112.976 -176.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -174.57 65.65 0.27 Allowed Pre-proline 0 N--CA 1.454 -0.266 0 N-CA-C 108.933 -0.765 . . . . 5.7 108.933 -167.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -87.2 14.68 2.35 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.578 2.852 . . . . 4.03 112.499 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -111.82 5.43 19.03 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.045 -0.525 . . . . 6.35 109.709 177.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.569 ' HB3' ' OG1' ' A' ' 51' ' ' THR . 74.5 m -125.4 129.85 50.71 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 115.858 -0.61 . . . . 3.85 110.492 -175.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.943 ' HA ' ' HB2' ' A' ' 52' ' ' ASP . 37.9 tt0 -111.1 -41.07 4.29 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.25 -1.341 . . . . 6.78 109.565 176.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.6 ' O ' ' HD3' ' A' ' 50' ' ' LYS . 1.2 m-20 -38.57 -87.64 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 111.629 -2.532 . . . . 5.47 112.225 -154.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.644 ' HE3' HG23 ' A' ' 110' ' ' THR . 53.2 mmtt -119.99 7.93 10.96 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 106.114 -1.81 . . . . 3.54 106.114 163.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.569 ' OG1' ' HB3' ' A' ' 47' ' ' SER . 20.5 p -109.65 -11.59 14.74 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 112.895 -1.957 . . . . 4.89 111.735 -165.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.943 ' HB2' ' HA ' ' A' ' 48' ' ' GLU . 32.4 t0 -59.32 -173.38 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.715 -0.394 . . . . 2.6 111.195 166.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.721 ' HD2' ' HA ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -76.13 66.47 2.28 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.204 0.526 . . . . 3.98 110.946 -173.203 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.527 ' H ' ' HH ' ' A' ' 56' ' ' TYR . . . -94.89 -159.83 33.68 Favored Glycine 0 N--CA 1.437 -1.259 0 CA-C-N 115.292 -0.867 . . . . 0.94 111.064 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 1.043 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -110.15 145.93 16.05 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.738 0 N-CA-C 108.791 -0.818 . . . . 1.27 108.791 175.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.604 ' HD1' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -140.0 147.39 40.34 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 119.235 0.925 . . . . 1.91 110.281 -176.453 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.569 HG13 ' HB2' ' A' ' 75' ' ' ASP . 7.1 p -94.18 135.72 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 CA-C-N 115.14 -0.936 . . . . 1.22 109.796 175.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.678 ' O ' ' HB3' ' A' ' 32' ' ' SER . 21.4 m -128.32 68.49 1.36 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.765 -1.107 . . . . 1.29 109.198 176.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.555 ' HA ' HG23 ' A' ' 73' ' ' ILE . 34.0 mtm180 150.06 -179.95 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 125.512 1.525 . . . . 2.63 110.397 163.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.405 ' N ' HG12 ' A' ' 73' ' ' ILE . 40.1 t -163.55 134.77 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 O-C-N 125.542 1.776 . . . . 1.53 107.561 163.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.2 p -77.59 169.44 18.29 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.633 0.73 . . . . 2.38 111.031 175.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -103.43 128.43 50.58 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 114.783 -1.099 . . . . 1.85 110.198 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.68 -5.42 52.4 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.324 -0.853 . . . . 0.95 113.564 173.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.558 ' O ' HD12 ' A' ' 68' ' ' ILE . . . -76.24 -129.13 0.31 Allowed Glycine 0 CA--C 1.506 -0.525 0 C-N-CA 120.35 -0.929 . . . . 0.99 112.564 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.497 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 69.6 Cg_endo -102.76 -50.43 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 122.706 2.271 . . . . 0.63 115.572 177.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 29' ' ' LEU . . . -57.23 -32.43 66.52 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.534 0.938 . . . . 1.1 113.534 -172.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -74.46 -28.65 61.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.596 0.712 . . . . 1.79 109.418 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.583 ' N ' HD13 ' A' ' 68' ' ' ILE . 1.4 mp -74.32 -34.99 38.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.886 -1.052 . . . . 1.18 109.648 -178.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.673 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -77.82 -23.01 49.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.574 -0.739 . . . . 1.07 110.358 175.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.67 56.05 0.92 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.466 -0.873 . . . . 0.5 114.132 175.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.663 ' HG ' HG23 ' A' ' 16' ' ' VAL . 2.2 mt -100.56 158.52 15.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 117.302 0.551 . . . . 1.5 110.722 174.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 1.021 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 29.0 mt-30 -130.33 25.31 5.16 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 114.868 1.433 . . . . 1.53 114.868 -165.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.555 HG23 ' HA ' ' A' ' 59' ' ' ARG . 91.1 mt 72.95 -10.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 113.95 1.092 . . . . 1.43 113.95 168.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.62 60.58 0.24 Allowed Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.436 -0.888 . . . . 0.37 111.974 -166.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.569 ' HB2' HG13 ' A' ' 57' ' ' VAL . 36.6 m-20 -122.59 156.1 34.93 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.078 -0.561 . . . . 0.89 110.376 -170.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.484 ' HG3' ' HD2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -104.39 102.02 11.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.314 0.578 . . . . 2.71 109.546 -175.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 1.034 HG13 HG21 ' A' ' 109' ' ' VAL . 3.6 mp -74.71 125.37 34.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.491 -0.777 . . . . 1.22 112.311 -171.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.921 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 3.0 mmt -92.1 -18.41 23.6 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 125.607 1.817 . . . . 1.61 112.184 177.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.596 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -173.01 155.43 3.04 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.759 0.281 . . . . 0.88 111.759 -175.306 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.433 ' N ' ' HG3' ' A' ' 79' ' ' GLN . 11.7 p -142.35 126.9 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 121.291 0.567 . . . . 1.93 110.516 173.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.699 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 1.1 m-80 56.95 27.65 13.48 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.426 -0.806 . . . . 1.8 112.378 176.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.53 -11.1 63.14 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.122 -1.037 . . . . 0.38 112.605 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.468 ' HB2' ' HE3' ' A' ' 85' ' ' MET . 80.9 m95 -83.91 160.16 21.15 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 108.696 -0.853 . . . . 0.91 108.696 176.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -111.0 113.36 25.86 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.292 0.568 . . . . 1.89 111.858 -171.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.637 ' HG3' HG12 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -109.1 102.46 11.43 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.723 -0.671 . . . . 1.38 111.58 -178.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.44 -50.93 2.31 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.262 -1.014 . . . . 1.1 108.262 168.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -135.38 86.99 2.29 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.549 -1.66 . . . . 2.15 106.807 172.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.747 HG13 ' HG2' ' A' ' 92' ' ' GLN . 1.4 t -137.27 138.17 45.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.022 -0.99 . . . . 1.68 109.754 -172.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.803 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 70.4 p -57.87 147.56 28.24 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 122.159 -0.338 . . . . 1.1 111.609 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.808 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 19.8 t-160 -56.6 -40.63 75.64 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.312 0.577 . . . . 0.41 110.175 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.25 -30.45 68.58 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.455 -1.248 . . . . 1.67 110.042 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.759 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 2.3 tp-100 -63.48 -50.92 67.76 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.122 -1.066 . . . . 0.79 108.122 178.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.6 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -70.81 -32.72 69.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.532 -0.758 . . . . 1.06 110.856 -177.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -70.51 -40.04 73.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.067 -0.515 . . . . 2.45 110.666 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.432 ' HD3' ' C ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -70.27 -41.26 73.69 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.259 -0.645 . . . . 1.51 109.259 -178.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.759 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 21.9 mmt180 -71.33 -21.44 62.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.28 -0.873 . . . . 4.23 110.67 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.526 HD12 ' CZ ' ' A' ' 31' ' ' PHE . 2.4 tt -70.99 -58.22 3.79 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.938 -0.574 . . . . 2.24 110.443 175.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 m -100.71 90.04 4.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.599 0.714 . . . . 1.63 111.862 -171.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.696 ' HE2' ' O ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -110.42 118.19 35.6 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.766 -1.106 . . . . 3.16 109.34 170.476 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -68.54 31.62 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.989 0.515 . . . . 4.79 111.614 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 99' ' ' LYS . 14.2 m -139.07 -27.82 0.8 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.292 -0.413 . . . . 2.83 110.997 -173.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 66.3 mm-40 -67.13 143.1 56.82 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 110.165 -0.309 . . . . 3.4 110.165 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -94.27 -10.02 34.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.391 0.615 . . . . 2.68 109.985 176.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.666 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 6.2 p -152.32 148.42 14.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.482 -0.781 . . . . 1.15 109.482 -175.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.525 HG13 HD22 ' A' ' 81' ' ' ASN . 55.5 t -117.04 117.94 57.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 122.051 0.929 . . . . 1.13 111.53 -177.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.699 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.2 OUTLIER -99.29 133.02 44.19 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 113.426 -1.716 . . . . 2.28 110.305 -175.432 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.635 HD23 HD11 ' A' ' 71' ' ' LEU . 22.2 tp -134.63 134.69 41.49 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.541 -0.3 . . . . 1.68 110.901 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.921 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 40.0 tp -115.53 114.3 24.79 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 106.843 -1.54 . . . . 1.1 106.843 172.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 1.034 HG21 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -129.4 149.9 34.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 120.122 -0.631 . . . . 1.39 110.488 -171.545 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.644 HG23 ' HE3' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -97.65 115.62 28.28 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.637 0.732 . . . . 1.13 109.898 171.456 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.837 ' HB2' HE22 ' A' ' 72' ' ' GLN . 0.3 OUTLIER -99.61 136.71 39.13 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.006 -1.452 . . . . 2.34 109.596 -173.231 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.507 ' CD ' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -106.57 -56.99 2.11 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.104 -1.038 . . . . 1.97 112.762 -177.593 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.439 ' H ' ' HG2' ' A' ' 112' ' ' GLN . 23.2 t -174.95 27.83 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.609 -0.436 . . . . 2.0 112.125 -175.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 1.021 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -99.38 22.82 10.1 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.913 -0.492 . . . . 2.0 110.583 -175.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.52 124.48 21.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.633 0.254 . . . . 3.83 111.239 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -82.48 36.35 0.48 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.306 -0.406 . . . . 3.96 110.874 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 57.57 33.58 23.44 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.18 0.514 . . . . 3.76 109.862 -172.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.9 p -66.55 -28.13 42.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 114.882 -1.054 . . . . 5.11 112.747 -171.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -138.08 -40.18 0.54 Allowed 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.889 -0.324 . . . . 8.35 110.826 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 65.51 -165.59 0.23 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.575 0.547 . . . . 6.63 110.409 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.4 m 63.45 34.22 13.01 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.089 0.471 . . . . 8.94 111.063 177.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 72.4 mmm -73.37 115.03 12.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.035 -0.529 . . . . 12.46 111.376 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 pp -92.8 -171.92 2.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.897 -0.592 . . . . 13.06 110.67 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.572 -0.728 . . . . 14.64 110.475 179.303 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtm . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 109.922 -0.399 . . . . 14.35 109.922 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.7 m -73.83 -47.83 35.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.159 0.504 . . . . 11.48 110.268 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -88.0 118.75 27.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.894 -0.594 . . . . 9.53 110.569 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.863 ' H ' ' HB3' ' A' ' 8' ' ' PRO . 63.3 mt -107.69 130.24 23.09 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 115.619 -0.718 . . . . 6.82 109.53 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 4' ' ' ILE . 16.8 Cg_exo -68.24 67.65 1.01 Allowed 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.442 2.095 . . . . 7.95 112.254 177.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 148.34 -41.55 0.89 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.453 -0.88 . . . . 6.42 113.763 176.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -144.13 50.36 1.25 Allowed Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 114.384 1.253 . . . . 6.63 114.384 -171.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.863 ' HB3' ' H ' ' A' ' 4' ' ' ILE . 95.2 Cg_endo -85.17 108.05 1.1 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.561 2.174 . . . . 3.98 111.778 173.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 8' ' ' PRO . 73.5 t 71.09 -52.62 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 122.672 0.389 . . . . 2.77 111.052 -176.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.3 m -71.12 82.74 0.71 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.731 0.777 . . . . 2.49 109.56 175.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.19 170.81 9.42 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.091 -1.413 . . . . 1.24 111.084 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.9 m -111.4 161.89 9.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.936 -1.029 . . . . 2.16 109.084 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.539 HG22 HG23 ' A' ' 110' ' ' THR . 94.6 t -106.55 119.99 56.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.267 0.556 . . . . 1.65 111.388 -176.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 1.0 HE22 HG11 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -111.47 155.49 23.14 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.507 0.67 . . . . 1.39 111.035 174.724 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.06 110.65 13.17 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.754 -0.657 . . . . 4.11 110.156 -172.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 1.006 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 12.7 m -106.29 149.58 9.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 119.434 -0.907 . . . . 1.59 110.325 176.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -145.23 121.37 10.8 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.005 -0.543 . . . . 1.35 109.953 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.526 ' HB ' ' HB1' ' A' ' 69' ' ' ALA . 10.9 tp -142.34 143.64 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 108.256 -1.016 . . . . 1.33 108.256 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.815 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.0 m-70 -74.96 117.67 17.06 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.307 -0.557 . . . . 0.7 109.528 -176.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.542 ' HD3' ' HG ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -29.47 127.16 0.11 Allowed 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.776 1.297 . . . . 4.39 111.256 177.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.416 ' HB3' ' HB ' ' A' ' 28' ' ' ILE . 45.6 tp -98.05 101.74 13.3 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.252 0.548 . . . . 1.23 110.478 -173.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -69.43 135.49 50.31 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.371 0.605 . . . . 4.63 111.366 -176.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -128.86 93.59 3.64 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.433 -0.951 . . . . 1.5 108.433 174.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.21 -87.94 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.772 -0.931 . . . . 1.33 110.772 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.52 14.34 4.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.324 0.583 . . . . 2.33 110.776 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -108.98 159.76 16.56 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.682 -0.69 . . . . 1.87 109.492 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.542 ' HG ' ' HD3' ' A' ' 20' ' ' LYS . 9.0 mp -112.77 119.18 37.14 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 109.062 -0.718 . . . . 2.8 109.062 174.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 40.5 mm -98.73 109.55 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 115.415 -0.811 . . . . 1.45 109.981 -176.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.653 HD12 HD11 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -83.93 -25.61 29.98 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.463 -1.244 . . . . 1.87 109.088 175.355 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.408 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 93.67 -27.11 13.14 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.119 -0.946 . . . . 1.14 112.673 174.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.621 ' HD2' ' HB1' ' A' ' 66' ' ' ALA . 32.8 p90 -110.43 151.32 27.65 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 122.291 -0.535 . . . . 0.61 111.384 -173.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.533 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 10.2 t -101.82 158.43 16.13 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 107.578 -1.267 . . . . 0.91 107.578 175.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -160.19 143.04 4.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 C-N-CA 120.158 -0.617 . . . . 1.24 112.529 -163.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.444 ' HA2' ' CD2' ' A' ' 90' ' ' HIS . . . -139.51 118.28 1.48 Allowed Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 110.007 -1.237 . . . . 0.78 110.007 154.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.996 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.39 119.06 1.43 Allowed Glycine 0 CA--C 1.491 -1.419 0 CA-C-O 118.518 -1.157 . . . . 1.66 111.42 172.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.658 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.29 146.49 10.78 Favored Glycine 0 C--N 1.303 -1.3 0 C-N-CA 117.304 -2.379 . . . . 0.95 113.1 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.451 HG12 ' N ' ' A' ' 88' ' ' VAL . 1.1 pt -68.43 -19.74 24.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 107.562 -1.273 . . . . 1.15 107.562 151.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.754 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 2.5 t70 -58.8 -36.6 74.75 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.026 -1.443 . . . . 0.72 109.541 168.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -70.75 -43.78 68.12 Favored 'General case' 0 C--N 1.338 0.067 0 CA-C-N 114.73 -1.123 . . . . 1.47 109.793 -176.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.407 ' HB2' ' HE2' ' A' ' 53' ' ' LYS . 12.9 m-20 -127.93 91.56 44.6 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.984 -0.553 . . . . 2.57 110.451 176.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.09 -17.3 50.73 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.538 2.159 . . . . 2.82 110.891 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.9 t -74.7 -40.81 61.12 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.327 -0.851 . . . . 3.26 109.296 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -99.93 73.59 1.76 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.671 0.748 . . . . 3.88 109.85 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.517 ' H ' ' CD ' ' A' ' 45' ' ' PRO . 25.0 t30 -132.41 -38.51 0.03 OUTLIER Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 114.539 -1.21 . . . . 5.7 109.074 175.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.517 ' CD ' ' H ' ' A' ' 44' ' ' ASN . 23.1 Cg_exo -71.33 6.82 1.68 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 121.517 1.478 . . . . 4.03 110.52 161.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.477 ' H ' ' C ' ' A' ' 44' ' ' ASN . 66.8 t80 -107.88 -26.2 10.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.976 -1.011 . . . . 6.35 109.807 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.647 ' HA ' ' HB2' ' A' ' 52' ' ' ASP . 34.7 p -71.61 97.47 1.71 Allowed 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 122.507 1.146 . . . . 3.85 110.111 -174.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -99.66 -37.69 9.02 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 113.038 -1.892 . . . . 6.78 109.663 -175.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.424 ' HB3' ' H ' ' A' ' 50' ' ' LYS . 16.3 m-20 -176.41 -151.04 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 112.882 -1.963 . . . . 5.47 107.428 -160.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.601 ' HD3' ' HE1' ' A' ' 78' ' ' MET . 0.1 OUTLIER -79.51 8.17 6.85 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 120.616 -0.434 . . . . 3.54 111.931 172.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.6 t -72.23 -34.66 68.48 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.742 -0.836 . . . . 4.89 108.742 171.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.647 ' HB2' ' HA ' ' A' ' 47' ' ' SER . 8.3 t70 -70.01 -170.04 0.31 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.54 -0.755 . . . . 2.6 110.036 166.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.441 ' HD2' ' H ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -95.9 -41.23 8.91 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.518 -0.31 . . . . 3.98 110.712 175.169 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.441 ' H ' ' HD2' ' A' ' 53' ' ' LYS . . . 74.09 -133.18 16.27 Favored Glycine 0 C--O 1.241 0.567 0 C-N-CA 120.941 -0.647 . . . . 0.94 111.613 -179.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.996 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -111.32 143.89 20.28 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 N-CA-C 106.846 -1.539 . . . . 1.27 106.846 172.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.732 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -154.96 148.35 25.11 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 120.155 1.343 . . . . 1.91 112.039 -178.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.527 HG22 HD23 ' A' ' 71' ' ' LEU . 1.5 p -87.49 136.68 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-N 114.529 -1.214 . . . . 1.22 110.421 -175.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.2 m -105.34 -11.97 16.25 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.116 -0.947 . . . . 1.29 110.697 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.689 ' O ' HG22 ' A' ' 60' ' ' VAL . 41.3 mtt180 -145.54 -170.11 3.38 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.083 0.771 . . . . 2.63 113.083 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 59' ' ' ARG . 53.2 t -170.33 146.37 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.37 1.868 . . . . 1.53 106.627 167.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.4 p -97.48 123.49 41.36 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.674 0.75 . . . . 2.38 112.088 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -66.0 112.34 3.79 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 113.658 -1.61 . . . . 1.85 110.359 169.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.76 -3.03 48.91 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.164 -0.925 . . . . 0.95 112.634 -177.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.616 ' O ' HD11 ' A' ' 68' ' ' ILE . . . -91.52 -139.66 8.63 Favored Glycine 0 CA--C 1.501 -0.835 0 C-N-CA 120.367 -0.921 . . . . 0.99 111.785 178.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.491 ' HB2' HG23 ' A' ' 18' ' ' ILE . 77.6 Cg_endo -102.07 -50.07 0.01 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 122.73 2.287 . . . . 0.63 114.959 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.621 ' HB1' ' HD2' ' A' ' 31' ' ' PHE . . . -50.45 -29.46 10.38 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.589 0.959 . . . . 1.1 113.589 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -71.46 -32.22 68.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.745 0.784 . . . . 1.79 109.463 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.616 HD11 ' O ' ' A' ' 64' ' ' GLY . 1.5 mp -79.08 -36.54 18.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.444 -1.253 . . . . 1.18 108.516 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 1.006 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . . . -66.17 -35.11 79.6 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.409 -1.268 . . . . 1.07 109.91 173.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.43 33.15 2.77 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.223 -0.989 . . . . 0.5 114.233 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.527 HD23 HG22 ' A' ' 57' ' ' VAL . 17.8 tp -90.66 154.79 19.31 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.466 -0.568 . . . . 1.5 109.466 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.432 HE22 ' HG3' ' A' ' 111' ' ' ARG . 4.6 mt-30 -129.34 31.89 4.76 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 115.449 1.648 . . . . 1.53 115.449 -165.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 73' ' ' ILE . 58.1 mt 71.33 2.1 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 CA-C-N 118.993 0.815 . . . . 1.43 113.188 167.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.17 46.19 0.25 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 119.58 -1.295 . . . . 0.37 112.439 -170.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.436 ' HB2' HG12 ' A' ' 57' ' ' VAL . 20.0 m-20 -119.83 142.31 48.74 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.331 -0.435 . . . . 0.89 110.864 -169.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.732 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 13.0 mptt -96.68 102.64 14.46 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.803 0.811 . . . . 2.71 111.0 -171.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.8 HG13 HG22 ' A' ' 109' ' ' VAL . 2.8 mp -63.05 123.42 15.78 Favored 'Isoleucine or valine' 0 C--O 1.255 1.342 0 CA-C-N 115.274 -0.876 . . . . 1.22 112.505 -178.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.886 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 2.0 mmt -91.74 -18.99 23.09 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 113.494 -1.685 . . . . 1.61 111.281 173.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.596 ' HB3' HD21 ' A' ' 108' ' ' LEU . 4.3 tt0 -172.03 151.53 2.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.071 -0.513 . . . . 0.88 111.876 -174.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.614 HG13 ' CE ' ' A' ' 85' ' ' MET . 9.8 p -145.53 127.21 8.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.729 -0.669 . . . . 1.93 109.735 173.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 58.44 20.0 7.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.75 -0.659 . . . . 1.8 111.874 178.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.69 -7.86 53.88 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 119.733 -1.222 . . . . 0.38 113.368 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.48 ' HB2' ' HE1' ' A' ' 85' ' ' MET . 68.0 m95 -85.21 159.85 20.02 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 117.451 0.626 . . . . 0.91 110.014 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -102.46 113.72 27.3 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.668 -0.696 . . . . 1.89 111.454 -172.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.614 ' CE ' HG13 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -104.57 100.58 10.25 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 122.667 1.222 . . . . 1.38 110.116 179.219 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.6 p -142.16 -49.9 0.38 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 112.854 -1.975 . . . . 1.1 105.83 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.41 ' HA ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -133.97 75.15 1.58 Allowed 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 112.178 -2.283 . . . . 2.15 108.828 173.4 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.783 ' O ' HD12 ' A' ' 55' ' ' ILE . 1.2 t -132.72 138.55 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 108.007 -1.108 . . . . 1.68 108.007 177.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.715 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 68.8 p -59.5 152.16 22.48 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.884 -0.51 . . . . 1.1 112.018 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.798 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 16.5 t-160 -57.25 -38.0 73.19 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-O 122.516 1.15 . . . . 0.41 109.925 -177.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -71.66 -31.78 67.18 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 112.79 -2.005 . . . . 1.67 109.889 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.717 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.5 OUTLIER -65.55 -39.15 91.38 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 108.158 -1.053 . . . . 0.79 108.158 179.842 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.574 ' HB1' HG12 ' A' ' 55' ' ' ILE . . . -74.75 -41.6 59.78 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.439 -1.255 . . . . 1.06 109.793 -176.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -68.22 -37.79 81.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.287 -0.869 . . . . 2.45 110.661 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.472 ' HD3' ' HD2' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -70.97 -30.09 66.26 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.012 0.434 . . . . 1.51 109.844 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.717 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 9.4 mmm180 -76.23 -24.35 54.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.223 -0.444 . . . . 4.23 111.881 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.653 HD11 HD12 ' A' ' 29' ' ' LEU . 3.3 pp -96.92 -8.26 31.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.236 0.458 . . . . 2.24 112.236 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.521 HG21 ' HB2' ' A' ' 27' ' ' LEU . 31.5 m -145.02 97.6 3.04 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.183 0.516 . . . . 1.63 111.225 174.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.478 ' HG3' ' HB2' ' A' ' 101' ' ' SER . 5.2 ptpp? -142.56 9.7 1.81 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.592 -0.731 . . . . 3.16 112.403 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 39.4 mtm-85 63.96 24.15 13.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.61 -0.723 . . . . 4.79 110.886 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.478 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 69.8 m -153.63 83.95 1.17 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.335 0.588 . . . . 2.83 110.46 -178.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.472 ' C ' ' H ' ' A' ' 104' ' ' VAL . 1.2 pm0 -163.0 -44.74 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.538 -0.755 . . . . 3.4 110.085 178.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 71.76 -41.97 0.52 Allowed 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.34 1.025 . . . . 2.68 111.045 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.815 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 2.7 p -133.33 133.4 57.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.351 -1.352 . . . . 1.15 107.351 176.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 53.3 t -109.85 119.37 58.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 122.151 0.976 . . . . 1.13 112.198 -171.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.93 123.05 41.74 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 113.397 -1.729 . . . . 2.28 109.803 -176.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.459 HD11 HG12 ' A' ' 77' ' ' ILE . 11.1 tp -131.42 116.76 17.93 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.656 -0.702 . . . . 1.68 111.171 -173.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.886 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 41.0 tp -104.31 117.87 35.24 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.611 -1.255 . . . . 1.1 107.611 177.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.8 HG22 HG13 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -131.35 152.4 37.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-O 121.38 0.61 . . . . 1.39 110.803 -173.092 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.539 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -97.53 117.21 31.28 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.721 -0.672 . . . . 1.13 110.321 171.429 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.596 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 30.7 ttt180 -97.76 136.48 38.03 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.597 -1.183 . . . . 2.34 110.375 -177.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.437 ' N ' ' CD ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -123.02 -70.61 0.76 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.753 0.649 . . . . 1.97 112.753 -174.181 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.649 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 0.5 OUTLIER -153.09 27.79 0.52 Allowed 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.266 -0.574 . . . . 2.0 112.418 -170.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 114' ' ' LEU . 2.3 mm? -107.01 26.96 9.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.485 0.66 . . . . 2.0 110.11 177.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.649 ' NE2' ' HA ' ' A' ' 113' ' ' SER . 0.7 OUTLIER -87.92 17.88 4.57 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.163 -0.926 . . . . 3.83 111.928 -174.721 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt 69.61 156.15 0.14 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 123.839 0.712 . . . . 3.96 111.284 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 65.91 14.5 9.61 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.829 -0.623 . . . . 3.76 112.341 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.512 HG22 HE21 ' A' ' 115' ' ' GLN . 57.1 t -107.38 -27.48 2.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.688 0.756 . . . . 5.11 110.18 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.69 -15.14 57.29 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.941 -1.027 . . . . 8.35 110.207 -176.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -97.42 117.35 31.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.844 -0.616 . . . . 6.63 110.538 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.7 m -106.36 -18.93 13.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.104 -0.498 . . . . 8.94 111.002 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 25.6 ptm -166.81 164.49 16.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.271 -0.422 . . . . 12.46 110.554 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 29.9 tp 62.07 91.72 0.06 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 124.108 0.88 . . . . 13.06 111.885 174.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.2 m . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.428 -0.796 . . . . 14.64 110.006 177.988 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptp . . . . . 0 N--CA 1.484 1.228 0 CA-C-O 120.876 0.369 . . . . 14.35 110.631 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.5 t -82.15 149.09 28.14 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.158 -0.682 . . . . 11.48 109.158 175.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -86.63 136.82 32.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.076 0.465 . . . . 9.53 110.478 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.563 HD13 ' HD2' ' A' ' 8' ' ' PRO . 5.7 pt -114.49 99.37 51.24 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.597 -0.728 . . . . 6.82 110.738 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -65.84 126.95 16.84 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.798 2.332 . . . . 7.95 111.908 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.41 -27.6 13.28 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.826 -0.702 . . . . 6.42 111.905 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 64.92 100.08 0.04 OUTLIER Pre-proline 0 N--CA 1.462 0.17 0 CA-C-O 121.556 0.693 . . . . 6.63 111.86 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.563 ' HD2' HD13 ' A' ' 4' ' ' ILE . 1.9 Cg_endo -83.62 -171.51 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.439 2.759 . . . . 3.98 111.505 176.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.5 m -103.8 -3.13 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 109.658 -0.497 . . . . 2.77 109.658 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.423 HG23 ' HB2' ' A' ' 8' ' ' PRO . 1.8 t -85.87 81.96 8.34 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 123.283 1.516 . . . . 2.49 111.078 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.3 179.05 5.31 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 112.087 -2.324 . . . . 1.24 109.758 173.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.17 108.41 25.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.328 -0.396 . . . . 2.16 110.386 -174.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.569 HG21 HG22 ' A' ' 110' ' ' THR . 26.1 t -76.83 98.52 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.291 0.567 . . . . 1.65 110.203 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.929 HE22 HG21 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -103.3 165.02 11.28 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.68 -0.691 . . . . 1.39 111.122 178.259 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.41 ' H ' ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -126.07 116.98 22.24 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.704 -0.623 . . . . 4.11 110.987 -178.791 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.929 HG21 HE22 ' A' ' 14' ' ' GLN . 4.9 t -88.85 127.41 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 115.303 -0.862 . . . . 1.59 109.597 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 31.9 tt0 -131.03 116.99 18.52 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.437 -0.579 . . . . 1.35 109.437 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.1 tp -145.1 146.43 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 108.562 -0.903 . . . . 1.33 108.562 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.72 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.3 m-70 -68.85 119.14 12.74 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.175 -0.676 . . . . 0.7 109.175 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.874 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -37.44 133.41 0.73 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.944 0.778 . . . . 4.39 110.105 171.782 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.5 tp -94.02 85.9 4.86 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.959 0.885 . . . . 1.23 109.747 -170.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -84.55 139.33 32.2 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.15 -1.386 . . . . 4.63 111.783 -174.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.508 ' HG3' HD13 ' A' ' 28' ' ' ILE . 2.9 mt-30 -139.47 94.14 2.75 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.125 -0.943 . . . . 1.5 109.145 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.68 -73.6 0.24 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.014 -0.612 . . . . 1.33 112.547 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -139.45 1.69 1.98 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.416 0.627 . . . . 2.33 110.388 -177.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -114.06 120.63 41.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.567 -0.742 . . . . 1.87 109.465 -173.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.528 HD22 ' HA ' ' A' ' 100' ' ' ARG . 7.6 mp -103.09 116.62 32.86 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.103 -0.703 . . . . 2.8 109.103 176.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.508 HD13 ' HG3' ' A' ' 23' ' ' GLN . 1.8 mp -96.01 126.5 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 115.493 -0.776 . . . . 1.45 110.2 -172.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 31' ' ' PHE . 0.4 OUTLIER -103.38 109.12 20.63 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.334 -1.303 . . . . 1.87 108.041 174.037 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.647 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -77.92 43.5 2.2 Favored Glycine 0 C--O 1.216 -0.987 0 C-N-CA 121.016 -0.611 . . . . 1.14 112.574 -175.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.595 ' HB2' ' CG2' ' A' ' 57' ' ' VAL . 40.0 p90 -159.7 147.15 16.84 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.417 -1.327 . . . . 0.61 107.417 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.617 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -102.4 163.82 12.02 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 118.466 -1.294 . . . . 0.91 107.605 176.184 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.526 HD13 HD22 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -154.26 139.83 10.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 119.242 -0.983 . . . . 1.24 113.0 -168.261 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -141.09 118.07 1.32 Allowed Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 109.83 -1.308 . . . . 0.78 109.83 154.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 1.041 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -142.39 117.69 1.18 Allowed Glycine 0 C--N 1.302 -1.323 0 CA-C-O 118.251 -1.305 . . . . 1.66 111.577 170.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.63 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.8 141.93 7.26 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 117.641 -2.219 . . . . 0.95 113.507 175.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.434 HG12 ' C ' ' A' ' 88' ' ' VAL . 13.7 pt -61.9 -20.37 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 N-CA-C 107.363 -1.347 . . . . 1.15 107.363 151.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.826 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 3.0 t70 -59.32 -43.95 92.65 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 113.588 -1.642 . . . . 0.72 109.759 171.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -64.05 -68.62 0.34 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.008 -0.996 . . . . 1.47 109.967 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.446 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 0.3 OUTLIER -172.77 117.52 0.4 Allowed Pre-proline 0 N--CA 1.47 0.57 0 CA-C-O 121.652 0.739 . . . . 2.57 111.18 169.422 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 1.1 Cg_endo -88.71 -20.92 1.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.691 2.928 . . . . 2.82 111.651 172.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.9 t -61.16 -29.89 70.07 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.676 -1.147 . . . . 3.26 112.18 -169.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -117.62 13.89 14.37 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.878 -0.329 . . . . 3.88 111.002 -174.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.709 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 91.2 m-20 -147.24 34.09 0.11 Allowed Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 112.162 0.43 . . . . 5.7 112.162 -169.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.709 ' HD3' ' N ' ' A' ' 44' ' ' ASN . 12.1 Cg_exo -70.94 -29.26 18.49 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 121.388 1.392 . . . . 4.03 110.205 -177.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -151.38 59.52 0.89 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.905 -1.517 . . . . 6.35 106.905 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.557 ' HB2' ' HA ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -85.74 -166.4 1.51 Allowed 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 113.888 -1.505 . . . . 3.85 111.588 -173.805 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -22.12 -58.26 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 112.666 -2.061 . . . . 6.78 115.866 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 38.2 t70 -167.27 -124.8 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 120.55 -0.46 . . . . 5.47 110.869 -164.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.828 ' HB3' ' HE1' ' A' ' 78' ' ' MET . 8.3 mptt -102.86 8.84 39.15 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.861 -0.792 . . . . 3.54 108.861 173.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.507 HG22 ' HB3' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -84.37 -62.9 1.44 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.135 -1.061 . . . . 4.89 108.135 -178.343 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.675 ' HB2' ' HE2' ' A' ' 53' ' ' LYS . 1.7 m-20 21.13 -113.0 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 O-C-N 125.211 1.569 . . . . 2.6 113.721 170.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.756 ' HE2' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -110.69 18.4 19.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.795 -1.093 . . . . 3.98 109.682 175.134 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.12 -157.11 13.63 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 110.064 -1.214 . . . . 0.94 110.064 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 1.041 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -116.5 135.06 57.98 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.145 0 N-CA-C 107.423 -1.325 . . . . 1.27 107.423 174.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.68 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -152.49 150.53 29.71 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.052 0.842 . . . . 1.91 111.485 -177.245 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.595 ' CG2' ' HB2' ' A' ' 31' ' ' PHE . 10.0 p -93.5 133.58 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 114.574 -1.193 . . . . 1.22 111.191 -169.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.617 ' O ' ' HB3' ' A' ' 32' ' ' SER . 32.6 m -123.89 70.32 1.07 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.803 -1.09 . . . . 1.29 109.479 174.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.582 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 41.8 mtt180 151.73 177.25 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 125.47 1.508 . . . . 2.63 110.823 163.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 91.7 t -161.36 138.49 2.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 125.432 1.707 . . . . 1.53 107.249 163.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.7 p -86.16 122.93 30.86 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.191 0.519 . . . . 2.38 110.87 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -48.67 117.3 1.97 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.315 -1.311 . . . . 1.85 111.855 171.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.15 12.3 84.75 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.656 -0.783 . . . . 0.95 113.222 173.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.585 ' O ' HD12 ' A' ' 68' ' ' ILE . . . -87.29 -132.63 3.63 Favored Glycine 0 C--O 1.22 -0.755 0 C-N-CA 119.942 -1.123 . . . . 0.99 111.31 174.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.647 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 97.6 Cg_endo -101.15 -42.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.538 2.159 . . . . 0.63 115.463 177.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.563 ' HB2' ' HD1' ' A' ' 31' ' ' PHE . . . -64.48 -27.1 68.75 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.0 -0.546 . . . . 1.1 111.898 -173.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -70.81 -33.34 70.6 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.652 0.739 . . . . 1.79 109.151 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.585 HD12 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -71.48 -40.37 72.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.496 -1.229 . . . . 1.18 110.627 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.721 ' CB ' HG12 ' A' ' 16' ' ' VAL . . . -77.61 -15.59 59.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 1.07 110.626 177.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.0 47.68 2.83 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.124 -1.036 . . . . 0.5 114.123 173.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.496 HD22 HG21 ' A' ' 57' ' ' VAL . 19.7 tp -97.68 149.98 21.68 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.94 -0.763 . . . . 1.5 108.94 176.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.688 HE22 ' HG3' ' A' ' 111' ' ' ARG . 7.6 mt-30 -122.56 33.31 5.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 114.576 1.324 . . . . 1.53 114.576 -165.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.586 HG23 ' O ' ' A' ' 73' ' ' ILE . 56.2 mt 72.05 -1.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 113.185 0.809 . . . . 1.43 113.185 165.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -173.08 52.23 0.16 Allowed Glycine 0 CA--C 1.509 -0.298 0 C-N-CA 120.084 -1.055 . . . . 0.37 111.999 -164.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.425 ' H ' ' CG1' ' A' ' 57' ' ' VAL . 43.9 m-20 -120.48 149.67 42.02 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.157 -0.521 . . . . 0.89 110.603 -172.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.68 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -95.4 101.54 13.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.332 -0.394 . . . . 2.71 110.593 -173.71 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.655 HD11 ' HA ' ' A' ' 56' ' ' TYR . 4.3 mt -72.72 123.01 26.55 Favored 'Isoleucine or valine' 0 C--O 1.261 1.669 0 CA-C-O 121.434 0.635 . . . . 1.22 112.424 -175.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.828 ' HE1' ' HB3' ' A' ' 50' ' ' LYS . 4.2 mmt -89.92 -19.49 24.49 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 113.242 -1.799 . . . . 1.61 112.286 176.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.533 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -172.39 157.21 3.99 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.184 0.438 . . . . 0.88 112.184 -174.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.604 HG12 ' SD ' ' A' ' 85' ' ' MET . 12.3 p -141.59 122.74 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.247 0.546 . . . . 1.93 110.712 171.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.7 m120 50.1 36.5 12.29 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.371 -0.831 . . . . 1.8 112.192 176.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.67 -18.66 49.87 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.451 -0.88 . . . . 0.38 113.244 175.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.479 ' CB ' ' HE3' ' A' ' 85' ' ' MET . 52.9 m95 -81.84 149.39 28.34 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 109.684 -0.488 . . . . 0.91 109.684 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -95.91 116.33 28.76 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.635 -0.711 . . . . 1.89 111.0 -175.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.604 ' SD ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -105.8 99.36 8.96 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 122.626 1.203 . . . . 1.38 110.177 177.567 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.1 p -138.09 -44.42 0.51 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.112 -1.858 . . . . 1.1 106.765 173.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.428 ' HA ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -148.46 75.15 1.31 Allowed 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.514 -1.676 . . . . 2.15 109.674 177.284 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.63 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -140.96 154.25 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 108.779 -0.823 . . . . 1.68 108.779 173.723 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.7 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 74.7 p -60.01 151.95 25.09 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 113.168 0.803 . . . . 1.1 113.168 -173.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.826 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 21.5 t-160 -58.81 -40.37 83.92 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 115.74 -0.664 . . . . 0.41 110.092 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -66.17 -31.01 71.6 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.13 -1.395 . . . . 1.67 109.838 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.579 ' HB3' ' O ' ' A' ' 89' ' ' THR . 1.9 tp-100 -63.63 -51.81 63.57 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.677 0.751 . . . . 0.79 109.514 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.53 ' HB2' HG12 ' A' ' 55' ' ' ILE . . . -72.54 -33.38 66.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.935 -1.029 . . . . 1.06 109.801 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 90' ' ' HIS . 11.3 ttp180 -61.77 -48.46 80.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.2 -0.909 . . . . 2.45 110.642 -177.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.647 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -70.52 -28.45 64.95 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 119.768 -0.773 . . . . 1.51 110.647 -179.738 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.547 ' HD2' ' HD3' ' A' ' 95' ' ' LYS . 1.8 mmm180 -70.0 -41.66 74.07 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.196 -0.601 . . . . 4.23 112.155 -177.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.567 ' HB3' HG22 ' A' ' 80' ' ' VAL . 3.3 pp -80.58 -25.21 38.64 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.636 -0.426 . . . . 2.24 110.965 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.473 ' N ' HD12 ' A' ' 97' ' ' LEU . 21.5 m -153.68 95.27 1.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.442 0.639 . . . . 1.63 111.436 178.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.647 ' HB3' ' O ' ' A' ' 95' ' ' LYS . 7.0 ptpt -112.67 9.89 19.32 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.454 -0.794 . . . . 3.16 109.118 174.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.528 ' HA ' HD22 ' A' ' 27' ' ' LEU . 11.9 mtt180 70.01 19.05 7.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.09 -1.414 . . . . 4.79 111.904 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.6 t -137.29 9.96 2.98 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 120.623 -0.431 . . . . 2.83 111.827 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.469 ' HB2' ' HG3' ' A' ' 20' ' ' LYS . 6.1 mm-40 -85.39 148.48 25.99 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.998 0.428 . . . . 3.4 111.398 -177.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.515 ' HG3' HG12 ' A' ' 104' ' ' VAL . 7.3 pt-20 -95.83 -49.71 5.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.881 -0.6 . . . . 2.68 110.702 178.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.72 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 2.6 p -143.69 142.14 25.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.166 -1.05 . . . . 1.15 108.166 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.637 HG21 ' HG2' ' A' ' 20' ' ' LYS . 42.1 t -123.3 117.85 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 CA-C-O 122.22 1.01 . . . . 1.13 112.403 -164.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -101.16 127.32 47.78 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 112.865 -1.97 . . . . 2.28 109.954 -174.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.518 HD11 HG12 ' A' ' 77' ' ' ILE . 20.7 tp -130.87 124.4 31.12 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.915 -0.584 . . . . 1.68 109.587 -174.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.623 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 33.9 tp -100.31 119.84 39.02 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.247 -1.761 . . . . 1.1 106.247 176.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.701 HG11 ' HG3' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -126.6 150.66 32.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.239 0.542 . . . . 1.39 109.946 -171.763 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.569 HG22 HG21 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -98.07 115.13 27.6 Favored 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 119.436 -0.906 . . . . 1.13 109.421 168.266 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.688 ' HG3' HE22 ' A' ' 72' ' ' GLN . 7.9 ttm180 -105.39 149.23 26.3 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.384 -1.28 . . . . 2.34 110.704 -171.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.446 HE21 HD12 ' A' ' 114' ' ' LEU . 0.9 OUTLIER -138.29 -156.22 0.67 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.352 -0.981 . . . . 1.97 108.352 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.03 72.5 8.37 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.846 0.831 . . . . 2.0 112.223 -171.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 3.3 mt -118.55 -10.11 10.15 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.445 -1.252 . . . . 2.0 107.734 175.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -41.15 112.99 0.35 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 112.821 -1.99 . . . . 3.83 112.567 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -85.48 41.65 0.91 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.334 -0.848 . . . . 3.96 110.929 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 59.83 32.19 21.17 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.824 -0.626 . . . . 3.76 110.915 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.6 p -66.18 -10.51 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.642 -0.708 . . . . 5.11 111.497 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -86.01 -20.16 29.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.272 -0.422 . . . . 8.35 111.179 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.414 ' HB3' ' H ' ' A' ' 121' ' ' SER . 83.4 mm-40 57.38 -153.56 0.37 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.183 0.516 . . . . 6.63 111.676 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.414 ' H ' ' HB3' ' A' ' 120' ' ' GLN . 52.9 p -138.97 179.81 6.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.614 -0.721 . . . . 8.94 109.196 177.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 21.0 ptm -153.19 144.88 23.45 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.752 0.31 . . . . 12.46 110.751 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.0 mt -88.6 120.35 29.91 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.474 -0.565 . . . . 13.06 109.474 175.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.7 m . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.585 -0.721 . . . . 14.64 110.948 179.925 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ptm . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 111.596 0.221 . . . . 14.35 111.596 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 m -73.5 -19.22 60.98 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.471 0.545 . . . . 11.48 112.471 -172.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.417 ' CZ ' ' HG3' ' A' ' 5' ' ' PRO . 42.4 p90 -95.75 9.37 40.66 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.81 -0.356 . . . . 9.53 111.144 -177.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.9 pt 35.94 88.52 0.09 OUTLIER Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 124.075 0.95 . . . . 6.82 113.491 -177.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.417 ' HG3' ' CZ ' ' A' ' 3' ' ' TYR . 20.4 Cg_exo -64.19 -63.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.846 2.364 . . . . 7.95 111.302 -178.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.21 14.99 10.17 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.2 -1.16 . . . . 6.42 110.2 172.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.448 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 80.1 mt-30 69.06 138.84 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 123.962 0.905 . . . . 6.63 111.148 -176.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 7' ' ' GLN . 11.6 Cg_endo -92.78 -154.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.153 2.569 . . . . 3.98 112.306 -177.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.1 m -95.09 4.22 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 108.388 -0.967 . . . . 2.77 108.388 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.7 m -77.19 81.46 3.69 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 122.64 1.21 . . . . 2.49 110.115 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.497 ' HB1' HG21 ' A' ' 110' ' ' THR . . . -92.76 132.35 37.03 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 113.01 -1.905 . . . . 1.24 108.584 170.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 p -107.23 123.45 62.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.047 -0.524 . . . . 2.16 110.231 -173.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.755 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 1.0 OUTLIER -81.33 128.2 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 121.861 0.838 . . . . 1.65 111.124 -173.564 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.844 HE22 HG22 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -101.87 167.34 10.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.92 -1.036 . . . . 1.39 111.172 173.383 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.449 ' N ' HE21 ' A' ' 14' ' ' GLN . 0.0 OUTLIER -124.82 106.83 10.33 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.688 -0.687 . . . . 4.11 110.027 -174.109 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.844 HG22 HE22 ' A' ' 14' ' ' GLN . 1.5 t -104.78 133.19 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 109.857 -0.423 . . . . 1.59 109.857 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -137.81 126.66 23.99 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.778 -0.453 . . . . 1.35 109.778 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.517 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 9.8 tp -142.91 161.57 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 108.239 -1.023 . . . . 1.33 108.239 -178.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -95.2 113.09 24.73 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.822 -0.751 . . . . 0.7 109.838 -175.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.837 ' HB2' HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -26.8 130.01 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 125.125 1.515 . . . . 4.39 112.341 179.544 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 36.1 tp -100.61 95.76 6.9 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 119.936 -0.705 . . . . 1.23 109.208 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -74.67 140.02 43.92 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.499 -0.773 . . . . 4.63 111.54 -172.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.516 ' HB2' HD13 ' A' ' 28' ' ' ILE . 4.3 tp-100 -134.58 93.99 3.13 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.393 -0.966 . . . . 1.5 108.393 177.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.07 -83.28 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.686 -0.768 . . . . 1.33 111.545 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.775 ' HB3' HH11 ' A' ' 100' ' ' ARG . 30.5 mt-10 -132.38 8.24 4.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.926 0.393 . . . . 2.33 110.572 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -109.02 166.97 10.43 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.257 -0.428 . . . . 1.87 110.762 -173.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.991 HD22 ' HA ' ' A' ' 98' ' ' THR . 4.9 tp -119.91 122.86 42.2 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.78 -0.646 . . . . 2.8 109.388 173.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.516 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.7 mp -98.44 113.83 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 107.66 -1.237 . . . . 1.45 107.66 173.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.528 HD12 ' CE2' ' A' ' 31' ' ' PHE . 1.1 pt? -95.02 -15.31 23.58 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.053 -0.976 . . . . 1.87 110.833 -173.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.519 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 87.06 -9.65 71.66 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.45 -0.881 . . . . 1.14 113.718 172.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.781 ' HD1' ' HB2' ' A' ' 66' ' ' ALA . 48.5 p90 -133.43 165.72 24.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.296 0.548 . . . . 0.61 110.801 178.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.689 ' HB3' ' O ' ' A' ' 58' ' ' THR . 7.8 t -106.07 171.56 7.28 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.41 -0.589 . . . . 0.91 109.41 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.646 HG12 ' HE2' ' A' ' 90' ' ' HIS . 5.4 tt -150.17 131.83 5.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 C-N-CA 120.564 -0.454 . . . . 1.24 111.675 -167.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -102.97 171.66 20.94 Favored Glycine 0 C--O 1.237 0.341 0 N-CA-C 110.693 -0.963 . . . . 0.78 110.693 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.976 ' HA3' ' NE2' ' A' ' 39' ' ' GLN . . . -114.6 169.3 12.82 Favored Glycine 0 N--CA 1.42 -2.389 0 N-CA-C 118.855 2.302 . . . . 1.66 118.855 -160.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.448 ' H ' ' HB2' ' A' ' 90' ' ' HIS . . . -87.58 -162.14 37.53 Favored Glycine 0 N--CA 1.415 -2.726 0 CA-C-N 110.073 -3.063 . . . . 0.95 113.5 -165.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.56 HD11 ' O ' ' A' ' 87' ' ' MET . 27.5 pt -55.88 -9.6 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.434 0.635 . . . . 1.15 111.002 168.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 1.026 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 0.2 OUTLIER -59.92 -40.73 89.9 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.262 -0.881 . . . . 0.72 109.629 173.424 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.976 ' NE2' ' HA3' ' A' ' 35' ' ' GLY . 28.4 mt-30 -84.03 -46.67 11.76 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 114.788 -1.096 . . . . 1.47 110.956 -175.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -117.85 88.63 31.3 Favored Pre-proline 0 C--N 1.314 -0.976 0 CA-C-N 114.216 -1.357 . . . . 2.57 111.063 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.01 -18.47 35.8 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.597 2.198 . . . . 2.82 110.896 174.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.1 t -70.07 -31.74 69.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.856 -1.066 . . . . 3.26 109.734 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -98.4 65.47 1.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.563 0.697 . . . . 3.88 110.489 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.53 ' C ' ' H ' ' A' ' 46' ' ' PHE . 25.8 t-20 -122.52 -47.73 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 114.997 -1.001 . . . . 5.7 109.581 174.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.485 ' HD2' ' H ' ' A' ' 44' ' ' ASN . 29.9 Cg_endo -65.69 11.79 0.14 Allowed 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.587 1.525 . . . . 4.03 112.181 160.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.53 ' H ' ' C ' ' A' ' 44' ' ' ASN . 79.7 t80 -120.1 -27.07 5.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.98 -0.554 . . . . 6.35 109.932 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.55 ' HA ' ' HB2' ' A' ' 52' ' ' ASP . 44.0 p -74.66 101.87 4.41 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.177 0.989 . . . . 3.85 109.266 -174.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -91.13 -29.2 17.42 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 113.908 -1.496 . . . . 6.78 110.736 -172.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 10.3 t70 170.47 -151.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.444 -1.253 . . . . 5.47 108.428 -162.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.791 ' HE3' HG22 ' A' ' 110' ' ' THR . 3.4 mppt? -72.66 -4.47 31.27 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.813 0.339 . . . . 3.54 110.409 176.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.2 t -69.48 -36.41 76.5 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.018 -0.537 . . . . 4.89 109.966 177.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.55 ' HB2' ' HA ' ' A' ' 47' ' ' SER . 4.9 t70 -67.19 -161.38 0.02 OUTLIER 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.486 0.66 . . . . 2.6 109.709 163.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.43 ' H ' ' CG ' ' A' ' 52' ' ' ASP . 9.9 ptpt -97.81 -46.41 5.96 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.375 -0.375 . . . . 3.98 110.371 -178.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 52.18 -149.25 9.72 Favored Glycine 0 C--O 1.225 -0.452 0 C-N-CA 121.058 -0.591 . . . . 0.94 111.63 -172.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.532 HG23 ' CD1' ' A' ' 77' ' ' ILE . 2.2 mp -99.93 132.39 45.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 108.347 -0.983 . . . . 1.27 108.347 168.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.528 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -155.01 138.76 16.17 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 120.898 0.38 . . . . 1.91 110.339 -170.369 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 32' ' ' SER . 8.6 p -67.38 129.37 31.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.648 -0.706 . . . . 1.22 110.484 -176.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.689 ' O ' ' HB3' ' A' ' 32' ' ' SER . 18.5 m -125.64 59.59 1.28 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.463 -0.79 . . . . 1.29 109.896 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.584 ' HA ' HG22 ' A' ' 73' ' ' ILE . 13.9 mtt180 154.49 -179.88 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 126.084 1.754 . . . . 2.63 109.979 167.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 59' ' ' ARG . 88.0 t -166.7 125.71 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 O-C-N 125.638 1.836 . . . . 1.53 106.348 163.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.8 m -85.15 128.27 34.59 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.889 -0.725 . . . . 2.38 109.259 174.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -65.15 106.36 1.29 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.374 -0.83 . . . . 1.85 110.4 174.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 120.64 -21.56 8.48 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.27 -1.332 . . . . 0.95 110.396 -173.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 67' ' ' GLU . . . -72.76 152.82 48.05 Favored Glycine 0 CA--C 1.495 -1.214 0 N-CA-C 111.384 -0.686 . . . . 0.99 111.384 172.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.519 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 83.3 Cg_exo -47.13 -30.9 11.09 Favored 'Trans proline' 0 C--N 1.325 -0.659 0 C-N-CA 123.882 3.055 . . . . 0.63 114.17 -176.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.781 ' HB2' ' HD1' ' A' ' 31' ' ' PHE . . . -66.75 -26.73 67.12 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.016 -0.538 . . . . 1.1 111.454 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.493 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 5.5 tp10 -68.36 -31.61 71.12 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.247 0.546 . . . . 1.79 109.821 174.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.612 ' N ' HD13 ' A' ' 68' ' ' ILE . 2.7 mp -81.05 -36.78 15.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.807 -0.633 . . . . 1.18 109.938 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.717 ' HB1' HG11 ' A' ' 16' ' ' VAL . . . -79.56 -31.79 42.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.553 -0.748 . . . . 1.07 110.456 176.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.18 69.36 0.95 Allowed Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.442 -0.885 . . . . 0.5 113.562 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.439 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 21.9 tp -116.05 158.32 23.33 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.738 -0.468 . . . . 1.5 109.738 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.538 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 5.1 mt-30 -125.43 29.81 5.94 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 115.196 1.554 . . . . 1.53 115.196 -163.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' A' ' 59' ' ' ARG . 82.6 mt 75.97 -10.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 N-CA-C 114.621 1.341 . . . . 1.43 114.621 165.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -166.75 52.22 0.25 Allowed Glycine 0 N--CA 1.465 0.569 0 C-N-CA 118.983 -1.579 . . . . 0.37 113.432 -165.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.487 ' H ' ' CG1' ' A' ' 57' ' ' VAL . 17.6 m-20 -122.42 147.1 46.72 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.38 -0.41 . . . . 0.89 110.407 -172.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.528 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 1.3 mptm? -91.74 120.85 32.84 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-O 121.014 0.435 . . . . 2.71 110.673 -176.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.683 HG12 HD12 ' A' ' 107' ' ' LEU . 5.9 mt -80.3 120.46 31.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.172 0.511 . . . . 1.22 112.206 -170.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 1.012 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 11.0 mmt -88.38 -20.97 24.59 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.507 -1.224 . . . . 1.61 111.326 177.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.57 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -171.71 157.82 4.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.988 0.423 . . . . 0.88 111.2 -178.609 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.62 HG23 ' HG ' ' A' ' 97' ' ' LEU . 9.5 p -146.55 126.53 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.985 -0.552 . . . . 1.93 109.778 172.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.45 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 1.0 OUTLIER 62.64 9.72 3.69 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.015 -0.539 . . . . 1.8 112.213 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.89 -10.68 27.43 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.244 -0.979 . . . . 0.38 112.485 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.413 ' CD1' ' HB3' ' A' ' 96' ' ' ARG . 81.4 m95 -82.39 143.16 31.41 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 120.819 0.342 . . . . 0.91 110.587 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -92.06 110.88 22.25 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.235 -0.893 . . . . 1.89 111.84 -170.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.484 ' HE1' HG11 ' A' ' 80' ' ' VAL . 20.6 mmt -109.35 122.19 46.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.906 -0.588 . . . . 1.38 112.227 -175.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.5 p -137.38 -72.29 0.43 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.45 0.643 . . . . 1.1 109.281 167.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.56 ' O ' HD11 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -125.19 62.39 1.18 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.272 -0.876 . . . . 2.15 109.099 177.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.488 HG23 HE21 ' A' ' 92' ' ' GLN . 3.6 p -112.34 177.32 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 108.835 -0.802 . . . . 1.68 108.835 177.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 1.026 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 63.1 p -72.22 153.07 41.8 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 118.283 0.492 . . . . 1.1 111.432 -177.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.871 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 23.7 t-160 -56.78 -41.6 77.94 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 121.896 0.855 . . . . 0.41 108.928 177.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -67.25 -30.35 70.23 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.186 -1.824 . . . . 1.67 109.855 -175.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.808 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 2.4 tp-100 -59.65 -53.38 58.66 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.378 -0.601 . . . . 0.79 109.378 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 97' ' ' LEU . . . -74.38 -30.62 62.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.654 -0.703 . . . . 1.06 110.297 -176.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -63.35 -47.43 82.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.424 -0.807 . . . . 2.45 110.47 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.427 ' HD3' ' C ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -71.84 -41.73 67.78 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.743 -0.662 . . . . 1.51 109.823 -174.462 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.808 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 22.4 mmt180 -69.0 -24.3 64.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.927 -0.579 . . . . 4.23 110.271 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.62 ' HG ' HG23 ' A' ' 80' ' ' VAL . 3.8 tt -79.93 -52.47 7.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.777 -0.647 . . . . 2.24 110.86 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.991 ' HA ' HD22 ' A' ' 27' ' ' LEU . 5.3 m -94.83 92.05 6.75 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 122.685 1.231 . . . . 1.63 110.901 -169.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.48 ' HE3' ' HB2' ' A' ' 99' ' ' LYS . 3.6 mtmt -134.95 110.65 9.24 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 112.8 -2.0 . . . . 3.16 109.552 -177.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.775 HH11 ' HB3' ' A' ' 25' ' ' GLU . 37.6 ptt180 -67.4 5.31 0.79 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.73 -0.668 . . . . 4.79 112.105 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.447 ' H ' ' C ' ' A' ' 99' ' ' LYS . 3.0 p -107.73 -23.26 12.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.496 -0.32 . . . . 2.83 111.634 -174.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -68.16 151.61 46.73 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.193 -0.299 . . . . 3.4 110.193 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -97.71 -20.27 17.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.313 0.578 . . . . 2.68 110.315 175.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.29 145.27 18.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.783 -0.644 . . . . 1.15 109.51 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 74.5 t -113.53 118.35 57.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 122.089 0.947 . . . . 1.13 111.709 -176.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.45 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -99.29 134.55 41.99 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 113.619 -1.628 . . . . 2.28 110.298 -176.239 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.683 HD12 HG12 ' A' ' 77' ' ' ILE . 37.0 tp -132.86 132.33 41.98 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.199 -0.455 . . . . 1.68 110.596 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 1.012 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 40.1 tp -115.22 114.02 24.68 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.211 -1.774 . . . . 1.1 106.211 171.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.644 HG13 ' HG3' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -127.26 150.38 33.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 109.991 -0.374 . . . . 1.39 109.991 -171.331 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.791 HG22 ' HE3' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -95.88 121.26 37.43 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 120.32 -0.552 . . . . 1.13 110.936 171.258 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.432 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 2.4 ttt180 -110.46 139.53 45.58 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.876 -1.056 . . . . 2.34 110.987 -171.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.63 -107.04 0.35 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.899 -0.591 . . . . 1.97 111.468 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.406 ' O ' HD21 ' A' ' 114' ' ' LEU . 13.9 t -131.91 81.08 1.95 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.635 0.731 . . . . 2.0 110.579 -173.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 3.1 mt -133.91 -12.06 2.59 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.875 -1.057 . . . . 2.0 109.518 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -51.2 128.79 22.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.491 -1.231 . . . . 3.83 111.058 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.61 35.55 0.51 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.641 -0.254 . . . . 3.96 110.471 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 58.28 34.57 24.2 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.435 0.636 . . . . 3.76 109.995 -172.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.2 p -68.89 145.8 13.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.29 -0.868 . . . . 5.11 110.884 -177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -55.58 108.31 0.42 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.448 -0.797 . . . . 8.35 111.106 174.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -98.32 108.9 21.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.108 -0.496 . . . . 6.63 109.883 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 57.5 m -74.96 120.51 20.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.089 -0.505 . . . . 8.94 110.411 -177.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 89.2 mtp -93.27 176.48 6.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.833 -0.621 . . . . 12.46 110.344 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.5 tp 64.0 85.39 0.14 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.519 0.676 . . . . 13.06 110.955 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.4 p . . . . . 0 C--O 1.242 0.686 0 CA-C-N 115.235 -0.893 . . . . 14.64 109.613 179.107 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.8 mtp . . . . . 0 N--CA 1.481 1.118 0 CA-C-O 120.779 0.323 . . . . 14.35 110.487 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 t -122.87 115.17 21.51 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.864 -0.421 . . . . 11.48 109.864 177.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -99.4 173.02 6.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.373 -0.376 . . . . 9.53 110.232 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.622 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 16.9 pt -99.22 107.88 46.93 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 121.103 0.478 . . . . 6.82 111.432 -176.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -71.52 117.11 4.98 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.645 2.23 . . . . 7.95 111.79 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.37 -24.1 15.66 Favored Glycine 0 CA--C 1.516 0.151 0 C-N-CA 121.022 -0.609 . . . . 6.42 112.331 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 69.39 106.42 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.327 0 C-N-CA 123.472 0.709 . . . . 6.63 110.813 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.622 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 6.0 Cg_exo -78.5 -155.82 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 123.081 2.521 . . . . 3.98 112.964 -176.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.7 m -95.12 -0.34 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.635 -0.712 . . . . 2.77 109.465 -177.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.6 p -76.92 80.9 3.47 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 122.461 1.124 . . . . 2.49 110.413 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' A' ' 111' ' ' ARG . . . -88.76 177.83 6.62 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.97 -1.923 . . . . 1.24 110.618 176.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.67 129.59 40.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.658 -0.701 . . . . 2.16 110.169 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 45.1 t -77.04 112.93 15.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.969 0.414 . . . . 1.65 111.553 -175.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.642 ' HG3' HG13 ' A' ' 109' ' ' VAL . 0.1 OUTLIER -111.41 166.6 10.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.92 -0.582 . . . . 1.39 109.98 171.478 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -120.93 138.64 54.02 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 120.797 -1.189 . . . . 4.11 111.302 -176.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.645 HG12 ' CB ' ' A' ' 69' ' ' ALA . 19.7 t -108.29 108.57 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 CA-C-N 115.325 -0.852 . . . . 1.59 109.492 177.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -122.23 111.57 17.11 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.394 -0.821 . . . . 1.35 109.532 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.775 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 10.8 tp -134.89 147.93 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 108.817 -0.809 . . . . 1.33 108.817 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.635 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 14.2 m-70 -78.15 105.9 9.68 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.395 -0.965 . . . . 0.7 108.395 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.72 ' HB3' HG22 ' A' ' 105' ' ' VAL . 2.5 pptp? -27.34 139.89 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 O-C-N 125.376 1.672 . . . . 4.39 112.924 -175.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 43.8 tp -93.62 85.8 4.99 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 122.175 0.988 . . . . 1.23 109.703 -171.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.595 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -54.41 134.41 45.72 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 113.639 -1.619 . . . . 4.63 112.136 -175.291 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.506 ' HB2' HD12 ' A' ' 28' ' ' ILE . 6.3 tp-100 -123.78 94.5 4.25 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.501 -1.227 . . . . 1.5 108.471 176.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.77 -84.37 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.493 -0.86 . . . . 1.33 111.289 -173.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -129.57 6.73 5.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.199 0.523 . . . . 2.33 110.694 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 3.8 m-80 -110.71 -177.11 3.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.697 -0.683 . . . . 1.87 109.871 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.632 ' HB2' ' HB2' ' A' ' 20' ' ' LYS . 1.6 pt? -127.73 144.78 51.06 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.202 -1.036 . . . . 2.8 108.202 172.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.506 HD12 ' HB2' ' A' ' 23' ' ' GLN . 1.1 mp -113.24 139.96 35.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-O 121.142 0.496 . . . . 1.45 110.711 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.25 127.34 47.89 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.667 -1.152 . . . . 1.87 109.144 173.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.725 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -95.08 48.8 1.96 Allowed Glycine 0 C--O 1.22 -0.731 0 C-N-CA 120.165 -1.016 . . . . 1.14 113.154 -172.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 35.3 p90 -158.52 163.1 37.39 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.634 -0.876 . . . . 0.61 108.634 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.565 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.1 OUTLIER -105.14 161.06 14.58 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.865 -1.161 . . . . 0.91 107.865 170.569 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -156.72 137.32 4.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 119.107 -1.037 . . . . 1.24 113.757 -165.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.429 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -146.63 118.22 1.02 Allowed Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.43 -1.068 . . . . 0.78 110.43 156.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 1.053 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.45 117.48 1.22 Allowed Glycine 0 CA--C 1.492 -1.356 0 CA-C-O 118.641 -1.088 . . . . 1.66 111.401 172.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.29 143.25 8.12 Favored Glycine 0 C--N 1.299 -1.496 0 C-N-CA 117.929 -2.081 . . . . 0.95 112.954 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.634 HG12 ' O ' ' A' ' 87' ' ' MET . 5.2 pt -59.89 -26.1 34.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 106.813 -1.551 . . . . 1.15 106.813 151.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.997 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 6.0 t70 -53.08 -44.68 67.72 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 113.003 -1.908 . . . . 0.72 110.752 173.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -62.32 -69.34 0.26 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.811 -1.086 . . . . 1.47 111.668 -172.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -178.09 110.69 0.22 Allowed Pre-proline 0 N--CA 1.468 0.43 0 N-CA-C 110.257 -0.275 . . . . 2.57 110.257 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.426 ' HA ' ' CG ' ' A' ' 53' ' ' LYS . 1.0 OUTLIER -87.81 11.9 3.03 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 123.819 3.013 . . . . 2.82 113.707 -179.052 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.0 t -104.64 31.14 4.91 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.054 0.454 . . . . 3.26 111.709 -169.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -140.2 12.06 2.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.311 0.577 . . . . 3.88 109.823 -173.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.723 HD21 ' HB2' ' A' ' 48' ' ' GLU . 6.6 p30 174.84 60.74 0.04 OUTLIER Pre-proline 0 N--CA 1.441 -0.914 0 N-CA-C 108.035 -1.098 . . . . 5.7 108.035 -169.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.56 10.95 0.89 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.691 2.261 . . . . 4.03 112.353 -171.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -139.83 -58.44 0.56 Allowed 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 106.63 -1.618 . . . . 6.35 106.63 173.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.649 ' HA ' ' OD1' ' A' ' 52' ' ' ASP . 1.4 m -160.7 157.1 26.46 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.924 -1.034 . . . . 3.85 109.151 173.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.723 ' HB2' HD21 ' A' ' 44' ' ' ASN . 73.3 tt0 -108.24 -28.82 9.24 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.661 0.743 . . . . 6.78 109.512 170.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.914 ' HB3' HG22 ' A' ' 51' ' ' THR . 27.6 t70 172.95 -138.34 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 103.999 -2.593 . . . . 5.47 103.999 -172.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.611 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 9.2 tppt? -78.36 -18.05 55.65 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.424 -0.954 . . . . 3.54 108.424 166.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.914 HG22 ' HB3' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -64.04 -55.25 23.53 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.859 -1.064 . . . . 4.89 110.924 -178.115 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.706 ' O ' ' HE2' ' A' ' 53' ' ' LYS . 35.6 t70 44.15 -135.3 0.56 Allowed 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.516 0.51 . . . . 2.6 110.04 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.706 ' HE2' ' O ' ' A' ' 52' ' ' ASP . 2.1 mmpt? -109.49 49.19 0.84 Allowed 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 121.843 -0.536 . . . . 3.98 110.776 174.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -99.4 -149.2 24.04 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 110.862 -0.895 . . . . 0.94 110.862 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 1.053 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -114.76 138.39 45.08 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 109.018 -0.734 . . . . 1.27 109.018 174.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.626 ' HA ' HD13 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -142.94 140.04 30.95 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 119.185 0.902 . . . . 1.91 110.405 -176.23 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.58 HG22 HD21 ' A' ' 71' ' ' LEU . 8.8 p -82.92 138.84 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 CA-C-N 114.623 -1.172 . . . . 1.22 110.056 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.669 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 23.5 m -127.98 68.55 1.33 Allowed 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.153 -0.931 . . . . 1.29 109.33 172.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 24.1 mtp180 148.54 -171.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.637 1.575 . . . . 2.63 111.001 162.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 58.4 t -162.14 143.5 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 125.543 1.777 . . . . 1.53 107.622 164.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.3 p -86.65 133.84 33.66 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.611 0.719 . . . . 2.38 110.88 175.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -71.45 105.62 3.64 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.195 -1.366 . . . . 1.85 111.055 178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.21 9.65 50.74 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 119.764 -1.208 . . . . 0.95 113.093 176.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.643 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -90.18 -140.05 8.08 Favored Glycine 0 C--O 1.217 -0.938 0 C-N-CA 120.279 -0.962 . . . . 0.99 111.082 175.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.725 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 66.0 Cg_endo -98.26 -32.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 122.475 2.116 . . . . 0.63 114.525 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.49 ' HB3' HG12 ' A' ' 60' ' ' VAL . . . -71.99 -22.83 61.37 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.906 -0.588 . . . . 1.1 111.727 -174.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -71.96 -30.92 65.78 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.626 -0.879 . . . . 1.79 108.626 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.643 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -81.57 -44.18 20.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.539 -1.21 . . . . 1.18 110.41 -176.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.775 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . . . -68.25 -26.4 65.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.936 -0.575 . . . . 1.07 110.31 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.08 70.03 1.01 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.368 -0.92 . . . . 0.5 113.278 177.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.58 HD21 HG22 ' A' ' 57' ' ' VAL . 13.9 tp -113.75 153.52 28.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.192 -0.669 . . . . 1.5 109.192 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.601 HE22 ' HG3' ' A' ' 111' ' ' ARG . 12.3 mt-30 -123.65 29.36 6.6 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 114.83 1.419 . . . . 1.53 114.83 -166.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.669 ' O ' ' HA ' ' A' ' 58' ' ' THR . 2.9 mp 72.06 -12.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 N-CA-C 113.418 0.895 . . . . 1.43 113.418 171.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -164.31 60.89 0.25 Allowed Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.225 -0.988 . . . . 0.37 111.407 -165.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.554 ' HB2' HG13 ' A' ' 57' ' ' VAL . 17.4 m-20 -123.09 153.26 40.16 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.015 -0.593 . . . . 0.89 109.593 -169.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.78 ' HG2' ' HA ' ' A' ' 51' ' ' THR . 6.8 mptt -104.09 100.31 10.06 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.125 -0.63 . . . . 2.71 109.77 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.978 HG13 HG22 ' A' ' 109' ' ' VAL . 4.8 mp -75.0 128.91 37.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.55 -0.75 . . . . 1.22 110.053 -175.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -114.02 4.6 15.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 112.863 0.69 . . . . 1.61 112.863 -179.067 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.531 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 2.2 tt0 -172.11 152.38 2.86 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 122.442 -0.161 . . . . 0.88 111.095 176.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.766 HG21 ' HB3' ' A' ' 97' ' ' LEU . 7.0 p -150.06 130.81 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 121.237 0.541 . . . . 1.93 111.317 175.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.494 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 14.3 m120 50.37 34.3 8.87 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.149 0.979 . . . . 1.8 112.787 176.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.32 3.62 64.95 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.482 -0.866 . . . . 0.38 113.24 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -99.74 161.61 13.51 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 109.524 -0.547 . . . . 0.91 109.524 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -110.69 97.78 7.11 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.45 -0.795 . . . . 1.89 110.082 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.752 ' HB2' HD12 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -107.45 98.15 7.8 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 122.151 0.977 . . . . 1.38 109.731 174.359 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.18 -10.57 13.85 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.982 -1.463 . . . . 1.1 107.841 175.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.634 ' O ' HG12 ' A' ' 37' ' ' ILE . 1.9 mtt -149.89 -42.29 0.13 Allowed 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 112.543 -2.117 . . . . 2.15 108.905 -171.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.711 HG11 ' HG2' ' A' ' 92' ' ' GLN . 0.9 OUTLIER -22.68 141.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 C-N-CA 126.249 1.82 . . . . 1.68 115.711 -177.825 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.997 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 49.7 p -58.17 154.1 13.72 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 112.475 0.546 . . . . 1.1 112.475 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.757 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 22.1 t-160 -56.27 -44.42 79.74 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 115.988 -0.551 . . . . 0.41 110.66 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.8 -31.76 68.61 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.13 -0.941 . . . . 1.67 110.139 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.779 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.7 OUTLIER -64.36 -49.69 70.65 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.78 -0.822 . . . . 0.79 108.78 -178.68 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.612 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -74.13 -32.88 63.35 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.709 -0.678 . . . . 1.06 110.528 -177.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.516 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 35.1 ttp180 -64.16 -44.58 91.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 2.45 109.991 177.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.464 ' HD3' ' C ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -67.02 -36.29 81.79 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.688 -0.687 . . . . 1.51 109.481 -178.609 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.779 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 22.7 mmt180 -70.96 -23.9 62.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.988 -0.551 . . . . 4.23 111.193 -176.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.766 ' HB3' HG21 ' A' ' 80' ' ' VAL . 3.4 pp -94.41 -15.09 24.6 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.964 -0.294 . . . . 2.24 110.901 177.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.2 m -111.53 89.47 3.06 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.866 0.841 . . . . 1.63 110.888 -175.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.434 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 12.1 mtmt -136.7 103.99 5.39 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.476 -1.238 . . . . 3.16 109.548 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.476 ' CB ' ' HA ' ' A' ' 26' ' ' ASN . 38.1 ptt180 -76.11 53.65 0.81 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.479 0.657 . . . . 4.79 111.072 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.0 t -140.41 -51.43 0.48 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.533 -0.758 . . . . 2.83 110.201 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 41.5 mt-10 -69.09 150.8 47.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.832 0.348 . . . . 3.4 111.303 -177.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.675 ' HA ' ' HZ1' ' A' ' 20' ' ' LYS . 10.3 pt-20 -84.83 -15.46 44.71 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.834 0.679 . . . . 2.68 112.834 -174.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.635 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 5.7 p -149.13 149.28 15.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.868 0.365 . . . . 1.15 110.274 -172.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.72 HG22 ' HB3' ' A' ' 20' ' ' LYS . 44.2 t -120.72 118.83 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 121.906 0.86 . . . . 1.13 111.523 -173.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER -99.75 125.18 45.6 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.593 -1.639 . . . . 2.28 110.385 -175.164 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.48 HD23 ' HB ' ' A' ' 16' ' ' VAL . 10.1 tt -133.73 128.09 34.18 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.547 -0.297 . . . . 1.68 110.229 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.531 ' HB3' ' HB3' ' A' ' 79' ' ' GLN . 9.8 tp -101.37 114.27 28.12 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 107.347 -1.353 . . . . 1.1 107.347 174.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.978 HG22 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -111.37 150.29 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 CA-C-O 121.522 0.677 . . . . 1.39 109.665 -175.382 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.521 HG22 ' HG2' ' A' ' 50' ' ' LYS . 1.3 m -97.35 113.48 25.13 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 118.512 -1.275 . . . . 1.13 108.748 167.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.601 ' HG3' HE22 ' A' ' 72' ' ' GLN . 1.0 OUTLIER -91.9 153.9 19.2 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.14 -1.391 . . . . 2.34 109.951 -173.257 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.467 ' N ' ' HG2' ' A' ' 111' ' ' ARG . 0.1 OUTLIER -125.1 -95.16 0.47 Allowed 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.692 -0.403 . . . . 1.97 111.675 -177.509 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.437 ' H ' ' CG ' ' A' ' 112' ' ' GLN . 9.0 t -149.78 38.33 0.75 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.645 0.736 . . . . 2.0 110.764 -170.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 6.3 mt -106.28 -25.28 12.02 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.21 -0.905 . . . . 2.0 109.225 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.443 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 4.7 mm-40 -57.95 152.67 15.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.365 -1.288 . . . . 3.83 110.727 173.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -86.97 26.0 1.22 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.383 -0.371 . . . . 3.96 111.03 -173.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 62.68 21.5 12.77 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.643 -0.708 . . . . 3.76 111.665 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 13.7 p -81.43 136.34 23.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.075 -0.511 . . . . 5.11 111.551 -175.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 64.49 -90.18 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.174 -0.921 . . . . 8.35 111.909 177.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 53.52 54.7 9.66 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 122.884 0.473 . . . . 6.63 111.396 -177.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 73.6 m -76.16 75.09 3.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.088 0.47 . . . . 8.94 111.339 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 74.9 mmm -151.1 150.44 30.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.598 -0.728 . . . . 12.46 109.905 177.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.4 mt -111.76 153.18 26.91 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.739 -0.467 . . . . 13.06 109.739 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.3 m . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.606 -0.712 . . . . 14.64 109.685 -178.722 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 123.362 1.553 . . . . 2.0899999999999999 111.175 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.65 178.77 5.36 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 112.515 -2.13 . . . . 0.95999999999999996 110.509 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.0 t -106.32 110.95 33.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.762 -0.654 . . . . 1.5700000000000001 110.52 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.855 HG22 HG23 ' A' ' 110' ' ' THR . 33.6 t -77.66 108.45 10.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.751 -0.462 . . . . 1.02 109.751 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 1.036 ' HG2' ' HD3' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -113.33 169.47 8.93 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.257 -0.577 . . . . 1.3899999999999999 111.801 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 15' ' ' ARG . 1.9 mmm180 -115.43 126.76 54.75 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.016 0.436 . . . . 3.6299999999999999 111.719 -175.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.602 HG13 ' CB ' ' A' ' 69' ' ' ALA . 26.2 t -107.39 121.85 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.614 -0.721 . . . . 1.02 109.323 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -143.82 111.94 6.26 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.748 -0.464 . . . . 1.3500000000000001 109.748 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.494 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 9.6 tp -139.18 148.79 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.568 -0.901 . . . . 0.60999999999999999 108.568 -176.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 16.5 m-70 -79.36 115.8 19.22 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.981 -0.687 . . . . 0.59999999999999998 109.411 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.865 ' HB2' HD12 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -26.93 139.07 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 O-C-N 125.142 1.526 . . . . 4.0 112.715 178.402 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.1 tp -97.66 93.91 6.67 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 121.418 -0.802 . . . . 0.55000000000000004 110.31 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -60.81 143.06 55.43 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.366 0.603 . . . . 3.9700000000000002 112.183 -173.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.545 ' HB2' HD13 ' A' ' 28' ' ' ILE . 20.5 tp60 -140.88 94.9 2.77 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.283 -0.871 . . . . 1.3500000000000001 109.493 174.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.86 -82.49 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.042 -0.599 . . . . 1.3300000000000001 112.506 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.531 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 18.2 mt-10 -118.4 -17.35 9.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.098 0.475 . . . . 2.3300000000000001 110.561 -177.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.484 ' OD1' ' HB3' ' A' ' 23' ' ' GLN . 1.0 OUTLIER -112.85 -177.66 3.19 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.895 -0.593 . . . . 1.8700000000000001 111.679 -169.162 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.865 HD12 ' HB2' ' A' ' 20' ' ' LYS . 2.1 pt? -126.98 138.25 53.23 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.764 -1.199 . . . . 2.2799999999999998 107.764 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.545 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.3 mp -101.46 130.14 51.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.42 0.628 . . . . 0.80000000000000004 110.4 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.481 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -96.08 125.47 40.64 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.088 -1.414 . . . . 1.74 108.652 172.051 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -85.47 41.24 3.05 Favored Glycine 0 C--O 1.22 -0.745 0 C-N-CA 120.386 -0.911 . . . . 0.68999999999999995 112.648 -175.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.619 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 42.5 p90 -157.07 154.67 29.86 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 122.752 0.421 . . . . 0.51000000000000001 110.385 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.497 ' CB ' ' HB2' ' A' ' 59' ' ' ARG . 8.1 t -103.98 159.25 15.82 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.085 -1.45 . . . . 0.53000000000000003 107.085 169.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.401 HG12 ' N ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -160.69 141.59 3.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 112.745 0.646 . . . . 0.48999999999999999 112.745 -165.282 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.438 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -144.44 119.16 1.23 Allowed Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 110.089 -1.205 . . . . 0.71999999999999997 110.089 157.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.972 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.92 118.14 1.27 Allowed Glycine 0 CA--C 1.492 -1.358 0 CA-C-O 118.555 -1.136 . . . . 1.4199999999999999 111.621 171.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.734 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.69 143.77 8.58 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 117.483 -2.294 . . . . 0.47999999999999998 113.796 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.3 pt -61.65 -19.31 20.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.104 -1.073 . . . . 0.52000000000000002 108.104 149.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.832 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 0.4 OUTLIER -66.18 -35.15 79.71 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.749 -1.569 . . . . 0.71999999999999997 109.97 174.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 . . . . . 0 C--N 1.339 0.143 0 CA-C-N 115.065 -0.971 . . . . 1.1899999999999999 110.713 -178.013 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.414 ' C ' HD12 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.431 -1.696 0 N-CA-C 110.901 -0.88 . . . . 0.78000000000000003 110.901 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.972 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -111.32 141.45 26.67 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 N-CA-C 107.297 -1.372 . . . . 0.54000000000000004 107.297 176.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.688 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER -152.21 145.2 24.49 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 119.405 1.002 . . . . 1.4199999999999999 110.99 -177.627 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.758 HG12 ' H ' ' A' ' 75' ' ' ASP . 2.7 p -85.59 133.23 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-N 114.597 -1.183 . . . . 0.57999999999999996 110.471 -171.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 37.7 m -100.09 -16.23 17.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.942 -1.026 . . . . 1.1100000000000001 110.822 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.671 ' HA ' HG23 ' A' ' 73' ' ' ILE . 72.2 mtt180 -149.04 -169.4 3.36 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.667 0.618 . . . . 2.27 112.667 175.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 59' ' ' ARG . 79.4 t -167.84 138.27 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 113.271 -1.786 . . . . 0.82999999999999996 107.212 163.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.5 p -82.29 126.27 31.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.232 0.539 . . . . 1.6499999999999999 110.88 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -57.19 112.24 1.31 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.429 -1.259 . . . . 1.8500000000000001 110.841 171.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.0 -2.43 66.13 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.51 -0.852 . . . . 0.92000000000000004 112.566 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.578 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -92.33 173.58 35.92 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 120.569 -0.824 . . . . 0.98999999999999999 111.623 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.493 ' HB2' HG12 ' A' ' 18' ' ' ILE . 64.8 Cg_endo -70.7 -22.81 27.25 Favored 'Trans proline' 0 CA--C 1.504 -1.002 0 C-N-CA 122.732 2.288 . . . . 0.44 113.477 -165.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.56 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -66.84 -32.7 74.15 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.731 -1.122 . . . . 0.35999999999999999 110.882 176.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -77.74 -30.08 51.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.236 0.541 . . . . 1.79 109.609 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.578 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.3 mp -68.98 -36.98 76.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.374 -0.83 . . . . 0.51000000000000001 109.629 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.602 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -78.11 -25.34 47.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.746 -0.661 . . . . 0.40999999999999998 110.838 176.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.89 43.62 1.9 Allowed Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.355 -0.926 . . . . 0.45000000000000001 113.874 177.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.462 ' O ' HG21 ' A' ' 60' ' ' VAL . 14.1 tp -95.1 148.7 22.07 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.44 -0.948 . . . . 0.89000000000000001 108.44 174.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.64 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 84.9 mt-30 -134.28 40.07 3.04 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 116.018 1.858 . . . . 1.21 116.018 -161.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.671 HG23 ' HA ' ' A' ' 59' ' ' ARG . 59.1 mt 69.85 -11.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 114.654 1.353 . . . . 0.77000000000000002 114.654 162.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.37 43.72 0.33 Allowed Glycine 0 CA--C 1.508 -0.348 0 C-N-CA 120.163 -1.018 . . . . 0.37 111.846 -170.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.758 ' H ' HG12 ' A' ' 57' ' ' VAL . 9.3 m-20 -119.61 141.27 49.45 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.047 -0.576 . . . . 0.89000000000000001 111.831 -168.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.688 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -87.47 102.95 15.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.333 -0.849 . . . . 2.2000000000000002 111.16 -175.352 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.551 HD12 ' CA ' ' A' ' 56' ' ' TYR . 5.1 mt -73.63 122.99 27.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 114.772 -1.104 . . . . 0.48999999999999999 111.874 -177.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.787 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 2.2 mmt -93.32 -9.19 39.75 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.945 -1.025 . . . . 1.0600000000000001 113.399 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.606 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -167.88 150.99 5.86 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.05 0.452 . . . . 0.81999999999999995 112.196 -178.608 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.713 ' HB ' ' HE1' ' A' ' 85' ' ' MET . 40.6 t -133.05 112.06 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 114.927 -1.033 . . . . 1.3100000000000001 110.316 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.943 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 14.4 m120 57.4 27.85 14.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.727 -0.669 . . . . 1.5 112.613 174.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.84 -13.37 53.22 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 119.987 -1.101 . . . . 0.38 112.353 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.416 ' HE1' ' CZ ' ' A' ' 96' ' ' ARG . 74.1 m95 -80.68 170.16 16.68 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.875 -0.787 . . . . 0.77000000000000002 108.875 176.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -115.47 112.88 22.92 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.098 0.475 . . . . 1.8899999999999999 111.141 -172.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.713 ' HE1' ' HB ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -106.28 100.88 10.39 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 122.43 1.11 . . . . 1.01 110.676 -177.849 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.9 p -137.22 -41.27 0.58 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.536 -1.665 . . . . 1.05 107.73 173.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.61 73.98 1.34 Allowed 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 112.777 -2.01 . . . . 1.6200000000000001 108.31 174.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.734 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.2 t -135.57 140.76 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 108.89 -0.782 . . . . 1.0900000000000001 108.89 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.668 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 70.1 p -55.77 148.75 15.89 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.08 0.467 . . . . 0.34999999999999998 112.111 -177.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.832 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 21.8 t-160 -54.28 -42.94 70.59 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-O 121.616 0.722 . . . . 0.34999999999999998 110.131 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.72 -30.38 66.9 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.188 -1.369 . . . . 1.6699999999999999 110.445 -177.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.6 ' HB3' HG13 ' A' ' 88' ' ' VAL . 1.8 tp-100 -60.05 -47.62 85.12 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 122.039 0.923 . . . . 0.77000000000000002 108.537 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.637 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -74.47 -40.95 61.54 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.433 -1.258 . . . . 0.33000000000000002 110.444 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -66.22 -40.66 90.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.639 -0.71 . . . . 2.1000000000000001 110.715 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 1.2 tmtp? -64.33 -38.01 89.53 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 116.006 -0.543 . . . . 0.95999999999999996 109.541 -177.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.432 ' HB2' HG11 ' A' ' 80' ' ' VAL . 9.9 mmm180 -64.83 -48.9 72.69 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.823 -0.626 . . . . 3.5699999999999998 111.352 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.447 HD13 HD13 ' A' ' 29' ' ' LEU . 3.8 pp -79.25 -1.86 38.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.467 -0.333 . . . . 1.6499999999999999 111.756 -176.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.545 ' HA ' HD21 ' A' ' 27' ' ' LEU . 3.3 m -115.84 23.55 12.18 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 122.114 0.959 . . . . 1.53 109.884 173.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 1.006 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 5.8 mmpt? -81.76 112.56 19.03 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.431 -0.804 . . . . 2.7200000000000002 108.983 169.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.531 ' HD2' ' O ' ' A' ' 25' ' ' GLU . 35.6 ptt180 -71.26 19.06 0.06 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.652 -0.704 . . . . 4.3799999999999999 111.023 -177.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.543 ' H ' ' C ' ' A' ' 99' ' ' LYS . 5.8 p -115.02 -22.96 9.29 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.32 -0.855 . . . . 2.5099999999999998 109.948 -176.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -72.0 91.86 1.25 Allowed 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 122.13 0.967 . . . . 3.3999999999999999 109.956 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.578 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 5.2 tp10 -52.5 -29.63 26.04 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.142 -1.845 . . . . 2.6800000000000002 111.107 175.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 7.7 p -134.63 141.95 41.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.882 -0.784 . . . . 0.44 108.882 176.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.4 t -114.21 118.81 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 122.053 0.93 . . . . 0.46000000000000002 112.168 -171.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.943 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.3 OUTLIER -101.08 126.16 47.75 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.584 -1.643 . . . . 1.76 111.942 -173.506 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.545 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 9.4 tt -134.75 129.11 34.14 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.316 -0.402 . . . . 1.1200000000000001 109.999 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.787 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 24.5 tp -102.73 124.27 47.95 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 106.489 -1.671 . . . . 0.41999999999999998 106.489 175.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.714 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -127.47 145.22 35.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 119.147 -1.021 . . . . 0.77000000000000002 111.648 -174.431 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.855 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -99.54 113.38 25.74 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.611 -0.836 . . . . 0.34000000000000002 109.737 166.004 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 1.036 ' HD3' ' HG2' ' A' ' 14' ' ' GLN . 1.1 ptt180 -107.19 127.35 53.43 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.281 -1.327 . . . . 2.0099999999999998 108.943 -174.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.629 ' N ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -99.53 -55.99 2.52 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.838 0.681 . . . . 1.97 112.838 -165.422 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.473 ' N ' ' HG2' ' A' ' 112' ' ' GLN . 1.4 t -159.93 19.13 0.16 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.181 -0.608 . . . . 1.6200000000000001 111.037 -173.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 121.671 0.748 . . . . 1.6499999999999999 109.271 178.317 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 N--CA 1.429 -1.52 0 CA-C-O 121.995 0.902 . . . . 2.0899999999999999 110.651 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.427 ' HB1' ' O ' ' A' ' 111' ' ' ARG . . . -94.52 179.25 5.34 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.629 -1.623 . . . . 0.95999999999999996 109.662 176.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 m -112.91 124.02 69.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.235 0.541 . . . . 1.5700000000000001 110.523 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.734 HG22 HG23 ' A' ' 110' ' ' THR . 21.5 t -81.76 106.22 12.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.27 0.557 . . . . 1.02 110.025 -175.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.747 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -101.74 170.05 8.42 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.289 -0.869 . . . . 1.3899999999999999 112.051 -177.235 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -115.02 139.83 49.54 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 116.112 -0.494 . . . . 3.6299999999999999 111.359 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.65 HG13 ' CB ' ' A' ' 69' ' ' ALA . 12.4 t -128.86 126.46 64.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.868 -0.79 . . . . 1.02 108.868 173.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -142.09 121.52 13.21 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 122.11 -0.369 . . . . 1.3500000000000001 110.188 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.545 HG12 ' HB2' ' A' ' 65' ' ' PRO . 10.9 tp -145.15 147.53 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 N-CA-C 108.973 -0.751 . . . . 0.60999999999999999 108.973 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.757 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 13.5 m-70 -76.15 114.83 15.26 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.62 -0.511 . . . . 0.59999999999999998 109.62 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.822 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -28.82 129.27 0.08 Allowed 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.437 1.086 . . . . 4.0 112.358 176.476 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.5 tp -99.88 89.94 4.25 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.469 0.652 . . . . 0.55000000000000004 109.857 -173.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -77.58 143.49 38.28 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.185 -0.916 . . . . 3.9700000000000002 112.213 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -128.53 94.17 3.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.844 -1.071 . . . . 1.3500000000000001 108.142 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.31 -83.65 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.607 -0.806 . . . . 1.3300000000000001 111.671 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -137.59 12.51 2.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.224 0.535 . . . . 2.3300000000000001 110.724 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -115.93 135.73 53.71 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 108.584 -0.895 . . . . 1.8700000000000001 108.584 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.498 HD23 ' HG3' ' A' ' 20' ' ' LYS . 9.6 mp -107.42 123.78 48.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.585 0.707 . . . . 2.2799999999999998 110.959 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.441 ' O ' ' HE2' ' A' ' 20' ' ' LYS . 1.9 mp -98.15 129.47 48.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 114.933 -1.03 . . . . 0.80000000000000004 110.06 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.442 HD22 ' OG1' ' A' ' 98' ' ' THR . 0.1 OUTLIER -89.81 -31.08 17.54 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.791 -0.641 . . . . 1.74 110.867 -176.603 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.857 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 86.55 9.92 74.44 Favored Glycine 0 C--O 1.224 -0.501 0 C-N-CA 120.591 -0.814 . . . . 0.68999999999999995 112.559 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.611 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 47.0 p90 -150.28 149.53 30.27 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.72 0.295 . . . . 0.51000000000000001 110.237 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.725 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -102.47 150.19 23.63 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.827 -0.805 . . . . 0.53000000000000003 108.827 172.935 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.46 HG12 ' N ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -157.01 145.35 11.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 112.283 0.475 . . . . 0.48999999999999999 112.283 -163.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.46 ' N ' HG12 ' A' ' 33' ' ' ILE . . . -142.1 119.0 1.37 Allowed Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 110.572 -1.011 . . . . 0.71999999999999997 110.572 157.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.957 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -139.38 118.59 1.54 Allowed Glycine 0 CA--C 1.493 -1.328 0 CA-C-O 118.388 -1.229 . . . . 1.4199999999999999 111.119 170.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -168.6 142.8 7.65 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 117.751 -2.166 . . . . 0.47999999999999998 113.258 178.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.731 HG12 ' O ' ' A' ' 87' ' ' MET . 0.5 OUTLIER -65.71 -22.6 31.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 106.726 -1.583 . . . . 0.52000000000000002 106.726 153.839 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.758 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 1.1 t70 -58.18 -36.72 73.48 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 112.839 -1.982 . . . . 0.71999999999999997 109.222 169.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 . . . . . 0 CA--C 1.53 0.184 0 CA-C-N 115.165 -0.925 . . . . 1.1899999999999999 110.488 -175.448 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.048 0 N-CA-C 109.984 -1.246 . . . . 0.78000000000000003 109.984 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.957 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.7 mp -114.48 125.14 71.72 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.765 0 N-CA-C 108.225 -1.028 . . . . 0.54000000000000004 108.225 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.929 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.8 OUTLIER -145.4 148.33 33.22 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 119.984 1.266 . . . . 1.4199999999999999 112.261 -172.157 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.69 HG12 ' H ' ' A' ' 75' ' ' ASP . 3.4 p -87.11 136.46 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-N 114.172 -1.376 . . . . 0.57999999999999996 110.489 -173.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.3 m -106.33 -15.01 14.94 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.034 -0.984 . . . . 1.1100000000000001 110.615 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.725 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 42.1 mtp180 -149.82 -167.16 2.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.024 0.75 . . . . 2.27 113.024 177.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 51.0 t -161.88 154.9 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 106.197 -1.779 . . . . 0.82999999999999996 106.197 166.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.463 ' N ' HG12 ' A' ' 60' ' ' VAL . 59.2 p -104.41 131.33 51.89 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.622 0.725 . . . . 1.6499999999999999 111.552 176.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -63.42 107.57 1.14 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.464 -1.244 . . . . 1.8500000000000001 111.281 175.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.74 -14.95 45.56 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 115.144 -0.935 . . . . 0.92000000000000004 111.58 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.503 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -78.32 178.22 52.95 Favored Glycine 0 N--CA 1.438 -1.171 0 C-N-CA 120.514 -0.85 . . . . 0.98999999999999999 111.451 177.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.857 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 97.4 Cg_endo -74.77 -27.15 10.73 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 122.379 2.053 . . . . 0.44 113.334 -168.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.611 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -66.11 -26.41 67.45 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.169 -0.923 . . . . 0.35999999999999999 111.139 176.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -72.94 -31.45 64.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.805 0.812 . . . . 1.79 109.114 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.503 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -76.19 -39.8 35.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.908 -1.042 . . . . 0.51000000000000001 110.631 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.65 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -77.85 -15.59 58.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.0 -0.545 . . . . 0.40999999999999998 110.757 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.16 67.06 1.34 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.522 -0.847 . . . . 0.45000000000000001 113.44 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.487 HD21 HG21 ' A' ' 57' ' ' VAL . 17.8 tp -110.1 151.99 26.55 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.763 -0.829 . . . . 0.89000000000000001 108.763 175.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.515 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 65.8 mt-30 -123.06 28.98 6.94 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 115.701 1.741 . . . . 1.21 115.701 -164.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.634 HG23 ' HA ' ' A' ' 59' ' ' ARG . 75.5 mt 69.78 2.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-N 119.455 1.025 . . . . 0.77000000000000002 113.308 167.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.89 48.36 0.19 Allowed Glycine 0 CA--C 1.51 -0.237 0 C-N-CA 119.528 -1.32 . . . . 0.37 112.77 -170.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.69 ' H ' HG12 ' A' ' 57' ' ' VAL . 50.7 m-20 -120.83 145.92 47.1 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.376 -0.412 . . . . 0.89000000000000001 110.852 -172.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.909 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 32.4 mmtt -97.23 105.48 17.63 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 121.35 0.595 . . . . 2.2000000000000002 109.845 -174.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.991 HG13 HG23 ' A' ' 109' ' ' VAL . 2.7 mp -73.03 125.64 32.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.33 0.586 . . . . 0.48999999999999999 112.139 -177.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.723 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 1.5 mmt -91.5 -18.37 24.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 113.504 -1.68 . . . . 1.0600000000000001 111.769 177.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.742 ' HB2' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -171.88 157.62 4.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.972 0.415 . . . . 0.81999999999999995 111.357 -175.212 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.835 HG21 ' HB3' ' A' ' 97' ' ' LEU . 6.5 p -145.45 120.84 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.859 -0.61 . . . . 1.3100000000000001 110.576 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.814 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 19.6 m-80 54.88 29.81 12.72 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.503 -0.771 . . . . 1.5 112.264 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.35 -19.85 46.89 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.255 -0.974 . . . . 0.38 112.503 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -86.21 120.68 27.84 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.678 -0.86 . . . . 0.77000000000000002 108.678 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.742 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 6.6 p-10 -88.56 114.86 25.62 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 114.99 -1.005 . . . . 1.8899999999999999 111.289 -172.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.73 ' HB3' HD13 ' A' ' 55' ' ' ILE . 12.0 mmt -107.32 103.24 12.55 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.847 -1.07 . . . . 1.01 110.965 -175.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.0 p -106.96 -20.77 13.22 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.801 -0.636 . . . . 1.05 110.075 172.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.731 ' O ' HG12 ' A' ' 37' ' ' ILE . 1.8 mtt -143.66 -42.96 0.28 Allowed 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.278 -0.874 . . . . 1.6200000000000001 111.901 -172.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.754 ' O ' HD11 ' A' ' 55' ' ' ILE . 1.9 p -49.5 165.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 114.874 1.435 . . . . 1.0900000000000001 114.874 -158.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 80.6 p -54.78 151.94 7.81 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.423 0.897 . . . . 0.34999999999999998 113.423 -175.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.77 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 18.2 t-160 -59.38 -40.63 87.18 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.427 -0.806 . . . . 0.34999999999999998 110.116 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.93 -32.17 73.24 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.292 -1.322 . . . . 1.6699999999999999 109.779 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.773 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 4.1 tp-100 -61.6 -52.22 65.27 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.929 -0.767 . . . . 0.77000000000000002 108.929 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.678 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -75.29 -34.78 61.34 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.15 -0.932 . . . . 0.33000000000000002 110.69 -176.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -63.9 -36.58 84.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.118 0.485 . . . . 2.1000000000000001 109.808 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.487 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -69.07 -36.04 77.18 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.809 -0.632 . . . . 0.95999999999999996 109.823 178.933 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.773 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 20.8 mmt180 -75.87 -26.12 56.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.048 -0.524 . . . . 3.5699999999999998 111.517 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.835 ' HB3' HG21 ' A' ' 80' ' ' VAL . 4.2 pp -88.47 -26.7 21.94 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 111.905 0.335 . . . . 1.6499999999999999 111.905 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.513 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 67.1 m -148.72 109.77 4.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.642 0.734 . . . . 1.53 110.289 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.404 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 7.4 ptpp? -126.99 16.95 7.31 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.641 -1.163 . . . . 2.7200000000000002 110.857 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.433 ' CA ' HD22 ' A' ' 27' ' ' LEU . 60.2 mtt180 66.69 6.03 4.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.965 -1.016 . . . . 4.3799999999999999 111.829 175.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.474 ' C ' ' HG3' ' A' ' 102' ' ' GLU . 1.4 p -146.32 70.4 1.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.197 0.522 . . . . 2.5099999999999998 111.002 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.644 ' HB2' ' HG3' ' A' ' 20' ' ' LYS . 14.9 mt-10 -142.26 151.86 42.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.716 -0.675 . . . . 3.3999999999999999 110.733 -173.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -111.5 -29.15 7.88 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.765 -0.652 . . . . 2.6800000000000002 110.62 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.757 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 6.3 p -150.6 146.23 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.99 -0.55 . . . . 0.44 109.58 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.73 HG21 ' HG2' ' A' ' 20' ' ' LYS . 31.5 t -126.63 119.91 54.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 CA-C-O 122.227 1.013 . . . . 0.46000000000000002 112.361 -171.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.814 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 1.1 mpt_? -99.47 135.32 41.05 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.138 -1.846 . . . . 1.76 110.959 -175.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.604 HD11 HG12 ' A' ' 77' ' ' ILE . 19.9 tp -133.58 137.97 45.77 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.589 -0.278 . . . . 1.1200000000000001 110.6 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.723 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 38.8 tp -116.05 120.52 39.34 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.259 -1.386 . . . . 0.41999999999999998 107.259 172.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.991 HG23 HG13 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -130.18 152.2 37.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 121.22 0.533 . . . . 0.77000000000000002 110.712 -174.352 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.734 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -96.58 116.06 28.46 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.502 -0.772 . . . . 0.34000000000000002 109.377 168.763 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.427 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 7.8 ttt180 -100.58 135.56 41.83 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.187 -0.915 . . . . 2.0099999999999998 110.547 -176.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.447 ' HG2' ' CD2' ' A' ' 114' ' ' LEU . 0.2 OUTLIER -117.26 -108.48 0.37 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.96 -0.564 . . . . 1.97 110.559 176.855 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.9 t -115.12 28.6 8.59 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.239 0.542 . . . . 1.6200000000000001 111.074 -170.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.515 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 3.1 mm? . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 116.038 -0.528 . . . . 1.6499999999999999 111.509 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.43 -1.443 0 CA-C-O 122.217 1.008 . . . . 2.0899999999999999 111.589 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.42 177.09 5.29 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 113.581 -1.645 . . . . 0.95999999999999996 109.337 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -123.66 127.92 74.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.231 0.538 . . . . 1.5700000000000001 111.064 -177.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.672 HG22 HG23 ' A' ' 110' ' ' THR . 15.9 t -83.63 111.12 19.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.68 -0.489 . . . . 1.02 109.68 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 1.018 HE22 HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -115.36 170.44 8.39 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.56 -0.746 . . . . 1.3899999999999999 112.581 -174.224 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -123.9 113.86 19.06 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.65 -0.705 . . . . 3.6299999999999999 110.544 -175.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 1.018 HG23 HE22 ' A' ' 14' ' ' GLN . 4.1 t -99.61 110.07 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 109.082 -0.71 . . . . 1.02 109.082 174.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -123.11 118.14 27.0 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.337 -0.616 . . . . 1.3500000000000001 109.337 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.58 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 10.9 tp -138.12 145.73 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 108.673 -0.862 . . . . 0.60999999999999999 108.673 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 11.0 m-70 -76.21 116.51 16.97 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.977 -0.689 . . . . 0.59999999999999998 109.529 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.583 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -23.65 133.89 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 O-C-N 125.037 1.461 . . . . 4.0 112.31 176.345 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.3 tp -95.84 89.11 5.15 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.992 0.901 . . . . 0.55000000000000004 110.379 -175.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -63.46 136.68 57.76 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.497 -1.229 . . . . 3.9700000000000002 111.56 -173.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -132.99 94.47 3.37 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.983 -1.008 . . . . 1.3500000000000001 108.437 175.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.01 -82.17 0.18 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.394 -0.908 . . . . 1.3300000000000001 111.394 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -129.3 -5.93 4.83 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.148 0.499 . . . . 2.3300000000000001 110.629 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.566 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 5.9 m-80 -94.0 169.95 9.9 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.711 -0.677 . . . . 1.8700000000000001 109.889 -174.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 20' ' ' LYS . 2.0 pt? -128.39 126.74 41.25 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.698 -1.223 . . . . 2.2799999999999998 107.698 171.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.42 138.15 23.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 109.441 -0.578 . . . . 0.80000000000000004 109.441 -176.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.48 ' HG ' ' CE2' ' A' ' 31' ' ' PHE . 18.3 tp -91.5 -33.0 15.36 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.879 -1.055 . . . . 1.74 110.572 -171.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.683 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 89.87 -38.05 3.27 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.765 -0.731 . . . . 0.68999999999999995 112.122 177.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.83 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 52.3 p90 -113.5 155.67 24.93 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 122.803 -0.233 . . . . 0.51000000000000001 110.766 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.571 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 12.5 t -101.89 163.87 12.02 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.905 -1.146 . . . . 0.53000000000000003 107.905 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.42 HD12 HD21 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -160.36 140.68 3.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 C-N-CA 120.981 -0.288 . . . . 0.48999999999999999 111.352 -164.58 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -143.06 120.15 1.49 Allowed Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 110.547 -1.021 . . . . 0.71999999999999997 110.547 158.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 1.048 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -138.35 119.09 1.72 Allowed Glycine 0 CA--C 1.492 -1.387 0 CA-C-O 118.784 -1.009 . . . . 1.4199999999999999 110.771 171.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.897 ' HA3' ' HG2' ' A' ' 39' ' ' GLN . . . -156.13 118.52 0.85 Allowed Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 118.251 -1.928 . . . . 0.47999999999999998 113.37 -170.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.594 HG12 ' C ' ' A' ' 88' ' ' VAL . 20.8 pt -64.4 -21.38 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 105.728 -1.953 . . . . 0.52000000000000002 105.728 145.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.77 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 14.3 t70 -64.55 -36.42 84.17 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 112.672 -2.058 . . . . 0.71999999999999997 110.782 171.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.897 ' HG2' ' HA3' ' A' ' 36' ' ' GLY . 25.4 mm-40 . . . . . 0 C--N 1.349 0.586 0 N-CA-C 112.486 0.55 . . . . 1.1899999999999999 112.486 -171.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.509 ' C ' HD12 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.442 -0.931 0 N-CA-C 111.878 -0.489 . . . . 0.78000000000000003 111.878 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.048 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.9 mp -118.76 147.13 22.46 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 N-CA-C 108.404 -0.961 . . . . 0.54000000000000004 108.404 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.805 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -155.48 156.35 35.09 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 118.97 0.805 . . . . 1.4199999999999999 111.215 178.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.55 ' CG1' ' H ' ' A' ' 75' ' ' ASP . 8.1 p -92.38 132.84 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-N 115.481 -0.781 . . . . 0.57999999999999996 110.92 -173.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.5 m -103.89 -17.14 15.14 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.497 -1.229 . . . . 1.1100000000000001 111.467 -174.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.926 ' HA ' HG23 ' A' ' 73' ' ' ILE . 46.2 mtt180 -143.63 -175.41 4.56 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.982 1.104 . . . . 2.27 113.982 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 59' ' ' ARG . 75.4 t -167.73 111.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 112.959 -1.928 . . . . 0.82999999999999996 106.956 161.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.5 m -79.56 128.47 33.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.212 0.53 . . . . 1.6499999999999999 110.655 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -50.43 116.59 1.97 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.679 -1.146 . . . . 1.8500000000000001 111.47 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.29 -20.39 30.52 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.241 -0.89 . . . . 0.92000000000000004 112.931 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.74 172.96 55.17 Favored Glycine 0 CA--C 1.502 -0.762 0 C-N-CA 120.345 -0.931 . . . . 0.98999999999999999 111.771 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.683 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 73.2 Cg_endo -71.45 -19.2 28.92 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.43 2.087 . . . . 0.44 113.184 -169.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.83 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -67.2 -28.91 68.47 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.654 -1.157 . . . . 0.35999999999999999 111.643 175.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -73.13 -34.85 66.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 122.013 0.911 . . . . 1.79 109.151 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.479 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.4 mp -74.44 -38.06 45.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.526 -1.215 . . . . 0.51000000000000001 110.221 -177.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.708 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -80.17 -20.26 45.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.361 -0.382 . . . . 0.40999999999999998 110.699 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.13 65.24 1.12 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.37 -0.919 . . . . 0.45000000000000001 114.017 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.54 HD21 HG21 ' A' ' 57' ' ' VAL . 18.1 tp -113.34 155.56 24.97 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.357 -0.609 . . . . 0.89000000000000001 109.357 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.976 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 12.3 mt-30 -124.23 31.13 5.86 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 115.176 1.547 . . . . 1.21 115.176 -166.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.926 HG23 ' HA ' ' A' ' 59' ' ' ARG . 42.6 mt 68.55 1.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 113.201 0.815 . . . . 0.77000000000000002 113.201 166.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -172.53 51.02 0.17 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 119.757 -1.211 . . . . 0.37 112.355 -168.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.55 ' H ' ' CG1' ' A' ' 57' ' ' VAL . 32.1 m-20 -121.45 151.8 39.82 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.358 -0.608 . . . . 0.89000000000000001 109.358 -175.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.805 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 64.0 mmtt -95.33 122.14 37.72 Favored 'General case' 0 C--O 1.208 -1.084 0 CA-C-O 121.302 0.572 . . . . 2.2000000000000002 110.55 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.713 HG12 HD11 ' A' ' 107' ' ' LEU . 8.5 mt -88.11 125.36 41.53 Favored 'Isoleucine or valine' 0 C--O 1.258 1.525 0 CA-C-O 121.309 0.576 . . . . 0.48999999999999999 112.006 -174.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.841 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -96.74 -16.4 20.89 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.202 -1.817 . . . . 1.0600000000000001 111.649 -177.515 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.749 ' HB3' HD23 ' A' ' 108' ' ' LEU . 0.9 OUTLIER -168.99 150.51 4.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.729 0.299 . . . . 0.81999999999999995 111.481 -175.33 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.73 ' HB ' ' CE ' ' A' ' 85' ' ' MET . 3.3 t -139.36 118.59 13.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.807 -0.633 . . . . 1.3100000000000001 110.811 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.896 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 12.9 m120 52.87 31.05 10.06 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.01 -0.541 . . . . 1.5 111.856 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.11 -5.7 59.44 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.293 -0.956 . . . . 0.38 113.042 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.526 ' HE1' ' CZ ' ' A' ' 96' ' ' ARG . 54.7 m95 -87.03 175.21 8.22 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 110.091 -0.336 . . . . 0.77000000000000002 110.091 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -115.88 113.2 23.01 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.751 -0.659 . . . . 1.8899999999999999 109.938 -173.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.73 ' CE ' ' HB ' ' A' ' 80' ' ' VAL . 19.6 mmt -107.14 100.59 10.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.949 0.881 . . . . 1.01 110.152 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.4 p -132.98 -35.85 1.05 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.408 -1.269 . . . . 1.05 107.98 171.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.28 78.17 0.57 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 113.755 -1.566 . . . . 1.6200000000000001 109.996 176.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.594 ' C ' HG12 ' A' ' 37' ' ' ILE . 1.4 p -137.7 164.21 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 109.5 -0.555 . . . . 1.0900000000000001 109.5 174.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.747 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 61.7 p -63.04 151.39 40.0 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.348 0.594 . . . . 0.34999999999999998 112.312 -176.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.77 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 20.4 t-160 -61.86 -34.97 76.95 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-O 121.589 0.709 . . . . 0.34999999999999998 109.882 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.65 -31.55 69.7 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 113.97 -1.468 . . . . 1.6699999999999999 109.618 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.583 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 4.8 tp60 -61.59 -52.21 65.34 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.681 -0.859 . . . . 0.77000000000000002 108.681 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.646 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.08 -41.45 77.51 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.528 -1.214 . . . . 0.33000000000000002 110.188 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.419 ' HA ' HD11 ' A' ' 97' ' ' LEU . 34.3 ttp180 -64.89 -41.32 95.71 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.157 -0.929 . . . . 2.1000000000000001 111.201 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.659 ' HE3' ' HD3' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -68.33 -29.16 67.83 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 121.168 0.509 . . . . 0.95999999999999996 109.848 -177.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.583 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 12.8 mmm180 -74.96 -48.77 22.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.023 -0.535 . . . . 3.5699999999999998 112.276 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.5 pp -82.6 -4.81 58.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.021 0.439 . . . . 1.6499999999999999 111.493 -178.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.2 m -138.12 78.7 1.7 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 122.137 0.97 . . . . 1.53 109.379 175.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.659 ' HD3' ' HE3' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -84.78 -79.18 0.23 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.006 -1.452 . . . . 2.7200000000000002 110.347 -178.88 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.41 ' H ' ' HB3' ' A' ' 99' ' ' LYS . 26.8 ptt180 174.11 -26.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.158 -0.928 . . . . 4.3799999999999999 111.059 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.7 m -160.89 40.05 0.16 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.955 0.407 . . . . 2.5099999999999998 110.396 -171.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 46.1 mm-40 -58.86 156.61 11.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.838 -0.619 . . . . 3.3999999999999999 110.714 175.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.58 ' HG3' HG12 ' A' ' 104' ' ' VAL . 6.0 pt-20 -84.74 -38.52 19.57 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.636 0.732 . . . . 2.6800000000000002 109.474 172.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.58 HG12 ' HG3' ' A' ' 103' ' ' GLU . 3.1 p -156.8 156.04 4.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 114.745 -1.116 . . . . 0.44 108.332 -176.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.6 t -115.87 117.81 56.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 122.11 0.957 . . . . 0.46000000000000002 111.643 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.896 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 1.4 mpt_? -100.55 123.73 45.15 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 113.422 -1.717 . . . . 1.76 111.626 -171.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.713 HD11 HG12 ' A' ' 77' ' ' ILE . 28.4 tp -132.12 125.77 32.1 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.88 -0.6 . . . . 1.1200000000000001 110.756 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.841 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 31.8 tp -108.18 120.88 43.61 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 107.688 -1.227 . . . . 0.41999999999999998 107.688 172.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.742 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -132.95 150.33 32.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.398 0.618 . . . . 0.77000000000000002 110.635 -172.212 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.672 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -95.76 116.58 29.09 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.295 -0.866 . . . . 0.34000000000000002 109.37 168.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.63 ' CB ' ' HG2' ' A' ' 14' ' ' GLN . 27.4 ttt180 -110.58 139.75 45.54 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.474 -1.239 . . . . 2.0099999999999998 110.755 -169.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.66 -90.87 0.57 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.531 0.567 . . . . 1.97 112.531 -176.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.8 m -151.33 41.75 0.73 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 112.539 0.57 . . . . 1.6200000000000001 112.539 -164.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.976 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 0.3 OUTLIER . . . . . 0 C--N 1.32 -0.683 0 N-CA-C 109.516 -0.55 . . . . 1.6499999999999999 109.516 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.433 -1.304 0 CA-C-O 122.167 0.984 . . . . 2.0899999999999999 108.906 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.7 165.84 23.17 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.51 -1.677 . . . . 0.95999999999999996 111.075 173.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.97 132.03 71.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 115.456 -0.793 . . . . 1.5700000000000001 110.123 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.501 ' CG1' HD11 ' A' ' 108' ' ' LEU . 59.1 t -87.14 119.1 34.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.342 0.591 . . . . 1.02 111.497 -173.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.764 ' HG2' ' HD2' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -114.04 171.17 7.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.542 -0.753 . . . . 1.3899999999999999 111.585 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.429 ' NE ' HD13 ' A' ' 108' ' ' LEU . 26.7 mmt180 -115.55 137.77 51.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.929 0.395 . . . . 3.6299999999999999 111.959 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.611 HG13 ' CB ' ' A' ' 69' ' ' ALA . 23.0 t -123.55 123.4 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 109.234 -0.654 . . . . 1.02 109.234 171.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -144.78 123.87 12.85 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.831 -0.433 . . . . 1.3500000000000001 109.831 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.547 HG21 ' HB2' ' A' ' 65' ' ' PRO . 10.2 tp -144.88 150.2 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 109.279 -0.638 . . . . 0.60999999999999999 109.279 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 15.5 m-70 -81.0 109.93 16.06 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.231 -0.655 . . . . 0.59999999999999998 109.231 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.412 ' HD3' ' N ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -27.49 135.22 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 O-C-N 125.228 1.58 . . . . 4.0 113.094 -177.579 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.1 tp -101.65 90.36 4.01 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.737 -0.468 . . . . 0.55000000000000004 109.737 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 26.8 ptt180 -70.35 144.89 51.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.312 0.577 . . . . 3.9700000000000002 111.191 -173.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -124.21 93.78 4.02 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.745 -0.835 . . . . 1.3500000000000001 108.745 173.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.57 -88.85 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.625 -0.59 . . . . 1.3300000000000001 111.625 -174.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.448 ' HB3' HH21 ' A' ' 100' ' ' ARG . 28.9 mm-40 -110.3 -5.45 15.25 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.261 -0.47 . . . . 2.3300000000000001 111.524 -177.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.405 ' O ' HD12 ' A' ' 27' ' ' LEU . 10.3 m-80 -105.8 171.47 7.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.083 -0.508 . . . . 1.8700000000000001 111.143 -173.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.826 HD13 ' HA ' ' A' ' 100' ' ' ARG . 7.8 mp -124.58 125.51 44.28 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.284 -1.006 . . . . 2.2799999999999998 108.284 172.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.5 mm -97.18 116.22 38.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 109.291 -0.633 . . . . 0.80000000000000004 109.291 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.815 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.8 pt? -78.52 -32.6 48.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.684 -1.143 . . . . 1.74 110.707 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.639 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 82.51 17.08 69.4 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.487 -0.863 . . . . 0.68999999999999995 113.027 173.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.642 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 48.1 p90 -154.24 161.49 41.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.733 0.267 . . . . 0.51000000000000001 110.691 173.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.61 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 11.6 t -106.11 158.68 16.64 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.219 -1.03 . . . . 0.53000000000000003 108.219 173.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -160.33 138.8 2.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 112.521 0.563 . . . . 0.48999999999999999 112.521 -164.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.423 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -139.26 118.24 1.5 Allowed Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 119.679 -1.248 . . . . 0.71999999999999997 110.283 156.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 1.035 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -140.26 117.42 1.29 Allowed Glycine 0 CA--C 1.492 -1.365 0 CA-C-O 118.925 -0.931 . . . . 1.4199999999999999 111.657 170.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.671 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.01 143.51 8.35 Favored Glycine 0 C--N 1.3 -1.47 0 C-N-CA 118.364 -1.874 . . . . 0.47999999999999998 112.563 174.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.412 HG12 ' C ' ' A' ' 88' ' ' VAL . 9.8 pt -62.14 -22.26 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 107.797 -1.186 . . . . 0.52000000000000002 107.797 152.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.676 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 1.1 t70 -56.46 -47.7 78.61 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.473 -1.694 . . . . 0.71999999999999997 110.345 171.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 . . . . . 0 C--O 1.231 0.123 0 CA-C-N 114.866 -1.061 . . . . 1.1899999999999999 111.248 -174.041 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 86' ' ' THR . . . . . . . . 0 N--CA 1.446 -0.691 0 N-CA-C 111.295 -0.722 . . . . 0.78000000000000003 111.295 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.035 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -110.68 137.4 43.26 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.166 0 N-CA-C 106.666 -1.605 . . . . 0.54000000000000004 106.666 170.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.665 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -152.2 147.12 26.03 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 119.655 1.116 . . . . 1.4199999999999999 111.215 -176.224 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 75' ' ' ASP . 7.7 p -87.15 139.65 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 114.728 -1.124 . . . . 0.57999999999999996 110.05 -172.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.9 m -110.88 -14.21 14.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.181 -0.918 . . . . 1.1100000000000001 111.107 -174.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.841 ' HA ' HG23 ' A' ' 73' ' ' ILE . 37.6 mtt180 -146.86 -167.56 2.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.234 0.827 . . . . 2.27 113.234 175.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.533 HG13 ' HB3' ' A' ' 66' ' ' ALA . 63.9 t -161.58 148.66 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 112.413 -2.176 . . . . 0.82999999999999996 106.44 162.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.4 p -91.82 137.33 32.45 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.06 0.457 . . . . 1.6499999999999999 110.654 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -62.94 109.08 1.34 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.769 -1.105 . . . . 1.8500000000000001 111.367 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.26 -10.89 67.49 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.484 -0.865 . . . . 0.92000000000000004 111.903 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.526 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -75.47 173.29 53.26 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 120.766 -0.731 . . . . 0.98999999999999999 111.525 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.639 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 73.2 Cg_endo -72.25 -24.63 19.64 Favored 'Trans proline' 0 C--N 1.32 -0.935 0 C-N-CA 122.842 2.361 . . . . 0.44 113.252 -166.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.642 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -64.14 -31.38 72.55 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.717 -1.129 . . . . 0.35999999999999999 111.283 176.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -74.49 -36.35 63.25 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.517 0.675 . . . . 1.79 109.189 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -64.79 -42.44 94.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.673 -1.149 . . . . 0.51000000000000001 110.104 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.611 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -73.0 -24.4 60.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.40999999999999998 110.543 175.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.66 58.3 1.06 Allowed Glycine 0 C--O 1.226 -0.354 0 C-N-CA 120.509 -0.853 . . . . 0.45000000000000001 113.722 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.521 HD21 HG21 ' A' ' 57' ' ' VAL . 14.8 tp -102.77 154.25 19.36 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.876 -0.787 . . . . 0.89000000000000001 108.876 175.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.581 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 6.5 mt-30 -129.33 34.19 4.42 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 115.604 1.705 . . . . 1.21 115.604 -166.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.841 HG23 ' HA ' ' A' ' 59' ' ' ARG . 59.8 mt 69.2 0.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 N-CA-C 113.34 0.867 . . . . 0.77000000000000002 113.34 165.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -174.18 55.68 0.14 Allowed Glycine 0 C--N 1.33 0.22 0 C-N-CA 119.984 -1.103 . . . . 0.37 112.914 -169.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.601 ' H ' HG12 ' A' ' 57' ' ' VAL . 31.7 m-20 -122.72 142.3 50.85 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.644 -0.278 . . . . 0.89000000000000001 111.524 -173.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.665 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 1.4 mptm? -83.31 102.8 12.22 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-O 120.983 0.421 . . . . 2.2000000000000002 111.062 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.624 ' HB ' HG22 ' A' ' 55' ' ' ILE . 6.9 mt -76.56 125.85 36.69 Favored 'Isoleucine or valine' 0 C--O 1.254 1.337 0 C-N-CA 123.617 0.767 . . . . 0.48999999999999999 111.594 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.775 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 9.1 mmt -90.52 -27.84 18.92 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.195 -1.366 . . . . 1.0600000000000001 112.046 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.584 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 1.0 OUTLIER -159.52 150.6 19.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.858 0.361 . . . . 0.81999999999999995 111.448 -171.523 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.673 HG12 ' SD ' ' A' ' 85' ' ' MET . 11.2 p -137.05 126.49 37.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.868 -0.605 . . . . 1.3100000000000001 110.474 174.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.682 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 4.3 t-20 57.99 22.82 9.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.154 -0.93 . . . . 1.5 112.171 170.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.92 -5.52 46.69 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 119.683 -1.246 . . . . 0.38 113.316 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -92.75 156.85 16.76 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 109.471 -0.566 . . . . 0.77000000000000002 109.471 175.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -111.94 99.17 7.89 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.075 -0.511 . . . . 1.8899999999999999 110.682 -175.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.909 ' HB2' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -111.0 100.41 9.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.642 0.734 . . . . 1.01 112.091 -178.598 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.525 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 14.6 p -103.23 -35.62 8.38 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.867 -1.16 . . . . 1.05 107.867 165.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.07 76.6 1.55 Allowed 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.415 -1.72 . . . . 1.6200000000000001 109.187 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.671 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -138.22 157.28 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 108.724 -0.843 . . . . 1.0900000000000001 108.724 175.247 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.656 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 81.1 p -62.7 154.59 28.95 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 112.995 0.739 . . . . 0.34999999999999998 112.995 -177.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.796 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 21.8 t-160 -58.69 -38.69 78.8 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-N 115.289 -0.868 . . . . 0.34999999999999998 110.464 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.89 -30.95 67.45 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.169 -1.378 . . . . 1.6699999999999999 109.732 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.622 ' HB3' HG13 ' A' ' 88' ' ' VAL . 1.6 tp-100 -63.82 -46.58 84.45 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.672 0.749 . . . . 0.77000000000000002 109.265 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.622 ' HB2' HG12 ' A' ' 55' ' ' ILE . . . -74.3 -36.17 63.72 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.025 -0.989 . . . . 0.33000000000000002 110.756 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -67.23 -41.19 86.13 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.232 0.539 . . . . 2.1000000000000001 110.514 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -68.1 -34.79 77.05 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.291 -0.868 . . . . 0.95999999999999996 109.516 -177.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -75.46 -33.43 60.85 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.709 -0.678 . . . . 3.5699999999999998 111.335 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.597 HD11 ' CZ ' ' A' ' 31' ' ' PHE . 3.1 tt -54.99 -61.04 2.57 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.385 -1.28 . . . . 1.6499999999999999 111.861 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.516 HG23 HD22 ' A' ' 97' ' ' LEU . 12.6 p -110.36 -78.84 0.59 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.485 -0.486 . . . . 1.53 112.124 -176.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 19.2 ttpt 70.05 -2.65 2.0 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.806 0.812 . . . . 2.7200000000000002 112.185 176.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.826 ' HA ' HD13 ' A' ' 27' ' ' LEU . 78.4 mtp180 71.69 23.23 3.77 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.168 -0.924 . . . . 4.3799999999999999 112.515 171.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.426 ' OG ' ' HG2' ' A' ' 99' ' ' LYS . 4.9 p -154.94 29.04 0.42 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.92 0.711 . . . . 2.5099999999999998 112.92 -174.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -97.98 166.2 11.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.971 0.415 . . . . 3.3999999999999999 111.731 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.538 ' HG3' HG12 ' A' ' 104' ' ' VAL . 18.7 pt-20 -114.05 -28.61 7.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.592 0.711 . . . . 2.6800000000000002 110.159 177.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.56 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 3.9 p -152.92 143.05 14.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 107.756 -1.202 . . . . 0.44 107.756 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.6 t -115.2 117.5 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-O 122.238 1.018 . . . . 0.46000000000000002 111.817 -170.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.682 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 1.3 mpt_? -99.82 129.02 45.88 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 113.036 -1.893 . . . . 1.76 111.118 -173.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.528 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 19.7 tp -133.31 129.61 37.77 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.87 -0.604 . . . . 1.1200000000000001 109.931 177.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.775 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 22.6 tp -106.04 113.61 27.25 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 107.389 -1.337 . . . . 0.41999999999999998 107.389 173.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.733 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.5 OUTLIER -121.9 143.96 32.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 C-N-CA 119.998 -0.681 . . . . 0.77000000000000002 110.523 -173.092 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.501 HG23 HG22 ' A' ' 13' ' ' VAL . 1.3 m -96.77 120.31 36.87 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.313 -0.858 . . . . 0.34000000000000002 110.623 173.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.764 ' HD2' ' HG2' ' A' ' 14' ' ' GLN . 7.7 ttt180 -90.74 153.41 20.28 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.57 -1.195 . . . . 2.0099999999999998 109.794 -176.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.429 ' N ' ' CD ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -145.98 -60.82 0.32 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.134 0.791 . . . . 1.97 113.134 -168.299 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.9 t -157.77 10.87 0.19 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.89 0.376 . . . . 1.6200000000000001 111.727 -174.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 3.1 mm? . . . . . 0 C--N 1.325 -0.49 0 O-C-N 122.13 -0.356 . . . . 1.6499999999999999 111.44 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.2 p . . . . . 0 N--CA 1.429 -1.499 0 CA-C-O 122.057 0.932 . . . . 2.0899999999999999 110.447 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -102.16 165.23 11.26 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.69 -1.595 . . . . 0.95999999999999996 109.359 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.9 m -117.61 136.8 53.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 116.131 -0.486 . . . . 1.5700000000000001 109.913 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.805 HG12 HG23 ' A' ' 110' ' ' THR . 3.1 m -88.16 120.65 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 122.311 1.053 . . . . 1.02 110.878 -177.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.743 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -97.51 170.99 8.66 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 113.939 -1.482 . . . . 1.3899999999999999 110.545 178.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -115.9 116.55 28.17 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.064 0.394 . . . . 3.6299999999999999 112.064 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.695 HG13 ' CB ' ' A' ' 69' ' ' ALA . 3.9 t -104.58 118.19 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 109.352 -0.61 . . . . 1.02 109.352 173.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -132.3 115.75 16.02 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.335 -0.848 . . . . 1.3500000000000001 109.117 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.632 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 9.3 tp -144.58 152.37 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 109.002 -0.74 . . . . 0.60999999999999999 109.002 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 10.3 m-70 -79.99 114.32 18.82 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.621 -0.881 . . . . 0.59999999999999998 108.621 174.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.979 ' HB2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -25.33 139.25 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.906 1.379 . . . . 4.0 113.335 177.739 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.641 HD22 ' HD3' ' A' ' 65' ' ' PRO . 32.3 tp -98.91 91.48 5.07 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 119.177 -1.009 . . . . 0.55000000000000004 109.451 -177.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 28.7 ptt180 -76.24 135.91 39.68 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.617 0.722 . . . . 3.9700000000000002 111.316 -173.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.573 ' HB2' HD13 ' A' ' 28' ' ' ILE . 25.0 tp60 -119.36 94.88 4.57 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.04 -0.982 . . . . 1.3500000000000001 108.422 176.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.53 -80.47 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.729 -0.748 . . . . 1.3300000000000001 111.318 -173.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -134.9 10.95 3.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.003 0.43 . . . . 2.3300000000000001 110.567 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 11.5 m-80 -110.35 173.89 6.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.963 -0.562 . . . . 1.8700000000000001 110.625 -176.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.979 HD13 ' HB2' ' A' ' 20' ' ' LYS . 7.3 tp -127.11 123.75 37.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.378 0.608 . . . . 2.2799999999999998 110.061 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.573 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.7 mp -98.81 132.51 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.227 -0.897 . . . . 0.80000000000000004 108.955 175.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.696 HD13 HD21 ' A' ' 97' ' ' LEU . 0.6 OUTLIER -84.09 -42.74 15.78 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 114.657 -1.156 . . . . 1.74 109.964 -174.653 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.522 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 92.57 13.49 56.89 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 115.099 -0.955 . . . . 0.68999999999999995 111.479 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.591 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 24.4 p90 -155.33 172.66 17.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.517 -0.179 . . . . 0.51000000000000001 110.517 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.932 ' HB3' ' O ' ' A' ' 58' ' ' THR . 5.6 t -112.81 170.79 7.94 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.578 -0.897 . . . . 0.53000000000000003 108.578 169.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 5.2 tt -148.36 136.4 14.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 120.448 -0.501 . . . . 0.48999999999999999 112.138 -167.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -103.58 170.73 19.55 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.869 -0.892 . . . . 0.71999999999999997 110.869 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.593 ' HA2' ' CG ' ' A' ' 90' ' ' HIS . . . -103.97 166.13 15.5 Favored Glycine 0 N--CA 1.418 -2.52 0 N-CA-C 117.828 1.891 . . . . 1.4199999999999999 117.828 -163.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.708 ' HA3' ' O ' ' A' ' 88' ' ' VAL . . . -86.37 -143.24 7.29 Favored Glycine 0 N--CA 1.417 -2.623 0 CA-C-N 110.073 -3.064 . . . . 0.47999999999999998 113.392 -173.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.662 HD13 ' O ' ' A' ' 87' ' ' MET . 10.6 pt -83.52 -4.77 8.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.02 -0.59 . . . . 0.52000000000000002 112.213 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.983 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 11.3 p-10 -70.91 -32.43 69.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.852 0.358 . . . . 0.71999999999999997 110.511 -175.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.519 -0.221 0 N-CA-C 108.752 -0.833 . . . . 1.1899999999999999 108.752 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.6 0 N-CA-C 107.896 -2.082 . . . . 0.78000000000000003 107.896 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.718 HG22 HD13 ' A' ' 77' ' ' ILE . 2.2 mp -93.74 119.43 41.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 119.89 1.845 . . . . 0.54000000000000004 108.943 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.785 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -151.78 131.26 12.98 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.188 0.994 . . . . 1.4199999999999999 110.122 -170.584 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.958 HG21 HD21 ' A' ' 71' ' ' LEU . 1.2 t -62.05 139.93 20.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 113.594 -1.639 . . . . 0.57999999999999996 112.22 -173.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.932 ' O ' ' HB3' ' A' ' 32' ' ' SER . 6.4 m -129.28 64.17 1.48 Allowed 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.613 -1.176 . . . . 1.1100000000000001 109.216 173.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.63 ' C ' ' HA ' ' A' ' 73' ' ' ILE . 15.4 mtt180 148.97 -171.22 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 125.391 1.476 . . . . 2.27 111.475 163.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 61.9 t -161.13 130.42 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 113.028 -1.897 . . . . 0.82999999999999996 106.635 163.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.8 m -88.43 123.57 33.1 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.154 0.502 . . . . 1.6499999999999999 109.991 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.492 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 77.3 mt-10 -52.1 118.54 3.56 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.935 -1.03 . . . . 1.8500000000000001 111.876 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.79 -3.02 60.55 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.203 -0.908 . . . . 0.92000000000000004 111.907 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.42 172.2 39.2 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.613 -0.803 . . . . 0.98999999999999999 111.503 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.641 ' HD3' HD22 ' A' ' 21' ' ' LEU . 92.2 Cg_endo -74.1 -24.69 14.6 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 122.962 2.441 . . . . 0.44 113.408 -168.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.591 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -67.51 -23.91 65.51 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.05 -0.977 . . . . 0.35999999999999999 110.928 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.492 ' OE1' ' HA ' ' A' ' 62' ' ' GLU . 28.2 tt0 -75.7 -36.77 59.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.771 0.796 . . . . 1.79 108.935 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.525 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.5 mp -73.35 -42.14 57.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.145 -1.389 . . . . 0.51000000000000001 110.351 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.695 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -71.23 -21.32 62.14 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.995 -0.548 . . . . 0.40999999999999998 111.026 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.46 54.3 1.09 Allowed Glycine 0 C--O 1.225 -0.437 0 C-N-CA 120.037 -1.078 . . . . 0.45000000000000001 114.174 174.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.958 HD21 HG21 ' A' ' 57' ' ' VAL . 6.5 tp -97.25 161.34 13.85 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.269 -0.641 . . . . 0.89000000000000001 109.269 174.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.6 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 4.7 pt20 -131.47 29.57 4.54 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 115.071 1.508 . . . . 1.21 115.071 -168.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.63 ' HA ' ' C ' ' A' ' 59' ' ' ARG . 2.3 mp 75.3 -6.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-O 120.975 0.417 . . . . 0.77000000000000002 111.349 173.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -164.82 66.32 0.22 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.851 -0.69 . . . . 0.37 111.628 -169.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.478 ' HB3' ' CG2' ' A' ' 109' ' ' VAL . 3.8 m-20 -118.8 135.88 54.29 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 115.613 -0.293 . . . . 0.89000000000000001 110.966 -169.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.5 mmtt -95.49 102.95 14.8 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 121.054 0.454 . . . . 2.2000000000000002 109.981 -174.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.785 HD12 ' HA ' ' A' ' 56' ' ' TYR . 2.9 mp -72.24 118.04 16.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 112.473 0.545 . . . . 0.48999999999999999 112.473 -171.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.98 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 1.3 mmt -93.61 -10.48 34.49 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.088 -0.96 . . . . 1.0600000000000001 112.869 177.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.634 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -172.23 154.01 3.2 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.329 0.492 . . . . 0.81999999999999995 112.329 -178.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.508 ' N ' ' HG3' ' A' ' 79' ' ' GLN . 87.8 t -133.08 105.59 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.68 -0.691 . . . . 1.3100000000000001 110.731 177.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.753 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 6.3 m120 55.13 33.22 19.98 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.969 0.729 . . . . 1.5 112.969 176.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.48 -12.26 50.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 119.77 -1.205 . . . . 0.38 112.202 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.44 ' NE1' ' HD2' ' A' ' 96' ' ' ARG . 90.2 m95 -75.92 162.69 27.9 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.875 -0.787 . . . . 0.77000000000000002 108.875 171.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -116.54 115.14 25.2 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.406 -0.361 . . . . 1.8899999999999999 110.466 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.431 ' SD ' HG11 ' A' ' 88' ' ' VAL . 21.4 mmt -106.89 101.4 10.84 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.567 0.699 . . . . 1.01 110.92 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.05 91.69 2.71 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.05 -0.977 . . . . 1.05 109.384 170.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.662 ' O ' HD13 ' A' ' 37' ' ' ILE . 0.1 OUTLIER 48.88 65.14 1.45 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.711 -1.131 . . . . 1.6200000000000001 110.332 -173.803 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.708 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 6.0 p -108.67 178.35 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 107.434 -1.321 . . . . 1.0900000000000001 107.434 170.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.983 ' HB ' ' HB3' ' A' ' 38' ' ' ASP . 49.2 p -66.27 147.89 52.66 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 119.093 0.86 . . . . 0.34999999999999998 111.601 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.593 ' CG ' ' HA2' ' A' ' 35' ' ' GLY . 20.7 t-160 -54.68 -38.46 67.01 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-O 122.121 0.962 . . . . 0.34999999999999998 108.827 174.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.47 -33.04 74.81 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 113.109 -1.86 . . . . 1.6699999999999999 109.865 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.758 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 3.7 tp-100 -59.45 -52.96 63.37 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 109.207 -0.664 . . . . 0.77000000000000002 109.207 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.642 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . -74.44 -35.73 63.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.233 -0.894 . . . . 0.33000000000000002 110.375 -175.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -61.06 -44.2 97.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.936 -0.574 . . . . 2.1000000000000001 110.356 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.63 ' HE3' ' O ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -71.2 -46.54 61.01 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.847 -0.615 . . . . 0.95999999999999996 109.439 -176.51 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.758 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 29.4 mmt180 -65.6 -25.33 67.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.035 -0.53 . . . . 3.5699999999999998 110.672 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.696 HD21 HD13 ' A' ' 29' ' ' LEU . 17.0 tp -68.45 -61.04 2.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.06 -0.518 . . . . 1.6499999999999999 111.603 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.851 ' HA ' HD23 ' A' ' 27' ' ' LEU . 2.5 m -69.44 -32.64 71.72 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.256 -0.646 . . . . 1.53 109.256 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.496 ' HB3' ' H ' ' A' ' 100' ' ' ARG . 0.4 OUTLIER 61.36 -105.72 0.21 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.713 -1.13 . . . . 2.7200000000000002 110.87 168.22 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.496 ' H ' ' HB3' ' A' ' 99' ' ' LYS . 59.9 mtm180 -143.99 14.49 1.69 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.813 -1.18 . . . . 4.3799999999999999 107.813 172.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.5 m 73.57 42.03 0.42 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.61 -1.177 . . . . 2.5099999999999998 111.015 -173.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -57.07 154.17 10.29 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.032 -0.531 . . . . 3.3999999999999999 109.793 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -58.99 -25.18 63.39 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.87 1.063 . . . . 2.6800000000000002 113.87 -164.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 7.2 p -146.38 151.91 14.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 120.758 -0.377 . . . . 0.44 110.298 -175.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.412 ' HA ' HD21 ' A' ' 81' ' ' ASN . 51.8 t -133.31 118.37 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.016 0 CA-C-O 122.344 1.069 . . . . 0.46000000000000002 112.266 -169.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.753 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -100.98 130.53 46.99 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 113.023 -1.899 . . . . 1.76 110.309 -177.01 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.679 HD11 HG12 ' A' ' 77' ' ' ILE . 34.3 tp -131.84 131.79 43.14 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.574 -0.528 . . . . 1.1200000000000001 109.574 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.98 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 15.3 tp -105.46 129.31 53.79 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 105.412 -2.07 . . . . 0.41999999999999998 105.412 172.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.743 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -140.97 146.5 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 C-N-CA 119.916 -0.714 . . . . 0.77000000000000002 110.267 -173.596 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.805 HG23 HG12 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -92.36 125.73 37.14 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.566 0.698 . . . . 0.34000000000000002 111.077 172.684 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.59 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 34.6 ttt180 -111.45 146.81 36.56 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.224 -1.353 . . . . 2.0099999999999998 110.958 -172.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.5 -105.66 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.637 -0.71 . . . . 1.97 111.232 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.7 t -136.15 36.34 2.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.2 0.524 . . . . 1.6200000000000001 111.708 -171.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.551 ' HB2' ' HG3' ' A' ' 72' ' ' GLN . 2.9 mt . . . . . 0 C--N 1.319 -0.734 0 CA-C-O 121.41 0.624 . . . . 1.6499999999999999 110.372 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.431 -1.407 0 CA-C-O 122.462 1.125 . . . . 2.0899999999999999 108.79 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.522 ' HB1' ' O ' ' A' ' 111' ' ' ARG . . . -65.73 174.08 2.52 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.09 -1.868 . . . . 0.95999999999999996 111.716 176.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.42 119.98 58.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.882 -1.053 . . . . 1.5700000000000001 110.041 -175.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.528 HG22 HG23 ' A' ' 110' ' ' THR . 94.0 t -76.29 106.64 6.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 122.035 0.921 . . . . 1.02 111.532 -175.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.532 ' O ' ' HB ' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -100.27 138.15 37.73 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.642 -1.617 . . . . 1.3899999999999999 110.66 177.381 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.594 ' HG2' ' HA ' ' A' ' 108' ' ' LEU . 3.3 tmm_? -124.7 121.1 33.72 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 120.869 -1.144 . . . . 3.6299999999999999 109.914 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.935 ' HB ' ' HB1' ' A' ' 69' ' ' ALA . 4.1 m -113.38 155.64 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 119.626 -0.83 . . . . 1.02 110.199 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -144.63 126.75 15.59 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.332 -0.849 . . . . 1.3500000000000001 109.145 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.559 HG12 ' HB2' ' A' ' 65' ' ' PRO . 7.8 tp -146.07 143.35 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 C-N-CA 119.728 -0.789 . . . . 0.60999999999999999 109.58 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.716 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.9 m-70 -72.6 112.11 8.37 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.735 -0.666 . . . . 0.59999999999999998 109.455 -176.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.805 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -31.58 135.69 0.06 Allowed 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.329 1.018 . . . . 4.0 113.331 178.911 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.0 tp -100.71 98.61 9.13 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.197 0.523 . . . . 0.55000000000000004 110.509 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -71.4 142.48 50.3 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.653 -0.703 . . . . 3.9700000000000002 111.124 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.512 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 2.5 tp60 -135.0 95.07 3.24 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.525 -0.762 . . . . 1.3500000000000001 109.398 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.27 -81.85 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.362 -0.923 . . . . 1.3300000000000001 112.14 -177.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -138.09 12.0 2.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.043 0.449 . . . . 2.3300000000000001 111.357 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.512 ' OD1' ' HB3' ' A' ' 23' ' ' GLN . 1.5 p30 -127.05 171.06 11.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.063 -0.517 . . . . 1.8700000000000001 110.715 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.475 HD21 ' HG2' ' A' ' 102' ' ' GLU . 10.3 mp -122.09 123.81 42.44 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.988 0.423 . . . . 2.2799999999999998 110.619 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.442 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.7 mp -99.13 135.6 33.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.959 -0.564 . . . . 0.80000000000000004 110.003 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.763 HD22 HD22 ' A' ' 97' ' ' LEU . 9.6 mt -86.8 -35.19 19.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.36 -0.837 . . . . 1.74 110.717 -174.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.87 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 89.87 10.48 64.76 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 115.321 -0.854 . . . . 0.68999999999999995 110.967 -172.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.751 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 25.7 p90 -156.84 160.35 39.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 122.342 0.257 . . . . 0.51000000000000001 110.793 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.534 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 22.1 t -104.1 160.7 14.63 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.77 -1.196 . . . . 0.53000000000000003 107.77 170.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.42 ' HA ' ' H ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -161.19 138.99 2.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 120.253 -0.579 . . . . 0.48999999999999999 112.561 -165.768 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -142.53 117.89 1.2 Allowed Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 110.431 -1.067 . . . . 0.71999999999999997 110.431 156.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 1.065 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -140.15 117.28 1.28 Allowed Glycine 0 CA--C 1.49 -1.524 0 CA-C-O 118.927 -0.929 . . . . 1.4199999999999999 111.518 171.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.711 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -165.41 144.46 9.29 Favored Glycine 0 C--N 1.3 -1.46 0 C-N-CA 118.17 -1.966 . . . . 0.47999999999999998 112.77 175.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.563 HG23 ' HA ' ' A' ' 87' ' ' MET . 8.8 pt -61.23 -20.64 22.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 107.577 -1.268 . . . . 0.52000000000000002 107.577 153.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.661 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 3.8 t70 -61.33 -37.87 84.84 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.239 -1.801 . . . . 0.71999999999999997 110.747 174.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 . . . . . 0 CA--C 1.534 0.354 0 CA-C-N 115.369 -0.832 . . . . 1.1899999999999999 112.658 -169.079 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.634 ' HA2' ' O ' ' A' ' 86' ' ' THR . . . . . . . . 0 N--CA 1.441 -1.016 0 N-CA-C 110.895 -0.882 . . . . 0.78000000000000003 110.895 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.065 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -106.53 146.44 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 106.522 -1.658 . . . . 0.54000000000000004 106.522 169.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.679 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -153.51 141.5 20.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 119.613 1.097 . . . . 1.4199999999999999 111.072 178.706 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.789 HG12 ' H ' ' A' ' 75' ' ' ASP . 2.5 p -81.5 132.39 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 CA-C-N 114.392 -1.276 . . . . 0.57999999999999996 109.374 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.42 ' H ' ' HA ' ' A' ' 33' ' ' ILE . 27.8 m -100.18 -18.52 16.86 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.075 -0.966 . . . . 1.1100000000000001 110.294 -173.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.816 ' HA ' HG23 ' A' ' 73' ' ' ILE . 50.5 mtt180 -146.34 -168.07 2.91 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.333 0.587 . . . . 2.27 112.022 174.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.605 HG13 ' HB3' ' A' ' 66' ' ' ALA . 75.4 t -166.33 146.75 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 113.003 -1.908 . . . . 0.82999999999999996 106.218 165.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.4 p -95.47 133.32 39.58 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.359 0.6 . . . . 1.6499999999999999 111.519 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -64.83 115.03 4.9 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.456 -1.247 . . . . 1.8500000000000001 110.138 171.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.88 -16.81 59.74 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 114.983 -1.008 . . . . 0.92000000000000004 112.171 -177.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.516 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -77.25 172.16 55.13 Favored Glycine 0 CA--C 1.502 -0.755 0 C-N-CA 120.588 -0.815 . . . . 0.98999999999999999 111.551 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.87 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 60.0 Cg_endo -73.27 -28.1 12.85 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.273 1.982 . . . . 0.44 113.214 -166.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.751 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -58.75 -32.97 69.74 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.269 -0.878 . . . . 0.35999999999999999 111.922 172.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -77.61 -28.94 51.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.558 0.694 . . . . 1.79 109.648 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.516 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -71.28 -41.15 74.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.199 -0.909 . . . . 0.51000000000000001 108.888 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.935 ' HB1' ' HB ' ' A' ' 16' ' ' VAL . . . -69.54 -31.2 69.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.249 -0.887 . . . . 0.40999999999999998 110.055 175.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.31 52.24 1.16 Allowed Glycine 0 CA--C 1.521 0.414 0 C-N-CA 121.043 -0.599 . . . . 0.45000000000000001 113.66 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.515 HD21 HG21 ' A' ' 57' ' ' VAL . 19.8 tp -102.46 155.74 18.06 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.254 -0.647 . . . . 0.89000000000000001 109.254 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.59 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 51.5 mt-30 -126.34 29.59 5.76 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 115.778 1.77 . . . . 1.21 115.778 -163.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.816 HG23 ' HA ' ' A' ' 59' ' ' ARG . 53.9 mt 72.52 1.58 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-N 119.102 0.864 . . . . 0.77000000000000002 113.026 166.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -172.24 51.41 0.17 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 119.668 -1.253 . . . . 0.37 113.118 -171.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.789 ' H ' HG12 ' A' ' 57' ' ' VAL . 21.1 m-20 -122.08 142.55 50.25 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.595 -0.302 . . . . 0.89000000000000001 111.736 -172.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.64 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 59.3 mttm -82.76 130.57 35.15 Favored 'General case' 0 C--O 1.207 -1.163 0 CA-C-O 121.138 0.494 . . . . 2.2000000000000002 109.668 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.679 HD12 ' HA ' ' A' ' 56' ' ' TYR . 2.8 mp -99.8 125.22 53.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 C-N-CA 122.689 0.396 . . . . 0.48999999999999999 110.562 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.768 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 7.5 mmt -90.81 -17.17 27.04 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 125.099 1.499 . . . . 1.0600000000000001 112.941 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 1.4 tt0 -163.99 151.48 12.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.041 0.448 . . . . 0.81999999999999995 112.128 -175.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.578 ' HB ' ' HE1' ' A' ' 85' ' ' MET . 39.5 t -130.51 105.07 10.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.344 -0.844 . . . . 1.3100000000000001 110.38 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.673 HD21 HG13 ' A' ' 105' ' ' VAL . 27.2 m-80 49.48 46.95 23.1 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.751 -0.659 . . . . 1.5 111.997 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.03 -15.17 61.93 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.337 -0.935 . . . . 0.38 112.978 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -85.58 170.16 12.85 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 109.782 -0.451 . . . . 0.77000000000000002 109.782 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -115.92 112.47 21.94 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.114 0.483 . . . . 1.8899999999999999 111.39 -172.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.578 ' HE1' ' HB ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -107.11 100.5 9.97 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.136 0.969 . . . . 1.01 110.922 -179.257 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.634 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 1.1 p -132.03 -58.38 0.96 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.939 -1.482 . . . . 1.05 107.408 170.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.563 ' HA ' HG23 ' A' ' 37' ' ' ILE . 1.3 mtt -125.36 79.33 1.8 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.642 -1.617 . . . . 1.6200000000000001 108.563 172.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.711 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.2 t -139.25 137.28 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 115.351 -0.841 . . . . 1.0900000000000001 108.879 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.661 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 79.3 p -56.78 152.6 12.16 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.333 0.587 . . . . 0.34999999999999998 112.529 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.766 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 21.0 t-160 -57.11 -38.18 73.03 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 115.552 -0.749 . . . . 0.34999999999999998 110.395 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.57 -32.05 69.29 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.491 -1.231 . . . . 1.6699999999999999 109.877 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.639 ' HB3' HG13 ' A' ' 88' ' ' VAL . 1.0 OUTLIER -65.7 -45.05 84.25 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 109.088 -0.708 . . . . 0.77000000000000002 109.088 -177.737 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.66 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -74.91 -37.41 62.08 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.173 -0.922 . . . . 0.33000000000000002 110.565 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.406 ' HD3' HH11 ' A' ' 94' ' ' ARG . 29.6 ttp180 -65.05 -37.53 87.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.048 -0.524 . . . . 2.1000000000000001 110.356 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.518 ' HE3' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -70.98 -40.79 71.71 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.631 -0.713 . . . . 0.95999999999999996 110.175 -177.678 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 13.1 mmm180 -69.06 -27.71 65.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.2 0.524 . . . . 3.5699999999999998 110.564 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.763 HD22 HD22 ' A' ' 29' ' ' LEU . 2.3 tt -78.59 -48.06 15.93 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.452 -0.795 . . . . 1.6499999999999999 110.426 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.4 HG23 ' HB2' ' A' ' 27' ' ' LEU . 2.3 m -108.74 70.24 0.74 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.51 -0.768 . . . . 1.53 110.389 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.518 ' HB2' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -108.98 8.9 26.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.661 0.743 . . . . 2.7200000000000002 110.839 -176.539 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 75.8 mtp180 73.0 20.41 3.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.622 -1.172 . . . . 4.3799999999999999 112.681 173.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.7 p -71.28 -46.02 61.82 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.457 -0.572 . . . . 2.5099999999999998 109.457 174.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.475 ' HG2' HD21 ' A' ' 27' ' ' LEU . 35.6 mt-10 68.18 6.06 5.03 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.148 -0.933 . . . . 3.3999999999999999 113.067 169.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.444 ' HG3' ' H ' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -70.58 -68.47 0.43 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.67 0.748 . . . . 2.6800000000000002 109.767 174.636 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.716 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 4.8 p -159.58 156.14 3.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.816 -1.084 . . . . 0.44 108.52 -176.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.723 HG21 ' HG2' ' A' ' 20' ' ' LYS . 3.1 t -132.11 119.88 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-O 121.958 0.885 . . . . 0.46000000000000002 112.968 -177.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.576 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 1.2 mpt_? -100.31 130.75 46.45 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.393 -1.731 . . . . 1.76 111.236 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.14 135.64 41.28 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.916 -0.314 . . . . 1.1200000000000001 110.592 172.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.768 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 26.2 tp -98.45 130.34 45.06 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 107.008 -1.479 . . . . 0.41999999999999998 107.008 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.592 HG13 ' HB3' ' A' ' 75' ' ' ASP . 2.2 t -128.32 142.53 43.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 121.611 0.719 . . . . 0.77000000000000002 111.317 -170.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.528 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -98.74 114.29 26.75 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.511 -0.768 . . . . 0.34000000000000002 109.973 164.806 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.522 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 20.1 ttt180 -98.68 146.52 25.78 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.102 -0.953 . . . . 2.0099999999999998 110.31 -175.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.471 ' N ' ' CD ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -136.22 -69.44 0.48 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.036 0.754 . . . . 1.97 113.036 -171.346 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.9 t -158.38 26.91 0.24 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.059 0.457 . . . . 1.6200000000000001 111.661 -173.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 4.0 mm? . . . . . 0 C--N 1.318 -0.781 0 N-CA-C 112.217 0.451 . . . . 1.6499999999999999 112.217 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.435 -1.207 0 CA-C-O 122.632 1.206 . . . . 2.0899999999999999 111.847 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.61 178.72 4.2 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.265 -1.789 . . . . 0.95999999999999996 110.09 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.6 t -120.49 117.17 52.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 116.081 -0.509 . . . . 1.5700000000000001 110.273 -174.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.705 HG22 HG23 ' A' ' 110' ' ' THR . 21.8 t -76.71 115.72 18.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.954 0.406 . . . . 1.02 109.942 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.999 HE22 HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -105.48 172.37 6.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.708 -0.678 . . . . 1.3899999999999999 110.637 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.629 ' NH1' ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -128.17 128.3 44.53 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.814 -0.175 . . . . 3.6299999999999999 110.919 172.41 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.999 HG23 HE22 ' A' ' 14' ' ' GLN . 24.2 t -102.08 132.54 47.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 110.196 -0.298 . . . . 1.02 110.196 173.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.629 ' HB2' ' NH1' ' A' ' 15' ' ' ARG . 10.1 tt0 -144.71 115.47 7.75 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.357 -0.238 . . . . 1.3500000000000001 110.357 171.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.545 HG12 ' HB2' ' A' ' 65' ' ' PRO . 9.0 tp -145.39 155.73 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 108.561 -0.903 . . . . 0.60999999999999999 108.561 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -83.39 116.59 22.56 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 119.711 -0.796 . . . . 0.59999999999999998 109.603 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -28.8 140.77 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.958 1.411 . . . . 4.0 112.441 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.431 HD22 ' HD3' ' A' ' 65' ' ' PRO . 39.6 tp -97.1 102.9 14.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.173 0.511 . . . . 0.55000000000000004 110.24 -173.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 12.3 ptp180 -71.11 141.17 50.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.571 -0.74 . . . . 3.9700000000000002 111.887 -175.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.567 ' HG3' HD13 ' A' ' 28' ' ' ILE . 6.7 mm-40 -132.66 92.28 3.04 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.398 -0.964 . . . . 1.3500000000000001 108.398 170.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.27 -68.29 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.053 -0.594 . . . . 1.3300000000000001 112.251 -173.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -147.08 12.42 1.08 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.45 0.643 . . . . 2.3300000000000001 109.829 -176.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.559 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 34.0 m-80 -112.17 161.77 16.18 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.276 -0.875 . . . . 1.8700000000000001 110.534 -174.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.79 ' HB2' HG23 ' A' ' 98' ' ' THR . 10.9 mp -121.93 113.07 19.09 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.758 -0.831 . . . . 2.2799999999999998 108.758 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.567 HD13 ' HG3' ' A' ' 23' ' ' GLN . 1.2 mp -97.88 133.43 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 CA-C-O 121.311 0.577 . . . . 0.80000000000000004 109.996 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.474 HD22 HD22 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -77.18 -41.29 42.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.647 -1.161 . . . . 1.74 109.832 -173.13 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.685 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 94.17 9.5 59.3 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.191 -0.913 . . . . 0.68999999999999995 111.036 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 31.0 p90 -156.18 177.51 11.35 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 122.659 0.384 . . . . 0.51000000000000001 110.299 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.445 ' H ' ' HB2' ' A' ' 59' ' ' ARG . 15.9 t -114.45 161.23 18.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.619 -1.252 . . . . 0.53000000000000003 107.619 169.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -161.45 136.09 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 112.6 0.593 . . . . 0.48999999999999999 112.6 -167.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.474 ' HA2' ' CD2' ' A' ' 90' ' ' HIS . . . -143.82 118.72 1.22 Allowed Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 110.518 -1.033 . . . . 0.71999999999999997 110.518 156.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 1.101 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -139.19 116.54 1.25 Allowed Glycine 0 CA--C 1.492 -1.36 0 CA-C-O 118.982 -0.899 . . . . 1.4199999999999999 111.148 172.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.52 140.4 6.24 Favored Glycine 0 C--N 1.3 -1.465 0 C-N-CA 118.139 -1.982 . . . . 0.47999999999999998 112.659 177.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.6 pt -58.26 -22.51 19.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 107.42 -1.326 . . . . 0.52000000000000002 107.42 151.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.796 ' HB2' ' CB ' ' A' ' 89' ' ' THR . 13.0 t70 -57.97 -43.71 86.64 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 113.223 -1.808 . . . . 0.71999999999999997 111.435 173.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 . . . . . 0 N--CA 1.466 0.349 0 CA-C-N 115.402 -0.817 . . . . 1.1899999999999999 112.629 -168.058 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.432 ' C ' HD12 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.422 -2.247 0 N-CA-C 108.813 -1.715 . . . . 0.78000000000000003 108.813 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.101 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -113.92 141.45 29.99 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 CA-C-N 118.935 1.368 . . . . 0.54000000000000004 109.002 173.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.585 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -142.64 142.25 32.05 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 119.036 0.834 . . . . 1.4199999999999999 110.791 -178.09 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.879 HG21 HD21 ' A' ' 71' ' ' LEU . 1.4 p -82.66 143.48 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-N 114.848 -1.069 . . . . 0.57999999999999996 109.66 178.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.9 m -110.87 -17.6 13.29 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 124.191 0.932 . . . . 1.1100000000000001 111.454 -173.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.452 ' CA ' ' HA ' ' A' ' 73' ' ' ILE . 78.7 mtt180 -152.56 -166.31 2.44 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.953 0.882 . . . . 2.27 112.097 175.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 8.7 p -173.35 139.58 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 112.982 -1.917 . . . . 0.82999999999999996 107.529 164.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.6 m -109.05 136.89 47.82 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.474 0.654 . . . . 1.6499999999999999 111.196 -173.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.37 125.93 26.2 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.555 -1.202 . . . . 1.8500000000000001 110.777 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.54 -18.02 58.02 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 114.671 -1.15 . . . . 0.92000000000000004 111.253 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.453 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -78.95 167.68 52.87 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.385 -0.912 . . . . 0.98999999999999999 111.016 174.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.685 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 91.3 Cg_endo -75.95 -19.33 16.03 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 122.861 2.374 . . . . 0.44 113.912 -169.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.536 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -73.05 -26.71 61.39 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.962 -1.017 . . . . 0.35999999999999999 111.695 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -72.88 -29.98 63.6 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.458 -0.941 . . . . 1.79 108.458 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.481 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.4 mp -77.85 -35.4 20.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.689 -1.141 . . . . 0.51000000000000001 110.095 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.794 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -81.66 -14.23 56.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.454 -0.794 . . . . 0.40999999999999998 111.504 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.0 60.48 1.19 Allowed Glycine 0 CA--C 1.522 0.473 0 C-N-CA 119.291 -1.433 . . . . 0.45000000000000001 114.314 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.879 HD21 HG21 ' A' ' 57' ' ' VAL . 35.2 tp -123.81 156.74 35.57 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.457 -0.572 . . . . 0.89000000000000001 109.457 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.84 ' HG3' ' HB2' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -148.9 81.12 1.43 Allowed 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 115.532 1.678 . . . . 1.21 115.532 -177.144 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.539 HG13 HG12 ' A' ' 60' ' ' VAL . 4.2 mp 62.82 -22.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 117.001 2.223 . . . . 0.77000000000000002 117.001 158.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -162.53 61.46 0.27 Allowed Glycine 0 CA--C 1.506 -0.51 0 O-C-N 120.732 -1.23 . . . . 0.37 112.194 -167.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.766 ' H ' HG12 ' A' ' 57' ' ' VAL . 61.7 m-20 -121.88 152.05 40.02 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.356 -0.422 . . . . 0.89000000000000001 110.668 -167.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.63 ' HD2' ' N ' ' A' ' 76' ' ' LYS . 3.7 mptt -103.8 101.61 11.43 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.79 0.805 . . . . 2.2000000000000002 109.548 -173.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 1.02 HG13 HG23 ' A' ' 109' ' ' VAL . 3.3 mp -71.22 121.71 21.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 114.523 -1.217 . . . . 0.48999999999999999 111.392 -176.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.858 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 1.4 mmt -89.05 -17.9 28.4 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 125.843 1.965 . . . . 1.0600000000000001 111.215 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.8 OUTLIER -172.12 153.25 3.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.808 0.337 . . . . 0.81999999999999995 111.74 -175.66 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.556 HG12 ' HE1' ' A' ' 85' ' ' MET . 9.8 p -139.66 125.31 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 121.323 0.583 . . . . 1.3100000000000001 109.87 175.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.927 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 13.0 m120 52.44 28.89 6.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.225 -0.898 . . . . 1.5 112.529 175.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.48 -16.64 44.44 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.093 -1.051 . . . . 0.38 113.309 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -87.56 148.58 24.81 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 109.475 -0.565 . . . . 0.77000000000000002 109.475 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -96.63 117.99 32.15 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.345 0.593 . . . . 1.8899999999999999 111.305 -174.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.556 ' HE1' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -106.71 102.33 11.71 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.834 0.826 . . . . 1.01 111.355 -178.503 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 p -123.16 -38.38 2.59 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.805 -1.088 . . . . 1.05 108.433 167.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.38 76.95 1.23 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.21 -1.359 . . . . 1.6200000000000001 109.255 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.65 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.5 OUTLIER -138.12 151.61 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 108.966 -0.753 . . . . 1.0900000000000001 108.966 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.796 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 75.2 p -60.51 151.45 28.48 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 112.888 0.699 . . . . 0.34999999999999998 112.888 -175.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.743 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 18.0 t-160 -57.71 -41.36 81.57 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 115.588 -0.733 . . . . 0.34999999999999998 110.467 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.65 -30.1 67.71 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.188 -1.369 . . . . 1.6699999999999999 109.964 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.553 ' HB3' HG13 ' A' ' 88' ' ' VAL . 2.4 tp-100 -62.55 -49.59 74.67 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.691 0.758 . . . . 0.77000000000000002 109.467 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.54 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -73.92 -31.88 63.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.988 -1.005 . . . . 0.33000000000000002 110.116 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -71.02 -41.8 70.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.411 -0.813 . . . . 2.1000000000000001 111.004 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.559 ' HD3' ' HD2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -71.42 -30.8 66.5 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 119.773 -0.771 . . . . 0.95999999999999996 109.873 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.559 ' HD2' ' HD3' ' A' ' 95' ' ' LYS . 2.4 mmm180 -67.41 -37.6 83.32 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.003 -0.679 . . . . 3.5699999999999998 110.954 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.496 HD11 ' CZ ' ' A' ' 31' ' ' PHE . 4.6 tt -58.68 -55.34 36.34 Favored 'General case' 0 C--N 1.316 -0.859 0 O-C-N 124.232 0.958 . . . . 1.6499999999999999 110.062 173.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.79 HG23 ' HB2' ' A' ' 27' ' ' LEU . 36.9 m -108.18 -94.96 0.39 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.789 -0.641 . . . . 1.53 112.55 -174.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 99' ' ' LYS . 0.3 OUTLIER 64.52 2.74 1.68 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.315 1.055 . . . . 2.7200000000000002 110.963 -175.843 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.699 ' H ' HG22 ' A' ' 98' ' ' THR . 41.6 mtm180 57.54 57.95 4.04 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.061 -1.427 . . . . 4.3799999999999999 110.862 -177.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.2 t -155.11 -48.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.27 -0.572 . . . . 2.5099999999999998 112.01 -175.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -53.83 135.44 41.86 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.044 0.449 . . . . 3.3999999999999999 112.026 -174.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -89.0 -16.14 32.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.47 0.652 . . . . 2.6800000000000002 110.54 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.7 p -152.47 148.54 14.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 108.39 -0.967 . . . . 0.44 108.39 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.0 t -114.42 117.61 56.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 122.229 1.014 . . . . 0.46000000000000002 112.621 -173.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.927 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.2 OUTLIER -101.3 124.9 47.72 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 113.411 -1.722 . . . . 1.76 110.681 -176.367 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.971 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 25.3 tp -132.74 126.73 33.12 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.398 -0.364 . . . . 1.1200000000000001 110.755 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.858 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 33.1 tp -109.96 115.94 30.71 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.105 -1.443 . . . . 0.41999999999999998 107.105 172.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 1.02 HG23 HG13 ' A' ' 77' ' ' ILE . 0.5 OUTLIER -128.23 149.51 33.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 121.397 0.617 . . . . 0.77000000000000002 110.591 -173.571 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.705 HG23 HG22 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -97.57 114.7 26.66 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.584 -0.734 . . . . 0.34000000000000002 109.61 168.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -99.16 139.03 35.42 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.281 -0.872 . . . . 2.0099999999999998 109.696 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.16 -73.08 0.65 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.854 0.359 . . . . 1.97 110.441 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.5 t 177.43 73.27 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.775 0.798 . . . . 1.6200000000000001 110.723 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.84 ' HB2' ' HG3' ' A' ' 72' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.312 -1.064 0 CA-C-N 114.677 -1.147 . . . . 1.6499999999999999 108.757 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.448 -0.55 0 CA-C-O 123.485 1.612 . . . . 2.0899999999999999 111.081 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.29 148.29 23.28 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 111.99 -2.368 . . . . 0.95999999999999996 108.0 168.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -95.42 130.38 44.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 121.185 0.517 . . . . 1.5700000000000001 111.133 -173.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.745 HG22 HG23 ' A' ' 110' ' ' THR . 44.9 t -83.36 110.92 18.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.327 0.585 . . . . 1.02 110.556 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.71 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -119.45 163.04 17.85 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.426 -0.807 . . . . 1.3899999999999999 109.757 175.145 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.475 ' HB3' ' CD1' ' A' ' 108' ' ' LEU . 2.3 ppt_? -127.08 124.45 39.27 Favored 'General case' 0 C--N 1.31 -1.113 0 O-C-N 121.491 -0.755 . . . . 3.6299999999999999 111.649 -174.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.735 HG13 ' CB ' ' A' ' 69' ' ' ALA . 9.6 t -90.85 125.2 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-N 115.255 -0.884 . . . . 1.02 110.23 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -123.86 114.32 19.69 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.926 -0.398 . . . . 1.3500000000000001 109.926 175.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.85 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 11.1 tp -144.57 137.12 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 109.108 -0.701 . . . . 0.60999999999999999 109.108 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.99 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 15.0 m-70 -65.27 115.91 6.06 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.887 -0.597 . . . . 0.59999999999999998 110.263 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.658 ' CG ' HD12 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -33.23 126.99 0.34 Allowed 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.364 1.04 . . . . 4.0 110.056 172.349 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.2 tp -103.58 79.59 1.7 Allowed 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 118.978 -1.089 . . . . 0.55000000000000004 111.398 -163.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.985 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 15.1 ptt-85 -60.87 136.18 58.0 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.481 -0.781 . . . . 3.9700000000000002 110.947 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.56 ' HB2' HG12 ' A' ' 28' ' ' ILE . 34.2 tp60 -122.11 94.44 4.3 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.212 -0.904 . . . . 1.3500000000000001 109.069 -174.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.24 -89.19 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.82 -0.705 . . . . 1.3300000000000001 112.211 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -115.97 -6.54 11.99 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.477 0.656 . . . . 2.3300000000000001 110.786 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.52 -178.08 3.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.384 -0.825 . . . . 1.8700000000000001 109.078 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.985 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.4 pt? -130.69 144.46 51.45 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.107 -1.071 . . . . 2.2799999999999998 108.107 167.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.56 HG12 ' HB2' ' A' ' 23' ' ' GLN . 11.6 mm -101.27 130.85 50.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-O 121.417 0.627 . . . . 0.80000000000000004 111.374 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.758 HD11 HD21 ' A' ' 97' ' ' LEU . 13.1 tp -74.18 -58.22 3.44 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.474 -1.239 . . . . 1.74 109.917 175.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.953 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 100.96 -0.13 55.04 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.316 -0.945 . . . . 0.68999999999999995 113.019 173.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.602 ' HD1' ' HB2' ' A' ' 66' ' ' ALA . 29.6 p90 -157.49 163.4 38.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.147 0.474 . . . . 0.51000000000000001 110.865 175.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.557 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 35.6 t -102.74 160.74 14.32 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.038 -1.097 . . . . 0.53000000000000003 108.038 173.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -161.77 141.77 2.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 C-N-CA 120.665 -0.414 . . . . 0.48999999999999999 111.99 -166.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.409 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -144.97 118.75 1.15 Allowed Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.361 -0.923 . . . . 0.71999999999999997 110.882 158.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 1.028 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -139.7 118.17 1.45 Allowed Glycine 0 CA--C 1.489 -1.539 0 CA-C-O 118.546 -1.141 . . . . 1.4199999999999999 110.49 172.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 1.013 ' HA3' ' HG2' ' A' ' 39' ' ' GLN . . . -156.18 117.05 0.75 Allowed Glycine 0 N--CA 1.434 -1.469 0 C-N-CA 117.909 -2.091 . . . . 0.47999999999999998 114.187 -171.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.598 HG23 ' O ' ' A' ' 87' ' ' MET . 5.1 pt -61.91 -26.61 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 104.798 -2.297 . . . . 0.52000000000000002 104.798 146.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.987 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 7.1 t70 -55.31 -47.78 75.09 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 112.052 -2.34 . . . . 0.71999999999999997 109.627 170.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 1.013 ' HG2' ' HA3' ' A' ' 36' ' ' GLY . 19.2 mm-40 . . . . . 0 C--N 1.345 0.407 0 CA-C-N 114.821 -1.081 . . . . 1.1899999999999999 111.374 -172.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 86' ' ' THR . . . . . . . . 0 N--CA 1.444 -0.772 0 N-CA-C 109.989 -1.244 . . . . 0.78000000000000003 109.989 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.028 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -108.33 146.07 14.61 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.855 0 CA-C-N 119.331 1.565 . . . . 0.54000000000000004 108.413 172.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.775 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -153.63 143.02 21.61 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.898 0.856 . . . . 1.4199999999999999 111.44 178.433 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.578 HG12 ' H ' ' A' ' 75' ' ' ASP . 8.4 p -83.11 127.96 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 CA-C-N 113.907 -1.497 . . . . 0.57999999999999996 110.229 -177.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.2 m -94.88 -19.25 20.44 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.68 -1.145 . . . . 1.1100000000000001 111.206 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.963 ' HA ' HG23 ' A' ' 73' ' ' ILE . 25.7 mtp180 -150.4 -165.15 2.19 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.92 0.711 . . . . 2.27 112.92 177.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 91.9 t -156.01 138.71 6.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 112.756 -2.02 . . . . 0.82999999999999996 107.202 161.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.1 m -94.9 121.58 36.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.226 0.536 . . . . 1.6499999999999999 110.217 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -52.74 127.6 23.75 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.531 -1.213 . . . . 1.8500000000000001 111.869 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.14 -4.38 84.54 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.614 -0.803 . . . . 0.92000000000000004 112.466 174.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.601 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -82.82 -153.2 12.53 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.256 -0.973 . . . . 0.98999999999999999 110.95 173.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.953 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 40.4 Cg_endo -94.72 -33.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.081 1.854 . . . . 0.44 115.018 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.602 ' HB2' ' HD1' ' A' ' 31' ' ' PHE . . . -66.72 -25.54 66.57 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.073 0.463 . . . . 0.35999999999999999 111.837 -174.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -72.78 -30.83 64.43 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.758 0.79 . . . . 1.79 108.923 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.601 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -78.03 -41.89 27.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.64 -1.164 . . . . 0.51000000000000001 110.751 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.85 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . . . -72.55 -20.17 61.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.291 -0.413 . . . . 0.40999999999999998 110.736 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.43 64.58 1.02 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.279 -0.963 . . . . 0.45000000000000001 113.445 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.0 tp -109.45 149.28 29.79 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.151 -0.685 . . . . 0.89000000000000001 109.151 175.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 1.069 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 32.3 mt-30 -115.05 23.74 12.28 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 115.031 1.493 . . . . 1.21 115.031 -164.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.963 HG23 ' HA ' ' A' ' 59' ' ' ARG . 62.1 mt 69.51 2.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 CA-C-N 118.761 0.709 . . . . 0.77000000000000002 112.477 168.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.71 46.77 0.21 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.268 -0.968 . . . . 0.37 112.4 -168.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.578 ' H ' HG12 ' A' ' 57' ' ' VAL . 49.0 m-20 -120.89 152.9 37.88 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.614 -0.514 . . . . 0.89000000000000001 109.614 -172.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.682 ' HD2' ' N ' ' A' ' 76' ' ' LYS . 8.9 mptt -102.29 122.75 44.83 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.822 -0.807 . . . . 2.2000000000000002 108.822 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.775 HD12 ' HA ' ' A' ' 56' ' ' TYR . 4.2 mp -91.6 134.27 30.54 Favored 'Isoleucine or valine' 0 C--O 1.264 1.851 0 CA-C-O 121.168 0.508 . . . . 0.48999999999999999 112.176 -172.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.698 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 0.9 OUTLIER -92.43 -25.68 18.36 Favored 'General case' 0 C--N 1.346 0.452 0 O-C-N 126.381 2.3 . . . . 1.0600000000000001 112.442 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.67 ' HA ' ' HG2' ' A' ' 85' ' ' MET . 0.2 OUTLIER -170.77 156.02 4.98 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.281 0.475 . . . . 0.81999999999999995 112.281 -172.347 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.653 HG12 ' HE3' ' A' ' 85' ' ' MET . 6.4 p -143.14 127.51 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.095 -0.502 . . . . 1.3100000000000001 110.317 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 59.39 19.87 8.16 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.888 -0.597 . . . . 1.5 111.929 176.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.79 -6.21 58.59 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 119.96 -1.114 . . . . 0.38 112.262 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -83.13 124.18 30.24 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-O 121.332 0.587 . . . . 0.77000000000000002 109.825 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -86.13 96.74 9.99 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.536 -1.211 . . . . 1.8899999999999999 110.084 -177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.67 ' HG2' ' HA ' ' A' ' 79' ' ' GLN . 3.9 ptp -109.41 102.39 11.29 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.129 0.966 . . . . 1.01 111.534 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.435 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 4.6 p -101.91 -33.89 9.59 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.236 -1.347 . . . . 1.05 109.115 176.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.598 ' O ' HG23 ' A' ' 37' ' ' ILE . 1.7 mtt -129.03 -16.07 4.13 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 113.88 -1.509 . . . . 1.6200000000000001 110.042 -176.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.626 ' O ' HD11 ' A' ' 55' ' ' ILE . 2.1 t -40.6 150.59 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 C-N-CA 125.726 1.61 . . . . 1.0900000000000001 115.222 -167.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.987 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 47.7 p -60.25 150.44 30.24 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.778 -0.576 . . . . 0.34999999999999998 111.637 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.783 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 21.9 t-160 -61.49 -33.69 74.21 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-N 115.975 -0.557 . . . . 0.34999999999999998 109.886 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.94 -33.98 68.66 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.687 -1.142 . . . . 1.6699999999999999 109.546 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.584 ' HB3' HG13 ' A' ' 88' ' ' VAL . 2.0 tp-100 -68.66 -46.56 68.81 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.402 -0.962 . . . . 0.77000000000000002 108.402 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.556 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -66.68 -37.94 85.77 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.92 -1.036 . . . . 0.33000000000000002 109.866 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 90' ' ' HIS . 27.6 ttp-105 -71.13 -43.64 67.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.626 -0.716 . . . . 2.1000000000000001 110.814 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.503 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -69.39 -43.01 74.37 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 116.109 -0.496 . . . . 0.95999999999999996 110.467 -177.664 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 28.2 mmt180 -72.08 -23.37 61.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.237 0.541 . . . . 3.5699999999999998 110.555 -178.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.758 HD21 HD11 ' A' ' 29' ' ' LEU . 7.2 tp -78.57 -57.47 3.75 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.261 -0.881 . . . . 1.6499999999999999 112.167 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.729 ' OG1' HD13 ' A' ' 29' ' ' LEU . 35.8 m -124.95 91.65 3.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.586 0.708 . . . . 1.53 110.872 -174.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.639 ' HG2' ' OE1' ' A' ' 102' ' ' GLU . 7.0 ptpp? -122.08 7.93 9.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.379 -0.828 . . . . 2.7200000000000002 112.831 -176.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.905 ' HA ' HD13 ' A' ' 27' ' ' LEU . 26.3 mtm180 67.07 16.5 10.31 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.75 -0.659 . . . . 4.3799999999999999 111.057 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.489 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 28.0 m -124.74 21.59 8.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.985 0.421 . . . . 2.5099999999999998 111.441 -175.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.639 ' OE1' ' HG2' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -137.52 131.13 31.32 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.45 -0.341 . . . . 3.3999999999999999 110.358 179.068 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -85.98 -22.29 27.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.374 0.607 . . . . 2.6800000000000002 110.257 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.99 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 4.0 p -135.85 141.86 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.519 -0.764 . . . . 0.44 109.367 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.551 HG23 ' HB2' ' A' ' 20' ' ' LYS . 52.5 t -119.62 120.88 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-O 122.083 0.944 . . . . 0.46000000000000002 111.904 -172.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.406 ' CD ' ' N ' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -99.26 129.39 45.49 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.271 -1.786 . . . . 1.76 109.789 -179.053 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.592 HD11 HG12 ' A' ' 77' ' ' ILE . 21.1 tp -133.29 134.12 43.47 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.927 -0.579 . . . . 1.1200000000000001 109.643 -177.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.569 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 17.6 tp -110.23 124.51 51.74 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.682 -1.599 . . . . 0.41999999999999998 106.682 173.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.736 HG23 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -129.88 149.31 33.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 121.757 0.789 . . . . 0.77000000000000002 111.001 -171.516 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.745 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -98.04 114.71 26.95 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.355 -0.839 . . . . 0.34000000000000002 109.205 165.187 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.633 ' HD3' ' HG2' ' A' ' 14' ' ' GLN . 22.3 ttt180 -105.33 131.5 52.69 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.15 -0.932 . . . . 2.0099999999999998 110.498 -171.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.45 ' HG2' ' CD2' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -106.4 -89.67 0.43 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.39 -0.368 . . . . 1.97 111.845 -178.365 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.8 t -157.18 44.94 0.37 Allowed 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.168 -0.613 . . . . 1.6200000000000001 112.071 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 1.069 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.592 0 N-CA-C 108.801 -0.814 . . . . 1.6499999999999999 108.801 175.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.445 -0.688 0 CA-C-O 123.054 1.407 . . . . 2.0899999999999999 109.788 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -109.98 178.85 4.28 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 112.626 -2.079 . . . . 0.95999999999999996 110.583 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.8 t -110.18 149.07 13.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 108.894 -0.78 . . . . 1.5700000000000001 108.894 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.688 HG22 HG23 ' A' ' 110' ' ' THR . 34.8 t -103.69 112.7 38.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 120.315 -0.554 . . . . 1.02 110.956 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.74 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.5 OUTLIER -95.06 172.36 8.18 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.845 -0.616 . . . . 1.3899999999999999 110.345 176.861 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.527 ' HD3' ' O ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -127.21 127.14 43.99 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 116.718 -0.219 . . . . 3.6299999999999999 111.573 174.042 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.67 ' HB ' ' HB3' ' A' ' 107' ' ' LEU . 28.8 t -101.6 131.04 50.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.647 -0.501 . . . . 1.02 109.647 171.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 25.0 tt0 -145.68 112.96 6.19 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.699 -0.482 . . . . 1.3500000000000001 109.699 173.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.622 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 8.8 tp -142.63 145.64 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 C-N-CA 120.012 -0.675 . . . . 0.60999999999999999 109.281 -177.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.747 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 9.7 m-70 -75.66 112.73 12.32 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.207 -0.664 . . . . 0.59999999999999998 109.207 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.719 ' CE ' ' HB3' ' A' ' 27' ' ' LEU . 25.6 mmmt -31.59 137.18 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.463 1.102 . . . . 4.0 112.578 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.3 tp -96.97 99.74 11.27 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.596 -0.52 . . . . 0.55000000000000004 109.596 -173.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -92.83 144.74 24.98 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.671 0.748 . . . . 3.9700000000000002 112.481 -172.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.445 ' CG ' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -124.12 92.89 3.76 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.22 -1.4 . . . . 1.3500000000000001 107.22 170.166 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.85 -78.4 0.1 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.733 -0.746 . . . . 1.3300000000000001 111.95 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -138.11 10.09 2.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.533 0.683 . . . . 2.3300000000000001 110.503 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -107.94 118.74 37.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.238 -0.892 . . . . 1.8700000000000001 109.119 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.005 HD22 ' HA ' ' A' ' 100' ' ' ARG . 8.8 mp -105.14 113.95 27.84 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.498 0.666 . . . . 2.2799999999999998 110.437 -176.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.445 HD13 ' CG ' ' A' ' 23' ' ' GLN . 1.7 mp -94.97 141.46 15.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.831 -1.077 . . . . 0.80000000000000004 109.56 -173.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.91 -38.78 13.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.064 -0.516 . . . . 1.74 110.811 -174.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.685 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 88.78 15.2 60.0 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.268 -0.968 . . . . 0.68999999999999995 111.56 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.677 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 42.5 p90 -155.28 166.96 31.94 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 122.201 0.201 . . . . 0.51000000000000001 110.651 176.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.579 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 17.2 t -109.93 159.0 17.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.493 -1.299 . . . . 0.53000000000000003 107.493 170.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.418 HD12 HD21 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -161.26 138.08 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 C-N-CA 120.427 -0.509 . . . . 0.48999999999999999 112.238 -164.376 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.414 ' HA2' ' CD2' ' A' ' 90' ' ' HIS . . . -141.57 117.8 1.25 Allowed Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.172 -1.013 . . . . 0.71999999999999997 110.851 156.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 1.065 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -140.74 117.09 1.21 Allowed Glycine 0 CA--C 1.491 -1.417 0 CA-C-O 118.656 -1.08 . . . . 1.4199999999999999 111.067 170.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.666 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -164.15 145.67 10.64 Favored Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 117.429 -2.319 . . . . 0.47999999999999998 113.469 175.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.504 HG12 ' C ' ' A' ' 88' ' ' VAL . 34.1 pt -69.54 -11.53 14.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 107.282 -1.377 . . . . 0.52000000000000002 107.282 152.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.823 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 0.1 OUTLIER -70.61 -39.14 73.94 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 113.815 -1.538 . . . . 0.71999999999999997 109.852 172.642 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 . . . . . 0 N--CA 1.466 0.337 0 CA-C-N 115.188 -0.915 . . . . 1.1899999999999999 111.409 -172.241 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.985 0 N-CA-C 109.247 -1.541 . . . . 0.78000000000000003 109.247 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.065 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -110.83 138.03 40.7 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.113 0 CA-C-N 119.361 1.58 . . . . 0.54000000000000004 107.364 168.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.82 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -152.67 151.72 30.9 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 119.865 1.211 . . . . 1.4199999999999999 111.655 -177.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.787 HG12 ' H ' ' A' ' 75' ' ' ASP . 3.4 p -91.19 131.93 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-N 114.621 -1.172 . . . . 0.57999999999999996 109.862 -174.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.6 m -99.06 -16.16 18.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.157 -0.929 . . . . 1.1100000000000001 110.796 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.803 ' HA ' HG23 ' A' ' 73' ' ' ILE . 56.8 mtt180 -148.36 -167.04 2.7 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.553 0.692 . . . . 2.27 112.514 175.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 59' ' ' ARG . 75.7 t -163.68 117.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 112.46 -2.155 . . . . 0.82999999999999996 106.972 159.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.4 m -65.8 117.7 8.59 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.137 0.494 . . . . 1.6499999999999999 109.894 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -46.14 112.05 0.44 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.581 -1.191 . . . . 1.8500000000000001 112.394 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.24 -14.89 56.79 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.692 -0.766 . . . . 0.92000000000000004 112.607 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.517 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -76.55 172.71 54.65 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.219 -0.991 . . . . 0.98999999999999999 112.072 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.685 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 58.9 Cg_endo -68.91 -24.8 33.31 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 123.088 2.526 . . . . 0.44 113.158 -166.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.677 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -61.45 -36.32 80.05 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 114.783 -1.099 . . . . 0.35999999999999999 111.392 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -77.75 -29.57 51.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.428 0.632 . . . . 1.79 109.461 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.517 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -69.42 -37.48 75.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.241 -0.891 . . . . 0.51000000000000001 109.812 177.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.643 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -77.35 -23.01 50.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.025 -0.534 . . . . 0.40999999999999998 110.601 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.27 52.46 0.93 Allowed Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.387 -0.911 . . . . 0.45000000000000001 114.112 176.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.497 HD21 HG21 ' A' ' 57' ' ' VAL . 14.7 tp -106.52 148.0 28.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.597 -0.89 . . . . 0.89000000000000001 108.597 174.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.521 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 37.1 mt-30 -130.11 38.34 3.8 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 115.375 1.62 . . . . 1.21 115.375 -164.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.803 HG23 ' HA ' ' A' ' 59' ' ' ARG . 53.9 mt 72.22 -4.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 N-CA-C 114.186 1.18 . . . . 0.77000000000000002 114.186 163.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.28 45.03 0.23 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 119.22 -1.467 . . . . 0.37 112.277 -171.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.787 ' H ' HG12 ' A' ' 57' ' ' VAL . 20.9 m-20 -118.38 142.07 47.9 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 120.903 0.382 . . . . 0.89000000000000001 111.558 -169.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.82 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 45.0 mmtm -86.41 103.37 14.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.629 -0.714 . . . . 2.2000000000000002 110.566 -175.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.766 ' HB ' HG22 ' A' ' 55' ' ' ILE . 5.6 mt -74.4 128.82 36.76 Favored 'Isoleucine or valine' 0 C--O 1.259 1.587 0 C-N-CA 123.904 0.882 . . . . 0.48999999999999999 112.001 -177.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.731 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 3.8 mmt -93.66 -25.95 17.26 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.569 -1.651 . . . . 1.0600000000000001 112.234 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.529 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -160.28 156.88 27.13 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.61 -0.436 . . . . 0.81999999999999995 112.116 -173.586 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.522 HG12 ' CE ' ' A' ' 85' ' ' MET . 10.4 p -148.44 128.44 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.278 -0.638 . . . . 1.3100000000000001 109.278 175.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.479 ' OD1' ' HG3' ' A' ' 102' ' ' GLU . 0.9 OUTLIER 67.53 5.82 4.58 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.253 -0.431 . . . . 1.5 111.565 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.59 -7.54 53.7 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 119.882 -1.151 . . . . 0.38 111.403 -172.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -75.0 118.08 17.56 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.708 -0.849 . . . . 0.77000000000000002 108.708 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.424 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 0.5 OUTLIER -89.69 94.94 10.04 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.661 -0.7 . . . . 1.8899999999999999 109.594 -175.424 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.522 ' CE ' HG12 ' A' ' 80' ' ' VAL . 11.2 ptp -112.43 104.05 12.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.502 -0.772 . . . . 1.01 112.756 -172.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.1 p -96.86 -20.36 18.21 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 122.183 0.992 . . . . 1.05 108.773 170.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.87 81.65 0.65 Allowed 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.713 -1.585 . . . . 1.6200000000000001 110.26 -175.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.666 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.9 OUTLIER -140.49 162.57 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 108.519 -0.919 . . . . 1.0900000000000001 108.519 173.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.674 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 66.7 p -59.75 150.84 26.83 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 112.742 0.645 . . . . 0.34999999999999998 112.742 -175.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.823 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 16.2 t-160 -59.89 -35.57 75.11 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 121.743 0.782 . . . . 0.34999999999999998 109.855 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.4 -29.85 66.58 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 113.894 -1.503 . . . . 1.6699999999999999 109.64 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.557 ' HB3' ' O ' ' A' ' 89' ' ' THR . 3.4 tp-100 -63.77 -48.81 75.43 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.691 0.758 . . . . 0.77000000000000002 109.023 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.54 ' HB2' HG12 ' A' ' 55' ' ' ILE . . . -69.96 -39.29 76.1 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.905 -1.043 . . . . 0.33000000000000002 109.52 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -66.39 -42.24 88.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.083 -0.962 . . . . 2.1000000000000001 111.222 -175.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.567 ' HD3' ' HD2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -68.08 -31.08 70.45 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 119.91 -0.716 . . . . 0.95999999999999996 109.809 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.567 ' HD2' ' HD3' ' A' ' 95' ' ' LYS . 13.8 mmm180 -67.29 -47.44 70.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 120.706 -0.398 . . . . 3.5699999999999998 111.249 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 3.4 pp -83.39 0.96 43.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.35 -0.386 . . . . 1.6499999999999999 111.684 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.1 m -128.4 28.24 5.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.413 0.625 . . . . 1.53 111.33 173.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.936 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 1.3 mmpt? -82.04 118.79 23.28 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.752 -0.833 . . . . 2.7200000000000002 108.752 167.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 1.005 ' HA ' HD22 ' A' ' 27' ' ' LEU . 32.9 ptt180 -76.64 30.83 0.13 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.379 0.609 . . . . 4.3799999999999999 110.719 -177.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 99' ' ' LYS . 40.9 t -123.51 -30.61 3.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.453 -0.794 . . . . 2.5099999999999998 109.531 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.479 ' HG3' ' OD1' ' A' ' 81' ' ' ASN . 81.3 mm-40 -79.52 103.9 9.75 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.026 -0.534 . . . . 3.3999999999999999 110.01 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -71.94 -14.56 61.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.962 -0.563 . . . . 2.6800000000000002 111.404 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.747 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 5.5 p -138.04 134.79 45.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.36 0.6 . . . . 0.44 109.462 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.658 HG23 ' HG2' ' A' ' 20' ' ' LYS . 1.4 t -115.2 122.34 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-O 122.378 1.085 . . . . 0.46000000000000002 111.817 -173.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -99.97 126.86 46.2 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 113.2 -1.818 . . . . 1.76 109.364 177.783 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.67 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 10.4 tt -133.9 127.0 31.58 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.534 -0.543 . . . . 1.1200000000000001 109.534 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.666 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 39.5 tp -107.81 117.71 34.84 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.007 -1.479 . . . . 0.41999999999999998 107.007 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.74 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.5 OUTLIER -123.96 148.79 27.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 C-N-CA 119.671 -0.811 . . . . 0.77000000000000002 110.28 -176.298 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.688 HG23 HG22 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -95.85 117.48 30.65 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.195 -0.911 . . . . 0.34000000000000002 109.39 169.892 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.564 HH11 ' HB3' ' A' ' 14' ' ' GLN . 28.0 ttp180 -91.56 114.74 27.36 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.814 -1.539 . . . . 2.0099999999999998 109.255 -172.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.508 ' N ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -109.76 -55.12 2.48 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.106 -1.037 . . . . 1.97 113.48 -171.11 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.497 ' N ' ' HG2' ' A' ' 112' ' ' GLN . 33.3 t -156.66 13.98 0.28 Allowed 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.759 -0.776 . . . . 1.6200000000000001 111.965 -173.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.424 HD22 ' H ' ' A' ' 113' ' ' SER . 1.3 mm? . . . . . 0 C--N 1.321 -0.661 0 CA-C-O 121.657 0.741 . . . . 1.6499999999999999 110.312 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.44 -0.958 0 CA-C-O 122.562 1.172 . . . . 2.0899999999999999 109.394 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.14 178.67 8.26 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 113.001 -1.909 . . . . 0.95999999999999996 110.178 175.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.6 t -111.65 107.97 24.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.625 -0.716 . . . . 1.5700000000000001 109.891 -174.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.772 HG22 HG23 ' A' ' 110' ' ' THR . 48.6 t -77.36 108.65 10.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.247 0.546 . . . . 1.02 109.585 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.757 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -108.58 167.54 9.98 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.372 -0.831 . . . . 1.3899999999999999 111.612 -173.866 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -122.3 114.49 20.87 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.96 -0.564 . . . . 3.6299999999999999 110.802 -172.327 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.713 HG13 ' CB ' ' A' ' 69' ' ' ALA . 4.9 t -99.24 132.6 44.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.211 -0.663 . . . . 1.02 109.211 176.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -144.63 117.1 8.55 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 110.137 -0.32 . . . . 1.3500000000000001 110.137 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.592 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 10.9 tp -144.89 148.25 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 108.741 -0.837 . . . . 0.60999999999999999 108.741 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.734 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 15.3 m-70 -76.22 116.08 16.57 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.008 -0.677 . . . . 0.59999999999999998 109.693 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.666 ' HB2' HD12 ' A' ' 27' ' ' LEU . 3.1 pptp? -30.59 136.44 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 O-C-N 125.065 1.478 . . . . 4.0 112.108 177.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 65' ' ' PRO . 47.1 tp -98.44 89.59 4.49 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 119.888 -0.725 . . . . 0.55000000000000004 110.761 -171.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 24.7 ptt180 -68.71 139.22 55.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.072 0.463 . . . . 3.9700000000000002 112.063 -172.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.403 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 12.1 tp60 -129.47 93.95 3.66 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.651 -0.704 . . . . 1.3500000000000001 109.238 174.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.28 -80.33 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.839 -0.696 . . . . 1.3300000000000001 112.863 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -127.09 2.71 6.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.849 0.357 . . . . 2.3300000000000001 111.699 -173.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.403 ' OD1' ' HB3' ' A' ' 23' ' ' GLN . 1.1 p30 -126.73 174.39 8.78 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.097 -0.501 . . . . 1.8700000000000001 110.426 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.666 HD12 ' HB2' ' A' ' 20' ' ' LYS . 2.0 pt? -127.42 134.39 49.88 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.777 -1.194 . . . . 2.2799999999999998 107.777 175.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 26.0 mm -98.92 136.28 30.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-O 121.13 0.491 . . . . 0.80000000000000004 111.665 -171.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.464 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -106.6 116.19 31.5 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.341 -1.299 . . . . 1.74 107.558 173.137 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.37 51.86 4.42 Favored Glycine 0 C--O 1.221 -0.691 0 C-N-CA 120.223 -0.989 . . . . 0.68999999999999995 113.249 -172.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.585 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 29.2 p90 -158.47 170.74 21.53 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.591 -0.522 . . . . 0.51000000000000001 109.591 176.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.878 ' HB3' ' O ' ' A' ' 58' ' ' THR . 1.0 OUTLIER -110.66 168.85 9.16 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 107.978 -1.119 . . . . 0.53000000000000003 107.978 170.303 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -159.82 135.91 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 113.65 0.981 . . . . 0.48999999999999999 113.65 -163.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.407 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -147.64 117.4 0.91 Allowed Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.592 -1.003 . . . . 0.71999999999999997 110.592 155.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 1.083 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -142.58 117.78 1.18 Allowed Glycine 0 CA--C 1.488 -1.63 0 CA-C-O 118.427 -1.207 . . . . 1.4199999999999999 111.141 171.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.694 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.59 137.99 4.92 Favored Glycine 0 C--N 1.298 -1.539 0 C-N-CA 117.222 -2.418 . . . . 0.47999999999999998 113.086 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.418 HG12 ' N ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -60.53 -25.32 34.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 107.345 -1.354 . . . . 0.52000000000000002 107.345 151.314 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.82 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 4.5 t70 -54.6 -40.2 68.62 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 113.524 -1.671 . . . . 0.71999999999999997 110.179 169.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 . . . . . 0 C--O 1.234 0.285 0 CA-C-N 115.378 -0.828 . . . . 1.1899999999999999 110.51 -173.448 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.432 ' C ' HD12 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.443 -0.855 0 N-CA-C 110.248 -1.141 . . . . 0.78000000000000003 110.248 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.083 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.7 mp -112.1 142.57 24.07 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 N-CA-C 107.783 -1.191 . . . . 0.54000000000000004 107.783 171.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.717 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -152.16 141.98 21.98 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 122.219 1.009 . . . . 1.4199999999999999 111.577 -177.613 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.899 HG12 ' H ' ' A' ' 75' ' ' ASP . 1.8 p -79.92 135.98 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 113.928 -1.487 . . . . 0.57999999999999996 109.565 -178.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.878 ' O ' ' HB3' ' A' ' 32' ' ' SER . 15.8 m -125.09 64.47 1.14 Allowed 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.322 -0.854 . . . . 1.1100000000000001 109.372 175.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.565 ' HA ' HG23 ' A' ' 73' ' ' ILE . 64.2 mtt180 148.01 -168.5 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 125.939 1.696 . . . . 2.27 110.109 164.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.585 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 57.8 t -164.0 137.89 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 125.89 1.994 . . . . 0.82999999999999996 106.29 164.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.3 m -75.03 121.57 22.19 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.915 -0.772 . . . . 1.6499999999999999 108.915 173.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -50.39 108.94 0.26 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.174 -0.921 . . . . 1.8500000000000001 111.927 177.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.58 -6.05 70.57 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.557 -0.747 . . . . 0.92000000000000004 112.482 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.557 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -80.12 174.47 55.03 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.726 -0.75 . . . . 0.98999999999999999 112.17 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.462 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 46.7 Cg_endo -68.37 -28.4 32.99 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 122.837 2.358 . . . . 0.44 113.708 -164.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.471 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -65.57 -30.77 71.55 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.203 -0.908 . . . . 0.35999999999999999 110.881 177.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.507 ' HB2' HG11 ' A' ' 60' ' ' VAL . 14.6 tt0 -77.65 -31.2 52.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.326 0.584 . . . . 1.79 109.528 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.557 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.3 mp -65.81 -39.77 85.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.314 -0.857 . . . . 0.51000000000000001 109.84 175.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.713 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -75.27 -23.22 57.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.852 -0.613 . . . . 0.40999999999999998 110.295 176.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.53 46.63 1.2 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.843 -1.17 . . . . 0.45000000000000001 114.427 173.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.786 HD22 HG11 ' A' ' 57' ' ' VAL . 2.9 mt -91.93 156.51 17.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.62 0.71 . . . . 0.89000000000000001 111.079 175.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 46.1 mt-30 -132.82 32.09 3.86 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 114.599 1.333 . . . . 1.21 114.599 -166.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.565 HG23 ' HA ' ' A' ' 59' ' ' ARG . 3.4 mp 75.05 -14.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 N-CA-C 114.059 1.133 . . . . 0.77000000000000002 114.059 167.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.6 52.27 0.37 Allowed Glycine 0 N--CA 1.463 0.482 0 C-N-CA 119.761 -1.209 . . . . 0.37 112.405 -167.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.899 ' H ' HG12 ' A' ' 57' ' ' VAL . 21.5 m-20 -120.7 146.51 46.37 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.117 -0.541 . . . . 0.89000000000000001 110.388 -169.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.598 ' HD2' ' N ' ' A' ' 76' ' ' LYS . 10.3 mptt -101.44 102.4 13.19 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.516 0.674 . . . . 2.2000000000000002 110.483 -170.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.931 HG13 HG23 ' A' ' 109' ' ' VAL . 3.1 mp -64.49 122.79 16.05 Favored 'Isoleucine or valine' 0 C--O 1.256 1.424 0 CA-C-N 114.742 -1.117 . . . . 0.48999999999999999 112.295 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.881 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 2.7 mmt -91.92 -16.91 25.95 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 125.909 2.006 . . . . 1.0600000000000001 111.148 173.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.581 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 1.1 tt0 -172.42 152.26 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.908 0.336 . . . . 0.81999999999999995 111.908 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.712 HG12 ' HE1' ' A' ' 85' ' ' MET . 2.4 p -138.4 124.41 24.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.285 0.564 . . . . 1.3100000000000001 110.133 173.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.485 ' OD1' HG22 ' A' ' 80' ' ' VAL . 20.0 m120 53.02 28.65 6.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.298 -0.864 . . . . 1.5 112.669 174.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.41 -13.75 47.46 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.285 -0.959 . . . . 0.38 113.132 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.474 ' CE2' ' HD2' ' A' ' 96' ' ' ARG . 80.4 m95 -86.88 148.16 25.48 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.623 -0.51 . . . . 0.77000000000000002 109.623 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.64 118.68 37.28 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.663 -0.698 . . . . 1.8899999999999999 111.975 -173.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.712 ' HE1' HG12 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -107.13 103.48 12.89 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.901 0.858 . . . . 1.01 111.377 179.603 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 p -131.16 -48.3 1.0 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.221 -1.4 . . . . 1.05 107.221 168.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.86 84.67 2.1 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 112.622 -2.081 . . . . 1.6200000000000001 107.509 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.695 ' O ' HD11 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -137.73 136.45 45.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.026 -0.988 . . . . 1.0900000000000001 108.453 -177.258 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.766 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 72.9 p -58.1 149.9 22.46 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.161 0.505 . . . . 0.34999999999999998 112.205 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.82 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 21.9 t-160 -58.11 -36.82 73.46 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.635 0.731 . . . . 0.34999999999999998 109.792 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.72 -31.36 66.63 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.203 -1.362 . . . . 1.6699999999999999 109.961 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.694 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -65.65 -50.47 64.84 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.583 -0.895 . . . . 0.77000000000000002 108.583 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.72 ' HB2' HG12 ' A' ' 55' ' ' ILE . . . -65.59 -37.2 85.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.678 -0.692 . . . . 0.33000000000000002 110.274 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -68.53 -42.21 78.81 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.489 -0.778 . . . . 2.1000000000000001 110.935 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.557 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -72.8 -41.9 64.46 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 116.363 -0.38 . . . . 0.95999999999999996 110.228 -176.59 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.694 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 29.8 mmt180 -68.04 -32.9 73.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.015 0.436 . . . . 3.5699999999999998 110.315 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.663 ' HB2' HG21 ' A' ' 80' ' ' VAL . 10.8 tp -73.18 -55.24 6.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.394 -0.821 . . . . 1.6499999999999999 110.203 173.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 m -94.23 77.59 3.99 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 122.949 1.357 . . . . 1.53 109.779 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.535 ' HE2' ' HB3' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -138.5 108.72 6.43 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 112.316 -2.22 . . . . 2.7200000000000002 106.35 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -70.79 70.1 0.47 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.384 0.611 . . . . 4.3799999999999999 112.091 -170.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.0 t -137.55 -31.49 0.8 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.784 -0.644 . . . . 2.5099999999999998 110.805 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 19.3 mm-40 -68.21 141.32 56.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.476 -0.329 . . . . 3.3999999999999999 110.9 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.503 ' HG3' HG12 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -94.84 -11.22 29.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.922 0.868 . . . . 2.6800000000000002 108.872 169.9 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.734 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 3.7 p -153.2 145.55 14.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.237 -1.347 . . . . 0.44 108.211 -175.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.442 HG23 ' HB3' ' A' ' 20' ' ' LYS . 43.8 t -119.98 118.93 58.61 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.03 0 CA-C-O 122.439 1.114 . . . . 0.46000000000000002 112.065 -169.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.403 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 2.1 mpt_? -99.62 129.31 45.76 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 112.72 -2.036 . . . . 1.76 111.006 -175.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.799 HD11 HG12 ' A' ' 77' ' ' ILE . 35.0 tp -132.8 130.77 40.31 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 116.489 -0.323 . . . . 1.1200000000000001 110.745 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.881 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 35.5 tp -107.19 114.81 29.09 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 106.785 -1.561 . . . . 0.41999999999999998 106.785 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.931 HG23 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -128.76 147.14 33.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 C-N-CA 120.313 -0.555 . . . . 0.77000000000000002 110.562 -172.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.772 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -97.56 117.11 31.09 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.707 -0.797 . . . . 0.34000000000000002 110.556 173.401 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.501 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -110.04 135.46 50.83 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.418 -1.265 . . . . 2.0099999999999998 109.495 -175.456 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.515 ' OE1' HD23 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -114.25 -72.74 0.68 Allowed 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.687 0.625 . . . . 1.97 112.687 -169.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.4 t -140.87 18.15 2.31 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.647 0.737 . . . . 1.6200000000000001 110.216 -172.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 4.1 mm? . . . . . 0 C--N 1.317 -0.811 0 CA-C-N 115.36 -0.836 . . . . 1.6499999999999999 109.766 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 p . . . . . 0 N--CA 1.435 -1.19 0 CA-C-O 122.167 0.984 . . . . 2.0899999999999999 111.445 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.577 ' CB ' ' HA ' ' A' ' 112' ' ' GLN . . . -86.5 178.4 7.11 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.614 -1.63 . . . . 0.95999999999999996 111.045 177.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -129.46 138.46 54.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.268 -0.878 . . . . 1.5700000000000001 108.986 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.696 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 0.9 OUTLIER -90.72 127.2 43.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 C-N-CA 119.413 -0.915 . . . . 1.02 110.897 -174.778 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.681 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -118.63 166.38 12.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.527 -1.215 . . . . 1.3899999999999999 110.137 176.951 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.523 ' HD2' ' H ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -124.98 135.29 52.66 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.605 -0.685 . . . . 3.6299999999999999 110.325 -175.909 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.708 HG13 ' CB ' ' A' ' 69' ' ' ALA . 4.1 t -105.95 109.04 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 CA-C-O 121.501 0.667 . . . . 1.02 109.436 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -109.31 119.53 39.76 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.37 -0.832 . . . . 1.3500000000000001 109.586 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.707 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 11.3 tp -145.71 146.18 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.871 -0.789 . . . . 0.60999999999999999 108.871 174.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 14.6 m-70 -80.15 112.0 17.05 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.529 -0.915 . . . . 0.59999999999999998 108.529 177.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.684 ' HB2' HD12 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -25.16 140.16 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 O-C-N 124.923 1.389 . . . . 4.0 112.814 -178.692 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.58 HD22 ' HA2' ' A' ' 64' ' ' GLY . 43.9 tp -96.16 97.5 9.59 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 119.102 -1.039 . . . . 0.55000000000000004 110.009 -172.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.638 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 12.4 ptp180 -61.13 142.71 56.51 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.744 0.783 . . . . 3.9700000000000002 112.067 -173.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.568 ' HB2' HD13 ' A' ' 28' ' ' ILE . 4.3 tp60 -128.43 93.42 3.64 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.141 -1.059 . . . . 1.3500000000000001 108.141 172.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.6 -78.16 0.26 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.418 -0.896 . . . . 1.3300000000000001 111.352 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.463 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 54.5 mt-10 -139.2 11.44 2.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.156 0.503 . . . . 2.3300000000000001 110.63 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.638 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 10.8 m-80 -108.48 -177.53 3.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.895 -0.593 . . . . 1.8700000000000001 109.685 -177.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.684 HD12 ' HB2' ' A' ' 20' ' ' LYS . 1.0 OUTLIER -127.68 135.48 50.25 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 108.226 -1.027 . . . . 2.2799999999999998 108.226 173.924 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.568 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.0 OUTLIER -102.49 138.0 28.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 120.99 0.424 . . . . 0.80000000000000004 110.871 -179.173 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.8 tp -98.6 124.18 43.23 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.938 -1.483 . . . . 1.74 108.394 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.728 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -93.92 35.1 4.31 Favored Glycine 0 C--O 1.223 -0.582 0 C-N-CA 120.226 -0.988 . . . . 0.68999999999999995 114.075 -170.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.569 ' CD1' HG23 ' A' ' 57' ' ' VAL . 39.8 p90 -157.77 169.84 23.71 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.544 -0.539 . . . . 0.51000000000000001 109.544 177.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.709 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -104.43 159.75 15.47 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.845 -1.169 . . . . 0.53000000000000003 107.845 171.512 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.419 HD12 HD21 ' A' ' 97' ' ' LEU . 0.9 OUTLIER -152.91 135.24 6.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 113.354 0.872 . . . . 0.48999999999999999 113.354 -167.112 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -145.06 118.06 1.07 Allowed Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 110.059 -1.216 . . . . 0.71999999999999997 110.059 154.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 1.069 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -139.6 117.74 1.39 Allowed Glycine 0 CA--C 1.49 -1.487 0 CA-C-O 119.093 -0.837 . . . . 1.4199999999999999 111.233 172.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.782 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.15 137.32 4.57 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 118.012 -2.042 . . . . 0.47999999999999998 112.79 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.9 pt -58.75 -24.6 26.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.479 -1.304 . . . . 0.52000000000000002 107.479 153.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.738 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 4.1 t70 -56.1 -43.71 78.36 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 113.156 -1.838 . . . . 0.71999999999999997 110.182 171.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 . . . . . 0 C--O 1.233 0.225 0 CA-C-N 114.977 -1.01 . . . . 1.1899999999999999 112.317 -171.469 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.495 ' C ' HD12 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.429 -1.778 0 N-CA-C 109.156 -1.577 . . . . 0.78000000000000003 109.156 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.069 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -117.41 140.58 39.72 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.403 0 C-N-CA 119.656 -0.818 . . . . 0.54000000000000004 108.889 176.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.661 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -142.36 142.43 32.45 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 119.553 1.069 . . . . 1.4199999999999999 110.374 -176.111 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.58 HG12 ' H ' ' A' ' 75' ' ' ASP . 11.9 p -82.63 136.23 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 114.664 -1.153 . . . . 0.57999999999999996 110.301 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.709 ' O ' ' HB3' ' A' ' 32' ' ' SER . 23.7 m -127.23 66.05 1.3 Allowed 'General case' 0 N--CA 1.439 -1.006 0 O-C-N 124.346 1.029 . . . . 1.1100000000000001 109.035 172.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 37.7 mtt180 150.01 -170.28 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.746 1.619 . . . . 2.27 110.434 162.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 90.8 t -160.97 111.46 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 113.595 -1.639 . . . . 0.82999999999999996 106.625 161.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 m -70.76 158.52 36.16 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.504 0.669 . . . . 1.6499999999999999 110.021 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -97.62 130.41 44.65 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.027 -0.988 . . . . 1.8500000000000001 111.289 -169.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.9 -9.83 72.7 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.327 -0.94 . . . . 0.92000000000000004 111.325 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.637 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -85.05 -158.95 30.35 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.607 -0.806 . . . . 0.98999999999999999 111.436 174.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.728 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 40.5 Cg_endo -90.02 -30.21 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.664 2.243 . . . . 0.44 115.382 -171.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 30' ' ' GLY . . . -69.17 -23.1 63.89 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 116.229 -0.441 . . . . 0.35999999999999999 111.473 -174.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -72.03 -38.14 69.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.797 0.808 . . . . 1.79 108.959 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.637 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.3 mp -69.69 -45.29 78.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.526 -1.215 . . . . 0.51000000000000001 110.585 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.708 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -67.26 -30.53 70.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.40999999999999998 109.898 175.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.34 62.3 1.0 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.459 -0.877 . . . . 0.45000000000000001 113.427 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.481 ' O ' HG21 ' A' ' 60' ' ' VAL . 21.6 tp -98.15 158.31 15.63 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.045 -0.724 . . . . 0.89000000000000001 109.045 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.527 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 43.9 mt-30 -132.21 42.25 3.15 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 115.15 1.537 . . . . 1.21 115.15 -164.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.541 ' O ' ' HA ' ' A' ' 58' ' ' THR . 3.4 mp 71.56 -20.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 N-CA-C 115.741 1.756 . . . . 0.77000000000000002 115.741 161.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -164.06 57.77 0.27 Allowed Glycine 0 N--CA 1.463 0.484 0 C-N-CA 119.803 -1.189 . . . . 0.37 112.148 -164.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.582 ' HB3' ' CG2' ' A' ' 109' ' ' VAL . 9.5 m-20 -124.76 154.15 41.34 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.823 -0.688 . . . . 0.89000000000000001 109.819 -168.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.661 ' HD3' ' HB3' ' A' ' 56' ' ' TYR . 72.2 mmtt -106.68 103.01 12.35 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.511 0.672 . . . . 2.2000000000000002 109.878 -170.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 1.002 HG13 HG23 ' A' ' 109' ' ' VAL . 3.5 mp -73.65 125.14 32.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 114.696 -1.138 . . . . 0.48999999999999999 113.344 -172.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.718 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 4.4 mmt -86.18 -21.8 27.32 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 113.053 -1.885 . . . . 1.0600000000000001 112.174 176.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.515 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -168.91 149.95 4.51 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.455 0.539 . . . . 0.81999999999999995 112.455 -174.586 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.656 HG22 ' SD ' ' A' ' 85' ' ' MET . 30.1 m -132.55 123.04 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.84 -0.618 . . . . 1.3100000000000001 110.313 174.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.704 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 1.0 OUTLIER 56.87 25.13 10.07 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.071 0.767 . . . . 1.5 113.071 174.58 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.64 -7.13 57.62 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.358 -1.401 . . . . 0.38 112.669 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -91.84 152.57 20.04 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.817 -0.809 . . . . 0.77000000000000002 108.817 174.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -103.05 112.96 26.05 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.669 0.747 . . . . 1.8899999999999999 111.742 -172.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.656 ' SD ' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -106.34 101.62 11.08 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.055 -0.975 . . . . 1.01 111.359 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.1 p -118.24 -41.33 2.87 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.745 1.259 . . . . 1.05 107.741 168.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -148.22 84.49 1.51 Allowed 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 112.556 -2.111 . . . . 1.6200000000000001 107.825 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.782 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.5 t -140.04 135.05 37.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.219 -0.901 . . . . 1.0900000000000001 109.56 -172.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.738 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 69.5 p -55.92 148.28 17.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.292 0.479 . . . . 0.34999999999999998 112.292 -178.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.743 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 22.7 t-160 -56.14 -40.25 73.52 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 115.883 -0.599 . . . . 0.34999999999999998 110.715 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.6 -32.29 70.94 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.115 -0.948 . . . . 1.6699999999999999 109.365 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.826 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 2.5 tp-100 -63.0 -49.45 74.62 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 108.598 -0.89 . . . . 0.77000000000000002 108.598 -178.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.732 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -73.06 -40.47 65.04 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.632 -0.713 . . . . 0.33000000000000002 110.611 -177.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 94' ' ' ARG . 33.2 ttp180 -57.16 -44.32 83.37 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.304 0.573 . . . . 2.1000000000000001 109.644 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.453 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -66.68 -35.51 80.33 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.368 -0.833 . . . . 0.95999999999999996 109.638 -178.451 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.826 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 22.2 mmt180 -76.18 -26.36 56.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.006 -0.543 . . . . 3.5699999999999998 111.602 -176.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.684 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 2.8 pp -101.49 -0.19 35.56 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.098 0.777 . . . . 1.6499999999999999 113.098 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.2 m -126.67 65.47 1.26 Allowed 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 122.373 1.082 . . . . 1.53 110.871 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE2' ' O ' ' A' ' 96' ' ' ARG . 20.4 mtmt -112.25 114.32 27.04 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 113.937 -1.483 . . . . 2.7200000000000002 108.538 171.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' A' ' 25' ' ' GLU . 15.6 ptt180 -74.88 32.32 0.09 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.348 0.595 . . . . 4.3799999999999999 110.764 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 99' ' ' LYS . 13.2 p -119.73 -41.79 2.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.511 -0.768 . . . . 2.5099999999999998 109.747 -177.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -52.1 142.84 15.32 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.466 -0.788 . . . . 3.3999999999999999 110.477 175.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -93.66 -13.21 27.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.28 0.562 . . . . 2.6800000000000002 110.43 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 5.7 p -151.06 146.74 16.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.77 -0.65 . . . . 0.44 109.547 -176.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.422 HG13 HD21 ' A' ' 81' ' ' ASN . 47.8 t -114.24 120.36 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-O 121.946 0.879 . . . . 0.46000000000000002 111.708 -175.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.704 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.2 OUTLIER -100.26 127.76 46.48 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.488 -1.687 . . . . 1.76 110.613 -177.114 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.806 HD11 HG12 ' A' ' 77' ' ' ILE . 31.1 tp -133.39 126.92 32.34 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.044 -0.526 . . . . 1.1200000000000001 109.947 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.718 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 35.4 tp -111.53 116.01 30.14 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.47 -1.308 . . . . 0.41999999999999998 107.47 175.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 1.002 HG23 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -120.93 153.74 24.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.019 0.438 . . . . 0.77000000000000002 110.391 -173.507 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.696 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 0.7 OUTLIER -98.71 115.09 27.95 Favored 'General case' 0 N--CA 1.426 -1.673 0 C-N-CA 119.619 -0.832 . . . . 0.34000000000000002 110.018 165.482 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.504 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 17.3 ttt180 -92.23 112.79 24.86 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.689 -1.142 . . . . 2.0099999999999998 109.329 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.577 ' HA ' ' CB ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -86.1 -58.56 2.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.471 -0.786 . . . . 1.97 112.197 -171.822 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.2 t -149.17 8.59 0.73 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.164 0.507 . . . . 1.6200000000000001 110.906 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 3.1 mm? . . . . . 0 N--CA 1.439 -0.975 0 N-CA-C 108.207 -1.034 . . . . 1.6499999999999999 108.207 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.441 -0.91 0 CA-C-O 123.27 1.51 . . . . 2.0899999999999999 109.639 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.22 177.01 9.25 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 112.215 -2.266 . . . . 0.95999999999999996 110.05 172.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.9 m -120.72 132.41 70.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 116.039 -0.528 . . . . 1.5700000000000001 110.371 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.697 HG22 HG23 ' A' ' 110' ' ' THR . 16.3 t -85.94 114.28 25.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.904 0.383 . . . . 1.02 110.626 -176.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.735 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -112.61 169.96 8.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.402 0.62 . . . . 1.3899999999999999 112.232 -179.061 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -110.11 141.77 42.52 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.594 0.712 . . . . 3.6299999999999999 112.409 -173.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.707 ' HB ' ' HB3' ' A' ' 107' ' ' LEU . 34.0 t -129.99 128.74 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 108.28 -1.008 . . . . 1.02 108.28 170.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -143.38 119.74 10.92 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.673 0.273 . . . . 1.3500000000000001 110.418 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.541 HG12 ' HB2' ' A' ' 65' ' ' PRO . 10.7 tp -145.33 150.57 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.275 0 N-CA-C 108.818 -0.808 . . . . 0.60999999999999999 108.818 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.785 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 15.8 m-70 -80.71 114.99 19.99 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.187 -0.605 . . . . 0.59999999999999998 109.402 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 3.0 pptp? -27.62 136.2 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 O-C-N 125.051 1.469 . . . . 4.0 112.459 177.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.2 tp -109.14 98.1 7.61 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 120.656 -0.418 . . . . 0.55000000000000004 110.684 -175.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 57.7 mtt180 -67.04 135.66 54.03 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.452 0.644 . . . . 3.9700000000000002 111.537 177.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -120.76 92.41 3.76 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.107 -1.071 . . . . 1.3500000000000001 108.107 172.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.1 -81.48 0.13 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.104 -0.57 . . . . 1.3300000000000001 111.748 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -129.88 5.1 4.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.779 0.799 . . . . 2.3300000000000001 110.819 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 7.4 m-80 -108.27 167.8 9.76 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.336 -0.847 . . . . 1.8700000000000001 110.224 -177.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.437 HD13 ' HG2' ' A' ' 100' ' ' ARG . 6.6 mp -121.73 122.58 39.86 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.564 -0.902 . . . . 2.2799999999999998 108.564 171.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.7 mm -98.0 127.71 50.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.599 -0.728 . . . . 0.80000000000000004 110.234 -174.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.613 HD13 HD21 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -84.96 -38.27 19.5 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 114.581 -1.19 . . . . 1.74 109.063 -179.36 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.99 5.76 62.33 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.02 -0.991 . . . . 0.68999999999999995 111.479 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 39.5 p90 -151.57 167.12 29.06 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.462 -0.57 . . . . 0.51000000000000001 109.462 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.715 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -106.0 169.18 8.65 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 118.822 -1.151 . . . . 0.53000000000000003 108.889 173.302 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.458 HD11 HG21 ' A' ' 55' ' ' ILE . 6.8 tt -140.92 134.72 32.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 119.87 -0.732 . . . . 0.48999999999999999 112.323 -164.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -103.14 173.17 22.11 Favored Glycine 0 C--N 1.329 0.191 0 N-CA-C 110.77 -0.932 . . . . 0.71999999999999997 110.77 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.574 ' HA2' ' CG ' ' A' ' 90' ' ' HIS . . . -110.46 168.57 13.06 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 118.243 2.057 . . . . 1.4199999999999999 118.243 -162.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.632 ' HA3' ' O ' ' A' ' 88' ' ' VAL . . . -84.5 -142.42 5.55 Favored Glycine 0 N--CA 1.422 -2.254 0 CA-C-N 110.816 -2.692 . . . . 0.47999999999999998 113.272 -176.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.756 HG23 ' O ' ' A' ' 87' ' ' MET . 8.7 pt -83.1 -5.2 8.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 113.258 0.836 . . . . 0.52000000000000002 113.258 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.966 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 13.3 p-10 -70.02 -32.74 71.05 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 120.996 -0.282 . . . . 0.71999999999999997 111.248 -173.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.517 -0.3 0 CA-C-O 121.616 0.722 . . . . 1.1899999999999999 109.116 -172.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.598 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . . . . . . 0 N--CA 1.445 -0.749 0 N-CA-C 110.276 -1.13 . . . . 0.78000000000000003 110.276 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.88 HG12 ' HB3' ' A' ' 93' ' ' ALA . 1.8 mp -108.89 146.07 14.96 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.175 0 N-CA-C 105.839 -1.911 . . . . 0.54000000000000004 105.839 170.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.725 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 1.0 OUTLIER -153.54 140.27 19.0 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 119.295 0.952 . . . . 1.4199999999999999 110.264 -169.72 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.588 ' O ' ' HA2' ' A' ' 74' ' ' GLY . 14.4 p -72.15 132.08 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 CA-C-N 115.44 -0.8 . . . . 0.57999999999999996 110.718 -171.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.715 ' O ' ' HB3' ' A' ' 32' ' ' SER . 19.3 m -125.34 64.71 1.16 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.98 -1.009 . . . . 1.1100000000000001 109.225 174.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.561 ' HA ' HG13 ' A' ' 73' ' ' ILE . 34.5 mtt180 149.38 -173.19 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.392 1.477 . . . . 2.27 111.407 165.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.621 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 4.8 p -174.34 120.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 113.167 -1.833 . . . . 0.82999999999999996 108.269 162.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.9 m -94.27 133.92 37.29 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.132 0.492 . . . . 1.6499999999999999 110.993 -175.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -61.4 124.51 20.83 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.643 -1.162 . . . . 1.8500000000000001 110.382 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.07 -13.06 45.02 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.047 -0.979 . . . . 0.92000000000000004 111.642 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.99 166.82 30.13 Favored Glycine 0 N--CA 1.438 -1.177 0 N-CA-C 111.026 -0.83 . . . . 0.98999999999999999 111.026 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.637 ' HA ' HD13 ' A' ' 68' ' ' ILE . 77.7 Cg_endo -73.98 -23.03 16.57 Favored 'Trans proline' 0 C--N 1.325 -0.676 0 C-N-CA 122.798 2.332 . . . . 0.44 113.036 -170.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.508 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -63.13 -29.38 70.75 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.688 -1.142 . . . . 0.35999999999999999 111.635 176.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -68.96 -37.29 78.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.417 0.627 . . . . 1.79 109.531 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.637 HD13 ' HA ' ' A' ' 65' ' ' PRO . 2.9 mp -67.76 -43.59 86.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 114.894 -1.048 . . . . 0.51000000000000001 110.533 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.69 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -75.76 -19.58 58.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.288 0.566 . . . . 0.40999999999999998 109.686 175.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.13 70.63 1.28 Allowed Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.365 -0.834 . . . . 0.45000000000000001 113.258 176.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.6 ' CD2' HG11 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -79.23 170.09 17.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.808 0.813 . . . . 0.89000000000000001 112.132 178.583 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.494 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 6.2 mm100 -108.26 -20.9 12.98 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 115.593 1.701 . . . . 1.21 115.593 -161.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.61 HD12 HG12 ' A' ' 60' ' ' VAL . 0.8 OUTLIER 82.41 -24.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 112.418 0.525 . . . . 0.77000000000000002 112.418 -172.556 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.588 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -172.02 53.34 0.17 Allowed Glycine 0 C--N 1.341 0.826 0 C-N-CA 119.873 -1.156 . . . . 0.37 112.691 -164.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.661 ' HB3' HG22 ' A' ' 109' ' ' VAL . 0.7 OUTLIER -122.19 149.71 43.26 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 122.204 0.201 . . . . 0.89000000000000001 110.548 -175.206 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.725 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 66.8 mttm -82.39 113.03 19.88 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.691 0.281 . . . . 2.2000000000000002 111.16 -174.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.552 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 17.1 mt -85.66 122.3 38.26 Favored 'Isoleucine or valine' 0 C--O 1.264 1.827 0 CA-C-O 121.254 0.549 . . . . 0.48999999999999999 111.571 -175.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.791 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 15.5 mmt -89.2 -20.01 24.73 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 125.831 1.957 . . . . 1.0600000000000001 112.763 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.61 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -167.25 154.05 8.44 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.434 -0.506 . . . . 0.81999999999999995 112.221 -174.877 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.781 HG21 ' HB2' ' A' ' 97' ' ' LEU . 12.0 p -139.61 125.49 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.381 -0.827 . . . . 1.3100000000000001 110.029 174.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.803 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 13.6 m120 52.75 30.22 8.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.168 -0.924 . . . . 1.5 113.193 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.88 -10.64 62.32 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.085 -1.055 . . . . 0.38 112.849 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -80.7 149.74 29.62 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-N 117.06 0.43 . . . . 0.77000000000000002 110.106 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -103.94 97.8 7.74 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.274 -0.875 . . . . 1.8899999999999999 111.081 -175.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.583 ' SD ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -113.3 101.88 9.82 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.842 -0.617 . . . . 1.01 111.19 176.934 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.4 p -99.02 -32.64 11.18 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.675 0.75 . . . . 1.05 110.258 173.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.756 ' O ' HG23 ' A' ' 37' ' ' ILE . 4.0 mtt -136.94 -15.48 1.53 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.756 -1.111 . . . . 1.6200000000000001 110.284 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.632 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 p -56.51 169.45 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 120.888 0.375 . . . . 1.0900000000000001 111.755 -162.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.966 ' HB ' ' HB3' ' A' ' 38' ' ' ASP . 72.4 p -56.56 145.02 29.46 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 122.223 -0.298 . . . . 0.34999999999999998 111.756 -174.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.574 ' CG ' ' HA2' ' A' ' 35' ' ' GLY . 23.3 t-160 -55.84 -35.4 66.37 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 122.045 0.926 . . . . 0.34999999999999998 108.614 175.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -69.02 -32.53 72.11 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 113.256 -1.793 . . . . 1.6699999999999999 110.313 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.815 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 4.3 tp-100 -62.54 -47.86 82.06 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 108.008 -1.108 . . . . 0.77000000000000002 108.008 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.88 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . -76.72 -34.06 58.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.243 -0.889 . . . . 0.33000000000000002 110.21 -173.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 94' ' ' ARG . 38.6 ttp180 -65.35 -43.53 90.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.386 -0.824 . . . . 2.1000000000000001 110.395 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.535 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -69.35 -40.88 77.26 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.53 -0.759 . . . . 0.95999999999999996 109.904 -176.403 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.815 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 21.9 mmt180 -70.36 -23.57 62.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.953 -0.567 . . . . 3.5699999999999998 110.633 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.781 ' HB2' HG21 ' A' ' 80' ' ' VAL . 15.9 tp -83.26 -44.48 14.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.631 -0.713 . . . . 1.6499999999999999 112.007 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.0 m -107.87 75.42 1.0 Allowed 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 122.807 1.289 . . . . 1.53 111.014 -169.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE2' ' HA ' ' A' ' 96' ' ' ARG . 6.6 mtmt -115.44 123.87 49.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.541 -2.118 . . . . 2.7200000000000002 109.041 173.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.437 ' HG2' HD13 ' A' ' 27' ' ' LEU . 41.8 mtp180 -69.69 40.01 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 O-C-N 123.324 0.39 . . . . 4.3799999999999999 111.229 177.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 99' ' ' LYS . 18.4 m -136.41 -41.74 0.63 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.056 -0.35 . . . . 2.5099999999999998 110.056 -172.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.564 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 46.9 mm-40 -56.36 140.69 44.53 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.383 -0.599 . . . . 3.3999999999999999 109.383 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.76 -16.87 15.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.502 0.668 . . . . 2.6800000000000002 109.862 176.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.785 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 3.0 p -143.26 150.29 17.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.128 -1.064 . . . . 0.44 108.128 -178.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.455 ' HA ' HD21 ' A' ' 81' ' ' ASN . 54.9 t -124.57 119.38 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.807 0 CA-C-O 122.22 1.009 . . . . 0.46000000000000002 111.513 -170.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.803 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -100.68 133.62 44.86 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 113.342 -1.754 . . . . 1.76 110.73 -176.228 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.707 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 19.3 tp -132.4 132.58 42.98 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 110.007 -0.368 . . . . 1.1200000000000001 110.007 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.791 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 23.8 tp -109.73 114.59 28.3 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.147 -1.797 . . . . 0.41999999999999998 106.147 171.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.735 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -121.67 141.18 43.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.898 -0.721 . . . . 0.77000000000000002 110.305 -173.641 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.697 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -96.28 115.81 28.02 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.831 -0.748 . . . . 0.34000000000000002 110.313 173.68 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.695 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 1.6 ttt180 -90.28 104.27 16.86 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.289 -1.323 . . . . 2.0099999999999998 109.655 -170.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.486 ' HG2' ' N ' ' A' ' 113' ' ' SER . 1.0 OUTLIER -91.59 -45.17 8.63 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.371 0.508 . . . . 1.97 112.371 -171.533 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.486 ' N ' ' HG2' ' A' ' 112' ' ' GLN . 22.8 t -163.1 14.92 0.07 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.408 0.623 . . . . 1.6200000000000001 110.311 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.463 HD23 ' OD1' ' A' ' 75' ' ' ASP . 3.6 mm? . . . . . 0 C--N 1.322 -0.619 0 CA-C-O 121.382 0.611 . . . . 1.6499999999999999 109.861 -176.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 49.2 p . . . . . 0 N--CA 1.434 -1.271 0 CA-C-O 122.309 1.052 . . . . 2.0899999999999999 111.461 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.07 179.36 5.6 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.399 -1.728 . . . . 0.95999999999999996 109.484 173.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.76 122.28 68.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.218 0.533 . . . . 1.5700000000000001 110.711 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.771 HG22 HG23 ' A' ' 110' ' ' THR . 15.8 t -79.56 105.61 9.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.004 -0.543 . . . . 1.02 110.367 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.75 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -102.05 169.19 8.91 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.725 -0.67 . . . . 1.3899999999999999 111.766 179.095 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.525 ' HD3' ' O ' ' A' ' 107' ' ' LEU . 1.8 mmt180 -123.96 116.09 22.31 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.334 -0.394 . . . . 3.6299999999999999 110.932 -177.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.702 ' HB ' ' HB3' ' A' ' 107' ' ' LEU . 25.1 t -97.29 125.71 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.597 -0.52 . . . . 1.02 109.597 176.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -139.04 116.21 11.05 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.89 -0.781 . . . . 1.3500000000000001 108.89 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.689 HG13 ' O ' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -144.57 139.8 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 107.841 -1.17 . . . . 0.60999999999999999 107.841 -177.42 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.849 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 17.1 m-70 -72.06 115.09 10.88 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.139 -0.689 . . . . 0.59999999999999998 109.139 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.652 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -31.96 141.01 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 O-C-N 124.958 1.411 . . . . 4.0 112.228 178.414 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.81 ' HB3' ' HB ' ' A' ' 28' ' ' ILE . 56.5 tp -98.18 102.58 14.37 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.595 -0.442 . . . . 0.55000000000000004 110.764 -171.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -58.13 139.35 54.97 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.371 0.605 . . . . 3.9700000000000002 112.069 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -142.99 92.46 2.4 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.555 -0.748 . . . . 1.3500000000000001 109.13 172.846 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.35 -79.85 0.01 OUTLIER Glycine 0 CA--C 1.522 0.473 0 C-N-CA 121.455 -0.403 . . . . 1.3300000000000001 112.541 -173.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -130.16 5.06 4.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.513 0.673 . . . . 2.3300000000000001 110.508 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 23' ' ' GLN . 12.0 m-80 -106.63 165.36 11.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.532 -0.758 . . . . 1.8700000000000001 110.146 -177.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.91 HD21 ' HB ' ' A' ' 98' ' ' THR . 2.2 pt? -128.66 124.63 36.21 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.759 -1.2 . . . . 2.2799999999999998 107.759 171.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.81 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 36.0 mm -98.43 115.95 40.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 116.028 -0.533 . . . . 0.80000000000000004 110.731 -170.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.806 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.3 pt? -71.7 -26.54 62.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.632 -0.713 . . . . 1.74 110.353 175.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.07 -31.3 7.1 Favored Glycine 0 C--O 1.223 -0.585 0 C-N-CA 120.731 -0.747 . . . . 0.68999999999999995 113.201 172.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.552 ' HZ ' HD11 ' A' ' 97' ' ' LEU . 44.9 p90 -112.24 163.07 14.79 Favored 'General case' 0 C--N 1.313 -0.999 0 O-C-N 122.264 -0.551 . . . . 0.51000000000000001 110.815 -176.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.535 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 24.0 t -100.47 163.2 12.47 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.268 -1.382 . . . . 0.53000000000000003 107.268 173.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -162.64 137.82 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 112.416 0.524 . . . . 0.48999999999999999 112.416 -164.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.74 117.79 1.06 Allowed Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 110.616 -0.994 . . . . 0.71999999999999997 110.616 157.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 1.031 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -142.65 118.56 1.27 Allowed Glycine 0 CA--C 1.49 -1.507 0 CA-C-O 118.607 -1.107 . . . . 1.4199999999999999 111.564 173.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.68 144.86 9.42 Favored Glycine 0 C--N 1.294 -1.764 0 C-N-CA 117.133 -2.46 . . . . 0.47999999999999998 113.319 177.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.453 HG12 ' C ' ' A' ' 88' ' ' VAL . 13.2 pt -62.58 -17.64 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.801 -1.185 . . . . 0.52000000000000002 107.801 151.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.847 ' HB2' ' CB ' ' A' ' 89' ' ' THR . 21.9 t70 -62.89 -37.09 85.53 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 113.962 -1.472 . . . . 0.71999999999999997 109.802 173.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 . . . . . 0 N--CA 1.456 -0.161 0 CA-C-N 114.662 -1.154 . . . . 1.1899999999999999 110.704 -174.733 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.445 ' C ' HD12 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.433 -1.556 0 N-CA-C 111.026 -0.83 . . . . 0.78000000000000003 111.026 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.031 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -114.25 144.25 22.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 N-CA-C 109.223 -0.658 . . . . 0.54000000000000004 109.223 178.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.814 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -145.92 146.78 31.19 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 122.59 1.186 . . . . 1.4199999999999999 113.334 178.218 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.814 HG23 HD11 ' A' ' 77' ' ' ILE . 54.5 t -72.21 137.42 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 112.509 -2.132 . . . . 0.57999999999999996 110.38 175.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.7 m -113.73 -19.7 11.45 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 124.502 1.126 . . . . 1.1100000000000001 111.478 -178.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.637 ' O ' HG23 ' A' ' 60' ' ' VAL . 72.8 mtt180 -149.48 -165.97 2.42 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.754 -0.591 . . . . 2.27 112.21 174.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 59' ' ' ARG . 79.7 t -168.4 138.61 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.705 1.602 . . . . 0.82999999999999996 107.407 166.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.415 ' OG ' ' HA3' ' A' ' 64' ' ' GLY . 32.2 p -81.09 132.87 35.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.922 0.392 . . . . 1.6499999999999999 111.123 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -58.71 111.17 1.17 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.864 -1.062 . . . . 1.8500000000000001 110.52 170.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.26 -15.16 63.83 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.55 -0.834 . . . . 0.92000000000000004 112.145 177.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.455 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -72.21 175.51 42.51 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.515 -0.85 . . . . 0.98999999999999999 111.35 177.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.689 ' O ' HG13 ' A' ' 18' ' ' ILE . 73.5 Cg_endo -72.8 -30.08 11.84 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.288 1.992 . . . . 0.44 112.69 -166.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.501 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -60.72 -28.25 68.52 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.011 -0.995 . . . . 0.35999999999999999 111.415 178.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -76.0 -35.49 59.55 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.517 0.675 . . . . 1.79 109.287 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.455 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -65.27 -43.43 95.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.882 -1.053 . . . . 0.51000000000000001 110.244 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.698 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -72.46 -22.87 61.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.908 -0.587 . . . . 0.40999999999999998 110.52 177.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.89 66.38 0.86 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.019 -1.086 . . . . 0.45000000000000001 113.389 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.593 HD13 HG21 ' A' ' 16' ' ' VAL . 9.0 tp -119.12 151.0 39.06 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.893 -0.41 . . . . 0.89000000000000001 109.893 177.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.53 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 57.5 mt-30 -129.91 31.73 4.66 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 115.806 1.78 . . . . 1.21 115.806 -162.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 72' ' ' GLN . 2.7 mp 72.95 -8.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 CA-C-N 118.992 0.815 . . . . 0.77000000000000002 112.988 170.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.13 54.58 0.32 Allowed Glycine 0 CA--C 1.507 -0.454 0 C-N-CA 119.155 -1.498 . . . . 0.37 112.69 -168.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.577 ' H ' ' HB ' ' A' ' 57' ' ' VAL . 16.8 m-20 -120.83 148.36 44.12 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.491 -0.354 . . . . 0.89000000000000001 110.51 -168.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.814 ' HD3' ' HB3' ' A' ' 56' ' ' TYR . 14.0 mmtp -105.93 102.86 12.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.168 0.508 . . . . 2.2000000000000002 110.0 -169.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 1.059 HG13 HG23 ' A' ' 109' ' ' VAL . 3.4 mp -72.99 126.99 34.63 Favored 'Isoleucine or valine' 0 C--O 1.257 1.471 0 N-CA-C 113.629 0.974 . . . . 0.48999999999999999 113.629 -172.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.793 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 5.5 mmt -92.12 -28.55 17.03 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 126.265 2.228 . . . . 1.0600000000000001 112.113 172.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.587 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 52.3 mt-30 -150.87 158.57 44.31 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.52 0.933 . . . . 0.81999999999999995 113.52 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.586 ' HB ' ' CE ' ' A' ' 85' ' ' MET . 24.4 t -139.6 107.46 3.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 113.515 -1.675 . . . . 1.3100000000000001 109.951 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 1.011 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 23.1 m-80 54.92 32.27 17.59 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.848 0.459 . . . . 1.5 112.007 176.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.46 -3.9 59.76 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.224 -0.989 . . . . 0.38 112.817 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.435 ' CE2' ' HD2' ' A' ' 96' ' ' ARG . 84.0 m95 -87.54 168.27 13.21 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.669 -0.493 . . . . 0.77000000000000002 109.669 177.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -109.78 113.69 26.66 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.242 0.544 . . . . 1.8899999999999999 111.155 -171.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.586 ' CE ' ' HB ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -106.95 101.97 11.36 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 122.217 1.008 . . . . 1.01 110.965 -179.702 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.8 p -142.1 -46.18 0.34 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.428 -1.714 . . . . 1.05 107.707 173.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.413 ' HA ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -146.85 74.45 1.35 Allowed 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 113.704 -1.589 . . . . 1.6200000000000001 110.127 176.105 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.545 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 22.9 m -133.3 154.93 40.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.285 -1.006 . . . . 1.0900000000000001 108.285 171.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.847 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 72.0 p -62.57 154.4 29.02 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 120.792 0.33 . . . . 0.34999999999999998 111.331 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.818 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 17.7 t-160 -52.59 -45.14 66.39 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 121.722 0.772 . . . . 0.34999999999999998 110.143 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -71.35 -29.56 65.13 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 113.692 -1.594 . . . . 1.6699999999999999 109.964 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.745 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 1.8 tt0 -60.19 -47.14 87.2 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.402 -0.592 . . . . 0.77000000000000002 109.402 178.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.586 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -74.06 -41.0 62.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.322 0.582 . . . . 0.33000000000000002 110.531 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -56.62 -44.17 80.94 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.817 -1.083 . . . . 2.1000000000000001 110.896 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.402 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -71.82 -34.35 69.25 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.396 -0.82 . . . . 0.95999999999999996 109.92 -176.682 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.745 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 27.2 mmt180 -74.56 -26.15 59.76 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.172 -0.467 . . . . 3.5699999999999998 110.712 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.552 HD11 ' HZ ' ' A' ' 31' ' ' PHE . 5.6 tt -68.94 -60.85 2.09 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.527 -0.76 . . . . 1.6499999999999999 111.277 -176.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.91 ' HB ' HD21 ' A' ' 27' ' ' LEU . 5.8 p -97.43 -83.56 0.39 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.387 -0.369 . . . . 1.53 111.408 -176.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 99' ' ' LYS . 2.8 ttpt 66.97 -1.66 1.35 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.8 -0.636 . . . . 2.7200000000000002 112.026 176.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.482 ' HA ' HD22 ' A' ' 27' ' ' LEU . 97.4 mtt180 60.34 47.79 8.61 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.026 -0.988 . . . . 4.3799999999999999 111.188 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.1 t -137.02 -56.44 0.72 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.466 -0.334 . . . . 2.5099999999999998 111.741 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.652 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 19.5 mm-40 -63.83 149.5 46.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.474 -0.33 . . . . 3.3999999999999999 111.123 -174.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -93.5 -10.17 35.82 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.431 0.634 . . . . 2.6800000000000002 109.843 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.849 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 3.8 p -147.58 142.18 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 108.634 -0.876 . . . . 0.44 108.634 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.5 t -116.64 120.24 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-O 122.02 0.914 . . . . 0.46000000000000002 111.867 -169.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 1.011 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -99.66 128.33 45.77 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 113.444 -1.707 . . . . 1.76 111.322 -174.403 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.885 HD11 HG12 ' A' ' 77' ' ' ILE . 17.6 tp -134.49 133.87 40.85 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.127 -0.488 . . . . 1.1200000000000001 110.492 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.793 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 29.9 tp -111.38 117.01 31.92 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 105.998 -1.853 . . . . 0.41999999999999998 105.998 170.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 1.059 HG23 HG13 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -126.63 144.46 36.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.868 -0.733 . . . . 0.77000000000000002 110.407 -174.578 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.771 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -95.68 115.29 27.22 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.614 -0.834 . . . . 0.34000000000000002 109.297 169.608 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.5 ttt180 -102.97 138.9 39.24 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.258 -1.337 . . . . 2.0099999999999998 110.482 -172.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.545 ' HG2' HD21 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -125.41 -96.35 0.44 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.326 0.491 . . . . 1.97 112.326 -178.433 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.0 t -124.97 35.39 4.79 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.273 0.559 . . . . 1.6200000000000001 111.792 -168.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.545 HD21 ' HG2' ' A' ' 112' ' ' GLN . 0.3 OUTLIER . . . . . 0 C--N 1.319 -0.736 0 CA-C-O 121.32 0.581 . . . . 1.6499999999999999 109.835 -178.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.447 -0.586 0 CA-C-O 123.605 1.669 . . . . 2.0899999999999999 110.86 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 111' ' ' ARG . . . -110.9 178.19 4.43 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 112.196 -2.274 . . . . 0.95999999999999996 110.541 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.8 t -111.64 118.19 56.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.989 -0.551 . . . . 1.5700000000000001 110.487 -176.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.741 HG22 HG23 ' A' ' 110' ' ' THR . 39.4 t -76.37 111.81 13.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.219 0.533 . . . . 1.02 109.637 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.63 ' HG2' ' HB3' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -118.69 169.35 9.89 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.009 -0.541 . . . . 1.3899999999999999 112.235 -171.465 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 15' ' ' ARG . 6.1 mmm-85 -124.06 118.11 26.21 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.998 0.428 . . . . 3.6299999999999999 112.126 -175.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.74 HG13 ' CB ' ' A' ' 69' ' ' ALA . 7.7 t -108.26 119.59 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 108.25 -1.018 . . . . 1.02 108.25 171.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -132.75 114.41 14.1 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.93 -0.767 . . . . 1.3500000000000001 108.93 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.716 HG13 ' O ' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -136.89 138.29 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 108.097 -1.075 . . . . 0.60999999999999999 108.097 -173.619 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.847 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.3 m-70 -66.09 114.14 5.01 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.495 -0.32 . . . . 0.59999999999999998 110.358 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.973 ' HB2' HD13 ' A' ' 27' ' ' LEU . 2.2 pptp? -28.02 135.4 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 O-C-N 125.097 1.498 . . . . 4.0 112.814 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.716 HD22 ' HD3' ' A' ' 65' ' ' PRO . 33.1 tp -96.68 90.24 5.24 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.937 0.875 . . . . 0.55000000000000004 109.377 -175.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.489 ' H ' ' CD ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -62.3 133.23 54.84 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.854 -1.521 . . . . 3.9700000000000002 111.311 -178.501 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.403 ' HB2' HD13 ' A' ' 28' ' ' ILE . 21.1 tp60 -133.71 94.18 3.24 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.773 -0.825 . . . . 1.3500000000000001 108.773 173.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.5 -80.26 0.12 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.828 -0.701 . . . . 1.3300000000000001 111.778 -175.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -132.52 1.47 3.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.832 0.348 . . . . 2.3300000000000001 110.511 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -107.61 172.04 7.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.24 0.543 . . . . 1.8700000000000001 111.283 -171.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.973 HD13 ' HB2' ' A' ' 20' ' ' LYS . 2.7 tp -124.4 121.77 35.84 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.14 -0.936 . . . . 2.2799999999999998 109.06 175.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.403 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.5 mp -99.25 129.65 49.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.686 -0.857 . . . . 0.80000000000000004 108.686 176.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mt -84.7 -32.39 23.58 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.418 -0.81 . . . . 1.74 110.279 -174.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.429 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 86.59 11.6 71.06 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.227 -0.987 . . . . 0.68999999999999995 111.487 -175.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.616 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 33.3 p90 -155.0 167.73 29.37 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.305 -0.628 . . . . 0.51000000000000001 109.305 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.567 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -107.67 164.09 12.53 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 107.873 -1.158 . . . . 0.53000000000000003 107.873 172.697 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -148.78 136.47 14.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 119.573 -0.851 . . . . 0.48999999999999999 112.664 -167.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.418 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -147.46 118.41 1.01 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.25 -0.976 . . . . 0.71999999999999997 111.066 157.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 1.033 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -137.99 119.04 1.75 Allowed Glycine 0 CA--C 1.492 -1.354 0 CA-C-O 118.807 -0.996 . . . . 1.4199999999999999 110.703 171.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 1.017 ' HA3' ' HG2' ' A' ' 39' ' ' GLN . . . -156.77 116.9 0.74 Allowed Glycine 0 N--CA 1.435 -1.423 0 C-N-CA 118.277 -1.916 . . . . 0.47999999999999998 113.614 -169.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.533 HG12 ' C ' ' A' ' 88' ' ' VAL . 15.9 pt -67.86 -20.89 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 N-CA-C 105.738 -1.949 . . . . 0.52000000000000002 105.738 147.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.742 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 2.8 t70 -63.17 -40.72 98.35 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 112.644 -2.071 . . . . 0.71999999999999997 109.765 168.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 1.017 ' HG2' ' HA3' ' A' ' 36' ' ' GLY . 28.7 mm-40 . . . . . 0 C--N 1.345 0.373 0 CA-C-N 115.034 -0.984 . . . . 1.1899999999999999 111.777 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.476 ' C ' HD12 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.44 -1.053 0 N-CA-C 109.732 -1.347 . . . . 0.78000000000000003 109.732 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.033 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -117.1 141.16 36.7 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.151 0 C-N-CA 119.268 -0.973 . . . . 0.54000000000000004 109.187 177.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.774 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -148.28 138.13 22.38 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.698 0.761 . . . . 1.4199999999999999 110.509 -176.043 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.546 HG12 ' H ' ' A' ' 75' ' ' ASP . 14.6 p -79.49 137.17 22.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 114.485 -1.234 . . . . 0.57999999999999996 110.468 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 58' ' ' THR . 12.1 t -127.18 68.91 1.28 Allowed 'General case' 0 C--O 1.21 -1.021 0 O-C-N 124.325 1.016 . . . . 1.1100000000000001 108.998 174.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.646 ' HA ' HG23 ' A' ' 73' ' ' ILE . 18.0 mtt180 153.55 -172.9 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.897 -1.502 . . . . 2.27 110.939 159.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.1 t -160.7 112.92 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 111.897 -2.41 . . . . 0.82999999999999996 106.621 161.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 m -76.44 121.75 23.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.96 0.41 . . . . 1.6499999999999999 109.933 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -48.14 116.72 1.63 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.01 -0.995 . . . . 1.8500000000000001 112.066 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.41 -16.06 49.24 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.517 -0.849 . . . . 0.92000000000000004 112.189 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.64 169.83 54.83 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.153 -1.022 . . . . 0.98999999999999999 111.415 177.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.716 ' O ' HG13 ' A' ' 18' ' ' ILE . 90.5 Cg_endo -71.35 -24.59 22.68 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.603 2.202 . . . . 0.44 113.064 -170.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.616 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -63.15 -25.67 68.46 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.26 -0.882 . . . . 0.35999999999999999 111.521 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -73.67 -37.42 65.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.656 -0.868 . . . . 1.79 108.656 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.53 HD13 ' HA ' ' A' ' 65' ' ' PRO . 2.2 mp -65.86 -47.99 83.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.245 -1.343 . . . . 0.51000000000000001 111.095 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.74 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -71.93 -22.07 61.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.388 -0.369 . . . . 0.40999999999999998 110.405 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.27 72.27 1.29 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.505 -0.855 . . . . 0.45000000000000001 113.109 178.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.473 ' CD2' HG21 ' A' ' 57' ' ' VAL . 15.3 tp -105.04 158.16 16.75 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.699 -0.482 . . . . 0.89000000000000001 109.699 176.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.672 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 35.2 mt-30 -114.04 20.83 15.37 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 114.756 1.391 . . . . 1.21 114.756 -168.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.646 HG23 ' HA ' ' A' ' 59' ' ' ARG . 75.8 mt 73.88 -5.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 113.059 0.762 . . . . 0.77000000000000002 113.059 170.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -171.03 63.9 0.16 Allowed Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.667 -0.777 . . . . 0.37 111.621 -165.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.546 ' H ' HG12 ' A' ' 57' ' ' VAL . 20.6 m-20 -122.66 148.26 45.49 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.245 -0.478 . . . . 0.89000000000000001 110.055 -170.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -97.98 101.39 12.86 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.29 0.567 . . . . 2.2000000000000002 109.775 -176.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 1.009 HG13 HG12 ' A' ' 109' ' ' VAL . 3.1 mp -73.86 121.89 25.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 115.29 -0.868 . . . . 0.48999999999999999 112.005 -175.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.665 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 4.5 mmt -88.59 -21.74 23.88 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 125.687 1.867 . . . . 1.0600000000000001 111.933 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.561 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 1.0 OUTLIER -160.77 148.94 16.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.166 0.508 . . . . 0.81999999999999995 112.194 -175.756 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.622 HG13 ' HB3' ' A' ' 97' ' ' LEU . 21.9 t -129.49 110.52 20.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.172 -0.922 . . . . 1.3100000000000001 110.594 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.786 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 9.4 m-80 52.38 37.22 21.94 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.694 0.627 . . . . 1.5 112.694 174.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.9 -11.13 62.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.292 -0.956 . . . . 0.38 112.563 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.557 ' HB2' ' HE2' ' A' ' 85' ' ' MET . 80.1 m95 -89.57 161.87 15.95 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 109.282 -0.636 . . . . 0.77000000000000002 109.282 177.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -108.81 111.79 23.71 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.197 -0.456 . . . . 1.8899999999999999 110.653 -172.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.79 ' SD ' HG11 ' A' ' 88' ' ' VAL . 13.7 mmt -107.41 99.92 9.4 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 121.85 0.834 . . . . 1.01 109.91 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.64 -48.61 2.04 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.706 -1.134 . . . . 1.05 107.998 171.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.411 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 3.2 mtt -143.41 85.01 1.83 Allowed 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.517 -1.674 . . . . 1.6200000000000001 108.022 173.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.79 HG11 ' SD ' ' A' ' 85' ' ' MET . 0.5 OUTLIER -140.32 151.2 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 115.781 -0.645 . . . . 1.0900000000000001 109.904 -176.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.682 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 82.6 p -61.25 151.19 32.4 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.143 0.497 . . . . 0.34999999999999998 112.278 -177.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.742 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 22.6 t-160 -61.53 -34.36 75.41 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 115.814 -0.63 . . . . 0.34999999999999998 109.891 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -70.58 -33.24 70.85 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.171 -1.377 . . . . 1.6699999999999999 109.235 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.727 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -63.56 -52.36 61.4 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.747 -0.834 . . . . 0.77000000000000002 108.747 -179.775 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.715 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -66.72 -41.14 88.42 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.504 -0.771 . . . . 0.33000000000000002 110.281 -178.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -60.25 -47.46 85.91 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.375 -0.829 . . . . 2.1000000000000001 110.676 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.517 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -69.95 -39.45 76.04 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.67 -0.695 . . . . 0.95999999999999996 110.203 -176.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.727 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 25.1 mmt180 -69.24 -23.01 63.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.991 -0.549 . . . . 3.5699999999999998 112.152 -175.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.622 ' HB3' HG13 ' A' ' 80' ' ' VAL . 4.4 pp -98.93 -14.04 19.72 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.406 -0.517 . . . . 1.6499999999999999 111.948 175.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.751 ' HA ' HD23 ' A' ' 27' ' ' LEU . 1.9 m -112.74 86.02 2.28 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 122.35 1.071 . . . . 1.53 109.945 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.493 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 4.6 mtmt -120.17 119.15 32.43 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 113.462 -1.699 . . . . 2.7200000000000002 109.969 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -67.62 48.77 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.181 -0.918 . . . . 4.3799999999999999 111.84 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.4 t -151.42 -54.11 0.14 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.311 0.486 . . . . 2.5099999999999998 112.311 -172.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 43.9 mt-10 -71.67 158.51 36.02 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.323 0.49 . . . . 3.3999999999999999 112.323 -171.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -95.4 -18.34 20.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.81 -0.632 . . . . 2.6800000000000002 111.399 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.847 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 4.9 p -142.41 148.25 20.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.726 0.298 . . . . 0.44 110.362 -172.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.546 HG13 HD22 ' A' ' 81' ' ' ASN . 44.1 t -119.73 119.78 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-O 121.813 0.816 . . . . 0.46000000000000002 111.736 -173.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.786 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.9 OUTLIER -102.11 124.92 48.55 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 113.875 -1.511 . . . . 1.76 111.529 -174.039 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.431 HD21 HG12 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -133.52 131.06 39.33 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.19 0.519 . . . . 1.1200000000000001 111.071 174.445 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.665 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 35.4 tp -103.2 113.99 27.91 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.011 -1.477 . . . . 0.41999999999999998 107.011 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 1.009 HG12 HG13 ' A' ' 77' ' ' ILE . 23.1 m -118.12 152.06 20.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 C-N-CA 119.921 -0.712 . . . . 0.77000000000000002 110.581 -176.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.741 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -95.73 115.18 27.06 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.825 -0.75 . . . . 0.34000000000000002 109.287 167.129 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.63 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . 0.9 OUTLIER -105.16 143.08 33.84 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.925 -1.034 . . . . 2.0099999999999998 110.475 -171.255 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.43 -89.27 0.49 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.067 -0.515 . . . . 1.97 110.633 -176.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.2 t -160.47 74.26 0.53 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.322 0.582 . . . . 1.6200000000000001 110.998 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.672 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 6.8 mt . . . . . 0 C--N 1.312 -1.034 0 CA-C-N 115.284 -0.871 . . . . 1.6499999999999999 110.081 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.448 -0.536 0 CA-C-O 123.559 1.647 . . . . 2.0899999999999999 110.869 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.64 157.45 17.17 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 112.343 -2.208 . . . . 0.95999999999999996 109.227 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.687 HG23 ' HG2' ' A' ' 111' ' ' ARG . 20.2 m -99.92 125.78 53.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 109.502 -0.555 . . . . 1.5700000000000001 109.502 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.657 HG22 HG23 ' A' ' 110' ' ' THR . 56.1 t -77.19 97.67 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 122.0 0.905 . . . . 1.02 111.168 -176.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.591 ' O ' ' HB ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -95.91 139.84 31.54 Favored 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 114.095 -1.411 . . . . 1.3899999999999999 109.515 175.885 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.432 ' HB3' HD12 ' A' ' 108' ' ' LEU . 5.3 ppt_? -125.6 129.05 48.87 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 120.32 -1.487 . . . . 3.6299999999999999 111.326 176.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.772 HG13 ' CB ' ' A' ' 69' ' ' ALA . 22.7 t -92.57 133.93 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 114.909 -1.041 . . . . 1.02 110.259 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -135.32 112.51 10.44 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.008 -0.738 . . . . 1.3500000000000001 109.008 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.646 HG13 ' O ' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -144.45 139.24 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 N-CA-C 107.742 -1.207 . . . . 0.60999999999999999 107.742 -177.553 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.68 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 14.6 m-70 -73.75 114.88 12.53 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.054 -0.721 . . . . 0.59999999999999998 109.054 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.778 ' HB2' HD12 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -31.46 143.71 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 O-C-N 125.02 1.45 . . . . 4.0 112.424 -178.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.548 HD22 ' HD3' ' A' ' 65' ' ' PRO . 30.7 tp -94.98 97.59 10.08 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.847 -0.741 . . . . 0.55000000000000004 110.037 -171.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.468 ' HD3' ' H ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -54.95 131.34 44.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.792 -1.094 . . . . 3.9700000000000002 111.583 -178.684 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.412 ' HB2' HD13 ' A' ' 28' ' ' ILE . 38.1 tp60 -139.8 102.13 4.35 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.755 -1.111 . . . . 1.3500000000000001 108.549 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.9 -92.04 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.556 -0.831 . . . . 1.3300000000000001 111.108 -175.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.449 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 35.7 mt-10 -126.6 -0.55 6.81 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.101 0.477 . . . . 2.3300000000000001 110.607 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.444 ' HA ' ' CB ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -112.54 -175.94 2.79 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.969 -0.56 . . . . 1.8700000000000001 110.457 -173.747 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.778 HD12 ' HB2' ' A' ' 20' ' ' LYS . 1.7 pt? -123.9 142.84 50.78 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.405 -0.961 . . . . 2.2799999999999998 108.405 175.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.412 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.2 mp -106.78 130.89 57.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 121.062 0.458 . . . . 0.80000000000000004 110.357 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.6 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.3 pt? -96.28 117.33 30.58 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.032 -1.099 . . . . 1.74 108.032 172.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.623 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -81.5 43.54 2.93 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.738 -0.744 . . . . 0.68999999999999995 113.521 -171.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.61 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 29.0 p90 -158.28 160.44 37.05 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 122.575 0.35 . . . . 0.51000000000000001 110.33 178.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 18.6 t -103.89 159.9 15.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.183 -1.414 . . . . 0.53000000000000003 107.183 170.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -160.3 140.15 3.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 120.695 -0.402 . . . . 0.48999999999999999 111.778 -165.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -145.61 119.22 1.17 Allowed Glycine 0 N--CA 1.436 -1.314 0 N-CA-C 110.257 -1.137 . . . . 0.71999999999999997 110.257 157.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 1.005 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -138.67 116.68 1.3 Allowed Glycine 0 CA--C 1.488 -1.643 0 N-CA-C 110.652 -0.979 . . . . 1.4199999999999999 110.652 169.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.7 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.47 137.15 4.5 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 117.498 -2.287 . . . . 0.47999999999999998 114.329 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.514 HG12 ' C ' ' A' ' 88' ' ' VAL . 23.3 pt -66.79 -11.4 13.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.773 -1.195 . . . . 0.52000000000000002 107.773 149.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.81 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 0.0 OUTLIER -72.3 -40.69 67.32 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.091 -1.413 . . . . 0.71999999999999997 108.789 170.351 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 . . . . . 0 C--O 1.234 0.287 0 CA-C-N 114.965 -1.016 . . . . 1.1899999999999999 109.213 178.198 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.431 ' C ' HD12 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.446 -0.663 0 N-CA-C 109.828 -1.309 . . . . 0.78000000000000003 109.828 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.005 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -115.32 141.25 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 106.755 -1.572 . . . . 0.54000000000000004 106.755 168.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.67 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -153.85 146.97 24.61 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 119.42 1.009 . . . . 1.4199999999999999 110.887 -178.615 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.807 HG12 ' H ' ' A' ' 75' ' ' ASP . 1.4 p -81.88 140.84 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-N 114.732 -1.122 . . . . 0.57999999999999996 109.71 -175.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.9 m -110.25 -14.47 14.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.295 -0.866 . . . . 1.1100000000000001 110.841 -173.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.546 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 67.1 mtt180 -149.55 -166.59 2.59 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.728 0.775 . . . . 2.27 112.395 174.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 66' ' ' ALA . 88.3 t -160.0 140.02 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 112.525 -2.125 . . . . 0.82999999999999996 106.474 162.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.9 p -82.73 121.16 26.52 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 121.503 0.668 . . . . 1.6499999999999999 110.308 175.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -60.46 101.08 0.12 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 113.965 -1.47 . . . . 1.8500000000000001 111.08 174.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.88 -6.57 23.88 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.495 -0.86 . . . . 0.92000000000000004 112.319 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.513 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -91.82 -176.99 42.58 Favored Glycine 0 CA--C 1.5 -0.888 0 C-N-CA 120.914 -0.66 . . . . 0.98999999999999999 111.7 177.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.646 ' O ' HG13 ' A' ' 18' ' ' ILE . 65.6 Cg_endo -71.89 -25.83 19.49 Favored 'Trans proline' 0 CA--C 1.509 -0.738 0 C-N-CA 122.94 2.427 . . . . 0.44 113.097 -168.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.61 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -67.93 -25.9 65.7 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.034 -0.985 . . . . 0.35999999999999999 110.873 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -74.67 -32.47 62.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.934 0.874 . . . . 1.79 109.002 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.513 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -71.65 -44.47 69.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.477 -1.238 . . . . 0.51000000000000001 110.549 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.772 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -75.3 -23.09 57.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.091 -0.504 . . . . 0.40999999999999998 110.556 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.91 70.29 1.08 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.001 -1.095 . . . . 0.45000000000000001 113.315 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.67 HD21 HG21 ' A' ' 57' ' ' VAL . 16.7 tp -112.17 155.24 24.28 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.25 -0.648 . . . . 0.89000000000000001 109.25 174.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.426 HE22 ' HD2' ' A' ' 111' ' ' ARG . 0.5 OUTLIER -132.51 35.61 3.62 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 115.193 1.553 . . . . 1.21 115.193 -165.718 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.546 HG23 ' HA ' ' A' ' 59' ' ' ARG . 4.4 mp 68.89 -7.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 N-CA-C 113.793 1.034 . . . . 0.77000000000000002 113.793 165.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.49 52.63 0.35 Allowed Glycine 0 CA--C 1.509 -0.311 0 C-N-CA 119.903 -1.141 . . . . 0.37 112.108 -170.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.807 ' H ' HG12 ' A' ' 57' ' ' VAL . 40.7 m-20 -119.75 132.17 55.56 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.341 -0.43 . . . . 0.89000000000000001 111.387 -168.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.67 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 10.8 mmmm -82.16 100.67 9.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.338 0.59 . . . . 2.2000000000000002 110.466 -174.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.637 ' HB ' HG22 ' A' ' 55' ' ' ILE . 5.6 mt -73.64 123.38 28.62 Favored 'Isoleucine or valine' 0 C--O 1.261 1.674 0 CA-C-N 115.546 -0.752 . . . . 0.48999999999999999 111.664 -176.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.796 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 10.6 mmt -94.73 -11.88 28.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 125.572 1.795 . . . . 1.0600000000000001 113.075 177.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.52 ' HB3' ' CB ' ' A' ' 108' ' ' LEU . 2.6 tt0 -173.13 156.04 3.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.654 0.264 . . . . 0.81999999999999995 111.513 -175.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.8 p -145.36 122.93 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 121.415 0.626 . . . . 1.3100000000000001 110.352 174.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.48 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 1.1 m-80 60.04 21.31 10.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.231 -0.895 . . . . 1.5 112.181 178.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.94 -10.33 55.54 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.019 -1.086 . . . . 0.38 112.432 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.414 ' CD1' ' HB3' ' A' ' 96' ' ' ARG . 86.6 m95 -86.94 131.3 34.13 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 109.092 -0.707 . . . . 0.77000000000000002 109.092 176.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -85.09 115.73 23.06 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.747 -1.115 . . . . 1.8899999999999999 110.515 -174.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.707 ' HE3' ' HA ' ' A' ' 93' ' ' ALA . 23.2 mmt -106.66 101.12 10.59 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.097 -0.956 . . . . 1.01 111.134 -175.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.4 ' C ' ' HG3' ' A' ' 87' ' ' MET . 1.2 p -135.36 111.59 9.69 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.632 -1.167 . . . . 1.05 108.963 169.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.4 ' HG3' ' C ' ' A' ' 86' ' ' THR . 0.0 OUTLIER 44.96 65.69 1.04 Allowed 'General case' 0 C--N 1.33 -0.28 0 O-C-N 124.052 0.845 . . . . 1.6200000000000001 111.386 -176.117 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.7 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 3.8 p -129.71 166.48 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.146 -1.057 . . . . 1.0900000000000001 108.146 172.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.654 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 71.7 p -58.35 149.63 24.15 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.987 0.736 . . . . 0.34999999999999998 112.987 -175.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.81 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 19.0 t-160 -61.52 -35.71 78.5 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-O 121.499 0.666 . . . . 0.34999999999999998 109.508 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.48 ' CG ' HH12 ' A' ' 94' ' ' ARG . 0.6 OUTLIER -67.27 -31.46 71.8 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 113.992 -1.458 . . . . 1.6699999999999999 109.517 178.048 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.757 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 3.8 tp-100 -62.49 -51.65 66.59 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 108.965 -0.754 . . . . 0.77000000000000002 108.965 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.707 ' HA ' ' HE3' ' A' ' 85' ' ' MET . . . -72.62 -36.61 68.11 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.5 -0.773 . . . . 0.33000000000000002 110.195 -177.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.48 HH12 ' CG ' ' A' ' 91' ' ' ASP . 26.6 ttp-105 -67.01 -38.76 86.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.689 -0.687 . . . . 2.1000000000000001 110.694 -177.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.52 ' HE3' ' O ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -70.79 -45.89 63.84 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.302 -0.629 . . . . 0.95999999999999996 109.302 -178.777 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.757 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 25.2 mmt180 -67.71 -23.61 65.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.765 -0.652 . . . . 3.5699999999999998 110.175 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.529 HD11 ' CZ ' ' A' ' 31' ' ' PHE . 4.1 tt -77.14 -53.55 7.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.674 -0.694 . . . . 1.6499999999999999 110.985 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.5 m -90.97 90.23 7.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.92 0.867 . . . . 1.53 111.238 -169.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.606 ' HE2' ' O ' ' A' ' 96' ' ' ARG . 22.8 mtmt -133.85 110.11 9.53 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.023 -1.444 . . . . 2.7200000000000002 109.241 176.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.449 ' HD2' ' O ' ' A' ' 25' ' ' GLU . 17.9 ptt180 -76.56 36.5 0.16 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.268 0.556 . . . . 4.3799999999999999 110.833 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 99' ' ' LYS . 4.0 p -124.4 -58.92 1.5 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.774 -0.648 . . . . 2.5099999999999998 111.254 -176.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.22 147.84 42.93 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.084 0.468 . . . . 3.3999999999999999 111.549 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -84.0 -18.74 36.15 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.66 0.615 . . . . 2.6800000000000002 112.66 -172.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.68 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 6.9 p -144.01 145.36 21.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.775 0.321 . . . . 0.44 110.25 -171.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.9 t -114.84 118.46 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-O 122.502 1.144 . . . . 0.46000000000000002 111.914 -175.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.48 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -98.75 129.81 45.2 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 113.065 -1.88 . . . . 1.76 109.766 -178.308 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.442 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 26.2 tp -133.98 125.72 28.76 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 116.218 -0.446 . . . . 1.1200000000000001 110.097 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.796 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 14.6 tp -101.52 130.17 47.74 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.522 -1.288 . . . . 0.41999999999999998 107.522 176.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.709 HG13 ' HB3' ' A' ' 75' ' ' ASP . 2.2 t -131.83 140.12 48.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.998 0.904 . . . . 0.77000000000000002 111.018 -171.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.657 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -105.19 116.53 32.11 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.126 -0.943 . . . . 0.34000000000000002 109.759 163.523 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.687 ' HG2' HG23 ' A' ' 12' ' ' VAL . 1.5 ptt180 -114.35 140.46 48.63 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.175 -0.92 . . . . 2.0099999999999998 110.322 -170.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.513 HE22 ' HG2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -118.97 -41.52 2.76 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.034 0.921 . . . . 1.97 111.035 -170.875 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.528 ' H ' HD22 ' A' ' 114' ' ' LEU . 36.5 t -159.94 -128.84 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.029 -1.441 . . . . 1.6200000000000001 107.521 -169.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.528 HD22 ' H ' ' A' ' 113' ' ' SER . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.574 0 O-C-N 124.018 0.823 . . . . 1.6499999999999999 111.826 171.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.442 -0.846 0 CA-C-O 122.307 1.051 . . . . 2.0899999999999999 109.181 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.31 179.17 7.97 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.159 -1.837 . . . . 0.95999999999999996 111.791 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.8 t -105.77 121.56 58.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.262 -0.881 . . . . 1.5700000000000001 110.531 -176.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.609 HG22 HG23 ' A' ' 110' ' ' THR . 38.6 t -77.98 120.7 29.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.85 0.357 . . . . 1.02 110.968 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.78 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -121.08 167.52 12.54 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.015 -0.539 . . . . 1.3899999999999999 111.289 -178.616 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.587 ' HD3' ' O ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -124.12 113.6 18.57 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.676 0.391 . . . . 3.6299999999999999 111.492 -175.778 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.687 HG13 ' CB ' ' A' ' 69' ' ' ALA . 2.2 t -98.16 130.76 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.753 -0.462 . . . . 1.02 109.753 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -142.51 117.81 10.19 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 110.119 -0.326 . . . . 1.3500000000000001 110.119 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 11.2 tp -140.27 144.62 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 108.64 -0.874 . . . . 0.60999999999999999 108.64 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.8 m-70 -77.03 111.09 12.23 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.248 -0.581 . . . . 0.59999999999999998 109.772 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.504 ' HD2' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -23.77 136.64 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 O-C-N 125.433 1.708 . . . . 4.0 113.464 -179.425 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.1 tp -96.46 92.74 6.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.857 0.837 . . . . 0.55000000000000004 109.96 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HD3' ' H ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -65.3 135.93 55.94 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.186 -1.37 . . . . 3.9700000000000002 111.275 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.406 ' HB2' HD13 ' A' ' 28' ' ' ILE . 9.6 tp60 -138.39 93.97 2.8 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.115 -0.698 . . . . 1.3500000000000001 109.115 173.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 60.59 -86.7 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.909 -0.663 . . . . 1.3300000000000001 111.621 -174.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -131.89 12.07 4.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.261 0.553 . . . . 2.3300000000000001 110.335 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -111.42 154.91 23.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.599 -0.728 . . . . 1.8700000000000001 109.047 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.0 mp -120.8 122.13 39.66 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.431 -0.581 . . . . 2.2799999999999998 109.431 174.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.406 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.8 mp -98.19 121.29 48.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 115.266 -0.879 . . . . 0.80000000000000004 109.456 -177.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.651 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -89.72 -27.99 19.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.772 -1.103 . . . . 1.74 110.77 179.272 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.519 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 82.68 17.53 67.96 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.237 -0.982 . . . . 0.68999999999999995 113.381 175.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.651 ' CE2' ' HB2' ' A' ' 29' ' ' LEU . 44.5 p90 -148.94 159.68 43.97 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.496 -0.557 . . . . 0.51000000000000001 109.496 172.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.7 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -102.33 161.93 13.31 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 118.625 -1.23 . . . . 0.53000000000000003 107.893 175.213 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -151.22 135.94 9.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 C-N-CA 119.672 -0.811 . . . . 0.48999999999999999 112.658 -167.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.6 ' O ' ' HD1' ' A' ' 56' ' ' TYR . . . -147.41 117.2 0.89 Allowed Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.163 -1.175 . . . . 0.71999999999999997 110.163 156.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 1.074 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.72 118.62 1.35 Allowed Glycine 0 CA--C 1.489 -1.589 0 CA-C-O 118.464 -1.186 . . . . 1.4199999999999999 110.806 173.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.705 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.9 135.8 3.84 Favored Glycine 0 C--N 1.299 -1.525 0 C-N-CA 117.188 -2.434 . . . . 0.47999999999999998 113.712 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.486 HG12 ' N ' ' A' ' 88' ' ' VAL . 0.6 OUTLIER -57.69 -26.58 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 107.541 -1.281 . . . . 0.52000000000000002 107.541 150.062 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.818 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 0.5 OUTLIER -57.69 -39.98 78.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 113.446 -1.706 . . . . 0.71999999999999997 110.435 171.075 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 . . . . . 0 N--CA 1.463 0.202 0 CA-C-N 115.266 -0.879 . . . . 1.1899999999999999 110.721 -172.884 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.426 ' N ' ' HH ' ' A' ' 56' ' ' TYR . . . . . . . . 0 N--CA 1.437 -1.259 0 N-CA-C 111.064 -0.814 . . . . 0.78000000000000003 111.064 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.074 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -110.15 145.93 16.05 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.738 0 N-CA-C 108.791 -0.818 . . . . 0.54000000000000004 108.791 175.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.6 ' HD1' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -140.0 147.39 40.34 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 119.235 0.925 . . . . 1.4199999999999999 110.281 -176.453 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.651 HG12 ' H ' ' A' ' 75' ' ' ASP . 7.1 p -94.18 135.72 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 CA-C-N 115.14 -0.936 . . . . 0.57999999999999996 109.796 175.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.7 ' O ' ' HB3' ' A' ' 32' ' ' SER . 21.4 m -128.32 68.49 1.36 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.765 -1.107 . . . . 1.1100000000000001 109.198 176.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.614 ' HA ' HG23 ' A' ' 73' ' ' ILE . 34.0 mtm180 150.06 -179.95 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 125.512 1.525 . . . . 2.27 110.397 163.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.423 ' N ' HG12 ' A' ' 73' ' ' ILE . 40.1 t -163.55 134.77 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 O-C-N 125.542 1.776 . . . . 0.82999999999999996 107.561 163.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.405 ' O ' HG12 ' A' ' 60' ' ' VAL . 19.2 p -77.59 169.44 18.29 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.633 0.73 . . . . 1.6499999999999999 111.031 175.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -103.43 128.43 50.58 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 114.783 -1.099 . . . . 1.8500000000000001 110.198 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.68 -5.42 52.4 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.324 -0.853 . . . . 0.92000000000000004 113.564 173.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.503 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -76.24 -129.13 0.31 Allowed Glycine 0 CA--C 1.506 -0.525 0 C-N-CA 120.35 -0.929 . . . . 0.98999999999999999 112.564 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.519 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 69.6 Cg_endo -102.76 -50.43 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 122.706 2.271 . . . . 0.44 115.572 177.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.529 ' HB2' ' O ' ' A' ' 29' ' ' LEU . . . -57.23 -32.43 66.52 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.534 0.938 . . . . 0.35999999999999999 113.534 -172.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -74.46 -28.65 61.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.596 0.712 . . . . 1.79 109.418 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.4 mp -74.32 -34.99 38.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.886 -1.052 . . . . 0.51000000000000001 109.648 -178.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.687 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -77.82 -23.01 49.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.574 -0.739 . . . . 0.40999999999999998 110.358 175.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.67 56.05 0.92 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.466 -0.873 . . . . 0.45000000000000001 114.132 175.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.682 ' HG ' HG21 ' A' ' 16' ' ' VAL . 2.2 mt -100.56 158.52 15.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 117.302 0.551 . . . . 0.89000000000000001 110.722 174.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 1.034 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 29.3 mt-30 -130.33 25.31 5.16 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 114.868 1.433 . . . . 1.21 114.868 -165.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.614 HG23 ' HA ' ' A' ' 59' ' ' ARG . 91.1 mt 72.95 -10.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 113.95 1.092 . . . . 0.77000000000000002 113.95 168.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.62 60.58 0.24 Allowed Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.436 -0.888 . . . . 0.37 111.974 -166.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.651 ' H ' HG12 ' A' ' 57' ' ' VAL . 36.6 m-20 -122.59 156.1 34.93 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.078 -0.561 . . . . 0.89000000000000001 110.376 -170.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.488 ' HG3' ' HD2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -104.39 102.02 11.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.314 0.578 . . . . 2.2000000000000002 109.546 -175.934 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 1.045 HG13 HG23 ' A' ' 109' ' ' VAL . 3.6 mp -74.71 125.37 34.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.491 -0.777 . . . . 0.48999999999999999 112.311 -171.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.906 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 3.0 mmt -92.1 -18.41 23.6 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 125.607 1.817 . . . . 1.0600000000000001 112.184 177.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.604 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -173.01 155.43 3.04 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.759 0.281 . . . . 0.81999999999999995 111.759 -175.306 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.44 ' N ' ' HG3' ' A' ' 79' ' ' GLN . 11.7 p -142.35 126.9 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 121.291 0.567 . . . . 1.3100000000000001 110.516 173.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.725 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 3.5 m-20 56.95 27.65 13.48 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.426 -0.806 . . . . 1.5 112.378 176.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.53 -11.1 63.14 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.122 -1.037 . . . . 0.38 112.605 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.42 ' CE2' ' HD2' ' A' ' 96' ' ' ARG . 80.9 m95 -83.91 160.16 21.15 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 108.696 -0.853 . . . . 0.77000000000000002 108.696 176.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -111.0 113.36 25.86 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.292 0.568 . . . . 1.8899999999999999 111.858 -171.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.541 ' HG3' HG11 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -109.1 102.46 11.43 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.723 -0.671 . . . . 1.01 111.58 -178.893 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.44 -50.93 2.31 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.262 -1.014 . . . . 1.05 108.262 168.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -135.38 86.99 2.29 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.549 -1.66 . . . . 1.6200000000000001 106.807 172.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.705 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.4 t -137.27 138.17 45.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.022 -0.99 . . . . 1.0900000000000001 109.754 -172.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.818 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 70.4 p -57.87 147.56 28.24 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 122.159 -0.338 . . . . 0.34999999999999998 111.609 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.809 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 19.8 t-160 -56.6 -40.63 75.64 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.312 0.577 . . . . 0.34999999999999998 110.175 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.25 -30.45 68.58 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.455 -1.248 . . . . 1.6699999999999999 110.042 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.769 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 2.3 tp-100 -63.48 -50.92 67.76 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.122 -1.066 . . . . 0.77000000000000002 108.122 178.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.615 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -70.81 -32.72 69.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.532 -0.758 . . . . 0.33000000000000002 110.856 -177.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -70.51 -40.04 73.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.067 -0.515 . . . . 2.1000000000000001 110.666 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.416 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -70.27 -41.26 73.69 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.259 -0.645 . . . . 0.95999999999999996 109.259 -178.856 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.769 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 21.9 mmt180 -71.33 -21.44 62.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.28 -0.873 . . . . 3.5699999999999998 110.67 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.536 HD11 ' CZ ' ' A' ' 31' ' ' PHE . 2.4 tt -70.99 -58.22 3.79 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.938 -0.574 . . . . 1.6499999999999999 110.443 175.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 m -100.71 90.04 4.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.599 0.714 . . . . 1.53 111.862 -171.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.709 ' HE2' ' O ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -110.42 118.19 35.6 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.766 -1.106 . . . . 2.7200000000000002 109.34 170.476 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -68.54 31.62 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.989 0.515 . . . . 4.3799999999999999 111.614 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 99' ' ' LYS . 14.2 m -139.07 -27.82 0.8 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.292 -0.413 . . . . 2.5099999999999998 110.997 -173.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.535 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 66.3 mm-40 -67.13 143.1 56.82 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 110.165 -0.309 . . . . 3.3999999999999999 110.165 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -94.27 -10.02 34.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.391 0.615 . . . . 2.6800000000000002 109.985 176.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.696 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 6.2 p -152.32 148.42 14.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.482 -0.781 . . . . 0.44 109.482 -175.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' A' ' 20' ' ' LYS . 55.5 t -117.04 117.94 57.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 122.051 0.929 . . . . 0.46000000000000002 111.53 -177.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.725 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.2 OUTLIER -99.29 133.02 44.19 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 113.426 -1.716 . . . . 1.76 110.305 -175.432 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.66 HD22 HD11 ' A' ' 71' ' ' LEU . 22.2 tp -134.63 134.69 41.49 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.541 -0.3 . . . . 1.1200000000000001 110.901 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.906 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 40.0 tp -115.53 114.3 24.79 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 106.843 -1.54 . . . . 0.41999999999999998 106.843 172.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 1.045 HG23 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -129.4 149.9 34.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 120.122 -0.631 . . . . 0.77000000000000002 110.488 -171.545 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.609 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -97.65 115.62 28.28 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.637 0.732 . . . . 0.34000000000000002 109.898 171.456 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.61 136.71 39.13 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.006 -1.452 . . . . 2.0099999999999998 109.596 -173.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.498 ' CD ' HD21 ' A' ' 114' ' ' LEU . 16.8 pm0 -106.57 -56.99 2.11 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.104 -1.038 . . . . 1.97 112.762 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.44 ' H ' HD22 ' A' ' 114' ' ' LEU . 23.2 t -174.95 27.83 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.609 -0.436 . . . . 1.6200000000000001 112.125 -175.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 1.034 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.402 0 O-C-N 121.913 -0.492 . . . . 1.6499999999999999 110.583 -175.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.442 -0.837 0 CA-C-O 121.731 0.777 . . . . 2.0899999999999999 109.56 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.19 170.81 9.42 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.091 -1.413 . . . . 0.95999999999999996 111.084 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.9 m -111.4 161.89 9.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.936 -1.029 . . . . 1.5700000000000001 109.084 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.571 HG22 HG23 ' A' ' 110' ' ' THR . 94.6 t -106.55 119.99 56.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.267 0.556 . . . . 1.02 111.388 -176.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.779 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -111.47 155.49 23.14 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.507 0.67 . . . . 1.3899999999999999 111.035 174.724 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.06 110.65 13.17 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.754 -0.657 . . . . 3.6299999999999999 110.156 -172.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 1.065 ' HB ' ' HB1' ' A' ' 69' ' ' ALA . 12.7 m -106.29 149.58 9.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 119.434 -0.907 . . . . 1.02 110.325 176.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -145.23 121.37 10.8 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.005 -0.543 . . . . 1.3500000000000001 109.953 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.543 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 10.9 tp -142.34 143.64 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 108.256 -1.016 . . . . 0.60999999999999999 108.256 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.834 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 5.3 m80 -74.96 117.67 17.06 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.307 -0.557 . . . . 0.59999999999999998 109.528 -176.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.562 ' HD3' ' HG ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -29.47 127.16 0.11 Allowed 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.776 1.297 . . . . 4.0 111.256 177.757 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.416 ' HB3' ' HB ' ' A' ' 28' ' ' ILE . 45.6 tp -98.05 101.74 13.3 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.252 0.548 . . . . 0.55000000000000004 110.478 -173.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -69.43 135.49 50.31 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.371 0.605 . . . . 3.9700000000000002 111.366 -176.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 34.1 tp60 -128.86 93.59 3.64 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.433 -0.951 . . . . 1.3500000000000001 108.433 174.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.21 -87.94 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.772 -0.931 . . . . 1.3300000000000001 110.772 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.52 14.34 4.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.324 0.583 . . . . 2.3300000000000001 110.776 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -108.98 159.76 16.56 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.682 -0.69 . . . . 1.8700000000000001 109.492 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.562 ' HG ' ' HD3' ' A' ' 20' ' ' LYS . 9.0 mp -112.77 119.18 37.14 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 109.062 -0.718 . . . . 2.2799999999999998 109.062 174.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 40.5 mm -98.73 109.55 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 115.415 -0.811 . . . . 0.80000000000000004 109.981 -176.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.576 HD13 HD13 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -83.93 -25.61 29.98 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.463 -1.244 . . . . 1.74 109.088 175.355 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.442 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 93.67 -27.11 13.14 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.119 -0.946 . . . . 0.68999999999999995 112.673 174.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.631 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 32.8 p90 -110.43 151.32 27.65 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 122.291 -0.535 . . . . 0.51000000000000001 111.384 -173.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.545 ' H ' ' HB2' ' A' ' 59' ' ' ARG . 10.2 t -101.82 158.43 16.13 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 107.578 -1.267 . . . . 0.53000000000000003 107.578 175.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.407 HG12 ' N ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -160.19 143.04 4.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 C-N-CA 120.158 -0.617 . . . . 0.48999999999999999 112.529 -163.739 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.447 ' HA2' ' CD2' ' A' ' 90' ' ' HIS . . . -139.51 118.28 1.48 Allowed Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 110.007 -1.237 . . . . 0.71999999999999997 110.007 154.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 1.029 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.39 119.06 1.43 Allowed Glycine 0 CA--C 1.491 -1.419 0 CA-C-O 118.518 -1.157 . . . . 1.4199999999999999 111.42 172.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.671 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.29 146.49 10.78 Favored Glycine 0 C--N 1.303 -1.3 0 C-N-CA 117.304 -2.379 . . . . 0.47999999999999998 113.1 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.471 HG12 ' N ' ' A' ' 88' ' ' VAL . 1.1 pt -68.43 -19.74 24.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 107.562 -1.273 . . . . 0.52000000000000002 107.562 151.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.774 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 2.5 t70 -58.8 -36.6 74.75 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.026 -1.443 . . . . 0.71999999999999997 109.541 168.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 . . . . . 0 C--N 1.338 0.067 0 CA-C-N 114.73 -1.123 . . . . 1.1899999999999999 109.793 -176.843 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.567 0 N-CA-C 111.613 -0.595 . . . . 0.78000000000000003 111.613 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.029 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -111.32 143.89 20.28 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 N-CA-C 106.846 -1.539 . . . . 0.54000000000000004 106.846 172.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.767 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -154.96 148.35 25.11 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 120.155 1.343 . . . . 1.4199999999999999 112.039 -178.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.842 HG12 ' H ' ' A' ' 75' ' ' ASP . 1.5 p -87.49 136.68 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-N 114.529 -1.214 . . . . 0.57999999999999996 110.421 -175.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.2 m -105.34 -11.97 16.25 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.116 -0.947 . . . . 1.1100000000000001 110.697 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.897 ' HA ' HG23 ' A' ' 73' ' ' ILE . 41.3 mtt180 -145.54 -170.11 3.38 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.083 0.771 . . . . 2.27 113.083 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 59' ' ' ARG . 53.2 t -170.33 146.37 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.37 1.868 . . . . 0.82999999999999996 106.627 167.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.4 p -97.48 123.49 41.36 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.674 0.75 . . . . 1.6499999999999999 112.088 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -66.0 112.34 3.79 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 113.658 -1.61 . . . . 1.8500000000000001 110.359 169.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.76 -3.03 48.91 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.164 -0.925 . . . . 0.92000000000000004 112.634 -177.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.566 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -91.52 -139.66 8.63 Favored Glycine 0 CA--C 1.501 -0.835 0 C-N-CA 120.367 -0.921 . . . . 0.98999999999999999 111.785 178.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.523 ' HB2' HG21 ' A' ' 18' ' ' ILE . 77.6 Cg_endo -102.07 -50.07 0.01 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 122.73 2.287 . . . . 0.44 114.959 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.631 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -50.45 -29.46 10.38 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.589 0.959 . . . . 0.35999999999999999 113.589 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -71.46 -32.22 68.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.745 0.784 . . . . 1.79 109.463 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.566 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.5 mp -79.08 -36.54 18.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.444 -1.253 . . . . 0.51000000000000001 108.516 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 1.065 ' HB1' ' HB ' ' A' ' 16' ' ' VAL . . . -66.17 -35.11 79.6 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.409 -1.268 . . . . 0.40999999999999998 109.91 173.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.43 33.15 2.77 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.223 -0.989 . . . . 0.45000000000000001 114.233 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.453 HD21 HG21 ' A' ' 57' ' ' VAL . 17.8 tp -90.66 154.79 19.31 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.466 -0.568 . . . . 0.89000000000000001 109.466 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.42 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 36.8 mt-30 -129.34 31.89 4.76 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 115.449 1.648 . . . . 1.21 115.449 -165.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.897 HG23 ' HA ' ' A' ' 59' ' ' ARG . 58.1 mt 71.33 2.1 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 CA-C-N 118.993 0.815 . . . . 0.77000000000000002 113.188 167.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.17 46.19 0.25 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 119.58 -1.295 . . . . 0.37 112.439 -170.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.842 ' H ' HG12 ' A' ' 57' ' ' VAL . 20.0 m-20 -119.83 142.31 48.74 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.331 -0.435 . . . . 0.89000000000000001 110.864 -169.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.767 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 13.0 mptt -96.68 102.64 14.46 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.803 0.811 . . . . 2.2000000000000002 111.0 -171.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.823 HG13 HG23 ' A' ' 109' ' ' VAL . 2.8 mp -63.05 123.42 15.78 Favored 'Isoleucine or valine' 0 C--O 1.255 1.342 0 CA-C-N 115.274 -0.876 . . . . 0.48999999999999999 112.505 -178.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.881 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 2.0 mmt -91.74 -18.99 23.09 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 113.494 -1.685 . . . . 1.0600000000000001 111.281 173.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.617 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 4.3 tt0 -172.03 151.53 2.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.071 -0.513 . . . . 0.81999999999999995 111.876 -174.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.776 HG12 ' HE1' ' A' ' 85' ' ' MET . 9.8 p -145.53 127.21 8.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.729 -0.669 . . . . 1.3100000000000001 109.735 173.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 58.44 20.0 7.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.75 -0.659 . . . . 1.5 111.874 178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.69 -7.86 53.88 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 119.733 -1.222 . . . . 0.38 113.368 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 68.0 m95 -85.21 159.85 20.02 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 117.451 0.626 . . . . 0.77000000000000002 110.014 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -102.46 113.72 27.3 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.668 -0.696 . . . . 1.8899999999999999 111.454 -172.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.776 ' HE1' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -104.57 100.58 10.25 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 122.667 1.222 . . . . 1.01 110.116 179.219 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.6 p -142.16 -49.9 0.38 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 112.854 -1.975 . . . . 1.05 105.83 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.415 ' HA ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -133.97 75.15 1.58 Allowed 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 112.178 -2.283 . . . . 1.6200000000000001 108.828 173.4 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.758 ' O ' HD11 ' A' ' 55' ' ' ILE . 1.2 t -132.72 138.55 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 108.007 -1.108 . . . . 1.0900000000000001 108.007 177.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.719 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 68.8 p -59.5 152.16 22.48 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.884 -0.51 . . . . 0.34999999999999998 112.018 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.81 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 16.5 t-160 -57.25 -38.0 73.19 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-O 122.516 1.15 . . . . 0.34999999999999998 109.925 -177.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.402 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 5.1 p-10 -71.66 -31.78 67.18 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 112.79 -2.005 . . . . 1.6699999999999999 109.889 -177.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.717 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.5 OUTLIER -65.55 -39.15 91.38 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 108.158 -1.053 . . . . 0.77000000000000002 108.158 179.842 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.594 ' HB2' HG12 ' A' ' 55' ' ' ILE . . . -74.75 -41.6 59.78 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.439 -1.255 . . . . 0.33000000000000002 109.793 -176.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -68.22 -37.79 81.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.287 -0.869 . . . . 2.1000000000000001 110.661 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.504 ' HD3' ' HD2' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -70.97 -30.09 66.26 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.012 0.434 . . . . 0.95999999999999996 109.844 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.717 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 9.4 mmm180 -76.23 -24.35 54.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.223 -0.444 . . . . 3.5699999999999998 111.881 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.576 HD13 HD13 ' A' ' 29' ' ' LEU . 3.3 pp -96.92 -8.26 31.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.236 0.458 . . . . 1.6499999999999999 112.236 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.55 HG23 ' HB2' ' A' ' 27' ' ' LEU . 31.5 m -145.02 97.6 3.04 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.183 0.516 . . . . 1.53 111.225 174.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.482 ' HG3' ' HB2' ' A' ' 101' ' ' SER . 5.2 ptpp? -142.56 9.7 1.81 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.592 -0.731 . . . . 2.7200000000000002 112.403 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 39.4 mtm-85 63.96 24.15 13.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.61 -0.723 . . . . 4.3799999999999999 110.886 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.482 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 69.8 m -153.63 83.95 1.17 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.335 0.588 . . . . 2.5099999999999998 110.46 -178.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.444 ' C ' ' H ' ' A' ' 104' ' ' VAL . 1.2 pm0 -163.0 -44.74 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.538 -0.755 . . . . 3.3999999999999999 110.085 178.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 71.76 -41.97 0.52 Allowed 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.34 1.025 . . . . 2.6800000000000002 111.045 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.834 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 2.7 p -133.33 133.4 57.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.351 -1.352 . . . . 0.44 107.351 176.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 53.3 t -109.85 119.37 58.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 122.151 0.976 . . . . 0.46000000000000002 112.198 -171.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.93 123.05 41.74 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 113.397 -1.729 . . . . 1.76 109.803 -176.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.509 HD11 HG12 ' A' ' 77' ' ' ILE . 11.1 tp -131.42 116.76 17.93 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.656 -0.702 . . . . 1.1200000000000001 111.171 -173.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.881 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 41.0 tp -104.31 117.87 35.24 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.611 -1.255 . . . . 0.41999999999999998 107.611 177.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.823 HG23 HG13 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -131.35 152.4 37.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-O 121.38 0.61 . . . . 0.77000000000000002 110.803 -173.092 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.571 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -97.53 117.21 31.28 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.721 -0.672 . . . . 0.34000000000000002 110.321 171.429 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.644 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 30.7 ttt180 -97.76 136.48 38.03 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.597 -1.183 . . . . 2.0099999999999998 110.375 -177.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.437 ' N ' ' CD ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -123.02 -70.61 0.76 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.753 0.649 . . . . 1.97 112.753 -174.181 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.09 27.79 0.52 Allowed 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.266 -0.574 . . . . 1.6200000000000001 112.418 -170.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 114' ' ' LEU . 2.3 mm? . . . . . 0 C--N 1.323 -0.545 0 CA-C-O 121.485 0.66 . . . . 1.6499999999999999 110.11 177.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.446 -0.668 0 CA-C-O 123.283 1.516 . . . . 2.0899999999999999 111.078 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.3 179.05 5.31 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 112.087 -2.324 . . . . 0.95999999999999996 109.758 173.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.17 108.41 25.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.328 -0.396 . . . . 1.5700000000000001 110.386 -174.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.709 HG22 HG23 ' A' ' 110' ' ' THR . 26.1 t -76.83 98.52 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.291 0.567 . . . . 1.02 110.203 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.705 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -103.3 165.02 11.28 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.68 -0.691 . . . . 1.3899999999999999 111.122 178.259 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.505 ' HD2' ' H ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -126.07 116.98 22.24 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.704 -0.623 . . . . 3.6299999999999999 110.987 -178.791 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.732 HG13 ' CB ' ' A' ' 69' ' ' ALA . 4.9 t -88.85 127.41 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 115.303 -0.862 . . . . 1.02 109.597 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 31.9 tt0 -131.03 116.99 18.52 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.437 -0.579 . . . . 1.3500000000000001 109.437 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 18' ' ' ILE . 10.1 tp -145.1 146.43 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 108.562 -0.903 . . . . 0.60999999999999999 108.562 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.754 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.3 m-70 -68.85 119.14 12.74 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.175 -0.676 . . . . 0.59999999999999998 109.175 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.869 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -37.44 133.41 0.73 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.944 0.778 . . . . 4.0 110.105 171.782 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.5 tp -94.02 85.9 4.86 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.959 0.885 . . . . 0.55000000000000004 109.747 -170.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -84.55 139.33 32.2 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.15 -1.386 . . . . 3.9700000000000002 111.783 -174.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.532 ' HG3' HD13 ' A' ' 28' ' ' ILE . 2.9 mt-30 -139.47 94.14 2.75 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.125 -0.943 . . . . 1.3500000000000001 109.145 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.68 -73.6 0.24 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.014 -0.612 . . . . 1.3300000000000001 112.547 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -139.45 1.69 1.98 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.416 0.627 . . . . 2.3300000000000001 110.388 -177.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -114.06 120.63 41.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.567 -0.742 . . . . 1.8700000000000001 109.465 -173.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.537 HD22 ' HA ' ' A' ' 100' ' ' ARG . 7.6 mp -103.09 116.62 32.86 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.103 -0.703 . . . . 2.2799999999999998 109.103 176.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.532 HD13 ' HG3' ' A' ' 23' ' ' GLN . 1.8 mp -96.01 126.5 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 115.493 -0.776 . . . . 0.80000000000000004 110.2 -172.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.464 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -103.38 109.12 20.63 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.334 -1.303 . . . . 1.74 108.041 174.037 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.671 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -77.92 43.5 2.2 Favored Glycine 0 C--O 1.216 -0.987 0 C-N-CA 121.016 -0.611 . . . . 0.68999999999999995 112.574 -175.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.601 ' HB2' ' CG2' ' A' ' 57' ' ' VAL . 40.0 p90 -159.7 147.15 16.84 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.417 -1.327 . . . . 0.51000000000000001 107.417 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.639 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -102.4 163.82 12.02 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 118.466 -1.294 . . . . 0.53000000000000003 107.605 176.184 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.532 HD12 HD21 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -154.26 139.83 10.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 119.242 -0.983 . . . . 0.48999999999999999 113.0 -168.261 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.421 ' N ' HG12 ' A' ' 33' ' ' ILE . . . -141.09 118.07 1.32 Allowed Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 109.83 -1.308 . . . . 0.71999999999999997 109.83 154.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.999 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -142.39 117.69 1.18 Allowed Glycine 0 C--N 1.302 -1.323 0 CA-C-O 118.251 -1.305 . . . . 1.4199999999999999 111.577 170.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.645 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.8 141.93 7.26 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 117.641 -2.219 . . . . 0.47999999999999998 113.507 175.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.439 HG23 ' HA ' ' A' ' 87' ' ' MET . 13.7 pt -61.9 -20.37 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 N-CA-C 107.363 -1.347 . . . . 0.52000000000000002 107.363 151.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.834 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 3.0 t70 -59.32 -43.95 92.65 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 113.588 -1.642 . . . . 0.71999999999999997 109.759 171.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 . . . . . 0 CA--C 1.533 0.309 0 CA-C-N 115.008 -0.996 . . . . 1.1899999999999999 109.967 -178.489 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 110.064 -1.214 . . . . 0.78000000000000003 110.064 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.999 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -116.5 135.06 57.98 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.145 0 N-CA-C 107.423 -1.325 . . . . 0.54000000000000004 107.423 174.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.707 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -152.49 150.53 29.71 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.052 0.842 . . . . 1.4199999999999999 111.485 -177.245 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.611 HG12 ' H ' ' A' ' 75' ' ' ASP . 10.0 p -93.5 133.58 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 114.574 -1.193 . . . . 0.57999999999999996 111.191 -169.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.639 ' O ' ' HB3' ' A' ' 32' ' ' SER . 32.6 m -123.89 70.32 1.07 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.803 -1.09 . . . . 1.1100000000000001 109.479 174.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 1.003 ' HA ' HG23 ' A' ' 73' ' ' ILE . 41.8 mtt180 151.73 177.25 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 125.47 1.508 . . . . 2.27 110.823 163.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.649 HG13 ' HB3' ' A' ' 66' ' ' ALA . 91.7 t -161.36 138.49 2.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 125.432 1.707 . . . . 0.82999999999999996 107.249 163.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.7 p -86.16 122.93 30.86 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.191 0.519 . . . . 1.6499999999999999 110.87 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -48.67 117.3 1.97 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.315 -1.311 . . . . 1.8500000000000001 111.855 171.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.15 12.3 84.75 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.656 -0.783 . . . . 0.92000000000000004 113.222 173.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.529 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -87.29 -132.63 3.63 Favored Glycine 0 C--O 1.22 -0.755 0 C-N-CA 119.942 -1.123 . . . . 0.98999999999999999 111.31 174.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.671 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 97.6 Cg_endo -101.15 -42.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.538 2.159 . . . . 0.44 115.463 177.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.649 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -64.48 -27.1 68.75 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.0 -0.546 . . . . 0.35999999999999999 111.898 -173.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -70.81 -33.34 70.6 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.652 0.739 . . . . 1.79 109.151 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -71.48 -40.37 72.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.496 -1.229 . . . . 0.51000000000000001 110.627 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.732 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -77.61 -15.59 59.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.40999999999999998 110.626 177.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.0 47.68 2.83 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.124 -1.036 . . . . 0.45000000000000001 114.123 173.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.454 HD21 HG21 ' A' ' 57' ' ' VAL . 19.7 tp -97.68 149.98 21.68 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.94 -0.763 . . . . 0.89000000000000001 108.94 176.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.507 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 56.0 mt-30 -122.56 33.31 5.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 114.576 1.324 . . . . 1.21 114.576 -165.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.003 HG23 ' HA ' ' A' ' 59' ' ' ARG . 56.2 mt 72.05 -1.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 113.185 0.809 . . . . 0.77000000000000002 113.185 165.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -173.08 52.23 0.16 Allowed Glycine 0 CA--C 1.509 -0.298 0 C-N-CA 120.084 -1.055 . . . . 0.37 111.999 -164.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.611 ' H ' HG12 ' A' ' 57' ' ' VAL . 43.9 m-20 -120.48 149.67 42.02 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.157 -0.521 . . . . 0.89000000000000001 110.603 -172.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.707 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -95.4 101.54 13.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.332 -0.394 . . . . 2.2000000000000002 110.593 -173.71 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.662 HD12 ' HA ' ' A' ' 56' ' ' TYR . 4.3 mt -72.72 123.01 26.55 Favored 'Isoleucine or valine' 0 C--O 1.261 1.669 0 CA-C-O 121.434 0.635 . . . . 0.48999999999999999 112.424 -175.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.758 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 4.2 mmt -89.92 -19.49 24.49 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 113.242 -1.799 . . . . 1.0600000000000001 112.286 176.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.551 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 1.0 OUTLIER -172.39 157.21 3.99 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.184 0.438 . . . . 0.81999999999999995 112.184 -174.825 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.614 HG12 ' SD ' ' A' ' 85' ' ' MET . 12.3 p -141.59 122.74 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.247 0.546 . . . . 1.3100000000000001 110.712 171.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.7 m120 50.1 36.5 12.29 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.371 -0.831 . . . . 1.5 112.192 176.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.67 -18.66 49.87 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.451 -0.88 . . . . 0.38 113.244 175.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 52.9 m95 -81.84 149.39 28.34 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 109.684 -0.488 . . . . 0.77000000000000002 109.684 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -95.91 116.33 28.76 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.635 -0.711 . . . . 1.8899999999999999 111.0 -175.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.614 ' SD ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -105.8 99.36 8.96 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 122.626 1.203 . . . . 1.01 110.177 177.567 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.1 p -138.09 -44.42 0.51 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.112 -1.858 . . . . 1.05 106.765 173.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.439 ' HA ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -148.46 75.15 1.31 Allowed 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.514 -1.676 . . . . 1.6200000000000001 109.674 177.284 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.645 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -140.96 154.25 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 108.779 -0.823 . . . . 1.0900000000000001 108.779 173.723 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.705 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 74.7 p -60.01 151.95 25.09 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 113.168 0.803 . . . . 0.34999999999999998 113.168 -173.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.834 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 21.5 t-160 -58.81 -40.37 83.92 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 115.74 -0.664 . . . . 0.34999999999999998 110.092 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -66.17 -31.01 71.6 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.13 -1.395 . . . . 1.6699999999999999 109.838 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.59 ' HB3' ' O ' ' A' ' 89' ' ' THR . 10.0 tp60 -63.63 -51.81 63.57 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.677 0.751 . . . . 0.77000000000000002 109.514 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.538 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -72.54 -33.38 66.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.935 -1.029 . . . . 0.33000000000000002 109.801 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 90' ' ' HIS . 11.3 ttp180 -61.77 -48.46 80.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.2 -0.909 . . . . 2.1000000000000001 110.642 -177.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.651 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -70.52 -28.45 64.95 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 119.768 -0.773 . . . . 0.95999999999999996 110.647 -179.738 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.559 ' HD2' ' HD3' ' A' ' 95' ' ' LYS . 1.8 mmm180 -70.0 -41.66 74.07 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.196 -0.601 . . . . 3.5699999999999998 112.155 -177.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.557 ' HB3' HG21 ' A' ' 80' ' ' VAL . 3.3 pp -80.58 -25.21 38.64 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.636 -0.426 . . . . 1.6499999999999999 110.965 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.472 ' N ' HD12 ' A' ' 97' ' ' LEU . 21.5 m -153.68 95.27 1.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.442 0.639 . . . . 1.53 111.436 178.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.651 ' HB3' ' O ' ' A' ' 95' ' ' LYS . 7.0 ptpt -112.67 9.89 19.32 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.454 -0.794 . . . . 2.7200000000000002 109.118 174.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.537 ' HA ' HD22 ' A' ' 27' ' ' LEU . 11.9 mtt180 70.01 19.05 7.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.09 -1.414 . . . . 4.3799999999999999 111.904 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.6 t -137.29 9.96 2.98 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 120.623 -0.431 . . . . 2.5099999999999998 111.827 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.492 ' HB2' ' HG3' ' A' ' 20' ' ' LYS . 6.1 mm-40 -85.39 148.48 25.99 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.998 0.428 . . . . 3.3999999999999999 111.398 -177.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.547 ' HG3' HG12 ' A' ' 104' ' ' VAL . 7.3 pt-20 -95.83 -49.71 5.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.881 -0.6 . . . . 2.6800000000000002 110.702 178.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.754 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 2.6 p -143.69 142.14 25.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.166 -1.05 . . . . 0.44 108.166 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.761 HG21 ' HG2' ' A' ' 20' ' ' LYS . 42.1 t -123.3 117.85 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 CA-C-O 122.22 1.01 . . . . 0.46000000000000002 112.403 -164.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -101.16 127.32 47.78 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 112.865 -1.97 . . . . 1.76 109.954 -174.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.523 HD11 HG12 ' A' ' 77' ' ' ILE . 20.7 tp -130.87 124.4 31.12 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.915 -0.584 . . . . 1.1200000000000001 109.587 -174.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.605 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 33.9 tp -100.31 119.84 39.02 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.247 -1.761 . . . . 0.41999999999999998 106.247 176.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.705 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -126.6 150.66 32.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.239 0.542 . . . . 0.77000000000000002 109.946 -171.763 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.709 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -98.07 115.13 27.6 Favored 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 119.436 -0.906 . . . . 0.34000000000000002 109.421 168.266 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.424 ' CD ' ' HG2' ' A' ' 14' ' ' GLN . 7.9 ttm180 -105.39 149.23 26.3 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.384 -1.28 . . . . 2.0099999999999998 110.704 -171.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.467 HE21 HD11 ' A' ' 114' ' ' LEU . 0.9 OUTLIER -138.29 -156.22 0.67 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.352 -0.981 . . . . 1.97 108.352 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.03 72.5 8.37 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.846 0.831 . . . . 1.6200000000000001 112.223 -171.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.507 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 3.3 mt . . . . . 0 C--N 1.31 -1.114 0 CA-C-N 114.445 -1.252 . . . . 1.6499999999999999 107.734 175.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.438 -1.07 0 CA-C-O 122.64 1.21 . . . . 2.0899999999999999 110.115 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.76 132.35 37.03 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 113.01 -1.905 . . . . 0.95999999999999996 108.584 170.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 p -107.23 123.45 62.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.047 -0.524 . . . . 1.5700000000000001 110.231 -173.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.983 HG12 HG23 ' A' ' 110' ' ' THR . 1.0 OUTLIER -81.33 128.2 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 121.861 0.838 . . . . 1.02 111.124 -173.564 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.698 ' HG3' HG12 ' A' ' 109' ' ' VAL . 1.1 pp0? -101.87 167.34 10.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.92 -1.036 . . . . 1.3899999999999999 111.172 173.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.447 ' HD3' ' O ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -124.82 106.83 10.33 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.688 -0.687 . . . . 3.6299999999999999 110.027 -174.109 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.691 HG13 ' CB ' ' A' ' 69' ' ' ALA . 1.5 t -104.78 133.19 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 109.857 -0.423 . . . . 1.02 109.857 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -137.81 126.66 23.99 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.778 -0.453 . . . . 1.3500000000000001 109.778 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 9.8 tp -142.91 161.57 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 108.239 -1.023 . . . . 0.60999999999999999 108.239 -178.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -95.2 113.09 24.73 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.822 -0.751 . . . . 0.59999999999999998 109.838 -175.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.854 ' HB2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -26.8 130.01 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 125.125 1.515 . . . . 4.0 112.341 179.544 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 36.1 tp -100.61 95.76 6.9 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 119.936 -0.705 . . . . 0.55000000000000004 109.208 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 22' ' ' ARG . 16.5 ptt180 -74.67 140.02 43.92 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.499 -0.773 . . . . 3.9700000000000002 111.54 -172.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.526 ' HB2' HD13 ' A' ' 28' ' ' ILE . 23.3 tp60 -134.58 93.99 3.13 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.393 -0.966 . . . . 1.3500000000000001 108.393 177.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.07 -83.28 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.686 -0.768 . . . . 1.3300000000000001 111.545 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.786 ' HB3' HH11 ' A' ' 100' ' ' ARG . 30.5 mt-10 -132.38 8.24 4.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.926 0.393 . . . . 2.3300000000000001 110.572 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -109.02 166.97 10.43 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.257 -0.428 . . . . 1.8700000000000001 110.762 -173.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.994 HD23 ' HA ' ' A' ' 98' ' ' THR . 4.9 tp -119.91 122.86 42.2 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.78 -0.646 . . . . 2.2799999999999998 109.388 173.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.526 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.7 mp -98.44 113.83 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 107.66 -1.237 . . . . 0.80000000000000004 107.66 173.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.859 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.1 pt? -95.02 -15.31 23.58 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.053 -0.976 . . . . 1.74 110.833 -173.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.513 ' CA ' ' HD2' ' A' ' 65' ' ' PRO . . . 87.06 -9.65 71.66 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.45 -0.881 . . . . 0.68999999999999995 113.718 172.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.788 ' HD1' ' HB2' ' A' ' 66' ' ' ALA . 48.5 p90 -133.43 165.72 24.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.296 0.548 . . . . 0.51000000000000001 110.801 178.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.696 ' HB3' ' O ' ' A' ' 58' ' ' THR . 7.8 t -106.07 171.56 7.28 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.41 -0.589 . . . . 0.53000000000000003 109.41 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.45 HG12 ' NE2' ' A' ' 90' ' ' HIS . 5.4 tt -150.17 131.83 5.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 C-N-CA 120.564 -0.454 . . . . 0.48999999999999999 111.675 -167.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -102.97 171.66 20.94 Favored Glycine 0 C--O 1.237 0.341 0 N-CA-C 110.693 -0.963 . . . . 0.71999999999999997 110.693 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.861 ' HA3' ' OE1' ' A' ' 39' ' ' GLN . . . -114.6 169.3 12.82 Favored Glycine 0 N--CA 1.42 -2.389 0 N-CA-C 118.855 2.302 . . . . 1.4199999999999999 118.855 -160.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 88' ' ' VAL . . . -87.58 -162.14 37.53 Favored Glycine 0 N--CA 1.415 -2.726 0 CA-C-N 110.073 -3.063 . . . . 0.47999999999999998 113.5 -165.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.55 HD13 ' O ' ' A' ' 87' ' ' MET . 27.5 pt -55.88 -9.6 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.434 0.635 . . . . 0.52000000000000002 111.002 168.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 1.025 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 0.2 OUTLIER -59.92 -40.73 89.9 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.262 -0.881 . . . . 0.71999999999999997 109.629 173.424 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.861 ' OE1' ' HA3' ' A' ' 35' ' ' GLY . 13.1 mt-30 . . . . . 0 CA--C 1.502 -0.899 0 CA-C-N 114.788 -1.096 . . . . 1.1899999999999999 110.956 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.452 0 N-CA-C 111.63 -0.588 . . . . 0.78000000000000003 111.63 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.546 HG22 ' CD1' ' A' ' 77' ' ' ILE . 2.2 mp -99.93 132.39 45.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 108.347 -0.983 . . . . 0.54000000000000004 108.347 168.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.561 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -155.01 138.76 16.17 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 120.898 0.38 . . . . 1.4199999999999999 110.339 -170.369 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.575 ' CG1' ' H ' ' A' ' 75' ' ' ASP . 8.6 p -67.38 129.37 31.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.648 -0.706 . . . . 0.57999999999999996 110.484 -176.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.696 ' O ' ' HB3' ' A' ' 32' ' ' SER . 18.5 m -125.64 59.59 1.28 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.463 -0.79 . . . . 1.1100000000000001 109.896 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.624 ' HA ' HG23 ' A' ' 73' ' ' ILE . 13.9 mtt180 154.49 -179.88 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 126.084 1.754 . . . . 2.27 109.979 167.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.635 HG13 ' HB3' ' A' ' 66' ' ' ALA . 88.0 t -166.7 125.71 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 O-C-N 125.638 1.836 . . . . 0.82999999999999996 106.348 163.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.8 m -85.15 128.27 34.59 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.889 -0.725 . . . . 1.6499999999999999 109.259 174.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -65.15 106.36 1.29 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.374 -0.83 . . . . 1.8500000000000001 110.4 174.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 120.64 -21.56 8.48 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.27 -1.332 . . . . 0.92000000000000004 110.396 -173.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.502 ' O ' ' HB3' ' A' ' 67' ' ' GLU . . . -72.76 152.82 48.05 Favored Glycine 0 CA--C 1.495 -1.214 0 N-CA-C 111.384 -0.686 . . . . 0.98999999999999999 111.384 172.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.629 ' HA ' HD13 ' A' ' 68' ' ' ILE . 83.3 Cg_exo -47.13 -30.9 11.09 Favored 'Trans proline' 0 C--N 1.325 -0.659 0 C-N-CA 123.882 3.055 . . . . 0.44 114.17 -176.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.788 ' HB2' ' HD1' ' A' ' 31' ' ' PHE . . . -66.75 -26.73 67.12 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.016 -0.538 . . . . 0.35999999999999999 111.454 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 5.5 tp10 -68.36 -31.61 71.12 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.247 0.546 . . . . 1.79 109.821 174.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.629 HD13 ' HA ' ' A' ' 65' ' ' PRO . 2.7 mp -81.05 -36.78 15.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.807 -0.633 . . . . 0.51000000000000001 109.938 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.691 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -79.56 -31.79 42.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.553 -0.748 . . . . 0.40999999999999998 110.456 176.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.18 69.36 0.95 Allowed Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.442 -0.885 . . . . 0.45000000000000001 113.562 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.453 ' HB3' ' HB1' ' A' ' 66' ' ' ALA . 21.9 tp -116.05 158.32 23.33 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.738 -0.468 . . . . 0.89000000000000001 109.738 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.543 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 41.3 mt-30 -125.43 29.81 5.94 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 115.196 1.554 . . . . 1.21 115.196 -163.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.624 HG23 ' HA ' ' A' ' 59' ' ' ARG . 82.6 mt 75.97 -10.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 N-CA-C 114.621 1.341 . . . . 0.77000000000000002 114.621 165.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -166.75 52.22 0.25 Allowed Glycine 0 N--CA 1.465 0.569 0 C-N-CA 118.983 -1.579 . . . . 0.37 113.432 -165.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.575 ' H ' ' CG1' ' A' ' 57' ' ' VAL . 17.6 m-20 -122.42 147.1 46.72 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.38 -0.41 . . . . 0.89000000000000001 110.407 -172.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.561 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 1.3 mptm? -91.74 120.85 32.84 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-O 121.014 0.435 . . . . 2.2000000000000002 110.673 -176.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.692 HG12 HD11 ' A' ' 107' ' ' LEU . 5.9 mt -80.3 120.46 31.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.172 0.511 . . . . 0.48999999999999999 112.206 -170.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.998 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 11.0 mmt -88.38 -20.97 24.59 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.507 -1.224 . . . . 1.0600000000000001 111.326 177.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.581 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 1.0 OUTLIER -171.71 157.82 4.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.988 0.423 . . . . 0.81999999999999995 111.2 -178.609 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.624 HG21 ' HG ' ' A' ' 97' ' ' LEU . 9.5 p -146.55 126.53 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.985 -0.552 . . . . 1.3100000000000001 109.778 172.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 1.0 OUTLIER 62.64 9.72 3.69 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.015 -0.539 . . . . 1.5 112.213 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.89 -10.68 27.43 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.244 -0.979 . . . . 0.38 112.485 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.416 ' CD1' ' HB3' ' A' ' 96' ' ' ARG . 81.4 m95 -82.39 143.16 31.41 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 120.819 0.342 . . . . 0.77000000000000002 110.587 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -92.06 110.88 22.25 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.235 -0.893 . . . . 1.8899999999999999 111.84 -170.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.669 ' HE3' ' HA ' ' A' ' 93' ' ' ALA . 20.6 mmt -109.35 122.19 46.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.906 -0.588 . . . . 1.01 112.227 -175.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.5 p -137.38 -72.29 0.43 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.45 0.643 . . . . 1.05 109.281 167.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.55 ' O ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -125.19 62.39 1.18 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.272 -0.876 . . . . 1.6200000000000001 109.099 177.885 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.563 HG21 HE21 ' A' ' 92' ' ' GLN . 3.6 p -112.34 177.32 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 108.835 -0.802 . . . . 1.0900000000000001 108.835 177.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . 1.025 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 63.1 p -72.22 153.07 41.8 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 118.283 0.492 . . . . 0.34999999999999998 111.432 -177.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.892 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 23.7 t-160 -56.78 -41.6 77.94 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 121.896 0.855 . . . . 0.34999999999999998 108.928 177.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -67.25 -30.35 70.23 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.186 -1.824 . . . . 1.6699999999999999 109.855 -175.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.816 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 2.4 tp-100 -59.65 -53.38 58.66 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.378 -0.601 . . . . 0.77000000000000002 109.378 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.669 ' HA ' ' HE3' ' A' ' 85' ' ' MET . . . -74.38 -30.62 62.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.654 -0.703 . . . . 0.33000000000000002 110.297 -176.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -63.35 -47.43 82.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.424 -0.807 . . . . 2.1000000000000001 110.47 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.408 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -71.84 -41.73 67.78 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.743 -0.662 . . . . 0.95999999999999996 109.823 -174.462 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.816 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 22.4 mmt180 -69.0 -24.3 64.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.927 -0.579 . . . . 3.5699999999999998 110.271 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.624 ' HG ' HG21 ' A' ' 80' ' ' VAL . 3.8 tt -79.93 -52.47 7.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.777 -0.647 . . . . 1.6499999999999999 110.86 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.994 ' HA ' HD23 ' A' ' 27' ' ' LEU . 5.3 m -94.83 92.05 6.75 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 122.685 1.231 . . . . 1.53 110.901 -169.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.491 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 3.6 mtmt -134.95 110.65 9.24 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 112.8 -2.0 . . . . 2.7200000000000002 109.552 -177.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.786 HH11 ' HB3' ' A' ' 25' ' ' GLU . 37.6 ptt180 -67.4 5.31 0.79 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.73 -0.668 . . . . 4.3799999999999999 112.105 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 99' ' ' LYS . 3.0 p -107.73 -23.26 12.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.496 -0.32 . . . . 2.5099999999999998 111.634 -174.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.404 ' HG2' ' HB3' ' A' ' 99' ' ' LYS . 81.0 mm-40 -68.16 151.61 46.73 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.193 -0.299 . . . . 3.3999999999999999 110.193 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -97.71 -20.27 17.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.313 0.578 . . . . 2.6800000000000002 110.315 175.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.29 145.27 18.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.783 -0.644 . . . . 0.44 109.51 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 74.5 t -113.53 118.35 57.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 122.089 0.947 . . . . 0.46000000000000002 111.709 -176.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.528 ' HD3' ' H ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -99.29 134.55 41.99 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 113.619 -1.628 . . . . 1.76 110.298 -176.239 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.692 HD11 HG12 ' A' ' 77' ' ' ILE . 37.0 tp -132.86 132.33 41.98 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.199 -0.455 . . . . 1.1200000000000001 110.596 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.998 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 40.1 tp -115.22 114.02 24.68 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.211 -1.774 . . . . 0.41999999999999998 106.211 171.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.698 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -127.26 150.38 33.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 109.991 -0.374 . . . . 0.77000000000000002 109.991 -171.331 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.983 HG23 HG12 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -95.88 121.26 37.43 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 120.32 -0.552 . . . . 0.34000000000000002 110.936 171.258 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.438 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 2.4 ttt180 -110.46 139.53 45.58 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.876 -1.056 . . . . 2.0099999999999998 110.987 -171.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.63 -107.04 0.35 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.899 -0.591 . . . . 1.97 111.468 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.411 ' O ' HD23 ' A' ' 114' ' ' LEU . 13.9 t -131.91 81.08 1.95 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.635 0.731 . . . . 1.6200000000000001 110.579 -173.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.511 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 3.1 mt . . . . . 0 C--N 1.309 -1.159 0 CA-C-N 114.875 -1.057 . . . . 1.6499999999999999 109.518 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.6 p . . . . . 0 N--CA 1.429 -1.515 0 CA-C-O 122.461 1.124 . . . . 2.0899999999999999 110.413 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 111' ' ' ARG . . . -88.76 177.83 6.62 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.97 -1.923 . . . . 0.95999999999999996 110.618 176.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.67 129.59 40.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.658 -0.701 . . . . 1.5700000000000001 110.169 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.555 HG22 HG23 ' A' ' 110' ' ' THR . 45.1 t -77.04 112.93 15.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.969 0.414 . . . . 1.02 111.553 -175.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.652 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -111.41 166.6 10.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.92 -0.582 . . . . 1.3899999999999999 109.98 171.478 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -120.93 138.64 54.02 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 120.797 -1.189 . . . . 3.6299999999999999 111.302 -176.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.658 HG13 ' CB ' ' A' ' 69' ' ' ALA . 19.7 t -108.29 108.57 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 CA-C-N 115.325 -0.852 . . . . 1.02 109.492 177.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -122.23 111.57 17.11 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.394 -0.821 . . . . 1.3500000000000001 109.532 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.81 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 10.8 tp -134.89 147.93 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 108.817 -0.809 . . . . 0.60999999999999999 108.817 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 14.2 m-70 -78.15 105.9 9.68 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.395 -0.965 . . . . 0.59999999999999998 108.395 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.648 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 2.5 pptp? -27.34 139.89 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 O-C-N 125.376 1.672 . . . . 4.0 112.924 -175.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 43.8 tp -93.62 85.8 4.99 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 122.175 0.988 . . . . 0.55000000000000004 109.703 -171.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.602 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -54.41 134.41 45.72 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 113.639 -1.619 . . . . 3.9700000000000002 112.136 -175.291 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.525 ' HB2' HD13 ' A' ' 28' ' ' ILE . 33.9 tp60 -123.78 94.5 4.25 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.501 -1.227 . . . . 1.3500000000000001 108.471 176.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.77 -84.37 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.493 -0.86 . . . . 1.3300000000000001 111.289 -173.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -129.57 6.73 5.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.199 0.523 . . . . 2.3300000000000001 110.694 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 3.8 m-80 -110.71 -177.11 3.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.697 -0.683 . . . . 1.8700000000000001 109.871 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 20' ' ' LYS . 1.6 pt? -127.73 144.78 51.06 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.202 -1.036 . . . . 2.2799999999999998 108.202 172.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.525 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.1 mp -113.24 139.96 35.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-O 121.142 0.496 . . . . 0.80000000000000004 110.711 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -101.25 127.34 47.89 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.667 -1.152 . . . . 1.74 109.144 173.013 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.749 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -95.08 48.8 1.96 Allowed Glycine 0 C--O 1.22 -0.731 0 C-N-CA 120.165 -1.016 . . . . 0.68999999999999995 113.154 -172.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 35.3 p90 -158.52 163.1 37.39 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.634 -0.876 . . . . 0.51000000000000001 108.634 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.582 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.1 OUTLIER -105.14 161.06 14.58 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.865 -1.161 . . . . 0.53000000000000003 107.865 170.569 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -156.72 137.32 4.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 119.107 -1.037 . . . . 0.48999999999999999 113.757 -165.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.434 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -146.63 118.22 1.02 Allowed Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.43 -1.068 . . . . 0.71999999999999997 110.43 156.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 1.045 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.45 117.48 1.22 Allowed Glycine 0 CA--C 1.492 -1.356 0 CA-C-O 118.641 -1.088 . . . . 1.4199999999999999 111.401 172.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.541 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.29 143.25 8.12 Favored Glycine 0 C--N 1.299 -1.496 0 C-N-CA 117.929 -2.081 . . . . 0.47999999999999998 112.954 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.624 HG12 ' O ' ' A' ' 87' ' ' MET . 5.2 pt -59.89 -26.1 34.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 106.813 -1.551 . . . . 0.52000000000000002 106.813 151.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 1.003 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 6.0 t70 -53.08 -44.68 67.72 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 113.003 -1.908 . . . . 0.71999999999999997 110.752 173.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 . . . . . 0 CA--C 1.535 0.393 0 CA-C-N 114.811 -1.086 . . . . 1.1899999999999999 111.668 -172.497 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.202 0 N-CA-C 110.862 -0.895 . . . . 0.78000000000000003 110.862 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.045 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -114.76 138.39 45.08 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 109.018 -0.734 . . . . 0.54000000000000004 109.018 174.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.591 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -142.94 140.04 30.95 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 119.185 0.902 . . . . 1.4199999999999999 110.405 -176.23 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.68 HG12 ' H ' ' A' ' 75' ' ' ASP . 8.8 p -82.92 138.84 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 CA-C-N 114.623 -1.172 . . . . 0.57999999999999996 110.056 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.655 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 23.5 m -127.98 68.55 1.33 Allowed 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.153 -0.931 . . . . 1.1100000000000001 109.33 172.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.49 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 24.1 mtp180 148.54 -171.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.637 1.575 . . . . 2.27 111.001 162.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.582 HG13 ' HB3' ' A' ' 66' ' ' ALA . 58.4 t -162.14 143.5 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 125.543 1.777 . . . . 0.82999999999999996 107.622 164.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.3 p -86.65 133.84 33.66 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.611 0.719 . . . . 1.6499999999999999 110.88 175.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -71.45 105.62 3.64 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.195 -1.366 . . . . 1.8500000000000001 111.055 178.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.21 9.65 50.74 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 119.764 -1.208 . . . . 0.92000000000000004 113.093 176.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.606 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -90.18 -140.05 8.08 Favored Glycine 0 C--O 1.217 -0.938 0 C-N-CA 120.279 -0.962 . . . . 0.98999999999999999 111.082 175.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.749 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 66.0 Cg_endo -98.26 -32.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 122.475 2.116 . . . . 0.44 114.525 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.582 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -71.99 -22.83 61.37 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.906 -0.588 . . . . 0.35999999999999999 111.727 -174.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -71.96 -30.92 65.78 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.626 -0.879 . . . . 1.79 108.626 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.606 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -81.57 -44.18 20.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.539 -1.21 . . . . 0.51000000000000001 110.41 -176.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.81 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . . . -68.25 -26.4 65.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.936 -0.575 . . . . 0.40999999999999998 110.31 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.08 70.03 1.01 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.368 -0.92 . . . . 0.45000000000000001 113.278 177.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.565 HD21 HG21 ' A' ' 57' ' ' VAL . 13.9 tp -113.75 153.52 28.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.192 -0.669 . . . . 0.89000000000000001 109.192 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.537 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 10.5 mt-30 -123.65 29.36 6.6 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 114.83 1.419 . . . . 1.21 114.83 -166.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.655 ' O ' ' HA ' ' A' ' 58' ' ' THR . 2.9 mp 72.06 -12.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 N-CA-C 113.418 0.895 . . . . 0.77000000000000002 113.418 171.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -164.31 60.89 0.25 Allowed Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.225 -0.988 . . . . 0.37 111.407 -165.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.68 ' H ' HG12 ' A' ' 57' ' ' VAL . 17.4 m-20 -123.09 153.26 40.16 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.015 -0.593 . . . . 0.89000000000000001 109.593 -169.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.441 ' HD2' HE22 ' A' ' 112' ' ' GLN . 6.8 mptt -104.09 100.31 10.06 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.125 -0.63 . . . . 2.2000000000000002 109.77 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.991 HG13 HG23 ' A' ' 109' ' ' VAL . 4.8 mp -75.0 128.91 37.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.55 -0.75 . . . . 0.48999999999999999 110.053 -175.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.48 ' HE3' ' HB2' ' A' ' 78' ' ' MET . 0.0 OUTLIER -114.02 4.6 15.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 112.863 0.69 . . . . 1.0600000000000001 112.863 -179.067 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.568 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 2.2 tt0 -172.11 152.38 2.86 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 122.442 -0.161 . . . . 0.81999999999999995 111.095 176.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.786 HG21 ' HB3' ' A' ' 97' ' ' LEU . 7.0 p -150.06 130.81 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 121.237 0.541 . . . . 1.3100000000000001 111.317 175.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.515 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 14.3 m120 50.37 34.3 8.87 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.149 0.979 . . . . 1.5 112.787 176.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.32 3.62 64.95 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.482 -0.866 . . . . 0.38 113.24 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -99.74 161.61 13.51 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 109.524 -0.547 . . . . 0.77000000000000002 109.524 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -110.69 97.78 7.11 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.45 -0.795 . . . . 1.8899999999999999 110.082 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.776 ' HB2' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -107.45 98.15 7.8 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 122.151 0.977 . . . . 1.01 109.731 174.359 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.18 -10.57 13.85 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.982 -1.463 . . . . 1.05 107.841 175.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.624 ' O ' HG12 ' A' ' 37' ' ' ILE . 1.9 mtt -149.89 -42.29 0.13 Allowed 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 112.543 -2.117 . . . . 1.6200000000000001 108.905 -171.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.63 ' O ' HD11 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -22.68 141.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 C-N-CA 126.249 1.82 . . . . 1.0900000000000001 115.711 -177.825 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . 1.003 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 49.7 p -58.17 154.1 13.72 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 112.475 0.546 . . . . 0.34999999999999998 112.475 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.773 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 22.1 t-160 -56.27 -44.42 79.74 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 115.988 -0.551 . . . . 0.34999999999999998 110.66 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.8 -31.76 68.61 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.13 -0.941 . . . . 1.6699999999999999 110.139 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.784 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.7 OUTLIER -64.36 -49.69 70.65 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.78 -0.822 . . . . 0.77000000000000002 108.78 -178.68 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.619 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -74.13 -32.88 63.35 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.709 -0.678 . . . . 0.33000000000000002 110.528 -177.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.525 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 35.1 ttp180 -64.16 -44.58 91.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 2.1000000000000001 109.991 177.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.449 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -67.02 -36.29 81.79 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.688 -0.687 . . . . 0.95999999999999996 109.481 -178.609 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.784 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 22.7 mmt180 -70.96 -23.9 62.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.988 -0.551 . . . . 3.5699999999999998 111.193 -176.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.786 ' HB3' HG21 ' A' ' 80' ' ' VAL . 3.4 pp -94.41 -15.09 24.6 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.964 -0.294 . . . . 1.6499999999999999 110.901 177.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.2 m -111.53 89.47 3.06 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.866 0.841 . . . . 1.53 110.888 -175.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.438 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 12.1 mtmt -136.7 103.99 5.39 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.476 -1.238 . . . . 2.7200000000000002 109.548 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.479 ' CB ' ' HA ' ' A' ' 26' ' ' ASN . 38.1 ptt180 -76.11 53.65 0.81 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.479 0.657 . . . . 4.3799999999999999 111.072 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.0 t -140.41 -51.43 0.48 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.533 -0.758 . . . . 2.5099999999999998 110.201 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 41.5 mt-10 -69.09 150.8 47.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.832 0.348 . . . . 3.3999999999999999 111.303 -177.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.473 ' HA ' ' NZ ' ' A' ' 20' ' ' LYS . 10.3 pt-20 -84.83 -15.46 44.71 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.834 0.679 . . . . 2.6800000000000002 112.834 -174.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.66 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 5.7 p -149.13 149.28 15.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.868 0.365 . . . . 0.44 110.274 -172.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.611 HG23 ' HB3' ' A' ' 20' ' ' LYS . 44.2 t -120.72 118.83 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 121.906 0.86 . . . . 0.46000000000000002 111.523 -173.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.515 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER -99.75 125.18 45.6 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.593 -1.639 . . . . 1.76 110.385 -175.164 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.464 HD22 ' HB ' ' A' ' 16' ' ' VAL . 10.1 tt -133.73 128.09 34.18 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.547 -0.297 . . . . 1.1200000000000001 110.229 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 79' ' ' GLN . 9.8 tp -101.37 114.27 28.12 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 107.347 -1.353 . . . . 0.41999999999999998 107.347 174.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.991 HG23 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -111.37 150.29 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 CA-C-O 121.522 0.677 . . . . 0.77000000000000002 109.665 -175.382 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.555 HG23 HG22 ' A' ' 13' ' ' VAL . 1.3 m -97.35 113.48 25.13 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 118.512 -1.275 . . . . 0.34000000000000002 108.748 167.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.553 ' HB2' ' CG ' ' A' ' 14' ' ' GLN . 1.0 OUTLIER -91.9 153.9 19.2 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.14 -1.391 . . . . 2.0099999999999998 109.951 -173.257 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.469 ' N ' ' HG2' ' A' ' 111' ' ' ARG . 0.1 OUTLIER -125.1 -95.16 0.47 Allowed 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.692 -0.403 . . . . 1.97 111.675 -177.509 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.401 ' H ' ' CG ' ' A' ' 112' ' ' GLN . 9.0 t -149.78 38.33 0.75 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.645 0.736 . . . . 1.6200000000000001 110.764 -170.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.491 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 6.3 mt . . . . . 0 C--N 1.314 -0.94 0 CA-C-N 115.21 -0.905 . . . . 1.6499999999999999 109.225 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptm . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 120.277 0.084 . . . . 14.33 111.192 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 p -126.34 111.03 14.04 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.813 0.339 . . . . 11.220000000000001 111.385 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -157.3 122.85 4.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.919 -0.582 . . . . 9.1899999999999995 109.743 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.568 HG13 ' HG3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -117.21 98.71 52.25 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-O 121.171 0.51 . . . . 6.6500000000000004 110.252 -179.096 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.3 -41.66 20.42 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.711 2.274 . . . . 7.46 111.265 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.35 32.12 0.44 Allowed Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.512 -0.767 . . . . 5.8899999999999997 111.311 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.564 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 3.5 pt20 -145.12 41.49 0.31 Allowed Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 114.16 1.17 . . . . 6.3700000000000001 114.16 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.568 ' HG3' HG13 ' A' ' 4' ' ' ILE . 35.2 Cg_exo -56.79 122.62 12.13 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.753 1.636 . . . . 3.3999999999999999 111.899 172.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.9 t 75.16 -44.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.33 0.652 . . . . 2.2599999999999998 111.866 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 t -76.32 83.42 3.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 123.362 1.553 . . . . 2.0899999999999999 111.175 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.65 178.77 5.36 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 112.515 -2.13 . . . . 0.95999999999999996 110.509 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.0 t -106.32 110.95 33.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.762 -0.654 . . . . 1.5700000000000001 110.52 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.855 HG22 HG23 ' A' ' 110' ' ' THR . 33.6 t -77.66 108.45 10.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.751 -0.462 . . . . 1.02 109.751 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 1.036 ' HG2' ' HD3' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -113.33 169.47 8.93 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.257 -0.577 . . . . 1.3899999999999999 111.801 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 15' ' ' ARG . 1.9 mmm180 -115.43 126.76 54.75 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.016 0.436 . . . . 3.6299999999999999 111.719 -175.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.602 HG13 ' CB ' ' A' ' 69' ' ' ALA . 26.2 t -107.39 121.85 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.614 -0.721 . . . . 1.02 109.323 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -143.82 111.94 6.26 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.748 -0.464 . . . . 1.3500000000000001 109.748 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.494 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 9.6 tp -139.18 148.79 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.568 -0.901 . . . . 0.60999999999999999 108.568 -176.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 16.5 m-70 -79.36 115.8 19.22 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.981 -0.687 . . . . 0.59999999999999998 109.411 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.865 ' HB2' HD12 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -26.93 139.07 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 O-C-N 125.142 1.526 . . . . 4.0 112.715 178.402 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.1 tp -97.66 93.91 6.67 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 121.418 -0.802 . . . . 0.55000000000000004 110.31 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -60.81 143.06 55.43 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.366 0.603 . . . . 3.9700000000000002 112.183 -173.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.545 ' HB2' HD13 ' A' ' 28' ' ' ILE . 20.5 tp60 -140.88 94.9 2.77 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.283 -0.871 . . . . 1.3500000000000001 109.493 174.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.86 -82.49 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.042 -0.599 . . . . 1.3300000000000001 112.506 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.531 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 18.2 mt-10 -118.4 -17.35 9.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.098 0.475 . . . . 2.3300000000000001 110.561 -177.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.484 ' OD1' ' HB3' ' A' ' 23' ' ' GLN . 1.0 OUTLIER -112.85 -177.66 3.19 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.895 -0.593 . . . . 1.8700000000000001 111.679 -169.162 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.865 HD12 ' HB2' ' A' ' 20' ' ' LYS . 2.1 pt? -126.98 138.25 53.23 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.764 -1.199 . . . . 2.2799999999999998 107.764 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.545 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.3 mp -101.46 130.14 51.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.42 0.628 . . . . 0.80000000000000004 110.4 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.481 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -96.08 125.47 40.64 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.088 -1.414 . . . . 1.74 108.652 172.051 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -85.47 41.24 3.05 Favored Glycine 0 C--O 1.22 -0.745 0 C-N-CA 120.386 -0.911 . . . . 0.68999999999999995 112.648 -175.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.619 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 42.5 p90 -157.07 154.67 29.86 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 122.752 0.421 . . . . 0.51000000000000001 110.385 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.497 ' CB ' ' HB2' ' A' ' 59' ' ' ARG . 8.1 t -103.98 159.25 15.82 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.085 -1.45 . . . . 0.53000000000000003 107.085 169.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.401 HG12 ' N ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -160.69 141.59 3.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 112.745 0.646 . . . . 0.48999999999999999 112.745 -165.282 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.438 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -144.44 119.16 1.23 Allowed Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 110.089 -1.205 . . . . 0.71999999999999997 110.089 157.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.972 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.92 118.14 1.27 Allowed Glycine 0 CA--C 1.492 -1.358 0 CA-C-O 118.555 -1.136 . . . . 1.4199999999999999 111.621 171.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.734 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.69 143.77 8.58 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 117.483 -2.294 . . . . 0.47999999999999998 113.796 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.3 pt -61.65 -19.31 20.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.104 -1.073 . . . . 0.52000000000000002 108.104 149.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.832 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 0.4 OUTLIER -66.18 -35.15 79.71 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.749 -1.569 . . . . 0.71999999999999997 109.97 174.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.483 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 29.2 mm-40 -71.37 -166.37 0.18 Allowed 'General case' 0 C--N 1.339 0.143 0 CA-C-N 115.065 -0.971 . . . . 1.1899999999999999 110.713 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -85.44 104.91 5.68 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 116.03 -0.532 . . . . 2.5699999999999998 110.736 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 39' ' ' GLN . 4.4 Cg_exo -83.97 6.91 5.5 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 123.653 2.902 . . . . 2.8199999999999998 112.8 -177.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.8 t -95.54 32.21 1.85 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.059 -0.519 . . . . 3.2599999999999998 111.37 -171.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -137.92 14.71 2.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.438 0.637 . . . . 3.8799999999999999 109.614 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.962 ' HB3' ' HB2' ' A' ' 48' ' ' GLU . 9.3 p30 -178.72 59.24 0.12 Allowed Pre-proline 0 N--CA 1.435 -1.209 0 N-CA-C 107.967 -1.123 . . . . 5.1399999999999997 107.967 -166.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.97 -4.54 10.34 Favored 'Trans proline' 0 CA--C 1.527 0.139 0 C-N-CA 122.817 2.345 . . . . 3.71 112.474 -169.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -134.24 -53.82 0.85 Allowed 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.479 -1.304 . . . . 5.6200000000000001 107.479 173.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.0 m -160.2 156.42 26.57 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.677 -0.86 . . . . 3.77 108.677 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.962 ' HB2' ' HB3' ' A' ' 44' ' ' ASN . 37.5 tt0 -108.77 -26.5 10.27 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.726 0.774 . . . . 6.7800000000000002 109.917 170.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.882 ' HB3' HG22 ' A' ' 51' ' ' THR . 20.8 t70 178.75 -144.49 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 104.771 -2.307 . . . . 5.4699999999999998 104.771 -169.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.994 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 1.5 tmtp? -83.74 4.57 28.31 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 122.011 0.91 . . . . 3.0699999999999998 108.613 170.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.882 HG22 ' HB3' ' A' ' 49' ' ' ASP . 1.7 t -84.33 -58.07 2.9 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.479 -0.782 . . . . 4.5599999999999996 111.375 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.434 ' H ' HG23 ' A' ' 51' ' ' THR . 26.5 t70 44.81 -120.78 0.83 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.236 0.458 . . . . 2.6000000000000001 112.236 -177.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.555 ' HE3' ' OD1' ' A' ' 44' ' ' ASN . 20.6 mmtm -104.53 21.46 16.73 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 109.081 -0.711 . . . . 3.48 109.081 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.414 ' C ' HD12 ' A' ' 55' ' ' ILE . . . -85.5 -162.74 36.48 Favored Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 114.729 -1.123 . . . . 0.78000000000000003 110.901 -174.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.972 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -111.32 141.45 26.67 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 N-CA-C 107.297 -1.372 . . . . 0.54000000000000004 107.297 176.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.688 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER -152.21 145.2 24.49 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 119.405 1.002 . . . . 1.4199999999999999 110.99 -177.627 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.758 HG12 ' H ' ' A' ' 75' ' ' ASP . 2.7 p -85.59 133.23 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-N 114.597 -1.183 . . . . 0.57999999999999996 110.471 -171.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 37.7 m -100.09 -16.23 17.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.942 -1.026 . . . . 1.1100000000000001 110.822 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.671 ' HA ' HG23 ' A' ' 73' ' ' ILE . 72.2 mtt180 -149.04 -169.4 3.36 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.667 0.618 . . . . 2.27 112.667 175.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 59' ' ' ARG . 79.4 t -167.84 138.27 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 113.271 -1.786 . . . . 0.82999999999999996 107.212 163.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.5 p -82.29 126.27 31.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.232 0.539 . . . . 1.6499999999999999 110.88 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -57.19 112.24 1.31 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.429 -1.259 . . . . 1.8500000000000001 110.841 171.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.0 -2.43 66.13 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.51 -0.852 . . . . 0.92000000000000004 112.566 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.578 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -92.33 173.58 35.92 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 120.569 -0.824 . . . . 0.98999999999999999 111.623 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.493 ' HB2' HG12 ' A' ' 18' ' ' ILE . 64.8 Cg_endo -70.7 -22.81 27.25 Favored 'Trans proline' 0 CA--C 1.504 -1.002 0 C-N-CA 122.732 2.288 . . . . 0.44 113.477 -165.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.56 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -66.84 -32.7 74.15 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.731 -1.122 . . . . 0.35999999999999999 110.882 176.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -77.74 -30.08 51.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.236 0.541 . . . . 1.79 109.609 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.578 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.3 mp -68.98 -36.98 76.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.374 -0.83 . . . . 0.51000000000000001 109.629 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.602 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -78.11 -25.34 47.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.746 -0.661 . . . . 0.40999999999999998 110.838 176.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.89 43.62 1.9 Allowed Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.355 -0.926 . . . . 0.45000000000000001 113.874 177.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.462 ' O ' HG21 ' A' ' 60' ' ' VAL . 14.1 tp -95.1 148.7 22.07 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.44 -0.948 . . . . 0.89000000000000001 108.44 174.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.64 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 84.9 mt-30 -134.28 40.07 3.04 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 116.018 1.858 . . . . 1.21 116.018 -161.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.671 HG23 ' HA ' ' A' ' 59' ' ' ARG . 59.1 mt 69.85 -11.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 114.654 1.353 . . . . 0.77000000000000002 114.654 162.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.37 43.72 0.33 Allowed Glycine 0 CA--C 1.508 -0.348 0 C-N-CA 120.163 -1.018 . . . . 0.37 111.846 -170.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.758 ' H ' HG12 ' A' ' 57' ' ' VAL . 9.3 m-20 -119.61 141.27 49.45 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.047 -0.576 . . . . 0.89000000000000001 111.831 -168.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.994 ' HG3' ' HB3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -87.47 102.95 15.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.333 -0.849 . . . . 2.2000000000000002 111.16 -175.352 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.551 HD12 ' CA ' ' A' ' 56' ' ' TYR . 5.1 mt -73.63 122.99 27.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 114.772 -1.104 . . . . 0.48999999999999999 111.874 -177.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.787 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 2.2 mmt -93.32 -9.19 39.75 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.945 -1.025 . . . . 1.0600000000000001 113.399 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.606 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -167.88 150.99 5.86 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.05 0.452 . . . . 0.81999999999999995 112.196 -178.608 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.713 ' HB ' ' HE1' ' A' ' 85' ' ' MET . 40.6 t -133.05 112.06 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 114.927 -1.033 . . . . 1.3100000000000001 110.316 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.943 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 14.4 m120 57.4 27.85 14.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.727 -0.669 . . . . 1.5 112.613 174.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.84 -13.37 53.22 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 119.987 -1.101 . . . . 0.38 112.353 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.416 ' HE1' ' CZ ' ' A' ' 96' ' ' ARG . 74.1 m95 -80.68 170.16 16.68 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.875 -0.787 . . . . 0.77000000000000002 108.875 176.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -115.47 112.88 22.92 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.098 0.475 . . . . 1.8899999999999999 111.141 -172.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.713 ' HE1' ' HB ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -106.28 100.88 10.39 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 122.43 1.11 . . . . 1.01 110.676 -177.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.9 p -137.22 -41.27 0.58 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.536 -1.665 . . . . 1.05 107.73 173.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.61 73.98 1.34 Allowed 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 112.777 -2.01 . . . . 1.6200000000000001 108.31 174.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.734 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.2 t -135.57 140.76 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 108.89 -0.782 . . . . 1.0900000000000001 108.89 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.668 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 70.1 p -55.77 148.75 15.89 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.08 0.467 . . . . 0.34999999999999998 112.111 -177.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.832 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 21.8 t-160 -54.28 -42.94 70.59 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-O 121.616 0.722 . . . . 0.34999999999999998 110.131 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.72 -30.38 66.9 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.188 -1.369 . . . . 1.6699999999999999 110.445 -177.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.6 ' HB3' HG13 ' A' ' 88' ' ' VAL . 1.8 tp-100 -60.05 -47.62 85.12 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 122.039 0.923 . . . . 0.77000000000000002 108.537 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.637 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -74.47 -40.95 61.54 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.433 -1.258 . . . . 0.33000000000000002 110.444 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -66.22 -40.66 90.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.639 -0.71 . . . . 2.1000000000000001 110.715 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 1.2 tmtp? -64.33 -38.01 89.53 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 116.006 -0.543 . . . . 0.95999999999999996 109.541 -177.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.432 ' HB2' HG11 ' A' ' 80' ' ' VAL . 9.9 mmm180 -64.83 -48.9 72.69 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.823 -0.626 . . . . 3.5699999999999998 111.352 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.447 HD13 HD13 ' A' ' 29' ' ' LEU . 3.8 pp -79.25 -1.86 38.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.467 -0.333 . . . . 1.6499999999999999 111.756 -176.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.545 ' HA ' HD21 ' A' ' 27' ' ' LEU . 3.3 m -115.84 23.55 12.18 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 122.114 0.959 . . . . 1.53 109.884 173.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 1.006 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 5.8 mmpt? -81.76 112.56 19.03 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.431 -0.804 . . . . 2.7200000000000002 108.983 169.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.531 ' HD2' ' O ' ' A' ' 25' ' ' GLU . 35.6 ptt180 -71.26 19.06 0.06 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.652 -0.704 . . . . 4.3799999999999999 111.023 -177.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.543 ' H ' ' C ' ' A' ' 99' ' ' LYS . 5.8 p -115.02 -22.96 9.29 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.32 -0.855 . . . . 2.5099999999999998 109.948 -176.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -72.0 91.86 1.25 Allowed 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 122.13 0.967 . . . . 3.3999999999999999 109.956 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.578 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 5.2 tp10 -52.5 -29.63 26.04 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.142 -1.845 . . . . 2.6800000000000002 111.107 175.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 7.7 p -134.63 141.95 41.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.882 -0.784 . . . . 0.44 108.882 176.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.4 t -114.21 118.81 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 122.053 0.93 . . . . 0.46000000000000002 112.168 -171.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.943 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.3 OUTLIER -101.08 126.16 47.75 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.584 -1.643 . . . . 1.76 111.942 -173.506 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.545 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 9.4 tt -134.75 129.11 34.14 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.316 -0.402 . . . . 1.1200000000000001 109.999 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.787 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 24.5 tp -102.73 124.27 47.95 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 106.489 -1.671 . . . . 0.41999999999999998 106.489 175.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.714 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -127.47 145.22 35.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 119.147 -1.021 . . . . 0.77000000000000002 111.648 -174.431 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.855 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -99.54 113.38 25.74 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.611 -0.836 . . . . 0.34000000000000002 109.737 166.004 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 1.036 ' HD3' ' HG2' ' A' ' 14' ' ' GLN . 1.1 ptt180 -107.19 127.35 53.43 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.281 -1.327 . . . . 2.0099999999999998 108.943 -174.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.629 ' N ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -99.53 -55.99 2.52 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.838 0.681 . . . . 1.97 112.838 -165.422 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.473 ' N ' ' HG2' ' A' ' 112' ' ' GLN . 1.4 t -159.93 19.13 0.16 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.181 -0.608 . . . . 1.6200000000000001 111.037 -173.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -79.64 70.07 6.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.671 0.748 . . . . 1.6499999999999999 109.271 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.4 ' H ' ' HG2' ' A' ' 115' ' ' GLN . 7.2 pt20 -82.08 125.25 30.62 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.922 -1.035 . . . . 3.5299999999999998 111.171 -174.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -138.33 131.57 30.24 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.542 -0.754 . . . . 3.6000000000000001 109.402 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 72.15 21.76 3.84 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.905 0.753 . . . . 3.5600000000000001 111.179 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.0 p -62.82 128.5 24.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.045 -0.525 . . . . 4.9900000000000002 110.298 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -93.52 133.18 37.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.94 -0.573 . . . . 7.7699999999999996 110.753 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -77.57 145.28 36.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 6.5999999999999996 111.13 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 50.9 m -144.97 108.8 4.71 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.617 -0.512 . . . . 8.9399999999999995 109.617 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 43.1 tpp -79.83 109.66 14.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.09 -0.505 . . . . 12.1 111.471 -175.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.5 mt -95.58 116.11 28.38 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.022 -0.536 . . . . 12.82 109.683 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.585 -0.721 . . . . 14.640000000000001 110.741 -176.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.8 mmm . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.972 0.415 . . . . 14.33 110.7 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.9 p -129.59 -19.64 3.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.208 -0.451 . . . . 11.220000000000001 110.956 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -115.58 125.85 53.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.425 -0.352 . . . . 9.1899999999999995 110.719 -174.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.587 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 19.0 pt -113.16 104.07 55.67 Favored Pre-proline 0 N--CA 1.451 -0.424 0 CA-C-O 121.126 0.489 . . . . 6.6500000000000004 109.996 173.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 4' ' ' ILE . 7.2 Cg_exo -73.91 -44.2 0.5 Allowed 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.784 2.322 . . . . 7.46 113.204 -175.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.87 -4.26 69.67 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.727 -0.749 . . . . 5.8899999999999997 112.803 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 57.25 86.95 0.15 Allowed Pre-proline 0 N--CA 1.466 0.371 0 CA-C-O 121.334 0.588 . . . . 6.3700000000000001 111.68 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.587 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 3.3 Cg_endo -87.27 109.14 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.43 2.753 . . . . 3.3999999999999999 111.48 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.441 ' HB ' ' O ' ' A' ' 8' ' ' PRO . 69.5 t 70.84 -59.26 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 123.542 0.526 . . . . 2.2599999999999998 111.263 -175.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.1 p -75.59 82.48 2.61 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 121.995 0.902 . . . . 2.0899999999999999 110.651 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.427 ' HB1' ' O ' ' A' ' 111' ' ' ARG . . . -94.52 179.25 5.34 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.629 -1.623 . . . . 0.95999999999999996 109.662 176.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 m -112.91 124.02 69.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.235 0.541 . . . . 1.5700000000000001 110.523 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.734 HG22 HG23 ' A' ' 110' ' ' THR . 21.5 t -81.76 106.22 12.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.27 0.557 . . . . 1.02 110.025 -175.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.747 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -101.74 170.05 8.42 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.289 -0.869 . . . . 1.3899999999999999 112.051 -177.235 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -115.02 139.83 49.54 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 116.112 -0.494 . . . . 3.6299999999999999 111.359 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.65 HG13 ' CB ' ' A' ' 69' ' ' ALA . 12.4 t -128.86 126.46 64.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.868 -0.79 . . . . 1.02 108.868 173.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -142.09 121.52 13.21 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 122.11 -0.369 . . . . 1.3500000000000001 110.188 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.545 HG12 ' HB2' ' A' ' 65' ' ' PRO . 10.9 tp -145.15 147.53 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 N-CA-C 108.973 -0.751 . . . . 0.60999999999999999 108.973 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.757 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 13.5 m-70 -76.15 114.83 15.26 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.62 -0.511 . . . . 0.59999999999999998 109.62 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.822 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -28.82 129.27 0.08 Allowed 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.437 1.086 . . . . 4.0 112.358 176.476 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.5 tp -99.88 89.94 4.25 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.469 0.652 . . . . 0.55000000000000004 109.857 -173.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -77.58 143.49 38.28 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.185 -0.916 . . . . 3.9700000000000002 112.213 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -128.53 94.17 3.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.844 -1.071 . . . . 1.3500000000000001 108.142 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.31 -83.65 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.607 -0.806 . . . . 1.3300000000000001 111.671 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -137.59 12.51 2.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.224 0.535 . . . . 2.3300000000000001 110.724 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -115.93 135.73 53.71 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 108.584 -0.895 . . . . 1.8700000000000001 108.584 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.498 HD23 ' HG3' ' A' ' 20' ' ' LYS . 9.6 mp -107.42 123.78 48.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.585 0.707 . . . . 2.2799999999999998 110.959 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.441 ' O ' ' HE2' ' A' ' 20' ' ' LYS . 1.9 mp -98.15 129.47 48.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 114.933 -1.03 . . . . 0.80000000000000004 110.06 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.442 HD22 ' OG1' ' A' ' 98' ' ' THR . 0.1 OUTLIER -89.81 -31.08 17.54 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.791 -0.641 . . . . 1.74 110.867 -176.603 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.857 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 86.55 9.92 74.44 Favored Glycine 0 C--O 1.224 -0.501 0 C-N-CA 120.591 -0.814 . . . . 0.68999999999999995 112.559 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.611 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 47.0 p90 -150.28 149.53 30.27 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.72 0.295 . . . . 0.51000000000000001 110.237 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.725 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -102.47 150.19 23.63 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.827 -0.805 . . . . 0.53000000000000003 108.827 172.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.46 HG12 ' N ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -157.01 145.35 11.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 112.283 0.475 . . . . 0.48999999999999999 112.283 -163.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.46 ' N ' HG12 ' A' ' 33' ' ' ILE . . . -142.1 119.0 1.37 Allowed Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 110.572 -1.011 . . . . 0.71999999999999997 110.572 157.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.957 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -139.38 118.59 1.54 Allowed Glycine 0 CA--C 1.493 -1.328 0 CA-C-O 118.388 -1.229 . . . . 1.4199999999999999 111.119 170.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -168.6 142.8 7.65 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 117.751 -2.166 . . . . 0.47999999999999998 113.258 178.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.731 HG12 ' O ' ' A' ' 87' ' ' MET . 0.5 OUTLIER -65.71 -22.6 31.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 106.726 -1.583 . . . . 0.52000000000000002 106.726 153.839 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.758 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 1.1 t70 -58.18 -36.72 73.48 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 112.839 -1.982 . . . . 0.71999999999999997 109.222 169.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -74.43 -67.93 0.58 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.165 -0.925 . . . . 1.1899999999999999 110.488 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -161.05 113.36 1.29 Allowed Pre-proline 0 N--CA 1.461 0.112 0 CA-C-O 120.74 0.305 . . . . 2.5699999999999998 110.802 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -95.46 10.6 1.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.847 3.031 . . . . 2.8199999999999998 112.768 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.1 t -101.45 -10.6 20.04 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.399 0.518 . . . . 3.2599999999999998 112.399 -164.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -124.1 25.91 7.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.364 0.602 . . . . 3.8799999999999999 109.956 -176.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.409 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 12.6 p30 -178.09 47.71 0.04 OUTLIER Pre-proline 0 N--CA 1.442 -0.837 0 CA-C-N 115.489 -0.778 . . . . 5.1399999999999997 109.107 -166.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 44' ' ' ASN . 14.0 Cg_endo -53.88 -31.61 63.4 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.674 2.249 . . . . 3.71 111.05 -170.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -121.6 -53.34 2.0 Allowed 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 106.514 -1.661 . . . . 5.6200000000000001 106.514 170.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.0 p -159.42 160.6 35.03 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 114.736 -1.12 . . . . 3.77 110.102 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -109.53 -30.21 8.03 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.939 -0.763 . . . . 6.7800000000000002 108.939 171.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -175.2 -96.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.814 -1.085 . . . . 5.4699999999999998 108.638 -176.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.546 ' HA ' ' CE ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -130.47 8.26 4.99 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.619 -0.882 . . . . 3.0699999999999998 108.619 163.689 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.05 -48.22 6.6 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 108.431 -0.951 . . . . 4.5599999999999996 108.431 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 44.89 -142.13 0.24 Allowed 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 114.835 -1.075 . . . . 2.6000000000000001 112.082 170.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.435 ' C ' ' HD2' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -118.0 30.53 7.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.147 -0.933 . . . . 3.48 109.206 176.568 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.58 -155.28 8.32 Favored Glycine 0 N--CA 1.44 -1.048 0 N-CA-C 109.984 -1.246 . . . . 0.78000000000000003 109.984 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.957 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.7 mp -114.48 125.14 71.72 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.765 0 N-CA-C 108.225 -1.028 . . . . 0.54000000000000004 108.225 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.929 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.8 OUTLIER -145.4 148.33 33.22 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 119.984 1.266 . . . . 1.4199999999999999 112.261 -172.157 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.69 HG12 ' H ' ' A' ' 75' ' ' ASP . 3.4 p -87.11 136.46 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-N 114.172 -1.376 . . . . 0.57999999999999996 110.489 -173.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.3 m -106.33 -15.01 14.94 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.034 -0.984 . . . . 1.1100000000000001 110.615 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.725 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 42.1 mtp180 -149.82 -167.16 2.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.024 0.75 . . . . 2.27 113.024 177.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 51.0 t -161.88 154.9 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 106.197 -1.779 . . . . 0.82999999999999996 106.197 166.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.463 ' N ' HG12 ' A' ' 60' ' ' VAL . 59.2 p -104.41 131.33 51.89 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.622 0.725 . . . . 1.6499999999999999 111.552 176.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -63.42 107.57 1.14 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.464 -1.244 . . . . 1.8500000000000001 111.281 175.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.74 -14.95 45.56 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 115.144 -0.935 . . . . 0.92000000000000004 111.58 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.503 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -78.32 178.22 52.95 Favored Glycine 0 N--CA 1.438 -1.171 0 C-N-CA 120.514 -0.85 . . . . 0.98999999999999999 111.451 177.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.857 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 97.4 Cg_endo -74.77 -27.15 10.73 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 122.379 2.053 . . . . 0.44 113.334 -168.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.611 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -66.11 -26.41 67.45 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.169 -0.923 . . . . 0.35999999999999999 111.139 176.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -72.94 -31.45 64.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.805 0.812 . . . . 1.79 109.114 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.503 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -76.19 -39.8 35.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.908 -1.042 . . . . 0.51000000000000001 110.631 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.65 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -77.85 -15.59 58.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.0 -0.545 . . . . 0.40999999999999998 110.757 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.16 67.06 1.34 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.522 -0.847 . . . . 0.45000000000000001 113.44 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.487 HD21 HG21 ' A' ' 57' ' ' VAL . 17.8 tp -110.1 151.99 26.55 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.763 -0.829 . . . . 0.89000000000000001 108.763 175.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.515 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 65.8 mt-30 -123.06 28.98 6.94 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 115.701 1.741 . . . . 1.21 115.701 -164.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.634 HG23 ' HA ' ' A' ' 59' ' ' ARG . 75.5 mt 69.78 2.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-N 119.455 1.025 . . . . 0.77000000000000002 113.308 167.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.89 48.36 0.19 Allowed Glycine 0 CA--C 1.51 -0.237 0 C-N-CA 119.528 -1.32 . . . . 0.37 112.77 -170.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.69 ' H ' HG12 ' A' ' 57' ' ' VAL . 50.7 m-20 -120.83 145.92 47.1 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.376 -0.412 . . . . 0.89000000000000001 110.852 -172.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.909 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 32.4 mmtt -97.23 105.48 17.63 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 121.35 0.595 . . . . 2.2000000000000002 109.845 -174.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.991 HG13 HG23 ' A' ' 109' ' ' VAL . 2.7 mp -73.03 125.64 32.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.33 0.586 . . . . 0.48999999999999999 112.139 -177.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.723 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 1.5 mmt -91.5 -18.37 24.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 113.504 -1.68 . . . . 1.0600000000000001 111.769 177.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.742 ' HB2' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -171.88 157.62 4.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.972 0.415 . . . . 0.81999999999999995 111.357 -175.212 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.835 HG21 ' HB3' ' A' ' 97' ' ' LEU . 6.5 p -145.45 120.84 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.859 -0.61 . . . . 1.3100000000000001 110.576 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.814 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 19.6 m-80 54.88 29.81 12.72 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.503 -0.771 . . . . 1.5 112.264 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.35 -19.85 46.89 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.255 -0.974 . . . . 0.38 112.503 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -86.21 120.68 27.84 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.678 -0.86 . . . . 0.77000000000000002 108.678 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.742 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 6.6 p-10 -88.56 114.86 25.62 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 114.99 -1.005 . . . . 1.8899999999999999 111.289 -172.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.73 ' HB3' HD13 ' A' ' 55' ' ' ILE . 12.0 mmt -107.32 103.24 12.55 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.847 -1.07 . . . . 1.01 110.965 -175.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.0 p -106.96 -20.77 13.22 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.801 -0.636 . . . . 1.05 110.075 172.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.731 ' O ' HG12 ' A' ' 37' ' ' ILE . 1.8 mtt -143.66 -42.96 0.28 Allowed 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.278 -0.874 . . . . 1.6200000000000001 111.901 -172.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.754 ' O ' HD11 ' A' ' 55' ' ' ILE . 1.9 p -49.5 165.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 114.874 1.435 . . . . 1.0900000000000001 114.874 -158.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 80.6 p -54.78 151.94 7.81 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.423 0.897 . . . . 0.34999999999999998 113.423 -175.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.77 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 18.2 t-160 -59.38 -40.63 87.18 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.427 -0.806 . . . . 0.34999999999999998 110.116 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.93 -32.17 73.24 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.292 -1.322 . . . . 1.6699999999999999 109.779 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.773 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 4.1 tp-100 -61.6 -52.22 65.27 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.929 -0.767 . . . . 0.77000000000000002 108.929 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.678 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -75.29 -34.78 61.34 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.15 -0.932 . . . . 0.33000000000000002 110.69 -176.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -63.9 -36.58 84.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.118 0.485 . . . . 2.1000000000000001 109.808 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.487 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -69.07 -36.04 77.18 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.809 -0.632 . . . . 0.95999999999999996 109.823 178.933 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.773 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 20.8 mmt180 -75.87 -26.12 56.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.048 -0.524 . . . . 3.5699999999999998 111.517 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.835 ' HB3' HG21 ' A' ' 80' ' ' VAL . 4.2 pp -88.47 -26.7 21.94 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 111.905 0.335 . . . . 1.6499999999999999 111.905 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.513 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 67.1 m -148.72 109.77 4.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.642 0.734 . . . . 1.53 110.289 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.404 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 7.4 ptpp? -126.99 16.95 7.31 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.641 -1.163 . . . . 2.7200000000000002 110.857 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.433 ' CA ' HD22 ' A' ' 27' ' ' LEU . 60.2 mtt180 66.69 6.03 4.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.965 -1.016 . . . . 4.3799999999999999 111.829 175.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.474 ' C ' ' HG3' ' A' ' 102' ' ' GLU . 1.4 p -146.32 70.4 1.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.197 0.522 . . . . 2.5099999999999998 111.002 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.644 ' HB2' ' HG3' ' A' ' 20' ' ' LYS . 14.9 mt-10 -142.26 151.86 42.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.716 -0.675 . . . . 3.3999999999999999 110.733 -173.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -111.5 -29.15 7.88 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.765 -0.652 . . . . 2.6800000000000002 110.62 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.757 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 6.3 p -150.6 146.23 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.99 -0.55 . . . . 0.44 109.58 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.73 HG21 ' HG2' ' A' ' 20' ' ' LYS . 31.5 t -126.63 119.91 54.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 CA-C-O 122.227 1.013 . . . . 0.46000000000000002 112.361 -171.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.814 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 1.1 mpt_? -99.47 135.32 41.05 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.138 -1.846 . . . . 1.76 110.959 -175.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.604 HD11 HG12 ' A' ' 77' ' ' ILE . 19.9 tp -133.58 137.97 45.77 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.589 -0.278 . . . . 1.1200000000000001 110.6 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.723 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 38.8 tp -116.05 120.52 39.34 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.259 -1.386 . . . . 0.41999999999999998 107.259 172.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.991 HG23 HG13 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -130.18 152.2 37.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 121.22 0.533 . . . . 0.77000000000000002 110.712 -174.352 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.734 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -96.58 116.06 28.46 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.502 -0.772 . . . . 0.34000000000000002 109.377 168.763 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.427 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 7.8 ttt180 -100.58 135.56 41.83 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.187 -0.915 . . . . 2.0099999999999998 110.547 -176.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.447 ' HG2' ' CD2' ' A' ' 114' ' ' LEU . 0.2 OUTLIER -117.26 -108.48 0.37 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.96 -0.564 . . . . 1.97 110.559 176.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.719 ' HA ' HE22 ' A' ' 115' ' ' GLN . 14.9 t -115.12 28.6 8.59 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.239 0.542 . . . . 1.6200000000000001 111.074 -170.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.515 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 3.1 mm? -92.62 29.64 1.71 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.038 -0.528 . . . . 1.6499999999999999 111.509 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.719 HE22 ' HA ' ' A' ' 113' ' ' SER . 2.4 mp0 -54.51 105.15 0.14 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.34 0.59 . . . . 3.5299999999999998 111.317 -175.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -109.54 -6.04 15.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.406 -0.815 . . . . 3.6000000000000001 110.98 -172.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -164.27 21.85 0.07 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.418 -0.81 . . . . 3.5600000000000001 110.481 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.1 t -105.98 130.24 57.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.925 -0.58 . . . . 4.9900000000000002 110.844 -176.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -54.69 139.19 39.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.918 -1.037 . . . . 7.7699999999999996 111.919 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -161.54 141.61 10.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.852 -0.613 . . . . 6.5999999999999996 110.421 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.9 p -123.91 121.57 35.67 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.714 -0.476 . . . . 8.9399999999999995 109.714 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 60.0 mtm -100.88 -39.06 7.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.043 -0.526 . . . . 12.1 111.392 -173.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 36.0 tp -82.24 99.38 9.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.148 0.499 . . . . 12.82 110.748 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 C--O 1.248 0.995 0 CA-C-N 115.565 -0.743 . . . . 14.640000000000001 109.173 177.332 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.1 mtp . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.682 0.277 . . . . 14.33 110.642 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m -69.31 139.01 54.28 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.092 -0.504 . . . . 11.220000000000001 111.795 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -128.11 159.25 35.68 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.778 -0.823 . . . . 9.1899999999999995 108.778 173.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.561 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 17.8 pt -107.22 104.94 54.31 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 121.062 0.458 . . . . 6.6500000000000004 111.396 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.25 109.59 2.7 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.016 2.477 . . . . 7.46 111.701 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.02 -15.42 60.97 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.863 -0.684 . . . . 5.8899999999999997 112.467 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 67.65 98.58 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.236 0 C-N-CA 123.144 0.578 . . . . 6.3700000000000001 111.362 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.561 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 1.1 Cg_endo -83.4 125.96 4.06 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.252 2.634 . . . . 3.3999999999999999 111.366 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.454 ' HB ' ' O ' ' A' ' 8' ' ' PRO . 53.9 t 73.96 -54.19 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 O-C-N 123.604 0.565 . . . . 2.2599999999999998 111.735 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.2 p -76.64 82.75 3.29 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.217 1.008 . . . . 2.0899999999999999 111.589 -175.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.42 177.09 5.29 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 113.581 -1.645 . . . . 0.95999999999999996 109.337 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -123.66 127.92 74.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.231 0.538 . . . . 1.5700000000000001 111.064 -177.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.672 HG22 HG23 ' A' ' 110' ' ' THR . 15.9 t -83.63 111.12 19.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.68 -0.489 . . . . 1.02 109.68 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 1.018 HE22 HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -115.36 170.44 8.39 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.56 -0.746 . . . . 1.3899999999999999 112.581 -174.224 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -123.9 113.86 19.06 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.65 -0.705 . . . . 3.6299999999999999 110.544 -175.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 1.018 HG23 HE22 ' A' ' 14' ' ' GLN . 4.1 t -99.61 110.07 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 109.082 -0.71 . . . . 1.02 109.082 174.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -123.11 118.14 27.0 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.337 -0.616 . . . . 1.3500000000000001 109.337 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.58 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 10.9 tp -138.12 145.73 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 108.673 -0.862 . . . . 0.60999999999999999 108.673 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 11.0 m-70 -76.21 116.51 16.97 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.977 -0.689 . . . . 0.59999999999999998 109.529 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.583 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -23.65 133.89 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 O-C-N 125.037 1.461 . . . . 4.0 112.31 176.345 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.3 tp -95.84 89.11 5.15 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.992 0.901 . . . . 0.55000000000000004 110.379 -175.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -63.46 136.68 57.76 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.497 -1.229 . . . . 3.9700000000000002 111.56 -173.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -132.99 94.47 3.37 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.983 -1.008 . . . . 1.3500000000000001 108.437 175.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.01 -82.17 0.18 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.394 -0.908 . . . . 1.3300000000000001 111.394 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -129.3 -5.93 4.83 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.148 0.499 . . . . 2.3300000000000001 110.629 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.566 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 5.9 m-80 -94.0 169.95 9.9 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.711 -0.677 . . . . 1.8700000000000001 109.889 -174.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 20' ' ' LYS . 2.0 pt? -128.39 126.74 41.25 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.698 -1.223 . . . . 2.2799999999999998 107.698 171.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.42 138.15 23.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 109.441 -0.578 . . . . 0.80000000000000004 109.441 -176.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.48 ' HG ' ' CE2' ' A' ' 31' ' ' PHE . 18.3 tp -91.5 -33.0 15.36 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.879 -1.055 . . . . 1.74 110.572 -171.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.683 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 89.87 -38.05 3.27 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.765 -0.731 . . . . 0.68999999999999995 112.122 177.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.83 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 52.3 p90 -113.5 155.67 24.93 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 122.803 -0.233 . . . . 0.51000000000000001 110.766 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.571 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 12.5 t -101.89 163.87 12.02 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.905 -1.146 . . . . 0.53000000000000003 107.905 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.42 HD12 HD21 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -160.36 140.68 3.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 C-N-CA 120.981 -0.288 . . . . 0.48999999999999999 111.352 -164.58 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -143.06 120.15 1.49 Allowed Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 110.547 -1.021 . . . . 0.71999999999999997 110.547 158.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 1.048 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -138.35 119.09 1.72 Allowed Glycine 0 CA--C 1.492 -1.387 0 CA-C-O 118.784 -1.009 . . . . 1.4199999999999999 110.771 171.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.897 ' HA3' ' HG2' ' A' ' 39' ' ' GLN . . . -156.13 118.52 0.85 Allowed Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 118.251 -1.928 . . . . 0.47999999999999998 113.37 -170.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.594 HG12 ' C ' ' A' ' 88' ' ' VAL . 20.8 pt -64.4 -21.38 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 105.728 -1.953 . . . . 0.52000000000000002 105.728 145.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.77 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 14.3 t70 -64.55 -36.42 84.17 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 112.672 -2.058 . . . . 0.71999999999999997 110.782 171.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.897 ' HG2' ' HA3' ' A' ' 36' ' ' GLY . 25.4 mm-40 -71.38 -100.17 0.01 OUTLIER 'General case' 0 C--N 1.349 0.586 0 N-CA-C 112.486 0.55 . . . . 1.1899999999999999 112.486 -171.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.476 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 24.2 t70 -149.7 126.94 5.49 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.7 -0.227 . . . . 2.5699999999999998 111.602 -173.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 9.9 Cg_endo -94.89 8.38 2.01 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.699 2.933 . . . . 2.8199999999999998 113.14 176.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.2 t -103.87 10.93 36.2 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.052 0.453 . . . . 3.2599999999999998 111.207 -171.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -134.12 21.81 3.78 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.163 0.982 . . . . 3.8799999999999999 108.379 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.446 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 12.5 p30 -177.73 58.54 0.13 Allowed Pre-proline 0 N--CA 1.44 -0.95 0 CA-C-N 113.136 -1.847 . . . . 5.1399999999999997 106.966 -175.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.446 ' HD3' ' N ' ' A' ' 44' ' ' ASN . 78.4 Cg_exo -53.42 -15.24 5.59 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.88 3.053 . . . . 3.71 114.293 -166.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -134.86 -47.44 0.73 Allowed 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.928 -1.138 . . . . 5.6200000000000001 107.928 174.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 3.1 m -155.41 160.59 40.77 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 107.828 -1.175 . . . . 3.77 107.828 -177.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.513 ' HB3' HG23 ' A' ' 51' ' ' THR . 20.9 tt0 -107.18 -32.48 7.79 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.081 0.467 . . . . 6.7800000000000002 110.79 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.554 ' OD2' ' HD2' ' A' ' 50' ' ' LYS . 23.1 t0 177.08 -130.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.288 -1.004 . . . . 5.4699999999999998 108.288 -167.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.602 ' HG2' HG21 ' A' ' 110' ' ' THR . 3.7 mptt -75.63 -19.04 59.47 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.846 -0.798 . . . . 3.0699999999999998 108.846 173.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.513 HG23 ' HB3' ' A' ' 48' ' ' GLU . 1.9 t -77.34 -48.27 17.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.952 -1.022 . . . . 4.5599999999999996 110.716 -175.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 11.3 t70 73.03 -80.34 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.747 0.655 . . . . 2.6000000000000001 110.035 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 87' ' ' MET . 0.0 OUTLIER -141.57 29.85 1.73 Allowed 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.134 -1.432 . . . . 3.48 107.134 175.321 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.509 ' C ' HD12 ' A' ' 55' ' ' ILE . . . -100.05 -145.44 17.81 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 114.033 -1.439 . . . . 0.78000000000000003 111.878 -167.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.048 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.9 mp -118.76 147.13 22.46 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 N-CA-C 108.404 -0.961 . . . . 0.54000000000000004 108.404 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.805 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -155.48 156.35 35.09 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 118.97 0.805 . . . . 1.4199999999999999 111.215 178.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.55 ' CG1' ' H ' ' A' ' 75' ' ' ASP . 8.1 p -92.38 132.84 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-N 115.481 -0.781 . . . . 0.57999999999999996 110.92 -173.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.5 m -103.89 -17.14 15.14 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.497 -1.229 . . . . 1.1100000000000001 111.467 -174.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.926 ' HA ' HG23 ' A' ' 73' ' ' ILE . 46.2 mtt180 -143.63 -175.41 4.56 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.982 1.104 . . . . 2.27 113.982 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 59' ' ' ARG . 75.4 t -167.73 111.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 112.959 -1.928 . . . . 0.82999999999999996 106.956 161.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.5 m -79.56 128.47 33.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.212 0.53 . . . . 1.6499999999999999 110.655 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -50.43 116.59 1.97 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.679 -1.146 . . . . 1.8500000000000001 111.47 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.29 -20.39 30.52 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.241 -0.89 . . . . 0.92000000000000004 112.931 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.74 172.96 55.17 Favored Glycine 0 CA--C 1.502 -0.762 0 C-N-CA 120.345 -0.931 . . . . 0.98999999999999999 111.771 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.683 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 73.2 Cg_endo -71.45 -19.2 28.92 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.43 2.087 . . . . 0.44 113.184 -169.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.83 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -67.2 -28.91 68.47 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.654 -1.157 . . . . 0.35999999999999999 111.643 175.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -73.13 -34.85 66.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 122.013 0.911 . . . . 1.79 109.151 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.479 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.4 mp -74.44 -38.06 45.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.526 -1.215 . . . . 0.51000000000000001 110.221 -177.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.708 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -80.17 -20.26 45.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.361 -0.382 . . . . 0.40999999999999998 110.699 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.13 65.24 1.12 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.37 -0.919 . . . . 0.45000000000000001 114.017 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.54 HD21 HG21 ' A' ' 57' ' ' VAL . 18.1 tp -113.34 155.56 24.97 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.357 -0.609 . . . . 0.89000000000000001 109.357 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.976 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 12.9 mt-30 -124.23 31.13 5.86 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 115.176 1.547 . . . . 1.21 115.176 -166.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.926 HG23 ' HA ' ' A' ' 59' ' ' ARG . 42.6 mt 68.55 1.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 113.201 0.815 . . . . 0.77000000000000002 113.201 166.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -172.53 51.02 0.17 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 119.757 -1.211 . . . . 0.37 112.355 -168.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.55 ' H ' ' CG1' ' A' ' 57' ' ' VAL . 32.1 m-20 -121.45 151.8 39.82 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.358 -0.608 . . . . 0.89000000000000001 109.358 -175.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.805 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 64.0 mmtt -95.33 122.14 37.72 Favored 'General case' 0 C--O 1.208 -1.084 0 CA-C-O 121.302 0.572 . . . . 2.2000000000000002 110.55 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.713 HG12 HD11 ' A' ' 107' ' ' LEU . 8.5 mt -88.11 125.36 41.53 Favored 'Isoleucine or valine' 0 C--O 1.258 1.525 0 CA-C-O 121.309 0.576 . . . . 0.48999999999999999 112.006 -174.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.841 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -96.74 -16.4 20.89 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.202 -1.817 . . . . 1.0600000000000001 111.649 -177.515 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.749 ' HB3' HD23 ' A' ' 108' ' ' LEU . 0.9 OUTLIER -168.99 150.51 4.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.729 0.299 . . . . 0.81999999999999995 111.481 -175.33 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.73 ' HB ' ' CE ' ' A' ' 85' ' ' MET . 3.3 t -139.36 118.59 13.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.807 -0.633 . . . . 1.3100000000000001 110.811 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.896 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 12.9 m120 52.87 31.05 10.06 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.01 -0.541 . . . . 1.5 111.856 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.11 -5.7 59.44 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.293 -0.956 . . . . 0.38 113.042 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.526 ' HE1' ' CZ ' ' A' ' 96' ' ' ARG . 54.7 m95 -87.03 175.21 8.22 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 110.091 -0.336 . . . . 0.77000000000000002 110.091 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -115.88 113.2 23.01 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.751 -0.659 . . . . 1.8899999999999999 109.938 -173.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.73 ' CE ' ' HB ' ' A' ' 80' ' ' VAL . 19.6 mmt -107.14 100.59 10.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.949 0.881 . . . . 1.01 110.152 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.4 p -132.98 -35.85 1.05 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.408 -1.269 . . . . 1.05 107.98 171.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.513 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -161.28 78.17 0.57 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 113.755 -1.566 . . . . 1.6200000000000001 109.996 176.203 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.594 ' C ' HG12 ' A' ' 37' ' ' ILE . 1.4 p -137.7 164.21 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 109.5 -0.555 . . . . 1.0900000000000001 109.5 174.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.747 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 61.7 p -63.04 151.39 40.0 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.348 0.594 . . . . 0.34999999999999998 112.312 -176.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.77 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 20.4 t-160 -61.86 -34.97 76.95 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-O 121.589 0.709 . . . . 0.34999999999999998 109.882 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.65 -31.55 69.7 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 113.97 -1.468 . . . . 1.6699999999999999 109.618 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.583 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 4.8 tp60 -61.59 -52.21 65.34 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.681 -0.859 . . . . 0.77000000000000002 108.681 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.646 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.08 -41.45 77.51 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.528 -1.214 . . . . 0.33000000000000002 110.188 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.419 ' HA ' HD11 ' A' ' 97' ' ' LEU . 34.3 ttp180 -64.89 -41.32 95.71 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.157 -0.929 . . . . 2.1000000000000001 111.201 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.659 ' HE3' ' HD3' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -68.33 -29.16 67.83 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 121.168 0.509 . . . . 0.95999999999999996 109.848 -177.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.583 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 12.8 mmm180 -74.96 -48.77 22.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.023 -0.535 . . . . 3.5699999999999998 112.276 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.5 pp -82.6 -4.81 58.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.021 0.439 . . . . 1.6499999999999999 111.493 -178.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.2 m -138.12 78.7 1.7 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 122.137 0.97 . . . . 1.53 109.379 175.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.659 ' HD3' ' HE3' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -84.78 -79.18 0.23 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.006 -1.452 . . . . 2.7200000000000002 110.347 -178.88 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.41 ' H ' ' HB3' ' A' ' 99' ' ' LYS . 26.8 ptt180 174.11 -26.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.158 -0.928 . . . . 4.3799999999999999 111.059 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.7 m -160.89 40.05 0.16 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.955 0.407 . . . . 2.5099999999999998 110.396 -171.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 46.1 mm-40 -58.86 156.61 11.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.838 -0.619 . . . . 3.3999999999999999 110.714 175.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.58 ' HG3' HG12 ' A' ' 104' ' ' VAL . 6.0 pt-20 -84.74 -38.52 19.57 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.636 0.732 . . . . 2.6800000000000002 109.474 172.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.58 HG12 ' HG3' ' A' ' 103' ' ' GLU . 3.1 p -156.8 156.04 4.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 114.745 -1.116 . . . . 0.44 108.332 -176.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.6 t -115.87 117.81 56.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 122.11 0.957 . . . . 0.46000000000000002 111.643 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.896 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 1.4 mpt_? -100.55 123.73 45.15 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 113.422 -1.717 . . . . 1.76 111.626 -171.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.713 HD11 HG12 ' A' ' 77' ' ' ILE . 28.4 tp -132.12 125.77 32.1 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.88 -0.6 . . . . 1.1200000000000001 110.756 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.841 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 31.8 tp -108.18 120.88 43.61 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 107.688 -1.227 . . . . 0.41999999999999998 107.688 172.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.742 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -132.95 150.33 32.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.398 0.618 . . . . 0.77000000000000002 110.635 -172.212 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.672 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -95.76 116.58 29.09 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.295 -0.866 . . . . 0.34000000000000002 109.37 168.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.784 ' HG3' HE22 ' A' ' 72' ' ' GLN . 27.4 ttt180 -110.58 139.75 45.54 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.474 -1.239 . . . . 2.0099999999999998 110.755 -169.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.66 -90.87 0.57 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.531 0.567 . . . . 1.97 112.531 -176.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.424 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 18.8 m -151.33 41.75 0.73 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 112.539 0.57 . . . . 1.6200000000000001 112.539 -164.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.976 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 0.3 OUTLIER -103.5 -0.79 29.38 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.516 -0.55 . . . . 1.6499999999999999 109.516 177.765 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.435 ' HG3' ' OE1' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -52.76 136.13 34.14 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.542 -0.753 . . . . 3.5299999999999998 111.658 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -81.48 23.9 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.952 -0.567 . . . . 3.6000000000000001 111.776 -173.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 59.22 87.16 0.08 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.228 0.537 . . . . 3.5600000000000001 110.899 -175.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.7 p -110.96 143.65 20.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.727 -0.67 . . . . 4.9900000000000002 110.467 -176.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 62.03 71.07 0.55 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.662 -0.699 . . . . 7.7699999999999996 110.681 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -122.47 -46.0 2.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.109 -0.496 . . . . 6.5999999999999996 111.178 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.8 t -108.28 118.27 36.32 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.167 -0.469 . . . . 8.9399999999999995 109.889 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 91.4 mmm -91.11 139.2 30.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.256 -0.429 . . . . 12.1 110.289 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 46.9 tp -68.92 135.61 51.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.202 -0.454 . . . . 12.82 110.801 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 41.6 t . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.659 -0.686 . . . . 14.640000000000001 109.297 177.761 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 120.898 0.38 . . . . 14.33 110.332 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.6 m -157.31 121.44 4.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.899 -0.591 . . . . 11.220000000000001 110.414 177.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -148.22 137.79 22.24 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.084 -0.709 . . . . 9.1899999999999995 109.084 176.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.624 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 11.2 pt -113.27 95.35 35.05 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 121.37 0.605 . . . . 6.6500000000000004 111.368 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.13 112.93 2.43 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 123.048 2.499 . . . . 7.46 112.125 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.06 -15.94 62.05 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.788 -0.72 . . . . 5.8899999999999997 112.903 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 65.37 97.01 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.407 0 CA-C-O 121.352 0.596 . . . . 6.3700000000000001 110.939 -177.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 1.6 Cg_endo -82.87 -172.78 1.49 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.269 2.646 . . . . 3.3999999999999999 112.392 -173.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 p -71.05 105.44 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.705 0.764 . . . . 2.2599999999999998 109.724 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.23 79.7 6.76 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 122.167 0.984 . . . . 2.0899999999999999 108.906 178.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.7 165.84 23.17 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.51 -1.677 . . . . 0.95999999999999996 111.075 173.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.97 132.03 71.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 115.456 -0.793 . . . . 1.5700000000000001 110.123 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.501 ' CG1' HD11 ' A' ' 108' ' ' LEU . 59.1 t -87.14 119.1 34.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.342 0.591 . . . . 1.02 111.497 -173.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.764 ' HG2' ' HD2' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -114.04 171.17 7.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.542 -0.753 . . . . 1.3899999999999999 111.585 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.429 ' NE ' HD13 ' A' ' 108' ' ' LEU . 26.7 mmt180 -115.55 137.77 51.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.929 0.395 . . . . 3.6299999999999999 111.959 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.611 HG13 ' CB ' ' A' ' 69' ' ' ALA . 23.0 t -123.55 123.4 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 109.234 -0.654 . . . . 1.02 109.234 171.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -144.78 123.87 12.85 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.831 -0.433 . . . . 1.3500000000000001 109.831 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.547 HG21 ' HB2' ' A' ' 65' ' ' PRO . 10.2 tp -144.88 150.2 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 109.279 -0.638 . . . . 0.60999999999999999 109.279 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 15.5 m-70 -81.0 109.93 16.06 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.231 -0.655 . . . . 0.59999999999999998 109.231 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.412 ' HD3' ' N ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -27.49 135.22 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 O-C-N 125.228 1.58 . . . . 4.0 113.094 -177.579 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.1 tp -101.65 90.36 4.01 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.737 -0.468 . . . . 0.55000000000000004 109.737 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 26.8 ptt180 -70.35 144.89 51.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.312 0.577 . . . . 3.9700000000000002 111.191 -173.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -124.21 93.78 4.02 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.745 -0.835 . . . . 1.3500000000000001 108.745 173.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.57 -88.85 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.625 -0.59 . . . . 1.3300000000000001 111.625 -174.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.448 ' HB3' HH21 ' A' ' 100' ' ' ARG . 28.9 mm-40 -110.3 -5.45 15.25 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.261 -0.47 . . . . 2.3300000000000001 111.524 -177.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.405 ' O ' HD12 ' A' ' 27' ' ' LEU . 10.3 m-80 -105.8 171.47 7.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.083 -0.508 . . . . 1.8700000000000001 111.143 -173.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.826 HD13 ' HA ' ' A' ' 100' ' ' ARG . 7.8 mp -124.58 125.51 44.28 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.284 -1.006 . . . . 2.2799999999999998 108.284 172.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.5 mm -97.18 116.22 38.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 109.291 -0.633 . . . . 0.80000000000000004 109.291 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.815 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.8 pt? -78.52 -32.6 48.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.684 -1.143 . . . . 1.74 110.707 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.639 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 82.51 17.08 69.4 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.487 -0.863 . . . . 0.68999999999999995 113.027 173.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.642 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 48.1 p90 -154.24 161.49 41.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.733 0.267 . . . . 0.51000000000000001 110.691 173.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.61 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 11.6 t -106.11 158.68 16.64 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.219 -1.03 . . . . 0.53000000000000003 108.219 173.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -160.33 138.8 2.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 112.521 0.563 . . . . 0.48999999999999999 112.521 -164.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.423 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -139.26 118.24 1.5 Allowed Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 119.679 -1.248 . . . . 0.71999999999999997 110.283 156.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 1.035 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -140.26 117.42 1.29 Allowed Glycine 0 CA--C 1.492 -1.365 0 CA-C-O 118.925 -0.931 . . . . 1.4199999999999999 111.657 170.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.671 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.01 143.51 8.35 Favored Glycine 0 C--N 1.3 -1.47 0 C-N-CA 118.364 -1.874 . . . . 0.47999999999999998 112.563 174.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.412 HG12 ' C ' ' A' ' 88' ' ' VAL . 9.8 pt -62.14 -22.26 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 107.797 -1.186 . . . . 0.52000000000000002 107.797 152.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.676 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 1.1 t70 -56.46 -47.7 78.61 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.473 -1.694 . . . . 0.71999999999999997 110.345 171.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -60.57 -53.2 60.35 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 114.866 -1.061 . . . . 1.1899999999999999 111.248 -174.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.516 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . 9.2 t0 -142.62 99.41 5.72 Favored Pre-proline 0 C--O 1.238 0.482 0 CA-C-N 116.127 -0.488 . . . . 2.5699999999999998 110.451 -176.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -80.07 -16.98 10.87 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.434 2.756 . . . . 2.8199999999999998 112.231 176.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.5 t -68.93 -50.93 45.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.57 -0.741 . . . . 3.2599999999999998 109.863 -176.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -87.24 65.46 8.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.665 -0.698 . . . . 3.8799999999999999 110.726 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.662 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 38.7 t30 -158.02 55.4 0.89 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.629 -0.714 . . . . 5.1399999999999997 109.766 174.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.662 ' HD3' ' N ' ' A' ' 44' ' ' ASN . 85.2 Cg_endo -104.58 -0.53 0.24 Allowed 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 122.709 2.273 . . . . 3.71 111.798 175.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -169.87 22.37 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.53 0.681 . . . . 5.6200000000000001 109.806 -173.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.811 ' HB3' ' HA ' ' A' ' 52' ' ' ASP . 2.8 m -122.98 115.57 22.11 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 108.509 -0.923 . . . . 3.77 108.509 -171.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.74 ' H ' HG23 ' A' ' 51' ' ' THR . 2.2 mt-10 -101.25 -42.38 6.35 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.785 -1.098 . . . . 6.7800000000000002 112.191 -169.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.42 ' OD2' ' HB3' ' A' ' 48' ' ' GLU . 24.1 m-20 -139.85 -121.94 0.12 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 113.452 -1.704 . . . . 5.4699999999999998 111.732 -158.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.539 ' HD2' ' SD ' ' A' ' 78' ' ' MET . 3.7 mppt? -66.54 -20.89 66.13 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.672 -1.149 . . . . 3.0699999999999998 107.97 170.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.74 HG23 ' H ' ' A' ' 48' ' ' GLU . 2.5 t -72.05 -39.82 68.81 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 114.729 -1.123 . . . . 4.5599999999999996 109.71 172.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.811 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 8.9 t70 -74.01 -166.05 0.36 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.716 0.769 . . . . 2.6000000000000001 109.818 163.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.57 ' H ' ' CG ' ' A' ' 52' ' ' ASP . 3.2 ptpp? -95.53 -37.69 10.76 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.485 -0.78 . . . . 3.48 108.928 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 86' ' ' THR . . . 62.46 -139.88 45.89 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.487 -0.778 . . . . 0.78000000000000003 111.295 178.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.035 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -110.68 137.4 43.26 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.166 0 N-CA-C 106.666 -1.605 . . . . 0.54000000000000004 106.666 170.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.665 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -152.2 147.12 26.03 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 119.655 1.116 . . . . 1.4199999999999999 111.215 -176.224 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 75' ' ' ASP . 7.7 p -87.15 139.65 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 114.728 -1.124 . . . . 0.57999999999999996 110.05 -172.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.9 m -110.88 -14.21 14.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.181 -0.918 . . . . 1.1100000000000001 111.107 -174.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.841 ' HA ' HG23 ' A' ' 73' ' ' ILE . 37.6 mtt180 -146.86 -167.56 2.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.234 0.827 . . . . 2.27 113.234 175.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.533 HG13 ' HB3' ' A' ' 66' ' ' ALA . 63.9 t -161.58 148.66 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 112.413 -2.176 . . . . 0.82999999999999996 106.44 162.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.4 p -91.82 137.33 32.45 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.06 0.457 . . . . 1.6499999999999999 110.654 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -62.94 109.08 1.34 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.769 -1.105 . . . . 1.8500000000000001 111.367 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.26 -10.89 67.49 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.484 -0.865 . . . . 0.92000000000000004 111.903 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.526 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -75.47 173.29 53.26 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 120.766 -0.731 . . . . 0.98999999999999999 111.525 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.639 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 73.2 Cg_endo -72.25 -24.63 19.64 Favored 'Trans proline' 0 C--N 1.32 -0.935 0 C-N-CA 122.842 2.361 . . . . 0.44 113.252 -166.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.642 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -64.14 -31.38 72.55 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.717 -1.129 . . . . 0.35999999999999999 111.283 176.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -74.49 -36.35 63.25 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.517 0.675 . . . . 1.79 109.189 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -64.79 -42.44 94.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.673 -1.149 . . . . 0.51000000000000001 110.104 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.611 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -73.0 -24.4 60.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.40999999999999998 110.543 175.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.66 58.3 1.06 Allowed Glycine 0 C--O 1.226 -0.354 0 C-N-CA 120.509 -0.853 . . . . 0.45000000000000001 113.722 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.521 HD21 HG21 ' A' ' 57' ' ' VAL . 14.8 tp -102.77 154.25 19.36 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.876 -0.787 . . . . 0.89000000000000001 108.876 175.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.581 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 6.5 mt-30 -129.33 34.19 4.42 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 115.604 1.705 . . . . 1.21 115.604 -166.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.841 HG23 ' HA ' ' A' ' 59' ' ' ARG . 59.8 mt 69.2 0.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 N-CA-C 113.34 0.867 . . . . 0.77000000000000002 113.34 165.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -174.18 55.68 0.14 Allowed Glycine 0 C--N 1.33 0.22 0 C-N-CA 119.984 -1.103 . . . . 0.37 112.914 -169.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.601 ' H ' HG12 ' A' ' 57' ' ' VAL . 31.7 m-20 -122.72 142.3 50.85 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.644 -0.278 . . . . 0.89000000000000001 111.524 -173.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.665 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 1.4 mptm? -83.31 102.8 12.22 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-O 120.983 0.421 . . . . 2.2000000000000002 111.062 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.624 ' HB ' HG22 ' A' ' 55' ' ' ILE . 6.9 mt -76.56 125.85 36.69 Favored 'Isoleucine or valine' 0 C--O 1.254 1.337 0 C-N-CA 123.617 0.767 . . . . 0.48999999999999999 111.594 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.775 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 9.1 mmt -90.52 -27.84 18.92 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.195 -1.366 . . . . 1.0600000000000001 112.046 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.584 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 1.0 OUTLIER -159.52 150.6 19.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.858 0.361 . . . . 0.81999999999999995 111.448 -171.523 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.673 HG12 ' SD ' ' A' ' 85' ' ' MET . 11.2 p -137.05 126.49 37.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.868 -0.605 . . . . 1.3100000000000001 110.474 174.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.682 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 4.3 t-20 57.99 22.82 9.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.154 -0.93 . . . . 1.5 112.171 170.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.92 -5.52 46.69 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 119.683 -1.246 . . . . 0.38 113.316 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -92.75 156.85 16.76 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 109.471 -0.566 . . . . 0.77000000000000002 109.471 175.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -111.94 99.17 7.89 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.075 -0.511 . . . . 1.8899999999999999 110.682 -175.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.909 ' HB2' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -111.0 100.41 9.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.642 0.734 . . . . 1.01 112.091 -178.598 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.525 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 14.6 p -103.23 -35.62 8.38 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.867 -1.16 . . . . 1.05 107.867 165.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.07 76.6 1.55 Allowed 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.415 -1.72 . . . . 1.6200000000000001 109.187 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.671 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -138.22 157.28 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 108.724 -0.843 . . . . 1.0900000000000001 108.724 175.247 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.656 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 81.1 p -62.7 154.59 28.95 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 112.995 0.739 . . . . 0.34999999999999998 112.995 -177.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.796 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 21.8 t-160 -58.69 -38.69 78.8 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-N 115.289 -0.868 . . . . 0.34999999999999998 110.464 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.89 -30.95 67.45 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.169 -1.378 . . . . 1.6699999999999999 109.732 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.622 ' HB3' HG13 ' A' ' 88' ' ' VAL . 1.6 tp-100 -63.82 -46.58 84.45 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.672 0.749 . . . . 0.77000000000000002 109.265 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.622 ' HB2' HG12 ' A' ' 55' ' ' ILE . . . -74.3 -36.17 63.72 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.025 -0.989 . . . . 0.33000000000000002 110.756 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -67.23 -41.19 86.13 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.232 0.539 . . . . 2.1000000000000001 110.514 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -68.1 -34.79 77.05 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.291 -0.868 . . . . 0.95999999999999996 109.516 -177.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -75.46 -33.43 60.85 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.709 -0.678 . . . . 3.5699999999999998 111.335 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.597 HD11 ' CZ ' ' A' ' 31' ' ' PHE . 3.1 tt -54.99 -61.04 2.57 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.385 -1.28 . . . . 1.6499999999999999 111.861 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.516 HG23 HD22 ' A' ' 97' ' ' LEU . 12.6 p -110.36 -78.84 0.59 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.485 -0.486 . . . . 1.53 112.124 -176.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 19.2 ttpt 70.05 -2.65 2.0 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.806 0.812 . . . . 2.7200000000000002 112.185 176.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.826 ' HA ' HD13 ' A' ' 27' ' ' LEU . 78.4 mtp180 71.69 23.23 3.77 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.168 -0.924 . . . . 4.3799999999999999 112.515 171.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.426 ' OG ' ' HG2' ' A' ' 99' ' ' LYS . 4.9 p -154.94 29.04 0.42 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.92 0.711 . . . . 2.5099999999999998 112.92 -174.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -97.98 166.2 11.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.971 0.415 . . . . 3.3999999999999999 111.731 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.538 ' HG3' HG12 ' A' ' 104' ' ' VAL . 18.7 pt-20 -114.05 -28.61 7.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.592 0.711 . . . . 2.6800000000000002 110.159 177.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.56 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 3.9 p -152.92 143.05 14.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 107.756 -1.202 . . . . 0.44 107.756 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.6 t -115.2 117.5 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-O 122.238 1.018 . . . . 0.46000000000000002 111.817 -170.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.682 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 1.3 mpt_? -99.82 129.02 45.88 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 113.036 -1.893 . . . . 1.76 111.118 -173.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.528 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 19.7 tp -133.31 129.61 37.77 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.87 -0.604 . . . . 1.1200000000000001 109.931 177.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.775 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 22.6 tp -106.04 113.61 27.25 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 107.389 -1.337 . . . . 0.41999999999999998 107.389 173.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.733 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.5 OUTLIER -121.9 143.96 32.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 C-N-CA 119.998 -0.681 . . . . 0.77000000000000002 110.523 -173.092 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.501 HG23 HG22 ' A' ' 13' ' ' VAL . 1.3 m -96.77 120.31 36.87 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.313 -0.858 . . . . 0.34000000000000002 110.623 173.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.764 ' HD2' ' HG2' ' A' ' 14' ' ' GLN . 7.7 ttt180 -90.74 153.41 20.28 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.57 -1.195 . . . . 2.0099999999999998 109.794 -176.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.429 ' N ' ' CD ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -145.98 -60.82 0.32 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.134 0.791 . . . . 1.97 113.134 -168.299 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.9 t -157.77 10.87 0.19 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.89 0.376 . . . . 1.6200000000000001 111.727 -174.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 3.1 mm? -101.01 17.92 21.06 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.13 -0.356 . . . . 1.6499999999999999 111.44 -176.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.651 HE21 ' HG2' ' A' ' 111' ' ' ARG . 28.4 mp0 -57.65 121.59 10.74 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.937 -0.574 . . . . 3.5299999999999998 109.662 176.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -93.26 50.26 1.49 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.239 -0.437 . . . . 3.6000000000000001 111.857 -167.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 59.68 100.86 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.136 -0.938 . . . . 3.5600000000000001 111.461 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.1 p -127.19 143.61 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-O 121.164 0.507 . . . . 4.9900000000000002 110.809 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -80.73 135.33 35.98 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.593 -0.73 . . . . 7.7699999999999996 110.703 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -157.43 142.12 16.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.019 -0.537 . . . . 6.5999999999999996 110.39 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.5 m -129.13 100.84 5.77 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.706 0.288 . . . . 8.9399999999999995 110.625 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 70.2 mtm -77.22 -38.0 52.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.429 -0.351 . . . . 12.1 110.266 178.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 82.3 mt 67.91 108.75 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.347 -0.842 . . . . 12.82 111.559 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.1 m . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.425 -0.798 . . . . 14.640000000000001 109.658 -179.807 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.7 ttm . . . . . 0 N--CA 1.476 0.864 0 CA-C-O 120.867 0.365 . . . . 14.33 110.573 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 m -67.38 147.74 52.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.09 -0.504 . . . . 11.220000000000001 109.909 177.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -124.66 166.11 16.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.704 0.287 . . . . 9.1899999999999995 110.644 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.822 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -96.33 113.36 62.29 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.148 -0.478 . . . . 6.6500000000000004 109.783 175.791 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -58.69 -63.18 0.15 Allowed 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.11 2.54 . . . . 7.46 113.636 -174.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -119.53 24.01 8.23 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.408 -0.901 . . . . 5.8899999999999997 112.324 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 60.53 93.15 0.06 OUTLIER Pre-proline 0 N--CA 1.467 0.379 0 CA-C-O 121.295 0.569 . . . . 6.3700000000000001 111.058 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.755 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 4.1 Cg_endo -87.66 125.56 2.06 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.512 2.808 . . . . 3.3999999999999999 112.075 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 8' ' ' PRO . 66.6 t 72.09 -57.38 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 123.639 0.587 . . . . 2.2599999999999998 111.472 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.2 p -76.53 82.03 3.21 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 122.057 0.932 . . . . 2.0899999999999999 110.447 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.511 ' HB3' ' HE2' ' A' ' 50' ' ' LYS . . . -102.16 165.23 11.26 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.69 -1.595 . . . . 0.95999999999999996 109.359 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.9 m -117.61 136.8 53.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 116.131 -0.486 . . . . 1.5700000000000001 109.913 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.805 HG12 HG23 ' A' ' 110' ' ' THR . 3.1 m -88.16 120.65 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 122.311 1.053 . . . . 1.02 110.878 -177.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.743 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -97.51 170.99 8.66 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 113.939 -1.482 . . . . 1.3899999999999999 110.545 178.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -115.9 116.55 28.17 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.064 0.394 . . . . 3.6299999999999999 112.064 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.695 HG13 ' CB ' ' A' ' 69' ' ' ALA . 3.9 t -104.58 118.19 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 109.352 -0.61 . . . . 1.02 109.352 173.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -132.3 115.75 16.02 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.335 -0.848 . . . . 1.3500000000000001 109.117 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.632 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 9.3 tp -144.58 152.37 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 109.002 -0.74 . . . . 0.60999999999999999 109.002 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 10.3 m-70 -79.99 114.32 18.82 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.621 -0.881 . . . . 0.59999999999999998 108.621 174.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.979 ' HB2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -25.33 139.25 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.906 1.379 . . . . 4.0 113.335 177.739 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.641 HD22 ' HD3' ' A' ' 65' ' ' PRO . 32.3 tp -98.91 91.48 5.07 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 119.177 -1.009 . . . . 0.55000000000000004 109.451 -177.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 28.7 ptt180 -76.24 135.91 39.68 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.617 0.722 . . . . 3.9700000000000002 111.316 -173.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.573 ' HB2' HD13 ' A' ' 28' ' ' ILE . 25.0 tp60 -119.36 94.88 4.57 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.04 -0.982 . . . . 1.3500000000000001 108.422 176.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.53 -80.47 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.729 -0.748 . . . . 1.3300000000000001 111.318 -173.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -134.9 10.95 3.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.003 0.43 . . . . 2.3300000000000001 110.567 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 11.5 m-80 -110.35 173.89 6.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.963 -0.562 . . . . 1.8700000000000001 110.625 -176.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.979 HD13 ' HB2' ' A' ' 20' ' ' LYS . 7.3 tp -127.11 123.75 37.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.378 0.608 . . . . 2.2799999999999998 110.061 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.573 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.7 mp -98.81 132.51 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.227 -0.897 . . . . 0.80000000000000004 108.955 175.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.696 HD13 HD21 ' A' ' 97' ' ' LEU . 0.6 OUTLIER -84.09 -42.74 15.78 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 114.657 -1.156 . . . . 1.74 109.964 -174.653 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.522 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 92.57 13.49 56.89 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 115.099 -0.955 . . . . 0.68999999999999995 111.479 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.591 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 24.4 p90 -155.33 172.66 17.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.517 -0.179 . . . . 0.51000000000000001 110.517 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.932 ' HB3' ' O ' ' A' ' 58' ' ' THR . 5.6 t -112.81 170.79 7.94 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.578 -0.897 . . . . 0.53000000000000003 108.578 169.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 5.2 tt -148.36 136.4 14.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 120.448 -0.501 . . . . 0.48999999999999999 112.138 -167.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -103.58 170.73 19.55 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.869 -0.892 . . . . 0.71999999999999997 110.869 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.593 ' HA2' ' CG ' ' A' ' 90' ' ' HIS . . . -103.97 166.13 15.5 Favored Glycine 0 N--CA 1.418 -2.52 0 N-CA-C 117.828 1.891 . . . . 1.4199999999999999 117.828 -163.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.708 ' HA3' ' O ' ' A' ' 88' ' ' VAL . . . -86.37 -143.24 7.29 Favored Glycine 0 N--CA 1.417 -2.623 0 CA-C-N 110.073 -3.064 . . . . 0.47999999999999998 113.392 -173.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.662 HD13 ' O ' ' A' ' 87' ' ' MET . 10.6 pt -83.52 -4.77 8.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.02 -0.59 . . . . 0.52000000000000002 112.213 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.983 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 11.3 p-10 -70.91 -32.43 69.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.852 0.358 . . . . 0.71999999999999997 110.511 -175.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.32 -49.15 20.06 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.752 -0.833 . . . . 1.1899999999999999 108.752 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.617 ' OD2' ' HB2' ' A' ' 43' ' ' GLN . 1.6 t70 -138.36 107.47 7.91 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 114.394 -1.276 . . . . 2.5699999999999998 110.29 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -96.27 9.5 1.5 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.824 3.016 . . . . 2.8199999999999998 112.737 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.1 t -109.09 5.55 24.15 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.301 -0.408 . . . . 3.2599999999999998 111.824 -171.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.617 ' HB2' ' OD2' ' A' ' 40' ' ' ASP . 64.3 mt-30 -149.25 50.45 0.96 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.634 0.254 . . . . 3.8799999999999999 110.355 -176.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.703 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -149.92 33.56 0.08 OUTLIER Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 112.91 0.708 . . . . 5.1399999999999997 112.91 -177.417 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.703 ' HD3' ' N ' ' A' ' 44' ' ' ASN . 87.6 Cg_endo -93.73 -1.5 3.19 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.767 1.644 . . . . 3.71 112.38 -173.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.2 t80 174.26 34.82 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 107.513 -1.291 . . . . 5.6200000000000001 107.513 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.4 m -78.56 -175.99 4.6 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 114.285 -1.325 . . . . 3.77 112.59 -166.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -28.37 -68.75 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 O-C-N 124.978 1.424 . . . . 6.7800000000000002 114.65 -172.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.459 ' OD2' ' HD2' ' A' ' 50' ' ' LYS . 32.1 t0 -178.78 -154.7 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.526 -0.916 . . . . 5.4699999999999998 108.526 -170.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.717 ' HE3' HG21 ' A' ' 110' ' ' THR . 0.4 OUTLIER -68.03 0.01 4.0 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.839 0.352 . . . . 3.0699999999999998 110.226 176.311 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -108.53 8.98 27.49 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.139 0.422 . . . . 4.5599999999999996 112.139 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.511 ' OD2' ' HG2' ' A' ' 53' ' ' LYS . 8.9 t70 -81.8 -125.82 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.747 0.308 . . . . 2.6000000000000001 110.9 177.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.648 ' HB3' ' HA ' ' A' ' 37' ' ' ILE . 2.0 mmpp? -74.83 71.29 1.99 Allowed 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 107.574 -1.269 . . . . 3.48 107.574 169.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -136.04 163.92 25.04 Favored Glycine 0 N--CA 1.417 -2.6 0 N-CA-C 107.896 -2.082 . . . . 0.78000000000000003 107.896 -172.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.718 HG22 HD13 ' A' ' 77' ' ' ILE . 2.2 mp -93.74 119.43 41.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 119.89 1.845 . . . . 0.54000000000000004 108.943 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.785 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -151.78 131.26 12.98 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.188 0.994 . . . . 1.4199999999999999 110.122 -170.584 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.958 HG21 HD21 ' A' ' 71' ' ' LEU . 1.2 t -62.05 139.93 20.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 113.594 -1.639 . . . . 0.57999999999999996 112.22 -173.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.932 ' O ' ' HB3' ' A' ' 32' ' ' SER . 6.4 m -129.28 64.17 1.48 Allowed 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.613 -1.176 . . . . 1.1100000000000001 109.216 173.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.63 ' C ' ' HA ' ' A' ' 73' ' ' ILE . 15.4 mtt180 148.97 -171.22 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 125.391 1.476 . . . . 2.27 111.475 163.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 61.9 t -161.13 130.42 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 113.028 -1.897 . . . . 0.82999999999999996 106.635 163.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.8 m -88.43 123.57 33.1 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.154 0.502 . . . . 1.6499999999999999 109.991 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.492 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 77.3 mt-10 -52.1 118.54 3.56 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.935 -1.03 . . . . 1.8500000000000001 111.876 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.79 -3.02 60.55 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.203 -0.908 . . . . 0.92000000000000004 111.907 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.42 172.2 39.2 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.613 -0.803 . . . . 0.98999999999999999 111.503 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.641 ' HD3' HD22 ' A' ' 21' ' ' LEU . 92.2 Cg_endo -74.1 -24.69 14.6 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 122.962 2.441 . . . . 0.44 113.408 -168.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.591 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -67.51 -23.91 65.51 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.05 -0.977 . . . . 0.35999999999999999 110.928 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.492 ' OE1' ' HA ' ' A' ' 62' ' ' GLU . 28.2 tt0 -75.7 -36.77 59.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.771 0.796 . . . . 1.79 108.935 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.525 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.5 mp -73.35 -42.14 57.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.145 -1.389 . . . . 0.51000000000000001 110.351 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.695 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -71.23 -21.32 62.14 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.995 -0.548 . . . . 0.40999999999999998 111.026 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.46 54.3 1.09 Allowed Glycine 0 C--O 1.225 -0.437 0 C-N-CA 120.037 -1.078 . . . . 0.45000000000000001 114.174 174.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.958 HD21 HG21 ' A' ' 57' ' ' VAL . 6.5 tp -97.25 161.34 13.85 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.269 -0.641 . . . . 0.89000000000000001 109.269 174.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.6 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 4.7 pt20 -131.47 29.57 4.54 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 115.071 1.508 . . . . 1.21 115.071 -168.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.63 ' HA ' ' C ' ' A' ' 59' ' ' ARG . 2.3 mp 75.3 -6.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-O 120.975 0.417 . . . . 0.77000000000000002 111.349 173.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -164.82 66.32 0.22 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.851 -0.69 . . . . 0.37 111.628 -169.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.478 ' HB3' ' CG2' ' A' ' 109' ' ' VAL . 3.8 m-20 -118.8 135.88 54.29 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 115.613 -0.293 . . . . 0.89000000000000001 110.966 -169.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.5 mmtt -95.49 102.95 14.8 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 121.054 0.454 . . . . 2.2000000000000002 109.981 -174.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.785 HD12 ' HA ' ' A' ' 56' ' ' TYR . 2.9 mp -72.24 118.04 16.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 112.473 0.545 . . . . 0.48999999999999999 112.473 -171.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.98 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 1.3 mmt -93.61 -10.48 34.49 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.088 -0.96 . . . . 1.0600000000000001 112.869 177.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.634 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -172.23 154.01 3.2 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.329 0.492 . . . . 0.81999999999999995 112.329 -178.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.508 ' N ' ' HG3' ' A' ' 79' ' ' GLN . 87.8 t -133.08 105.59 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.68 -0.691 . . . . 1.3100000000000001 110.731 177.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.753 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 6.3 m120 55.13 33.22 19.98 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.969 0.729 . . . . 1.5 112.969 176.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.48 -12.26 50.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 119.77 -1.205 . . . . 0.38 112.202 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.44 ' NE1' ' HD2' ' A' ' 96' ' ' ARG . 90.2 m95 -75.92 162.69 27.9 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.875 -0.787 . . . . 0.77000000000000002 108.875 171.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -116.54 115.14 25.2 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.406 -0.361 . . . . 1.8899999999999999 110.466 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.431 ' SD ' HG11 ' A' ' 88' ' ' VAL . 21.4 mmt -106.89 101.4 10.84 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.567 0.699 . . . . 1.01 110.92 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.05 91.69 2.71 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.05 -0.977 . . . . 1.05 109.384 170.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.662 ' O ' HD13 ' A' ' 37' ' ' ILE . 0.1 OUTLIER 48.88 65.14 1.45 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.711 -1.131 . . . . 1.6200000000000001 110.332 -173.803 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.708 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 6.0 p -108.67 178.35 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 107.434 -1.321 . . . . 1.0900000000000001 107.434 170.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.983 ' HB ' ' HB3' ' A' ' 38' ' ' ASP . 49.2 p -66.27 147.89 52.66 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 119.093 0.86 . . . . 0.34999999999999998 111.601 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.593 ' CG ' ' HA2' ' A' ' 35' ' ' GLY . 20.7 t-160 -54.68 -38.46 67.01 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-O 122.121 0.962 . . . . 0.34999999999999998 108.827 174.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.47 -33.04 74.81 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 113.109 -1.86 . . . . 1.6699999999999999 109.865 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.758 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 3.7 tp-100 -59.45 -52.96 63.37 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 109.207 -0.664 . . . . 0.77000000000000002 109.207 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.642 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . -74.44 -35.73 63.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.233 -0.894 . . . . 0.33000000000000002 110.375 -175.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -61.06 -44.2 97.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.936 -0.574 . . . . 2.1000000000000001 110.356 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.63 ' HE3' ' O ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -71.2 -46.54 61.01 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.847 -0.615 . . . . 0.95999999999999996 109.439 -176.51 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.758 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 29.4 mmt180 -65.6 -25.33 67.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.035 -0.53 . . . . 3.5699999999999998 110.672 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.696 HD21 HD13 ' A' ' 29' ' ' LEU . 17.0 tp -68.45 -61.04 2.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.06 -0.518 . . . . 1.6499999999999999 111.603 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.851 ' HA ' HD23 ' A' ' 27' ' ' LEU . 2.5 m -69.44 -32.64 71.72 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.256 -0.646 . . . . 1.53 109.256 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.496 ' HB3' ' H ' ' A' ' 100' ' ' ARG . 0.4 OUTLIER 61.36 -105.72 0.21 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.713 -1.13 . . . . 2.7200000000000002 110.87 168.22 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.496 ' H ' ' HB3' ' A' ' 99' ' ' LYS . 59.9 mtm180 -143.99 14.49 1.69 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.813 -1.18 . . . . 4.3799999999999999 107.813 172.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.5 m 73.57 42.03 0.42 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.61 -1.177 . . . . 2.5099999999999998 111.015 -173.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -57.07 154.17 10.29 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.032 -0.531 . . . . 3.3999999999999999 109.793 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -58.99 -25.18 63.39 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.87 1.063 . . . . 2.6800000000000002 113.87 -164.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 7.2 p -146.38 151.91 14.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 120.758 -0.377 . . . . 0.44 110.298 -175.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.412 ' HA ' HD21 ' A' ' 81' ' ' ASN . 51.8 t -133.31 118.37 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.016 0 CA-C-O 122.344 1.069 . . . . 0.46000000000000002 112.266 -169.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.753 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -100.98 130.53 46.99 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 113.023 -1.899 . . . . 1.76 110.309 -177.01 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.679 HD11 HG12 ' A' ' 77' ' ' ILE . 34.3 tp -131.84 131.79 43.14 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.574 -0.528 . . . . 1.1200000000000001 109.574 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.98 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 15.3 tp -105.46 129.31 53.79 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 105.412 -2.07 . . . . 0.41999999999999998 105.412 172.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.743 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -140.97 146.5 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 C-N-CA 119.916 -0.714 . . . . 0.77000000000000002 110.267 -173.596 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.805 HG23 HG12 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -92.36 125.73 37.14 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.566 0.698 . . . . 0.34000000000000002 111.077 172.684 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.59 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 34.6 ttt180 -111.45 146.81 36.56 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.224 -1.353 . . . . 2.0099999999999998 110.958 -172.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.5 -105.66 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.637 -0.71 . . . . 1.97 111.232 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.7 t -136.15 36.34 2.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.2 0.524 . . . . 1.6200000000000001 111.708 -171.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.551 ' HB2' ' HG3' ' A' ' 72' ' ' GLN . 2.9 mt -110.57 -17.46 13.41 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.41 0.624 . . . . 1.6499999999999999 110.372 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.48 ' NE2' ' HB ' ' A' ' 118' ' ' VAL . 10.3 mm100 -47.26 124.91 7.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.563 -1.199 . . . . 3.5299999999999998 112.526 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.848 ' HD3' ' H ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -99.25 72.5 1.85 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.394 -0.821 . . . . 3.6000000000000001 110.561 -178.267 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 51.59 81.51 0.07 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.005 -0.998 . . . . 3.5600000000000001 111.603 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.48 ' HB ' ' NE2' ' A' ' 115' ' ' GLN . 8.7 p -90.35 140.27 16.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.893 0.377 . . . . 4.9900000000000002 110.757 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -70.32 123.89 22.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.574 -0.739 . . . . 7.7699999999999996 110.723 177.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -118.53 -47.15 2.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.206 -0.452 . . . . 6.5999999999999996 109.919 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.8 t -94.49 145.5 24.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.265 -0.88 . . . . 8.9399999999999995 110.071 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -139.04 -175.06 4.02 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.973 -0.38 . . . . 12.1 109.973 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.513 ' HG ' ' H ' ' A' ' 124' ' ' SER . 21.9 tp -114.58 173.64 6.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.091 0.472 . . . . 12.82 111.075 -171.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.513 ' H ' ' HG ' ' A' ' 123' ' ' LEU . 21.4 m . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.725 -0.655 . . . . 14.640000000000001 109.427 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.8 mmm . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.393 0.139 . . . . 14.33 110.94 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.0 m 64.66 98.29 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.046 0.758 . . . . 11.220000000000001 113.046 173.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -101.85 105.16 15.96 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.78 -0.452 . . . . 9.1899999999999995 109.78 172.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.667 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -106.07 108.18 61.17 Favored Pre-proline 0 C--O 1.216 -0.702 0 CA-C-O 120.879 0.371 . . . . 6.6500000000000004 111.368 -178.601 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -80.68 -6.27 13.41 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.102 2.535 . . . . 7.46 111.127 173.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.59 -31.57 24.12 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.492 -0.777 . . . . 5.8899999999999997 112.176 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.437 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 10.9 pt20 -150.02 50.01 0.71 Allowed Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 113.514 0.931 . . . . 6.3700000000000001 113.514 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 7' ' ' GLN . 87.0 Cg_endo -81.46 -155.53 0.06 OUTLIER 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.565 2.177 . . . . 3.3999999999999999 110.974 173.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.5 p -87.01 82.0 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 122.602 1.191 . . . . 2.2599999999999998 108.989 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 m -77.54 79.84 4.03 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 113.841 -1.527 . . . . 2.0899999999999999 108.79 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.522 ' HB1' ' O ' ' A' ' 111' ' ' ARG . . . -65.73 174.08 2.52 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.09 -1.868 . . . . 0.95999999999999996 111.716 176.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.42 119.98 58.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.882 -1.053 . . . . 1.5700000000000001 110.041 -175.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.528 HG22 HG23 ' A' ' 110' ' ' THR . 94.0 t -76.29 106.64 6.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 122.035 0.921 . . . . 1.02 111.532 -175.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.532 ' O ' ' HB ' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -100.27 138.15 37.73 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.642 -1.617 . . . . 1.3899999999999999 110.66 177.381 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.594 ' HG2' ' HA ' ' A' ' 108' ' ' LEU . 3.3 tmm_? -124.7 121.1 33.72 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 120.869 -1.144 . . . . 3.6299999999999999 109.914 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.935 ' HB ' ' HB1' ' A' ' 69' ' ' ALA . 4.1 m -113.38 155.64 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 119.626 -0.83 . . . . 1.02 110.199 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -144.63 126.75 15.59 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.332 -0.849 . . . . 1.3500000000000001 109.145 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.559 HG12 ' HB2' ' A' ' 65' ' ' PRO . 7.8 tp -146.07 143.35 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 C-N-CA 119.728 -0.789 . . . . 0.60999999999999999 109.58 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.716 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.9 m-70 -72.6 112.11 8.37 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.735 -0.666 . . . . 0.59999999999999998 109.455 -176.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.805 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -31.58 135.69 0.06 Allowed 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.329 1.018 . . . . 4.0 113.331 178.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.0 tp -100.71 98.61 9.13 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.197 0.523 . . . . 0.55000000000000004 110.509 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -71.4 142.48 50.3 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.653 -0.703 . . . . 3.9700000000000002 111.124 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.512 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 2.5 tp60 -135.0 95.07 3.24 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.525 -0.762 . . . . 1.3500000000000001 109.398 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.27 -81.85 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.362 -0.923 . . . . 1.3300000000000001 112.14 -177.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -138.09 12.0 2.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.043 0.449 . . . . 2.3300000000000001 111.357 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.512 ' OD1' ' HB3' ' A' ' 23' ' ' GLN . 1.5 p30 -127.05 171.06 11.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.063 -0.517 . . . . 1.8700000000000001 110.715 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.475 HD21 ' HG2' ' A' ' 102' ' ' GLU . 10.3 mp -122.09 123.81 42.44 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.988 0.423 . . . . 2.2799999999999998 110.619 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.442 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.7 mp -99.13 135.6 33.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.959 -0.564 . . . . 0.80000000000000004 110.003 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.763 HD22 HD22 ' A' ' 97' ' ' LEU . 9.6 mt -86.8 -35.19 19.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.36 -0.837 . . . . 1.74 110.717 -174.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.87 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 89.87 10.48 64.76 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 115.321 -0.854 . . . . 0.68999999999999995 110.967 -172.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.751 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 25.7 p90 -156.84 160.35 39.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 122.342 0.257 . . . . 0.51000000000000001 110.793 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.534 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 22.1 t -104.1 160.7 14.63 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.77 -1.196 . . . . 0.53000000000000003 107.77 170.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.42 ' HA ' ' H ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -161.19 138.99 2.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 120.253 -0.579 . . . . 0.48999999999999999 112.561 -165.768 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -142.53 117.89 1.2 Allowed Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 110.431 -1.067 . . . . 0.71999999999999997 110.431 156.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 1.065 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -140.15 117.28 1.28 Allowed Glycine 0 CA--C 1.49 -1.524 0 CA-C-O 118.927 -0.929 . . . . 1.4199999999999999 111.518 171.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.711 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -165.41 144.46 9.29 Favored Glycine 0 C--N 1.3 -1.46 0 C-N-CA 118.17 -1.966 . . . . 0.47999999999999998 112.77 175.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.563 HG23 ' HA ' ' A' ' 87' ' ' MET . 8.8 pt -61.23 -20.64 22.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 107.577 -1.268 . . . . 0.52000000000000002 107.577 153.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.661 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 3.8 t70 -61.33 -37.87 84.84 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.239 -1.801 . . . . 0.71999999999999997 110.747 174.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -67.24 -69.88 0.28 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.369 -0.832 . . . . 1.1899999999999999 112.658 -169.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -145.2 115.98 5.07 Favored Pre-proline 0 N--CA 1.469 0.509 0 CA-C-O 120.944 0.402 . . . . 2.5699999999999998 112.035 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -58.96 -32.43 97.49 Favored 'Trans proline' 0 N--CA 1.476 0.481 0 C-N-CA 123.892 3.061 . . . . 2.8199999999999998 113.184 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.5 m -60.96 -17.92 54.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.376 -0.829 . . . . 3.2599999999999998 111.703 -172.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.685 ' HB2' ' HG3' ' A' ' 53' ' ' LYS . 39.1 mm-40 -96.96 47.37 1.04 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 3.8799999999999999 109.903 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.608 ' H ' ' HD2' ' A' ' 45' ' ' PRO . 4.5 t-20 -130.15 -52.17 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.681 0 CA-C-N 116.238 -0.437 . . . . 5.1399999999999997 112.142 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.608 ' HD2' ' H ' ' A' ' 44' ' ' ASN . 4.4 Cg_endo -45.81 -12.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.365 1.395 0 C-N-CA 123.369 2.712 . . . . 3.71 115.026 173.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -136.59 25.71 3.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.125 0.488 . . . . 5.6200000000000001 109.863 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.931 ' HB3' ' HA ' ' A' ' 52' ' ' ASP . 3.7 m -150.52 108.23 3.68 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 121.834 0.825 . . . . 3.77 108.822 -172.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.574 ' H ' ' HB ' ' A' ' 51' ' ' THR . 2.0 mp0 -85.53 -52.34 5.89 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.931 -1.031 . . . . 6.7800000000000002 113.344 -171.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.419 ' OD2' ' HB3' ' A' ' 48' ' ' GLU . 22.2 m-20 -134.52 -109.09 0.22 Allowed 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.021 -1.445 . . . . 5.4699999999999998 110.932 -159.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.566 ' HE2' HG21 ' A' ' 110' ' ' THR . 1.2 tmmt? -66.97 -26.75 66.97 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 106.184 -1.784 . . . . 3.0699999999999998 106.184 161.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.574 ' HB ' ' H ' ' A' ' 48' ' ' GLU . 3.3 m -57.17 -40.7 77.84 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 112.863 -1.971 . . . . 4.5599999999999996 109.764 172.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.931 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 12.8 t70 -56.2 174.99 0.11 Allowed 'General case' 0 N--CA 1.477 0.911 0 O-C-N 123.709 0.631 . . . . 2.6000000000000001 110.732 170.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.685 ' HG3' ' HB2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -56.81 -53.44 57.85 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.361 -0.607 . . . . 3.48 109.361 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.634 ' HA2' ' O ' ' A' ' 86' ' ' THR . . . 64.53 -153.99 48.76 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.243 -0.89 . . . . 0.78000000000000003 110.895 -175.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.065 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -106.53 146.44 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 106.522 -1.658 . . . . 0.54000000000000004 106.522 169.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.679 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -153.51 141.5 20.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 119.613 1.097 . . . . 1.4199999999999999 111.072 178.706 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.789 HG12 ' H ' ' A' ' 75' ' ' ASP . 2.5 p -81.5 132.39 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 CA-C-N 114.392 -1.276 . . . . 0.57999999999999996 109.374 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.42 ' H ' ' HA ' ' A' ' 33' ' ' ILE . 27.8 m -100.18 -18.52 16.86 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.075 -0.966 . . . . 1.1100000000000001 110.294 -173.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.816 ' HA ' HG23 ' A' ' 73' ' ' ILE . 50.5 mtt180 -146.34 -168.07 2.91 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.333 0.587 . . . . 2.27 112.022 174.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.605 HG13 ' HB3' ' A' ' 66' ' ' ALA . 75.4 t -166.33 146.75 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 113.003 -1.908 . . . . 0.82999999999999996 106.218 165.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.4 p -95.47 133.32 39.58 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.359 0.6 . . . . 1.6499999999999999 111.519 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -64.83 115.03 4.9 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.456 -1.247 . . . . 1.8500000000000001 110.138 171.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.88 -16.81 59.74 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 114.983 -1.008 . . . . 0.92000000000000004 112.171 -177.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.516 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -77.25 172.16 55.13 Favored Glycine 0 CA--C 1.502 -0.755 0 C-N-CA 120.588 -0.815 . . . . 0.98999999999999999 111.551 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.87 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 60.0 Cg_endo -73.27 -28.1 12.85 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.273 1.982 . . . . 0.44 113.214 -166.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.751 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -58.75 -32.97 69.74 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.269 -0.878 . . . . 0.35999999999999999 111.922 172.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -77.61 -28.94 51.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.558 0.694 . . . . 1.79 109.648 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.516 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -71.28 -41.15 74.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.199 -0.909 . . . . 0.51000000000000001 108.888 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.935 ' HB1' ' HB ' ' A' ' 16' ' ' VAL . . . -69.54 -31.2 69.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.249 -0.887 . . . . 0.40999999999999998 110.055 175.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.31 52.24 1.16 Allowed Glycine 0 CA--C 1.521 0.414 0 C-N-CA 121.043 -0.599 . . . . 0.45000000000000001 113.66 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.515 HD21 HG21 ' A' ' 57' ' ' VAL . 19.8 tp -102.46 155.74 18.06 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.254 -0.647 . . . . 0.89000000000000001 109.254 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.59 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 51.5 mt-30 -126.34 29.59 5.76 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 115.778 1.77 . . . . 1.21 115.778 -163.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.816 HG23 ' HA ' ' A' ' 59' ' ' ARG . 53.9 mt 72.52 1.58 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-N 119.102 0.864 . . . . 0.77000000000000002 113.026 166.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -172.24 51.41 0.17 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 119.668 -1.253 . . . . 0.37 113.118 -171.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.789 ' H ' HG12 ' A' ' 57' ' ' VAL . 21.1 m-20 -122.08 142.55 50.25 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.595 -0.302 . . . . 0.89000000000000001 111.736 -172.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.64 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 59.3 mttm -82.76 130.57 35.15 Favored 'General case' 0 C--O 1.207 -1.163 0 CA-C-O 121.138 0.494 . . . . 2.2000000000000002 109.668 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.679 HD12 ' HA ' ' A' ' 56' ' ' TYR . 2.8 mp -99.8 125.22 53.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 C-N-CA 122.689 0.396 . . . . 0.48999999999999999 110.562 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.768 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 7.5 mmt -90.81 -17.17 27.04 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 125.099 1.499 . . . . 1.0600000000000001 112.941 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 1.4 tt0 -163.99 151.48 12.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.041 0.448 . . . . 0.81999999999999995 112.128 -175.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.578 ' HB ' ' HE1' ' A' ' 85' ' ' MET . 39.5 t -130.51 105.07 10.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.344 -0.844 . . . . 1.3100000000000001 110.38 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.673 HD21 HG13 ' A' ' 105' ' ' VAL . 27.2 m-80 49.48 46.95 23.1 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.751 -0.659 . . . . 1.5 111.997 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.03 -15.17 61.93 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.337 -0.935 . . . . 0.38 112.978 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -85.58 170.16 12.85 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 109.782 -0.451 . . . . 0.77000000000000002 109.782 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -115.92 112.47 21.94 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.114 0.483 . . . . 1.8899999999999999 111.39 -172.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.578 ' HE1' ' HB ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -107.11 100.5 9.97 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.136 0.969 . . . . 1.01 110.922 -179.257 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.634 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 1.1 p -132.03 -58.38 0.96 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.939 -1.482 . . . . 1.05 107.408 170.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.563 ' HA ' HG23 ' A' ' 37' ' ' ILE . 1.3 mtt -125.36 79.33 1.8 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.642 -1.617 . . . . 1.6200000000000001 108.563 172.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.711 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.2 t -139.25 137.28 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 115.351 -0.841 . . . . 1.0900000000000001 108.879 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.661 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 79.3 p -56.78 152.6 12.16 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.333 0.587 . . . . 0.34999999999999998 112.529 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.766 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 21.0 t-160 -57.11 -38.18 73.03 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 115.552 -0.749 . . . . 0.34999999999999998 110.395 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.57 -32.05 69.29 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.491 -1.231 . . . . 1.6699999999999999 109.877 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.639 ' HB3' HG13 ' A' ' 88' ' ' VAL . 1.0 OUTLIER -65.7 -45.05 84.25 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 109.088 -0.708 . . . . 0.77000000000000002 109.088 -177.737 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.66 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -74.91 -37.41 62.08 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.173 -0.922 . . . . 0.33000000000000002 110.565 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.406 ' HD3' HH11 ' A' ' 94' ' ' ARG . 29.6 ttp180 -65.05 -37.53 87.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.048 -0.524 . . . . 2.1000000000000001 110.356 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.518 ' HE3' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -70.98 -40.79 71.71 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.631 -0.713 . . . . 0.95999999999999996 110.175 -177.678 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 13.1 mmm180 -69.06 -27.71 65.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.2 0.524 . . . . 3.5699999999999998 110.564 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.763 HD22 HD22 ' A' ' 29' ' ' LEU . 2.3 tt -78.59 -48.06 15.93 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.452 -0.795 . . . . 1.6499999999999999 110.426 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.4 HG23 ' HB2' ' A' ' 27' ' ' LEU . 2.3 m -108.74 70.24 0.74 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.51 -0.768 . . . . 1.53 110.389 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.518 ' HB2' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -108.98 8.9 26.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.661 0.743 . . . . 2.7200000000000002 110.839 -176.539 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 75.8 mtp180 73.0 20.41 3.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.622 -1.172 . . . . 4.3799999999999999 112.681 173.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.7 p -71.28 -46.02 61.82 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.457 -0.572 . . . . 2.5099999999999998 109.457 174.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.475 ' HG2' HD21 ' A' ' 27' ' ' LEU . 35.6 mt-10 68.18 6.06 5.03 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.148 -0.933 . . . . 3.3999999999999999 113.067 169.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.444 ' HG3' ' H ' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -70.58 -68.47 0.43 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.67 0.748 . . . . 2.6800000000000002 109.767 174.636 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.716 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 4.8 p -159.58 156.14 3.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.816 -1.084 . . . . 0.44 108.52 -176.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.723 HG21 ' HG2' ' A' ' 20' ' ' LYS . 3.1 t -132.11 119.88 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-O 121.958 0.885 . . . . 0.46000000000000002 112.968 -177.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.576 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 1.2 mpt_? -100.31 130.75 46.45 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.393 -1.731 . . . . 1.76 111.236 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.14 135.64 41.28 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.916 -0.314 . . . . 1.1200000000000001 110.592 172.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.768 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 26.2 tp -98.45 130.34 45.06 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 107.008 -1.479 . . . . 0.41999999999999998 107.008 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.592 HG13 ' HB3' ' A' ' 75' ' ' ASP . 2.2 t -128.32 142.53 43.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 121.611 0.719 . . . . 0.77000000000000002 111.317 -170.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.566 HG21 ' HE2' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -98.74 114.29 26.75 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.511 -0.768 . . . . 0.34000000000000002 109.973 164.806 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.522 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 20.1 ttt180 -98.68 146.52 25.78 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.102 -0.953 . . . . 2.0099999999999998 110.31 -175.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.471 ' N ' ' CD ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -136.22 -69.44 0.48 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.036 0.754 . . . . 1.97 113.036 -171.346 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.9 t -158.38 26.91 0.24 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.059 0.457 . . . . 1.6200000000000001 111.661 -173.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 4.0 mm? -98.83 23.21 9.1 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.217 0.451 . . . . 1.6499999999999999 112.217 -176.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.608 ' HB2' ' HB ' ' A' ' 118' ' ' VAL . 1.3 mp0 -72.6 158.42 35.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.873 0.368 . . . . 3.5299999999999998 110.722 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -93.44 -61.09 1.63 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.915 0.864 . . . . 3.6000000000000001 109.782 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -92.12 65.29 4.71 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.663 -1.153 . . . . 3.5600000000000001 110.046 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.608 ' HB ' ' HB2' ' A' ' 115' ' ' GLN . 13.1 p -111.67 -28.16 2.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.609 -0.723 . . . . 4.9900000000000002 110.965 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.508 ' HG3' HG13 ' A' ' 118' ' ' VAL . 94.8 mt-30 -114.19 11.58 17.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.531 -0.759 . . . . 7.7699999999999996 109.726 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -143.76 139.95 29.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.798 -1.092 . . . . 6.5999999999999996 108.869 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.0 m -82.79 179.44 7.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.238 0.542 . . . . 8.9399999999999995 112.405 -172.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 94.4 mmm -73.99 90.29 1.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.533 -0.758 . . . . 12.1 111.612 -175.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 27.8 tp -112.21 12.83 20.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.994 0.902 . . . . 12.82 108.771 172.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.7 m . . . . . 0 C--O 1.247 0.946 0 CA-C-N 114.78 -1.1 . . . . 14.640000000000001 109.032 178.996 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptt? . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 111.573 0.212 . . . . 14.33 111.573 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 t -165.04 154.16 12.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.901 0.381 . . . . 11.220000000000001 110.65 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -141.01 135.05 30.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.526 -0.761 . . . . 9.1899999999999995 109.776 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.842 HG13 ' HB3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -110.53 98.19 35.63 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 121.107 0.48 . . . . 6.6500000000000004 110.578 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.81 -16.0 20.96 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.887 2.392 . . . . 7.46 112.02 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.58 39.75 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.607 -0.724 . . . . 5.8899999999999997 111.503 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.621 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 17.8 pt20 -152.86 35.54 0.08 OUTLIER Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 114.084 1.142 . . . . 6.3700000000000001 114.084 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.842 ' HB3' HG13 ' A' ' 4' ' ' ILE . 11.8 Cg_endo -80.27 114.3 3.05 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.046 1.83 . . . . 3.3999999999999999 111.929 172.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.562 ' HB ' ' O ' ' A' ' 8' ' ' PRO . 24.3 t 78.85 -48.56 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 O-C-N 123.363 0.415 . . . . 2.2599999999999998 111.419 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.3 p -70.51 82.55 0.58 Allowed 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 122.632 1.206 . . . . 2.0899999999999999 111.847 -175.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.61 178.72 4.2 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.265 -1.789 . . . . 0.95999999999999996 110.09 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.6 t -120.49 117.17 52.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 116.081 -0.509 . . . . 1.5700000000000001 110.273 -174.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.705 HG22 HG23 ' A' ' 110' ' ' THR . 21.8 t -76.71 115.72 18.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.954 0.406 . . . . 1.02 109.942 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.999 HE22 HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -105.48 172.37 6.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.708 -0.678 . . . . 1.3899999999999999 110.637 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.629 ' NH1' ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -128.17 128.3 44.53 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.814 -0.175 . . . . 3.6299999999999999 110.919 172.41 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.999 HG23 HE22 ' A' ' 14' ' ' GLN . 24.2 t -102.08 132.54 47.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 110.196 -0.298 . . . . 1.02 110.196 173.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.629 ' HB2' ' NH1' ' A' ' 15' ' ' ARG . 10.1 tt0 -144.71 115.47 7.75 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.357 -0.238 . . . . 1.3500000000000001 110.357 171.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.545 HG12 ' HB2' ' A' ' 65' ' ' PRO . 9.0 tp -145.39 155.73 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 108.561 -0.903 . . . . 0.60999999999999999 108.561 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -83.39 116.59 22.56 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 119.711 -0.796 . . . . 0.59999999999999998 109.603 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -28.8 140.77 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.958 1.411 . . . . 4.0 112.441 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.431 HD22 ' HD3' ' A' ' 65' ' ' PRO . 39.6 tp -97.1 102.9 14.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.173 0.511 . . . . 0.55000000000000004 110.24 -173.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 12.3 ptp180 -71.11 141.17 50.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.571 -0.74 . . . . 3.9700000000000002 111.887 -175.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.567 ' HG3' HD13 ' A' ' 28' ' ' ILE . 6.7 mm-40 -132.66 92.28 3.04 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.398 -0.964 . . . . 1.3500000000000001 108.398 170.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.27 -68.29 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.053 -0.594 . . . . 1.3300000000000001 112.251 -173.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -147.08 12.42 1.08 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.45 0.643 . . . . 2.3300000000000001 109.829 -176.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.559 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 34.0 m-80 -112.17 161.77 16.18 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.276 -0.875 . . . . 1.8700000000000001 110.534 -174.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.79 ' HB2' HG23 ' A' ' 98' ' ' THR . 10.9 mp -121.93 113.07 19.09 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.758 -0.831 . . . . 2.2799999999999998 108.758 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.567 HD13 ' HG3' ' A' ' 23' ' ' GLN . 1.2 mp -97.88 133.43 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 CA-C-O 121.311 0.577 . . . . 0.80000000000000004 109.996 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.474 HD22 HD22 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -77.18 -41.29 42.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.647 -1.161 . . . . 1.74 109.832 -173.13 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.685 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 94.17 9.5 59.3 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.191 -0.913 . . . . 0.68999999999999995 111.036 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 31.0 p90 -156.18 177.51 11.35 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 122.659 0.384 . . . . 0.51000000000000001 110.299 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.445 ' H ' ' HB2' ' A' ' 59' ' ' ARG . 15.9 t -114.45 161.23 18.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.619 -1.252 . . . . 0.53000000000000003 107.619 169.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -161.45 136.09 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 112.6 0.593 . . . . 0.48999999999999999 112.6 -167.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.474 ' HA2' ' CD2' ' A' ' 90' ' ' HIS . . . -143.82 118.72 1.22 Allowed Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 110.518 -1.033 . . . . 0.71999999999999997 110.518 156.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 1.101 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -139.19 116.54 1.25 Allowed Glycine 0 CA--C 1.492 -1.36 0 CA-C-O 118.982 -0.899 . . . . 1.4199999999999999 111.148 172.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.52 140.4 6.24 Favored Glycine 0 C--N 1.3 -1.465 0 C-N-CA 118.139 -1.982 . . . . 0.47999999999999998 112.659 177.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.412 ' HA ' ' HB3' ' A' ' 53' ' ' LYS . 11.6 pt -58.26 -22.51 19.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 107.42 -1.326 . . . . 0.52000000000000002 107.42 151.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.796 ' HB2' ' CB ' ' A' ' 89' ' ' THR . 13.0 t70 -57.97 -43.71 86.64 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 113.223 -1.808 . . . . 0.71999999999999997 111.435 173.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -63.4 -80.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.402 -0.817 . . . . 1.1899999999999999 112.629 -168.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 10.3 t70 -170.18 111.12 0.45 Allowed Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.689 -0.232 . . . . 2.5699999999999998 110.483 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.759 ' HA ' ' HE3' ' A' ' 53' ' ' LYS . 5.7 Cg_exo -83.79 -2.59 10.36 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 C-N-CA 123.341 2.694 . . . . 2.8199999999999998 113.145 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 t -87.7 25.66 1.45 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.129 0.418 . . . . 3.2599999999999998 112.129 -165.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -127.6 -7.81 5.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.092 0.472 . . . . 3.8799999999999999 109.995 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.457 ' HB2' ' OE2' ' A' ' 48' ' ' GLU . 6.5 m-20 174.79 72.41 0.05 OUTLIER Pre-proline 0 N--CA 1.444 -0.729 0 N-CA-C 106.522 -1.658 . . . . 5.1399999999999997 106.522 -169.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -86.59 30.44 0.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.948 2.432 . . . . 3.71 112.27 -169.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -144.81 -49.37 0.26 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.907 -1.042 . . . . 5.6200000000000001 108.335 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.7 m -160.37 98.58 1.28 Allowed 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.577 -0.738 . . . . 3.77 110.493 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.914 ' H ' ' HA ' ' A' ' 52' ' ' ASP . 13.9 mm-40 -54.59 -57.6 10.8 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 122.312 1.053 . . . . 6.7800000000000002 109.769 167.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.558 ' CG ' ' HE2' ' A' ' 76' ' ' LYS . 7.6 m-20 -130.04 -110.56 0.26 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.751 -1.568 . . . . 5.4699999999999998 109.956 -172.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.521 ' HD2' ' HB3' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -91.09 -35.17 14.75 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.496 -1.229 . . . . 3.0699999999999998 108.497 169.859 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.51 HG21 ' CE ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -127.98 24.56 6.01 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 114.19 1.182 . . . . 4.5599999999999996 114.19 -168.191 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.914 ' HA ' ' H ' ' A' ' 48' ' ' GLU . 34.9 t70 56.23 -130.99 1.76 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.533 -0.758 . . . . 2.6000000000000001 112.764 164.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.759 ' HE3' ' HA ' ' A' ' 41' ' ' PRO . 29.8 mmtt -83.13 50.85 1.82 Allowed 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 122.18 0.991 . . . . 3.48 109.616 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.432 ' C ' HD12 ' A' ' 55' ' ' ILE . . . -86.55 -145.35 8.87 Favored Glycine 0 N--CA 1.422 -2.247 0 N-CA-C 108.813 -1.715 . . . . 0.78000000000000003 108.813 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.101 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -113.92 141.45 29.99 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 CA-C-N 118.935 1.368 . . . . 0.54000000000000004 109.002 173.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.585 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -142.64 142.25 32.05 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 119.036 0.834 . . . . 1.4199999999999999 110.791 -178.09 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.879 HG21 HD21 ' A' ' 71' ' ' LEU . 1.4 p -82.66 143.48 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-N 114.848 -1.069 . . . . 0.57999999999999996 109.66 178.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.9 m -110.87 -17.6 13.29 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 124.191 0.932 . . . . 1.1100000000000001 111.454 -173.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.452 ' CA ' ' HA ' ' A' ' 73' ' ' ILE . 78.7 mtt180 -152.56 -166.31 2.44 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.953 0.882 . . . . 2.27 112.097 175.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 8.7 p -173.35 139.58 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 112.982 -1.917 . . . . 0.82999999999999996 107.529 164.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.6 m -109.05 136.89 47.82 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.474 0.654 . . . . 1.6499999999999999 111.196 -173.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.37 125.93 26.2 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.555 -1.202 . . . . 1.8500000000000001 110.777 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.54 -18.02 58.02 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 114.671 -1.15 . . . . 0.92000000000000004 111.253 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.453 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -78.95 167.68 52.87 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.385 -0.912 . . . . 0.98999999999999999 111.016 174.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.685 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 91.3 Cg_endo -75.95 -19.33 16.03 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 122.861 2.374 . . . . 0.44 113.912 -169.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.536 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -73.05 -26.71 61.39 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.962 -1.017 . . . . 0.35999999999999999 111.695 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -72.88 -29.98 63.6 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.458 -0.941 . . . . 1.79 108.458 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.481 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.4 mp -77.85 -35.4 20.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.689 -1.141 . . . . 0.51000000000000001 110.095 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.794 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -81.66 -14.23 56.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.454 -0.794 . . . . 0.40999999999999998 111.504 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.0 60.48 1.19 Allowed Glycine 0 CA--C 1.522 0.473 0 C-N-CA 119.291 -1.433 . . . . 0.45000000000000001 114.314 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.879 HD21 HG21 ' A' ' 57' ' ' VAL . 35.2 tp -123.81 156.74 35.57 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.457 -0.572 . . . . 0.89000000000000001 109.457 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.84 ' HG3' ' HB2' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -148.9 81.12 1.43 Allowed 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 115.532 1.678 . . . . 1.21 115.532 -177.144 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.539 HG13 HG12 ' A' ' 60' ' ' VAL . 4.2 mp 62.82 -22.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 117.001 2.223 . . . . 0.77000000000000002 117.001 158.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -162.53 61.46 0.27 Allowed Glycine 0 CA--C 1.506 -0.51 0 O-C-N 120.732 -1.23 . . . . 0.37 112.194 -167.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.766 ' H ' HG12 ' A' ' 57' ' ' VAL . 61.7 m-20 -121.88 152.05 40.02 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.356 -0.422 . . . . 0.89000000000000001 110.668 -167.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.63 ' HD2' ' N ' ' A' ' 76' ' ' LYS . 3.7 mptt -103.8 101.61 11.43 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.79 0.805 . . . . 2.2000000000000002 109.548 -173.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 1.02 HG13 HG23 ' A' ' 109' ' ' VAL . 3.3 mp -71.22 121.71 21.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 114.523 -1.217 . . . . 0.48999999999999999 111.392 -176.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.858 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 1.4 mmt -89.05 -17.9 28.4 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 125.843 1.965 . . . . 1.0600000000000001 111.215 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.8 OUTLIER -172.12 153.25 3.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.808 0.337 . . . . 0.81999999999999995 111.74 -175.66 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.556 HG12 ' HE1' ' A' ' 85' ' ' MET . 9.8 p -139.66 125.31 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 121.323 0.583 . . . . 1.3100000000000001 109.87 175.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.927 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 13.0 m120 52.44 28.89 6.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.225 -0.898 . . . . 1.5 112.529 175.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.48 -16.64 44.44 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.093 -1.051 . . . . 0.38 113.309 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -87.56 148.58 24.81 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 109.475 -0.565 . . . . 0.77000000000000002 109.475 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -96.63 117.99 32.15 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.345 0.593 . . . . 1.8899999999999999 111.305 -174.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.556 ' HE1' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -106.71 102.33 11.71 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.834 0.826 . . . . 1.01 111.355 -178.503 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 p -123.16 -38.38 2.59 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.805 -1.088 . . . . 1.05 108.433 167.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.38 76.95 1.23 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.21 -1.359 . . . . 1.6200000000000001 109.255 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.65 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.5 OUTLIER -138.12 151.61 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 108.966 -0.753 . . . . 1.0900000000000001 108.966 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.796 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 75.2 p -60.51 151.45 28.48 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 112.888 0.699 . . . . 0.34999999999999998 112.888 -175.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.743 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 18.0 t-160 -57.71 -41.36 81.57 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 115.588 -0.733 . . . . 0.34999999999999998 110.467 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.65 -30.1 67.71 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.188 -1.369 . . . . 1.6699999999999999 109.964 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.553 ' HB3' HG13 ' A' ' 88' ' ' VAL . 2.4 tp-100 -62.55 -49.59 74.67 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.691 0.758 . . . . 0.77000000000000002 109.467 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.54 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -73.92 -31.88 63.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.988 -1.005 . . . . 0.33000000000000002 110.116 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -71.02 -41.8 70.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.411 -0.813 . . . . 2.1000000000000001 111.004 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.559 ' HD3' ' HD2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -71.42 -30.8 66.5 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 119.773 -0.771 . . . . 0.95999999999999996 109.873 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.559 ' HD2' ' HD3' ' A' ' 95' ' ' LYS . 2.4 mmm180 -67.41 -37.6 83.32 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.003 -0.679 . . . . 3.5699999999999998 110.954 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.496 HD11 ' CZ ' ' A' ' 31' ' ' PHE . 4.6 tt -58.68 -55.34 36.34 Favored 'General case' 0 C--N 1.316 -0.859 0 O-C-N 124.232 0.958 . . . . 1.6499999999999999 110.062 173.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.79 HG23 ' HB2' ' A' ' 27' ' ' LEU . 36.9 m -108.18 -94.96 0.39 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.789 -0.641 . . . . 1.53 112.55 -174.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 99' ' ' LYS . 0.3 OUTLIER 64.52 2.74 1.68 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.315 1.055 . . . . 2.7200000000000002 110.963 -175.843 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.699 ' H ' HG22 ' A' ' 98' ' ' THR . 41.6 mtm180 57.54 57.95 4.04 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.061 -1.427 . . . . 4.3799999999999999 110.862 -177.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.2 t -155.11 -48.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.27 -0.572 . . . . 2.5099999999999998 112.01 -175.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -53.83 135.44 41.86 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.044 0.449 . . . . 3.3999999999999999 112.026 -174.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -89.0 -16.14 32.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.47 0.652 . . . . 2.6800000000000002 110.54 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.7 p -152.47 148.54 14.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 108.39 -0.967 . . . . 0.44 108.39 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.0 t -114.42 117.61 56.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 122.229 1.014 . . . . 0.46000000000000002 112.621 -173.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.927 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.2 OUTLIER -101.3 124.9 47.72 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 113.411 -1.722 . . . . 1.76 110.681 -176.367 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.971 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 25.3 tp -132.74 126.73 33.12 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.398 -0.364 . . . . 1.1200000000000001 110.755 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.858 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 33.1 tp -109.96 115.94 30.71 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.105 -1.443 . . . . 0.41999999999999998 107.105 172.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 1.02 HG23 HG13 ' A' ' 77' ' ' ILE . 0.5 OUTLIER -128.23 149.51 33.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 121.397 0.617 . . . . 0.77000000000000002 110.591 -173.571 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.705 HG23 HG22 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -97.57 114.7 26.66 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.584 -0.734 . . . . 0.34000000000000002 109.61 168.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -99.16 139.03 35.42 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.281 -0.872 . . . . 2.0099999999999998 109.696 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.16 -73.08 0.65 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.854 0.359 . . . . 1.97 110.441 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.5 t 177.43 73.27 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.775 0.798 . . . . 1.6200000000000001 110.723 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.84 ' HB2' ' HG3' ' A' ' 72' ' ' GLN . 0.2 OUTLIER -135.9 -8.63 2.09 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.677 -1.147 . . . . 1.6499999999999999 108.757 178.385 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.577 ' HB2' ' OE1' ' A' ' 72' ' ' GLN . 2.3 tp-100 -63.37 154.95 30.33 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.428 -1.26 . . . . 3.5299999999999998 112.479 -175.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.54 ' HD2' ' N ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -85.75 -178.12 6.54 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.077 -0.965 . . . . 3.6000000000000001 108.762 178.251 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -80.53 56.56 2.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.527 0.679 . . . . 3.5600000000000001 110.125 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.6 p -81.83 -51.57 14.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.41 -0.814 . . . . 4.9900000000000002 112.191 -173.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -101.33 82.47 2.33 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.499 0.666 . . . . 7.7699999999999996 110.978 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -142.74 127.72 18.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.936 -1.029 . . . . 6.5999999999999996 109.372 174.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.7 t -92.32 -41.69 10.23 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.438 -0.579 . . . . 8.9399999999999995 109.438 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 47.1 ttp -69.62 -37.86 77.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.656 -0.702 . . . . 12.1 110.863 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 97.3 mt 68.0 -179.63 0.22 Allowed 'General case' 0 CA--C 1.531 0.22 0 O-C-N 123.823 0.702 . . . . 12.82 110.308 -173.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.556 -0.735 . . . . 14.640000000000001 110.377 -176.562 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtm . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 111.326 0.121 . . . . 14.33 111.326 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.2 m -71.59 146.33 48.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.632 0.253 . . . . 11.220000000000001 110.724 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.485 ' CE2' ' HG3' ' A' ' 5' ' ' PRO . 53.5 t80 -68.63 119.99 13.94 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.463 -0.569 . . . . 9.1899999999999995 109.463 177.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.423 HD12 ' CD ' ' A' ' 8' ' ' PRO . 1.9 pt -120.09 89.31 42.61 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.798 -0.637 . . . . 6.6500000000000004 111.481 -172.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.485 ' HG3' ' CE2' ' A' ' 3' ' ' TYR . 13.7 Cg_exo -70.06 -39.5 5.87 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.187 2.592 . . . . 7.46 112.516 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.87 -20.87 72.65 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.997 -0.621 . . . . 5.8899999999999997 111.801 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 25.8 mm-40 68.84 119.71 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.313 0 O-C-N 124.28 0.635 . . . . 6.3700000000000001 112.193 178.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.423 ' CD ' HD12 ' A' ' 4' ' ' ILE . 1.0 OUTLIER -84.11 178.59 5.18 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.008 2.472 . . . . 3.3999999999999999 111.969 177.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 t -95.18 -22.38 5.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 108.891 -0.781 . . . . 2.2599999999999998 108.891 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.7 t -82.25 82.05 7.91 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 123.485 1.612 . . . . 2.0899999999999999 111.081 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.29 148.29 23.28 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 111.99 -2.368 . . . . 0.95999999999999996 108.0 168.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -95.42 130.38 44.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 121.185 0.517 . . . . 1.5700000000000001 111.133 -173.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.745 HG22 HG23 ' A' ' 110' ' ' THR . 44.9 t -83.36 110.92 18.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.327 0.585 . . . . 1.02 110.556 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.71 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -119.45 163.04 17.85 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.426 -0.807 . . . . 1.3899999999999999 109.757 175.145 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.475 ' HB3' ' CD1' ' A' ' 108' ' ' LEU . 2.3 ppt_? -127.08 124.45 39.27 Favored 'General case' 0 C--N 1.31 -1.113 0 O-C-N 121.491 -0.755 . . . . 3.6299999999999999 111.649 -174.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.735 HG13 ' CB ' ' A' ' 69' ' ' ALA . 9.6 t -90.85 125.2 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-N 115.255 -0.884 . . . . 1.02 110.23 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -123.86 114.32 19.69 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.926 -0.398 . . . . 1.3500000000000001 109.926 175.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.85 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 11.1 tp -144.57 137.12 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 109.108 -0.701 . . . . 0.60999999999999999 109.108 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.99 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 15.0 m-70 -65.27 115.91 6.06 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.887 -0.597 . . . . 0.59999999999999998 110.263 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.658 ' CG ' HD12 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -33.23 126.99 0.34 Allowed 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.364 1.04 . . . . 4.0 110.056 172.349 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.2 tp -103.58 79.59 1.7 Allowed 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 118.978 -1.089 . . . . 0.55000000000000004 111.398 -163.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.985 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 15.1 ptt-85 -60.87 136.18 58.0 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.481 -0.781 . . . . 3.9700000000000002 110.947 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.56 ' HB2' HG12 ' A' ' 28' ' ' ILE . 34.2 tp60 -122.11 94.44 4.3 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.212 -0.904 . . . . 1.3500000000000001 109.069 -174.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.24 -89.19 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.82 -0.705 . . . . 1.3300000000000001 112.211 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -115.97 -6.54 11.99 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.477 0.656 . . . . 2.3300000000000001 110.786 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.52 -178.08 3.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.384 -0.825 . . . . 1.8700000000000001 109.078 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.985 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.4 pt? -130.69 144.46 51.45 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.107 -1.071 . . . . 2.2799999999999998 108.107 167.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.56 HG12 ' HB2' ' A' ' 23' ' ' GLN . 11.6 mm -101.27 130.85 50.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-O 121.417 0.627 . . . . 0.80000000000000004 111.374 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.758 HD11 HD21 ' A' ' 97' ' ' LEU . 13.1 tp -74.18 -58.22 3.44 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.474 -1.239 . . . . 1.74 109.917 175.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.953 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 100.96 -0.13 55.04 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.316 -0.945 . . . . 0.68999999999999995 113.019 173.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.602 ' HD1' ' HB2' ' A' ' 66' ' ' ALA . 29.6 p90 -157.49 163.4 38.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.147 0.474 . . . . 0.51000000000000001 110.865 175.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.557 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 35.6 t -102.74 160.74 14.32 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.038 -1.097 . . . . 0.53000000000000003 108.038 173.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -161.77 141.77 2.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 C-N-CA 120.665 -0.414 . . . . 0.48999999999999999 111.99 -166.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.409 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -144.97 118.75 1.15 Allowed Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.361 -0.923 . . . . 0.71999999999999997 110.882 158.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 1.028 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -139.7 118.17 1.45 Allowed Glycine 0 CA--C 1.489 -1.539 0 CA-C-O 118.546 -1.141 . . . . 1.4199999999999999 110.49 172.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 1.013 ' HA3' ' HG2' ' A' ' 39' ' ' GLN . . . -156.18 117.05 0.75 Allowed Glycine 0 N--CA 1.434 -1.469 0 C-N-CA 117.909 -2.091 . . . . 0.47999999999999998 114.187 -171.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.86 HG22 HD22 ' A' ' 44' ' ' ASN . 5.1 pt -61.91 -26.61 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 104.798 -2.297 . . . . 0.52000000000000002 104.798 146.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.987 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 7.1 t70 -55.31 -47.78 75.09 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 112.052 -2.34 . . . . 0.71999999999999997 109.627 170.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 1.013 ' HG2' ' HA3' ' A' ' 36' ' ' GLY . 19.2 mm-40 -62.3 -43.61 98.42 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 114.821 -1.081 . . . . 1.1899999999999999 111.374 -172.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.641 ' HB3' ' HD2' ' A' ' 53' ' ' LYS . 10.7 t70 -152.92 99.22 2.76 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.866 0.365 . . . . 2.5699999999999998 110.523 176.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -86.87 16.95 1.85 Allowed 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.861 3.041 . . . . 2.8199999999999998 112.456 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 t -102.2 -23.62 14.01 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.175 -0.466 . . . . 3.2599999999999998 111.254 -171.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.49 71.32 1.33 Allowed 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 109.277 -0.638 . . . . 3.8799999999999999 109.277 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.86 HD22 HG22 ' A' ' 37' ' ' ILE . 30.0 p-10 -158.68 34.61 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 113.119 0.785 . . . . 5.1399999999999997 113.119 -174.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.713 ' HD3' ' N ' ' A' ' 44' ' ' ASN . 44.4 Cg_endo -99.21 -0.85 0.92 Allowed 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.275 1.983 . . . . 3.71 112.879 -174.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 18.4 t80 179.86 29.38 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.072 -1.084 . . . . 5.6200000000000001 108.072 -172.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.465 ' HB3' ' CG ' ' A' ' 52' ' ' ASP . 30.5 m -81.09 -176.97 6.23 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.185 -1.37 . . . . 3.77 113.641 -165.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 26.8 mm-40 -39.28 -69.81 0.12 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.536 -1.666 . . . . 6.7800000000000002 114.731 -168.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.48 ' CG ' ' HD3' ' A' ' 50' ' ' LYS . 17.2 t0 170.39 -156.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.681 -0.859 . . . . 5.4699999999999998 108.681 -166.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.567 ' HB3' ' HE1' ' A' ' 78' ' ' MET . 0.0 OUTLIER -51.79 -28.3 15.03 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.726 0.41 . . . . 3.0699999999999998 111.337 172.893 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 t -80.54 -6.43 58.2 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.075 -0.511 . . . . 4.5599999999999996 111.414 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.548 ' OD2' ' HG2' ' A' ' 53' ' ' LYS . 17.9 t70 -83.71 -123.75 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.002 0.43 . . . . 2.6000000000000001 110.365 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.671 ' HG3' ' HB3' ' A' ' 44' ' ' ASN . 15.1 mmtp -88.9 29.83 0.99 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.276 0.56 . . . . 3.48 109.841 177.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 86' ' ' THR . . . -72.43 -161.55 5.69 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 109.989 -1.244 . . . . 0.78000000000000003 109.989 174.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.028 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -108.33 146.07 14.61 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.855 0 CA-C-N 119.331 1.565 . . . . 0.54000000000000004 108.413 172.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.775 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -153.63 143.02 21.61 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.898 0.856 . . . . 1.4199999999999999 111.44 178.433 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.578 HG12 ' H ' ' A' ' 75' ' ' ASP . 8.4 p -83.11 127.96 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 CA-C-N 113.907 -1.497 . . . . 0.57999999999999996 110.229 -177.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.2 m -94.88 -19.25 20.44 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.68 -1.145 . . . . 1.1100000000000001 111.206 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.963 ' HA ' HG23 ' A' ' 73' ' ' ILE . 25.7 mtp180 -150.4 -165.15 2.19 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.92 0.711 . . . . 2.27 112.92 177.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 91.9 t -156.01 138.71 6.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 112.756 -2.02 . . . . 0.82999999999999996 107.202 161.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.1 m -94.9 121.58 36.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.226 0.536 . . . . 1.6499999999999999 110.217 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -52.74 127.6 23.75 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.531 -1.213 . . . . 1.8500000000000001 111.869 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.14 -4.38 84.54 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.614 -0.803 . . . . 0.92000000000000004 112.466 174.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.601 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -82.82 -153.2 12.53 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.256 -0.973 . . . . 0.98999999999999999 110.95 173.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.953 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 40.4 Cg_endo -94.72 -33.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.081 1.854 . . . . 0.44 115.018 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.602 ' HB2' ' HD1' ' A' ' 31' ' ' PHE . . . -66.72 -25.54 66.57 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.073 0.463 . . . . 0.35999999999999999 111.837 -174.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -72.78 -30.83 64.43 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.758 0.79 . . . . 1.79 108.923 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.601 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -78.03 -41.89 27.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.64 -1.164 . . . . 0.51000000000000001 110.751 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.85 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . . . -72.55 -20.17 61.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.291 -0.413 . . . . 0.40999999999999998 110.736 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.43 64.58 1.02 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.279 -0.963 . . . . 0.45000000000000001 113.445 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.0 tp -109.45 149.28 29.79 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.151 -0.685 . . . . 0.89000000000000001 109.151 175.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 1.069 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 30.3 mt-30 -115.05 23.74 12.28 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 115.031 1.493 . . . . 1.21 115.031 -164.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.963 HG23 ' HA ' ' A' ' 59' ' ' ARG . 62.1 mt 69.51 2.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 CA-C-N 118.761 0.709 . . . . 0.77000000000000002 112.477 168.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.71 46.77 0.21 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.268 -0.968 . . . . 0.37 112.4 -168.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.578 ' H ' HG12 ' A' ' 57' ' ' VAL . 49.0 m-20 -120.89 152.9 37.88 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.614 -0.514 . . . . 0.89000000000000001 109.614 -172.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.682 ' HD2' ' N ' ' A' ' 76' ' ' LYS . 8.9 mptt -102.29 122.75 44.83 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.822 -0.807 . . . . 2.2000000000000002 108.822 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.775 HD12 ' HA ' ' A' ' 56' ' ' TYR . 4.2 mp -91.6 134.27 30.54 Favored 'Isoleucine or valine' 0 C--O 1.264 1.851 0 CA-C-O 121.168 0.508 . . . . 0.48999999999999999 112.176 -172.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.824 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 0.9 OUTLIER -92.43 -25.68 18.36 Favored 'General case' 0 C--N 1.346 0.452 0 O-C-N 126.381 2.3 . . . . 1.0600000000000001 112.442 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.67 ' HA ' ' HG2' ' A' ' 85' ' ' MET . 0.2 OUTLIER -170.77 156.02 4.98 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.281 0.475 . . . . 0.81999999999999995 112.281 -172.347 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.653 HG12 ' HE3' ' A' ' 85' ' ' MET . 6.4 p -143.14 127.51 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.095 -0.502 . . . . 1.3100000000000001 110.317 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 59.39 19.87 8.16 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.888 -0.597 . . . . 1.5 111.929 176.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.79 -6.21 58.59 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 119.96 -1.114 . . . . 0.38 112.262 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -83.13 124.18 30.24 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-O 121.332 0.587 . . . . 0.77000000000000002 109.825 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -86.13 96.74 9.99 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.536 -1.211 . . . . 1.8899999999999999 110.084 -177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.67 ' HG2' ' HA ' ' A' ' 79' ' ' GLN . 3.9 ptp -109.41 102.39 11.29 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.129 0.966 . . . . 1.01 111.534 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.435 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 4.6 p -101.91 -33.89 9.59 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.236 -1.347 . . . . 1.05 109.115 176.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.598 ' O ' HG23 ' A' ' 37' ' ' ILE . 1.7 mtt -129.03 -16.07 4.13 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 113.88 -1.509 . . . . 1.6200000000000001 110.042 -176.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.626 ' O ' HD11 ' A' ' 55' ' ' ILE . 2.1 t -40.6 150.59 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 C-N-CA 125.726 1.61 . . . . 1.0900000000000001 115.222 -167.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.987 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 47.7 p -60.25 150.44 30.24 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.778 -0.576 . . . . 0.34999999999999998 111.637 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.783 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 21.9 t-160 -61.49 -33.69 74.21 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-N 115.975 -0.557 . . . . 0.34999999999999998 109.886 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.94 -33.98 68.66 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.687 -1.142 . . . . 1.6699999999999999 109.546 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.584 ' HB3' HG13 ' A' ' 88' ' ' VAL . 2.0 tp-100 -68.66 -46.56 68.81 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.402 -0.962 . . . . 0.77000000000000002 108.402 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.556 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -66.68 -37.94 85.77 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.92 -1.036 . . . . 0.33000000000000002 109.866 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 90' ' ' HIS . 27.6 ttp-105 -71.13 -43.64 67.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.626 -0.716 . . . . 2.1000000000000001 110.814 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.503 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -69.39 -43.01 74.37 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 116.109 -0.496 . . . . 0.95999999999999996 110.467 -177.664 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 28.2 mmt180 -72.08 -23.37 61.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.237 0.541 . . . . 3.5699999999999998 110.555 -178.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.758 HD21 HD11 ' A' ' 29' ' ' LEU . 7.2 tp -78.57 -57.47 3.75 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.261 -0.881 . . . . 1.6499999999999999 112.167 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.729 ' OG1' HD13 ' A' ' 29' ' ' LEU . 35.8 m -124.95 91.65 3.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.586 0.708 . . . . 1.53 110.872 -174.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.639 ' HG2' ' OE1' ' A' ' 102' ' ' GLU . 7.0 ptpp? -122.08 7.93 9.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.379 -0.828 . . . . 2.7200000000000002 112.831 -176.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.905 ' HA ' HD13 ' A' ' 27' ' ' LEU . 26.3 mtm180 67.07 16.5 10.31 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.75 -0.659 . . . . 4.3799999999999999 111.057 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.489 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 28.0 m -124.74 21.59 8.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.985 0.421 . . . . 2.5099999999999998 111.441 -175.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.639 ' OE1' ' HG2' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -137.52 131.13 31.32 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.45 -0.341 . . . . 3.3999999999999999 110.358 179.068 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -85.98 -22.29 27.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.374 0.607 . . . . 2.6800000000000002 110.257 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.99 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 4.0 p -135.85 141.86 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.519 -0.764 . . . . 0.44 109.367 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.551 HG23 ' HB2' ' A' ' 20' ' ' LYS . 52.5 t -119.62 120.88 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-O 122.083 0.944 . . . . 0.46000000000000002 111.904 -172.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.406 ' CD ' ' N ' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -99.26 129.39 45.49 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.271 -1.786 . . . . 1.76 109.789 -179.053 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.592 HD11 HG12 ' A' ' 77' ' ' ILE . 21.1 tp -133.29 134.12 43.47 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.927 -0.579 . . . . 1.1200000000000001 109.643 -177.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.569 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 17.6 tp -110.23 124.51 51.74 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.682 -1.599 . . . . 0.41999999999999998 106.682 173.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.736 HG23 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -129.88 149.31 33.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 121.757 0.789 . . . . 0.77000000000000002 111.001 -171.516 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.745 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -98.04 114.71 26.95 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.355 -0.839 . . . . 0.34000000000000002 109.205 165.187 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.664 ' HG3' HE22 ' A' ' 72' ' ' GLN . 22.3 ttt180 -105.33 131.5 52.69 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.15 -0.932 . . . . 2.0099999999999998 110.498 -171.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.45 ' HG2' ' CD2' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -106.4 -89.67 0.43 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.39 -0.368 . . . . 1.97 111.845 -178.365 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.8 t -157.18 44.94 0.37 Allowed 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.168 -0.613 . . . . 1.6200000000000001 112.071 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 1.069 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 0.2 OUTLIER -101.2 21.25 14.27 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.801 -0.814 . . . . 1.6499999999999999 108.801 175.185 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.495 ' HG3' ' OE1' ' A' ' 72' ' ' GLN . 9.9 mt-30 -66.63 129.07 38.62 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 114.876 -1.056 . . . . 3.5299999999999998 111.869 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -110.24 84.49 1.94 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.444 -0.798 . . . . 3.6000000000000001 111.315 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 65.38 33.17 9.15 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.469 -0.787 . . . . 3.5600000000000001 111.747 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.5 p -105.45 -15.9 8.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.402 0.62 . . . . 4.9900000000000002 110.601 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -90.82 92.68 8.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.443 0.64 . . . . 7.7699999999999996 110.64 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -100.21 84.35 2.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.253 -0.885 . . . . 6.5999999999999996 110.616 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.6 m -89.0 -80.03 0.3 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.038 -0.528 . . . . 8.9399999999999995 109.728 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.501 ' HG3' ' H ' ' A' ' 124' ' ' SER . 26.7 ptt? -158.76 -36.18 0.06 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.015 -0.365 . . . . 12.1 110.015 174.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.7 mt 63.8 30.3 14.57 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.688 -0.687 . . . . 12.82 111.461 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.501 ' H ' ' HG3' ' A' ' 122' ' ' MET . 50.8 m . . . . . 0 C--O 1.248 0.984 0 N-CA-C 109.366 -0.605 . . . . 14.640000000000001 109.366 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.458 ' HG3' ' H ' ' A' ' 2' ' ' SER . 20.4 ptm . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 120.827 0.346 . . . . 14.33 111.236 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.458 ' H ' ' HG3' ' A' ' 1' ' ' MET . 27.0 t -100.44 -37.03 9.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.023 0.439 . . . . 11.220000000000001 110.17 -177.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -101.73 108.46 19.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.236 -0.438 . . . . 9.1899999999999995 110.365 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.6 pt -115.18 112.64 44.05 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.209 -0.451 . . . . 6.6500000000000004 110.031 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.24 109.39 0.4 Allowed 'Trans proline' 0 N--CA 1.471 0.192 0 C-N-CA 123.439 2.759 . . . . 7.46 113.212 -176.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.43 -6.28 61.31 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-N 115.906 -0.588 . . . . 5.8899999999999997 112.924 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 55.11 70.17 1.72 Allowed Pre-proline 0 CA--C 1.532 0.254 0 CA-C-O 121.309 0.576 . . . . 6.3700000000000001 110.934 -176.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -90.62 20.78 0.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.744 2.963 . . . . 3.3999999999999999 112.977 -170.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.0 t -124.43 -50.01 2.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.108 -0.951 . . . . 2.2599999999999998 109.695 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 10' ' ' THR . 1.3 t -77.43 82.44 3.87 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 123.054 1.407 . . . . 2.0899999999999999 109.788 174.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -109.98 178.85 4.28 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 112.626 -2.079 . . . . 0.95999999999999996 110.583 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.8 t -110.18 149.07 13.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 108.894 -0.78 . . . . 1.5700000000000001 108.894 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.688 HG22 HG23 ' A' ' 110' ' ' THR . 34.8 t -103.69 112.7 38.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 120.315 -0.554 . . . . 1.02 110.956 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.74 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.5 OUTLIER -95.06 172.36 8.18 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.845 -0.616 . . . . 1.3899999999999999 110.345 176.861 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.527 ' HD3' ' O ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -127.21 127.14 43.99 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 116.718 -0.219 . . . . 3.6299999999999999 111.573 174.042 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.67 ' HB ' ' HB3' ' A' ' 107' ' ' LEU . 28.8 t -101.6 131.04 50.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.647 -0.501 . . . . 1.02 109.647 171.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 25.0 tt0 -145.68 112.96 6.19 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.699 -0.482 . . . . 1.3500000000000001 109.699 173.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.622 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 8.8 tp -142.63 145.64 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 C-N-CA 120.012 -0.675 . . . . 0.60999999999999999 109.281 -177.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.747 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 9.7 m-70 -75.66 112.73 12.32 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.207 -0.664 . . . . 0.59999999999999998 109.207 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.719 ' CE ' ' HB3' ' A' ' 27' ' ' LEU . 25.6 mmmt -31.59 137.18 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.463 1.102 . . . . 4.0 112.578 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.3 tp -96.97 99.74 11.27 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.596 -0.52 . . . . 0.55000000000000004 109.596 -173.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -92.83 144.74 24.98 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.671 0.748 . . . . 3.9700000000000002 112.481 -172.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.445 ' CG ' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -124.12 92.89 3.76 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.22 -1.4 . . . . 1.3500000000000001 107.22 170.166 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.85 -78.4 0.1 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.733 -0.746 . . . . 1.3300000000000001 111.95 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -138.11 10.09 2.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.533 0.683 . . . . 2.3300000000000001 110.503 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -107.94 118.74 37.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.238 -0.892 . . . . 1.8700000000000001 109.119 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.005 HD22 ' HA ' ' A' ' 100' ' ' ARG . 8.8 mp -105.14 113.95 27.84 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.498 0.666 . . . . 2.2799999999999998 110.437 -176.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.445 HD13 ' CG ' ' A' ' 23' ' ' GLN . 1.7 mp -94.97 141.46 15.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.831 -1.077 . . . . 0.80000000000000004 109.56 -173.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.91 -38.78 13.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.064 -0.516 . . . . 1.74 110.811 -174.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.685 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 88.78 15.2 60.0 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.268 -0.968 . . . . 0.68999999999999995 111.56 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.677 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 42.5 p90 -155.28 166.96 31.94 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 122.201 0.201 . . . . 0.51000000000000001 110.651 176.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.579 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 17.2 t -109.93 159.0 17.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.493 -1.299 . . . . 0.53000000000000003 107.493 170.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.418 HD12 HD21 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -161.26 138.08 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 C-N-CA 120.427 -0.509 . . . . 0.48999999999999999 112.238 -164.376 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.414 ' HA2' ' CD2' ' A' ' 90' ' ' HIS . . . -141.57 117.8 1.25 Allowed Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.172 -1.013 . . . . 0.71999999999999997 110.851 156.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 1.065 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -140.74 117.09 1.21 Allowed Glycine 0 CA--C 1.491 -1.417 0 CA-C-O 118.656 -1.08 . . . . 1.4199999999999999 111.067 170.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.666 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -164.15 145.67 10.64 Favored Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 117.429 -2.319 . . . . 0.47999999999999998 113.469 175.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.504 HG12 ' C ' ' A' ' 88' ' ' VAL . 34.1 pt -69.54 -11.53 14.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 107.282 -1.377 . . . . 0.52000000000000002 107.282 152.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.823 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 0.1 OUTLIER -70.61 -39.14 73.94 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 113.815 -1.538 . . . . 0.71999999999999997 109.852 172.642 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -60.25 -81.89 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.188 -0.915 . . . . 1.1899999999999999 111.409 -172.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -157.7 93.29 2.16 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.764 0.792 . . . . 2.5699999999999998 111.483 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.57 ' HA ' ' HG2' ' A' ' 53' ' ' LYS . 4.1 Cg_exo -79.25 -9.99 15.04 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.178 2.585 . . . . 2.8199999999999998 111.463 175.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.7 t -73.43 28.77 0.07 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.38 -0.827 . . . . 3.2599999999999998 112.307 -171.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 44' ' ' ASN . 53.1 mm-40 -110.11 -49.39 3.08 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.926 -1.139 . . . . 3.8799999999999999 107.926 176.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 43' ' ' GLN . 53.5 t30 162.84 82.32 0.0 OUTLIER Pre-proline 0 N--CA 1.44 -0.933 0 N-CA-C 106.06 -1.83 . . . . 5.1399999999999997 106.06 -171.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.569 ' HG3' ' O ' ' A' ' 41' ' ' PRO . 4.2 Cg_exo -77.36 26.16 0.47 Allowed 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.244 2.629 . . . . 3.71 112.381 -167.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.418 ' H ' ' C ' ' A' ' 44' ' ' ASN . 24.3 t80 -141.82 23.25 2.09 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.84 -1.073 . . . . 5.6200000000000001 108.533 -173.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.519 ' HB2' ' CG ' ' A' ' 52' ' ' ASP . 19.6 m -71.66 -172.81 0.85 Allowed 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 114.852 -1.067 . . . . 3.77 112.243 -172.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -21.8 -69.81 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 112.924 -1.944 . . . . 6.7800000000000002 116.115 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.58 ' OD2' ' HG3' ' A' ' 50' ' ' LYS . 22.8 t70 -173.01 -142.92 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.796 -0.446 . . . . 5.4699999999999998 109.796 -167.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.58 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -60.79 -12.98 12.43 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 120.682 0.277 . . . . 3.0699999999999998 111.346 174.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.5 t -78.07 -14.59 59.44 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 120.48 -0.488 . . . . 4.5599999999999996 110.639 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.607 ' CG ' ' HE2' ' A' ' 53' ' ' LYS . 24.1 t0 -66.88 -162.17 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.627 -0.715 . . . . 2.6000000000000001 110.79 172.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.607 ' HE2' ' CG ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -77.19 64.54 2.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.508 0.67 . . . . 3.48 112.037 178.38 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.44 -142.56 11.35 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 109.247 -1.541 . . . . 0.78000000000000003 109.247 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.065 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -110.83 138.03 40.7 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.113 0 CA-C-N 119.361 1.58 . . . . 0.54000000000000004 107.364 168.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.82 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -152.67 151.72 30.9 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 119.865 1.211 . . . . 1.4199999999999999 111.655 -177.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.787 HG12 ' H ' ' A' ' 75' ' ' ASP . 3.4 p -91.19 131.93 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-N 114.621 -1.172 . . . . 0.57999999999999996 109.862 -174.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.6 m -99.06 -16.16 18.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.157 -0.929 . . . . 1.1100000000000001 110.796 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.803 ' HA ' HG23 ' A' ' 73' ' ' ILE . 56.8 mtt180 -148.36 -167.04 2.7 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.553 0.692 . . . . 2.27 112.514 175.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 59' ' ' ARG . 75.7 t -163.68 117.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 112.46 -2.155 . . . . 0.82999999999999996 106.972 159.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.4 m -65.8 117.7 8.59 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.137 0.494 . . . . 1.6499999999999999 109.894 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -46.14 112.05 0.44 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.581 -1.191 . . . . 1.8500000000000001 112.394 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.24 -14.89 56.79 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.692 -0.766 . . . . 0.92000000000000004 112.607 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.517 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -76.55 172.71 54.65 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.219 -0.991 . . . . 0.98999999999999999 112.072 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.685 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 58.9 Cg_endo -68.91 -24.8 33.31 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 123.088 2.526 . . . . 0.44 113.158 -166.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.677 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -61.45 -36.32 80.05 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 114.783 -1.099 . . . . 0.35999999999999999 111.392 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -77.75 -29.57 51.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.428 0.632 . . . . 1.79 109.461 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.517 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -69.42 -37.48 75.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.241 -0.891 . . . . 0.51000000000000001 109.812 177.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.643 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -77.35 -23.01 50.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.025 -0.534 . . . . 0.40999999999999998 110.601 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.27 52.46 0.93 Allowed Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.387 -0.911 . . . . 0.45000000000000001 114.112 176.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.497 HD21 HG21 ' A' ' 57' ' ' VAL . 14.7 tp -106.52 148.0 28.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.597 -0.89 . . . . 0.89000000000000001 108.597 174.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.674 ' NE2' ' HA ' ' A' ' 115' ' ' GLN . 37.1 mt-30 -130.11 38.34 3.8 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 115.375 1.62 . . . . 1.21 115.375 -164.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.803 HG23 ' HA ' ' A' ' 59' ' ' ARG . 53.9 mt 72.22 -4.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 N-CA-C 114.186 1.18 . . . . 0.77000000000000002 114.186 163.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.28 45.03 0.23 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 119.22 -1.467 . . . . 0.37 112.277 -171.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.787 ' H ' HG12 ' A' ' 57' ' ' VAL . 20.9 m-20 -118.38 142.07 47.9 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 120.903 0.382 . . . . 0.89000000000000001 111.558 -169.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.82 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 45.0 mmtm -86.41 103.37 14.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.629 -0.714 . . . . 2.2000000000000002 110.566 -175.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.766 ' HB ' HG22 ' A' ' 55' ' ' ILE . 5.6 mt -74.4 128.82 36.76 Favored 'Isoleucine or valine' 0 C--O 1.259 1.587 0 C-N-CA 123.904 0.882 . . . . 0.48999999999999999 112.001 -177.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.895 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 3.8 mmt -93.66 -25.95 17.26 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.569 -1.651 . . . . 1.0600000000000001 112.234 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.529 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -160.28 156.88 27.13 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.61 -0.436 . . . . 0.81999999999999995 112.116 -173.586 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.522 HG12 ' CE ' ' A' ' 85' ' ' MET . 10.4 p -148.44 128.44 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.278 -0.638 . . . . 1.3100000000000001 109.278 175.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.479 ' OD1' ' HG3' ' A' ' 102' ' ' GLU . 0.9 OUTLIER 67.53 5.82 4.58 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.253 -0.431 . . . . 1.5 111.565 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.59 -7.54 53.7 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 119.882 -1.151 . . . . 0.38 111.403 -172.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -75.0 118.08 17.56 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.708 -0.849 . . . . 0.77000000000000002 108.708 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.424 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 0.5 OUTLIER -89.69 94.94 10.04 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.661 -0.7 . . . . 1.8899999999999999 109.594 -175.424 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.522 ' CE ' HG12 ' A' ' 80' ' ' VAL . 11.2 ptp -112.43 104.05 12.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.502 -0.772 . . . . 1.01 112.756 -172.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.1 p -96.86 -20.36 18.21 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 122.183 0.992 . . . . 1.05 108.773 170.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.87 81.65 0.65 Allowed 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.713 -1.585 . . . . 1.6200000000000001 110.26 -175.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.666 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.9 OUTLIER -140.49 162.57 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 108.519 -0.919 . . . . 1.0900000000000001 108.519 173.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.674 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 66.7 p -59.75 150.84 26.83 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 112.742 0.645 . . . . 0.34999999999999998 112.742 -175.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.823 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 16.2 t-160 -59.89 -35.57 75.11 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 121.743 0.782 . . . . 0.34999999999999998 109.855 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.4 -29.85 66.58 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 113.894 -1.503 . . . . 1.6699999999999999 109.64 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.557 ' HB3' ' O ' ' A' ' 89' ' ' THR . 3.4 tp-100 -63.77 -48.81 75.43 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.691 0.758 . . . . 0.77000000000000002 109.023 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.54 ' HB2' HG12 ' A' ' 55' ' ' ILE . . . -69.96 -39.29 76.1 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.905 -1.043 . . . . 0.33000000000000002 109.52 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -66.39 -42.24 88.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.083 -0.962 . . . . 2.1000000000000001 111.222 -175.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.567 ' HD3' ' HD2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -68.08 -31.08 70.45 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 119.91 -0.716 . . . . 0.95999999999999996 109.809 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.567 ' HD2' ' HD3' ' A' ' 95' ' ' LYS . 13.8 mmm180 -67.29 -47.44 70.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 120.706 -0.398 . . . . 3.5699999999999998 111.249 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 3.4 pp -83.39 0.96 43.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.35 -0.386 . . . . 1.6499999999999999 111.684 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.1 m -128.4 28.24 5.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.413 0.625 . . . . 1.53 111.33 173.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.936 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 1.3 mmpt? -82.04 118.79 23.28 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.752 -0.833 . . . . 2.7200000000000002 108.752 167.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 1.005 ' HA ' HD22 ' A' ' 27' ' ' LEU . 32.9 ptt180 -76.64 30.83 0.13 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.379 0.609 . . . . 4.3799999999999999 110.719 -177.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 99' ' ' LYS . 40.9 t -123.51 -30.61 3.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.453 -0.794 . . . . 2.5099999999999998 109.531 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.479 ' HG3' ' OD1' ' A' ' 81' ' ' ASN . 81.3 mm-40 -79.52 103.9 9.75 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.026 -0.534 . . . . 3.3999999999999999 110.01 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -71.94 -14.56 61.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.962 -0.563 . . . . 2.6800000000000002 111.404 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.747 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 5.5 p -138.04 134.79 45.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.36 0.6 . . . . 0.44 109.462 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.658 HG23 ' HG2' ' A' ' 20' ' ' LYS . 1.4 t -115.2 122.34 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-O 122.378 1.085 . . . . 0.46000000000000002 111.817 -173.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -99.97 126.86 46.2 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 113.2 -1.818 . . . . 1.76 109.364 177.783 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.67 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 10.4 tt -133.9 127.0 31.58 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.534 -0.543 . . . . 1.1200000000000001 109.534 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.666 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 39.5 tp -107.81 117.71 34.84 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.007 -1.479 . . . . 0.41999999999999998 107.007 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.74 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.5 OUTLIER -123.96 148.79 27.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 C-N-CA 119.671 -0.811 . . . . 0.77000000000000002 110.28 -176.298 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.688 HG23 HG22 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -95.85 117.48 30.65 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.195 -0.911 . . . . 0.34000000000000002 109.39 169.892 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.564 HH11 ' HB3' ' A' ' 14' ' ' GLN . 28.0 ttp180 -91.56 114.74 27.36 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.814 -1.539 . . . . 2.0099999999999998 109.255 -172.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.508 ' N ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -109.76 -55.12 2.48 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.106 -1.037 . . . . 1.97 113.48 -171.11 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.497 ' N ' ' HG2' ' A' ' 112' ' ' GLN . 33.3 t -156.66 13.98 0.28 Allowed 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.759 -0.776 . . . . 1.6200000000000001 111.965 -173.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.424 HD22 ' H ' ' A' ' 113' ' ' SER . 1.3 mm? -104.63 21.41 16.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.657 0.741 . . . . 1.6499999999999999 110.312 -177.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.674 ' HA ' ' NE2' ' A' ' 72' ' ' GLN . 34.5 mt-30 -68.96 101.18 1.33 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.785 -1.098 . . . . 3.5299999999999998 110.972 -174.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -110.4 -28.83 8.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.593 -0.731 . . . . 3.6000000000000001 111.183 -175.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -120.78 19.72 11.76 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.416 -0.811 . . . . 3.5600000000000001 110.375 -176.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 115' ' ' GLN . 95.2 t -99.67 -71.2 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.223 -0.898 . . . . 4.9900000000000002 110.852 -177.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -88.28 -60.38 1.98 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.345 -0.843 . . . . 7.7699999999999996 110.789 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 60.05 85.59 0.1 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.794 -0.639 . . . . 6.5999999999999996 111.027 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.5 t -91.3 98.4 11.69 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.063 -0.517 . . . . 8.9399999999999995 109.678 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 14.8 tpt -88.31 112.38 22.77 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.636 -0.711 . . . . 12.1 109.829 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.42 107.55 3.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.146 -0.479 . . . . 12.82 110.659 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.3 p . . . . . 0 C--O 1.253 1.281 0 CA-C-O 118.173 -0.918 . . . . 14.640000000000001 109.653 178.292 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.3 mtp . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 109.845 -0.428 . . . . 14.33 109.845 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 t 73.72 168.93 0.31 Allowed 'General case' 0 CA--C 1.533 0.3 0 O-C-N 124.108 0.88 . . . . 11.220000000000001 109.514 -176.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.503 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 42.2 p90 -161.59 175.17 12.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.65 0.262 . . . . 9.1899999999999995 111.146 -173.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.591 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -104.79 95.63 9.23 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.741 -0.663 . . . . 6.6500000000000004 110.082 177.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 3' ' ' TYR . 24.5 Cg_exo -62.42 -49.16 6.3 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.77 2.314 . . . . 7.46 111.922 -176.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -145.88 32.95 1.54 Allowed Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.695 -0.684 . . . . 5.8899999999999997 111.563 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.581 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 13.7 pt20 -148.71 45.35 0.39 Allowed Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 114.076 1.139 . . . . 6.3700000000000001 114.076 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.581 ' HD3' ' N ' ' A' ' 7' ' ' GLN . 32.9 Cg_exo -64.64 -141.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.692 2.261 . . . . 3.3999999999999999 112.218 165.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.7 m -92.0 2.9 7.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.68 -0.691 . . . . 2.2599999999999998 109.354 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 m -72.88 79.83 1.16 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 122.562 1.172 . . . . 2.0899999999999999 109.394 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.14 178.67 8.26 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 113.001 -1.909 . . . . 0.95999999999999996 110.178 175.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.6 t -111.65 107.97 24.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.625 -0.716 . . . . 1.5700000000000001 109.891 -174.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.772 HG22 HG23 ' A' ' 110' ' ' THR . 48.6 t -77.36 108.65 10.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.247 0.546 . . . . 1.02 109.585 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.757 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -108.58 167.54 9.98 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.372 -0.831 . . . . 1.3899999999999999 111.612 -173.866 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -122.3 114.49 20.87 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.96 -0.564 . . . . 3.6299999999999999 110.802 -172.327 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.713 HG13 ' CB ' ' A' ' 69' ' ' ALA . 4.9 t -99.24 132.6 44.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.211 -0.663 . . . . 1.02 109.211 176.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -144.63 117.1 8.55 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 110.137 -0.32 . . . . 1.3500000000000001 110.137 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.592 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 10.9 tp -144.89 148.25 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 108.741 -0.837 . . . . 0.60999999999999999 108.741 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.734 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 15.3 m-70 -76.22 116.08 16.57 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.008 -0.677 . . . . 0.59999999999999998 109.693 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.666 ' HB2' HD12 ' A' ' 27' ' ' LEU . 3.1 pptp? -30.59 136.44 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 O-C-N 125.065 1.478 . . . . 4.0 112.108 177.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 65' ' ' PRO . 47.1 tp -98.44 89.59 4.49 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 119.888 -0.725 . . . . 0.55000000000000004 110.761 -171.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 24.7 ptt180 -68.71 139.22 55.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.072 0.463 . . . . 3.9700000000000002 112.063 -172.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.403 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 12.1 tp60 -129.47 93.95 3.66 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.651 -0.704 . . . . 1.3500000000000001 109.238 174.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.28 -80.33 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.839 -0.696 . . . . 1.3300000000000001 112.863 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -127.09 2.71 6.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.849 0.357 . . . . 2.3300000000000001 111.699 -173.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.403 ' OD1' ' HB3' ' A' ' 23' ' ' GLN . 1.1 p30 -126.73 174.39 8.78 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.097 -0.501 . . . . 1.8700000000000001 110.426 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.666 HD12 ' HB2' ' A' ' 20' ' ' LYS . 2.0 pt? -127.42 134.39 49.88 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.777 -1.194 . . . . 2.2799999999999998 107.777 175.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 26.0 mm -98.92 136.28 30.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-O 121.13 0.491 . . . . 0.80000000000000004 111.665 -171.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.464 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -106.6 116.19 31.5 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.341 -1.299 . . . . 1.74 107.558 173.137 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.37 51.86 4.42 Favored Glycine 0 C--O 1.221 -0.691 0 C-N-CA 120.223 -0.989 . . . . 0.68999999999999995 113.249 -172.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.585 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 29.2 p90 -158.47 170.74 21.53 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.591 -0.522 . . . . 0.51000000000000001 109.591 176.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.878 ' HB3' ' O ' ' A' ' 58' ' ' THR . 1.0 OUTLIER -110.66 168.85 9.16 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 107.978 -1.119 . . . . 0.53000000000000003 107.978 170.303 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -159.82 135.91 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 113.65 0.981 . . . . 0.48999999999999999 113.65 -163.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.407 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -147.64 117.4 0.91 Allowed Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.592 -1.003 . . . . 0.71999999999999997 110.592 155.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 1.083 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -142.58 117.78 1.18 Allowed Glycine 0 CA--C 1.488 -1.63 0 CA-C-O 118.427 -1.207 . . . . 1.4199999999999999 111.141 171.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.694 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.59 137.99 4.92 Favored Glycine 0 C--N 1.298 -1.539 0 C-N-CA 117.222 -2.418 . . . . 0.47999999999999998 113.086 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.418 HG12 ' N ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -60.53 -25.32 34.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 107.345 -1.354 . . . . 0.52000000000000002 107.345 151.314 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.82 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 4.5 t70 -54.6 -40.2 68.62 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 113.524 -1.671 . . . . 0.71999999999999997 110.179 169.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -62.91 -57.63 10.13 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.378 -0.828 . . . . 1.1899999999999999 110.51 -173.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.451 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 0.3 OUTLIER -172.68 119.88 0.42 Allowed Pre-proline 0 N--CA 1.463 0.205 0 CA-C-O 121.147 0.498 . . . . 2.5699999999999998 110.329 167.691 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 7.4 Cg_endo -92.89 10.36 2.31 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.391 2.727 . . . . 2.8199999999999998 112.15 175.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.7 t -103.21 -34.57 8.77 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.1 -0.5 . . . . 3.2599999999999998 111.664 -169.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.36 18.95 13.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.987 0.899 . . . . 3.8799999999999999 108.584 -178.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.606 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 39.7 m-20 -161.24 54.97 0.58 Allowed Pre-proline 0 N--CA 1.443 -0.776 0 CA-C-N 113.813 -1.539 . . . . 5.1399999999999997 109.275 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.606 ' HD3' ' N ' ' A' ' 44' ' ' ASN . 93.4 Cg_endo -102.46 0.92 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.716 2.278 . . . . 3.71 112.657 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -179.65 27.66 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.879 0.847 . . . . 5.6200000000000001 108.987 -169.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 44' ' ' ASN . 6.0 m -75.75 -173.08 2.1 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 113.754 1.02 . . . . 3.77 113.754 -169.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -19.68 -69.48 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 112.327 -2.215 . . . . 6.7800000000000002 116.522 -175.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.745 ' HB3' HG22 ' A' ' 51' ' ' THR . 44.2 t0 -141.41 -157.62 0.78 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.05 -0.722 . . . . 5.4699999999999998 109.05 -166.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.622 ' HD2' ' CG ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -60.55 -22.88 64.13 Favored 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 120.377 -0.529 . . . . 3.0699999999999998 110.282 171.294 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.745 HG22 ' HB3' ' A' ' 49' ' ' ASP . 5.8 t -61.03 -52.94 62.84 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.338 -0.846 . . . . 4.5599999999999996 110.598 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.442 ' H ' HG23 ' A' ' 51' ' ' THR . 51.6 t0 24.19 -96.85 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 O-C-N 124.34 1.025 . . . . 2.6000000000000001 113.288 166.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.586 ' C ' ' HD2' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -130.59 29.76 4.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.585 0.707 . . . . 3.48 109.568 172.643 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.432 ' C ' HD12 ' A' ' 55' ' ' ILE . . . -78.93 -156.73 10.15 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.248 -1.141 . . . . 0.78000000000000003 110.248 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.083 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.7 mp -112.1 142.57 24.07 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 N-CA-C 107.783 -1.191 . . . . 0.54000000000000004 107.783 171.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.717 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -152.16 141.98 21.98 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 122.219 1.009 . . . . 1.4199999999999999 111.577 -177.613 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.899 HG12 ' H ' ' A' ' 75' ' ' ASP . 1.8 p -79.92 135.98 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 113.928 -1.487 . . . . 0.57999999999999996 109.565 -178.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.878 ' O ' ' HB3' ' A' ' 32' ' ' SER . 15.8 m -125.09 64.47 1.14 Allowed 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.322 -0.854 . . . . 1.1100000000000001 109.372 175.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.565 ' HA ' HG23 ' A' ' 73' ' ' ILE . 64.2 mtt180 148.01 -168.5 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 125.939 1.696 . . . . 2.27 110.109 164.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.585 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 57.8 t -164.0 137.89 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 125.89 1.994 . . . . 0.82999999999999996 106.29 164.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.3 m -75.03 121.57 22.19 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.915 -0.772 . . . . 1.6499999999999999 108.915 173.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -50.39 108.94 0.26 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.174 -0.921 . . . . 1.8500000000000001 111.927 177.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.58 -6.05 70.57 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.557 -0.747 . . . . 0.92000000000000004 112.482 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.557 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -80.12 174.47 55.03 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.726 -0.75 . . . . 0.98999999999999999 112.17 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.462 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 46.7 Cg_endo -68.37 -28.4 32.99 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 122.837 2.358 . . . . 0.44 113.708 -164.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.471 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -65.57 -30.77 71.55 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.203 -0.908 . . . . 0.35999999999999999 110.881 177.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.507 ' HB2' HG11 ' A' ' 60' ' ' VAL . 14.6 tt0 -77.65 -31.2 52.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.326 0.584 . . . . 1.79 109.528 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.557 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.3 mp -65.81 -39.77 85.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.314 -0.857 . . . . 0.51000000000000001 109.84 175.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.713 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -75.27 -23.22 57.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.852 -0.613 . . . . 0.40999999999999998 110.295 176.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.53 46.63 1.2 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.843 -1.17 . . . . 0.45000000000000001 114.427 173.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.786 HD22 HG11 ' A' ' 57' ' ' VAL . 2.9 mt -91.93 156.51 17.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.62 0.71 . . . . 0.89000000000000001 111.079 175.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 46.1 mt-30 -132.82 32.09 3.86 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 114.599 1.333 . . . . 1.21 114.599 -166.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.565 HG23 ' HA ' ' A' ' 59' ' ' ARG . 3.4 mp 75.05 -14.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 N-CA-C 114.059 1.133 . . . . 0.77000000000000002 114.059 167.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.6 52.27 0.37 Allowed Glycine 0 N--CA 1.463 0.482 0 C-N-CA 119.761 -1.209 . . . . 0.37 112.405 -167.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.899 ' H ' HG12 ' A' ' 57' ' ' VAL . 21.5 m-20 -120.7 146.51 46.37 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.117 -0.541 . . . . 0.89000000000000001 110.388 -169.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.598 ' HD2' ' N ' ' A' ' 76' ' ' LYS . 10.3 mptt -101.44 102.4 13.19 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.516 0.674 . . . . 2.2000000000000002 110.483 -170.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.931 HG13 HG23 ' A' ' 109' ' ' VAL . 3.1 mp -64.49 122.79 16.05 Favored 'Isoleucine or valine' 0 C--O 1.256 1.424 0 CA-C-N 114.742 -1.117 . . . . 0.48999999999999999 112.295 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.881 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 2.7 mmt -91.92 -16.91 25.95 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 125.909 2.006 . . . . 1.0600000000000001 111.148 173.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.581 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 1.1 tt0 -172.42 152.26 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.908 0.336 . . . . 0.81999999999999995 111.908 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.712 HG12 ' HE1' ' A' ' 85' ' ' MET . 2.4 p -138.4 124.41 24.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.285 0.564 . . . . 1.3100000000000001 110.133 173.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.485 ' OD1' HG22 ' A' ' 80' ' ' VAL . 20.0 m120 53.02 28.65 6.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.298 -0.864 . . . . 1.5 112.669 174.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.41 -13.75 47.46 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.285 -0.959 . . . . 0.38 113.132 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.474 ' CE2' ' HD2' ' A' ' 96' ' ' ARG . 80.4 m95 -86.88 148.16 25.48 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.623 -0.51 . . . . 0.77000000000000002 109.623 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.64 118.68 37.28 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.663 -0.698 . . . . 1.8899999999999999 111.975 -173.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.712 ' HE1' HG12 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -107.13 103.48 12.89 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.901 0.858 . . . . 1.01 111.377 179.603 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 p -131.16 -48.3 1.0 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.221 -1.4 . . . . 1.05 107.221 168.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.86 84.67 2.1 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 112.622 -2.081 . . . . 1.6200000000000001 107.509 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.695 ' O ' HD11 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -137.73 136.45 45.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.026 -0.988 . . . . 1.0900000000000001 108.453 -177.258 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.766 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 72.9 p -58.1 149.9 22.46 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.161 0.505 . . . . 0.34999999999999998 112.205 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.82 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 21.9 t-160 -58.11 -36.82 73.46 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.635 0.731 . . . . 0.34999999999999998 109.792 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.72 -31.36 66.63 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.203 -1.362 . . . . 1.6699999999999999 109.961 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.694 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -65.65 -50.47 64.84 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.583 -0.895 . . . . 0.77000000000000002 108.583 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.72 ' HB2' HG12 ' A' ' 55' ' ' ILE . . . -65.59 -37.2 85.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.678 -0.692 . . . . 0.33000000000000002 110.274 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -68.53 -42.21 78.81 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.489 -0.778 . . . . 2.1000000000000001 110.935 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.557 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -72.8 -41.9 64.46 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 116.363 -0.38 . . . . 0.95999999999999996 110.228 -176.59 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.694 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 29.8 mmt180 -68.04 -32.9 73.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.015 0.436 . . . . 3.5699999999999998 110.315 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.663 ' HB2' HG21 ' A' ' 80' ' ' VAL . 10.8 tp -73.18 -55.24 6.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.394 -0.821 . . . . 1.6499999999999999 110.203 173.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 m -94.23 77.59 3.99 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 122.949 1.357 . . . . 1.53 109.779 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.535 ' HE2' ' HB3' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -138.5 108.72 6.43 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 112.316 -2.22 . . . . 2.7200000000000002 106.35 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -70.79 70.1 0.47 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.384 0.611 . . . . 4.3799999999999999 112.091 -170.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.0 t -137.55 -31.49 0.8 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.784 -0.644 . . . . 2.5099999999999998 110.805 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 19.3 mm-40 -68.21 141.32 56.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.476 -0.329 . . . . 3.3999999999999999 110.9 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.503 ' HG3' HG12 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -94.84 -11.22 29.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.922 0.868 . . . . 2.6800000000000002 108.872 169.9 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.734 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 3.7 p -153.2 145.55 14.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.237 -1.347 . . . . 0.44 108.211 -175.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.442 HG23 ' HB3' ' A' ' 20' ' ' LYS . 43.8 t -119.98 118.93 58.61 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.03 0 CA-C-O 122.439 1.114 . . . . 0.46000000000000002 112.065 -169.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.403 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 2.1 mpt_? -99.62 129.31 45.76 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 112.72 -2.036 . . . . 1.76 111.006 -175.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.799 HD11 HG12 ' A' ' 77' ' ' ILE . 35.0 tp -132.8 130.77 40.31 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 116.489 -0.323 . . . . 1.1200000000000001 110.745 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.881 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 35.5 tp -107.19 114.81 29.09 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 106.785 -1.561 . . . . 0.41999999999999998 106.785 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.931 HG23 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -128.76 147.14 33.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 C-N-CA 120.313 -0.555 . . . . 0.77000000000000002 110.562 -172.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.772 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -97.56 117.11 31.09 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.707 -0.797 . . . . 0.34000000000000002 110.556 173.401 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.501 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -110.04 135.46 50.83 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.418 -1.265 . . . . 2.0099999999999998 109.495 -175.456 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.515 ' OE1' HD23 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -114.25 -72.74 0.68 Allowed 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.687 0.625 . . . . 1.97 112.687 -169.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.4 t -140.87 18.15 2.31 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.647 0.737 . . . . 1.6200000000000001 110.216 -172.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 4.1 mm? -96.3 22.55 7.63 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.36 -0.836 . . . . 1.6499999999999999 109.766 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.416 ' HG3' ' H ' ' A' ' 115' ' ' GLN . 0.8 OUTLIER -60.44 142.94 54.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.834 -1.076 . . . . 3.5299999999999998 111.522 -178.789 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -104.31 93.59 4.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.18 -0.464 . . . . 3.6000000000000001 111.786 -175.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 40.2 80.2 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.297 0.998 . . . . 3.5600000000000001 113.508 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.1 p -136.33 -7.76 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.022 0.439 . . . . 4.9900000000000002 111.707 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -89.82 -16.65 29.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.826 0.346 . . . . 7.7699999999999996 110.882 -175.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -78.98 96.24 5.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.662 0.744 . . . . 6.5999999999999996 110.63 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 40.8 t -83.85 -65.36 1.02 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.363 -0.835 . . . . 8.9399999999999995 110.364 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 57.8 ttp -87.04 142.45 27.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.919 -0.582 . . . . 12.1 109.943 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 98.2 mt -84.65 135.26 34.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.772 0.32 . . . . 12.82 110.43 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.096 -0.954 . . . . 14.640000000000001 109.296 176.098 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.773 0.321 . . . . 14.33 110.392 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 p -88.7 107.24 18.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.295 0.569 . . . . 11.220000000000001 110.787 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.418 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 70.1 t80 -107.44 131.01 54.75 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.658 -0.701 . . . . 9.1899999999999995 109.485 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.798 HG22 ' HG3' ' A' ' 7' ' ' GLN . 0.9 OUTLIER -113.17 94.13 29.11 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-O 121.227 0.537 . . . . 6.6500000000000004 110.936 -178.242 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 3' ' ' TYR . 12.9 Cg_exo -67.69 -57.56 0.16 Allowed 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.702 2.268 . . . . 7.46 111.293 -177.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -135.4 36.03 2.09 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.659 -0.781 . . . . 5.8899999999999997 112.187 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.798 ' HG3' HG22 ' A' ' 4' ' ' ILE . 19.6 pt20 -146.31 34.27 0.13 Allowed Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 115.27 1.581 . . . . 6.3700000000000001 115.27 177.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.641 ' HD3' ' N ' ' A' ' 7' ' ' GLN . 5.3 Cg_exo -74.37 118.95 5.55 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.538 1.492 . . . . 3.3999999999999999 111.13 167.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.567 ' HB ' ' O ' ' A' ' 8' ' ' PRO . 37.3 t 80.03 -51.64 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 122.803 0.441 . . . . 2.2599999999999998 111.672 177.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 p -69.45 82.81 0.4 Allowed 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 122.167 0.984 . . . . 2.0899999999999999 111.445 -176.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.577 ' CB ' ' HA ' ' A' ' 112' ' ' GLN . . . -86.5 178.4 7.11 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.614 -1.63 . . . . 0.95999999999999996 111.045 177.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -129.46 138.46 54.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.268 -0.878 . . . . 1.5700000000000001 108.986 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.696 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 0.9 OUTLIER -90.72 127.2 43.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 C-N-CA 119.413 -0.915 . . . . 1.02 110.897 -174.778 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.681 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -118.63 166.38 12.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.527 -1.215 . . . . 1.3899999999999999 110.137 176.951 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.523 ' HD2' ' H ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -124.98 135.29 52.66 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.605 -0.685 . . . . 3.6299999999999999 110.325 -175.909 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.708 HG13 ' CB ' ' A' ' 69' ' ' ALA . 4.1 t -105.95 109.04 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 CA-C-O 121.501 0.667 . . . . 1.02 109.436 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -109.31 119.53 39.76 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.37 -0.832 . . . . 1.3500000000000001 109.586 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.707 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 11.3 tp -145.71 146.18 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.871 -0.789 . . . . 0.60999999999999999 108.871 174.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 14.6 m-70 -80.15 112.0 17.05 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.529 -0.915 . . . . 0.59999999999999998 108.529 177.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.684 ' HB2' HD12 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -25.16 140.16 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 O-C-N 124.923 1.389 . . . . 4.0 112.814 -178.692 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.58 HD22 ' HA2' ' A' ' 64' ' ' GLY . 43.9 tp -96.16 97.5 9.59 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 119.102 -1.039 . . . . 0.55000000000000004 110.009 -172.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.638 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 12.4 ptp180 -61.13 142.71 56.51 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.744 0.783 . . . . 3.9700000000000002 112.067 -173.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.568 ' HB2' HD13 ' A' ' 28' ' ' ILE . 4.3 tp60 -128.43 93.42 3.64 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.141 -1.059 . . . . 1.3500000000000001 108.141 172.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.6 -78.16 0.26 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.418 -0.896 . . . . 1.3300000000000001 111.352 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.463 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 54.5 mt-10 -139.2 11.44 2.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.156 0.503 . . . . 2.3300000000000001 110.63 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.638 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 10.8 m-80 -108.48 -177.53 3.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.895 -0.593 . . . . 1.8700000000000001 109.685 -177.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.684 HD12 ' HB2' ' A' ' 20' ' ' LYS . 1.0 OUTLIER -127.68 135.48 50.25 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 108.226 -1.027 . . . . 2.2799999999999998 108.226 173.924 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.568 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.0 OUTLIER -102.49 138.0 28.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 120.99 0.424 . . . . 0.80000000000000004 110.871 -179.173 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.8 tp -98.6 124.18 43.23 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.938 -1.483 . . . . 1.74 108.394 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.728 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -93.92 35.1 4.31 Favored Glycine 0 C--O 1.223 -0.582 0 C-N-CA 120.226 -0.988 . . . . 0.68999999999999995 114.075 -170.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.569 ' CD1' HG23 ' A' ' 57' ' ' VAL . 39.8 p90 -157.77 169.84 23.71 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.544 -0.539 . . . . 0.51000000000000001 109.544 177.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.709 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -104.43 159.75 15.47 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.845 -1.169 . . . . 0.53000000000000003 107.845 171.512 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.419 HD12 HD21 ' A' ' 97' ' ' LEU . 0.9 OUTLIER -152.91 135.24 6.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 113.354 0.872 . . . . 0.48999999999999999 113.354 -167.112 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -145.06 118.06 1.07 Allowed Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 110.059 -1.216 . . . . 0.71999999999999997 110.059 154.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 1.069 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -139.6 117.74 1.39 Allowed Glycine 0 CA--C 1.49 -1.487 0 CA-C-O 119.093 -0.837 . . . . 1.4199999999999999 111.233 172.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.782 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.15 137.32 4.57 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 118.012 -2.042 . . . . 0.47999999999999998 112.79 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.9 pt -58.75 -24.6 26.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.479 -1.304 . . . . 0.52000000000000002 107.479 153.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.738 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 4.1 t70 -56.1 -43.71 78.36 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 113.156 -1.838 . . . . 0.71999999999999997 110.182 171.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -63.75 -51.69 63.74 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 114.977 -1.01 . . . . 1.1899999999999999 112.317 -171.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.598 ' OD2' ' HB2' ' A' ' 43' ' ' GLN . 0.4 OUTLIER -166.56 103.8 0.67 Allowed Pre-proline 0 C--O 1.214 -0.77 0 CA-C-O 121.323 0.582 . . . . 2.5699999999999998 111.911 -174.453 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -88.7 12.94 2.63 Favored 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 123.222 2.615 . . . . 2.8199999999999998 112.804 176.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.45 ' O ' ' HG3' ' A' ' 43' ' ' GLN . 6.6 t -109.26 17.45 21.53 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.482 -0.326 . . . . 3.2599999999999998 111.035 -172.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.598 ' HB2' ' OD2' ' A' ' 40' ' ' ASP . 52.3 mt-30 -150.9 50.53 0.86 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.642 0.734 . . . . 3.8799999999999999 109.853 -178.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.547 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 4.4 p-10 -169.52 51.66 0.19 Allowed Pre-proline 0 N--CA 1.444 -0.749 0 CA-C-N 114.603 -1.181 . . . . 5.1399999999999997 108.297 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 44' ' ' ASN . 50.2 Cg_exo -53.57 -28.04 43.92 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.805 2.337 . . . . 3.71 111.76 -171.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -132.81 -49.79 0.89 Allowed 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.999 -1.482 . . . . 5.6200000000000001 106.999 170.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.5 ' HB2' ' OD1' ' A' ' 52' ' ' ASP . 2.5 p -159.76 171.37 19.63 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.559 -1.2 . . . . 3.77 108.857 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.572 ' HB3' HG23 ' A' ' 51' ' ' THR . 40.4 tt0 -111.1 -30.3 7.53 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 121.105 -0.238 . . . . 6.7800000000000002 111.051 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.669 ' HB3' HG22 ' A' ' 51' ' ' THR . 9.7 t70 169.43 -114.99 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.379 -0.971 . . . . 5.4699999999999998 108.379 -176.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.583 ' HD2' ' H ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -99.71 10.59 41.08 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.434 0.635 . . . . 3.0699999999999998 109.672 161.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.769 ' HB ' ' HD2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -102.88 -54.81 2.55 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.281 -0.872 . . . . 4.5599999999999996 109.116 -175.264 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.5 ' OD1' ' HB2' ' A' ' 47' ' ' SER . 18.4 m-20 52.74 30.77 9.36 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 124.07 0.856 . . . . 2.6000000000000001 112.589 172.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.479 ' HD3' ' OH ' ' A' ' 56' ' ' TYR . 2.3 tppt? 68.52 40.14 1.99 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.132 0.968 . . . . 3.48 110.273 -178.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.495 ' C ' HD12 ' A' ' 55' ' ' ILE . . . -89.12 -135.34 5.47 Favored Glycine 0 N--CA 1.429 -1.778 0 N-CA-C 109.156 -1.577 . . . . 0.78000000000000003 109.156 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.069 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -117.41 140.58 39.72 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.403 0 C-N-CA 119.656 -0.818 . . . . 0.54000000000000004 108.889 176.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.661 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -142.36 142.43 32.45 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 119.553 1.069 . . . . 1.4199999999999999 110.374 -176.111 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.58 HG12 ' H ' ' A' ' 75' ' ' ASP . 11.9 p -82.63 136.23 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 114.664 -1.153 . . . . 0.57999999999999996 110.301 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.709 ' O ' ' HB3' ' A' ' 32' ' ' SER . 23.7 m -127.23 66.05 1.3 Allowed 'General case' 0 N--CA 1.439 -1.006 0 O-C-N 124.346 1.029 . . . . 1.1100000000000001 109.035 172.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 37.7 mtt180 150.01 -170.28 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.746 1.619 . . . . 2.27 110.434 162.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 90.8 t -160.97 111.46 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 113.595 -1.639 . . . . 0.82999999999999996 106.625 161.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 m -70.76 158.52 36.16 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.504 0.669 . . . . 1.6499999999999999 110.021 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -97.62 130.41 44.65 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.027 -0.988 . . . . 1.8500000000000001 111.289 -169.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.9 -9.83 72.7 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.327 -0.94 . . . . 0.92000000000000004 111.325 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.637 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -85.05 -158.95 30.35 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.607 -0.806 . . . . 0.98999999999999999 111.436 174.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.728 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 40.5 Cg_endo -90.02 -30.21 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.664 2.243 . . . . 0.44 115.382 -171.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 30' ' ' GLY . . . -69.17 -23.1 63.89 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 116.229 -0.441 . . . . 0.35999999999999999 111.473 -174.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -72.03 -38.14 69.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.797 0.808 . . . . 1.79 108.959 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.637 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.3 mp -69.69 -45.29 78.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.526 -1.215 . . . . 0.51000000000000001 110.585 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.708 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -67.26 -30.53 70.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.40999999999999998 109.898 175.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.34 62.3 1.0 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.459 -0.877 . . . . 0.45000000000000001 113.427 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.481 ' O ' HG21 ' A' ' 60' ' ' VAL . 21.6 tp -98.15 158.31 15.63 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.045 -0.724 . . . . 0.89000000000000001 109.045 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.527 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 43.9 mt-30 -132.21 42.25 3.15 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 115.15 1.537 . . . . 1.21 115.15 -164.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.541 ' O ' ' HA ' ' A' ' 58' ' ' THR . 3.4 mp 71.56 -20.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 N-CA-C 115.741 1.756 . . . . 0.77000000000000002 115.741 161.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -164.06 57.77 0.27 Allowed Glycine 0 N--CA 1.463 0.484 0 C-N-CA 119.803 -1.189 . . . . 0.37 112.148 -164.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.582 ' HB3' ' CG2' ' A' ' 109' ' ' VAL . 9.5 m-20 -124.76 154.15 41.34 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.823 -0.688 . . . . 0.89000000000000001 109.819 -168.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.769 ' HD2' ' HB ' ' A' ' 51' ' ' THR . 72.2 mmtt -106.68 103.01 12.35 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.511 0.672 . . . . 2.2000000000000002 109.878 -170.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 1.002 HG13 HG23 ' A' ' 109' ' ' VAL . 3.5 mp -73.65 125.14 32.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 114.696 -1.138 . . . . 0.48999999999999999 113.344 -172.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.718 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 4.4 mmt -86.18 -21.8 27.32 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 113.053 -1.885 . . . . 1.0600000000000001 112.174 176.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.515 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -168.91 149.95 4.51 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.455 0.539 . . . . 0.81999999999999995 112.455 -174.586 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.656 HG22 ' SD ' ' A' ' 85' ' ' MET . 30.1 m -132.55 123.04 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.84 -0.618 . . . . 1.3100000000000001 110.313 174.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.704 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 1.0 OUTLIER 56.87 25.13 10.07 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.071 0.767 . . . . 1.5 113.071 174.58 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.64 -7.13 57.62 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.358 -1.401 . . . . 0.38 112.669 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -91.84 152.57 20.04 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.817 -0.809 . . . . 0.77000000000000002 108.817 174.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -103.05 112.96 26.05 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.669 0.747 . . . . 1.8899999999999999 111.742 -172.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.656 ' SD ' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -106.34 101.62 11.08 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.055 -0.975 . . . . 1.01 111.359 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.1 p -118.24 -41.33 2.87 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.745 1.259 . . . . 1.05 107.741 168.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -148.22 84.49 1.51 Allowed 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 112.556 -2.111 . . . . 1.6200000000000001 107.825 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.782 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.5 t -140.04 135.05 37.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.219 -0.901 . . . . 1.0900000000000001 109.56 -172.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.738 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 69.5 p -55.92 148.28 17.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.292 0.479 . . . . 0.34999999999999998 112.292 -178.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.743 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 22.7 t-160 -56.14 -40.25 73.52 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 115.883 -0.599 . . . . 0.34999999999999998 110.715 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.6 -32.29 70.94 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.115 -0.948 . . . . 1.6699999999999999 109.365 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.826 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 2.5 tp-100 -63.0 -49.45 74.62 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 108.598 -0.89 . . . . 0.77000000000000002 108.598 -178.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.732 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -73.06 -40.47 65.04 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.632 -0.713 . . . . 0.33000000000000002 110.611 -177.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 94' ' ' ARG . 33.2 ttp180 -57.16 -44.32 83.37 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.304 0.573 . . . . 2.1000000000000001 109.644 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.453 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -66.68 -35.51 80.33 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.368 -0.833 . . . . 0.95999999999999996 109.638 -178.451 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.826 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 22.2 mmt180 -76.18 -26.36 56.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.006 -0.543 . . . . 3.5699999999999998 111.602 -176.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.684 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 2.8 pp -101.49 -0.19 35.56 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.098 0.777 . . . . 1.6499999999999999 113.098 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.2 m -126.67 65.47 1.26 Allowed 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 122.373 1.082 . . . . 1.53 110.871 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE2' ' O ' ' A' ' 96' ' ' ARG . 20.4 mtmt -112.25 114.32 27.04 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 113.937 -1.483 . . . . 2.7200000000000002 108.538 171.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' A' ' 25' ' ' GLU . 15.6 ptt180 -74.88 32.32 0.09 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.348 0.595 . . . . 4.3799999999999999 110.764 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 99' ' ' LYS . 13.2 p -119.73 -41.79 2.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.511 -0.768 . . . . 2.5099999999999998 109.747 -177.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -52.1 142.84 15.32 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.466 -0.788 . . . . 3.3999999999999999 110.477 175.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -93.66 -13.21 27.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.28 0.562 . . . . 2.6800000000000002 110.43 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 5.7 p -151.06 146.74 16.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.77 -0.65 . . . . 0.44 109.547 -176.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.422 HG13 HD21 ' A' ' 81' ' ' ASN . 47.8 t -114.24 120.36 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-O 121.946 0.879 . . . . 0.46000000000000002 111.708 -175.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.704 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.2 OUTLIER -100.26 127.76 46.48 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.488 -1.687 . . . . 1.76 110.613 -177.114 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.806 HD11 HG12 ' A' ' 77' ' ' ILE . 31.1 tp -133.39 126.92 32.34 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.044 -0.526 . . . . 1.1200000000000001 109.947 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.718 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 35.4 tp -111.53 116.01 30.14 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.47 -1.308 . . . . 0.41999999999999998 107.47 175.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 1.002 HG23 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -120.93 153.74 24.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.019 0.438 . . . . 0.77000000000000002 110.391 -173.507 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.696 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 0.7 OUTLIER -98.71 115.09 27.95 Favored 'General case' 0 N--CA 1.426 -1.673 0 C-N-CA 119.619 -0.832 . . . . 0.34000000000000002 110.018 165.482 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.504 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 17.3 ttt180 -92.23 112.79 24.86 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.689 -1.142 . . . . 2.0099999999999998 109.329 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.577 ' HA ' ' CB ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -86.1 -58.56 2.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.471 -0.786 . . . . 1.97 112.197 -171.822 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.2 t -149.17 8.59 0.73 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.164 0.507 . . . . 1.6200000000000001 110.906 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 3.1 mm? -81.66 106.19 13.41 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.207 -1.034 . . . . 1.6499999999999999 108.207 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -128.63 149.5 50.62 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.643 -0.708 . . . . 3.5299999999999998 110.191 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -138.82 145.33 39.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.568 0.223 . . . . 3.6000000000000001 111.27 -174.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 53.91 56.21 7.41 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.554 -0.748 . . . . 3.5600000000000001 110.987 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.04 -5.94 11.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.396 -0.82 . . . . 4.9900000000000002 110.61 -175.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -123.85 99.5 6.3 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.356 -0.609 . . . . 7.7699999999999996 109.356 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -139.35 115.31 10.22 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.006 -0.543 . . . . 6.5999999999999996 110.534 -174.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.5 m -65.08 115.81 5.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.642 -0.708 . . . . 8.9399999999999995 111.235 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 87.6 mtp -84.3 133.24 34.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.106 -0.497 . . . . 12.1 110.701 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.4 tp -124.73 14.89 8.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.631 0.729 . . . . 12.82 109.472 178.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.3 p . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.059 -0.972 . . . . 14.640000000000001 109.638 -176.493 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 110.289 -0.263 . . . . 14.33 110.289 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.6 t -93.94 174.26 7.25 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.09 -0.337 . . . . 11.220000000000001 110.09 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -115.41 134.73 54.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.376 -0.602 . . . . 9.1899999999999995 109.376 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.9 HD12 ' HA ' ' A' ' 8' ' ' PRO . 7.4 pt -120.3 78.03 26.41 Favored Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-O 121.119 0.485 . . . . 6.6500000000000004 111.169 -173.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.52 -38.42 3.4 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.25 1.967 . . . . 7.46 111.83 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.26 22.78 4.17 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.679 -0.692 . . . . 5.8899999999999997 111.623 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.713 ' HG3' HG22 ' A' ' 4' ' ' ILE . 30.1 pt20 -145.3 38.98 0.24 Allowed Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 114.274 1.213 . . . . 6.3700000000000001 114.274 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.9 ' HA ' HD12 ' A' ' 4' ' ' ILE . 50.6 Cg_exo -56.0 163.45 5.93 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.093 1.862 . . . . 3.3999999999999999 112.213 171.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 9' ' ' VAL . 12.9 p -109.37 17.92 7.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.729 0.776 . . . . 2.2599999999999998 109.437 -173.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 t -73.43 79.79 1.41 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 123.27 1.51 . . . . 2.0899999999999999 109.639 173.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.22 177.01 9.25 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 112.215 -2.266 . . . . 0.95999999999999996 110.05 172.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.9 m -120.72 132.41 70.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 116.039 -0.528 . . . . 1.5700000000000001 110.371 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.697 HG22 HG23 ' A' ' 110' ' ' THR . 16.3 t -85.94 114.28 25.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.904 0.383 . . . . 1.02 110.626 -176.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.735 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -112.61 169.96 8.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.402 0.62 . . . . 1.3899999999999999 112.232 -179.061 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -110.11 141.77 42.52 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.594 0.712 . . . . 3.6299999999999999 112.409 -173.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.707 ' HB ' ' HB3' ' A' ' 107' ' ' LEU . 34.0 t -129.99 128.74 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 108.28 -1.008 . . . . 1.02 108.28 170.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -143.38 119.74 10.92 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.673 0.273 . . . . 1.3500000000000001 110.418 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.541 HG12 ' HB2' ' A' ' 65' ' ' PRO . 10.7 tp -145.33 150.57 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.275 0 N-CA-C 108.818 -0.808 . . . . 0.60999999999999999 108.818 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.785 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 15.8 m-70 -80.71 114.99 19.99 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.187 -0.605 . . . . 0.59999999999999998 109.402 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 3.0 pptp? -27.62 136.2 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 O-C-N 125.051 1.469 . . . . 4.0 112.459 177.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.2 tp -109.14 98.1 7.61 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 120.656 -0.418 . . . . 0.55000000000000004 110.684 -175.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 57.7 mtt180 -67.04 135.66 54.03 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.452 0.644 . . . . 3.9700000000000002 111.537 177.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -120.76 92.41 3.76 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.107 -1.071 . . . . 1.3500000000000001 108.107 172.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.1 -81.48 0.13 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.104 -0.57 . . . . 1.3300000000000001 111.748 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -129.88 5.1 4.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.779 0.799 . . . . 2.3300000000000001 110.819 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 7.4 m-80 -108.27 167.8 9.76 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.336 -0.847 . . . . 1.8700000000000001 110.224 -177.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.437 HD13 ' HG2' ' A' ' 100' ' ' ARG . 6.6 mp -121.73 122.58 39.86 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.564 -0.902 . . . . 2.2799999999999998 108.564 171.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.7 mm -98.0 127.71 50.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.599 -0.728 . . . . 0.80000000000000004 110.234 -174.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.613 HD13 HD21 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -84.96 -38.27 19.5 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 114.581 -1.19 . . . . 1.74 109.063 -179.36 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.99 5.76 62.33 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.02 -0.991 . . . . 0.68999999999999995 111.479 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 39.5 p90 -151.57 167.12 29.06 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.462 -0.57 . . . . 0.51000000000000001 109.462 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.715 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -106.0 169.18 8.65 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 118.822 -1.151 . . . . 0.53000000000000003 108.889 173.302 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.458 HD11 HG21 ' A' ' 55' ' ' ILE . 6.8 tt -140.92 134.72 32.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 119.87 -0.732 . . . . 0.48999999999999999 112.323 -164.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -103.14 173.17 22.11 Favored Glycine 0 C--N 1.329 0.191 0 N-CA-C 110.77 -0.932 . . . . 0.71999999999999997 110.77 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.574 ' HA2' ' CG ' ' A' ' 90' ' ' HIS . . . -110.46 168.57 13.06 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 118.243 2.057 . . . . 1.4199999999999999 118.243 -162.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.632 ' HA3' ' O ' ' A' ' 88' ' ' VAL . . . -84.5 -142.42 5.55 Favored Glycine 0 N--CA 1.422 -2.254 0 CA-C-N 110.816 -2.692 . . . . 0.47999999999999998 113.272 -176.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.756 HG23 ' O ' ' A' ' 87' ' ' MET . 8.7 pt -83.1 -5.2 8.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 113.258 0.836 . . . . 0.52000000000000002 113.258 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.966 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 13.3 p-10 -70.02 -32.74 71.05 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 120.996 -0.282 . . . . 0.71999999999999997 111.248 -173.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.36 -52.16 66.84 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.616 0.722 . . . . 1.1899999999999999 109.116 -172.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 2.0 m-20 -143.0 118.07 6.42 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 114.516 -1.22 . . . . 2.5699999999999998 110.29 171.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 17.7 Cg_exo -67.75 -1.93 7.66 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.096 2.531 . . . . 2.8199999999999998 112.386 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.8 t -92.34 14.8 15.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.534 0.683 . . . . 3.2599999999999998 109.342 176.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -123.93 34.76 4.98 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.943 -1.132 . . . . 3.8799999999999999 107.943 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.633 ' H ' ' CD ' ' A' ' 45' ' ' PRO . 3.7 m-20 -115.56 -41.24 0.07 OUTLIER Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 113.731 -1.577 . . . . 5.1399999999999997 109.763 -170.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.633 ' CD ' ' H ' ' A' ' 44' ' ' ASN . 22.7 Cg_exo -68.78 7.0 0.82 Allowed 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.23 1.953 . . . . 3.71 112.583 173.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -106.91 -6.56 17.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.023 -0.535 . . . . 5.6200000000000001 110.256 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.451 ' HA ' ' HB2' ' A' ' 52' ' ' ASP . 3.8 m -85.5 97.3 9.97 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-O 122.525 1.155 . . . . 3.77 109.45 -171.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.794 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 3.4 tp10 -62.91 -39.97 96.17 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 113.163 -1.835 . . . . 6.7800000000000002 110.307 -178.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 48' ' ' GLU . 14.7 t70 169.5 -128.87 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 106.263 -1.755 . . . . 5.4699999999999998 106.263 -175.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.553 ' HD2' ' C ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -54.25 -33.88 59.51 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.9 0.857 . . . . 3.0699999999999998 109.108 164.183 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.794 ' HB ' ' HB3' ' A' ' 48' ' ' GLU . 2.0 m -56.39 -22.9 34.42 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 113.859 -1.519 . . . . 4.5599999999999996 112.612 -173.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' HB2' ' HA ' ' A' ' 47' ' ' SER . 37.4 t70 -57.26 -106.64 0.0 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.677 0.751 . . . . 2.6000000000000001 110.132 170.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -172.63 -28.29 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.517 -0.765 . . . . 3.48 109.823 174.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.598 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 53.79 -121.2 17.25 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 110.276 -1.13 . . . . 0.78000000000000003 110.276 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.88 HG12 ' HB3' ' A' ' 93' ' ' ALA . 1.8 mp -108.89 146.07 14.96 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.175 0 N-CA-C 105.839 -1.911 . . . . 0.54000000000000004 105.839 170.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.725 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 1.0 OUTLIER -153.54 140.27 19.0 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 119.295 0.952 . . . . 1.4199999999999999 110.264 -169.72 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.588 ' O ' ' HA2' ' A' ' 74' ' ' GLY . 14.4 p -72.15 132.08 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 CA-C-N 115.44 -0.8 . . . . 0.57999999999999996 110.718 -171.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.715 ' O ' ' HB3' ' A' ' 32' ' ' SER . 19.3 m -125.34 64.71 1.16 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.98 -1.009 . . . . 1.1100000000000001 109.225 174.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.561 ' HA ' HG13 ' A' ' 73' ' ' ILE . 34.5 mtt180 149.38 -173.19 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.392 1.477 . . . . 2.27 111.407 165.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.621 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 4.8 p -174.34 120.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 113.167 -1.833 . . . . 0.82999999999999996 108.269 162.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.9 m -94.27 133.92 37.29 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.132 0.492 . . . . 1.6499999999999999 110.993 -175.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -61.4 124.51 20.83 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.643 -1.162 . . . . 1.8500000000000001 110.382 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.07 -13.06 45.02 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.047 -0.979 . . . . 0.92000000000000004 111.642 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.99 166.82 30.13 Favored Glycine 0 N--CA 1.438 -1.177 0 N-CA-C 111.026 -0.83 . . . . 0.98999999999999999 111.026 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.637 ' HA ' HD13 ' A' ' 68' ' ' ILE . 77.7 Cg_endo -73.98 -23.03 16.57 Favored 'Trans proline' 0 C--N 1.325 -0.676 0 C-N-CA 122.798 2.332 . . . . 0.44 113.036 -170.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.508 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -63.13 -29.38 70.75 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.688 -1.142 . . . . 0.35999999999999999 111.635 176.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -68.96 -37.29 78.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.417 0.627 . . . . 1.79 109.531 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.637 HD13 ' HA ' ' A' ' 65' ' ' PRO . 2.9 mp -67.76 -43.59 86.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 114.894 -1.048 . . . . 0.51000000000000001 110.533 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.69 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -75.76 -19.58 58.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.288 0.566 . . . . 0.40999999999999998 109.686 175.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.13 70.63 1.28 Allowed Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.365 -0.834 . . . . 0.45000000000000001 113.258 176.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.6 ' CD2' HG11 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -79.23 170.09 17.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.808 0.813 . . . . 0.89000000000000001 112.132 178.583 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.494 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 6.2 mm100 -108.26 -20.9 12.98 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 115.593 1.701 . . . . 1.21 115.593 -161.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.61 HD12 HG12 ' A' ' 60' ' ' VAL . 0.8 OUTLIER 82.41 -24.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 112.418 0.525 . . . . 0.77000000000000002 112.418 -172.556 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.588 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -172.02 53.34 0.17 Allowed Glycine 0 C--N 1.341 0.826 0 C-N-CA 119.873 -1.156 . . . . 0.37 112.691 -164.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.661 ' HB3' HG22 ' A' ' 109' ' ' VAL . 0.7 OUTLIER -122.19 149.71 43.26 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 122.204 0.201 . . . . 0.89000000000000001 110.548 -175.206 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.725 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 66.8 mttm -82.39 113.03 19.88 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.691 0.281 . . . . 2.2000000000000002 111.16 -174.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.552 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 17.1 mt -85.66 122.3 38.26 Favored 'Isoleucine or valine' 0 C--O 1.264 1.827 0 CA-C-O 121.254 0.549 . . . . 0.48999999999999999 111.571 -175.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.791 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 15.5 mmt -89.2 -20.01 24.73 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 125.831 1.957 . . . . 1.0600000000000001 112.763 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.61 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -167.25 154.05 8.44 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.434 -0.506 . . . . 0.81999999999999995 112.221 -174.877 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.781 HG21 ' HB2' ' A' ' 97' ' ' LEU . 12.0 p -139.61 125.49 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.381 -0.827 . . . . 1.3100000000000001 110.029 174.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.803 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 13.6 m120 52.75 30.22 8.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.168 -0.924 . . . . 1.5 113.193 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.88 -10.64 62.32 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.085 -1.055 . . . . 0.38 112.849 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -80.7 149.74 29.62 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-N 117.06 0.43 . . . . 0.77000000000000002 110.106 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -103.94 97.8 7.74 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.274 -0.875 . . . . 1.8899999999999999 111.081 -175.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.583 ' SD ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -113.3 101.88 9.82 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.842 -0.617 . . . . 1.01 111.19 176.934 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.4 p -99.02 -32.64 11.18 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.675 0.75 . . . . 1.05 110.258 173.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.756 ' O ' HG23 ' A' ' 37' ' ' ILE . 4.0 mtt -136.94 -15.48 1.53 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.756 -1.111 . . . . 1.6200000000000001 110.284 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.632 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 p -56.51 169.45 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 120.888 0.375 . . . . 1.0900000000000001 111.755 -162.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.966 ' HB ' ' HB3' ' A' ' 38' ' ' ASP . 72.4 p -56.56 145.02 29.46 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 122.223 -0.298 . . . . 0.34999999999999998 111.756 -174.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.574 ' CG ' ' HA2' ' A' ' 35' ' ' GLY . 23.3 t-160 -55.84 -35.4 66.37 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 122.045 0.926 . . . . 0.34999999999999998 108.614 175.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -69.02 -32.53 72.11 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 113.256 -1.793 . . . . 1.6699999999999999 110.313 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.815 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 4.3 tp-100 -62.54 -47.86 82.06 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 108.008 -1.108 . . . . 0.77000000000000002 108.008 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.88 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . -76.72 -34.06 58.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.243 -0.889 . . . . 0.33000000000000002 110.21 -173.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 94' ' ' ARG . 38.6 ttp180 -65.35 -43.53 90.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.386 -0.824 . . . . 2.1000000000000001 110.395 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.535 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -69.35 -40.88 77.26 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.53 -0.759 . . . . 0.95999999999999996 109.904 -176.403 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.815 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 21.9 mmt180 -70.36 -23.57 62.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.953 -0.567 . . . . 3.5699999999999998 110.633 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.781 ' HB2' HG21 ' A' ' 80' ' ' VAL . 15.9 tp -83.26 -44.48 14.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.631 -0.713 . . . . 1.6499999999999999 112.007 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.0 m -107.87 75.42 1.0 Allowed 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 122.807 1.289 . . . . 1.53 111.014 -169.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE2' ' HA ' ' A' ' 96' ' ' ARG . 6.6 mtmt -115.44 123.87 49.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.541 -2.118 . . . . 2.7200000000000002 109.041 173.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.437 ' HG2' HD13 ' A' ' 27' ' ' LEU . 41.8 mtp180 -69.69 40.01 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 O-C-N 123.324 0.39 . . . . 4.3799999999999999 111.229 177.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 99' ' ' LYS . 18.4 m -136.41 -41.74 0.63 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.056 -0.35 . . . . 2.5099999999999998 110.056 -172.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.564 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 46.9 mm-40 -56.36 140.69 44.53 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.383 -0.599 . . . . 3.3999999999999999 109.383 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.76 -16.87 15.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.502 0.668 . . . . 2.6800000000000002 109.862 176.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.785 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 3.0 p -143.26 150.29 17.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.128 -1.064 . . . . 0.44 108.128 -178.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.455 ' HA ' HD21 ' A' ' 81' ' ' ASN . 54.9 t -124.57 119.38 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.807 0 CA-C-O 122.22 1.009 . . . . 0.46000000000000002 111.513 -170.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.803 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -100.68 133.62 44.86 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 113.342 -1.754 . . . . 1.76 110.73 -176.228 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.707 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 19.3 tp -132.4 132.58 42.98 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 110.007 -0.368 . . . . 1.1200000000000001 110.007 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.791 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 23.8 tp -109.73 114.59 28.3 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.147 -1.797 . . . . 0.41999999999999998 106.147 171.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.735 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -121.67 141.18 43.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.898 -0.721 . . . . 0.77000000000000002 110.305 -173.641 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.697 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -96.28 115.81 28.02 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.831 -0.748 . . . . 0.34000000000000002 110.313 173.68 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.695 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 1.6 ttt180 -90.28 104.27 16.86 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.289 -1.323 . . . . 2.0099999999999998 109.655 -170.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.486 ' HG2' ' N ' ' A' ' 113' ' ' SER . 1.0 OUTLIER -91.59 -45.17 8.63 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.371 0.508 . . . . 1.97 112.371 -171.533 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.486 ' N ' ' HG2' ' A' ' 112' ' ' GLN . 22.8 t -163.1 14.92 0.07 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.408 0.623 . . . . 1.6200000000000001 110.311 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.463 HD23 ' OD1' ' A' ' 75' ' ' ASP . 3.6 mm? -92.66 83.32 4.85 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.382 0.611 . . . . 1.6499999999999999 109.861 -176.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.46 144.42 31.68 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 113.645 0.98 . . . . 3.5299999999999998 113.645 -176.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -161.24 145.77 13.51 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 113.49 -1.687 . . . . 3.6000000000000001 107.227 175.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -43.73 108.96 0.12 Allowed 'General case' 0 C--N 1.322 -0.626 0 O-C-N 123.834 0.709 . . . . 3.5600000000000001 111.054 174.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.76 -40.47 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.874 -0.603 . . . . 4.9900000000000002 111.381 -175.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -126.41 63.75 1.26 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.458 0.647 . . . . 7.7699999999999996 109.481 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -165.51 -28.68 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.311 -0.859 . . . . 6.5999999999999996 109.915 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.5 m -93.1 170.5 9.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.718 -0.674 . . . . 8.9399999999999995 109.797 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 15.2 tpt -84.66 129.91 34.78 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.942 -0.392 . . . . 12.1 109.942 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.459 ' H ' HD23 ' A' ' 123' ' ' LEU . 2.5 pt? -135.39 166.74 22.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.291 -0.413 . . . . 12.82 110.165 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.7 m . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.461 -0.781 . . . . 14.640000000000001 111.073 -178.649 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.8 tpt . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 120.661 0.267 . . . . 14.33 110.426 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 t -137.55 122.02 18.37 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.713 -0.476 . . . . 11.220000000000001 109.713 178.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -109.01 126.84 53.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.437 -0.347 . . . . 9.1899999999999995 110.584 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.1 pt -106.62 98.79 21.79 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 6.6500000000000004 110.788 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -87.5 -11.34 5.03 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.462 2.108 . . . . 7.46 111.568 174.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.65 -42.15 4.56 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.674 -0.694 . . . . 5.8899999999999997 112.405 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.44 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 24.7 pt20 -128.13 46.02 1.94 Allowed Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 114.286 1.217 . . . . 6.3700000000000001 114.286 -177.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.563 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 9.4 Cg_endo -71.49 130.68 17.6 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.436 1.424 . . . . 3.3999999999999999 110.564 172.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.563 ' HB ' ' O ' ' A' ' 8' ' ' PRO . 42.3 t 77.84 -47.63 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 O-C-N 123.426 0.454 . . . . 2.2599999999999998 111.107 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 49.2 p -75.0 82.67 2.23 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 122.309 1.052 . . . . 2.0899999999999999 111.461 -176.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.07 179.36 5.6 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.399 -1.728 . . . . 0.95999999999999996 109.484 173.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.76 122.28 68.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.218 0.533 . . . . 1.5700000000000001 110.711 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.771 HG22 HG23 ' A' ' 110' ' ' THR . 15.8 t -79.56 105.61 9.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.004 -0.543 . . . . 1.02 110.367 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.75 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -102.05 169.19 8.91 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.725 -0.67 . . . . 1.3899999999999999 111.766 179.095 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.525 ' HD3' ' O ' ' A' ' 107' ' ' LEU . 1.8 mmt180 -123.96 116.09 22.31 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.334 -0.394 . . . . 3.6299999999999999 110.932 -177.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.702 ' HB ' ' HB3' ' A' ' 107' ' ' LEU . 25.1 t -97.29 125.71 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.597 -0.52 . . . . 1.02 109.597 176.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -139.04 116.21 11.05 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.89 -0.781 . . . . 1.3500000000000001 108.89 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.689 HG13 ' O ' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -144.57 139.8 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 107.841 -1.17 . . . . 0.60999999999999999 107.841 -177.42 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.849 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 17.1 m-70 -72.06 115.09 10.88 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.139 -0.689 . . . . 0.59999999999999998 109.139 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.652 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -31.96 141.01 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 O-C-N 124.958 1.411 . . . . 4.0 112.228 178.414 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.81 ' HB3' ' HB ' ' A' ' 28' ' ' ILE . 56.5 tp -98.18 102.58 14.37 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.595 -0.442 . . . . 0.55000000000000004 110.764 -171.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -58.13 139.35 54.97 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.371 0.605 . . . . 3.9700000000000002 112.069 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -142.99 92.46 2.4 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.555 -0.748 . . . . 1.3500000000000001 109.13 172.846 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.35 -79.85 0.01 OUTLIER Glycine 0 CA--C 1.522 0.473 0 C-N-CA 121.455 -0.403 . . . . 1.3300000000000001 112.541 -173.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -130.16 5.06 4.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.513 0.673 . . . . 2.3300000000000001 110.508 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 23' ' ' GLN . 12.0 m-80 -106.63 165.36 11.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.532 -0.758 . . . . 1.8700000000000001 110.146 -177.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.91 HD21 ' HB ' ' A' ' 98' ' ' THR . 2.2 pt? -128.66 124.63 36.21 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.759 -1.2 . . . . 2.2799999999999998 107.759 171.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.81 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 36.0 mm -98.43 115.95 40.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 116.028 -0.533 . . . . 0.80000000000000004 110.731 -170.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.806 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.3 pt? -71.7 -26.54 62.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.632 -0.713 . . . . 1.74 110.353 175.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.07 -31.3 7.1 Favored Glycine 0 C--O 1.223 -0.585 0 C-N-CA 120.731 -0.747 . . . . 0.68999999999999995 113.201 172.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.552 ' HZ ' HD11 ' A' ' 97' ' ' LEU . 44.9 p90 -112.24 163.07 14.79 Favored 'General case' 0 C--N 1.313 -0.999 0 O-C-N 122.264 -0.551 . . . . 0.51000000000000001 110.815 -176.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.535 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 24.0 t -100.47 163.2 12.47 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.268 -1.382 . . . . 0.53000000000000003 107.268 173.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -162.64 137.82 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 112.416 0.524 . . . . 0.48999999999999999 112.416 -164.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.74 117.79 1.06 Allowed Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 110.616 -0.994 . . . . 0.71999999999999997 110.616 157.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 1.031 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -142.65 118.56 1.27 Allowed Glycine 0 CA--C 1.49 -1.507 0 CA-C-O 118.607 -1.107 . . . . 1.4199999999999999 111.564 173.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.68 144.86 9.42 Favored Glycine 0 C--N 1.294 -1.764 0 C-N-CA 117.133 -2.46 . . . . 0.47999999999999998 113.319 177.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.637 ' HA ' ' HG3' ' A' ' 53' ' ' LYS . 13.2 pt -62.58 -17.64 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.801 -1.185 . . . . 0.52000000000000002 107.801 151.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.847 ' HB2' ' CB ' ' A' ' 89' ' ' THR . 21.9 t70 -62.89 -37.09 85.53 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 113.962 -1.472 . . . . 0.71999999999999997 109.802 173.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -74.0 -164.31 0.23 Allowed 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 114.662 -1.154 . . . . 1.1899999999999999 110.704 -174.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.512 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 2.2 p-10 -98.79 122.39 53.09 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-O 121.429 0.633 . . . . 2.5699999999999998 111.348 -175.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 10.3 Cg_exo -76.93 19.9 0.66 Allowed 'Trans proline' 0 N--CA 1.474 0.334 0 C-N-CA 123.853 3.035 . . . . 2.8199999999999998 113.047 177.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 t -98.84 13.9 30.81 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.884 0.373 . . . . 3.2599999999999998 111.553 -170.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -134.48 16.78 3.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.632 0.73 . . . . 3.8799999999999999 109.429 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -177.8 56.33 0.1 Allowed Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-N 114.649 -1.16 . . . . 5.1399999999999997 108.587 -168.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.07 -4.12 12.93 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.641 2.227 . . . . 3.71 113.009 -167.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -141.21 -42.28 0.38 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.047 -1.094 . . . . 5.6200000000000001 108.047 176.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.6 m -157.26 158.88 36.93 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.826 -1.176 . . . . 3.77 107.826 174.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.555 ' HB3' HG23 ' A' ' 51' ' ' THR . 32.5 tt0 -107.25 -38.22 6.04 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.571 -0.9 . . . . 6.7800000000000002 108.571 169.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.6 ' HB2' HG22 ' A' ' 51' ' ' THR . 21.2 m-20 -176.93 -147.93 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 105.758 -1.942 . . . . 5.4699999999999998 105.758 -169.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.824 ' HG3' HG21 ' A' ' 110' ' ' THR . 0.1 OUTLIER -75.74 55.08 0.84 Allowed 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.625 -0.879 . . . . 3.0699999999999998 108.625 163.12 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 1.111 ' HB ' ' HB3' ' A' ' 76' ' ' LYS . 7.3 t -151.17 -54.17 0.14 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 119.78 -0.768 . . . . 4.5599999999999996 110.706 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.444 ' N ' HG23 ' A' ' 51' ' ' THR . 19.9 t0 63.97 -99.05 0.07 Allowed 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 115.926 -0.579 . . . . 2.6000000000000001 111.064 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.637 ' HG3' ' HA ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -111.52 33.09 4.92 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.402 -1.333 . . . . 3.48 107.402 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.445 ' C ' HD12 ' A' ' 55' ' ' ILE . . . -93.2 -154.21 30.94 Favored Glycine 0 N--CA 1.433 -1.556 0 CA-C-N 113.545 -1.662 . . . . 0.78000000000000003 111.026 -169.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.031 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -114.25 144.25 22.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 N-CA-C 109.223 -0.658 . . . . 0.54000000000000004 109.223 178.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.814 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -145.92 146.78 31.19 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 122.59 1.186 . . . . 1.4199999999999999 113.334 178.218 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.814 HG23 HD11 ' A' ' 77' ' ' ILE . 54.5 t -72.21 137.42 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 112.509 -2.132 . . . . 0.57999999999999996 110.38 175.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.7 m -113.73 -19.7 11.45 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 124.502 1.126 . . . . 1.1100000000000001 111.478 -178.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.637 ' O ' HG23 ' A' ' 60' ' ' VAL . 72.8 mtt180 -149.48 -165.97 2.42 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.754 -0.591 . . . . 2.27 112.21 174.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 59' ' ' ARG . 79.7 t -168.4 138.61 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.705 1.602 . . . . 0.82999999999999996 107.407 166.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.415 ' OG ' ' HA3' ' A' ' 64' ' ' GLY . 32.2 p -81.09 132.87 35.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.922 0.392 . . . . 1.6499999999999999 111.123 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -58.71 111.17 1.17 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.864 -1.062 . . . . 1.8500000000000001 110.52 170.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.26 -15.16 63.83 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.55 -0.834 . . . . 0.92000000000000004 112.145 177.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.455 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -72.21 175.51 42.51 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.515 -0.85 . . . . 0.98999999999999999 111.35 177.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.689 ' O ' HG13 ' A' ' 18' ' ' ILE . 73.5 Cg_endo -72.8 -30.08 11.84 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.288 1.992 . . . . 0.44 112.69 -166.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.501 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -60.72 -28.25 68.52 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.011 -0.995 . . . . 0.35999999999999999 111.415 178.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -76.0 -35.49 59.55 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.517 0.675 . . . . 1.79 109.287 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.455 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -65.27 -43.43 95.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.882 -1.053 . . . . 0.51000000000000001 110.244 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.698 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -72.46 -22.87 61.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.908 -0.587 . . . . 0.40999999999999998 110.52 177.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.89 66.38 0.86 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.019 -1.086 . . . . 0.45000000000000001 113.389 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.593 HD13 HG21 ' A' ' 16' ' ' VAL . 9.0 tp -119.12 151.0 39.06 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.893 -0.41 . . . . 0.89000000000000001 109.893 177.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.53 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 57.5 mt-30 -129.91 31.73 4.66 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 115.806 1.78 . . . . 1.21 115.806 -162.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 72' ' ' GLN . 2.7 mp 72.95 -8.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 CA-C-N 118.992 0.815 . . . . 0.77000000000000002 112.988 170.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.13 54.58 0.32 Allowed Glycine 0 CA--C 1.507 -0.454 0 C-N-CA 119.155 -1.498 . . . . 0.37 112.69 -168.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.577 ' H ' ' HB ' ' A' ' 57' ' ' VAL . 16.8 m-20 -120.83 148.36 44.12 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.491 -0.354 . . . . 0.89000000000000001 110.51 -168.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 1.111 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 14.0 mmtp -105.93 102.86 12.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.168 0.508 . . . . 2.2000000000000002 110.0 -169.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 1.059 HG13 HG23 ' A' ' 109' ' ' VAL . 3.4 mp -72.99 126.99 34.63 Favored 'Isoleucine or valine' 0 C--O 1.257 1.471 0 N-CA-C 113.629 0.974 . . . . 0.48999999999999999 113.629 -172.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.793 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 5.5 mmt -92.12 -28.55 17.03 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 126.265 2.228 . . . . 1.0600000000000001 112.113 172.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.587 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 52.3 mt-30 -150.87 158.57 44.31 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.52 0.933 . . . . 0.81999999999999995 113.52 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.586 ' HB ' ' CE ' ' A' ' 85' ' ' MET . 24.4 t -139.6 107.46 3.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 113.515 -1.675 . . . . 1.3100000000000001 109.951 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 1.011 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 23.1 m-80 54.92 32.27 17.59 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.848 0.459 . . . . 1.5 112.007 176.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.46 -3.9 59.76 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.224 -0.989 . . . . 0.38 112.817 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.435 ' CE2' ' HD2' ' A' ' 96' ' ' ARG . 84.0 m95 -87.54 168.27 13.21 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.669 -0.493 . . . . 0.77000000000000002 109.669 177.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -109.78 113.69 26.66 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.242 0.544 . . . . 1.8899999999999999 111.155 -171.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.586 ' CE ' ' HB ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -106.95 101.97 11.36 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 122.217 1.008 . . . . 1.01 110.965 -179.702 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.8 p -142.1 -46.18 0.34 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.428 -1.714 . . . . 1.05 107.707 173.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.413 ' HA ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -146.85 74.45 1.35 Allowed 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 113.704 -1.589 . . . . 1.6200000000000001 110.127 176.105 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.545 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 22.9 m -133.3 154.93 40.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.285 -1.006 . . . . 1.0900000000000001 108.285 171.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.847 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 72.0 p -62.57 154.4 29.02 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 120.792 0.33 . . . . 0.34999999999999998 111.331 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.818 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 17.7 t-160 -52.59 -45.14 66.39 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 121.722 0.772 . . . . 0.34999999999999998 110.143 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -71.35 -29.56 65.13 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 113.692 -1.594 . . . . 1.6699999999999999 109.964 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.745 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 1.8 tt0 -60.19 -47.14 87.2 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.402 -0.592 . . . . 0.77000000000000002 109.402 178.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.586 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -74.06 -41.0 62.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.322 0.582 . . . . 0.33000000000000002 110.531 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -56.62 -44.17 80.94 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.817 -1.083 . . . . 2.1000000000000001 110.896 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.402 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -71.82 -34.35 69.25 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.396 -0.82 . . . . 0.95999999999999996 109.92 -176.682 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.745 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 27.2 mmt180 -74.56 -26.15 59.76 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.172 -0.467 . . . . 3.5699999999999998 110.712 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.552 HD11 ' HZ ' ' A' ' 31' ' ' PHE . 5.6 tt -68.94 -60.85 2.09 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.527 -0.76 . . . . 1.6499999999999999 111.277 -176.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.91 ' HB ' HD21 ' A' ' 27' ' ' LEU . 5.8 p -97.43 -83.56 0.39 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.387 -0.369 . . . . 1.53 111.408 -176.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 99' ' ' LYS . 2.8 ttpt 66.97 -1.66 1.35 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.8 -0.636 . . . . 2.7200000000000002 112.026 176.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.482 ' HA ' HD22 ' A' ' 27' ' ' LEU . 97.4 mtt180 60.34 47.79 8.61 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.026 -0.988 . . . . 4.3799999999999999 111.188 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.1 t -137.02 -56.44 0.72 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.466 -0.334 . . . . 2.5099999999999998 111.741 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.652 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 19.5 mm-40 -63.83 149.5 46.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.474 -0.33 . . . . 3.3999999999999999 111.123 -174.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -93.5 -10.17 35.82 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.431 0.634 . . . . 2.6800000000000002 109.843 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.849 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 3.8 p -147.58 142.18 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 108.634 -0.876 . . . . 0.44 108.634 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.5 t -116.64 120.24 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-O 122.02 0.914 . . . . 0.46000000000000002 111.867 -169.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 1.011 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -99.66 128.33 45.77 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 113.444 -1.707 . . . . 1.76 111.322 -174.403 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.885 HD11 HG12 ' A' ' 77' ' ' ILE . 17.6 tp -134.49 133.87 40.85 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.127 -0.488 . . . . 1.1200000000000001 110.492 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.793 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 29.9 tp -111.38 117.01 31.92 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 105.998 -1.853 . . . . 0.41999999999999998 105.998 170.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 1.059 HG23 HG13 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -126.63 144.46 36.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.868 -0.733 . . . . 0.77000000000000002 110.407 -174.578 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.824 HG21 ' HG3' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -95.68 115.29 27.22 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.614 -0.834 . . . . 0.34000000000000002 109.297 169.608 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.5 ttt180 -102.97 138.9 39.24 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.258 -1.337 . . . . 2.0099999999999998 110.482 -172.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.545 ' HG2' HD21 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -125.41 -96.35 0.44 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.326 0.491 . . . . 1.97 112.326 -178.433 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.0 t -124.97 35.39 4.79 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.273 0.559 . . . . 1.6200000000000001 111.792 -168.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.545 HD21 ' HG2' ' A' ' 112' ' ' GLN . 0.3 OUTLIER -99.16 18.46 17.41 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.32 0.581 . . . . 1.6499999999999999 109.835 -178.671 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -67.26 149.19 50.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.196 -0.911 . . . . 3.5299999999999998 110.869 -176.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -126.7 67.06 1.25 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.021 0.438 . . . . 3.6000000000000001 111.466 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 53.01 72.2 0.44 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.976 -1.011 . . . . 3.5600000000000001 112.056 175.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.29 -20.22 7.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.468 0.652 . . . . 4.9900000000000002 110.219 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -91.72 68.13 5.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.628 -0.715 . . . . 7.7699999999999996 110.849 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -141.02 117.9 11.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.931 -0.577 . . . . 6.5999999999999996 110.39 177.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.0 p -152.91 90.55 1.47 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.627 -0.715 . . . . 8.9399999999999995 110.413 -177.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -91.54 -28.77 17.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.336 -0.393 . . . . 12.1 110.497 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 98.3 mt 64.09 174.97 0.18 Allowed 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.783 0.677 . . . . 12.82 110.948 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.304 -0.855 . . . . 14.640000000000001 109.72 179.366 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.8 mtp . . . . . 0 N--CA 1.482 1.129 0 CA-C-O 120.683 0.278 . . . . 14.33 111.079 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -59.62 -44.34 93.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.018 -0.537 . . . . 11.220000000000001 111.498 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -110.14 114.49 28.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.044 0.449 . . . . 9.1899999999999995 110.521 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.549 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 8.5 pt -109.84 101.99 48.82 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.829 -0.623 . . . . 6.6500000000000004 110.591 176.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -66.0 105.3 0.8 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.18 2.587 . . . . 7.46 112.284 -177.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.4 -24.75 30.1 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.99 -0.624 . . . . 5.8899999999999997 112.424 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 70.36 113.44 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 123.49 0.716 . . . . 6.3700000000000001 111.482 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.549 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 9.6 Cg_endo -89.17 172.78 4.16 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.064 2.509 . . . . 3.3999999999999999 112.195 178.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.456 ' HA ' ' OD1' ' A' ' 49' ' ' ASP . 67.3 t 70.27 -68.12 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 123.439 0.696 . . . . 2.2599999999999998 112.074 177.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 t -77.86 82.15 4.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 123.605 1.669 . . . . 2.0899999999999999 110.86 -176.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.429 ' HB2' ' HZ1' ' A' ' 50' ' ' LYS . . . -110.9 178.19 4.43 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 112.196 -2.274 . . . . 0.95999999999999996 110.541 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.8 t -111.64 118.19 56.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.989 -0.551 . . . . 1.5700000000000001 110.487 -176.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.741 HG22 HG23 ' A' ' 110' ' ' THR . 39.4 t -76.37 111.81 13.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.219 0.533 . . . . 1.02 109.637 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.63 ' HG2' ' HB3' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -118.69 169.35 9.89 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.009 -0.541 . . . . 1.3899999999999999 112.235 -171.465 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 15' ' ' ARG . 6.1 mmm-85 -124.06 118.11 26.21 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.998 0.428 . . . . 3.6299999999999999 112.126 -175.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.74 HG13 ' CB ' ' A' ' 69' ' ' ALA . 7.7 t -108.26 119.59 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 108.25 -1.018 . . . . 1.02 108.25 171.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -132.75 114.41 14.1 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.93 -0.767 . . . . 1.3500000000000001 108.93 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.716 HG13 ' O ' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -136.89 138.29 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 108.097 -1.075 . . . . 0.60999999999999999 108.097 -173.619 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.847 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.3 m-70 -66.09 114.14 5.01 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.495 -0.32 . . . . 0.59999999999999998 110.358 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.973 ' HB2' HD13 ' A' ' 27' ' ' LEU . 2.2 pptp? -28.02 135.4 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 O-C-N 125.097 1.498 . . . . 4.0 112.814 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.716 HD22 ' HD3' ' A' ' 65' ' ' PRO . 33.1 tp -96.68 90.24 5.24 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.937 0.875 . . . . 0.55000000000000004 109.377 -175.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.489 ' H ' ' CD ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -62.3 133.23 54.84 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.854 -1.521 . . . . 3.9700000000000002 111.311 -178.501 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.403 ' HB2' HD13 ' A' ' 28' ' ' ILE . 21.1 tp60 -133.71 94.18 3.24 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.773 -0.825 . . . . 1.3500000000000001 108.773 173.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.5 -80.26 0.12 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.828 -0.701 . . . . 1.3300000000000001 111.778 -175.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -132.52 1.47 3.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.832 0.348 . . . . 2.3300000000000001 110.511 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -107.61 172.04 7.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.24 0.543 . . . . 1.8700000000000001 111.283 -171.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.973 HD13 ' HB2' ' A' ' 20' ' ' LYS . 2.7 tp -124.4 121.77 35.84 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.14 -0.936 . . . . 2.2799999999999998 109.06 175.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.403 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.5 mp -99.25 129.65 49.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.686 -0.857 . . . . 0.80000000000000004 108.686 176.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mt -84.7 -32.39 23.58 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.418 -0.81 . . . . 1.74 110.279 -174.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.429 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 86.59 11.6 71.06 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.227 -0.987 . . . . 0.68999999999999995 111.487 -175.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.616 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 33.3 p90 -155.0 167.73 29.37 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.305 -0.628 . . . . 0.51000000000000001 109.305 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.567 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -107.67 164.09 12.53 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 107.873 -1.158 . . . . 0.53000000000000003 107.873 172.697 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -148.78 136.47 14.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 119.573 -0.851 . . . . 0.48999999999999999 112.664 -167.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.418 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -147.46 118.41 1.01 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.25 -0.976 . . . . 0.71999999999999997 111.066 157.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 1.033 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -137.99 119.04 1.75 Allowed Glycine 0 CA--C 1.492 -1.354 0 CA-C-O 118.807 -0.996 . . . . 1.4199999999999999 110.703 171.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 1.017 ' HA3' ' HG2' ' A' ' 39' ' ' GLN . . . -156.77 116.9 0.74 Allowed Glycine 0 N--CA 1.435 -1.423 0 C-N-CA 118.277 -1.916 . . . . 0.47999999999999998 113.614 -169.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.533 HG12 ' C ' ' A' ' 88' ' ' VAL . 15.9 pt -67.86 -20.89 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 N-CA-C 105.738 -1.949 . . . . 0.52000000000000002 105.738 147.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.742 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 2.8 t70 -63.17 -40.72 98.35 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 112.644 -2.071 . . . . 0.71999999999999997 109.765 168.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 1.017 ' HG2' ' HA3' ' A' ' 36' ' ' GLY . 28.7 mm-40 -64.53 -70.4 0.23 Allowed 'General case' 0 C--N 1.345 0.373 0 CA-C-N 115.034 -0.984 . . . . 1.1899999999999999 111.777 -175.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.51 ' O ' ' HG3' ' A' ' 53' ' ' LYS . 0.9 OUTLIER -138.71 95.98 9.66 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 120.609 -0.437 . . . . 2.5699999999999998 111.136 -176.457 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.37 24.38 0.61 Allowed 'Trans proline' 0 C--N 1.332 -0.309 0 C-N-CA 122.838 2.358 . . . . 2.8199999999999998 112.46 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.8 t -139.88 29.52 2.09 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.469 0.652 . . . . 3.2599999999999998 110.078 -177.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.784 ' HB2' ' HE3' ' A' ' 53' ' ' LYS . 81.2 mm-40 -131.3 14.82 5.08 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.614 0.721 . . . . 3.8799999999999999 109.294 -177.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.496 ' H ' ' HD2' ' A' ' 45' ' ' PRO . 8.5 m120 -86.59 -43.6 0.56 Allowed Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 114.773 -1.103 . . . . 5.1399999999999997 109.408 -175.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.496 ' HD2' ' H ' ' A' ' 44' ' ' ASN . 1.6 Cg_endo -45.14 -29.31 4.02 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.016 2.477 . . . . 3.71 112.579 161.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -102.95 27.61 6.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.658 -0.701 . . . . 5.6200000000000001 110.899 -178.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.0 t -70.02 140.78 52.92 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 122.52 1.152 . . . . 3.77 110.067 -176.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -107.78 -19.16 13.62 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-N 112.952 -1.931 . . . . 6.7800000000000002 110.605 -163.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.456 ' OD1' ' HA ' ' A' ' 9' ' ' VAL . 20.4 t0 168.1 -158.77 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.067 -1.086 . . . . 5.4699999999999998 108.067 -162.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.595 ' HG2' HG21 ' A' ' 110' ' ' THR . 0.1 OUTLIER -66.49 1.71 1.58 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.525 0.203 . . . . 3.0699999999999998 111.506 171.055 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.404 HG23 ' N ' ' A' ' 52' ' ' ASP . 14.5 t -78.92 -54.62 5.86 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 120.202 -0.599 . . . . 4.5599999999999996 110.296 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.404 ' N ' HG23 ' A' ' 51' ' ' THR . 9.5 t70 42.44 -120.24 0.54 Allowed 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.737 0.648 . . . . 2.6000000000000001 110.765 170.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.784 ' HE3' ' HB2' ' A' ' 43' ' ' GLN . 20.3 mmtt -128.66 44.5 2.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.924 0.868 . . . . 3.48 110.276 171.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.476 ' C ' HD12 ' A' ' 55' ' ' ILE . . . -82.44 -144.77 5.18 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 109.732 -1.347 . . . . 0.78000000000000003 109.732 172.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.033 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -117.1 141.16 36.7 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.151 0 C-N-CA 119.268 -0.973 . . . . 0.54000000000000004 109.187 177.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.774 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -148.28 138.13 22.38 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.698 0.761 . . . . 1.4199999999999999 110.509 -176.043 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.546 HG12 ' H ' ' A' ' 75' ' ' ASP . 14.6 p -79.49 137.17 22.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 114.485 -1.234 . . . . 0.57999999999999996 110.468 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 58' ' ' THR . 12.1 t -127.18 68.91 1.28 Allowed 'General case' 0 C--O 1.21 -1.021 0 O-C-N 124.325 1.016 . . . . 1.1100000000000001 108.998 174.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.646 ' HA ' HG23 ' A' ' 73' ' ' ILE . 18.0 mtt180 153.55 -172.9 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.897 -1.502 . . . . 2.27 110.939 159.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.1 t -160.7 112.92 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 111.897 -2.41 . . . . 0.82999999999999996 106.621 161.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 m -76.44 121.75 23.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.96 0.41 . . . . 1.6499999999999999 109.933 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -48.14 116.72 1.63 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.01 -0.995 . . . . 1.8500000000000001 112.066 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.41 -16.06 49.24 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.517 -0.849 . . . . 0.92000000000000004 112.189 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.64 169.83 54.83 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.153 -1.022 . . . . 0.98999999999999999 111.415 177.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.716 ' O ' HG13 ' A' ' 18' ' ' ILE . 90.5 Cg_endo -71.35 -24.59 22.68 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.603 2.202 . . . . 0.44 113.064 -170.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.616 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -63.15 -25.67 68.46 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.26 -0.882 . . . . 0.35999999999999999 111.521 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -73.67 -37.42 65.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.656 -0.868 . . . . 1.79 108.656 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.53 HD13 ' HA ' ' A' ' 65' ' ' PRO . 2.2 mp -65.86 -47.99 83.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.245 -1.343 . . . . 0.51000000000000001 111.095 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.74 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -71.93 -22.07 61.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.388 -0.369 . . . . 0.40999999999999998 110.405 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.27 72.27 1.29 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.505 -0.855 . . . . 0.45000000000000001 113.109 178.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.473 ' CD2' HG21 ' A' ' 57' ' ' VAL . 15.3 tp -105.04 158.16 16.75 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.699 -0.482 . . . . 0.89000000000000001 109.699 176.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.672 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 35.2 mt-30 -114.04 20.83 15.37 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 114.756 1.391 . . . . 1.21 114.756 -168.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.646 HG23 ' HA ' ' A' ' 59' ' ' ARG . 75.8 mt 73.88 -5.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 113.059 0.762 . . . . 0.77000000000000002 113.059 170.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -171.03 63.9 0.16 Allowed Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.667 -0.777 . . . . 0.37 111.621 -165.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.546 ' H ' HG12 ' A' ' 57' ' ' VAL . 20.6 m-20 -122.66 148.26 45.49 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.245 -0.478 . . . . 0.89000000000000001 110.055 -170.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -97.98 101.39 12.86 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.29 0.567 . . . . 2.2000000000000002 109.775 -176.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 1.009 HG13 HG12 ' A' ' 109' ' ' VAL . 3.1 mp -73.86 121.89 25.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 115.29 -0.868 . . . . 0.48999999999999999 112.005 -175.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.665 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 4.5 mmt -88.59 -21.74 23.88 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 125.687 1.867 . . . . 1.0600000000000001 111.933 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.561 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 1.0 OUTLIER -160.77 148.94 16.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.166 0.508 . . . . 0.81999999999999995 112.194 -175.756 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.622 HG13 ' HB3' ' A' ' 97' ' ' LEU . 21.9 t -129.49 110.52 20.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.172 -0.922 . . . . 1.3100000000000001 110.594 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.786 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 9.4 m-80 52.38 37.22 21.94 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.694 0.627 . . . . 1.5 112.694 174.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.9 -11.13 62.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.292 -0.956 . . . . 0.38 112.563 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.557 ' HB2' ' HE2' ' A' ' 85' ' ' MET . 80.1 m95 -89.57 161.87 15.95 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 109.282 -0.636 . . . . 0.77000000000000002 109.282 177.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -108.81 111.79 23.71 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.197 -0.456 . . . . 1.8899999999999999 110.653 -172.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.79 ' SD ' HG11 ' A' ' 88' ' ' VAL . 13.7 mmt -107.41 99.92 9.4 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 121.85 0.834 . . . . 1.01 109.91 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.64 -48.61 2.04 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.706 -1.134 . . . . 1.05 107.998 171.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.411 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 3.2 mtt -143.41 85.01 1.83 Allowed 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.517 -1.674 . . . . 1.6200000000000001 108.022 173.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.79 HG11 ' SD ' ' A' ' 85' ' ' MET . 0.5 OUTLIER -140.32 151.2 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 115.781 -0.645 . . . . 1.0900000000000001 109.904 -176.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.682 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 82.6 p -61.25 151.19 32.4 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.143 0.497 . . . . 0.34999999999999998 112.278 -177.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.742 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 22.6 t-160 -61.53 -34.36 75.41 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 115.814 -0.63 . . . . 0.34999999999999998 109.891 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -70.58 -33.24 70.85 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.171 -1.377 . . . . 1.6699999999999999 109.235 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.727 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -63.56 -52.36 61.4 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.747 -0.834 . . . . 0.77000000000000002 108.747 -179.775 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.715 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -66.72 -41.14 88.42 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.504 -0.771 . . . . 0.33000000000000002 110.281 -178.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -60.25 -47.46 85.91 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.375 -0.829 . . . . 2.1000000000000001 110.676 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.517 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -69.95 -39.45 76.04 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.67 -0.695 . . . . 0.95999999999999996 110.203 -176.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.727 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 25.1 mmt180 -69.24 -23.01 63.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.991 -0.549 . . . . 3.5699999999999998 112.152 -175.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.622 ' HB3' HG13 ' A' ' 80' ' ' VAL . 4.4 pp -98.93 -14.04 19.72 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.406 -0.517 . . . . 1.6499999999999999 111.948 175.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.751 ' HA ' HD23 ' A' ' 27' ' ' LEU . 1.9 m -112.74 86.02 2.28 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 122.35 1.071 . . . . 1.53 109.945 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.493 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 4.6 mtmt -120.17 119.15 32.43 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 113.462 -1.699 . . . . 2.7200000000000002 109.969 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -67.62 48.77 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.181 -0.918 . . . . 4.3799999999999999 111.84 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.4 t -151.42 -54.11 0.14 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.311 0.486 . . . . 2.5099999999999998 112.311 -172.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 43.9 mt-10 -71.67 158.51 36.02 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.323 0.49 . . . . 3.3999999999999999 112.323 -171.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -95.4 -18.34 20.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.81 -0.632 . . . . 2.6800000000000002 111.399 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.847 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 4.9 p -142.41 148.25 20.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.726 0.298 . . . . 0.44 110.362 -172.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.546 HG13 HD22 ' A' ' 81' ' ' ASN . 44.1 t -119.73 119.78 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-O 121.813 0.816 . . . . 0.46000000000000002 111.736 -173.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.786 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.9 OUTLIER -102.11 124.92 48.55 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 113.875 -1.511 . . . . 1.76 111.529 -174.039 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.431 HD21 HG12 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -133.52 131.06 39.33 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.19 0.519 . . . . 1.1200000000000001 111.071 174.445 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.665 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 35.4 tp -103.2 113.99 27.91 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.011 -1.477 . . . . 0.41999999999999998 107.011 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 1.009 HG12 HG13 ' A' ' 77' ' ' ILE . 23.1 m -118.12 152.06 20.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 C-N-CA 119.921 -0.712 . . . . 0.77000000000000002 110.581 -176.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.741 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -95.73 115.18 27.06 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.825 -0.75 . . . . 0.34000000000000002 109.287 167.129 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.63 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . 0.9 OUTLIER -105.16 143.08 33.84 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.925 -1.034 . . . . 2.0099999999999998 110.475 -171.255 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.43 -89.27 0.49 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.067 -0.515 . . . . 1.97 110.633 -176.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.2 t -160.47 74.26 0.53 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.322 0.582 . . . . 1.6200000000000001 110.998 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.672 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 6.8 mt -123.03 -10.18 8.18 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.284 -0.871 . . . . 1.6499999999999999 110.081 -179.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.433 ' HG2' HG11 ' A' ' 118' ' ' VAL . 2.1 mp0 -41.29 141.84 0.63 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.536 -1.211 . . . . 3.5299999999999998 112.38 172.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -134.93 114.04 12.12 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.091 -0.504 . . . . 3.6000000000000001 111.291 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 61.04 22.04 12.34 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.012 0.745 . . . . 3.5600000000000001 113.012 170.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.433 HG11 ' HG2' ' A' ' 115' ' ' GLN . 12.2 p -86.2 -22.73 7.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.617 0.722 . . . . 4.9900000000000002 110.886 -176.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -103.45 10.83 37.07 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.25 -0.886 . . . . 7.7699999999999996 110.208 -175.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -113.02 84.78 2.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.876 -0.602 . . . . 6.5999999999999996 110.622 -173.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.1 m -99.72 -5.96 27.9 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.351 0.596 . . . . 8.9399999999999995 109.865 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 92.0 mmm -95.31 172.44 8.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.543 -0.753 . . . . 12.1 111.078 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.4 tp -110.38 138.36 46.87 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.504 -0.771 . . . . 12.82 110.146 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.4 t . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.764 -0.636 . . . . 14.640000000000001 109.595 175.65 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.9 ttp . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 109.873 -0.417 . . . . 14.33 109.873 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.8 m -93.88 117.92 30.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.927 0.394 . . . . 11.220000000000001 111.536 -174.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -80.83 -15.1 57.28 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.418 -0.586 . . . . 9.1899999999999995 109.418 173.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.731 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 43.3 mm 72.55 118.84 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 114.788 -1.096 . . . . 6.6500000000000004 110.804 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -52.7 -38.82 77.38 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.394 2.729 . . . . 7.46 113.38 -178.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.53 -1.36 56.59 Favored Glycine 0 C--O 1.23 -0.115 0 C-N-CA 120.669 -0.777 . . . . 5.8899999999999997 111.631 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 24.0 mp0 66.78 137.22 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.806 0.842 . . . . 6.3700000000000001 112.403 -176.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.731 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 43.0 Cg_exo -55.87 152.05 37.81 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 123.193 2.595 . . . . 3.3999999999999999 113.199 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 8' ' ' PRO . 91.8 t 76.16 -56.92 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.289 -0.869 . . . . 2.2599999999999998 111.72 176.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.2 t -78.29 83.25 4.55 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 123.559 1.647 . . . . 2.0899999999999999 110.869 -177.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.64 157.45 17.17 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 112.343 -2.208 . . . . 0.95999999999999996 109.227 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.687 HG23 ' HG2' ' A' ' 111' ' ' ARG . 20.2 m -99.92 125.78 53.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 109.502 -0.555 . . . . 1.5700000000000001 109.502 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.657 HG22 HG23 ' A' ' 110' ' ' THR . 56.1 t -77.19 97.67 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 122.0 0.905 . . . . 1.02 111.168 -176.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.591 ' O ' ' HB ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -95.91 139.84 31.54 Favored 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 114.095 -1.411 . . . . 1.3899999999999999 109.515 175.885 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.432 ' HB3' HD12 ' A' ' 108' ' ' LEU . 5.3 ppt_? -125.6 129.05 48.87 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 120.32 -1.487 . . . . 3.6299999999999999 111.326 176.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.772 HG13 ' CB ' ' A' ' 69' ' ' ALA . 22.7 t -92.57 133.93 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 114.909 -1.041 . . . . 1.02 110.259 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -135.32 112.51 10.44 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.008 -0.738 . . . . 1.3500000000000001 109.008 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.646 HG13 ' O ' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -144.45 139.24 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 N-CA-C 107.742 -1.207 . . . . 0.60999999999999999 107.742 -177.553 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.68 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 14.6 m-70 -73.75 114.88 12.53 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.054 -0.721 . . . . 0.59999999999999998 109.054 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.778 ' HB2' HD12 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -31.46 143.71 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 O-C-N 125.02 1.45 . . . . 4.0 112.424 -178.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.548 HD22 ' HD3' ' A' ' 65' ' ' PRO . 30.7 tp -94.98 97.59 10.08 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.847 -0.741 . . . . 0.55000000000000004 110.037 -171.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.468 ' HD3' ' H ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -54.95 131.34 44.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.792 -1.094 . . . . 3.9700000000000002 111.583 -178.684 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.412 ' HB2' HD13 ' A' ' 28' ' ' ILE . 38.1 tp60 -139.8 102.13 4.35 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.755 -1.111 . . . . 1.3500000000000001 108.549 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.9 -92.04 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.556 -0.831 . . . . 1.3300000000000001 111.108 -175.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.449 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 35.7 mt-10 -126.6 -0.55 6.81 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.101 0.477 . . . . 2.3300000000000001 110.607 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.444 ' HA ' ' CB ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -112.54 -175.94 2.79 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.969 -0.56 . . . . 1.8700000000000001 110.457 -173.747 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.778 HD12 ' HB2' ' A' ' 20' ' ' LYS . 1.7 pt? -123.9 142.84 50.78 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.405 -0.961 . . . . 2.2799999999999998 108.405 175.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.412 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.2 mp -106.78 130.89 57.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 121.062 0.458 . . . . 0.80000000000000004 110.357 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.6 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.3 pt? -96.28 117.33 30.58 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.032 -1.099 . . . . 1.74 108.032 172.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.623 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -81.5 43.54 2.93 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.738 -0.744 . . . . 0.68999999999999995 113.521 -171.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.61 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 29.0 p90 -158.28 160.44 37.05 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 122.575 0.35 . . . . 0.51000000000000001 110.33 178.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 18.6 t -103.89 159.9 15.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.183 -1.414 . . . . 0.53000000000000003 107.183 170.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -160.3 140.15 3.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 120.695 -0.402 . . . . 0.48999999999999999 111.778 -165.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -145.61 119.22 1.17 Allowed Glycine 0 N--CA 1.436 -1.314 0 N-CA-C 110.257 -1.137 . . . . 0.71999999999999997 110.257 157.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 1.005 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -138.67 116.68 1.3 Allowed Glycine 0 CA--C 1.488 -1.643 0 N-CA-C 110.652 -0.979 . . . . 1.4199999999999999 110.652 169.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.7 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.47 137.15 4.5 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 117.498 -2.287 . . . . 0.47999999999999998 114.329 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.514 HG12 ' C ' ' A' ' 88' ' ' VAL . 23.3 pt -66.79 -11.4 13.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.773 -1.195 . . . . 0.52000000000000002 107.773 149.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.81 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 0.0 OUTLIER -72.3 -40.69 67.32 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.091 -1.413 . . . . 0.71999999999999997 108.789 170.351 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -63.2 -55.6 23.7 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.965 -1.016 . . . . 1.1899999999999999 109.213 178.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -111.28 98.16 38.58 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.293 -0.867 . . . . 2.5699999999999998 109.534 173.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -87.75 16.0 2.01 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.268 2.645 . . . . 2.8199999999999998 112.086 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.6 t -97.84 -56.57 2.46 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.454 -0.794 . . . . 3.2599999999999998 112.837 -167.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.79 52.06 0.63 Allowed 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 120.316 -0.554 . . . . 3.8799999999999999 111.563 -167.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.721 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 6.3 p-10 -158.31 37.8 0.06 OUTLIER Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 112.576 0.584 . . . . 5.1399999999999997 112.576 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.721 ' HD3' ' N ' ' A' ' 44' ' ' ASN . 41.4 Cg_endo -98.93 7.76 0.93 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.641 2.227 . . . . 3.71 111.611 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -167.11 23.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.746 -0.835 . . . . 5.6200000000000001 108.746 -172.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.619 ' OG ' ' HA ' ' A' ' 44' ' ' ASN . 27.4 m -79.41 -172.1 3.06 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.187 -0.915 . . . . 3.77 111.959 -169.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 49' ' ' ASP . 34.9 mm-40 -21.08 -72.41 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 115.32 1.6 . . . . 6.7800000000000002 115.32 -174.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.529 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 27.9 t70 174.76 -140.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.648 -1.612 . . . . 5.4699999999999998 106.648 -174.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.57 ' HE2' HG21 ' A' ' 110' ' ' THR . 0.0 OUTLIER -54.83 -28.21 47.91 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.985 0.898 . . . . 3.0699999999999998 109.303 164.476 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.5 m -63.75 -18.74 64.35 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.348 -1.296 . . . . 4.5599999999999996 111.896 -174.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.48 ' OD2' ' HD2' ' A' ' 53' ' ' LYS . 22.6 t70 -71.2 -165.78 0.14 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.581 -0.896 . . . . 2.6000000000000001 108.581 173.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.485 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -70.66 -49.66 44.96 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.821 -0.807 . . . . 3.48 108.821 178.805 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.431 ' C ' HD12 ' A' ' 55' ' ' ILE . . . 56.58 -131.69 51.35 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 109.828 -1.309 . . . . 0.78000000000000003 109.828 -174.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.005 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -115.32 141.25 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 106.755 -1.572 . . . . 0.54000000000000004 106.755 168.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.67 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -153.85 146.97 24.61 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 119.42 1.009 . . . . 1.4199999999999999 110.887 -178.615 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.807 HG12 ' H ' ' A' ' 75' ' ' ASP . 1.4 p -81.88 140.84 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-N 114.732 -1.122 . . . . 0.57999999999999996 109.71 -175.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.9 m -110.25 -14.47 14.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.295 -0.866 . . . . 1.1100000000000001 110.841 -173.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.546 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 67.1 mtt180 -149.55 -166.59 2.59 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.728 0.775 . . . . 2.27 112.395 174.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 66' ' ' ALA . 88.3 t -160.0 140.02 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 112.525 -2.125 . . . . 0.82999999999999996 106.474 162.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.9 p -82.73 121.16 26.52 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 121.503 0.668 . . . . 1.6499999999999999 110.308 175.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -60.46 101.08 0.12 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 113.965 -1.47 . . . . 1.8500000000000001 111.08 174.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.88 -6.57 23.88 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.495 -0.86 . . . . 0.92000000000000004 112.319 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.513 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -91.82 -176.99 42.58 Favored Glycine 0 CA--C 1.5 -0.888 0 C-N-CA 120.914 -0.66 . . . . 0.98999999999999999 111.7 177.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.646 ' O ' HG13 ' A' ' 18' ' ' ILE . 65.6 Cg_endo -71.89 -25.83 19.49 Favored 'Trans proline' 0 CA--C 1.509 -0.738 0 C-N-CA 122.94 2.427 . . . . 0.44 113.097 -168.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.61 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -67.93 -25.9 65.7 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.034 -0.985 . . . . 0.35999999999999999 110.873 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -74.67 -32.47 62.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.934 0.874 . . . . 1.79 109.002 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.513 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -71.65 -44.47 69.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.477 -1.238 . . . . 0.51000000000000001 110.549 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.772 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -75.3 -23.09 57.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.091 -0.504 . . . . 0.40999999999999998 110.556 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.91 70.29 1.08 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.001 -1.095 . . . . 0.45000000000000001 113.315 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.67 HD21 HG21 ' A' ' 57' ' ' VAL . 16.7 tp -112.17 155.24 24.28 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.25 -0.648 . . . . 0.89000000000000001 109.25 174.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.426 HE22 ' HD2' ' A' ' 111' ' ' ARG . 0.5 OUTLIER -132.51 35.61 3.62 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 115.193 1.553 . . . . 1.21 115.193 -165.718 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.546 HG23 ' HA ' ' A' ' 59' ' ' ARG . 4.4 mp 68.89 -7.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 N-CA-C 113.793 1.034 . . . . 0.77000000000000002 113.793 165.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.49 52.63 0.35 Allowed Glycine 0 CA--C 1.509 -0.311 0 C-N-CA 119.903 -1.141 . . . . 0.37 112.108 -170.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.807 ' H ' HG12 ' A' ' 57' ' ' VAL . 40.7 m-20 -119.75 132.17 55.56 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.341 -0.43 . . . . 0.89000000000000001 111.387 -168.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.67 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 10.8 mmmm -82.16 100.67 9.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.338 0.59 . . . . 2.2000000000000002 110.466 -174.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.637 ' HB ' HG22 ' A' ' 55' ' ' ILE . 5.6 mt -73.64 123.38 28.62 Favored 'Isoleucine or valine' 0 C--O 1.261 1.674 0 CA-C-N 115.546 -0.752 . . . . 0.48999999999999999 111.664 -176.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.796 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 10.6 mmt -94.73 -11.88 28.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 125.572 1.795 . . . . 1.0600000000000001 113.075 177.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.52 ' HB3' ' CB ' ' A' ' 108' ' ' LEU . 2.6 tt0 -173.13 156.04 3.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.654 0.264 . . . . 0.81999999999999995 111.513 -175.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.8 p -145.36 122.93 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 121.415 0.626 . . . . 1.3100000000000001 110.352 174.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.48 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 1.1 m-80 60.04 21.31 10.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.231 -0.895 . . . . 1.5 112.181 178.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.94 -10.33 55.54 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.019 -1.086 . . . . 0.38 112.432 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.414 ' CD1' ' HB3' ' A' ' 96' ' ' ARG . 86.6 m95 -86.94 131.3 34.13 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 109.092 -0.707 . . . . 0.77000000000000002 109.092 176.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -85.09 115.73 23.06 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.747 -1.115 . . . . 1.8899999999999999 110.515 -174.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.707 ' HE3' ' HA ' ' A' ' 93' ' ' ALA . 23.2 mmt -106.66 101.12 10.59 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.097 -0.956 . . . . 1.01 111.134 -175.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.4 ' C ' ' HG3' ' A' ' 87' ' ' MET . 1.2 p -135.36 111.59 9.69 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.632 -1.167 . . . . 1.05 108.963 169.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.4 ' HG3' ' C ' ' A' ' 86' ' ' THR . 0.0 OUTLIER 44.96 65.69 1.04 Allowed 'General case' 0 C--N 1.33 -0.28 0 O-C-N 124.052 0.845 . . . . 1.6200000000000001 111.386 -176.117 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.7 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 3.8 p -129.71 166.48 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.146 -1.057 . . . . 1.0900000000000001 108.146 172.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.654 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 71.7 p -58.35 149.63 24.15 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.987 0.736 . . . . 0.34999999999999998 112.987 -175.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.81 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 19.0 t-160 -61.52 -35.71 78.5 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-O 121.499 0.666 . . . . 0.34999999999999998 109.508 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.48 ' CG ' HH12 ' A' ' 94' ' ' ARG . 0.6 OUTLIER -67.27 -31.46 71.8 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 113.992 -1.458 . . . . 1.6699999999999999 109.517 178.048 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.757 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 3.8 tp-100 -62.49 -51.65 66.59 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 108.965 -0.754 . . . . 0.77000000000000002 108.965 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.707 ' HA ' ' HE3' ' A' ' 85' ' ' MET . . . -72.62 -36.61 68.11 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.5 -0.773 . . . . 0.33000000000000002 110.195 -177.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.48 HH12 ' CG ' ' A' ' 91' ' ' ASP . 26.6 ttp-105 -67.01 -38.76 86.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.689 -0.687 . . . . 2.1000000000000001 110.694 -177.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.52 ' HE3' ' O ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -70.79 -45.89 63.84 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.302 -0.629 . . . . 0.95999999999999996 109.302 -178.777 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.757 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 25.2 mmt180 -67.71 -23.61 65.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.765 -0.652 . . . . 3.5699999999999998 110.175 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.529 HD11 ' CZ ' ' A' ' 31' ' ' PHE . 4.1 tt -77.14 -53.55 7.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.674 -0.694 . . . . 1.6499999999999999 110.985 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.5 m -90.97 90.23 7.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.92 0.867 . . . . 1.53 111.238 -169.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.606 ' HE2' ' O ' ' A' ' 96' ' ' ARG . 22.8 mtmt -133.85 110.11 9.53 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.023 -1.444 . . . . 2.7200000000000002 109.241 176.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.449 ' HD2' ' O ' ' A' ' 25' ' ' GLU . 17.9 ptt180 -76.56 36.5 0.16 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.268 0.556 . . . . 4.3799999999999999 110.833 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 99' ' ' LYS . 4.0 p -124.4 -58.92 1.5 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.774 -0.648 . . . . 2.5099999999999998 111.254 -176.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.22 147.84 42.93 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.084 0.468 . . . . 3.3999999999999999 111.549 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -84.0 -18.74 36.15 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.66 0.615 . . . . 2.6800000000000002 112.66 -172.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.68 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 6.9 p -144.01 145.36 21.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.775 0.321 . . . . 0.44 110.25 -171.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.9 t -114.84 118.46 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-O 122.502 1.144 . . . . 0.46000000000000002 111.914 -175.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.48 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -98.75 129.81 45.2 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 113.065 -1.88 . . . . 1.76 109.766 -178.308 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.442 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 26.2 tp -133.98 125.72 28.76 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 116.218 -0.446 . . . . 1.1200000000000001 110.097 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.796 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 14.6 tp -101.52 130.17 47.74 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.522 -1.288 . . . . 0.41999999999999998 107.522 176.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.709 HG13 ' HB3' ' A' ' 75' ' ' ASP . 2.2 t -131.83 140.12 48.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.998 0.904 . . . . 0.77000000000000002 111.018 -171.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.657 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -105.19 116.53 32.11 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.126 -0.943 . . . . 0.34000000000000002 109.759 163.523 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.687 ' HG2' HG23 ' A' ' 12' ' ' VAL . 1.5 ptt180 -114.35 140.46 48.63 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.175 -0.92 . . . . 2.0099999999999998 110.322 -170.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.513 HE22 ' HG2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -118.97 -41.52 2.76 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.034 0.921 . . . . 1.97 111.035 -170.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.528 ' H ' HD22 ' A' ' 114' ' ' LEU . 36.5 t -159.94 -128.84 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.029 -1.441 . . . . 1.6200000000000001 107.521 -169.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.528 HD22 ' H ' ' A' ' 113' ' ' SER . 0.2 OUTLIER 64.74 -0.22 1.02 Allowed 'General case' 0 C--N 1.323 -0.574 0 O-C-N 124.018 0.823 . . . . 1.6499999999999999 111.826 171.578 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -72.14 134.0 45.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.964 0.411 . . . . 3.5299999999999998 111.337 -174.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -120.84 106.05 11.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.847 -0.615 . . . . 3.6000000000000001 111.212 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 51.68 82.69 0.06 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.613 -0.721 . . . . 3.5600000000000001 111.951 178.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.545 HG13 ' HG2' ' A' ' 119' ' ' GLN . 11.3 p -113.84 -33.13 2.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.134 0.492 . . . . 4.9900000000000002 111.181 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.545 ' HG2' HG13 ' A' ' 118' ' ' VAL . 14.2 mm100 -107.01 16.7 23.94 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.031 -0.531 . . . . 7.7699999999999996 110.249 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -100.98 152.03 21.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.066 -0.515 . . . . 6.5999999999999996 111.242 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 41.7 t -73.61 136.59 43.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.805 -0.634 . . . . 8.9399999999999995 110.26 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -72.39 -43.44 63.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.965 0.412 . . . . 12.1 110.07 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 52.3 tp -98.63 132.05 44.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.871 -0.604 . . . . 12.82 110.107 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.9 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.587 -0.721 . . . . 14.640000000000001 109.352 177.787 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.771 ' HG3' ' H ' ' A' ' 2' ' ' SER . 35.2 tpp . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.308 -0.627 . . . . 14.33 109.308 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.771 ' H ' ' HG3' ' A' ' 1' ' ' MET . 4.3 p -60.06 -41.27 92.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.976 0.417 . . . . 11.220000000000001 111.288 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -98.6 108.77 21.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.991 -0.55 . . . . 9.1899999999999995 110.313 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.481 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 69.4 mt -121.23 127.79 26.0 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.46 -0.336 . . . . 6.6500000000000004 110.105 174.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 4' ' ' ILE . 15.7 Cg_exo -70.54 37.81 0.29 Allowed 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 123.187 2.592 . . . . 7.46 112.054 176.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 4' ' ' ILE . . . -169.51 -45.3 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 121.045 -0.598 . . . . 5.8899999999999997 112.75 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.411 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 7.6 pt20 -151.83 66.46 6.78 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 113.989 1.107 . . . . 6.3700000000000001 113.989 -174.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.432 ' HG3' ' H ' ' A' ' 4' ' ' ILE . 20.7 Cg_exo -66.81 -148.46 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.697 2.265 . . . . 3.3999999999999999 111.886 165.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.7 m -80.61 -11.69 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 121.42 0.629 . . . . 2.2599999999999998 109.456 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.2 m -80.27 80.52 6.69 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.307 1.051 . . . . 2.0899999999999999 109.181 173.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.31 179.17 7.97 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.159 -1.837 . . . . 0.95999999999999996 111.791 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.8 t -105.77 121.56 58.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.262 -0.881 . . . . 1.5700000000000001 110.531 -176.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.609 HG22 HG23 ' A' ' 110' ' ' THR . 38.6 t -77.98 120.7 29.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.85 0.357 . . . . 1.02 110.968 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.78 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -121.08 167.52 12.54 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.015 -0.539 . . . . 1.3899999999999999 111.289 -178.616 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.587 ' HD3' ' O ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -124.12 113.6 18.57 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.676 0.391 . . . . 3.6299999999999999 111.492 -175.778 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.687 HG13 ' CB ' ' A' ' 69' ' ' ALA . 2.2 t -98.16 130.76 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.753 -0.462 . . . . 1.02 109.753 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -142.51 117.81 10.19 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 110.119 -0.326 . . . . 1.3500000000000001 110.119 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 11.2 tp -140.27 144.62 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 108.64 -0.874 . . . . 0.60999999999999999 108.64 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.8 m-70 -77.03 111.09 12.23 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.248 -0.581 . . . . 0.59999999999999998 109.772 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.504 ' HD2' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -23.77 136.64 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 O-C-N 125.433 1.708 . . . . 4.0 113.464 -179.425 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.1 tp -96.46 92.74 6.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.857 0.837 . . . . 0.55000000000000004 109.96 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HD3' ' H ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -65.3 135.93 55.94 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.186 -1.37 . . . . 3.9700000000000002 111.275 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.406 ' HB2' HD13 ' A' ' 28' ' ' ILE . 9.6 tp60 -138.39 93.97 2.8 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.115 -0.698 . . . . 1.3500000000000001 109.115 173.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 60.59 -86.7 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.909 -0.663 . . . . 1.3300000000000001 111.621 -174.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -131.89 12.07 4.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.261 0.553 . . . . 2.3300000000000001 110.335 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -111.42 154.91 23.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.599 -0.728 . . . . 1.8700000000000001 109.047 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.0 mp -120.8 122.13 39.66 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.431 -0.581 . . . . 2.2799999999999998 109.431 174.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.406 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.8 mp -98.19 121.29 48.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 115.266 -0.879 . . . . 0.80000000000000004 109.456 -177.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.651 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -89.72 -27.99 19.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.772 -1.103 . . . . 1.74 110.77 179.272 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.519 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 82.68 17.53 67.96 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.237 -0.982 . . . . 0.68999999999999995 113.381 175.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.651 ' CE2' ' HB2' ' A' ' 29' ' ' LEU . 44.5 p90 -148.94 159.68 43.97 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.496 -0.557 . . . . 0.51000000000000001 109.496 172.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.7 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -102.33 161.93 13.31 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 118.625 -1.23 . . . . 0.53000000000000003 107.893 175.213 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -151.22 135.94 9.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 C-N-CA 119.672 -0.811 . . . . 0.48999999999999999 112.658 -167.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.6 ' O ' ' HD1' ' A' ' 56' ' ' TYR . . . -147.41 117.2 0.89 Allowed Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.163 -1.175 . . . . 0.71999999999999997 110.163 156.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 1.074 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.72 118.62 1.35 Allowed Glycine 0 CA--C 1.489 -1.589 0 CA-C-O 118.464 -1.186 . . . . 1.4199999999999999 110.806 173.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.705 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.9 135.8 3.84 Favored Glycine 0 C--N 1.299 -1.525 0 C-N-CA 117.188 -2.434 . . . . 0.47999999999999998 113.712 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.554 HG23 ' HB2' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -57.69 -26.58 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 107.541 -1.281 . . . . 0.52000000000000002 107.541 150.062 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.818 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 0.5 OUTLIER -57.69 -39.98 78.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 113.446 -1.706 . . . . 0.71999999999999997 110.435 171.075 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -62.61 -61.38 2.47 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.266 -0.879 . . . . 1.1899999999999999 110.721 -172.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -179.1 113.27 0.21 Allowed Pre-proline 0 N--CA 1.467 0.385 0 O-C-N 123.394 0.434 . . . . 2.5699999999999998 110.129 172.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.804 ' HA ' ' HD2' ' A' ' 53' ' ' LYS . 72.6 Cg_endo -77.09 -16.32 15.84 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.701 2.267 . . . . 2.8199999999999998 113.082 -178.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.3 t -94.13 10.53 33.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.915 0.388 . . . . 3.2599999999999998 111.232 -170.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -88.38 -19.04 27.15 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.976 0.732 . . . . 3.8799999999999999 112.976 -176.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -174.57 65.65 0.27 Allowed Pre-proline 0 N--CA 1.454 -0.266 0 N-CA-C 108.933 -0.765 . . . . 5.1399999999999997 108.933 -167.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -87.2 14.68 2.35 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.578 2.852 . . . . 3.71 112.499 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -111.82 5.43 19.03 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.045 -0.525 . . . . 5.6200000000000001 109.709 177.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.592 ' HB3' ' OG1' ' A' ' 51' ' ' THR . 74.5 m -125.4 129.85 50.71 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 115.858 -0.61 . . . . 3.77 110.492 -175.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.958 ' HA ' ' HB2' ' A' ' 52' ' ' ASP . 37.9 tt0 -111.1 -41.07 4.29 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.25 -1.341 . . . . 6.7800000000000002 109.565 176.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.602 ' O ' ' HD3' ' A' ' 50' ' ' LYS . 1.2 m-20 -38.57 -87.64 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 111.629 -2.532 . . . . 5.4699999999999998 112.225 -154.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.623 ' HE3' HG21 ' A' ' 110' ' ' THR . 53.2 mmtt -119.99 7.93 10.96 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 106.114 -1.81 . . . . 3.0699999999999998 106.114 163.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.592 ' OG1' ' HB3' ' A' ' 47' ' ' SER . 20.5 p -109.65 -11.59 14.74 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 112.895 -1.957 . . . . 4.5599999999999996 111.735 -165.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.958 ' HB2' ' HA ' ' A' ' 48' ' ' GLU . 32.4 t0 -59.32 -173.38 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.715 -0.394 . . . . 2.6000000000000001 111.195 166.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.804 ' HD2' ' HA ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -76.13 66.47 2.28 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.204 0.526 . . . . 3.48 110.946 -173.203 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.89 -159.83 33.68 Favored Glycine 0 N--CA 1.437 -1.259 0 CA-C-N 115.292 -0.867 . . . . 0.78000000000000003 111.064 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.074 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -110.15 145.93 16.05 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.738 0 N-CA-C 108.791 -0.818 . . . . 0.54000000000000004 108.791 175.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.6 ' HD1' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -140.0 147.39 40.34 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 119.235 0.925 . . . . 1.4199999999999999 110.281 -176.453 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.651 HG12 ' H ' ' A' ' 75' ' ' ASP . 7.1 p -94.18 135.72 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 CA-C-N 115.14 -0.936 . . . . 0.57999999999999996 109.796 175.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.7 ' O ' ' HB3' ' A' ' 32' ' ' SER . 21.4 m -128.32 68.49 1.36 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.765 -1.107 . . . . 1.1100000000000001 109.198 176.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.614 ' HA ' HG23 ' A' ' 73' ' ' ILE . 34.0 mtm180 150.06 -179.95 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 125.512 1.525 . . . . 2.27 110.397 163.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.423 ' N ' HG12 ' A' ' 73' ' ' ILE . 40.1 t -163.55 134.77 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 O-C-N 125.542 1.776 . . . . 0.82999999999999996 107.561 163.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.405 ' O ' HG12 ' A' ' 60' ' ' VAL . 19.2 p -77.59 169.44 18.29 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.633 0.73 . . . . 1.6499999999999999 111.031 175.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -103.43 128.43 50.58 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 114.783 -1.099 . . . . 1.8500000000000001 110.198 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.68 -5.42 52.4 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.324 -0.853 . . . . 0.92000000000000004 113.564 173.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.503 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -76.24 -129.13 0.31 Allowed Glycine 0 CA--C 1.506 -0.525 0 C-N-CA 120.35 -0.929 . . . . 0.98999999999999999 112.564 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.519 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 69.6 Cg_endo -102.76 -50.43 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 122.706 2.271 . . . . 0.44 115.572 177.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.529 ' HB2' ' O ' ' A' ' 29' ' ' LEU . . . -57.23 -32.43 66.52 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.534 0.938 . . . . 0.35999999999999999 113.534 -172.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -74.46 -28.65 61.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.596 0.712 . . . . 1.79 109.418 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.4 mp -74.32 -34.99 38.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.886 -1.052 . . . . 0.51000000000000001 109.648 -178.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.687 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -77.82 -23.01 49.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.574 -0.739 . . . . 0.40999999999999998 110.358 175.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.67 56.05 0.92 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.466 -0.873 . . . . 0.45000000000000001 114.132 175.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.682 ' HG ' HG21 ' A' ' 16' ' ' VAL . 2.2 mt -100.56 158.52 15.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 117.302 0.551 . . . . 0.89000000000000001 110.722 174.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 1.034 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 29.0 mt-30 -130.33 25.31 5.16 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 114.868 1.433 . . . . 1.21 114.868 -165.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.614 HG23 ' HA ' ' A' ' 59' ' ' ARG . 91.1 mt 72.95 -10.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 113.95 1.092 . . . . 0.77000000000000002 113.95 168.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.62 60.58 0.24 Allowed Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.436 -0.888 . . . . 0.37 111.974 -166.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.651 ' H ' HG12 ' A' ' 57' ' ' VAL . 36.6 m-20 -122.59 156.1 34.93 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.078 -0.561 . . . . 0.89000000000000001 110.376 -170.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.488 ' HG3' ' HD2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -104.39 102.02 11.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.314 0.578 . . . . 2.2000000000000002 109.546 -175.934 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 1.045 HG13 HG23 ' A' ' 109' ' ' VAL . 3.6 mp -74.71 125.37 34.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.491 -0.777 . . . . 0.48999999999999999 112.311 -171.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.906 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 3.0 mmt -92.1 -18.41 23.6 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 125.607 1.817 . . . . 1.0600000000000001 112.184 177.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.604 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -173.01 155.43 3.04 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.759 0.281 . . . . 0.81999999999999995 111.759 -175.306 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.44 ' N ' ' HG3' ' A' ' 79' ' ' GLN . 11.7 p -142.35 126.9 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 121.291 0.567 . . . . 1.3100000000000001 110.516 173.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.725 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 3.5 m-20 56.95 27.65 13.48 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.426 -0.806 . . . . 1.5 112.378 176.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.53 -11.1 63.14 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.122 -1.037 . . . . 0.38 112.605 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.42 ' CE2' ' HD2' ' A' ' 96' ' ' ARG . 80.9 m95 -83.91 160.16 21.15 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 108.696 -0.853 . . . . 0.77000000000000002 108.696 176.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -111.0 113.36 25.86 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.292 0.568 . . . . 1.8899999999999999 111.858 -171.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.541 ' HG3' HG11 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -109.1 102.46 11.43 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.723 -0.671 . . . . 1.01 111.58 -178.893 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.44 -50.93 2.31 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.262 -1.014 . . . . 1.05 108.262 168.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -135.38 86.99 2.29 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.549 -1.66 . . . . 1.6200000000000001 106.807 172.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.705 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.4 t -137.27 138.17 45.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.022 -0.99 . . . . 1.0900000000000001 109.754 -172.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.818 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 70.4 p -57.87 147.56 28.24 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 122.159 -0.338 . . . . 0.34999999999999998 111.609 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.809 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 19.8 t-160 -56.6 -40.63 75.64 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.312 0.577 . . . . 0.34999999999999998 110.175 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.25 -30.45 68.58 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.455 -1.248 . . . . 1.6699999999999999 110.042 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.769 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 2.3 tp-100 -63.48 -50.92 67.76 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.122 -1.066 . . . . 0.77000000000000002 108.122 178.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.615 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -70.81 -32.72 69.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.532 -0.758 . . . . 0.33000000000000002 110.856 -177.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -70.51 -40.04 73.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.067 -0.515 . . . . 2.1000000000000001 110.666 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.416 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -70.27 -41.26 73.69 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.259 -0.645 . . . . 0.95999999999999996 109.259 -178.856 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.769 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 21.9 mmt180 -71.33 -21.44 62.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.28 -0.873 . . . . 3.5699999999999998 110.67 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.536 HD11 ' CZ ' ' A' ' 31' ' ' PHE . 2.4 tt -70.99 -58.22 3.79 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.938 -0.574 . . . . 1.6499999999999999 110.443 175.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 m -100.71 90.04 4.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.599 0.714 . . . . 1.53 111.862 -171.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.709 ' HE2' ' O ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -110.42 118.19 35.6 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.766 -1.106 . . . . 2.7200000000000002 109.34 170.476 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -68.54 31.62 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.989 0.515 . . . . 4.3799999999999999 111.614 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 99' ' ' LYS . 14.2 m -139.07 -27.82 0.8 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.292 -0.413 . . . . 2.5099999999999998 110.997 -173.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.535 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 66.3 mm-40 -67.13 143.1 56.82 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 110.165 -0.309 . . . . 3.3999999999999999 110.165 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -94.27 -10.02 34.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.391 0.615 . . . . 2.6800000000000002 109.985 176.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.696 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 6.2 p -152.32 148.42 14.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.482 -0.781 . . . . 0.44 109.482 -175.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' A' ' 20' ' ' LYS . 55.5 t -117.04 117.94 57.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 122.051 0.929 . . . . 0.46000000000000002 111.53 -177.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.725 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.2 OUTLIER -99.29 133.02 44.19 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 113.426 -1.716 . . . . 1.76 110.305 -175.432 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.66 HD22 HD11 ' A' ' 71' ' ' LEU . 22.2 tp -134.63 134.69 41.49 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.541 -0.3 . . . . 1.1200000000000001 110.901 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.906 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 40.0 tp -115.53 114.3 24.79 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 106.843 -1.54 . . . . 0.41999999999999998 106.843 172.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 1.045 HG23 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -129.4 149.9 34.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 120.122 -0.631 . . . . 0.77000000000000002 110.488 -171.545 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.623 HG21 ' HE3' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -97.65 115.62 28.28 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.637 0.732 . . . . 0.34000000000000002 109.898 171.456 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.896 ' HB2' HE22 ' A' ' 72' ' ' GLN . 0.3 OUTLIER -99.61 136.71 39.13 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.006 -1.452 . . . . 2.0099999999999998 109.596 -173.231 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.498 ' CD ' HD21 ' A' ' 114' ' ' LEU . 16.8 pm0 -106.57 -56.99 2.11 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.104 -1.038 . . . . 1.97 112.762 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.44 ' H ' HD22 ' A' ' 114' ' ' LEU . 23.2 t -174.95 27.83 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.609 -0.436 . . . . 1.6200000000000001 112.125 -175.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 1.034 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -99.38 22.82 10.1 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.913 -0.492 . . . . 1.6499999999999999 110.583 -175.781 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.52 124.48 21.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.633 0.254 . . . . 3.5299999999999998 111.239 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -82.48 36.35 0.48 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.306 -0.406 . . . . 3.6000000000000001 110.874 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 57.57 33.58 23.44 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.18 0.514 . . . . 3.5600000000000001 109.862 -172.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.9 p -66.55 -28.13 42.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 114.882 -1.054 . . . . 4.9900000000000002 112.747 -171.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -138.08 -40.18 0.54 Allowed 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.889 -0.324 . . . . 7.7699999999999996 110.826 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 65.51 -165.59 0.23 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.575 0.547 . . . . 6.5999999999999996 110.409 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.4 m 63.45 34.22 13.01 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.089 0.471 . . . . 8.9399999999999995 111.063 177.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 72.4 mmm -73.37 115.03 12.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.035 -0.529 . . . . 12.1 111.376 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 pp -92.8 -171.92 2.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.897 -0.592 . . . . 12.82 110.67 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.572 -0.728 . . . . 14.640000000000001 110.475 179.303 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtm . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 109.922 -0.399 . . . . 14.33 109.922 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.7 m -73.83 -47.83 35.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.159 0.504 . . . . 11.220000000000001 110.268 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -88.0 118.75 27.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.894 -0.594 . . . . 9.1899999999999995 110.569 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.965 ' H ' ' HB3' ' A' ' 8' ' ' PRO . 63.3 mt -107.69 130.24 23.09 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 115.619 -0.718 . . . . 6.6500000000000004 109.53 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 4' ' ' ILE . 16.8 Cg_exo -68.24 67.65 1.01 Allowed 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.442 2.095 . . . . 7.46 112.254 177.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 148.34 -41.55 0.89 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.453 -0.88 . . . . 5.8899999999999997 113.763 176.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.41 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 3.5 pt20 -144.13 50.36 1.25 Allowed Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 114.384 1.253 . . . . 6.3700000000000001 114.384 -171.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.965 ' HB3' ' H ' ' A' ' 4' ' ' ILE . 95.2 Cg_endo -85.17 108.05 1.1 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.561 2.174 . . . . 3.3999999999999999 111.778 173.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 8' ' ' PRO . 73.5 t 71.09 -52.62 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 122.672 0.389 . . . . 2.2599999999999998 111.052 -176.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.3 m -71.12 82.74 0.71 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.731 0.777 . . . . 2.0899999999999999 109.56 175.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.19 170.81 9.42 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.091 -1.413 . . . . 0.95999999999999996 111.084 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.9 m -111.4 161.89 9.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.936 -1.029 . . . . 1.5700000000000001 109.084 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.571 HG22 HG23 ' A' ' 110' ' ' THR . 94.6 t -106.55 119.99 56.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.267 0.556 . . . . 1.02 111.388 -176.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.779 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -111.47 155.49 23.14 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.507 0.67 . . . . 1.3899999999999999 111.035 174.724 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.06 110.65 13.17 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.754 -0.657 . . . . 3.6299999999999999 110.156 -172.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 1.065 ' HB ' ' HB1' ' A' ' 69' ' ' ALA . 12.7 m -106.29 149.58 9.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 119.434 -0.907 . . . . 1.02 110.325 176.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -145.23 121.37 10.8 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.005 -0.543 . . . . 1.3500000000000001 109.953 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.543 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 10.9 tp -142.34 143.64 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 108.256 -1.016 . . . . 0.60999999999999999 108.256 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.834 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 5.3 m80 -74.96 117.67 17.06 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.307 -0.557 . . . . 0.59999999999999998 109.528 -176.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.562 ' HD3' ' HG ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -29.47 127.16 0.11 Allowed 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.776 1.297 . . . . 4.0 111.256 177.757 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.416 ' HB3' ' HB ' ' A' ' 28' ' ' ILE . 45.6 tp -98.05 101.74 13.3 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.252 0.548 . . . . 0.55000000000000004 110.478 -173.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -69.43 135.49 50.31 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.371 0.605 . . . . 3.9700000000000002 111.366 -176.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 34.1 tp60 -128.86 93.59 3.64 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.433 -0.951 . . . . 1.3500000000000001 108.433 174.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.21 -87.94 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.772 -0.931 . . . . 1.3300000000000001 110.772 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.52 14.34 4.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.324 0.583 . . . . 2.3300000000000001 110.776 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -108.98 159.76 16.56 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.682 -0.69 . . . . 1.8700000000000001 109.492 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.562 ' HG ' ' HD3' ' A' ' 20' ' ' LYS . 9.0 mp -112.77 119.18 37.14 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 109.062 -0.718 . . . . 2.2799999999999998 109.062 174.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 40.5 mm -98.73 109.55 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 115.415 -0.811 . . . . 0.80000000000000004 109.981 -176.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.576 HD13 HD13 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -83.93 -25.61 29.98 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.463 -1.244 . . . . 1.74 109.088 175.355 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.442 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 93.67 -27.11 13.14 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.119 -0.946 . . . . 0.68999999999999995 112.673 174.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.631 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 32.8 p90 -110.43 151.32 27.65 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 122.291 -0.535 . . . . 0.51000000000000001 111.384 -173.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.545 ' H ' ' HB2' ' A' ' 59' ' ' ARG . 10.2 t -101.82 158.43 16.13 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 107.578 -1.267 . . . . 0.53000000000000003 107.578 175.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.407 HG12 ' N ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -160.19 143.04 4.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 C-N-CA 120.158 -0.617 . . . . 0.48999999999999999 112.529 -163.739 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.447 ' HA2' ' CD2' ' A' ' 90' ' ' HIS . . . -139.51 118.28 1.48 Allowed Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 110.007 -1.237 . . . . 0.71999999999999997 110.007 154.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 1.029 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.39 119.06 1.43 Allowed Glycine 0 CA--C 1.491 -1.419 0 CA-C-O 118.518 -1.157 . . . . 1.4199999999999999 111.42 172.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.671 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.29 146.49 10.78 Favored Glycine 0 C--N 1.303 -1.3 0 C-N-CA 117.304 -2.379 . . . . 0.47999999999999998 113.1 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.471 HG12 ' N ' ' A' ' 88' ' ' VAL . 1.1 pt -68.43 -19.74 24.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 107.562 -1.273 . . . . 0.52000000000000002 107.562 151.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.774 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 2.5 t70 -58.8 -36.6 74.75 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.026 -1.443 . . . . 0.71999999999999997 109.541 168.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -70.75 -43.78 68.12 Favored 'General case' 0 C--N 1.338 0.067 0 CA-C-N 114.73 -1.123 . . . . 1.1899999999999999 109.793 -176.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.413 ' HB2' ' HE2' ' A' ' 53' ' ' LYS . 12.9 m-20 -127.93 91.56 44.6 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.984 -0.553 . . . . 2.5699999999999998 110.451 176.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.09 -17.3 50.73 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.538 2.159 . . . . 2.8199999999999998 110.891 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.9 t -74.7 -40.81 61.12 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.327 -0.851 . . . . 3.2599999999999998 109.296 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -99.93 73.59 1.76 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.671 0.748 . . . . 3.8799999999999999 109.85 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.602 ' H ' ' CD ' ' A' ' 45' ' ' PRO . 25.0 t30 -132.41 -38.51 0.03 OUTLIER Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 114.539 -1.21 . . . . 5.1399999999999997 109.074 175.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.602 ' CD ' ' H ' ' A' ' 44' ' ' ASN . 23.1 Cg_exo -71.33 6.82 1.68 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 121.517 1.478 . . . . 3.71 110.52 161.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.457 ' H ' ' C ' ' A' ' 44' ' ' ASN . 66.8 t80 -107.88 -26.2 10.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.976 -1.011 . . . . 5.6200000000000001 109.807 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.675 ' HA ' ' HB2' ' A' ' 52' ' ' ASP . 34.7 p -71.61 97.47 1.71 Allowed 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 122.507 1.146 . . . . 3.77 110.111 -174.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -99.66 -37.69 9.02 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 113.038 -1.892 . . . . 6.7800000000000002 109.663 -175.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -176.41 -151.04 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 112.882 -1.963 . . . . 5.4699999999999998 107.428 -160.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.534 ' HA ' ' HD2' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -79.51 8.17 6.85 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 120.616 -0.434 . . . . 3.0699999999999998 111.931 172.959 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.6 t -72.23 -34.66 68.48 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.742 -0.836 . . . . 4.5599999999999996 108.742 171.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.675 ' HB2' ' HA ' ' A' ' 47' ' ' SER . 8.3 t70 -70.01 -170.04 0.31 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.54 -0.755 . . . . 2.6000000000000001 110.036 166.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.455 ' HD2' ' H ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -95.9 -41.23 8.91 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.518 -0.31 . . . . 3.48 110.712 175.169 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.455 ' H ' ' HD2' ' A' ' 53' ' ' LYS . . . 74.09 -133.18 16.27 Favored Glycine 0 C--O 1.241 0.567 0 C-N-CA 120.941 -0.647 . . . . 0.78000000000000003 111.613 -179.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.029 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -111.32 143.89 20.28 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 N-CA-C 106.846 -1.539 . . . . 0.54000000000000004 106.846 172.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.767 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -154.96 148.35 25.11 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 120.155 1.343 . . . . 1.4199999999999999 112.039 -178.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.842 HG12 ' H ' ' A' ' 75' ' ' ASP . 1.5 p -87.49 136.68 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-N 114.529 -1.214 . . . . 0.57999999999999996 110.421 -175.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.2 m -105.34 -11.97 16.25 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.116 -0.947 . . . . 1.1100000000000001 110.697 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.897 ' HA ' HG23 ' A' ' 73' ' ' ILE . 41.3 mtt180 -145.54 -170.11 3.38 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.083 0.771 . . . . 2.27 113.083 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 59' ' ' ARG . 53.2 t -170.33 146.37 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.37 1.868 . . . . 0.82999999999999996 106.627 167.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.4 p -97.48 123.49 41.36 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.674 0.75 . . . . 1.6499999999999999 112.088 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -66.0 112.34 3.79 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 113.658 -1.61 . . . . 1.8500000000000001 110.359 169.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.76 -3.03 48.91 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.164 -0.925 . . . . 0.92000000000000004 112.634 -177.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.566 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -91.52 -139.66 8.63 Favored Glycine 0 CA--C 1.501 -0.835 0 C-N-CA 120.367 -0.921 . . . . 0.98999999999999999 111.785 178.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.523 ' HB2' HG21 ' A' ' 18' ' ' ILE . 77.6 Cg_endo -102.07 -50.07 0.01 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 122.73 2.287 . . . . 0.44 114.959 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.631 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -50.45 -29.46 10.38 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.589 0.959 . . . . 0.35999999999999999 113.589 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -71.46 -32.22 68.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.745 0.784 . . . . 1.79 109.463 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.566 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.5 mp -79.08 -36.54 18.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.444 -1.253 . . . . 0.51000000000000001 108.516 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 1.065 ' HB1' ' HB ' ' A' ' 16' ' ' VAL . . . -66.17 -35.11 79.6 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.409 -1.268 . . . . 0.40999999999999998 109.91 173.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.43 33.15 2.77 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.223 -0.989 . . . . 0.45000000000000001 114.233 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.453 HD21 HG21 ' A' ' 57' ' ' VAL . 17.8 tp -90.66 154.79 19.31 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.466 -0.568 . . . . 0.89000000000000001 109.466 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.42 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 36.8 mt-30 -129.34 31.89 4.76 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 115.449 1.648 . . . . 1.21 115.449 -165.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.897 HG23 ' HA ' ' A' ' 59' ' ' ARG . 58.1 mt 71.33 2.1 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 CA-C-N 118.993 0.815 . . . . 0.77000000000000002 113.188 167.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.17 46.19 0.25 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 119.58 -1.295 . . . . 0.37 112.439 -170.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.842 ' H ' HG12 ' A' ' 57' ' ' VAL . 20.0 m-20 -119.83 142.31 48.74 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.331 -0.435 . . . . 0.89000000000000001 110.864 -169.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.767 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 13.0 mptt -96.68 102.64 14.46 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.803 0.811 . . . . 2.2000000000000002 111.0 -171.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.823 HG13 HG23 ' A' ' 109' ' ' VAL . 2.8 mp -63.05 123.42 15.78 Favored 'Isoleucine or valine' 0 C--O 1.255 1.342 0 CA-C-N 115.274 -0.876 . . . . 0.48999999999999999 112.505 -178.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.9 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 2.0 mmt -91.74 -18.99 23.09 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 113.494 -1.685 . . . . 1.0600000000000001 111.281 173.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.617 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 4.3 tt0 -172.03 151.53 2.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.071 -0.513 . . . . 0.81999999999999995 111.876 -174.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.776 HG12 ' HE1' ' A' ' 85' ' ' MET . 9.8 p -145.53 127.21 8.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.729 -0.669 . . . . 1.3100000000000001 109.735 173.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 58.44 20.0 7.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.75 -0.659 . . . . 1.5 111.874 178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.69 -7.86 53.88 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 119.733 -1.222 . . . . 0.38 113.368 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 68.0 m95 -85.21 159.85 20.02 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 117.451 0.626 . . . . 0.77000000000000002 110.014 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -102.46 113.72 27.3 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.668 -0.696 . . . . 1.8899999999999999 111.454 -172.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.776 ' HE1' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -104.57 100.58 10.25 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 122.667 1.222 . . . . 1.01 110.116 179.219 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.6 p -142.16 -49.9 0.38 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 112.854 -1.975 . . . . 1.05 105.83 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.415 ' HA ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -133.97 75.15 1.58 Allowed 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 112.178 -2.283 . . . . 1.6200000000000001 108.828 173.4 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.758 ' O ' HD11 ' A' ' 55' ' ' ILE . 1.2 t -132.72 138.55 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 108.007 -1.108 . . . . 1.0900000000000001 108.007 177.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.719 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 68.8 p -59.5 152.16 22.48 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.884 -0.51 . . . . 0.34999999999999998 112.018 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.81 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 16.5 t-160 -57.25 -38.0 73.19 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-O 122.516 1.15 . . . . 0.34999999999999998 109.925 -177.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.402 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 5.1 p-10 -71.66 -31.78 67.18 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 112.79 -2.005 . . . . 1.6699999999999999 109.889 -177.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.717 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.5 OUTLIER -65.55 -39.15 91.38 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 108.158 -1.053 . . . . 0.77000000000000002 108.158 179.842 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.594 ' HB2' HG12 ' A' ' 55' ' ' ILE . . . -74.75 -41.6 59.78 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.439 -1.255 . . . . 0.33000000000000002 109.793 -176.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -68.22 -37.79 81.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.287 -0.869 . . . . 2.1000000000000001 110.661 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.504 ' HD3' ' HD2' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -70.97 -30.09 66.26 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.012 0.434 . . . . 0.95999999999999996 109.844 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.717 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 9.4 mmm180 -76.23 -24.35 54.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.223 -0.444 . . . . 3.5699999999999998 111.881 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.576 HD13 HD13 ' A' ' 29' ' ' LEU . 3.3 pp -96.92 -8.26 31.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.236 0.458 . . . . 1.6499999999999999 112.236 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.55 HG23 ' HB2' ' A' ' 27' ' ' LEU . 31.5 m -145.02 97.6 3.04 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.183 0.516 . . . . 1.53 111.225 174.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.482 ' HG3' ' HB2' ' A' ' 101' ' ' SER . 5.2 ptpp? -142.56 9.7 1.81 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.592 -0.731 . . . . 2.7200000000000002 112.403 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 39.4 mtm-85 63.96 24.15 13.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.61 -0.723 . . . . 4.3799999999999999 110.886 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.482 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 69.8 m -153.63 83.95 1.17 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.335 0.588 . . . . 2.5099999999999998 110.46 -178.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.444 ' C ' ' H ' ' A' ' 104' ' ' VAL . 1.2 pm0 -163.0 -44.74 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.538 -0.755 . . . . 3.3999999999999999 110.085 178.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 71.76 -41.97 0.52 Allowed 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.34 1.025 . . . . 2.6800000000000002 111.045 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.834 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 2.7 p -133.33 133.4 57.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.351 -1.352 . . . . 0.44 107.351 176.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 53.3 t -109.85 119.37 58.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 122.151 0.976 . . . . 0.46000000000000002 112.198 -171.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.93 123.05 41.74 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 113.397 -1.729 . . . . 1.76 109.803 -176.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.509 HD11 HG12 ' A' ' 77' ' ' ILE . 11.1 tp -131.42 116.76 17.93 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.656 -0.702 . . . . 1.1200000000000001 111.171 -173.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.881 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 41.0 tp -104.31 117.87 35.24 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.611 -1.255 . . . . 0.41999999999999998 107.611 177.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.823 HG23 HG13 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -131.35 152.4 37.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-O 121.38 0.61 . . . . 0.77000000000000002 110.803 -173.092 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.571 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -97.53 117.21 31.28 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.721 -0.672 . . . . 0.34000000000000002 110.321 171.429 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.644 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 30.7 ttt180 -97.76 136.48 38.03 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.597 -1.183 . . . . 2.0099999999999998 110.375 -177.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.437 ' N ' ' CD ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -123.02 -70.61 0.76 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.753 0.649 . . . . 1.97 112.753 -174.181 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.669 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 0.5 OUTLIER -153.09 27.79 0.52 Allowed 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.266 -0.574 . . . . 1.6200000000000001 112.418 -170.831 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 114' ' ' LEU . 2.3 mm? -107.01 26.96 9.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.485 0.66 . . . . 1.6499999999999999 110.11 177.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.669 ' NE2' ' HA ' ' A' ' 113' ' ' SER . 0.7 OUTLIER -87.92 17.88 4.57 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.163 -0.926 . . . . 3.5299999999999998 111.928 -174.721 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt 69.61 156.15 0.14 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 123.839 0.712 . . . . 3.6000000000000001 111.284 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 65.91 14.5 9.61 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.829 -0.623 . . . . 3.5600000000000001 112.341 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.574 HG21 HE21 ' A' ' 115' ' ' GLN . 57.1 t -107.38 -27.48 2.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.688 0.756 . . . . 4.9900000000000002 110.18 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.69 -15.14 57.29 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.941 -1.027 . . . . 7.7699999999999996 110.207 -176.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -97.42 117.35 31.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.844 -0.616 . . . . 6.5999999999999996 110.538 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.7 m -106.36 -18.93 13.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.104 -0.498 . . . . 8.9399999999999995 111.002 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 25.6 ptm -166.81 164.49 16.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.271 -0.422 . . . . 12.1 110.554 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 29.9 tp 62.07 91.72 0.06 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 124.108 0.88 . . . . 12.82 111.885 174.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.2 m . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.428 -0.796 . . . . 14.640000000000001 110.006 177.988 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptp . . . . . 0 N--CA 1.484 1.228 0 CA-C-O 120.876 0.369 . . . . 14.33 110.631 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.5 t -82.15 149.09 28.14 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.158 -0.682 . . . . 11.220000000000001 109.158 175.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -86.63 136.82 32.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.076 0.465 . . . . 9.1899999999999995 110.478 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.601 HD12 ' HD2' ' A' ' 8' ' ' PRO . 5.7 pt -114.49 99.37 51.24 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.597 -0.728 . . . . 6.6500000000000004 110.738 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -65.84 126.95 16.84 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.798 2.332 . . . . 7.46 111.908 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.41 -27.6 13.28 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.826 -0.702 . . . . 5.8899999999999997 111.905 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 64.92 100.08 0.04 OUTLIER Pre-proline 0 N--CA 1.462 0.17 0 CA-C-O 121.556 0.693 . . . . 6.3700000000000001 111.86 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.601 ' HD2' HD12 ' A' ' 4' ' ' ILE . 1.9 Cg_endo -83.62 -171.51 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.439 2.759 . . . . 3.3999999999999999 111.505 176.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.5 m -103.8 -3.13 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 109.658 -0.497 . . . . 2.2599999999999998 109.658 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.489 HG22 ' HB2' ' A' ' 8' ' ' PRO . 1.8 t -85.87 81.96 8.34 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 123.283 1.516 . . . . 2.0899999999999999 111.078 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.3 179.05 5.31 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 112.087 -2.324 . . . . 0.95999999999999996 109.758 173.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.17 108.41 25.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.328 -0.396 . . . . 1.5700000000000001 110.386 -174.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.709 HG22 HG23 ' A' ' 110' ' ' THR . 26.1 t -76.83 98.52 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.291 0.567 . . . . 1.02 110.203 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.705 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -103.3 165.02 11.28 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.68 -0.691 . . . . 1.3899999999999999 111.122 178.259 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.505 ' HD2' ' H ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -126.07 116.98 22.24 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.704 -0.623 . . . . 3.6299999999999999 110.987 -178.791 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.732 HG13 ' CB ' ' A' ' 69' ' ' ALA . 4.9 t -88.85 127.41 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 115.303 -0.862 . . . . 1.02 109.597 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 31.9 tt0 -131.03 116.99 18.52 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.437 -0.579 . . . . 1.3500000000000001 109.437 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 18' ' ' ILE . 10.1 tp -145.1 146.43 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 108.562 -0.903 . . . . 0.60999999999999999 108.562 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.754 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.3 m-70 -68.85 119.14 12.74 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.175 -0.676 . . . . 0.59999999999999998 109.175 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.869 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -37.44 133.41 0.73 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.944 0.778 . . . . 4.0 110.105 171.782 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.5 tp -94.02 85.9 4.86 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.959 0.885 . . . . 0.55000000000000004 109.747 -170.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -84.55 139.33 32.2 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.15 -1.386 . . . . 3.9700000000000002 111.783 -174.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.532 ' HG3' HD13 ' A' ' 28' ' ' ILE . 2.9 mt-30 -139.47 94.14 2.75 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.125 -0.943 . . . . 1.3500000000000001 109.145 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.68 -73.6 0.24 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.014 -0.612 . . . . 1.3300000000000001 112.547 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -139.45 1.69 1.98 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.416 0.627 . . . . 2.3300000000000001 110.388 -177.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -114.06 120.63 41.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.567 -0.742 . . . . 1.8700000000000001 109.465 -173.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.537 HD22 ' HA ' ' A' ' 100' ' ' ARG . 7.6 mp -103.09 116.62 32.86 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.103 -0.703 . . . . 2.2799999999999998 109.103 176.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.532 HD13 ' HG3' ' A' ' 23' ' ' GLN . 1.8 mp -96.01 126.5 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 115.493 -0.776 . . . . 0.80000000000000004 110.2 -172.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.464 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -103.38 109.12 20.63 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.334 -1.303 . . . . 1.74 108.041 174.037 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.671 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -77.92 43.5 2.2 Favored Glycine 0 C--O 1.216 -0.987 0 C-N-CA 121.016 -0.611 . . . . 0.68999999999999995 112.574 -175.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.601 ' HB2' ' CG2' ' A' ' 57' ' ' VAL . 40.0 p90 -159.7 147.15 16.84 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.417 -1.327 . . . . 0.51000000000000001 107.417 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.639 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -102.4 163.82 12.02 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 118.466 -1.294 . . . . 0.53000000000000003 107.605 176.184 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.532 HD12 HD21 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -154.26 139.83 10.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 119.242 -0.983 . . . . 0.48999999999999999 113.0 -168.261 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.421 ' N ' HG12 ' A' ' 33' ' ' ILE . . . -141.09 118.07 1.32 Allowed Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 109.83 -1.308 . . . . 0.71999999999999997 109.83 154.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.999 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -142.39 117.69 1.18 Allowed Glycine 0 C--N 1.302 -1.323 0 CA-C-O 118.251 -1.305 . . . . 1.4199999999999999 111.577 170.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.645 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.8 141.93 7.26 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 117.641 -2.219 . . . . 0.47999999999999998 113.507 175.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.439 HG23 ' HA ' ' A' ' 87' ' ' MET . 13.7 pt -61.9 -20.37 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 N-CA-C 107.363 -1.347 . . . . 0.52000000000000002 107.363 151.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.834 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 3.0 t70 -59.32 -43.95 92.65 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 113.588 -1.642 . . . . 0.71999999999999997 109.759 171.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -64.05 -68.62 0.34 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.008 -0.996 . . . . 1.1899999999999999 109.967 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.442 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 0.3 OUTLIER -172.77 117.52 0.4 Allowed Pre-proline 0 N--CA 1.47 0.57 0 CA-C-O 121.652 0.739 . . . . 2.5699999999999998 111.18 169.422 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 1.1 Cg_endo -88.71 -20.92 1.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.691 2.928 . . . . 2.8199999999999998 111.651 172.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.9 t -61.16 -29.89 70.07 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.676 -1.147 . . . . 3.2599999999999998 112.18 -169.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -117.62 13.89 14.37 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.878 -0.329 . . . . 3.8799999999999999 111.002 -174.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.718 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 91.2 m-20 -147.24 34.09 0.11 Allowed Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 112.162 0.43 . . . . 5.1399999999999997 112.162 -169.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.718 ' HD3' ' N ' ' A' ' 44' ' ' ASN . 12.1 Cg_exo -70.94 -29.26 18.49 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 121.388 1.392 . . . . 3.71 110.205 -177.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -151.38 59.52 0.89 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.905 -1.517 . . . . 5.6200000000000001 106.905 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.533 ' HB2' ' HA ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -85.74 -166.4 1.51 Allowed 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 113.888 -1.505 . . . . 3.77 111.588 -173.805 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -22.12 -58.26 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 112.666 -2.061 . . . . 6.7800000000000002 115.866 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.521 ' HB3' HG22 ' A' ' 51' ' ' THR . 38.2 t70 -167.27 -124.8 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 120.55 -0.46 . . . . 5.4699999999999998 110.869 -164.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.627 ' HB3' ' HE1' ' A' ' 78' ' ' MET . 8.3 mptt -102.86 8.84 39.15 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.861 -0.792 . . . . 3.0699999999999998 108.861 173.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.521 HG22 ' HB3' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -84.37 -62.9 1.44 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.135 -1.061 . . . . 4.5599999999999996 108.135 -178.343 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.682 ' HB2' ' HE2' ' A' ' 53' ' ' LYS . 1.7 m-20 21.13 -113.0 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 O-C-N 125.211 1.569 . . . . 2.6000000000000001 113.721 170.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.802 ' HE2' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -110.69 18.4 19.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.795 -1.093 . . . . 3.48 109.682 175.134 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.12 -157.11 13.63 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 110.064 -1.214 . . . . 0.78000000000000003 110.064 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.999 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -116.5 135.06 57.98 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.145 0 N-CA-C 107.423 -1.325 . . . . 0.54000000000000004 107.423 174.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.707 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -152.49 150.53 29.71 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.052 0.842 . . . . 1.4199999999999999 111.485 -177.245 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.611 HG12 ' H ' ' A' ' 75' ' ' ASP . 10.0 p -93.5 133.58 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 114.574 -1.193 . . . . 0.57999999999999996 111.191 -169.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.639 ' O ' ' HB3' ' A' ' 32' ' ' SER . 32.6 m -123.89 70.32 1.07 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.803 -1.09 . . . . 1.1100000000000001 109.479 174.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 1.003 ' HA ' HG23 ' A' ' 73' ' ' ILE . 41.8 mtt180 151.73 177.25 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 125.47 1.508 . . . . 2.27 110.823 163.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.649 HG13 ' HB3' ' A' ' 66' ' ' ALA . 91.7 t -161.36 138.49 2.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 125.432 1.707 . . . . 0.82999999999999996 107.249 163.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.7 p -86.16 122.93 30.86 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.191 0.519 . . . . 1.6499999999999999 110.87 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -48.67 117.3 1.97 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.315 -1.311 . . . . 1.8500000000000001 111.855 171.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.15 12.3 84.75 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.656 -0.783 . . . . 0.92000000000000004 113.222 173.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.529 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -87.29 -132.63 3.63 Favored Glycine 0 C--O 1.22 -0.755 0 C-N-CA 119.942 -1.123 . . . . 0.98999999999999999 111.31 174.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.671 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 97.6 Cg_endo -101.15 -42.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.538 2.159 . . . . 0.44 115.463 177.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.649 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -64.48 -27.1 68.75 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.0 -0.546 . . . . 0.35999999999999999 111.898 -173.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -70.81 -33.34 70.6 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.652 0.739 . . . . 1.79 109.151 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -71.48 -40.37 72.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.496 -1.229 . . . . 0.51000000000000001 110.627 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.732 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -77.61 -15.59 59.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.40999999999999998 110.626 177.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.0 47.68 2.83 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.124 -1.036 . . . . 0.45000000000000001 114.123 173.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.454 HD21 HG21 ' A' ' 57' ' ' VAL . 19.7 tp -97.68 149.98 21.68 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.94 -0.763 . . . . 0.89000000000000001 108.94 176.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.507 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 56.0 mt-30 -122.56 33.31 5.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 114.576 1.324 . . . . 1.21 114.576 -165.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.003 HG23 ' HA ' ' A' ' 59' ' ' ARG . 56.2 mt 72.05 -1.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 113.185 0.809 . . . . 0.77000000000000002 113.185 165.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -173.08 52.23 0.16 Allowed Glycine 0 CA--C 1.509 -0.298 0 C-N-CA 120.084 -1.055 . . . . 0.37 111.999 -164.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.611 ' H ' HG12 ' A' ' 57' ' ' VAL . 43.9 m-20 -120.48 149.67 42.02 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.157 -0.521 . . . . 0.89000000000000001 110.603 -172.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.707 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -95.4 101.54 13.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.332 -0.394 . . . . 2.2000000000000002 110.593 -173.71 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.662 HD12 ' HA ' ' A' ' 56' ' ' TYR . 4.3 mt -72.72 123.01 26.55 Favored 'Isoleucine or valine' 0 C--O 1.261 1.669 0 CA-C-O 121.434 0.635 . . . . 0.48999999999999999 112.424 -175.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.917 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 4.2 mmt -89.92 -19.49 24.49 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 113.242 -1.799 . . . . 1.0600000000000001 112.286 176.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.551 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 1.0 OUTLIER -172.39 157.21 3.99 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.184 0.438 . . . . 0.81999999999999995 112.184 -174.825 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.614 HG12 ' SD ' ' A' ' 85' ' ' MET . 12.3 p -141.59 122.74 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.247 0.546 . . . . 1.3100000000000001 110.712 171.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.7 m120 50.1 36.5 12.29 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.371 -0.831 . . . . 1.5 112.192 176.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.67 -18.66 49.87 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.451 -0.88 . . . . 0.38 113.244 175.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 52.9 m95 -81.84 149.39 28.34 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 109.684 -0.488 . . . . 0.77000000000000002 109.684 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -95.91 116.33 28.76 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.635 -0.711 . . . . 1.8899999999999999 111.0 -175.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.614 ' SD ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -105.8 99.36 8.96 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 122.626 1.203 . . . . 1.01 110.177 177.567 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.1 p -138.09 -44.42 0.51 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.112 -1.858 . . . . 1.05 106.765 173.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.439 ' HA ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -148.46 75.15 1.31 Allowed 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.514 -1.676 . . . . 1.6200000000000001 109.674 177.284 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.645 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -140.96 154.25 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 108.779 -0.823 . . . . 1.0900000000000001 108.779 173.723 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.705 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 74.7 p -60.01 151.95 25.09 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 113.168 0.803 . . . . 0.34999999999999998 113.168 -173.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.834 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 21.5 t-160 -58.81 -40.37 83.92 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 115.74 -0.664 . . . . 0.34999999999999998 110.092 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -66.17 -31.01 71.6 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.13 -1.395 . . . . 1.6699999999999999 109.838 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.59 ' HB3' ' O ' ' A' ' 89' ' ' THR . 10.0 tp60 -63.63 -51.81 63.57 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.677 0.751 . . . . 0.77000000000000002 109.514 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.538 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -72.54 -33.38 66.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.935 -1.029 . . . . 0.33000000000000002 109.801 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 90' ' ' HIS . 11.3 ttp180 -61.77 -48.46 80.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.2 -0.909 . . . . 2.1000000000000001 110.642 -177.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.651 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -70.52 -28.45 64.95 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 119.768 -0.773 . . . . 0.95999999999999996 110.647 -179.738 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.559 ' HD2' ' HD3' ' A' ' 95' ' ' LYS . 1.8 mmm180 -70.0 -41.66 74.07 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.196 -0.601 . . . . 3.5699999999999998 112.155 -177.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.557 ' HB3' HG21 ' A' ' 80' ' ' VAL . 3.3 pp -80.58 -25.21 38.64 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.636 -0.426 . . . . 1.6499999999999999 110.965 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.472 ' N ' HD12 ' A' ' 97' ' ' LEU . 21.5 m -153.68 95.27 1.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.442 0.639 . . . . 1.53 111.436 178.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.651 ' HB3' ' O ' ' A' ' 95' ' ' LYS . 7.0 ptpt -112.67 9.89 19.32 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.454 -0.794 . . . . 2.7200000000000002 109.118 174.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.537 ' HA ' HD22 ' A' ' 27' ' ' LEU . 11.9 mtt180 70.01 19.05 7.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.09 -1.414 . . . . 4.3799999999999999 111.904 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.6 t -137.29 9.96 2.98 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 120.623 -0.431 . . . . 2.5099999999999998 111.827 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.492 ' HB2' ' HG3' ' A' ' 20' ' ' LYS . 6.1 mm-40 -85.39 148.48 25.99 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.998 0.428 . . . . 3.3999999999999999 111.398 -177.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.547 ' HG3' HG12 ' A' ' 104' ' ' VAL . 7.3 pt-20 -95.83 -49.71 5.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.881 -0.6 . . . . 2.6800000000000002 110.702 178.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.754 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 2.6 p -143.69 142.14 25.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.166 -1.05 . . . . 0.44 108.166 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.761 HG21 ' HG2' ' A' ' 20' ' ' LYS . 42.1 t -123.3 117.85 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 CA-C-O 122.22 1.01 . . . . 0.46000000000000002 112.403 -164.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -101.16 127.32 47.78 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 112.865 -1.97 . . . . 1.76 109.954 -174.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.523 HD11 HG12 ' A' ' 77' ' ' ILE . 20.7 tp -130.87 124.4 31.12 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.915 -0.584 . . . . 1.1200000000000001 109.587 -174.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.605 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 33.9 tp -100.31 119.84 39.02 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.247 -1.761 . . . . 0.41999999999999998 106.247 176.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.705 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -126.6 150.66 32.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.239 0.542 . . . . 0.77000000000000002 109.946 -171.763 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.709 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -98.07 115.13 27.6 Favored 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 119.436 -0.906 . . . . 0.34000000000000002 109.421 168.266 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.424 ' CD ' ' HG2' ' A' ' 14' ' ' GLN . 7.9 ttm180 -105.39 149.23 26.3 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.384 -1.28 . . . . 2.0099999999999998 110.704 -171.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.467 HE21 HD11 ' A' ' 114' ' ' LEU . 0.9 OUTLIER -138.29 -156.22 0.67 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.352 -0.981 . . . . 1.97 108.352 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.03 72.5 8.37 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.846 0.831 . . . . 1.6200000000000001 112.223 -171.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.507 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 3.3 mt -118.55 -10.11 10.15 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.445 -1.252 . . . . 1.6499999999999999 107.734 175.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.504 ' HG3' ' NE2' ' A' ' 72' ' ' GLN . 23.1 mt-30 -41.15 112.99 0.35 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 112.821 -1.99 . . . . 3.5299999999999998 112.567 176.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -85.48 41.65 0.91 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.334 -0.848 . . . . 3.6000000000000001 110.929 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 59.83 32.19 21.17 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.824 -0.626 . . . . 3.5600000000000001 110.915 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.6 p -66.18 -10.51 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.642 -0.708 . . . . 4.9900000000000002 111.497 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -86.01 -20.16 29.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.272 -0.422 . . . . 7.7699999999999996 111.179 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 57.38 -153.56 0.37 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.183 0.516 . . . . 6.5999999999999996 111.676 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 52.9 p -138.97 179.81 6.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.614 -0.721 . . . . 8.9399999999999995 109.196 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 21.0 ptm -153.19 144.88 23.45 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.752 0.31 . . . . 12.1 110.751 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.0 mt -88.6 120.35 29.91 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.474 -0.565 . . . . 12.82 109.474 175.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.7 m . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.585 -0.721 . . . . 14.640000000000001 110.948 179.925 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ptm . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 111.596 0.221 . . . . 14.33 111.596 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 m -73.5 -19.22 60.98 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.471 0.545 . . . . 11.220000000000001 112.471 -172.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.422 ' CZ ' ' HG3' ' A' ' 5' ' ' PRO . 42.4 p90 -95.75 9.37 40.66 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.81 -0.356 . . . . 9.1899999999999995 111.144 -177.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.436 HG22 ' HD3' ' A' ' 8' ' ' PRO . 22.9 pt 35.94 88.52 0.09 OUTLIER Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 124.075 0.95 . . . . 6.6500000000000004 113.491 -177.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.422 ' HG3' ' CZ ' ' A' ' 3' ' ' TYR . 20.4 Cg_exo -64.19 -63.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.846 2.364 . . . . 7.46 111.302 -178.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.21 14.99 10.17 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.2 -1.16 . . . . 5.8899999999999997 110.2 172.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.482 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 80.1 mt-30 69.06 138.84 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 123.962 0.905 . . . . 6.3700000000000001 111.148 -176.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 7' ' ' GLN . 11.6 Cg_endo -92.78 -154.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.153 2.569 . . . . 3.3999999999999999 112.306 -177.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.1 m -95.09 4.22 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 108.388 -0.967 . . . . 2.2599999999999998 108.388 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.7 m -77.19 81.46 3.69 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 122.64 1.21 . . . . 2.0899999999999999 110.115 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.76 132.35 37.03 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 113.01 -1.905 . . . . 0.95999999999999996 108.584 170.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 p -107.23 123.45 62.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.047 -0.524 . . . . 1.5700000000000001 110.231 -173.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.983 HG12 HG23 ' A' ' 110' ' ' THR . 1.0 OUTLIER -81.33 128.2 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 121.861 0.838 . . . . 1.02 111.124 -173.564 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.698 ' HG3' HG12 ' A' ' 109' ' ' VAL . 1.1 pp0? -101.87 167.34 10.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.92 -1.036 . . . . 1.3899999999999999 111.172 173.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.447 ' HD3' ' O ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -124.82 106.83 10.33 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.688 -0.687 . . . . 3.6299999999999999 110.027 -174.109 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.691 HG13 ' CB ' ' A' ' 69' ' ' ALA . 1.5 t -104.78 133.19 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 109.857 -0.423 . . . . 1.02 109.857 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -137.81 126.66 23.99 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.778 -0.453 . . . . 1.3500000000000001 109.778 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 9.8 tp -142.91 161.57 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 108.239 -1.023 . . . . 0.60999999999999999 108.239 -178.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -95.2 113.09 24.73 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.822 -0.751 . . . . 0.59999999999999998 109.838 -175.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.854 ' HB2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -26.8 130.01 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 125.125 1.515 . . . . 4.0 112.341 179.544 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 36.1 tp -100.61 95.76 6.9 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 119.936 -0.705 . . . . 0.55000000000000004 109.208 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 22' ' ' ARG . 16.5 ptt180 -74.67 140.02 43.92 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.499 -0.773 . . . . 3.9700000000000002 111.54 -172.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.526 ' HB2' HD13 ' A' ' 28' ' ' ILE . 23.3 tp60 -134.58 93.99 3.13 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.393 -0.966 . . . . 1.3500000000000001 108.393 177.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.07 -83.28 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.686 -0.768 . . . . 1.3300000000000001 111.545 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.786 ' HB3' HH11 ' A' ' 100' ' ' ARG . 30.5 mt-10 -132.38 8.24 4.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.926 0.393 . . . . 2.3300000000000001 110.572 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -109.02 166.97 10.43 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.257 -0.428 . . . . 1.8700000000000001 110.762 -173.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.994 HD23 ' HA ' ' A' ' 98' ' ' THR . 4.9 tp -119.91 122.86 42.2 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.78 -0.646 . . . . 2.2799999999999998 109.388 173.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.526 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.7 mp -98.44 113.83 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 107.66 -1.237 . . . . 0.80000000000000004 107.66 173.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.859 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.1 pt? -95.02 -15.31 23.58 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.053 -0.976 . . . . 1.74 110.833 -173.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.513 ' CA ' ' HD2' ' A' ' 65' ' ' PRO . . . 87.06 -9.65 71.66 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.45 -0.881 . . . . 0.68999999999999995 113.718 172.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.788 ' HD1' ' HB2' ' A' ' 66' ' ' ALA . 48.5 p90 -133.43 165.72 24.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.296 0.548 . . . . 0.51000000000000001 110.801 178.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.696 ' HB3' ' O ' ' A' ' 58' ' ' THR . 7.8 t -106.07 171.56 7.28 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.41 -0.589 . . . . 0.53000000000000003 109.41 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.45 HG12 ' NE2' ' A' ' 90' ' ' HIS . 5.4 tt -150.17 131.83 5.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 C-N-CA 120.564 -0.454 . . . . 0.48999999999999999 111.675 -167.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -102.97 171.66 20.94 Favored Glycine 0 C--O 1.237 0.341 0 N-CA-C 110.693 -0.963 . . . . 0.71999999999999997 110.693 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.861 ' HA3' ' OE1' ' A' ' 39' ' ' GLN . . . -114.6 169.3 12.82 Favored Glycine 0 N--CA 1.42 -2.389 0 N-CA-C 118.855 2.302 . . . . 1.4199999999999999 118.855 -160.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 88' ' ' VAL . . . -87.58 -162.14 37.53 Favored Glycine 0 N--CA 1.415 -2.726 0 CA-C-N 110.073 -3.063 . . . . 0.47999999999999998 113.5 -165.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.55 HD13 ' O ' ' A' ' 87' ' ' MET . 27.5 pt -55.88 -9.6 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.434 0.635 . . . . 0.52000000000000002 111.002 168.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 1.025 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 0.2 OUTLIER -59.92 -40.73 89.9 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.262 -0.881 . . . . 0.71999999999999997 109.629 173.424 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.861 ' OE1' ' HA3' ' A' ' 35' ' ' GLY . 13.1 mt-30 -84.03 -46.67 11.76 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 114.788 -1.096 . . . . 1.1899999999999999 110.956 -175.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -117.85 88.63 31.3 Favored Pre-proline 0 C--N 1.314 -0.976 0 CA-C-N 114.216 -1.357 . . . . 2.5699999999999998 111.063 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.01 -18.47 35.8 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.597 2.198 . . . . 2.8199999999999998 110.896 174.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.1 t -70.07 -31.74 69.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.856 -1.066 . . . . 3.2599999999999998 109.734 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -98.4 65.47 1.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.563 0.697 . . . . 3.8799999999999999 110.489 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.587 ' H ' ' HD2' ' A' ' 45' ' ' PRO . 8.6 t30 -122.52 -47.73 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 114.997 -1.001 . . . . 5.1399999999999997 109.581 174.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.587 ' HD2' ' H ' ' A' ' 44' ' ' ASN . 29.9 Cg_endo -65.69 11.79 0.14 Allowed 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.587 1.525 . . . . 3.71 112.181 160.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.505 ' H ' ' C ' ' A' ' 44' ' ' ASN . 79.7 t80 -120.1 -27.07 5.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.98 -0.554 . . . . 5.6200000000000001 109.932 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.572 ' HA ' ' HB2' ' A' ' 52' ' ' ASP . 44.0 p -74.66 101.87 4.41 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.177 0.989 . . . . 3.77 109.266 -174.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -91.13 -29.2 17.42 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 113.908 -1.496 . . . . 6.7800000000000002 110.736 -172.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.3 t70 170.47 -151.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.444 -1.253 . . . . 5.4699999999999998 108.428 -162.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.697 ' HE3' HG21 ' A' ' 110' ' ' THR . 3.4 mppt? -72.66 -4.47 31.27 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.813 0.339 . . . . 3.0699999999999998 110.409 176.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.2 t -69.48 -36.41 76.5 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.018 -0.537 . . . . 4.5599999999999996 109.966 177.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.572 ' HB2' ' HA ' ' A' ' 47' ' ' SER . 4.9 t70 -67.19 -161.38 0.02 OUTLIER 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.486 0.66 . . . . 2.6000000000000001 109.709 163.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 53' ' ' LYS . 9.9 ptpt -97.81 -46.41 5.96 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.375 -0.375 . . . . 3.48 110.371 -178.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 52.18 -149.25 9.72 Favored Glycine 0 C--O 1.225 -0.452 0 C-N-CA 121.058 -0.591 . . . . 0.78000000000000003 111.63 -172.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.546 HG22 ' CD1' ' A' ' 77' ' ' ILE . 2.2 mp -99.93 132.39 45.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 108.347 -0.983 . . . . 0.54000000000000004 108.347 168.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.561 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -155.01 138.76 16.17 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 120.898 0.38 . . . . 1.4199999999999999 110.339 -170.369 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.575 ' CG1' ' H ' ' A' ' 75' ' ' ASP . 8.6 p -67.38 129.37 31.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.648 -0.706 . . . . 0.57999999999999996 110.484 -176.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.696 ' O ' ' HB3' ' A' ' 32' ' ' SER . 18.5 m -125.64 59.59 1.28 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.463 -0.79 . . . . 1.1100000000000001 109.896 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.624 ' HA ' HG23 ' A' ' 73' ' ' ILE . 13.9 mtt180 154.49 -179.88 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 126.084 1.754 . . . . 2.27 109.979 167.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.635 HG13 ' HB3' ' A' ' 66' ' ' ALA . 88.0 t -166.7 125.71 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 O-C-N 125.638 1.836 . . . . 0.82999999999999996 106.348 163.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.8 m -85.15 128.27 34.59 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.889 -0.725 . . . . 1.6499999999999999 109.259 174.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -65.15 106.36 1.29 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.374 -0.83 . . . . 1.8500000000000001 110.4 174.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 120.64 -21.56 8.48 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.27 -1.332 . . . . 0.92000000000000004 110.396 -173.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.502 ' O ' ' HB3' ' A' ' 67' ' ' GLU . . . -72.76 152.82 48.05 Favored Glycine 0 CA--C 1.495 -1.214 0 N-CA-C 111.384 -0.686 . . . . 0.98999999999999999 111.384 172.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.629 ' HA ' HD13 ' A' ' 68' ' ' ILE . 83.3 Cg_exo -47.13 -30.9 11.09 Favored 'Trans proline' 0 C--N 1.325 -0.659 0 C-N-CA 123.882 3.055 . . . . 0.44 114.17 -176.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.788 ' HB2' ' HD1' ' A' ' 31' ' ' PHE . . . -66.75 -26.73 67.12 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.016 -0.538 . . . . 0.35999999999999999 111.454 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 5.5 tp10 -68.36 -31.61 71.12 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.247 0.546 . . . . 1.79 109.821 174.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.629 HD13 ' HA ' ' A' ' 65' ' ' PRO . 2.7 mp -81.05 -36.78 15.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.807 -0.633 . . . . 0.51000000000000001 109.938 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.691 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -79.56 -31.79 42.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.553 -0.748 . . . . 0.40999999999999998 110.456 176.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.18 69.36 0.95 Allowed Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.442 -0.885 . . . . 0.45000000000000001 113.562 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.453 ' HB3' ' HB1' ' A' ' 66' ' ' ALA . 21.9 tp -116.05 158.32 23.33 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.738 -0.468 . . . . 0.89000000000000001 109.738 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.543 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 5.1 mt-30 -125.43 29.81 5.94 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 115.196 1.554 . . . . 1.21 115.196 -163.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.624 HG23 ' HA ' ' A' ' 59' ' ' ARG . 82.6 mt 75.97 -10.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 N-CA-C 114.621 1.341 . . . . 0.77000000000000002 114.621 165.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -166.75 52.22 0.25 Allowed Glycine 0 N--CA 1.465 0.569 0 C-N-CA 118.983 -1.579 . . . . 0.37 113.432 -165.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.575 ' H ' ' CG1' ' A' ' 57' ' ' VAL . 17.6 m-20 -122.42 147.1 46.72 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.38 -0.41 . . . . 0.89000000000000001 110.407 -172.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.561 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 1.3 mptm? -91.74 120.85 32.84 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-O 121.014 0.435 . . . . 2.2000000000000002 110.673 -176.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.692 HG12 HD11 ' A' ' 107' ' ' LEU . 5.9 mt -80.3 120.46 31.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.172 0.511 . . . . 0.48999999999999999 112.206 -170.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.998 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 11.0 mmt -88.38 -20.97 24.59 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.507 -1.224 . . . . 1.0600000000000001 111.326 177.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.581 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 1.0 OUTLIER -171.71 157.82 4.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.988 0.423 . . . . 0.81999999999999995 111.2 -178.609 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.624 HG21 ' HG ' ' A' ' 97' ' ' LEU . 9.5 p -146.55 126.53 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.985 -0.552 . . . . 1.3100000000000001 109.778 172.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 1.0 OUTLIER 62.64 9.72 3.69 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.015 -0.539 . . . . 1.5 112.213 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.89 -10.68 27.43 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.244 -0.979 . . . . 0.38 112.485 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.416 ' CD1' ' HB3' ' A' ' 96' ' ' ARG . 81.4 m95 -82.39 143.16 31.41 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 120.819 0.342 . . . . 0.77000000000000002 110.587 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -92.06 110.88 22.25 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.235 -0.893 . . . . 1.8899999999999999 111.84 -170.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.669 ' HE3' ' HA ' ' A' ' 93' ' ' ALA . 20.6 mmt -109.35 122.19 46.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.906 -0.588 . . . . 1.01 112.227 -175.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.5 p -137.38 -72.29 0.43 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.45 0.643 . . . . 1.05 109.281 167.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.55 ' O ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -125.19 62.39 1.18 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.272 -0.876 . . . . 1.6200000000000001 109.099 177.885 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.563 HG21 HE21 ' A' ' 92' ' ' GLN . 3.6 p -112.34 177.32 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 108.835 -0.802 . . . . 1.0900000000000001 108.835 177.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . 1.025 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 63.1 p -72.22 153.07 41.8 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 118.283 0.492 . . . . 0.34999999999999998 111.432 -177.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.892 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 23.7 t-160 -56.78 -41.6 77.94 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 121.896 0.855 . . . . 0.34999999999999998 108.928 177.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -67.25 -30.35 70.23 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.186 -1.824 . . . . 1.6699999999999999 109.855 -175.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.816 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 2.4 tp-100 -59.65 -53.38 58.66 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.378 -0.601 . . . . 0.77000000000000002 109.378 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.669 ' HA ' ' HE3' ' A' ' 85' ' ' MET . . . -74.38 -30.62 62.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.654 -0.703 . . . . 0.33000000000000002 110.297 -176.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -63.35 -47.43 82.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.424 -0.807 . . . . 2.1000000000000001 110.47 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.408 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -71.84 -41.73 67.78 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.743 -0.662 . . . . 0.95999999999999996 109.823 -174.462 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.816 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 22.4 mmt180 -69.0 -24.3 64.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.927 -0.579 . . . . 3.5699999999999998 110.271 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.624 ' HG ' HG21 ' A' ' 80' ' ' VAL . 3.8 tt -79.93 -52.47 7.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.777 -0.647 . . . . 1.6499999999999999 110.86 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.994 ' HA ' HD23 ' A' ' 27' ' ' LEU . 5.3 m -94.83 92.05 6.75 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 122.685 1.231 . . . . 1.53 110.901 -169.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.491 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 3.6 mtmt -134.95 110.65 9.24 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 112.8 -2.0 . . . . 2.7200000000000002 109.552 -177.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.786 HH11 ' HB3' ' A' ' 25' ' ' GLU . 37.6 ptt180 -67.4 5.31 0.79 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.73 -0.668 . . . . 4.3799999999999999 112.105 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 99' ' ' LYS . 3.0 p -107.73 -23.26 12.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.496 -0.32 . . . . 2.5099999999999998 111.634 -174.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.404 ' HG2' ' HB3' ' A' ' 99' ' ' LYS . 81.0 mm-40 -68.16 151.61 46.73 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.193 -0.299 . . . . 3.3999999999999999 110.193 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -97.71 -20.27 17.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.313 0.578 . . . . 2.6800000000000002 110.315 175.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.29 145.27 18.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.783 -0.644 . . . . 0.44 109.51 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 74.5 t -113.53 118.35 57.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 122.089 0.947 . . . . 0.46000000000000002 111.709 -176.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.528 ' HD3' ' H ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -99.29 134.55 41.99 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 113.619 -1.628 . . . . 1.76 110.298 -176.239 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.692 HD11 HG12 ' A' ' 77' ' ' ILE . 37.0 tp -132.86 132.33 41.98 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.199 -0.455 . . . . 1.1200000000000001 110.596 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.998 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 40.1 tp -115.22 114.02 24.68 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.211 -1.774 . . . . 0.41999999999999998 106.211 171.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.698 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -127.26 150.38 33.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 109.991 -0.374 . . . . 0.77000000000000002 109.991 -171.331 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.983 HG23 HG12 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -95.88 121.26 37.43 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 120.32 -0.552 . . . . 0.34000000000000002 110.936 171.258 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.438 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 2.4 ttt180 -110.46 139.53 45.58 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.876 -1.056 . . . . 2.0099999999999998 110.987 -171.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.63 -107.04 0.35 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.899 -0.591 . . . . 1.97 111.468 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.411 ' O ' HD23 ' A' ' 114' ' ' LEU . 13.9 t -131.91 81.08 1.95 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.635 0.731 . . . . 1.6200000000000001 110.579 -173.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.511 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 3.1 mt -133.91 -12.06 2.59 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.875 -1.057 . . . . 1.6499999999999999 109.518 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.488 ' H ' ' CD ' ' A' ' 115' ' ' GLN . 20.9 mp0 -51.2 128.79 22.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.491 -1.231 . . . . 3.5299999999999998 111.058 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.61 35.55 0.51 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.641 -0.254 . . . . 3.6000000000000001 110.471 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 58.28 34.57 24.2 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.435 0.636 . . . . 3.5600000000000001 109.995 -172.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.2 p -68.89 145.8 13.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.29 -0.868 . . . . 4.9900000000000002 110.884 -177.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -55.58 108.31 0.42 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.448 -0.797 . . . . 7.7699999999999996 111.106 174.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -98.32 108.9 21.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.108 -0.496 . . . . 6.5999999999999996 109.883 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 57.5 m -74.96 120.51 20.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.089 -0.505 . . . . 8.9399999999999995 110.411 -177.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 89.2 mtp -93.27 176.48 6.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.833 -0.621 . . . . 12.1 110.344 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.5 tp 64.0 85.39 0.14 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.519 0.676 . . . . 12.82 110.955 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.4 p . . . . . 0 C--O 1.242 0.686 0 CA-C-N 115.235 -0.893 . . . . 14.640000000000001 109.613 179.107 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.8 mtp . . . . . 0 N--CA 1.481 1.118 0 CA-C-O 120.779 0.323 . . . . 14.33 110.487 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 t -122.87 115.17 21.51 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.864 -0.421 . . . . 11.220000000000001 109.864 177.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -99.4 173.02 6.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.373 -0.376 . . . . 9.1899999999999995 110.232 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.654 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 16.9 pt -99.22 107.88 46.93 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 121.103 0.478 . . . . 6.6500000000000004 111.432 -176.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -71.52 117.11 4.98 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.645 2.23 . . . . 7.46 111.79 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.37 -24.1 15.66 Favored Glycine 0 CA--C 1.516 0.151 0 C-N-CA 121.022 -0.609 . . . . 5.8899999999999997 112.331 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 22.7 mt-30 69.39 106.42 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.327 0 C-N-CA 123.472 0.709 . . . . 6.3700000000000001 110.813 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.654 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 6.0 Cg_exo -78.5 -155.82 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 123.081 2.521 . . . . 3.3999999999999999 112.964 -176.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.7 m -95.12 -0.34 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.635 -0.712 . . . . 2.2599999999999998 109.465 -177.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.6 p -76.92 80.9 3.47 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 122.461 1.124 . . . . 2.0899999999999999 110.413 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 111' ' ' ARG . . . -88.76 177.83 6.62 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.97 -1.923 . . . . 0.95999999999999996 110.618 176.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.67 129.59 40.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.658 -0.701 . . . . 1.5700000000000001 110.169 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.555 HG22 HG23 ' A' ' 110' ' ' THR . 45.1 t -77.04 112.93 15.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.969 0.414 . . . . 1.02 111.553 -175.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.652 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -111.41 166.6 10.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.92 -0.582 . . . . 1.3899999999999999 109.98 171.478 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -120.93 138.64 54.02 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 120.797 -1.189 . . . . 3.6299999999999999 111.302 -176.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.658 HG13 ' CB ' ' A' ' 69' ' ' ALA . 19.7 t -108.29 108.57 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 CA-C-N 115.325 -0.852 . . . . 1.02 109.492 177.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -122.23 111.57 17.11 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.394 -0.821 . . . . 1.3500000000000001 109.532 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.81 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 10.8 tp -134.89 147.93 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 108.817 -0.809 . . . . 0.60999999999999999 108.817 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 14.2 m-70 -78.15 105.9 9.68 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.395 -0.965 . . . . 0.59999999999999998 108.395 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.648 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 2.5 pptp? -27.34 139.89 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 O-C-N 125.376 1.672 . . . . 4.0 112.924 -175.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 43.8 tp -93.62 85.8 4.99 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 122.175 0.988 . . . . 0.55000000000000004 109.703 -171.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.602 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -54.41 134.41 45.72 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 113.639 -1.619 . . . . 3.9700000000000002 112.136 -175.291 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.525 ' HB2' HD13 ' A' ' 28' ' ' ILE . 33.9 tp60 -123.78 94.5 4.25 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.501 -1.227 . . . . 1.3500000000000001 108.471 176.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.77 -84.37 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.493 -0.86 . . . . 1.3300000000000001 111.289 -173.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -129.57 6.73 5.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.199 0.523 . . . . 2.3300000000000001 110.694 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 3.8 m-80 -110.71 -177.11 3.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.697 -0.683 . . . . 1.8700000000000001 109.871 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 20' ' ' LYS . 1.6 pt? -127.73 144.78 51.06 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.202 -1.036 . . . . 2.2799999999999998 108.202 172.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.525 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.1 mp -113.24 139.96 35.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-O 121.142 0.496 . . . . 0.80000000000000004 110.711 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -101.25 127.34 47.89 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.667 -1.152 . . . . 1.74 109.144 173.013 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.749 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -95.08 48.8 1.96 Allowed Glycine 0 C--O 1.22 -0.731 0 C-N-CA 120.165 -1.016 . . . . 0.68999999999999995 113.154 -172.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 35.3 p90 -158.52 163.1 37.39 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.634 -0.876 . . . . 0.51000000000000001 108.634 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.582 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.1 OUTLIER -105.14 161.06 14.58 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.865 -1.161 . . . . 0.53000000000000003 107.865 170.569 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -156.72 137.32 4.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 119.107 -1.037 . . . . 0.48999999999999999 113.757 -165.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.434 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -146.63 118.22 1.02 Allowed Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.43 -1.068 . . . . 0.71999999999999997 110.43 156.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 1.045 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.45 117.48 1.22 Allowed Glycine 0 CA--C 1.492 -1.356 0 CA-C-O 118.641 -1.088 . . . . 1.4199999999999999 111.401 172.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.541 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.29 143.25 8.12 Favored Glycine 0 C--N 1.299 -1.496 0 C-N-CA 117.929 -2.081 . . . . 0.47999999999999998 112.954 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.624 HG12 ' O ' ' A' ' 87' ' ' MET . 5.2 pt -59.89 -26.1 34.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 106.813 -1.551 . . . . 0.52000000000000002 106.813 151.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 1.003 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 6.0 t70 -53.08 -44.68 67.72 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 113.003 -1.908 . . . . 0.71999999999999997 110.752 173.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -62.32 -69.34 0.26 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.811 -1.086 . . . . 1.1899999999999999 111.668 -172.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -178.09 110.69 0.22 Allowed Pre-proline 0 N--CA 1.468 0.43 0 N-CA-C 110.257 -0.275 . . . . 2.5699999999999998 110.257 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -87.81 11.9 3.03 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 123.819 3.013 . . . . 2.8199999999999998 113.707 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.0 t -104.64 31.14 4.91 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.054 0.454 . . . . 3.2599999999999998 111.709 -169.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.459 HE21 ' HB3' ' A' ' 43' ' ' GLN . 0.8 OUTLIER -140.2 12.06 2.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.311 0.577 . . . . 3.8799999999999999 109.823 -173.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.75 HD22 ' HB2' ' A' ' 48' ' ' GLU . 6.6 p30 174.84 60.74 0.04 OUTLIER Pre-proline 0 N--CA 1.441 -0.914 0 N-CA-C 108.035 -1.098 . . . . 5.1399999999999997 108.035 -169.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.56 10.95 0.89 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.691 2.261 . . . . 3.71 112.353 -171.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -139.83 -58.44 0.56 Allowed 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 106.63 -1.618 . . . . 5.6200000000000001 106.63 173.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.663 ' HA ' ' OD1' ' A' ' 52' ' ' ASP . 1.4 m -160.7 157.1 26.46 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.924 -1.034 . . . . 3.77 109.151 173.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.75 ' HB2' HD22 ' A' ' 44' ' ' ASN . 73.3 tt0 -108.24 -28.82 9.24 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.661 0.743 . . . . 6.7800000000000002 109.512 170.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.993 ' HB3' HG22 ' A' ' 51' ' ' THR . 27.6 t70 172.95 -138.34 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 103.999 -2.593 . . . . 5.4699999999999998 103.999 -172.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.576 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 9.2 tppt? -78.36 -18.05 55.65 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.424 -0.954 . . . . 3.0699999999999998 108.424 166.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.993 HG22 ' HB3' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -64.04 -55.25 23.53 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.859 -1.064 . . . . 4.5599999999999996 110.924 -178.115 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.712 ' O ' ' HE2' ' A' ' 53' ' ' LYS . 35.6 t70 44.15 -135.3 0.56 Allowed 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.516 0.51 . . . . 2.6000000000000001 110.04 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.712 ' HE2' ' O ' ' A' ' 52' ' ' ASP . 2.1 mmpt? -109.49 49.19 0.84 Allowed 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 121.843 -0.536 . . . . 3.48 110.776 174.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -99.4 -149.2 24.04 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 110.862 -0.895 . . . . 0.78000000000000003 110.862 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.045 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -114.76 138.39 45.08 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 109.018 -0.734 . . . . 0.54000000000000004 109.018 174.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.591 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -142.94 140.04 30.95 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 119.185 0.902 . . . . 1.4199999999999999 110.405 -176.23 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.68 HG12 ' H ' ' A' ' 75' ' ' ASP . 8.8 p -82.92 138.84 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 CA-C-N 114.623 -1.172 . . . . 0.57999999999999996 110.056 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.655 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 23.5 m -127.98 68.55 1.33 Allowed 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.153 -0.931 . . . . 1.1100000000000001 109.33 172.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.49 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 24.1 mtp180 148.54 -171.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.637 1.575 . . . . 2.27 111.001 162.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.582 HG13 ' HB3' ' A' ' 66' ' ' ALA . 58.4 t -162.14 143.5 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 125.543 1.777 . . . . 0.82999999999999996 107.622 164.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.3 p -86.65 133.84 33.66 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.611 0.719 . . . . 1.6499999999999999 110.88 175.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -71.45 105.62 3.64 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.195 -1.366 . . . . 1.8500000000000001 111.055 178.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.21 9.65 50.74 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 119.764 -1.208 . . . . 0.92000000000000004 113.093 176.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.606 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -90.18 -140.05 8.08 Favored Glycine 0 C--O 1.217 -0.938 0 C-N-CA 120.279 -0.962 . . . . 0.98999999999999999 111.082 175.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.749 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 66.0 Cg_endo -98.26 -32.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 122.475 2.116 . . . . 0.44 114.525 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.582 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -71.99 -22.83 61.37 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.906 -0.588 . . . . 0.35999999999999999 111.727 -174.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -71.96 -30.92 65.78 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.626 -0.879 . . . . 1.79 108.626 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.606 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -81.57 -44.18 20.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.539 -1.21 . . . . 0.51000000000000001 110.41 -176.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.81 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . . . -68.25 -26.4 65.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.936 -0.575 . . . . 0.40999999999999998 110.31 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.08 70.03 1.01 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.368 -0.92 . . . . 0.45000000000000001 113.278 177.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.565 HD21 HG21 ' A' ' 57' ' ' VAL . 13.9 tp -113.75 153.52 28.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.192 -0.669 . . . . 0.89000000000000001 109.192 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.678 HE22 ' HG3' ' A' ' 111' ' ' ARG . 12.3 mt-30 -123.65 29.36 6.6 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 114.83 1.419 . . . . 1.21 114.83 -166.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.655 ' O ' ' HA ' ' A' ' 58' ' ' THR . 2.9 mp 72.06 -12.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 N-CA-C 113.418 0.895 . . . . 0.77000000000000002 113.418 171.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -164.31 60.89 0.25 Allowed Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.225 -0.988 . . . . 0.37 111.407 -165.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.68 ' H ' HG12 ' A' ' 57' ' ' VAL . 17.4 m-20 -123.09 153.26 40.16 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.015 -0.593 . . . . 0.89000000000000001 109.593 -169.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.796 ' HG2' ' HA ' ' A' ' 51' ' ' THR . 6.8 mptt -104.09 100.31 10.06 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.125 -0.63 . . . . 2.2000000000000002 109.77 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.991 HG13 HG23 ' A' ' 109' ' ' VAL . 4.8 mp -75.0 128.91 37.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.55 -0.75 . . . . 0.48999999999999999 110.053 -175.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.48 ' HE3' ' HB2' ' A' ' 78' ' ' MET . 0.0 OUTLIER -114.02 4.6 15.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 112.863 0.69 . . . . 1.0600000000000001 112.863 -179.067 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.568 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 2.2 tt0 -172.11 152.38 2.86 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 122.442 -0.161 . . . . 0.81999999999999995 111.095 176.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.786 HG21 ' HB3' ' A' ' 97' ' ' LEU . 7.0 p -150.06 130.81 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 121.237 0.541 . . . . 1.3100000000000001 111.317 175.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.515 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 14.3 m120 50.37 34.3 8.87 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.149 0.979 . . . . 1.5 112.787 176.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.32 3.62 64.95 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.482 -0.866 . . . . 0.38 113.24 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -99.74 161.61 13.51 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 109.524 -0.547 . . . . 0.77000000000000002 109.524 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -110.69 97.78 7.11 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.45 -0.795 . . . . 1.8899999999999999 110.082 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.776 ' HB2' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -107.45 98.15 7.8 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 122.151 0.977 . . . . 1.01 109.731 174.359 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.18 -10.57 13.85 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.982 -1.463 . . . . 1.05 107.841 175.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.624 ' O ' HG12 ' A' ' 37' ' ' ILE . 1.9 mtt -149.89 -42.29 0.13 Allowed 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 112.543 -2.117 . . . . 1.6200000000000001 108.905 -171.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.63 ' O ' HD11 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -22.68 141.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 C-N-CA 126.249 1.82 . . . . 1.0900000000000001 115.711 -177.825 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . 1.003 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 49.7 p -58.17 154.1 13.72 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 112.475 0.546 . . . . 0.34999999999999998 112.475 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.773 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 22.1 t-160 -56.27 -44.42 79.74 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 115.988 -0.551 . . . . 0.34999999999999998 110.66 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.8 -31.76 68.61 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.13 -0.941 . . . . 1.6699999999999999 110.139 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.784 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.7 OUTLIER -64.36 -49.69 70.65 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.78 -0.822 . . . . 0.77000000000000002 108.78 -178.68 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.619 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -74.13 -32.88 63.35 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.709 -0.678 . . . . 0.33000000000000002 110.528 -177.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.525 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 35.1 ttp180 -64.16 -44.58 91.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 2.1000000000000001 109.991 177.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.449 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -67.02 -36.29 81.79 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.688 -0.687 . . . . 0.95999999999999996 109.481 -178.609 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.784 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 22.7 mmt180 -70.96 -23.9 62.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.988 -0.551 . . . . 3.5699999999999998 111.193 -176.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.786 ' HB3' HG21 ' A' ' 80' ' ' VAL . 3.4 pp -94.41 -15.09 24.6 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.964 -0.294 . . . . 1.6499999999999999 110.901 177.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.2 m -111.53 89.47 3.06 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.866 0.841 . . . . 1.53 110.888 -175.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.438 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 12.1 mtmt -136.7 103.99 5.39 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.476 -1.238 . . . . 2.7200000000000002 109.548 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.479 ' CB ' ' HA ' ' A' ' 26' ' ' ASN . 38.1 ptt180 -76.11 53.65 0.81 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.479 0.657 . . . . 4.3799999999999999 111.072 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.0 t -140.41 -51.43 0.48 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.533 -0.758 . . . . 2.5099999999999998 110.201 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 41.5 mt-10 -69.09 150.8 47.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.832 0.348 . . . . 3.3999999999999999 111.303 -177.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.473 ' HA ' ' NZ ' ' A' ' 20' ' ' LYS . 10.3 pt-20 -84.83 -15.46 44.71 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.834 0.679 . . . . 2.6800000000000002 112.834 -174.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.66 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 5.7 p -149.13 149.28 15.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.868 0.365 . . . . 0.44 110.274 -172.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.611 HG23 ' HB3' ' A' ' 20' ' ' LYS . 44.2 t -120.72 118.83 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 121.906 0.86 . . . . 0.46000000000000002 111.523 -173.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.515 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER -99.75 125.18 45.6 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.593 -1.639 . . . . 1.76 110.385 -175.164 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.464 HD22 ' HB ' ' A' ' 16' ' ' VAL . 10.1 tt -133.73 128.09 34.18 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.547 -0.297 . . . . 1.1200000000000001 110.229 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 79' ' ' GLN . 9.8 tp -101.37 114.27 28.12 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 107.347 -1.353 . . . . 0.41999999999999998 107.347 174.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.991 HG23 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -111.37 150.29 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 CA-C-O 121.522 0.677 . . . . 0.77000000000000002 109.665 -175.382 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.557 HG21 ' HG2' ' A' ' 50' ' ' LYS . 1.3 m -97.35 113.48 25.13 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 118.512 -1.275 . . . . 0.34000000000000002 108.748 167.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.678 ' HG3' HE22 ' A' ' 72' ' ' GLN . 1.0 OUTLIER -91.9 153.9 19.2 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.14 -1.391 . . . . 2.0099999999999998 109.951 -173.257 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.469 ' N ' ' HG2' ' A' ' 111' ' ' ARG . 0.1 OUTLIER -125.1 -95.16 0.47 Allowed 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.692 -0.403 . . . . 1.97 111.675 -177.509 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.401 ' H ' ' CG ' ' A' ' 112' ' ' GLN . 9.0 t -149.78 38.33 0.75 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.645 0.736 . . . . 1.6200000000000001 110.764 -170.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.491 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 6.3 mt -106.28 -25.28 12.02 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.21 -0.905 . . . . 1.6499999999999999 109.225 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -57.95 152.67 15.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.365 -1.288 . . . . 3.5299999999999998 110.727 173.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -86.97 26.0 1.22 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.383 -0.371 . . . . 3.6000000000000001 111.03 -173.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 62.68 21.5 12.77 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.643 -0.708 . . . . 3.5600000000000001 111.665 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 13.7 p -81.43 136.34 23.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.075 -0.511 . . . . 4.9900000000000002 111.551 -175.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 64.49 -90.18 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.174 -0.921 . . . . 7.7699999999999996 111.909 177.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 53.52 54.7 9.66 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 122.884 0.473 . . . . 6.5999999999999996 111.396 -177.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 73.6 m -76.16 75.09 3.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.088 0.47 . . . . 8.9399999999999995 111.339 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 74.9 mmm -151.1 150.44 30.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.598 -0.728 . . . . 12.1 109.905 177.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.4 mt -111.76 153.18 26.91 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.739 -0.467 . . . . 12.82 109.739 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.3 m . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.606 -0.712 . . . . 14.640000000000001 109.685 -178.722 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 123.362 1.553 . . . . 2.0899999999999999 111.175 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.65 178.77 5.36 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 112.515 -2.13 . . . . 0.95999999999999996 110.509 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.0 t -106.32 110.95 33.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.762 -0.654 . . . . 1.5700000000000001 110.52 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.855 HG22 HG23 ' A' ' 110' ' ' THR . 33.6 t -77.66 108.45 10.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.751 -0.462 . . . . 1.02 109.751 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 1.036 ' HG2' ' HD3' ' A' ' 111' ' ' ARG . 0.3 OUTLIER -113.33 169.47 8.93 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.257 -0.577 . . . . 1.3899999999999999 111.801 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 15' ' ' ARG . 1.9 mmm180 -115.43 126.76 54.75 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.016 0.436 . . . . 3.6299999999999999 111.719 -175.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.926 HG23 HE22 ' A' ' 14' ' ' GLN . 26.2 t -107.39 121.85 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.614 -0.721 . . . . 1.02 109.323 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -143.82 111.94 6.26 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.748 -0.464 . . . . 1.3500000000000001 109.748 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.494 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 9.6 tp -139.18 148.79 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.568 -0.901 . . . . 0.60999999999999999 108.568 -176.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 16.5 m-70 -79.36 115.8 19.22 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.981 -0.687 . . . . 0.59999999999999998 109.411 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.865 ' HB2' HD12 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -26.93 139.07 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 O-C-N 125.142 1.526 . . . . 4.0 112.715 178.402 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.1 tp -97.66 93.91 6.67 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 121.418 -0.802 . . . . 0.55000000000000004 110.31 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -60.81 143.06 55.43 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.366 0.603 . . . . 3.9700000000000002 112.183 -173.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.545 ' HB2' HD13 ' A' ' 28' ' ' ILE . 4.3 tp-100 -140.88 94.9 2.77 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.283 -0.871 . . . . 1.3500000000000001 109.493 174.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.86 -82.49 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.042 -0.599 . . . . 1.3300000000000001 112.506 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.531 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 18.2 mt-10 -118.4 -17.35 9.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.098 0.475 . . . . 2.3300000000000001 110.561 -177.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.484 ' OD1' ' HB3' ' A' ' 23' ' ' GLN . 1.0 OUTLIER -112.85 -177.66 3.19 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.895 -0.593 . . . . 1.8700000000000001 111.679 -169.162 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.865 HD12 ' HB2' ' A' ' 20' ' ' LYS . 2.1 pt? -126.98 138.25 53.23 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.764 -1.199 . . . . 2.2799999999999998 107.764 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.545 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.3 mp -101.46 130.14 51.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.42 0.628 . . . . 0.80000000000000004 110.4 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.481 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -96.08 125.47 40.64 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.088 -1.414 . . . . 1.74 108.652 172.051 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -85.47 41.24 3.05 Favored Glycine 0 C--O 1.22 -0.745 0 C-N-CA 120.386 -0.911 . . . . 0.68999999999999995 112.648 -175.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.619 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 42.5 p90 -157.07 154.67 29.86 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 122.752 0.421 . . . . 0.51000000000000001 110.385 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.497 ' CB ' ' HB2' ' A' ' 59' ' ' ARG . 8.1 t -103.98 159.25 15.82 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.085 -1.45 . . . . 0.53000000000000003 107.085 169.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.401 HG12 ' N ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -160.69 141.59 3.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 112.745 0.646 . . . . 0.48999999999999999 112.745 -165.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.438 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -144.44 119.16 1.23 Allowed Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 110.089 -1.205 . . . . 0.71999999999999997 110.089 157.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.972 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.92 118.14 1.27 Allowed Glycine 0 CA--C 1.492 -1.358 0 CA-C-O 118.555 -1.136 . . . . 1.4199999999999999 111.621 171.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.734 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.69 143.77 8.58 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 117.483 -2.294 . . . . 0.47999999999999998 113.796 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.3 pt -61.65 -19.31 20.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.104 -1.073 . . . . 0.52000000000000002 108.104 149.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.832 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 0.4 OUTLIER -66.18 -35.15 79.71 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.749 -1.569 . . . . 0.71999999999999997 109.97 174.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 . . . . . 0 C--N 1.339 0.143 0 CA-C-N 115.065 -0.971 . . . . 1.1899999999999999 110.713 -178.013 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.414 ' C ' HD12 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.431 -1.696 0 N-CA-C 110.901 -0.88 . . . . 0.78000000000000003 110.901 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.972 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -111.32 141.45 26.67 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 N-CA-C 107.297 -1.372 . . . . 0.54000000000000004 107.297 176.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.688 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER -152.21 145.2 24.49 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 119.405 1.002 . . . . 1.4199999999999999 110.99 -177.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.758 HG12 ' H ' ' A' ' 75' ' ' ASP . 2.7 p -85.59 133.23 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-N 114.597 -1.183 . . . . 0.57999999999999996 110.471 -171.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 37.7 m -100.09 -16.23 17.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.942 -1.026 . . . . 1.1100000000000001 110.822 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.671 ' HA ' HG23 ' A' ' 73' ' ' ILE . 72.2 mtt180 -149.04 -169.4 3.36 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.667 0.618 . . . . 2.27 112.667 175.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 59' ' ' ARG . 79.4 t -167.84 138.27 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 113.271 -1.786 . . . . 0.82999999999999996 107.212 163.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.5 p -82.29 126.27 31.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.232 0.539 . . . . 1.6499999999999999 110.88 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -57.19 112.24 1.31 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.429 -1.259 . . . . 1.8500000000000001 110.841 171.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.0 -2.43 66.13 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.51 -0.852 . . . . 0.92000000000000004 112.566 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.578 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -92.33 173.58 35.92 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 120.569 -0.824 . . . . 0.98999999999999999 111.623 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.493 ' HB2' HG12 ' A' ' 18' ' ' ILE . 64.8 Cg_endo -70.7 -22.81 27.25 Favored 'Trans proline' 0 CA--C 1.504 -1.002 0 C-N-CA 122.732 2.288 . . . . 0.44 113.477 -165.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.56 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -66.84 -32.7 74.15 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.731 -1.122 . . . . 0.35999999999999999 110.882 176.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -77.74 -30.08 51.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.236 0.541 . . . . 1.79 109.609 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.578 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.3 mp -68.98 -36.98 76.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.374 -0.83 . . . . 0.51000000000000001 109.629 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.602 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -78.11 -25.34 47.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.746 -0.661 . . . . 0.40999999999999998 110.838 176.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.89 43.62 1.9 Allowed Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.355 -0.926 . . . . 0.45000000000000001 113.874 177.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.462 ' O ' HG21 ' A' ' 60' ' ' VAL . 14.1 tp -95.1 148.7 22.07 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.44 -0.948 . . . . 0.89000000000000001 108.44 174.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.64 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 14.4 mt-30 -134.28 40.07 3.04 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 116.018 1.858 . . . . 1.21 116.018 -161.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.671 HG23 ' HA ' ' A' ' 59' ' ' ARG . 59.1 mt 69.85 -11.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 114.654 1.353 . . . . 0.77000000000000002 114.654 162.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.37 43.72 0.33 Allowed Glycine 0 CA--C 1.508 -0.348 0 C-N-CA 120.163 -1.018 . . . . 0.37 111.846 -170.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.758 ' H ' HG12 ' A' ' 57' ' ' VAL . 9.3 m-20 -119.61 141.27 49.45 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.047 -0.576 . . . . 0.89000000000000001 111.831 -168.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.688 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -87.47 102.95 15.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.333 -0.849 . . . . 2.2000000000000002 111.16 -175.352 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.551 HD12 ' CA ' ' A' ' 56' ' ' TYR . 5.1 mt -73.63 122.99 27.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 114.772 -1.104 . . . . 0.48999999999999999 111.874 -177.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.787 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 2.2 mmt -93.32 -9.19 39.75 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.945 -1.025 . . . . 1.0600000000000001 113.399 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.606 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -167.88 150.99 5.86 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.05 0.452 . . . . 0.81999999999999995 112.196 -178.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.713 ' HB ' ' HE1' ' A' ' 85' ' ' MET . 40.6 t -133.05 112.06 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 114.927 -1.033 . . . . 1.3100000000000001 110.316 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.943 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 14.4 m120 57.4 27.85 14.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.727 -0.669 . . . . 1.5 112.613 174.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.84 -13.37 53.22 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 119.987 -1.101 . . . . 0.38 112.353 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.416 ' HE1' ' CZ ' ' A' ' 96' ' ' ARG . 74.1 m95 -80.68 170.16 16.68 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.875 -0.787 . . . . 0.77000000000000002 108.875 176.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -115.47 112.88 22.92 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.098 0.475 . . . . 1.8899999999999999 111.141 -172.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.713 ' HE1' ' HB ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -106.28 100.88 10.39 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 122.43 1.11 . . . . 1.01 110.676 -177.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.9 p -137.22 -41.27 0.58 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.536 -1.665 . . . . 1.05 107.73 173.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.61 73.98 1.34 Allowed 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 112.777 -2.01 . . . . 1.6200000000000001 108.31 174.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.734 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.2 t -135.57 140.76 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 108.89 -0.782 . . . . 1.0900000000000001 108.89 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.668 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 70.1 p -55.77 148.75 15.89 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.08 0.467 . . . . 0.34999999999999998 112.111 -177.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.832 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 21.8 t-160 -54.28 -42.94 70.59 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-O 121.616 0.722 . . . . 0.34999999999999998 110.131 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.72 -30.38 66.9 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.188 -1.369 . . . . 1.6699999999999999 110.445 -177.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.6 ' HB3' HG13 ' A' ' 88' ' ' VAL . 1.8 tp-100 -60.05 -47.62 85.12 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 122.039 0.923 . . . . 0.77000000000000002 108.537 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.637 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -74.47 -40.95 61.54 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.433 -1.258 . . . . 0.33000000000000002 110.444 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -66.22 -40.66 90.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.639 -0.71 . . . . 2.1000000000000001 110.715 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 1.2 tmtp? -64.33 -38.01 89.53 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 116.006 -0.543 . . . . 0.95999999999999996 109.541 -177.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.432 ' HB2' HG11 ' A' ' 80' ' ' VAL . 9.9 mmm180 -64.83 -48.9 72.69 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.823 -0.626 . . . . 3.5699999999999998 111.352 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.447 HD13 HD13 ' A' ' 29' ' ' LEU . 3.8 pp -79.25 -1.86 38.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.467 -0.333 . . . . 1.6499999999999999 111.756 -176.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.545 ' HA ' HD21 ' A' ' 27' ' ' LEU . 3.3 m -115.84 23.55 12.18 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 122.114 0.959 . . . . 1.53 109.884 173.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 1.006 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 5.8 mmpt? -81.76 112.56 19.03 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.431 -0.804 . . . . 2.7200000000000002 108.983 169.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.531 ' HD2' ' O ' ' A' ' 25' ' ' GLU . 35.6 ptt180 -71.26 19.06 0.06 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.652 -0.704 . . . . 4.3799999999999999 111.023 -177.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.543 ' H ' ' C ' ' A' ' 99' ' ' LYS . 5.8 p -115.02 -22.96 9.29 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.32 -0.855 . . . . 2.5099999999999998 109.948 -176.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -72.0 91.86 1.25 Allowed 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 122.13 0.967 . . . . 3.3999999999999999 109.956 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.578 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 5.2 tp10 -52.5 -29.63 26.04 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.142 -1.845 . . . . 2.6800000000000002 111.107 175.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 7.7 p -134.63 141.95 41.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.882 -0.784 . . . . 0.44 108.882 176.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.4 t -114.21 118.81 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 122.053 0.93 . . . . 0.46000000000000002 112.168 -171.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.943 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.3 OUTLIER -101.08 126.16 47.75 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.584 -1.643 . . . . 1.76 111.942 -173.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.545 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 9.4 tt -134.75 129.11 34.14 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.316 -0.402 . . . . 1.1200000000000001 109.999 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.787 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 24.5 tp -102.73 124.27 47.95 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 106.489 -1.671 . . . . 0.41999999999999998 106.489 175.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.714 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -127.47 145.22 35.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 119.147 -1.021 . . . . 0.77000000000000002 111.648 -174.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.855 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -99.54 113.38 25.74 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.611 -0.836 . . . . 0.34000000000000002 109.737 166.004 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 1.036 ' HD3' ' HG2' ' A' ' 14' ' ' GLN . 1.1 ptt180 -107.19 127.35 53.43 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.281 -1.327 . . . . 2.0099999999999998 108.943 -174.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.629 ' N ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -99.53 -55.99 2.52 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.838 0.681 . . . . 1.97 112.838 -165.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.473 ' N ' ' HG2' ' A' ' 112' ' ' GLN . 1.4 t -159.93 19.13 0.16 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.181 -0.608 . . . . 1.6200000000000001 111.037 -173.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 121.671 0.748 . . . . 1.6499999999999999 109.271 178.317 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 N--CA 1.429 -1.52 0 CA-C-O 121.995 0.902 . . . . 2.0899999999999999 110.651 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.427 ' HB1' ' O ' ' A' ' 111' ' ' ARG . . . -94.52 179.25 5.34 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.629 -1.623 . . . . 0.95999999999999996 109.662 176.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 m -112.91 124.02 69.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.235 0.541 . . . . 1.5700000000000001 110.523 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.734 HG22 HG23 ' A' ' 110' ' ' THR . 21.5 t -81.76 106.22 12.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.27 0.557 . . . . 1.02 110.025 -175.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.976 HE22 HG23 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -101.74 170.05 8.42 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.289 -0.869 . . . . 1.3899999999999999 112.051 -177.235 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -115.02 139.83 49.54 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 116.112 -0.494 . . . . 3.6299999999999999 111.359 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.976 HG23 HE22 ' A' ' 14' ' ' GLN . 12.4 t -128.86 126.46 64.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.868 -0.79 . . . . 1.02 108.868 173.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -142.09 121.52 13.21 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 122.11 -0.369 . . . . 1.3500000000000001 110.188 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.545 HG12 ' HB2' ' A' ' 65' ' ' PRO . 10.9 tp -145.15 147.53 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 N-CA-C 108.973 -0.751 . . . . 0.60999999999999999 108.973 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.757 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 13.5 m-70 -76.15 114.83 15.26 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.62 -0.511 . . . . 0.59999999999999998 109.62 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.822 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -28.82 129.27 0.08 Allowed 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.437 1.086 . . . . 4.0 112.358 176.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.5 tp -99.88 89.94 4.25 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.469 0.652 . . . . 0.55000000000000004 109.857 -173.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -77.58 143.49 38.28 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.185 -0.916 . . . . 3.9700000000000002 112.213 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.53 94.17 3.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.844 -1.071 . . . . 1.3500000000000001 108.142 175.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.31 -83.65 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.607 -0.806 . . . . 1.3300000000000001 111.671 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -137.59 12.51 2.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.224 0.535 . . . . 2.3300000000000001 110.724 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -115.93 135.73 53.71 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 108.584 -0.895 . . . . 1.8700000000000001 108.584 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.498 HD23 ' HG3' ' A' ' 20' ' ' LYS . 9.6 mp -107.42 123.78 48.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.585 0.707 . . . . 2.2799999999999998 110.959 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.441 ' O ' ' HE2' ' A' ' 20' ' ' LYS . 1.9 mp -98.15 129.47 48.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 114.933 -1.03 . . . . 0.80000000000000004 110.06 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.442 HD22 ' OG1' ' A' ' 98' ' ' THR . 0.1 OUTLIER -89.81 -31.08 17.54 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.791 -0.641 . . . . 1.74 110.867 -176.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.857 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 86.55 9.92 74.44 Favored Glycine 0 C--O 1.224 -0.501 0 C-N-CA 120.591 -0.814 . . . . 0.68999999999999995 112.559 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.611 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 47.0 p90 -150.28 149.53 30.27 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.72 0.295 . . . . 0.51000000000000001 110.237 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.725 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -102.47 150.19 23.63 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.827 -0.805 . . . . 0.53000000000000003 108.827 172.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.46 HG12 ' N ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -157.01 145.35 11.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 112.283 0.475 . . . . 0.48999999999999999 112.283 -163.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.46 ' N ' HG12 ' A' ' 33' ' ' ILE . . . -142.1 119.0 1.37 Allowed Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 110.572 -1.011 . . . . 0.71999999999999997 110.572 157.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.957 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -139.38 118.59 1.54 Allowed Glycine 0 CA--C 1.493 -1.328 0 CA-C-O 118.388 -1.229 . . . . 1.4199999999999999 111.119 170.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -168.6 142.8 7.65 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 117.751 -2.166 . . . . 0.47999999999999998 113.258 178.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.731 HG12 ' O ' ' A' ' 87' ' ' MET . 0.5 OUTLIER -65.71 -22.6 31.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 106.726 -1.583 . . . . 0.52000000000000002 106.726 153.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.758 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 1.1 t70 -58.18 -36.72 73.48 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 112.839 -1.982 . . . . 0.71999999999999997 109.222 169.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 . . . . . 0 CA--C 1.53 0.184 0 CA-C-N 115.165 -0.925 . . . . 1.1899999999999999 110.488 -175.448 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.048 0 N-CA-C 109.984 -1.246 . . . . 0.78000000000000003 109.984 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.957 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.7 mp -114.48 125.14 71.72 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.765 0 N-CA-C 108.225 -1.028 . . . . 0.54000000000000004 108.225 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.929 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.8 OUTLIER -145.4 148.33 33.22 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 119.984 1.266 . . . . 1.4199999999999999 112.261 -172.157 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.69 HG12 ' H ' ' A' ' 75' ' ' ASP . 3.4 p -87.11 136.46 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-N 114.172 -1.376 . . . . 0.57999999999999996 110.489 -173.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.3 m -106.33 -15.01 14.94 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.034 -0.984 . . . . 1.1100000000000001 110.615 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.725 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 42.1 mtp180 -149.82 -167.16 2.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.024 0.75 . . . . 2.27 113.024 177.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 51.0 t -161.88 154.9 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 106.197 -1.779 . . . . 0.82999999999999996 106.197 166.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.463 ' N ' HG12 ' A' ' 60' ' ' VAL . 59.2 p -104.41 131.33 51.89 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.622 0.725 . . . . 1.6499999999999999 111.552 176.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -63.42 107.57 1.14 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.464 -1.244 . . . . 1.8500000000000001 111.281 175.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.74 -14.95 45.56 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 115.144 -0.935 . . . . 0.92000000000000004 111.58 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.503 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -78.32 178.22 52.95 Favored Glycine 0 N--CA 1.438 -1.171 0 C-N-CA 120.514 -0.85 . . . . 0.98999999999999999 111.451 177.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.857 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 97.4 Cg_endo -74.77 -27.15 10.73 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 122.379 2.053 . . . . 0.44 113.334 -168.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.611 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -66.11 -26.41 67.45 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.169 -0.923 . . . . 0.35999999999999999 111.139 176.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -72.94 -31.45 64.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.805 0.812 . . . . 1.79 109.114 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.503 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -76.19 -39.8 35.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.908 -1.042 . . . . 0.51000000000000001 110.631 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.65 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -77.85 -15.59 58.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.0 -0.545 . . . . 0.40999999999999998 110.757 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.16 67.06 1.34 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.522 -0.847 . . . . 0.45000000000000001 113.44 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.487 HD21 HG21 ' A' ' 57' ' ' VAL . 17.8 tp -110.1 151.99 26.55 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.763 -0.829 . . . . 0.89000000000000001 108.763 175.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.515 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 9.7 mt-30 -123.06 28.98 6.94 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 115.701 1.741 . . . . 1.21 115.701 -164.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.634 HG23 ' HA ' ' A' ' 59' ' ' ARG . 75.5 mt 69.78 2.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-N 119.455 1.025 . . . . 0.77000000000000002 113.308 167.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.89 48.36 0.19 Allowed Glycine 0 CA--C 1.51 -0.237 0 C-N-CA 119.528 -1.32 . . . . 0.37 112.77 -170.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.69 ' H ' HG12 ' A' ' 57' ' ' VAL . 50.7 m-20 -120.83 145.92 47.1 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.376 -0.412 . . . . 0.89000000000000001 110.852 -172.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.909 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 32.4 mmtt -97.23 105.48 17.63 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 121.35 0.595 . . . . 2.2000000000000002 109.845 -174.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.991 HG13 HG23 ' A' ' 109' ' ' VAL . 2.7 mp -73.03 125.64 32.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.33 0.586 . . . . 0.48999999999999999 112.139 -177.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.723 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 1.5 mmt -91.5 -18.37 24.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 113.504 -1.68 . . . . 1.0600000000000001 111.769 177.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.742 ' HB2' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -171.88 157.62 4.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.972 0.415 . . . . 0.81999999999999995 111.357 -175.212 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.835 HG21 ' HB3' ' A' ' 97' ' ' LEU . 6.5 p -145.45 120.84 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.859 -0.61 . . . . 1.3100000000000001 110.576 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.814 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 19.6 m-80 54.88 29.81 12.72 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.503 -0.771 . . . . 1.5 112.264 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.35 -19.85 46.89 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.255 -0.974 . . . . 0.38 112.503 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -86.21 120.68 27.84 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.678 -0.86 . . . . 0.77000000000000002 108.678 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.742 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 6.6 p-10 -88.56 114.86 25.62 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 114.99 -1.005 . . . . 1.8899999999999999 111.289 -172.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.73 ' HB3' HD13 ' A' ' 55' ' ' ILE . 12.0 mmt -107.32 103.24 12.55 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.847 -1.07 . . . . 1.01 110.965 -175.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.0 p -106.96 -20.77 13.22 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.801 -0.636 . . . . 1.05 110.075 172.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.731 ' O ' HG12 ' A' ' 37' ' ' ILE . 1.8 mtt -143.66 -42.96 0.28 Allowed 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.278 -0.874 . . . . 1.6200000000000001 111.901 -172.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.754 ' O ' HD11 ' A' ' 55' ' ' ILE . 1.9 p -49.5 165.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 114.874 1.435 . . . . 1.0900000000000001 114.874 -158.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 80.6 p -54.78 151.94 7.81 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.423 0.897 . . . . 0.34999999999999998 113.423 -175.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.77 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 18.2 t-160 -59.38 -40.63 87.18 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.427 -0.806 . . . . 0.34999999999999998 110.116 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.93 -32.17 73.24 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.292 -1.322 . . . . 1.6699999999999999 109.779 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.773 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 4.1 tp-100 -61.6 -52.22 65.27 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.929 -0.767 . . . . 0.77000000000000002 108.929 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.678 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -75.29 -34.78 61.34 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.15 -0.932 . . . . 0.33000000000000002 110.69 -176.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -63.9 -36.58 84.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.118 0.485 . . . . 2.1000000000000001 109.808 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.487 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -69.07 -36.04 77.18 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.809 -0.632 . . . . 0.95999999999999996 109.823 178.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.773 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 20.8 mmt180 -75.87 -26.12 56.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.048 -0.524 . . . . 3.5699999999999998 111.517 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.835 ' HB3' HG21 ' A' ' 80' ' ' VAL . 4.2 pp -88.47 -26.7 21.94 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 111.905 0.335 . . . . 1.6499999999999999 111.905 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.513 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 67.1 m -148.72 109.77 4.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.642 0.734 . . . . 1.53 110.289 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.404 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 7.4 ptpp? -126.99 16.95 7.31 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.641 -1.163 . . . . 2.7200000000000002 110.857 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.433 ' CA ' HD22 ' A' ' 27' ' ' LEU . 60.2 mtt180 66.69 6.03 4.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.965 -1.016 . . . . 4.3799999999999999 111.829 175.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.474 ' C ' ' HG3' ' A' ' 102' ' ' GLU . 1.4 p -146.32 70.4 1.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.197 0.522 . . . . 2.5099999999999998 111.002 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.644 ' HB2' ' HG3' ' A' ' 20' ' ' LYS . 14.9 mt-10 -142.26 151.86 42.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.716 -0.675 . . . . 3.3999999999999999 110.733 -173.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -111.5 -29.15 7.88 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.765 -0.652 . . . . 2.6800000000000002 110.62 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.757 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 6.3 p -150.6 146.23 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.99 -0.55 . . . . 0.44 109.58 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.73 HG21 ' HG2' ' A' ' 20' ' ' LYS . 31.5 t -126.63 119.91 54.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 CA-C-O 122.227 1.013 . . . . 0.46000000000000002 112.361 -171.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.814 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 1.1 mpt_? -99.47 135.32 41.05 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.138 -1.846 . . . . 1.76 110.959 -175.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.604 HD11 HG12 ' A' ' 77' ' ' ILE . 19.9 tp -133.58 137.97 45.77 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.589 -0.278 . . . . 1.1200000000000001 110.6 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.723 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 38.8 tp -116.05 120.52 39.34 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.259 -1.386 . . . . 0.41999999999999998 107.259 172.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.991 HG23 HG13 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -130.18 152.2 37.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 121.22 0.533 . . . . 0.77000000000000002 110.712 -174.352 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.734 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -96.58 116.06 28.46 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.502 -0.772 . . . . 0.34000000000000002 109.377 168.763 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.473 ' HG3' HE22 ' A' ' 72' ' ' GLN . 7.8 ttt180 -100.58 135.56 41.83 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.187 -0.915 . . . . 2.0099999999999998 110.547 -176.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.447 ' HG2' ' CD2' ' A' ' 114' ' ' LEU . 0.2 OUTLIER -117.26 -108.48 0.37 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.96 -0.564 . . . . 1.97 110.559 176.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.9 t -115.12 28.6 8.59 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.239 0.542 . . . . 1.6200000000000001 111.074 -170.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.515 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 3.1 mm? . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 116.038 -0.528 . . . . 1.6499999999999999 111.509 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.43 -1.443 0 CA-C-O 122.217 1.008 . . . . 2.0899999999999999 111.589 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.42 177.09 5.29 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 113.581 -1.645 . . . . 0.95999999999999996 109.337 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -123.66 127.92 74.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.231 0.538 . . . . 1.5700000000000001 111.064 -177.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.672 HG22 HG23 ' A' ' 110' ' ' THR . 15.9 t -83.63 111.12 19.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.68 -0.489 . . . . 1.02 109.68 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 1.018 HE22 HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -115.36 170.44 8.39 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.56 -0.746 . . . . 1.3899999999999999 112.581 -174.224 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -123.9 113.86 19.06 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.65 -0.705 . . . . 3.6299999999999999 110.544 -175.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.018 HG23 HE22 ' A' ' 14' ' ' GLN . 4.1 t -99.61 110.07 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 109.082 -0.71 . . . . 1.02 109.082 174.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -123.11 118.14 27.0 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.337 -0.616 . . . . 1.3500000000000001 109.337 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.58 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 10.9 tp -138.12 145.73 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 108.673 -0.862 . . . . 0.60999999999999999 108.673 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 11.0 m-70 -76.21 116.51 16.97 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.977 -0.689 . . . . 0.59999999999999998 109.529 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.583 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -23.65 133.89 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 O-C-N 125.037 1.461 . . . . 4.0 112.31 176.345 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.3 tp -95.84 89.11 5.15 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.992 0.901 . . . . 0.55000000000000004 110.379 -175.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -63.46 136.68 57.76 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.497 -1.229 . . . . 3.9700000000000002 111.56 -173.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -132.99 94.47 3.37 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.983 -1.008 . . . . 1.3500000000000001 108.437 175.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.01 -82.17 0.18 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.394 -0.908 . . . . 1.3300000000000001 111.394 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -129.3 -5.93 4.83 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.148 0.499 . . . . 2.3300000000000001 110.629 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.566 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 5.9 m-80 -94.0 169.95 9.9 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.711 -0.677 . . . . 1.8700000000000001 109.889 -174.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 20' ' ' LYS . 2.0 pt? -128.39 126.74 41.25 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.698 -1.223 . . . . 2.2799999999999998 107.698 171.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.42 138.15 23.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 109.441 -0.578 . . . . 0.80000000000000004 109.441 -176.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.48 ' HG ' ' CE2' ' A' ' 31' ' ' PHE . 18.3 tp -91.5 -33.0 15.36 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.879 -1.055 . . . . 1.74 110.572 -171.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.683 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 89.87 -38.05 3.27 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.765 -0.731 . . . . 0.68999999999999995 112.122 177.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.83 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 52.3 p90 -113.5 155.67 24.93 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 122.803 -0.233 . . . . 0.51000000000000001 110.766 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.571 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 12.5 t -101.89 163.87 12.02 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.905 -1.146 . . . . 0.53000000000000003 107.905 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.42 HD12 HD21 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -160.36 140.68 3.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 C-N-CA 120.981 -0.288 . . . . 0.48999999999999999 111.352 -164.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -143.06 120.15 1.49 Allowed Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 110.547 -1.021 . . . . 0.71999999999999997 110.547 158.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 1.048 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -138.35 119.09 1.72 Allowed Glycine 0 CA--C 1.492 -1.387 0 CA-C-O 118.784 -1.009 . . . . 1.4199999999999999 110.771 171.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.897 ' HA3' ' HG2' ' A' ' 39' ' ' GLN . . . -156.13 118.52 0.85 Allowed Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 118.251 -1.928 . . . . 0.47999999999999998 113.37 -170.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.594 HG12 ' C ' ' A' ' 88' ' ' VAL . 20.8 pt -64.4 -21.38 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 105.728 -1.953 . . . . 0.52000000000000002 105.728 145.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.77 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 14.3 t70 -64.55 -36.42 84.17 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 112.672 -2.058 . . . . 0.71999999999999997 110.782 171.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.897 ' HG2' ' HA3' ' A' ' 36' ' ' GLY . 25.4 mm-40 . . . . . 0 C--N 1.349 0.586 0 N-CA-C 112.486 0.55 . . . . 1.1899999999999999 112.486 -171.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.509 ' C ' HD12 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.442 -0.931 0 N-CA-C 111.878 -0.489 . . . . 0.78000000000000003 111.878 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.048 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.9 mp -118.76 147.13 22.46 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 N-CA-C 108.404 -0.961 . . . . 0.54000000000000004 108.404 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.805 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -155.48 156.35 35.09 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 118.97 0.805 . . . . 1.4199999999999999 111.215 178.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.55 ' CG1' ' H ' ' A' ' 75' ' ' ASP . 8.1 p -92.38 132.84 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-N 115.481 -0.781 . . . . 0.57999999999999996 110.92 -173.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.5 m -103.89 -17.14 15.14 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.497 -1.229 . . . . 1.1100000000000001 111.467 -174.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.926 ' HA ' HG23 ' A' ' 73' ' ' ILE . 46.2 mtt180 -143.63 -175.41 4.56 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.982 1.104 . . . . 2.27 113.982 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 59' ' ' ARG . 75.4 t -167.73 111.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 112.959 -1.928 . . . . 0.82999999999999996 106.956 161.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.5 m -79.56 128.47 33.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.212 0.53 . . . . 1.6499999999999999 110.655 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -50.43 116.59 1.97 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.679 -1.146 . . . . 1.8500000000000001 111.47 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.29 -20.39 30.52 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.241 -0.89 . . . . 0.92000000000000004 112.931 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.74 172.96 55.17 Favored Glycine 0 CA--C 1.502 -0.762 0 C-N-CA 120.345 -0.931 . . . . 0.98999999999999999 111.771 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.683 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 73.2 Cg_endo -71.45 -19.2 28.92 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.43 2.087 . . . . 0.44 113.184 -169.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.83 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -67.2 -28.91 68.47 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.654 -1.157 . . . . 0.35999999999999999 111.643 175.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -73.13 -34.85 66.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 122.013 0.911 . . . . 1.79 109.151 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.479 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.4 mp -74.44 -38.06 45.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.526 -1.215 . . . . 0.51000000000000001 110.221 -177.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.708 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -80.17 -20.26 45.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.361 -0.382 . . . . 0.40999999999999998 110.699 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.13 65.24 1.12 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.37 -0.919 . . . . 0.45000000000000001 114.017 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.54 HD21 HG21 ' A' ' 57' ' ' VAL . 18.1 tp -113.34 155.56 24.97 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.357 -0.609 . . . . 0.89000000000000001 109.357 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.976 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 12.9 mt-30 -124.23 31.13 5.86 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 115.176 1.547 . . . . 1.21 115.176 -166.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.926 HG23 ' HA ' ' A' ' 59' ' ' ARG . 42.6 mt 68.55 1.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 113.201 0.815 . . . . 0.77000000000000002 113.201 166.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -172.53 51.02 0.17 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 119.757 -1.211 . . . . 0.37 112.355 -168.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.55 ' H ' ' CG1' ' A' ' 57' ' ' VAL . 32.1 m-20 -121.45 151.8 39.82 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.358 -0.608 . . . . 0.89000000000000001 109.358 -175.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.805 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 64.0 mmtt -95.33 122.14 37.72 Favored 'General case' 0 C--O 1.208 -1.084 0 CA-C-O 121.302 0.572 . . . . 2.2000000000000002 110.55 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.713 HG12 HD11 ' A' ' 107' ' ' LEU . 8.5 mt -88.11 125.36 41.53 Favored 'Isoleucine or valine' 0 C--O 1.258 1.525 0 CA-C-O 121.309 0.576 . . . . 0.48999999999999999 112.006 -174.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.841 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -96.74 -16.4 20.89 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.202 -1.817 . . . . 1.0600000000000001 111.649 -177.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.749 ' HB3' HD23 ' A' ' 108' ' ' LEU . 0.9 OUTLIER -168.99 150.51 4.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.729 0.299 . . . . 0.81999999999999995 111.481 -175.33 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.73 ' HB ' ' CE ' ' A' ' 85' ' ' MET . 3.3 t -139.36 118.59 13.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.807 -0.633 . . . . 1.3100000000000001 110.811 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.896 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 12.9 m120 52.87 31.05 10.06 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.01 -0.541 . . . . 1.5 111.856 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.11 -5.7 59.44 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.293 -0.956 . . . . 0.38 113.042 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.526 ' HE1' ' CZ ' ' A' ' 96' ' ' ARG . 54.7 m95 -87.03 175.21 8.22 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 110.091 -0.336 . . . . 0.77000000000000002 110.091 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -115.88 113.2 23.01 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.751 -0.659 . . . . 1.8899999999999999 109.938 -173.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.73 ' CE ' ' HB ' ' A' ' 80' ' ' VAL . 19.6 mmt -107.14 100.59 10.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.949 0.881 . . . . 1.01 110.152 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.4 p -132.98 -35.85 1.05 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.408 -1.269 . . . . 1.05 107.98 171.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.28 78.17 0.57 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 113.755 -1.566 . . . . 1.6200000000000001 109.996 176.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.626 HG21 HE21 ' A' ' 92' ' ' GLN . 1.4 p -137.7 164.21 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 109.5 -0.555 . . . . 1.0900000000000001 109.5 174.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.747 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 61.7 p -63.04 151.39 40.0 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.348 0.594 . . . . 0.34999999999999998 112.312 -176.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.77 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 20.4 t-160 -61.86 -34.97 76.95 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-O 121.589 0.709 . . . . 0.34999999999999998 109.882 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.65 -31.55 69.7 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 113.97 -1.468 . . . . 1.6699999999999999 109.618 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.626 HE21 HG21 ' A' ' 88' ' ' VAL . 1.7 tp-100 -61.59 -52.21 65.34 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.681 -0.859 . . . . 0.77000000000000002 108.681 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.646 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.08 -41.45 77.51 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.528 -1.214 . . . . 0.33000000000000002 110.188 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.419 ' HA ' HD11 ' A' ' 97' ' ' LEU . 34.3 ttp180 -64.89 -41.32 95.71 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.157 -0.929 . . . . 2.1000000000000001 111.201 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.659 ' HE3' ' HD3' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -68.33 -29.16 67.83 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 121.168 0.509 . . . . 0.95999999999999996 109.848 -177.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.583 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 12.8 mmm180 -74.96 -48.77 22.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.023 -0.535 . . . . 3.5699999999999998 112.276 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.5 pp -82.6 -4.81 58.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.021 0.439 . . . . 1.6499999999999999 111.493 -178.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.2 m -138.12 78.7 1.7 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 122.137 0.97 . . . . 1.53 109.379 175.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.659 ' HD3' ' HE3' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -84.78 -79.18 0.23 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.006 -1.452 . . . . 2.7200000000000002 110.347 -178.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.41 ' H ' ' HB3' ' A' ' 99' ' ' LYS . 26.8 ptt180 174.11 -26.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.158 -0.928 . . . . 4.3799999999999999 111.059 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.7 m -160.89 40.05 0.16 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.955 0.407 . . . . 2.5099999999999998 110.396 -171.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 46.1 mm-40 -58.86 156.61 11.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.838 -0.619 . . . . 3.3999999999999999 110.714 175.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.58 ' HG3' HG12 ' A' ' 104' ' ' VAL . 6.0 pt-20 -84.74 -38.52 19.57 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.636 0.732 . . . . 2.6800000000000002 109.474 172.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.58 HG12 ' HG3' ' A' ' 103' ' ' GLU . 3.1 p -156.8 156.04 4.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 114.745 -1.116 . . . . 0.44 108.332 -176.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.6 t -115.87 117.81 56.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 122.11 0.957 . . . . 0.46000000000000002 111.643 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.896 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 1.4 mpt_? -100.55 123.73 45.15 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 113.422 -1.717 . . . . 1.76 111.626 -171.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.713 HD11 HG12 ' A' ' 77' ' ' ILE . 28.4 tp -132.12 125.77 32.1 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.88 -0.6 . . . . 1.1200000000000001 110.756 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.841 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 31.8 tp -108.18 120.88 43.61 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 107.688 -1.227 . . . . 0.41999999999999998 107.688 172.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.742 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -132.95 150.33 32.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.398 0.618 . . . . 0.77000000000000002 110.635 -172.212 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.672 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -95.76 116.58 29.09 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.295 -0.866 . . . . 0.34000000000000002 109.37 168.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.784 ' HG3' HE22 ' A' ' 72' ' ' GLN . 27.4 ttt180 -110.58 139.75 45.54 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.474 -1.239 . . . . 2.0099999999999998 110.755 -169.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.66 -90.87 0.57 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.531 0.567 . . . . 1.97 112.531 -176.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.8 m -151.33 41.75 0.73 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 112.539 0.57 . . . . 1.6200000000000001 112.539 -164.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.976 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 0.3 OUTLIER . . . . . 0 C--N 1.32 -0.683 0 N-CA-C 109.516 -0.55 . . . . 1.6499999999999999 109.516 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.433 -1.304 0 CA-C-O 122.167 0.984 . . . . 2.0899999999999999 108.906 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.7 165.84 23.17 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.51 -1.677 . . . . 0.95999999999999996 111.075 173.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.97 132.03 71.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 115.456 -0.793 . . . . 1.5700000000000001 110.123 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.501 ' CG1' HD11 ' A' ' 108' ' ' LEU . 59.1 t -87.14 119.1 34.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.342 0.591 . . . . 1.02 111.497 -173.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 1.08 HE22 HG23 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -114.04 171.17 7.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.542 -0.753 . . . . 1.3899999999999999 111.585 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.429 ' NE ' HD13 ' A' ' 108' ' ' LEU . 26.7 mmt180 -115.55 137.77 51.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.929 0.395 . . . . 3.6299999999999999 111.959 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.08 HG23 HE22 ' A' ' 14' ' ' GLN . 23.0 t -123.55 123.4 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 109.234 -0.654 . . . . 1.02 109.234 171.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -144.78 123.87 12.85 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.831 -0.433 . . . . 1.3500000000000001 109.831 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.547 HG21 ' HB2' ' A' ' 65' ' ' PRO . 10.2 tp -144.88 150.2 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 109.279 -0.638 . . . . 0.60999999999999999 109.279 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 15.5 m-70 -81.0 109.93 16.06 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.231 -0.655 . . . . 0.59999999999999998 109.231 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.412 ' HD3' ' N ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -27.49 135.22 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 O-C-N 125.228 1.58 . . . . 4.0 113.094 -177.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.1 tp -101.65 90.36 4.01 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.737 -0.468 . . . . 0.55000000000000004 109.737 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 26.8 ptt180 -70.35 144.89 51.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.312 0.577 . . . . 3.9700000000000002 111.191 -173.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.21 93.78 4.02 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.745 -0.835 . . . . 1.3500000000000001 108.745 173.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.57 -88.85 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.625 -0.59 . . . . 1.3300000000000001 111.625 -174.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.448 ' HB3' HH21 ' A' ' 100' ' ' ARG . 28.9 mm-40 -110.3 -5.45 15.25 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.261 -0.47 . . . . 2.3300000000000001 111.524 -177.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.405 ' O ' HD12 ' A' ' 27' ' ' LEU . 10.3 m-80 -105.8 171.47 7.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.083 -0.508 . . . . 1.8700000000000001 111.143 -173.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.826 HD13 ' HA ' ' A' ' 100' ' ' ARG . 7.8 mp -124.58 125.51 44.28 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.284 -1.006 . . . . 2.2799999999999998 108.284 172.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.5 mm -97.18 116.22 38.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 109.291 -0.633 . . . . 0.80000000000000004 109.291 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.815 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.8 pt? -78.52 -32.6 48.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.684 -1.143 . . . . 1.74 110.707 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.639 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 82.51 17.08 69.4 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.487 -0.863 . . . . 0.68999999999999995 113.027 173.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.642 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 48.1 p90 -154.24 161.49 41.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.733 0.267 . . . . 0.51000000000000001 110.691 173.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.61 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 11.6 t -106.11 158.68 16.64 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.219 -1.03 . . . . 0.53000000000000003 108.219 173.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -160.33 138.8 2.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 112.521 0.563 . . . . 0.48999999999999999 112.521 -164.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.423 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -139.26 118.24 1.5 Allowed Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 119.679 -1.248 . . . . 0.71999999999999997 110.283 156.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 1.035 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -140.26 117.42 1.29 Allowed Glycine 0 CA--C 1.492 -1.365 0 CA-C-O 118.925 -0.931 . . . . 1.4199999999999999 111.657 170.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.671 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.01 143.51 8.35 Favored Glycine 0 C--N 1.3 -1.47 0 C-N-CA 118.364 -1.874 . . . . 0.47999999999999998 112.563 174.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.412 HG12 ' C ' ' A' ' 88' ' ' VAL . 9.8 pt -62.14 -22.26 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 107.797 -1.186 . . . . 0.52000000000000002 107.797 152.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.676 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 1.1 t70 -56.46 -47.7 78.61 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.473 -1.694 . . . . 0.71999999999999997 110.345 171.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 . . . . . 0 C--O 1.231 0.123 0 CA-C-N 114.866 -1.061 . . . . 1.1899999999999999 111.248 -174.041 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 86' ' ' THR . . . . . . . . 0 N--CA 1.446 -0.691 0 N-CA-C 111.295 -0.722 . . . . 0.78000000000000003 111.295 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.035 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -110.68 137.4 43.26 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.166 0 N-CA-C 106.666 -1.605 . . . . 0.54000000000000004 106.666 170.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.665 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -152.2 147.12 26.03 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 119.655 1.116 . . . . 1.4199999999999999 111.215 -176.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 75' ' ' ASP . 7.7 p -87.15 139.65 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 114.728 -1.124 . . . . 0.57999999999999996 110.05 -172.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.9 m -110.88 -14.21 14.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.181 -0.918 . . . . 1.1100000000000001 111.107 -174.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.841 ' HA ' HG23 ' A' ' 73' ' ' ILE . 37.6 mtt180 -146.86 -167.56 2.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.234 0.827 . . . . 2.27 113.234 175.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.533 HG13 ' HB3' ' A' ' 66' ' ' ALA . 63.9 t -161.58 148.66 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 112.413 -2.176 . . . . 0.82999999999999996 106.44 162.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.4 p -91.82 137.33 32.45 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.06 0.457 . . . . 1.6499999999999999 110.654 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -62.94 109.08 1.34 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.769 -1.105 . . . . 1.8500000000000001 111.367 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.26 -10.89 67.49 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.484 -0.865 . . . . 0.92000000000000004 111.903 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.526 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -75.47 173.29 53.26 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 120.766 -0.731 . . . . 0.98999999999999999 111.525 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.639 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 73.2 Cg_endo -72.25 -24.63 19.64 Favored 'Trans proline' 0 C--N 1.32 -0.935 0 C-N-CA 122.842 2.361 . . . . 0.44 113.252 -166.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.642 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -64.14 -31.38 72.55 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.717 -1.129 . . . . 0.35999999999999999 111.283 176.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -74.49 -36.35 63.25 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.517 0.675 . . . . 1.79 109.189 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -64.79 -42.44 94.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.673 -1.149 . . . . 0.51000000000000001 110.104 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.611 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -73.0 -24.4 60.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.40999999999999998 110.543 175.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.66 58.3 1.06 Allowed Glycine 0 C--O 1.226 -0.354 0 C-N-CA 120.509 -0.853 . . . . 0.45000000000000001 113.722 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.521 HD21 HG21 ' A' ' 57' ' ' VAL . 14.8 tp -102.77 154.25 19.36 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.876 -0.787 . . . . 0.89000000000000001 108.876 175.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.581 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 6.5 mt-30 -129.33 34.19 4.42 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 115.604 1.705 . . . . 1.21 115.604 -166.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.841 HG23 ' HA ' ' A' ' 59' ' ' ARG . 59.8 mt 69.2 0.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 N-CA-C 113.34 0.867 . . . . 0.77000000000000002 113.34 165.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -174.18 55.68 0.14 Allowed Glycine 0 C--N 1.33 0.22 0 C-N-CA 119.984 -1.103 . . . . 0.37 112.914 -169.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.601 ' H ' HG12 ' A' ' 57' ' ' VAL . 31.7 m-20 -122.72 142.3 50.85 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.644 -0.278 . . . . 0.89000000000000001 111.524 -173.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.665 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 1.4 mptm? -83.31 102.8 12.22 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-O 120.983 0.421 . . . . 2.2000000000000002 111.062 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.624 ' HB ' HG22 ' A' ' 55' ' ' ILE . 6.9 mt -76.56 125.85 36.69 Favored 'Isoleucine or valine' 0 C--O 1.254 1.337 0 C-N-CA 123.617 0.767 . . . . 0.48999999999999999 111.594 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.775 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 9.1 mmt -90.52 -27.84 18.92 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.195 -1.366 . . . . 1.0600000000000001 112.046 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.584 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 1.0 OUTLIER -159.52 150.6 19.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.858 0.361 . . . . 0.81999999999999995 111.448 -171.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.673 HG12 ' SD ' ' A' ' 85' ' ' MET . 11.2 p -137.05 126.49 37.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.868 -0.605 . . . . 1.3100000000000001 110.474 174.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.682 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 4.3 t-20 57.99 22.82 9.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.154 -0.93 . . . . 1.5 112.171 170.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.92 -5.52 46.69 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 119.683 -1.246 . . . . 0.38 113.316 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -92.75 156.85 16.76 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 109.471 -0.566 . . . . 0.77000000000000002 109.471 175.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -111.94 99.17 7.89 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.075 -0.511 . . . . 1.8899999999999999 110.682 -175.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.909 ' HB2' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -111.0 100.41 9.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.642 0.734 . . . . 1.01 112.091 -178.598 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.525 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 14.6 p -103.23 -35.62 8.38 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.867 -1.16 . . . . 1.05 107.867 165.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.07 76.6 1.55 Allowed 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.415 -1.72 . . . . 1.6200000000000001 109.187 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.671 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -138.22 157.28 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 108.724 -0.843 . . . . 1.0900000000000001 108.724 175.247 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.656 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 81.1 p -62.7 154.59 28.95 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 112.995 0.739 . . . . 0.34999999999999998 112.995 -177.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.796 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 21.8 t-160 -58.69 -38.69 78.8 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-N 115.289 -0.868 . . . . 0.34999999999999998 110.464 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.89 -30.95 67.45 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.169 -1.378 . . . . 1.6699999999999999 109.732 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.622 ' HB3' HG13 ' A' ' 88' ' ' VAL . 1.6 tp-100 -63.82 -46.58 84.45 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.672 0.749 . . . . 0.77000000000000002 109.265 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.622 ' HB2' HG12 ' A' ' 55' ' ' ILE . . . -74.3 -36.17 63.72 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.025 -0.989 . . . . 0.33000000000000002 110.756 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -67.23 -41.19 86.13 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.232 0.539 . . . . 2.1000000000000001 110.514 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -68.1 -34.79 77.05 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.291 -0.868 . . . . 0.95999999999999996 109.516 -177.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -75.46 -33.43 60.85 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.709 -0.678 . . . . 3.5699999999999998 111.335 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.597 HD11 ' CZ ' ' A' ' 31' ' ' PHE . 3.1 tt -54.99 -61.04 2.57 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.385 -1.28 . . . . 1.6499999999999999 111.861 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.516 HG23 HD22 ' A' ' 97' ' ' LEU . 12.6 p -110.36 -78.84 0.59 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.485 -0.486 . . . . 1.53 112.124 -176.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 19.2 ttpt 70.05 -2.65 2.0 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.806 0.812 . . . . 2.7200000000000002 112.185 176.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.826 ' HA ' HD13 ' A' ' 27' ' ' LEU . 78.4 mtp180 71.69 23.23 3.77 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.168 -0.924 . . . . 4.3799999999999999 112.515 171.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.426 ' OG ' ' HG2' ' A' ' 99' ' ' LYS . 4.9 p -154.94 29.04 0.42 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.92 0.711 . . . . 2.5099999999999998 112.92 -174.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -97.98 166.2 11.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.971 0.415 . . . . 3.3999999999999999 111.731 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.538 ' HG3' HG12 ' A' ' 104' ' ' VAL . 18.7 pt-20 -114.05 -28.61 7.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.592 0.711 . . . . 2.6800000000000002 110.159 177.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.56 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 3.9 p -152.92 143.05 14.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 107.756 -1.202 . . . . 0.44 107.756 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.6 t -115.2 117.5 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-O 122.238 1.018 . . . . 0.46000000000000002 111.817 -170.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.682 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 1.3 mpt_? -99.82 129.02 45.88 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 113.036 -1.893 . . . . 1.76 111.118 -173.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.528 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 19.7 tp -133.31 129.61 37.77 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.87 -0.604 . . . . 1.1200000000000001 109.931 177.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.775 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 22.6 tp -106.04 113.61 27.25 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 107.389 -1.337 . . . . 0.41999999999999998 107.389 173.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.733 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.5 OUTLIER -121.9 143.96 32.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 C-N-CA 119.998 -0.681 . . . . 0.77000000000000002 110.523 -173.092 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.501 HG23 HG22 ' A' ' 13' ' ' VAL . 1.3 m -96.77 120.31 36.87 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.313 -0.858 . . . . 0.34000000000000002 110.623 173.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.764 ' HD2' ' HG2' ' A' ' 14' ' ' GLN . 7.7 ttt180 -90.74 153.41 20.28 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.57 -1.195 . . . . 2.0099999999999998 109.794 -176.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.429 ' N ' ' CD ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -145.98 -60.82 0.32 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.134 0.791 . . . . 1.97 113.134 -168.299 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.9 t -157.77 10.87 0.19 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.89 0.376 . . . . 1.6200000000000001 111.727 -174.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 3.1 mm? . . . . . 0 C--N 1.325 -0.49 0 O-C-N 122.13 -0.356 . . . . 1.6499999999999999 111.44 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.2 p . . . . . 0 N--CA 1.429 -1.499 0 CA-C-O 122.057 0.932 . . . . 2.0899999999999999 110.447 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -102.16 165.23 11.26 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.69 -1.595 . . . . 0.95999999999999996 109.359 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.9 m -117.61 136.8 53.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 116.131 -0.486 . . . . 1.5700000000000001 109.913 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.805 HG12 HG23 ' A' ' 110' ' ' THR . 3.1 m -88.16 120.65 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 122.311 1.053 . . . . 1.02 110.878 -177.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.956 HE22 HG23 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -97.51 170.99 8.66 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 113.939 -1.482 . . . . 1.3899999999999999 110.545 178.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -115.9 116.55 28.17 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.064 0.394 . . . . 3.6299999999999999 112.064 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.956 HG23 HE22 ' A' ' 14' ' ' GLN . 3.9 t -104.58 118.19 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 109.352 -0.61 . . . . 1.02 109.352 173.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -132.3 115.75 16.02 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.335 -0.848 . . . . 1.3500000000000001 109.117 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.632 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 9.3 tp -144.58 152.37 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 109.002 -0.74 . . . . 0.60999999999999999 109.002 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 10.3 m-70 -79.99 114.32 18.82 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.621 -0.881 . . . . 0.59999999999999998 108.621 174.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.979 ' HB2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -25.33 139.25 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.906 1.379 . . . . 4.0 113.335 177.739 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.641 HD22 ' HD3' ' A' ' 65' ' ' PRO . 32.3 tp -98.91 91.48 5.07 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 119.177 -1.009 . . . . 0.55000000000000004 109.451 -177.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 28.7 ptt180 -76.24 135.91 39.68 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.617 0.722 . . . . 3.9700000000000002 111.316 -173.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.573 ' HB2' HD13 ' A' ' 28' ' ' ILE . 4.8 tp-100 -119.36 94.88 4.57 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.04 -0.982 . . . . 1.3500000000000001 108.422 176.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.53 -80.47 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.729 -0.748 . . . . 1.3300000000000001 111.318 -173.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -134.9 10.95 3.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.003 0.43 . . . . 2.3300000000000001 110.567 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 11.5 m-80 -110.35 173.89 6.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.963 -0.562 . . . . 1.8700000000000001 110.625 -176.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.979 HD13 ' HB2' ' A' ' 20' ' ' LYS . 7.3 tp -127.11 123.75 37.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.378 0.608 . . . . 2.2799999999999998 110.061 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.573 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.7 mp -98.81 132.51 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.227 -0.897 . . . . 0.80000000000000004 108.955 175.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.696 HD13 HD21 ' A' ' 97' ' ' LEU . 0.6 OUTLIER -84.09 -42.74 15.78 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 114.657 -1.156 . . . . 1.74 109.964 -174.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.522 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 92.57 13.49 56.89 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 115.099 -0.955 . . . . 0.68999999999999995 111.479 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.591 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 24.4 p90 -155.33 172.66 17.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.517 -0.179 . . . . 0.51000000000000001 110.517 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.932 ' HB3' ' O ' ' A' ' 58' ' ' THR . 5.6 t -112.81 170.79 7.94 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.578 -0.897 . . . . 0.53000000000000003 108.578 169.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 5.2 tt -148.36 136.4 14.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 120.448 -0.501 . . . . 0.48999999999999999 112.138 -167.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -103.58 170.73 19.55 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.869 -0.892 . . . . 0.71999999999999997 110.869 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.724 ' C ' HE22 ' A' ' 39' ' ' GLN . . . -103.97 166.13 15.5 Favored Glycine 0 N--CA 1.418 -2.52 0 N-CA-C 117.828 1.891 . . . . 1.4199999999999999 117.828 -163.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.784 ' N ' HE22 ' A' ' 39' ' ' GLN . . . -86.37 -143.24 7.29 Favored Glycine 0 N--CA 1.417 -2.623 0 CA-C-N 110.073 -3.064 . . . . 0.47999999999999998 113.392 -173.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.662 HD13 ' O ' ' A' ' 87' ' ' MET . 10.6 pt -83.52 -4.77 8.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.02 -0.59 . . . . 0.52000000000000002 112.213 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.983 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 11.3 p-10 -70.91 -32.43 69.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.852 0.358 . . . . 0.71999999999999997 110.511 -175.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.784 HE22 ' N ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER . . . . . 0 CA--C 1.519 -0.221 0 N-CA-C 108.752 -0.833 . . . . 1.1899999999999999 108.752 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.6 0 N-CA-C 107.896 -2.082 . . . . 0.78000000000000003 107.896 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.718 HG22 HD13 ' A' ' 77' ' ' ILE . 2.2 mp -93.74 119.43 41.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 119.89 1.845 . . . . 0.54000000000000004 108.943 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.785 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -151.78 131.26 12.98 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.188 0.994 . . . . 1.4199999999999999 110.122 -170.584 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.958 HG21 HD21 ' A' ' 71' ' ' LEU . 1.2 t -62.05 139.93 20.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 113.594 -1.639 . . . . 0.57999999999999996 112.22 -173.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.932 ' O ' ' HB3' ' A' ' 32' ' ' SER . 6.4 m -129.28 64.17 1.48 Allowed 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.613 -1.176 . . . . 1.1100000000000001 109.216 173.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.63 ' C ' ' HA ' ' A' ' 73' ' ' ILE . 15.4 mtt180 148.97 -171.22 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 125.391 1.476 . . . . 2.27 111.475 163.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 61.9 t -161.13 130.42 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 113.028 -1.897 . . . . 0.82999999999999996 106.635 163.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.8 m -88.43 123.57 33.1 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.154 0.502 . . . . 1.6499999999999999 109.991 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.492 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 77.3 mt-10 -52.1 118.54 3.56 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.935 -1.03 . . . . 1.8500000000000001 111.876 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.79 -3.02 60.55 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.203 -0.908 . . . . 0.92000000000000004 111.907 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.42 172.2 39.2 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.613 -0.803 . . . . 0.98999999999999999 111.503 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.641 ' HD3' HD22 ' A' ' 21' ' ' LEU . 92.2 Cg_endo -74.1 -24.69 14.6 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 122.962 2.441 . . . . 0.44 113.408 -168.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.591 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -67.51 -23.91 65.51 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.05 -0.977 . . . . 0.35999999999999999 110.928 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.492 ' OE1' ' HA ' ' A' ' 62' ' ' GLU . 28.2 tt0 -75.7 -36.77 59.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.771 0.796 . . . . 1.79 108.935 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.525 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.5 mp -73.35 -42.14 57.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.145 -1.389 . . . . 0.51000000000000001 110.351 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.695 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -71.23 -21.32 62.14 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.995 -0.548 . . . . 0.40999999999999998 111.026 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.46 54.3 1.09 Allowed Glycine 0 C--O 1.225 -0.437 0 C-N-CA 120.037 -1.078 . . . . 0.45000000000000001 114.174 174.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.958 HD21 HG21 ' A' ' 57' ' ' VAL . 6.5 tp -97.25 161.34 13.85 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.269 -0.641 . . . . 0.89000000000000001 109.269 174.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.6 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 4.7 pt20 -131.47 29.57 4.54 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 115.071 1.508 . . . . 1.21 115.071 -168.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.63 ' HA ' ' C ' ' A' ' 59' ' ' ARG . 2.3 mp 75.3 -6.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-O 120.975 0.417 . . . . 0.77000000000000002 111.349 173.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -164.82 66.32 0.22 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.851 -0.69 . . . . 0.37 111.628 -169.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.478 ' HB3' ' CG2' ' A' ' 109' ' ' VAL . 3.8 m-20 -118.8 135.88 54.29 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 115.613 -0.293 . . . . 0.89000000000000001 110.966 -169.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.5 mmtt -95.49 102.95 14.8 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 121.054 0.454 . . . . 2.2000000000000002 109.981 -174.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.785 HD12 ' HA ' ' A' ' 56' ' ' TYR . 2.9 mp -72.24 118.04 16.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 112.473 0.545 . . . . 0.48999999999999999 112.473 -171.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.98 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 1.3 mmt -93.61 -10.48 34.49 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.088 -0.96 . . . . 1.0600000000000001 112.869 177.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.634 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -172.23 154.01 3.2 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.329 0.492 . . . . 0.81999999999999995 112.329 -178.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.508 ' N ' ' HG3' ' A' ' 79' ' ' GLN . 87.8 t -133.08 105.59 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.68 -0.691 . . . . 1.3100000000000001 110.731 177.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.753 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 6.3 m120 55.13 33.22 19.98 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.969 0.729 . . . . 1.5 112.969 176.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.48 -12.26 50.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 119.77 -1.205 . . . . 0.38 112.202 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.44 ' NE1' ' HD2' ' A' ' 96' ' ' ARG . 90.2 m95 -75.92 162.69 27.9 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.875 -0.787 . . . . 0.77000000000000002 108.875 171.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -116.54 115.14 25.2 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.406 -0.361 . . . . 1.8899999999999999 110.466 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.431 ' SD ' HG11 ' A' ' 88' ' ' VAL . 21.4 mmt -106.89 101.4 10.84 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.567 0.699 . . . . 1.01 110.92 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.05 91.69 2.71 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.05 -0.977 . . . . 1.05 109.384 170.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.662 ' O ' HD13 ' A' ' 37' ' ' ILE . 0.1 OUTLIER 48.88 65.14 1.45 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.711 -1.131 . . . . 1.6200000000000001 110.332 -173.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.708 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 6.0 p -108.67 178.35 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 107.434 -1.321 . . . . 1.0900000000000001 107.434 170.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.983 ' HB ' ' HB3' ' A' ' 38' ' ' ASP . 49.2 p -66.27 147.89 52.66 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 119.093 0.86 . . . . 0.34999999999999998 111.601 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.593 ' CG ' ' HA2' ' A' ' 35' ' ' GLY . 20.7 t-160 -54.68 -38.46 67.01 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-O 122.121 0.962 . . . . 0.34999999999999998 108.827 174.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.47 -33.04 74.81 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 113.109 -1.86 . . . . 1.6699999999999999 109.865 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.758 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 3.7 tp-100 -59.45 -52.96 63.37 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 109.207 -0.664 . . . . 0.77000000000000002 109.207 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.642 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . -74.44 -35.73 63.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.233 -0.894 . . . . 0.33000000000000002 110.375 -175.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -61.06 -44.2 97.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.936 -0.574 . . . . 2.1000000000000001 110.356 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.63 ' HE3' ' O ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -71.2 -46.54 61.01 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.847 -0.615 . . . . 0.95999999999999996 109.439 -176.51 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.758 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 29.4 mmt180 -65.6 -25.33 67.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.035 -0.53 . . . . 3.5699999999999998 110.672 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.696 HD21 HD13 ' A' ' 29' ' ' LEU . 17.0 tp -68.45 -61.04 2.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.06 -0.518 . . . . 1.6499999999999999 111.603 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.851 ' HA ' HD23 ' A' ' 27' ' ' LEU . 2.5 m -69.44 -32.64 71.72 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.256 -0.646 . . . . 1.53 109.256 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.496 ' HB3' ' H ' ' A' ' 100' ' ' ARG . 0.4 OUTLIER 61.36 -105.72 0.21 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.713 -1.13 . . . . 2.7200000000000002 110.87 168.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.496 ' H ' ' HB3' ' A' ' 99' ' ' LYS . 59.9 mtm180 -143.99 14.49 1.69 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.813 -1.18 . . . . 4.3799999999999999 107.813 172.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.5 m 73.57 42.03 0.42 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.61 -1.177 . . . . 2.5099999999999998 111.015 -173.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -57.07 154.17 10.29 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.032 -0.531 . . . . 3.3999999999999999 109.793 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -58.99 -25.18 63.39 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.87 1.063 . . . . 2.6800000000000002 113.87 -164.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 7.2 p -146.38 151.91 14.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 120.758 -0.377 . . . . 0.44 110.298 -175.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.412 ' HA ' HD21 ' A' ' 81' ' ' ASN . 51.8 t -133.31 118.37 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.016 0 CA-C-O 122.344 1.069 . . . . 0.46000000000000002 112.266 -169.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.753 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -100.98 130.53 46.99 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 113.023 -1.899 . . . . 1.76 110.309 -177.01 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.679 HD11 HG12 ' A' ' 77' ' ' ILE . 34.3 tp -131.84 131.79 43.14 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.574 -0.528 . . . . 1.1200000000000001 109.574 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.98 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 15.3 tp -105.46 129.31 53.79 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 105.412 -2.07 . . . . 0.41999999999999998 105.412 172.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.743 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -140.97 146.5 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 C-N-CA 119.916 -0.714 . . . . 0.77000000000000002 110.267 -173.596 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.805 HG23 HG12 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -92.36 125.73 37.14 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.566 0.698 . . . . 0.34000000000000002 111.077 172.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.59 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 34.6 ttt180 -111.45 146.81 36.56 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.224 -1.353 . . . . 2.0099999999999998 110.958 -172.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.5 -105.66 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.637 -0.71 . . . . 1.97 111.232 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.7 t -136.15 36.34 2.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.2 0.524 . . . . 1.6200000000000001 111.708 -171.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.551 ' HB2' ' HG3' ' A' ' 72' ' ' GLN . 2.9 mt . . . . . 0 C--N 1.319 -0.734 0 CA-C-O 121.41 0.624 . . . . 1.6499999999999999 110.372 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.431 -1.407 0 CA-C-O 122.462 1.125 . . . . 2.0899999999999999 108.79 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.522 ' HB1' ' O ' ' A' ' 111' ' ' ARG . . . -65.73 174.08 2.52 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.09 -1.868 . . . . 0.95999999999999996 111.716 176.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.42 119.98 58.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.882 -1.053 . . . . 1.5700000000000001 110.041 -175.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.528 HG22 HG23 ' A' ' 110' ' ' THR . 94.0 t -76.29 106.64 6.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 122.035 0.921 . . . . 1.02 111.532 -175.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.656 ' NE2' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -100.27 138.15 37.73 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.642 -1.617 . . . . 1.3899999999999999 110.66 177.381 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.594 ' HG2' ' HA ' ' A' ' 108' ' ' LEU . 3.3 tmm_? -124.7 121.1 33.72 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 120.869 -1.144 . . . . 3.6299999999999999 109.914 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.935 ' HB ' ' HB1' ' A' ' 69' ' ' ALA . 4.1 m -113.38 155.64 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 119.626 -0.83 . . . . 1.02 110.199 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -144.63 126.75 15.59 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.332 -0.849 . . . . 1.3500000000000001 109.145 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.559 HG12 ' HB2' ' A' ' 65' ' ' PRO . 7.8 tp -146.07 143.35 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 C-N-CA 119.728 -0.789 . . . . 0.60999999999999999 109.58 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.716 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.9 m-70 -72.6 112.11 8.37 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.735 -0.666 . . . . 0.59999999999999998 109.455 -176.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.805 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -31.58 135.69 0.06 Allowed 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.329 1.018 . . . . 4.0 113.331 178.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.0 tp -100.71 98.61 9.13 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.197 0.523 . . . . 0.55000000000000004 110.509 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -71.4 142.48 50.3 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.653 -0.703 . . . . 3.9700000000000002 111.124 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.512 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -135.0 95.07 3.24 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.525 -0.762 . . . . 1.3500000000000001 109.398 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.27 -81.85 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.362 -0.923 . . . . 1.3300000000000001 112.14 -177.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -138.09 12.0 2.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.043 0.449 . . . . 2.3300000000000001 111.357 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.512 ' OD1' ' HB3' ' A' ' 23' ' ' GLN . 1.5 p30 -127.05 171.06 11.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.063 -0.517 . . . . 1.8700000000000001 110.715 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.475 HD21 ' HG2' ' A' ' 102' ' ' GLU . 10.3 mp -122.09 123.81 42.44 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.988 0.423 . . . . 2.2799999999999998 110.619 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.442 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.7 mp -99.13 135.6 33.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.959 -0.564 . . . . 0.80000000000000004 110.003 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.763 HD22 HD22 ' A' ' 97' ' ' LEU . 9.6 mt -86.8 -35.19 19.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.36 -0.837 . . . . 1.74 110.717 -174.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.87 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 89.87 10.48 64.76 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 115.321 -0.854 . . . . 0.68999999999999995 110.967 -172.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.751 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 25.7 p90 -156.84 160.35 39.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 122.342 0.257 . . . . 0.51000000000000001 110.793 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.534 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 22.1 t -104.1 160.7 14.63 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.77 -1.196 . . . . 0.53000000000000003 107.77 170.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.42 ' HA ' ' H ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -161.19 138.99 2.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 120.253 -0.579 . . . . 0.48999999999999999 112.561 -165.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -142.53 117.89 1.2 Allowed Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 110.431 -1.067 . . . . 0.71999999999999997 110.431 156.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 1.065 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -140.15 117.28 1.28 Allowed Glycine 0 CA--C 1.49 -1.524 0 CA-C-O 118.927 -0.929 . . . . 1.4199999999999999 111.518 171.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.711 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -165.41 144.46 9.29 Favored Glycine 0 C--N 1.3 -1.46 0 C-N-CA 118.17 -1.966 . . . . 0.47999999999999998 112.77 175.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.563 HG23 ' HA ' ' A' ' 87' ' ' MET . 8.8 pt -61.23 -20.64 22.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 107.577 -1.268 . . . . 0.52000000000000002 107.577 153.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.661 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 3.8 t70 -61.33 -37.87 84.84 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.239 -1.801 . . . . 0.71999999999999997 110.747 174.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 . . . . . 0 CA--C 1.534 0.354 0 CA-C-N 115.369 -0.832 . . . . 1.1899999999999999 112.658 -169.079 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.634 ' HA2' ' O ' ' A' ' 86' ' ' THR . . . . . . . . 0 N--CA 1.441 -1.016 0 N-CA-C 110.895 -0.882 . . . . 0.78000000000000003 110.895 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.065 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -106.53 146.44 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 106.522 -1.658 . . . . 0.54000000000000004 106.522 169.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.679 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -153.51 141.5 20.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 119.613 1.097 . . . . 1.4199999999999999 111.072 178.706 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.789 HG12 ' H ' ' A' ' 75' ' ' ASP . 2.5 p -81.5 132.39 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 CA-C-N 114.392 -1.276 . . . . 0.57999999999999996 109.374 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.42 ' H ' ' HA ' ' A' ' 33' ' ' ILE . 27.8 m -100.18 -18.52 16.86 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.075 -0.966 . . . . 1.1100000000000001 110.294 -173.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.816 ' HA ' HG23 ' A' ' 73' ' ' ILE . 50.5 mtt180 -146.34 -168.07 2.91 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.333 0.587 . . . . 2.27 112.022 174.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.605 HG13 ' HB3' ' A' ' 66' ' ' ALA . 75.4 t -166.33 146.75 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 113.003 -1.908 . . . . 0.82999999999999996 106.218 165.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.4 p -95.47 133.32 39.58 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.359 0.6 . . . . 1.6499999999999999 111.519 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -64.83 115.03 4.9 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.456 -1.247 . . . . 1.8500000000000001 110.138 171.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.88 -16.81 59.74 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 114.983 -1.008 . . . . 0.92000000000000004 112.171 -177.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.516 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -77.25 172.16 55.13 Favored Glycine 0 CA--C 1.502 -0.755 0 C-N-CA 120.588 -0.815 . . . . 0.98999999999999999 111.551 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.87 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 60.0 Cg_endo -73.27 -28.1 12.85 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.273 1.982 . . . . 0.44 113.214 -166.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.751 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -58.75 -32.97 69.74 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.269 -0.878 . . . . 0.35999999999999999 111.922 172.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -77.61 -28.94 51.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.558 0.694 . . . . 1.79 109.648 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.516 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -71.28 -41.15 74.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.199 -0.909 . . . . 0.51000000000000001 108.888 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.935 ' HB1' ' HB ' ' A' ' 16' ' ' VAL . . . -69.54 -31.2 69.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.249 -0.887 . . . . 0.40999999999999998 110.055 175.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.31 52.24 1.16 Allowed Glycine 0 CA--C 1.521 0.414 0 C-N-CA 121.043 -0.599 . . . . 0.45000000000000001 113.66 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.515 HD21 HG21 ' A' ' 57' ' ' VAL . 19.8 tp -102.46 155.74 18.06 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.254 -0.647 . . . . 0.89000000000000001 109.254 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.657 HE22 ' HG3' ' A' ' 111' ' ' ARG . 7.2 mt-30 -126.34 29.59 5.76 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 115.778 1.77 . . . . 1.21 115.778 -163.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.816 HG23 ' HA ' ' A' ' 59' ' ' ARG . 53.9 mt 72.52 1.58 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-N 119.102 0.864 . . . . 0.77000000000000002 113.026 166.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -172.24 51.41 0.17 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 119.668 -1.253 . . . . 0.37 113.118 -171.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.789 ' H ' HG12 ' A' ' 57' ' ' VAL . 21.1 m-20 -122.08 142.55 50.25 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.595 -0.302 . . . . 0.89000000000000001 111.736 -172.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.64 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 59.3 mttm -82.76 130.57 35.15 Favored 'General case' 0 C--O 1.207 -1.163 0 CA-C-O 121.138 0.494 . . . . 2.2000000000000002 109.668 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.679 HD12 ' HA ' ' A' ' 56' ' ' TYR . 2.8 mp -99.8 125.22 53.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 C-N-CA 122.689 0.396 . . . . 0.48999999999999999 110.562 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.768 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 7.5 mmt -90.81 -17.17 27.04 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 125.099 1.499 . . . . 1.0600000000000001 112.941 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -163.99 151.48 12.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.041 0.448 . . . . 0.81999999999999995 112.128 -175.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.578 ' HB ' ' HE1' ' A' ' 85' ' ' MET . 39.5 t -130.51 105.07 10.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.344 -0.844 . . . . 1.3100000000000001 110.38 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.673 HD21 HG13 ' A' ' 105' ' ' VAL . 27.2 m-80 49.48 46.95 23.1 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.751 -0.659 . . . . 1.5 111.997 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.03 -15.17 61.93 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.337 -0.935 . . . . 0.38 112.978 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -85.58 170.16 12.85 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 109.782 -0.451 . . . . 0.77000000000000002 109.782 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -115.92 112.47 21.94 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.114 0.483 . . . . 1.8899999999999999 111.39 -172.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.578 ' HE1' ' HB ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -107.11 100.5 9.97 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.136 0.969 . . . . 1.01 110.922 -179.257 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.634 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 1.1 p -132.03 -58.38 0.96 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.939 -1.482 . . . . 1.05 107.408 170.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.563 ' HA ' HG23 ' A' ' 37' ' ' ILE . 1.3 mtt -125.36 79.33 1.8 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.642 -1.617 . . . . 1.6200000000000001 108.563 172.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.711 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.2 t -139.25 137.28 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 115.351 -0.841 . . . . 1.0900000000000001 108.879 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.661 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 79.3 p -56.78 152.6 12.16 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.333 0.587 . . . . 0.34999999999999998 112.529 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.766 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 21.0 t-160 -57.11 -38.18 73.03 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 115.552 -0.749 . . . . 0.34999999999999998 110.395 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.57 -32.05 69.29 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.491 -1.231 . . . . 1.6699999999999999 109.877 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.639 ' HB3' HG13 ' A' ' 88' ' ' VAL . 1.0 OUTLIER -65.7 -45.05 84.25 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 109.088 -0.708 . . . . 0.77000000000000002 109.088 -177.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.66 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -74.91 -37.41 62.08 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.173 -0.922 . . . . 0.33000000000000002 110.565 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.406 ' HD3' HH11 ' A' ' 94' ' ' ARG . 29.6 ttp180 -65.05 -37.53 87.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.048 -0.524 . . . . 2.1000000000000001 110.356 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.518 ' HE3' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -70.98 -40.79 71.71 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.631 -0.713 . . . . 0.95999999999999996 110.175 -177.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 13.1 mmm180 -69.06 -27.71 65.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.2 0.524 . . . . 3.5699999999999998 110.564 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.763 HD22 HD22 ' A' ' 29' ' ' LEU . 2.3 tt -78.59 -48.06 15.93 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.452 -0.795 . . . . 1.6499999999999999 110.426 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.4 HG23 ' HB2' ' A' ' 27' ' ' LEU . 2.3 m -108.74 70.24 0.74 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.51 -0.768 . . . . 1.53 110.389 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.518 ' HB2' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -108.98 8.9 26.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.661 0.743 . . . . 2.7200000000000002 110.839 -176.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 75.8 mtp180 73.0 20.41 3.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.622 -1.172 . . . . 4.3799999999999999 112.681 173.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.7 p -71.28 -46.02 61.82 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.457 -0.572 . . . . 2.5099999999999998 109.457 174.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.475 ' HG2' HD21 ' A' ' 27' ' ' LEU . 35.6 mt-10 68.18 6.06 5.03 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.148 -0.933 . . . . 3.3999999999999999 113.067 169.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.444 ' HG3' ' H ' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -70.58 -68.47 0.43 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.67 0.748 . . . . 2.6800000000000002 109.767 174.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.716 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 4.8 p -159.58 156.14 3.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.816 -1.084 . . . . 0.44 108.52 -176.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.723 HG21 ' HG2' ' A' ' 20' ' ' LYS . 3.1 t -132.11 119.88 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-O 121.958 0.885 . . . . 0.46000000000000002 112.968 -177.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.576 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 1.2 mpt_? -100.31 130.75 46.45 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.393 -1.731 . . . . 1.76 111.236 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.14 135.64 41.28 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.916 -0.314 . . . . 1.1200000000000001 110.592 172.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.768 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 26.2 tp -98.45 130.34 45.06 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 107.008 -1.479 . . . . 0.41999999999999998 107.008 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.592 HG13 ' HB3' ' A' ' 75' ' ' ASP . 2.2 t -128.32 142.53 43.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 121.611 0.719 . . . . 0.77000000000000002 111.317 -170.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.528 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -98.74 114.29 26.75 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.511 -0.768 . . . . 0.34000000000000002 109.973 164.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.657 ' HG3' HE22 ' A' ' 72' ' ' GLN . 20.1 ttt180 -98.68 146.52 25.78 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.102 -0.953 . . . . 2.0099999999999998 110.31 -175.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.471 ' N ' ' CD ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -136.22 -69.44 0.48 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.036 0.754 . . . . 1.97 113.036 -171.346 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.9 t -158.38 26.91 0.24 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.059 0.457 . . . . 1.6200000000000001 111.661 -173.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 4.0 mm? . . . . . 0 C--N 1.318 -0.781 0 N-CA-C 112.217 0.451 . . . . 1.6499999999999999 112.217 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.435 -1.207 0 CA-C-O 122.632 1.206 . . . . 2.0899999999999999 111.847 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.61 178.72 4.2 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.265 -1.789 . . . . 0.95999999999999996 110.09 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.6 t -120.49 117.17 52.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 116.081 -0.509 . . . . 1.5700000000000001 110.273 -174.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.705 HG22 HG23 ' A' ' 110' ' ' THR . 21.8 t -76.71 115.72 18.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.954 0.406 . . . . 1.02 109.942 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.999 HE22 HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -105.48 172.37 6.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.708 -0.678 . . . . 1.3899999999999999 110.637 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.629 ' NH1' ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -128.17 128.3 44.53 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.814 -0.175 . . . . 3.6299999999999999 110.919 172.41 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.999 HG23 HE22 ' A' ' 14' ' ' GLN . 24.2 t -102.08 132.54 47.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 110.196 -0.298 . . . . 1.02 110.196 173.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.629 ' HB2' ' NH1' ' A' ' 15' ' ' ARG . 10.1 tt0 -144.71 115.47 7.75 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.357 -0.238 . . . . 1.3500000000000001 110.357 171.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.545 HG12 ' HB2' ' A' ' 65' ' ' PRO . 9.0 tp -145.39 155.73 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 108.561 -0.903 . . . . 0.60999999999999999 108.561 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -83.39 116.59 22.56 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 119.711 -0.796 . . . . 0.59999999999999998 109.603 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -28.8 140.77 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.958 1.411 . . . . 4.0 112.441 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.431 HD22 ' HD3' ' A' ' 65' ' ' PRO . 39.6 tp -97.1 102.9 14.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.173 0.511 . . . . 0.55000000000000004 110.24 -173.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 12.3 ptp180 -71.11 141.17 50.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.571 -0.74 . . . . 3.9700000000000002 111.887 -175.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.567 ' HG3' HD13 ' A' ' 28' ' ' ILE . 6.7 mm-40 -132.66 92.28 3.04 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.398 -0.964 . . . . 1.3500000000000001 108.398 170.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.27 -68.29 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.053 -0.594 . . . . 1.3300000000000001 112.251 -173.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -147.08 12.42 1.08 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.45 0.643 . . . . 2.3300000000000001 109.829 -176.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.559 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 34.0 m-80 -112.17 161.77 16.18 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.276 -0.875 . . . . 1.8700000000000001 110.534 -174.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.79 ' HB2' HG23 ' A' ' 98' ' ' THR . 10.9 mp -121.93 113.07 19.09 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.758 -0.831 . . . . 2.2799999999999998 108.758 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.567 HD13 ' HG3' ' A' ' 23' ' ' GLN . 1.2 mp -97.88 133.43 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 CA-C-O 121.311 0.577 . . . . 0.80000000000000004 109.996 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.474 HD22 HD22 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -77.18 -41.29 42.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.647 -1.161 . . . . 1.74 109.832 -173.13 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.685 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 94.17 9.5 59.3 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.191 -0.913 . . . . 0.68999999999999995 111.036 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 31.0 p90 -156.18 177.51 11.35 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 122.659 0.384 . . . . 0.51000000000000001 110.299 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.445 ' H ' ' HB2' ' A' ' 59' ' ' ARG . 15.9 t -114.45 161.23 18.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.619 -1.252 . . . . 0.53000000000000003 107.619 169.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -161.45 136.09 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 112.6 0.593 . . . . 0.48999999999999999 112.6 -167.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.474 ' HA2' ' CD2' ' A' ' 90' ' ' HIS . . . -143.82 118.72 1.22 Allowed Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 110.518 -1.033 . . . . 0.71999999999999997 110.518 156.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 1.101 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -139.19 116.54 1.25 Allowed Glycine 0 CA--C 1.492 -1.36 0 CA-C-O 118.982 -0.899 . . . . 1.4199999999999999 111.148 172.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.52 140.4 6.24 Favored Glycine 0 C--N 1.3 -1.465 0 C-N-CA 118.139 -1.982 . . . . 0.47999999999999998 112.659 177.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.6 pt -58.26 -22.51 19.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 107.42 -1.326 . . . . 0.52000000000000002 107.42 151.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.796 ' HB2' ' CB ' ' A' ' 89' ' ' THR . 13.0 t70 -57.97 -43.71 86.64 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 113.223 -1.808 . . . . 0.71999999999999997 111.435 173.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 . . . . . 0 N--CA 1.466 0.349 0 CA-C-N 115.402 -0.817 . . . . 1.1899999999999999 112.629 -168.058 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.432 ' C ' HD12 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.422 -2.247 0 N-CA-C 108.813 -1.715 . . . . 0.78000000000000003 108.813 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.101 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -113.92 141.45 29.99 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 CA-C-N 118.935 1.368 . . . . 0.54000000000000004 109.002 173.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.585 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -142.64 142.25 32.05 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 119.036 0.834 . . . . 1.4199999999999999 110.791 -178.09 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.879 HG21 HD21 ' A' ' 71' ' ' LEU . 1.4 p -82.66 143.48 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-N 114.848 -1.069 . . . . 0.57999999999999996 109.66 178.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.9 m -110.87 -17.6 13.29 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 124.191 0.932 . . . . 1.1100000000000001 111.454 -173.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.452 ' CA ' ' HA ' ' A' ' 73' ' ' ILE . 78.7 mtt180 -152.56 -166.31 2.44 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.953 0.882 . . . . 2.27 112.097 175.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 8.7 p -173.35 139.58 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 112.982 -1.917 . . . . 0.82999999999999996 107.529 164.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.6 m -109.05 136.89 47.82 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.474 0.654 . . . . 1.6499999999999999 111.196 -173.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.37 125.93 26.2 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.555 -1.202 . . . . 1.8500000000000001 110.777 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.54 -18.02 58.02 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 114.671 -1.15 . . . . 0.92000000000000004 111.253 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.453 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -78.95 167.68 52.87 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.385 -0.912 . . . . 0.98999999999999999 111.016 174.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.685 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 91.3 Cg_endo -75.95 -19.33 16.03 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 122.861 2.374 . . . . 0.44 113.912 -169.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.536 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -73.05 -26.71 61.39 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.962 -1.017 . . . . 0.35999999999999999 111.695 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -72.88 -29.98 63.6 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.458 -0.941 . . . . 1.79 108.458 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.481 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.4 mp -77.85 -35.4 20.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.689 -1.141 . . . . 0.51000000000000001 110.095 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.794 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -81.66 -14.23 56.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.454 -0.794 . . . . 0.40999999999999998 111.504 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.0 60.48 1.19 Allowed Glycine 0 CA--C 1.522 0.473 0 C-N-CA 119.291 -1.433 . . . . 0.45000000000000001 114.314 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.879 HD21 HG21 ' A' ' 57' ' ' VAL . 35.2 tp -123.81 156.74 35.57 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.457 -0.572 . . . . 0.89000000000000001 109.457 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.84 ' HG3' ' HB2' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -148.9 81.12 1.43 Allowed 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 115.532 1.678 . . . . 1.21 115.532 -177.144 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.539 HG13 HG12 ' A' ' 60' ' ' VAL . 4.2 mp 62.82 -22.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 117.001 2.223 . . . . 0.77000000000000002 117.001 158.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -162.53 61.46 0.27 Allowed Glycine 0 CA--C 1.506 -0.51 0 O-C-N 120.732 -1.23 . . . . 0.37 112.194 -167.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.766 ' H ' HG12 ' A' ' 57' ' ' VAL . 61.7 m-20 -121.88 152.05 40.02 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.356 -0.422 . . . . 0.89000000000000001 110.668 -167.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.63 ' HD2' ' N ' ' A' ' 76' ' ' LYS . 3.7 mptt -103.8 101.61 11.43 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.79 0.805 . . . . 2.2000000000000002 109.548 -173.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 1.02 HG13 HG23 ' A' ' 109' ' ' VAL . 3.3 mp -71.22 121.71 21.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 114.523 -1.217 . . . . 0.48999999999999999 111.392 -176.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.858 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 1.4 mmt -89.05 -17.9 28.4 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 125.843 1.965 . . . . 1.0600000000000001 111.215 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -172.12 153.25 3.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.808 0.337 . . . . 0.81999999999999995 111.74 -175.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.556 HG12 ' HE1' ' A' ' 85' ' ' MET . 9.8 p -139.66 125.31 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 121.323 0.583 . . . . 1.3100000000000001 109.87 175.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.927 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 13.0 m120 52.44 28.89 6.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.225 -0.898 . . . . 1.5 112.529 175.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.48 -16.64 44.44 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.093 -1.051 . . . . 0.38 113.309 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -87.56 148.58 24.81 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 109.475 -0.565 . . . . 0.77000000000000002 109.475 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -96.63 117.99 32.15 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.345 0.593 . . . . 1.8899999999999999 111.305 -174.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.556 ' HE1' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -106.71 102.33 11.71 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.834 0.826 . . . . 1.01 111.355 -178.503 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 p -123.16 -38.38 2.59 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.805 -1.088 . . . . 1.05 108.433 167.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.38 76.95 1.23 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.21 -1.359 . . . . 1.6200000000000001 109.255 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.65 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.5 OUTLIER -138.12 151.61 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 108.966 -0.753 . . . . 1.0900000000000001 108.966 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.796 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 75.2 p -60.51 151.45 28.48 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 112.888 0.699 . . . . 0.34999999999999998 112.888 -175.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.743 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 18.0 t-160 -57.71 -41.36 81.57 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 115.588 -0.733 . . . . 0.34999999999999998 110.467 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.65 -30.1 67.71 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.188 -1.369 . . . . 1.6699999999999999 109.964 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.553 ' HB3' HG13 ' A' ' 88' ' ' VAL . 2.4 tp-100 -62.55 -49.59 74.67 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.691 0.758 . . . . 0.77000000000000002 109.467 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.54 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -73.92 -31.88 63.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.988 -1.005 . . . . 0.33000000000000002 110.116 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -71.02 -41.8 70.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.411 -0.813 . . . . 2.1000000000000001 111.004 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.559 ' HD3' ' HD2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -71.42 -30.8 66.5 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 119.773 -0.771 . . . . 0.95999999999999996 109.873 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.559 ' HD2' ' HD3' ' A' ' 95' ' ' LYS . 2.4 mmm180 -67.41 -37.6 83.32 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.003 -0.679 . . . . 3.5699999999999998 110.954 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.496 HD11 ' CZ ' ' A' ' 31' ' ' PHE . 4.6 tt -58.68 -55.34 36.34 Favored 'General case' 0 C--N 1.316 -0.859 0 O-C-N 124.232 0.958 . . . . 1.6499999999999999 110.062 173.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.79 HG23 ' HB2' ' A' ' 27' ' ' LEU . 36.9 m -108.18 -94.96 0.39 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.789 -0.641 . . . . 1.53 112.55 -174.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 99' ' ' LYS . 0.3 OUTLIER 64.52 2.74 1.68 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.315 1.055 . . . . 2.7200000000000002 110.963 -175.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.699 ' H ' HG22 ' A' ' 98' ' ' THR . 41.6 mtm180 57.54 57.95 4.04 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.061 -1.427 . . . . 4.3799999999999999 110.862 -177.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.2 t -155.11 -48.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.27 -0.572 . . . . 2.5099999999999998 112.01 -175.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -53.83 135.44 41.86 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.044 0.449 . . . . 3.3999999999999999 112.026 -174.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -89.0 -16.14 32.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.47 0.652 . . . . 2.6800000000000002 110.54 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.7 p -152.47 148.54 14.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 108.39 -0.967 . . . . 0.44 108.39 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.0 t -114.42 117.61 56.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 122.229 1.014 . . . . 0.46000000000000002 112.621 -173.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.927 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.2 OUTLIER -101.3 124.9 47.72 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 113.411 -1.722 . . . . 1.76 110.681 -176.367 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.971 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 25.3 tp -132.74 126.73 33.12 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.398 -0.364 . . . . 1.1200000000000001 110.755 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.858 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 33.1 tp -109.96 115.94 30.71 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.105 -1.443 . . . . 0.41999999999999998 107.105 172.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 1.02 HG23 HG13 ' A' ' 77' ' ' ILE . 0.5 OUTLIER -128.23 149.51 33.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 121.397 0.617 . . . . 0.77000000000000002 110.591 -173.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.705 HG23 HG22 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -97.57 114.7 26.66 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.584 -0.734 . . . . 0.34000000000000002 109.61 168.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -99.16 139.03 35.42 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.281 -0.872 . . . . 2.0099999999999998 109.696 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.16 -73.08 0.65 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.854 0.359 . . . . 1.97 110.441 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.5 t 177.43 73.27 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.775 0.798 . . . . 1.6200000000000001 110.723 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.84 ' HB2' ' HG3' ' A' ' 72' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.312 -1.064 0 CA-C-N 114.677 -1.147 . . . . 1.6499999999999999 108.757 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.448 -0.55 0 CA-C-O 123.485 1.612 . . . . 2.0899999999999999 111.081 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.29 148.29 23.28 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 111.99 -2.368 . . . . 0.95999999999999996 108.0 168.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -95.42 130.38 44.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 121.185 0.517 . . . . 1.5700000000000001 111.133 -173.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.745 HG22 HG23 ' A' ' 110' ' ' THR . 44.9 t -83.36 110.92 18.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.327 0.585 . . . . 1.02 110.556 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.71 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -119.45 163.04 17.85 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.426 -0.807 . . . . 1.3899999999999999 109.757 175.145 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.475 ' HB3' ' CD1' ' A' ' 108' ' ' LEU . 2.3 ppt_? -127.08 124.45 39.27 Favored 'General case' 0 C--N 1.31 -1.113 0 O-C-N 121.491 -0.755 . . . . 3.6299999999999999 111.649 -174.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.735 HG13 ' CB ' ' A' ' 69' ' ' ALA . 9.6 t -90.85 125.2 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-N 115.255 -0.884 . . . . 1.02 110.23 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -123.86 114.32 19.69 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.926 -0.398 . . . . 1.3500000000000001 109.926 175.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.85 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 11.1 tp -144.57 137.12 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 109.108 -0.701 . . . . 0.60999999999999999 109.108 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.99 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 15.0 m-70 -65.27 115.91 6.06 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.887 -0.597 . . . . 0.59999999999999998 110.263 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.658 ' CG ' HD12 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -33.23 126.99 0.34 Allowed 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.364 1.04 . . . . 4.0 110.056 172.349 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.2 tp -103.58 79.59 1.7 Allowed 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 118.978 -1.089 . . . . 0.55000000000000004 111.398 -163.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.985 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 15.1 ptt-85 -60.87 136.18 58.0 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.481 -0.781 . . . . 3.9700000000000002 110.947 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.56 ' HB2' HG12 ' A' ' 28' ' ' ILE . 6.0 tp-100 -122.11 94.44 4.3 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.212 -0.904 . . . . 1.3500000000000001 109.069 -174.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.24 -89.19 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.82 -0.705 . . . . 1.3300000000000001 112.211 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -115.97 -6.54 11.99 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.477 0.656 . . . . 2.3300000000000001 110.786 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.52 -178.08 3.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.384 -0.825 . . . . 1.8700000000000001 109.078 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.985 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.4 pt? -130.69 144.46 51.45 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.107 -1.071 . . . . 2.2799999999999998 108.107 167.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.56 HG12 ' HB2' ' A' ' 23' ' ' GLN . 11.6 mm -101.27 130.85 50.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-O 121.417 0.627 . . . . 0.80000000000000004 111.374 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.758 HD11 HD21 ' A' ' 97' ' ' LEU . 13.1 tp -74.18 -58.22 3.44 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.474 -1.239 . . . . 1.74 109.917 175.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.953 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 100.96 -0.13 55.04 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.316 -0.945 . . . . 0.68999999999999995 113.019 173.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.602 ' HD1' ' HB2' ' A' ' 66' ' ' ALA . 29.6 p90 -157.49 163.4 38.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.147 0.474 . . . . 0.51000000000000001 110.865 175.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.557 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 35.6 t -102.74 160.74 14.32 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.038 -1.097 . . . . 0.53000000000000003 108.038 173.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -161.77 141.77 2.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 C-N-CA 120.665 -0.414 . . . . 0.48999999999999999 111.99 -166.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.409 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -144.97 118.75 1.15 Allowed Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.361 -0.923 . . . . 0.71999999999999997 110.882 158.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 1.028 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -139.7 118.17 1.45 Allowed Glycine 0 CA--C 1.489 -1.539 0 CA-C-O 118.546 -1.141 . . . . 1.4199999999999999 110.49 172.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 1.013 ' HA3' ' HG2' ' A' ' 39' ' ' GLN . . . -156.18 117.05 0.75 Allowed Glycine 0 N--CA 1.434 -1.469 0 C-N-CA 117.909 -2.091 . . . . 0.47999999999999998 114.187 -171.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.598 HG23 ' O ' ' A' ' 87' ' ' MET . 5.1 pt -61.91 -26.61 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 104.798 -2.297 . . . . 0.52000000000000002 104.798 146.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.987 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 7.1 t70 -55.31 -47.78 75.09 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 112.052 -2.34 . . . . 0.71999999999999997 109.627 170.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 1.013 ' HG2' ' HA3' ' A' ' 36' ' ' GLY . 19.2 mm-40 . . . . . 0 C--N 1.345 0.407 0 CA-C-N 114.821 -1.081 . . . . 1.1899999999999999 111.374 -172.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 86' ' ' THR . . . . . . . . 0 N--CA 1.444 -0.772 0 N-CA-C 109.989 -1.244 . . . . 0.78000000000000003 109.989 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.028 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -108.33 146.07 14.61 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.855 0 CA-C-N 119.331 1.565 . . . . 0.54000000000000004 108.413 172.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.775 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -153.63 143.02 21.61 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.898 0.856 . . . . 1.4199999999999999 111.44 178.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.578 HG12 ' H ' ' A' ' 75' ' ' ASP . 8.4 p -83.11 127.96 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 CA-C-N 113.907 -1.497 . . . . 0.57999999999999996 110.229 -177.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.2 m -94.88 -19.25 20.44 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.68 -1.145 . . . . 1.1100000000000001 111.206 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.963 ' HA ' HG23 ' A' ' 73' ' ' ILE . 25.7 mtp180 -150.4 -165.15 2.19 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.92 0.711 . . . . 2.27 112.92 177.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 91.9 t -156.01 138.71 6.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 112.756 -2.02 . . . . 0.82999999999999996 107.202 161.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.1 m -94.9 121.58 36.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.226 0.536 . . . . 1.6499999999999999 110.217 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -52.74 127.6 23.75 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.531 -1.213 . . . . 1.8500000000000001 111.869 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.14 -4.38 84.54 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.614 -0.803 . . . . 0.92000000000000004 112.466 174.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.601 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -82.82 -153.2 12.53 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.256 -0.973 . . . . 0.98999999999999999 110.95 173.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.953 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 40.4 Cg_endo -94.72 -33.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.081 1.854 . . . . 0.44 115.018 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.602 ' HB2' ' HD1' ' A' ' 31' ' ' PHE . . . -66.72 -25.54 66.57 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.073 0.463 . . . . 0.35999999999999999 111.837 -174.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -72.78 -30.83 64.43 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.758 0.79 . . . . 1.79 108.923 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.601 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -78.03 -41.89 27.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.64 -1.164 . . . . 0.51000000000000001 110.751 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.85 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . . . -72.55 -20.17 61.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.291 -0.413 . . . . 0.40999999999999998 110.736 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.43 64.58 1.02 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.279 -0.963 . . . . 0.45000000000000001 113.445 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.0 tp -109.45 149.28 29.79 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.151 -0.685 . . . . 0.89000000000000001 109.151 175.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 1.069 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 30.3 mt-30 -115.05 23.74 12.28 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 115.031 1.493 . . . . 1.21 115.031 -164.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.963 HG23 ' HA ' ' A' ' 59' ' ' ARG . 62.1 mt 69.51 2.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 CA-C-N 118.761 0.709 . . . . 0.77000000000000002 112.477 168.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.71 46.77 0.21 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.268 -0.968 . . . . 0.37 112.4 -168.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.578 ' H ' HG12 ' A' ' 57' ' ' VAL . 49.0 m-20 -120.89 152.9 37.88 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.614 -0.514 . . . . 0.89000000000000001 109.614 -172.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.682 ' HD2' ' N ' ' A' ' 76' ' ' LYS . 8.9 mptt -102.29 122.75 44.83 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.822 -0.807 . . . . 2.2000000000000002 108.822 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.775 HD12 ' HA ' ' A' ' 56' ' ' TYR . 4.2 mp -91.6 134.27 30.54 Favored 'Isoleucine or valine' 0 C--O 1.264 1.851 0 CA-C-O 121.168 0.508 . . . . 0.48999999999999999 112.176 -172.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.698 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 0.9 OUTLIER -92.43 -25.68 18.36 Favored 'General case' 0 C--N 1.346 0.452 0 O-C-N 126.381 2.3 . . . . 1.0600000000000001 112.442 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.67 ' HA ' ' HG2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -170.77 156.02 4.98 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.281 0.475 . . . . 0.81999999999999995 112.281 -172.347 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.653 HG12 ' HE3' ' A' ' 85' ' ' MET . 6.4 p -143.14 127.51 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.095 -0.502 . . . . 1.3100000000000001 110.317 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.46 ' N ' HD22 ' A' ' 81' ' ' ASN . 0.9 OUTLIER 59.39 19.87 8.16 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.888 -0.597 . . . . 1.5 111.929 176.046 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.79 -6.21 58.59 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 119.96 -1.114 . . . . 0.38 112.262 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -83.13 124.18 30.24 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-O 121.332 0.587 . . . . 0.77000000000000002 109.825 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -86.13 96.74 9.99 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.536 -1.211 . . . . 1.8899999999999999 110.084 -177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.67 ' HG2' ' HA ' ' A' ' 79' ' ' GLN . 3.9 ptp -109.41 102.39 11.29 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.129 0.966 . . . . 1.01 111.534 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.435 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 4.6 p -101.91 -33.89 9.59 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.236 -1.347 . . . . 1.05 109.115 176.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.598 ' O ' HG23 ' A' ' 37' ' ' ILE . 1.7 mtt -129.03 -16.07 4.13 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 113.88 -1.509 . . . . 1.6200000000000001 110.042 -176.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.626 ' O ' HD11 ' A' ' 55' ' ' ILE . 2.1 t -40.6 150.59 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 C-N-CA 125.726 1.61 . . . . 1.0900000000000001 115.222 -167.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.987 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 47.7 p -60.25 150.44 30.24 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.778 -0.576 . . . . 0.34999999999999998 111.637 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.783 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 21.9 t-160 -61.49 -33.69 74.21 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-N 115.975 -0.557 . . . . 0.34999999999999998 109.886 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.94 -33.98 68.66 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.687 -1.142 . . . . 1.6699999999999999 109.546 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.584 ' HB3' HG13 ' A' ' 88' ' ' VAL . 2.0 tp-100 -68.66 -46.56 68.81 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.402 -0.962 . . . . 0.77000000000000002 108.402 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.556 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -66.68 -37.94 85.77 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.92 -1.036 . . . . 0.33000000000000002 109.866 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 90' ' ' HIS . 27.6 ttp-105 -71.13 -43.64 67.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.626 -0.716 . . . . 2.1000000000000001 110.814 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.503 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -69.39 -43.01 74.37 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 116.109 -0.496 . . . . 0.95999999999999996 110.467 -177.664 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 28.2 mmt180 -72.08 -23.37 61.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.237 0.541 . . . . 3.5699999999999998 110.555 -178.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.758 HD21 HD11 ' A' ' 29' ' ' LEU . 7.2 tp -78.57 -57.47 3.75 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.261 -0.881 . . . . 1.6499999999999999 112.167 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.729 ' OG1' HD13 ' A' ' 29' ' ' LEU . 35.8 m -124.95 91.65 3.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.586 0.708 . . . . 1.53 110.872 -174.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.639 ' HG2' ' OE1' ' A' ' 102' ' ' GLU . 7.0 ptpp? -122.08 7.93 9.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.379 -0.828 . . . . 2.7200000000000002 112.831 -176.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.905 ' HA ' HD13 ' A' ' 27' ' ' LEU . 26.3 mtm180 67.07 16.5 10.31 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.75 -0.659 . . . . 4.3799999999999999 111.057 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.489 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 28.0 m -124.74 21.59 8.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.985 0.421 . . . . 2.5099999999999998 111.441 -175.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.639 ' OE1' ' HG2' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -137.52 131.13 31.32 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.45 -0.341 . . . . 3.3999999999999999 110.358 179.068 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -85.98 -22.29 27.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.374 0.607 . . . . 2.6800000000000002 110.257 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.99 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 4.0 p -135.85 141.86 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.519 -0.764 . . . . 0.44 109.367 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.551 HG23 ' HB2' ' A' ' 20' ' ' LYS . 52.5 t -119.62 120.88 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-O 122.083 0.944 . . . . 0.46000000000000002 111.904 -172.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.406 ' CD ' ' N ' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -99.26 129.39 45.49 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.271 -1.786 . . . . 1.76 109.789 -179.053 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.592 HD11 HG12 ' A' ' 77' ' ' ILE . 21.1 tp -133.29 134.12 43.47 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.927 -0.579 . . . . 1.1200000000000001 109.643 -177.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.569 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 17.6 tp -110.23 124.51 51.74 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.682 -1.599 . . . . 0.41999999999999998 106.682 173.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.736 HG23 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -129.88 149.31 33.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 121.757 0.789 . . . . 0.77000000000000002 111.001 -171.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.745 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -98.04 114.71 26.95 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.355 -0.839 . . . . 0.34000000000000002 109.205 165.187 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.664 ' HG3' HE22 ' A' ' 72' ' ' GLN . 22.3 ttt180 -105.33 131.5 52.69 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.15 -0.932 . . . . 2.0099999999999998 110.498 -171.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.45 ' HG2' ' CD2' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -106.4 -89.67 0.43 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.39 -0.368 . . . . 1.97 111.845 -178.365 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.8 t -157.18 44.94 0.37 Allowed 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.168 -0.613 . . . . 1.6200000000000001 112.071 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 1.069 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.592 0 N-CA-C 108.801 -0.814 . . . . 1.6499999999999999 108.801 175.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.445 -0.688 0 CA-C-O 123.054 1.407 . . . . 2.0899999999999999 109.788 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -109.98 178.85 4.28 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 112.626 -2.079 . . . . 0.95999999999999996 110.583 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.8 t -110.18 149.07 13.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 108.894 -0.78 . . . . 1.5700000000000001 108.894 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.688 HG22 HG23 ' A' ' 110' ' ' THR . 34.8 t -103.69 112.7 38.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 120.315 -0.554 . . . . 1.02 110.956 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 1.022 HE22 HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -95.06 172.36 8.18 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.845 -0.616 . . . . 1.3899999999999999 110.345 176.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.527 ' HD3' ' O ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -127.21 127.14 43.99 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 116.718 -0.219 . . . . 3.6299999999999999 111.573 174.042 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.022 HG23 HE22 ' A' ' 14' ' ' GLN . 28.8 t -101.6 131.04 50.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.647 -0.501 . . . . 1.02 109.647 171.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 25.0 tt0 -145.68 112.96 6.19 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.699 -0.482 . . . . 1.3500000000000001 109.699 173.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.622 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 8.8 tp -142.63 145.64 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 C-N-CA 120.012 -0.675 . . . . 0.60999999999999999 109.281 -177.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.747 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 9.7 m-70 -75.66 112.73 12.32 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.207 -0.664 . . . . 0.59999999999999998 109.207 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.719 ' CE ' ' HB3' ' A' ' 27' ' ' LEU . 25.6 mmmt -31.59 137.18 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.463 1.102 . . . . 4.0 112.578 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.3 tp -96.97 99.74 11.27 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.596 -0.52 . . . . 0.55000000000000004 109.596 -173.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -92.83 144.74 24.98 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.671 0.748 . . . . 3.9700000000000002 112.481 -172.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.445 ' CG ' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -124.12 92.89 3.76 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.22 -1.4 . . . . 1.3500000000000001 107.22 170.166 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.85 -78.4 0.1 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.733 -0.746 . . . . 1.3300000000000001 111.95 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -138.11 10.09 2.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.533 0.683 . . . . 2.3300000000000001 110.503 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -107.94 118.74 37.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.238 -0.892 . . . . 1.8700000000000001 109.119 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.005 HD22 ' HA ' ' A' ' 100' ' ' ARG . 8.8 mp -105.14 113.95 27.84 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.498 0.666 . . . . 2.2799999999999998 110.437 -176.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.445 HD13 ' CG ' ' A' ' 23' ' ' GLN . 1.7 mp -94.97 141.46 15.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.831 -1.077 . . . . 0.80000000000000004 109.56 -173.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.91 -38.78 13.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.064 -0.516 . . . . 1.74 110.811 -174.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.685 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 88.78 15.2 60.0 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.268 -0.968 . . . . 0.68999999999999995 111.56 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.677 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 42.5 p90 -155.28 166.96 31.94 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 122.201 0.201 . . . . 0.51000000000000001 110.651 176.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.579 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 17.2 t -109.93 159.0 17.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.493 -1.299 . . . . 0.53000000000000003 107.493 170.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.418 HD12 HD21 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -161.26 138.08 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 C-N-CA 120.427 -0.509 . . . . 0.48999999999999999 112.238 -164.376 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.414 ' HA2' ' CD2' ' A' ' 90' ' ' HIS . . . -141.57 117.8 1.25 Allowed Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.172 -1.013 . . . . 0.71999999999999997 110.851 156.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 1.065 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -140.74 117.09 1.21 Allowed Glycine 0 CA--C 1.491 -1.417 0 CA-C-O 118.656 -1.08 . . . . 1.4199999999999999 111.067 170.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.666 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -164.15 145.67 10.64 Favored Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 117.429 -2.319 . . . . 0.47999999999999998 113.469 175.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.504 HG12 ' C ' ' A' ' 88' ' ' VAL . 34.1 pt -69.54 -11.53 14.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 107.282 -1.377 . . . . 0.52000000000000002 107.282 152.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.823 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 0.1 OUTLIER -70.61 -39.14 73.94 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 113.815 -1.538 . . . . 0.71999999999999997 109.852 172.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 . . . . . 0 N--CA 1.466 0.337 0 CA-C-N 115.188 -0.915 . . . . 1.1899999999999999 111.409 -172.241 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.985 0 N-CA-C 109.247 -1.541 . . . . 0.78000000000000003 109.247 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.065 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -110.83 138.03 40.7 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.113 0 CA-C-N 119.361 1.58 . . . . 0.54000000000000004 107.364 168.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.82 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -152.67 151.72 30.9 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 119.865 1.211 . . . . 1.4199999999999999 111.655 -177.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.787 HG12 ' H ' ' A' ' 75' ' ' ASP . 3.4 p -91.19 131.93 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-N 114.621 -1.172 . . . . 0.57999999999999996 109.862 -174.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.6 m -99.06 -16.16 18.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.157 -0.929 . . . . 1.1100000000000001 110.796 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.803 ' HA ' HG23 ' A' ' 73' ' ' ILE . 56.8 mtt180 -148.36 -167.04 2.7 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.553 0.692 . . . . 2.27 112.514 175.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 59' ' ' ARG . 75.7 t -163.68 117.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 112.46 -2.155 . . . . 0.82999999999999996 106.972 159.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.4 m -65.8 117.7 8.59 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.137 0.494 . . . . 1.6499999999999999 109.894 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -46.14 112.05 0.44 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.581 -1.191 . . . . 1.8500000000000001 112.394 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.24 -14.89 56.79 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.692 -0.766 . . . . 0.92000000000000004 112.607 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.517 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -76.55 172.71 54.65 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.219 -0.991 . . . . 0.98999999999999999 112.072 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.685 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 58.9 Cg_endo -68.91 -24.8 33.31 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 123.088 2.526 . . . . 0.44 113.158 -166.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.677 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -61.45 -36.32 80.05 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 114.783 -1.099 . . . . 0.35999999999999999 111.392 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -77.75 -29.57 51.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.428 0.632 . . . . 1.79 109.461 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.517 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -69.42 -37.48 75.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.241 -0.891 . . . . 0.51000000000000001 109.812 177.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.643 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -77.35 -23.01 50.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.025 -0.534 . . . . 0.40999999999999998 110.601 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.27 52.46 0.93 Allowed Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.387 -0.911 . . . . 0.45000000000000001 114.112 176.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.497 HD21 HG21 ' A' ' 57' ' ' VAL . 14.7 tp -106.52 148.0 28.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.597 -0.89 . . . . 0.89000000000000001 108.597 174.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.781 HE22 ' HG3' ' A' ' 111' ' ' ARG . 4.6 mt-30 -130.11 38.34 3.8 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 115.375 1.62 . . . . 1.21 115.375 -164.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.803 HG23 ' HA ' ' A' ' 59' ' ' ARG . 53.9 mt 72.22 -4.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 N-CA-C 114.186 1.18 . . . . 0.77000000000000002 114.186 163.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.28 45.03 0.23 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 119.22 -1.467 . . . . 0.37 112.277 -171.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.787 ' H ' HG12 ' A' ' 57' ' ' VAL . 20.9 m-20 -118.38 142.07 47.9 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 120.903 0.382 . . . . 0.89000000000000001 111.558 -169.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.82 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 45.0 mmtm -86.41 103.37 14.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.629 -0.714 . . . . 2.2000000000000002 110.566 -175.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.766 ' HB ' HG22 ' A' ' 55' ' ' ILE . 5.6 mt -74.4 128.82 36.76 Favored 'Isoleucine or valine' 0 C--O 1.259 1.587 0 C-N-CA 123.904 0.882 . . . . 0.48999999999999999 112.001 -177.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.731 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 3.8 mmt -93.66 -25.95 17.26 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.569 -1.651 . . . . 1.0600000000000001 112.234 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.529 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -160.28 156.88 27.13 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.61 -0.436 . . . . 0.81999999999999995 112.116 -173.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.522 HG12 ' CE ' ' A' ' 85' ' ' MET . 10.4 p -148.44 128.44 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.278 -0.638 . . . . 1.3100000000000001 109.278 175.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.479 ' OD1' ' HG3' ' A' ' 102' ' ' GLU . 0.9 OUTLIER 67.53 5.82 4.58 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.253 -0.431 . . . . 1.5 111.565 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.59 -7.54 53.7 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 119.882 -1.151 . . . . 0.38 111.403 -172.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -75.0 118.08 17.56 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.708 -0.849 . . . . 0.77000000000000002 108.708 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.424 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 0.5 OUTLIER -89.69 94.94 10.04 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.661 -0.7 . . . . 1.8899999999999999 109.594 -175.424 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.522 ' CE ' HG12 ' A' ' 80' ' ' VAL . 11.2 ptp -112.43 104.05 12.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.502 -0.772 . . . . 1.01 112.756 -172.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.1 p -96.86 -20.36 18.21 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 122.183 0.992 . . . . 1.05 108.773 170.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.87 81.65 0.65 Allowed 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.713 -1.585 . . . . 1.6200000000000001 110.26 -175.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.666 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.9 OUTLIER -140.49 162.57 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 108.519 -0.919 . . . . 1.0900000000000001 108.519 173.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.674 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 66.7 p -59.75 150.84 26.83 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 112.742 0.645 . . . . 0.34999999999999998 112.742 -175.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.823 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 16.2 t-160 -59.89 -35.57 75.11 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 121.743 0.782 . . . . 0.34999999999999998 109.855 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.4 -29.85 66.58 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 113.894 -1.503 . . . . 1.6699999999999999 109.64 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.557 ' HB3' ' O ' ' A' ' 89' ' ' THR . 3.4 tp-100 -63.77 -48.81 75.43 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.691 0.758 . . . . 0.77000000000000002 109.023 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.54 ' HB2' HG12 ' A' ' 55' ' ' ILE . . . -69.96 -39.29 76.1 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.905 -1.043 . . . . 0.33000000000000002 109.52 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -66.39 -42.24 88.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.083 -0.962 . . . . 2.1000000000000001 111.222 -175.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.567 ' HD3' ' HD2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -68.08 -31.08 70.45 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 119.91 -0.716 . . . . 0.95999999999999996 109.809 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.567 ' HD2' ' HD3' ' A' ' 95' ' ' LYS . 13.8 mmm180 -67.29 -47.44 70.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 120.706 -0.398 . . . . 3.5699999999999998 111.249 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 3.4 pp -83.39 0.96 43.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.35 -0.386 . . . . 1.6499999999999999 111.684 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.1 m -128.4 28.24 5.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.413 0.625 . . . . 1.53 111.33 173.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.936 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 1.3 mmpt? -82.04 118.79 23.28 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.752 -0.833 . . . . 2.7200000000000002 108.752 167.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 1.005 ' HA ' HD22 ' A' ' 27' ' ' LEU . 32.9 ptt180 -76.64 30.83 0.13 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.379 0.609 . . . . 4.3799999999999999 110.719 -177.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 99' ' ' LYS . 40.9 t -123.51 -30.61 3.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.453 -0.794 . . . . 2.5099999999999998 109.531 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.479 ' HG3' ' OD1' ' A' ' 81' ' ' ASN . 81.3 mm-40 -79.52 103.9 9.75 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.026 -0.534 . . . . 3.3999999999999999 110.01 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -71.94 -14.56 61.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.962 -0.563 . . . . 2.6800000000000002 111.404 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.747 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 5.5 p -138.04 134.79 45.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.36 0.6 . . . . 0.44 109.462 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.658 HG23 ' HG2' ' A' ' 20' ' ' LYS . 1.4 t -115.2 122.34 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-O 122.378 1.085 . . . . 0.46000000000000002 111.817 -173.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -99.97 126.86 46.2 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 113.2 -1.818 . . . . 1.76 109.364 177.783 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.67 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 10.4 tt -133.9 127.0 31.58 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.534 -0.543 . . . . 1.1200000000000001 109.534 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.666 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 39.5 tp -107.81 117.71 34.84 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.007 -1.479 . . . . 0.41999999999999998 107.007 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.74 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.5 OUTLIER -123.96 148.79 27.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 C-N-CA 119.671 -0.811 . . . . 0.77000000000000002 110.28 -176.298 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.688 HG23 HG22 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -95.85 117.48 30.65 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.195 -0.911 . . . . 0.34000000000000002 109.39 169.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.781 ' HG3' HE22 ' A' ' 72' ' ' GLN . 28.0 ttp180 -91.56 114.74 27.36 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.814 -1.539 . . . . 2.0099999999999998 109.255 -172.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.508 ' N ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -109.76 -55.12 2.48 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.106 -1.037 . . . . 1.97 113.48 -171.11 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.497 ' N ' ' HG2' ' A' ' 112' ' ' GLN . 33.3 t -156.66 13.98 0.28 Allowed 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.759 -0.776 . . . . 1.6200000000000001 111.965 -173.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.424 HD22 ' H ' ' A' ' 113' ' ' SER . 1.3 mm? . . . . . 0 C--N 1.321 -0.661 0 CA-C-O 121.657 0.741 . . . . 1.6499999999999999 110.312 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.44 -0.958 0 CA-C-O 122.562 1.172 . . . . 2.0899999999999999 109.394 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.14 178.67 8.26 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 113.001 -1.909 . . . . 0.95999999999999996 110.178 175.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.6 t -111.65 107.97 24.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.625 -0.716 . . . . 1.5700000000000001 109.891 -174.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.772 HG22 HG23 ' A' ' 110' ' ' THR . 48.6 t -77.36 108.65 10.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.247 0.546 . . . . 1.02 109.585 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 1.065 HE22 HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -108.58 167.54 9.98 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.372 -0.831 . . . . 1.3899999999999999 111.612 -173.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -122.3 114.49 20.87 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.96 -0.564 . . . . 3.6299999999999999 110.802 -172.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.065 HG23 HE22 ' A' ' 14' ' ' GLN . 4.9 t -99.24 132.6 44.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.211 -0.663 . . . . 1.02 109.211 176.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -144.63 117.1 8.55 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 110.137 -0.32 . . . . 1.3500000000000001 110.137 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.592 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 10.9 tp -144.89 148.25 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 108.741 -0.837 . . . . 0.60999999999999999 108.741 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.734 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 15.3 m-70 -76.22 116.08 16.57 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.008 -0.677 . . . . 0.59999999999999998 109.693 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.666 ' HB2' HD12 ' A' ' 27' ' ' LEU . 3.1 pptp? -30.59 136.44 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 O-C-N 125.065 1.478 . . . . 4.0 112.108 177.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 65' ' ' PRO . 47.1 tp -98.44 89.59 4.49 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 119.888 -0.725 . . . . 0.55000000000000004 110.761 -171.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 24.7 ptt180 -68.71 139.22 55.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.072 0.463 . . . . 3.9700000000000002 112.063 -172.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.403 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 3.1 tp-100 -129.47 93.95 3.66 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.651 -0.704 . . . . 1.3500000000000001 109.238 174.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.28 -80.33 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.839 -0.696 . . . . 1.3300000000000001 112.863 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -127.09 2.71 6.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.849 0.357 . . . . 2.3300000000000001 111.699 -173.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.403 ' OD1' ' HB3' ' A' ' 23' ' ' GLN . 1.1 p30 -126.73 174.39 8.78 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.097 -0.501 . . . . 1.8700000000000001 110.426 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.666 HD12 ' HB2' ' A' ' 20' ' ' LYS . 2.0 pt? -127.42 134.39 49.88 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.777 -1.194 . . . . 2.2799999999999998 107.777 175.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 26.0 mm -98.92 136.28 30.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-O 121.13 0.491 . . . . 0.80000000000000004 111.665 -171.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.464 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -106.6 116.19 31.5 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.341 -1.299 . . . . 1.74 107.558 173.137 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.37 51.86 4.42 Favored Glycine 0 C--O 1.221 -0.691 0 C-N-CA 120.223 -0.989 . . . . 0.68999999999999995 113.249 -172.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.585 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 29.2 p90 -158.47 170.74 21.53 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.591 -0.522 . . . . 0.51000000000000001 109.591 176.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.878 ' HB3' ' O ' ' A' ' 58' ' ' THR . 1.0 OUTLIER -110.66 168.85 9.16 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 107.978 -1.119 . . . . 0.53000000000000003 107.978 170.303 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -159.82 135.91 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 113.65 0.981 . . . . 0.48999999999999999 113.65 -163.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.407 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -147.64 117.4 0.91 Allowed Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.592 -1.003 . . . . 0.71999999999999997 110.592 155.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 1.083 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -142.58 117.78 1.18 Allowed Glycine 0 CA--C 1.488 -1.63 0 CA-C-O 118.427 -1.207 . . . . 1.4199999999999999 111.141 171.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.694 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.59 137.99 4.92 Favored Glycine 0 C--N 1.298 -1.539 0 C-N-CA 117.222 -2.418 . . . . 0.47999999999999998 113.086 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.418 HG12 ' N ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -60.53 -25.32 34.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 107.345 -1.354 . . . . 0.52000000000000002 107.345 151.314 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.82 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 4.5 t70 -54.6 -40.2 68.62 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 113.524 -1.671 . . . . 0.71999999999999997 110.179 169.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 . . . . . 0 C--O 1.234 0.285 0 CA-C-N 115.378 -0.828 . . . . 1.1899999999999999 110.51 -173.448 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.432 ' C ' HD12 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.443 -0.855 0 N-CA-C 110.248 -1.141 . . . . 0.78000000000000003 110.248 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.083 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.7 mp -112.1 142.57 24.07 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 N-CA-C 107.783 -1.191 . . . . 0.54000000000000004 107.783 171.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.717 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -152.16 141.98 21.98 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 122.219 1.009 . . . . 1.4199999999999999 111.577 -177.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.899 HG12 ' H ' ' A' ' 75' ' ' ASP . 1.8 p -79.92 135.98 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 113.928 -1.487 . . . . 0.57999999999999996 109.565 -178.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.878 ' O ' ' HB3' ' A' ' 32' ' ' SER . 15.8 m -125.09 64.47 1.14 Allowed 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.322 -0.854 . . . . 1.1100000000000001 109.372 175.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.565 ' HA ' HG23 ' A' ' 73' ' ' ILE . 64.2 mtt180 148.01 -168.5 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 125.939 1.696 . . . . 2.27 110.109 164.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.585 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 57.8 t -164.0 137.89 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 125.89 1.994 . . . . 0.82999999999999996 106.29 164.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.3 m -75.03 121.57 22.19 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.915 -0.772 . . . . 1.6499999999999999 108.915 173.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -50.39 108.94 0.26 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.174 -0.921 . . . . 1.8500000000000001 111.927 177.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.58 -6.05 70.57 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.557 -0.747 . . . . 0.92000000000000004 112.482 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.557 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -80.12 174.47 55.03 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.726 -0.75 . . . . 0.98999999999999999 112.17 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.462 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 46.7 Cg_endo -68.37 -28.4 32.99 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 122.837 2.358 . . . . 0.44 113.708 -164.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.471 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -65.57 -30.77 71.55 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.203 -0.908 . . . . 0.35999999999999999 110.881 177.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.507 ' HB2' HG11 ' A' ' 60' ' ' VAL . 14.6 tt0 -77.65 -31.2 52.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.326 0.584 . . . . 1.79 109.528 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.557 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.3 mp -65.81 -39.77 85.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.314 -0.857 . . . . 0.51000000000000001 109.84 175.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.713 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -75.27 -23.22 57.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.852 -0.613 . . . . 0.40999999999999998 110.295 176.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.53 46.63 1.2 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.843 -1.17 . . . . 0.45000000000000001 114.427 173.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.786 HD22 HG11 ' A' ' 57' ' ' VAL . 2.9 mt -91.93 156.51 17.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.62 0.71 . . . . 0.89000000000000001 111.079 175.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 6.0 mt-30 -132.82 32.09 3.86 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 114.599 1.333 . . . . 1.21 114.599 -166.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.565 HG23 ' HA ' ' A' ' 59' ' ' ARG . 3.4 mp 75.05 -14.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 N-CA-C 114.059 1.133 . . . . 0.77000000000000002 114.059 167.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.6 52.27 0.37 Allowed Glycine 0 N--CA 1.463 0.482 0 C-N-CA 119.761 -1.209 . . . . 0.37 112.405 -167.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.899 ' H ' HG12 ' A' ' 57' ' ' VAL . 21.5 m-20 -120.7 146.51 46.37 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.117 -0.541 . . . . 0.89000000000000001 110.388 -169.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.598 ' HD2' ' N ' ' A' ' 76' ' ' LYS . 10.3 mptt -101.44 102.4 13.19 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.516 0.674 . . . . 2.2000000000000002 110.483 -170.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.931 HG13 HG23 ' A' ' 109' ' ' VAL . 3.1 mp -64.49 122.79 16.05 Favored 'Isoleucine or valine' 0 C--O 1.256 1.424 0 CA-C-N 114.742 -1.117 . . . . 0.48999999999999999 112.295 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.881 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 2.7 mmt -91.92 -16.91 25.95 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 125.909 2.006 . . . . 1.0600000000000001 111.148 173.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.581 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -172.42 152.26 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.908 0.336 . . . . 0.81999999999999995 111.908 -177.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.712 HG12 ' HE1' ' A' ' 85' ' ' MET . 2.4 p -138.4 124.41 24.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.285 0.564 . . . . 1.3100000000000001 110.133 173.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.485 ' OD1' HG22 ' A' ' 80' ' ' VAL . 20.0 m120 53.02 28.65 6.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.298 -0.864 . . . . 1.5 112.669 174.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.41 -13.75 47.46 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.285 -0.959 . . . . 0.38 113.132 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.474 ' CE2' ' HD2' ' A' ' 96' ' ' ARG . 80.4 m95 -86.88 148.16 25.48 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.623 -0.51 . . . . 0.77000000000000002 109.623 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.64 118.68 37.28 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.663 -0.698 . . . . 1.8899999999999999 111.975 -173.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.712 ' HE1' HG12 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -107.13 103.48 12.89 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.901 0.858 . . . . 1.01 111.377 179.603 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 p -131.16 -48.3 1.0 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.221 -1.4 . . . . 1.05 107.221 168.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.86 84.67 2.1 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 112.622 -2.081 . . . . 1.6200000000000001 107.509 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.695 ' O ' HD11 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -137.73 136.45 45.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.026 -0.988 . . . . 1.0900000000000001 108.453 -177.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.766 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 72.9 p -58.1 149.9 22.46 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.161 0.505 . . . . 0.34999999999999998 112.205 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.82 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 21.9 t-160 -58.11 -36.82 73.46 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.635 0.731 . . . . 0.34999999999999998 109.792 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.72 -31.36 66.63 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.203 -1.362 . . . . 1.6699999999999999 109.961 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.694 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -65.65 -50.47 64.84 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.583 -0.895 . . . . 0.77000000000000002 108.583 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.72 ' HB2' HG12 ' A' ' 55' ' ' ILE . . . -65.59 -37.2 85.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.678 -0.692 . . . . 0.33000000000000002 110.274 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -68.53 -42.21 78.81 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.489 -0.778 . . . . 2.1000000000000001 110.935 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.557 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -72.8 -41.9 64.46 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 116.363 -0.38 . . . . 0.95999999999999996 110.228 -176.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.694 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 29.8 mmt180 -68.04 -32.9 73.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.015 0.436 . . . . 3.5699999999999998 110.315 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.663 ' HB2' HG21 ' A' ' 80' ' ' VAL . 10.8 tp -73.18 -55.24 6.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.394 -0.821 . . . . 1.6499999999999999 110.203 173.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 m -94.23 77.59 3.99 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 122.949 1.357 . . . . 1.53 109.779 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.535 ' HE2' ' HB3' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -138.5 108.72 6.43 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 112.316 -2.22 . . . . 2.7200000000000002 106.35 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -70.79 70.1 0.47 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.384 0.611 . . . . 4.3799999999999999 112.091 -170.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.0 t -137.55 -31.49 0.8 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.784 -0.644 . . . . 2.5099999999999998 110.805 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 19.3 mm-40 -68.21 141.32 56.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.476 -0.329 . . . . 3.3999999999999999 110.9 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.503 ' HG3' HG12 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -94.84 -11.22 29.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.922 0.868 . . . . 2.6800000000000002 108.872 169.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.734 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 3.7 p -153.2 145.55 14.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.237 -1.347 . . . . 0.44 108.211 -175.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.442 HG23 ' HB3' ' A' ' 20' ' ' LYS . 43.8 t -119.98 118.93 58.61 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.03 0 CA-C-O 122.439 1.114 . . . . 0.46000000000000002 112.065 -169.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.403 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 2.1 mpt_? -99.62 129.31 45.76 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 112.72 -2.036 . . . . 1.76 111.006 -175.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.799 HD11 HG12 ' A' ' 77' ' ' ILE . 35.0 tp -132.8 130.77 40.31 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 116.489 -0.323 . . . . 1.1200000000000001 110.745 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.881 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 35.5 tp -107.19 114.81 29.09 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 106.785 -1.561 . . . . 0.41999999999999998 106.785 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.931 HG23 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -128.76 147.14 33.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 C-N-CA 120.313 -0.555 . . . . 0.77000000000000002 110.562 -172.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.772 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -97.56 117.11 31.09 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.707 -0.797 . . . . 0.34000000000000002 110.556 173.401 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.501 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -110.04 135.46 50.83 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.418 -1.265 . . . . 2.0099999999999998 109.495 -175.456 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.515 ' OE1' HD23 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -114.25 -72.74 0.68 Allowed 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.687 0.625 . . . . 1.97 112.687 -169.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.4 t -140.87 18.15 2.31 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.647 0.737 . . . . 1.6200000000000001 110.216 -172.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 4.1 mm? . . . . . 0 C--N 1.317 -0.811 0 CA-C-N 115.36 -0.836 . . . . 1.6499999999999999 109.766 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 p . . . . . 0 N--CA 1.435 -1.19 0 CA-C-O 122.167 0.984 . . . . 2.0899999999999999 111.445 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.577 ' CB ' ' HA ' ' A' ' 112' ' ' GLN . . . -86.5 178.4 7.11 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.614 -1.63 . . . . 0.95999999999999996 111.045 177.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -129.46 138.46 54.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.268 -0.878 . . . . 1.5700000000000001 108.986 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.696 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 0.9 OUTLIER -90.72 127.2 43.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 C-N-CA 119.413 -0.915 . . . . 1.02 110.897 -174.778 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.959 HE22 HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -118.63 166.38 12.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.527 -1.215 . . . . 1.3899999999999999 110.137 176.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.523 ' HD2' ' H ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -124.98 135.29 52.66 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.605 -0.685 . . . . 3.6299999999999999 110.325 -175.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.959 HG23 HE22 ' A' ' 14' ' ' GLN . 4.1 t -105.95 109.04 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 CA-C-O 121.501 0.667 . . . . 1.02 109.436 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -109.31 119.53 39.76 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.37 -0.832 . . . . 1.3500000000000001 109.586 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.707 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 11.3 tp -145.71 146.18 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.871 -0.789 . . . . 0.60999999999999999 108.871 174.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 14.6 m-70 -80.15 112.0 17.05 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.529 -0.915 . . . . 0.59999999999999998 108.529 177.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.684 ' HB2' HD12 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -25.16 140.16 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 O-C-N 124.923 1.389 . . . . 4.0 112.814 -178.692 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.58 HD22 ' HA2' ' A' ' 64' ' ' GLY . 43.9 tp -96.16 97.5 9.59 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 119.102 -1.039 . . . . 0.55000000000000004 110.009 -172.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.638 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 12.4 ptp180 -61.13 142.71 56.51 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.744 0.783 . . . . 3.9700000000000002 112.067 -173.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.568 ' HB2' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -128.43 93.42 3.64 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.141 -1.059 . . . . 1.3500000000000001 108.141 172.397 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.6 -78.16 0.26 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.418 -0.896 . . . . 1.3300000000000001 111.352 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.463 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 54.5 mt-10 -139.2 11.44 2.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.156 0.503 . . . . 2.3300000000000001 110.63 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.638 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 10.8 m-80 -108.48 -177.53 3.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.895 -0.593 . . . . 1.8700000000000001 109.685 -177.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.684 HD12 ' HB2' ' A' ' 20' ' ' LYS . 1.0 OUTLIER -127.68 135.48 50.25 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 108.226 -1.027 . . . . 2.2799999999999998 108.226 173.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.568 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.0 OUTLIER -102.49 138.0 28.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 120.99 0.424 . . . . 0.80000000000000004 110.871 -179.173 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.8 tp -98.6 124.18 43.23 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.938 -1.483 . . . . 1.74 108.394 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.728 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -93.92 35.1 4.31 Favored Glycine 0 C--O 1.223 -0.582 0 C-N-CA 120.226 -0.988 . . . . 0.68999999999999995 114.075 -170.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.569 ' CD1' HG23 ' A' ' 57' ' ' VAL . 39.8 p90 -157.77 169.84 23.71 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.544 -0.539 . . . . 0.51000000000000001 109.544 177.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.709 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -104.43 159.75 15.47 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.845 -1.169 . . . . 0.53000000000000003 107.845 171.512 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.419 HD12 HD21 ' A' ' 97' ' ' LEU . 0.9 OUTLIER -152.91 135.24 6.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 113.354 0.872 . . . . 0.48999999999999999 113.354 -167.112 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -145.06 118.06 1.07 Allowed Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 110.059 -1.216 . . . . 0.71999999999999997 110.059 154.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 1.069 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -139.6 117.74 1.39 Allowed Glycine 0 CA--C 1.49 -1.487 0 CA-C-O 119.093 -0.837 . . . . 1.4199999999999999 111.233 172.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.782 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.15 137.32 4.57 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 118.012 -2.042 . . . . 0.47999999999999998 112.79 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.9 pt -58.75 -24.6 26.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.479 -1.304 . . . . 0.52000000000000002 107.479 153.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.738 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 4.1 t70 -56.1 -43.71 78.36 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 113.156 -1.838 . . . . 0.71999999999999997 110.182 171.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 . . . . . 0 C--O 1.233 0.225 0 CA-C-N 114.977 -1.01 . . . . 1.1899999999999999 112.317 -171.469 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.495 ' C ' HD12 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.429 -1.778 0 N-CA-C 109.156 -1.577 . . . . 0.78000000000000003 109.156 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.069 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -117.41 140.58 39.72 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.403 0 C-N-CA 119.656 -0.818 . . . . 0.54000000000000004 108.889 176.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.661 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -142.36 142.43 32.45 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 119.553 1.069 . . . . 1.4199999999999999 110.374 -176.111 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.58 HG12 ' H ' ' A' ' 75' ' ' ASP . 11.9 p -82.63 136.23 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 114.664 -1.153 . . . . 0.57999999999999996 110.301 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.709 ' O ' ' HB3' ' A' ' 32' ' ' SER . 23.7 m -127.23 66.05 1.3 Allowed 'General case' 0 N--CA 1.439 -1.006 0 O-C-N 124.346 1.029 . . . . 1.1100000000000001 109.035 172.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 37.7 mtt180 150.01 -170.28 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.746 1.619 . . . . 2.27 110.434 162.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 90.8 t -160.97 111.46 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 113.595 -1.639 . . . . 0.82999999999999996 106.625 161.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 m -70.76 158.52 36.16 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.504 0.669 . . . . 1.6499999999999999 110.021 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -97.62 130.41 44.65 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.027 -0.988 . . . . 1.8500000000000001 111.289 -169.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.9 -9.83 72.7 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.327 -0.94 . . . . 0.92000000000000004 111.325 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.637 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -85.05 -158.95 30.35 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.607 -0.806 . . . . 0.98999999999999999 111.436 174.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.728 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 40.5 Cg_endo -90.02 -30.21 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.664 2.243 . . . . 0.44 115.382 -171.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 30' ' ' GLY . . . -69.17 -23.1 63.89 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 116.229 -0.441 . . . . 0.35999999999999999 111.473 -174.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -72.03 -38.14 69.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.797 0.808 . . . . 1.79 108.959 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.637 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.3 mp -69.69 -45.29 78.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.526 -1.215 . . . . 0.51000000000000001 110.585 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.708 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -67.26 -30.53 70.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.40999999999999998 109.898 175.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.34 62.3 1.0 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.459 -0.877 . . . . 0.45000000000000001 113.427 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.481 ' O ' HG21 ' A' ' 60' ' ' VAL . 21.6 tp -98.15 158.31 15.63 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.045 -0.724 . . . . 0.89000000000000001 109.045 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.527 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 5.2 mt-30 -132.21 42.25 3.15 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 115.15 1.537 . . . . 1.21 115.15 -164.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.541 ' O ' ' HA ' ' A' ' 58' ' ' THR . 3.4 mp 71.56 -20.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 N-CA-C 115.741 1.756 . . . . 0.77000000000000002 115.741 161.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -164.06 57.77 0.27 Allowed Glycine 0 N--CA 1.463 0.484 0 C-N-CA 119.803 -1.189 . . . . 0.37 112.148 -164.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.582 ' HB3' ' CG2' ' A' ' 109' ' ' VAL . 9.5 m-20 -124.76 154.15 41.34 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.823 -0.688 . . . . 0.89000000000000001 109.819 -168.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.661 ' HD3' ' HB3' ' A' ' 56' ' ' TYR . 72.2 mmtt -106.68 103.01 12.35 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.511 0.672 . . . . 2.2000000000000002 109.878 -170.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 1.002 HG13 HG23 ' A' ' 109' ' ' VAL . 3.5 mp -73.65 125.14 32.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 114.696 -1.138 . . . . 0.48999999999999999 113.344 -172.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.718 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 4.4 mmt -86.18 -21.8 27.32 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 113.053 -1.885 . . . . 1.0600000000000001 112.174 176.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.515 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -168.91 149.95 4.51 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.455 0.539 . . . . 0.81999999999999995 112.455 -174.586 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.656 HG22 ' SD ' ' A' ' 85' ' ' MET . 30.1 m -132.55 123.04 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.84 -0.618 . . . . 1.3100000000000001 110.313 174.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.704 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 1.0 OUTLIER 56.87 25.13 10.07 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.071 0.767 . . . . 1.5 113.071 174.58 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.64 -7.13 57.62 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.358 -1.401 . . . . 0.38 112.669 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -91.84 152.57 20.04 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.817 -0.809 . . . . 0.77000000000000002 108.817 174.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -103.05 112.96 26.05 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.669 0.747 . . . . 1.8899999999999999 111.742 -172.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.656 ' SD ' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -106.34 101.62 11.08 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.055 -0.975 . . . . 1.01 111.359 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.1 p -118.24 -41.33 2.87 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.745 1.259 . . . . 1.05 107.741 168.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -148.22 84.49 1.51 Allowed 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 112.556 -2.111 . . . . 1.6200000000000001 107.825 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.782 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.5 t -140.04 135.05 37.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.219 -0.901 . . . . 1.0900000000000001 109.56 -172.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.738 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 69.5 p -55.92 148.28 17.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.292 0.479 . . . . 0.34999999999999998 112.292 -178.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.743 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 22.7 t-160 -56.14 -40.25 73.52 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 115.883 -0.599 . . . . 0.34999999999999998 110.715 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.6 -32.29 70.94 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.115 -0.948 . . . . 1.6699999999999999 109.365 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.826 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 2.5 tp-100 -63.0 -49.45 74.62 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 108.598 -0.89 . . . . 0.77000000000000002 108.598 -178.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.732 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -73.06 -40.47 65.04 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.632 -0.713 . . . . 0.33000000000000002 110.611 -177.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 94' ' ' ARG . 33.2 ttp180 -57.16 -44.32 83.37 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.304 0.573 . . . . 2.1000000000000001 109.644 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.453 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -66.68 -35.51 80.33 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.368 -0.833 . . . . 0.95999999999999996 109.638 -178.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.826 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 22.2 mmt180 -76.18 -26.36 56.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.006 -0.543 . . . . 3.5699999999999998 111.602 -176.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.684 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 2.8 pp -101.49 -0.19 35.56 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.098 0.777 . . . . 1.6499999999999999 113.098 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.2 m -126.67 65.47 1.26 Allowed 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 122.373 1.082 . . . . 1.53 110.871 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE2' ' O ' ' A' ' 96' ' ' ARG . 20.4 mtmt -112.25 114.32 27.04 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 113.937 -1.483 . . . . 2.7200000000000002 108.538 171.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' A' ' 25' ' ' GLU . 15.6 ptt180 -74.88 32.32 0.09 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.348 0.595 . . . . 4.3799999999999999 110.764 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 99' ' ' LYS . 13.2 p -119.73 -41.79 2.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.511 -0.768 . . . . 2.5099999999999998 109.747 -177.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -52.1 142.84 15.32 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.466 -0.788 . . . . 3.3999999999999999 110.477 175.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -93.66 -13.21 27.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.28 0.562 . . . . 2.6800000000000002 110.43 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 5.7 p -151.06 146.74 16.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.77 -0.65 . . . . 0.44 109.547 -176.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.422 HG13 HD21 ' A' ' 81' ' ' ASN . 47.8 t -114.24 120.36 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-O 121.946 0.879 . . . . 0.46000000000000002 111.708 -175.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.704 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.2 OUTLIER -100.26 127.76 46.48 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.488 -1.687 . . . . 1.76 110.613 -177.114 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.806 HD11 HG12 ' A' ' 77' ' ' ILE . 31.1 tp -133.39 126.92 32.34 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.044 -0.526 . . . . 1.1200000000000001 109.947 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.718 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 35.4 tp -111.53 116.01 30.14 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.47 -1.308 . . . . 0.41999999999999998 107.47 175.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 1.002 HG23 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -120.93 153.74 24.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.019 0.438 . . . . 0.77000000000000002 110.391 -173.507 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.696 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 0.7 OUTLIER -98.71 115.09 27.95 Favored 'General case' 0 N--CA 1.426 -1.673 0 C-N-CA 119.619 -0.832 . . . . 0.34000000000000002 110.018 165.482 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.504 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 17.3 ttt180 -92.23 112.79 24.86 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.689 -1.142 . . . . 2.0099999999999998 109.329 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.577 ' HA ' ' CB ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -86.1 -58.56 2.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.471 -0.786 . . . . 1.97 112.197 -171.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.2 t -149.17 8.59 0.73 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.164 0.507 . . . . 1.6200000000000001 110.906 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 3.1 mm? . . . . . 0 N--CA 1.439 -0.975 0 N-CA-C 108.207 -1.034 . . . . 1.6499999999999999 108.207 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.441 -0.91 0 CA-C-O 123.27 1.51 . . . . 2.0899999999999999 109.639 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.22 177.01 9.25 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 112.215 -2.266 . . . . 0.95999999999999996 110.05 172.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.9 m -120.72 132.41 70.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 116.039 -0.528 . . . . 1.5700000000000001 110.371 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.697 HG22 HG23 ' A' ' 110' ' ' THR . 16.3 t -85.94 114.28 25.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.904 0.383 . . . . 1.02 110.626 -176.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.735 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -112.61 169.96 8.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.402 0.62 . . . . 1.3899999999999999 112.232 -179.061 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -110.11 141.77 42.52 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.594 0.712 . . . . 3.6299999999999999 112.409 -173.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.707 ' HB ' ' HB3' ' A' ' 107' ' ' LEU . 34.0 t -129.99 128.74 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 108.28 -1.008 . . . . 1.02 108.28 170.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -143.38 119.74 10.92 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.673 0.273 . . . . 1.3500000000000001 110.418 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.541 HG12 ' HB2' ' A' ' 65' ' ' PRO . 10.7 tp -145.33 150.57 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.275 0 N-CA-C 108.818 -0.808 . . . . 0.60999999999999999 108.818 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.785 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 15.8 m-70 -80.71 114.99 19.99 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.187 -0.605 . . . . 0.59999999999999998 109.402 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 3.0 pptp? -27.62 136.2 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 O-C-N 125.051 1.469 . . . . 4.0 112.459 177.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.2 tp -109.14 98.1 7.61 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 120.656 -0.418 . . . . 0.55000000000000004 110.684 -175.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 57.7 mtt180 -67.04 135.66 54.03 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.452 0.644 . . . . 3.9700000000000002 111.537 177.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.76 92.41 3.76 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.107 -1.071 . . . . 1.3500000000000001 108.107 172.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.1 -81.48 0.13 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.104 -0.57 . . . . 1.3300000000000001 111.748 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -129.88 5.1 4.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.779 0.799 . . . . 2.3300000000000001 110.819 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 7.4 m-80 -108.27 167.8 9.76 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.336 -0.847 . . . . 1.8700000000000001 110.224 -177.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.437 HD13 ' HG2' ' A' ' 100' ' ' ARG . 6.6 mp -121.73 122.58 39.86 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.564 -0.902 . . . . 2.2799999999999998 108.564 171.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.7 mm -98.0 127.71 50.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.599 -0.728 . . . . 0.80000000000000004 110.234 -174.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.613 HD13 HD21 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -84.96 -38.27 19.5 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 114.581 -1.19 . . . . 1.74 109.063 -179.36 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.99 5.76 62.33 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.02 -0.991 . . . . 0.68999999999999995 111.479 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 39.5 p90 -151.57 167.12 29.06 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.462 -0.57 . . . . 0.51000000000000001 109.462 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.715 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -106.0 169.18 8.65 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 118.822 -1.151 . . . . 0.53000000000000003 108.889 173.302 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.458 HD11 HG21 ' A' ' 55' ' ' ILE . 6.8 tt -140.92 134.72 32.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 119.87 -0.732 . . . . 0.48999999999999999 112.323 -164.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -103.14 173.17 22.11 Favored Glycine 0 C--N 1.329 0.191 0 N-CA-C 110.77 -0.932 . . . . 0.71999999999999997 110.77 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.68 ' C ' HE22 ' A' ' 39' ' ' GLN . . . -110.46 168.57 13.06 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 118.243 2.057 . . . . 1.4199999999999999 118.243 -162.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.736 ' N ' HE22 ' A' ' 39' ' ' GLN . . . -84.5 -142.42 5.55 Favored Glycine 0 N--CA 1.422 -2.254 0 CA-C-N 110.816 -2.692 . . . . 0.47999999999999998 113.272 -176.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.756 HG23 ' O ' ' A' ' 87' ' ' MET . 8.7 pt -83.1 -5.2 8.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 113.258 0.836 . . . . 0.52000000000000002 113.258 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.966 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 13.3 p-10 -70.02 -32.74 71.05 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 120.996 -0.282 . . . . 0.71999999999999997 111.248 -173.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.736 HE22 ' N ' ' A' ' 36' ' ' GLY . 0.9 OUTLIER . . . . . 0 CA--C 1.517 -0.3 0 CA-C-O 121.616 0.722 . . . . 1.1899999999999999 109.116 -172.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.598 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . . . . . . 0 N--CA 1.445 -0.749 0 N-CA-C 110.276 -1.13 . . . . 0.78000000000000003 110.276 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.88 HG12 ' HB3' ' A' ' 93' ' ' ALA . 1.8 mp -108.89 146.07 14.96 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.175 0 N-CA-C 105.839 -1.911 . . . . 0.54000000000000004 105.839 170.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.725 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 1.0 OUTLIER -153.54 140.27 19.0 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 119.295 0.952 . . . . 1.4199999999999999 110.264 -169.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.588 ' O ' ' HA2' ' A' ' 74' ' ' GLY . 14.4 p -72.15 132.08 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 CA-C-N 115.44 -0.8 . . . . 0.57999999999999996 110.718 -171.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.715 ' O ' ' HB3' ' A' ' 32' ' ' SER . 19.3 m -125.34 64.71 1.16 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.98 -1.009 . . . . 1.1100000000000001 109.225 174.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.561 ' HA ' HG13 ' A' ' 73' ' ' ILE . 34.5 mtt180 149.38 -173.19 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.392 1.477 . . . . 2.27 111.407 165.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.621 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 4.8 p -174.34 120.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 113.167 -1.833 . . . . 0.82999999999999996 108.269 162.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.9 m -94.27 133.92 37.29 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.132 0.492 . . . . 1.6499999999999999 110.993 -175.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -61.4 124.51 20.83 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.643 -1.162 . . . . 1.8500000000000001 110.382 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.07 -13.06 45.02 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.047 -0.979 . . . . 0.92000000000000004 111.642 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.99 166.82 30.13 Favored Glycine 0 N--CA 1.438 -1.177 0 N-CA-C 111.026 -0.83 . . . . 0.98999999999999999 111.026 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.637 ' HA ' HD13 ' A' ' 68' ' ' ILE . 77.7 Cg_endo -73.98 -23.03 16.57 Favored 'Trans proline' 0 C--N 1.325 -0.676 0 C-N-CA 122.798 2.332 . . . . 0.44 113.036 -170.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.508 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -63.13 -29.38 70.75 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.688 -1.142 . . . . 0.35999999999999999 111.635 176.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -68.96 -37.29 78.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.417 0.627 . . . . 1.79 109.531 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.637 HD13 ' HA ' ' A' ' 65' ' ' PRO . 2.9 mp -67.76 -43.59 86.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 114.894 -1.048 . . . . 0.51000000000000001 110.533 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.69 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -75.76 -19.58 58.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.288 0.566 . . . . 0.40999999999999998 109.686 175.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.13 70.63 1.28 Allowed Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.365 -0.834 . . . . 0.45000000000000001 113.258 176.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.6 ' CD2' HG11 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -79.23 170.09 17.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.808 0.813 . . . . 0.89000000000000001 112.132 178.583 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.494 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 6.2 mm100 -108.26 -20.9 12.98 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 115.593 1.701 . . . . 1.21 115.593 -161.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.61 HD12 HG12 ' A' ' 60' ' ' VAL . 0.8 OUTLIER 82.41 -24.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 112.418 0.525 . . . . 0.77000000000000002 112.418 -172.556 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.588 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -172.02 53.34 0.17 Allowed Glycine 0 C--N 1.341 0.826 0 C-N-CA 119.873 -1.156 . . . . 0.37 112.691 -164.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.661 ' HB3' HG22 ' A' ' 109' ' ' VAL . 0.7 OUTLIER -122.19 149.71 43.26 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 122.204 0.201 . . . . 0.89000000000000001 110.548 -175.206 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.725 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 66.8 mttm -82.39 113.03 19.88 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.691 0.281 . . . . 2.2000000000000002 111.16 -174.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.552 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 17.1 mt -85.66 122.3 38.26 Favored 'Isoleucine or valine' 0 C--O 1.264 1.827 0 CA-C-O 121.254 0.549 . . . . 0.48999999999999999 111.571 -175.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.791 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 15.5 mmt -89.2 -20.01 24.73 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 125.831 1.957 . . . . 1.0600000000000001 112.763 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.61 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -167.25 154.05 8.44 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.434 -0.506 . . . . 0.81999999999999995 112.221 -174.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.781 HG21 ' HB2' ' A' ' 97' ' ' LEU . 12.0 p -139.61 125.49 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.381 -0.827 . . . . 1.3100000000000001 110.029 174.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.803 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 13.6 m120 52.75 30.22 8.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.168 -0.924 . . . . 1.5 113.193 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.88 -10.64 62.32 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.085 -1.055 . . . . 0.38 112.849 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -80.7 149.74 29.62 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-N 117.06 0.43 . . . . 0.77000000000000002 110.106 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -103.94 97.8 7.74 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.274 -0.875 . . . . 1.8899999999999999 111.081 -175.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.583 ' SD ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -113.3 101.88 9.82 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.842 -0.617 . . . . 1.01 111.19 176.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.4 p -99.02 -32.64 11.18 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.675 0.75 . . . . 1.05 110.258 173.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.756 ' O ' HG23 ' A' ' 37' ' ' ILE . 4.0 mtt -136.94 -15.48 1.53 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.756 -1.111 . . . . 1.6200000000000001 110.284 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.632 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 p -56.51 169.45 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 120.888 0.375 . . . . 1.0900000000000001 111.755 -162.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.966 ' HB ' ' HB3' ' A' ' 38' ' ' ASP . 72.4 p -56.56 145.02 29.46 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 122.223 -0.298 . . . . 0.34999999999999998 111.756 -174.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.574 ' CG ' ' HA2' ' A' ' 35' ' ' GLY . 23.3 t-160 -55.84 -35.4 66.37 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 122.045 0.926 . . . . 0.34999999999999998 108.614 175.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -69.02 -32.53 72.11 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 113.256 -1.793 . . . . 1.6699999999999999 110.313 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.815 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 4.3 tp-100 -62.54 -47.86 82.06 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 108.008 -1.108 . . . . 0.77000000000000002 108.008 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.88 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . -76.72 -34.06 58.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.243 -0.889 . . . . 0.33000000000000002 110.21 -173.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 94' ' ' ARG . 38.6 ttp180 -65.35 -43.53 90.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.386 -0.824 . . . . 2.1000000000000001 110.395 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.535 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -69.35 -40.88 77.26 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.53 -0.759 . . . . 0.95999999999999996 109.904 -176.403 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.815 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 21.9 mmt180 -70.36 -23.57 62.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.953 -0.567 . . . . 3.5699999999999998 110.633 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.781 ' HB2' HG21 ' A' ' 80' ' ' VAL . 15.9 tp -83.26 -44.48 14.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.631 -0.713 . . . . 1.6499999999999999 112.007 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.0 m -107.87 75.42 1.0 Allowed 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 122.807 1.289 . . . . 1.53 111.014 -169.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE2' ' HA ' ' A' ' 96' ' ' ARG . 6.6 mtmt -115.44 123.87 49.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.541 -2.118 . . . . 2.7200000000000002 109.041 173.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.437 ' HG2' HD13 ' A' ' 27' ' ' LEU . 41.8 mtp180 -69.69 40.01 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 O-C-N 123.324 0.39 . . . . 4.3799999999999999 111.229 177.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 99' ' ' LYS . 18.4 m -136.41 -41.74 0.63 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.056 -0.35 . . . . 2.5099999999999998 110.056 -172.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.564 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 46.9 mm-40 -56.36 140.69 44.53 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.383 -0.599 . . . . 3.3999999999999999 109.383 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.76 -16.87 15.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.502 0.668 . . . . 2.6800000000000002 109.862 176.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.785 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 3.0 p -143.26 150.29 17.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.128 -1.064 . . . . 0.44 108.128 -178.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.455 ' HA ' HD21 ' A' ' 81' ' ' ASN . 54.9 t -124.57 119.38 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.807 0 CA-C-O 122.22 1.009 . . . . 0.46000000000000002 111.513 -170.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.803 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -100.68 133.62 44.86 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 113.342 -1.754 . . . . 1.76 110.73 -176.228 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.707 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 19.3 tp -132.4 132.58 42.98 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 110.007 -0.368 . . . . 1.1200000000000001 110.007 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.791 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 23.8 tp -109.73 114.59 28.3 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.147 -1.797 . . . . 0.41999999999999998 106.147 171.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.735 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -121.67 141.18 43.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.898 -0.721 . . . . 0.77000000000000002 110.305 -173.641 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.697 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -96.28 115.81 28.02 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.831 -0.748 . . . . 0.34000000000000002 110.313 173.68 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.695 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 1.6 ttt180 -90.28 104.27 16.86 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.289 -1.323 . . . . 2.0099999999999998 109.655 -170.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.486 ' HG2' ' N ' ' A' ' 113' ' ' SER . 0.0 OUTLIER -91.59 -45.17 8.63 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.371 0.508 . . . . 1.97 112.371 -171.533 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.486 ' N ' ' HG2' ' A' ' 112' ' ' GLN . 22.8 t -163.1 14.92 0.07 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.408 0.623 . . . . 1.6200000000000001 110.311 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.463 HD23 ' OD1' ' A' ' 75' ' ' ASP . 3.6 mm? . . . . . 0 C--N 1.322 -0.619 0 CA-C-O 121.382 0.611 . . . . 1.6499999999999999 109.861 -176.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 49.2 p . . . . . 0 N--CA 1.434 -1.271 0 CA-C-O 122.309 1.052 . . . . 2.0899999999999999 111.461 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.07 179.36 5.6 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.399 -1.728 . . . . 0.95999999999999996 109.484 173.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.76 122.28 68.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.218 0.533 . . . . 1.5700000000000001 110.711 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.771 HG22 HG23 ' A' ' 110' ' ' THR . 15.8 t -79.56 105.61 9.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.004 -0.543 . . . . 1.02 110.367 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.999 HE22 HG23 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -102.05 169.19 8.91 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.725 -0.67 . . . . 1.3899999999999999 111.766 179.095 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.525 ' HD3' ' O ' ' A' ' 107' ' ' LEU . 1.8 mmt180 -123.96 116.09 22.31 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.334 -0.394 . . . . 3.6299999999999999 110.932 -177.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.999 HG23 HE22 ' A' ' 14' ' ' GLN . 25.1 t -97.29 125.71 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.597 -0.52 . . . . 1.02 109.597 176.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -139.04 116.21 11.05 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.89 -0.781 . . . . 1.3500000000000001 108.89 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.689 HG13 ' O ' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -144.57 139.8 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 107.841 -1.17 . . . . 0.60999999999999999 107.841 -177.42 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.849 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 17.1 m-70 -72.06 115.09 10.88 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.139 -0.689 . . . . 0.59999999999999998 109.139 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.652 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -31.96 141.01 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 O-C-N 124.958 1.411 . . . . 4.0 112.228 178.414 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.81 ' HB3' ' HB ' ' A' ' 28' ' ' ILE . 56.5 tp -98.18 102.58 14.37 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.595 -0.442 . . . . 0.55000000000000004 110.764 -171.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -58.13 139.35 54.97 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.371 0.605 . . . . 3.9700000000000002 112.069 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -142.99 92.46 2.4 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.555 -0.748 . . . . 1.3500000000000001 109.13 172.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.35 -79.85 0.01 OUTLIER Glycine 0 CA--C 1.522 0.473 0 C-N-CA 121.455 -0.403 . . . . 1.3300000000000001 112.541 -173.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -130.16 5.06 4.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.513 0.673 . . . . 2.3300000000000001 110.508 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 23' ' ' GLN . 12.0 m-80 -106.63 165.36 11.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.532 -0.758 . . . . 1.8700000000000001 110.146 -177.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.91 HD21 ' HB ' ' A' ' 98' ' ' THR . 2.2 pt? -128.66 124.63 36.21 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.759 -1.2 . . . . 2.2799999999999998 107.759 171.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.81 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 36.0 mm -98.43 115.95 40.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 116.028 -0.533 . . . . 0.80000000000000004 110.731 -170.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.806 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.3 pt? -71.7 -26.54 62.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.632 -0.713 . . . . 1.74 110.353 175.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.07 -31.3 7.1 Favored Glycine 0 C--O 1.223 -0.585 0 C-N-CA 120.731 -0.747 . . . . 0.68999999999999995 113.201 172.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.552 ' HZ ' HD11 ' A' ' 97' ' ' LEU . 44.9 p90 -112.24 163.07 14.79 Favored 'General case' 0 C--N 1.313 -0.999 0 O-C-N 122.264 -0.551 . . . . 0.51000000000000001 110.815 -176.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.535 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 24.0 t -100.47 163.2 12.47 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.268 -1.382 . . . . 0.53000000000000003 107.268 173.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -162.64 137.82 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 112.416 0.524 . . . . 0.48999999999999999 112.416 -164.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.74 117.79 1.06 Allowed Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 110.616 -0.994 . . . . 0.71999999999999997 110.616 157.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 1.031 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -142.65 118.56 1.27 Allowed Glycine 0 CA--C 1.49 -1.507 0 CA-C-O 118.607 -1.107 . . . . 1.4199999999999999 111.564 173.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.68 144.86 9.42 Favored Glycine 0 C--N 1.294 -1.764 0 C-N-CA 117.133 -2.46 . . . . 0.47999999999999998 113.319 177.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.453 HG12 ' C ' ' A' ' 88' ' ' VAL . 13.2 pt -62.58 -17.64 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.801 -1.185 . . . . 0.52000000000000002 107.801 151.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.847 ' HB2' ' CB ' ' A' ' 89' ' ' THR . 21.9 t70 -62.89 -37.09 85.53 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 113.962 -1.472 . . . . 0.71999999999999997 109.802 173.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 . . . . . 0 N--CA 1.456 -0.161 0 CA-C-N 114.662 -1.154 . . . . 1.1899999999999999 110.704 -174.733 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.445 ' C ' HD12 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.433 -1.556 0 N-CA-C 111.026 -0.83 . . . . 0.78000000000000003 111.026 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.031 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -114.25 144.25 22.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 N-CA-C 109.223 -0.658 . . . . 0.54000000000000004 109.223 178.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.814 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -145.92 146.78 31.19 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 122.59 1.186 . . . . 1.4199999999999999 113.334 178.218 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.814 HG23 HD11 ' A' ' 77' ' ' ILE . 54.5 t -72.21 137.42 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 112.509 -2.132 . . . . 0.57999999999999996 110.38 175.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.7 m -113.73 -19.7 11.45 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 124.502 1.126 . . . . 1.1100000000000001 111.478 -178.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.637 ' O ' HG23 ' A' ' 60' ' ' VAL . 72.8 mtt180 -149.48 -165.97 2.42 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.754 -0.591 . . . . 2.27 112.21 174.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 59' ' ' ARG . 79.7 t -168.4 138.61 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.705 1.602 . . . . 0.82999999999999996 107.407 166.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.415 ' OG ' ' HA3' ' A' ' 64' ' ' GLY . 32.2 p -81.09 132.87 35.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.922 0.392 . . . . 1.6499999999999999 111.123 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -58.71 111.17 1.17 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.864 -1.062 . . . . 1.8500000000000001 110.52 170.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.26 -15.16 63.83 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.55 -0.834 . . . . 0.92000000000000004 112.145 177.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.455 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -72.21 175.51 42.51 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.515 -0.85 . . . . 0.98999999999999999 111.35 177.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.689 ' O ' HG13 ' A' ' 18' ' ' ILE . 73.5 Cg_endo -72.8 -30.08 11.84 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.288 1.992 . . . . 0.44 112.69 -166.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.501 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -60.72 -28.25 68.52 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.011 -0.995 . . . . 0.35999999999999999 111.415 178.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -76.0 -35.49 59.55 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.517 0.675 . . . . 1.79 109.287 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.455 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -65.27 -43.43 95.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.882 -1.053 . . . . 0.51000000000000001 110.244 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.698 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -72.46 -22.87 61.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.908 -0.587 . . . . 0.40999999999999998 110.52 177.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.89 66.38 0.86 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.019 -1.086 . . . . 0.45000000000000001 113.389 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.593 HD13 HG21 ' A' ' 16' ' ' VAL . 9.0 tp -119.12 151.0 39.06 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.893 -0.41 . . . . 0.89000000000000001 109.893 177.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.842 HE22 ' HG3' ' A' ' 111' ' ' ARG . 7.9 mt-30 -129.91 31.73 4.66 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 115.806 1.78 . . . . 1.21 115.806 -162.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 72' ' ' GLN . 2.7 mp 72.95 -8.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 CA-C-N 118.992 0.815 . . . . 0.77000000000000002 112.988 170.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.13 54.58 0.32 Allowed Glycine 0 CA--C 1.507 -0.454 0 C-N-CA 119.155 -1.498 . . . . 0.37 112.69 -168.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.577 ' H ' ' HB ' ' A' ' 57' ' ' VAL . 16.8 m-20 -120.83 148.36 44.12 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.491 -0.354 . . . . 0.89000000000000001 110.51 -168.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.814 ' HD3' ' HB3' ' A' ' 56' ' ' TYR . 14.0 mmtp -105.93 102.86 12.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.168 0.508 . . . . 2.2000000000000002 110.0 -169.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 1.059 HG13 HG23 ' A' ' 109' ' ' VAL . 3.4 mp -72.99 126.99 34.63 Favored 'Isoleucine or valine' 0 C--O 1.257 1.471 0 N-CA-C 113.629 0.974 . . . . 0.48999999999999999 113.629 -172.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.793 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 5.5 mmt -92.12 -28.55 17.03 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 126.265 2.228 . . . . 1.0600000000000001 112.113 172.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.587 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 52.3 mt-30 -150.87 158.57 44.31 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.52 0.933 . . . . 0.81999999999999995 113.52 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.586 ' HB ' ' CE ' ' A' ' 85' ' ' MET . 24.4 t -139.6 107.46 3.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 113.515 -1.675 . . . . 1.3100000000000001 109.951 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 1.011 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 23.1 m-80 54.92 32.27 17.59 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.848 0.459 . . . . 1.5 112.007 176.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.46 -3.9 59.76 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.224 -0.989 . . . . 0.38 112.817 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.435 ' CE2' ' HD2' ' A' ' 96' ' ' ARG . 84.0 m95 -87.54 168.27 13.21 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.669 -0.493 . . . . 0.77000000000000002 109.669 177.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -109.78 113.69 26.66 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.242 0.544 . . . . 1.8899999999999999 111.155 -171.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.586 ' CE ' ' HB ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -106.95 101.97 11.36 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 122.217 1.008 . . . . 1.01 110.965 -179.702 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.8 p -142.1 -46.18 0.34 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.428 -1.714 . . . . 1.05 107.707 173.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.413 ' HA ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -146.85 74.45 1.35 Allowed 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 113.704 -1.589 . . . . 1.6200000000000001 110.127 176.105 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.774 ' HB ' HE21 ' A' ' 92' ' ' GLN . 22.9 m -133.3 154.93 40.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.285 -1.006 . . . . 1.0900000000000001 108.285 171.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.847 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 72.0 p -62.57 154.4 29.02 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 120.792 0.33 . . . . 0.34999999999999998 111.331 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.818 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 17.7 t-160 -52.59 -45.14 66.39 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 121.722 0.772 . . . . 0.34999999999999998 110.143 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -71.35 -29.56 65.13 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 113.692 -1.594 . . . . 1.6699999999999999 109.964 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.774 HE21 ' HB ' ' A' ' 88' ' ' VAL . 2.5 tt0 -60.19 -47.14 87.2 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.402 -0.592 . . . . 0.77000000000000002 109.402 178.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.586 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -74.06 -41.0 62.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.322 0.582 . . . . 0.33000000000000002 110.531 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -56.62 -44.17 80.94 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.817 -1.083 . . . . 2.1000000000000001 110.896 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.402 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -71.82 -34.35 69.25 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.396 -0.82 . . . . 0.95999999999999996 109.92 -176.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.745 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 27.2 mmt180 -74.56 -26.15 59.76 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.172 -0.467 . . . . 3.5699999999999998 110.712 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.552 HD11 ' HZ ' ' A' ' 31' ' ' PHE . 5.6 tt -68.94 -60.85 2.09 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.527 -0.76 . . . . 1.6499999999999999 111.277 -176.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.91 ' HB ' HD21 ' A' ' 27' ' ' LEU . 5.8 p -97.43 -83.56 0.39 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.387 -0.369 . . . . 1.53 111.408 -176.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 99' ' ' LYS . 2.8 ttpt 66.97 -1.66 1.35 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.8 -0.636 . . . . 2.7200000000000002 112.026 176.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.482 ' HA ' HD22 ' A' ' 27' ' ' LEU . 97.4 mtt180 60.34 47.79 8.61 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.026 -0.988 . . . . 4.3799999999999999 111.188 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.1 t -137.02 -56.44 0.72 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.466 -0.334 . . . . 2.5099999999999998 111.741 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.652 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 19.5 mm-40 -63.83 149.5 46.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.474 -0.33 . . . . 3.3999999999999999 111.123 -174.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -93.5 -10.17 35.82 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.431 0.634 . . . . 2.6800000000000002 109.843 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.849 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 3.8 p -147.58 142.18 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 108.634 -0.876 . . . . 0.44 108.634 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.5 t -116.64 120.24 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-O 122.02 0.914 . . . . 0.46000000000000002 111.867 -169.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 1.011 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -99.66 128.33 45.77 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 113.444 -1.707 . . . . 1.76 111.322 -174.403 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.885 HD11 HG12 ' A' ' 77' ' ' ILE . 17.6 tp -134.49 133.87 40.85 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.127 -0.488 . . . . 1.1200000000000001 110.492 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.793 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 29.9 tp -111.38 117.01 31.92 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 105.998 -1.853 . . . . 0.41999999999999998 105.998 170.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 1.059 HG23 HG13 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -126.63 144.46 36.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.868 -0.733 . . . . 0.77000000000000002 110.407 -174.578 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.771 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -95.68 115.29 27.22 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.614 -0.834 . . . . 0.34000000000000002 109.297 169.608 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.842 ' HG3' HE22 ' A' ' 72' ' ' GLN . 8.5 ttt180 -102.97 138.9 39.24 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.258 -1.337 . . . . 2.0099999999999998 110.482 -172.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.545 ' HG2' HD21 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -125.41 -96.35 0.44 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.326 0.491 . . . . 1.97 112.326 -178.433 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.0 t -124.97 35.39 4.79 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.273 0.559 . . . . 1.6200000000000001 111.792 -168.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.545 HD21 ' HG2' ' A' ' 112' ' ' GLN . 0.3 OUTLIER . . . . . 0 C--N 1.319 -0.736 0 CA-C-O 121.32 0.581 . . . . 1.6499999999999999 109.835 -178.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.447 -0.586 0 CA-C-O 123.605 1.669 . . . . 2.0899999999999999 110.86 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 111' ' ' ARG . . . -110.9 178.19 4.43 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 112.196 -2.274 . . . . 0.95999999999999996 110.541 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.8 t -111.64 118.19 56.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.989 -0.551 . . . . 1.5700000000000001 110.487 -176.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.741 HG22 HG23 ' A' ' 110' ' ' THR . 39.4 t -76.37 111.81 13.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.219 0.533 . . . . 1.02 109.637 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 1.005 HE22 HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -118.69 169.35 9.89 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.009 -0.541 . . . . 1.3899999999999999 112.235 -171.465 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 15' ' ' ARG . 6.1 mmm-85 -124.06 118.11 26.21 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.998 0.428 . . . . 3.6299999999999999 112.126 -175.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.005 HG23 HE22 ' A' ' 14' ' ' GLN . 7.7 t -108.26 119.59 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 108.25 -1.018 . . . . 1.02 108.25 171.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -132.75 114.41 14.1 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.93 -0.767 . . . . 1.3500000000000001 108.93 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.716 HG13 ' O ' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -136.89 138.29 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 108.097 -1.075 . . . . 0.60999999999999999 108.097 -173.619 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.847 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.3 m-70 -66.09 114.14 5.01 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.495 -0.32 . . . . 0.59999999999999998 110.358 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.973 ' HB2' HD13 ' A' ' 27' ' ' LEU . 2.2 pptp? -28.02 135.4 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 O-C-N 125.097 1.498 . . . . 4.0 112.814 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.716 HD22 ' HD3' ' A' ' 65' ' ' PRO . 33.1 tp -96.68 90.24 5.24 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.937 0.875 . . . . 0.55000000000000004 109.377 -175.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.489 ' H ' ' CD ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -62.3 133.23 54.84 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.854 -1.521 . . . . 3.9700000000000002 111.311 -178.501 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.403 ' HB2' HD13 ' A' ' 28' ' ' ILE . 4.2 tp-100 -133.71 94.18 3.24 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.773 -0.825 . . . . 1.3500000000000001 108.773 173.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.5 -80.26 0.12 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.828 -0.701 . . . . 1.3300000000000001 111.778 -175.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -132.52 1.47 3.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.832 0.348 . . . . 2.3300000000000001 110.511 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -107.61 172.04 7.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.24 0.543 . . . . 1.8700000000000001 111.283 -171.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.973 HD13 ' HB2' ' A' ' 20' ' ' LYS . 2.7 tp -124.4 121.77 35.84 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.14 -0.936 . . . . 2.2799999999999998 109.06 175.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.403 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.5 mp -99.25 129.65 49.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.686 -0.857 . . . . 0.80000000000000004 108.686 176.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mt -84.7 -32.39 23.58 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.418 -0.81 . . . . 1.74 110.279 -174.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.429 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 86.59 11.6 71.06 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.227 -0.987 . . . . 0.68999999999999995 111.487 -175.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.616 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 33.3 p90 -155.0 167.73 29.37 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.305 -0.628 . . . . 0.51000000000000001 109.305 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.567 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -107.67 164.09 12.53 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 107.873 -1.158 . . . . 0.53000000000000003 107.873 172.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -148.78 136.47 14.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 119.573 -0.851 . . . . 0.48999999999999999 112.664 -167.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.418 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -147.46 118.41 1.01 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.25 -0.976 . . . . 0.71999999999999997 111.066 157.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 1.033 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -137.99 119.04 1.75 Allowed Glycine 0 CA--C 1.492 -1.354 0 CA-C-O 118.807 -0.996 . . . . 1.4199999999999999 110.703 171.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 1.017 ' HA3' ' HG2' ' A' ' 39' ' ' GLN . . . -156.77 116.9 0.74 Allowed Glycine 0 N--CA 1.435 -1.423 0 C-N-CA 118.277 -1.916 . . . . 0.47999999999999998 113.614 -169.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.533 HG12 ' C ' ' A' ' 88' ' ' VAL . 15.9 pt -67.86 -20.89 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 N-CA-C 105.738 -1.949 . . . . 0.52000000000000002 105.738 147.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.742 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 2.8 t70 -63.17 -40.72 98.35 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 112.644 -2.071 . . . . 0.71999999999999997 109.765 168.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 1.017 ' HG2' ' HA3' ' A' ' 36' ' ' GLY . 28.7 mm-40 . . . . . 0 C--N 1.345 0.373 0 CA-C-N 115.034 -0.984 . . . . 1.1899999999999999 111.777 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.476 ' C ' HD12 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.44 -1.053 0 N-CA-C 109.732 -1.347 . . . . 0.78000000000000003 109.732 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.033 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -117.1 141.16 36.7 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.151 0 C-N-CA 119.268 -0.973 . . . . 0.54000000000000004 109.187 177.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.774 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -148.28 138.13 22.38 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.698 0.761 . . . . 1.4199999999999999 110.509 -176.043 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.546 HG12 ' H ' ' A' ' 75' ' ' ASP . 14.6 p -79.49 137.17 22.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 114.485 -1.234 . . . . 0.57999999999999996 110.468 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 58' ' ' THR . 12.1 t -127.18 68.91 1.28 Allowed 'General case' 0 C--O 1.21 -1.021 0 O-C-N 124.325 1.016 . . . . 1.1100000000000001 108.998 174.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.646 ' HA ' HG23 ' A' ' 73' ' ' ILE . 18.0 mtt180 153.55 -172.9 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.897 -1.502 . . . . 2.27 110.939 159.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.1 t -160.7 112.92 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 111.897 -2.41 . . . . 0.82999999999999996 106.621 161.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 m -76.44 121.75 23.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.96 0.41 . . . . 1.6499999999999999 109.933 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -48.14 116.72 1.63 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.01 -0.995 . . . . 1.8500000000000001 112.066 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.41 -16.06 49.24 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.517 -0.849 . . . . 0.92000000000000004 112.189 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.64 169.83 54.83 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.153 -1.022 . . . . 0.98999999999999999 111.415 177.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.716 ' O ' HG13 ' A' ' 18' ' ' ILE . 90.5 Cg_endo -71.35 -24.59 22.68 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.603 2.202 . . . . 0.44 113.064 -170.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.616 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -63.15 -25.67 68.46 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.26 -0.882 . . . . 0.35999999999999999 111.521 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -73.67 -37.42 65.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.656 -0.868 . . . . 1.79 108.656 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.53 HD13 ' HA ' ' A' ' 65' ' ' PRO . 2.2 mp -65.86 -47.99 83.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.245 -1.343 . . . . 0.51000000000000001 111.095 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.74 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -71.93 -22.07 61.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.388 -0.369 . . . . 0.40999999999999998 110.405 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.27 72.27 1.29 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.505 -0.855 . . . . 0.45000000000000001 113.109 178.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.473 ' CD2' HG21 ' A' ' 57' ' ' VAL . 15.3 tp -105.04 158.16 16.75 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.699 -0.482 . . . . 0.89000000000000001 109.699 176.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.672 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 35.2 mt-30 -114.04 20.83 15.37 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 114.756 1.391 . . . . 1.21 114.756 -168.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.646 HG23 ' HA ' ' A' ' 59' ' ' ARG . 75.8 mt 73.88 -5.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 113.059 0.762 . . . . 0.77000000000000002 113.059 170.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -171.03 63.9 0.16 Allowed Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.667 -0.777 . . . . 0.37 111.621 -165.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.546 ' H ' HG12 ' A' ' 57' ' ' VAL . 20.6 m-20 -122.66 148.26 45.49 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.245 -0.478 . . . . 0.89000000000000001 110.055 -170.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -97.98 101.39 12.86 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.29 0.567 . . . . 2.2000000000000002 109.775 -176.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 1.009 HG13 HG12 ' A' ' 109' ' ' VAL . 3.1 mp -73.86 121.89 25.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 115.29 -0.868 . . . . 0.48999999999999999 112.005 -175.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.665 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 4.5 mmt -88.59 -21.74 23.88 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 125.687 1.867 . . . . 1.0600000000000001 111.933 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.561 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -160.77 148.94 16.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.166 0.508 . . . . 0.81999999999999995 112.194 -175.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.622 HG13 ' HB3' ' A' ' 97' ' ' LEU . 21.9 t -129.49 110.52 20.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.172 -0.922 . . . . 1.3100000000000001 110.594 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.786 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 5.9 m120 52.38 37.22 21.94 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.694 0.627 . . . . 1.5 112.694 174.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.9 -11.13 62.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.292 -0.956 . . . . 0.38 112.563 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.557 ' HB2' ' HE2' ' A' ' 85' ' ' MET . 80.1 m95 -89.57 161.87 15.95 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 109.282 -0.636 . . . . 0.77000000000000002 109.282 177.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -108.81 111.79 23.71 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.197 -0.456 . . . . 1.8899999999999999 110.653 -172.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.79 ' SD ' HG11 ' A' ' 88' ' ' VAL . 13.7 mmt -107.41 99.92 9.4 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 121.85 0.834 . . . . 1.01 109.91 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.64 -48.61 2.04 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.706 -1.134 . . . . 1.05 107.998 171.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.411 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 3.2 mtt -143.41 85.01 1.83 Allowed 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.517 -1.674 . . . . 1.6200000000000001 108.022 173.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.79 HG11 ' SD ' ' A' ' 85' ' ' MET . 0.5 OUTLIER -140.32 151.2 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 115.781 -0.645 . . . . 1.0900000000000001 109.904 -176.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.682 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 82.6 p -61.25 151.19 32.4 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.143 0.497 . . . . 0.34999999999999998 112.278 -177.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.742 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 22.6 t-160 -61.53 -34.36 75.41 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 115.814 -0.63 . . . . 0.34999999999999998 109.891 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -70.58 -33.24 70.85 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.171 -1.377 . . . . 1.6699999999999999 109.235 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.727 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -63.56 -52.36 61.4 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.747 -0.834 . . . . 0.77000000000000002 108.747 -179.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.715 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -66.72 -41.14 88.42 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.504 -0.771 . . . . 0.33000000000000002 110.281 -178.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -60.25 -47.46 85.91 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.375 -0.829 . . . . 2.1000000000000001 110.676 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.517 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -69.95 -39.45 76.04 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.67 -0.695 . . . . 0.95999999999999996 110.203 -176.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.727 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 25.1 mmt180 -69.24 -23.01 63.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.991 -0.549 . . . . 3.5699999999999998 112.152 -175.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.622 ' HB3' HG13 ' A' ' 80' ' ' VAL . 4.4 pp -98.93 -14.04 19.72 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.406 -0.517 . . . . 1.6499999999999999 111.948 175.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.751 ' HA ' HD23 ' A' ' 27' ' ' LEU . 1.9 m -112.74 86.02 2.28 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 122.35 1.071 . . . . 1.53 109.945 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.493 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 4.6 mtmt -120.17 119.15 32.43 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 113.462 -1.699 . . . . 2.7200000000000002 109.969 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -67.62 48.77 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.181 -0.918 . . . . 4.3799999999999999 111.84 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.4 t -151.42 -54.11 0.14 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.311 0.486 . . . . 2.5099999999999998 112.311 -172.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 43.9 mt-10 -71.67 158.51 36.02 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.323 0.49 . . . . 3.3999999999999999 112.323 -171.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -95.4 -18.34 20.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.81 -0.632 . . . . 2.6800000000000002 111.399 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.847 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 4.9 p -142.41 148.25 20.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.726 0.298 . . . . 0.44 110.362 -172.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.46 HG23 ' HB3' ' A' ' 20' ' ' LYS . 44.1 t -119.73 119.78 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-O 121.813 0.816 . . . . 0.46000000000000002 111.736 -173.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.786 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.9 OUTLIER -102.11 124.92 48.55 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 113.875 -1.511 . . . . 1.76 111.529 -174.039 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.431 HD21 HG12 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -133.52 131.06 39.33 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.19 0.519 . . . . 1.1200000000000001 111.071 174.445 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.665 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 35.4 tp -103.2 113.99 27.91 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.011 -1.477 . . . . 0.41999999999999998 107.011 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 1.009 HG12 HG13 ' A' ' 77' ' ' ILE . 23.1 m -118.12 152.06 20.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 C-N-CA 119.921 -0.712 . . . . 0.77000000000000002 110.581 -176.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.741 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -95.73 115.18 27.06 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.825 -0.75 . . . . 0.34000000000000002 109.287 167.129 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.63 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . 0.9 OUTLIER -105.16 143.08 33.84 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.925 -1.034 . . . . 2.0099999999999998 110.475 -171.255 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.43 -89.27 0.49 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.067 -0.515 . . . . 1.97 110.633 -176.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.2 t -160.47 74.26 0.53 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.322 0.582 . . . . 1.6200000000000001 110.998 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.672 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 6.8 mt . . . . . 0 C--N 1.312 -1.034 0 CA-C-N 115.284 -0.871 . . . . 1.6499999999999999 110.081 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.448 -0.536 0 CA-C-O 123.559 1.647 . . . . 2.0899999999999999 110.869 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.64 157.45 17.17 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 112.343 -2.208 . . . . 0.95999999999999996 109.227 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.687 HG23 ' HG2' ' A' ' 111' ' ' ARG . 20.2 m -99.92 125.78 53.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 109.502 -0.555 . . . . 1.5700000000000001 109.502 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.657 HG22 HG23 ' A' ' 110' ' ' THR . 56.1 t -77.19 97.67 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 122.0 0.905 . . . . 1.02 111.168 -176.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.728 ' NE2' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -95.91 139.84 31.54 Favored 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 114.095 -1.411 . . . . 1.3899999999999999 109.515 175.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.432 ' HB3' HD12 ' A' ' 108' ' ' LEU . 5.3 ppt_? -125.6 129.05 48.87 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 120.32 -1.487 . . . . 3.6299999999999999 111.326 176.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.772 HG13 ' CB ' ' A' ' 69' ' ' ALA . 22.7 t -92.57 133.93 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 114.909 -1.041 . . . . 1.02 110.259 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -135.32 112.51 10.44 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.008 -0.738 . . . . 1.3500000000000001 109.008 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.646 HG13 ' O ' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -144.45 139.24 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 N-CA-C 107.742 -1.207 . . . . 0.60999999999999999 107.742 -177.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.68 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 14.6 m-70 -73.75 114.88 12.53 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.054 -0.721 . . . . 0.59999999999999998 109.054 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.778 ' HB2' HD12 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -31.46 143.71 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 O-C-N 125.02 1.45 . . . . 4.0 112.424 -178.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.548 HD22 ' HD3' ' A' ' 65' ' ' PRO . 30.7 tp -94.98 97.59 10.08 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.847 -0.741 . . . . 0.55000000000000004 110.037 -171.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.468 ' HD3' ' H ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -54.95 131.34 44.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.792 -1.094 . . . . 3.9700000000000002 111.583 -178.684 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.412 ' HB2' HD13 ' A' ' 28' ' ' ILE . 6.4 tp-100 -139.8 102.13 4.35 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.755 -1.111 . . . . 1.3500000000000001 108.549 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.9 -92.04 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.556 -0.831 . . . . 1.3300000000000001 111.108 -175.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.449 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 35.7 mt-10 -126.6 -0.55 6.81 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.101 0.477 . . . . 2.3300000000000001 110.607 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.444 ' HA ' ' CB ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -112.54 -175.94 2.79 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.969 -0.56 . . . . 1.8700000000000001 110.457 -173.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.778 HD12 ' HB2' ' A' ' 20' ' ' LYS . 1.7 pt? -123.9 142.84 50.78 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.405 -0.961 . . . . 2.2799999999999998 108.405 175.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.412 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.2 mp -106.78 130.89 57.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 121.062 0.458 . . . . 0.80000000000000004 110.357 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.6 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.3 pt? -96.28 117.33 30.58 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.032 -1.099 . . . . 1.74 108.032 172.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.623 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -81.5 43.54 2.93 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.738 -0.744 . . . . 0.68999999999999995 113.521 -171.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.61 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 29.0 p90 -158.28 160.44 37.05 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 122.575 0.35 . . . . 0.51000000000000001 110.33 178.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 18.6 t -103.89 159.9 15.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.183 -1.414 . . . . 0.53000000000000003 107.183 170.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -160.3 140.15 3.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 120.695 -0.402 . . . . 0.48999999999999999 111.778 -165.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -145.61 119.22 1.17 Allowed Glycine 0 N--CA 1.436 -1.314 0 N-CA-C 110.257 -1.137 . . . . 0.71999999999999997 110.257 157.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 1.005 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -138.67 116.68 1.3 Allowed Glycine 0 CA--C 1.488 -1.643 0 N-CA-C 110.652 -0.979 . . . . 1.4199999999999999 110.652 169.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.7 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.47 137.15 4.5 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 117.498 -2.287 . . . . 0.47999999999999998 114.329 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.514 HG12 ' C ' ' A' ' 88' ' ' VAL . 23.3 pt -66.79 -11.4 13.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.773 -1.195 . . . . 0.52000000000000002 107.773 149.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.81 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 0.0 OUTLIER -72.3 -40.69 67.32 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.091 -1.413 . . . . 0.71999999999999997 108.789 170.351 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 . . . . . 0 C--O 1.234 0.287 0 CA-C-N 114.965 -1.016 . . . . 1.1899999999999999 109.213 178.198 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.431 ' C ' HD12 ' A' ' 55' ' ' ILE . . . . . . . . 0 N--CA 1.446 -0.663 0 N-CA-C 109.828 -1.309 . . . . 0.78000000000000003 109.828 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.005 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -115.32 141.25 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 106.755 -1.572 . . . . 0.54000000000000004 106.755 168.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.67 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -153.85 146.97 24.61 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 119.42 1.009 . . . . 1.4199999999999999 110.887 -178.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.807 HG12 ' H ' ' A' ' 75' ' ' ASP . 1.4 p -81.88 140.84 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-N 114.732 -1.122 . . . . 0.57999999999999996 109.71 -175.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.9 m -110.25 -14.47 14.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.295 -0.866 . . . . 1.1100000000000001 110.841 -173.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.546 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 67.1 mtt180 -149.55 -166.59 2.59 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.728 0.775 . . . . 2.27 112.395 174.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 66' ' ' ALA . 88.3 t -160.0 140.02 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 112.525 -2.125 . . . . 0.82999999999999996 106.474 162.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.9 p -82.73 121.16 26.52 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 121.503 0.668 . . . . 1.6499999999999999 110.308 175.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -60.46 101.08 0.12 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 113.965 -1.47 . . . . 1.8500000000000001 111.08 174.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.88 -6.57 23.88 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.495 -0.86 . . . . 0.92000000000000004 112.319 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.513 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -91.82 -176.99 42.58 Favored Glycine 0 CA--C 1.5 -0.888 0 C-N-CA 120.914 -0.66 . . . . 0.98999999999999999 111.7 177.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.646 ' O ' HG13 ' A' ' 18' ' ' ILE . 65.6 Cg_endo -71.89 -25.83 19.49 Favored 'Trans proline' 0 CA--C 1.509 -0.738 0 C-N-CA 122.94 2.427 . . . . 0.44 113.097 -168.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.61 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -67.93 -25.9 65.7 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.034 -0.985 . . . . 0.35999999999999999 110.873 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -74.67 -32.47 62.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.934 0.874 . . . . 1.79 109.002 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.513 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -71.65 -44.47 69.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.477 -1.238 . . . . 0.51000000000000001 110.549 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.772 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -75.3 -23.09 57.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.091 -0.504 . . . . 0.40999999999999998 110.556 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.91 70.29 1.08 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.001 -1.095 . . . . 0.45000000000000001 113.315 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.67 HD21 HG21 ' A' ' 57' ' ' VAL . 16.7 tp -112.17 155.24 24.28 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.25 -0.648 . . . . 0.89000000000000001 109.25 174.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.426 HE22 ' HD2' ' A' ' 111' ' ' ARG . 0.5 OUTLIER -132.51 35.61 3.62 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 115.193 1.553 . . . . 1.21 115.193 -165.718 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.546 HG23 ' HA ' ' A' ' 59' ' ' ARG . 4.4 mp 68.89 -7.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 N-CA-C 113.793 1.034 . . . . 0.77000000000000002 113.793 165.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.49 52.63 0.35 Allowed Glycine 0 CA--C 1.509 -0.311 0 C-N-CA 119.903 -1.141 . . . . 0.37 112.108 -170.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.807 ' H ' HG12 ' A' ' 57' ' ' VAL . 40.7 m-20 -119.75 132.17 55.56 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.341 -0.43 . . . . 0.89000000000000001 111.387 -168.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.67 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 10.8 mmmm -82.16 100.67 9.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.338 0.59 . . . . 2.2000000000000002 110.466 -174.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.637 ' HB ' HG22 ' A' ' 55' ' ' ILE . 5.6 mt -73.64 123.38 28.62 Favored 'Isoleucine or valine' 0 C--O 1.261 1.674 0 CA-C-N 115.546 -0.752 . . . . 0.48999999999999999 111.664 -176.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.796 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 10.6 mmt -94.73 -11.88 28.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 125.572 1.795 . . . . 1.0600000000000001 113.075 177.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.52 ' HB3' ' CB ' ' A' ' 108' ' ' LEU . 2.6 tt0 -173.13 156.04 3.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.654 0.264 . . . . 0.81999999999999995 111.513 -175.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.8 p -145.36 122.93 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 121.415 0.626 . . . . 1.3100000000000001 110.352 174.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.48 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 1.1 m-80 60.04 21.31 10.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.231 -0.895 . . . . 1.5 112.181 178.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.94 -10.33 55.54 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.019 -1.086 . . . . 0.38 112.432 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.414 ' CD1' ' HB3' ' A' ' 96' ' ' ARG . 86.6 m95 -86.94 131.3 34.13 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 109.092 -0.707 . . . . 0.77000000000000002 109.092 176.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -85.09 115.73 23.06 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.747 -1.115 . . . . 1.8899999999999999 110.515 -174.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.707 ' HE3' ' HA ' ' A' ' 93' ' ' ALA . 23.2 mmt -106.66 101.12 10.59 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.097 -0.956 . . . . 1.01 111.134 -175.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.4 ' C ' ' HG3' ' A' ' 87' ' ' MET . 1.2 p -135.36 111.59 9.69 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.632 -1.167 . . . . 1.05 108.963 169.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.4 ' HG3' ' C ' ' A' ' 86' ' ' THR . 0.0 OUTLIER 44.96 65.69 1.04 Allowed 'General case' 0 C--N 1.33 -0.28 0 O-C-N 124.052 0.845 . . . . 1.6200000000000001 111.386 -176.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.7 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 3.8 p -129.71 166.48 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.146 -1.057 . . . . 1.0900000000000001 108.146 172.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.654 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 71.7 p -58.35 149.63 24.15 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.987 0.736 . . . . 0.34999999999999998 112.987 -175.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.81 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 19.0 t-160 -61.52 -35.71 78.5 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-O 121.499 0.666 . . . . 0.34999999999999998 109.508 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.48 ' CG ' HH12 ' A' ' 94' ' ' ARG . 0.6 OUTLIER -67.27 -31.46 71.8 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 113.992 -1.458 . . . . 1.6699999999999999 109.517 178.048 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.757 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 3.8 tp-100 -62.49 -51.65 66.59 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 108.965 -0.754 . . . . 0.77000000000000002 108.965 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.707 ' HA ' ' HE3' ' A' ' 85' ' ' MET . . . -72.62 -36.61 68.11 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.5 -0.773 . . . . 0.33000000000000002 110.195 -177.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.48 HH12 ' CG ' ' A' ' 91' ' ' ASP . 26.6 ttp-105 -67.01 -38.76 86.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.689 -0.687 . . . . 2.1000000000000001 110.694 -177.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.52 ' HE3' ' O ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -70.79 -45.89 63.84 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.302 -0.629 . . . . 0.95999999999999996 109.302 -178.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.757 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 25.2 mmt180 -67.71 -23.61 65.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.765 -0.652 . . . . 3.5699999999999998 110.175 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.529 HD11 ' CZ ' ' A' ' 31' ' ' PHE . 4.1 tt -77.14 -53.55 7.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.674 -0.694 . . . . 1.6499999999999999 110.985 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.5 m -90.97 90.23 7.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.92 0.867 . . . . 1.53 111.238 -169.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.606 ' HE2' ' O ' ' A' ' 96' ' ' ARG . 22.8 mtmt -133.85 110.11 9.53 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.023 -1.444 . . . . 2.7200000000000002 109.241 176.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.449 ' HD2' ' O ' ' A' ' 25' ' ' GLU . 17.9 ptt180 -76.56 36.5 0.16 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.268 0.556 . . . . 4.3799999999999999 110.833 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 99' ' ' LYS . 4.0 p -124.4 -58.92 1.5 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.774 -0.648 . . . . 2.5099999999999998 111.254 -176.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.22 147.84 42.93 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.084 0.468 . . . . 3.3999999999999999 111.549 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -84.0 -18.74 36.15 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.66 0.615 . . . . 2.6800000000000002 112.66 -172.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.68 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 6.9 p -144.01 145.36 21.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.775 0.321 . . . . 0.44 110.25 -171.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.9 t -114.84 118.46 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-O 122.502 1.144 . . . . 0.46000000000000002 111.914 -175.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.48 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -98.75 129.81 45.2 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 113.065 -1.88 . . . . 1.76 109.766 -178.308 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.442 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 26.2 tp -133.98 125.72 28.76 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 116.218 -0.446 . . . . 1.1200000000000001 110.097 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.796 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 14.6 tp -101.52 130.17 47.74 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.522 -1.288 . . . . 0.41999999999999998 107.522 176.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.709 HG13 ' HB3' ' A' ' 75' ' ' ASP . 2.2 t -131.83 140.12 48.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.998 0.904 . . . . 0.77000000000000002 111.018 -171.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.657 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -105.19 116.53 32.11 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.126 -0.943 . . . . 0.34000000000000002 109.759 163.523 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.687 ' HG2' HG23 ' A' ' 12' ' ' VAL . 1.5 ptt180 -114.35 140.46 48.63 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.175 -0.92 . . . . 2.0099999999999998 110.322 -170.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.513 HE22 ' HG2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -118.97 -41.52 2.76 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.034 0.921 . . . . 1.97 111.035 -170.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.528 ' H ' HD22 ' A' ' 114' ' ' LEU . 36.5 t -159.94 -128.84 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.029 -1.441 . . . . 1.6200000000000001 107.521 -169.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.528 HD22 ' H ' ' A' ' 113' ' ' SER . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.574 0 O-C-N 124.018 0.823 . . . . 1.6499999999999999 111.826 171.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.442 -0.846 0 CA-C-O 122.307 1.051 . . . . 2.0899999999999999 109.181 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.31 179.17 7.97 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.159 -1.837 . . . . 0.95999999999999996 111.791 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.8 t -105.77 121.56 58.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.262 -0.881 . . . . 1.5700000000000001 110.531 -176.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.609 HG22 HG23 ' A' ' 110' ' ' THR . 38.6 t -77.98 120.7 29.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.85 0.357 . . . . 1.02 110.968 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.924 HE22 HG23 ' A' ' 16' ' ' VAL . 3.7 pp0? -121.08 167.52 12.54 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.015 -0.539 . . . . 1.3899999999999999 111.289 -178.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.587 ' HD3' ' O ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -124.12 113.6 18.57 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.676 0.391 . . . . 3.6299999999999999 111.492 -175.778 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.924 HG23 HE22 ' A' ' 14' ' ' GLN . 2.2 t -98.16 130.76 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.753 -0.462 . . . . 1.02 109.753 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -142.51 117.81 10.19 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 110.119 -0.326 . . . . 1.3500000000000001 110.119 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 11.2 tp -140.27 144.62 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 108.64 -0.874 . . . . 0.60999999999999999 108.64 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.8 m-70 -77.03 111.09 12.23 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.248 -0.581 . . . . 0.59999999999999998 109.772 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.504 ' HD2' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -23.77 136.64 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 O-C-N 125.433 1.708 . . . . 4.0 113.464 -179.425 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.1 tp -96.46 92.74 6.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.857 0.837 . . . . 0.55000000000000004 109.96 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HD3' ' H ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -65.3 135.93 55.94 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.186 -1.37 . . . . 3.9700000000000002 111.275 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.406 ' HB2' HD13 ' A' ' 28' ' ' ILE . 2.1 tp-100 -138.39 93.97 2.8 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.115 -0.698 . . . . 1.3500000000000001 109.115 173.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 60.59 -86.7 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.909 -0.663 . . . . 1.3300000000000001 111.621 -174.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -131.89 12.07 4.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.261 0.553 . . . . 2.3300000000000001 110.335 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -111.42 154.91 23.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.599 -0.728 . . . . 1.8700000000000001 109.047 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.0 mp -120.8 122.13 39.66 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.431 -0.581 . . . . 2.2799999999999998 109.431 174.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.406 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.8 mp -98.19 121.29 48.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 115.266 -0.879 . . . . 0.80000000000000004 109.456 -177.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.651 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -89.72 -27.99 19.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.772 -1.103 . . . . 1.74 110.77 179.272 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.519 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 82.68 17.53 67.96 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.237 -0.982 . . . . 0.68999999999999995 113.381 175.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.651 ' CE2' ' HB2' ' A' ' 29' ' ' LEU . 44.5 p90 -148.94 159.68 43.97 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.496 -0.557 . . . . 0.51000000000000001 109.496 172.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.7 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -102.33 161.93 13.31 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 118.625 -1.23 . . . . 0.53000000000000003 107.893 175.213 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -151.22 135.94 9.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 C-N-CA 119.672 -0.811 . . . . 0.48999999999999999 112.658 -167.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.6 ' O ' ' HD1' ' A' ' 56' ' ' TYR . . . -147.41 117.2 0.89 Allowed Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.163 -1.175 . . . . 0.71999999999999997 110.163 156.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 1.074 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.72 118.62 1.35 Allowed Glycine 0 CA--C 1.489 -1.589 0 CA-C-O 118.464 -1.186 . . . . 1.4199999999999999 110.806 173.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.705 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.9 135.8 3.84 Favored Glycine 0 C--N 1.299 -1.525 0 C-N-CA 117.188 -2.434 . . . . 0.47999999999999998 113.712 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.486 HG12 ' N ' ' A' ' 88' ' ' VAL . 0.6 OUTLIER -57.69 -26.58 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 107.541 -1.281 . . . . 0.52000000000000002 107.541 150.062 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.818 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 0.5 OUTLIER -57.69 -39.98 78.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 113.446 -1.706 . . . . 0.71999999999999997 110.435 171.075 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 . . . . . 0 N--CA 1.463 0.202 0 CA-C-N 115.266 -0.879 . . . . 1.1899999999999999 110.721 -172.884 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.426 ' N ' ' HH ' ' A' ' 56' ' ' TYR . . . . . . . . 0 N--CA 1.437 -1.259 0 N-CA-C 111.064 -0.814 . . . . 0.78000000000000003 111.064 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.074 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -110.15 145.93 16.05 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.738 0 N-CA-C 108.791 -0.818 . . . . 0.54000000000000004 108.791 175.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.6 ' HD1' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -140.0 147.39 40.34 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 119.235 0.925 . . . . 1.4199999999999999 110.281 -176.453 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.651 HG12 ' H ' ' A' ' 75' ' ' ASP . 7.1 p -94.18 135.72 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 CA-C-N 115.14 -0.936 . . . . 0.57999999999999996 109.796 175.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.7 ' O ' ' HB3' ' A' ' 32' ' ' SER . 21.4 m -128.32 68.49 1.36 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.765 -1.107 . . . . 1.1100000000000001 109.198 176.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.614 ' HA ' HG23 ' A' ' 73' ' ' ILE . 34.0 mtm180 150.06 -179.95 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 125.512 1.525 . . . . 2.27 110.397 163.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.423 ' N ' HG12 ' A' ' 73' ' ' ILE . 40.1 t -163.55 134.77 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 O-C-N 125.542 1.776 . . . . 0.82999999999999996 107.561 163.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.405 ' O ' HG12 ' A' ' 60' ' ' VAL . 19.2 p -77.59 169.44 18.29 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.633 0.73 . . . . 1.6499999999999999 111.031 175.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -103.43 128.43 50.58 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 114.783 -1.099 . . . . 1.8500000000000001 110.198 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.68 -5.42 52.4 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.324 -0.853 . . . . 0.92000000000000004 113.564 173.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.503 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -76.24 -129.13 0.31 Allowed Glycine 0 CA--C 1.506 -0.525 0 C-N-CA 120.35 -0.929 . . . . 0.98999999999999999 112.564 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.519 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 69.6 Cg_endo -102.76 -50.43 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 122.706 2.271 . . . . 0.44 115.572 177.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.529 ' HB2' ' O ' ' A' ' 29' ' ' LEU . . . -57.23 -32.43 66.52 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.534 0.938 . . . . 0.35999999999999999 113.534 -172.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -74.46 -28.65 61.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.596 0.712 . . . . 1.79 109.418 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.4 mp -74.32 -34.99 38.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.886 -1.052 . . . . 0.51000000000000001 109.648 -178.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.687 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -77.82 -23.01 49.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.574 -0.739 . . . . 0.40999999999999998 110.358 175.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.67 56.05 0.92 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.466 -0.873 . . . . 0.45000000000000001 114.132 175.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.682 ' HG ' HG21 ' A' ' 16' ' ' VAL . 2.2 mt -100.56 158.52 15.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 117.302 0.551 . . . . 0.89000000000000001 110.722 174.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 1.034 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 29.0 mt-30 -130.33 25.31 5.16 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 114.868 1.433 . . . . 1.21 114.868 -165.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.614 HG23 ' HA ' ' A' ' 59' ' ' ARG . 91.1 mt 72.95 -10.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 113.95 1.092 . . . . 0.77000000000000002 113.95 168.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.62 60.58 0.24 Allowed Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.436 -0.888 . . . . 0.37 111.974 -166.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.651 ' H ' HG12 ' A' ' 57' ' ' VAL . 36.6 m-20 -122.59 156.1 34.93 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.078 -0.561 . . . . 0.89000000000000001 110.376 -170.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.488 ' HG3' ' HD2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -104.39 102.02 11.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.314 0.578 . . . . 2.2000000000000002 109.546 -175.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 1.045 HG13 HG23 ' A' ' 109' ' ' VAL . 3.6 mp -74.71 125.37 34.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.491 -0.777 . . . . 0.48999999999999999 112.311 -171.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.906 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 3.0 mmt -92.1 -18.41 23.6 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 125.607 1.817 . . . . 1.0600000000000001 112.184 177.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.604 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -173.01 155.43 3.04 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.759 0.281 . . . . 0.81999999999999995 111.759 -175.306 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.44 ' N ' ' HG3' ' A' ' 79' ' ' GLN . 11.7 p -142.35 126.9 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 121.291 0.567 . . . . 1.3100000000000001 110.516 173.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.725 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 1.1 m-80 56.95 27.65 13.48 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.426 -0.806 . . . . 1.5 112.378 176.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.53 -11.1 63.14 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.122 -1.037 . . . . 0.38 112.605 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.42 ' CE2' ' HD2' ' A' ' 96' ' ' ARG . 80.9 m95 -83.91 160.16 21.15 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 108.696 -0.853 . . . . 0.77000000000000002 108.696 176.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -111.0 113.36 25.86 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.292 0.568 . . . . 1.8899999999999999 111.858 -171.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.541 ' HG3' HG11 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -109.1 102.46 11.43 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.723 -0.671 . . . . 1.01 111.58 -178.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.44 -50.93 2.31 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.262 -1.014 . . . . 1.05 108.262 168.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -135.38 86.99 2.29 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.549 -1.66 . . . . 1.6200000000000001 106.807 172.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.705 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.4 t -137.27 138.17 45.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.022 -0.99 . . . . 1.0900000000000001 109.754 -172.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.818 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 70.4 p -57.87 147.56 28.24 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 122.159 -0.338 . . . . 0.34999999999999998 111.609 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.809 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 19.8 t-160 -56.6 -40.63 75.64 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.312 0.577 . . . . 0.34999999999999998 110.175 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.25 -30.45 68.58 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.455 -1.248 . . . . 1.6699999999999999 110.042 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.769 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 2.3 tp-100 -63.48 -50.92 67.76 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.122 -1.066 . . . . 0.77000000000000002 108.122 178.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.615 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -70.81 -32.72 69.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.532 -0.758 . . . . 0.33000000000000002 110.856 -177.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -70.51 -40.04 73.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.067 -0.515 . . . . 2.1000000000000001 110.666 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.416 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -70.27 -41.26 73.69 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.259 -0.645 . . . . 0.95999999999999996 109.259 -178.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.769 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 21.9 mmt180 -71.33 -21.44 62.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.28 -0.873 . . . . 3.5699999999999998 110.67 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.536 HD11 ' CZ ' ' A' ' 31' ' ' PHE . 2.4 tt -70.99 -58.22 3.79 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.938 -0.574 . . . . 1.6499999999999999 110.443 175.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 m -100.71 90.04 4.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.599 0.714 . . . . 1.53 111.862 -171.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.709 ' HE2' ' O ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -110.42 118.19 35.6 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.766 -1.106 . . . . 2.7200000000000002 109.34 170.476 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -68.54 31.62 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.989 0.515 . . . . 4.3799999999999999 111.614 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 99' ' ' LYS . 14.2 m -139.07 -27.82 0.8 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.292 -0.413 . . . . 2.5099999999999998 110.997 -173.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.535 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 66.3 mm-40 -67.13 143.1 56.82 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 110.165 -0.309 . . . . 3.3999999999999999 110.165 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -94.27 -10.02 34.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.391 0.615 . . . . 2.6800000000000002 109.985 176.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.696 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 6.2 p -152.32 148.42 14.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.482 -0.781 . . . . 0.44 109.482 -175.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.583 HG13 HD21 ' A' ' 81' ' ' ASN . 55.5 t -117.04 117.94 57.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 122.051 0.929 . . . . 0.46000000000000002 111.53 -177.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.725 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.2 OUTLIER -99.29 133.02 44.19 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 113.426 -1.716 . . . . 1.76 110.305 -175.432 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.66 HD22 HD11 ' A' ' 71' ' ' LEU . 22.2 tp -134.63 134.69 41.49 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.541 -0.3 . . . . 1.1200000000000001 110.901 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.906 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 40.0 tp -115.53 114.3 24.79 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 106.843 -1.54 . . . . 0.41999999999999998 106.843 172.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 1.045 HG23 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -129.4 149.9 34.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 120.122 -0.631 . . . . 0.77000000000000002 110.488 -171.545 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.609 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -97.65 115.62 28.28 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.637 0.732 . . . . 0.34000000000000002 109.898 171.456 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.896 ' HB2' HE22 ' A' ' 72' ' ' GLN . 0.3 OUTLIER -99.61 136.71 39.13 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.006 -1.452 . . . . 2.0099999999999998 109.596 -173.231 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.522 ' N ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -106.57 -56.99 2.11 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.104 -1.038 . . . . 1.97 112.762 -177.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.44 ' H ' HD22 ' A' ' 114' ' ' LEU . 23.2 t -174.95 27.83 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.609 -0.436 . . . . 1.6200000000000001 112.125 -175.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 1.034 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.402 0 O-C-N 121.913 -0.492 . . . . 1.6499999999999999 110.583 -175.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.442 -0.837 0 CA-C-O 121.731 0.777 . . . . 2.0899999999999999 109.56 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.19 170.81 9.42 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.091 -1.413 . . . . 0.95999999999999996 111.084 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.9 m -111.4 161.89 9.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.936 -1.029 . . . . 1.5700000000000001 109.084 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.571 HG22 HG23 ' A' ' 110' ' ' THR . 94.6 t -106.55 119.99 56.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.267 0.556 . . . . 1.02 111.388 -176.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.993 HE22 HG13 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -111.47 155.49 23.14 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.507 0.67 . . . . 1.3899999999999999 111.035 174.724 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.06 110.65 13.17 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.754 -0.657 . . . . 3.6299999999999999 110.156 -172.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.065 ' HB ' ' HB1' ' A' ' 69' ' ' ALA . 12.7 m -106.29 149.58 9.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 119.434 -0.907 . . . . 1.02 110.325 176.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -145.23 121.37 10.8 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.005 -0.543 . . . . 1.3500000000000001 109.953 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.543 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 10.9 tp -142.34 143.64 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 108.256 -1.016 . . . . 0.60999999999999999 108.256 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.834 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.0 m-70 -74.96 117.67 17.06 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.307 -0.557 . . . . 0.59999999999999998 109.528 -176.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.562 ' HD3' ' HG ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -29.47 127.16 0.11 Allowed 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.776 1.297 . . . . 4.0 111.256 177.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.416 ' HB3' ' HB ' ' A' ' 28' ' ' ILE . 45.6 tp -98.05 101.74 13.3 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.252 0.548 . . . . 0.55000000000000004 110.478 -173.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -69.43 135.49 50.31 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.371 0.605 . . . . 3.9700000000000002 111.366 -176.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -128.86 93.59 3.64 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.433 -0.951 . . . . 1.3500000000000001 108.433 174.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.21 -87.94 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.772 -0.931 . . . . 1.3300000000000001 110.772 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.52 14.34 4.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.324 0.583 . . . . 2.3300000000000001 110.776 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -108.98 159.76 16.56 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.682 -0.69 . . . . 1.8700000000000001 109.492 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.562 ' HG ' ' HD3' ' A' ' 20' ' ' LYS . 9.0 mp -112.77 119.18 37.14 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 109.062 -0.718 . . . . 2.2799999999999998 109.062 174.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 40.5 mm -98.73 109.55 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 115.415 -0.811 . . . . 0.80000000000000004 109.981 -176.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.576 HD13 HD13 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -83.93 -25.61 29.98 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.463 -1.244 . . . . 1.74 109.088 175.355 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.442 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 93.67 -27.11 13.14 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.119 -0.946 . . . . 0.68999999999999995 112.673 174.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.631 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 32.8 p90 -110.43 151.32 27.65 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 122.291 -0.535 . . . . 0.51000000000000001 111.384 -173.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.545 ' H ' ' HB2' ' A' ' 59' ' ' ARG . 10.2 t -101.82 158.43 16.13 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 107.578 -1.267 . . . . 0.53000000000000003 107.578 175.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.407 HG12 ' N ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -160.19 143.04 4.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 C-N-CA 120.158 -0.617 . . . . 0.48999999999999999 112.529 -163.739 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.447 ' HA2' ' CD2' ' A' ' 90' ' ' HIS . . . -139.51 118.28 1.48 Allowed Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 110.007 -1.237 . . . . 0.71999999999999997 110.007 154.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 1.029 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.39 119.06 1.43 Allowed Glycine 0 CA--C 1.491 -1.419 0 CA-C-O 118.518 -1.157 . . . . 1.4199999999999999 111.42 172.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.671 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.29 146.49 10.78 Favored Glycine 0 C--N 1.303 -1.3 0 C-N-CA 117.304 -2.379 . . . . 0.47999999999999998 113.1 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.471 HG12 ' N ' ' A' ' 88' ' ' VAL . 1.1 pt -68.43 -19.74 24.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 107.562 -1.273 . . . . 0.52000000000000002 107.562 151.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.774 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 2.5 t70 -58.8 -36.6 74.75 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.026 -1.443 . . . . 0.71999999999999997 109.541 168.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 . . . . . 0 C--N 1.338 0.067 0 CA-C-N 114.73 -1.123 . . . . 1.1899999999999999 109.793 -176.843 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.567 0 N-CA-C 111.613 -0.595 . . . . 0.78000000000000003 111.613 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.029 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -111.32 143.89 20.28 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 N-CA-C 106.846 -1.539 . . . . 0.54000000000000004 106.846 172.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.767 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -154.96 148.35 25.11 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 120.155 1.343 . . . . 1.4199999999999999 112.039 -178.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.842 HG12 ' H ' ' A' ' 75' ' ' ASP . 1.5 p -87.49 136.68 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-N 114.529 -1.214 . . . . 0.57999999999999996 110.421 -175.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.2 m -105.34 -11.97 16.25 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.116 -0.947 . . . . 1.1100000000000001 110.697 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.897 ' HA ' HG23 ' A' ' 73' ' ' ILE . 41.3 mtt180 -145.54 -170.11 3.38 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.083 0.771 . . . . 2.27 113.083 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 59' ' ' ARG . 53.2 t -170.33 146.37 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.37 1.868 . . . . 0.82999999999999996 106.627 167.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.4 p -97.48 123.49 41.36 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.674 0.75 . . . . 1.6499999999999999 112.088 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -66.0 112.34 3.79 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 113.658 -1.61 . . . . 1.8500000000000001 110.359 169.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.76 -3.03 48.91 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.164 -0.925 . . . . 0.92000000000000004 112.634 -177.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.566 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -91.52 -139.66 8.63 Favored Glycine 0 CA--C 1.501 -0.835 0 C-N-CA 120.367 -0.921 . . . . 0.98999999999999999 111.785 178.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.523 ' HB2' HG21 ' A' ' 18' ' ' ILE . 77.6 Cg_endo -102.07 -50.07 0.01 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 122.73 2.287 . . . . 0.44 114.959 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.631 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -50.45 -29.46 10.38 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.589 0.959 . . . . 0.35999999999999999 113.589 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -71.46 -32.22 68.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.745 0.784 . . . . 1.79 109.463 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.566 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.5 mp -79.08 -36.54 18.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.444 -1.253 . . . . 0.51000000000000001 108.516 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.065 ' HB1' ' HB ' ' A' ' 16' ' ' VAL . . . -66.17 -35.11 79.6 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.409 -1.268 . . . . 0.40999999999999998 109.91 173.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.43 33.15 2.77 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.223 -0.989 . . . . 0.45000000000000001 114.233 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.453 HD21 HG21 ' A' ' 57' ' ' VAL . 17.8 tp -90.66 154.79 19.31 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.466 -0.568 . . . . 0.89000000000000001 109.466 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.491 HE22 ' HG3' ' A' ' 111' ' ' ARG . 4.6 mt-30 -129.34 31.89 4.76 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 115.449 1.648 . . . . 1.21 115.449 -165.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.897 HG23 ' HA ' ' A' ' 59' ' ' ARG . 58.1 mt 71.33 2.1 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 CA-C-N 118.993 0.815 . . . . 0.77000000000000002 113.188 167.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.17 46.19 0.25 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 119.58 -1.295 . . . . 0.37 112.439 -170.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.842 ' H ' HG12 ' A' ' 57' ' ' VAL . 20.0 m-20 -119.83 142.31 48.74 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.331 -0.435 . . . . 0.89000000000000001 110.864 -169.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.767 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 13.0 mptt -96.68 102.64 14.46 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.803 0.811 . . . . 2.2000000000000002 111.0 -171.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.823 HG13 HG23 ' A' ' 109' ' ' VAL . 2.8 mp -63.05 123.42 15.78 Favored 'Isoleucine or valine' 0 C--O 1.255 1.342 0 CA-C-N 115.274 -0.876 . . . . 0.48999999999999999 112.505 -178.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.881 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 2.0 mmt -91.74 -18.99 23.09 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 113.494 -1.685 . . . . 1.0600000000000001 111.281 173.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.617 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 4.3 tt0 -172.03 151.53 2.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.071 -0.513 . . . . 0.81999999999999995 111.876 -174.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.776 HG12 ' HE1' ' A' ' 85' ' ' MET . 9.8 p -145.53 127.21 8.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.729 -0.669 . . . . 1.3100000000000001 109.735 173.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 58.44 20.0 7.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.75 -0.659 . . . . 1.5 111.874 178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.69 -7.86 53.88 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 119.733 -1.222 . . . . 0.38 113.368 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 68.0 m95 -85.21 159.85 20.02 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 117.451 0.626 . . . . 0.77000000000000002 110.014 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -102.46 113.72 27.3 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.668 -0.696 . . . . 1.8899999999999999 111.454 -172.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.776 ' HE1' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -104.57 100.58 10.25 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 122.667 1.222 . . . . 1.01 110.116 179.219 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.6 p -142.16 -49.9 0.38 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 112.854 -1.975 . . . . 1.05 105.83 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.415 ' HA ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -133.97 75.15 1.58 Allowed 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 112.178 -2.283 . . . . 1.6200000000000001 108.828 173.4 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.758 ' O ' HD11 ' A' ' 55' ' ' ILE . 1.2 t -132.72 138.55 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 108.007 -1.108 . . . . 1.0900000000000001 108.007 177.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.719 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 68.8 p -59.5 152.16 22.48 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.884 -0.51 . . . . 0.34999999999999998 112.018 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.81 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 16.5 t-160 -57.25 -38.0 73.19 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-O 122.516 1.15 . . . . 0.34999999999999998 109.925 -177.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.402 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 5.1 p-10 -71.66 -31.78 67.18 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 112.79 -2.005 . . . . 1.6699999999999999 109.889 -177.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.717 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.5 OUTLIER -65.55 -39.15 91.38 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 108.158 -1.053 . . . . 0.77000000000000002 108.158 179.842 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.594 ' HB2' HG12 ' A' ' 55' ' ' ILE . . . -74.75 -41.6 59.78 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.439 -1.255 . . . . 0.33000000000000002 109.793 -176.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -68.22 -37.79 81.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.287 -0.869 . . . . 2.1000000000000001 110.661 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.504 ' HD3' ' HD2' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -70.97 -30.09 66.26 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.012 0.434 . . . . 0.95999999999999996 109.844 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.717 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 9.4 mmm180 -76.23 -24.35 54.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.223 -0.444 . . . . 3.5699999999999998 111.881 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.576 HD13 HD13 ' A' ' 29' ' ' LEU . 3.3 pp -96.92 -8.26 31.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.236 0.458 . . . . 1.6499999999999999 112.236 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.55 HG23 ' HB2' ' A' ' 27' ' ' LEU . 31.5 m -145.02 97.6 3.04 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.183 0.516 . . . . 1.53 111.225 174.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.482 ' HG3' ' HB2' ' A' ' 101' ' ' SER . 5.2 ptpp? -142.56 9.7 1.81 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.592 -0.731 . . . . 2.7200000000000002 112.403 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 39.4 mtm-85 63.96 24.15 13.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.61 -0.723 . . . . 4.3799999999999999 110.886 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.482 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 69.8 m -153.63 83.95 1.17 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.335 0.588 . . . . 2.5099999999999998 110.46 -178.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.444 ' C ' ' H ' ' A' ' 104' ' ' VAL . 1.2 pm0 -163.0 -44.74 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.538 -0.755 . . . . 3.3999999999999999 110.085 178.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 71.76 -41.97 0.52 Allowed 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.34 1.025 . . . . 2.6800000000000002 111.045 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.834 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 2.7 p -133.33 133.4 57.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.351 -1.352 . . . . 0.44 107.351 176.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 53.3 t -109.85 119.37 58.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 122.151 0.976 . . . . 0.46000000000000002 112.198 -171.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.93 123.05 41.74 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 113.397 -1.729 . . . . 1.76 109.803 -176.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.509 HD11 HG12 ' A' ' 77' ' ' ILE . 11.1 tp -131.42 116.76 17.93 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.656 -0.702 . . . . 1.1200000000000001 111.171 -173.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.881 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 41.0 tp -104.31 117.87 35.24 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.611 -1.255 . . . . 0.41999999999999998 107.611 177.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.823 HG23 HG13 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -131.35 152.4 37.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-O 121.38 0.61 . . . . 0.77000000000000002 110.803 -173.092 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.571 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -97.53 117.21 31.28 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.721 -0.672 . . . . 0.34000000000000002 110.321 171.429 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.644 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 30.7 ttt180 -97.76 136.48 38.03 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.597 -1.183 . . . . 2.0099999999999998 110.375 -177.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.437 ' N ' ' CD ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -123.02 -70.61 0.76 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.753 0.649 . . . . 1.97 112.753 -174.181 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.09 27.79 0.52 Allowed 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.266 -0.574 . . . . 1.6200000000000001 112.418 -170.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 114' ' ' LEU . 2.3 mm? . . . . . 0 C--N 1.323 -0.545 0 CA-C-O 121.485 0.66 . . . . 1.6499999999999999 110.11 177.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.446 -0.668 0 CA-C-O 123.283 1.516 . . . . 2.0899999999999999 111.078 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.3 179.05 5.31 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 112.087 -2.324 . . . . 0.95999999999999996 109.758 173.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.17 108.41 25.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.328 -0.396 . . . . 1.5700000000000001 110.386 -174.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.709 HG22 HG23 ' A' ' 110' ' ' THR . 26.1 t -76.83 98.52 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.291 0.567 . . . . 1.02 110.203 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.992 HE22 HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -103.3 165.02 11.28 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.68 -0.691 . . . . 1.3899999999999999 111.122 178.259 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.505 ' HD2' ' H ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -126.07 116.98 22.24 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.704 -0.623 . . . . 3.6299999999999999 110.987 -178.791 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.992 HG23 HE22 ' A' ' 14' ' ' GLN . 4.9 t -88.85 127.41 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 115.303 -0.862 . . . . 1.02 109.597 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 31.9 tt0 -131.03 116.99 18.52 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.437 -0.579 . . . . 1.3500000000000001 109.437 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 18' ' ' ILE . 10.1 tp -145.1 146.43 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 108.562 -0.903 . . . . 0.60999999999999999 108.562 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.754 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.3 m-70 -68.85 119.14 12.74 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.175 -0.676 . . . . 0.59999999999999998 109.175 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.869 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -37.44 133.41 0.73 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.944 0.778 . . . . 4.0 110.105 171.782 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.5 tp -94.02 85.9 4.86 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.959 0.885 . . . . 0.55000000000000004 109.747 -170.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -84.55 139.33 32.2 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.15 -1.386 . . . . 3.9700000000000002 111.783 -174.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.532 ' HG3' HD13 ' A' ' 28' ' ' ILE . 2.9 mt-30 -139.47 94.14 2.75 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.125 -0.943 . . . . 1.3500000000000001 109.145 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.68 -73.6 0.24 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.014 -0.612 . . . . 1.3300000000000001 112.547 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -139.45 1.69 1.98 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.416 0.627 . . . . 2.3300000000000001 110.388 -177.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -114.06 120.63 41.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.567 -0.742 . . . . 1.8700000000000001 109.465 -173.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.537 HD22 ' HA ' ' A' ' 100' ' ' ARG . 7.6 mp -103.09 116.62 32.86 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.103 -0.703 . . . . 2.2799999999999998 109.103 176.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.532 HD13 ' HG3' ' A' ' 23' ' ' GLN . 1.8 mp -96.01 126.5 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 115.493 -0.776 . . . . 0.80000000000000004 110.2 -172.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.464 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -103.38 109.12 20.63 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.334 -1.303 . . . . 1.74 108.041 174.037 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.671 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -77.92 43.5 2.2 Favored Glycine 0 C--O 1.216 -0.987 0 C-N-CA 121.016 -0.611 . . . . 0.68999999999999995 112.574 -175.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.601 ' HB2' ' CG2' ' A' ' 57' ' ' VAL . 40.0 p90 -159.7 147.15 16.84 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.417 -1.327 . . . . 0.51000000000000001 107.417 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.639 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -102.4 163.82 12.02 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 118.466 -1.294 . . . . 0.53000000000000003 107.605 176.184 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.532 HD12 HD21 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -154.26 139.83 10.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 119.242 -0.983 . . . . 0.48999999999999999 113.0 -168.261 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.421 ' N ' HG12 ' A' ' 33' ' ' ILE . . . -141.09 118.07 1.32 Allowed Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 109.83 -1.308 . . . . 0.71999999999999997 109.83 154.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.999 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -142.39 117.69 1.18 Allowed Glycine 0 C--N 1.302 -1.323 0 CA-C-O 118.251 -1.305 . . . . 1.4199999999999999 111.577 170.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.645 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.8 141.93 7.26 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 117.641 -2.219 . . . . 0.47999999999999998 113.507 175.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.439 HG23 ' HA ' ' A' ' 87' ' ' MET . 13.7 pt -61.9 -20.37 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 N-CA-C 107.363 -1.347 . . . . 0.52000000000000002 107.363 151.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.834 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 3.0 t70 -59.32 -43.95 92.65 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 113.588 -1.642 . . . . 0.71999999999999997 109.759 171.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 . . . . . 0 CA--C 1.533 0.309 0 CA-C-N 115.008 -0.996 . . . . 1.1899999999999999 109.967 -178.489 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 110.064 -1.214 . . . . 0.78000000000000003 110.064 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.999 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -116.5 135.06 57.98 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.145 0 N-CA-C 107.423 -1.325 . . . . 0.54000000000000004 107.423 174.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.707 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -152.49 150.53 29.71 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.052 0.842 . . . . 1.4199999999999999 111.485 -177.245 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.611 HG12 ' H ' ' A' ' 75' ' ' ASP . 10.0 p -93.5 133.58 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 114.574 -1.193 . . . . 0.57999999999999996 111.191 -169.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.639 ' O ' ' HB3' ' A' ' 32' ' ' SER . 32.6 m -123.89 70.32 1.07 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.803 -1.09 . . . . 1.1100000000000001 109.479 174.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 1.003 ' HA ' HG23 ' A' ' 73' ' ' ILE . 41.8 mtt180 151.73 177.25 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 125.47 1.508 . . . . 2.27 110.823 163.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.649 HG13 ' HB3' ' A' ' 66' ' ' ALA . 91.7 t -161.36 138.49 2.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 125.432 1.707 . . . . 0.82999999999999996 107.249 163.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.7 p -86.16 122.93 30.86 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.191 0.519 . . . . 1.6499999999999999 110.87 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -48.67 117.3 1.97 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.315 -1.311 . . . . 1.8500000000000001 111.855 171.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.15 12.3 84.75 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.656 -0.783 . . . . 0.92000000000000004 113.222 173.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.529 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -87.29 -132.63 3.63 Favored Glycine 0 C--O 1.22 -0.755 0 C-N-CA 119.942 -1.123 . . . . 0.98999999999999999 111.31 174.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.671 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 97.6 Cg_endo -101.15 -42.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.538 2.159 . . . . 0.44 115.463 177.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.649 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -64.48 -27.1 68.75 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.0 -0.546 . . . . 0.35999999999999999 111.898 -173.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -70.81 -33.34 70.6 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.652 0.739 . . . . 1.79 109.151 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -71.48 -40.37 72.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.496 -1.229 . . . . 0.51000000000000001 110.627 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.732 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -77.61 -15.59 59.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.40999999999999998 110.626 177.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.0 47.68 2.83 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.124 -1.036 . . . . 0.45000000000000001 114.123 173.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.454 HD21 HG21 ' A' ' 57' ' ' VAL . 19.7 tp -97.68 149.98 21.68 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.94 -0.763 . . . . 0.89000000000000001 108.94 176.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.773 HE22 ' HG3' ' A' ' 111' ' ' ARG . 7.6 mt-30 -122.56 33.31 5.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 114.576 1.324 . . . . 1.21 114.576 -165.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.003 HG23 ' HA ' ' A' ' 59' ' ' ARG . 56.2 mt 72.05 -1.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 113.185 0.809 . . . . 0.77000000000000002 113.185 165.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -173.08 52.23 0.16 Allowed Glycine 0 CA--C 1.509 -0.298 0 C-N-CA 120.084 -1.055 . . . . 0.37 111.999 -164.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.611 ' H ' HG12 ' A' ' 57' ' ' VAL . 43.9 m-20 -120.48 149.67 42.02 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.157 -0.521 . . . . 0.89000000000000001 110.603 -172.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.707 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -95.4 101.54 13.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.332 -0.394 . . . . 2.2000000000000002 110.593 -173.71 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.662 HD12 ' HA ' ' A' ' 56' ' ' TYR . 4.3 mt -72.72 123.01 26.55 Favored 'Isoleucine or valine' 0 C--O 1.261 1.669 0 CA-C-O 121.434 0.635 . . . . 0.48999999999999999 112.424 -175.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.758 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 4.2 mmt -89.92 -19.49 24.49 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 113.242 -1.799 . . . . 1.0600000000000001 112.286 176.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.551 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -172.39 157.21 3.99 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.184 0.438 . . . . 0.81999999999999995 112.184 -174.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.614 HG12 ' SD ' ' A' ' 85' ' ' MET . 12.3 p -141.59 122.74 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.247 0.546 . . . . 1.3100000000000001 110.712 171.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.7 m120 50.1 36.5 12.29 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.371 -0.831 . . . . 1.5 112.192 176.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.67 -18.66 49.87 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.451 -0.88 . . . . 0.38 113.244 175.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 52.9 m95 -81.84 149.39 28.34 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 109.684 -0.488 . . . . 0.77000000000000002 109.684 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -95.91 116.33 28.76 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.635 -0.711 . . . . 1.8899999999999999 111.0 -175.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.614 ' SD ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -105.8 99.36 8.96 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 122.626 1.203 . . . . 1.01 110.177 177.567 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.1 p -138.09 -44.42 0.51 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.112 -1.858 . . . . 1.05 106.765 173.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.439 ' HA ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -148.46 75.15 1.31 Allowed 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.514 -1.676 . . . . 1.6200000000000001 109.674 177.284 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.645 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -140.96 154.25 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 108.779 -0.823 . . . . 1.0900000000000001 108.779 173.723 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.705 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 74.7 p -60.01 151.95 25.09 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 113.168 0.803 . . . . 0.34999999999999998 113.168 -173.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.834 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 21.5 t-160 -58.81 -40.37 83.92 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 115.74 -0.664 . . . . 0.34999999999999998 110.092 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -66.17 -31.01 71.6 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.13 -1.395 . . . . 1.6699999999999999 109.838 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.59 ' HB3' ' O ' ' A' ' 89' ' ' THR . 1.9 tp-100 -63.63 -51.81 63.57 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.677 0.751 . . . . 0.77000000000000002 109.514 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.538 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -72.54 -33.38 66.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.935 -1.029 . . . . 0.33000000000000002 109.801 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 90' ' ' HIS . 11.3 ttp180 -61.77 -48.46 80.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.2 -0.909 . . . . 2.1000000000000001 110.642 -177.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.651 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -70.52 -28.45 64.95 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 119.768 -0.773 . . . . 0.95999999999999996 110.647 -179.738 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.559 ' HD2' ' HD3' ' A' ' 95' ' ' LYS . 1.8 mmm180 -70.0 -41.66 74.07 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.196 -0.601 . . . . 3.5699999999999998 112.155 -177.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.557 ' HB3' HG21 ' A' ' 80' ' ' VAL . 3.3 pp -80.58 -25.21 38.64 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.636 -0.426 . . . . 1.6499999999999999 110.965 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.472 ' N ' HD12 ' A' ' 97' ' ' LEU . 21.5 m -153.68 95.27 1.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.442 0.639 . . . . 1.53 111.436 178.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.651 ' HB3' ' O ' ' A' ' 95' ' ' LYS . 7.0 ptpt -112.67 9.89 19.32 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.454 -0.794 . . . . 2.7200000000000002 109.118 174.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.537 ' HA ' HD22 ' A' ' 27' ' ' LEU . 11.9 mtt180 70.01 19.05 7.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.09 -1.414 . . . . 4.3799999999999999 111.904 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.6 t -137.29 9.96 2.98 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 120.623 -0.431 . . . . 2.5099999999999998 111.827 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.492 ' HB2' ' HG3' ' A' ' 20' ' ' LYS . 6.1 mm-40 -85.39 148.48 25.99 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.998 0.428 . . . . 3.3999999999999999 111.398 -177.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.547 ' HG3' HG12 ' A' ' 104' ' ' VAL . 7.3 pt-20 -95.83 -49.71 5.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.881 -0.6 . . . . 2.6800000000000002 110.702 178.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.754 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 2.6 p -143.69 142.14 25.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.166 -1.05 . . . . 0.44 108.166 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.761 HG21 ' HG2' ' A' ' 20' ' ' LYS . 42.1 t -123.3 117.85 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 CA-C-O 122.22 1.01 . . . . 0.46000000000000002 112.403 -164.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -101.16 127.32 47.78 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 112.865 -1.97 . . . . 1.76 109.954 -174.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.523 HD11 HG12 ' A' ' 77' ' ' ILE . 20.7 tp -130.87 124.4 31.12 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.915 -0.584 . . . . 1.1200000000000001 109.587 -174.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.605 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 33.9 tp -100.31 119.84 39.02 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.247 -1.761 . . . . 0.41999999999999998 106.247 176.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.705 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -126.6 150.66 32.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.239 0.542 . . . . 0.77000000000000002 109.946 -171.763 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.709 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -98.07 115.13 27.6 Favored 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 119.436 -0.906 . . . . 0.34000000000000002 109.421 168.266 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.773 ' HG3' HE22 ' A' ' 72' ' ' GLN . 7.9 ttm180 -105.39 149.23 26.3 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.384 -1.28 . . . . 2.0099999999999998 110.704 -171.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.467 HE21 HD11 ' A' ' 114' ' ' LEU . 0.9 OUTLIER -138.29 -156.22 0.67 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.352 -0.981 . . . . 1.97 108.352 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.03 72.5 8.37 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.846 0.831 . . . . 1.6200000000000001 112.223 -171.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.507 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 3.3 mt . . . . . 0 C--N 1.31 -1.114 0 CA-C-N 114.445 -1.252 . . . . 1.6499999999999999 107.734 175.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.438 -1.07 0 CA-C-O 122.64 1.21 . . . . 2.0899999999999999 110.115 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.76 132.35 37.03 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 113.01 -1.905 . . . . 0.95999999999999996 108.584 170.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 p -107.23 123.45 62.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.047 -0.524 . . . . 1.5700000000000001 110.231 -173.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.983 HG12 HG23 ' A' ' 110' ' ' THR . 1.0 OUTLIER -81.33 128.2 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 121.861 0.838 . . . . 1.02 111.124 -173.564 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.869 HE22 HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -101.87 167.34 10.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.92 -1.036 . . . . 1.3899999999999999 111.172 173.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.502 ' N ' HE21 ' A' ' 14' ' ' GLN . 0.0 OUTLIER -124.82 106.83 10.33 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.688 -0.687 . . . . 3.6299999999999999 110.027 -174.109 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.869 HG23 HE22 ' A' ' 14' ' ' GLN . 1.5 t -104.78 133.19 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 109.857 -0.423 . . . . 1.02 109.857 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -137.81 126.66 23.99 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.778 -0.453 . . . . 1.3500000000000001 109.778 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 9.8 tp -142.91 161.57 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 108.239 -1.023 . . . . 0.60999999999999999 108.239 -178.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -95.2 113.09 24.73 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.822 -0.751 . . . . 0.59999999999999998 109.838 -175.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.854 ' HB2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -26.8 130.01 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 125.125 1.515 . . . . 4.0 112.341 179.544 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 36.1 tp -100.61 95.76 6.9 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 119.936 -0.705 . . . . 0.55000000000000004 109.208 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 22' ' ' ARG . 16.5 ptt180 -74.67 140.02 43.92 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.499 -0.773 . . . . 3.9700000000000002 111.54 -172.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.526 ' HB2' HD13 ' A' ' 28' ' ' ILE . 4.3 tp-100 -134.58 93.99 3.13 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.393 -0.966 . . . . 1.3500000000000001 108.393 177.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.07 -83.28 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.686 -0.768 . . . . 1.3300000000000001 111.545 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.786 ' HB3' HH11 ' A' ' 100' ' ' ARG . 30.5 mt-10 -132.38 8.24 4.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.926 0.393 . . . . 2.3300000000000001 110.572 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -109.02 166.97 10.43 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.257 -0.428 . . . . 1.8700000000000001 110.762 -173.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.994 HD23 ' HA ' ' A' ' 98' ' ' THR . 4.9 tp -119.91 122.86 42.2 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.78 -0.646 . . . . 2.2799999999999998 109.388 173.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.526 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.7 mp -98.44 113.83 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 107.66 -1.237 . . . . 0.80000000000000004 107.66 173.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.859 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.1 pt? -95.02 -15.31 23.58 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.053 -0.976 . . . . 1.74 110.833 -173.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.513 ' CA ' ' HD2' ' A' ' 65' ' ' PRO . . . 87.06 -9.65 71.66 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.45 -0.881 . . . . 0.68999999999999995 113.718 172.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.788 ' HD1' ' HB2' ' A' ' 66' ' ' ALA . 48.5 p90 -133.43 165.72 24.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.296 0.548 . . . . 0.51000000000000001 110.801 178.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.696 ' HB3' ' O ' ' A' ' 58' ' ' THR . 7.8 t -106.07 171.56 7.28 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.41 -0.589 . . . . 0.53000000000000003 109.41 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.45 HG12 ' NE2' ' A' ' 90' ' ' HIS . 5.4 tt -150.17 131.83 5.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 C-N-CA 120.564 -0.454 . . . . 0.48999999999999999 111.675 -167.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -102.97 171.66 20.94 Favored Glycine 0 C--O 1.237 0.341 0 N-CA-C 110.693 -0.963 . . . . 0.71999999999999997 110.693 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.989 ' HA3' ' NE2' ' A' ' 39' ' ' GLN . . . -114.6 169.3 12.82 Favored Glycine 0 N--CA 1.42 -2.389 0 N-CA-C 118.855 2.302 . . . . 1.4199999999999999 118.855 -160.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 88' ' ' VAL . . . -87.58 -162.14 37.53 Favored Glycine 0 N--CA 1.415 -2.726 0 CA-C-N 110.073 -3.063 . . . . 0.47999999999999998 113.5 -165.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.55 HD13 ' O ' ' A' ' 87' ' ' MET . 27.5 pt -55.88 -9.6 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.434 0.635 . . . . 0.52000000000000002 111.002 168.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 1.025 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 0.2 OUTLIER -59.92 -40.73 89.9 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.262 -0.881 . . . . 0.71999999999999997 109.629 173.424 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.989 ' NE2' ' HA3' ' A' ' 35' ' ' GLY . 28.4 mt-30 . . . . . 0 CA--C 1.502 -0.899 0 CA-C-N 114.788 -1.096 . . . . 1.1899999999999999 110.956 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.452 0 N-CA-C 111.63 -0.588 . . . . 0.78000000000000003 111.63 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.546 HG22 ' CD1' ' A' ' 77' ' ' ILE . 2.2 mp -99.93 132.39 45.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 108.347 -0.983 . . . . 0.54000000000000004 108.347 168.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.561 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -155.01 138.76 16.17 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 120.898 0.38 . . . . 1.4199999999999999 110.339 -170.369 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.575 ' CG1' ' H ' ' A' ' 75' ' ' ASP . 8.6 p -67.38 129.37 31.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.648 -0.706 . . . . 0.57999999999999996 110.484 -176.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.696 ' O ' ' HB3' ' A' ' 32' ' ' SER . 18.5 m -125.64 59.59 1.28 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.463 -0.79 . . . . 1.1100000000000001 109.896 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.624 ' HA ' HG23 ' A' ' 73' ' ' ILE . 13.9 mtt180 154.49 -179.88 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 126.084 1.754 . . . . 2.27 109.979 167.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.635 HG13 ' HB3' ' A' ' 66' ' ' ALA . 88.0 t -166.7 125.71 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 O-C-N 125.638 1.836 . . . . 0.82999999999999996 106.348 163.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.8 m -85.15 128.27 34.59 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.889 -0.725 . . . . 1.6499999999999999 109.259 174.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -65.15 106.36 1.29 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.374 -0.83 . . . . 1.8500000000000001 110.4 174.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 120.64 -21.56 8.48 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.27 -1.332 . . . . 0.92000000000000004 110.396 -173.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.502 ' O ' ' HB3' ' A' ' 67' ' ' GLU . . . -72.76 152.82 48.05 Favored Glycine 0 CA--C 1.495 -1.214 0 N-CA-C 111.384 -0.686 . . . . 0.98999999999999999 111.384 172.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.629 ' HA ' HD13 ' A' ' 68' ' ' ILE . 83.3 Cg_exo -47.13 -30.9 11.09 Favored 'Trans proline' 0 C--N 1.325 -0.659 0 C-N-CA 123.882 3.055 . . . . 0.44 114.17 -176.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.788 ' HB2' ' HD1' ' A' ' 31' ' ' PHE . . . -66.75 -26.73 67.12 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.016 -0.538 . . . . 0.35999999999999999 111.454 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 5.5 tp10 -68.36 -31.61 71.12 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.247 0.546 . . . . 1.79 109.821 174.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.629 HD13 ' HA ' ' A' ' 65' ' ' PRO . 2.7 mp -81.05 -36.78 15.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.807 -0.633 . . . . 0.51000000000000001 109.938 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.691 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -79.56 -31.79 42.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.553 -0.748 . . . . 0.40999999999999998 110.456 176.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.18 69.36 0.95 Allowed Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.442 -0.885 . . . . 0.45000000000000001 113.562 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.453 ' HB3' ' HB1' ' A' ' 66' ' ' ALA . 21.9 tp -116.05 158.32 23.33 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.738 -0.468 . . . . 0.89000000000000001 109.738 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.543 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 5.1 mt-30 -125.43 29.81 5.94 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 115.196 1.554 . . . . 1.21 115.196 -163.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.624 HG23 ' HA ' ' A' ' 59' ' ' ARG . 82.6 mt 75.97 -10.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 N-CA-C 114.621 1.341 . . . . 0.77000000000000002 114.621 165.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -166.75 52.22 0.25 Allowed Glycine 0 N--CA 1.465 0.569 0 C-N-CA 118.983 -1.579 . . . . 0.37 113.432 -165.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.575 ' H ' ' CG1' ' A' ' 57' ' ' VAL . 17.6 m-20 -122.42 147.1 46.72 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.38 -0.41 . . . . 0.89000000000000001 110.407 -172.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.561 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 1.3 mptm? -91.74 120.85 32.84 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-O 121.014 0.435 . . . . 2.2000000000000002 110.673 -176.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.692 HG12 HD11 ' A' ' 107' ' ' LEU . 5.9 mt -80.3 120.46 31.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.172 0.511 . . . . 0.48999999999999999 112.206 -170.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.998 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 11.0 mmt -88.38 -20.97 24.59 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.507 -1.224 . . . . 1.0600000000000001 111.326 177.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.581 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -171.71 157.82 4.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.988 0.423 . . . . 0.81999999999999995 111.2 -178.609 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.624 HG21 ' HG ' ' A' ' 97' ' ' LEU . 9.5 p -146.55 126.53 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.985 -0.552 . . . . 1.3100000000000001 109.778 172.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 1.0 OUTLIER 62.64 9.72 3.69 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.015 -0.539 . . . . 1.5 112.213 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.89 -10.68 27.43 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.244 -0.979 . . . . 0.38 112.485 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.416 ' CD1' ' HB3' ' A' ' 96' ' ' ARG . 81.4 m95 -82.39 143.16 31.41 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 120.819 0.342 . . . . 0.77000000000000002 110.587 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -92.06 110.88 22.25 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.235 -0.893 . . . . 1.8899999999999999 111.84 -170.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.669 ' HE3' ' HA ' ' A' ' 93' ' ' ALA . 20.6 mmt -109.35 122.19 46.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.906 -0.588 . . . . 1.01 112.227 -175.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.5 p -137.38 -72.29 0.43 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.45 0.643 . . . . 1.05 109.281 167.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.55 ' O ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -125.19 62.39 1.18 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.272 -0.876 . . . . 1.6200000000000001 109.099 177.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.563 HG21 HE21 ' A' ' 92' ' ' GLN . 3.6 p -112.34 177.32 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 108.835 -0.802 . . . . 1.0900000000000001 108.835 177.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 1.025 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 63.1 p -72.22 153.07 41.8 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 118.283 0.492 . . . . 0.34999999999999998 111.432 -177.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.892 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 23.7 t-160 -56.78 -41.6 77.94 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 121.896 0.855 . . . . 0.34999999999999998 108.928 177.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -67.25 -30.35 70.23 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.186 -1.824 . . . . 1.6699999999999999 109.855 -175.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.816 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 2.4 tp-100 -59.65 -53.38 58.66 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.378 -0.601 . . . . 0.77000000000000002 109.378 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.669 ' HA ' ' HE3' ' A' ' 85' ' ' MET . . . -74.38 -30.62 62.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.654 -0.703 . . . . 0.33000000000000002 110.297 -176.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -63.35 -47.43 82.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.424 -0.807 . . . . 2.1000000000000001 110.47 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.408 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -71.84 -41.73 67.78 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.743 -0.662 . . . . 0.95999999999999996 109.823 -174.462 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.816 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 22.4 mmt180 -69.0 -24.3 64.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.927 -0.579 . . . . 3.5699999999999998 110.271 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.624 ' HG ' HG21 ' A' ' 80' ' ' VAL . 3.8 tt -79.93 -52.47 7.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.777 -0.647 . . . . 1.6499999999999999 110.86 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.994 ' HA ' HD23 ' A' ' 27' ' ' LEU . 5.3 m -94.83 92.05 6.75 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 122.685 1.231 . . . . 1.53 110.901 -169.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.491 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 3.6 mtmt -134.95 110.65 9.24 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 112.8 -2.0 . . . . 2.7200000000000002 109.552 -177.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.786 HH11 ' HB3' ' A' ' 25' ' ' GLU . 37.6 ptt180 -67.4 5.31 0.79 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.73 -0.668 . . . . 4.3799999999999999 112.105 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 99' ' ' LYS . 3.0 p -107.73 -23.26 12.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.496 -0.32 . . . . 2.5099999999999998 111.634 -174.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.404 ' HG2' ' HB3' ' A' ' 99' ' ' LYS . 81.0 mm-40 -68.16 151.61 46.73 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.193 -0.299 . . . . 3.3999999999999999 110.193 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -97.71 -20.27 17.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.313 0.578 . . . . 2.6800000000000002 110.315 175.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.29 145.27 18.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.783 -0.644 . . . . 0.44 109.51 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 74.5 t -113.53 118.35 57.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 122.089 0.947 . . . . 0.46000000000000002 111.709 -176.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.528 ' HD3' ' H ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -99.29 134.55 41.99 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 113.619 -1.628 . . . . 1.76 110.298 -176.239 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.692 HD11 HG12 ' A' ' 77' ' ' ILE . 37.0 tp -132.86 132.33 41.98 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.199 -0.455 . . . . 1.1200000000000001 110.596 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.998 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 40.1 tp -115.22 114.02 24.68 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.211 -1.774 . . . . 0.41999999999999998 106.211 171.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.698 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -127.26 150.38 33.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 109.991 -0.374 . . . . 0.77000000000000002 109.991 -171.331 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.983 HG23 HG12 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -95.88 121.26 37.43 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 120.32 -0.552 . . . . 0.34000000000000002 110.936 171.258 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.438 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 2.4 ttt180 -110.46 139.53 45.58 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.876 -1.056 . . . . 2.0099999999999998 110.987 -171.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.446 HE22 ' HA ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -122.63 -107.04 0.35 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.899 -0.591 . . . . 1.97 111.468 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.411 ' O ' HD23 ' A' ' 114' ' ' LEU . 13.9 t -131.91 81.08 1.95 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.635 0.731 . . . . 1.6200000000000001 110.579 -173.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.511 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 3.1 mt . . . . . 0 C--N 1.309 -1.159 0 CA-C-N 114.875 -1.057 . . . . 1.6499999999999999 109.518 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.6 p . . . . . 0 N--CA 1.429 -1.515 0 CA-C-O 122.461 1.124 . . . . 2.0899999999999999 110.413 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 111' ' ' ARG . . . -88.76 177.83 6.62 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.97 -1.923 . . . . 0.95999999999999996 110.618 176.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.67 129.59 40.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.658 -0.701 . . . . 1.5700000000000001 110.169 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.555 HG22 HG23 ' A' ' 110' ' ' THR . 45.1 t -77.04 112.93 15.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.969 0.414 . . . . 1.02 111.553 -175.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.706 HE22 HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -111.41 166.6 10.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.92 -0.582 . . . . 1.3899999999999999 109.98 171.478 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -120.93 138.64 54.02 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 120.797 -1.189 . . . . 3.6299999999999999 111.302 -176.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.706 HG23 HE22 ' A' ' 14' ' ' GLN . 19.7 t -108.29 108.57 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 CA-C-N 115.325 -0.852 . . . . 1.02 109.492 177.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -122.23 111.57 17.11 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.394 -0.821 . . . . 1.3500000000000001 109.532 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.81 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 10.8 tp -134.89 147.93 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 108.817 -0.809 . . . . 0.60999999999999999 108.817 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 14.2 m-70 -78.15 105.9 9.68 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.395 -0.965 . . . . 0.59999999999999998 108.395 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.648 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 2.5 pptp? -27.34 139.89 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 O-C-N 125.376 1.672 . . . . 4.0 112.924 -175.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 43.8 tp -93.62 85.8 4.99 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 122.175 0.988 . . . . 0.55000000000000004 109.703 -171.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.602 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -54.41 134.41 45.72 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 113.639 -1.619 . . . . 3.9700000000000002 112.136 -175.291 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.525 ' HB2' HD13 ' A' ' 28' ' ' ILE . 6.3 tp-100 -123.78 94.5 4.25 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.501 -1.227 . . . . 1.3500000000000001 108.471 176.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.77 -84.37 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.493 -0.86 . . . . 1.3300000000000001 111.289 -173.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -129.57 6.73 5.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.199 0.523 . . . . 2.3300000000000001 110.694 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 3.8 m-80 -110.71 -177.11 3.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.697 -0.683 . . . . 1.8700000000000001 109.871 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 20' ' ' LYS . 1.6 pt? -127.73 144.78 51.06 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.202 -1.036 . . . . 2.2799999999999998 108.202 172.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.525 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.1 mp -113.24 139.96 35.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-O 121.142 0.496 . . . . 0.80000000000000004 110.711 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -101.25 127.34 47.89 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.667 -1.152 . . . . 1.74 109.144 173.013 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.749 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -95.08 48.8 1.96 Allowed Glycine 0 C--O 1.22 -0.731 0 C-N-CA 120.165 -1.016 . . . . 0.68999999999999995 113.154 -172.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 35.3 p90 -158.52 163.1 37.39 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.634 -0.876 . . . . 0.51000000000000001 108.634 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.582 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.1 OUTLIER -105.14 161.06 14.58 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.865 -1.161 . . . . 0.53000000000000003 107.865 170.569 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -156.72 137.32 4.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 119.107 -1.037 . . . . 0.48999999999999999 113.757 -165.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.434 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -146.63 118.22 1.02 Allowed Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.43 -1.068 . . . . 0.71999999999999997 110.43 156.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 1.045 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.45 117.48 1.22 Allowed Glycine 0 CA--C 1.492 -1.356 0 CA-C-O 118.641 -1.088 . . . . 1.4199999999999999 111.401 172.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.541 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.29 143.25 8.12 Favored Glycine 0 C--N 1.299 -1.496 0 C-N-CA 117.929 -2.081 . . . . 0.47999999999999998 112.954 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.624 HG12 ' O ' ' A' ' 87' ' ' MET . 5.2 pt -59.89 -26.1 34.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 106.813 -1.551 . . . . 0.52000000000000002 106.813 151.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 1.003 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 6.0 t70 -53.08 -44.68 67.72 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 113.003 -1.908 . . . . 0.71999999999999997 110.752 173.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 . . . . . 0 CA--C 1.535 0.393 0 CA-C-N 114.811 -1.086 . . . . 1.1899999999999999 111.668 -172.497 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.202 0 N-CA-C 110.862 -0.895 . . . . 0.78000000000000003 110.862 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.045 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -114.76 138.39 45.08 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 109.018 -0.734 . . . . 0.54000000000000004 109.018 174.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.591 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -142.94 140.04 30.95 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 119.185 0.902 . . . . 1.4199999999999999 110.405 -176.23 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.68 HG12 ' H ' ' A' ' 75' ' ' ASP . 8.8 p -82.92 138.84 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 CA-C-N 114.623 -1.172 . . . . 0.57999999999999996 110.056 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.655 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 23.5 m -127.98 68.55 1.33 Allowed 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.153 -0.931 . . . . 1.1100000000000001 109.33 172.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.49 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 24.1 mtp180 148.54 -171.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.637 1.575 . . . . 2.27 111.001 162.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.582 HG13 ' HB3' ' A' ' 66' ' ' ALA . 58.4 t -162.14 143.5 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 125.543 1.777 . . . . 0.82999999999999996 107.622 164.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.3 p -86.65 133.84 33.66 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.611 0.719 . . . . 1.6499999999999999 110.88 175.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -71.45 105.62 3.64 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.195 -1.366 . . . . 1.8500000000000001 111.055 178.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.21 9.65 50.74 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 119.764 -1.208 . . . . 0.92000000000000004 113.093 176.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.606 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -90.18 -140.05 8.08 Favored Glycine 0 C--O 1.217 -0.938 0 C-N-CA 120.279 -0.962 . . . . 0.98999999999999999 111.082 175.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.749 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 66.0 Cg_endo -98.26 -32.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 122.475 2.116 . . . . 0.44 114.525 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.582 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -71.99 -22.83 61.37 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.906 -0.588 . . . . 0.35999999999999999 111.727 -174.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -71.96 -30.92 65.78 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.626 -0.879 . . . . 1.79 108.626 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.606 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -81.57 -44.18 20.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.539 -1.21 . . . . 0.51000000000000001 110.41 -176.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.81 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . . . -68.25 -26.4 65.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.936 -0.575 . . . . 0.40999999999999998 110.31 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.08 70.03 1.01 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.368 -0.92 . . . . 0.45000000000000001 113.278 177.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.565 HD21 HG21 ' A' ' 57' ' ' VAL . 13.9 tp -113.75 153.52 28.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.192 -0.669 . . . . 0.89000000000000001 109.192 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.678 HE22 ' HG3' ' A' ' 111' ' ' ARG . 12.3 mt-30 -123.65 29.36 6.6 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 114.83 1.419 . . . . 1.21 114.83 -166.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.655 ' O ' ' HA ' ' A' ' 58' ' ' THR . 2.9 mp 72.06 -12.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 N-CA-C 113.418 0.895 . . . . 0.77000000000000002 113.418 171.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -164.31 60.89 0.25 Allowed Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.225 -0.988 . . . . 0.37 111.407 -165.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.68 ' H ' HG12 ' A' ' 57' ' ' VAL . 17.4 m-20 -123.09 153.26 40.16 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.015 -0.593 . . . . 0.89000000000000001 109.593 -169.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.441 ' HD2' HE22 ' A' ' 112' ' ' GLN . 6.8 mptt -104.09 100.31 10.06 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.125 -0.63 . . . . 2.2000000000000002 109.77 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.991 HG13 HG23 ' A' ' 109' ' ' VAL . 4.8 mp -75.0 128.91 37.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.55 -0.75 . . . . 0.48999999999999999 110.053 -175.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.48 ' HE3' ' HB2' ' A' ' 78' ' ' MET . 0.0 OUTLIER -114.02 4.6 15.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 112.863 0.69 . . . . 1.0600000000000001 112.863 -179.067 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.568 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 2.2 tt0 -172.11 152.38 2.86 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 122.442 -0.161 . . . . 0.81999999999999995 111.095 176.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.786 HG21 ' HB3' ' A' ' 97' ' ' LEU . 7.0 p -150.06 130.81 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 121.237 0.541 . . . . 1.3100000000000001 111.317 175.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.515 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 14.3 m120 50.37 34.3 8.87 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.149 0.979 . . . . 1.5 112.787 176.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.32 3.62 64.95 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.482 -0.866 . . . . 0.38 113.24 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -99.74 161.61 13.51 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 109.524 -0.547 . . . . 0.77000000000000002 109.524 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -110.69 97.78 7.11 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.45 -0.795 . . . . 1.8899999999999999 110.082 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.776 ' HB2' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -107.45 98.15 7.8 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 122.151 0.977 . . . . 1.01 109.731 174.359 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.18 -10.57 13.85 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.982 -1.463 . . . . 1.05 107.841 175.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.624 ' O ' HG12 ' A' ' 37' ' ' ILE . 1.9 mtt -149.89 -42.29 0.13 Allowed 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 112.543 -2.117 . . . . 1.6200000000000001 108.905 -171.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.63 ' O ' HD11 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -22.68 141.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 C-N-CA 126.249 1.82 . . . . 1.0900000000000001 115.711 -177.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 1.003 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 49.7 p -58.17 154.1 13.72 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 112.475 0.546 . . . . 0.34999999999999998 112.475 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.773 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 22.1 t-160 -56.27 -44.42 79.74 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 115.988 -0.551 . . . . 0.34999999999999998 110.66 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.8 -31.76 68.61 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.13 -0.941 . . . . 1.6699999999999999 110.139 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.784 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.7 OUTLIER -64.36 -49.69 70.65 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.78 -0.822 . . . . 0.77000000000000002 108.78 -178.68 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.619 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -74.13 -32.88 63.35 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.709 -0.678 . . . . 0.33000000000000002 110.528 -177.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.525 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 35.1 ttp180 -64.16 -44.58 91.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 2.1000000000000001 109.991 177.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.449 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -67.02 -36.29 81.79 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.688 -0.687 . . . . 0.95999999999999996 109.481 -178.609 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.784 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 22.7 mmt180 -70.96 -23.9 62.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.988 -0.551 . . . . 3.5699999999999998 111.193 -176.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.786 ' HB3' HG21 ' A' ' 80' ' ' VAL . 3.4 pp -94.41 -15.09 24.6 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.964 -0.294 . . . . 1.6499999999999999 110.901 177.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.2 m -111.53 89.47 3.06 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.866 0.841 . . . . 1.53 110.888 -175.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.438 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 12.1 mtmt -136.7 103.99 5.39 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.476 -1.238 . . . . 2.7200000000000002 109.548 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.479 ' CB ' ' HA ' ' A' ' 26' ' ' ASN . 38.1 ptt180 -76.11 53.65 0.81 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.479 0.657 . . . . 4.3799999999999999 111.072 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.0 t -140.41 -51.43 0.48 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.533 -0.758 . . . . 2.5099999999999998 110.201 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 41.5 mt-10 -69.09 150.8 47.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.832 0.348 . . . . 3.3999999999999999 111.303 -177.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.473 ' HA ' ' NZ ' ' A' ' 20' ' ' LYS . 10.3 pt-20 -84.83 -15.46 44.71 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.834 0.679 . . . . 2.6800000000000002 112.834 -174.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.66 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 5.7 p -149.13 149.28 15.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.868 0.365 . . . . 0.44 110.274 -172.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.611 HG23 ' HB3' ' A' ' 20' ' ' LYS . 44.2 t -120.72 118.83 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 121.906 0.86 . . . . 0.46000000000000002 111.523 -173.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.515 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER -99.75 125.18 45.6 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.593 -1.639 . . . . 1.76 110.385 -175.164 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.464 HD22 ' HB ' ' A' ' 16' ' ' VAL . 10.1 tt -133.73 128.09 34.18 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.547 -0.297 . . . . 1.1200000000000001 110.229 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 79' ' ' GLN . 9.8 tp -101.37 114.27 28.12 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 107.347 -1.353 . . . . 0.41999999999999998 107.347 174.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.991 HG23 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -111.37 150.29 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 CA-C-O 121.522 0.677 . . . . 0.77000000000000002 109.665 -175.382 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.555 HG23 HG22 ' A' ' 13' ' ' VAL . 1.3 m -97.35 113.48 25.13 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 118.512 -1.275 . . . . 0.34000000000000002 108.748 167.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.678 ' HG3' HE22 ' A' ' 72' ' ' GLN . 1.0 OUTLIER -91.9 153.9 19.2 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.14 -1.391 . . . . 2.0099999999999998 109.951 -173.257 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.469 ' N ' ' HG2' ' A' ' 111' ' ' ARG . 0.1 OUTLIER -125.1 -95.16 0.47 Allowed 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.692 -0.403 . . . . 1.97 111.675 -177.509 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.401 ' H ' ' CG ' ' A' ' 112' ' ' GLN . 9.0 t -149.78 38.33 0.75 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.645 0.736 . . . . 1.6200000000000001 110.764 -170.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.491 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 6.3 mt . . . . . 0 C--N 1.314 -0.94 0 CA-C-N 115.21 -0.905 . . . . 1.6499999999999999 109.225 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptm . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 120.277 0.084 . . . . 14.33 111.192 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 p -126.34 111.03 14.04 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.813 0.339 . . . . 11.220000000000001 111.385 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -157.3 122.85 4.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.919 -0.582 . . . . 9.1899999999999995 109.743 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.568 HG13 ' HG3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -117.21 98.71 52.25 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-O 121.171 0.51 . . . . 6.6500000000000004 110.252 -179.096 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.3 -41.66 20.42 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.711 2.274 . . . . 7.46 111.265 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.35 32.12 0.44 Allowed Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.512 -0.767 . . . . 5.8899999999999997 111.311 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.564 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 3.5 pt20 -145.12 41.49 0.31 Allowed Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 114.16 1.17 . . . . 6.3700000000000001 114.16 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.568 ' HG3' HG13 ' A' ' 4' ' ' ILE . 35.2 Cg_exo -56.79 122.62 12.13 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.753 1.636 . . . . 3.3999999999999999 111.899 172.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.9 t 75.16 -44.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.33 0.652 . . . . 2.2599999999999998 111.866 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 t -76.32 83.42 3.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 123.362 1.553 . . . . 2.0899999999999999 111.175 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.65 178.77 5.36 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 112.515 -2.13 . . . . 0.95999999999999996 110.509 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.0 t -106.32 110.95 33.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.762 -0.654 . . . . 1.5700000000000001 110.52 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.855 HG22 HG23 ' A' ' 110' ' ' THR . 33.6 t -77.66 108.45 10.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.751 -0.462 . . . . 1.02 109.751 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 1.036 ' HG2' ' HD3' ' A' ' 111' ' ' ARG . 0.3 OUTLIER -113.33 169.47 8.93 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.257 -0.577 . . . . 1.3899999999999999 111.801 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 15' ' ' ARG . 1.9 mmm180 -115.43 126.76 54.75 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.016 0.436 . . . . 3.6299999999999999 111.719 -175.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.926 HG23 HE22 ' A' ' 14' ' ' GLN . 26.2 t -107.39 121.85 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.614 -0.721 . . . . 1.02 109.323 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -143.82 111.94 6.26 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.748 -0.464 . . . . 1.3500000000000001 109.748 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.494 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 9.6 tp -139.18 148.79 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.568 -0.901 . . . . 0.60999999999999999 108.568 -176.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 16.5 m-70 -79.36 115.8 19.22 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.981 -0.687 . . . . 0.59999999999999998 109.411 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.865 ' HB2' HD12 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -26.93 139.07 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 O-C-N 125.142 1.526 . . . . 4.0 112.715 178.402 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.1 tp -97.66 93.91 6.67 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 121.418 -0.802 . . . . 0.55000000000000004 110.31 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -60.81 143.06 55.43 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.366 0.603 . . . . 3.9700000000000002 112.183 -173.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.545 ' HB2' HD13 ' A' ' 28' ' ' ILE . 4.3 tp-100 -140.88 94.9 2.77 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.283 -0.871 . . . . 1.3500000000000001 109.493 174.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.86 -82.49 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.042 -0.599 . . . . 1.3300000000000001 112.506 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.531 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 18.2 mt-10 -118.4 -17.35 9.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.098 0.475 . . . . 2.3300000000000001 110.561 -177.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.484 ' OD1' ' HB3' ' A' ' 23' ' ' GLN . 1.0 OUTLIER -112.85 -177.66 3.19 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.895 -0.593 . . . . 1.8700000000000001 111.679 -169.162 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.865 HD12 ' HB2' ' A' ' 20' ' ' LYS . 2.1 pt? -126.98 138.25 53.23 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.764 -1.199 . . . . 2.2799999999999998 107.764 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.545 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.3 mp -101.46 130.14 51.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.42 0.628 . . . . 0.80000000000000004 110.4 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.481 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -96.08 125.47 40.64 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.088 -1.414 . . . . 1.74 108.652 172.051 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -85.47 41.24 3.05 Favored Glycine 0 C--O 1.22 -0.745 0 C-N-CA 120.386 -0.911 . . . . 0.68999999999999995 112.648 -175.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.619 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 42.5 p90 -157.07 154.67 29.86 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 122.752 0.421 . . . . 0.51000000000000001 110.385 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.497 ' CB ' ' HB2' ' A' ' 59' ' ' ARG . 8.1 t -103.98 159.25 15.82 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.085 -1.45 . . . . 0.53000000000000003 107.085 169.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.401 HG12 ' N ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -160.69 141.59 3.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 112.745 0.646 . . . . 0.48999999999999999 112.745 -165.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.438 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -144.44 119.16 1.23 Allowed Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 110.089 -1.205 . . . . 0.71999999999999997 110.089 157.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.972 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.92 118.14 1.27 Allowed Glycine 0 CA--C 1.492 -1.358 0 CA-C-O 118.555 -1.136 . . . . 1.4199999999999999 111.621 171.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.734 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.69 143.77 8.58 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 117.483 -2.294 . . . . 0.47999999999999998 113.796 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.3 pt -61.65 -19.31 20.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.104 -1.073 . . . . 0.52000000000000002 108.104 149.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.832 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 0.4 OUTLIER -66.18 -35.15 79.71 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.749 -1.569 . . . . 0.71999999999999997 109.97 174.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.483 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 29.2 mm-40 -71.37 -166.37 0.18 Allowed 'General case' 0 C--N 1.339 0.143 0 CA-C-N 115.065 -0.971 . . . . 1.1899999999999999 110.713 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -85.44 104.91 5.68 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 116.03 -0.532 . . . . 2.5699999999999998 110.736 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 39' ' ' GLN . 4.4 Cg_exo -83.97 6.91 5.5 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 123.653 2.902 . . . . 2.8199999999999998 112.8 -177.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.8 t -95.54 32.21 1.85 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.059 -0.519 . . . . 3.2599999999999998 111.37 -171.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -137.92 14.71 2.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.438 0.637 . . . . 3.8799999999999999 109.614 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.962 ' HB3' ' HB2' ' A' ' 48' ' ' GLU . 9.3 p30 -178.72 59.24 0.12 Allowed Pre-proline 0 N--CA 1.435 -1.209 0 N-CA-C 107.967 -1.123 . . . . 5.1399999999999997 107.967 -166.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.97 -4.54 10.34 Favored 'Trans proline' 0 CA--C 1.527 0.139 0 C-N-CA 122.817 2.345 . . . . 3.71 112.474 -169.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -134.24 -53.82 0.85 Allowed 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.479 -1.304 . . . . 5.6200000000000001 107.479 173.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.0 m -160.2 156.42 26.57 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.677 -0.86 . . . . 3.77 108.677 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.962 ' HB2' ' HB3' ' A' ' 44' ' ' ASN . 37.5 tt0 -108.77 -26.5 10.27 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.726 0.774 . . . . 6.7800000000000002 109.917 170.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.882 ' HB3' HG22 ' A' ' 51' ' ' THR . 20.8 t70 178.75 -144.49 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 104.771 -2.307 . . . . 5.4699999999999998 104.771 -169.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.994 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 1.5 tmtp? -83.74 4.57 28.31 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 122.011 0.91 . . . . 3.0699999999999998 108.613 170.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.882 HG22 ' HB3' ' A' ' 49' ' ' ASP . 1.7 t -84.33 -58.07 2.9 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.479 -0.782 . . . . 4.5599999999999996 111.375 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.434 ' H ' HG23 ' A' ' 51' ' ' THR . 26.5 t70 44.81 -120.78 0.83 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.236 0.458 . . . . 2.6000000000000001 112.236 -177.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.555 ' HE3' ' OD1' ' A' ' 44' ' ' ASN . 20.6 mmtm -104.53 21.46 16.73 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 109.081 -0.711 . . . . 3.48 109.081 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.414 ' C ' HD12 ' A' ' 55' ' ' ILE . . . -85.5 -162.74 36.48 Favored Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 114.729 -1.123 . . . . 0.78000000000000003 110.901 -174.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.972 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -111.32 141.45 26.67 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 N-CA-C 107.297 -1.372 . . . . 0.54000000000000004 107.297 176.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.688 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER -152.21 145.2 24.49 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 119.405 1.002 . . . . 1.4199999999999999 110.99 -177.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.758 HG12 ' H ' ' A' ' 75' ' ' ASP . 2.7 p -85.59 133.23 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-N 114.597 -1.183 . . . . 0.57999999999999996 110.471 -171.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 37.7 m -100.09 -16.23 17.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.942 -1.026 . . . . 1.1100000000000001 110.822 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.671 ' HA ' HG23 ' A' ' 73' ' ' ILE . 72.2 mtt180 -149.04 -169.4 3.36 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.667 0.618 . . . . 2.27 112.667 175.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 59' ' ' ARG . 79.4 t -167.84 138.27 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 113.271 -1.786 . . . . 0.82999999999999996 107.212 163.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.5 p -82.29 126.27 31.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.232 0.539 . . . . 1.6499999999999999 110.88 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -57.19 112.24 1.31 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.429 -1.259 . . . . 1.8500000000000001 110.841 171.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.0 -2.43 66.13 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.51 -0.852 . . . . 0.92000000000000004 112.566 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.578 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -92.33 173.58 35.92 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 120.569 -0.824 . . . . 0.98999999999999999 111.623 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.493 ' HB2' HG12 ' A' ' 18' ' ' ILE . 64.8 Cg_endo -70.7 -22.81 27.25 Favored 'Trans proline' 0 CA--C 1.504 -1.002 0 C-N-CA 122.732 2.288 . . . . 0.44 113.477 -165.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.56 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -66.84 -32.7 74.15 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.731 -1.122 . . . . 0.35999999999999999 110.882 176.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -77.74 -30.08 51.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.236 0.541 . . . . 1.79 109.609 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.578 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.3 mp -68.98 -36.98 76.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.374 -0.83 . . . . 0.51000000000000001 109.629 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.602 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -78.11 -25.34 47.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.746 -0.661 . . . . 0.40999999999999998 110.838 176.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.89 43.62 1.9 Allowed Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.355 -0.926 . . . . 0.45000000000000001 113.874 177.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.462 ' O ' HG21 ' A' ' 60' ' ' VAL . 14.1 tp -95.1 148.7 22.07 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.44 -0.948 . . . . 0.89000000000000001 108.44 174.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.64 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 14.4 mt-30 -134.28 40.07 3.04 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 116.018 1.858 . . . . 1.21 116.018 -161.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.671 HG23 ' HA ' ' A' ' 59' ' ' ARG . 59.1 mt 69.85 -11.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 114.654 1.353 . . . . 0.77000000000000002 114.654 162.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.37 43.72 0.33 Allowed Glycine 0 CA--C 1.508 -0.348 0 C-N-CA 120.163 -1.018 . . . . 0.37 111.846 -170.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.758 ' H ' HG12 ' A' ' 57' ' ' VAL . 9.3 m-20 -119.61 141.27 49.45 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.047 -0.576 . . . . 0.89000000000000001 111.831 -168.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.994 ' HG3' ' HB3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -87.47 102.95 15.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.333 -0.849 . . . . 2.2000000000000002 111.16 -175.352 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.551 HD12 ' CA ' ' A' ' 56' ' ' TYR . 5.1 mt -73.63 122.99 27.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 114.772 -1.104 . . . . 0.48999999999999999 111.874 -177.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.787 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 2.2 mmt -93.32 -9.19 39.75 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.945 -1.025 . . . . 1.0600000000000001 113.399 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.606 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -167.88 150.99 5.86 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.05 0.452 . . . . 0.81999999999999995 112.196 -178.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.713 ' HB ' ' HE1' ' A' ' 85' ' ' MET . 40.6 t -133.05 112.06 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 114.927 -1.033 . . . . 1.3100000000000001 110.316 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.943 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 14.4 m120 57.4 27.85 14.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.727 -0.669 . . . . 1.5 112.613 174.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.84 -13.37 53.22 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 119.987 -1.101 . . . . 0.38 112.353 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.416 ' HE1' ' CZ ' ' A' ' 96' ' ' ARG . 74.1 m95 -80.68 170.16 16.68 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.875 -0.787 . . . . 0.77000000000000002 108.875 176.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -115.47 112.88 22.92 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.098 0.475 . . . . 1.8899999999999999 111.141 -172.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.713 ' HE1' ' HB ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -106.28 100.88 10.39 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 122.43 1.11 . . . . 1.01 110.676 -177.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.9 p -137.22 -41.27 0.58 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.536 -1.665 . . . . 1.05 107.73 173.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.61 73.98 1.34 Allowed 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 112.777 -2.01 . . . . 1.6200000000000001 108.31 174.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.734 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.2 t -135.57 140.76 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 108.89 -0.782 . . . . 1.0900000000000001 108.89 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.668 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 70.1 p -55.77 148.75 15.89 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.08 0.467 . . . . 0.34999999999999998 112.111 -177.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.832 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 21.8 t-160 -54.28 -42.94 70.59 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-O 121.616 0.722 . . . . 0.34999999999999998 110.131 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.72 -30.38 66.9 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.188 -1.369 . . . . 1.6699999999999999 110.445 -177.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.6 ' HB3' HG13 ' A' ' 88' ' ' VAL . 1.8 tp-100 -60.05 -47.62 85.12 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 122.039 0.923 . . . . 0.77000000000000002 108.537 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.637 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -74.47 -40.95 61.54 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.433 -1.258 . . . . 0.33000000000000002 110.444 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -66.22 -40.66 90.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.639 -0.71 . . . . 2.1000000000000001 110.715 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 1.2 tmtp? -64.33 -38.01 89.53 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 116.006 -0.543 . . . . 0.95999999999999996 109.541 -177.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.432 ' HB2' HG11 ' A' ' 80' ' ' VAL . 9.9 mmm180 -64.83 -48.9 72.69 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.823 -0.626 . . . . 3.5699999999999998 111.352 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.447 HD13 HD13 ' A' ' 29' ' ' LEU . 3.8 pp -79.25 -1.86 38.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.467 -0.333 . . . . 1.6499999999999999 111.756 -176.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.545 ' HA ' HD21 ' A' ' 27' ' ' LEU . 3.3 m -115.84 23.55 12.18 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 122.114 0.959 . . . . 1.53 109.884 173.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 1.006 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 5.8 mmpt? -81.76 112.56 19.03 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.431 -0.804 . . . . 2.7200000000000002 108.983 169.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.531 ' HD2' ' O ' ' A' ' 25' ' ' GLU . 35.6 ptt180 -71.26 19.06 0.06 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.652 -0.704 . . . . 4.3799999999999999 111.023 -177.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.543 ' H ' ' C ' ' A' ' 99' ' ' LYS . 5.8 p -115.02 -22.96 9.29 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.32 -0.855 . . . . 2.5099999999999998 109.948 -176.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -72.0 91.86 1.25 Allowed 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 122.13 0.967 . . . . 3.3999999999999999 109.956 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.578 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 5.2 tp10 -52.5 -29.63 26.04 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.142 -1.845 . . . . 2.6800000000000002 111.107 175.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 7.7 p -134.63 141.95 41.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.882 -0.784 . . . . 0.44 108.882 176.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.4 t -114.21 118.81 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 122.053 0.93 . . . . 0.46000000000000002 112.168 -171.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.943 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.3 OUTLIER -101.08 126.16 47.75 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.584 -1.643 . . . . 1.76 111.942 -173.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.545 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 9.4 tt -134.75 129.11 34.14 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.316 -0.402 . . . . 1.1200000000000001 109.999 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.787 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 24.5 tp -102.73 124.27 47.95 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 106.489 -1.671 . . . . 0.41999999999999998 106.489 175.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.714 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -127.47 145.22 35.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 119.147 -1.021 . . . . 0.77000000000000002 111.648 -174.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.855 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -99.54 113.38 25.74 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.611 -0.836 . . . . 0.34000000000000002 109.737 166.004 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 1.036 ' HD3' ' HG2' ' A' ' 14' ' ' GLN . 1.1 ptt180 -107.19 127.35 53.43 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.281 -1.327 . . . . 2.0099999999999998 108.943 -174.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.629 ' N ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -99.53 -55.99 2.52 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.838 0.681 . . . . 1.97 112.838 -165.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.473 ' N ' ' HG2' ' A' ' 112' ' ' GLN . 1.4 t -159.93 19.13 0.16 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.181 -0.608 . . . . 1.6200000000000001 111.037 -173.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -79.64 70.07 6.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.671 0.748 . . . . 1.6499999999999999 109.271 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.4 ' H ' ' HG2' ' A' ' 115' ' ' GLN . 7.2 pt20 -82.08 125.25 30.62 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.922 -1.035 . . . . 3.5299999999999998 111.171 -174.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -138.33 131.57 30.24 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.542 -0.754 . . . . 3.6000000000000001 109.402 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 72.15 21.76 3.84 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.905 0.753 . . . . 3.5600000000000001 111.179 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.0 p -62.82 128.5 24.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.045 -0.525 . . . . 4.9900000000000002 110.298 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -93.52 133.18 37.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.94 -0.573 . . . . 7.7699999999999996 110.753 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -77.57 145.28 36.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 6.5999999999999996 111.13 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 50.9 m -144.97 108.8 4.71 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.617 -0.512 . . . . 8.9399999999999995 109.617 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 43.1 tpp -79.83 109.66 14.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.09 -0.505 . . . . 12.1 111.471 -175.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.5 mt -95.58 116.11 28.38 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.022 -0.536 . . . . 12.82 109.683 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.585 -0.721 . . . . 14.640000000000001 110.741 -176.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.8 mmm . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.972 0.415 . . . . 14.33 110.7 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.9 p -129.59 -19.64 3.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.208 -0.451 . . . . 11.220000000000001 110.956 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -115.58 125.85 53.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.425 -0.352 . . . . 9.1899999999999995 110.719 -174.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.587 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 19.0 pt -113.16 104.07 55.67 Favored Pre-proline 0 N--CA 1.451 -0.424 0 CA-C-O 121.126 0.489 . . . . 6.6500000000000004 109.996 173.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 4' ' ' ILE . 7.2 Cg_exo -73.91 -44.2 0.5 Allowed 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.784 2.322 . . . . 7.46 113.204 -175.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.87 -4.26 69.67 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.727 -0.749 . . . . 5.8899999999999997 112.803 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 57.25 86.95 0.15 Allowed Pre-proline 0 N--CA 1.466 0.371 0 CA-C-O 121.334 0.588 . . . . 6.3700000000000001 111.68 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.587 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 3.3 Cg_endo -87.27 109.14 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.43 2.753 . . . . 3.3999999999999999 111.48 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.441 ' HB ' ' O ' ' A' ' 8' ' ' PRO . 69.5 t 70.84 -59.26 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 123.542 0.526 . . . . 2.2599999999999998 111.263 -175.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.1 p -75.59 82.48 2.61 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 121.995 0.902 . . . . 2.0899999999999999 110.651 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.427 ' HB1' ' O ' ' A' ' 111' ' ' ARG . . . -94.52 179.25 5.34 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.629 -1.623 . . . . 0.95999999999999996 109.662 176.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 m -112.91 124.02 69.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.235 0.541 . . . . 1.5700000000000001 110.523 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.734 HG22 HG23 ' A' ' 110' ' ' THR . 21.5 t -81.76 106.22 12.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.27 0.557 . . . . 1.02 110.025 -175.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.976 HE22 HG23 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -101.74 170.05 8.42 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.289 -0.869 . . . . 1.3899999999999999 112.051 -177.235 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -115.02 139.83 49.54 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 116.112 -0.494 . . . . 3.6299999999999999 111.359 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.976 HG23 HE22 ' A' ' 14' ' ' GLN . 12.4 t -128.86 126.46 64.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.868 -0.79 . . . . 1.02 108.868 173.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -142.09 121.52 13.21 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 122.11 -0.369 . . . . 1.3500000000000001 110.188 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.545 HG12 ' HB2' ' A' ' 65' ' ' PRO . 10.9 tp -145.15 147.53 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 N-CA-C 108.973 -0.751 . . . . 0.60999999999999999 108.973 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.757 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 13.5 m-70 -76.15 114.83 15.26 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.62 -0.511 . . . . 0.59999999999999998 109.62 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.822 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -28.82 129.27 0.08 Allowed 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.437 1.086 . . . . 4.0 112.358 176.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.5 tp -99.88 89.94 4.25 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.469 0.652 . . . . 0.55000000000000004 109.857 -173.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -77.58 143.49 38.28 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.185 -0.916 . . . . 3.9700000000000002 112.213 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.53 94.17 3.81 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.844 -1.071 . . . . 1.3500000000000001 108.142 175.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.31 -83.65 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.607 -0.806 . . . . 1.3300000000000001 111.671 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -137.59 12.51 2.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.224 0.535 . . . . 2.3300000000000001 110.724 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -115.93 135.73 53.71 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 108.584 -0.895 . . . . 1.8700000000000001 108.584 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.498 HD23 ' HG3' ' A' ' 20' ' ' LYS . 9.6 mp -107.42 123.78 48.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.585 0.707 . . . . 2.2799999999999998 110.959 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.441 ' O ' ' HE2' ' A' ' 20' ' ' LYS . 1.9 mp -98.15 129.47 48.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 114.933 -1.03 . . . . 0.80000000000000004 110.06 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.442 HD22 ' OG1' ' A' ' 98' ' ' THR . 0.1 OUTLIER -89.81 -31.08 17.54 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.791 -0.641 . . . . 1.74 110.867 -176.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.857 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 86.55 9.92 74.44 Favored Glycine 0 C--O 1.224 -0.501 0 C-N-CA 120.591 -0.814 . . . . 0.68999999999999995 112.559 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.611 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 47.0 p90 -150.28 149.53 30.27 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.72 0.295 . . . . 0.51000000000000001 110.237 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.725 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -102.47 150.19 23.63 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.827 -0.805 . . . . 0.53000000000000003 108.827 172.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.46 HG12 ' N ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -157.01 145.35 11.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 112.283 0.475 . . . . 0.48999999999999999 112.283 -163.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.46 ' N ' HG12 ' A' ' 33' ' ' ILE . . . -142.1 119.0 1.37 Allowed Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 110.572 -1.011 . . . . 0.71999999999999997 110.572 157.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.957 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -139.38 118.59 1.54 Allowed Glycine 0 CA--C 1.493 -1.328 0 CA-C-O 118.388 -1.229 . . . . 1.4199999999999999 111.119 170.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -168.6 142.8 7.65 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 117.751 -2.166 . . . . 0.47999999999999998 113.258 178.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.731 HG12 ' O ' ' A' ' 87' ' ' MET . 0.5 OUTLIER -65.71 -22.6 31.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 106.726 -1.583 . . . . 0.52000000000000002 106.726 153.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.758 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 1.1 t70 -58.18 -36.72 73.48 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 112.839 -1.982 . . . . 0.71999999999999997 109.222 169.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -74.43 -67.93 0.58 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.165 -0.925 . . . . 1.1899999999999999 110.488 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -161.05 113.36 1.29 Allowed Pre-proline 0 N--CA 1.461 0.112 0 CA-C-O 120.74 0.305 . . . . 2.5699999999999998 110.802 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -95.46 10.6 1.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.847 3.031 . . . . 2.8199999999999998 112.768 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.1 t -101.45 -10.6 20.04 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.399 0.518 . . . . 3.2599999999999998 112.399 -164.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.421 HE21 ' HB3' ' A' ' 43' ' ' GLN . 1.7 pt20 -124.1 25.91 7.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.364 0.602 . . . . 3.8799999999999999 109.956 -176.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.409 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 12.6 p30 -178.09 47.71 0.04 OUTLIER Pre-proline 0 N--CA 1.442 -0.837 0 CA-C-N 115.489 -0.778 . . . . 5.1399999999999997 109.107 -166.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 44' ' ' ASN . 14.0 Cg_endo -53.88 -31.61 63.4 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.674 2.249 . . . . 3.71 111.05 -170.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -121.6 -53.34 2.0 Allowed 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 106.514 -1.661 . . . . 5.6200000000000001 106.514 170.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.0 p -159.42 160.6 35.03 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 114.736 -1.12 . . . . 3.77 110.102 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -109.53 -30.21 8.03 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.939 -0.763 . . . . 6.7800000000000002 108.939 171.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -175.2 -96.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.814 -1.085 . . . . 5.4699999999999998 108.638 -176.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.546 ' HA ' ' CE ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -130.47 8.26 4.99 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.619 -0.882 . . . . 3.0699999999999998 108.619 163.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.05 -48.22 6.6 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 108.431 -0.951 . . . . 4.5599999999999996 108.431 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 44.89 -142.13 0.24 Allowed 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 114.835 -1.075 . . . . 2.6000000000000001 112.082 170.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.435 ' C ' ' HD2' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -118.0 30.53 7.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.147 -0.933 . . . . 3.48 109.206 176.568 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.58 -155.28 8.32 Favored Glycine 0 N--CA 1.44 -1.048 0 N-CA-C 109.984 -1.246 . . . . 0.78000000000000003 109.984 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.957 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.7 mp -114.48 125.14 71.72 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.765 0 N-CA-C 108.225 -1.028 . . . . 0.54000000000000004 108.225 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.929 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.8 OUTLIER -145.4 148.33 33.22 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 119.984 1.266 . . . . 1.4199999999999999 112.261 -172.157 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.69 HG12 ' H ' ' A' ' 75' ' ' ASP . 3.4 p -87.11 136.46 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-N 114.172 -1.376 . . . . 0.57999999999999996 110.489 -173.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.3 m -106.33 -15.01 14.94 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.034 -0.984 . . . . 1.1100000000000001 110.615 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.725 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 42.1 mtp180 -149.82 -167.16 2.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.024 0.75 . . . . 2.27 113.024 177.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 51.0 t -161.88 154.9 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 106.197 -1.779 . . . . 0.82999999999999996 106.197 166.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.463 ' N ' HG12 ' A' ' 60' ' ' VAL . 59.2 p -104.41 131.33 51.89 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.622 0.725 . . . . 1.6499999999999999 111.552 176.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -63.42 107.57 1.14 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.464 -1.244 . . . . 1.8500000000000001 111.281 175.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.74 -14.95 45.56 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 115.144 -0.935 . . . . 0.92000000000000004 111.58 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.503 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -78.32 178.22 52.95 Favored Glycine 0 N--CA 1.438 -1.171 0 C-N-CA 120.514 -0.85 . . . . 0.98999999999999999 111.451 177.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.857 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 97.4 Cg_endo -74.77 -27.15 10.73 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 122.379 2.053 . . . . 0.44 113.334 -168.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.611 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -66.11 -26.41 67.45 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.169 -0.923 . . . . 0.35999999999999999 111.139 176.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -72.94 -31.45 64.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.805 0.812 . . . . 1.79 109.114 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.503 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -76.19 -39.8 35.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.908 -1.042 . . . . 0.51000000000000001 110.631 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.65 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -77.85 -15.59 58.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.0 -0.545 . . . . 0.40999999999999998 110.757 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.16 67.06 1.34 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.522 -0.847 . . . . 0.45000000000000001 113.44 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.487 HD21 HG21 ' A' ' 57' ' ' VAL . 17.8 tp -110.1 151.99 26.55 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.763 -0.829 . . . . 0.89000000000000001 108.763 175.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.515 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 9.7 mt-30 -123.06 28.98 6.94 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 115.701 1.741 . . . . 1.21 115.701 -164.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.634 HG23 ' HA ' ' A' ' 59' ' ' ARG . 75.5 mt 69.78 2.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-N 119.455 1.025 . . . . 0.77000000000000002 113.308 167.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.89 48.36 0.19 Allowed Glycine 0 CA--C 1.51 -0.237 0 C-N-CA 119.528 -1.32 . . . . 0.37 112.77 -170.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.69 ' H ' HG12 ' A' ' 57' ' ' VAL . 50.7 m-20 -120.83 145.92 47.1 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.376 -0.412 . . . . 0.89000000000000001 110.852 -172.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.909 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 32.4 mmtt -97.23 105.48 17.63 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 121.35 0.595 . . . . 2.2000000000000002 109.845 -174.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.991 HG13 HG23 ' A' ' 109' ' ' VAL . 2.7 mp -73.03 125.64 32.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.33 0.586 . . . . 0.48999999999999999 112.139 -177.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.723 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 1.5 mmt -91.5 -18.37 24.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 113.504 -1.68 . . . . 1.0600000000000001 111.769 177.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.742 ' HB2' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -171.88 157.62 4.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.972 0.415 . . . . 0.81999999999999995 111.357 -175.212 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.835 HG21 ' HB3' ' A' ' 97' ' ' LEU . 6.5 p -145.45 120.84 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.859 -0.61 . . . . 1.3100000000000001 110.576 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.814 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 19.6 m-80 54.88 29.81 12.72 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.503 -0.771 . . . . 1.5 112.264 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.35 -19.85 46.89 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.255 -0.974 . . . . 0.38 112.503 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -86.21 120.68 27.84 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.678 -0.86 . . . . 0.77000000000000002 108.678 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.742 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 6.6 p-10 -88.56 114.86 25.62 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 114.99 -1.005 . . . . 1.8899999999999999 111.289 -172.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.73 ' HB3' HD13 ' A' ' 55' ' ' ILE . 12.0 mmt -107.32 103.24 12.55 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.847 -1.07 . . . . 1.01 110.965 -175.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.0 p -106.96 -20.77 13.22 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.801 -0.636 . . . . 1.05 110.075 172.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.731 ' O ' HG12 ' A' ' 37' ' ' ILE . 1.8 mtt -143.66 -42.96 0.28 Allowed 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.278 -0.874 . . . . 1.6200000000000001 111.901 -172.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.754 ' O ' HD11 ' A' ' 55' ' ' ILE . 1.9 p -49.5 165.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 114.874 1.435 . . . . 1.0900000000000001 114.874 -158.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 80.6 p -54.78 151.94 7.81 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.423 0.897 . . . . 0.34999999999999998 113.423 -175.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.77 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 18.2 t-160 -59.38 -40.63 87.18 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.427 -0.806 . . . . 0.34999999999999998 110.116 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.93 -32.17 73.24 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.292 -1.322 . . . . 1.6699999999999999 109.779 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.773 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 4.1 tp-100 -61.6 -52.22 65.27 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.929 -0.767 . . . . 0.77000000000000002 108.929 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.678 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -75.29 -34.78 61.34 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.15 -0.932 . . . . 0.33000000000000002 110.69 -176.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -63.9 -36.58 84.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.118 0.485 . . . . 2.1000000000000001 109.808 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.487 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -69.07 -36.04 77.18 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.809 -0.632 . . . . 0.95999999999999996 109.823 178.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.773 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 20.8 mmt180 -75.87 -26.12 56.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.048 -0.524 . . . . 3.5699999999999998 111.517 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.835 ' HB3' HG21 ' A' ' 80' ' ' VAL . 4.2 pp -88.47 -26.7 21.94 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 111.905 0.335 . . . . 1.6499999999999999 111.905 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.513 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 67.1 m -148.72 109.77 4.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.642 0.734 . . . . 1.53 110.289 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.404 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 7.4 ptpp? -126.99 16.95 7.31 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.641 -1.163 . . . . 2.7200000000000002 110.857 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.433 ' CA ' HD22 ' A' ' 27' ' ' LEU . 60.2 mtt180 66.69 6.03 4.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.965 -1.016 . . . . 4.3799999999999999 111.829 175.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.474 ' C ' ' HG3' ' A' ' 102' ' ' GLU . 1.4 p -146.32 70.4 1.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.197 0.522 . . . . 2.5099999999999998 111.002 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.644 ' HB2' ' HG3' ' A' ' 20' ' ' LYS . 14.9 mt-10 -142.26 151.86 42.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.716 -0.675 . . . . 3.3999999999999999 110.733 -173.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -111.5 -29.15 7.88 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.765 -0.652 . . . . 2.6800000000000002 110.62 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.757 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 6.3 p -150.6 146.23 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.99 -0.55 . . . . 0.44 109.58 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.73 HG21 ' HG2' ' A' ' 20' ' ' LYS . 31.5 t -126.63 119.91 54.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 CA-C-O 122.227 1.013 . . . . 0.46000000000000002 112.361 -171.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.814 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 1.1 mpt_? -99.47 135.32 41.05 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.138 -1.846 . . . . 1.76 110.959 -175.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.604 HD11 HG12 ' A' ' 77' ' ' ILE . 19.9 tp -133.58 137.97 45.77 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.589 -0.278 . . . . 1.1200000000000001 110.6 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.723 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 38.8 tp -116.05 120.52 39.34 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.259 -1.386 . . . . 0.41999999999999998 107.259 172.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.991 HG23 HG13 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -130.18 152.2 37.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 121.22 0.533 . . . . 0.77000000000000002 110.712 -174.352 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.734 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -96.58 116.06 28.46 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.502 -0.772 . . . . 0.34000000000000002 109.377 168.763 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.473 ' HG3' HE22 ' A' ' 72' ' ' GLN . 7.8 ttt180 -100.58 135.56 41.83 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.187 -0.915 . . . . 2.0099999999999998 110.547 -176.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.447 ' HG2' ' CD2' ' A' ' 114' ' ' LEU . 0.2 OUTLIER -117.26 -108.48 0.37 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.96 -0.564 . . . . 1.97 110.559 176.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.9 t -115.12 28.6 8.59 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.239 0.542 . . . . 1.6200000000000001 111.074 -170.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.515 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 3.1 mm? -92.62 29.64 1.71 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.038 -0.528 . . . . 1.6499999999999999 111.509 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -54.51 105.15 0.14 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.34 0.59 . . . . 3.5299999999999998 111.317 -175.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -109.54 -6.04 15.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.406 -0.815 . . . . 3.6000000000000001 110.98 -172.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -164.27 21.85 0.07 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.418 -0.81 . . . . 3.5600000000000001 110.481 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.1 t -105.98 130.24 57.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.925 -0.58 . . . . 4.9900000000000002 110.844 -176.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -54.69 139.19 39.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.918 -1.037 . . . . 7.7699999999999996 111.919 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -161.54 141.61 10.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.852 -0.613 . . . . 6.5999999999999996 110.421 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.9 p -123.91 121.57 35.67 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.714 -0.476 . . . . 8.9399999999999995 109.714 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 60.0 mtm -100.88 -39.06 7.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.043 -0.526 . . . . 12.1 111.392 -173.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 36.0 tp -82.24 99.38 9.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.148 0.499 . . . . 12.82 110.748 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 C--O 1.248 0.995 0 CA-C-N 115.565 -0.743 . . . . 14.640000000000001 109.173 177.332 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.1 mtp . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.682 0.277 . . . . 14.33 110.642 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m -69.31 139.01 54.28 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.092 -0.504 . . . . 11.220000000000001 111.795 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -128.11 159.25 35.68 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.778 -0.823 . . . . 9.1899999999999995 108.778 173.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.561 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 17.8 pt -107.22 104.94 54.31 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 121.062 0.458 . . . . 6.6500000000000004 111.396 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.25 109.59 2.7 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.016 2.477 . . . . 7.46 111.701 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.02 -15.42 60.97 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.863 -0.684 . . . . 5.8899999999999997 112.467 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 67.65 98.58 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.236 0 C-N-CA 123.144 0.578 . . . . 6.3700000000000001 111.362 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.561 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 1.1 Cg_endo -83.4 125.96 4.06 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.252 2.634 . . . . 3.3999999999999999 111.366 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.454 ' HB ' ' O ' ' A' ' 8' ' ' PRO . 53.9 t 73.96 -54.19 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 O-C-N 123.604 0.565 . . . . 2.2599999999999998 111.735 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.2 p -76.64 82.75 3.29 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.217 1.008 . . . . 2.0899999999999999 111.589 -175.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.42 177.09 5.29 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 113.581 -1.645 . . . . 0.95999999999999996 109.337 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -123.66 127.92 74.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.231 0.538 . . . . 1.5700000000000001 111.064 -177.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.672 HG22 HG23 ' A' ' 110' ' ' THR . 15.9 t -83.63 111.12 19.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.68 -0.489 . . . . 1.02 109.68 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 1.018 HE22 HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -115.36 170.44 8.39 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.56 -0.746 . . . . 1.3899999999999999 112.581 -174.224 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -123.9 113.86 19.06 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.65 -0.705 . . . . 3.6299999999999999 110.544 -175.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.018 HG23 HE22 ' A' ' 14' ' ' GLN . 4.1 t -99.61 110.07 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 109.082 -0.71 . . . . 1.02 109.082 174.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -123.11 118.14 27.0 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.337 -0.616 . . . . 1.3500000000000001 109.337 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.58 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 10.9 tp -138.12 145.73 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 108.673 -0.862 . . . . 0.60999999999999999 108.673 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 11.0 m-70 -76.21 116.51 16.97 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.977 -0.689 . . . . 0.59999999999999998 109.529 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.583 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -23.65 133.89 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 O-C-N 125.037 1.461 . . . . 4.0 112.31 176.345 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.3 tp -95.84 89.11 5.15 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.992 0.901 . . . . 0.55000000000000004 110.379 -175.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -63.46 136.68 57.76 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.497 -1.229 . . . . 3.9700000000000002 111.56 -173.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -132.99 94.47 3.37 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.983 -1.008 . . . . 1.3500000000000001 108.437 175.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.01 -82.17 0.18 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.394 -0.908 . . . . 1.3300000000000001 111.394 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -129.3 -5.93 4.83 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.148 0.499 . . . . 2.3300000000000001 110.629 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.566 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 5.9 m-80 -94.0 169.95 9.9 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.711 -0.677 . . . . 1.8700000000000001 109.889 -174.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 20' ' ' LYS . 2.0 pt? -128.39 126.74 41.25 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.698 -1.223 . . . . 2.2799999999999998 107.698 171.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.42 138.15 23.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 109.441 -0.578 . . . . 0.80000000000000004 109.441 -176.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.48 ' HG ' ' CE2' ' A' ' 31' ' ' PHE . 18.3 tp -91.5 -33.0 15.36 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.879 -1.055 . . . . 1.74 110.572 -171.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.683 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 89.87 -38.05 3.27 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.765 -0.731 . . . . 0.68999999999999995 112.122 177.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.83 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 52.3 p90 -113.5 155.67 24.93 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 122.803 -0.233 . . . . 0.51000000000000001 110.766 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.571 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 12.5 t -101.89 163.87 12.02 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.905 -1.146 . . . . 0.53000000000000003 107.905 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.42 HD12 HD21 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -160.36 140.68 3.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 C-N-CA 120.981 -0.288 . . . . 0.48999999999999999 111.352 -164.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -143.06 120.15 1.49 Allowed Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 110.547 -1.021 . . . . 0.71999999999999997 110.547 158.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 1.048 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -138.35 119.09 1.72 Allowed Glycine 0 CA--C 1.492 -1.387 0 CA-C-O 118.784 -1.009 . . . . 1.4199999999999999 110.771 171.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.897 ' HA3' ' HG2' ' A' ' 39' ' ' GLN . . . -156.13 118.52 0.85 Allowed Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 118.251 -1.928 . . . . 0.47999999999999998 113.37 -170.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.594 HG12 ' C ' ' A' ' 88' ' ' VAL . 20.8 pt -64.4 -21.38 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 105.728 -1.953 . . . . 0.52000000000000002 105.728 145.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.77 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 14.3 t70 -64.55 -36.42 84.17 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 112.672 -2.058 . . . . 0.71999999999999997 110.782 171.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.897 ' HG2' ' HA3' ' A' ' 36' ' ' GLY . 25.4 mm-40 -71.38 -100.17 0.01 OUTLIER 'General case' 0 C--N 1.349 0.586 0 N-CA-C 112.486 0.55 . . . . 1.1899999999999999 112.486 -171.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.476 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 24.2 t70 -149.7 126.94 5.49 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.7 -0.227 . . . . 2.5699999999999998 111.602 -173.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 9.9 Cg_endo -94.89 8.38 2.01 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.699 2.933 . . . . 2.8199999999999998 113.14 176.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.2 t -103.87 10.93 36.2 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.052 0.453 . . . . 3.2599999999999998 111.207 -171.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.422 HE21 ' HB2' ' A' ' 43' ' ' GLN . 2.1 mt-30 -134.12 21.81 3.78 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.163 0.982 . . . . 3.8799999999999999 108.379 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.446 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 12.5 p30 -177.73 58.54 0.13 Allowed Pre-proline 0 N--CA 1.44 -0.95 0 CA-C-N 113.136 -1.847 . . . . 5.1399999999999997 106.966 -175.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.446 ' HD3' ' N ' ' A' ' 44' ' ' ASN . 78.4 Cg_exo -53.42 -15.24 5.59 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.88 3.053 . . . . 3.71 114.293 -166.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -134.86 -47.44 0.73 Allowed 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.928 -1.138 . . . . 5.6200000000000001 107.928 174.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 3.1 m -155.41 160.59 40.77 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 107.828 -1.175 . . . . 3.77 107.828 -177.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.513 ' HB3' HG23 ' A' ' 51' ' ' THR . 20.9 tt0 -107.18 -32.48 7.79 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.081 0.467 . . . . 6.7800000000000002 110.79 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.554 ' OD2' ' HD2' ' A' ' 50' ' ' LYS . 23.1 t0 177.08 -130.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.288 -1.004 . . . . 5.4699999999999998 108.288 -167.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.602 ' HG2' HG21 ' A' ' 110' ' ' THR . 3.7 mptt -75.63 -19.04 59.47 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.846 -0.798 . . . . 3.0699999999999998 108.846 173.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.513 HG23 ' HB3' ' A' ' 48' ' ' GLU . 1.9 t -77.34 -48.27 17.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.952 -1.022 . . . . 4.5599999999999996 110.716 -175.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 11.3 t70 73.03 -80.34 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.747 0.655 . . . . 2.6000000000000001 110.035 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 87' ' ' MET . 0.0 OUTLIER -141.57 29.85 1.73 Allowed 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.134 -1.432 . . . . 3.48 107.134 175.321 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.509 ' C ' HD12 ' A' ' 55' ' ' ILE . . . -100.05 -145.44 17.81 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 114.033 -1.439 . . . . 0.78000000000000003 111.878 -167.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.048 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.9 mp -118.76 147.13 22.46 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 N-CA-C 108.404 -0.961 . . . . 0.54000000000000004 108.404 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.805 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -155.48 156.35 35.09 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 118.97 0.805 . . . . 1.4199999999999999 111.215 178.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.55 ' CG1' ' H ' ' A' ' 75' ' ' ASP . 8.1 p -92.38 132.84 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-N 115.481 -0.781 . . . . 0.57999999999999996 110.92 -173.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.5 m -103.89 -17.14 15.14 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.497 -1.229 . . . . 1.1100000000000001 111.467 -174.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.926 ' HA ' HG23 ' A' ' 73' ' ' ILE . 46.2 mtt180 -143.63 -175.41 4.56 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.982 1.104 . . . . 2.27 113.982 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 59' ' ' ARG . 75.4 t -167.73 111.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 112.959 -1.928 . . . . 0.82999999999999996 106.956 161.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.5 m -79.56 128.47 33.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.212 0.53 . . . . 1.6499999999999999 110.655 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -50.43 116.59 1.97 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.679 -1.146 . . . . 1.8500000000000001 111.47 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.29 -20.39 30.52 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.241 -0.89 . . . . 0.92000000000000004 112.931 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.74 172.96 55.17 Favored Glycine 0 CA--C 1.502 -0.762 0 C-N-CA 120.345 -0.931 . . . . 0.98999999999999999 111.771 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.683 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 73.2 Cg_endo -71.45 -19.2 28.92 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.43 2.087 . . . . 0.44 113.184 -169.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.83 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -67.2 -28.91 68.47 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.654 -1.157 . . . . 0.35999999999999999 111.643 175.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -73.13 -34.85 66.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 122.013 0.911 . . . . 1.79 109.151 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.479 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.4 mp -74.44 -38.06 45.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.526 -1.215 . . . . 0.51000000000000001 110.221 -177.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.708 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -80.17 -20.26 45.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.361 -0.382 . . . . 0.40999999999999998 110.699 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.13 65.24 1.12 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.37 -0.919 . . . . 0.45000000000000001 114.017 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.54 HD21 HG21 ' A' ' 57' ' ' VAL . 18.1 tp -113.34 155.56 24.97 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.357 -0.609 . . . . 0.89000000000000001 109.357 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.976 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 12.9 mt-30 -124.23 31.13 5.86 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 115.176 1.547 . . . . 1.21 115.176 -166.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.926 HG23 ' HA ' ' A' ' 59' ' ' ARG . 42.6 mt 68.55 1.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 113.201 0.815 . . . . 0.77000000000000002 113.201 166.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -172.53 51.02 0.17 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 119.757 -1.211 . . . . 0.37 112.355 -168.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.55 ' H ' ' CG1' ' A' ' 57' ' ' VAL . 32.1 m-20 -121.45 151.8 39.82 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.358 -0.608 . . . . 0.89000000000000001 109.358 -175.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.805 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 64.0 mmtt -95.33 122.14 37.72 Favored 'General case' 0 C--O 1.208 -1.084 0 CA-C-O 121.302 0.572 . . . . 2.2000000000000002 110.55 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.713 HG12 HD11 ' A' ' 107' ' ' LEU . 8.5 mt -88.11 125.36 41.53 Favored 'Isoleucine or valine' 0 C--O 1.258 1.525 0 CA-C-O 121.309 0.576 . . . . 0.48999999999999999 112.006 -174.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.841 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -96.74 -16.4 20.89 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.202 -1.817 . . . . 1.0600000000000001 111.649 -177.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.749 ' HB3' HD23 ' A' ' 108' ' ' LEU . 0.9 OUTLIER -168.99 150.51 4.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.729 0.299 . . . . 0.81999999999999995 111.481 -175.33 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.73 ' HB ' ' CE ' ' A' ' 85' ' ' MET . 3.3 t -139.36 118.59 13.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.807 -0.633 . . . . 1.3100000000000001 110.811 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.896 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 12.9 m120 52.87 31.05 10.06 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.01 -0.541 . . . . 1.5 111.856 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.11 -5.7 59.44 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.293 -0.956 . . . . 0.38 113.042 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.526 ' HE1' ' CZ ' ' A' ' 96' ' ' ARG . 54.7 m95 -87.03 175.21 8.22 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 110.091 -0.336 . . . . 0.77000000000000002 110.091 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -115.88 113.2 23.01 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.751 -0.659 . . . . 1.8899999999999999 109.938 -173.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.73 ' CE ' ' HB ' ' A' ' 80' ' ' VAL . 19.6 mmt -107.14 100.59 10.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.949 0.881 . . . . 1.01 110.152 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.4 p -132.98 -35.85 1.05 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.408 -1.269 . . . . 1.05 107.98 171.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.513 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -161.28 78.17 0.57 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 113.755 -1.566 . . . . 1.6200000000000001 109.996 176.203 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.626 HG21 HE21 ' A' ' 92' ' ' GLN . 1.4 p -137.7 164.21 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 109.5 -0.555 . . . . 1.0900000000000001 109.5 174.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.747 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 61.7 p -63.04 151.39 40.0 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.348 0.594 . . . . 0.34999999999999998 112.312 -176.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.77 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 20.4 t-160 -61.86 -34.97 76.95 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-O 121.589 0.709 . . . . 0.34999999999999998 109.882 178.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.65 -31.55 69.7 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 113.97 -1.468 . . . . 1.6699999999999999 109.618 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.626 HE21 HG21 ' A' ' 88' ' ' VAL . 1.7 tp-100 -61.59 -52.21 65.34 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.681 -0.859 . . . . 0.77000000000000002 108.681 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.646 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.08 -41.45 77.51 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.528 -1.214 . . . . 0.33000000000000002 110.188 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.419 ' HA ' HD11 ' A' ' 97' ' ' LEU . 34.3 ttp180 -64.89 -41.32 95.71 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.157 -0.929 . . . . 2.1000000000000001 111.201 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.659 ' HE3' ' HD3' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -68.33 -29.16 67.83 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 121.168 0.509 . . . . 0.95999999999999996 109.848 -177.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.583 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 12.8 mmm180 -74.96 -48.77 22.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.023 -0.535 . . . . 3.5699999999999998 112.276 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.5 pp -82.6 -4.81 58.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.021 0.439 . . . . 1.6499999999999999 111.493 -178.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.2 m -138.12 78.7 1.7 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 122.137 0.97 . . . . 1.53 109.379 175.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.659 ' HD3' ' HE3' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -84.78 -79.18 0.23 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.006 -1.452 . . . . 2.7200000000000002 110.347 -178.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.41 ' H ' ' HB3' ' A' ' 99' ' ' LYS . 26.8 ptt180 174.11 -26.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.158 -0.928 . . . . 4.3799999999999999 111.059 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.7 m -160.89 40.05 0.16 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.955 0.407 . . . . 2.5099999999999998 110.396 -171.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 46.1 mm-40 -58.86 156.61 11.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.838 -0.619 . . . . 3.3999999999999999 110.714 175.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.58 ' HG3' HG12 ' A' ' 104' ' ' VAL . 6.0 pt-20 -84.74 -38.52 19.57 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.636 0.732 . . . . 2.6800000000000002 109.474 172.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.58 HG12 ' HG3' ' A' ' 103' ' ' GLU . 3.1 p -156.8 156.04 4.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 114.745 -1.116 . . . . 0.44 108.332 -176.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.6 t -115.87 117.81 56.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 122.11 0.957 . . . . 0.46000000000000002 111.643 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.896 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 1.4 mpt_? -100.55 123.73 45.15 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 113.422 -1.717 . . . . 1.76 111.626 -171.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.713 HD11 HG12 ' A' ' 77' ' ' ILE . 28.4 tp -132.12 125.77 32.1 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.88 -0.6 . . . . 1.1200000000000001 110.756 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.841 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 31.8 tp -108.18 120.88 43.61 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 107.688 -1.227 . . . . 0.41999999999999998 107.688 172.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.742 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -132.95 150.33 32.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.398 0.618 . . . . 0.77000000000000002 110.635 -172.212 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.672 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -95.76 116.58 29.09 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.295 -0.866 . . . . 0.34000000000000002 109.37 168.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.784 ' HG3' HE22 ' A' ' 72' ' ' GLN . 27.4 ttt180 -110.58 139.75 45.54 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.474 -1.239 . . . . 2.0099999999999998 110.755 -169.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.66 -90.87 0.57 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.531 0.567 . . . . 1.97 112.531 -176.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.424 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 18.8 m -151.33 41.75 0.73 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 112.539 0.57 . . . . 1.6200000000000001 112.539 -164.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.976 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 0.3 OUTLIER -103.5 -0.79 29.38 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.516 -0.55 . . . . 1.6499999999999999 109.516 177.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.435 ' HG3' ' OE1' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -52.76 136.13 34.14 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.542 -0.753 . . . . 3.5299999999999998 111.658 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -81.48 23.9 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.952 -0.567 . . . . 3.6000000000000001 111.776 -173.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 59.22 87.16 0.08 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.228 0.537 . . . . 3.5600000000000001 110.899 -175.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.7 p -110.96 143.65 20.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.727 -0.67 . . . . 4.9900000000000002 110.467 -176.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 62.03 71.07 0.55 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.662 -0.699 . . . . 7.7699999999999996 110.681 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -122.47 -46.0 2.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.109 -0.496 . . . . 6.5999999999999996 111.178 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.8 t -108.28 118.27 36.32 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.167 -0.469 . . . . 8.9399999999999995 109.889 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 91.4 mmm -91.11 139.2 30.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.256 -0.429 . . . . 12.1 110.289 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 46.9 tp -68.92 135.61 51.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.202 -0.454 . . . . 12.82 110.801 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 41.6 t . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.659 -0.686 . . . . 14.640000000000001 109.297 177.761 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 120.898 0.38 . . . . 14.33 110.332 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.6 m -157.31 121.44 4.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.899 -0.591 . . . . 11.220000000000001 110.414 177.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -148.22 137.79 22.24 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.084 -0.709 . . . . 9.1899999999999995 109.084 176.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.624 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 11.2 pt -113.27 95.35 35.05 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 121.37 0.605 . . . . 6.6500000000000004 111.368 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.13 112.93 2.43 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 123.048 2.499 . . . . 7.46 112.125 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.06 -15.94 62.05 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.788 -0.72 . . . . 5.8899999999999997 112.903 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 65.37 97.01 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.407 0 CA-C-O 121.352 0.596 . . . . 6.3700000000000001 110.939 -177.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 1.6 Cg_endo -82.87 -172.78 1.49 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.269 2.646 . . . . 3.3999999999999999 112.392 -173.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 p -71.05 105.44 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.705 0.764 . . . . 2.2599999999999998 109.724 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.23 79.7 6.76 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 122.167 0.984 . . . . 2.0899999999999999 108.906 178.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.7 165.84 23.17 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.51 -1.677 . . . . 0.95999999999999996 111.075 173.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.97 132.03 71.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 115.456 -0.793 . . . . 1.5700000000000001 110.123 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.501 ' CG1' HD11 ' A' ' 108' ' ' LEU . 59.1 t -87.14 119.1 34.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.342 0.591 . . . . 1.02 111.497 -173.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 1.08 HE22 HG23 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -114.04 171.17 7.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.542 -0.753 . . . . 1.3899999999999999 111.585 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.429 ' NE ' HD13 ' A' ' 108' ' ' LEU . 26.7 mmt180 -115.55 137.77 51.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.929 0.395 . . . . 3.6299999999999999 111.959 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.08 HG23 HE22 ' A' ' 14' ' ' GLN . 23.0 t -123.55 123.4 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 109.234 -0.654 . . . . 1.02 109.234 171.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -144.78 123.87 12.85 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.831 -0.433 . . . . 1.3500000000000001 109.831 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.547 HG21 ' HB2' ' A' ' 65' ' ' PRO . 10.2 tp -144.88 150.2 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 109.279 -0.638 . . . . 0.60999999999999999 109.279 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 15.5 m-70 -81.0 109.93 16.06 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.231 -0.655 . . . . 0.59999999999999998 109.231 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.412 ' HD3' ' N ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -27.49 135.22 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 O-C-N 125.228 1.58 . . . . 4.0 113.094 -177.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.1 tp -101.65 90.36 4.01 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.737 -0.468 . . . . 0.55000000000000004 109.737 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 26.8 ptt180 -70.35 144.89 51.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.312 0.577 . . . . 3.9700000000000002 111.191 -173.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.21 93.78 4.02 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.745 -0.835 . . . . 1.3500000000000001 108.745 173.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.57 -88.85 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.625 -0.59 . . . . 1.3300000000000001 111.625 -174.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.448 ' HB3' HH21 ' A' ' 100' ' ' ARG . 28.9 mm-40 -110.3 -5.45 15.25 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.261 -0.47 . . . . 2.3300000000000001 111.524 -177.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.405 ' O ' HD12 ' A' ' 27' ' ' LEU . 10.3 m-80 -105.8 171.47 7.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.083 -0.508 . . . . 1.8700000000000001 111.143 -173.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.826 HD13 ' HA ' ' A' ' 100' ' ' ARG . 7.8 mp -124.58 125.51 44.28 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.284 -1.006 . . . . 2.2799999999999998 108.284 172.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.5 mm -97.18 116.22 38.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 109.291 -0.633 . . . . 0.80000000000000004 109.291 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.815 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.8 pt? -78.52 -32.6 48.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.684 -1.143 . . . . 1.74 110.707 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.639 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 82.51 17.08 69.4 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.487 -0.863 . . . . 0.68999999999999995 113.027 173.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.642 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 48.1 p90 -154.24 161.49 41.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.733 0.267 . . . . 0.51000000000000001 110.691 173.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.61 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 11.6 t -106.11 158.68 16.64 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.219 -1.03 . . . . 0.53000000000000003 108.219 173.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -160.33 138.8 2.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 112.521 0.563 . . . . 0.48999999999999999 112.521 -164.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.423 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -139.26 118.24 1.5 Allowed Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 119.679 -1.248 . . . . 0.71999999999999997 110.283 156.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 1.035 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -140.26 117.42 1.29 Allowed Glycine 0 CA--C 1.492 -1.365 0 CA-C-O 118.925 -0.931 . . . . 1.4199999999999999 111.657 170.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.671 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.01 143.51 8.35 Favored Glycine 0 C--N 1.3 -1.47 0 C-N-CA 118.364 -1.874 . . . . 0.47999999999999998 112.563 174.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.412 HG12 ' C ' ' A' ' 88' ' ' VAL . 9.8 pt -62.14 -22.26 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 107.797 -1.186 . . . . 0.52000000000000002 107.797 152.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.676 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 1.1 t70 -56.46 -47.7 78.61 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.473 -1.694 . . . . 0.71999999999999997 110.345 171.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -60.57 -53.2 60.35 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 114.866 -1.061 . . . . 1.1899999999999999 111.248 -174.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.516 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . 9.2 t0 -142.62 99.41 5.72 Favored Pre-proline 0 C--O 1.238 0.482 0 CA-C-N 116.127 -0.488 . . . . 2.5699999999999998 110.451 -176.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -80.07 -16.98 10.87 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.434 2.756 . . . . 2.8199999999999998 112.231 176.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.5 t -68.93 -50.93 45.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.57 -0.741 . . . . 3.2599999999999998 109.863 -176.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -87.24 65.46 8.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.665 -0.698 . . . . 3.8799999999999999 110.726 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.662 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 38.7 t30 -158.02 55.4 0.89 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.629 -0.714 . . . . 5.1399999999999997 109.766 174.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.662 ' HD3' ' N ' ' A' ' 44' ' ' ASN . 85.2 Cg_endo -104.58 -0.53 0.24 Allowed 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 122.709 2.273 . . . . 3.71 111.798 175.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -169.87 22.37 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.53 0.681 . . . . 5.6200000000000001 109.806 -173.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.811 ' HB3' ' HA ' ' A' ' 52' ' ' ASP . 2.8 m -122.98 115.57 22.11 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 108.509 -0.923 . . . . 3.77 108.509 -171.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.74 ' H ' HG23 ' A' ' 51' ' ' THR . 2.2 mt-10 -101.25 -42.38 6.35 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.785 -1.098 . . . . 6.7800000000000002 112.191 -169.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.42 ' OD2' ' HB3' ' A' ' 48' ' ' GLU . 24.1 m-20 -139.85 -121.94 0.12 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 113.452 -1.704 . . . . 5.4699999999999998 111.732 -158.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.539 ' HD2' ' SD ' ' A' ' 78' ' ' MET . 3.7 mppt? -66.54 -20.89 66.13 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.672 -1.149 . . . . 3.0699999999999998 107.97 170.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.74 HG23 ' H ' ' A' ' 48' ' ' GLU . 2.5 t -72.05 -39.82 68.81 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 114.729 -1.123 . . . . 4.5599999999999996 109.71 172.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.811 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 8.9 t70 -74.01 -166.05 0.36 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.716 0.769 . . . . 2.6000000000000001 109.818 163.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.57 ' H ' ' CG ' ' A' ' 52' ' ' ASP . 3.2 ptpp? -95.53 -37.69 10.76 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.485 -0.78 . . . . 3.48 108.928 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 86' ' ' THR . . . 62.46 -139.88 45.89 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.487 -0.778 . . . . 0.78000000000000003 111.295 178.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.035 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -110.68 137.4 43.26 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.166 0 N-CA-C 106.666 -1.605 . . . . 0.54000000000000004 106.666 170.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.665 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -152.2 147.12 26.03 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 119.655 1.116 . . . . 1.4199999999999999 111.215 -176.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 75' ' ' ASP . 7.7 p -87.15 139.65 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 114.728 -1.124 . . . . 0.57999999999999996 110.05 -172.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.9 m -110.88 -14.21 14.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.181 -0.918 . . . . 1.1100000000000001 111.107 -174.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.841 ' HA ' HG23 ' A' ' 73' ' ' ILE . 37.6 mtt180 -146.86 -167.56 2.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.234 0.827 . . . . 2.27 113.234 175.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.533 HG13 ' HB3' ' A' ' 66' ' ' ALA . 63.9 t -161.58 148.66 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 112.413 -2.176 . . . . 0.82999999999999996 106.44 162.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.4 p -91.82 137.33 32.45 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.06 0.457 . . . . 1.6499999999999999 110.654 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -62.94 109.08 1.34 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.769 -1.105 . . . . 1.8500000000000001 111.367 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.26 -10.89 67.49 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.484 -0.865 . . . . 0.92000000000000004 111.903 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.526 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -75.47 173.29 53.26 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 120.766 -0.731 . . . . 0.98999999999999999 111.525 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.639 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 73.2 Cg_endo -72.25 -24.63 19.64 Favored 'Trans proline' 0 C--N 1.32 -0.935 0 C-N-CA 122.842 2.361 . . . . 0.44 113.252 -166.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.642 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -64.14 -31.38 72.55 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.717 -1.129 . . . . 0.35999999999999999 111.283 176.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -74.49 -36.35 63.25 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.517 0.675 . . . . 1.79 109.189 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -64.79 -42.44 94.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.673 -1.149 . . . . 0.51000000000000001 110.104 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.611 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -73.0 -24.4 60.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.40999999999999998 110.543 175.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.66 58.3 1.06 Allowed Glycine 0 C--O 1.226 -0.354 0 C-N-CA 120.509 -0.853 . . . . 0.45000000000000001 113.722 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.521 HD21 HG21 ' A' ' 57' ' ' VAL . 14.8 tp -102.77 154.25 19.36 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.876 -0.787 . . . . 0.89000000000000001 108.876 175.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.581 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 6.5 mt-30 -129.33 34.19 4.42 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 115.604 1.705 . . . . 1.21 115.604 -166.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.841 HG23 ' HA ' ' A' ' 59' ' ' ARG . 59.8 mt 69.2 0.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 N-CA-C 113.34 0.867 . . . . 0.77000000000000002 113.34 165.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -174.18 55.68 0.14 Allowed Glycine 0 C--N 1.33 0.22 0 C-N-CA 119.984 -1.103 . . . . 0.37 112.914 -169.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.601 ' H ' HG12 ' A' ' 57' ' ' VAL . 31.7 m-20 -122.72 142.3 50.85 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.644 -0.278 . . . . 0.89000000000000001 111.524 -173.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.665 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 1.4 mptm? -83.31 102.8 12.22 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-O 120.983 0.421 . . . . 2.2000000000000002 111.062 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.624 ' HB ' HG22 ' A' ' 55' ' ' ILE . 6.9 mt -76.56 125.85 36.69 Favored 'Isoleucine or valine' 0 C--O 1.254 1.337 0 C-N-CA 123.617 0.767 . . . . 0.48999999999999999 111.594 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.775 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 9.1 mmt -90.52 -27.84 18.92 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.195 -1.366 . . . . 1.0600000000000001 112.046 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.584 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 1.0 OUTLIER -159.52 150.6 19.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.858 0.361 . . . . 0.81999999999999995 111.448 -171.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.673 HG12 ' SD ' ' A' ' 85' ' ' MET . 11.2 p -137.05 126.49 37.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.868 -0.605 . . . . 1.3100000000000001 110.474 174.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.682 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 4.3 t-20 57.99 22.82 9.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.154 -0.93 . . . . 1.5 112.171 170.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.92 -5.52 46.69 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 119.683 -1.246 . . . . 0.38 113.316 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -92.75 156.85 16.76 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 109.471 -0.566 . . . . 0.77000000000000002 109.471 175.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -111.94 99.17 7.89 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.075 -0.511 . . . . 1.8899999999999999 110.682 -175.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.909 ' HB2' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -111.0 100.41 9.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.642 0.734 . . . . 1.01 112.091 -178.598 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.525 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 14.6 p -103.23 -35.62 8.38 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.867 -1.16 . . . . 1.05 107.867 165.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.07 76.6 1.55 Allowed 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.415 -1.72 . . . . 1.6200000000000001 109.187 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.671 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -138.22 157.28 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 108.724 -0.843 . . . . 1.0900000000000001 108.724 175.247 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.656 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 81.1 p -62.7 154.59 28.95 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 112.995 0.739 . . . . 0.34999999999999998 112.995 -177.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.796 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 21.8 t-160 -58.69 -38.69 78.8 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-N 115.289 -0.868 . . . . 0.34999999999999998 110.464 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.89 -30.95 67.45 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.169 -1.378 . . . . 1.6699999999999999 109.732 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.622 ' HB3' HG13 ' A' ' 88' ' ' VAL . 1.6 tp-100 -63.82 -46.58 84.45 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.672 0.749 . . . . 0.77000000000000002 109.265 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.622 ' HB2' HG12 ' A' ' 55' ' ' ILE . . . -74.3 -36.17 63.72 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.025 -0.989 . . . . 0.33000000000000002 110.756 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -67.23 -41.19 86.13 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.232 0.539 . . . . 2.1000000000000001 110.514 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -68.1 -34.79 77.05 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.291 -0.868 . . . . 0.95999999999999996 109.516 -177.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -75.46 -33.43 60.85 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.709 -0.678 . . . . 3.5699999999999998 111.335 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.597 HD11 ' CZ ' ' A' ' 31' ' ' PHE . 3.1 tt -54.99 -61.04 2.57 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.385 -1.28 . . . . 1.6499999999999999 111.861 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.516 HG23 HD22 ' A' ' 97' ' ' LEU . 12.6 p -110.36 -78.84 0.59 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.485 -0.486 . . . . 1.53 112.124 -176.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 95' ' ' LYS . 19.2 ttpt 70.05 -2.65 2.0 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.806 0.812 . . . . 2.7200000000000002 112.185 176.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.826 ' HA ' HD13 ' A' ' 27' ' ' LEU . 78.4 mtp180 71.69 23.23 3.77 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.168 -0.924 . . . . 4.3799999999999999 112.515 171.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.426 ' OG ' ' HG2' ' A' ' 99' ' ' LYS . 4.9 p -154.94 29.04 0.42 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.92 0.711 . . . . 2.5099999999999998 112.92 -174.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -97.98 166.2 11.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.971 0.415 . . . . 3.3999999999999999 111.731 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.538 ' HG3' HG12 ' A' ' 104' ' ' VAL . 18.7 pt-20 -114.05 -28.61 7.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.592 0.711 . . . . 2.6800000000000002 110.159 177.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.56 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 3.9 p -152.92 143.05 14.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 107.756 -1.202 . . . . 0.44 107.756 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.6 t -115.2 117.5 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-O 122.238 1.018 . . . . 0.46000000000000002 111.817 -170.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.682 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 1.3 mpt_? -99.82 129.02 45.88 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 113.036 -1.893 . . . . 1.76 111.118 -173.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.528 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 19.7 tp -133.31 129.61 37.77 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.87 -0.604 . . . . 1.1200000000000001 109.931 177.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.775 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 22.6 tp -106.04 113.61 27.25 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 107.389 -1.337 . . . . 0.41999999999999998 107.389 173.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.733 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.5 OUTLIER -121.9 143.96 32.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 C-N-CA 119.998 -0.681 . . . . 0.77000000000000002 110.523 -173.092 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.501 HG23 HG22 ' A' ' 13' ' ' VAL . 1.3 m -96.77 120.31 36.87 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.313 -0.858 . . . . 0.34000000000000002 110.623 173.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.764 ' HD2' ' HG2' ' A' ' 14' ' ' GLN . 7.7 ttt180 -90.74 153.41 20.28 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.57 -1.195 . . . . 2.0099999999999998 109.794 -176.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.429 ' N ' ' CD ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -145.98 -60.82 0.32 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.134 0.791 . . . . 1.97 113.134 -168.299 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.662 ' HA ' HE22 ' A' ' 115' ' ' GLN . 20.9 t -157.77 10.87 0.19 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.89 0.376 . . . . 1.6200000000000001 111.727 -174.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 3.1 mm? -101.01 17.92 21.06 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.13 -0.356 . . . . 1.6499999999999999 111.44 -176.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.662 HE22 ' HA ' ' A' ' 113' ' ' SER . 2.3 mp0 -57.65 121.59 10.74 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.937 -0.574 . . . . 3.5299999999999998 109.662 176.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -93.26 50.26 1.49 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.239 -0.437 . . . . 3.6000000000000001 111.857 -167.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 59.68 100.86 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.136 -0.938 . . . . 3.5600000000000001 111.461 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.1 p -127.19 143.61 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-O 121.164 0.507 . . . . 4.9900000000000002 110.809 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.436 HE21 ' HB2' ' A' ' 119' ' ' GLN . 13.2 mt-30 -80.73 135.33 35.98 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.593 -0.73 . . . . 7.7699999999999996 110.703 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -157.43 142.12 16.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.019 -0.537 . . . . 6.5999999999999996 110.39 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.5 m -129.13 100.84 5.77 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.706 0.288 . . . . 8.9399999999999995 110.625 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 70.2 mtm -77.22 -38.0 52.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.429 -0.351 . . . . 12.1 110.266 178.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 82.3 mt 67.91 108.75 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.347 -0.842 . . . . 12.82 111.559 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.1 m . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.425 -0.798 . . . . 14.640000000000001 109.658 -179.807 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.7 ttm . . . . . 0 N--CA 1.476 0.864 0 CA-C-O 120.867 0.365 . . . . 14.33 110.573 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 m -67.38 147.74 52.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.09 -0.504 . . . . 11.220000000000001 109.909 177.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -124.66 166.11 16.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.704 0.287 . . . . 9.1899999999999995 110.644 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.822 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -96.33 113.36 62.29 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.148 -0.478 . . . . 6.6500000000000004 109.783 175.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -58.69 -63.18 0.15 Allowed 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.11 2.54 . . . . 7.46 113.636 -174.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -119.53 24.01 8.23 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.408 -0.901 . . . . 5.8899999999999997 112.324 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 60.53 93.15 0.06 OUTLIER Pre-proline 0 N--CA 1.467 0.379 0 CA-C-O 121.295 0.569 . . . . 6.3700000000000001 111.058 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.755 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 4.1 Cg_endo -87.66 125.56 2.06 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.512 2.808 . . . . 3.3999999999999999 112.075 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 8' ' ' PRO . 66.6 t 72.09 -57.38 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 123.639 0.587 . . . . 2.2599999999999998 111.472 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.2 p -76.53 82.03 3.21 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 122.057 0.932 . . . . 2.0899999999999999 110.447 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.511 ' HB3' ' HE2' ' A' ' 50' ' ' LYS . . . -102.16 165.23 11.26 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.69 -1.595 . . . . 0.95999999999999996 109.359 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.9 m -117.61 136.8 53.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 116.131 -0.486 . . . . 1.5700000000000001 109.913 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.805 HG12 HG23 ' A' ' 110' ' ' THR . 3.1 m -88.16 120.65 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 122.311 1.053 . . . . 1.02 110.878 -177.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.956 HE22 HG23 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -97.51 170.99 8.66 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 113.939 -1.482 . . . . 1.3899999999999999 110.545 178.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -115.9 116.55 28.17 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.064 0.394 . . . . 3.6299999999999999 112.064 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.956 HG23 HE22 ' A' ' 14' ' ' GLN . 3.9 t -104.58 118.19 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 109.352 -0.61 . . . . 1.02 109.352 173.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -132.3 115.75 16.02 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.335 -0.848 . . . . 1.3500000000000001 109.117 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.632 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 9.3 tp -144.58 152.37 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 109.002 -0.74 . . . . 0.60999999999999999 109.002 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 10.3 m-70 -79.99 114.32 18.82 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.621 -0.881 . . . . 0.59999999999999998 108.621 174.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.979 ' HB2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -25.33 139.25 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.906 1.379 . . . . 4.0 113.335 177.739 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.641 HD22 ' HD3' ' A' ' 65' ' ' PRO . 32.3 tp -98.91 91.48 5.07 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 119.177 -1.009 . . . . 0.55000000000000004 109.451 -177.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 28.7 ptt180 -76.24 135.91 39.68 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.617 0.722 . . . . 3.9700000000000002 111.316 -173.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.573 ' HB2' HD13 ' A' ' 28' ' ' ILE . 4.8 tp-100 -119.36 94.88 4.57 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.04 -0.982 . . . . 1.3500000000000001 108.422 176.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.53 -80.47 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.729 -0.748 . . . . 1.3300000000000001 111.318 -173.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -134.9 10.95 3.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.003 0.43 . . . . 2.3300000000000001 110.567 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 11.5 m-80 -110.35 173.89 6.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.963 -0.562 . . . . 1.8700000000000001 110.625 -176.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.979 HD13 ' HB2' ' A' ' 20' ' ' LYS . 7.3 tp -127.11 123.75 37.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.378 0.608 . . . . 2.2799999999999998 110.061 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.573 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.7 mp -98.81 132.51 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.227 -0.897 . . . . 0.80000000000000004 108.955 175.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.696 HD13 HD21 ' A' ' 97' ' ' LEU . 0.6 OUTLIER -84.09 -42.74 15.78 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 114.657 -1.156 . . . . 1.74 109.964 -174.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.522 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 92.57 13.49 56.89 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 115.099 -0.955 . . . . 0.68999999999999995 111.479 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.591 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 24.4 p90 -155.33 172.66 17.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.517 -0.179 . . . . 0.51000000000000001 110.517 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.932 ' HB3' ' O ' ' A' ' 58' ' ' THR . 5.6 t -112.81 170.79 7.94 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.578 -0.897 . . . . 0.53000000000000003 108.578 169.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 5.2 tt -148.36 136.4 14.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 120.448 -0.501 . . . . 0.48999999999999999 112.138 -167.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -103.58 170.73 19.55 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.869 -0.892 . . . . 0.71999999999999997 110.869 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.724 ' C ' HE22 ' A' ' 39' ' ' GLN . . . -103.97 166.13 15.5 Favored Glycine 0 N--CA 1.418 -2.52 0 N-CA-C 117.828 1.891 . . . . 1.4199999999999999 117.828 -163.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.784 ' N ' HE22 ' A' ' 39' ' ' GLN . . . -86.37 -143.24 7.29 Favored Glycine 0 N--CA 1.417 -2.623 0 CA-C-N 110.073 -3.064 . . . . 0.47999999999999998 113.392 -173.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.662 HD13 ' O ' ' A' ' 87' ' ' MET . 10.6 pt -83.52 -4.77 8.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.02 -0.59 . . . . 0.52000000000000002 112.213 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.983 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 11.3 p-10 -70.91 -32.43 69.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.852 0.358 . . . . 0.71999999999999997 110.511 -175.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.784 HE22 ' N ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -75.32 -49.15 20.06 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.752 -0.833 . . . . 1.1899999999999999 108.752 -175.471 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.617 ' OD2' ' HB2' ' A' ' 43' ' ' GLN . 1.6 t70 -138.36 107.47 7.91 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 114.394 -1.276 . . . . 2.5699999999999998 110.29 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.696 ' HA ' HD21 ' A' ' 44' ' ' ASN . 23.1 Cg_endo -96.27 9.5 1.5 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.824 3.016 . . . . 2.8199999999999998 112.737 177.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.1 t -109.09 5.55 24.15 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.301 -0.408 . . . . 3.2599999999999998 111.824 -171.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.617 ' HB2' ' OD2' ' A' ' 40' ' ' ASP . 10.3 mt-30 -149.25 50.45 0.96 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.634 0.254 . . . . 3.8799999999999999 110.355 -176.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.703 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 30.5 p30 -149.92 33.56 0.08 OUTLIER Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 112.91 0.708 . . . . 5.1399999999999997 112.91 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.703 ' HD3' ' N ' ' A' ' 44' ' ' ASN . 87.6 Cg_endo -93.73 -1.5 3.19 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.767 1.644 . . . . 3.71 112.38 -173.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.2 t80 174.26 34.82 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 107.513 -1.291 . . . . 5.6200000000000001 107.513 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.4 m -78.56 -175.99 4.6 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 114.285 -1.325 . . . . 3.77 112.59 -166.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -28.37 -68.75 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 O-C-N 124.978 1.424 . . . . 6.7800000000000002 114.65 -172.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.459 ' OD2' ' HD2' ' A' ' 50' ' ' LYS . 32.1 t0 -178.78 -154.7 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.526 -0.916 . . . . 5.4699999999999998 108.526 -170.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.717 ' HE3' HG21 ' A' ' 110' ' ' THR . 0.4 OUTLIER -68.03 0.01 4.0 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.839 0.352 . . . . 3.0699999999999998 110.226 176.311 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -108.53 8.98 27.49 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.139 0.422 . . . . 4.5599999999999996 112.139 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.511 ' OD2' ' HG2' ' A' ' 53' ' ' LYS . 8.9 t70 -81.8 -125.82 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.747 0.308 . . . . 2.6000000000000001 110.9 177.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.648 ' HB3' ' HA ' ' A' ' 37' ' ' ILE . 2.0 mmpp? -74.83 71.29 1.99 Allowed 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 107.574 -1.269 . . . . 3.48 107.574 169.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -136.04 163.92 25.04 Favored Glycine 0 N--CA 1.417 -2.6 0 N-CA-C 107.896 -2.082 . . . . 0.78000000000000003 107.896 -172.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.718 HG22 HD13 ' A' ' 77' ' ' ILE . 2.2 mp -93.74 119.43 41.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 119.89 1.845 . . . . 0.54000000000000004 108.943 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.785 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -151.78 131.26 12.98 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.188 0.994 . . . . 1.4199999999999999 110.122 -170.584 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.958 HG21 HD21 ' A' ' 71' ' ' LEU . 1.2 t -62.05 139.93 20.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 113.594 -1.639 . . . . 0.57999999999999996 112.22 -173.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.932 ' O ' ' HB3' ' A' ' 32' ' ' SER . 6.4 m -129.28 64.17 1.48 Allowed 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.613 -1.176 . . . . 1.1100000000000001 109.216 173.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.63 ' C ' ' HA ' ' A' ' 73' ' ' ILE . 15.4 mtt180 148.97 -171.22 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 125.391 1.476 . . . . 2.27 111.475 163.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 61.9 t -161.13 130.42 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 113.028 -1.897 . . . . 0.82999999999999996 106.635 163.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.8 m -88.43 123.57 33.1 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.154 0.502 . . . . 1.6499999999999999 109.991 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.492 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 77.3 mt-10 -52.1 118.54 3.56 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.935 -1.03 . . . . 1.8500000000000001 111.876 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.79 -3.02 60.55 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.203 -0.908 . . . . 0.92000000000000004 111.907 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.42 172.2 39.2 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.613 -0.803 . . . . 0.98999999999999999 111.503 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.641 ' HD3' HD22 ' A' ' 21' ' ' LEU . 92.2 Cg_endo -74.1 -24.69 14.6 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 122.962 2.441 . . . . 0.44 113.408 -168.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.591 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -67.51 -23.91 65.51 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.05 -0.977 . . . . 0.35999999999999999 110.928 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.492 ' OE1' ' HA ' ' A' ' 62' ' ' GLU . 28.2 tt0 -75.7 -36.77 59.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.771 0.796 . . . . 1.79 108.935 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.525 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.5 mp -73.35 -42.14 57.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.145 -1.389 . . . . 0.51000000000000001 110.351 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.695 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -71.23 -21.32 62.14 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.995 -0.548 . . . . 0.40999999999999998 111.026 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.46 54.3 1.09 Allowed Glycine 0 C--O 1.225 -0.437 0 C-N-CA 120.037 -1.078 . . . . 0.45000000000000001 114.174 174.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.958 HD21 HG21 ' A' ' 57' ' ' VAL . 6.5 tp -97.25 161.34 13.85 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.269 -0.641 . . . . 0.89000000000000001 109.269 174.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.6 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 4.7 pt20 -131.47 29.57 4.54 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 115.071 1.508 . . . . 1.21 115.071 -168.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.63 ' HA ' ' C ' ' A' ' 59' ' ' ARG . 2.3 mp 75.3 -6.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-O 120.975 0.417 . . . . 0.77000000000000002 111.349 173.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -164.82 66.32 0.22 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.851 -0.69 . . . . 0.37 111.628 -169.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.478 ' HB3' ' CG2' ' A' ' 109' ' ' VAL . 3.8 m-20 -118.8 135.88 54.29 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 115.613 -0.293 . . . . 0.89000000000000001 110.966 -169.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.5 mmtt -95.49 102.95 14.8 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 121.054 0.454 . . . . 2.2000000000000002 109.981 -174.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.785 HD12 ' HA ' ' A' ' 56' ' ' TYR . 2.9 mp -72.24 118.04 16.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 112.473 0.545 . . . . 0.48999999999999999 112.473 -171.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.98 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 1.3 mmt -93.61 -10.48 34.49 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.088 -0.96 . . . . 1.0600000000000001 112.869 177.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.634 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -172.23 154.01 3.2 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.329 0.492 . . . . 0.81999999999999995 112.329 -178.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.508 ' N ' ' HG3' ' A' ' 79' ' ' GLN . 87.8 t -133.08 105.59 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.68 -0.691 . . . . 1.3100000000000001 110.731 177.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.753 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 6.3 m120 55.13 33.22 19.98 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.969 0.729 . . . . 1.5 112.969 176.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.48 -12.26 50.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 119.77 -1.205 . . . . 0.38 112.202 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.44 ' NE1' ' HD2' ' A' ' 96' ' ' ARG . 90.2 m95 -75.92 162.69 27.9 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.875 -0.787 . . . . 0.77000000000000002 108.875 171.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -116.54 115.14 25.2 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.406 -0.361 . . . . 1.8899999999999999 110.466 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.431 ' SD ' HG11 ' A' ' 88' ' ' VAL . 21.4 mmt -106.89 101.4 10.84 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.567 0.699 . . . . 1.01 110.92 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.05 91.69 2.71 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.05 -0.977 . . . . 1.05 109.384 170.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.662 ' O ' HD13 ' A' ' 37' ' ' ILE . 0.1 OUTLIER 48.88 65.14 1.45 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.711 -1.131 . . . . 1.6200000000000001 110.332 -173.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.708 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 6.0 p -108.67 178.35 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 107.434 -1.321 . . . . 1.0900000000000001 107.434 170.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.983 ' HB ' ' HB3' ' A' ' 38' ' ' ASP . 49.2 p -66.27 147.89 52.66 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 119.093 0.86 . . . . 0.34999999999999998 111.601 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.593 ' CG ' ' HA2' ' A' ' 35' ' ' GLY . 20.7 t-160 -54.68 -38.46 67.01 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-O 122.121 0.962 . . . . 0.34999999999999998 108.827 174.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.47 -33.04 74.81 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 113.109 -1.86 . . . . 1.6699999999999999 109.865 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.758 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 3.7 tp-100 -59.45 -52.96 63.37 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 109.207 -0.664 . . . . 0.77000000000000002 109.207 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.642 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . -74.44 -35.73 63.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.233 -0.894 . . . . 0.33000000000000002 110.375 -175.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -61.06 -44.2 97.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.936 -0.574 . . . . 2.1000000000000001 110.356 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.63 ' HE3' ' O ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -71.2 -46.54 61.01 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.847 -0.615 . . . . 0.95999999999999996 109.439 -176.51 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.758 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 29.4 mmt180 -65.6 -25.33 67.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.035 -0.53 . . . . 3.5699999999999998 110.672 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.696 HD21 HD13 ' A' ' 29' ' ' LEU . 17.0 tp -68.45 -61.04 2.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.06 -0.518 . . . . 1.6499999999999999 111.603 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.851 ' HA ' HD23 ' A' ' 27' ' ' LEU . 2.5 m -69.44 -32.64 71.72 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.256 -0.646 . . . . 1.53 109.256 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.496 ' HB3' ' H ' ' A' ' 100' ' ' ARG . 0.4 OUTLIER 61.36 -105.72 0.21 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.713 -1.13 . . . . 2.7200000000000002 110.87 168.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.496 ' H ' ' HB3' ' A' ' 99' ' ' LYS . 59.9 mtm180 -143.99 14.49 1.69 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.813 -1.18 . . . . 4.3799999999999999 107.813 172.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.5 m 73.57 42.03 0.42 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.61 -1.177 . . . . 2.5099999999999998 111.015 -173.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -57.07 154.17 10.29 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.032 -0.531 . . . . 3.3999999999999999 109.793 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -58.99 -25.18 63.39 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.87 1.063 . . . . 2.6800000000000002 113.87 -164.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 7.2 p -146.38 151.91 14.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 120.758 -0.377 . . . . 0.44 110.298 -175.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.412 ' HA ' HD21 ' A' ' 81' ' ' ASN . 51.8 t -133.31 118.37 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.016 0 CA-C-O 122.344 1.069 . . . . 0.46000000000000002 112.266 -169.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.753 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -100.98 130.53 46.99 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 113.023 -1.899 . . . . 1.76 110.309 -177.01 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.679 HD11 HG12 ' A' ' 77' ' ' ILE . 34.3 tp -131.84 131.79 43.14 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.574 -0.528 . . . . 1.1200000000000001 109.574 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.98 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 15.3 tp -105.46 129.31 53.79 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 105.412 -2.07 . . . . 0.41999999999999998 105.412 172.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.743 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -140.97 146.5 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 C-N-CA 119.916 -0.714 . . . . 0.77000000000000002 110.267 -173.596 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.805 HG23 HG12 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -92.36 125.73 37.14 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.566 0.698 . . . . 0.34000000000000002 111.077 172.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.59 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 34.6 ttt180 -111.45 146.81 36.56 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.224 -1.353 . . . . 2.0099999999999998 110.958 -172.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.5 -105.66 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.637 -0.71 . . . . 1.97 111.232 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.7 t -136.15 36.34 2.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.2 0.524 . . . . 1.6200000000000001 111.708 -171.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.551 ' HB2' ' HG3' ' A' ' 72' ' ' GLN . 2.9 mt -110.57 -17.46 13.41 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.41 0.624 . . . . 1.6499999999999999 110.372 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.587 HE21 ' NE2' ' A' ' 72' ' ' GLN . 64.2 mm-40 -47.26 124.91 7.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.563 -1.199 . . . . 3.5299999999999998 112.526 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.848 ' HD3' ' H ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -99.25 72.5 1.85 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.394 -0.821 . . . . 3.6000000000000001 110.561 -178.267 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 51.59 81.51 0.07 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.005 -0.998 . . . . 3.5600000000000001 111.603 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.7 p -90.35 140.27 16.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.893 0.377 . . . . 4.9900000000000002 110.757 -177.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -70.32 123.89 22.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.574 -0.739 . . . . 7.7699999999999996 110.723 177.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -118.53 -47.15 2.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.206 -0.452 . . . . 6.5999999999999996 109.919 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.8 t -94.49 145.5 24.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.265 -0.88 . . . . 8.9399999999999995 110.071 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -139.04 -175.06 4.02 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.973 -0.38 . . . . 12.1 109.973 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.513 ' HG ' ' H ' ' A' ' 124' ' ' SER . 21.9 tp -114.58 173.64 6.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.091 0.472 . . . . 12.82 111.075 -171.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.513 ' H ' ' HG ' ' A' ' 123' ' ' LEU . 21.4 m . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.725 -0.655 . . . . 14.640000000000001 109.427 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.8 mmm . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.393 0.139 . . . . 14.33 110.94 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.0 m 64.66 98.29 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.046 0.758 . . . . 11.220000000000001 113.046 173.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -101.85 105.16 15.96 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.78 -0.452 . . . . 9.1899999999999995 109.78 172.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.667 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -106.07 108.18 61.17 Favored Pre-proline 0 C--O 1.216 -0.702 0 CA-C-O 120.879 0.371 . . . . 6.6500000000000004 111.368 -178.601 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -80.68 -6.27 13.41 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.102 2.535 . . . . 7.46 111.127 173.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.59 -31.57 24.12 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.492 -0.777 . . . . 5.8899999999999997 112.176 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.437 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 10.9 pt20 -150.02 50.01 0.71 Allowed Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 113.514 0.931 . . . . 6.3700000000000001 113.514 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 7' ' ' GLN . 87.0 Cg_endo -81.46 -155.53 0.06 OUTLIER 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.565 2.177 . . . . 3.3999999999999999 110.974 173.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.5 p -87.01 82.0 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 122.602 1.191 . . . . 2.2599999999999998 108.989 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 m -77.54 79.84 4.03 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 113.841 -1.527 . . . . 2.0899999999999999 108.79 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.522 ' HB1' ' O ' ' A' ' 111' ' ' ARG . . . -65.73 174.08 2.52 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.09 -1.868 . . . . 0.95999999999999996 111.716 176.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.42 119.98 58.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.882 -1.053 . . . . 1.5700000000000001 110.041 -175.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.528 HG22 HG23 ' A' ' 110' ' ' THR . 94.0 t -76.29 106.64 6.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 122.035 0.921 . . . . 1.02 111.532 -175.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.656 ' NE2' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -100.27 138.15 37.73 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.642 -1.617 . . . . 1.3899999999999999 110.66 177.381 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.594 ' HG2' ' HA ' ' A' ' 108' ' ' LEU . 3.3 tmm_? -124.7 121.1 33.72 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 120.869 -1.144 . . . . 3.6299999999999999 109.914 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.935 ' HB ' ' HB1' ' A' ' 69' ' ' ALA . 4.1 m -113.38 155.64 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 119.626 -0.83 . . . . 1.02 110.199 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -144.63 126.75 15.59 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.332 -0.849 . . . . 1.3500000000000001 109.145 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.559 HG12 ' HB2' ' A' ' 65' ' ' PRO . 7.8 tp -146.07 143.35 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 C-N-CA 119.728 -0.789 . . . . 0.60999999999999999 109.58 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.716 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.9 m-70 -72.6 112.11 8.37 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.735 -0.666 . . . . 0.59999999999999998 109.455 -176.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.805 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -31.58 135.69 0.06 Allowed 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.329 1.018 . . . . 4.0 113.331 178.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.0 tp -100.71 98.61 9.13 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.197 0.523 . . . . 0.55000000000000004 110.509 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -71.4 142.48 50.3 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.653 -0.703 . . . . 3.9700000000000002 111.124 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.512 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -135.0 95.07 3.24 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.525 -0.762 . . . . 1.3500000000000001 109.398 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.27 -81.85 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.362 -0.923 . . . . 1.3300000000000001 112.14 -177.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -138.09 12.0 2.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.043 0.449 . . . . 2.3300000000000001 111.357 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.512 ' OD1' ' HB3' ' A' ' 23' ' ' GLN . 1.5 p30 -127.05 171.06 11.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.063 -0.517 . . . . 1.8700000000000001 110.715 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.475 HD21 ' HG2' ' A' ' 102' ' ' GLU . 10.3 mp -122.09 123.81 42.44 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.988 0.423 . . . . 2.2799999999999998 110.619 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.442 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.7 mp -99.13 135.6 33.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.959 -0.564 . . . . 0.80000000000000004 110.003 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.763 HD22 HD22 ' A' ' 97' ' ' LEU . 9.6 mt -86.8 -35.19 19.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.36 -0.837 . . . . 1.74 110.717 -174.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.87 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 89.87 10.48 64.76 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 115.321 -0.854 . . . . 0.68999999999999995 110.967 -172.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.751 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 25.7 p90 -156.84 160.35 39.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 122.342 0.257 . . . . 0.51000000000000001 110.793 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.534 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 22.1 t -104.1 160.7 14.63 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.77 -1.196 . . . . 0.53000000000000003 107.77 170.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.42 ' HA ' ' H ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -161.19 138.99 2.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 120.253 -0.579 . . . . 0.48999999999999999 112.561 -165.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -142.53 117.89 1.2 Allowed Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 110.431 -1.067 . . . . 0.71999999999999997 110.431 156.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 1.065 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -140.15 117.28 1.28 Allowed Glycine 0 CA--C 1.49 -1.524 0 CA-C-O 118.927 -0.929 . . . . 1.4199999999999999 111.518 171.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.711 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -165.41 144.46 9.29 Favored Glycine 0 C--N 1.3 -1.46 0 C-N-CA 118.17 -1.966 . . . . 0.47999999999999998 112.77 175.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.563 HG23 ' HA ' ' A' ' 87' ' ' MET . 8.8 pt -61.23 -20.64 22.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 107.577 -1.268 . . . . 0.52000000000000002 107.577 153.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.661 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 3.8 t70 -61.33 -37.87 84.84 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.239 -1.801 . . . . 0.71999999999999997 110.747 174.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -67.24 -69.88 0.28 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.369 -0.832 . . . . 1.1899999999999999 112.658 -169.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -145.2 115.98 5.07 Favored Pre-proline 0 N--CA 1.469 0.509 0 CA-C-O 120.944 0.402 . . . . 2.5699999999999998 112.035 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -58.96 -32.43 97.49 Favored 'Trans proline' 0 N--CA 1.476 0.481 0 C-N-CA 123.892 3.061 . . . . 2.8199999999999998 113.184 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.5 m -60.96 -17.92 54.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.376 -0.829 . . . . 3.2599999999999998 111.703 -172.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.685 ' HB2' ' HG3' ' A' ' 53' ' ' LYS . 39.1 mm-40 -96.96 47.37 1.04 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 3.8799999999999999 109.903 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.608 ' H ' ' HD2' ' A' ' 45' ' ' PRO . 4.5 t-20 -130.15 -52.17 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.681 0 CA-C-N 116.238 -0.437 . . . . 5.1399999999999997 112.142 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.608 ' HD2' ' H ' ' A' ' 44' ' ' ASN . 4.4 Cg_endo -45.81 -12.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.365 1.395 0 C-N-CA 123.369 2.712 . . . . 3.71 115.026 173.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -136.59 25.71 3.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.125 0.488 . . . . 5.6200000000000001 109.863 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.931 ' HB3' ' HA ' ' A' ' 52' ' ' ASP . 3.7 m -150.52 108.23 3.68 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 121.834 0.825 . . . . 3.77 108.822 -172.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.574 ' H ' ' HB ' ' A' ' 51' ' ' THR . 2.0 mp0 -85.53 -52.34 5.89 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.931 -1.031 . . . . 6.7800000000000002 113.344 -171.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.419 ' OD2' ' HB3' ' A' ' 48' ' ' GLU . 22.2 m-20 -134.52 -109.09 0.22 Allowed 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.021 -1.445 . . . . 5.4699999999999998 110.932 -159.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.566 ' HE2' HG21 ' A' ' 110' ' ' THR . 1.2 tmmt? -66.97 -26.75 66.97 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 106.184 -1.784 . . . . 3.0699999999999998 106.184 161.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.574 ' HB ' ' H ' ' A' ' 48' ' ' GLU . 3.3 m -57.17 -40.7 77.84 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 112.863 -1.971 . . . . 4.5599999999999996 109.764 172.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.931 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 12.8 t70 -56.2 174.99 0.11 Allowed 'General case' 0 N--CA 1.477 0.911 0 O-C-N 123.709 0.631 . . . . 2.6000000000000001 110.732 170.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.685 ' HG3' ' HB2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -56.81 -53.44 57.85 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.361 -0.607 . . . . 3.48 109.361 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.634 ' HA2' ' O ' ' A' ' 86' ' ' THR . . . 64.53 -153.99 48.76 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.243 -0.89 . . . . 0.78000000000000003 110.895 -175.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.065 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -106.53 146.44 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 106.522 -1.658 . . . . 0.54000000000000004 106.522 169.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.679 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -153.51 141.5 20.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 119.613 1.097 . . . . 1.4199999999999999 111.072 178.706 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.789 HG12 ' H ' ' A' ' 75' ' ' ASP . 2.5 p -81.5 132.39 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 CA-C-N 114.392 -1.276 . . . . 0.57999999999999996 109.374 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.42 ' H ' ' HA ' ' A' ' 33' ' ' ILE . 27.8 m -100.18 -18.52 16.86 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.075 -0.966 . . . . 1.1100000000000001 110.294 -173.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.816 ' HA ' HG23 ' A' ' 73' ' ' ILE . 50.5 mtt180 -146.34 -168.07 2.91 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.333 0.587 . . . . 2.27 112.022 174.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.605 HG13 ' HB3' ' A' ' 66' ' ' ALA . 75.4 t -166.33 146.75 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 113.003 -1.908 . . . . 0.82999999999999996 106.218 165.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.4 p -95.47 133.32 39.58 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.359 0.6 . . . . 1.6499999999999999 111.519 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -64.83 115.03 4.9 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.456 -1.247 . . . . 1.8500000000000001 110.138 171.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.88 -16.81 59.74 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 114.983 -1.008 . . . . 0.92000000000000004 112.171 -177.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.516 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -77.25 172.16 55.13 Favored Glycine 0 CA--C 1.502 -0.755 0 C-N-CA 120.588 -0.815 . . . . 0.98999999999999999 111.551 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.87 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 60.0 Cg_endo -73.27 -28.1 12.85 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.273 1.982 . . . . 0.44 113.214 -166.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.751 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -58.75 -32.97 69.74 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.269 -0.878 . . . . 0.35999999999999999 111.922 172.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -77.61 -28.94 51.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.558 0.694 . . . . 1.79 109.648 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.516 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -71.28 -41.15 74.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.199 -0.909 . . . . 0.51000000000000001 108.888 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.935 ' HB1' ' HB ' ' A' ' 16' ' ' VAL . . . -69.54 -31.2 69.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.249 -0.887 . . . . 0.40999999999999998 110.055 175.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.31 52.24 1.16 Allowed Glycine 0 CA--C 1.521 0.414 0 C-N-CA 121.043 -0.599 . . . . 0.45000000000000001 113.66 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.515 HD21 HG21 ' A' ' 57' ' ' VAL . 19.8 tp -102.46 155.74 18.06 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.254 -0.647 . . . . 0.89000000000000001 109.254 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.657 HE22 ' HG3' ' A' ' 111' ' ' ARG . 7.2 mt-30 -126.34 29.59 5.76 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 115.778 1.77 . . . . 1.21 115.778 -163.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.816 HG23 ' HA ' ' A' ' 59' ' ' ARG . 53.9 mt 72.52 1.58 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-N 119.102 0.864 . . . . 0.77000000000000002 113.026 166.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -172.24 51.41 0.17 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 119.668 -1.253 . . . . 0.37 113.118 -171.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.789 ' H ' HG12 ' A' ' 57' ' ' VAL . 21.1 m-20 -122.08 142.55 50.25 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.595 -0.302 . . . . 0.89000000000000001 111.736 -172.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.64 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 59.3 mttm -82.76 130.57 35.15 Favored 'General case' 0 C--O 1.207 -1.163 0 CA-C-O 121.138 0.494 . . . . 2.2000000000000002 109.668 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.679 HD12 ' HA ' ' A' ' 56' ' ' TYR . 2.8 mp -99.8 125.22 53.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 C-N-CA 122.689 0.396 . . . . 0.48999999999999999 110.562 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.768 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 7.5 mmt -90.81 -17.17 27.04 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 125.099 1.499 . . . . 1.0600000000000001 112.941 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -163.99 151.48 12.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.041 0.448 . . . . 0.81999999999999995 112.128 -175.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.578 ' HB ' ' HE1' ' A' ' 85' ' ' MET . 39.5 t -130.51 105.07 10.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.344 -0.844 . . . . 1.3100000000000001 110.38 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.673 HD21 HG13 ' A' ' 105' ' ' VAL . 27.2 m-80 49.48 46.95 23.1 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.751 -0.659 . . . . 1.5 111.997 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.03 -15.17 61.93 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.337 -0.935 . . . . 0.38 112.978 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -85.58 170.16 12.85 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 109.782 -0.451 . . . . 0.77000000000000002 109.782 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -115.92 112.47 21.94 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.114 0.483 . . . . 1.8899999999999999 111.39 -172.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.578 ' HE1' ' HB ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -107.11 100.5 9.97 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.136 0.969 . . . . 1.01 110.922 -179.257 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.634 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 1.1 p -132.03 -58.38 0.96 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.939 -1.482 . . . . 1.05 107.408 170.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.563 ' HA ' HG23 ' A' ' 37' ' ' ILE . 1.3 mtt -125.36 79.33 1.8 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.642 -1.617 . . . . 1.6200000000000001 108.563 172.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.711 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.2 t -139.25 137.28 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 115.351 -0.841 . . . . 1.0900000000000001 108.879 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.661 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 79.3 p -56.78 152.6 12.16 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.333 0.587 . . . . 0.34999999999999998 112.529 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.766 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 21.0 t-160 -57.11 -38.18 73.03 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 115.552 -0.749 . . . . 0.34999999999999998 110.395 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.57 -32.05 69.29 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.491 -1.231 . . . . 1.6699999999999999 109.877 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.639 ' HB3' HG13 ' A' ' 88' ' ' VAL . 1.0 OUTLIER -65.7 -45.05 84.25 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 109.088 -0.708 . . . . 0.77000000000000002 109.088 -177.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.66 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -74.91 -37.41 62.08 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.173 -0.922 . . . . 0.33000000000000002 110.565 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.406 ' HD3' HH11 ' A' ' 94' ' ' ARG . 29.6 ttp180 -65.05 -37.53 87.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.048 -0.524 . . . . 2.1000000000000001 110.356 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.518 ' HE3' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -70.98 -40.79 71.71 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.631 -0.713 . . . . 0.95999999999999996 110.175 -177.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 13.1 mmm180 -69.06 -27.71 65.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.2 0.524 . . . . 3.5699999999999998 110.564 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.763 HD22 HD22 ' A' ' 29' ' ' LEU . 2.3 tt -78.59 -48.06 15.93 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.452 -0.795 . . . . 1.6499999999999999 110.426 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.4 HG23 ' HB2' ' A' ' 27' ' ' LEU . 2.3 m -108.74 70.24 0.74 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.51 -0.768 . . . . 1.53 110.389 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.518 ' HB2' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -108.98 8.9 26.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.661 0.743 . . . . 2.7200000000000002 110.839 -176.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 75.8 mtp180 73.0 20.41 3.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.622 -1.172 . . . . 4.3799999999999999 112.681 173.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.7 p -71.28 -46.02 61.82 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.457 -0.572 . . . . 2.5099999999999998 109.457 174.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.475 ' HG2' HD21 ' A' ' 27' ' ' LEU . 35.6 mt-10 68.18 6.06 5.03 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.148 -0.933 . . . . 3.3999999999999999 113.067 169.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.444 ' HG3' ' H ' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -70.58 -68.47 0.43 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.67 0.748 . . . . 2.6800000000000002 109.767 174.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.716 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 4.8 p -159.58 156.14 3.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.816 -1.084 . . . . 0.44 108.52 -176.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.723 HG21 ' HG2' ' A' ' 20' ' ' LYS . 3.1 t -132.11 119.88 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-O 121.958 0.885 . . . . 0.46000000000000002 112.968 -177.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.576 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 1.2 mpt_? -100.31 130.75 46.45 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.393 -1.731 . . . . 1.76 111.236 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.14 135.64 41.28 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.916 -0.314 . . . . 1.1200000000000001 110.592 172.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.768 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 26.2 tp -98.45 130.34 45.06 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 107.008 -1.479 . . . . 0.41999999999999998 107.008 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.592 HG13 ' HB3' ' A' ' 75' ' ' ASP . 2.2 t -128.32 142.53 43.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 121.611 0.719 . . . . 0.77000000000000002 111.317 -170.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.566 HG21 ' HE2' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -98.74 114.29 26.75 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.511 -0.768 . . . . 0.34000000000000002 109.973 164.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.657 ' HG3' HE22 ' A' ' 72' ' ' GLN . 20.1 ttt180 -98.68 146.52 25.78 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.102 -0.953 . . . . 2.0099999999999998 110.31 -175.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.471 ' N ' ' CD ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -136.22 -69.44 0.48 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.036 0.754 . . . . 1.97 113.036 -171.346 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.9 t -158.38 26.91 0.24 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.059 0.457 . . . . 1.6200000000000001 111.661 -173.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 4.0 mm? -98.83 23.21 9.1 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.217 0.451 . . . . 1.6499999999999999 112.217 -176.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.608 ' HB2' ' HB ' ' A' ' 118' ' ' VAL . 1.7 mp0 -72.6 158.42 35.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.873 0.368 . . . . 3.5299999999999998 110.722 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -93.44 -61.09 1.63 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.915 0.864 . . . . 3.6000000000000001 109.782 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -92.12 65.29 4.71 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.663 -1.153 . . . . 3.5600000000000001 110.046 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.608 ' HB ' ' HB2' ' A' ' 115' ' ' GLN . 13.1 p -111.67 -28.16 2.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.609 -0.723 . . . . 4.9900000000000002 110.965 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.508 ' HG3' HG13 ' A' ' 118' ' ' VAL . 94.8 mt-30 -114.19 11.58 17.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.531 -0.759 . . . . 7.7699999999999996 109.726 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -143.76 139.95 29.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.798 -1.092 . . . . 6.5999999999999996 108.869 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.0 m -82.79 179.44 7.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.238 0.542 . . . . 8.9399999999999995 112.405 -172.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 94.4 mmm -73.99 90.29 1.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.533 -0.758 . . . . 12.1 111.612 -175.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 27.8 tp -112.21 12.83 20.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.994 0.902 . . . . 12.82 108.771 172.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.7 m . . . . . 0 C--O 1.247 0.946 0 CA-C-N 114.78 -1.1 . . . . 14.640000000000001 109.032 178.996 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptt? . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 111.573 0.212 . . . . 14.33 111.573 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 t -165.04 154.16 12.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.901 0.381 . . . . 11.220000000000001 110.65 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -141.01 135.05 30.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.526 -0.761 . . . . 9.1899999999999995 109.776 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.842 HG13 ' HB3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -110.53 98.19 35.63 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 121.107 0.48 . . . . 6.6500000000000004 110.578 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.81 -16.0 20.96 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.887 2.392 . . . . 7.46 112.02 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.58 39.75 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.607 -0.724 . . . . 5.8899999999999997 111.503 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.621 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 17.8 pt20 -152.86 35.54 0.08 OUTLIER Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 114.084 1.142 . . . . 6.3700000000000001 114.084 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.842 ' HB3' HG13 ' A' ' 4' ' ' ILE . 11.8 Cg_endo -80.27 114.3 3.05 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.046 1.83 . . . . 3.3999999999999999 111.929 172.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.562 ' HB ' ' O ' ' A' ' 8' ' ' PRO . 24.3 t 78.85 -48.56 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 O-C-N 123.363 0.415 . . . . 2.2599999999999998 111.419 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.3 p -70.51 82.55 0.58 Allowed 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 122.632 1.206 . . . . 2.0899999999999999 111.847 -175.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.61 178.72 4.2 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.265 -1.789 . . . . 0.95999999999999996 110.09 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.6 t -120.49 117.17 52.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 116.081 -0.509 . . . . 1.5700000000000001 110.273 -174.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.705 HG22 HG23 ' A' ' 110' ' ' THR . 21.8 t -76.71 115.72 18.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.954 0.406 . . . . 1.02 109.942 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.999 HE22 HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -105.48 172.37 6.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.708 -0.678 . . . . 1.3899999999999999 110.637 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.629 ' NH1' ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -128.17 128.3 44.53 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.814 -0.175 . . . . 3.6299999999999999 110.919 172.41 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.999 HG23 HE22 ' A' ' 14' ' ' GLN . 24.2 t -102.08 132.54 47.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 110.196 -0.298 . . . . 1.02 110.196 173.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.629 ' HB2' ' NH1' ' A' ' 15' ' ' ARG . 10.1 tt0 -144.71 115.47 7.75 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.357 -0.238 . . . . 1.3500000000000001 110.357 171.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.545 HG12 ' HB2' ' A' ' 65' ' ' PRO . 9.0 tp -145.39 155.73 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 108.561 -0.903 . . . . 0.60999999999999999 108.561 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -83.39 116.59 22.56 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 119.711 -0.796 . . . . 0.59999999999999998 109.603 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -28.8 140.77 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.958 1.411 . . . . 4.0 112.441 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.431 HD22 ' HD3' ' A' ' 65' ' ' PRO . 39.6 tp -97.1 102.9 14.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.173 0.511 . . . . 0.55000000000000004 110.24 -173.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 12.3 ptp180 -71.11 141.17 50.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.571 -0.74 . . . . 3.9700000000000002 111.887 -175.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.567 ' HG3' HD13 ' A' ' 28' ' ' ILE . 6.7 mm-40 -132.66 92.28 3.04 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.398 -0.964 . . . . 1.3500000000000001 108.398 170.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.27 -68.29 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.053 -0.594 . . . . 1.3300000000000001 112.251 -173.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -147.08 12.42 1.08 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.45 0.643 . . . . 2.3300000000000001 109.829 -176.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.559 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 34.0 m-80 -112.17 161.77 16.18 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.276 -0.875 . . . . 1.8700000000000001 110.534 -174.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.79 ' HB2' HG23 ' A' ' 98' ' ' THR . 10.9 mp -121.93 113.07 19.09 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.758 -0.831 . . . . 2.2799999999999998 108.758 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.567 HD13 ' HG3' ' A' ' 23' ' ' GLN . 1.2 mp -97.88 133.43 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 CA-C-O 121.311 0.577 . . . . 0.80000000000000004 109.996 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.474 HD22 HD22 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -77.18 -41.29 42.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.647 -1.161 . . . . 1.74 109.832 -173.13 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.685 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 94.17 9.5 59.3 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.191 -0.913 . . . . 0.68999999999999995 111.036 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 31.0 p90 -156.18 177.51 11.35 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 122.659 0.384 . . . . 0.51000000000000001 110.299 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.445 ' H ' ' HB2' ' A' ' 59' ' ' ARG . 15.9 t -114.45 161.23 18.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.619 -1.252 . . . . 0.53000000000000003 107.619 169.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -161.45 136.09 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 112.6 0.593 . . . . 0.48999999999999999 112.6 -167.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.474 ' HA2' ' CD2' ' A' ' 90' ' ' HIS . . . -143.82 118.72 1.22 Allowed Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 110.518 -1.033 . . . . 0.71999999999999997 110.518 156.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 1.101 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -139.19 116.54 1.25 Allowed Glycine 0 CA--C 1.492 -1.36 0 CA-C-O 118.982 -0.899 . . . . 1.4199999999999999 111.148 172.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.52 140.4 6.24 Favored Glycine 0 C--N 1.3 -1.465 0 C-N-CA 118.139 -1.982 . . . . 0.47999999999999998 112.659 177.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.412 ' HA ' ' HB3' ' A' ' 53' ' ' LYS . 11.6 pt -58.26 -22.51 19.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 107.42 -1.326 . . . . 0.52000000000000002 107.42 151.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.796 ' HB2' ' CB ' ' A' ' 89' ' ' THR . 13.0 t70 -57.97 -43.71 86.64 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 113.223 -1.808 . . . . 0.71999999999999997 111.435 173.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -63.4 -80.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.402 -0.817 . . . . 1.1899999999999999 112.629 -168.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 10.3 t70 -170.18 111.12 0.45 Allowed Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.689 -0.232 . . . . 2.5699999999999998 110.483 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.759 ' HA ' ' HE3' ' A' ' 53' ' ' LYS . 5.7 Cg_exo -83.79 -2.59 10.36 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 C-N-CA 123.341 2.694 . . . . 2.8199999999999998 113.145 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 t -87.7 25.66 1.45 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.129 0.418 . . . . 3.2599999999999998 112.129 -165.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -127.6 -7.81 5.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.092 0.472 . . . . 3.8799999999999999 109.995 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.457 ' HB2' ' OE2' ' A' ' 48' ' ' GLU . 6.5 m-20 174.79 72.41 0.05 OUTLIER Pre-proline 0 N--CA 1.444 -0.729 0 N-CA-C 106.522 -1.658 . . . . 5.1399999999999997 106.522 -169.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -86.59 30.44 0.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.948 2.432 . . . . 3.71 112.27 -169.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -144.81 -49.37 0.26 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.907 -1.042 . . . . 5.6200000000000001 108.335 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.7 m -160.37 98.58 1.28 Allowed 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.577 -0.738 . . . . 3.77 110.493 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.914 ' H ' ' HA ' ' A' ' 52' ' ' ASP . 13.9 mm-40 -54.59 -57.6 10.8 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 122.312 1.053 . . . . 6.7800000000000002 109.769 167.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.558 ' CG ' ' HE2' ' A' ' 76' ' ' LYS . 7.6 m-20 -130.04 -110.56 0.26 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.751 -1.568 . . . . 5.4699999999999998 109.956 -172.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.521 ' HD2' ' HB3' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -91.09 -35.17 14.75 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.496 -1.229 . . . . 3.0699999999999998 108.497 169.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.51 HG21 ' CE ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -127.98 24.56 6.01 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 114.19 1.182 . . . . 4.5599999999999996 114.19 -168.191 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.914 ' HA ' ' H ' ' A' ' 48' ' ' GLU . 34.9 t70 56.23 -130.99 1.76 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.533 -0.758 . . . . 2.6000000000000001 112.764 164.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.759 ' HE3' ' HA ' ' A' ' 41' ' ' PRO . 29.8 mmtt -83.13 50.85 1.82 Allowed 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 122.18 0.991 . . . . 3.48 109.616 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.432 ' C ' HD12 ' A' ' 55' ' ' ILE . . . -86.55 -145.35 8.87 Favored Glycine 0 N--CA 1.422 -2.247 0 N-CA-C 108.813 -1.715 . . . . 0.78000000000000003 108.813 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.101 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -113.92 141.45 29.99 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 CA-C-N 118.935 1.368 . . . . 0.54000000000000004 109.002 173.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.585 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -142.64 142.25 32.05 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 119.036 0.834 . . . . 1.4199999999999999 110.791 -178.09 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.879 HG21 HD21 ' A' ' 71' ' ' LEU . 1.4 p -82.66 143.48 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-N 114.848 -1.069 . . . . 0.57999999999999996 109.66 178.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.9 m -110.87 -17.6 13.29 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 124.191 0.932 . . . . 1.1100000000000001 111.454 -173.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.452 ' CA ' ' HA ' ' A' ' 73' ' ' ILE . 78.7 mtt180 -152.56 -166.31 2.44 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.953 0.882 . . . . 2.27 112.097 175.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 8.7 p -173.35 139.58 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 112.982 -1.917 . . . . 0.82999999999999996 107.529 164.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.6 m -109.05 136.89 47.82 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.474 0.654 . . . . 1.6499999999999999 111.196 -173.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.37 125.93 26.2 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.555 -1.202 . . . . 1.8500000000000001 110.777 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.54 -18.02 58.02 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 114.671 -1.15 . . . . 0.92000000000000004 111.253 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.453 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -78.95 167.68 52.87 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.385 -0.912 . . . . 0.98999999999999999 111.016 174.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.685 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 91.3 Cg_endo -75.95 -19.33 16.03 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 122.861 2.374 . . . . 0.44 113.912 -169.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.536 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -73.05 -26.71 61.39 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.962 -1.017 . . . . 0.35999999999999999 111.695 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -72.88 -29.98 63.6 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.458 -0.941 . . . . 1.79 108.458 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.481 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.4 mp -77.85 -35.4 20.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.689 -1.141 . . . . 0.51000000000000001 110.095 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.794 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -81.66 -14.23 56.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.454 -0.794 . . . . 0.40999999999999998 111.504 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.0 60.48 1.19 Allowed Glycine 0 CA--C 1.522 0.473 0 C-N-CA 119.291 -1.433 . . . . 0.45000000000000001 114.314 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.879 HD21 HG21 ' A' ' 57' ' ' VAL . 35.2 tp -123.81 156.74 35.57 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.457 -0.572 . . . . 0.89000000000000001 109.457 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.84 ' HG3' ' HB2' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -148.9 81.12 1.43 Allowed 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 115.532 1.678 . . . . 1.21 115.532 -177.144 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.539 HG13 HG12 ' A' ' 60' ' ' VAL . 4.2 mp 62.82 -22.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 117.001 2.223 . . . . 0.77000000000000002 117.001 158.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -162.53 61.46 0.27 Allowed Glycine 0 CA--C 1.506 -0.51 0 O-C-N 120.732 -1.23 . . . . 0.37 112.194 -167.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.766 ' H ' HG12 ' A' ' 57' ' ' VAL . 61.7 m-20 -121.88 152.05 40.02 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.356 -0.422 . . . . 0.89000000000000001 110.668 -167.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.63 ' HD2' ' N ' ' A' ' 76' ' ' LYS . 3.7 mptt -103.8 101.61 11.43 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.79 0.805 . . . . 2.2000000000000002 109.548 -173.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 1.02 HG13 HG23 ' A' ' 109' ' ' VAL . 3.3 mp -71.22 121.71 21.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 114.523 -1.217 . . . . 0.48999999999999999 111.392 -176.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.858 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 1.4 mmt -89.05 -17.9 28.4 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 125.843 1.965 . . . . 1.0600000000000001 111.215 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -172.12 153.25 3.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.808 0.337 . . . . 0.81999999999999995 111.74 -175.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.556 HG12 ' HE1' ' A' ' 85' ' ' MET . 9.8 p -139.66 125.31 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 121.323 0.583 . . . . 1.3100000000000001 109.87 175.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.927 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 13.0 m120 52.44 28.89 6.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.225 -0.898 . . . . 1.5 112.529 175.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.48 -16.64 44.44 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.093 -1.051 . . . . 0.38 113.309 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -87.56 148.58 24.81 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 109.475 -0.565 . . . . 0.77000000000000002 109.475 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -96.63 117.99 32.15 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.345 0.593 . . . . 1.8899999999999999 111.305 -174.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.556 ' HE1' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -106.71 102.33 11.71 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.834 0.826 . . . . 1.01 111.355 -178.503 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 p -123.16 -38.38 2.59 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.805 -1.088 . . . . 1.05 108.433 167.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.38 76.95 1.23 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.21 -1.359 . . . . 1.6200000000000001 109.255 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.65 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.5 OUTLIER -138.12 151.61 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 108.966 -0.753 . . . . 1.0900000000000001 108.966 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.796 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 75.2 p -60.51 151.45 28.48 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 112.888 0.699 . . . . 0.34999999999999998 112.888 -175.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.743 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 18.0 t-160 -57.71 -41.36 81.57 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 115.588 -0.733 . . . . 0.34999999999999998 110.467 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.65 -30.1 67.71 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.188 -1.369 . . . . 1.6699999999999999 109.964 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.553 ' HB3' HG13 ' A' ' 88' ' ' VAL . 2.4 tp-100 -62.55 -49.59 74.67 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.691 0.758 . . . . 0.77000000000000002 109.467 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.54 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -73.92 -31.88 63.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.988 -1.005 . . . . 0.33000000000000002 110.116 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -71.02 -41.8 70.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.411 -0.813 . . . . 2.1000000000000001 111.004 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.559 ' HD3' ' HD2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -71.42 -30.8 66.5 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 119.773 -0.771 . . . . 0.95999999999999996 109.873 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.559 ' HD2' ' HD3' ' A' ' 95' ' ' LYS . 2.4 mmm180 -67.41 -37.6 83.32 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.003 -0.679 . . . . 3.5699999999999998 110.954 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.496 HD11 ' CZ ' ' A' ' 31' ' ' PHE . 4.6 tt -58.68 -55.34 36.34 Favored 'General case' 0 C--N 1.316 -0.859 0 O-C-N 124.232 0.958 . . . . 1.6499999999999999 110.062 173.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.79 HG23 ' HB2' ' A' ' 27' ' ' LEU . 36.9 m -108.18 -94.96 0.39 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.789 -0.641 . . . . 1.53 112.55 -174.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 99' ' ' LYS . 0.3 OUTLIER 64.52 2.74 1.68 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.315 1.055 . . . . 2.7200000000000002 110.963 -175.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.699 ' H ' HG22 ' A' ' 98' ' ' THR . 41.6 mtm180 57.54 57.95 4.04 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.061 -1.427 . . . . 4.3799999999999999 110.862 -177.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.2 t -155.11 -48.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.27 -0.572 . . . . 2.5099999999999998 112.01 -175.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -53.83 135.44 41.86 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.044 0.449 . . . . 3.3999999999999999 112.026 -174.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -89.0 -16.14 32.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.47 0.652 . . . . 2.6800000000000002 110.54 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.7 p -152.47 148.54 14.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 108.39 -0.967 . . . . 0.44 108.39 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.0 t -114.42 117.61 56.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 122.229 1.014 . . . . 0.46000000000000002 112.621 -173.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.927 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.2 OUTLIER -101.3 124.9 47.72 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 113.411 -1.722 . . . . 1.76 110.681 -176.367 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.971 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 25.3 tp -132.74 126.73 33.12 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.398 -0.364 . . . . 1.1200000000000001 110.755 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.858 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 33.1 tp -109.96 115.94 30.71 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.105 -1.443 . . . . 0.41999999999999998 107.105 172.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 1.02 HG23 HG13 ' A' ' 77' ' ' ILE . 0.5 OUTLIER -128.23 149.51 33.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 121.397 0.617 . . . . 0.77000000000000002 110.591 -173.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.705 HG23 HG22 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -97.57 114.7 26.66 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.584 -0.734 . . . . 0.34000000000000002 109.61 168.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -99.16 139.03 35.42 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.281 -0.872 . . . . 2.0099999999999998 109.696 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.16 -73.08 0.65 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.854 0.359 . . . . 1.97 110.441 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.5 t 177.43 73.27 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.775 0.798 . . . . 1.6200000000000001 110.723 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.84 ' HB2' ' HG3' ' A' ' 72' ' ' GLN . 0.2 OUTLIER -135.9 -8.63 2.09 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.677 -1.147 . . . . 1.6499999999999999 108.757 178.385 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.577 ' HB2' ' OE1' ' A' ' 72' ' ' GLN . 2.3 tp-100 -63.37 154.95 30.33 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.428 -1.26 . . . . 3.5299999999999998 112.479 -175.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.54 ' HD2' ' N ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -85.75 -178.12 6.54 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.077 -0.965 . . . . 3.6000000000000001 108.762 178.251 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -80.53 56.56 2.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.527 0.679 . . . . 3.5600000000000001 110.125 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.6 p -81.83 -51.57 14.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.41 -0.814 . . . . 4.9900000000000002 112.191 -173.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -101.33 82.47 2.33 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.499 0.666 . . . . 7.7699999999999996 110.978 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -142.74 127.72 18.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.936 -1.029 . . . . 6.5999999999999996 109.372 174.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.7 t -92.32 -41.69 10.23 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.438 -0.579 . . . . 8.9399999999999995 109.438 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 47.1 ttp -69.62 -37.86 77.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.656 -0.702 . . . . 12.1 110.863 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 97.3 mt 68.0 -179.63 0.22 Allowed 'General case' 0 CA--C 1.531 0.22 0 O-C-N 123.823 0.702 . . . . 12.82 110.308 -173.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.556 -0.735 . . . . 14.640000000000001 110.377 -176.562 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtm . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 111.326 0.121 . . . . 14.33 111.326 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.2 m -71.59 146.33 48.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.632 0.253 . . . . 11.220000000000001 110.724 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.485 ' CE2' ' HG3' ' A' ' 5' ' ' PRO . 53.5 t80 -68.63 119.99 13.94 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.463 -0.569 . . . . 9.1899999999999995 109.463 177.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.423 HD12 ' CD ' ' A' ' 8' ' ' PRO . 1.9 pt -120.09 89.31 42.61 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.798 -0.637 . . . . 6.6500000000000004 111.481 -172.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.485 ' HG3' ' CE2' ' A' ' 3' ' ' TYR . 13.7 Cg_exo -70.06 -39.5 5.87 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.187 2.592 . . . . 7.46 112.516 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.87 -20.87 72.65 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.997 -0.621 . . . . 5.8899999999999997 111.801 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 25.8 mm-40 68.84 119.71 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.313 0 O-C-N 124.28 0.635 . . . . 6.3700000000000001 112.193 178.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.423 ' CD ' HD12 ' A' ' 4' ' ' ILE . 1.0 OUTLIER -84.11 178.59 5.18 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.008 2.472 . . . . 3.3999999999999999 111.969 177.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 t -95.18 -22.38 5.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 108.891 -0.781 . . . . 2.2599999999999998 108.891 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.7 t -82.25 82.05 7.91 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 123.485 1.612 . . . . 2.0899999999999999 111.081 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.29 148.29 23.28 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 111.99 -2.368 . . . . 0.95999999999999996 108.0 168.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -95.42 130.38 44.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 121.185 0.517 . . . . 1.5700000000000001 111.133 -173.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.745 HG22 HG23 ' A' ' 110' ' ' THR . 44.9 t -83.36 110.92 18.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.327 0.585 . . . . 1.02 110.556 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.71 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -119.45 163.04 17.85 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.426 -0.807 . . . . 1.3899999999999999 109.757 175.145 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.475 ' HB3' ' CD1' ' A' ' 108' ' ' LEU . 2.3 ppt_? -127.08 124.45 39.27 Favored 'General case' 0 C--N 1.31 -1.113 0 O-C-N 121.491 -0.755 . . . . 3.6299999999999999 111.649 -174.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.735 HG13 ' CB ' ' A' ' 69' ' ' ALA . 9.6 t -90.85 125.2 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-N 115.255 -0.884 . . . . 1.02 110.23 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -123.86 114.32 19.69 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.926 -0.398 . . . . 1.3500000000000001 109.926 175.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.85 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 11.1 tp -144.57 137.12 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 109.108 -0.701 . . . . 0.60999999999999999 109.108 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.99 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 15.0 m-70 -65.27 115.91 6.06 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.887 -0.597 . . . . 0.59999999999999998 110.263 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.658 ' CG ' HD12 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -33.23 126.99 0.34 Allowed 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.364 1.04 . . . . 4.0 110.056 172.349 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.2 tp -103.58 79.59 1.7 Allowed 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 118.978 -1.089 . . . . 0.55000000000000004 111.398 -163.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.985 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 15.1 ptt-85 -60.87 136.18 58.0 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.481 -0.781 . . . . 3.9700000000000002 110.947 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.56 ' HB2' HG12 ' A' ' 28' ' ' ILE . 6.0 tp-100 -122.11 94.44 4.3 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.212 -0.904 . . . . 1.3500000000000001 109.069 -174.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.24 -89.19 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.82 -0.705 . . . . 1.3300000000000001 112.211 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -115.97 -6.54 11.99 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.477 0.656 . . . . 2.3300000000000001 110.786 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.52 -178.08 3.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.384 -0.825 . . . . 1.8700000000000001 109.078 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.985 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.4 pt? -130.69 144.46 51.45 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.107 -1.071 . . . . 2.2799999999999998 108.107 167.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.56 HG12 ' HB2' ' A' ' 23' ' ' GLN . 11.6 mm -101.27 130.85 50.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-O 121.417 0.627 . . . . 0.80000000000000004 111.374 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.758 HD11 HD21 ' A' ' 97' ' ' LEU . 13.1 tp -74.18 -58.22 3.44 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.474 -1.239 . . . . 1.74 109.917 175.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.953 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 100.96 -0.13 55.04 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.316 -0.945 . . . . 0.68999999999999995 113.019 173.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.602 ' HD1' ' HB2' ' A' ' 66' ' ' ALA . 29.6 p90 -157.49 163.4 38.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.147 0.474 . . . . 0.51000000000000001 110.865 175.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.557 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 35.6 t -102.74 160.74 14.32 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.038 -1.097 . . . . 0.53000000000000003 108.038 173.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -161.77 141.77 2.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 C-N-CA 120.665 -0.414 . . . . 0.48999999999999999 111.99 -166.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.409 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -144.97 118.75 1.15 Allowed Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.361 -0.923 . . . . 0.71999999999999997 110.882 158.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 1.028 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -139.7 118.17 1.45 Allowed Glycine 0 CA--C 1.489 -1.539 0 CA-C-O 118.546 -1.141 . . . . 1.4199999999999999 110.49 172.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 1.013 ' HA3' ' HG2' ' A' ' 39' ' ' GLN . . . -156.18 117.05 0.75 Allowed Glycine 0 N--CA 1.434 -1.469 0 C-N-CA 117.909 -2.091 . . . . 0.47999999999999998 114.187 -171.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.86 HG22 HD22 ' A' ' 44' ' ' ASN . 5.1 pt -61.91 -26.61 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 104.798 -2.297 . . . . 0.52000000000000002 104.798 146.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.987 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 7.1 t70 -55.31 -47.78 75.09 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 112.052 -2.34 . . . . 0.71999999999999997 109.627 170.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 1.013 ' HG2' ' HA3' ' A' ' 36' ' ' GLY . 19.2 mm-40 -62.3 -43.61 98.42 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 114.821 -1.081 . . . . 1.1899999999999999 111.374 -172.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.641 ' HB3' ' HD2' ' A' ' 53' ' ' LYS . 10.7 t70 -152.92 99.22 2.76 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.866 0.365 . . . . 2.5699999999999998 110.523 176.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -86.87 16.95 1.85 Allowed 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.861 3.041 . . . . 2.8199999999999998 112.456 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 t -102.2 -23.62 14.01 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.175 -0.466 . . . . 3.2599999999999998 111.254 -171.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.49 71.32 1.33 Allowed 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 109.277 -0.638 . . . . 3.8799999999999999 109.277 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.86 HD22 HG22 ' A' ' 37' ' ' ILE . 30.0 p-10 -158.68 34.61 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 113.119 0.785 . . . . 5.1399999999999997 113.119 -174.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.713 ' HD3' ' N ' ' A' ' 44' ' ' ASN . 44.4 Cg_endo -99.21 -0.85 0.92 Allowed 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.275 1.983 . . . . 3.71 112.879 -174.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 18.4 t80 179.86 29.38 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.072 -1.084 . . . . 5.6200000000000001 108.072 -172.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.465 ' HB3' ' CG ' ' A' ' 52' ' ' ASP . 30.5 m -81.09 -176.97 6.23 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.185 -1.37 . . . . 3.77 113.641 -165.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 26.8 mm-40 -39.28 -69.81 0.12 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.536 -1.666 . . . . 6.7800000000000002 114.731 -168.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.48 ' CG ' ' HD3' ' A' ' 50' ' ' LYS . 17.2 t0 170.39 -156.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.681 -0.859 . . . . 5.4699999999999998 108.681 -166.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.567 ' HB3' ' HE1' ' A' ' 78' ' ' MET . 0.0 OUTLIER -51.79 -28.3 15.03 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.726 0.41 . . . . 3.0699999999999998 111.337 172.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 t -80.54 -6.43 58.2 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.075 -0.511 . . . . 4.5599999999999996 111.414 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.548 ' OD2' ' HG2' ' A' ' 53' ' ' LYS . 17.9 t70 -83.71 -123.75 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.002 0.43 . . . . 2.6000000000000001 110.365 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.671 ' HG3' ' HB3' ' A' ' 44' ' ' ASN . 15.1 mmtp -88.9 29.83 0.99 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.276 0.56 . . . . 3.48 109.841 177.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 86' ' ' THR . . . -72.43 -161.55 5.69 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 109.989 -1.244 . . . . 0.78000000000000003 109.989 174.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.028 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -108.33 146.07 14.61 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.855 0 CA-C-N 119.331 1.565 . . . . 0.54000000000000004 108.413 172.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.775 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -153.63 143.02 21.61 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.898 0.856 . . . . 1.4199999999999999 111.44 178.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.578 HG12 ' H ' ' A' ' 75' ' ' ASP . 8.4 p -83.11 127.96 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 CA-C-N 113.907 -1.497 . . . . 0.57999999999999996 110.229 -177.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.2 m -94.88 -19.25 20.44 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.68 -1.145 . . . . 1.1100000000000001 111.206 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.963 ' HA ' HG23 ' A' ' 73' ' ' ILE . 25.7 mtp180 -150.4 -165.15 2.19 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.92 0.711 . . . . 2.27 112.92 177.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 91.9 t -156.01 138.71 6.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 112.756 -2.02 . . . . 0.82999999999999996 107.202 161.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.1 m -94.9 121.58 36.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.226 0.536 . . . . 1.6499999999999999 110.217 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -52.74 127.6 23.75 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.531 -1.213 . . . . 1.8500000000000001 111.869 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.14 -4.38 84.54 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.614 -0.803 . . . . 0.92000000000000004 112.466 174.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.601 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -82.82 -153.2 12.53 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.256 -0.973 . . . . 0.98999999999999999 110.95 173.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.953 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 40.4 Cg_endo -94.72 -33.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.081 1.854 . . . . 0.44 115.018 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.602 ' HB2' ' HD1' ' A' ' 31' ' ' PHE . . . -66.72 -25.54 66.57 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.073 0.463 . . . . 0.35999999999999999 111.837 -174.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -72.78 -30.83 64.43 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.758 0.79 . . . . 1.79 108.923 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.601 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -78.03 -41.89 27.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.64 -1.164 . . . . 0.51000000000000001 110.751 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.85 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . . . -72.55 -20.17 61.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.291 -0.413 . . . . 0.40999999999999998 110.736 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.43 64.58 1.02 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.279 -0.963 . . . . 0.45000000000000001 113.445 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.0 tp -109.45 149.28 29.79 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.151 -0.685 . . . . 0.89000000000000001 109.151 175.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 1.069 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 30.3 mt-30 -115.05 23.74 12.28 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 115.031 1.493 . . . . 1.21 115.031 -164.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.963 HG23 ' HA ' ' A' ' 59' ' ' ARG . 62.1 mt 69.51 2.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 CA-C-N 118.761 0.709 . . . . 0.77000000000000002 112.477 168.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.71 46.77 0.21 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.268 -0.968 . . . . 0.37 112.4 -168.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.578 ' H ' HG12 ' A' ' 57' ' ' VAL . 49.0 m-20 -120.89 152.9 37.88 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.614 -0.514 . . . . 0.89000000000000001 109.614 -172.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.682 ' HD2' ' N ' ' A' ' 76' ' ' LYS . 8.9 mptt -102.29 122.75 44.83 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.822 -0.807 . . . . 2.2000000000000002 108.822 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.775 HD12 ' HA ' ' A' ' 56' ' ' TYR . 4.2 mp -91.6 134.27 30.54 Favored 'Isoleucine or valine' 0 C--O 1.264 1.851 0 CA-C-O 121.168 0.508 . . . . 0.48999999999999999 112.176 -172.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.824 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 0.9 OUTLIER -92.43 -25.68 18.36 Favored 'General case' 0 C--N 1.346 0.452 0 O-C-N 126.381 2.3 . . . . 1.0600000000000001 112.442 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.67 ' HA ' ' HG2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -170.77 156.02 4.98 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.281 0.475 . . . . 0.81999999999999995 112.281 -172.347 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.653 HG12 ' HE3' ' A' ' 85' ' ' MET . 6.4 p -143.14 127.51 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.095 -0.502 . . . . 1.3100000000000001 110.317 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.46 ' N ' HD22 ' A' ' 81' ' ' ASN . 0.9 OUTLIER 59.39 19.87 8.16 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.888 -0.597 . . . . 1.5 111.929 176.046 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.79 -6.21 58.59 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 119.96 -1.114 . . . . 0.38 112.262 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -83.13 124.18 30.24 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-O 121.332 0.587 . . . . 0.77000000000000002 109.825 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -86.13 96.74 9.99 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.536 -1.211 . . . . 1.8899999999999999 110.084 -177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.67 ' HG2' ' HA ' ' A' ' 79' ' ' GLN . 3.9 ptp -109.41 102.39 11.29 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.129 0.966 . . . . 1.01 111.534 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.435 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 4.6 p -101.91 -33.89 9.59 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.236 -1.347 . . . . 1.05 109.115 176.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.598 ' O ' HG23 ' A' ' 37' ' ' ILE . 1.7 mtt -129.03 -16.07 4.13 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 113.88 -1.509 . . . . 1.6200000000000001 110.042 -176.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.626 ' O ' HD11 ' A' ' 55' ' ' ILE . 2.1 t -40.6 150.59 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 C-N-CA 125.726 1.61 . . . . 1.0900000000000001 115.222 -167.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.987 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 47.7 p -60.25 150.44 30.24 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.778 -0.576 . . . . 0.34999999999999998 111.637 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.783 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 21.9 t-160 -61.49 -33.69 74.21 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-N 115.975 -0.557 . . . . 0.34999999999999998 109.886 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.94 -33.98 68.66 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.687 -1.142 . . . . 1.6699999999999999 109.546 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.584 ' HB3' HG13 ' A' ' 88' ' ' VAL . 2.0 tp-100 -68.66 -46.56 68.81 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.402 -0.962 . . . . 0.77000000000000002 108.402 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.556 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -66.68 -37.94 85.77 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.92 -1.036 . . . . 0.33000000000000002 109.866 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 90' ' ' HIS . 27.6 ttp-105 -71.13 -43.64 67.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.626 -0.716 . . . . 2.1000000000000001 110.814 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.503 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -69.39 -43.01 74.37 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 116.109 -0.496 . . . . 0.95999999999999996 110.467 -177.664 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 28.2 mmt180 -72.08 -23.37 61.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.237 0.541 . . . . 3.5699999999999998 110.555 -178.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.758 HD21 HD11 ' A' ' 29' ' ' LEU . 7.2 tp -78.57 -57.47 3.75 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.261 -0.881 . . . . 1.6499999999999999 112.167 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.729 ' OG1' HD13 ' A' ' 29' ' ' LEU . 35.8 m -124.95 91.65 3.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.586 0.708 . . . . 1.53 110.872 -174.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.639 ' HG2' ' OE1' ' A' ' 102' ' ' GLU . 7.0 ptpp? -122.08 7.93 9.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.379 -0.828 . . . . 2.7200000000000002 112.831 -176.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.905 ' HA ' HD13 ' A' ' 27' ' ' LEU . 26.3 mtm180 67.07 16.5 10.31 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.75 -0.659 . . . . 4.3799999999999999 111.057 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.489 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 28.0 m -124.74 21.59 8.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.985 0.421 . . . . 2.5099999999999998 111.441 -175.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.639 ' OE1' ' HG2' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -137.52 131.13 31.32 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.45 -0.341 . . . . 3.3999999999999999 110.358 179.068 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -85.98 -22.29 27.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.374 0.607 . . . . 2.6800000000000002 110.257 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.99 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 4.0 p -135.85 141.86 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.519 -0.764 . . . . 0.44 109.367 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.551 HG23 ' HB2' ' A' ' 20' ' ' LYS . 52.5 t -119.62 120.88 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-O 122.083 0.944 . . . . 0.46000000000000002 111.904 -172.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.406 ' CD ' ' N ' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -99.26 129.39 45.49 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.271 -1.786 . . . . 1.76 109.789 -179.053 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.592 HD11 HG12 ' A' ' 77' ' ' ILE . 21.1 tp -133.29 134.12 43.47 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.927 -0.579 . . . . 1.1200000000000001 109.643 -177.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.569 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 17.6 tp -110.23 124.51 51.74 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.682 -1.599 . . . . 0.41999999999999998 106.682 173.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.736 HG23 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -129.88 149.31 33.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 121.757 0.789 . . . . 0.77000000000000002 111.001 -171.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.745 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -98.04 114.71 26.95 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.355 -0.839 . . . . 0.34000000000000002 109.205 165.187 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.664 ' HG3' HE22 ' A' ' 72' ' ' GLN . 22.3 ttt180 -105.33 131.5 52.69 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.15 -0.932 . . . . 2.0099999999999998 110.498 -171.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.45 ' HG2' ' CD2' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -106.4 -89.67 0.43 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.39 -0.368 . . . . 1.97 111.845 -178.365 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.8 t -157.18 44.94 0.37 Allowed 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.168 -0.613 . . . . 1.6200000000000001 112.071 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 1.069 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 0.2 OUTLIER -101.2 21.25 14.27 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.801 -0.814 . . . . 1.6499999999999999 108.801 175.185 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.495 ' HG3' ' OE1' ' A' ' 72' ' ' GLN . 9.9 mt-30 -66.63 129.07 38.62 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 114.876 -1.056 . . . . 3.5299999999999998 111.869 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -110.24 84.49 1.94 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.444 -0.798 . . . . 3.6000000000000001 111.315 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 65.38 33.17 9.15 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.469 -0.787 . . . . 3.5600000000000001 111.747 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.5 p -105.45 -15.9 8.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.402 0.62 . . . . 4.9900000000000002 110.601 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.402 ' NE2' ' HA ' ' A' ' 119' ' ' GLN . 19.5 mm-40 -90.82 92.68 8.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.443 0.64 . . . . 7.7699999999999996 110.64 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -100.21 84.35 2.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.253 -0.885 . . . . 6.5999999999999996 110.616 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.6 m -89.0 -80.03 0.3 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.038 -0.528 . . . . 8.9399999999999995 109.728 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.501 ' HG3' ' H ' ' A' ' 124' ' ' SER . 26.7 ptt? -158.76 -36.18 0.06 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.015 -0.365 . . . . 12.1 110.015 174.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.7 mt 63.8 30.3 14.57 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.688 -0.687 . . . . 12.82 111.461 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.501 ' H ' ' HG3' ' A' ' 122' ' ' MET . 50.8 m . . . . . 0 C--O 1.248 0.984 0 N-CA-C 109.366 -0.605 . . . . 14.640000000000001 109.366 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.458 ' HG3' ' H ' ' A' ' 2' ' ' SER . 20.4 ptm . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 120.827 0.346 . . . . 14.33 111.236 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.458 ' H ' ' HG3' ' A' ' 1' ' ' MET . 27.0 t -100.44 -37.03 9.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.023 0.439 . . . . 11.220000000000001 110.17 -177.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -101.73 108.46 19.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.236 -0.438 . . . . 9.1899999999999995 110.365 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.6 pt -115.18 112.64 44.05 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.209 -0.451 . . . . 6.6500000000000004 110.031 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.24 109.39 0.4 Allowed 'Trans proline' 0 N--CA 1.471 0.192 0 C-N-CA 123.439 2.759 . . . . 7.46 113.212 -176.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.43 -6.28 61.31 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-N 115.906 -0.588 . . . . 5.8899999999999997 112.924 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 55.11 70.17 1.72 Allowed Pre-proline 0 CA--C 1.532 0.254 0 CA-C-O 121.309 0.576 . . . . 6.3700000000000001 110.934 -176.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -90.62 20.78 0.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.744 2.963 . . . . 3.3999999999999999 112.977 -170.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.0 t -124.43 -50.01 2.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.108 -0.951 . . . . 2.2599999999999998 109.695 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 10' ' ' THR . 1.3 t -77.43 82.44 3.87 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 123.054 1.407 . . . . 2.0899999999999999 109.788 174.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -109.98 178.85 4.28 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 112.626 -2.079 . . . . 0.95999999999999996 110.583 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.8 t -110.18 149.07 13.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 108.894 -0.78 . . . . 1.5700000000000001 108.894 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.688 HG22 HG23 ' A' ' 110' ' ' THR . 34.8 t -103.69 112.7 38.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 120.315 -0.554 . . . . 1.02 110.956 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 1.022 HE22 HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -95.06 172.36 8.18 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.845 -0.616 . . . . 1.3899999999999999 110.345 176.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.527 ' HD3' ' O ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -127.21 127.14 43.99 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 116.718 -0.219 . . . . 3.6299999999999999 111.573 174.042 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.022 HG23 HE22 ' A' ' 14' ' ' GLN . 28.8 t -101.6 131.04 50.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.647 -0.501 . . . . 1.02 109.647 171.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 25.0 tt0 -145.68 112.96 6.19 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.699 -0.482 . . . . 1.3500000000000001 109.699 173.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.622 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 8.8 tp -142.63 145.64 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 C-N-CA 120.012 -0.675 . . . . 0.60999999999999999 109.281 -177.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.747 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 9.7 m-70 -75.66 112.73 12.32 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.207 -0.664 . . . . 0.59999999999999998 109.207 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.719 ' CE ' ' HB3' ' A' ' 27' ' ' LEU . 25.6 mmmt -31.59 137.18 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.463 1.102 . . . . 4.0 112.578 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.3 tp -96.97 99.74 11.27 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.596 -0.52 . . . . 0.55000000000000004 109.596 -173.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -92.83 144.74 24.98 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.671 0.748 . . . . 3.9700000000000002 112.481 -172.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.445 ' CG ' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -124.12 92.89 3.76 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.22 -1.4 . . . . 1.3500000000000001 107.22 170.166 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.85 -78.4 0.1 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.733 -0.746 . . . . 1.3300000000000001 111.95 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -138.11 10.09 2.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.533 0.683 . . . . 2.3300000000000001 110.503 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -107.94 118.74 37.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.238 -0.892 . . . . 1.8700000000000001 109.119 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.005 HD22 ' HA ' ' A' ' 100' ' ' ARG . 8.8 mp -105.14 113.95 27.84 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.498 0.666 . . . . 2.2799999999999998 110.437 -176.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.445 HD13 ' CG ' ' A' ' 23' ' ' GLN . 1.7 mp -94.97 141.46 15.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.831 -1.077 . . . . 0.80000000000000004 109.56 -173.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.91 -38.78 13.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.064 -0.516 . . . . 1.74 110.811 -174.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.685 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 88.78 15.2 60.0 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.268 -0.968 . . . . 0.68999999999999995 111.56 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.677 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 42.5 p90 -155.28 166.96 31.94 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 122.201 0.201 . . . . 0.51000000000000001 110.651 176.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.579 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 17.2 t -109.93 159.0 17.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.493 -1.299 . . . . 0.53000000000000003 107.493 170.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.418 HD12 HD21 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -161.26 138.08 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 C-N-CA 120.427 -0.509 . . . . 0.48999999999999999 112.238 -164.376 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.414 ' HA2' ' CD2' ' A' ' 90' ' ' HIS . . . -141.57 117.8 1.25 Allowed Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.172 -1.013 . . . . 0.71999999999999997 110.851 156.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 1.065 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -140.74 117.09 1.21 Allowed Glycine 0 CA--C 1.491 -1.417 0 CA-C-O 118.656 -1.08 . . . . 1.4199999999999999 111.067 170.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.666 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -164.15 145.67 10.64 Favored Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 117.429 -2.319 . . . . 0.47999999999999998 113.469 175.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.504 HG12 ' C ' ' A' ' 88' ' ' VAL . 34.1 pt -69.54 -11.53 14.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 107.282 -1.377 . . . . 0.52000000000000002 107.282 152.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.823 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 0.1 OUTLIER -70.61 -39.14 73.94 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 113.815 -1.538 . . . . 0.71999999999999997 109.852 172.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -60.25 -81.89 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.188 -0.915 . . . . 1.1899999999999999 111.409 -172.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -157.7 93.29 2.16 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.764 0.792 . . . . 2.5699999999999998 111.483 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.57 ' HA ' ' HG2' ' A' ' 53' ' ' LYS . 4.1 Cg_exo -79.25 -9.99 15.04 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.178 2.585 . . . . 2.8199999999999998 111.463 175.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.7 t -73.43 28.77 0.07 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.38 -0.827 . . . . 3.2599999999999998 112.307 -171.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 44' ' ' ASN . 53.1 mm-40 -110.11 -49.39 3.08 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.926 -1.139 . . . . 3.8799999999999999 107.926 176.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 43' ' ' GLN . 53.5 t30 162.84 82.32 0.0 OUTLIER Pre-proline 0 N--CA 1.44 -0.933 0 N-CA-C 106.06 -1.83 . . . . 5.1399999999999997 106.06 -171.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.569 ' HG3' ' O ' ' A' ' 41' ' ' PRO . 4.2 Cg_exo -77.36 26.16 0.47 Allowed 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.244 2.629 . . . . 3.71 112.381 -167.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.418 ' H ' ' C ' ' A' ' 44' ' ' ASN . 24.3 t80 -141.82 23.25 2.09 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.84 -1.073 . . . . 5.6200000000000001 108.533 -173.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.519 ' HB2' ' CG ' ' A' ' 52' ' ' ASP . 19.6 m -71.66 -172.81 0.85 Allowed 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 114.852 -1.067 . . . . 3.77 112.243 -172.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -21.8 -69.81 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 112.924 -1.944 . . . . 6.7800000000000002 116.115 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.58 ' OD2' ' HG3' ' A' ' 50' ' ' LYS . 22.8 t70 -173.01 -142.92 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.796 -0.446 . . . . 5.4699999999999998 109.796 -167.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.58 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -60.79 -12.98 12.43 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 120.682 0.277 . . . . 3.0699999999999998 111.346 174.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.5 t -78.07 -14.59 59.44 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 120.48 -0.488 . . . . 4.5599999999999996 110.639 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.607 ' CG ' ' HE2' ' A' ' 53' ' ' LYS . 24.1 t0 -66.88 -162.17 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.627 -0.715 . . . . 2.6000000000000001 110.79 172.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.607 ' HE2' ' CG ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -77.19 64.54 2.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.508 0.67 . . . . 3.48 112.037 178.38 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.44 -142.56 11.35 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 109.247 -1.541 . . . . 0.78000000000000003 109.247 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.065 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -110.83 138.03 40.7 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.113 0 CA-C-N 119.361 1.58 . . . . 0.54000000000000004 107.364 168.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.82 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -152.67 151.72 30.9 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 119.865 1.211 . . . . 1.4199999999999999 111.655 -177.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.787 HG12 ' H ' ' A' ' 75' ' ' ASP . 3.4 p -91.19 131.93 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-N 114.621 -1.172 . . . . 0.57999999999999996 109.862 -174.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.6 m -99.06 -16.16 18.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.157 -0.929 . . . . 1.1100000000000001 110.796 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.803 ' HA ' HG23 ' A' ' 73' ' ' ILE . 56.8 mtt180 -148.36 -167.04 2.7 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.553 0.692 . . . . 2.27 112.514 175.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 59' ' ' ARG . 75.7 t -163.68 117.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 112.46 -2.155 . . . . 0.82999999999999996 106.972 159.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.4 m -65.8 117.7 8.59 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.137 0.494 . . . . 1.6499999999999999 109.894 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -46.14 112.05 0.44 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.581 -1.191 . . . . 1.8500000000000001 112.394 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.24 -14.89 56.79 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.692 -0.766 . . . . 0.92000000000000004 112.607 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.517 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -76.55 172.71 54.65 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.219 -0.991 . . . . 0.98999999999999999 112.072 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.685 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 58.9 Cg_endo -68.91 -24.8 33.31 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 123.088 2.526 . . . . 0.44 113.158 -166.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.677 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -61.45 -36.32 80.05 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 114.783 -1.099 . . . . 0.35999999999999999 111.392 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -77.75 -29.57 51.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.428 0.632 . . . . 1.79 109.461 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.517 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -69.42 -37.48 75.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.241 -0.891 . . . . 0.51000000000000001 109.812 177.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.643 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -77.35 -23.01 50.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.025 -0.534 . . . . 0.40999999999999998 110.601 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.27 52.46 0.93 Allowed Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.387 -0.911 . . . . 0.45000000000000001 114.112 176.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.497 HD21 HG21 ' A' ' 57' ' ' VAL . 14.7 tp -106.52 148.0 28.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.597 -0.89 . . . . 0.89000000000000001 108.597 174.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.781 HE22 ' HG3' ' A' ' 111' ' ' ARG . 4.6 mt-30 -130.11 38.34 3.8 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 115.375 1.62 . . . . 1.21 115.375 -164.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.803 HG23 ' HA ' ' A' ' 59' ' ' ARG . 53.9 mt 72.22 -4.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 N-CA-C 114.186 1.18 . . . . 0.77000000000000002 114.186 163.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.28 45.03 0.23 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 119.22 -1.467 . . . . 0.37 112.277 -171.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.787 ' H ' HG12 ' A' ' 57' ' ' VAL . 20.9 m-20 -118.38 142.07 47.9 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 120.903 0.382 . . . . 0.89000000000000001 111.558 -169.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.82 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 45.0 mmtm -86.41 103.37 14.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.629 -0.714 . . . . 2.2000000000000002 110.566 -175.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.766 ' HB ' HG22 ' A' ' 55' ' ' ILE . 5.6 mt -74.4 128.82 36.76 Favored 'Isoleucine or valine' 0 C--O 1.259 1.587 0 C-N-CA 123.904 0.882 . . . . 0.48999999999999999 112.001 -177.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.895 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 3.8 mmt -93.66 -25.95 17.26 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 113.569 -1.651 . . . . 1.0600000000000001 112.234 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.529 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -160.28 156.88 27.13 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.61 -0.436 . . . . 0.81999999999999995 112.116 -173.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.522 HG12 ' CE ' ' A' ' 85' ' ' MET . 10.4 p -148.44 128.44 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.278 -0.638 . . . . 1.3100000000000001 109.278 175.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.479 ' OD1' ' HG3' ' A' ' 102' ' ' GLU . 0.9 OUTLIER 67.53 5.82 4.58 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.253 -0.431 . . . . 1.5 111.565 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.59 -7.54 53.7 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 119.882 -1.151 . . . . 0.38 111.403 -172.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -75.0 118.08 17.56 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 108.708 -0.849 . . . . 0.77000000000000002 108.708 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.424 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 0.5 OUTLIER -89.69 94.94 10.04 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.661 -0.7 . . . . 1.8899999999999999 109.594 -175.424 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.522 ' CE ' HG12 ' A' ' 80' ' ' VAL . 11.2 ptp -112.43 104.05 12.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.502 -0.772 . . . . 1.01 112.756 -172.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.1 p -96.86 -20.36 18.21 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 122.183 0.992 . . . . 1.05 108.773 170.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.87 81.65 0.65 Allowed 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.713 -1.585 . . . . 1.6200000000000001 110.26 -175.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.666 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.9 OUTLIER -140.49 162.57 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 108.519 -0.919 . . . . 1.0900000000000001 108.519 173.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.674 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 66.7 p -59.75 150.84 26.83 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 112.742 0.645 . . . . 0.34999999999999998 112.742 -175.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.823 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 16.2 t-160 -59.89 -35.57 75.11 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 121.743 0.782 . . . . 0.34999999999999998 109.855 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.4 -29.85 66.58 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 113.894 -1.503 . . . . 1.6699999999999999 109.64 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.557 ' HB3' ' O ' ' A' ' 89' ' ' THR . 3.4 tp-100 -63.77 -48.81 75.43 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.691 0.758 . . . . 0.77000000000000002 109.023 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.54 ' HB2' HG12 ' A' ' 55' ' ' ILE . . . -69.96 -39.29 76.1 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.905 -1.043 . . . . 0.33000000000000002 109.52 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -66.39 -42.24 88.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.083 -0.962 . . . . 2.1000000000000001 111.222 -175.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.567 ' HD3' ' HD2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -68.08 -31.08 70.45 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 119.91 -0.716 . . . . 0.95999999999999996 109.809 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.567 ' HD2' ' HD3' ' A' ' 95' ' ' LYS . 13.8 mmm180 -67.29 -47.44 70.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 120.706 -0.398 . . . . 3.5699999999999998 111.249 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 3.4 pp -83.39 0.96 43.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.35 -0.386 . . . . 1.6499999999999999 111.684 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.1 m -128.4 28.24 5.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.413 0.625 . . . . 1.53 111.33 173.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.936 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 1.3 mmpt? -82.04 118.79 23.28 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.752 -0.833 . . . . 2.7200000000000002 108.752 167.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 1.005 ' HA ' HD22 ' A' ' 27' ' ' LEU . 32.9 ptt180 -76.64 30.83 0.13 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.379 0.609 . . . . 4.3799999999999999 110.719 -177.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 99' ' ' LYS . 40.9 t -123.51 -30.61 3.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.453 -0.794 . . . . 2.5099999999999998 109.531 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.479 ' HG3' ' OD1' ' A' ' 81' ' ' ASN . 81.3 mm-40 -79.52 103.9 9.75 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.026 -0.534 . . . . 3.3999999999999999 110.01 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -71.94 -14.56 61.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.962 -0.563 . . . . 2.6800000000000002 111.404 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.747 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 5.5 p -138.04 134.79 45.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.36 0.6 . . . . 0.44 109.462 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.658 HG23 ' HG2' ' A' ' 20' ' ' LYS . 1.4 t -115.2 122.34 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-O 122.378 1.085 . . . . 0.46000000000000002 111.817 -173.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -99.97 126.86 46.2 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 113.2 -1.818 . . . . 1.76 109.364 177.783 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.67 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 10.4 tt -133.9 127.0 31.58 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.534 -0.543 . . . . 1.1200000000000001 109.534 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.666 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 39.5 tp -107.81 117.71 34.84 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.007 -1.479 . . . . 0.41999999999999998 107.007 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.74 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.5 OUTLIER -123.96 148.79 27.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 C-N-CA 119.671 -0.811 . . . . 0.77000000000000002 110.28 -176.298 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.688 HG23 HG22 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -95.85 117.48 30.65 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.195 -0.911 . . . . 0.34000000000000002 109.39 169.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.781 ' HG3' HE22 ' A' ' 72' ' ' GLN . 28.0 ttp180 -91.56 114.74 27.36 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.814 -1.539 . . . . 2.0099999999999998 109.255 -172.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.508 ' N ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -109.76 -55.12 2.48 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.106 -1.037 . . . . 1.97 113.48 -171.11 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.497 ' N ' ' HG2' ' A' ' 112' ' ' GLN . 33.3 t -156.66 13.98 0.28 Allowed 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.759 -0.776 . . . . 1.6200000000000001 111.965 -173.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.424 HD22 ' H ' ' A' ' 113' ' ' SER . 1.3 mm? -104.63 21.41 16.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.657 0.741 . . . . 1.6499999999999999 110.312 -177.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.524 ' HA ' ' OE1' ' A' ' 72' ' ' GLN . 34.5 mt-30 -68.96 101.18 1.33 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.785 -1.098 . . . . 3.5299999999999998 110.972 -174.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -110.4 -28.83 8.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.593 -0.731 . . . . 3.6000000000000001 111.183 -175.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -120.78 19.72 11.76 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.416 -0.811 . . . . 3.5600000000000001 110.375 -176.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 115' ' ' GLN . 95.2 t -99.67 -71.2 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.223 -0.898 . . . . 4.9900000000000002 110.852 -177.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -88.28 -60.38 1.98 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.345 -0.843 . . . . 7.7699999999999996 110.789 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 60.05 85.59 0.1 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.794 -0.639 . . . . 6.5999999999999996 111.027 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.5 t -91.3 98.4 11.69 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.063 -0.517 . . . . 8.9399999999999995 109.678 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 14.8 tpt -88.31 112.38 22.77 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.636 -0.711 . . . . 12.1 109.829 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.42 107.55 3.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.146 -0.479 . . . . 12.82 110.659 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.3 p . . . . . 0 C--O 1.253 1.281 0 CA-C-O 118.173 -0.918 . . . . 14.640000000000001 109.653 178.292 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.3 mtp . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 109.845 -0.428 . . . . 14.33 109.845 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 t 73.72 168.93 0.31 Allowed 'General case' 0 CA--C 1.533 0.3 0 O-C-N 124.108 0.88 . . . . 11.220000000000001 109.514 -176.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.503 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 42.2 p90 -161.59 175.17 12.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.65 0.262 . . . . 9.1899999999999995 111.146 -173.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.591 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -104.79 95.63 9.23 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.741 -0.663 . . . . 6.6500000000000004 110.082 177.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 3' ' ' TYR . 24.5 Cg_exo -62.42 -49.16 6.3 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.77 2.314 . . . . 7.46 111.922 -176.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -145.88 32.95 1.54 Allowed Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.695 -0.684 . . . . 5.8899999999999997 111.563 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.581 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 13.7 pt20 -148.71 45.35 0.39 Allowed Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 114.076 1.139 . . . . 6.3700000000000001 114.076 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.581 ' HD3' ' N ' ' A' ' 7' ' ' GLN . 32.9 Cg_exo -64.64 -141.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.692 2.261 . . . . 3.3999999999999999 112.218 165.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.7 m -92.0 2.9 7.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.68 -0.691 . . . . 2.2599999999999998 109.354 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 m -72.88 79.83 1.16 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 122.562 1.172 . . . . 2.0899999999999999 109.394 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.14 178.67 8.26 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 113.001 -1.909 . . . . 0.95999999999999996 110.178 175.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.6 t -111.65 107.97 24.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.625 -0.716 . . . . 1.5700000000000001 109.891 -174.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.772 HG22 HG23 ' A' ' 110' ' ' THR . 48.6 t -77.36 108.65 10.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.247 0.546 . . . . 1.02 109.585 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 1.065 HE22 HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -108.58 167.54 9.98 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.372 -0.831 . . . . 1.3899999999999999 111.612 -173.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -122.3 114.49 20.87 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.96 -0.564 . . . . 3.6299999999999999 110.802 -172.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.065 HG23 HE22 ' A' ' 14' ' ' GLN . 4.9 t -99.24 132.6 44.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.211 -0.663 . . . . 1.02 109.211 176.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -144.63 117.1 8.55 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 110.137 -0.32 . . . . 1.3500000000000001 110.137 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.592 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 10.9 tp -144.89 148.25 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 108.741 -0.837 . . . . 0.60999999999999999 108.741 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.734 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 15.3 m-70 -76.22 116.08 16.57 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.008 -0.677 . . . . 0.59999999999999998 109.693 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.666 ' HB2' HD12 ' A' ' 27' ' ' LEU . 3.1 pptp? -30.59 136.44 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 O-C-N 125.065 1.478 . . . . 4.0 112.108 177.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 65' ' ' PRO . 47.1 tp -98.44 89.59 4.49 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 119.888 -0.725 . . . . 0.55000000000000004 110.761 -171.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 24.7 ptt180 -68.71 139.22 55.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.072 0.463 . . . . 3.9700000000000002 112.063 -172.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.403 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 3.1 tp-100 -129.47 93.95 3.66 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.651 -0.704 . . . . 1.3500000000000001 109.238 174.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.28 -80.33 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.839 -0.696 . . . . 1.3300000000000001 112.863 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -127.09 2.71 6.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.849 0.357 . . . . 2.3300000000000001 111.699 -173.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.403 ' OD1' ' HB3' ' A' ' 23' ' ' GLN . 1.1 p30 -126.73 174.39 8.78 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.097 -0.501 . . . . 1.8700000000000001 110.426 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.666 HD12 ' HB2' ' A' ' 20' ' ' LYS . 2.0 pt? -127.42 134.39 49.88 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.777 -1.194 . . . . 2.2799999999999998 107.777 175.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 26.0 mm -98.92 136.28 30.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-O 121.13 0.491 . . . . 0.80000000000000004 111.665 -171.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.464 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -106.6 116.19 31.5 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.341 -1.299 . . . . 1.74 107.558 173.137 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.37 51.86 4.42 Favored Glycine 0 C--O 1.221 -0.691 0 C-N-CA 120.223 -0.989 . . . . 0.68999999999999995 113.249 -172.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.585 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 29.2 p90 -158.47 170.74 21.53 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.591 -0.522 . . . . 0.51000000000000001 109.591 176.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.878 ' HB3' ' O ' ' A' ' 58' ' ' THR . 1.0 OUTLIER -110.66 168.85 9.16 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 107.978 -1.119 . . . . 0.53000000000000003 107.978 170.303 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -159.82 135.91 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 113.65 0.981 . . . . 0.48999999999999999 113.65 -163.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.407 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -147.64 117.4 0.91 Allowed Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.592 -1.003 . . . . 0.71999999999999997 110.592 155.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 1.083 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -142.58 117.78 1.18 Allowed Glycine 0 CA--C 1.488 -1.63 0 CA-C-O 118.427 -1.207 . . . . 1.4199999999999999 111.141 171.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.694 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.59 137.99 4.92 Favored Glycine 0 C--N 1.298 -1.539 0 C-N-CA 117.222 -2.418 . . . . 0.47999999999999998 113.086 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.418 HG12 ' N ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -60.53 -25.32 34.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 107.345 -1.354 . . . . 0.52000000000000002 107.345 151.314 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.82 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 4.5 t70 -54.6 -40.2 68.62 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 113.524 -1.671 . . . . 0.71999999999999997 110.179 169.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -62.91 -57.63 10.13 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.378 -0.828 . . . . 1.1899999999999999 110.51 -173.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.451 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 0.3 OUTLIER -172.68 119.88 0.42 Allowed Pre-proline 0 N--CA 1.463 0.205 0 CA-C-O 121.147 0.498 . . . . 2.5699999999999998 110.329 167.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 7.4 Cg_endo -92.89 10.36 2.31 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.391 2.727 . . . . 2.8199999999999998 112.15 175.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.7 t -103.21 -34.57 8.77 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.1 -0.5 . . . . 3.2599999999999998 111.664 -169.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.36 18.95 13.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.987 0.899 . . . . 3.8799999999999999 108.584 -178.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.606 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 39.7 m-20 -161.24 54.97 0.58 Allowed Pre-proline 0 N--CA 1.443 -0.776 0 CA-C-N 113.813 -1.539 . . . . 5.1399999999999997 109.275 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.606 ' HD3' ' N ' ' A' ' 44' ' ' ASN . 93.4 Cg_endo -102.46 0.92 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.716 2.278 . . . . 3.71 112.657 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -179.65 27.66 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.879 0.847 . . . . 5.6200000000000001 108.987 -169.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 44' ' ' ASN . 6.0 m -75.75 -173.08 2.1 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 113.754 1.02 . . . . 3.77 113.754 -169.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -19.68 -69.48 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 112.327 -2.215 . . . . 6.7800000000000002 116.522 -175.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.745 ' HB3' HG22 ' A' ' 51' ' ' THR . 44.2 t0 -141.41 -157.62 0.78 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.05 -0.722 . . . . 5.4699999999999998 109.05 -166.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.622 ' HD2' ' CG ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -60.55 -22.88 64.13 Favored 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 120.377 -0.529 . . . . 3.0699999999999998 110.282 171.294 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.745 HG22 ' HB3' ' A' ' 49' ' ' ASP . 5.8 t -61.03 -52.94 62.84 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.338 -0.846 . . . . 4.5599999999999996 110.598 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.442 ' H ' HG23 ' A' ' 51' ' ' THR . 51.6 t0 24.19 -96.85 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 O-C-N 124.34 1.025 . . . . 2.6000000000000001 113.288 166.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.586 ' C ' ' HD2' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -130.59 29.76 4.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.585 0.707 . . . . 3.48 109.568 172.643 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.432 ' C ' HD12 ' A' ' 55' ' ' ILE . . . -78.93 -156.73 10.15 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.248 -1.141 . . . . 0.78000000000000003 110.248 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.083 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.7 mp -112.1 142.57 24.07 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 N-CA-C 107.783 -1.191 . . . . 0.54000000000000004 107.783 171.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.717 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -152.16 141.98 21.98 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 122.219 1.009 . . . . 1.4199999999999999 111.577 -177.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.899 HG12 ' H ' ' A' ' 75' ' ' ASP . 1.8 p -79.92 135.98 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 113.928 -1.487 . . . . 0.57999999999999996 109.565 -178.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.878 ' O ' ' HB3' ' A' ' 32' ' ' SER . 15.8 m -125.09 64.47 1.14 Allowed 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.322 -0.854 . . . . 1.1100000000000001 109.372 175.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.565 ' HA ' HG23 ' A' ' 73' ' ' ILE . 64.2 mtt180 148.01 -168.5 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 125.939 1.696 . . . . 2.27 110.109 164.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.585 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 57.8 t -164.0 137.89 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 125.89 1.994 . . . . 0.82999999999999996 106.29 164.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.3 m -75.03 121.57 22.19 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.915 -0.772 . . . . 1.6499999999999999 108.915 173.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -50.39 108.94 0.26 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.174 -0.921 . . . . 1.8500000000000001 111.927 177.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.58 -6.05 70.57 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.557 -0.747 . . . . 0.92000000000000004 112.482 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.557 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -80.12 174.47 55.03 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.726 -0.75 . . . . 0.98999999999999999 112.17 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.462 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 46.7 Cg_endo -68.37 -28.4 32.99 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 122.837 2.358 . . . . 0.44 113.708 -164.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.471 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -65.57 -30.77 71.55 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.203 -0.908 . . . . 0.35999999999999999 110.881 177.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.507 ' HB2' HG11 ' A' ' 60' ' ' VAL . 14.6 tt0 -77.65 -31.2 52.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.326 0.584 . . . . 1.79 109.528 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.557 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.3 mp -65.81 -39.77 85.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.314 -0.857 . . . . 0.51000000000000001 109.84 175.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.713 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -75.27 -23.22 57.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.852 -0.613 . . . . 0.40999999999999998 110.295 176.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.53 46.63 1.2 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.843 -1.17 . . . . 0.45000000000000001 114.427 173.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.786 HD22 HG11 ' A' ' 57' ' ' VAL . 2.9 mt -91.93 156.51 17.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.62 0.71 . . . . 0.89000000000000001 111.079 175.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 6.0 mt-30 -132.82 32.09 3.86 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 114.599 1.333 . . . . 1.21 114.599 -166.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.565 HG23 ' HA ' ' A' ' 59' ' ' ARG . 3.4 mp 75.05 -14.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 N-CA-C 114.059 1.133 . . . . 0.77000000000000002 114.059 167.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.6 52.27 0.37 Allowed Glycine 0 N--CA 1.463 0.482 0 C-N-CA 119.761 -1.209 . . . . 0.37 112.405 -167.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.899 ' H ' HG12 ' A' ' 57' ' ' VAL . 21.5 m-20 -120.7 146.51 46.37 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.117 -0.541 . . . . 0.89000000000000001 110.388 -169.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.598 ' HD2' ' N ' ' A' ' 76' ' ' LYS . 10.3 mptt -101.44 102.4 13.19 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.516 0.674 . . . . 2.2000000000000002 110.483 -170.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.931 HG13 HG23 ' A' ' 109' ' ' VAL . 3.1 mp -64.49 122.79 16.05 Favored 'Isoleucine or valine' 0 C--O 1.256 1.424 0 CA-C-N 114.742 -1.117 . . . . 0.48999999999999999 112.295 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.881 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 2.7 mmt -91.92 -16.91 25.95 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 125.909 2.006 . . . . 1.0600000000000001 111.148 173.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.581 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -172.42 152.26 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.908 0.336 . . . . 0.81999999999999995 111.908 -177.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.712 HG12 ' HE1' ' A' ' 85' ' ' MET . 2.4 p -138.4 124.41 24.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.285 0.564 . . . . 1.3100000000000001 110.133 173.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.485 ' OD1' HG22 ' A' ' 80' ' ' VAL . 20.0 m120 53.02 28.65 6.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.298 -0.864 . . . . 1.5 112.669 174.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.41 -13.75 47.46 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.285 -0.959 . . . . 0.38 113.132 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.474 ' CE2' ' HD2' ' A' ' 96' ' ' ARG . 80.4 m95 -86.88 148.16 25.48 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.623 -0.51 . . . . 0.77000000000000002 109.623 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.64 118.68 37.28 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.663 -0.698 . . . . 1.8899999999999999 111.975 -173.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.712 ' HE1' HG12 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -107.13 103.48 12.89 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.901 0.858 . . . . 1.01 111.377 179.603 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 p -131.16 -48.3 1.0 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.221 -1.4 . . . . 1.05 107.221 168.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.86 84.67 2.1 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 112.622 -2.081 . . . . 1.6200000000000001 107.509 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.695 ' O ' HD11 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -137.73 136.45 45.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.026 -0.988 . . . . 1.0900000000000001 108.453 -177.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.766 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 72.9 p -58.1 149.9 22.46 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.161 0.505 . . . . 0.34999999999999998 112.205 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.82 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 21.9 t-160 -58.11 -36.82 73.46 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.635 0.731 . . . . 0.34999999999999998 109.792 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.72 -31.36 66.63 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.203 -1.362 . . . . 1.6699999999999999 109.961 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.694 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -65.65 -50.47 64.84 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.583 -0.895 . . . . 0.77000000000000002 108.583 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.72 ' HB2' HG12 ' A' ' 55' ' ' ILE . . . -65.59 -37.2 85.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.678 -0.692 . . . . 0.33000000000000002 110.274 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -68.53 -42.21 78.81 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.489 -0.778 . . . . 2.1000000000000001 110.935 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.557 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -72.8 -41.9 64.46 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 116.363 -0.38 . . . . 0.95999999999999996 110.228 -176.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.694 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 29.8 mmt180 -68.04 -32.9 73.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.015 0.436 . . . . 3.5699999999999998 110.315 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.663 ' HB2' HG21 ' A' ' 80' ' ' VAL . 10.8 tp -73.18 -55.24 6.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.394 -0.821 . . . . 1.6499999999999999 110.203 173.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 m -94.23 77.59 3.99 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 122.949 1.357 . . . . 1.53 109.779 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.535 ' HE2' ' HB3' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -138.5 108.72 6.43 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 112.316 -2.22 . . . . 2.7200000000000002 106.35 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -70.79 70.1 0.47 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.384 0.611 . . . . 4.3799999999999999 112.091 -170.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.0 t -137.55 -31.49 0.8 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.784 -0.644 . . . . 2.5099999999999998 110.805 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 19.3 mm-40 -68.21 141.32 56.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.476 -0.329 . . . . 3.3999999999999999 110.9 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.503 ' HG3' HG12 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -94.84 -11.22 29.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.922 0.868 . . . . 2.6800000000000002 108.872 169.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.734 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 3.7 p -153.2 145.55 14.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.237 -1.347 . . . . 0.44 108.211 -175.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.442 HG23 ' HB3' ' A' ' 20' ' ' LYS . 43.8 t -119.98 118.93 58.61 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.03 0 CA-C-O 122.439 1.114 . . . . 0.46000000000000002 112.065 -169.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.403 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 2.1 mpt_? -99.62 129.31 45.76 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 112.72 -2.036 . . . . 1.76 111.006 -175.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.799 HD11 HG12 ' A' ' 77' ' ' ILE . 35.0 tp -132.8 130.77 40.31 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 116.489 -0.323 . . . . 1.1200000000000001 110.745 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.881 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 35.5 tp -107.19 114.81 29.09 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 106.785 -1.561 . . . . 0.41999999999999998 106.785 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.931 HG23 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -128.76 147.14 33.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 C-N-CA 120.313 -0.555 . . . . 0.77000000000000002 110.562 -172.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.772 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -97.56 117.11 31.09 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.707 -0.797 . . . . 0.34000000000000002 110.556 173.401 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.501 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -110.04 135.46 50.83 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.418 -1.265 . . . . 2.0099999999999998 109.495 -175.456 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.515 ' OE1' HD23 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -114.25 -72.74 0.68 Allowed 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.687 0.625 . . . . 1.97 112.687 -169.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.4 t -140.87 18.15 2.31 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.647 0.737 . . . . 1.6200000000000001 110.216 -172.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 4.1 mm? -96.3 22.55 7.63 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.36 -0.836 . . . . 1.6499999999999999 109.766 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.416 ' HG3' ' H ' ' A' ' 115' ' ' GLN . 0.8 OUTLIER -60.44 142.94 54.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.834 -1.076 . . . . 3.5299999999999998 111.522 -178.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -104.31 93.59 4.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.18 -0.464 . . . . 3.6000000000000001 111.786 -175.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.624 ' HB1' HE21 ' A' ' 120' ' ' GLN . . . 40.2 80.2 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.297 0.998 . . . . 3.5600000000000001 113.508 173.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.1 p -136.33 -7.76 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.022 0.439 . . . . 4.9900000000000002 111.707 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -89.82 -16.65 29.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.826 0.346 . . . . 7.7699999999999996 110.882 -175.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.624 HE21 ' HB1' ' A' ' 117' ' ' ALA . 25.5 pt20 -78.98 96.24 5.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.662 0.744 . . . . 6.5999999999999996 110.63 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 40.8 t -83.85 -65.36 1.02 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.363 -0.835 . . . . 8.9399999999999995 110.364 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 57.8 ttp -87.04 142.45 27.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.919 -0.582 . . . . 12.1 109.943 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 98.2 mt -84.65 135.26 34.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.772 0.32 . . . . 12.82 110.43 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.096 -0.954 . . . . 14.640000000000001 109.296 176.098 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.773 0.321 . . . . 14.33 110.392 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 p -88.7 107.24 18.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.295 0.569 . . . . 11.220000000000001 110.787 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.418 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 70.1 t80 -107.44 131.01 54.75 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.658 -0.701 . . . . 9.1899999999999995 109.485 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.798 HG22 ' HG3' ' A' ' 7' ' ' GLN . 0.9 OUTLIER -113.17 94.13 29.11 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-O 121.227 0.537 . . . . 6.6500000000000004 110.936 -178.242 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 3' ' ' TYR . 12.9 Cg_exo -67.69 -57.56 0.16 Allowed 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.702 2.268 . . . . 7.46 111.293 -177.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -135.4 36.03 2.09 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.659 -0.781 . . . . 5.8899999999999997 112.187 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.798 ' HG3' HG22 ' A' ' 4' ' ' ILE . 19.6 pt20 -146.31 34.27 0.13 Allowed Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 115.27 1.581 . . . . 6.3700000000000001 115.27 177.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.641 ' HD3' ' N ' ' A' ' 7' ' ' GLN . 5.3 Cg_exo -74.37 118.95 5.55 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.538 1.492 . . . . 3.3999999999999999 111.13 167.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.567 ' HB ' ' O ' ' A' ' 8' ' ' PRO . 37.3 t 80.03 -51.64 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 122.803 0.441 . . . . 2.2599999999999998 111.672 177.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 p -69.45 82.81 0.4 Allowed 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 122.167 0.984 . . . . 2.0899999999999999 111.445 -176.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.577 ' CB ' ' HA ' ' A' ' 112' ' ' GLN . . . -86.5 178.4 7.11 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.614 -1.63 . . . . 0.95999999999999996 111.045 177.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -129.46 138.46 54.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.268 -0.878 . . . . 1.5700000000000001 108.986 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.696 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 0.9 OUTLIER -90.72 127.2 43.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 C-N-CA 119.413 -0.915 . . . . 1.02 110.897 -174.778 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.959 HE22 HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -118.63 166.38 12.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.527 -1.215 . . . . 1.3899999999999999 110.137 176.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.523 ' HD2' ' H ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -124.98 135.29 52.66 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.605 -0.685 . . . . 3.6299999999999999 110.325 -175.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.959 HG23 HE22 ' A' ' 14' ' ' GLN . 4.1 t -105.95 109.04 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 CA-C-O 121.501 0.667 . . . . 1.02 109.436 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -109.31 119.53 39.76 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.37 -0.832 . . . . 1.3500000000000001 109.586 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.707 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 11.3 tp -145.71 146.18 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.871 -0.789 . . . . 0.60999999999999999 108.871 174.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 14.6 m-70 -80.15 112.0 17.05 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.529 -0.915 . . . . 0.59999999999999998 108.529 177.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.684 ' HB2' HD12 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -25.16 140.16 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 O-C-N 124.923 1.389 . . . . 4.0 112.814 -178.692 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.58 HD22 ' HA2' ' A' ' 64' ' ' GLY . 43.9 tp -96.16 97.5 9.59 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 119.102 -1.039 . . . . 0.55000000000000004 110.009 -172.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.638 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 12.4 ptp180 -61.13 142.71 56.51 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.744 0.783 . . . . 3.9700000000000002 112.067 -173.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.568 ' HB2' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -128.43 93.42 3.64 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.141 -1.059 . . . . 1.3500000000000001 108.141 172.397 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.6 -78.16 0.26 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.418 -0.896 . . . . 1.3300000000000001 111.352 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.463 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 54.5 mt-10 -139.2 11.44 2.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.156 0.503 . . . . 2.3300000000000001 110.63 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.638 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 10.8 m-80 -108.48 -177.53 3.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.895 -0.593 . . . . 1.8700000000000001 109.685 -177.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.684 HD12 ' HB2' ' A' ' 20' ' ' LYS . 1.0 OUTLIER -127.68 135.48 50.25 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 108.226 -1.027 . . . . 2.2799999999999998 108.226 173.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.568 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.0 OUTLIER -102.49 138.0 28.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 120.99 0.424 . . . . 0.80000000000000004 110.871 -179.173 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.8 tp -98.6 124.18 43.23 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.938 -1.483 . . . . 1.74 108.394 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.728 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -93.92 35.1 4.31 Favored Glycine 0 C--O 1.223 -0.582 0 C-N-CA 120.226 -0.988 . . . . 0.68999999999999995 114.075 -170.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.569 ' CD1' HG23 ' A' ' 57' ' ' VAL . 39.8 p90 -157.77 169.84 23.71 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.544 -0.539 . . . . 0.51000000000000001 109.544 177.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.709 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -104.43 159.75 15.47 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.845 -1.169 . . . . 0.53000000000000003 107.845 171.512 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.419 HD12 HD21 ' A' ' 97' ' ' LEU . 0.9 OUTLIER -152.91 135.24 6.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 113.354 0.872 . . . . 0.48999999999999999 113.354 -167.112 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -145.06 118.06 1.07 Allowed Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 110.059 -1.216 . . . . 0.71999999999999997 110.059 154.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 1.069 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -139.6 117.74 1.39 Allowed Glycine 0 CA--C 1.49 -1.487 0 CA-C-O 119.093 -0.837 . . . . 1.4199999999999999 111.233 172.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.782 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.15 137.32 4.57 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 118.012 -2.042 . . . . 0.47999999999999998 112.79 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.9 pt -58.75 -24.6 26.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.479 -1.304 . . . . 0.52000000000000002 107.479 153.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.738 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 4.1 t70 -56.1 -43.71 78.36 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 113.156 -1.838 . . . . 0.71999999999999997 110.182 171.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -63.75 -51.69 63.74 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 114.977 -1.01 . . . . 1.1899999999999999 112.317 -171.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.598 ' OD2' ' HB2' ' A' ' 43' ' ' GLN . 0.4 OUTLIER -166.56 103.8 0.67 Allowed Pre-proline 0 C--O 1.214 -0.77 0 CA-C-O 121.323 0.582 . . . . 2.5699999999999998 111.911 -174.453 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -88.7 12.94 2.63 Favored 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 123.222 2.615 . . . . 2.8199999999999998 112.804 176.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.45 ' O ' ' HG3' ' A' ' 43' ' ' GLN . 6.6 t -109.26 17.45 21.53 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.482 -0.326 . . . . 3.2599999999999998 111.035 -172.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.598 ' HB2' ' OD2' ' A' ' 40' ' ' ASP . 8.1 mt-30 -150.9 50.53 0.86 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.642 0.734 . . . . 3.8799999999999999 109.853 -178.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.547 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 4.4 p-10 -169.52 51.66 0.19 Allowed Pre-proline 0 N--CA 1.444 -0.749 0 CA-C-N 114.603 -1.181 . . . . 5.1399999999999997 108.297 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 44' ' ' ASN . 50.2 Cg_exo -53.57 -28.04 43.92 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.805 2.337 . . . . 3.71 111.76 -171.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -132.81 -49.79 0.89 Allowed 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.999 -1.482 . . . . 5.6200000000000001 106.999 170.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.5 ' HB2' ' OD1' ' A' ' 52' ' ' ASP . 2.5 p -159.76 171.37 19.63 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.559 -1.2 . . . . 3.77 108.857 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.572 ' HB3' HG23 ' A' ' 51' ' ' THR . 40.4 tt0 -111.1 -30.3 7.53 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 121.105 -0.238 . . . . 6.7800000000000002 111.051 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.669 ' HB3' HG22 ' A' ' 51' ' ' THR . 9.7 t70 169.43 -114.99 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.379 -0.971 . . . . 5.4699999999999998 108.379 -176.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.583 ' HD2' ' H ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -99.71 10.59 41.08 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.434 0.635 . . . . 3.0699999999999998 109.672 161.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.769 ' HB ' ' HD2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -102.88 -54.81 2.55 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.281 -0.872 . . . . 4.5599999999999996 109.116 -175.264 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.5 ' OD1' ' HB2' ' A' ' 47' ' ' SER . 18.4 m-20 52.74 30.77 9.36 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 124.07 0.856 . . . . 2.6000000000000001 112.589 172.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.479 ' HD3' ' OH ' ' A' ' 56' ' ' TYR . 2.3 tppt? 68.52 40.14 1.99 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.132 0.968 . . . . 3.48 110.273 -178.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.495 ' C ' HD12 ' A' ' 55' ' ' ILE . . . -89.12 -135.34 5.47 Favored Glycine 0 N--CA 1.429 -1.778 0 N-CA-C 109.156 -1.577 . . . . 0.78000000000000003 109.156 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.069 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -117.41 140.58 39.72 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.403 0 C-N-CA 119.656 -0.818 . . . . 0.54000000000000004 108.889 176.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.661 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -142.36 142.43 32.45 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 119.553 1.069 . . . . 1.4199999999999999 110.374 -176.111 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.58 HG12 ' H ' ' A' ' 75' ' ' ASP . 11.9 p -82.63 136.23 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 114.664 -1.153 . . . . 0.57999999999999996 110.301 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.709 ' O ' ' HB3' ' A' ' 32' ' ' SER . 23.7 m -127.23 66.05 1.3 Allowed 'General case' 0 N--CA 1.439 -1.006 0 O-C-N 124.346 1.029 . . . . 1.1100000000000001 109.035 172.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 37.7 mtt180 150.01 -170.28 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.746 1.619 . . . . 2.27 110.434 162.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 90.8 t -160.97 111.46 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 113.595 -1.639 . . . . 0.82999999999999996 106.625 161.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 m -70.76 158.52 36.16 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.504 0.669 . . . . 1.6499999999999999 110.021 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -97.62 130.41 44.65 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.027 -0.988 . . . . 1.8500000000000001 111.289 -169.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.9 -9.83 72.7 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.327 -0.94 . . . . 0.92000000000000004 111.325 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.637 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -85.05 -158.95 30.35 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.607 -0.806 . . . . 0.98999999999999999 111.436 174.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.728 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 40.5 Cg_endo -90.02 -30.21 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.664 2.243 . . . . 0.44 115.382 -171.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 30' ' ' GLY . . . -69.17 -23.1 63.89 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 116.229 -0.441 . . . . 0.35999999999999999 111.473 -174.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -72.03 -38.14 69.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.797 0.808 . . . . 1.79 108.959 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.637 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.3 mp -69.69 -45.29 78.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.526 -1.215 . . . . 0.51000000000000001 110.585 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.708 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -67.26 -30.53 70.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.40999999999999998 109.898 175.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.34 62.3 1.0 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.459 -0.877 . . . . 0.45000000000000001 113.427 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.481 ' O ' HG21 ' A' ' 60' ' ' VAL . 21.6 tp -98.15 158.31 15.63 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.045 -0.724 . . . . 0.89000000000000001 109.045 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.527 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 5.2 mt-30 -132.21 42.25 3.15 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 115.15 1.537 . . . . 1.21 115.15 -164.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.541 ' O ' ' HA ' ' A' ' 58' ' ' THR . 3.4 mp 71.56 -20.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 N-CA-C 115.741 1.756 . . . . 0.77000000000000002 115.741 161.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -164.06 57.77 0.27 Allowed Glycine 0 N--CA 1.463 0.484 0 C-N-CA 119.803 -1.189 . . . . 0.37 112.148 -164.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.582 ' HB3' ' CG2' ' A' ' 109' ' ' VAL . 9.5 m-20 -124.76 154.15 41.34 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.823 -0.688 . . . . 0.89000000000000001 109.819 -168.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.769 ' HD2' ' HB ' ' A' ' 51' ' ' THR . 72.2 mmtt -106.68 103.01 12.35 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.511 0.672 . . . . 2.2000000000000002 109.878 -170.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 1.002 HG13 HG23 ' A' ' 109' ' ' VAL . 3.5 mp -73.65 125.14 32.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 114.696 -1.138 . . . . 0.48999999999999999 113.344 -172.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.718 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 4.4 mmt -86.18 -21.8 27.32 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 113.053 -1.885 . . . . 1.0600000000000001 112.174 176.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.515 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -168.91 149.95 4.51 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.455 0.539 . . . . 0.81999999999999995 112.455 -174.586 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.656 HG22 ' SD ' ' A' ' 85' ' ' MET . 30.1 m -132.55 123.04 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.84 -0.618 . . . . 1.3100000000000001 110.313 174.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.704 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 1.0 OUTLIER 56.87 25.13 10.07 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.071 0.767 . . . . 1.5 113.071 174.58 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.64 -7.13 57.62 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.358 -1.401 . . . . 0.38 112.669 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -91.84 152.57 20.04 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.817 -0.809 . . . . 0.77000000000000002 108.817 174.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -103.05 112.96 26.05 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.669 0.747 . . . . 1.8899999999999999 111.742 -172.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.656 ' SD ' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -106.34 101.62 11.08 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.055 -0.975 . . . . 1.01 111.359 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.1 p -118.24 -41.33 2.87 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.745 1.259 . . . . 1.05 107.741 168.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -148.22 84.49 1.51 Allowed 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 112.556 -2.111 . . . . 1.6200000000000001 107.825 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.782 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.5 t -140.04 135.05 37.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.219 -0.901 . . . . 1.0900000000000001 109.56 -172.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.738 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 69.5 p -55.92 148.28 17.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.292 0.479 . . . . 0.34999999999999998 112.292 -178.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.743 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 22.7 t-160 -56.14 -40.25 73.52 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 115.883 -0.599 . . . . 0.34999999999999998 110.715 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.6 -32.29 70.94 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.115 -0.948 . . . . 1.6699999999999999 109.365 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.826 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 2.5 tp-100 -63.0 -49.45 74.62 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 108.598 -0.89 . . . . 0.77000000000000002 108.598 -178.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.732 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -73.06 -40.47 65.04 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.632 -0.713 . . . . 0.33000000000000002 110.611 -177.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 94' ' ' ARG . 33.2 ttp180 -57.16 -44.32 83.37 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.304 0.573 . . . . 2.1000000000000001 109.644 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.453 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -66.68 -35.51 80.33 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.368 -0.833 . . . . 0.95999999999999996 109.638 -178.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.826 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 22.2 mmt180 -76.18 -26.36 56.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.006 -0.543 . . . . 3.5699999999999998 111.602 -176.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.684 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 2.8 pp -101.49 -0.19 35.56 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.098 0.777 . . . . 1.6499999999999999 113.098 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.2 m -126.67 65.47 1.26 Allowed 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 122.373 1.082 . . . . 1.53 110.871 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE2' ' O ' ' A' ' 96' ' ' ARG . 20.4 mtmt -112.25 114.32 27.04 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 113.937 -1.483 . . . . 2.7200000000000002 108.538 171.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' A' ' 25' ' ' GLU . 15.6 ptt180 -74.88 32.32 0.09 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.348 0.595 . . . . 4.3799999999999999 110.764 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 99' ' ' LYS . 13.2 p -119.73 -41.79 2.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.511 -0.768 . . . . 2.5099999999999998 109.747 -177.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -52.1 142.84 15.32 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.466 -0.788 . . . . 3.3999999999999999 110.477 175.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -93.66 -13.21 27.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.28 0.562 . . . . 2.6800000000000002 110.43 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 5.7 p -151.06 146.74 16.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.77 -0.65 . . . . 0.44 109.547 -176.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.422 HG13 HD21 ' A' ' 81' ' ' ASN . 47.8 t -114.24 120.36 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-O 121.946 0.879 . . . . 0.46000000000000002 111.708 -175.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.704 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.2 OUTLIER -100.26 127.76 46.48 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.488 -1.687 . . . . 1.76 110.613 -177.114 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.806 HD11 HG12 ' A' ' 77' ' ' ILE . 31.1 tp -133.39 126.92 32.34 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.044 -0.526 . . . . 1.1200000000000001 109.947 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.718 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 35.4 tp -111.53 116.01 30.14 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.47 -1.308 . . . . 0.41999999999999998 107.47 175.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 1.002 HG23 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -120.93 153.74 24.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.019 0.438 . . . . 0.77000000000000002 110.391 -173.507 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.696 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 0.7 OUTLIER -98.71 115.09 27.95 Favored 'General case' 0 N--CA 1.426 -1.673 0 C-N-CA 119.619 -0.832 . . . . 0.34000000000000002 110.018 165.482 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.504 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 17.3 ttt180 -92.23 112.79 24.86 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.689 -1.142 . . . . 2.0099999999999998 109.329 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.577 ' HA ' ' CB ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -86.1 -58.56 2.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.471 -0.786 . . . . 1.97 112.197 -171.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.2 t -149.17 8.59 0.73 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.164 0.507 . . . . 1.6200000000000001 110.906 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 72' ' ' GLN . 3.1 mm? -81.66 106.19 13.41 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.207 -1.034 . . . . 1.6499999999999999 108.207 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -128.63 149.5 50.62 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.643 -0.708 . . . . 3.5299999999999998 110.191 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -138.82 145.33 39.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.568 0.223 . . . . 3.6000000000000001 111.27 -174.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 53.91 56.21 7.41 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.554 -0.748 . . . . 3.5600000000000001 110.987 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.04 -5.94 11.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.396 -0.82 . . . . 4.9900000000000002 110.61 -175.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -123.85 99.5 6.3 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.356 -0.609 . . . . 7.7699999999999996 109.356 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -139.35 115.31 10.22 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.006 -0.543 . . . . 6.5999999999999996 110.534 -174.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.5 m -65.08 115.81 5.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.642 -0.708 . . . . 8.9399999999999995 111.235 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 87.6 mtp -84.3 133.24 34.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.106 -0.497 . . . . 12.1 110.701 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.4 tp -124.73 14.89 8.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.631 0.729 . . . . 12.82 109.472 178.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.3 p . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.059 -0.972 . . . . 14.640000000000001 109.638 -176.493 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 110.289 -0.263 . . . . 14.33 110.289 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.6 t -93.94 174.26 7.25 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.09 -0.337 . . . . 11.220000000000001 110.09 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -115.41 134.73 54.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.376 -0.602 . . . . 9.1899999999999995 109.376 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.9 HD12 ' HA ' ' A' ' 8' ' ' PRO . 7.4 pt -120.3 78.03 26.41 Favored Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-O 121.119 0.485 . . . . 6.6500000000000004 111.169 -173.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.52 -38.42 3.4 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.25 1.967 . . . . 7.46 111.83 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.26 22.78 4.17 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.679 -0.692 . . . . 5.8899999999999997 111.623 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.713 ' HG3' HG22 ' A' ' 4' ' ' ILE . 4.5 pt20 -145.3 38.98 0.24 Allowed Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 114.274 1.213 . . . . 6.3700000000000001 114.274 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.9 ' HA ' HD12 ' A' ' 4' ' ' ILE . 50.6 Cg_exo -56.0 163.45 5.93 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.093 1.862 . . . . 3.3999999999999999 112.213 171.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 9' ' ' VAL . 12.9 p -109.37 17.92 7.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.729 0.776 . . . . 2.2599999999999998 109.437 -173.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 t -73.43 79.79 1.41 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 123.27 1.51 . . . . 2.0899999999999999 109.639 173.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.22 177.01 9.25 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 112.215 -2.266 . . . . 0.95999999999999996 110.05 172.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.9 m -120.72 132.41 70.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 116.039 -0.528 . . . . 1.5700000000000001 110.371 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.697 HG22 HG23 ' A' ' 110' ' ' THR . 16.3 t -85.94 114.28 25.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.904 0.383 . . . . 1.02 110.626 -176.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.735 ' HG3' HG12 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -112.61 169.96 8.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.402 0.62 . . . . 1.3899999999999999 112.232 -179.061 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -110.11 141.77 42.52 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.594 0.712 . . . . 3.6299999999999999 112.409 -173.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.707 ' HB ' ' HB3' ' A' ' 107' ' ' LEU . 34.0 t -129.99 128.74 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 108.28 -1.008 . . . . 1.02 108.28 170.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -143.38 119.74 10.92 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.673 0.273 . . . . 1.3500000000000001 110.418 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.541 HG12 ' HB2' ' A' ' 65' ' ' PRO . 10.7 tp -145.33 150.57 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.275 0 N-CA-C 108.818 -0.808 . . . . 0.60999999999999999 108.818 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.785 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 15.8 m-70 -80.71 114.99 19.99 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.187 -0.605 . . . . 0.59999999999999998 109.402 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 3.0 pptp? -27.62 136.2 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 O-C-N 125.051 1.469 . . . . 4.0 112.459 177.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 59.2 tp -109.14 98.1 7.61 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 120.656 -0.418 . . . . 0.55000000000000004 110.684 -175.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 57.7 mtt180 -67.04 135.66 54.03 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.452 0.644 . . . . 3.9700000000000002 111.537 177.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.76 92.41 3.76 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.107 -1.071 . . . . 1.3500000000000001 108.107 172.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.1 -81.48 0.13 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.104 -0.57 . . . . 1.3300000000000001 111.748 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -129.88 5.1 4.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.779 0.799 . . . . 2.3300000000000001 110.819 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 7.4 m-80 -108.27 167.8 9.76 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.336 -0.847 . . . . 1.8700000000000001 110.224 -177.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.437 HD13 ' HG2' ' A' ' 100' ' ' ARG . 6.6 mp -121.73 122.58 39.86 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.564 -0.902 . . . . 2.2799999999999998 108.564 171.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.7 mm -98.0 127.71 50.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.599 -0.728 . . . . 0.80000000000000004 110.234 -174.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.613 HD13 HD21 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -84.96 -38.27 19.5 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 114.581 -1.19 . . . . 1.74 109.063 -179.36 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.99 5.76 62.33 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.02 -0.991 . . . . 0.68999999999999995 111.479 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 39.5 p90 -151.57 167.12 29.06 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.462 -0.57 . . . . 0.51000000000000001 109.462 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.715 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -106.0 169.18 8.65 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 118.822 -1.151 . . . . 0.53000000000000003 108.889 173.302 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.458 HD11 HG21 ' A' ' 55' ' ' ILE . 6.8 tt -140.92 134.72 32.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 119.87 -0.732 . . . . 0.48999999999999999 112.323 -164.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -103.14 173.17 22.11 Favored Glycine 0 C--N 1.329 0.191 0 N-CA-C 110.77 -0.932 . . . . 0.71999999999999997 110.77 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.68 ' C ' HE22 ' A' ' 39' ' ' GLN . . . -110.46 168.57 13.06 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 118.243 2.057 . . . . 1.4199999999999999 118.243 -162.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.736 ' N ' HE22 ' A' ' 39' ' ' GLN . . . -84.5 -142.42 5.55 Favored Glycine 0 N--CA 1.422 -2.254 0 CA-C-N 110.816 -2.692 . . . . 0.47999999999999998 113.272 -176.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.756 HG23 ' O ' ' A' ' 87' ' ' MET . 8.7 pt -83.1 -5.2 8.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 113.258 0.836 . . . . 0.52000000000000002 113.258 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.966 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 13.3 p-10 -70.02 -32.74 71.05 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 120.996 -0.282 . . . . 0.71999999999999997 111.248 -173.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.736 HE22 ' N ' ' A' ' 36' ' ' GLY . 0.9 OUTLIER -59.36 -52.16 66.84 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.616 0.722 . . . . 1.1899999999999999 109.116 -172.411 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 2.0 m-20 -143.0 118.07 6.42 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 114.516 -1.22 . . . . 2.5699999999999998 110.29 171.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 17.7 Cg_exo -67.75 -1.93 7.66 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.096 2.531 . . . . 2.8199999999999998 112.386 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.8 t -92.34 14.8 15.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.534 0.683 . . . . 3.2599999999999998 109.342 176.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -123.93 34.76 4.98 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.943 -1.132 . . . . 3.8799999999999999 107.943 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.633 ' H ' ' CD ' ' A' ' 45' ' ' PRO . 3.7 m-20 -115.56 -41.24 0.07 OUTLIER Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 113.731 -1.577 . . . . 5.1399999999999997 109.763 -170.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.633 ' CD ' ' H ' ' A' ' 44' ' ' ASN . 22.7 Cg_exo -68.78 7.0 0.82 Allowed 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.23 1.953 . . . . 3.71 112.583 173.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -106.91 -6.56 17.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.023 -0.535 . . . . 5.6200000000000001 110.256 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.451 ' HA ' ' HB2' ' A' ' 52' ' ' ASP . 3.8 m -85.5 97.3 9.97 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-O 122.525 1.155 . . . . 3.77 109.45 -171.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.794 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 3.4 tp10 -62.91 -39.97 96.17 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 113.163 -1.835 . . . . 6.7800000000000002 110.307 -178.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 48' ' ' GLU . 14.7 t70 169.5 -128.87 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 106.263 -1.755 . . . . 5.4699999999999998 106.263 -175.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.553 ' HD2' ' C ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -54.25 -33.88 59.51 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.9 0.857 . . . . 3.0699999999999998 109.108 164.183 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.794 ' HB ' ' HB3' ' A' ' 48' ' ' GLU . 2.0 m -56.39 -22.9 34.42 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 113.859 -1.519 . . . . 4.5599999999999996 112.612 -173.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' HB2' ' HA ' ' A' ' 47' ' ' SER . 37.4 t70 -57.26 -106.64 0.0 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.677 0.751 . . . . 2.6000000000000001 110.132 170.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -172.63 -28.29 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.517 -0.765 . . . . 3.48 109.823 174.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.598 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 53.79 -121.2 17.25 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 110.276 -1.13 . . . . 0.78000000000000003 110.276 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.88 HG12 ' HB3' ' A' ' 93' ' ' ALA . 1.8 mp -108.89 146.07 14.96 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.175 0 N-CA-C 105.839 -1.911 . . . . 0.54000000000000004 105.839 170.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.725 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 1.0 OUTLIER -153.54 140.27 19.0 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 119.295 0.952 . . . . 1.4199999999999999 110.264 -169.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.588 ' O ' ' HA2' ' A' ' 74' ' ' GLY . 14.4 p -72.15 132.08 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 CA-C-N 115.44 -0.8 . . . . 0.57999999999999996 110.718 -171.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.715 ' O ' ' HB3' ' A' ' 32' ' ' SER . 19.3 m -125.34 64.71 1.16 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.98 -1.009 . . . . 1.1100000000000001 109.225 174.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.561 ' HA ' HG13 ' A' ' 73' ' ' ILE . 34.5 mtt180 149.38 -173.19 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.392 1.477 . . . . 2.27 111.407 165.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.621 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 4.8 p -174.34 120.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 113.167 -1.833 . . . . 0.82999999999999996 108.269 162.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.9 m -94.27 133.92 37.29 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.132 0.492 . . . . 1.6499999999999999 110.993 -175.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -61.4 124.51 20.83 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.643 -1.162 . . . . 1.8500000000000001 110.382 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.07 -13.06 45.02 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.047 -0.979 . . . . 0.92000000000000004 111.642 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.99 166.82 30.13 Favored Glycine 0 N--CA 1.438 -1.177 0 N-CA-C 111.026 -0.83 . . . . 0.98999999999999999 111.026 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.637 ' HA ' HD13 ' A' ' 68' ' ' ILE . 77.7 Cg_endo -73.98 -23.03 16.57 Favored 'Trans proline' 0 C--N 1.325 -0.676 0 C-N-CA 122.798 2.332 . . . . 0.44 113.036 -170.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.508 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -63.13 -29.38 70.75 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.688 -1.142 . . . . 0.35999999999999999 111.635 176.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -68.96 -37.29 78.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.417 0.627 . . . . 1.79 109.531 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.637 HD13 ' HA ' ' A' ' 65' ' ' PRO . 2.9 mp -67.76 -43.59 86.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 114.894 -1.048 . . . . 0.51000000000000001 110.533 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.69 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -75.76 -19.58 58.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.288 0.566 . . . . 0.40999999999999998 109.686 175.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.13 70.63 1.28 Allowed Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.365 -0.834 . . . . 0.45000000000000001 113.258 176.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.6 ' CD2' HG11 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -79.23 170.09 17.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.808 0.813 . . . . 0.89000000000000001 112.132 178.583 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.494 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 6.2 mm100 -108.26 -20.9 12.98 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 115.593 1.701 . . . . 1.21 115.593 -161.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.61 HD12 HG12 ' A' ' 60' ' ' VAL . 0.8 OUTLIER 82.41 -24.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 112.418 0.525 . . . . 0.77000000000000002 112.418 -172.556 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.588 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -172.02 53.34 0.17 Allowed Glycine 0 C--N 1.341 0.826 0 C-N-CA 119.873 -1.156 . . . . 0.37 112.691 -164.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.661 ' HB3' HG22 ' A' ' 109' ' ' VAL . 0.7 OUTLIER -122.19 149.71 43.26 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 122.204 0.201 . . . . 0.89000000000000001 110.548 -175.206 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.725 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 66.8 mttm -82.39 113.03 19.88 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.691 0.281 . . . . 2.2000000000000002 111.16 -174.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.552 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 17.1 mt -85.66 122.3 38.26 Favored 'Isoleucine or valine' 0 C--O 1.264 1.827 0 CA-C-O 121.254 0.549 . . . . 0.48999999999999999 111.571 -175.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.791 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 15.5 mmt -89.2 -20.01 24.73 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 125.831 1.957 . . . . 1.0600000000000001 112.763 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.61 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -167.25 154.05 8.44 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.434 -0.506 . . . . 0.81999999999999995 112.221 -174.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.781 HG21 ' HB2' ' A' ' 97' ' ' LEU . 12.0 p -139.61 125.49 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.381 -0.827 . . . . 1.3100000000000001 110.029 174.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.803 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 13.6 m120 52.75 30.22 8.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.168 -0.924 . . . . 1.5 113.193 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.88 -10.64 62.32 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.085 -1.055 . . . . 0.38 112.849 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -80.7 149.74 29.62 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-N 117.06 0.43 . . . . 0.77000000000000002 110.106 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -103.94 97.8 7.74 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.274 -0.875 . . . . 1.8899999999999999 111.081 -175.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.583 ' SD ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -113.3 101.88 9.82 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.842 -0.617 . . . . 1.01 111.19 176.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.4 p -99.02 -32.64 11.18 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.675 0.75 . . . . 1.05 110.258 173.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.756 ' O ' HG23 ' A' ' 37' ' ' ILE . 4.0 mtt -136.94 -15.48 1.53 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.756 -1.111 . . . . 1.6200000000000001 110.284 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.632 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 p -56.51 169.45 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 120.888 0.375 . . . . 1.0900000000000001 111.755 -162.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.966 ' HB ' ' HB3' ' A' ' 38' ' ' ASP . 72.4 p -56.56 145.02 29.46 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 122.223 -0.298 . . . . 0.34999999999999998 111.756 -174.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.574 ' CG ' ' HA2' ' A' ' 35' ' ' GLY . 23.3 t-160 -55.84 -35.4 66.37 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 122.045 0.926 . . . . 0.34999999999999998 108.614 175.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -69.02 -32.53 72.11 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 113.256 -1.793 . . . . 1.6699999999999999 110.313 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.815 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 4.3 tp-100 -62.54 -47.86 82.06 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 108.008 -1.108 . . . . 0.77000000000000002 108.008 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.88 ' HB3' HG12 ' A' ' 55' ' ' ILE . . . -76.72 -34.06 58.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.243 -0.889 . . . . 0.33000000000000002 110.21 -173.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 94' ' ' ARG . 38.6 ttp180 -65.35 -43.53 90.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.386 -0.824 . . . . 2.1000000000000001 110.395 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.535 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -69.35 -40.88 77.26 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.53 -0.759 . . . . 0.95999999999999996 109.904 -176.403 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.815 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 21.9 mmt180 -70.36 -23.57 62.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.953 -0.567 . . . . 3.5699999999999998 110.633 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.781 ' HB2' HG21 ' A' ' 80' ' ' VAL . 15.9 tp -83.26 -44.48 14.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.631 -0.713 . . . . 1.6499999999999999 112.007 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.0 m -107.87 75.42 1.0 Allowed 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 122.807 1.289 . . . . 1.53 111.014 -169.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE2' ' HA ' ' A' ' 96' ' ' ARG . 6.6 mtmt -115.44 123.87 49.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.541 -2.118 . . . . 2.7200000000000002 109.041 173.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.437 ' HG2' HD13 ' A' ' 27' ' ' LEU . 41.8 mtp180 -69.69 40.01 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 O-C-N 123.324 0.39 . . . . 4.3799999999999999 111.229 177.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 99' ' ' LYS . 18.4 m -136.41 -41.74 0.63 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.056 -0.35 . . . . 2.5099999999999998 110.056 -172.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.564 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 46.9 mm-40 -56.36 140.69 44.53 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.383 -0.599 . . . . 3.3999999999999999 109.383 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.76 -16.87 15.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.502 0.668 . . . . 2.6800000000000002 109.862 176.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.785 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 3.0 p -143.26 150.29 17.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.128 -1.064 . . . . 0.44 108.128 -178.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.455 ' HA ' HD21 ' A' ' 81' ' ' ASN . 54.9 t -124.57 119.38 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.807 0 CA-C-O 122.22 1.009 . . . . 0.46000000000000002 111.513 -170.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.803 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -100.68 133.62 44.86 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 113.342 -1.754 . . . . 1.76 110.73 -176.228 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.707 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 19.3 tp -132.4 132.58 42.98 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 110.007 -0.368 . . . . 1.1200000000000001 110.007 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.791 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 23.8 tp -109.73 114.59 28.3 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.147 -1.797 . . . . 0.41999999999999998 106.147 171.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.735 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -121.67 141.18 43.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.898 -0.721 . . . . 0.77000000000000002 110.305 -173.641 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.697 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -96.28 115.81 28.02 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.831 -0.748 . . . . 0.34000000000000002 110.313 173.68 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.695 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 1.6 ttt180 -90.28 104.27 16.86 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.289 -1.323 . . . . 2.0099999999999998 109.655 -170.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.486 ' HG2' ' N ' ' A' ' 113' ' ' SER . 0.0 OUTLIER -91.59 -45.17 8.63 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.371 0.508 . . . . 1.97 112.371 -171.533 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.486 ' N ' ' HG2' ' A' ' 112' ' ' GLN . 22.8 t -163.1 14.92 0.07 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.408 0.623 . . . . 1.6200000000000001 110.311 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.463 HD23 ' OD1' ' A' ' 75' ' ' ASP . 3.6 mm? -92.66 83.32 4.85 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.382 0.611 . . . . 1.6499999999999999 109.861 -176.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.43 ' NE2' ' HE ' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -104.46 144.42 31.68 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 113.645 0.98 . . . . 3.5299999999999998 113.645 -176.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -161.24 145.77 13.51 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 113.49 -1.687 . . . . 3.6000000000000001 107.227 175.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -43.73 108.96 0.12 Allowed 'General case' 0 C--N 1.322 -0.626 0 O-C-N 123.834 0.709 . . . . 3.5600000000000001 111.054 174.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.76 -40.47 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.874 -0.603 . . . . 4.9900000000000002 111.381 -175.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -126.41 63.75 1.26 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.458 0.647 . . . . 7.7699999999999996 109.481 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -165.51 -28.68 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.311 -0.859 . . . . 6.5999999999999996 109.915 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.5 m -93.1 170.5 9.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.718 -0.674 . . . . 8.9399999999999995 109.797 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 15.2 tpt -84.66 129.91 34.78 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.942 -0.392 . . . . 12.1 109.942 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.459 ' H ' HD23 ' A' ' 123' ' ' LEU . 2.5 pt? -135.39 166.74 22.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.291 -0.413 . . . . 12.82 110.165 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.7 m . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.461 -0.781 . . . . 14.640000000000001 111.073 -178.649 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.8 tpt . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 120.661 0.267 . . . . 14.33 110.426 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 t -137.55 122.02 18.37 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.713 -0.476 . . . . 11.220000000000001 109.713 178.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -109.01 126.84 53.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.437 -0.347 . . . . 9.1899999999999995 110.584 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.1 pt -106.62 98.79 21.79 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 6.6500000000000004 110.788 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -87.5 -11.34 5.03 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.462 2.108 . . . . 7.46 111.568 174.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.65 -42.15 4.56 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.674 -0.694 . . . . 5.8899999999999997 112.405 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.44 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 3.0 pt20 -128.13 46.02 1.94 Allowed Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 114.286 1.217 . . . . 6.3700000000000001 114.286 -177.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.563 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 9.4 Cg_endo -71.49 130.68 17.6 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.436 1.424 . . . . 3.3999999999999999 110.564 172.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.563 ' HB ' ' O ' ' A' ' 8' ' ' PRO . 42.3 t 77.84 -47.63 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 O-C-N 123.426 0.454 . . . . 2.2599999999999998 111.107 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 49.2 p -75.0 82.67 2.23 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 122.309 1.052 . . . . 2.0899999999999999 111.461 -176.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.07 179.36 5.6 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.399 -1.728 . . . . 0.95999999999999996 109.484 173.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.76 122.28 68.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.218 0.533 . . . . 1.5700000000000001 110.711 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.771 HG22 HG23 ' A' ' 110' ' ' THR . 15.8 t -79.56 105.61 9.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.004 -0.543 . . . . 1.02 110.367 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.999 HE22 HG23 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -102.05 169.19 8.91 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.725 -0.67 . . . . 1.3899999999999999 111.766 179.095 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.525 ' HD3' ' O ' ' A' ' 107' ' ' LEU . 1.8 mmt180 -123.96 116.09 22.31 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.334 -0.394 . . . . 3.6299999999999999 110.932 -177.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.999 HG23 HE22 ' A' ' 14' ' ' GLN . 25.1 t -97.29 125.71 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.597 -0.52 . . . . 1.02 109.597 176.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -139.04 116.21 11.05 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.89 -0.781 . . . . 1.3500000000000001 108.89 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.689 HG13 ' O ' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -144.57 139.8 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 107.841 -1.17 . . . . 0.60999999999999999 107.841 -177.42 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.849 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 17.1 m-70 -72.06 115.09 10.88 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.139 -0.689 . . . . 0.59999999999999998 109.139 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.652 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -31.96 141.01 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 O-C-N 124.958 1.411 . . . . 4.0 112.228 178.414 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.81 ' HB3' ' HB ' ' A' ' 28' ' ' ILE . 56.5 tp -98.18 102.58 14.37 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.595 -0.442 . . . . 0.55000000000000004 110.764 -171.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -58.13 139.35 54.97 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.371 0.605 . . . . 3.9700000000000002 112.069 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -142.99 92.46 2.4 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.555 -0.748 . . . . 1.3500000000000001 109.13 172.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.35 -79.85 0.01 OUTLIER Glycine 0 CA--C 1.522 0.473 0 C-N-CA 121.455 -0.403 . . . . 1.3300000000000001 112.541 -173.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -130.16 5.06 4.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.513 0.673 . . . . 2.3300000000000001 110.508 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 23' ' ' GLN . 12.0 m-80 -106.63 165.36 11.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.532 -0.758 . . . . 1.8700000000000001 110.146 -177.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.91 HD21 ' HB ' ' A' ' 98' ' ' THR . 2.2 pt? -128.66 124.63 36.21 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.759 -1.2 . . . . 2.2799999999999998 107.759 171.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.81 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 36.0 mm -98.43 115.95 40.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 116.028 -0.533 . . . . 0.80000000000000004 110.731 -170.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.806 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.3 pt? -71.7 -26.54 62.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.632 -0.713 . . . . 1.74 110.353 175.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.07 -31.3 7.1 Favored Glycine 0 C--O 1.223 -0.585 0 C-N-CA 120.731 -0.747 . . . . 0.68999999999999995 113.201 172.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.552 ' HZ ' HD11 ' A' ' 97' ' ' LEU . 44.9 p90 -112.24 163.07 14.79 Favored 'General case' 0 C--N 1.313 -0.999 0 O-C-N 122.264 -0.551 . . . . 0.51000000000000001 110.815 -176.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.535 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 24.0 t -100.47 163.2 12.47 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.268 -1.382 . . . . 0.53000000000000003 107.268 173.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -162.64 137.82 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 112.416 0.524 . . . . 0.48999999999999999 112.416 -164.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.74 117.79 1.06 Allowed Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 110.616 -0.994 . . . . 0.71999999999999997 110.616 157.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 1.031 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -142.65 118.56 1.27 Allowed Glycine 0 CA--C 1.49 -1.507 0 CA-C-O 118.607 -1.107 . . . . 1.4199999999999999 111.564 173.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.68 144.86 9.42 Favored Glycine 0 C--N 1.294 -1.764 0 C-N-CA 117.133 -2.46 . . . . 0.47999999999999998 113.319 177.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.637 ' HA ' ' HG3' ' A' ' 53' ' ' LYS . 13.2 pt -62.58 -17.64 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.801 -1.185 . . . . 0.52000000000000002 107.801 151.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.847 ' HB2' ' CB ' ' A' ' 89' ' ' THR . 21.9 t70 -62.89 -37.09 85.53 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 113.962 -1.472 . . . . 0.71999999999999997 109.802 173.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -74.0 -164.31 0.23 Allowed 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 114.662 -1.154 . . . . 1.1899999999999999 110.704 -174.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.512 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 2.2 p-10 -98.79 122.39 53.09 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-O 121.429 0.633 . . . . 2.5699999999999998 111.348 -175.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 10.3 Cg_exo -76.93 19.9 0.66 Allowed 'Trans proline' 0 N--CA 1.474 0.334 0 C-N-CA 123.853 3.035 . . . . 2.8199999999999998 113.047 177.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 t -98.84 13.9 30.81 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.884 0.373 . . . . 3.2599999999999998 111.553 -170.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -134.48 16.78 3.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.632 0.73 . . . . 3.8799999999999999 109.429 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -177.8 56.33 0.1 Allowed Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-N 114.649 -1.16 . . . . 5.1399999999999997 108.587 -168.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.07 -4.12 12.93 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.641 2.227 . . . . 3.71 113.009 -167.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -141.21 -42.28 0.38 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.047 -1.094 . . . . 5.6200000000000001 108.047 176.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.6 m -157.26 158.88 36.93 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.826 -1.176 . . . . 3.77 107.826 174.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.555 ' HB3' HG23 ' A' ' 51' ' ' THR . 32.5 tt0 -107.25 -38.22 6.04 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.571 -0.9 . . . . 6.7800000000000002 108.571 169.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.6 ' HB2' HG22 ' A' ' 51' ' ' THR . 21.2 m-20 -176.93 -147.93 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 105.758 -1.942 . . . . 5.4699999999999998 105.758 -169.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.824 ' HG3' HG21 ' A' ' 110' ' ' THR . 0.1 OUTLIER -75.74 55.08 0.84 Allowed 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.625 -0.879 . . . . 3.0699999999999998 108.625 163.12 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 1.111 ' HB ' ' HB3' ' A' ' 76' ' ' LYS . 7.3 t -151.17 -54.17 0.14 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 119.78 -0.768 . . . . 4.5599999999999996 110.706 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.444 ' N ' HG23 ' A' ' 51' ' ' THR . 19.9 t0 63.97 -99.05 0.07 Allowed 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 115.926 -0.579 . . . . 2.6000000000000001 111.064 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.637 ' HG3' ' HA ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -111.52 33.09 4.92 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.402 -1.333 . . . . 3.48 107.402 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.445 ' C ' HD12 ' A' ' 55' ' ' ILE . . . -93.2 -154.21 30.94 Favored Glycine 0 N--CA 1.433 -1.556 0 CA-C-N 113.545 -1.662 . . . . 0.78000000000000003 111.026 -169.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.031 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -114.25 144.25 22.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 N-CA-C 109.223 -0.658 . . . . 0.54000000000000004 109.223 178.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.814 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -145.92 146.78 31.19 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 122.59 1.186 . . . . 1.4199999999999999 113.334 178.218 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.814 HG23 HD11 ' A' ' 77' ' ' ILE . 54.5 t -72.21 137.42 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 112.509 -2.132 . . . . 0.57999999999999996 110.38 175.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.7 m -113.73 -19.7 11.45 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 124.502 1.126 . . . . 1.1100000000000001 111.478 -178.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.637 ' O ' HG23 ' A' ' 60' ' ' VAL . 72.8 mtt180 -149.48 -165.97 2.42 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.754 -0.591 . . . . 2.27 112.21 174.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 59' ' ' ARG . 79.7 t -168.4 138.61 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.705 1.602 . . . . 0.82999999999999996 107.407 166.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.415 ' OG ' ' HA3' ' A' ' 64' ' ' GLY . 32.2 p -81.09 132.87 35.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.922 0.392 . . . . 1.6499999999999999 111.123 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -58.71 111.17 1.17 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.864 -1.062 . . . . 1.8500000000000001 110.52 170.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.26 -15.16 63.83 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.55 -0.834 . . . . 0.92000000000000004 112.145 177.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.455 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -72.21 175.51 42.51 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.515 -0.85 . . . . 0.98999999999999999 111.35 177.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.689 ' O ' HG13 ' A' ' 18' ' ' ILE . 73.5 Cg_endo -72.8 -30.08 11.84 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.288 1.992 . . . . 0.44 112.69 -166.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.501 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -60.72 -28.25 68.52 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.011 -0.995 . . . . 0.35999999999999999 111.415 178.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -76.0 -35.49 59.55 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.517 0.675 . . . . 1.79 109.287 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.455 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -65.27 -43.43 95.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.882 -1.053 . . . . 0.51000000000000001 110.244 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.698 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -72.46 -22.87 61.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.908 -0.587 . . . . 0.40999999999999998 110.52 177.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.89 66.38 0.86 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.019 -1.086 . . . . 0.45000000000000001 113.389 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.593 HD13 HG21 ' A' ' 16' ' ' VAL . 9.0 tp -119.12 151.0 39.06 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.893 -0.41 . . . . 0.89000000000000001 109.893 177.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.842 HE22 ' HG3' ' A' ' 111' ' ' ARG . 7.9 mt-30 -129.91 31.73 4.66 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 115.806 1.78 . . . . 1.21 115.806 -162.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 72' ' ' GLN . 2.7 mp 72.95 -8.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 CA-C-N 118.992 0.815 . . . . 0.77000000000000002 112.988 170.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.13 54.58 0.32 Allowed Glycine 0 CA--C 1.507 -0.454 0 C-N-CA 119.155 -1.498 . . . . 0.37 112.69 -168.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.577 ' H ' ' HB ' ' A' ' 57' ' ' VAL . 16.8 m-20 -120.83 148.36 44.12 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.491 -0.354 . . . . 0.89000000000000001 110.51 -168.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 1.111 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 14.0 mmtp -105.93 102.86 12.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.168 0.508 . . . . 2.2000000000000002 110.0 -169.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 1.059 HG13 HG23 ' A' ' 109' ' ' VAL . 3.4 mp -72.99 126.99 34.63 Favored 'Isoleucine or valine' 0 C--O 1.257 1.471 0 N-CA-C 113.629 0.974 . . . . 0.48999999999999999 113.629 -172.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.793 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 5.5 mmt -92.12 -28.55 17.03 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 126.265 2.228 . . . . 1.0600000000000001 112.113 172.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.587 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 52.3 mt-30 -150.87 158.57 44.31 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.52 0.933 . . . . 0.81999999999999995 113.52 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.586 ' HB ' ' CE ' ' A' ' 85' ' ' MET . 24.4 t -139.6 107.46 3.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 113.515 -1.675 . . . . 1.3100000000000001 109.951 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 1.011 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 23.1 m-80 54.92 32.27 17.59 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.848 0.459 . . . . 1.5 112.007 176.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.46 -3.9 59.76 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.224 -0.989 . . . . 0.38 112.817 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.435 ' CE2' ' HD2' ' A' ' 96' ' ' ARG . 84.0 m95 -87.54 168.27 13.21 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.669 -0.493 . . . . 0.77000000000000002 109.669 177.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -109.78 113.69 26.66 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.242 0.544 . . . . 1.8899999999999999 111.155 -171.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.586 ' CE ' ' HB ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -106.95 101.97 11.36 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 122.217 1.008 . . . . 1.01 110.965 -179.702 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.8 p -142.1 -46.18 0.34 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.428 -1.714 . . . . 1.05 107.707 173.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.413 ' HA ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -146.85 74.45 1.35 Allowed 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 113.704 -1.589 . . . . 1.6200000000000001 110.127 176.105 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.774 ' HB ' HE21 ' A' ' 92' ' ' GLN . 22.9 m -133.3 154.93 40.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.285 -1.006 . . . . 1.0900000000000001 108.285 171.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.847 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 72.0 p -62.57 154.4 29.02 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 120.792 0.33 . . . . 0.34999999999999998 111.331 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.818 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 17.7 t-160 -52.59 -45.14 66.39 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 121.722 0.772 . . . . 0.34999999999999998 110.143 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -71.35 -29.56 65.13 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 113.692 -1.594 . . . . 1.6699999999999999 109.964 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.774 HE21 ' HB ' ' A' ' 88' ' ' VAL . 2.5 tt0 -60.19 -47.14 87.2 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.402 -0.592 . . . . 0.77000000000000002 109.402 178.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.586 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -74.06 -41.0 62.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.322 0.582 . . . . 0.33000000000000002 110.531 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -56.62 -44.17 80.94 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.817 -1.083 . . . . 2.1000000000000001 110.896 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.402 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -71.82 -34.35 69.25 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.396 -0.82 . . . . 0.95999999999999996 109.92 -176.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.745 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 27.2 mmt180 -74.56 -26.15 59.76 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.172 -0.467 . . . . 3.5699999999999998 110.712 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.552 HD11 ' HZ ' ' A' ' 31' ' ' PHE . 5.6 tt -68.94 -60.85 2.09 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.527 -0.76 . . . . 1.6499999999999999 111.277 -176.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.91 ' HB ' HD21 ' A' ' 27' ' ' LEU . 5.8 p -97.43 -83.56 0.39 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.387 -0.369 . . . . 1.53 111.408 -176.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 99' ' ' LYS . 2.8 ttpt 66.97 -1.66 1.35 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.8 -0.636 . . . . 2.7200000000000002 112.026 176.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.482 ' HA ' HD22 ' A' ' 27' ' ' LEU . 97.4 mtt180 60.34 47.79 8.61 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.026 -0.988 . . . . 4.3799999999999999 111.188 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.1 t -137.02 -56.44 0.72 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.466 -0.334 . . . . 2.5099999999999998 111.741 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.652 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 19.5 mm-40 -63.83 149.5 46.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.474 -0.33 . . . . 3.3999999999999999 111.123 -174.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -93.5 -10.17 35.82 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.431 0.634 . . . . 2.6800000000000002 109.843 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.849 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 3.8 p -147.58 142.18 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 108.634 -0.876 . . . . 0.44 108.634 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.5 t -116.64 120.24 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-O 122.02 0.914 . . . . 0.46000000000000002 111.867 -169.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 1.011 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -99.66 128.33 45.77 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 113.444 -1.707 . . . . 1.76 111.322 -174.403 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.885 HD11 HG12 ' A' ' 77' ' ' ILE . 17.6 tp -134.49 133.87 40.85 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.127 -0.488 . . . . 1.1200000000000001 110.492 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.793 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 29.9 tp -111.38 117.01 31.92 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 105.998 -1.853 . . . . 0.41999999999999998 105.998 170.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 1.059 HG23 HG13 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -126.63 144.46 36.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.868 -0.733 . . . . 0.77000000000000002 110.407 -174.578 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.824 HG21 ' HG3' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -95.68 115.29 27.22 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.614 -0.834 . . . . 0.34000000000000002 109.297 169.608 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.842 ' HG3' HE22 ' A' ' 72' ' ' GLN . 8.5 ttt180 -102.97 138.9 39.24 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.258 -1.337 . . . . 2.0099999999999998 110.482 -172.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.545 ' HG2' HD21 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -125.41 -96.35 0.44 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.326 0.491 . . . . 1.97 112.326 -178.433 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.0 t -124.97 35.39 4.79 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.273 0.559 . . . . 1.6200000000000001 111.792 -168.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.545 HD21 ' HG2' ' A' ' 112' ' ' GLN . 0.3 OUTLIER -99.16 18.46 17.41 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.32 0.581 . . . . 1.6499999999999999 109.835 -178.671 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -67.26 149.19 50.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.196 -0.911 . . . . 3.5299999999999998 110.869 -176.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -126.7 67.06 1.25 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.021 0.438 . . . . 3.6000000000000001 111.466 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 53.01 72.2 0.44 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.976 -1.011 . . . . 3.5600000000000001 112.056 175.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.29 -20.22 7.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.468 0.652 . . . . 4.9900000000000002 110.219 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -91.72 68.13 5.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.628 -0.715 . . . . 7.7699999999999996 110.849 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -141.02 117.9 11.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.931 -0.577 . . . . 6.5999999999999996 110.39 177.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.0 p -152.91 90.55 1.47 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.627 -0.715 . . . . 8.9399999999999995 110.413 -177.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -91.54 -28.77 17.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.336 -0.393 . . . . 12.1 110.497 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 98.3 mt 64.09 174.97 0.18 Allowed 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.783 0.677 . . . . 12.82 110.948 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.304 -0.855 . . . . 14.640000000000001 109.72 179.366 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.8 mtp . . . . . 0 N--CA 1.482 1.129 0 CA-C-O 120.683 0.278 . . . . 14.33 111.079 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -59.62 -44.34 93.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.018 -0.537 . . . . 11.220000000000001 111.498 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -110.14 114.49 28.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.044 0.449 . . . . 9.1899999999999995 110.521 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.549 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 8.5 pt -109.84 101.99 48.82 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.829 -0.623 . . . . 6.6500000000000004 110.591 176.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -66.0 105.3 0.8 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.18 2.587 . . . . 7.46 112.284 -177.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.4 -24.75 30.1 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.99 -0.624 . . . . 5.8899999999999997 112.424 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 70.36 113.44 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 123.49 0.716 . . . . 6.3700000000000001 111.482 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.549 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 9.6 Cg_endo -89.17 172.78 4.16 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.064 2.509 . . . . 3.3999999999999999 112.195 178.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.456 ' HA ' ' OD1' ' A' ' 49' ' ' ASP . 67.3 t 70.27 -68.12 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 123.439 0.696 . . . . 2.2599999999999998 112.074 177.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 t -77.86 82.15 4.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 123.605 1.669 . . . . 2.0899999999999999 110.86 -176.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.429 ' HB2' ' HZ1' ' A' ' 50' ' ' LYS . . . -110.9 178.19 4.43 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 112.196 -2.274 . . . . 0.95999999999999996 110.541 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.8 t -111.64 118.19 56.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.989 -0.551 . . . . 1.5700000000000001 110.487 -176.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.741 HG22 HG23 ' A' ' 110' ' ' THR . 39.4 t -76.37 111.81 13.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.219 0.533 . . . . 1.02 109.637 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 1.005 HE22 HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -118.69 169.35 9.89 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.009 -0.541 . . . . 1.3899999999999999 112.235 -171.465 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 15' ' ' ARG . 6.1 mmm-85 -124.06 118.11 26.21 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.998 0.428 . . . . 3.6299999999999999 112.126 -175.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.005 HG23 HE22 ' A' ' 14' ' ' GLN . 7.7 t -108.26 119.59 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 108.25 -1.018 . . . . 1.02 108.25 171.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -132.75 114.41 14.1 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.93 -0.767 . . . . 1.3500000000000001 108.93 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.716 HG13 ' O ' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -136.89 138.29 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 108.097 -1.075 . . . . 0.60999999999999999 108.097 -173.619 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.847 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.3 m-70 -66.09 114.14 5.01 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.495 -0.32 . . . . 0.59999999999999998 110.358 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.973 ' HB2' HD13 ' A' ' 27' ' ' LEU . 2.2 pptp? -28.02 135.4 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 O-C-N 125.097 1.498 . . . . 4.0 112.814 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.716 HD22 ' HD3' ' A' ' 65' ' ' PRO . 33.1 tp -96.68 90.24 5.24 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.937 0.875 . . . . 0.55000000000000004 109.377 -175.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.489 ' H ' ' CD ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -62.3 133.23 54.84 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.854 -1.521 . . . . 3.9700000000000002 111.311 -178.501 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.403 ' HB2' HD13 ' A' ' 28' ' ' ILE . 4.2 tp-100 -133.71 94.18 3.24 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.773 -0.825 . . . . 1.3500000000000001 108.773 173.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.5 -80.26 0.12 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.828 -0.701 . . . . 1.3300000000000001 111.778 -175.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -132.52 1.47 3.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.832 0.348 . . . . 2.3300000000000001 110.511 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -107.61 172.04 7.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.24 0.543 . . . . 1.8700000000000001 111.283 -171.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.973 HD13 ' HB2' ' A' ' 20' ' ' LYS . 2.7 tp -124.4 121.77 35.84 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.14 -0.936 . . . . 2.2799999999999998 109.06 175.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.403 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.5 mp -99.25 129.65 49.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.686 -0.857 . . . . 0.80000000000000004 108.686 176.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mt -84.7 -32.39 23.58 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.418 -0.81 . . . . 1.74 110.279 -174.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.429 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 86.59 11.6 71.06 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.227 -0.987 . . . . 0.68999999999999995 111.487 -175.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.616 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 33.3 p90 -155.0 167.73 29.37 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.305 -0.628 . . . . 0.51000000000000001 109.305 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.567 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -107.67 164.09 12.53 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 107.873 -1.158 . . . . 0.53000000000000003 107.873 172.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -148.78 136.47 14.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 119.573 -0.851 . . . . 0.48999999999999999 112.664 -167.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.418 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -147.46 118.41 1.01 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.25 -0.976 . . . . 0.71999999999999997 111.066 157.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 1.033 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -137.99 119.04 1.75 Allowed Glycine 0 CA--C 1.492 -1.354 0 CA-C-O 118.807 -0.996 . . . . 1.4199999999999999 110.703 171.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 1.017 ' HA3' ' HG2' ' A' ' 39' ' ' GLN . . . -156.77 116.9 0.74 Allowed Glycine 0 N--CA 1.435 -1.423 0 C-N-CA 118.277 -1.916 . . . . 0.47999999999999998 113.614 -169.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.533 HG12 ' C ' ' A' ' 88' ' ' VAL . 15.9 pt -67.86 -20.89 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 N-CA-C 105.738 -1.949 . . . . 0.52000000000000002 105.738 147.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.742 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 2.8 t70 -63.17 -40.72 98.35 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 112.644 -2.071 . . . . 0.71999999999999997 109.765 168.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 1.017 ' HG2' ' HA3' ' A' ' 36' ' ' GLY . 28.7 mm-40 -64.53 -70.4 0.23 Allowed 'General case' 0 C--N 1.345 0.373 0 CA-C-N 115.034 -0.984 . . . . 1.1899999999999999 111.777 -175.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.51 ' O ' ' HG3' ' A' ' 53' ' ' LYS . 0.9 OUTLIER -138.71 95.98 9.66 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 120.609 -0.437 . . . . 2.5699999999999998 111.136 -176.457 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.37 24.38 0.61 Allowed 'Trans proline' 0 C--N 1.332 -0.309 0 C-N-CA 122.838 2.358 . . . . 2.8199999999999998 112.46 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.8 t -139.88 29.52 2.09 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.469 0.652 . . . . 3.2599999999999998 110.078 -177.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.784 ' HB2' ' HE3' ' A' ' 53' ' ' LYS . 81.2 mm-40 -131.3 14.82 5.08 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.614 0.721 . . . . 3.8799999999999999 109.294 -177.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.496 ' H ' ' HD2' ' A' ' 45' ' ' PRO . 8.5 m120 -86.59 -43.6 0.56 Allowed Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 114.773 -1.103 . . . . 5.1399999999999997 109.408 -175.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.496 ' HD2' ' H ' ' A' ' 44' ' ' ASN . 1.6 Cg_endo -45.14 -29.31 4.02 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.016 2.477 . . . . 3.71 112.579 161.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -102.95 27.61 6.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.658 -0.701 . . . . 5.6200000000000001 110.899 -178.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.0 t -70.02 140.78 52.92 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 122.52 1.152 . . . . 3.77 110.067 -176.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -107.78 -19.16 13.62 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-N 112.952 -1.931 . . . . 6.7800000000000002 110.605 -163.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.456 ' OD1' ' HA ' ' A' ' 9' ' ' VAL . 20.4 t0 168.1 -158.77 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.067 -1.086 . . . . 5.4699999999999998 108.067 -162.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.595 ' HG2' HG21 ' A' ' 110' ' ' THR . 0.1 OUTLIER -66.49 1.71 1.58 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.525 0.203 . . . . 3.0699999999999998 111.506 171.055 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.404 HG23 ' N ' ' A' ' 52' ' ' ASP . 14.5 t -78.92 -54.62 5.86 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 120.202 -0.599 . . . . 4.5599999999999996 110.296 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.404 ' N ' HG23 ' A' ' 51' ' ' THR . 9.5 t70 42.44 -120.24 0.54 Allowed 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.737 0.648 . . . . 2.6000000000000001 110.765 170.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.784 ' HE3' ' HB2' ' A' ' 43' ' ' GLN . 20.3 mmtt -128.66 44.5 2.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.924 0.868 . . . . 3.48 110.276 171.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.476 ' C ' HD12 ' A' ' 55' ' ' ILE . . . -82.44 -144.77 5.18 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 109.732 -1.347 . . . . 0.78000000000000003 109.732 172.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.033 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -117.1 141.16 36.7 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.151 0 C-N-CA 119.268 -0.973 . . . . 0.54000000000000004 109.187 177.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.774 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -148.28 138.13 22.38 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.698 0.761 . . . . 1.4199999999999999 110.509 -176.043 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.546 HG12 ' H ' ' A' ' 75' ' ' ASP . 14.6 p -79.49 137.17 22.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 114.485 -1.234 . . . . 0.57999999999999996 110.468 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 58' ' ' THR . 12.1 t -127.18 68.91 1.28 Allowed 'General case' 0 C--O 1.21 -1.021 0 O-C-N 124.325 1.016 . . . . 1.1100000000000001 108.998 174.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.646 ' HA ' HG23 ' A' ' 73' ' ' ILE . 18.0 mtt180 153.55 -172.9 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.897 -1.502 . . . . 2.27 110.939 159.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.1 t -160.7 112.92 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 111.897 -2.41 . . . . 0.82999999999999996 106.621 161.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 m -76.44 121.75 23.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.96 0.41 . . . . 1.6499999999999999 109.933 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -48.14 116.72 1.63 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.01 -0.995 . . . . 1.8500000000000001 112.066 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.41 -16.06 49.24 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.517 -0.849 . . . . 0.92000000000000004 112.189 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.64 169.83 54.83 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.153 -1.022 . . . . 0.98999999999999999 111.415 177.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.716 ' O ' HG13 ' A' ' 18' ' ' ILE . 90.5 Cg_endo -71.35 -24.59 22.68 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.603 2.202 . . . . 0.44 113.064 -170.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.616 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -63.15 -25.67 68.46 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.26 -0.882 . . . . 0.35999999999999999 111.521 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -73.67 -37.42 65.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.656 -0.868 . . . . 1.79 108.656 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.53 HD13 ' HA ' ' A' ' 65' ' ' PRO . 2.2 mp -65.86 -47.99 83.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.245 -1.343 . . . . 0.51000000000000001 111.095 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.74 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -71.93 -22.07 61.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.388 -0.369 . . . . 0.40999999999999998 110.405 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.27 72.27 1.29 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.505 -0.855 . . . . 0.45000000000000001 113.109 178.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.473 ' CD2' HG21 ' A' ' 57' ' ' VAL . 15.3 tp -105.04 158.16 16.75 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.699 -0.482 . . . . 0.89000000000000001 109.699 176.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.672 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 35.2 mt-30 -114.04 20.83 15.37 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 114.756 1.391 . . . . 1.21 114.756 -168.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.646 HG23 ' HA ' ' A' ' 59' ' ' ARG . 75.8 mt 73.88 -5.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 113.059 0.762 . . . . 0.77000000000000002 113.059 170.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -171.03 63.9 0.16 Allowed Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.667 -0.777 . . . . 0.37 111.621 -165.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.546 ' H ' HG12 ' A' ' 57' ' ' VAL . 20.6 m-20 -122.66 148.26 45.49 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.245 -0.478 . . . . 0.89000000000000001 110.055 -170.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -97.98 101.39 12.86 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.29 0.567 . . . . 2.2000000000000002 109.775 -176.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 1.009 HG13 HG12 ' A' ' 109' ' ' VAL . 3.1 mp -73.86 121.89 25.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 115.29 -0.868 . . . . 0.48999999999999999 112.005 -175.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.665 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 4.5 mmt -88.59 -21.74 23.88 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 125.687 1.867 . . . . 1.0600000000000001 111.933 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.561 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -160.77 148.94 16.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.166 0.508 . . . . 0.81999999999999995 112.194 -175.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.622 HG13 ' HB3' ' A' ' 97' ' ' LEU . 21.9 t -129.49 110.52 20.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.172 -0.922 . . . . 1.3100000000000001 110.594 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.786 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 5.9 m120 52.38 37.22 21.94 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.694 0.627 . . . . 1.5 112.694 174.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.9 -11.13 62.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.292 -0.956 . . . . 0.38 112.563 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.557 ' HB2' ' HE2' ' A' ' 85' ' ' MET . 80.1 m95 -89.57 161.87 15.95 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 109.282 -0.636 . . . . 0.77000000000000002 109.282 177.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -108.81 111.79 23.71 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.197 -0.456 . . . . 1.8899999999999999 110.653 -172.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.79 ' SD ' HG11 ' A' ' 88' ' ' VAL . 13.7 mmt -107.41 99.92 9.4 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 121.85 0.834 . . . . 1.01 109.91 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.64 -48.61 2.04 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.706 -1.134 . . . . 1.05 107.998 171.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.411 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 3.2 mtt -143.41 85.01 1.83 Allowed 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.517 -1.674 . . . . 1.6200000000000001 108.022 173.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.79 HG11 ' SD ' ' A' ' 85' ' ' MET . 0.5 OUTLIER -140.32 151.2 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 115.781 -0.645 . . . . 1.0900000000000001 109.904 -176.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.682 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 82.6 p -61.25 151.19 32.4 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.143 0.497 . . . . 0.34999999999999998 112.278 -177.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.742 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 22.6 t-160 -61.53 -34.36 75.41 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 115.814 -0.63 . . . . 0.34999999999999998 109.891 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -70.58 -33.24 70.85 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.171 -1.377 . . . . 1.6699999999999999 109.235 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.727 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -63.56 -52.36 61.4 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.747 -0.834 . . . . 0.77000000000000002 108.747 -179.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.715 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -66.72 -41.14 88.42 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.504 -0.771 . . . . 0.33000000000000002 110.281 -178.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -60.25 -47.46 85.91 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.375 -0.829 . . . . 2.1000000000000001 110.676 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.517 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -69.95 -39.45 76.04 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.67 -0.695 . . . . 0.95999999999999996 110.203 -176.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.727 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 25.1 mmt180 -69.24 -23.01 63.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.991 -0.549 . . . . 3.5699999999999998 112.152 -175.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.622 ' HB3' HG13 ' A' ' 80' ' ' VAL . 4.4 pp -98.93 -14.04 19.72 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.406 -0.517 . . . . 1.6499999999999999 111.948 175.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.751 ' HA ' HD23 ' A' ' 27' ' ' LEU . 1.9 m -112.74 86.02 2.28 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 122.35 1.071 . . . . 1.53 109.945 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.493 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 4.6 mtmt -120.17 119.15 32.43 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 113.462 -1.699 . . . . 2.7200000000000002 109.969 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -67.62 48.77 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.181 -0.918 . . . . 4.3799999999999999 111.84 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.4 t -151.42 -54.11 0.14 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.311 0.486 . . . . 2.5099999999999998 112.311 -172.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 43.9 mt-10 -71.67 158.51 36.02 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.323 0.49 . . . . 3.3999999999999999 112.323 -171.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -95.4 -18.34 20.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.81 -0.632 . . . . 2.6800000000000002 111.399 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.847 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 4.9 p -142.41 148.25 20.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.726 0.298 . . . . 0.44 110.362 -172.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.46 HG23 ' HB3' ' A' ' 20' ' ' LYS . 44.1 t -119.73 119.78 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-O 121.813 0.816 . . . . 0.46000000000000002 111.736 -173.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.786 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.9 OUTLIER -102.11 124.92 48.55 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 113.875 -1.511 . . . . 1.76 111.529 -174.039 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.431 HD21 HG12 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -133.52 131.06 39.33 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.19 0.519 . . . . 1.1200000000000001 111.071 174.445 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.665 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 35.4 tp -103.2 113.99 27.91 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.011 -1.477 . . . . 0.41999999999999998 107.011 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 1.009 HG12 HG13 ' A' ' 77' ' ' ILE . 23.1 m -118.12 152.06 20.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 C-N-CA 119.921 -0.712 . . . . 0.77000000000000002 110.581 -176.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.741 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -95.73 115.18 27.06 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.825 -0.75 . . . . 0.34000000000000002 109.287 167.129 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.63 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . 0.9 OUTLIER -105.16 143.08 33.84 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.925 -1.034 . . . . 2.0099999999999998 110.475 -171.255 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.43 -89.27 0.49 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.067 -0.515 . . . . 1.97 110.633 -176.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.2 t -160.47 74.26 0.53 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.322 0.582 . . . . 1.6200000000000001 110.998 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.672 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 6.8 mt -123.03 -10.18 8.18 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.284 -0.871 . . . . 1.6499999999999999 110.081 -179.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.433 ' HG2' HG11 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -41.29 141.84 0.63 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.536 -1.211 . . . . 3.5299999999999998 112.38 172.471 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -134.93 114.04 12.12 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.091 -0.504 . . . . 3.6000000000000001 111.291 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 61.04 22.04 12.34 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.012 0.745 . . . . 3.5600000000000001 113.012 170.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.433 HG11 ' HG2' ' A' ' 115' ' ' GLN . 12.2 p -86.2 -22.73 7.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.617 0.722 . . . . 4.9900000000000002 110.886 -176.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -103.45 10.83 37.07 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.25 -0.886 . . . . 7.7699999999999996 110.208 -175.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -113.02 84.78 2.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.876 -0.602 . . . . 6.5999999999999996 110.622 -173.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.1 m -99.72 -5.96 27.9 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.351 0.596 . . . . 8.9399999999999995 109.865 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 92.0 mmm -95.31 172.44 8.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.543 -0.753 . . . . 12.1 111.078 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.4 tp -110.38 138.36 46.87 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.504 -0.771 . . . . 12.82 110.146 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.4 t . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.764 -0.636 . . . . 14.640000000000001 109.595 175.65 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.9 ttp . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 109.873 -0.417 . . . . 14.33 109.873 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.8 m -93.88 117.92 30.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.927 0.394 . . . . 11.220000000000001 111.536 -174.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -80.83 -15.1 57.28 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.418 -0.586 . . . . 9.1899999999999995 109.418 173.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.731 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 43.3 mm 72.55 118.84 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 114.788 -1.096 . . . . 6.6500000000000004 110.804 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -52.7 -38.82 77.38 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.394 2.729 . . . . 7.46 113.38 -178.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.53 -1.36 56.59 Favored Glycine 0 C--O 1.23 -0.115 0 C-N-CA 120.669 -0.777 . . . . 5.8899999999999997 111.631 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 24.0 mp0 66.78 137.22 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.806 0.842 . . . . 6.3700000000000001 112.403 -176.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.731 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 43.0 Cg_exo -55.87 152.05 37.81 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 123.193 2.595 . . . . 3.3999999999999999 113.199 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 8' ' ' PRO . 91.8 t 76.16 -56.92 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.289 -0.869 . . . . 2.2599999999999998 111.72 176.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.2 t -78.29 83.25 4.55 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 123.559 1.647 . . . . 2.0899999999999999 110.869 -177.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.64 157.45 17.17 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 112.343 -2.208 . . . . 0.95999999999999996 109.227 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.687 HG23 ' HG2' ' A' ' 111' ' ' ARG . 20.2 m -99.92 125.78 53.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 109.502 -0.555 . . . . 1.5700000000000001 109.502 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.657 HG22 HG23 ' A' ' 110' ' ' THR . 56.1 t -77.19 97.67 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 122.0 0.905 . . . . 1.02 111.168 -176.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.728 ' NE2' HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -95.91 139.84 31.54 Favored 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 114.095 -1.411 . . . . 1.3899999999999999 109.515 175.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.432 ' HB3' HD12 ' A' ' 108' ' ' LEU . 5.3 ppt_? -125.6 129.05 48.87 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 120.32 -1.487 . . . . 3.6299999999999999 111.326 176.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.772 HG13 ' CB ' ' A' ' 69' ' ' ALA . 22.7 t -92.57 133.93 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 114.909 -1.041 . . . . 1.02 110.259 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -135.32 112.51 10.44 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.008 -0.738 . . . . 1.3500000000000001 109.008 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.646 HG13 ' O ' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -144.45 139.24 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 N-CA-C 107.742 -1.207 . . . . 0.60999999999999999 107.742 -177.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.68 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 14.6 m-70 -73.75 114.88 12.53 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.054 -0.721 . . . . 0.59999999999999998 109.054 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.778 ' HB2' HD12 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -31.46 143.71 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 O-C-N 125.02 1.45 . . . . 4.0 112.424 -178.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.548 HD22 ' HD3' ' A' ' 65' ' ' PRO . 30.7 tp -94.98 97.59 10.08 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.847 -0.741 . . . . 0.55000000000000004 110.037 -171.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.468 ' HD3' ' H ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -54.95 131.34 44.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.792 -1.094 . . . . 3.9700000000000002 111.583 -178.684 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.412 ' HB2' HD13 ' A' ' 28' ' ' ILE . 6.4 tp-100 -139.8 102.13 4.35 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.755 -1.111 . . . . 1.3500000000000001 108.549 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.9 -92.04 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.556 -0.831 . . . . 1.3300000000000001 111.108 -175.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.449 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 35.7 mt-10 -126.6 -0.55 6.81 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.101 0.477 . . . . 2.3300000000000001 110.607 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.444 ' HA ' ' CB ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -112.54 -175.94 2.79 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.969 -0.56 . . . . 1.8700000000000001 110.457 -173.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.778 HD12 ' HB2' ' A' ' 20' ' ' LYS . 1.7 pt? -123.9 142.84 50.78 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.405 -0.961 . . . . 2.2799999999999998 108.405 175.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.412 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.2 mp -106.78 130.89 57.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 121.062 0.458 . . . . 0.80000000000000004 110.357 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.6 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.3 pt? -96.28 117.33 30.58 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.032 -1.099 . . . . 1.74 108.032 172.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.623 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -81.5 43.54 2.93 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.738 -0.744 . . . . 0.68999999999999995 113.521 -171.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.61 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 29.0 p90 -158.28 160.44 37.05 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 122.575 0.35 . . . . 0.51000000000000001 110.33 178.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 18.6 t -103.89 159.9 15.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.183 -1.414 . . . . 0.53000000000000003 107.183 170.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -160.3 140.15 3.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 120.695 -0.402 . . . . 0.48999999999999999 111.778 -165.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -145.61 119.22 1.17 Allowed Glycine 0 N--CA 1.436 -1.314 0 N-CA-C 110.257 -1.137 . . . . 0.71999999999999997 110.257 157.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 1.005 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -138.67 116.68 1.3 Allowed Glycine 0 CA--C 1.488 -1.643 0 N-CA-C 110.652 -0.979 . . . . 1.4199999999999999 110.652 169.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.7 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.47 137.15 4.5 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 117.498 -2.287 . . . . 0.47999999999999998 114.329 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.514 HG12 ' C ' ' A' ' 88' ' ' VAL . 23.3 pt -66.79 -11.4 13.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.773 -1.195 . . . . 0.52000000000000002 107.773 149.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.81 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 0.0 OUTLIER -72.3 -40.69 67.32 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.091 -1.413 . . . . 0.71999999999999997 108.789 170.351 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -63.2 -55.6 23.7 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.965 -1.016 . . . . 1.1899999999999999 109.213 178.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -111.28 98.16 38.58 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.293 -0.867 . . . . 2.5699999999999998 109.534 173.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -87.75 16.0 2.01 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.268 2.645 . . . . 2.8199999999999998 112.086 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.6 t -97.84 -56.57 2.46 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.454 -0.794 . . . . 3.2599999999999998 112.837 -167.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.79 52.06 0.63 Allowed 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 120.316 -0.554 . . . . 3.8799999999999999 111.563 -167.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.721 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 6.3 p-10 -158.31 37.8 0.06 OUTLIER Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 112.576 0.584 . . . . 5.1399999999999997 112.576 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.721 ' HD3' ' N ' ' A' ' 44' ' ' ASN . 41.4 Cg_endo -98.93 7.76 0.93 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.641 2.227 . . . . 3.71 111.611 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -167.11 23.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.746 -0.835 . . . . 5.6200000000000001 108.746 -172.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.619 ' OG ' ' HA ' ' A' ' 44' ' ' ASN . 27.4 m -79.41 -172.1 3.06 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.187 -0.915 . . . . 3.77 111.959 -169.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 49' ' ' ASP . 34.9 mm-40 -21.08 -72.41 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 115.32 1.6 . . . . 6.7800000000000002 115.32 -174.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.529 ' CG ' ' H ' ' A' ' 50' ' ' LYS . 27.9 t70 174.76 -140.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.648 -1.612 . . . . 5.4699999999999998 106.648 -174.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.57 ' HE2' HG21 ' A' ' 110' ' ' THR . 0.0 OUTLIER -54.83 -28.21 47.91 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.985 0.898 . . . . 3.0699999999999998 109.303 164.476 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.5 m -63.75 -18.74 64.35 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.348 -1.296 . . . . 4.5599999999999996 111.896 -174.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.48 ' OD2' ' HD2' ' A' ' 53' ' ' LYS . 22.6 t70 -71.2 -165.78 0.14 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.581 -0.896 . . . . 2.6000000000000001 108.581 173.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.485 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -70.66 -49.66 44.96 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.821 -0.807 . . . . 3.48 108.821 178.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.431 ' C ' HD12 ' A' ' 55' ' ' ILE . . . 56.58 -131.69 51.35 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 109.828 -1.309 . . . . 0.78000000000000003 109.828 -174.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.005 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -115.32 141.25 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 106.755 -1.572 . . . . 0.54000000000000004 106.755 168.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.67 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -153.85 146.97 24.61 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 119.42 1.009 . . . . 1.4199999999999999 110.887 -178.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.807 HG12 ' H ' ' A' ' 75' ' ' ASP . 1.4 p -81.88 140.84 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-N 114.732 -1.122 . . . . 0.57999999999999996 109.71 -175.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.9 m -110.25 -14.47 14.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.295 -0.866 . . . . 1.1100000000000001 110.841 -173.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.546 ' HB2' ' HB3' ' A' ' 32' ' ' SER . 67.1 mtt180 -149.55 -166.59 2.59 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.728 0.775 . . . . 2.27 112.395 174.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 66' ' ' ALA . 88.3 t -160.0 140.02 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 112.525 -2.125 . . . . 0.82999999999999996 106.474 162.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.9 p -82.73 121.16 26.52 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 121.503 0.668 . . . . 1.6499999999999999 110.308 175.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -60.46 101.08 0.12 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 113.965 -1.47 . . . . 1.8500000000000001 111.08 174.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.88 -6.57 23.88 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.495 -0.86 . . . . 0.92000000000000004 112.319 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.513 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -91.82 -176.99 42.58 Favored Glycine 0 CA--C 1.5 -0.888 0 C-N-CA 120.914 -0.66 . . . . 0.98999999999999999 111.7 177.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.646 ' O ' HG13 ' A' ' 18' ' ' ILE . 65.6 Cg_endo -71.89 -25.83 19.49 Favored 'Trans proline' 0 CA--C 1.509 -0.738 0 C-N-CA 122.94 2.427 . . . . 0.44 113.097 -168.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.61 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -67.93 -25.9 65.7 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.034 -0.985 . . . . 0.35999999999999999 110.873 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -74.67 -32.47 62.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.934 0.874 . . . . 1.79 109.002 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.513 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -71.65 -44.47 69.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.477 -1.238 . . . . 0.51000000000000001 110.549 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.772 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -75.3 -23.09 57.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.091 -0.504 . . . . 0.40999999999999998 110.556 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.91 70.29 1.08 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.001 -1.095 . . . . 0.45000000000000001 113.315 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.67 HD21 HG21 ' A' ' 57' ' ' VAL . 16.7 tp -112.17 155.24 24.28 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.25 -0.648 . . . . 0.89000000000000001 109.25 174.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.426 HE22 ' HD2' ' A' ' 111' ' ' ARG . 0.5 OUTLIER -132.51 35.61 3.62 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 115.193 1.553 . . . . 1.21 115.193 -165.718 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.546 HG23 ' HA ' ' A' ' 59' ' ' ARG . 4.4 mp 68.89 -7.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 N-CA-C 113.793 1.034 . . . . 0.77000000000000002 113.793 165.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.49 52.63 0.35 Allowed Glycine 0 CA--C 1.509 -0.311 0 C-N-CA 119.903 -1.141 . . . . 0.37 112.108 -170.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.807 ' H ' HG12 ' A' ' 57' ' ' VAL . 40.7 m-20 -119.75 132.17 55.56 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.341 -0.43 . . . . 0.89000000000000001 111.387 -168.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.67 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 10.8 mmmm -82.16 100.67 9.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.338 0.59 . . . . 2.2000000000000002 110.466 -174.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.637 ' HB ' HG22 ' A' ' 55' ' ' ILE . 5.6 mt -73.64 123.38 28.62 Favored 'Isoleucine or valine' 0 C--O 1.261 1.674 0 CA-C-N 115.546 -0.752 . . . . 0.48999999999999999 111.664 -176.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.796 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 10.6 mmt -94.73 -11.88 28.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 125.572 1.795 . . . . 1.0600000000000001 113.075 177.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.52 ' HB3' ' CB ' ' A' ' 108' ' ' LEU . 2.6 tt0 -173.13 156.04 3.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.654 0.264 . . . . 0.81999999999999995 111.513 -175.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.8 p -145.36 122.93 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 121.415 0.626 . . . . 1.3100000000000001 110.352 174.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.48 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 1.1 m-80 60.04 21.31 10.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.231 -0.895 . . . . 1.5 112.181 178.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.94 -10.33 55.54 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.019 -1.086 . . . . 0.38 112.432 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.414 ' CD1' ' HB3' ' A' ' 96' ' ' ARG . 86.6 m95 -86.94 131.3 34.13 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 109.092 -0.707 . . . . 0.77000000000000002 109.092 176.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -85.09 115.73 23.06 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.747 -1.115 . . . . 1.8899999999999999 110.515 -174.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.707 ' HE3' ' HA ' ' A' ' 93' ' ' ALA . 23.2 mmt -106.66 101.12 10.59 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.097 -0.956 . . . . 1.01 111.134 -175.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.4 ' C ' ' HG3' ' A' ' 87' ' ' MET . 1.2 p -135.36 111.59 9.69 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.632 -1.167 . . . . 1.05 108.963 169.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.4 ' HG3' ' C ' ' A' ' 86' ' ' THR . 0.0 OUTLIER 44.96 65.69 1.04 Allowed 'General case' 0 C--N 1.33 -0.28 0 O-C-N 124.052 0.845 . . . . 1.6200000000000001 111.386 -176.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.7 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 3.8 p -129.71 166.48 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.146 -1.057 . . . . 1.0900000000000001 108.146 172.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.654 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 71.7 p -58.35 149.63 24.15 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.987 0.736 . . . . 0.34999999999999998 112.987 -175.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.81 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 19.0 t-160 -61.52 -35.71 78.5 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-O 121.499 0.666 . . . . 0.34999999999999998 109.508 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.48 ' CG ' HH12 ' A' ' 94' ' ' ARG . 0.6 OUTLIER -67.27 -31.46 71.8 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 113.992 -1.458 . . . . 1.6699999999999999 109.517 178.048 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.757 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 3.8 tp-100 -62.49 -51.65 66.59 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 108.965 -0.754 . . . . 0.77000000000000002 108.965 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.707 ' HA ' ' HE3' ' A' ' 85' ' ' MET . . . -72.62 -36.61 68.11 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.5 -0.773 . . . . 0.33000000000000002 110.195 -177.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.48 HH12 ' CG ' ' A' ' 91' ' ' ASP . 26.6 ttp-105 -67.01 -38.76 86.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.689 -0.687 . . . . 2.1000000000000001 110.694 -177.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.52 ' HE3' ' O ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -70.79 -45.89 63.84 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.302 -0.629 . . . . 0.95999999999999996 109.302 -178.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.757 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 25.2 mmt180 -67.71 -23.61 65.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.765 -0.652 . . . . 3.5699999999999998 110.175 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.529 HD11 ' CZ ' ' A' ' 31' ' ' PHE . 4.1 tt -77.14 -53.55 7.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.674 -0.694 . . . . 1.6499999999999999 110.985 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.5 m -90.97 90.23 7.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.92 0.867 . . . . 1.53 111.238 -169.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.606 ' HE2' ' O ' ' A' ' 96' ' ' ARG . 22.8 mtmt -133.85 110.11 9.53 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.023 -1.444 . . . . 2.7200000000000002 109.241 176.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.449 ' HD2' ' O ' ' A' ' 25' ' ' GLU . 17.9 ptt180 -76.56 36.5 0.16 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.268 0.556 . . . . 4.3799999999999999 110.833 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 99' ' ' LYS . 4.0 p -124.4 -58.92 1.5 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.774 -0.648 . . . . 2.5099999999999998 111.254 -176.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.22 147.84 42.93 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.084 0.468 . . . . 3.3999999999999999 111.549 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -84.0 -18.74 36.15 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.66 0.615 . . . . 2.6800000000000002 112.66 -172.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.68 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 6.9 p -144.01 145.36 21.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.775 0.321 . . . . 0.44 110.25 -171.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.9 t -114.84 118.46 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-O 122.502 1.144 . . . . 0.46000000000000002 111.914 -175.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.48 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -98.75 129.81 45.2 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 113.065 -1.88 . . . . 1.76 109.766 -178.308 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.442 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 26.2 tp -133.98 125.72 28.76 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 116.218 -0.446 . . . . 1.1200000000000001 110.097 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.796 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 14.6 tp -101.52 130.17 47.74 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.522 -1.288 . . . . 0.41999999999999998 107.522 176.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.709 HG13 ' HB3' ' A' ' 75' ' ' ASP . 2.2 t -131.83 140.12 48.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.998 0.904 . . . . 0.77000000000000002 111.018 -171.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.657 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -105.19 116.53 32.11 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.126 -0.943 . . . . 0.34000000000000002 109.759 163.523 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.687 ' HG2' HG23 ' A' ' 12' ' ' VAL . 1.5 ptt180 -114.35 140.46 48.63 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.175 -0.92 . . . . 2.0099999999999998 110.322 -170.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.513 HE22 ' HG2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -118.97 -41.52 2.76 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.034 0.921 . . . . 1.97 111.035 -170.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.528 ' H ' HD22 ' A' ' 114' ' ' LEU . 36.5 t -159.94 -128.84 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.029 -1.441 . . . . 1.6200000000000001 107.521 -169.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.528 HD22 ' H ' ' A' ' 113' ' ' SER . 0.2 OUTLIER 64.74 -0.22 1.02 Allowed 'General case' 0 C--N 1.323 -0.574 0 O-C-N 124.018 0.823 . . . . 1.6499999999999999 111.826 171.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -72.14 134.0 45.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.964 0.411 . . . . 3.5299999999999998 111.337 -174.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -120.84 106.05 11.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.847 -0.615 . . . . 3.6000000000000001 111.212 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 51.68 82.69 0.06 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.613 -0.721 . . . . 3.5600000000000001 111.951 178.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.545 HG13 ' HG2' ' A' ' 119' ' ' GLN . 11.3 p -113.84 -33.13 2.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.134 0.492 . . . . 4.9900000000000002 111.181 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.545 ' HG2' HG13 ' A' ' 118' ' ' VAL . 14.2 mm100 -107.01 16.7 23.94 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.031 -0.531 . . . . 7.7699999999999996 110.249 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -100.98 152.03 21.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.066 -0.515 . . . . 6.5999999999999996 111.242 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 41.7 t -73.61 136.59 43.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.805 -0.634 . . . . 8.9399999999999995 110.26 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -72.39 -43.44 63.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.965 0.412 . . . . 12.1 110.07 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 52.3 tp -98.63 132.05 44.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.871 -0.604 . . . . 12.82 110.107 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.9 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.587 -0.721 . . . . 14.640000000000001 109.352 177.787 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.771 ' HG3' ' H ' ' A' ' 2' ' ' SER . 35.2 tpp . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.308 -0.627 . . . . 14.33 109.308 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.771 ' H ' ' HG3' ' A' ' 1' ' ' MET . 4.3 p -60.06 -41.27 92.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.976 0.417 . . . . 11.220000000000001 111.288 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -98.6 108.77 21.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.991 -0.55 . . . . 9.1899999999999995 110.313 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.481 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 69.4 mt -121.23 127.79 26.0 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.46 -0.336 . . . . 6.6500000000000004 110.105 174.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 4' ' ' ILE . 15.7 Cg_exo -70.54 37.81 0.29 Allowed 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 123.187 2.592 . . . . 7.46 112.054 176.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 4' ' ' ILE . . . -169.51 -45.3 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 121.045 -0.598 . . . . 5.8899999999999997 112.75 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.411 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 7.6 pt20 -151.83 66.46 6.78 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 113.989 1.107 . . . . 6.3700000000000001 113.989 -174.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.432 ' HG3' ' H ' ' A' ' 4' ' ' ILE . 20.7 Cg_exo -66.81 -148.46 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.697 2.265 . . . . 3.3999999999999999 111.886 165.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.7 m -80.61 -11.69 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 121.42 0.629 . . . . 2.2599999999999998 109.456 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.2 m -80.27 80.52 6.69 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.307 1.051 . . . . 2.0899999999999999 109.181 173.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.31 179.17 7.97 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.159 -1.837 . . . . 0.95999999999999996 111.791 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.8 t -105.77 121.56 58.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.262 -0.881 . . . . 1.5700000000000001 110.531 -176.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.609 HG22 HG23 ' A' ' 110' ' ' THR . 38.6 t -77.98 120.7 29.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.85 0.357 . . . . 1.02 110.968 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.924 HE22 HG23 ' A' ' 16' ' ' VAL . 3.7 pp0? -121.08 167.52 12.54 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.015 -0.539 . . . . 1.3899999999999999 111.289 -178.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.587 ' HD3' ' O ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -124.12 113.6 18.57 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.676 0.391 . . . . 3.6299999999999999 111.492 -175.778 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.924 HG23 HE22 ' A' ' 14' ' ' GLN . 2.2 t -98.16 130.76 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.753 -0.462 . . . . 1.02 109.753 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -142.51 117.81 10.19 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 110.119 -0.326 . . . . 1.3500000000000001 110.119 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 11.2 tp -140.27 144.62 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 108.64 -0.874 . . . . 0.60999999999999999 108.64 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.8 m-70 -77.03 111.09 12.23 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.248 -0.581 . . . . 0.59999999999999998 109.772 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.504 ' HD2' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -23.77 136.64 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 O-C-N 125.433 1.708 . . . . 4.0 113.464 -179.425 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.1 tp -96.46 92.74 6.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.857 0.837 . . . . 0.55000000000000004 109.96 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HD3' ' H ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -65.3 135.93 55.94 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.186 -1.37 . . . . 3.9700000000000002 111.275 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.406 ' HB2' HD13 ' A' ' 28' ' ' ILE . 2.1 tp-100 -138.39 93.97 2.8 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.115 -0.698 . . . . 1.3500000000000001 109.115 173.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 60.59 -86.7 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.909 -0.663 . . . . 1.3300000000000001 111.621 -174.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -131.89 12.07 4.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.261 0.553 . . . . 2.3300000000000001 110.335 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -111.42 154.91 23.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.599 -0.728 . . . . 1.8700000000000001 109.047 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.0 mp -120.8 122.13 39.66 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.431 -0.581 . . . . 2.2799999999999998 109.431 174.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.406 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.8 mp -98.19 121.29 48.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 115.266 -0.879 . . . . 0.80000000000000004 109.456 -177.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.651 ' HB2' ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -89.72 -27.99 19.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.772 -1.103 . . . . 1.74 110.77 179.272 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.519 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 82.68 17.53 67.96 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.237 -0.982 . . . . 0.68999999999999995 113.381 175.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.651 ' CE2' ' HB2' ' A' ' 29' ' ' LEU . 44.5 p90 -148.94 159.68 43.97 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.496 -0.557 . . . . 0.51000000000000001 109.496 172.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.7 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -102.33 161.93 13.31 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 118.625 -1.23 . . . . 0.53000000000000003 107.893 175.213 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -151.22 135.94 9.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 C-N-CA 119.672 -0.811 . . . . 0.48999999999999999 112.658 -167.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.6 ' O ' ' HD1' ' A' ' 56' ' ' TYR . . . -147.41 117.2 0.89 Allowed Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.163 -1.175 . . . . 0.71999999999999997 110.163 156.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 1.074 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.72 118.62 1.35 Allowed Glycine 0 CA--C 1.489 -1.589 0 CA-C-O 118.464 -1.186 . . . . 1.4199999999999999 110.806 173.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.705 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.9 135.8 3.84 Favored Glycine 0 C--N 1.299 -1.525 0 C-N-CA 117.188 -2.434 . . . . 0.47999999999999998 113.712 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.554 HG23 ' HB2' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -57.69 -26.58 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 107.541 -1.281 . . . . 0.52000000000000002 107.541 150.062 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.818 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 0.5 OUTLIER -57.69 -39.98 78.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 113.446 -1.706 . . . . 0.71999999999999997 110.435 171.075 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -62.61 -61.38 2.47 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.266 -0.879 . . . . 1.1899999999999999 110.721 -172.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -179.1 113.27 0.21 Allowed Pre-proline 0 N--CA 1.467 0.385 0 O-C-N 123.394 0.434 . . . . 2.5699999999999998 110.129 172.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.804 ' HA ' ' HD2' ' A' ' 53' ' ' LYS . 72.6 Cg_endo -77.09 -16.32 15.84 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.701 2.267 . . . . 2.8199999999999998 113.082 -178.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.3 t -94.13 10.53 33.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.915 0.388 . . . . 3.2599999999999998 111.232 -170.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -88.38 -19.04 27.15 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.976 0.732 . . . . 3.8799999999999999 112.976 -176.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -174.57 65.65 0.27 Allowed Pre-proline 0 N--CA 1.454 -0.266 0 N-CA-C 108.933 -0.765 . . . . 5.1399999999999997 108.933 -167.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -87.2 14.68 2.35 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.578 2.852 . . . . 3.71 112.499 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -111.82 5.43 19.03 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.045 -0.525 . . . . 5.6200000000000001 109.709 177.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.592 ' HB3' ' OG1' ' A' ' 51' ' ' THR . 74.5 m -125.4 129.85 50.71 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 115.858 -0.61 . . . . 3.77 110.492 -175.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.958 ' HA ' ' HB2' ' A' ' 52' ' ' ASP . 37.9 tt0 -111.1 -41.07 4.29 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.25 -1.341 . . . . 6.7800000000000002 109.565 176.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.602 ' O ' ' HD3' ' A' ' 50' ' ' LYS . 1.2 m-20 -38.57 -87.64 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 111.629 -2.532 . . . . 5.4699999999999998 112.225 -154.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.623 ' HE3' HG21 ' A' ' 110' ' ' THR . 53.2 mmtt -119.99 7.93 10.96 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 106.114 -1.81 . . . . 3.0699999999999998 106.114 163.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.592 ' OG1' ' HB3' ' A' ' 47' ' ' SER . 20.5 p -109.65 -11.59 14.74 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 112.895 -1.957 . . . . 4.5599999999999996 111.735 -165.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.958 ' HB2' ' HA ' ' A' ' 48' ' ' GLU . 32.4 t0 -59.32 -173.38 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.715 -0.394 . . . . 2.6000000000000001 111.195 166.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.804 ' HD2' ' HA ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -76.13 66.47 2.28 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.204 0.526 . . . . 3.48 110.946 -173.203 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.89 -159.83 33.68 Favored Glycine 0 N--CA 1.437 -1.259 0 CA-C-N 115.292 -0.867 . . . . 0.78000000000000003 111.064 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.074 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -110.15 145.93 16.05 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.738 0 N-CA-C 108.791 -0.818 . . . . 0.54000000000000004 108.791 175.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.6 ' HD1' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -140.0 147.39 40.34 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 119.235 0.925 . . . . 1.4199999999999999 110.281 -176.453 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.651 HG12 ' H ' ' A' ' 75' ' ' ASP . 7.1 p -94.18 135.72 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 CA-C-N 115.14 -0.936 . . . . 0.57999999999999996 109.796 175.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.7 ' O ' ' HB3' ' A' ' 32' ' ' SER . 21.4 m -128.32 68.49 1.36 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.765 -1.107 . . . . 1.1100000000000001 109.198 176.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.614 ' HA ' HG23 ' A' ' 73' ' ' ILE . 34.0 mtm180 150.06 -179.95 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 125.512 1.525 . . . . 2.27 110.397 163.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.423 ' N ' HG12 ' A' ' 73' ' ' ILE . 40.1 t -163.55 134.77 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 O-C-N 125.542 1.776 . . . . 0.82999999999999996 107.561 163.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.405 ' O ' HG12 ' A' ' 60' ' ' VAL . 19.2 p -77.59 169.44 18.29 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.633 0.73 . . . . 1.6499999999999999 111.031 175.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -103.43 128.43 50.58 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 114.783 -1.099 . . . . 1.8500000000000001 110.198 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.68 -5.42 52.4 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.324 -0.853 . . . . 0.92000000000000004 113.564 173.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.503 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -76.24 -129.13 0.31 Allowed Glycine 0 CA--C 1.506 -0.525 0 C-N-CA 120.35 -0.929 . . . . 0.98999999999999999 112.564 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.519 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 69.6 Cg_endo -102.76 -50.43 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 122.706 2.271 . . . . 0.44 115.572 177.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.529 ' HB2' ' O ' ' A' ' 29' ' ' LEU . . . -57.23 -32.43 66.52 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.534 0.938 . . . . 0.35999999999999999 113.534 -172.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -74.46 -28.65 61.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.596 0.712 . . . . 1.79 109.418 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.4 mp -74.32 -34.99 38.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.886 -1.052 . . . . 0.51000000000000001 109.648 -178.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.687 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -77.82 -23.01 49.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.574 -0.739 . . . . 0.40999999999999998 110.358 175.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.67 56.05 0.92 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.466 -0.873 . . . . 0.45000000000000001 114.132 175.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.682 ' HG ' HG21 ' A' ' 16' ' ' VAL . 2.2 mt -100.56 158.52 15.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 117.302 0.551 . . . . 0.89000000000000001 110.722 174.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 1.034 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 29.0 mt-30 -130.33 25.31 5.16 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 114.868 1.433 . . . . 1.21 114.868 -165.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.614 HG23 ' HA ' ' A' ' 59' ' ' ARG . 91.1 mt 72.95 -10.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 113.95 1.092 . . . . 0.77000000000000002 113.95 168.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.62 60.58 0.24 Allowed Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.436 -0.888 . . . . 0.37 111.974 -166.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.651 ' H ' HG12 ' A' ' 57' ' ' VAL . 36.6 m-20 -122.59 156.1 34.93 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.078 -0.561 . . . . 0.89000000000000001 110.376 -170.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.488 ' HG3' ' HD2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -104.39 102.02 11.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.314 0.578 . . . . 2.2000000000000002 109.546 -175.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 1.045 HG13 HG23 ' A' ' 109' ' ' VAL . 3.6 mp -74.71 125.37 34.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.491 -0.777 . . . . 0.48999999999999999 112.311 -171.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.906 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 3.0 mmt -92.1 -18.41 23.6 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 125.607 1.817 . . . . 1.0600000000000001 112.184 177.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.604 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -173.01 155.43 3.04 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.759 0.281 . . . . 0.81999999999999995 111.759 -175.306 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.44 ' N ' ' HG3' ' A' ' 79' ' ' GLN . 11.7 p -142.35 126.9 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 121.291 0.567 . . . . 1.3100000000000001 110.516 173.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.725 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 1.1 m-80 56.95 27.65 13.48 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.426 -0.806 . . . . 1.5 112.378 176.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.53 -11.1 63.14 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.122 -1.037 . . . . 0.38 112.605 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.42 ' CE2' ' HD2' ' A' ' 96' ' ' ARG . 80.9 m95 -83.91 160.16 21.15 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 108.696 -0.853 . . . . 0.77000000000000002 108.696 176.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -111.0 113.36 25.86 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.292 0.568 . . . . 1.8899999999999999 111.858 -171.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.541 ' HG3' HG11 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -109.1 102.46 11.43 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.723 -0.671 . . . . 1.01 111.58 -178.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.44 -50.93 2.31 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.262 -1.014 . . . . 1.05 108.262 168.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -135.38 86.99 2.29 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.549 -1.66 . . . . 1.6200000000000001 106.807 172.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.705 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 1.4 t -137.27 138.17 45.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.022 -0.99 . . . . 1.0900000000000001 109.754 -172.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.818 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 70.4 p -57.87 147.56 28.24 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 122.159 -0.338 . . . . 0.34999999999999998 111.609 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.809 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 19.8 t-160 -56.6 -40.63 75.64 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.312 0.577 . . . . 0.34999999999999998 110.175 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.25 -30.45 68.58 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.455 -1.248 . . . . 1.6699999999999999 110.042 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.769 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 2.3 tp-100 -63.48 -50.92 67.76 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.122 -1.066 . . . . 0.77000000000000002 108.122 178.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.615 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -70.81 -32.72 69.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.532 -0.758 . . . . 0.33000000000000002 110.856 -177.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -70.51 -40.04 73.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.067 -0.515 . . . . 2.1000000000000001 110.666 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.416 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -70.27 -41.26 73.69 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.259 -0.645 . . . . 0.95999999999999996 109.259 -178.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.769 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 21.9 mmt180 -71.33 -21.44 62.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.28 -0.873 . . . . 3.5699999999999998 110.67 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.536 HD11 ' CZ ' ' A' ' 31' ' ' PHE . 2.4 tt -70.99 -58.22 3.79 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.938 -0.574 . . . . 1.6499999999999999 110.443 175.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 m -100.71 90.04 4.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.599 0.714 . . . . 1.53 111.862 -171.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.709 ' HE2' ' O ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -110.42 118.19 35.6 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.766 -1.106 . . . . 2.7200000000000002 109.34 170.476 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -68.54 31.62 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.989 0.515 . . . . 4.3799999999999999 111.614 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 99' ' ' LYS . 14.2 m -139.07 -27.82 0.8 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.292 -0.413 . . . . 2.5099999999999998 110.997 -173.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.535 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 66.3 mm-40 -67.13 143.1 56.82 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 110.165 -0.309 . . . . 3.3999999999999999 110.165 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -94.27 -10.02 34.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.391 0.615 . . . . 2.6800000000000002 109.985 176.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.696 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 6.2 p -152.32 148.42 14.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.482 -0.781 . . . . 0.44 109.482 -175.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.583 HG13 HD21 ' A' ' 81' ' ' ASN . 55.5 t -117.04 117.94 57.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 122.051 0.929 . . . . 0.46000000000000002 111.53 -177.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.725 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.2 OUTLIER -99.29 133.02 44.19 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 113.426 -1.716 . . . . 1.76 110.305 -175.432 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.66 HD22 HD11 ' A' ' 71' ' ' LEU . 22.2 tp -134.63 134.69 41.49 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.541 -0.3 . . . . 1.1200000000000001 110.901 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.906 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 40.0 tp -115.53 114.3 24.79 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 106.843 -1.54 . . . . 0.41999999999999998 106.843 172.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 1.045 HG23 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -129.4 149.9 34.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 120.122 -0.631 . . . . 0.77000000000000002 110.488 -171.545 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.623 HG21 ' HE3' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -97.65 115.62 28.28 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.637 0.732 . . . . 0.34000000000000002 109.898 171.456 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.896 ' HB2' HE22 ' A' ' 72' ' ' GLN . 0.3 OUTLIER -99.61 136.71 39.13 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.006 -1.452 . . . . 2.0099999999999998 109.596 -173.231 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.522 ' N ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -106.57 -56.99 2.11 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.104 -1.038 . . . . 1.97 112.762 -177.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.44 ' H ' HD22 ' A' ' 114' ' ' LEU . 23.2 t -174.95 27.83 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.609 -0.436 . . . . 1.6200000000000001 112.125 -175.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 1.034 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -99.38 22.82 10.1 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.913 -0.492 . . . . 1.6499999999999999 110.583 -175.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.52 124.48 21.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.633 0.254 . . . . 3.5299999999999998 111.239 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -82.48 36.35 0.48 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.306 -0.406 . . . . 3.6000000000000001 110.874 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 57.57 33.58 23.44 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.18 0.514 . . . . 3.5600000000000001 109.862 -172.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.9 p -66.55 -28.13 42.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 114.882 -1.054 . . . . 4.9900000000000002 112.747 -171.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -138.08 -40.18 0.54 Allowed 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.889 -0.324 . . . . 7.7699999999999996 110.826 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 65.51 -165.59 0.23 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.575 0.547 . . . . 6.5999999999999996 110.409 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.4 m 63.45 34.22 13.01 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.089 0.471 . . . . 8.9399999999999995 111.063 177.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 72.4 mmm -73.37 115.03 12.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.035 -0.529 . . . . 12.1 111.376 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 pp -92.8 -171.92 2.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.897 -0.592 . . . . 12.82 110.67 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.572 -0.728 . . . . 14.640000000000001 110.475 179.303 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtm . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 109.922 -0.399 . . . . 14.33 109.922 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.7 m -73.83 -47.83 35.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.159 0.504 . . . . 11.220000000000001 110.268 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -88.0 118.75 27.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.894 -0.594 . . . . 9.1899999999999995 110.569 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.965 ' H ' ' HB3' ' A' ' 8' ' ' PRO . 63.3 mt -107.69 130.24 23.09 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 115.619 -0.718 . . . . 6.6500000000000004 109.53 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 4' ' ' ILE . 16.8 Cg_exo -68.24 67.65 1.01 Allowed 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.442 2.095 . . . . 7.46 112.254 177.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 148.34 -41.55 0.89 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.453 -0.88 . . . . 5.8899999999999997 113.763 176.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.41 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 3.5 pt20 -144.13 50.36 1.25 Allowed Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 114.384 1.253 . . . . 6.3700000000000001 114.384 -171.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.965 ' HB3' ' H ' ' A' ' 4' ' ' ILE . 95.2 Cg_endo -85.17 108.05 1.1 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.561 2.174 . . . . 3.3999999999999999 111.778 173.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 8' ' ' PRO . 73.5 t 71.09 -52.62 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 122.672 0.389 . . . . 2.2599999999999998 111.052 -176.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.3 m -71.12 82.74 0.71 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.731 0.777 . . . . 2.0899999999999999 109.56 175.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.19 170.81 9.42 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.091 -1.413 . . . . 0.95999999999999996 111.084 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.9 m -111.4 161.89 9.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.936 -1.029 . . . . 1.5700000000000001 109.084 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.571 HG22 HG23 ' A' ' 110' ' ' THR . 94.6 t -106.55 119.99 56.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.267 0.556 . . . . 1.02 111.388 -176.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.993 HE22 HG13 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -111.47 155.49 23.14 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.507 0.67 . . . . 1.3899999999999999 111.035 174.724 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.06 110.65 13.17 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.754 -0.657 . . . . 3.6299999999999999 110.156 -172.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.065 ' HB ' ' HB1' ' A' ' 69' ' ' ALA . 12.7 m -106.29 149.58 9.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 119.434 -0.907 . . . . 1.02 110.325 176.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -145.23 121.37 10.8 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.005 -0.543 . . . . 1.3500000000000001 109.953 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.543 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 10.9 tp -142.34 143.64 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 108.256 -1.016 . . . . 0.60999999999999999 108.256 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.834 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.0 m-70 -74.96 117.67 17.06 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.307 -0.557 . . . . 0.59999999999999998 109.528 -176.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.562 ' HD3' ' HG ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -29.47 127.16 0.11 Allowed 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.776 1.297 . . . . 4.0 111.256 177.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.416 ' HB3' ' HB ' ' A' ' 28' ' ' ILE . 45.6 tp -98.05 101.74 13.3 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.252 0.548 . . . . 0.55000000000000004 110.478 -173.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -69.43 135.49 50.31 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.371 0.605 . . . . 3.9700000000000002 111.366 -176.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -128.86 93.59 3.64 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.433 -0.951 . . . . 1.3500000000000001 108.433 174.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.21 -87.94 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.772 -0.931 . . . . 1.3300000000000001 110.772 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.52 14.34 4.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.324 0.583 . . . . 2.3300000000000001 110.776 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -108.98 159.76 16.56 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.682 -0.69 . . . . 1.8700000000000001 109.492 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.562 ' HG ' ' HD3' ' A' ' 20' ' ' LYS . 9.0 mp -112.77 119.18 37.14 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 109.062 -0.718 . . . . 2.2799999999999998 109.062 174.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 21' ' ' LEU . 40.5 mm -98.73 109.55 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 115.415 -0.811 . . . . 0.80000000000000004 109.981 -176.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.576 HD13 HD13 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -83.93 -25.61 29.98 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.463 -1.244 . . . . 1.74 109.088 175.355 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.442 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . 93.67 -27.11 13.14 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.119 -0.946 . . . . 0.68999999999999995 112.673 174.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.631 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 32.8 p90 -110.43 151.32 27.65 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 122.291 -0.535 . . . . 0.51000000000000001 111.384 -173.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.545 ' H ' ' HB2' ' A' ' 59' ' ' ARG . 10.2 t -101.82 158.43 16.13 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 107.578 -1.267 . . . . 0.53000000000000003 107.578 175.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.407 HG12 ' N ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -160.19 143.04 4.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 C-N-CA 120.158 -0.617 . . . . 0.48999999999999999 112.529 -163.739 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.447 ' HA2' ' CD2' ' A' ' 90' ' ' HIS . . . -139.51 118.28 1.48 Allowed Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 110.007 -1.237 . . . . 0.71999999999999997 110.007 154.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 1.029 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.39 119.06 1.43 Allowed Glycine 0 CA--C 1.491 -1.419 0 CA-C-O 118.518 -1.157 . . . . 1.4199999999999999 111.42 172.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.671 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.29 146.49 10.78 Favored Glycine 0 C--N 1.303 -1.3 0 C-N-CA 117.304 -2.379 . . . . 0.47999999999999998 113.1 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.471 HG12 ' N ' ' A' ' 88' ' ' VAL . 1.1 pt -68.43 -19.74 24.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 107.562 -1.273 . . . . 0.52000000000000002 107.562 151.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.774 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 2.5 t70 -58.8 -36.6 74.75 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.026 -1.443 . . . . 0.71999999999999997 109.541 168.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -70.75 -43.78 68.12 Favored 'General case' 0 C--N 1.338 0.067 0 CA-C-N 114.73 -1.123 . . . . 1.1899999999999999 109.793 -176.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.467 ' HB3' HE21 ' A' ' 43' ' ' GLN . 12.9 m-20 -127.93 91.56 44.6 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.984 -0.553 . . . . 2.5699999999999998 110.451 176.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.09 -17.3 50.73 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.538 2.159 . . . . 2.8199999999999998 110.891 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.9 t -74.7 -40.81 61.12 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.327 -0.851 . . . . 3.2599999999999998 109.296 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.467 HE21 ' HB3' ' A' ' 40' ' ' ASP . 2.5 mp0 -99.93 73.59 1.76 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.671 0.748 . . . . 3.8799999999999999 109.85 178.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.602 ' H ' ' CD ' ' A' ' 45' ' ' PRO . 25.0 t30 -132.41 -38.51 0.03 OUTLIER Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 114.539 -1.21 . . . . 5.1399999999999997 109.074 175.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.602 ' CD ' ' H ' ' A' ' 44' ' ' ASN . 23.1 Cg_exo -71.33 6.82 1.68 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 121.517 1.478 . . . . 3.71 110.52 161.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.457 ' H ' ' C ' ' A' ' 44' ' ' ASN . 66.8 t80 -107.88 -26.2 10.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.976 -1.011 . . . . 5.6200000000000001 109.807 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.675 ' HA ' ' HB2' ' A' ' 52' ' ' ASP . 34.7 p -71.61 97.47 1.71 Allowed 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 122.507 1.146 . . . . 3.77 110.111 -174.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -99.66 -37.69 9.02 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 113.038 -1.892 . . . . 6.7800000000000002 109.663 -175.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -176.41 -151.04 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 112.882 -1.963 . . . . 5.4699999999999998 107.428 -160.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.534 ' HA ' ' HD2' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -79.51 8.17 6.85 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 120.616 -0.434 . . . . 3.0699999999999998 111.931 172.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.6 t -72.23 -34.66 68.48 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.742 -0.836 . . . . 4.5599999999999996 108.742 171.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.675 ' HB2' ' HA ' ' A' ' 47' ' ' SER . 8.3 t70 -70.01 -170.04 0.31 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.54 -0.755 . . . . 2.6000000000000001 110.036 166.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.455 ' HD2' ' H ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -95.9 -41.23 8.91 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.518 -0.31 . . . . 3.48 110.712 175.169 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.455 ' H ' ' HD2' ' A' ' 53' ' ' LYS . . . 74.09 -133.18 16.27 Favored Glycine 0 C--O 1.241 0.567 0 C-N-CA 120.941 -0.647 . . . . 0.78000000000000003 111.613 -179.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.029 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -111.32 143.89 20.28 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 N-CA-C 106.846 -1.539 . . . . 0.54000000000000004 106.846 172.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.767 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -154.96 148.35 25.11 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 120.155 1.343 . . . . 1.4199999999999999 112.039 -178.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.842 HG12 ' H ' ' A' ' 75' ' ' ASP . 1.5 p -87.49 136.68 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-N 114.529 -1.214 . . . . 0.57999999999999996 110.421 -175.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.2 m -105.34 -11.97 16.25 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.116 -0.947 . . . . 1.1100000000000001 110.697 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.897 ' HA ' HG23 ' A' ' 73' ' ' ILE . 41.3 mtt180 -145.54 -170.11 3.38 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.083 0.771 . . . . 2.27 113.083 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 59' ' ' ARG . 53.2 t -170.33 146.37 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.37 1.868 . . . . 0.82999999999999996 106.627 167.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.4 p -97.48 123.49 41.36 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.674 0.75 . . . . 1.6499999999999999 112.088 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -66.0 112.34 3.79 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 113.658 -1.61 . . . . 1.8500000000000001 110.359 169.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.76 -3.03 48.91 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.164 -0.925 . . . . 0.92000000000000004 112.634 -177.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.566 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -91.52 -139.66 8.63 Favored Glycine 0 CA--C 1.501 -0.835 0 C-N-CA 120.367 -0.921 . . . . 0.98999999999999999 111.785 178.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.523 ' HB2' HG21 ' A' ' 18' ' ' ILE . 77.6 Cg_endo -102.07 -50.07 0.01 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 122.73 2.287 . . . . 0.44 114.959 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.631 ' HB2' ' HD2' ' A' ' 31' ' ' PHE . . . -50.45 -29.46 10.38 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.589 0.959 . . . . 0.35999999999999999 113.589 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -71.46 -32.22 68.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.745 0.784 . . . . 1.79 109.463 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.566 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.5 mp -79.08 -36.54 18.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.444 -1.253 . . . . 0.51000000000000001 108.516 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.065 ' HB1' ' HB ' ' A' ' 16' ' ' VAL . . . -66.17 -35.11 79.6 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.409 -1.268 . . . . 0.40999999999999998 109.91 173.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.43 33.15 2.77 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.223 -0.989 . . . . 0.45000000000000001 114.233 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.453 HD21 HG21 ' A' ' 57' ' ' VAL . 17.8 tp -90.66 154.79 19.31 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.466 -0.568 . . . . 0.89000000000000001 109.466 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.491 HE22 ' HG3' ' A' ' 111' ' ' ARG . 4.6 mt-30 -129.34 31.89 4.76 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 115.449 1.648 . . . . 1.21 115.449 -165.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.897 HG23 ' HA ' ' A' ' 59' ' ' ARG . 58.1 mt 71.33 2.1 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 CA-C-N 118.993 0.815 . . . . 0.77000000000000002 113.188 167.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.17 46.19 0.25 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 119.58 -1.295 . . . . 0.37 112.439 -170.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.842 ' H ' HG12 ' A' ' 57' ' ' VAL . 20.0 m-20 -119.83 142.31 48.74 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.331 -0.435 . . . . 0.89000000000000001 110.864 -169.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.767 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 13.0 mptt -96.68 102.64 14.46 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.803 0.811 . . . . 2.2000000000000002 111.0 -171.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.823 HG13 HG23 ' A' ' 109' ' ' VAL . 2.8 mp -63.05 123.42 15.78 Favored 'Isoleucine or valine' 0 C--O 1.255 1.342 0 CA-C-N 115.274 -0.876 . . . . 0.48999999999999999 112.505 -178.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.9 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 2.0 mmt -91.74 -18.99 23.09 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 113.494 -1.685 . . . . 1.0600000000000001 111.281 173.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.617 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 4.3 tt0 -172.03 151.53 2.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.071 -0.513 . . . . 0.81999999999999995 111.876 -174.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.776 HG12 ' HE1' ' A' ' 85' ' ' MET . 9.8 p -145.53 127.21 8.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.729 -0.669 . . . . 1.3100000000000001 109.735 173.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 58.44 20.0 7.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.75 -0.659 . . . . 1.5 111.874 178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.69 -7.86 53.88 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 119.733 -1.222 . . . . 0.38 113.368 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 68.0 m95 -85.21 159.85 20.02 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 117.451 0.626 . . . . 0.77000000000000002 110.014 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -102.46 113.72 27.3 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.668 -0.696 . . . . 1.8899999999999999 111.454 -172.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.776 ' HE1' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -104.57 100.58 10.25 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 122.667 1.222 . . . . 1.01 110.116 179.219 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.6 p -142.16 -49.9 0.38 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 112.854 -1.975 . . . . 1.05 105.83 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.415 ' HA ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -133.97 75.15 1.58 Allowed 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 112.178 -2.283 . . . . 1.6200000000000001 108.828 173.4 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.758 ' O ' HD11 ' A' ' 55' ' ' ILE . 1.2 t -132.72 138.55 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 108.007 -1.108 . . . . 1.0900000000000001 108.007 177.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.719 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 68.8 p -59.5 152.16 22.48 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.884 -0.51 . . . . 0.34999999999999998 112.018 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.81 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 16.5 t-160 -57.25 -38.0 73.19 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-O 122.516 1.15 . . . . 0.34999999999999998 109.925 -177.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.402 ' OD1' ' HB ' ' A' ' 89' ' ' THR . 5.1 p-10 -71.66 -31.78 67.18 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 112.79 -2.005 . . . . 1.6699999999999999 109.889 -177.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.717 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.5 OUTLIER -65.55 -39.15 91.38 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 108.158 -1.053 . . . . 0.77000000000000002 108.158 179.842 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.594 ' HB2' HG12 ' A' ' 55' ' ' ILE . . . -74.75 -41.6 59.78 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.439 -1.255 . . . . 0.33000000000000002 109.793 -176.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -68.22 -37.79 81.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.287 -0.869 . . . . 2.1000000000000001 110.661 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.504 ' HD3' ' HD2' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -70.97 -30.09 66.26 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.012 0.434 . . . . 0.95999999999999996 109.844 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.717 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 9.4 mmm180 -76.23 -24.35 54.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.223 -0.444 . . . . 3.5699999999999998 111.881 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.576 HD13 HD13 ' A' ' 29' ' ' LEU . 3.3 pp -96.92 -8.26 31.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.236 0.458 . . . . 1.6499999999999999 112.236 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.55 HG23 ' HB2' ' A' ' 27' ' ' LEU . 31.5 m -145.02 97.6 3.04 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.183 0.516 . . . . 1.53 111.225 174.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.482 ' HG3' ' HB2' ' A' ' 101' ' ' SER . 5.2 ptpp? -142.56 9.7 1.81 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.592 -0.731 . . . . 2.7200000000000002 112.403 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 39.4 mtm-85 63.96 24.15 13.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.61 -0.723 . . . . 4.3799999999999999 110.886 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.482 ' HB2' ' HG3' ' A' ' 99' ' ' LYS . 69.8 m -153.63 83.95 1.17 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.335 0.588 . . . . 2.5099999999999998 110.46 -178.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.444 ' C ' ' H ' ' A' ' 104' ' ' VAL . 1.2 pm0 -163.0 -44.74 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.538 -0.755 . . . . 3.3999999999999999 110.085 178.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 71.76 -41.97 0.52 Allowed 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.34 1.025 . . . . 2.6800000000000002 111.045 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.834 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 2.7 p -133.33 133.4 57.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.351 -1.352 . . . . 0.44 107.351 176.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 53.3 t -109.85 119.37 58.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 122.151 0.976 . . . . 0.46000000000000002 112.198 -171.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.93 123.05 41.74 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 113.397 -1.729 . . . . 1.76 109.803 -176.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.509 HD11 HG12 ' A' ' 77' ' ' ILE . 11.1 tp -131.42 116.76 17.93 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.656 -0.702 . . . . 1.1200000000000001 111.171 -173.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.881 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 41.0 tp -104.31 117.87 35.24 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.611 -1.255 . . . . 0.41999999999999998 107.611 177.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.823 HG23 HG13 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -131.35 152.4 37.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-O 121.38 0.61 . . . . 0.77000000000000002 110.803 -173.092 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.571 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -97.53 117.21 31.28 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.721 -0.672 . . . . 0.34000000000000002 110.321 171.429 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.644 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 30.7 ttt180 -97.76 136.48 38.03 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.597 -1.183 . . . . 2.0099999999999998 110.375 -177.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.437 ' N ' ' CD ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -123.02 -70.61 0.76 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.753 0.649 . . . . 1.97 112.753 -174.181 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.669 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 0.5 OUTLIER -153.09 27.79 0.52 Allowed 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.266 -0.574 . . . . 1.6200000000000001 112.418 -170.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 114' ' ' LEU . 2.3 mm? -107.01 26.96 9.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.485 0.66 . . . . 1.6499999999999999 110.11 177.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.669 ' NE2' ' HA ' ' A' ' 113' ' ' SER . 0.7 OUTLIER -87.92 17.88 4.57 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.163 -0.926 . . . . 3.5299999999999998 111.928 -174.721 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt 69.61 156.15 0.14 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 123.839 0.712 . . . . 3.6000000000000001 111.284 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 65.91 14.5 9.61 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.829 -0.623 . . . . 3.5600000000000001 112.341 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.574 HG21 HE21 ' A' ' 115' ' ' GLN . 57.1 t -107.38 -27.48 2.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.688 0.756 . . . . 4.9900000000000002 110.18 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.69 -15.14 57.29 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.941 -1.027 . . . . 7.7699999999999996 110.207 -176.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -97.42 117.35 31.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.844 -0.616 . . . . 6.5999999999999996 110.538 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.7 m -106.36 -18.93 13.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.104 -0.498 . . . . 8.9399999999999995 111.002 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 25.6 ptm -166.81 164.49 16.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.271 -0.422 . . . . 12.1 110.554 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 29.9 tp 62.07 91.72 0.06 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 124.108 0.88 . . . . 12.82 111.885 174.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.2 m . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.428 -0.796 . . . . 14.640000000000001 110.006 177.988 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptp . . . . . 0 N--CA 1.484 1.228 0 CA-C-O 120.876 0.369 . . . . 14.33 110.631 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.5 t -82.15 149.09 28.14 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.158 -0.682 . . . . 11.220000000000001 109.158 175.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -86.63 136.82 32.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.076 0.465 . . . . 9.1899999999999995 110.478 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.601 HD12 ' HD2' ' A' ' 8' ' ' PRO . 5.7 pt -114.49 99.37 51.24 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.597 -0.728 . . . . 6.6500000000000004 110.738 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -65.84 126.95 16.84 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.798 2.332 . . . . 7.46 111.908 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.41 -27.6 13.28 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.826 -0.702 . . . . 5.8899999999999997 111.905 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 64.92 100.08 0.04 OUTLIER Pre-proline 0 N--CA 1.462 0.17 0 CA-C-O 121.556 0.693 . . . . 6.3700000000000001 111.86 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.601 ' HD2' HD12 ' A' ' 4' ' ' ILE . 1.9 Cg_endo -83.62 -171.51 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.439 2.759 . . . . 3.3999999999999999 111.505 176.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.5 m -103.8 -3.13 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 109.658 -0.497 . . . . 2.2599999999999998 109.658 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.489 HG22 ' HB2' ' A' ' 8' ' ' PRO . 1.8 t -85.87 81.96 8.34 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 123.283 1.516 . . . . 2.0899999999999999 111.078 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.3 179.05 5.31 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 112.087 -2.324 . . . . 0.95999999999999996 109.758 173.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.17 108.41 25.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.328 -0.396 . . . . 1.5700000000000001 110.386 -174.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.709 HG22 HG23 ' A' ' 110' ' ' THR . 26.1 t -76.83 98.52 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.291 0.567 . . . . 1.02 110.203 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.992 HE22 HG23 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -103.3 165.02 11.28 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.68 -0.691 . . . . 1.3899999999999999 111.122 178.259 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.505 ' HD2' ' H ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -126.07 116.98 22.24 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.704 -0.623 . . . . 3.6299999999999999 110.987 -178.791 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.992 HG23 HE22 ' A' ' 14' ' ' GLN . 4.9 t -88.85 127.41 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 115.303 -0.862 . . . . 1.02 109.597 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 31.9 tt0 -131.03 116.99 18.52 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.437 -0.579 . . . . 1.3500000000000001 109.437 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 18' ' ' ILE . 10.1 tp -145.1 146.43 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 108.562 -0.903 . . . . 0.60999999999999999 108.562 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.754 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 12.3 m-70 -68.85 119.14 12.74 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.175 -0.676 . . . . 0.59999999999999998 109.175 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.869 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -37.44 133.41 0.73 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.944 0.778 . . . . 4.0 110.105 171.782 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.5 tp -94.02 85.9 4.86 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.959 0.885 . . . . 0.55000000000000004 109.747 -170.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -84.55 139.33 32.2 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.15 -1.386 . . . . 3.9700000000000002 111.783 -174.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.532 ' HG3' HD13 ' A' ' 28' ' ' ILE . 2.9 mt-30 -139.47 94.14 2.75 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.125 -0.943 . . . . 1.3500000000000001 109.145 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.68 -73.6 0.24 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.014 -0.612 . . . . 1.3300000000000001 112.547 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -139.45 1.69 1.98 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.416 0.627 . . . . 2.3300000000000001 110.388 -177.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -114.06 120.63 41.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.567 -0.742 . . . . 1.8700000000000001 109.465 -173.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.537 HD22 ' HA ' ' A' ' 100' ' ' ARG . 7.6 mp -103.09 116.62 32.86 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.103 -0.703 . . . . 2.2799999999999998 109.103 176.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.532 HD13 ' HG3' ' A' ' 23' ' ' GLN . 1.8 mp -96.01 126.5 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 115.493 -0.776 . . . . 0.80000000000000004 110.2 -172.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.464 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -103.38 109.12 20.63 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.334 -1.303 . . . . 1.74 108.041 174.037 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.671 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -77.92 43.5 2.2 Favored Glycine 0 C--O 1.216 -0.987 0 C-N-CA 121.016 -0.611 . . . . 0.68999999999999995 112.574 -175.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.601 ' HB2' ' CG2' ' A' ' 57' ' ' VAL . 40.0 p90 -159.7 147.15 16.84 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.417 -1.327 . . . . 0.51000000000000001 107.417 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.639 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -102.4 163.82 12.02 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 118.466 -1.294 . . . . 0.53000000000000003 107.605 176.184 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.532 HD12 HD21 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -154.26 139.83 10.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 119.242 -0.983 . . . . 0.48999999999999999 113.0 -168.261 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.421 ' N ' HG12 ' A' ' 33' ' ' ILE . . . -141.09 118.07 1.32 Allowed Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 109.83 -1.308 . . . . 0.71999999999999997 109.83 154.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.999 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -142.39 117.69 1.18 Allowed Glycine 0 C--N 1.302 -1.323 0 CA-C-O 118.251 -1.305 . . . . 1.4199999999999999 111.577 170.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.645 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -166.8 141.93 7.26 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 117.641 -2.219 . . . . 0.47999999999999998 113.507 175.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.439 HG23 ' HA ' ' A' ' 87' ' ' MET . 13.7 pt -61.9 -20.37 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 N-CA-C 107.363 -1.347 . . . . 0.52000000000000002 107.363 151.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.834 ' HB3' ' H ' ' A' ' 90' ' ' HIS . 3.0 t70 -59.32 -43.95 92.65 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 113.588 -1.642 . . . . 0.71999999999999997 109.759 171.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -64.05 -68.62 0.34 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.008 -0.996 . . . . 1.1899999999999999 109.967 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.442 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 0.3 OUTLIER -172.77 117.52 0.4 Allowed Pre-proline 0 N--CA 1.47 0.57 0 CA-C-O 121.652 0.739 . . . . 2.5699999999999998 111.18 169.422 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 1.1 Cg_endo -88.71 -20.92 1.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.691 2.928 . . . . 2.8199999999999998 111.651 172.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.9 t -61.16 -29.89 70.07 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.676 -1.147 . . . . 3.2599999999999998 112.18 -169.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.48 HE21 ' HB2' ' A' ' 43' ' ' GLN . 4.7 mt-30 -117.62 13.89 14.37 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.878 -0.329 . . . . 3.8799999999999999 111.002 -174.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.718 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 91.2 m-20 -147.24 34.09 0.11 Allowed Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 112.162 0.43 . . . . 5.1399999999999997 112.162 -169.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.718 ' HD3' ' N ' ' A' ' 44' ' ' ASN . 12.1 Cg_exo -70.94 -29.26 18.49 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 121.388 1.392 . . . . 3.71 110.205 -177.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -151.38 59.52 0.89 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.905 -1.517 . . . . 5.6200000000000001 106.905 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.533 ' HB2' ' HA ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -85.74 -166.4 1.51 Allowed 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 113.888 -1.505 . . . . 3.77 111.588 -173.805 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -22.12 -58.26 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 112.666 -2.061 . . . . 6.7800000000000002 115.866 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.521 ' HB3' HG22 ' A' ' 51' ' ' THR . 38.2 t70 -167.27 -124.8 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 120.55 -0.46 . . . . 5.4699999999999998 110.869 -164.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.627 ' HB3' ' HE1' ' A' ' 78' ' ' MET . 8.3 mptt -102.86 8.84 39.15 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.861 -0.792 . . . . 3.0699999999999998 108.861 173.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.521 HG22 ' HB3' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -84.37 -62.9 1.44 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.135 -1.061 . . . . 4.5599999999999996 108.135 -178.343 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.682 ' HB2' ' HE2' ' A' ' 53' ' ' LYS . 1.7 m-20 21.13 -113.0 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 O-C-N 125.211 1.569 . . . . 2.6000000000000001 113.721 170.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.802 ' HE2' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -110.69 18.4 19.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.795 -1.093 . . . . 3.48 109.682 175.134 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.12 -157.11 13.63 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 110.064 -1.214 . . . . 0.78000000000000003 110.064 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.999 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -116.5 135.06 57.98 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.145 0 N-CA-C 107.423 -1.325 . . . . 0.54000000000000004 107.423 174.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.707 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -152.49 150.53 29.71 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.052 0.842 . . . . 1.4199999999999999 111.485 -177.245 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.611 HG12 ' H ' ' A' ' 75' ' ' ASP . 10.0 p -93.5 133.58 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 114.574 -1.193 . . . . 0.57999999999999996 111.191 -169.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.639 ' O ' ' HB3' ' A' ' 32' ' ' SER . 32.6 m -123.89 70.32 1.07 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.803 -1.09 . . . . 1.1100000000000001 109.479 174.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 1.003 ' HA ' HG23 ' A' ' 73' ' ' ILE . 41.8 mtt180 151.73 177.25 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 125.47 1.508 . . . . 2.27 110.823 163.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.649 HG13 ' HB3' ' A' ' 66' ' ' ALA . 91.7 t -161.36 138.49 2.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 125.432 1.707 . . . . 0.82999999999999996 107.249 163.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.7 p -86.16 122.93 30.86 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.191 0.519 . . . . 1.6499999999999999 110.87 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -48.67 117.3 1.97 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.315 -1.311 . . . . 1.8500000000000001 111.855 171.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.15 12.3 84.75 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.656 -0.783 . . . . 0.92000000000000004 113.222 173.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.529 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -87.29 -132.63 3.63 Favored Glycine 0 C--O 1.22 -0.755 0 C-N-CA 119.942 -1.123 . . . . 0.98999999999999999 111.31 174.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.671 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 97.6 Cg_endo -101.15 -42.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.538 2.159 . . . . 0.44 115.463 177.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.649 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -64.48 -27.1 68.75 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.0 -0.546 . . . . 0.35999999999999999 111.898 -173.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -70.81 -33.34 70.6 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.652 0.739 . . . . 1.79 109.151 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -71.48 -40.37 72.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.496 -1.229 . . . . 0.51000000000000001 110.627 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.732 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -77.61 -15.59 59.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.40999999999999998 110.626 177.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.0 47.68 2.83 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.124 -1.036 . . . . 0.45000000000000001 114.123 173.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.454 HD21 HG21 ' A' ' 57' ' ' VAL . 19.7 tp -97.68 149.98 21.68 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.94 -0.763 . . . . 0.89000000000000001 108.94 176.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.773 HE22 ' HG3' ' A' ' 111' ' ' ARG . 7.6 mt-30 -122.56 33.31 5.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 114.576 1.324 . . . . 1.21 114.576 -165.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.003 HG23 ' HA ' ' A' ' 59' ' ' ARG . 56.2 mt 72.05 -1.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 113.185 0.809 . . . . 0.77000000000000002 113.185 165.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -173.08 52.23 0.16 Allowed Glycine 0 CA--C 1.509 -0.298 0 C-N-CA 120.084 -1.055 . . . . 0.37 111.999 -164.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.611 ' H ' HG12 ' A' ' 57' ' ' VAL . 43.9 m-20 -120.48 149.67 42.02 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.157 -0.521 . . . . 0.89000000000000001 110.603 -172.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.707 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -95.4 101.54 13.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.332 -0.394 . . . . 2.2000000000000002 110.593 -173.71 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.662 HD12 ' HA ' ' A' ' 56' ' ' TYR . 4.3 mt -72.72 123.01 26.55 Favored 'Isoleucine or valine' 0 C--O 1.261 1.669 0 CA-C-O 121.434 0.635 . . . . 0.48999999999999999 112.424 -175.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.917 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 4.2 mmt -89.92 -19.49 24.49 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 113.242 -1.799 . . . . 1.0600000000000001 112.286 176.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.551 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -172.39 157.21 3.99 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.184 0.438 . . . . 0.81999999999999995 112.184 -174.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.614 HG12 ' SD ' ' A' ' 85' ' ' MET . 12.3 p -141.59 122.74 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.247 0.546 . . . . 1.3100000000000001 110.712 171.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.7 m120 50.1 36.5 12.29 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.371 -0.831 . . . . 1.5 112.192 176.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.67 -18.66 49.87 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.451 -0.88 . . . . 0.38 113.244 175.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 52.9 m95 -81.84 149.39 28.34 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 109.684 -0.488 . . . . 0.77000000000000002 109.684 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -95.91 116.33 28.76 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.635 -0.711 . . . . 1.8899999999999999 111.0 -175.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.614 ' SD ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -105.8 99.36 8.96 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 122.626 1.203 . . . . 1.01 110.177 177.567 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.1 p -138.09 -44.42 0.51 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.112 -1.858 . . . . 1.05 106.765 173.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.439 ' HA ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -148.46 75.15 1.31 Allowed 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.514 -1.676 . . . . 1.6200000000000001 109.674 177.284 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.645 ' O ' ' HA2' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -140.96 154.25 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 108.779 -0.823 . . . . 1.0900000000000001 108.779 173.723 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.705 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 74.7 p -60.01 151.95 25.09 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 113.168 0.803 . . . . 0.34999999999999998 113.168 -173.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.834 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 21.5 t-160 -58.81 -40.37 83.92 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 115.74 -0.664 . . . . 0.34999999999999998 110.092 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -66.17 -31.01 71.6 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.13 -1.395 . . . . 1.6699999999999999 109.838 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.59 ' HB3' ' O ' ' A' ' 89' ' ' THR . 1.9 tp-100 -63.63 -51.81 63.57 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.677 0.751 . . . . 0.77000000000000002 109.514 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.538 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -72.54 -33.38 66.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.935 -1.029 . . . . 0.33000000000000002 109.801 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 90' ' ' HIS . 11.3 ttp180 -61.77 -48.46 80.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.2 -0.909 . . . . 2.1000000000000001 110.642 -177.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.651 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -70.52 -28.45 64.95 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 119.768 -0.773 . . . . 0.95999999999999996 110.647 -179.738 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.559 ' HD2' ' HD3' ' A' ' 95' ' ' LYS . 1.8 mmm180 -70.0 -41.66 74.07 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.196 -0.601 . . . . 3.5699999999999998 112.155 -177.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.557 ' HB3' HG21 ' A' ' 80' ' ' VAL . 3.3 pp -80.58 -25.21 38.64 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.636 -0.426 . . . . 1.6499999999999999 110.965 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.472 ' N ' HD12 ' A' ' 97' ' ' LEU . 21.5 m -153.68 95.27 1.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.442 0.639 . . . . 1.53 111.436 178.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.651 ' HB3' ' O ' ' A' ' 95' ' ' LYS . 7.0 ptpt -112.67 9.89 19.32 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.454 -0.794 . . . . 2.7200000000000002 109.118 174.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.537 ' HA ' HD22 ' A' ' 27' ' ' LEU . 11.9 mtt180 70.01 19.05 7.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.09 -1.414 . . . . 4.3799999999999999 111.904 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.6 t -137.29 9.96 2.98 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 120.623 -0.431 . . . . 2.5099999999999998 111.827 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.492 ' HB2' ' HG3' ' A' ' 20' ' ' LYS . 6.1 mm-40 -85.39 148.48 25.99 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.998 0.428 . . . . 3.3999999999999999 111.398 -177.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.547 ' HG3' HG12 ' A' ' 104' ' ' VAL . 7.3 pt-20 -95.83 -49.71 5.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.881 -0.6 . . . . 2.6800000000000002 110.702 178.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.754 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 2.6 p -143.69 142.14 25.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.166 -1.05 . . . . 0.44 108.166 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.761 HG21 ' HG2' ' A' ' 20' ' ' LYS . 42.1 t -123.3 117.85 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 CA-C-O 122.22 1.01 . . . . 0.46000000000000002 112.403 -164.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -101.16 127.32 47.78 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 112.865 -1.97 . . . . 1.76 109.954 -174.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.523 HD11 HG12 ' A' ' 77' ' ' ILE . 20.7 tp -130.87 124.4 31.12 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.915 -0.584 . . . . 1.1200000000000001 109.587 -174.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.605 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 33.9 tp -100.31 119.84 39.02 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.247 -1.761 . . . . 0.41999999999999998 106.247 176.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.705 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -126.6 150.66 32.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.239 0.542 . . . . 0.77000000000000002 109.946 -171.763 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.709 HG23 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -98.07 115.13 27.6 Favored 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 119.436 -0.906 . . . . 0.34000000000000002 109.421 168.266 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.773 ' HG3' HE22 ' A' ' 72' ' ' GLN . 7.9 ttm180 -105.39 149.23 26.3 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.384 -1.28 . . . . 2.0099999999999998 110.704 -171.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.467 HE21 HD11 ' A' ' 114' ' ' LEU . 0.9 OUTLIER -138.29 -156.22 0.67 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.352 -0.981 . . . . 1.97 108.352 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.03 72.5 8.37 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.846 0.831 . . . . 1.6200000000000001 112.223 -171.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.507 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 3.3 mt -118.55 -10.11 10.15 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.445 -1.252 . . . . 1.6499999999999999 107.734 175.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -41.15 112.99 0.35 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 112.821 -1.99 . . . . 3.5299999999999998 112.567 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -85.48 41.65 0.91 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.334 -0.848 . . . . 3.6000000000000001 110.929 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 59.83 32.19 21.17 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.824 -0.626 . . . . 3.5600000000000001 110.915 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.6 p -66.18 -10.51 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.642 -0.708 . . . . 4.9900000000000002 111.497 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -86.01 -20.16 29.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.272 -0.422 . . . . 7.7699999999999996 111.179 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 57.38 -153.56 0.37 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.183 0.516 . . . . 6.5999999999999996 111.676 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 52.9 p -138.97 179.81 6.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.614 -0.721 . . . . 8.9399999999999995 109.196 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 21.0 ptm -153.19 144.88 23.45 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.752 0.31 . . . . 12.1 110.751 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.0 mt -88.6 120.35 29.91 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.474 -0.565 . . . . 12.82 109.474 175.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.7 m . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.585 -0.721 . . . . 14.640000000000001 110.948 179.925 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ptm . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 111.596 0.221 . . . . 14.33 111.596 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 m -73.5 -19.22 60.98 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.471 0.545 . . . . 11.220000000000001 112.471 -172.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.422 ' CZ ' ' HG3' ' A' ' 5' ' ' PRO . 42.4 p90 -95.75 9.37 40.66 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.81 -0.356 . . . . 9.1899999999999995 111.144 -177.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.436 HG22 ' HD3' ' A' ' 8' ' ' PRO . 22.9 pt 35.94 88.52 0.09 OUTLIER Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 124.075 0.95 . . . . 6.6500000000000004 113.491 -177.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.422 ' HG3' ' CZ ' ' A' ' 3' ' ' TYR . 20.4 Cg_exo -64.19 -63.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.846 2.364 . . . . 7.46 111.302 -178.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.21 14.99 10.17 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.2 -1.16 . . . . 5.8899999999999997 110.2 172.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.482 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 80.1 mt-30 69.06 138.84 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 123.962 0.905 . . . . 6.3700000000000001 111.148 -176.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 7' ' ' GLN . 11.6 Cg_endo -92.78 -154.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.153 2.569 . . . . 3.3999999999999999 112.306 -177.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.1 m -95.09 4.22 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 108.388 -0.967 . . . . 2.2599999999999998 108.388 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.7 m -77.19 81.46 3.69 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 122.64 1.21 . . . . 2.0899999999999999 110.115 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.76 132.35 37.03 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 113.01 -1.905 . . . . 0.95999999999999996 108.584 170.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 p -107.23 123.45 62.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.047 -0.524 . . . . 1.5700000000000001 110.231 -173.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.983 HG12 HG23 ' A' ' 110' ' ' THR . 1.0 OUTLIER -81.33 128.2 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 121.861 0.838 . . . . 1.02 111.124 -173.564 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.869 HE22 HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -101.87 167.34 10.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.92 -1.036 . . . . 1.3899999999999999 111.172 173.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.502 ' N ' HE21 ' A' ' 14' ' ' GLN . 0.0 OUTLIER -124.82 106.83 10.33 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.688 -0.687 . . . . 3.6299999999999999 110.027 -174.109 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.869 HG23 HE22 ' A' ' 14' ' ' GLN . 1.5 t -104.78 133.19 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 109.857 -0.423 . . . . 1.02 109.857 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -137.81 126.66 23.99 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.778 -0.453 . . . . 1.3500000000000001 109.778 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 9.8 tp -142.91 161.57 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 108.239 -1.023 . . . . 0.60999999999999999 108.239 -178.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -95.2 113.09 24.73 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.822 -0.751 . . . . 0.59999999999999998 109.838 -175.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.854 ' HB2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -26.8 130.01 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 125.125 1.515 . . . . 4.0 112.341 179.544 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 36.1 tp -100.61 95.76 6.9 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 119.936 -0.705 . . . . 0.55000000000000004 109.208 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 22' ' ' ARG . 16.5 ptt180 -74.67 140.02 43.92 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.499 -0.773 . . . . 3.9700000000000002 111.54 -172.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.526 ' HB2' HD13 ' A' ' 28' ' ' ILE . 4.3 tp-100 -134.58 93.99 3.13 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.393 -0.966 . . . . 1.3500000000000001 108.393 177.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.07 -83.28 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.686 -0.768 . . . . 1.3300000000000001 111.545 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.786 ' HB3' HH11 ' A' ' 100' ' ' ARG . 30.5 mt-10 -132.38 8.24 4.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.926 0.393 . . . . 2.3300000000000001 110.572 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -109.02 166.97 10.43 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.257 -0.428 . . . . 1.8700000000000001 110.762 -173.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.994 HD23 ' HA ' ' A' ' 98' ' ' THR . 4.9 tp -119.91 122.86 42.2 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.78 -0.646 . . . . 2.2799999999999998 109.388 173.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.526 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.7 mp -98.44 113.83 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 107.66 -1.237 . . . . 0.80000000000000004 107.66 173.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.859 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.1 pt? -95.02 -15.31 23.58 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.053 -0.976 . . . . 1.74 110.833 -173.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.513 ' CA ' ' HD2' ' A' ' 65' ' ' PRO . . . 87.06 -9.65 71.66 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.45 -0.881 . . . . 0.68999999999999995 113.718 172.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.788 ' HD1' ' HB2' ' A' ' 66' ' ' ALA . 48.5 p90 -133.43 165.72 24.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.296 0.548 . . . . 0.51000000000000001 110.801 178.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.696 ' HB3' ' O ' ' A' ' 58' ' ' THR . 7.8 t -106.07 171.56 7.28 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.41 -0.589 . . . . 0.53000000000000003 109.41 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.45 HG12 ' NE2' ' A' ' 90' ' ' HIS . 5.4 tt -150.17 131.83 5.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 C-N-CA 120.564 -0.454 . . . . 0.48999999999999999 111.675 -167.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -102.97 171.66 20.94 Favored Glycine 0 C--O 1.237 0.341 0 N-CA-C 110.693 -0.963 . . . . 0.71999999999999997 110.693 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.989 ' HA3' ' NE2' ' A' ' 39' ' ' GLN . . . -114.6 169.3 12.82 Favored Glycine 0 N--CA 1.42 -2.389 0 N-CA-C 118.855 2.302 . . . . 1.4199999999999999 118.855 -160.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 88' ' ' VAL . . . -87.58 -162.14 37.53 Favored Glycine 0 N--CA 1.415 -2.726 0 CA-C-N 110.073 -3.063 . . . . 0.47999999999999998 113.5 -165.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.55 HD13 ' O ' ' A' ' 87' ' ' MET . 27.5 pt -55.88 -9.6 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.434 0.635 . . . . 0.52000000000000002 111.002 168.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 1.025 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 0.2 OUTLIER -59.92 -40.73 89.9 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.262 -0.881 . . . . 0.71999999999999997 109.629 173.424 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.989 ' NE2' ' HA3' ' A' ' 35' ' ' GLY . 28.4 mt-30 -84.03 -46.67 11.76 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 114.788 -1.096 . . . . 1.1899999999999999 110.956 -175.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -117.85 88.63 31.3 Favored Pre-proline 0 C--N 1.314 -0.976 0 CA-C-N 114.216 -1.357 . . . . 2.5699999999999998 111.063 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.01 -18.47 35.8 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.597 2.198 . . . . 2.8199999999999998 110.896 174.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.1 t -70.07 -31.74 69.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.856 -1.066 . . . . 3.2599999999999998 109.734 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -98.4 65.47 1.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.563 0.697 . . . . 3.8799999999999999 110.489 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.587 ' H ' ' HD2' ' A' ' 45' ' ' PRO . 25.8 t-20 -122.52 -47.73 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 114.997 -1.001 . . . . 5.1399999999999997 109.581 174.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.587 ' HD2' ' H ' ' A' ' 44' ' ' ASN . 29.9 Cg_endo -65.69 11.79 0.14 Allowed 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.587 1.525 . . . . 3.71 112.181 160.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.505 ' H ' ' C ' ' A' ' 44' ' ' ASN . 79.7 t80 -120.1 -27.07 5.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.98 -0.554 . . . . 5.6200000000000001 109.932 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.572 ' HA ' ' HB2' ' A' ' 52' ' ' ASP . 44.0 p -74.66 101.87 4.41 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.177 0.989 . . . . 3.77 109.266 -174.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -91.13 -29.2 17.42 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 113.908 -1.496 . . . . 6.7800000000000002 110.736 -172.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.3 t70 170.47 -151.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.444 -1.253 . . . . 5.4699999999999998 108.428 -162.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.697 ' HE3' HG21 ' A' ' 110' ' ' THR . 3.4 mppt? -72.66 -4.47 31.27 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.813 0.339 . . . . 3.0699999999999998 110.409 176.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.2 t -69.48 -36.41 76.5 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.018 -0.537 . . . . 4.5599999999999996 109.966 177.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.572 ' HB2' ' HA ' ' A' ' 47' ' ' SER . 4.9 t70 -67.19 -161.38 0.02 OUTLIER 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.486 0.66 . . . . 2.6000000000000001 109.709 163.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 53' ' ' LYS . 9.9 ptpt -97.81 -46.41 5.96 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.375 -0.375 . . . . 3.48 110.371 -178.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 52.18 -149.25 9.72 Favored Glycine 0 C--O 1.225 -0.452 0 C-N-CA 121.058 -0.591 . . . . 0.78000000000000003 111.63 -172.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.546 HG22 ' CD1' ' A' ' 77' ' ' ILE . 2.2 mp -99.93 132.39 45.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 108.347 -0.983 . . . . 0.54000000000000004 108.347 168.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.561 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -155.01 138.76 16.17 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 120.898 0.38 . . . . 1.4199999999999999 110.339 -170.369 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.575 ' CG1' ' H ' ' A' ' 75' ' ' ASP . 8.6 p -67.38 129.37 31.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.648 -0.706 . . . . 0.57999999999999996 110.484 -176.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.696 ' O ' ' HB3' ' A' ' 32' ' ' SER . 18.5 m -125.64 59.59 1.28 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.463 -0.79 . . . . 1.1100000000000001 109.896 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.624 ' HA ' HG23 ' A' ' 73' ' ' ILE . 13.9 mtt180 154.49 -179.88 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 126.084 1.754 . . . . 2.27 109.979 167.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.635 HG13 ' HB3' ' A' ' 66' ' ' ALA . 88.0 t -166.7 125.71 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 O-C-N 125.638 1.836 . . . . 0.82999999999999996 106.348 163.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.8 m -85.15 128.27 34.59 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.889 -0.725 . . . . 1.6499999999999999 109.259 174.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -65.15 106.36 1.29 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.374 -0.83 . . . . 1.8500000000000001 110.4 174.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 120.64 -21.56 8.48 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.27 -1.332 . . . . 0.92000000000000004 110.396 -173.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.502 ' O ' ' HB3' ' A' ' 67' ' ' GLU . . . -72.76 152.82 48.05 Favored Glycine 0 CA--C 1.495 -1.214 0 N-CA-C 111.384 -0.686 . . . . 0.98999999999999999 111.384 172.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.629 ' HA ' HD13 ' A' ' 68' ' ' ILE . 83.3 Cg_exo -47.13 -30.9 11.09 Favored 'Trans proline' 0 C--N 1.325 -0.659 0 C-N-CA 123.882 3.055 . . . . 0.44 114.17 -176.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.788 ' HB2' ' HD1' ' A' ' 31' ' ' PHE . . . -66.75 -26.73 67.12 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.016 -0.538 . . . . 0.35999999999999999 111.454 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 5.5 tp10 -68.36 -31.61 71.12 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.247 0.546 . . . . 1.79 109.821 174.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.629 HD13 ' HA ' ' A' ' 65' ' ' PRO . 2.7 mp -81.05 -36.78 15.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.807 -0.633 . . . . 0.51000000000000001 109.938 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.691 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -79.56 -31.79 42.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.553 -0.748 . . . . 0.40999999999999998 110.456 176.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.18 69.36 0.95 Allowed Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.442 -0.885 . . . . 0.45000000000000001 113.562 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.453 ' HB3' ' HB1' ' A' ' 66' ' ' ALA . 21.9 tp -116.05 158.32 23.33 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.738 -0.468 . . . . 0.89000000000000001 109.738 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.543 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 5.1 mt-30 -125.43 29.81 5.94 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 115.196 1.554 . . . . 1.21 115.196 -163.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.624 HG23 ' HA ' ' A' ' 59' ' ' ARG . 82.6 mt 75.97 -10.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 N-CA-C 114.621 1.341 . . . . 0.77000000000000002 114.621 165.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -166.75 52.22 0.25 Allowed Glycine 0 N--CA 1.465 0.569 0 C-N-CA 118.983 -1.579 . . . . 0.37 113.432 -165.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.575 ' H ' ' CG1' ' A' ' 57' ' ' VAL . 17.6 m-20 -122.42 147.1 46.72 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.38 -0.41 . . . . 0.89000000000000001 110.407 -172.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.561 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 1.3 mptm? -91.74 120.85 32.84 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-O 121.014 0.435 . . . . 2.2000000000000002 110.673 -176.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.692 HG12 HD11 ' A' ' 107' ' ' LEU . 5.9 mt -80.3 120.46 31.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.172 0.511 . . . . 0.48999999999999999 112.206 -170.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.998 ' HB2' ' HG ' ' A' ' 108' ' ' LEU . 11.0 mmt -88.38 -20.97 24.59 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.507 -1.224 . . . . 1.0600000000000001 111.326 177.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.581 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -171.71 157.82 4.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.988 0.423 . . . . 0.81999999999999995 111.2 -178.609 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.624 HG21 ' HG ' ' A' ' 97' ' ' LEU . 9.5 p -146.55 126.53 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.985 -0.552 . . . . 1.3100000000000001 109.778 172.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 1.0 OUTLIER 62.64 9.72 3.69 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.015 -0.539 . . . . 1.5 112.213 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.89 -10.68 27.43 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.244 -0.979 . . . . 0.38 112.485 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.416 ' CD1' ' HB3' ' A' ' 96' ' ' ARG . 81.4 m95 -82.39 143.16 31.41 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 120.819 0.342 . . . . 0.77000000000000002 110.587 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -92.06 110.88 22.25 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.235 -0.893 . . . . 1.8899999999999999 111.84 -170.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.669 ' HE3' ' HA ' ' A' ' 93' ' ' ALA . 20.6 mmt -109.35 122.19 46.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.906 -0.588 . . . . 1.01 112.227 -175.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.5 p -137.38 -72.29 0.43 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.45 0.643 . . . . 1.05 109.281 167.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.55 ' O ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -125.19 62.39 1.18 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.272 -0.876 . . . . 1.6200000000000001 109.099 177.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.563 HG21 HE21 ' A' ' 92' ' ' GLN . 3.6 p -112.34 177.32 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 108.835 -0.802 . . . . 1.0900000000000001 108.835 177.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 1.025 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 63.1 p -72.22 153.07 41.8 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 118.283 0.492 . . . . 0.34999999999999998 111.432 -177.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.892 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 23.7 t-160 -56.78 -41.6 77.94 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 121.896 0.855 . . . . 0.34999999999999998 108.928 177.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -67.25 -30.35 70.23 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.186 -1.824 . . . . 1.6699999999999999 109.855 -175.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.816 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 2.4 tp-100 -59.65 -53.38 58.66 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.378 -0.601 . . . . 0.77000000000000002 109.378 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.669 ' HA ' ' HE3' ' A' ' 85' ' ' MET . . . -74.38 -30.62 62.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.654 -0.703 . . . . 0.33000000000000002 110.297 -176.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -63.35 -47.43 82.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.424 -0.807 . . . . 2.1000000000000001 110.47 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.408 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -71.84 -41.73 67.78 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.743 -0.662 . . . . 0.95999999999999996 109.823 -174.462 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.816 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 22.4 mmt180 -69.0 -24.3 64.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.927 -0.579 . . . . 3.5699999999999998 110.271 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.624 ' HG ' HG21 ' A' ' 80' ' ' VAL . 3.8 tt -79.93 -52.47 7.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.777 -0.647 . . . . 1.6499999999999999 110.86 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.994 ' HA ' HD23 ' A' ' 27' ' ' LEU . 5.3 m -94.83 92.05 6.75 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 122.685 1.231 . . . . 1.53 110.901 -169.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.491 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 3.6 mtmt -134.95 110.65 9.24 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 112.8 -2.0 . . . . 2.7200000000000002 109.552 -177.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.786 HH11 ' HB3' ' A' ' 25' ' ' GLU . 37.6 ptt180 -67.4 5.31 0.79 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.73 -0.668 . . . . 4.3799999999999999 112.105 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 99' ' ' LYS . 3.0 p -107.73 -23.26 12.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.496 -0.32 . . . . 2.5099999999999998 111.634 -174.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.404 ' HG2' ' HB3' ' A' ' 99' ' ' LYS . 81.0 mm-40 -68.16 151.61 46.73 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.193 -0.299 . . . . 3.3999999999999999 110.193 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -97.71 -20.27 17.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.313 0.578 . . . . 2.6800000000000002 110.315 175.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.29 145.27 18.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.783 -0.644 . . . . 0.44 109.51 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 74.5 t -113.53 118.35 57.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 122.089 0.947 . . . . 0.46000000000000002 111.709 -176.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.528 ' HD3' ' H ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -99.29 134.55 41.99 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 113.619 -1.628 . . . . 1.76 110.298 -176.239 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.692 HD11 HG12 ' A' ' 77' ' ' ILE . 37.0 tp -132.86 132.33 41.98 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.199 -0.455 . . . . 1.1200000000000001 110.596 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.998 ' HG ' ' HB2' ' A' ' 78' ' ' MET . 40.1 tp -115.22 114.02 24.68 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.211 -1.774 . . . . 0.41999999999999998 106.211 171.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.698 HG12 ' HG3' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -127.26 150.38 33.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 109.991 -0.374 . . . . 0.77000000000000002 109.991 -171.331 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.983 HG23 HG12 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -95.88 121.26 37.43 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 120.32 -0.552 . . . . 0.34000000000000002 110.936 171.258 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.438 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 2.4 ttt180 -110.46 139.53 45.58 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.876 -1.056 . . . . 2.0099999999999998 110.987 -171.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.446 HE22 ' HA ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -122.63 -107.04 0.35 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.899 -0.591 . . . . 1.97 111.468 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.411 ' O ' HD23 ' A' ' 114' ' ' LEU . 13.9 t -131.91 81.08 1.95 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.635 0.731 . . . . 1.6200000000000001 110.579 -173.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.511 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 3.1 mt -133.91 -12.06 2.59 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.875 -1.057 . . . . 1.6499999999999999 109.518 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.488 ' H ' ' CD ' ' A' ' 115' ' ' GLN . 20.9 mp0 -51.2 128.79 22.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.491 -1.231 . . . . 3.5299999999999998 111.058 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.61 35.55 0.51 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.641 -0.254 . . . . 3.6000000000000001 110.471 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 58.28 34.57 24.2 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.435 0.636 . . . . 3.5600000000000001 109.995 -172.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.2 p -68.89 145.8 13.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.29 -0.868 . . . . 4.9900000000000002 110.884 -177.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -55.58 108.31 0.42 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.448 -0.797 . . . . 7.7699999999999996 111.106 174.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -98.32 108.9 21.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.108 -0.496 . . . . 6.5999999999999996 109.883 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 57.5 m -74.96 120.51 20.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.089 -0.505 . . . . 8.9399999999999995 110.411 -177.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 89.2 mtp -93.27 176.48 6.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.833 -0.621 . . . . 12.1 110.344 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.5 tp 64.0 85.39 0.14 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.519 0.676 . . . . 12.82 110.955 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.4 p . . . . . 0 C--O 1.242 0.686 0 CA-C-N 115.235 -0.893 . . . . 14.640000000000001 109.613 179.107 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.8 mtp . . . . . 0 N--CA 1.481 1.118 0 CA-C-O 120.779 0.323 . . . . 14.33 110.487 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 t -122.87 115.17 21.51 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.864 -0.421 . . . . 11.220000000000001 109.864 177.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -99.4 173.02 6.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.373 -0.376 . . . . 9.1899999999999995 110.232 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.654 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 16.9 pt -99.22 107.88 46.93 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 121.103 0.478 . . . . 6.6500000000000004 111.432 -176.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -71.52 117.11 4.98 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.645 2.23 . . . . 7.46 111.79 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.37 -24.1 15.66 Favored Glycine 0 CA--C 1.516 0.151 0 C-N-CA 121.022 -0.609 . . . . 5.8899999999999997 112.331 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 22.7 mt-30 69.39 106.42 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.327 0 C-N-CA 123.472 0.709 . . . . 6.3700000000000001 110.813 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.654 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 6.0 Cg_exo -78.5 -155.82 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 123.081 2.521 . . . . 3.3999999999999999 112.964 -176.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.7 m -95.12 -0.34 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.635 -0.712 . . . . 2.2599999999999998 109.465 -177.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.6 p -76.92 80.9 3.47 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 122.461 1.124 . . . . 2.0899999999999999 110.413 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 111' ' ' ARG . . . -88.76 177.83 6.62 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.97 -1.923 . . . . 0.95999999999999996 110.618 176.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.67 129.59 40.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.658 -0.701 . . . . 1.5700000000000001 110.169 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.555 HG22 HG23 ' A' ' 110' ' ' THR . 45.1 t -77.04 112.93 15.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.969 0.414 . . . . 1.02 111.553 -175.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.706 HE22 HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -111.41 166.6 10.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.92 -0.582 . . . . 1.3899999999999999 109.98 171.478 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -120.93 138.64 54.02 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 120.797 -1.189 . . . . 3.6299999999999999 111.302 -176.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.706 HG23 HE22 ' A' ' 14' ' ' GLN . 19.7 t -108.29 108.57 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 CA-C-N 115.325 -0.852 . . . . 1.02 109.492 177.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -122.23 111.57 17.11 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.394 -0.821 . . . . 1.3500000000000001 109.532 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.81 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 10.8 tp -134.89 147.93 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 108.817 -0.809 . . . . 0.60999999999999999 108.817 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 14.2 m-70 -78.15 105.9 9.68 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.395 -0.965 . . . . 0.59999999999999998 108.395 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.648 ' HB2' ' HB2' ' A' ' 27' ' ' LEU . 2.5 pptp? -27.34 139.89 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 O-C-N 125.376 1.672 . . . . 4.0 112.924 -175.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 43.8 tp -93.62 85.8 4.99 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 122.175 0.988 . . . . 0.55000000000000004 109.703 -171.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.602 ' HA ' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -54.41 134.41 45.72 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 113.639 -1.619 . . . . 3.9700000000000002 112.136 -175.291 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.525 ' HB2' HD13 ' A' ' 28' ' ' ILE . 6.3 tp-100 -123.78 94.5 4.25 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.501 -1.227 . . . . 1.3500000000000001 108.471 176.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.77 -84.37 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.493 -0.86 . . . . 1.3300000000000001 111.289 -173.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -129.57 6.73 5.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.199 0.523 . . . . 2.3300000000000001 110.694 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 3.8 m-80 -110.71 -177.11 3.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.697 -0.683 . . . . 1.8700000000000001 109.871 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 20' ' ' LYS . 1.6 pt? -127.73 144.78 51.06 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.202 -1.036 . . . . 2.2799999999999998 108.202 172.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.525 HD13 ' HB2' ' A' ' 23' ' ' GLN . 1.1 mp -113.24 139.96 35.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-O 121.142 0.496 . . . . 0.80000000000000004 110.711 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -101.25 127.34 47.89 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.667 -1.152 . . . . 1.74 109.144 173.013 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.749 ' HA3' ' HD2' ' A' ' 65' ' ' PRO . . . -95.08 48.8 1.96 Allowed Glycine 0 C--O 1.22 -0.731 0 C-N-CA 120.165 -1.016 . . . . 0.68999999999999995 113.154 -172.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 35.3 p90 -158.52 163.1 37.39 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.634 -0.876 . . . . 0.51000000000000001 108.634 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.582 ' HB3' ' O ' ' A' ' 58' ' ' THR . 0.1 OUTLIER -105.14 161.06 14.58 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.865 -1.161 . . . . 0.53000000000000003 107.865 170.569 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -156.72 137.32 4.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 119.107 -1.037 . . . . 0.48999999999999999 113.757 -165.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.434 ' HA2' ' NE2' ' A' ' 90' ' ' HIS . . . -146.63 118.22 1.02 Allowed Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.43 -1.068 . . . . 0.71999999999999997 110.43 156.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 1.045 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.45 117.48 1.22 Allowed Glycine 0 CA--C 1.492 -1.356 0 CA-C-O 118.641 -1.088 . . . . 1.4199999999999999 111.401 172.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.541 ' HA2' ' O ' ' A' ' 88' ' ' VAL . . . -167.29 143.25 8.12 Favored Glycine 0 C--N 1.299 -1.496 0 C-N-CA 117.929 -2.081 . . . . 0.47999999999999998 112.954 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.624 HG12 ' O ' ' A' ' 87' ' ' MET . 5.2 pt -59.89 -26.1 34.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 106.813 -1.551 . . . . 0.52000000000000002 106.813 151.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 1.003 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 6.0 t70 -53.08 -44.68 67.72 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 113.003 -1.908 . . . . 0.71999999999999997 110.752 173.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -62.32 -69.34 0.26 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.811 -1.086 . . . . 1.1899999999999999 111.668 -172.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -178.09 110.69 0.22 Allowed Pre-proline 0 N--CA 1.468 0.43 0 N-CA-C 110.257 -0.275 . . . . 2.5699999999999998 110.257 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -87.81 11.9 3.03 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 123.819 3.013 . . . . 2.8199999999999998 113.707 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.0 t -104.64 31.14 4.91 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.054 0.454 . . . . 3.2599999999999998 111.709 -169.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.459 HE21 ' HB3' ' A' ' 43' ' ' GLN . 0.8 OUTLIER -140.2 12.06 2.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.311 0.577 . . . . 3.8799999999999999 109.823 -173.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.75 HD22 ' HB2' ' A' ' 48' ' ' GLU . 6.6 p30 174.84 60.74 0.04 OUTLIER Pre-proline 0 N--CA 1.441 -0.914 0 N-CA-C 108.035 -1.098 . . . . 5.1399999999999997 108.035 -169.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.56 10.95 0.89 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.691 2.261 . . . . 3.71 112.353 -171.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -139.83 -58.44 0.56 Allowed 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 106.63 -1.618 . . . . 5.6200000000000001 106.63 173.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.663 ' HA ' ' OD1' ' A' ' 52' ' ' ASP . 1.4 m -160.7 157.1 26.46 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.924 -1.034 . . . . 3.77 109.151 173.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.75 ' HB2' HD22 ' A' ' 44' ' ' ASN . 73.3 tt0 -108.24 -28.82 9.24 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.661 0.743 . . . . 6.7800000000000002 109.512 170.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.993 ' HB3' HG22 ' A' ' 51' ' ' THR . 27.6 t70 172.95 -138.34 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 103.999 -2.593 . . . . 5.4699999999999998 103.999 -172.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.576 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 9.2 tppt? -78.36 -18.05 55.65 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.424 -0.954 . . . . 3.0699999999999998 108.424 166.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.993 HG22 ' HB3' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -64.04 -55.25 23.53 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.859 -1.064 . . . . 4.5599999999999996 110.924 -178.115 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.712 ' O ' ' HE2' ' A' ' 53' ' ' LYS . 35.6 t70 44.15 -135.3 0.56 Allowed 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.516 0.51 . . . . 2.6000000000000001 110.04 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.712 ' HE2' ' O ' ' A' ' 52' ' ' ASP . 2.1 mmpt? -109.49 49.19 0.84 Allowed 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 121.843 -0.536 . . . . 3.48 110.776 174.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -99.4 -149.2 24.04 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 110.862 -0.895 . . . . 0.78000000000000003 110.862 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.045 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 1.8 mp -114.76 138.39 45.08 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 109.018 -0.734 . . . . 0.54000000000000004 109.018 174.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.591 ' HA ' HD12 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -142.94 140.04 30.95 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 119.185 0.902 . . . . 1.4199999999999999 110.405 -176.23 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.68 HG12 ' H ' ' A' ' 75' ' ' ASP . 8.8 p -82.92 138.84 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 CA-C-N 114.623 -1.172 . . . . 0.57999999999999996 110.056 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.655 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 23.5 m -127.98 68.55 1.33 Allowed 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.153 -0.931 . . . . 1.1100000000000001 109.33 172.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.49 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 24.1 mtp180 148.54 -171.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.637 1.575 . . . . 2.27 111.001 162.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.582 HG13 ' HB3' ' A' ' 66' ' ' ALA . 58.4 t -162.14 143.5 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 125.543 1.777 . . . . 0.82999999999999996 107.622 164.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.3 p -86.65 133.84 33.66 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.611 0.719 . . . . 1.6499999999999999 110.88 175.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -71.45 105.62 3.64 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.195 -1.366 . . . . 1.8500000000000001 111.055 178.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.21 9.65 50.74 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 119.764 -1.208 . . . . 0.92000000000000004 113.093 176.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.606 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -90.18 -140.05 8.08 Favored Glycine 0 C--O 1.217 -0.938 0 C-N-CA 120.279 -0.962 . . . . 0.98999999999999999 111.082 175.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.749 ' HD2' ' HA3' ' A' ' 30' ' ' GLY . 66.0 Cg_endo -98.26 -32.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 122.475 2.116 . . . . 0.44 114.525 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.582 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -71.99 -22.83 61.37 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.906 -0.588 . . . . 0.35999999999999999 111.727 -174.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -71.96 -30.92 65.78 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.626 -0.879 . . . . 1.79 108.626 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.606 HD13 ' O ' ' A' ' 64' ' ' GLY . 1.4 mp -81.57 -44.18 20.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.539 -1.21 . . . . 0.51000000000000001 110.41 -176.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.81 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . . . -68.25 -26.4 65.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.936 -0.575 . . . . 0.40999999999999998 110.31 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.08 70.03 1.01 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.368 -0.92 . . . . 0.45000000000000001 113.278 177.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.565 HD21 HG21 ' A' ' 57' ' ' VAL . 13.9 tp -113.75 153.52 28.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.192 -0.669 . . . . 0.89000000000000001 109.192 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.678 HE22 ' HG3' ' A' ' 111' ' ' ARG . 12.3 mt-30 -123.65 29.36 6.6 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 114.83 1.419 . . . . 1.21 114.83 -166.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.655 ' O ' ' HA ' ' A' ' 58' ' ' THR . 2.9 mp 72.06 -12.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 N-CA-C 113.418 0.895 . . . . 0.77000000000000002 113.418 171.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 57' ' ' VAL . . . -164.31 60.89 0.25 Allowed Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.225 -0.988 . . . . 0.37 111.407 -165.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.68 ' H ' HG12 ' A' ' 57' ' ' VAL . 17.4 m-20 -123.09 153.26 40.16 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.015 -0.593 . . . . 0.89000000000000001 109.593 -169.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.796 ' HG2' ' HA ' ' A' ' 51' ' ' THR . 6.8 mptt -104.09 100.31 10.06 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.125 -0.63 . . . . 2.2000000000000002 109.77 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.991 HG13 HG23 ' A' ' 109' ' ' VAL . 4.8 mp -75.0 128.91 37.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.55 -0.75 . . . . 0.48999999999999999 110.053 -175.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.48 ' HE3' ' HB2' ' A' ' 78' ' ' MET . 0.0 OUTLIER -114.02 4.6 15.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 112.863 0.69 . . . . 1.0600000000000001 112.863 -179.067 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.568 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 2.2 tt0 -172.11 152.38 2.86 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 122.442 -0.161 . . . . 0.81999999999999995 111.095 176.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.786 HG21 ' HB3' ' A' ' 97' ' ' LEU . 7.0 p -150.06 130.81 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 121.237 0.541 . . . . 1.3100000000000001 111.317 175.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.515 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 14.3 m120 50.37 34.3 8.87 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.149 0.979 . . . . 1.5 112.787 176.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.32 3.62 64.95 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.482 -0.866 . . . . 0.38 113.24 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -99.74 161.61 13.51 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 109.524 -0.547 . . . . 0.77000000000000002 109.524 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -110.69 97.78 7.11 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.45 -0.795 . . . . 1.8899999999999999 110.082 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.776 ' HB2' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -107.45 98.15 7.8 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 122.151 0.977 . . . . 1.01 109.731 174.359 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.18 -10.57 13.85 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.982 -1.463 . . . . 1.05 107.841 175.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.624 ' O ' HG12 ' A' ' 37' ' ' ILE . 1.9 mtt -149.89 -42.29 0.13 Allowed 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 112.543 -2.117 . . . . 1.6200000000000001 108.905 -171.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.63 ' O ' HD11 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -22.68 141.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 C-N-CA 126.249 1.82 . . . . 1.0900000000000001 115.711 -177.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 1.003 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 49.7 p -58.17 154.1 13.72 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 112.475 0.546 . . . . 0.34999999999999998 112.475 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.773 ' H ' ' HB3' ' A' ' 38' ' ' ASP . 22.1 t-160 -56.27 -44.42 79.74 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 115.988 -0.551 . . . . 0.34999999999999998 110.66 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.8 -31.76 68.61 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.13 -0.941 . . . . 1.6699999999999999 110.139 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.784 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.7 OUTLIER -64.36 -49.69 70.65 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.78 -0.822 . . . . 0.77000000000000002 108.78 -178.68 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.619 ' CB ' HG12 ' A' ' 55' ' ' ILE . . . -74.13 -32.88 63.35 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.709 -0.678 . . . . 0.33000000000000002 110.528 -177.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.525 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 35.1 ttp180 -64.16 -44.58 91.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 2.1000000000000001 109.991 177.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.449 ' C ' ' HD3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -67.02 -36.29 81.79 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.688 -0.687 . . . . 0.95999999999999996 109.481 -178.609 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.784 ' HG2' ' O ' ' A' ' 92' ' ' GLN . 22.7 mmt180 -70.96 -23.9 62.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.988 -0.551 . . . . 3.5699999999999998 111.193 -176.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.786 ' HB3' HG21 ' A' ' 80' ' ' VAL . 3.4 pp -94.41 -15.09 24.6 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.964 -0.294 . . . . 1.6499999999999999 110.901 177.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.2 m -111.53 89.47 3.06 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.866 0.841 . . . . 1.53 110.888 -175.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.438 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 12.1 mtmt -136.7 103.99 5.39 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.476 -1.238 . . . . 2.7200000000000002 109.548 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.479 ' CB ' ' HA ' ' A' ' 26' ' ' ASN . 38.1 ptt180 -76.11 53.65 0.81 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.479 0.657 . . . . 4.3799999999999999 111.072 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.0 t -140.41 -51.43 0.48 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.533 -0.758 . . . . 2.5099999999999998 110.201 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 41.5 mt-10 -69.09 150.8 47.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.832 0.348 . . . . 3.3999999999999999 111.303 -177.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.473 ' HA ' ' NZ ' ' A' ' 20' ' ' LYS . 10.3 pt-20 -84.83 -15.46 44.71 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.834 0.679 . . . . 2.6800000000000002 112.834 -174.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.66 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 5.7 p -149.13 149.28 15.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.868 0.365 . . . . 0.44 110.274 -172.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.611 HG23 ' HB3' ' A' ' 20' ' ' LYS . 44.2 t -120.72 118.83 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 121.906 0.86 . . . . 0.46000000000000002 111.523 -173.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.515 ' HB2' ' HA ' ' A' ' 81' ' ' ASN . 0.8 OUTLIER -99.75 125.18 45.6 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.593 -1.639 . . . . 1.76 110.385 -175.164 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.464 HD22 ' HB ' ' A' ' 16' ' ' VAL . 10.1 tt -133.73 128.09 34.18 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.547 -0.297 . . . . 1.1200000000000001 110.229 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 79' ' ' GLN . 9.8 tp -101.37 114.27 28.12 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 107.347 -1.353 . . . . 0.41999999999999998 107.347 174.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.991 HG23 HG13 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -111.37 150.29 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 CA-C-O 121.522 0.677 . . . . 0.77000000000000002 109.665 -175.382 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.557 HG21 ' HG2' ' A' ' 50' ' ' LYS . 1.3 m -97.35 113.48 25.13 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 118.512 -1.275 . . . . 0.34000000000000002 108.748 167.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.678 ' HG3' HE22 ' A' ' 72' ' ' GLN . 1.0 OUTLIER -91.9 153.9 19.2 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.14 -1.391 . . . . 2.0099999999999998 109.951 -173.257 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.469 ' N ' ' HG2' ' A' ' 111' ' ' ARG . 0.1 OUTLIER -125.1 -95.16 0.47 Allowed 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.692 -0.403 . . . . 1.97 111.675 -177.509 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.401 ' H ' ' CG ' ' A' ' 112' ' ' GLN . 9.0 t -149.78 38.33 0.75 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.645 0.736 . . . . 1.6200000000000001 110.764 -170.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.491 ' HB2' ' HB3' ' A' ' 72' ' ' GLN . 6.3 mt -106.28 -25.28 12.02 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.21 -0.905 . . . . 1.6499999999999999 109.225 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.451 ' NE2' ' HA ' ' A' ' 115' ' ' GLN . 4.7 mm-40 -57.95 152.67 15.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.365 -1.288 . . . . 3.5299999999999998 110.727 173.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -86.97 26.0 1.22 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.383 -0.371 . . . . 3.6000000000000001 111.03 -173.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 62.68 21.5 12.77 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.643 -0.708 . . . . 3.5600000000000001 111.665 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 13.7 p -81.43 136.34 23.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.075 -0.511 . . . . 4.9900000000000002 111.551 -175.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 64.49 -90.18 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.174 -0.921 . . . . 7.7699999999999996 111.909 177.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 53.52 54.7 9.66 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 122.884 0.473 . . . . 6.5999999999999996 111.396 -177.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 73.6 m -76.16 75.09 3.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.088 0.47 . . . . 8.9399999999999995 111.339 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 74.9 mmm -151.1 150.44 30.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.598 -0.728 . . . . 12.1 109.905 177.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.4 mt -111.76 153.18 26.91 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.739 -0.467 . . . . 12.82 109.739 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.3 m . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.606 -0.712 . . . . 14.640000000000001 109.685 -178.722 . . . . . . . . 0 0 . 1 stop_ save_